PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lavrov, AV; Ustaeva, OA; Adilgereeva, EP; Smirnikhina, SA; Chelysheva, EY; Shukhov, OA; Shatokhin, YV; Mordanov, SV; Turkina, AG; Kutsev, SI				Lavrov, Alexander V.; Ustaeva, Oksana A.; Adilgereeva, Elmira P.; Smirnikhina, Svetlana A.; Chelysheva, Ekaterina Y.; Shukhov, Oleg A.; Shatokhin, Yuriy V.; Mordanov, Sergey V.; Turkina, Anna G.; Kutsev, Sergey I.			Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia	PLOS ONE			English	Article							GENE POLYMORPHISMS; IMATINIB TREATMENT; EXPRESSION; GSTT1; GSTM1; RISK; PHARMACOKINETICS; SUSCEPTIBILITY; TRANSPORTERS; RESISTANT	Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by the presence of BCR/ABL fusion gene in leukemic cells, which promotes uncontrolled cell proliferation. Up to 20% of CML patients show primary resistance or non-optimal response to tyrosine kinase inhibitor (TKI) therapy. We investigated the association between copy number variation (CNV) in glutathione S-transferases (GST) and cytochromes (CYP) and the response rate to TKI. We enrolled 47 patients with CML: 31 with an optimal response and 16 with failure at 6 months in accordance with European LeukemiaNet 2013 recommendations. CNV detection was performed using SALSA MLPA P128-C1 Cytochrome P450 probe mix. Patients with optimal response and with failure of TKI therapy showed different frequencies of wild type and mutated CYPs and GST (p<0.0013). Validation in the group of 15 patients proved high prognostic value (p = 0.02): positive and negative predictive value 83% and 78%; sensitivity and specificity 71% and 88%. Wild type genotypes of CYP and GST associate with a worse response to TKI treatment in CML patients. This test can be recommended for further clinical trials.	[Lavrov, Alexander V.; Adilgereeva, Elmira P.; Smirnikhina, Svetlana A.; Kutsev, Sergey I.] Res Ctr Med Genet, Fed State Budgetary Inst, Lab Mutagenesis, Moscow, Russia; [Lavrov, Alexander V.; Kutsev, Sergey I.] Russian Natl Res Med Univ, State Budgetary Educ Inst Higher Profess Educ, Dept Mol & Cellular Genet, Moscow, Russia; [Ustaeva, Oksana A.; Shatokhin, Yuriy V.; Mordanov, Sergey V.] Rostov State Med Univ, Lab Med Genet, Rostov Na Donu, Russia; [Chelysheva, Ekaterina Y.; Shukhov, Oleg A.; Turkina, Anna G.] Minist Healthcare Russian Federat, Natl Res Ctr Hematol, Fed State Funded Inst, Sci & Advisory Dept Chemotherapy Myeloproliferat, Moscow, Russia	Research Centre for Medical Genetics; Pirogov Russian National Research Medical University; Rostov State Medical University; Russian Academy of Medical Sciences; National Medical Research Center for Hematology	Lavrov, AV (corresponding author), Res Ctr Med Genet, Fed State Budgetary Inst, Lab Mutagenesis, Moscow, Russia.; Lavrov, AV (corresponding author), Russian Natl Res Med Univ, State Budgetary Educ Inst Higher Profess Educ, Dept Mol & Cellular Genet, Moscow, Russia.	alexandervlavrov@gmail.com	Kutsev, Sergey I/L-3633-2018; Turkina, Anna/GQP-6907-2022; Mordanov, Sergey/O-9226-2015; Smirnikhina, Svetlana/A-9637-2016	Kutsev, Sergey I/0000-0002-3133-8018; Adil'gereeva, El'mira/0000-0002-6440-0500; Smirnikhina, Svetlana/0000-0002-1558-3048	Russian Ministry of Education and Science [8113]	Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation)	This work was supported by Russian Ministry of Education and Science (agreement # 8113 from 28/08/2012). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini S, 2013, HAEMATOLOGICA, V98, P193, DOI 10.3324/haematol.2012.066480; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Ben Hassine I, 2017, CANCER CHEMOTH PHARM, V79, P737, DOI 10.1007/s00280-017-3266-0; Bixby D, 2011, LEUKEMIA, V25, P7, DOI 10.1038/leu.2010.238; Das P, 2009, LEUKEMIA LYMPHOMA, V50, P1345, DOI 10.1080/10428190903003236; Davies A, 2014, CLIN PHARMACOL THER, V96, P694, DOI 10.1038/clpt.2014.176; de Lima LT, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0851-5; Dinama O, 2014, AUST NZ J PSYCHIAT, V48, P778, DOI 10.1177/0004867413520050; Frank O, 2006, LEUKEMIA, V20, P1400, DOI 10.1038/sj.leu.2404270; Gromicho M, 2013, ONCOL REP, V29, P741, DOI 10.3892/or.2012.2153; Harrach S, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.79; He HR, 2014, JPN J CLIN ONCOL, V44, P1070, DOI 10.1093/jjco/hyu121; Hoffmann VS, 2015, LEUKEMIA, V29, P1336, DOI 10.1038/leu.2015.73; Hoglund M., 2015, Annals of Hematology, V94, P241, DOI 10.1007/s00277-015-2314-2; Joseph T, 2004, PEDIATR BLOOD CANCER, V43, P560, DOI 10.1002/pbc.20074; Kassogue Y, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0047-z; Koh Y, 2010, CANCER GENET CYTOGEN, V203, P215, DOI 10.1016/j.cancergencyto.2010.08.022; Lavrov AV, 2016, BMC GENET, V17, DOI 10.1186/s12863-015-0308-7; Maddin N, 2016, ONCOL THER, V4, P303, DOI 10.1007/s40487-016-0035-x; Mitchell B, 2011, LEUKEMIA LYMPHOMA, V52, P4, DOI 10.3109/10428194.2010.546916; Ogu C C, 2000, Proc (Bayl Univ Med Cent), V13, P421; Peng B, 2005, CLIN PHARMACOKINET, V44, P879, DOI 10.2165/00003088-200544090-00001; Quintes-Cardama A, 2009, CANCER CONTROL, V16, P122, DOI 10.1177/107327480901600204; San Jose-Eneriz E, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-69; Jose-Eneriz ES, 2009, EUR J CANCER, V45, P1877, DOI 10.1016/j.ejca.2009.04.005; Seong SJ, 2013, ANN ONCOL, V24, P756, DOI 10.1093/annonc/mds532; Shukhov O, 2016, HAEMATOLOGICA, V101, P744; Shuvaev V, 2016, HAEMATOLOGICA, V101, P835; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smahelova J, 2017, ONCOL REP, V37, P547, DOI 10.3892/or.2016.5226; Smirnikhina SA, 2016, LEUKEMIA LYMPHOMA, V57, P1669, DOI 10.3109/10428194.2015.1132420; Steinberg DM, 2009, BIOSTATISTICS, V10, P94, DOI 10.1093/biostatistics/kxn018; Voso MT, 2002, BLOOD, V100, P2703, DOI 10.1182/blood.V100.8.2703; Wang YF, 2008, BRIT J CLIN PHARMACO, V65, P885, DOI 10.1111/j.1365-2125.2008.03150.x; Ye Z, 2005, EUR J CANCER, V41, P980, DOI 10.1016/j.ejca.2005.01.014; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	36	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0182901	10.1371/journal.pone.0182901	http://dx.doi.org/10.1371/journal.pone.0182901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902850	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200007
J	Paluh, DJ; Bauer, AM				Paluh, Daniel J.; Bauer, Aaron M.			Comparative skull anatomy of terrestrial and crevice-dwelling Trachylepis skinks (Squamata: Scincidae) with a survey of resources in scincid cranial osteology	PLOS ONE			English	Article							HEAD SHAPE; LIZARD; PERFORMANCE; REPTILIA; KINESIS; CLASSIFICATION; CONVERGENCE; SYSTEMATICS; EVOLUTION; EUMECES	Skinks account for more than 25% of all lizard species; however, representatives of fewer than a quarter of all species have been characterized osteologically. All but a few of the available cranial descriptions concentrate solely on characters that can be seen externally on the intact skull. Mabuyid skinks of the genus Trachylepis are the dominant, fully limbed skinks in Sub-Saharan Africa, and nearly all species have the same generalized body plan. Although a few rock crevice-dwelling species possess slight body depression, extreme dorsoventral depression is observed only in Trachylepis laevis. We investigated the detailed skull anatomy of three Trachylepis skinks (T. laevis, T. sulcata, and T. gonwouoi, a recently described species allied to T. affinis) using high-resolution X-ray micro-computed tomography. Our goals were to review the scincid cranial osteology literature in a phylogenetic context, provide a detailed anatomical atlas for the mabuyid lineage, and investigate the morphological adaptations of the highly modified T. laevis. Our results demonstrate that there is significant morphological variation between these three taxa, including the loss and fusion of structures, as well as changes in the shape, scale, and relationship between individual elements. Trachylepis laevis possesses several osteological modifications that have produced a reducton in head depth that are likely functional consequences of extreme rupi-colous habits, including a flat skull roof, many strongly recumbent elements, and a depressed neurocranium. We hypothesize these modifications may correspond to descreased bite force and increased capabilities of cranial kinesis. Our study is the first element-by-element description of a skink using computed tomography technology.	[Paluh, Daniel J.; Bauer, Aaron M.] Villanova Univ, Dept Biol, Villanova, PA 19085 USA; [Paluh, Daniel J.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Paluh, Daniel J.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	Villanova University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Paluh, DJ (corresponding author), Villanova Univ, Dept Biol, Villanova, PA 19085 USA.; Paluh, DJ (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.; Paluh, DJ (corresponding author), Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA.	dpaluh@ufl.edu; aaron.bauer@villanova.edu	Paluh, Daniel/ABB-7618-2021	Paluh, Daniel/0000-0003-3506-2669	NIH [1S100D012287]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012287] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Imaging data was acquired through the Cornell University Biotechnology Resource Center, with NIH 1S100D012287 funding for the ZEISS-Xradia Versa 520 X-ray Microscope. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Imaging data was acquired through the Cornell University Biotechnology Resource Center, with NIH 1S100D012287 funding for the ZEISS-Xradia Versa 520 X-ray Microscope. We thank Jens Vindum (California Academy of Sciences), Jack W. Sites, Jr., Luke J. Welton (Brigham Young University), and Katie E. Allen (University of Kansas) for access to museum materials used in this study. We thank Dr. Hongyu Yi and one anonymous reviewer for helpful comments that improved the manuscript.	Allen KE, 2017, ZOOTAXA, V4268, P255, DOI 10.11646/zootaxa.4268.2.5; Arnold EN, 1998, EVOL BIOL, V30, P323; Baird IL, 1970, BIOL REPTILIA, V2, P263; Bell CJ, 2014, ANAT REC, V297, P344, DOI 10.1002/ar.22852; Bell CJ, 2003, ZOOL J LINN SOC-LOND, V139, P283, DOI 10.1046/j.1096-3642.2003.00077.x; Bever GS, 2005, PALAEONTOL ELECTRON, V8; Blom MPK, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0181; Branch B., 1998, FIELD GUIDE SNAKES O; Camp CL, 1923, B AM MUS NAT HIST, V48, P289; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Conrad JL, 2004, ZOOL J LINN SOC-LOND, V141, P399, DOI 10.1111/j.1096-3642.2004.00128.x; Cuvier G, 1824, RECHERCHES OSSEMENTS, V5; Daza J.D., 2015, ALL ANIMALS ARE INTE, P303; Daza JD, 2008, J MORPHOL, V269, P1340, DOI 10.1002/jmor.10664; Daza JD, 2012, ACTA ZOOL-STOCKHOLM, V93, P465, DOI 10.1111/j.1463-6395.2011.00521.x; de Vree F., 1989, Progress in Zoology, V35, P115; EL-TOUB1 M. R., 1959, JOUR MORPHOL, V105, P55, DOI 10.1002/jmor.1051050104; Estes R., 1988, P119; Evans Susan E., 2008, Contributions to Herpetology, V23, P1; FRAZZETTA TH, 1962, J MORPHOL, V111, P287, DOI 10.1002/jmor.1051110306; Gamble T, 2011, ZOOL J LINN SOC-LOND, V163, P1244, DOI 10.1111/j.1096-3642.2011.00741.x; GANS C, 1961, AM ZOOL, V1, P217; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Gelnaw WB., 2011, THESIS; GREER A E, 1979, Records of the Australian Museum, V32, P321; GREER A E, 1983, Records of the Australian Museum, V35, P29; GREER A E, 1970, Bulletin of the Museum of Comparative Zoology, V140, P1; GREER A E, 1968, Breviora, V302, P1; GREER A E, 1970, Bulletin of the Museum of Comparative Zoology, V139, P151; GREER A E, 1979, Records of the Australian Museum, V32, P339; Greer A.E., 1989, BIOL EVOLUTION AUSTR; Greer A.E. Jr., 1974, Australian J Zool, VNo. 31, P1; GREER AE, 1976, J NAT HIST, V10, P691, DOI 10.1080/00222937600770551; GREER AE, 1986, J HERPETOL, V20, P123, DOI 10.2307/1564144; GREER AE, 1977, J NAT HIST, V11, P515, DOI 10.1080/00222937700770451; Greer AE, 1967, EUMECIA BREVIORA, V276, P1; Greer AE, 1970, DASIA BREVIORA, V348, P1; GREER ALLEN E., 1967, BREVIORA, V267, P1; Hedges SB, 2014, ZOOTAXA, V3765, P317, DOI 10.11646/zootaxa.3765.4.2; Herrel A, 2000, J EXP BIOL, V203, P1415; Herrel A, 2001, J EXP ZOOL, V290, P101, DOI 10.1002/jez.1039; Herrel A, 2007, INTEGR COMP BIOL, V47, P107, DOI 10.1093/icb/icm014; HIKIDA T, 1978, Japanese Journal of Herpetology, V7, P56; Hollenshead Marci G., 2011, Records of the Western Australian Museum, V26, P138; Jerez Adriana, 2015, Acta Zool. Mex, V31, P391; Jerez Adriana, 2012, Actu Biol, V34, P207; JOLLIE M. T., 1960, ACTA ZOOL [STOCKHOLM], V41, P1; Jones MEH, 2011, PALAEONTOL ELECTRON, V14; Lambert SM, 2015, MOL PHYLOGENET EVOL, V82, P146, DOI 10.1016/j.ympev.2014.10.004; Lappin AK, 2006, BIOL J LINN SOC, V88, P215, DOI 10.1111/j.1095-8312.2006.00615.x; Linkem CW, 2016, SYST BIOL, V65, P465, DOI 10.1093/sysbio/syw001; LOURYAN S, 1989, ANN SOC ROY ZOOL BEL, V119, P47; Masterson Gavin, 2014, Suricata, V1, P267; McBrayer LD, 2004, ZOOL J LINN SOC-LOND, V140, P403, DOI 10.1111/j.1096-3642.2003.00106.x; McDOWELL SAMUEL BOOKER, 1954, BULL AMER MUS NAT HIST, V105, P1; Metzger K., 2002, TOPICS FUNCTIONAL EC, P15; Metzger KA, 2005, BIOL J LINN SOC, V86, P433, DOI 10.1111/j.1095-8312.2005.00546.x; MOHAMMED M B, 1988, Qatar University Science Bulletin, V8, P117; Mohammed M.B.H., 1991, Journal of the Egyptian German Society of Zoology, V3, P25; Oelrich T. M., 1956, Miscellaneous Publications Museum of Zoology University of Michigan, V94, P1; Olori JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032450; Pearson HS, 1921, J ANAT, V56, P20; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Revell LJ, 2007, EVOLUTION, V61, P2898, DOI 10.1111/j.1558-5646.2007.00225.x; Rice EL, 1920, J MORPHOL, V34, P119; RIEPPEL O, 1984, ZOOL J LINN SOC-LOND, V82, P291, DOI 10.1111/j.1096-3642.1984.tb00645.x; Rieppel O, 1980, PHYLOGENY ANGUIMORPH; SHEA G M, 1990, Memoirs of the Queensland Museum, V29, P495; Siebenrock R, 1892, ANN NATURHIST HOFMUS, V7, P163; SKINNER M M, 1973, Annale Universiteit van Stellenbosch Serie A, V48, P1; STEYN W., 1965, CIMBEBASIA, V12, P2; Tol P., 2012, SRONEPSTN09002; Travassos H, 1946, MABUYA PUNCTATA, V60, P1; Uetz P., 2020, REPTILE DATABASE; WEVER EG, 1973, J EXP ZOOL, V183, P225, DOI 10.1002/jez.1401830211; WINESKI LE, 1984, J MORPHOL, V181, P271, DOI 10.1002/jmor.1051810303	76	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184414	10.1371/journal.pone.0184414	http://dx.doi.org/10.1371/journal.pone.0184414			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902864	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200036
J	Rajkumar, R; Kops, ER; Mauler, J; Tellmann, L; Lerche, C; Herzog, H; Shah, NJ; Neuner, I				Rajkumar, Ravichandran; Kops, Elena Rota; Mauler, Joerg; Tellmann, Lutz; Lerche, Christoph; Herzog, Hans; Shah, N. Jon; Neuner, Irene			Simultaneous trimodal PET-MR- EEG imaging: Do EEG caps generate artefacts in PET images?	PLOS ONE			English	Article							BRAIN; ELECTRODES; SCANNER	Trimodal simultaneous acquisition of positron emission tomography (PET), magnetic resonance imaging (MRI), and electroencephalography (EEG) has become feasible due to the development of hybrid PET-MR scanners. To capture the temporal dynamics of neuronal activation on a millisecond-by-millisecond basis, an EEG system is appended to the quantitative high resolution PET-MR imaging modality already established in our institute. One of the major difficulties associated with the development of simultaneous trimodal acquisition is that the components traditionally used in each modality can cause interferences in its counterpart. The mutual interferences of MRI components and PET components on PET and MR images, and the influence of EEG electrodes on functional MRI images have been studied and reported on. Building on this, this study aims to investigate the influence of the EEG cap on the quality and quantification of PET images acquired during simultaneous PET-MR measurements. A preliminary transmission scan study on the ECAT HR+ scanner, using an Iida phantom, showed visible attenuation effect due to the EEG cap. The Brain-PET-MR emission images of the Iida phantom with [(18) F]Fluordeoxyglucose, as well as of human subjects with the EEG cap, did not show significant effects of the EEG cap, even though the applied attenuation correction did not take into account the attenuation of the EEG cap itself.	[Rajkumar, Ravichandran; Kops, Elena Rota; Mauler, Joerg; Tellmann, Lutz; Lerche, Christoph; Herzog, Hans; Shah, N. Jon; Neuner, Irene] Forschungszentrum Juelich, Inst Neurosci & Med INM4 4, Julich, Germany; [Rajkumar, Ravichandran; Neuner, Irene] Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Rajkumar, Ravichandran; Shah, N. Jon; Neuner, Irene] JARA BRAIN Translat Med, Julich, Germany; [Shah, N. Jon] Rhein Westfal TH Aachen, Dept Neurol, Aachen, Germany; [Shah, N. Jon] Monash Univ, Sch Psychol Sci, Dept Elect & Comp Syst Engn, Melbourne, Vic, Australia; [Shah, N. Jon] Monash Univ, Sch Psychol Sci, Monash Biomed Imaging, Melbourne, Vic, Australia	Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University; Monash University; Monash University	Neuner, I (corresponding author), Forschungszentrum Juelich, Inst Neurosci & Med INM4 4, Julich, Germany.; Neuner, I (corresponding author), Rhein Westfal TH Aachen, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany.; Neuner, I (corresponding author), JARA BRAIN Translat Med, Julich, Germany.	i.neuner@fz-juelich.de	Rajkumar, Ravichandran/AAA-8998-2019; Shah, N. Jon/H-5849-2013	Rajkumar, Ravichandran/0000-0001-5875-5316; Shah, N. Jon/0000-0002-8151-6169; Lerche, Christoph/0000-0003-2749-2108; Tellmann, Lutz/0000-0002-1154-2847; Neuner, Irene/0000-0002-5164-8873	EU-FP7 [602621]	EU-FP7(European Commission)	This trimodal imaging approach was supported by the EU-FP7 funded project TRIMAGE (Nr. 602621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is part of the doctoral thesis (Dr. rer. medic.) of Ravichandran Rajkumar at the Medical Faculty of the RWTH Aachen University, Germany. We gratefully thank Dr. Jorge Arrubla for assistance in trimodal human data acquisition. We thank Andrea Muren, Cornelia Frey, Silke Frensch, and Suzanne Schaden for their technical assistance. We appreciate Mrs. Claire Rick for proof reading the manuscript. This study was in part supported by the EU FP7 funded project TRIMAGE (Nr. 602621).	Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Bonmassar G, 2001, HUM BRAIN MAPP, V14, P108, DOI 10.1002/hbm.1045; Brix G, 1997, J NUCL MED, V38, P1614; BUSHBY KMD, 1992, ARCH DIS CHILD, V67, P1286, DOI 10.1136/adc.67.10.1286; Gosseries Olivia, 2016, Open Neuroimag J, V10, P52, DOI 10.2174/1874440001610010052; Hampel H, 2002, J NEURAL TRANSM, V109, P837, DOI 10.1007/s007020200069; Herzog H, 2011, NUKLEARMED-NUCL MED, V50, P74, DOI 10.3413/Nukmed-0347-10-09; Herzog H, 2012, Z MED PHYS, V22, P281, DOI 10.1016/j.zemedi.2012.07.003; Iida H, 2013, ANN NUCL MED, V27, P25, DOI 10.1007/s12149-012-0655-7; Kops ER, 2015, IEEE T NUCL SCI, V62, P2115, DOI 10.1109/TNS.2015.2452574; Laruelle M, 1997, SYNAPSE, V25, P1, DOI 10.1002/(SICI)1098-2396(199701)25:1<1::AID-SYN1>3.0.CO;2-H; Lemmens C, 2008, PHYS MED BIOL, V53, P4417, DOI 10.1088/0031-9155/53/16/013; Lindgren KA, 1999, BIOL PSYCHIAT, V45, P943, DOI 10.1016/S0006-3223(98)00350-3; Liu S., 2015, BRAIN INFORM, V2, P167, DOI [10.1007/s40708-015-0019-x, DOI 10.1007/S40708-015-0019-X]; Neuner I, 2013, NEUROIMAGE; Neuner I, 2016, PSMR 2016 5 C PET MR; Neuner Irene, 2015, EJNMMI Phys, V2, pA71, DOI 10.1186/2197-7364-2-S1-A71; O'Halloran R, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00063; Oakes TR, 2004, HUM BRAIN MAPP, V21, P257, DOI 10.1002/hbm.20004; Pizzagalli DA, 2003, PSYCHOPHYSIOLOGY, V40, P939, DOI 10.1111/1469-8986.00112; Polikar R, 2010, IEEE ENG MED BIO, P6058, DOI 10.1109/IEMBS.2010.5627621; Scheins JJ, 2011, IEEE T MED IMAGING, V30, P879, DOI 10.1109/TMI.2011.2109732; Schlemmer HPW, 2008, RADIOLOGY, V248, P1028, DOI 10.1148/radiol.2483071927; Schreckenberger M, 2004, NEUROIMAGE, V22, P637, DOI 10.1016/j.neuroimage.2004.01.047; Shah NJ, 2013, J MAGN RESON, V229, P101, DOI 10.1016/j.jmr.2012.11.027; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Struck AF, 2011, EPILEPSY BEHAV, V22, P293, DOI 10.1016/j.yebeh.2011.06.022; Tellmann L, 2011, MED PHYS, V38, P2795, DOI 10.1118/1.3582699; Uludag K, 2014, NEUROIMAGE, V102, P3, DOI 10.1016/j.neuroimage.2014.05.018; Villien M, 2014, NEUROIMAGE, V100, P192, DOI 10.1016/j.neuroimage.2014.06.025; Weirich C, 2012, IEEE T MED IMAGING, V31, P1372, DOI 10.1109/TMI.2012.2188903; Wielaard J, 2015, INT C BAS CLIN MULT	33	11	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184743	10.1371/journal.pone.0184743	http://dx.doi.org/10.1371/journal.pone.0184743			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902890	gold, Green Published			2022-12-27	WOS:000410669200058
J	Popolin, CP; Reis, JPB; Becceneri, AB; Graminha, AE; Almeida, MAP; Correa, RS; Colina-Vegas, LA; Ellena, J; Batista, AA; Cominetti, MR				Popolin, Cecilia P.; Reis, Joao P. B.; Becceneri, Amanda B.; Graminha, Angelica E.; Almeida, Marcio A. P.; Correa, Rodrigo S.; Colina-Vegas, Legna A.; Ellena, Javier; Batista, Alzir A.; Cominetti, Marcia R.			Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells	PLOS ONE			English	Article							BOTHROPS ALTERNATUS; TUMOR-CELLS; APOPTOSIS; MIGRATION; ADHESION; INVASION; MATRIX; VENOM; PCR; DNA	Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype. The high rate of metastasis associated to the fact that these cells frequently display multidrug resistance, make the treatment of metastatic disease difficult. Development of antitumor metal-based drugs was started with the discovery of cisplatin, however, the severe side effects represent a limitation for its clinical use. Ruthenium (Ru) complexes with different ligands have been successfully studied as prospective antitumor drugs. In this work, we demonstrated the activity of a series of biphosphine bipyridine Ru complexes (1) [Ru(SO4) (dppb)(bipy)], (2) [Ru(CO3)(dppb)(bipy)], (3) [Ru(C2O4)(dppb)(bipy)] and (4) [Ru(CH3CO2) (dppb)(bipy)]PF6 [where dppb = 1,4-bis(diphenylphosphino) butane and bipy = 2,2'-bipyridine], on proliferation of TNBC (MDA-MB-231), estrogen-dependent breast tumor cells (MCF-7) and a non-tumor breast cell line (MCF-10A). Complex (4) was most effective among the complexes and was selected to be further investigated on effects on tumor cell adhesion, migration, invasion and in apoptosis. Moreover, DNA and HSA binding properties of this complex were also investigated. Results show that complex (4) was more efficient inhibiting proliferation of MDA-MB-231 cells over non-tumor cells. In addition, complex (4) was able to inhibit MDA-MB231 cells adhesion, migration and invasion and to induce apoptosis and inhibit MMP-9 secretion in TNBC cells. Complex (4) should be further investigated in vivo in order to stablish its potential to improve breast cancer treatment.	[Popolin, Cecilia P.; Becceneri, Amanda B.; Graminha, Angelica E.; Cominetti, Marcia R.] Univ Fed Sao Carlos, Dept Gerontol, Sao Carlos, SP, Brazil; [Reis, Joao P. B.; Colina-Vegas, Legna A.; Batista, Alzir A.] Univ Fed Sao Carlos, Dept Quim, Sao Carlos, SP, Brazil; [Almeida, Marcio A. P.] Univ Fed Maranhao, Dept Quim, Sao Luis, Maranhao, Brazil; [Correa, Rodrigo S.] Univ Fed Ouro Preto, Dept Quim, Ouro Preto, MG, Brazil; [Ellena, Javier] Univ Sao Paulo, Inst Fis Sao Carlos, Dept Fis & Ciencia Interdisciplinar, Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos; Universidade Federal do Maranhao; Universidade Federal de Ouro Preto; Universidade de Sao Paulo	Cominetti, MR (corresponding author), Univ Fed Sao Carlos, Dept Gerontol, Sao Carlos, SP, Brazil.	mcominetti@ufscar.br	Almeida, Marcio/W-2857-2019; Cominetti, Marcia Regina/B-8080-2012; Ellena, Javier/B-9104-2012; Batista, Alzir A./C-3492-2012; Graminha, Angelica Ellen/GYA-2571-2022; Correa, Rodrigo/A-8227-2013; Graminha, Angelica E/C-9325-2014; Almeida, Marcio A.P./F-8902-2012; Colina Vegas, Legna/E-9402-2017	Almeida, Marcio/0000-0003-2494-7912; Cominetti, Marcia Regina/0000-0001-6385-7392; Ellena, Javier/0000-0002-0676-3098; Correa, Rodrigo/0000-0003-2783-0816; Graminha, Angelica E/0000-0002-5665-0817; Almeida, Marcio A.P./0000-0003-2494-7912; Colina Vegas, Legna/0000-0003-3557-5544; Blanque Becceneri, Amanda/0000-0001-5223-961X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/00798-2, 2015/24940-8]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 2013/00798-2 and 2015/24940-8); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson VG, 2015, CANCER-AM CANCER SOC, V121, P8, DOI 10.1002/cncr.28914; ALBERTS DS, 1980, LANCET, V2, P340; Baka E, 2008, J PHARMACEUT BIOMED, V46, P335, DOI 10.1016/j.jpba.2007.10.030; Ban KA, 2014, SURG ONCOL CLIN N AM, V23, P409, DOI 10.1016/j.soc.2014.03.011; Barbosa MIF, 2014, J INORG BIOCHEM, V136, P33, DOI 10.1016/j.jinorgbio.2014.03.009; Brabec V, 2006, DRUG RESIST UPDATE, V9, P111, DOI 10.1016/j.drup.2006.05.002; Brown GT, 2015, J PATHOL, V237, P273, DOI 10.1002/path.4586; Buss I, 2011, J INORG BIOCHEM, V105, P709, DOI 10.1016/j.jinorgbio.2011.02.005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao WQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09157; Carreira M, 2012, J INORG BIOCHEM, V116, P204, DOI 10.1016/j.jinorgbio.2012.06.017; Ciarimboli G, 2014, ANTICANCER RES, V34, P547; Cominetti MR, 2003, ARCH BIOCHEM BIOPHYS, V416, P171, DOI 10.1016/S0003-9861(03)00298-4; Correa RS, 2016, J INORG BIOCHEM, V156, P153, DOI 10.1016/j.jinorgbio.2015.12.024; da Silva JA, 2012, J CHROMATOGR B, V903, P157, DOI 10.1016/j.jchromb.2012.07.013; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fuzer AM, 2013, ANTI-CANCER AGENT ME, V13, P1645, DOI 10.2174/18715206113139990314; Gehler S, 2013, CRIT REV EUKAR GENE, V23, P139, DOI 10.1615/CritRevEukarGeneExpr.2013006647; Gou Y, 2015, CURR PHARM DESIGN, V21, P1848, DOI 10.2174/1381612821666150302114739; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hartinger CG, 2006, J INORG BIOCHEM, V100, P891, DOI 10.1016/j.jinorgbio.2006.02.013; Hongthong K, 2016, CURR CANCER DRUG TAR, V16, P606, DOI 10.2174/1568009616666160203113957; Leber TM, 2000, METH MOLEC MED, V39, P509; Leijen S, 2015, INVEST NEW DRUG, V33, P201, DOI 10.1007/s10637-014-0179-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacFarlane M, 2004, EMBO REP, V5, P674, DOI 10.1038/sj.embor.7400191; McKeage MJ, 2000, CANCER CHEMOTH PHARM, V46, P343, DOI 10.1007/s002800000166; Nhukeaw T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-73; Norum JH, 2014, BRIT J SURG, V101, P925, DOI 10.1002/bjs.9562; Pages BJ, 2015, DALTON T, V44, P3505, DOI 10.1039/c4dt02700k; Popolin CP, 2017, MINI REV MED CHEM; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Queiroz SL, 1998, INORG CHIM ACTA, V267, P209, DOI 10.1016/S0020-1693(97)05615-6; Ratanaphan A, 2016, ANTICANCER AGENTS ME; Sava G, 2004, EUR J CANCER, V40, P1383, DOI 10.1016/j.ejca.2004.01.034; Selistre-de-Araujo HS, 2005, BRAZ J MED BIOL RES, V38, P1505, DOI 10.1590/S0100-879X2005001000007; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Wu Q, 2014, METALLOMICS, V6, P2204, DOI 10.1039/c4mt00158c; Yue PYK, 2010, J BIOMOL SCREEN, V15, P427, DOI 10.1177/1087057110361772; Zeng ZP, 2016, INORG CHEM, V55, P5710, DOI 10.1021/acs.inorgchem.6b00824	41	37	37	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0183275	10.1371/journal.pone.0183275	http://dx.doi.org/10.1371/journal.pone.0183275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898246	Green Published, gold, Green Submitted			2022-12-27	WOS:000410449500003
J	Sun, ZL; Pan, T; Hu, CC; Sun, L; Ding, HW; Wang, H; Zhang, CL; Jin, H; Chang, Q; Kan, XZ; Zhang, BW				Sun, Zhonglou; Pan, Tao; Hu, Chaochao; Sun, Lu; Ding, Hengwu; Wang, Hui; Zhang, Chenling; Jin, Hong; Chang, Qing; Kan, Xianzhao; Zhang, Baowei			Rapid and recent diversification patterns in Anseriformes birds: Inferred from molecular phylogeny and diversification analyses	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; STEAMER-DUCKS ANATIDAE; PLIOPLEISTOCENE DIVERSIFICATION; PLEISTOCENE DIVERSIFICATION; CLIMATIC OSCILLATIONS; ADAPTIVE RADIATION; AVIAN POPULATIONS; SPECIATION; EVOLUTION; EOCENE	The Anseriformes is a well-known and widely distributed bird order, with more than 150 species in the world. This paper aims to revise the classification, determine the phylogenetic relationships and diversification patterns in Anseriformes by exploring the Cyt b, ND2, COI genes and the complete mitochondrial genomes (mito-genomes). Molecular phylogeny and genetic distance analyses suggest that the Dendrocygna species should be considered as an independent family, Dendrocygnidae, rather than a member of Anatidae. Molecular time-scale analyses suggests that the ancestral diversification occurred during the Early Eocene Climatic Optimum (58 similar to 50 Ma). Furthermore, diversification analyses showed that, after a long period of constant diversification, the median initial speciation rate was accelerated three times, and finally increased to approximately 0.3 sp/My. In the present study, both molecular phylogeny and diversification analyses results support that Anseriformes birds underwent rapid and recent diversification in their evolutionary history, especially in modern ducks, which show extreme diversification during the Plio-Pleistocene (similar to 5.3 Ma). Therefore, our study support that the Plio-Pleistocene climate fluctuations are likely to have played a significant role in promoting the recent diversification for Anseriformes.	[Sun, Zhonglou; Pan, Tao; Wang, Hui; Zhang, Baowei] Anhui Univ, Sch Life Sci, Anhui Key Lab Ecoengn & Biotech, Hefei, Anhui, Peoples R China; [Hu, Chaochao; Jin, Hong; Chang, Qing] Nanjing Normal Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China; [Sun, Lu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Ding, Hengwu; Kan, Xianzhao] Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China; [Zhang, Chenling] Jiangsu Second Normal Univ, Fac Life Sci & Chem Engn, Nanjing, Jiangsu, Peoples R China; [Jin, Hong] Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England	Anhui University; Nanjing Normal University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Anhui Normal University; Jiangsu Second Normal University; University of Leicester	Wang, H; Zhang, BW (corresponding author), Anhui Univ, Sch Life Sci, Anhui Key Lab Ecoengn & Biotech, Hefei, Anhui, Peoples R China.; Kan, XZ (corresponding author), Anhui Normal Univ, Coll Life Sci, Wuhu, Anhui, Peoples R China.	kikihui86025@163.com; xianzhao@ahnu.edu.cn; zhangbw@ahu.edu.cn	lu, sun/K-4484-2019; Kan, Xianzhao/AAA-5050-2021	lu, sun/0000-0002-7688-6472; Kan, Xianzhao/0000-0002-9225-407X	Anhui Province Higher Education Revitalization Plan	Anhui Province Higher Education Revitalization Plan	This work was supported by the Anhui Province Higher Education Revitalization Plan, 2014 Colleges and Universities Outstanding Youth Talent Support Program.	Alstrom P, 2013, MOL PHYLOGENET EVOL, V69, P1043, DOI 10.1016/j.ympev.2013.06.005; An M, 2016, MITOCHONDRIAL DNA A, V27, P2800, DOI 10.3109/19401736.2015.1053073; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; [Anonymous], 2014, TRACER V1 6; [Anonymous], 2001, PRIMER V5; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bijl PK, 2009, NATURE, V461, P776, DOI 10.1038/nature08399; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Bulgarella M, 2010, J AVIAN BIOL, V41, P186, DOI 10.1111/j.1600-048X.2009.04819.x; Burland T G, 2000, Methods Mol Biol, V132, P71; CORBIN KW, 1988, CONDOR, V90, P773, DOI 10.2307/1368834; CRACRAFT J, 1981, AUK, V98, P681; Currano ED, 2008, P NATL ACAD SCI USA, V105, P1960, DOI 10.1073/pnas.0708646105; Dawson NG, 2014, J BIOGEOGR, V41, P464, DOI 10.1111/jbi.12221; de Swardt D.H., 2010, Ornithological Observations, V1, P63; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Delacour Jean, 1945, WILSON BULL, V57, P3; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Dickinson EC., 2003, HOWARD MOORE COMPLET; Ding L, 2016, MITOCHONDRIAL DNA A, V27, P1003, DOI 10.3109/19401736.2014.926525; Donne-Gousse C, 2002, MOL PHYLOGENET EVOL, V23, P339, DOI 10.1016/S1055-7903(02)00019-2; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dubey S, 2010, MOL PHYLOGENET EVOL, V56, P1119, DOI 10.1016/j.ympev.2010.04.028; Dubey S, 2010, J BIOGEOGR, V37, P902, DOI 10.1111/j.1365-2699.2009.02266.x; FARRELL BD, 1994, AM ZOOL, V34, P57, DOI 10.1093/icb/34.1.57; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Freethy R., 1982, BIRDS WORK GUIDE BIR; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gibb GC, 2007, MOL BIOL EVOL, V24, P269, DOI 10.1093/molbev/msl158; Gingerich PD, 2006, TRENDS ECOL EVOL, V21, P246, DOI 10.1016/j.tree.2006.03.006; Giorgi CD, 1989, CELL BIOCH BIOPHYS, V14, P67; Gonzalez J, 2009, J ZOOL, V279, P310, DOI 10.1111/j.1469-7998.2009.00622.x; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; Harrison GL, 2004, MOL BIOL EVOL, V21, P974, DOI 10.1093/molbev/msh065; Hassanin A, 2012, CR BIOL, V335, P32, DOI 10.1016/j.crvi.2011.11.002; Hawlitschek O, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-142; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HOWARD R, 1991, COMPLETE CHECKLIST B; Hoyo JD, 1994, HDB BIRDS WORLD; Hu CC, 2015, MITOCHONDR DNA, V26, P625, DOI 10.3109/19401736.2013.834434; Huntley JW, 2017, ZOOL SCR, V46, P523, DOI 10.1111/zsc.12240; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jiang FW, 2010, MOL BIOL REP, V37, P3001, DOI 10.1007/s11033-009-9868-9; Jiang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136297; Jiang LC, 2014, GENE, V539, P21, DOI 10.1016/j.gene.2014.01.067; Johns GC, 1998, EVOLUTION, V52, P1135, DOI 10.1111/j.1558-5646.1998.tb01840.x; Johnson KP, 1998, MOL PHYLOGENET EVOL, V10, P82, DOI 10.1006/mpev.1997.0481; Johnson KP, 1999, AUK, V116, P792, DOI 10.2307/4089339; Johnson NK, 2004, EVOLUTION, V58, P1122; Kan XZ, 2010, GENET MOL RES, V9, P1234, DOI 10.4238/vol9-2gmr853; Kearney M, 2008, MOL ECOL, V17, P5257, DOI 10.1111/j.1365-294X.2008.03991.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koju NP, 2017, MOL PHYLOGENET EVOL, V107, P239, DOI 10.1016/j.ympev.2016.11.005; Koscinski D, 2008, MOL ECOL, V17, P2012, DOI 10.1111/j.1365-294X.2008.03733.x; Levsen ND, 2012, SYST BIOL, V61, P401, DOI 10.1093/sysbio/syr120; Li XJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1234-9; Liu G, 2013, PLOS ONE, V9; Liu G., 2013, INT J ANTENN PROPAG, V2013, P5; Liu G, 2012, MOL BIOL REP, V39, P2139, DOI 10.1007/s11033-011-0961-5; LIVEZEY BC, 1991, AUK, V108, P471, DOI 10.2307/4088089; LIVEZEY BC, 1995, CONDOR, V97, P233, DOI 10.2307/1368999; Livezey BC, 1997, ANN CARNEGIE MUS, V66, P457; LIVEZEY BC, 1986, SYST ZOOL, V35, P458, DOI 10.2307/2413109; Livezey BC, 1996, SYST BIOL, V45, P415, DOI 10.2307/2413524; LIVEZEY BC, 1986, AUK, V103, P737, DOI 10.1093/auk/103.4.737; Livezey BC, 1998, ZOOL J LINN SOC-LOND, V124, P397, DOI 10.1111/j.1096-3642.1998.tb00584.x; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lovette IJ, 2005, TRENDS ECOL EVOL, V20, P57, DOI 10.1016/j.tree.2004.11.011; Lovette IJ, 1999, P ROY SOC B-BIOL SCI, V266, P1629, DOI 10.1098/rspb.1999.0825; MacKinnon J, 2000, FIELD GUIDE BIRDS CH; Marshall DC, 2008, MOL PHYLOGENET EVOL, V48, P1054, DOI 10.1016/j.ympev.2008.05.007; McCracken KG, 1999, SYST BIOL, V48, P683, DOI 10.1080/106351599259979; Menezes L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154626; Meng SQ, 2016, MITOCHONDRIAL DNA A, V27, P318, DOI 10.3109/19401736.2014.892096; Mindell DP, 1998, P NATL ACAD SCI USA, V95, P10693, DOI 10.1073/pnas.95.18.10693; Montgelard C, 2012, ACTA OECOL, V42, P50, DOI 10.1016/j.actao.2012.02.001; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; Nadachowska-Brzyska K, 2015, CURR BIOL, V25, P1375, DOI 10.1016/j.cub.2015.03.047; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Nylander JAA., 2004, BIOINFORMATICS; Olson S.L., 1980, Smithsonian Contributions to Zoology, P1; Osborn HF, 1902, AM NAT, V36, P353, DOI 10.1086/278137; Ottenburghs J, 2016, MOL PHYLOGENET EVOL, V101, P303, DOI 10.1016/j.ympev.2016.05.021; Ottenburghs J, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0153-1; Ottenburghs J, 2015, IBIS, V157, P892, DOI 10.1111/ibi.12285; [欧先交 Ou Xianjiao], 2015, [第四纪研究, Quaternary Sciences], V35, P12; Pan T, 2014, MITOCHONDR DNA, V25, P111, DOI 10.3109/19401736.2013.786709; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parham JF, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-11; Parker Theodore A. Iii, 1996, P113; Peters JL, 2005, MOL PHYLOGENET EVOL, V35, P209, DOI 10.1016/j.ympev.2004.12.017; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; R Core Team, 2021, R LANGUAGE ENV STAT; Rabosky DL, 2014, METHODS ECOL EVOL, V5, P701, DOI 10.1111/2041-210X.12199; Rabosky DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089543; Rohl U, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001784; Ruber L, 2003, EVOLUTION, V57, P1584; Ruokonen M, 2000, J EVOLUTION BIOL, V13, P532, DOI 10.1046/j.1420-9101.2000.00184.x; Sambrook J., 2001, MOL CLONING LAB MANU; SANDERSON MJ, 1994, SCIENCE, V264, P1590, DOI 10.1126/science.264.5165.1590; Sarkar S, 2006, ANNU REV ENV RESOUR, V31, P123, DOI 10.1146/annurev.energy.31.042606.085844; Schattner P, 2007, NUCLEIC ACIDS RES, V33, P686; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shen Yong-Yi, 2010, BMC Evol Biol, V10, P132, DOI 10.1186/1471-2148-10-132; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Sibley CG, 1993, SUPPLEMENT DISTRIBUT; Sibley CG, 1990, DISTRIBUTION TAXONOM; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Sorenson MD, 1999, P ROY SOC B-BIOL SCI, V266, P2187, DOI 10.1098/rspb.1999.0907; Sorenson MD, 2003, MOL BIOL EVOL, V20, P1484, DOI 10.1093/molbev/msg157; Sraml M, 1996, AUST J ZOOL, V44, P47, DOI 10.1071/ZO9960047; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stumpel N, 2016, MOL PHYLOGENET EVOL, V101, P336, DOI 10.1016/j.ympev.2016.04.025; Sun ZL, 2016, MITOCHONDRIAL DNA A, V27, P4320, DOI 10.3109/19401736.2015.1089482; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tripati A, 2005, SCIENCE, V308, P1894, DOI 10.1126/science.1109202; Tu JF, 2016, MITOCHONDRIAL DNA A, V27, P682, DOI 10.3109/19401736.2014.913141; Turner GF, 2001, HEREDITY, V86, P749; van Tuinen M, 2000, MOL BIOL EVOL, V17, P451, DOI 10.1093/oxfordjournals.molbev.a026324; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630; Vieites DR, 2007, P NATL ACAD SCI USA, V104, P19903, DOI 10.1073/pnas.0705056104; Wang N, 2013, PLOS ONE, V8, P394; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Westerhold T, 2009, CLIM PAST, V5, P309, DOI 10.5194/cp-5-309-2009; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; Willows-Munro S, 2011, J BIOGEOGR, V38, P1976, DOI 10.1111/j.1365-2699.2011.02543.x; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Woodburne MO, 2009, P NATL ACAD SCI USA, V106, P13399, DOI 10.1073/pnas.0906802106; Wu Ai-Ping, 2005, Acta Zoologica Sinica, V51, P898; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yan LH, 2015, MITOCHONDR DNA, V26, P297, DOI 10.3109/19401736.2013.825783; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; YE Z, 2016, SCI REP UK, V6; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Yu L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-198; Yu W, 2014, J EVOLUTION BIOL, V27, P2204, DOI 10.1111/jeb.12477; Yu WH, 2012, INT J BIOL SCI, V8, P486, DOI 10.7150/ijbs.3982; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588; Zachos JC, 2003, SCIENCE, V302, P1551, DOI 10.1126/science.1090110; Zhou W, 2014, MITOCHONDR DNA, V27, P968; Zhou WL, 2015, MITOCHONDR DNA, V26, P265, DOI 10.3109/19401736.2013.823191	155	31	33	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184529	10.1371/journal.pone.0184529	http://dx.doi.org/10.1371/journal.pone.0184529			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892502	Green Published, gold, Green Submitted			2022-12-27	WOS:000410243200016
J	Casey, SE; Cannon, A; Balikubirhi, BM; Muyisa, JB; Amsalu, R; Tsolka, M				Casey, Sara E.; Cannon, Amy; Balikubirhi, Benjamin Mushagalusa; Muyisa, Jean-Bosco; Amsalu, Ribka; Tsolka, Maria			Twelve-month contraceptive continuation among women initiating short- and long-acting reversible contraceptives in North Kivu, Democratic Republic of the Congo	PLOS ONE			English	Article							QUALITY-OF-CARE; REPRODUCTIVE HEALTH; DEVELOPING-COUNTRIES; DISCONTINUATION; UGANDA	Context Despite the inclusion of sexual and reproductive health (SRH) services in the minimum standards of health care in humanitarian settings, access to SRH services, and especially to contraception, is often compromised in war. Very little is known about continuation and switching of contraceptive methods in these settings. An evaluation of a contraceptive services program in North Kivu, Democratic Republic of the Congo (DRC) was conducted to measure 12-month contraceptive continuation by type of contraceptive method (short-acting or long-acting). Methods A stratified systematic sample of women who initiated a contraceptive method 12-18 months prior to data collection was selected retrospectively from facility registers. A total of 548 women was interviewed about their contraceptive use: 304 who began a short-acting method (pills, injectables) and 244 who began a long-acting method (intra-uterine devices, implants). Key characteristics of short-acting method versus long-acting method acceptors were compared using chi-square statistics for categorical data and t-tests for continuous data. Unadjusted and adjusted Cox proportional hazard ratios were estimated to assess factors associated with discontinuation. Results At 12 months, 81.6% women reported using their baseline contraceptive method continuously, with more long-acting than short-acting contraceptive acceptors (86.1% versus 78.0%, p =.02) continuing contraceptive use. Use of a short-acting method (Hazard ratio (HR) 1.74 [95% CI 1.13 - 2.67]) and desiring a child within two years (HR 2.58 [95% CI 1.45 - 4.54]) were associated with discontinuation within the first 12 months of use. The vast majority (88.3%) of women reported no prior contraceptive use. Conclusion This is the first study of contraceptive continuation in a humanitarian setting. The high percentages of women continuing contraceptive use found here demonstrates that women will choose to initiate and continue use of their desired contraceptive method, even in a difficult, unstable and low contraceptive prevalence setting like North Kivu.	[Casey, Sara E.] Columbia Univ, Heilbrunn Dept Populat & Family Hlth, Mailman Sch Publ Hlth, RAISE Initiat, New York, NY 10027 USA; [Cannon, Amy; Amsalu, Ribka; Tsolka, Maria] Save Children USA, Washington, DC USA; [Balikubirhi, Benjamin Mushagalusa; Muyisa, Jean-Bosco] Save Children, Goma, DEM REP CONGO	Columbia University; Save the Children; Save the Children	Casey, SE (corresponding author), Columbia Univ, Heilbrunn Dept Populat & Family Hlth, Mailman Sch Publ Hlth, RAISE Initiat, New York, NY 10027 USA.	sec42@columbia.edu		Casey, Sara/0000-0002-8476-0327; AMSALU, Dr. RIBKA/0000-0001-8077-7685	Save the Children Innovation Fund (IDEA)	Save the Children Innovation Fund (IDEA)	This study was funded by the Save the Children Innovation Fund (IDEA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Gasseer N, 2004, J MIDWIFERY WOM HEAL, V49, P7, DOI 10.1016/j.jmwh.2004.05.001; Alberti KP, 2010, CONFL HEALTH, V4, P1; ALI M, 1995, INT FAM PLAN PERSPEC, V21, P92, DOI 10.2307/2133181; Ali M., 2012, CAUSES CONSEQUENCES; [Anonymous], 2007, REPR HLTH ASS TOOLK; Austin J, 2008, REPROD HEALTH MATTER, V16, P10, DOI 10.1016/S0968-8080(08)31351-2; Barden-O'Fallon J, 2011, STUD FAMILY PLANN, V42, P11, DOI 10.1111/j.1728-4465.2011.00260.x; Blanc AK, 2002, STUD FAMILY PLANN, V33, P127, DOI 10.1111/j.1728-4465.2002.00127.x; Blanc AK, 2009, INT PERSPECT SEX R H, V35, P63, DOI 10.1363/ipsrh.35.063.09; Bradley SE., 2009, DHS ANAL STUDIES; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; Casey SE, 2013, GLOB PUBLIC HEALTH, V8, P284, DOI 10.1080/17441692.2012.758302; CASEY SE, 2015, CONFL HEALTH S1, V9; Castle S, 2015, CONTRACEPTIVE DISCON, DOI DOI 10.1108/JHASS-09-2019-0056/FULL/HTML; Chynoweth SK, 2015, CONFL HEALTH, V9, DOI 10.1186/1752-1505-9-S1-I1; Curry DW, 2015, GLOB HEALTH, V3, P14, DOI 10.9745/GHSP-D-14-00164; Curry DW, 2015, GLOB HEALTH, V3, P25, DOI 10.9745/GHSP-D-14-00112; du Plan Ministere, 2014, ENQ DEM SANT REP DEM; Greaney P, 2011, SPHERE PROJECT HUMAN; Halpern V, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004317.pub4; Jain Anrudh K, 2013, Int Perspect Sex Reprod Health, V39, P133, DOI 10.1363/3913313; Kruk ME, 2010, SOC SCI MED, V70, P89, DOI 10.1016/j.socscimed.2009.09.042; Mukaba T, 2015, GLOB HEALTH, V3, P163, DOI 10.9745/GHSP-D-14-00244; Nanda K, 2011, CONTRACEPTION, V83, P542, DOI 10.1016/j.contraception.2010.09.003; Power J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001326.pub2; Raine TR, 2011, OBSTET GYNECOL, V117, P363, DOI 10.1097/AOG.0b013e31820563d3; RamaRao S, 2003, INT FAM PLAN PERSPEC, V29, P76, DOI 10.2307/3181061; Tanabe M, 2015, CONFL HEALTH, V9, DOI 10.1186/1752-1505-9-S1-S2; Tolley E, 2005, INT FAM PLAN PERSPEC, V31, P15, DOI 10.1363/3101505; Vitzthum VJ, 2005, STUD FAMILY PLANN, V36, P13, DOI 10.1111/j.1728-4465.2005.00038.x; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990	31	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182744	10.1371/journal.pone.0182744	http://dx.doi.org/10.1371/journal.pone.0182744			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886016	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100010
J	Kaido, M; Kawashima, M; Shigeno, Y; Yamada, Y; Tsubota, K				Kaido, Minako; Kawashima, Motoko; Shigeno, Yuta; Yamada, Yoshiaki; Tsubota, Kazuo			Relation of accommodative microfluctuation with dry eye symptoms in short tear break-up time dry eye	PLOS ONE			English	Article							FUNCTIONAL VISUAL-ACUITY; FILM; FLUCTUATIONS; ASSOCIATION; POPULATION; PREVALENCE; FATIGUE; SIGNS	Purpose To investigate accommodative microfluctuations (AMFs) and visual function in short tear break-up time (BUT)-type dry eye (DE) and non-DE subjects. Methods This prospective comparative study included 48 volunteers with DE symptoms (mean age 34.8-5.5 years, age range 25-42 years) and 73 without DE symptoms (mean age 30.6-4.7 years, age range 25-42 years). The eyes were divided into two groups: (1) DE group with DE symptoms and BUT <= 5 s and (2) non-DE group without DE symptoms and BUT > 5 s. We excluded eyes with Schirmer score <= 5 mm and positive keratoconjunctival epithelial damage. Tear evaluation, AMF, and functional visual acuity (VA) examinations were performed. AMF parameters included total high-frequency component (HFC), HFC with low accommodation for the task of staring into the distance (HFC1), and HFC with high accommodation for deskwork (HFC2). Functional VA parameters included starting VA, functional VA, visual maintenance ratio, and blink frequency. Results A total of 33 and 34 eyes were categorized in the DE and non-DE groups, respectively. Mean blink frequency and HFC1 values were significantly higher in the DE group than they were in the non-DE group. Conclusions DEs with symptoms showed abnormal AMF and visual function, which may be associated with DE symptoms.	[Kaido, Minako; Kawashima, Motoko; Shigeno, Yuta; Tsubota, Kazuo] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Kaido, Minako] Shinanozaka Clin, Tokyo, Japan; [Yamada, Yoshiaki] Santen Pharmaceut Co Ltd, Osaka, Japan	Keio University; Santen Pharmaceutical Co Ltd	Kaido, M (corresponding author), Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan.	fwiw1193@mb.infoweb.ne.jp	Tsubota, Kazuo/M-1915-2013	Tsubota, Kazuo/0000-0002-8874-7111	Santen Pharmaceutical Co., Ltd, Osaka	Santen Pharmaceutical Co., Ltd, Osaka	Provision of facilities and transport of equipment were supported by Santen Pharmaceutical Co., Ltd, Osaka. The funder provided support in the form of salary for one author [YY], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the 'author contributions' section.	Belmonte Carlos, 2015, Curr Ophthalmol Rep, V3, P111; Bron A J, 2004, Ocul Surf, V2, P149; Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; CAMPBELL FW, 1959, J PHYSIOL-LONDON, V145, P579, DOI 10.1113/jphysiol.1959.sp006164; CAMPBELL FW, 1958, J OPT SOC AM, V48, P669, DOI 10.1364/JOSA.48.000669; CHARMAN WN, 1988, OPHTHAL PHYSL OPT, V8, P153, DOI 10.1111/j.1475-1313.1988.tb01031.x; COLLINS M, 1995, VISION RES, V35, P2491; Craig JP, 2017, OCUL SURF, V15, P276, DOI 10.1016/j.jtos.2017.05.008; Foulks Gary N, 2003, Ocul Surf, V1, P107; Hua R, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005296; Ibrahim OMA, 2011, INVEST OPHTH VIS SCI, V52, P2194, DOI 10.1167/iovs.10-5986; Kaido M, 2007, CORNEA, V26, pS29, DOI 10.1097/ICO.0b013e31812f6913; Kaido M, 2017, CLIN OPHTHALMOL, V11, P861, DOI 10.2147/OPTH.S128939; Kaido M, 2016, INVEST OPHTH VIS SCI, V57, P914, DOI 10.1167/iovs.15-18447; Kaido M, 2015, BRIT J OPHTHALMOL, V99, P1488, DOI 10.1136/bjophthalmol-2015-306640; Kaido M, 2014, INVEST OPHTH VIS SCI, V55, P3275, DOI 10.1167/iovs.13-13000; Kaido M, 2013, J OCUL PHARMACOL TH, V29, P595, DOI 10.1089/jop.2012.0246; Kaido M, 2012, CORNEA, V31, P1009, DOI 10.1097/ICO.0b013e31823f8cfc; Kaido M, 2006, AM J OPHTHALMOL, V142, P917, DOI 10.1016/j.ajo.2006.07.055; Kajita M, 2001, Fukushima J Med Sci, V47, P13; Keech A, 2013, CURR EYE RES, V38, P428, DOI 10.3109/02713683.2013.763987; Koh S, 2008, INVEST OPHTH VIS SCI, V49, P133, DOI 10.1167/iovs.07-0762; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Liu HX, 2009, INVEST OPHTH VIS SCI, V50, P3671, DOI 10.1167/iovs.08-2689; Montes-Mico R, 2005, INVEST OPHTH VIS SCI, V46, P1615, DOI 10.1167/iovs.05-0017; Nichols KK, 2004, CORNEA, V23, P762, DOI 10.1097/01.ico.0000133997.07144.9e; OWENS DA, 1987, INVEST OPHTH VIS SCI, V28, P743; Parra A, 2014, PAIN, V155, P1481, DOI 10.1016/j.pain.2014.04.025; Rolando M, 2001, SURV OPHTHALMOL, V45, pS203, DOI 10.1016/S0039-6257(00)00203-4; Schein OD, 1997, OPHTHALMOLOGY, V104, P1395, DOI 10.1016/S0161-6420(97)30125-0; Schmidl D, 2015, INVEST OPHTH VIS SCI, V56, P1467, DOI 10.1167/iovs.14-15814; Shimazaki S., 2006, J EYE, V24, P181; Shimazaki-Den S, 2013, CORNEA, V32, P1211, DOI 10.1097/ICO.0b013e318295a2a5; TODA I, 1995, OPHTHALMOLOGY, V102, P302; TODA I, 1993, ACTA OPHTHALMOL, V71, P347, DOI 10.1111/j.1755-3768.1993.tb07146.x; Uchino M, 2011, OPHTHALMOLOGY, V118, P2361, DOI 10.1016/j.ophtha.2011.05.029; Uchino Y, 2014, JAMA OPHTHALMOL, V132, P985, DOI 10.1001/jamaophthalmol.2014.1008; VANBIJST.OP, 1969, ARCH OPHTHALMOL-CHIC, V82, P10; Watanabe Hitoshi, 2002, Cornea, V21, pS17, DOI 10.1097/00003226-200203001-00005; WINN B, 1990, CURR EYE RES, V9, P971, DOI 10.3109/02713689009069933; Yamamoto Yuji, 2012, Nippon Ganka Gakkai Zasshi, V116, P1137; Yokoi N, 2015, AM J OPHTHALMOL, V159, P748, DOI 10.1016/j.ajo.2014.12.019	42	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184296	10.1371/journal.pone.0184296	http://dx.doi.org/10.1371/journal.pone.0184296			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886090	gold, Green Submitted, Green Published			2022-12-27	WOS:000410001100093
J	Kayamba, V; Shibemba, A; Zyambo, K; Heimburger, DC; Morgan, DR; Kelly, P				Kayamba, Violet; Shibemba, Aaron; Zyambo, Kanekwa; Heimburger, Douglas C.; Morgan, Douglas R.; Kelly, Paul			High prevalence of gastric intestinal metaplasia detected by confocal laser endomicroscopy in Zambian adults	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; ENDOSCOPIC FINDINGS; PRECANCEROUS CONDITIONS; ANTIRETROVIRAL THERAPY; HIV-INFECTION; IN-VIVO; DIAGNOSIS; STOMACH; DISEASE; IMMUNODEFICIENCY	Background Confocal laser endomicroscopy (CLE) may increase the detection of gastric premalignant lesions, and facilitate targeted biopsies for histology. The study aim was to analyse premalignant lesions in Zambian adults using CLE. Methods Using CLE and histology we analysed the antral mucosa for gastric premalignant lesions in asymptomatic adults living with HIV and in HIV seronegative adults. Fasting gastric pH and the presence of Helicobacter pylori (H. pylori) were also evaluated. Results We enrolled 84 HIV seropositive participants (median age 43 years; 55 (65%) female), of whom 32 (38%) were anti-retroviral therapy (ART)-naive. Also enrolled were 22 HIV seronegative controls (median age 39 years, 12 (55%) females). Hypochlorhydria was found in 48 (57%) HIV positive and 8 (38%) HIV negative controls (P = 0.14). Detection of gastric intestinal metaplasia (GIM) was higher (P = 0.007) using CLE (49, 54%) than histology (9, 9%) and, using CLE, GIM was similar between HIV positive (41, 60%) and negative groups (8, 36%; P = 0.08). Gastric luminal fluorescein leakage was significantly associated with the presence of GIM [OR 8.2; 95% CI 2.5-31, P<0.001]. Conclusion CLE is useful for the detection of GIM, and luminal fluorescein leakage may represent a novel CLE marker for GIM. GIM is common in Zambian adults, and is highly prevalent irrespective of HIV infection or use of ART.	[Kayamba, Violet; Zyambo, Kanekwa; Kelly, Paul] Univ Zambia, Dept Internal Med, Trop Gastroenterol & Nutr Grp, Sch Med, Lusaka, Zambia; [Shibemba, Aaron] Canc Dis Hosp, Pathol Sect, Lusaka, Zambia; [Heimburger, Douglas C.; Morgan, Douglas R.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN USA; [Kelly, Paul] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, London, England	University of Zambia; Vanderbilt University; University of London; Queen Mary University London	Kayamba, V (corresponding author), Univ Zambia, Dept Internal Med, Trop Gastroenterol & Nutr Grp, Sch Med, Lusaka, Zambia.	viojole@yahoo.com	Kayamba, Violet/AEQ-9806-2022	Kayamba, Violet/0000-0002-6521-2501; Kelly, Paul/0000-0003-0844-6448	NIH Research Training Grant - Fogarty International Center, Office of the Director, National Institutes of Health [R25 TW009337]; National Heart, Blood, and Lung Institute; National Institute of Mental Health; Fogarty International Center of the National Institutes of Health grant [D43 TW009744]; FOGARTY INTERNATIONAL CENTER [D43TW009744] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA028842] Funding Source: NIH RePORTER	NIH Research Training Grant - Fogarty International Center, Office of the Director, National Institutes of Health; National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fogarty International Center of the National Institutes of Health grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIH Research Training Grant # R25 TW009337 funded by the Fogarty International Center, Office of the Director, National Institutes of Health, the National Heart, Blood, and Lung Institute, and the National Institute of Mental Health and the Fogarty International Center of the National Institutes of Health grant # D43 TW009744. https://www.fic.nih gov/FUNDING/pages/fogarty-funding-opps.aspx.	Ankouane F, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.52.5887; Bok GH, 2013, GASTROINTEST ENDOSC, V77, P899, DOI 10.1016/j.gie.2013.01.018; Boukhris SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082646; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Dinis-Ribeiro M, 2012, ENDOSCOPY, V44, P74, DOI 10.1055/s-0031-1291491; El-Zimaity HMT, 1999, HUM PATHOL, V30, P72, DOI 10.1016/S0046-8177(99)90303-9; Emura Fabian, 2013, Rev. gastroenterol. Perú, V33, P52; Fernando N, 2001, J CLIN MICROBIOL, V39, P1323, DOI 10.1128/JCM.39.4.1323-1327.2001; Fialho ABC, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-13; Geraghty J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132043; Guo YT, 2008, ENDOSCOPY, V40, P547, DOI 10.1055/s-2007-995633; Hunt RH, 2015, GUT, V64, P1650, DOI 10.1136/gutjnl-2014-307595; Kayamba V, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0353-8; Kelly P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004600; Kelly P, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-72; Kiesslich R, 2012, GUT, V61, P1146, DOI 10.1136/gutjnl-2011-300695; Kim HM, 2013, SCAND J GASTROENTERO, V48, P1371, DOI 10.3109/00365521.2013.838606; Korac M, 2009, HEPATO-GASTROENTEROL, V56, P1675; Lee SK, 2015, CLIN ENDOSC, V48, P511, DOI 10.5946/ce.2015.48.6.511; Li Z, 2014, ENDOSCOPY, V46, P282, DOI 10.1055/s-0033-1359215; Lim LG, 2013, SURG ENDOSC, V27, P4649, DOI 10.1007/s00464-013-3098-x; Mach T, 2007, MED SCI MONITOR, V13, pCR14; Mansour-Ghanaei F, 2012, ASIAN PAC J CANCER P, V13, P1407, DOI 10.7314/APJCP.2012.13.4.1407; Newton Robert, 2006, Infect Agent Cancer, V1, P5, DOI 10.1186/1750-9378-1-5; Nkuize M, 2010, HIV MED, V11, P412, DOI 10.1111/j.1468-1293.2009.00807.x; Nkuize M, 2012, HELICOBACTER, V17, P153, DOI 10.1111/j.1523-5378.2011.00929.x; Olmos M, 2004, DIGEST DIS SCI, V49, P1836, DOI 10.1007/s10620-004-9580-5; Romanelli F, 2007, AIDS PATIENT CARE ST, V21, P908, DOI 10.1089/apc.2006.0215; SHAFFER RT, 1992, AM J GASTROENTEROL, V87, P1777; Udoh M O, 2012, East Afr Med J, V89, P408; Wallace M, 2011, ENDOSCOPY, V43, P882, DOI 10.1055/s-0030-1256632; Wang FW, 2011, WORLD J GASTROENTERO, V17, P1199, DOI 10.3748/wjg.v17.i9.1199; Wilcox CM, 1999, GUT, V44, P101, DOI 10.1136/gut.44.1.101; World Health Organization, GLOB HLTH OBS HIV AI	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184272	10.1371/journal.pone.0184272	http://dx.doi.org/10.1371/journal.pone.0184272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886101	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100090
J	Lorant, A; Pedersen, S; Holst, I; Hufford, MB; Winter, K; Piperno, D; Ross-Ibarra, J				Lorant, Anne; Pedersen, Sarah; Holst, Irene; Hufford, Matthew B.; Winter, Klaus; Piperno, Dolores; Ross-Ibarra, Jeffrey			The potential role of genetic assimilation during maize domestication	PLOS ONE			English	Article							DEVELOPMENTAL PLASTICITY; PHENOTYPIC PLASTICITY; APICAL DOMINANCE; EVOLUTION; SELECTION; PATTERNS; ORIGIN; EXPRESSION; HISTORY	Domestication research has largely focused on identification of morphological and genetic differences between extant populations of crops and their wild relatives. Little attention has been paid to the potential effects of environment despite substantial known changes in climate from the time of domestication to modern day. In recent research, the exposure of teosinte (i.e., wild maize) to environments similar to the time of domestication, resulted in a plastic induction of domesticated phenotypes in teosinte. These results suggest that early agriculturalists may have selected for genetic mechanisms that cemented domestication phenotypes initially induced by a plastic response of teosinte to environment, a process known as genetic assimilation. To better understand this phenomenon and the potential role of environment in maize domestication, we examined differential gene expression in maize (Zea mays ssp. mays) and teosinte (Zea mays ssp. parviglumis) between past and present conditions. We identified a gene set of over 2000 loci showing a change in expression across environmental conditions in teosinte and invariance in maize. In fact, overall we observed both greater plasticity in gene expression and more substantial changes in co-expressionnal networks in teosinte across environments when compared to maize. While these results suggest genetic assimilation played at least some role in domestication, genes showing expression patterns consistent with assimilation are not significantly enriched for previously identified domestication candidates, indicating assimilation did not have a genome-wide effect.	[Lorant, Anne; Ross-Ibarra, Jeffrey] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Pedersen, Sarah; Hufford, Matthew B.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Holst, Irene; Winter, Klaus; Piperno, Dolores] Smithsonian Trop Res Inst, Panama City, Panama; [Piperno, Dolores] Smithsonian Natl Museum Nat Hist, Dept Anthropol, Washington, DC USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Ross-Ibarra, Jeffrey] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; Iowa State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Smithsonian Institution; Smithsonian National Museum of Natural History; University of California System; University of California Davis; University of California System; University of California Davis	Ross-Ibarra, J (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Ross-Ibarra, J (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Ross-Ibarra, J (corresponding author), Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA.	rossibarra@ucdavis.edu	Ross-Ibarra, Jeffrey/D-7782-2011	Ross-Ibarra, Jeffrey/0000-0003-1656-4954	US National Science Foundation [IOS-0922703, IOS-1238014]; USDA [CA-D-PLS-2066-H]; Smithsonian Institution; Division Of Integrative Organismal Systems [1238014] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); USDA(United States Department of Agriculture (USDA)); Smithsonian Institution(Smithsonian Institution); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded from the US National Science Foundation https://www.nsf.gov/ (IOS-0922703 and IOS-1238014) JRI, USDA https://usdasearch.usda.gov/ (Hatch project CA-D-PLS-2066-H) JRI, and the Smithsonian Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors wish to acknowledge funding support from the US National Science Foundation (IOS-0922703 and IOS-1238014), USDA (Hatch project CA-D-PLS-2066-H) and the Smithsonian Institution. We would like to acknowledge Milton Garcia for his technical assistance. We would also like to thank members of the Ross-Ibarra lab for comments on earlier drafts of the manuscript.	Ahn J, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004415; Alter P, 2016, PLANT PHYSIOL, V172, P389, DOI 10.1104/pp.16.00285; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bassu S, 2014, GLOBAL CHANGE BIOL, V20, P2301, DOI 10.1111/gcb.12520; Beadle George W., 1972, FIELD MUSEUM NATURAL; Beldade P, 2011, MOL ECOL, V20, P1347, DOI 10.1111/j.1365-294X.2011.05016.x; Bomblies K, 2006, GENETICS, V172, P519, DOI 10.1534/genetics.105.048595; Briggs WH, 2007, GENETICS, V177, P1915, DOI 10.1534/genetics.107.076497; Bush Mark B, 2009, CLIMATE VARIABILITY, P113; Colebrook EH, 2014, J EXP BIOL, V217, P67, DOI 10.1242/jeb.089938; Diggle PK, 2013, AM J BOT, V100, P1050, DOI 10.3732/ajb.1200647; Doebley J, 2004, ANNU REV GENET, V38, P37, DOI 10.1146/annurev.genet.38.072902.092425; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1995, GENETICS, V141, P333; Footitt S, 2013, PLANT J, V74, P1003, DOI 10.1111/tpj.12186; Gallavotti A, 2013, J EXP BOT, V64, P2593, DOI 10.1093/jxb/ert141; Gilbert Scott F, 2009, ECOLOGICAL DEV BIOL; Hartwig T, 2011, P NATL ACAD SCI USA, V108, P19814, DOI 10.1073/pnas.1108359108; Hendry AP, 2016, J HERED, V107, P25, DOI 10.1093/jhered/esv060; Hirsch Candice N, PALNT CELL; Hodell DA, 2008, QUATERNARY SCI REV, V27, P1152, DOI 10.1016/j.quascirev.2008.02.008; Hu ZJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-17; Hubbard L, 2002, GENETICS, V162, P1927; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hufford Matthew B, 2012, PLOS ONE, V7; Jane West-Eberhard Mary, 2003, DEV PLASTICITY EVOLU; Kebrom TH, 2013, TRENDS PLANT SCI, V18, P41, DOI 10.1016/j.tplants.2012.07.001; Kuzawa CW, 2012, CURR ANTHROPOL, V53, pS369, DOI 10.1086/667410; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Larson G, 2014, P NATL ACAD SCI USA, V111, P6139, DOI 10.1073/pnas.1323964111; Lawit Shai J, 2010, PLANT CELL PHYSL, V51, P1854; Ledon-Rettig Cris C, 1700, P BIOL SCI, V277, P3569; Lemmon ZH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004745; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Magalhaes IS, 2009, J EVOLUTION BIOL, V22, P260, DOI 10.1111/j.1420-9101.2008.01637.x; Marais DLD, 2013, ANNU REV ECOL EVOL S, V44, P5, DOI 10.1146/annurev-ecolsys-110512-135806; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; McSteen P, 2009, PLANT PHYSIOL, V149, P46, DOI 10.1104/pp.108.129056; Michael Lawrence, 2013, PLOS COMPUT BIOL, V9; Miller Jeremy A, 2010, P NATL ACAD SCI USA, V107, P12698; Moczek AP, 2011, P ROY SOC B-BIOL SCI, V278, P2705, DOI 10.1098/rspb.2011.0971; Paul Gepts, 2012, BIODIVERSITY AGR DOM; Pfennig DW, 2010, PHILOS T R SOC B, V365, P577, DOI 10.1098/rstb.2009.0244; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Piperno DR, 2007, P NATL ACAD SCI USA, V104, P11874, DOI 10.1073/pnas.0703442104; Piperno DR, 2011, CURR ANTHROPOL, V52, pS453, DOI 10.1086/659998; Piperno Dolores R, 2015, QUATERN INT, V363, P65; Piperno DR, 2001, P NATL ACAD SCI USA, V98, P2101, DOI 10.1073/pnas.98.4.2101; Restrepo A, 2012, ECOLOGY, V93, P1853, DOI 10.1890/11-1545.1; Schlichting CD, 2014, EVOLUTION, V68, P656, DOI 10.1111/evo.12348; Schneider RF, 2014, MOL ECOL, V23, P4511, DOI 10.1111/mec.12851; Sergi Munne A-Bosch, 2013, PLANT PHYSIOL, V161, P5; Silin Zhong, 2011, COLD SPRING HARB PRO, P940; Standen EM, 2014, NATURE, V513, P54, DOI 10.1038/nature13708; Studer A, 2011, NAT GENET, V43, P1160, DOI 10.1038/ng.942; Sultan SE, 2009, ECOLOGY, V90, P1831, DOI 10.1890/08-1064.1; Swanson-Wagner R, 2012, P NATL ACAD SCI USA, V109, P11878, DOI 10.1073/pnas.1201961109; Vollbrecht E, 2005, NATURE, V436, P1119, DOI 10.1038/nature03892; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Walworth NG, 2016, P NATL ACAD SCI USA, V113, pE7367, DOI 10.1073/pnas.1605202113; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Whipple CJ, 2011, P NATL ACAD SCI USA, V108, pE506, DOI 10.1073/pnas.1102819108; Wills David M, 2013, PLOS GENET, V9; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Wu Thomas D, 2016, METHOD MOL BIOL, V1418, P283	67	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184202	10.1371/journal.pone.0184202	http://dx.doi.org/10.1371/journal.pone.0184202			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886108	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100079
J	Mekango, DE; Alemayehu, M; Gebregergs, GB; Medhanyie, AA; Goba, G				Mekango, Dejene Ermias; Alemayehu, Mussie; Gebregergs, Gebremedhin Berhe; Medhanyie, Araya Abrha; Goba, Gelila			Determinants of maternal near miss among women in public hospital maternity wards in Northern Ethiopia: A facility based case-control study	PLOS ONE			English	Article							NEAR-MISS; MORBIDITY; BRAZIL; CARE	Background In Ethiopia, 20,000 women die each year from complications related to pregnancy, childbirth and post- partum. For every woman that dies, 20 more experience injury, infection, disease, or disability. "Maternal near miss" (MNM), defined by the World Health Organization (WHO) as a woman who nearly dies, but survives a complication during pregnancy, childbirth or within 42 days of a termination, is a proxy indicator of maternal mortality and quality of obstetric care. In Ethiopia, few studies have examined MNM. This study aims to identify determinants of MNM among a small population of women in Tigray, Ethiopia. Methods Unmatched case- control study was conducted in hospitals in Tigray Region, Northern Ethiopia, from January 30- March 30, 2016. The sample included 103 cases and 205 controls recruited from among women seeking obstetric care at six (6) public hospitals. Clients with life- threatening obstetric complications, including hemorrhage, hypertensive diseases of pregnancy, dystocia, infection, and anemia or clinical signs of severe anemia (in women without hemorrhage) were taken as cases and those with normal obstetric outcomes were controls. Cases were selected based on proportion to size allocation while systematic sampling was employed for controls. Binary and multiple variable logistic regression ("odds ratio") analyses were calculated at 95% CI. Results Roughly 90% of cases and controls were married and 25% experienced their first pregnancy before the age of 16 years. About two-thirds of controls and 45.6% of cases had gestational ages between 37-41 weeks. Among cases, severe obstetric hemorrhage (44.7%), hypertensive disorders (38.8%), dystocia (17.5%), sepsis (9.7%) and severe anemia (2.9%) were leading causes of MNM. Histories of chronic maternal medical problems like hypertension, diabetes were reported in 55.3% of cases and 33.2% of controls. Women with no formal education [AOR = 3.2; 95% CI:1.24, 8.12], being less than 16 years of age at first pregnancy [AOR = 2.5; 95% CI:1.12,5.63], induced labor[AOR = 3.0; 95% CI:1.44, 6.17], history of cesarean section[AOR = 4.6; 95% CI:1.98, 7.61] or chronic medical disorder[AOR = 3.5; 95% CI:1.78, 6.93], and women who traveled more than 60 minutes before reaching their final place of care[AOR = 2.8; 95% CI:1.19,6.35] had higher odds of experiencing MNM. Conclusions Macro-developments like increasing road and health facility access as well as expanding education will all help reduce MNM. Work should be continued to educate women and providers about common predictors of MNM like history of C-section and chronic illness as well as teenage pregnancy. These efforts should be carried out at the facility, community, and individual levels. Targeted follow-up with women with history of chronic disease and C-section could also help reduce MNM.	[Mekango, Dejene Ermias] Wachemo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Hosanna, Ethiopia; [Alemayehu, Mussie; Gebregergs, Gebremedhin Berhe; Medhanyie, Araya Abrha] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia; [Goba, Gelila] Univ Illinois, Dept Obstet & Gynecol, Chicago, IL USA	Mekelle University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mekango, DE (corresponding author), Wachemo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Hosanna, Ethiopia.	dj.ermi2005@gmail.com	Dangal, Ganesh/O-1989-2017; Alemayehu, Mussie/AAH-3016-2019	Dangal, Ganesh/0000-0002-5834-5525; Alemayehu, Mussie/0000-0002-0035-631X	Mekelle University's College of Health Sciences	Mekelle University's College of Health Sciences	We would like to thank Mekelle University's College of Health Sciences for funding this research.	Adeoye IA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-93; [Anonymous], 2012, ETHIOPIAN J REPROD H; Assarag B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116675; Dias MAB, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00154213; Cecatti JG, 2007, REPROD HEALTH MATTER, V15, P125, DOI 10.1016/S0968-8080(07)30333-9; Central Statistical Agency of Ethiopia, 2011, ETH DEM HLTH SURV 20; Pacheco AJC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-91; Dile M A T, 2015, GYNECOL OBSTET SUNNY, V5; Federal Ministry of Health, 2015, HLTH SECT PLAN 2015; Federal Ministry of Health, 2014, MAT DEATH SURV RESP; Filippi V, 2005, ACTA OBSTET GYN SCAN, V84, P11, DOI 10.1111/j.0001-6349.2005.00636.x; Filippi V, 2009, BEST PRACT RES CL OB, V23, P389, DOI 10.1016/j.bpobgyn.2008.12.006; Gedefaw M., 2014, OPEN J EPIDEMIOLOGY, V4, P199, DOI [10.4236/ojepi.2014.44026, DOI 10.4236/OJEPI.2014.44026]; Gray KE, 2012, PAEDIATR PERINAT EP, V26, P506, DOI 10.1111/ppe.12011; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Galvao LPL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-25; Lotufo FA, 2012, CLINICS, V67, P225, DOI 10.6061/clinics/2012(03)04; Luexay P, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-945; Paxton A, 2011, NEW ENGL J MED, V364, P1990, DOI 10.1056/NEJMp1012860; de Moraes APP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-11; Requejo JH, 2015, LANCET, V385, P466, DOI 10.1016/S0140-6736(14)60925-9; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Souza J P, 2007, BMC Pregnancy Childbirth, V7, P20, DOI 10.1186/1471-2393-7-20; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; Tigray Regional Health Bureau, 2014, GOVT NAT STAT TIGR R; WHO UNICEF, 2011, TRENDS MAT MORT 1990; WHO UNICEF UNFPA, 2014, WORLD BANK UN POP DI; Wianwiset W., 2012, THAI J OBSTET GYNAEC, V20, P69; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG; Zanette E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-4; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	31	21	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183886	10.1371/journal.pone.0183886	http://dx.doi.org/10.1371/journal.pone.0183886			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886034	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100043
J	Okahara, K; Nagata, N; Shimada, T; Joya, A; Hayashida, T; Gatanaga, H; Oka, S; Sakurai, T; Uemura, N; Akiyama, J				Okahara, Koki; Nagata, Naoyoshi; Shimada, Takayuki; Joya, Akane; Hayashida, Tsunefusa; Gatanaga, Hiroyuki; Oka, Shinichi; Sakurai, Toshiyuki; Uemura, Naomi; Akiyama, Junichi			Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; REAL-TIME PCR; INFECTION; CELLS; CMV; TRANSPLANTATION; MANAGEMENT; DIAGNOSIS; BIOPSY; TISSUE	Background We aimed to identify the risk factors associated with colonic cytomegalovirus (CMV) infection in ulcerative colitis (UC) and to compare the clinical course between antiviral therapy-treated and-untreated groups in mucosal CMV-polymerase chain reaction (PCR)-positive cases. Methods We retrospectively selected 46 UC patients (> 15 years old) in active phase who underwent colonoscopy with biopsy and were analyzed for CMV infection by mucosal PCR between October 2011 and December 2015 at our institution. Colonic CMV in inflamed mucosa was detected using quantitative real-time PCR. The clinical course was evaluated, including need for drug therapy/ surgery or drug therapy intensification. In addition, we evaluated the clinical course between CMV-DNA-cases and CMV-DNA+ cases with low viral load. Results At baseline, CMV-DNA+ patients were significantly older, had higher endoscopic scores, and required higher corticosteroid doses during the past 4 weeks than CMV-DNA-patients (p<0.05). No significant differences were observed in disease duration, disease distribution, laboratory data, or use of other medication between CMV-DNA+ and CMV-DNA-patients. In the anti-CMV-treated group with a median (range) DNA load of 16,000 (9,000-36,400), 3patients achieved remission without additional UC therapy, 2 required additional UC therapy, and 1 required colectomy despite azathioprine and infliximab therapy. In the CMV-untreated group with a median (range) DNA load of 919 (157-5,480), all patients achieved remission with UC therapy alone. No significant difference was observed in the clinical course between CMV-DNA-cases and CMV-DNA+ cases with low viral loads. Conclusions Aging, endoscopic UC activity, and corticosteroid dose predispose to colonic CMV infection, as determined by mucosal PCR, in UC. UC treatment without anti-CMV therapy may be warranted, particularly in patients with low-load CMV-DNA. Anti-CMV therapy alone does not always achieve clinical response in UC even in cases with high-load PCR.	[Okahara, Koki; Nagata, Naoyoshi; Shimada, Takayuki; Sakurai, Toshiyuki; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Okahara, Koki] Juntendo Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Joya, Akane; Hayashida, Tsunefusa; Gatanaga, Hiroyuki; Oka, Shinichi] Natl Ctr Global Hlth & Med, Dept AIDS Clin Ctr, Tokyo, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	National Center for Global Health & Medicine - Japan; Juntendo University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan.	nnagata_ncgm@yahoo.co.jp			National Center for Global Health and Medicine [29-2001]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This work was supported in part by a Grant for Research from the National Center for Global Health and Medicine (29-2001). The funding agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayre K, 2009, J CROHNS COLITIS, V3, P141, DOI 10.1016/j.crohns.2009.03.002; Bonta J, 2016, EUR J GASTROEN HEPAT, V28, P1329, DOI 10.1097/MEG.0000000000000716; Campos Sara T., 2017, INT J COLORECTAL DIS, V32, P645; Fukuchi T, 2013, J CROHNS COLITIS, V7, P803, DOI 10.1016/j.crohns.2012.12.003; GOODGAME RW, 1993, ANN INTERN MED, V119, P924, DOI 10.7326/0003-4819-119-9-199311010-00010; Lawlor G, 2010, INFLAMM BOWEL DIS, V16, P1620, DOI 10.1002/ibd.21275; Lu SH, 2011, J CELL MOL MED, V15, P587, DOI 10.1111/j.1582-4934.2010.01017.x; Machida U, 2000, J CLIN MICROBIOL, V38, P2536, DOI 10.1128/JCM.38.7.2536-2542.2000; Martonez-Montiel MP, 2013, CLIN GASTEROENTEROLH, V11, P673; Matsuoka K, 2007, AM J GASTROENTEROL, V102, P331, DOI 10.1111/j.1572-0241.2006.00989.x; Mills AM, 2013, AM J SURG PATHOL, V37, P995, DOI 10.1097/PAS.0b013e31827fcc33; Nagata N, 2013, CLIN GASTROENTEROL H, V11, P673, DOI 10.1016/j.cgh.2012.12.034; Nagata N, 2011, WORLD J GASTROENTERO, V17, P1185, DOI 10.3748/wjg.v17.i9.1185; Pillet S, 2016, WORLD J GASTROENTERO, V22, P2030, DOI 10.3748/wjg.v22.i6.2030; Rahier JF, 2014, J CROHNS COLITIS, V8, P443, DOI 10.1016/j.crohns.2013.12.013; Roblin X, 2011, AM J GASTROENTEROL, V106, P2001, DOI 10.1038/ajg.2011.202; SUTHERLAND LR, 1987, GASTROENTEROLOGY, V92, P1894, DOI 10.1016/0016-5085(87)90621-4; Suzuki H, 2010, WORLD J GASTROENTERO, V16, P1245, DOI 10.3748/wjg.v16.i10.1245; Takahashi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133589; Thorn M, 2016, SCAND J GASTROENTERO, V51, P1075, DOI 10.3109/00365521.2016.1156154; Tremaine WJ, 1997, NETH J MED, V50, pS12, DOI 10.1016/S0300-2977(96)00065-4; Widmann T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003634; Yoshino T, 2007, INFLAMM BOWEL DIS, V13, P1516, DOI 10.1002/ibd.20253; Zagorowicz E, 2016, J CROHNS COLITIS, V10, P1205, DOI 10.1093/ecco-jcc/jjw071	24	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183951	10.1371/journal.pone.0183951	http://dx.doi.org/10.1371/journal.pone.0183951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886066	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100046
J	Takase, H; Kurihara, Y; Yokoyama, T; Kawahara, N; Takei, K				Takase, Hajime; Kurihara, Yuji; Yokoyama, Taka-akira; Kawahara, Nobutaka; Takei, Kohtaro			LOTUS overexpression accelerates neuronal plasticity after focal brain ischemia in mice	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; FUNCTIONAL RECOVERY; NOGO-A; STROKE RECOVERY; MOUSE MODEL; ADULT RATS; OCCLUSION; FORELIMB; BLOCKADE; CORTEX	Nogo receptor-1 (NgR1) and its ligands inhibit neuronal plasticity and limit functional recovery after brain damage such as ischemic stroke. We have previously shown that lateral olfactory tract usher substance (LOTUS) antagonizes NgR1-mediated signaling. Here, we investigated whether LOTUS enhances neuronal plasticity and functional recovery after brain focal ischemia in adult mice. Focal ischemic infarcts were induced in wild-type and LOTUS-overexpressing transgenic mice via middle cerebral artery occlusion. Endogenous LOTUS expression was increased in brain and cervical spinal cord of the contralateral side of ischemia in the chronic phase after brain ischemia. LOTUS overexpression accelerated midline-crossing axonal sprouting from the contralateral side to the ipsilateral side of ischemia in the medullar reticular formation and gray matter of denervated cervical spinal cord. Importantly, LOTUS overexpression improved neurological score highly correlated with laterality ratio of corticoreticular fibers of the medulla oblongata, indicating that LOTUS overexpression may overcome the inhibitory environment induced by NgR1 signaling for damaged motor pathway reconstruction after ischemic stroke. Thus, our data suggest that LOTUS overexpression accelerates neuronal plasticity in the brainstem and cervical spinal cord after stroke and LOTUS administration is useful for future therapeutic strategies.	[Takase, Hajime; Yokoyama, Taka-akira; Kawahara, Nobutaka] Yokohama City Univ, Grad Sch Med, Dept Neurosurg, Yokohama, Kanagawa, Japan; [Takase, Hajime; Kurihara, Yuji; Yokoyama, Taka-akira; Takei, Kohtaro] Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Mol Med Biosci Lab, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University	Kawahara, N (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Neurosurg, Yokohama, Kanagawa, Japan.; Takei, K (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Dept Med Life Sci, Mol Med Biosci Lab, Yokohama, Kanagawa, Japan.	nkawa@yokohama-cu.ac.jp; kohtaro@yokohama-cu.ac.jp		Takei, Kohtaro/0000-0001-6938-0812; Takase, Hajime/0000-0001-5813-1386	Ministry of Education, Culture, Sport, Science and Technology of Japan [15H04951]; Mihara Cerebrovascular Disorder Research Promotion Fund; Japan Brain Foundation [2584]; Yokohama Academic Foundation	Ministry of Education, Culture, Sport, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mihara Cerebrovascular Disorder Research Promotion Fund; Japan Brain Foundation; Yokohama Academic Foundation	This work received support from The Ministry of Education, Culture, Sport, Science and Technology of Japan (Grant number; 15H04951, http://www.mext.go.jp/en/); Mihara Cerebrovascular Disorder Research Promotion Fund(no grant number, http://square.umin.ac.jp/mihara/index_j.html); Japan Brain Foundation (Grant Number; 2584, http://jbf.or.jp//; and Yokohama Academic Foundation(no Grant Number, https://www.hamakko.or.jp/similar to yokogaku/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alia C, 2016, SCI REP-UK, V6, DOI 10.1038/srep37823; [Anonymous], 2010, NATURE PRECEDINGS; Arai K, 2011, J CHILD NEUROL, V26, P1193, DOI 10.1177/0883073811408610; Baker SN, 2015, PROG BRAIN RES, V218, P389, DOI 10.1016/bs.pbr.2014.12.010; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Bradnam LV, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00184; Cheatwood JL, 2008, STROKE, V39, P2091, DOI 10.1161/STROKEAHA.107.507426; Egawa N, 2016, TRANSL STROKE RES; Fang PC, 2010, STROKE, V41, P544, DOI 10.1161/STROKEAHA.109.572073; Fisher KM, 2012, J PHYSIOL-LONDON, V590, P4045, DOI 10.1113/jphysiol.2011.226209; Fujii M, 1997, STROKE, V28, P1805, DOI 10.1161/01.STR.28.9.1805; Hetze S, 2012, J NEUROSCI METH, V206, P7, DOI 10.1016/j.jneumeth.2012.02.001; Jang SH, 2014, SOMATOSENS MOT RES, V31, P204, DOI 10.3109/08990220.2014.917292; Jiang W, 2009, TRANSL RES, V154, P40, DOI 10.1016/j.trsl.2009.04.005; Jolkkonen J, 2016, TRANSL STROKE RES, V7, P331, DOI 10.1007/s12975-016-0461-y; Kilic E, 2010, J CEREBR BLOOD F MET, V30, P969, DOI 10.1038/jcbfm.2009.268; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Kurihara Y, 2014, MOL CELL NEUROSCI, V61, P211, DOI 10.1016/j.mcn.2014.07.001; Lee JK, 2010, NEURON, V66, P663, DOI 10.1016/j.neuron.2010.05.002; Lee JK, 2004, J NEUROSCI, V24, P6209, DOI 10.1523/JNEUROSCI.1643-04.2004; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Markus TM, 2005, ANN NEUROL, V58, P950, DOI 10.1002/ana.20676; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Park Sin-Young, 2014, Exp Neurobiol, V23, P104, DOI 10.5607/en.2014.23.1.104; PASSINGHAM RE, 1983, BRAIN, V106, P675, DOI 10.1093/brain/106.3.675; Raineteau O, 1999, EUR J NEUROSCI, V11, P1486, DOI 10.1046/j.1460-9568.1999.00560.x; Reitmeir R, 2011, BRAIN, V134, P84, DOI 10.1093/brain/awq344; Rosell A, 2013, TRANSL STROKE RES, V4, P297, DOI 10.1007/s12975-012-0234-1; Rupadevi M, 2011, J PHARMACOL PHARMACO, V2, P36, DOI 10.4103/0976-500X.77113; Sato Y, 2011, SCIENCE, V333, P769, DOI 10.1126/science.1204144; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Soblosky JS, 1996, BEHAV BRAIN RES, V79, P79, DOI 10.1016/0166-4328(95)00264-2; Sozmen EG, 2016, P NATL ACAD SCI USA, V113, pE8453, DOI 10.1073/pnas.1615322113; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Takakusaki K, 2015, J NEURAL TRANSM VIEN; Takiguchi M, 2015, NEUROSCIENCE, V304, P349, DOI 10.1016/j.neuroscience.2015.07.046; Tamura M, 2001, BRAIN RES, V890, P170, DOI 10.1016/S0006-8993(00)03168-1; Tosolini AP, 2012, NEUROSCIENCE, V200, P19, DOI 10.1016/j.neuroscience.2011.10.054; Tsai SY, 2007, EXP BRAIN RES, V182, P261, DOI 10.1007/s00221-007-1067-0; Tsai SY, 2011, STROKE, V42, P186, DOI 10.1161/STROKEAHA.110.590083; Ueno M, 2012, BRAIN, V135, P1253, DOI 10.1093/brain/aws053; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wiessner C, 2003, J CEREBR BLOOD F MET, V23, P154, DOI 10.1097/01.WCB.0000040400.30600.AF; Ye YL, 2012, BIOL PHARM BULL, V35, P355, DOI 10.1248/bpb.35.355; Yuan FL, 2012, J NEUROTRAUM, V29, P1499, DOI 10.1089/neu.2011.2105; Zaleska MM, 2009, NEUROPHARMACOLOGY, V56, P329, DOI 10.1016/j.neuropharm.2008.10.006; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387; Zhou CM, 2003, BIOCHEM BIOPH RES CO, V309, P368, DOI 10.1016/j.bbrc.2003.08.006	50	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184258	10.1371/journal.pone.0184258	http://dx.doi.org/10.1371/journal.pone.0184258			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880879	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200044
J	Cherkaoui-Rbati, MH; Paine, SW; Littlewood, P; Rauch, C				Cherkaoui-Rbati, Mohammed H.; Paine, Stuart W.; Littlewood, Peter; Rauch, Cyril			A quantitative systems pharmacology approach, incorporating a novel liver model, for predicting pharmacokinetic drug-drug interactions	PLOS ONE			English	Article							CRYOPRESERVED HUMAN HEPATOCYTES; CYTOCHROME-P450 3A ACTIVITY; IN-VITRO; HEPATIC ELIMINATION; METABOLIC-CLEARANCE; DISPERSION MODEL; ORAL MIDAZOLAM; INDUCTION DATA; INHIBITION; CYP3A	All pharmaceutical companies are required to assess pharmacokinetic drug- drug interactions (DDIs) of new chemical entities (NCEs) and mathematical prediction helps to select the best NCE candidate with regard to adverse effects resulting from a DDI before any costly clinical studies. Most current models assume that the liver is a homogeneous organ where the majority of the metabolism occurs. However, the circulatory system of the liver has a complex hierarchical geometry which distributes xenobiotics throughout the organ. Nevertheless, the lobule (liver unit), located at the end of each branch, is composed of many sinusoids where the blood flow can vary and therefore creates heterogeneity (e. g. drug concentration, enzyme level). A liver model was constructed by describing the geometry of a lobule, where the blood velocity increases toward the central vein, and by modeling the exchange mechanisms between the blood and hepatocytes. Moreover, the three major DDI mechanisms of metabolic enzymes; competitive inhibition, mechanism based inhibition and induction, were accounted for with an undefined number of drugs and/or enzymes. The liver model was incorporated into a physiological- based pharmacokinetic (PBPK) model and simulations produced, that in turn were compared to ten clinical results. The liver model generated a hierarchy of 5 sinusoidal levels and estimated a blood volume of 283 mL and a cell density of 193 x 10(6) cells/g in the liver. The overall PBPK model predicted the pharmacokinetics of midazolam and the magnitude of the clinical DDI with perpetrator drug(s) including spatial and temporal enzyme levels changes. The model presented herein may reduce costs and the use of laboratory animals and give the opportunity to explore different clinical scenarios, which reduce the risk of adverse events, prior to costly human clinical studies.	[Cherkaoui-Rbati, Mohammed H.; Paine, Stuart W.; Rauch, Cyril] Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England; [Littlewood, Peter] Vertex Pharmaceut Europe Ltd, Abingdon, Oxon, England	University of Nottingham; Vertex Pharmaceuticals	Cherkaoui-Rbati, MH (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Loughborough, Leics, England.	mohammed.h.cherkaoui@gmail.com	rauch, cyril/G-5380-2011	CHERKAOUI RBATI, Mohammed, Hussain/0000-0001-9630-3863; Rauch, Cyril/0000-0001-8584-420X	Vertex Pharmaceutical	Vertex Pharmaceutical(Vertex Pharmaceuticals)	The funder, Vertex Pharmaceutical, provided support in the form of PhD sponsoring for MHCR and welcomed MHCR in their offices for 6 months to conduct his experiments, where PL was supervising him. Furthermore, PL was attending in a regular basis meetings at the University of Nottingham from the conceptualization to the validation of the PhD. Finally he was also part of the review of this manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Abdel-Rahman SM, 1998, ANTIMICROB AGENTS CH, V42, P2706, DOI 10.1128/AAC.42.10.2706; Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569; [Anonymous], 2015, MATLAB VERS 8 6 R201; BACKMAN JT, 1994, BRIT J CLIN PHARMACO, V37, P221, DOI 10.1111/j.1365-2125.1994.tb04266.x; Bjorkman S, 2001, J PHARM SCI-US, V90, P1226, DOI 10.1002/jps.1076; BRAMMER KW, 1990, REV INFECT DIS, V12, pS318; Brown HS, 2007, DRUG METAB DISPOS, V35, P293, DOI 10.1124/dmd.106.011569; Chien JY, 2006, DRUG METAB DISPOS, V34, P1208, DOI 10.1124/dmd.105.008730; Chung E, 2006, CLIN PHARMACOL THER, V79, P350, DOI 10.1016/j.clpt.2005.11.016; Dash A, 2013, AM J PHYSIOL-CELL PH, V304, pC1053, DOI 10.1152/ajpcell.00331.2012; Einolfl HJ, 2014, CLIN PHARMACOL THER, V95, P179, DOI 10.1038/clpt.2013.170; Fahmi OA, 2008, DRUG METAB DISPOS, V36, P1971, DOI 10.1124/dmd.108.021907; Fahmi OA, 2008, DRUG METAB DISPOS, V36, P1698, DOI 10.1124/dmd.107.018663; Fahmi OA, 2009, DRUG METAB DISPOS, V37, P1658, DOI 10.1124/dmd.108.026252; FEE JPH, 1987, CLIN PHARMACOL THER, V41, P80, DOI 10.1038/clpt.1987.13; FOULDS G, 1990, J ANTIMICROB CHEMOTH, V25, P73, DOI 10.1093/jac/25.suppl_A.73; Gertz M, 2011, DRUG METAB DISPOS, V39, P1633, DOI 10.1124/dmd.111.039248; Guest EJ, 2011, BRIT J CLIN PHARMACO, V71, P72, DOI 10.1111/j.1365-2125.2010.03799.x; Guo HF, 2013, J PHARM SCI-US, V102, P2819, DOI 10.1002/jps.23613; Gurley B, 2006, J CLIN PHARMACOL, V46, P201, DOI 10.1177/0091270005284854; Hisaka A, 2010, DRUG METAB PHARMACOK, V25, P48, DOI 10.2133/dmpk.25.48; Huang SM, 2008, J CLIN PHARMACOL, V48, P662, DOI 10.1177/0091270007312153; Ito K, 2003, DRUG METAB DISPOS, V31, P945, DOI 10.1124/dmd.31.7.945; Jungermann K, 2000, HEPATOLOGY, V31, P255, DOI 10.1002/hep.510310201; Lam YWF, 2003, J CLIN PHARMACOL, V43, P1274, DOI 10.1177/0091270003259216; Ma JD, 2006, J CLIN PHARMACOL, V46, P103, DOI 10.1177/0091270005283286; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; OLKKOLA KT, 1994, CLIN PHARMACOL THER, V55, P481, DOI 10.1038/clpt.1994.60; Olkkola KT, 1996, ANESTH ANALG, V82, P511, DOI 10.1097/00000539-199603000-00015; Paine SW, 2008, DRUG METAB DISPOS, V36, P1365, DOI 10.1124/dmd.107.019455; Paixao P, 2009, EUR J PHARM SCI, V36, P544, DOI 10.1016/j.ejps.2008.12.011; Palovaara S, 2000, BRIT J CLIN PHARMACO, V50, P333, DOI 10.1046/j.1365-2125.2000.00271.x; Pang K S, 1977, J Pharmacokinet Biopharm, V5, P655, DOI 10.1007/BF01059689; Pang KS, 1977, J PHARMACOKINET BIOP, V5; Quinney SK, 2010, DRUG METAB DISPOS, V38, P241, DOI 10.1124/dmd.109.028746; Rezania V, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-52; Riley RJ, 2005, DRUG METAB DISPOS, V33, P1304, DOI 10.1124/dmd.105.004259; ROBERTS MS, 1986, J PHARMACOKINET BIOP, V14, P261, DOI 10.1007/BF01106707; ROBERTS MS, 1986, J PHARMACOKINET BIOP, V14, P227, DOI 10.1007/BF01106706; Rodvold KA, 1999, CLIN PHARMACOKINET, V37, P385, DOI 10.2165/00003088-199937050-00003; Saito H, 2000, PHARM RES-DORDR, V17, P761, DOI 10.1023/A:1007550820196; SCHENKER S, 1988, CLIN PHARMACOL THER, V44, P353, DOI 10.1038/clpt.1988.161; Shitara Y, 2005, ANNU REV PHARMACOL, V45, P689, DOI 10.1146/annurev.pharmtox.44.101802.121444; Siggers JH, 2014, BIOMECH MODEL MECHAN, V13, P363, DOI 10.1007/s10237-013-0516-x; Snyder W, 1975, REPORT TASK GROUP RE, P23; Soars MG, 2009, MOL PHARMACEUT, V6, P1662, DOI 10.1021/mp800246x; Tannenbaum C, 2014, EXPERT REV CLIN PHAR, V7, P533, DOI 10.1586/17512433.2014.910111; *US FDA, 1997, GUID IND DRUG MET DR; Walsky RL, 2004, DRUG METAB DISPOS, V32, P647, DOI 10.1124/dmd.32.6.647; Wambaugh J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000756; Wilson ZE, 2003, BRIT J CLIN PHARMACO, V56, P433, DOI 10.1046/j.1365-2125.2003.01881.x; Yamano K, 1999, DRUG METAB DISPOS, V27, P1225; Yang JS, 2007, CURR DRUG METAB, V8, P676, DOI 10.2174/138920007782109733; Yee SY, 1997, PHARMACEUT RES, V14, P763, DOI 10.1023/A:1012102522787; Yeo KR, 2010, EUR J PHARM SCI, V39, P298, DOI 10.1016/j.ejps.2009.12.002; Zhang HJ, 2007, CLIN PHARMACOKINET, V46, P133, DOI 10.2165/00003088-200746020-00003; Zimmermann T, 1996, ARZNEIMITTEL-FORSCH, V46, P213	58	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183794	10.1371/journal.pone.0183794	http://dx.doi.org/10.1371/journal.pone.0183794			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910306	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200017
J	Khedoe, PPSJ; de Kleijn, S; van Oeveren-Rietdijk, AM; Plomp, JJ; de Boer, HC; van Pel, M; Rensen, PCN; Berbee, JFP; Hiemstra, PS				Khedoe, P. Padmini S. J.; de Kleijn, Stan; van Oeveren-Rietdijk, Annemarie M.; Plomp, Jaap J.; de Boer, Hetty C.; van Pel, Melissa; Rensen, Patrick C. N.; Berbee, Jimmy F. P.; Hiemstra, Pieter S.			Acute and chronic effects of treatment with mesenchymal stromal cells on LPS-induced pulmonary inflammation, emphysema and atherosclerosis development	PLOS ONE			English	Article							STEM-CELLS; LUNG INJURY; TRANSPLANTATION; MODEL; SURVIVAL; DELIVERY; DISEASE; COPD; MICE	Background COPD is a pulmonary disorder often accompanied by cardiovascular disease (CVD), and current treatment of this comorbidity is suboptimal. Systemic inflammation in COPD triggered by smoke and microbial exposure is suggested to link COPD and CVD. Mesenchymal stromal cells (MSC) possess anti-inflammatory capacities and MSC treatment is considered an attractive treatment option for various chronic inflammatory diseases. Therefore, we investigated the immunomodulatory properties of MSC in an acute and chronic model of lipopolysaccharide (LPS)-induced inflammation, emphysema and atherosclerosis development in APOE*3-Leiden (E3L) mice. Methods Hyperlipidemic E3L mice were intranasally instilled with 10 mu g LPS or vehicle twice in an acute 4-day study, or twice weekly during 20 weeks Western-type diet feeding in a chronic study. Mice received 0.5x10 6 MSC or vehicle intravenously twice after the first LPS instillation (acute study) or in week 14, 16, 18 and 20 (chronic study). Inflammatory parameters were measured in bronchoalveolar lavage (BAL) and lung tissue. Emphysema, pulmonary inflammation and atherosclerosis were assessed in the chronic study. Results In the acute study, intranasal LPS administration induced a marked systemic IL-6 response on day 3, which was inhibited after MSC treatment. Furthermore, MSC treatment reduced LPS-induced total cell count in BAL due to reduced neutrophil numbers. In the chronic study, LPS increased emphysema but did not aggravate atherosclerosis. Emphysema and atherosclerosis development were unaffected after MSC treatment. Conclusion These data show that MSC inhibit LPS-induced pulmonary and systemic inflammation in the acute study, whereas MSC treatment had no effect on inflammation, emphysema and atherosclerosis development in the chronic study.	[Khedoe, P. Padmini S. J.; de Kleijn, Stan; Hiemstra, Pieter S.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands; [Khedoe, P. Padmini S. J.; Rensen, Patrick C. N.; Berbee, Jimmy F. P.] Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Leiden, Netherlands; [van Oeveren-Rietdijk, Annemarie M.; de Boer, Hetty C.] Leiden Univ, Med Ctr, Div Nephrol, Dept Med, Leiden, Netherlands; [van Oeveren-Rietdijk, Annemarie M.; de Boer, Hetty C.; Rensen, Patrick C. N.; Berbee, Jimmy F. P.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Plomp, Jaap J.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [van Pel, Melissa] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Khedoe, PPSJ (corresponding author), Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands.; Khedoe, PPSJ (corresponding author), Leiden Univ, Med Ctr, Dept Med, Div Endocrinol, Leiden, Netherlands.	p.p.s.j.khedoe@lumc.nl	Hiemstra, Pieter S/K-8587-2018; /V-8478-2019; Rensen, Patrick C.N./D-7176-2018	Hiemstra, Pieter S/0000-0002-0238-5982; Rensen, Patrick C.N./0000-0002-8455-4988; Khedoe, Padmini/0000-0002-0798-014X	Lung Foundation Netherlands [3.2.10.048]; P.C.N.R. is an Established Investigator of the Dutch Heart Foundation [2009T038]	Lung Foundation Netherlands; P.C.N.R. is an Established Investigator of the Dutch Heart Foundation	This research was funded by a grant from the Lung Foundation Netherlands (grant 3.2.10.048). P.C.N.R. is an Established Investigator of the Dutch Heart Foundation (2009T038).	Abedin M, 2004, CIRC RES, V95, P671, DOI 10.1161/01.RES.0000143421.27684.12; Antunes MA, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0118-x; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Atsma DE, 2007, CURR OPIN LIPIDOL, V18, P645, DOI 10.1097/MOL.0b013e3282f0dd1f; Barua RS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00572; Bayes HK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35838; Bernardo ME, 2015, IMMUNOL LETT, V168, P215, DOI 10.1016/j.imlet.2015.06.013; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Duijvestein M, 2011, STEM CELLS, V29, P1549, DOI 10.1002/stem.698; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; Eggenhofer E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00148; Fabbri LM, 2008, EUR RESPIR J, V31, P204, DOI 10.1183/09031936.00114307; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Fang SM, 2013, THROMB RES, V131, pE253, DOI 10.1016/j.thromres.2013.04.002; Fibbe Willem E, 2014, Rinsho Ketsueki, V55, P2190; Frodermann V, 2015, SCI REP-UK, V5, DOI 10.1038/srep15559; Fruchter O, 2015, AM J MED SCI, V349, P338, DOI 10.1097/MAJ.0000000000000435; GOLD, 2016, GLOBAL STRATEGY DIAG; GU W, 2015, SCI REP UK, V5; Guan XJ, 2013, J CELL BIOCHEM, V114, P323, DOI 10.1002/jcb.24377; Gupta N, 2012, THORAX, V67, P533, DOI 10.1136/thoraxjnl-2011-201176; Havekes LM, 1997, PROSTAG LEUKOTR ESS, V57, P463, DOI 10.1016/S0952-3278(97)90429-4; Hoogduijn MJ, 2013, STEM CELLS DEV, V22, P2825, DOI 10.1089/scd.2013.0193; Huh JW, 2011, AM J PHYSIOL-LUNG C, V301, pL255, DOI 10.1152/ajplung.00253.2010; Katsha AM, 2011, MOL THER, V19, P196, DOI 10.1038/mt.2010.192; Khedoe PPSJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080196; Krasnodembskaya A, 2012, AM J PHYSIOL-LUNG C, V302, pL1003, DOI 10.1152/ajplung.00180.2011; Li MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082743; Liao JQ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/165296; Libby P, 2015, CIRC RES, V116, P307, DOI 10.1161/CIRCRESAHA.116.301313; Luppi Fabrizio, 2008, Proc Am Thorac Soc, V5, P848, DOI 10.1513/pats.200809-101TH; Nussbaumer-Ochsner Y, 2011, CHEST, V139, P165, DOI 10.1378/chest.10-1252; Ojo O, 2014, PULM PHARMACOL THER, V29, P121, DOI 10.1016/j.pupt.2014.04.004; Pera T, 2014, J PHARMACOL EXP THER, V349, P229, DOI 10.1124/jpet.113.210138; Qin ZH, 2012, J CELL MOL MED, V16, P2745, DOI 10.1111/j.1582-4934.2012.01597.x; Schepers K, 2016, ANN NY ACAD SCI, V1370, P15, DOI 10.1111/nyas.12984; Schweitzer KS, 2011, AM J RESP CRIT CARE, V183, P215, DOI 10.1164/rccm.201001-0126OC; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Song LC, 2014, ADV CLIM CHANG RES, V5, P1, DOI 10.3724/SP.J.1248.2014.001; Stolk J, 2016, QJM-INT J MED, V109, P331, DOI 10.1093/qjmed/hcw001; Tibboel J, 2014, COPD, V11, P310, DOI 10.3109/15412555.2013.854322; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Vivodtzev I, 2014, CHEST, V145, P861, DOI 10.1378/chest.13-1809; Weiss DJ, 2014, STEM CELLS, V32, P16, DOI 10.1002/stem.1506; Weiss DJ, 2013, CHEST, V143, P1590, DOI 10.1378/chest.12-2094; Xu QC, 2014, INT J CLIN EXP PATHO, V7, P1580; Zadelaar ASM, 2006, ARTERIOSCL THROM VAS, V26, P2560, DOI 10.1161/01.ATV.0000242904.34700.66; Zhen GH, 2008, FRONT BIOSCI, V13, P3415; Zhen GH, 2010, CYTOTHERAPY, V12, P605, DOI 10.3109/14653241003745888	49	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183741	10.1371/journal.pone.0183741	http://dx.doi.org/10.1371/journal.pone.0183741			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910300	gold, Green Published, Green Submitted			2022-12-27	WOS:000410859200016
J	Han, S; Olonisakin, TF; Pribis, JP; Zupetic, J; Yoon, JH; Holleran, KM; Jeong, K; Shaikh, N; Rubio, DM; Lee, JS				Han, SeungHye; Olonisakin, Tolani F.; Pribis, John P.; Zupetic, Jill; Yoon, Joo Heung; Holleran, Kyle M.; Jeong, Kwonho; Shaikh, Nader; Rubio, Doris M.; Lee, Janet S.			A checklist is associated with increased quality of reporting preclinical biomedical research: A systematic review	PLOS ONE			English	Review							SURGICAL SAFETY CHECKLIST; RANDOMIZED CONTROLLED-TRIALS; CONSORT CHECKLIST; REPRODUCIBILITY; TRANSLATION; STANDARDS; TARGETS; IMPROVE; POLICY	Irreproducibility of preclinical biomedical research has gained recent attention. It is suggested that requiring authors to complete a checklist at the time of manuscript submission would improve the quality and transparency of scientific reporting, and ultimately enhance reproducibility. Whether a checklist enhances quality and transparency in reporting preclinical animal studies, however, has not been empirically studied. Here we searched two highly cited life science journals, one that requires a checklist at submission (Nature) and one that does not (Cell), to identify in vivo animal studies. After screening 943 articles, a total of 80 articles were identified in 2013 (pre-checklist) and 2015 (post-checklist), and included for the detailed evaluation of reporting methodological and analytical information. We compared the quality of reporting preclinical animal studies between the two journals, accounting for differences between journals and changes over time in reporting. We find that reporting of randomization, blinding, and sample-size estimation significantly improved when comparing Nature to Cell from 2013 to 2015, likely due to implementation of a checklist. Specifically, improvement in reporting of the three methodological information was at least three times greater when a mandatory checklist was implemented than when it was not. Reporting the sex of animals and the number of independent experiments performed also improved from 2013 to 2015, likely from factors not related to a checklist. Our study demonstrates that completing a checklist at manuscript submission is associated with improved reporting of key methodological information in preclinical animal studies.	[Han, SeungHye; Olonisakin, Tolani F.; Zupetic, Jill; Yoon, Joo Heung; Lee, Janet S.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA USA; [Pribis, John P.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Holleran, Kyle M.; Jeong, Kwonho; Rubio, Doris M.] Univ Pittsburgh, Ctr Res Hlth Care Data Ctr, Pittsburgh, PA USA; [Shaikh, Nader] Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15213 USA; [Shaikh, Nader; Rubio, Doris M.; Lee, Janet S.] Univ Pittsburgh, Inst Clin Res Educ, Pittsburgh, PA USA; [Rubio, Doris M.] Univ Pittsburgh, Dept Med, Div Gen Internal Med, Pittsburgh, PA USA; [Lee, Janet S.] Univ Pittsburgh, Pittsburgh Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA USA; [Han, SeungHye] Northwestern Univ, Dept Med, Div Pulm & Crit Care, Chicago, IL 60611 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University	Han, S (corresponding author), Northwestern Univ, Dept Med, Div Pulm & Crit Care, Chicago, IL 60611 USA.	shan.workmd@gmail.com		Lee, Janet/0000-0002-6812-6043; Han, SeungHye/0000-0001-5625-6337; Holleran, Kyle/0000-0002-3317-0183; Yoon, Joo Heung/0000-0002-0127-8384	National Institutes of Health [UL1TR001857, HL086884, Al119042]; American Heart Association [15P0ST25700096]; Breathe Pennsylvania Lung Health Research Grant; Howard Hughes Medical Institute Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI119042] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Breathe Pennsylvania Lung Health Research Grant; Howard Hughes Medical Institute Research(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by the National Institutes of Health through Grant Numbers UL1TR001857 (University of Pittsburgh CTSI), HL086884 (JSL), Al119042 (JSL), American Heart Association Award 15P0ST25700096 (SH), Breathe Pennsylvania Lung Health Research Grant (SH), and Howard Hughes Medical Institute Research Fellow Award (TFO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, NATURE, V496, P398, DOI 10.1038/496398a; Baker D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001756; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a; Benger JR, 2002, BRIT MED J, V324, P780, DOI 10.1136/bmj.324.7340.780; Bergs J, 2014, BRIT J SURG, V101, P150, DOI 10.1002/bjs.9381; Bohmer AB, 2012, ACTA ANAESTH SCAND, V56, P332, DOI 10.1111/j.1399-6576.2011.02590.x; Casadevall A, 2010, INFECT IMMUN, V78, P4972, DOI 10.1128/IAI.00908-10; Chen JJ, 2010, CANCER CONTROL, V17, P58, DOI 10.1177/107327481001700108; Contopoulos-Ioannidis DG, 2003, AM J MED, V114, P477, DOI 10.1016/S0002-9343(03)00013-5; Cousens S, 2011, J EPIDEMIOL COMMUN H, V65, P576, DOI 10.1136/jech.2008.082610; Cramond F, 2016, SCIENTOMETRICS, V108, P315, DOI 10.1007/s11192-016-1964-8; Devereaux PJ, 2002, CONTROL CLIN TRIALS, V23, P380, DOI 10.1016/S0197-2456(02)00214-3; Drummond Chris, 2009, 4 WORKSH EV METH MAC; Festing Michael F W, 2002, ILAR J, V43, P244; Florez-Vargas O, 2016, ELIFE, V5, DOI 10.7554/eLife.13615; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; Group OLoEW, 2011, OCEBM LEV EV; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Harris AD, 2004, CLIN INFECT DIS, V38, P1586, DOI 10.1086/420936; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Kane RL, 2007, J CLIN EPIDEMIOL, V60, P241, DOI 10.1016/j.jclinepi.2006.06.016; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; McNutt M, 2014, SCIENCE, V343, P231, DOI 10.1126/science.1250475; Mobley A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063221; Morris R, 2012, NATURE, V491, P192, DOI 10.1038/491192c; Peng RD, 2009, BIOSTATISTICS, V10, P405, DOI 10.1093/biostatistics/kxp014; Plint AC, 2006, MED J AUSTRALIA, V185, P263, DOI 10.5694/j.1326-5377.2006.tb00557.x; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Ramirez FD, 2017, CIRC RES, V120, P1916, DOI 10.1161/CIRCRESAHA.117.310628; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Weiser TG, 2010, INT J QUAL HEALTH C, V22, P365, DOI 10.1093/intqhc/mzq039	35	51	51	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e183591	10.1371/journal.pone.0183591	http://dx.doi.org/10.1371/journal.pone.0183591			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902887	gold, Green Submitted, Green Published			2022-12-27	WOS:000410669200014
J	Bian, A; Shi, MJ; Flores, B; Gillings, N; Li, P; Yan, SX; Levine, B; Xing, CY; Hu, MC				Bian, Ao; Shi, Mingjun; Flores, Brianna; Gillings, Nancy; Li, Peng; Yan, Shirley Xiao; Levine, Beth; Xing, Changying; Hu, Ming Chang			Downregulation of autophagy is associated with severe ischemia-reperfusion-induced acute kidney injury in overexpressing C-reactive protein mice	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; PROXIMAL TUBULAR CELLS; IN-VIVO; INFLAMMATION; DISEASE; KLOTHO; MECHANISMS; MORTALITY; FIBROSIS; DEATH	C-mreactive protein (CRP), was recently reported to be closely associated with poor renal function in patients with acute kidney injury (AKI), but whether CRP is pathogenic or a mere biomarker in AKI remains largely unclear. Impaired autophagy is known to exacerbate renal ischemia-mreperfusion injury (IRI). We examined whether the pathogenic role of CRP in AKI is associated with reduction of autophagy. We mated transgenic rabbit CRP over-mexpressing mice (Tg-mCRP) with two autophagy reporter mouse lines, Tg-mGFP-mLC3 mice (LC3) and TgRFP-GFP-mLC3 mice (RG-mLC3) respectively to generate Tg-mCRP-mGFP-mLC3 mice (PLC3) and Tg-mCRP-mRFP-mGFP-mLC3 mice (PRG-mLC3). AKI was induced by IRI. Compared with LC3 mice, PLC3 mice developed more severe kidney damage after IRI. Renal tubules were isolated from LC3 mice at baseline for primary culture. OKP cells were transiently transfected with GFP-mLC3 plasmid. CRP addition exacerbated lactate dehydrogenase release from both cell types. Immunoblots showed lower LC-3 II/I ratios and higher levels of p62, markers of reduced autophagy flux, in the kidneys of PLC3 mice compared to LC3 mice after IRI, and in primary cultured renal tubules and OKP cells treated with CRP and H2O2 compared to H2O2 alone. Immunohistochemistry showed much fewer LC-m3 punctae, and electron microscopy showed fewer autophagosomes in kidneys of PLC3 mice compared to LC3 mice after IRI. Similarly, CRP addition reduced GFP-mLC3 punctae induced by H2O2 in primary cultured proximal tubules and in GFP-mLC3 plasmid transfected OKP cells. Rapamycin, an autophagy inducer, rescued impaired autophagy and reduced renal injury in vivo. In summary, it was suggested that CRP be more than mere biomarker in AKI, and render the kidney more susceptible to ischemic/oxidative injury, which is associated with down-mregulating autophagy flux.	[Bian, Ao; Li, Peng; Xing, Changying] Nanjing Med Univ, Affiliated Hosp 1, Dept Nephrol, Nanjing, Jiangsu, Peoples R China; [Bian, Ao; Shi, Mingjun; Flores, Brianna; Gillings, Nancy; Hu, Ming Chang] Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA; [Yan, Shirley Xiao] Univ Texas Southwestern Med Ctr Dallas, Dept Pathol, Dallas, TX USA; [Levine, Beth; Hu, Ming Chang] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX USA; [Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Ctr Autophagy Res, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX USA	Nanjing Medical University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Xing, CY (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Nephrol, Nanjing, Jiangsu, Peoples R China.; Hu, MC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA.; Hu, MC (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	cyxing62@126.com; ming-chang.hu@utsouthwestern.edu		Hu, Ming Chang/0000-0002-3235-8301	National Natural Science Foundation of China [81170660H0509, 81270408H0220]; The First Affiliated Hospital of Nanjing Medical University; Provincial Natural Science Foundation of Jiangsu, China [BK2011849]; National Institutes of Health [R01-DK091392, R01-DK092461, R01-CA109618]; University of Texas Southwestern Medical Center; The George M.O' Brien Kidney Research Center/UT Southwestern Medical Center [P30-DK-07938]; NATIONAL CANCER INSTITUTE [R01CA109618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092461] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The First Affiliated Hospital of Nanjing Medical University; Provincial Natural Science Foundation of Jiangsu, China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Southwestern Medical Center; The George M.O' Brien Kidney Research Center/UT Southwestern Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by: 1. National Natural Science Foundation of China (81170660H0509, 81270408H0220), http://www.nsfc.gov.cn/, The First Affiliated Hospital of Nanjing Medical University, CX; 2. Provincial Natural Science Foundation of Jiangsu, China (BK2011849), http.//www.jstd.gov.cn/, The First Affiliated Hospital of Nanjing Medical University, CX; 3. National Institutes of Health (R01-DK091392, R01-DK092461 and R01-CA109618), University of Texas Southwestern Medical Center, MCH; and 4. The George M.O' Brien Kidney Research Center/UT Southwestern Medical Center (P30-DK-07938), MCH.	Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bouchard J, 2015, CLIN J AM SOC NEPHRO, V10, P1324, DOI 10.2215/CJN.04360514; Bravo-San Pedro JM, 2015, AUTOPHAGY, V11, P452, DOI 10.1080/15548627.2015.1017191; Bucaloiu ID, 2012, KIDNEY INT, V81, P477, DOI 10.1038/ki.2011.405; Chang MK, 2002, P NATL ACAD SCI USA, V99, P13043, DOI 10.1073/pnas.192399699; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Ding Y, 2014, J AM SOC NEPHROL, V25, P2835, DOI 10.1681/ASN.2013101068; Ding Y, 2014, SEMIN NEPHROL, V34, P62, DOI 10.1016/j.semnephrol.2013.11.009; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Gao F, 2011, AM J NEPHROL, V34, P203, DOI 10.1159/000329534; Grams ME, 2011, CLIN J AM SOC NEPHRO, V6, P966, DOI 10.2215/CJN.08781010; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Hu MC, 2013, KIDNEY INT, V84, P468, DOI 10.1038/ki.2013.149; Hu MC, 2010, KIDNEY INT, V78, P1240, DOI 10.1038/ki.2010.328; Isaka Y, 2011, AUTOPHAGY, V7, P1085, DOI 10.4161/auto.7.9.16465; Jiang M, 2012, KIDNEY INT, V82, P1271, DOI 10.1038/ki.2012.261; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Kaushal GP, 2004, KIDNEY INT, V66, P500, DOI 10.1111/j.1523-1755.2004.761_6.x; Kaushal GP, 2012, KIDNEY INT, V82, P1250, DOI 10.1038/ki.2012.337; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kimura T, 2011, J AM SOC NEPHROL, V22, P902, DOI 10.1681/ASN.2010070705; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; KUSHNER I, 1961, J EXP MED, V114, P961, DOI 10.1084/jem.114.6.961; Li L, 2014, J AM SOC NEPHROL, V25, P305, DOI 10.1681/ASN.2013040374; Li Z, 2011, LAB INVEST, V91, P837, DOI 10.1038/labinvest.2011.42; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liu F, 2011, DIABETOLOGIA, V54, P2713, DOI 10.1007/s00125-011-2237-y; Liu KD, 2008, CRIT CARE MED, V36, pS187, DOI 10.1097/CCM.0b013e318168ca4a; Liu Y, 2015, CELL DEATH DIFFER, V22, P367, DOI 10.1038/cdd.2014.143; Livingston MJ, 2014, SEMIN NEPHROL, V34, P17, DOI 10.1016/j.semnephrol.2013.11.004; Maejima I, 2013, EMBO J, V32, P2336, DOI 10.1038/emboj.2013.171; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marin TM, 2011, J CLIN INVEST, V121, P1026, DOI 10.1172/JCI44972; Marquez RT, 2012, AM J CANCER RES, V2, P214; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mulvihill NT, 2002, HEART, V87, P201, DOI 10.1136/heart.87.3.201; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohsumi Y, 2014, CELL RES, V24, P9, DOI 10.1038/cr.2013.169; Panesso MC, 2014, KIDNEY INT, V85, P855, DOI 10.1038/ki.2013.489; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pegues MA, 2013, AM J PHYSIOL-RENAL, V304, pF1358, DOI 10.1152/ajprenal.00476.2012; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Roshdy A, 2012, INT UROL NEPHROL, V44, P1251, DOI 10.1007/s11255-011-0098-4; Rutkowski JM, 2013, J AM SOC NEPHROL, V24, P268, DOI 10.1681/ASN.2012040414; Schetz M, 2015, INTENS CARE MED, V41, P1648, DOI 10.1007/s00134-015-3946-3; Schwartz R, 2007, CIRC RES, V100, P1452, DOI 10.1161/01.RES.0000267745.03488.47; Shi M., 2015, J AM SOC NEPHROL; Simmons EM, 2004, KIDNEY INT, V65, P1357, DOI 10.1111/j.1523-1755.2004.00512.x; Takahashi A, 2012, AM J PATHOL, V180, P517, DOI 10.1016/j.ajpath.2011.11.001; Tang Y, 2014, CLIN SCI, V126, P645, DOI 10.1042/CS20130471; Tanigaki K, 2013, DIABETES, V62, P721, DOI 10.2337/db12-0133; Terryn S, 2007, AM J PHYSIOL-RENAL, V293, pF476, DOI 10.1152/ajprenal.00363.2006; Ueda N, 2000, AM J MED, V108, P403, DOI 10.1016/S0002-9343(00)00311-9; Valdivieso JRP, 2008, ARCH MED RES, V39, P326, DOI 10.1016/j.arcmed.2007.11.010; Vongpatanasin W, 2007, CIRCULATION, V115, P1020, DOI 10.1161/CIRCULATIONAHA.106.664854; Vuppalapati KK, 2015, J BONE MINER RES, V30, P2249, DOI 10.1002/jbmr.2575; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1143, DOI 10.1681/ASN.2005091017; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610; Xia DY, 1997, P NATL ACAD SCI USA, V94, P2575, DOI 10.1073/pnas.94.6.2575; Xie QH, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-30; Xu X, 2015, CLIN J AM SOC NEPHRO, V10, P1510, DOI 10.2215/CJN.02140215; Xue JL, 2006, J AM SOC NEPHROL, V17, P1135, DOI 10.1681/ASN.2005060668; Zhang RX, 2010, HYPERTENSION, V55, P953, DOI 10.1161/HYPERTENSIONAHA.109.140608	72	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0181848	10.1371/journal.pone.0181848	http://dx.doi.org/10.1371/journal.pone.0181848			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886014	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100003
J	Heinimann, A; Mertz, O; Frolking, S; Christensen, AE; Hurni, K; Sedano, F; Chini, LP; Sahajpal, R; Hansen, M; Hurtt, G				Heinimann, Andreas; Mertz, Ole; Frolking, Steve; Christensen, Andreas Egelund; Hurni, Kaspar; Sedano, Fernando; Chini, Louise Parsons; Sahajpal, Ritvik; Hansen, Matthew; Hurtt, George			A global view of shifting cultivation: Recent, current, and future extent	PLOS ONE			English	Article							SLASH-AND-BURN; FOREST-AGRICULTURE FRONTIERS; SOUTHEAST-ASIA; LAND-USE; SWIDDEN AGRICULTURE; DYNAMICS; LANDSCAPE; DEFORESTATION; SYSTEMS; CHALLENGES	Mosaic landscapes under shifting cultivation, with their dynamic mix of managed and natural land covers, often fall through the cracks in remote sensing-based land cover and land use classifications, as these are unable to adequately capture such landscapes' dynamic nature and complex spectral and spatial signatures. But information about such landscapes is urgently needed to improve the outcomes of global earth system modelling and large-scale carbon and greenhouse gas accounting. This study combines existing global Landsatbased deforestation data covering the years 2000 to 2014 with very high-resolution satellite imagery to visually detect the specific spatio-temporal pattern of shifting cultivation at a onedegree cell resolution worldwide. The accuracy levels of our classification were high with an overall accuracy above 87%. We estimate the current global extent of shifting cultivation and compare it to other current global mapping endeavors as well as results of literature searches. Based on an expert survey, we make a first attempt at estimating past trends as well as possible future trends in the global distribution of shifting cultivation until the end of the 21st century. With 62% of the investigated one-degree cells in the humid and sub-humid tropics currently showing signs of shifting cultivation-the majority in the Americas (41%) and Africa (37%)-this form of cultivation remains widespread, and it would be wrong to speak of its general global demise in the last decades. We estimate that shifting cultivation landscapes currently cover roughly 280 million hectares worldwide, including both cultivated fields and fallows. While only an approximation, this estimate is clearly smaller than the areas mentioned in the literature which range up to 1,000 million hectares. Based on our expert survey and historical trends we estimate a possible strong decrease in shifting cultivation over the next decades, raising issues of livelihood security and resilience among people currently depending on shifting cultivation.	[Heinimann, Andreas] Univ Bern, Inst Geog, Bern, Switzerland; [Heinimann, Andreas; Hurni, Kaspar] Univ Bern, Ctr Dev & Environm, Bern, Switzerland; [Mertz, Ole; Christensen, Andreas Egelund] Univ Copenhagen, Dept Geosci & Nat Resource Management, Copenhagen K, Denmark; [Frolking, Steve] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [Sedano, Fernando; Chini, Louise Parsons; Sahajpal, Ritvik; Hansen, Matthew; Hurtt, George] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA	University of Bern; University of Bern; University of Copenhagen; University System Of New Hampshire; University of New Hampshire; University System of Maryland; University of Maryland College Park	Heinimann, A (corresponding author), Univ Bern, Inst Geog, Bern, Switzerland.; Heinimann, A (corresponding author), Univ Bern, Ctr Dev & Environm, Bern, Switzerland.	andreas.heinimann@cde.unibe.ch	Frolking, Steve/ABF-9046-2021; Sahajpal, Ritvik/N-4565-2013; Hurtt, George/A-8450-2012; Hurni, Kaspar/H-6208-2019; Hansen, Matthew C/ABE-7226-2020	Frolking, Steve/0000-0001-6414-5004; Sahajpal, Ritvik/0000-0002-6418-289X; Hurtt, George/0000-0001-7278-202X; Hurni, Kaspar/0000-0001-7660-3404; Heinimann, Andreas/0000-0001-8905-8169	Institute of Geography; Centre for Development and Environment (CDE), University of Bern, Switzerland; Swiss National Science Foundation (SNSF); Swiss Agency for Development and Cooperation (SDC) [400440 152167]; U.S. Dept. of Energy [DE-SC0012972]; Global Land Project Grant from the University of Copenhagen; Swiss Programme for Research on Global Issues for Development (r4d)	Institute of Geography; Centre for Development and Environment (CDE), University of Bern, Switzerland; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Swiss Agency for Development and Cooperation (SDC); U.S. Dept. of Energy(United States Department of Energy (DOE)); Global Land Project Grant from the University of Copenhagen; Swiss Programme for Research on Global Issues for Development (r4d)	This research was supported by the Institute of Geography and the Centre for Development and Environment (CDE), University of Bern, Switzerland, as well as the Swiss Programme for Research on Global Issues for Development (r4d) supported by the Swiss National Science Foundation (SNSF) and the Swiss Agency for Development and Cooperation (SDC), grant number 400440 152167, the U.S. Dept. of Energy, grant number DE-SC0012972, and the Global Land Project Grant from the University of Copenhagen.	Bartholome E, 2005, INT J REMOTE SENS, V26, P1959, DOI 10.1080/01431160412331291297; Brovkin V, 2013, J CLIMATE, V26, P6859, DOI 10.1175/JCLI-D-12-00623.1; Bruun TB, 2009, HUM ECOL, V37, P375, DOI 10.1007/s10745-009-9257-y; Butler JH, 1980, EC GEOGRAPHY SPATIAL; Castella JC, 2013, HUM ECOL, V41, P63, DOI 10.1007/s10745-012-9538-8; Crains M, 2007, VOICES FOREST INTEGR; Crains M, 2015, SHIFTING CULTIVATION; Cramb RA, 2009, HUM ECOL, V37, P323, DOI 10.1007/s10745-009-9241-6; Davidson EA, 2008, GLOBAL CHANGE BIOL, V14, P998, DOI 10.1111/j.1365-2486.2008.01542.x; de Jong W, 2001, FOREST ECOL MANAG, V150, P135, DOI 10.1016/S0378-1127(00)00687-3; de Schlippe P., 1956, SHIFTING CULTIVATION; DeFries R, 2007, ENVIRON SCI POLICY, V10, P385, DOI 10.1016/j.envsci.2007.01.010; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Eyring V., 2016, GEOSCI MODEL DEV DIS, V8, P10, DOI [10.5194/gmdd-8-10539-2015, DOI 10.5194/GMDD-8-10539-2015]; FAO/UNDP, 1982, TROP FOR RES; Fox J, 2009, HUM ECOL, V37, P305, DOI 10.1007/s10745-009-9240-7; Frolking S, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000911; Fukushima M., 2007, SE ASIAN STUD, V45, P317; Galford GL, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI327.1; Gibbon D., 2001, FARMING SYSTEMS POVE; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Goswami K, 2012, FOREST POLICY ECON, V15, P146, DOI 10.1016/j.forpol.2011.11.005; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Heinimann A, 2013, HUM ECOL, V41, P51, DOI 10.1007/s10745-013-9564-1; Hett C, 2012, APPL GEOGR, V32, P608, DOI 10.1016/j.apgeog.2011.07.011; Houghton RA, 2012, BIOGEOSCIENCES, V9, P5125, DOI 10.5194/bg-9-5125-2012; Htwe TN, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4819-5; Hurni K, 2013, REMOTE SENS-BASEL, V5, P3377, DOI 10.3390/rs5073377; Hurni K, 2013, HUM ECOL, V41, P21, DOI 10.1007/s10745-012-9551-y; Hurtt GC, 2011, CLIMATIC CHANGE, V109, P117, DOI 10.1007/s10584-011-0153-2; Langner A, 2007, GLOBAL CHANGE BIOL, V13, P2329, DOI 10.1111/j.1365-2486.2007.01442.x; Lanly J. P., 1985, Unasylva, V37, P17; Lawrence D, 1998, LANDSCAPE ECOL, V13, P135, DOI 10.1023/A:1007985915187; Leimgruber P, 2005, ENVIRON CONSERV, V32, P356, DOI 10.1017/S0376892905002493; Leisz SJ, 2005, AGR SYST, V85, P340, DOI 10.1016/j.agsy.2005.06.015; Li P, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8010044; Li P, 2014, REMOTE SENS-BASEL, V6, P1654, DOI 10.3390/rs6021654; Liao CH, 2015, J GEOGR SCI, V25, P1218, DOI 10.1007/s11442-015-1229-0; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Mertz O, 2002, AGROFOREST SYST, V55, P149, DOI 10.1023/A:1020507631848; Mertz O, SHIFTING CULTIVATION; Mertz O, 2012, GEOGR TIDSSKR-DEN, V112, P63, DOI 10.1080/00167223.2012.709678; Mertz O, 2012, GEOGR J, V178, P175, DOI 10.1111/j.1475-4959.2011.00447.x; Mertz O, 2009, HUM ECOL, V37, P281, DOI 10.1007/s10745-009-9249-y; Mertz O, 2009, HUM ECOL, V37, P259, DOI 10.1007/s10745-009-9245-2; Messerli P, 2009, HUM ECOL, V37, P291, DOI 10.1007/s10745-009-9238-1; Miracle M. P., 1967, AGR CONGO BASIN TRAD; Molinario G, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/9/094009; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Muller D, 2014, GLOBAL ENVIRON CHANG, V28, P75, DOI 10.1016/j.gloenvcha.2014.06.003; Mukul SA, 2016, ENVIRON SCI POLICY, V55, P167, DOI 10.1016/j.envsci.2015.10.005; Nye P. H., 1960, TECHNICAL COMMUNICAT; Olofsson P, 2014, REMOTE SENS ENVIRON, V148, P42, DOI 10.1016/j.rse.2014.02.015; Padoch C, 2007, GEOGR TIDSSKR-DEN, V107, P29, DOI 10.1080/00167223.2007.10801373; Rasul G, 2003, LAND DEGRAD DEV, V14, P495, DOI 10.1002/ldr.570; Rounsevell MDA, 2012, LAND USE POLICY, V29, P899, DOI 10.1016/j.landusepol.2012.01.007; Rudel TK, 2009, P NATL ACAD SCI USA, V106, P20675, DOI 10.1073/pnas.0812540106; SANCHEZ PA, 2005, SLASH AND BURN AGR S, P3; Schmidt-Vogt D, 2009, HUM ECOL, V37, P269, DOI 10.1007/s10745-009-9239-0; Schmook B, 2010, REG ENVIRON CHANGE, V10, P233, DOI 10.1007/s10113-010-0128-2; Silva JMN, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2011JD016056; Spencer J. E., 1966, SHIFTING CULTIVATION; The Central Intelligence Agency, 2016, WORLD FACTBOOK; Thongmanivong S., 2009, SE ASIAN STUD, V47, P330; van Vliet N, 2013, SOC NATUR RESOUR, V26, P1454, DOI 10.1080/08941920.2013.820813; van Vliet N, 2012, GLOBAL ENVIRON CHANG, V22, P418, DOI 10.1016/j.gloenvcha.2011.10.009; Vongvisouk T, 2014, APPL GEOGR, V46, P1, DOI 10.1016/j.apgeog.2013.10.006; Vreugdenhil Meerman A, 2002, MAP OF THE ECOSYSTEM; Wastelands Atlas, 2010, CAT DISTR WAST AR; Xu JC, 2005, ENVIRON MANAGE, V36, P404, DOI 10.1007/s00267-003-0289-6; Yerena E, 2003, MT RES DEV, V23, P215, DOI 10.1659/0276-4741(2003)023[0215:BCOBCI]2.0.CO;2; Zaehringer JG, 2016, APPL GEOGR, V68, P9, DOI 10.1016/j.apgeog.2015.12.009; Zaehringer JG, 2015, LAND-BASEL, V4, P454, DOI 10.3390/land4020454	73	121	121	4	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184479	10.1371/journal.pone.0184479	http://dx.doi.org/10.1371/journal.pone.0184479			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886132	gold, Green Published			2022-12-27	WOS:000410001100134
J	Sacristan, HJ; Rodriguez, YE; Pereira, ND; Greco, LSL; Lovrich, GA; Gimenez, AVF				Javier Sacristan, Hernan; Eliana Rodriguez, Yamila; De los Angeles Pereira, Nair; Lopez Greco, Laura Susana; Alejandro Lovrich, Gustavo; Fernandez Gimenez, Analia Veronica			Energy reserves mobilization: Strategies of three decapod species	PLOS ONE			English	Article							CHERAX-QUADRICARINATUS DECAPODA; SHORT-TERM STARVATION; PACIFIC WHITE SHRIMP; PROLONGED STARVATION; BIOCHEMICAL-CHANGES; PENAEUS-ESCULENTUS; REDCLAW CRAYFISH; HIGH-PROTEIN; TIGER PRAWN; BODY-WEIGHT	In food deprivation assays, several different responses have been observed in crustaceans. However, studying energy reserves utilization among more than one species during the same starvation period has not yet been performed, particularly to discern whether the responses are due to intrinsic and/or environmental factors. We hypothesize that decapod species with similar feeding habits have the same strategies in the use of energetic reserves during starvation, even though they inhabit different environments. The aim of this study was to compare the energy reserves mobilization of three decapods species (Cherax quadricarinatus, Palaemon argentinus and Munida gregaria) with similar feeding habits, exposed to similar food deprivation conditions. The crayfish, shrimp and squat-lobster were experimentally kept at continuous feeding or continuous starvation throughout 15 days. Every 3rd day, the midgut gland index (MGI), and the glycogen, lipid and protein contents were measured in the midgut gland (MG) and pleon muscle. Palaemon argentinus mobilized more reserves during starvation, followed by C. quadricarinatus, and the last M. gregaria. The starved shrimps presented low MGI, whereas MG showed a reduction in glycogen (from day 6 to 15), lipid (from day 3 to 15), and protein levels (at day 9 and 15) while in their muscle, lipid reserves decreased at days 3 and 6. In C. quadricarinatus, the most affected parameters in the MG were MGI, glycogen (from day 6 to 15), and lipids (at day 12 and 15). In the MG of M. gregaria only the glycogen was reduced during fasting from 3 to 15 days. Even though the three studied species have similar feeding habitats, we found that their energetic profile utilization is different and it could be explained by the habitat, life span, temperature, organ/tissue, and metabolism of the species. Our results may be useful to understand the several different responses of crustaceans during starvation.	[Javier Sacristan, Hernan; Alejandro Lovrich, Gustavo] Consejo Nacl Invest Cient & Tecn, Ctr Austral Invest Cient, Houssay, Ushuaia, Argentina; [Eliana Rodriguez, Yamila; De los Angeles Pereira, Nair; Fernandez Gimenez, Analia Veronica] Univ Nacl Mar del Plata, CONICET, Inst Invest Marinas & Costeras, FCEyN, Mar Del Plata, Buenos Aires, Argentina; [Lopez Greco, Laura Susana] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Lab Biol Reprod & Crecimiento Crustaceos, Ciudad Univ, Buenos Aires, DF, Argentina; [Lopez Greco, Laura Susana] Univ Buenos Aires, CONICET, IBBEA, Ciudad Univ, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Sacristan, HJ (corresponding author), Consejo Nacl Invest Cient & Tecn, Ctr Austral Invest Cient, Houssay, Ushuaia, Argentina.	sacristanh@gmail.com		Rodriguez, Yamila/0000-0002-4596-3586	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2012-01333, PICT 2012-0554, PICT 2012-0137, 2015-2968]; Universidad Nacional de Mar del Plata [EXA 773/16]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad Nacional de Mar del Plata(National University of La Plata)	Funds for this research were provided by the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2012-01333 to LSLG; PICT 2012-0554 to GAL, PICT 2012-0137 to AVFG, and 2015-2968 to HJS). Additional funds were provided by the Universidad Nacional de Mar del Plata, EXA 773/16 to AVFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Dr. Mariano Diez and Sr. Marcelo Perez for field assistance with Munida gregaria. We also thank Lic. Amir Dyzenchauz for language revision. Funds for this research were provided by the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2012-01333 to LSLG; PICT 2012-0554 to GAL, 2012-0137 to AVFG, and 2015-2968 to HJS). Additional funds were provided by the Universidad Nacional de Mar del Plata, EXA 773/16	Albentosa M, 2007, COMP BIOCHEM PHYS B, V146, P241, DOI 10.1016/j.cbpb.2006.10.109; Auerswald L, 2015, POLAR BIOL, V38, P763, DOI 10.1007/s00300-014-1638-z; Baba K, 2008, CATALOGUE SQUAT LOBS, P220; Baden S, 1994, MARINE ECOLOGY PROGR; BARCLAY MC, 1983, J EXP MAR BIOL ECOL, V68, P229, DOI 10.1016/0022-0981(83)90055-2; Boudet LC, 2011, ECOTOXICOL ENV CONT, V6; BOURDIER GG, 1989, J PLANKTON RES, V11, P1201, DOI 10.1093/plankt/11.6.1201; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugnot AB, 2009, AQUACULTURE, V295, P292, DOI 10.1016/j.aquaculture.2009.07.021; Calvo NS, 2012, AQUAT BIOL, V16, P287, DOI 10.3354/ab00451; Calvo NS, 2011, AQUACULTURE, V319, P355, DOI 10.1016/j.aquaculture.2011.06.033; Chang ES, 1995, J EXP MAR BIOL ECOL, V193, P1, DOI 10.1016/0022-0981(95)00106-9; CLIFFORD HC, 1983, COMP BIOCHEM PHYS A, V74, P561, DOI 10.1016/0300-9629(83)90548-0; Collins PA, 1999, J CRUSTACEAN BIOL, V19, P485, DOI 10.2307/1549257; CUZON G, 1973, CR SOC BIOL, V167, P66; Cuzon G., 1980, Proceedings of the Annual Meeting of the World Mariculture Society, V11, P410; DALL W, 1987, MAR BIOL, V95, P509, DOI 10.1007/BF00393094; Faria SC, 2017, ECOL EVOL, V7, P3167, DOI 10.1002/ece3.2741; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRINGS CS, 1970, AM J CLIN PATHOL, V53, P89; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; HAZLETT B. A., 1975, CRUSTACEANA, V28, P11, DOI DOI 10.1163/156854075X00801; Hu MH, 2010, J EXP MAR BIOL ECOL, V395, P112, DOI 10.1016/j.jembe.2010.08.023; JALIHAL DR, 1993, CRUSTACEANA, V65, P363, DOI 10.1163/156854093X00793; Sacristan HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150854; Jones CM, 1995, AQUACULTURE, V138, P239, DOI 10.1016/0044-8486(95)00069-0; Jones PL, 2000, J CRUSTACEAN BIOL, V20, P431, DOI 10.1651/0278-0372(2000)020[0431:EOSASR]2.0.CO;2; Kawai T, 2016, GLOBAL OVERVIEW CONS, P430; Levi T, 1999, J CRUSTACEAN BIOL, V19, P477, DOI 10.2307/1549256; LO S, 1970, J APPL PHYSIOL, V28, P234, DOI 10.1152/jappl.1970.28.2.234; Moore LE, 2000, J EXP MAR BIOL ECOL, V244, P131, DOI 10.1016/S0022-0981(99)00127-6; Morales AE, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P281; Morrone Juan J., 1995, Neotropica (La Plata), V41, P3; Neiland KA, 1953, PHYSL COMP OECOL, V2, P198; Neves CA, 2004, DIS AQUAT ORGAN, V58, P209, DOI 10.3354/dao058209; Oliveira GT, 2004, COMP BIOCHEM PHYS A, V137, P383, DOI 10.1016/j.cbpb.2003.10.017; Parrish C, 2013, ISRN OCEANOGRAPHY; Parslow-Williams PJ, 1998, NEPHROPS NORVEGICUS; Perez-Barros P, 2007, J EXP MAR BIOL ECOL, V352, P35, DOI 10.1016/j.jembe.2007.06.035; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Powell ML, 2010, J WORLD AQUACULT SOC, V41, P71, DOI 10.1111/j.1749-7345.2009.00314.x; Romero M., 2003, THESIS; Romero MC, 2004, J MAR BIOL ASSOC UK, V84, P359, DOI 10.1017/S0025315404009282h; De Bock MS, 2010, AQUACULT INT, V18, P231, DOI 10.1007/s10499-008-9239-x; Sanchez-Paz A, 2006, INSECT BIOCHEM MOLEC, V36, P241, DOI 10.1016/j.ibmb.2006.01.002; Sanchez-Paz A, 2007, J EXP MAR BIOL ECOL, V340, P184, DOI 10.1016/j.jembe.2006.09.006; Saoud IP, 2013, J WORLD AQUACULT SOC, V44, P1, DOI 10.1111/jwas.12011; SCHAFER H J, 1968, FAO (Food and Agriculture Organization of the United Nations) Fisheries Reports, V57, P393; Schram Frederick R., 2009, Crustacean Issues, V18, P3; Signorell N, 2003, Z JAGDWISS, V49, P249, DOI [10.1590/S0073-47212003000300004, 10.1007/s10344-003-0022-z, 10.1007/BF02189633]; Speck U, 1969, Z VERGL PHYSIOL, P410; STEWART JE, 1972, J FISH RES BOARD CAN, V29, P439, DOI 10.1139/f72-072; Stuck KC, 1996, MAR BIOL, V125, P33, DOI 10.1007/BF00350758; Stumpf L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139372; Stumpf L, 2014, J CRUSTACEAN BIOL, V34, P639, DOI 10.1163/1937240X-00002259; Stumpf L, 2010, AQUACULTURE, V304, P34, DOI 10.1016/j.aquaculture.2010.03.011; Sugumar V, 2013, SAUDI J BIOL SCI, V20, P93, DOI 10.1016/j.sjbs.2012.10.003; Tapella F., 2002, THESIS; Tropea C, 2010, AQUACULTURE, V302, P49, DOI 10.1016/j.aquaculture.2010.01.027; Vazquez FJ, 2008, INVERTEBR BIOL, V127, P433, DOI 10.1111/j.1744-7410.2008.00148.x; Vinagre AS, 2016, MAR BIOL, V163, DOI 10.1007/s00227-015-2797-3; VINAGRE AS, 1992, COMP BIOCHEM PHYS A, V102, P579, DOI 10.1016/0300-9629(92)90213-A; Vogt G, 2012, ZOOL ANZ, V251, P1, DOI 10.1016/j.jcz.2011.05.003; Watts AJR, 2014, J EXP MAR BIOL ECOL, V457, P81, DOI 10.1016/j.jembe.2014.03.020; Zuur Alain F., 2009, P1; [No title captured]	67	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184060	10.1371/journal.pone.0184060	http://dx.doi.org/10.1371/journal.pone.0184060			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886062	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100061
J	Mao, WB; Caballero, A; Mckay, R; Primiano, C; Sun, W				Mao, Wenbin; Caballero, Andres; Mckay, Raymond; Primiano, Charles; Sun, Wei			Fully-coupled fluid-structure interaction simulation of the aortic and mitral valves in a realistic 3D left ventricle model	PLOS ONE			English	Article							SMOOTHED PARTICLE HYDRODYNAMICS; CHORDAL FORCE DISTRIBUTION; SADDLE-SHAPED ANNULUS; VITRO DYNAMIC STRAIN; BLOOD-FLOW; COMPUTATIONAL ANALYSIS; NUMERICAL-SIMULATION; BEHAVIOR; HEART; HEMODYNAMICS	In this study, we present a fully-coupled fluid-structure interaction (FSI) framework that combines smoothed particle hydrodynamics (SPH) and nonlinear finite element (FE) method to investigate the coupled aortic and mitral valves structural response and the bulk intraventricular hemodynamics in a realistic left ventricle (LV) model during the entire cardiac cycle. The FSI model incorporates valve structures that consider native asymmetric leaflet geometries, anisotropic hyperelastic material models and human material properties. Comparison of FSI results with subject-specific echocardiography data demonstrates that the SPH-FE approach is able to quantitatively predict the opening and closing times of the valves, the mitral leaflet opening and closing angles, and the large-scale intraventricular flow phenomena with a reasonable agreement. Moreover, comparison of FSI results with a LV model without valves reveals substantial differences in the flow field. Peak systolic velocities obtained from the FSI model and the LV model without valves are 2.56 m/s and 1.16 m/s, respectively, compared to the Doppler echo data of 2.17 m/s. The proposed SPH-FE FSI framework represents a further step towards modeling patient-specific coupled LV-valve dynamics, and has the potential to improve our understanding of cardiovascular physiology and to support professionals in clinical decision-making.	[Mao, Wenbin; Caballero, Andres; Sun, Wei] Georgia Inst Technol, Tissue Mech Lab, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Mao, Wenbin; Caballero, Andres; Sun, Wei] Emory Univ, Atlanta, GA 30322 USA; [Mckay, Raymond; Primiano, Charles] Hartford Hosp, Cardiol Dept, Hartford, CT 06115 USA	University System of Georgia; Georgia Institute of Technology; Emory University; Hartford Hospital	Sun, W (corresponding author), Georgia Inst Technol, Tissue Mech Lab, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.; Sun, W (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	wei.sun@bme.gatech.edu	Caballero, Andrés/AAQ-7567-2020; Mao, Wenbin/J-4546-2014	Caballero, Andrés/0000-0001-8640-9672; Mao, Wenbin/0000-0002-8582-0205	NIH [HL104080, HL127570]; American Heart Association Post-doctoral Fellowship [15P0ST25910002]; Fulbright-Colciencias fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104080, R21HL127570] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Post-doctoral Fellowship(American Heart Association); Fulbright-Colciencias fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the NIH HL104080 and HL127570 grants, https://grants.nih.gov/grants/funding/r01.htm. WM is in part supported by an American Heart Association Post-doctoral Fellowship 15P0ST25910002, https://professional.heart.org/professional/ResearchPrograms/ApplicationInformation/UCM_443314_Postdoctoral-Fellowship.isp. AC is in part supported by a Fulbright-Colciencias fellowship, http://www.fulbright.edu.co/us-scholar.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini R, 2012, ANN BIOMED ENG, V40, P1455, DOI 10.1007/s10439-012-0524-5; Bavo AM, 2017, J BIOMECH, V50, P144, DOI 10.1016/j.jbiomech.2016.11.039; Caballero A., 2017, CARDIOVASCULAR ENG T, P1; Carmody CJ, 2006, J BIOMECH, V39, P158, DOI 10.1016/j.jbiomech.2004.10.038; Chandran KB., 2012, BIOFLUID MECH HUMAN; Chandran KB, 2015, ANN BIOMED ENG, V43, P1348, DOI 10.1007/s10439-014-1094-5; Charonko JJ, 2013, ANN BIOMED ENG, V41, P1049, DOI 10.1007/s10439-013-0755-0; Chnafa C, 2016, ANN BIOMED ENG, V44, P3346, DOI 10.1007/s10439-016-1614-6; Dahl SK, 2012, COMPUT METHOD BIOMEC, V15, P121, DOI 10.1080/10255842.2010.517200; Dahl SK., 2012, CARDIOVASC ENG TECHN, V3, P269, DOI [10.1007/s13239-012-0099-1, DOI 10.1007/s13239-012-0099-1, DOI 10.1007/S13239-012-0099-1]; Date K, 2014, CIRCULATION, V130; Gao H, 2017, ARXIV170401960; Gasser TC, 2006, J R SOC INTERFACE, V3, P15, DOI 10.1098/rsif.2005.0073; He ZM, 2005, J BIOMECH ENG-T ASME, V127, P504, DOI 10.1115/1.1894385; He ZM, 2003, J HEART VALVE DIS, V12, P488; Hermange C., 2016, P 3 INT C VIOL FLOWS; HUGHES TJR, 1981, COMPUT METHOD APPL M, V29, P329, DOI 10.1016/0045-7825(81)90049-9; Imanparast A, 2016, J BIOMECH, V49, P1482, DOI 10.1016/j.jbiomech.2016.03.021; Jimenez JH, 2005, ANN BIOMED ENG, V33, P557, DOI 10.1007/s10439-005-1512-9; Jimenez JH, 2003, ANN BIOMED ENG, V31, P1171, DOI 10.1114/1.1616929; Jimenez JH, 2007, J THORAC CARDIOV SUR, V134, P1562, DOI 10.1016/j.jtcvs.2007.08.037; Kulp S., 2013, BIOM IM ISBI 2013 IE; Le TB, 2012, EUR J MECH B-FLUID, V35, P20, DOI 10.1016/j.euromechflu.2012.01.013; Lee CH, 2015, BIOMECH MODEL MECHAN, V14, P1281, DOI 10.1007/s10237-015-0674-0; Leyh RG, 1999, CIRCULATION, V100, P2153, DOI 10.1161/01.CIR.100.21.2153; Liang L, 2017, INT J NUMERICAL METH, V33; Ma C, 2017, 6 INT C MAR STRUCT M; Mao WB, 2016, CARDIOVASC ENG TECHN, V7, P374, DOI 10.1007/s13239-016-0285-7; Marom G, 2015, ARCH COMPUT METHOD E, V22, P595, DOI 10.1007/s11831-014-9133-9; MCQUEEN DM, 1982, AM J PHYSIOL, V242, P1095; Mittal R, 2016, J COMPUT PHYS, V305, P1065, DOI 10.1016/j.jcp.2015.11.022; Monaghan JJ, 2012, ANNU REV FLUID MECH, V44, P323, DOI 10.1146/annurev-fluid-120710-101220; Moosavi MH, 2014, COMPUT METHOD BIOMEC, V17, P740, DOI 10.1080/10255842.2012.715638; Nakamura M, 2006, J BIOMECH ENG-T ASME, V128, P837, DOI 10.1115/1.2400864; Ogden R., 1972, P ROYAL SOC LOND MAT; Padala M, 2009, ANN THORAC SURG, V88, P1499, DOI 10.1016/j.athoracsur.2009.06.042; Pedrizzetti G, 2014, NAT REV CARDIOL, V11, P545, DOI 10.1038/nrcardio.2014.75; PESKIN CS, 1989, J COMPUT PHYS, V81, P372, DOI 10.1016/0021-9991(89)90213-1; PESKIN CS, 1977, J COMPUT PHYS, V25, P220, DOI 10.1016/0021-9991(77)90100-0; PESKIN CS, 1972, J COMPUT PHYS, V10, P252, DOI 10.1016/0021-9991(72)90065-4; Pham T, 2013, J BIOMEDICAL MAT R A; Rausch MK, 2011, J BIOMECH, V44, P1149, DOI 10.1016/j.jbiomech.2011.01.020; Sacks MS, 2006, ANN THORAC SURG, V82, P1369, DOI 10.1016/j.athoracsur.2006.03.117; Sacks MS, 2002, ANN BIOMED ENG, V30, P1281, DOI 10.1114/1.1529194; Saikrishnan N, 2014, CIRCULATION, V129, P244, DOI 10.1161/CIRCULATIONAHA.113.002310; Seo JH, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4904094; Shahriari S, 2012, INT J NUMER METH BIO, V28, P1121, DOI 10.1002/cnm.2482; Shahriari S., 2011, COMPUTATIONAL MODELI; Sturla F, 2013, MED ENG PHYS, V35, P1721, DOI 10.1016/j.medengphy.2013.07.015; Su BY, 2014, COMPUT METH PROG BIO, V113, P474, DOI 10.1016/j.cmpb.2013.11.009; Sun W, 2014, ANNU REV BIOMED ENG, V16, P53, DOI 10.1146/annurev-bioeng-071813-104517; Sun W, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2979872; Le TB, 2013, J COMPUT PHYS, V244, P41, DOI 10.1016/j.jcp.2012.08.036; Wang Q., 2011, CARDIOVASC ENG TECHN, V2, P324, DOI DOI 10.1007/S13239-011-0052-8; Wang Q, 2013, ANN BIOMED ENG, V41, P142, DOI 10.1007/s10439-012-0620-6; Watton PN, 2008, J FLUID STRUCT, V24, P58, DOI 10.1016/j.jfluidstructs.2007.06.004; Yamaguchi T, 2010, ANN BIOMED ENG, V38, P1225, DOI 10.1007/s10439-010-9904-x; Zamorano JL, 2010, ESC TEXTBOOK OF CARDIOVASCULAR IMAGING, P1	58	51	54	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184729	10.1371/journal.pone.0184729	http://dx.doi.org/10.1371/journal.pone.0184729			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886196	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100182
J	May, ML; Gregoire, JA; Gregoire, SM; Lubertazzi, MA; Matthews, JH				May, Michael L.; Gregoire, John A.; Gregoire, Suzanne M.; Lubertazzi, Maria Aliberti; Matthews, John H.			Emergence phenology, uncertainty, and the evolution of migratory behavior in Anax junius (Odonata: Aeshnidae)	PLOS ONE			English	Article							DRAGONFLIES ODONATA; DISPERSAL; MIGRATIONS; RANGE	Mass migrations by Odonata, although less studied than those of Monarch butterflies and plague locusts, have provoked comment and study for many years. Relatively recently, increasing interest in dragonflies, supported by new technologies, has resulted in more detailed knowledge of the species involved, behavioral mechanisms, and geographic extent. In this paper we examine, in four independent but complementary studies, how larval habitat and emergence phenology interact with climate to shape the evolution of migratory strategy in Anax junius, a common species throughout much of the eastern United States and southern Canada. In brief, we argue that fish predation on larvae, coupled with the need for ample emergent vegetation for oviposition and adult eclosion, dictates that larval development and survival is optimal in ponds that are neither permanent nor extremely ephemeral. Coupled with annual variation in regional weather and winters in much of their range too cold for adult survival, conditions facing newly emerged A. junius may unpredictably favor either local reproduction or long-distance movement to more favorable areas. Both temperature and hydroperiod tend to favor local reproduction early in the adult activity period and migration later, so late emerging adults are more likely to migrate. No single pond is always predictably suitable or unsuitable, however, so ovipositing females also may spread the risk to their offspring by ovipositing at multiple sites that, for migrants, may be distributed over very long distances.	[May, Michael L.] Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08901 USA; [Gregoire, John A.; Gregoire, Suzanne M.] Kestrel Haven Avian Migrat Observ, Burdett, NY USA; [Lubertazzi, Maria Aliberti] Rhode Isl Sch Design, Concentrat Hist Philosophy & Social Sci, Providence, RI 02903 USA; [Matthews, John H.] Alliance Global Water Adaptat, Corvallis, OR USA	Rutgers State University New Brunswick	May, ML (corresponding author), Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08901 USA.	may@aesop.rutgers.edu			New Jersey Agricultural Experiment Station Project [08190]; University of Rhode Island College of the Environment and Life Sciences; NSF [DEB-0423834]; New Jersey Agricultural Experiment Station State; U.S. Hatch Act funds; University of Texas at Austin Section of Integrative Biology	New Jersey Agricultural Experiment Station Project; University of Rhode Island College of the Environment and Life Sciences; NSF(National Science Foundation (NSF)); New Jersey Agricultural Experiment Station State; U.S. Hatch Act funds; University of Texas at Austin Section of Integrative Biology	This research was funded in part by New Jersey Agricultural Experiment Station Project 08190 to MLM; a graduate student grant from the University of Rhode Island College of the Environment and Life Sciences to MAL; and a NSF Grant DEB-0423834, New Jersey Agricultural Experiment Station State and U.S. Hatch Act funds, and a graduate student grant from the University of Texas at Austin Section of Integrative Biology to JHM. No specific funding was received by JAG and SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are very grateful to Dennis Paulson for access to his extensive data, for being an unstinting source of ideas and advice, and for serving as a sounding board for half-formed ideas on many occasions; to John Abbott for providing formatted data on Anax observation from Odonata Central; to Richard Orr and Holliday Obrecht for logistical and physical assistance and suggestions throughout the course of work at Patuxent Research Refuge; to Bill Mauffray for access to data and specimens from the Florida State Collection of Arthropods; to Bob Barber and Jim Johnson for discussion and advice at various stages of this project; and to many email correspondents who shared their observations with us. Special thanks to Dr. Ulf Norling for supplying us with Kitegraph software for plotting the course of larval development. Supported in part by NSF Grant DEB-0423834 and New Jersey Agricultural Experiment Station State and U.S. Hatch Act funds.	Abtew W, 2006, S FLORIDA ENV REPORT, VI, p[5, 5]; Aliberti Lubertazzi MA, 2009, THESIS U RHODE ISLAN; Anderson RC, 2009, J TROP ECOL, V25, P347, DOI 10.1017/S0266467409006087; [Anonymous], 2007, FRESHWATER FISH DIST; [Anonymous], 2016, US CLIMATE DATA; [Anonymous], 2014, DRAG DAMS NEW JERS; [Anonymous], 2020, ECONOMIST 0326; [Anonymous], 2016, INSECT PHYSL BIOCH; Biggs K., 2012, ODONATA 1 ARCH; BUTLER T, 1975, CAN ENTOMOL, V107, P1253, DOI 10.4039/Ent1071253-12; CALVERT PHILIP P., 1934, PROC AMER PHILOSOPH SOC, V73, P1; Catling PM, 2003, ONT ODONATA, V4, P9; Chapman JW, 2015, ECOL LETT, V18, P287, DOI 10.1111/ele.12407; ClimaTemps, 2016, CLIMATEMPS; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Corbet Philip S., 2006, International Journal of Odonatology, V9, P1; CORBET PS, 1957, J ANIM ECOL, V26, P1, DOI 10.2307/1781; CROWDER LB, 1982, ECOLOGY, V63, P1802, DOI 10.2307/1940122; Daigle J. J., 1991, ARGIA, V3, P8; Dorn NJ, 2008, HYDROBIOLOGIA, V605, P209, DOI 10.1007/s10750-008-9355-7; Fincke O., 2010, MASS FLIGHT S CENTRA; Freeland JR, 2003, ECOL ENTOMOL, V28, P413, DOI 10.1046/j.1365-2311.2003.00521.x; Hu G, 2016, SCIENCE, V354, P1584, DOI 10.1126/science.aah4379; Jaramillo A., 2016, CALODES; JOHNSON D M, 1980, Odonatologica, V9, P297; Johnson D.M., 1989, Advances in Odonatology, V4, P27; KIME JB, 1974, THESIS U WASHINGTON; KOENIG W D, 1987, Odonatologica, V16, P249; Lubertazzi MAA, 2009, NORTHEAST NAT, V16, P141; Matthews JH, 2004, REPORT ANAX JUNIUS E, V5, P12; Matthews JH, 2007, ODONATE CONSERVATION, P183; Matthews JH, 2007, RES MOTION PATTERNS, P33; Matthews JH, 2007, RES MOTION PATTERNS, P7; Matthews JH, 2007, RES MOTION PATTERNS, P62; May ML, 2013, J INSECT CONSERV, V17, P1, DOI 10.1007/s10841-012-9540-x; May Michael L., 2008, P63; McCauley SJ, 2007, OIKOS, V116, P121, DOI 10.1111/j.2006.0030-1299.15105.x; McCauley SJ, 2006, ECOGRAPHY, V29, P585, DOI 10.1111/j.0906-7590.2006.04787.x; MCPEEK MA, 1989, OIKOS, V56, P187, DOI 10.2307/3565335; MCPEEK MA, 1990, ECOLOGY, V71, P83, DOI 10.2307/1940249; MICHIELS NK, 1991, ECOL ENTOMOL, V16, P449, DOI 10.1111/j.1365-2311.1991.tb00238.x; National Oceanic and Atmospheric Administration, 2016, CLIM DAT ONL; Needham JG, 1901, B ILLINOIS STATE LAB, V6, P1; Panek FM, 2013, NORTHEAST NAT, V20, P37, DOI 10.1656/045.020.0103; Parkos JJ, 2011, OIKOS, V120, P1519, DOI 10.1111/j.1600-0706.2011.19178.x; Paulson D.R., 2011, DRAGONFLIES E; Paulson D. R., 2010, CALODES; Paulson D. R, 2009, DRAGONFLIES W; Paulson DR, 1996, BYU STUDIES, V4, P7; Paulson DR, 1999, OCCASIONAL PAPERS SL; Paulson DR, 2009, TEXODES; Paulson DR., 1999, NOTES MEXICAN ODONAT; Russell, 2005, INTERACTIONS MIGRATI, V9, P327; Russell RW, 1998, AM MIDL NAT, V140, P325, DOI 10.1674/0003-0031(1998)140[0325:MSMODO]2.0.CO;2; Schenk K, 2004, ANIM BEHAV, V68, P599, DOI 10.1016/j.anbehav.2003.12.010; Shannon HJ, 1916, SCI MON, V3, P227; Sommer A., 2011, PIMEPHALES PROMELAS; Sprandel GL, 2001, FLA ENTOMOL, V84, P234, DOI 10.2307/3496172; Stacey BJ., 2013, OFFSHORE DARNERS; Suhling F, 2016, AUSTRAL ECOLOGY; TROTTIER R, 1966, CAN ENTOMOL, V98, P794, DOI 10.4039/Ent98794-8; TROTTIER R, 1971, CAN ENTOMOL, V103, P1671, DOI 10.4039/Ent1031671-12; USGS (United States Geological Survey), 2016, NAT WAT INF SYST WEB; Walker E.M., 1958, ODONATA CANADA ALASK; WERNER EE, 1994, ECOLOGY, V75, P1368, DOI 10.2307/1937461; WHITE HB, 1970, CAN ENTOMOL, V102, P498, DOI 10.4039/Ent102498-4; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; WISSINGER S A, 1988, Journal of the North American Benthological Society, V7, P13, DOI 10.2307/1467827; YOUNG AM, 1967, CAN ENTOMOL, V99, P886, DOI 10.4039/Ent99886-8; Zhan S, 2014, NATURE, V514, P317, DOI 10.1038/nature13812	70	8	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183508	10.1371/journal.pone.0183508	http://dx.doi.org/10.1371/journal.pone.0183508			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886032	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100028
J	Nwankwo, O; Glatting, G; Wenz, F; Fleckenstein, J				Nwankwo, Obioma; Glatting, Gerhard; Wenz, Frederik; Fleckenstein, Jens			A single-source photon source model of a linear accelerator for Monte Carlo dose calculation	PLOS ONE			English	Article							VIRTUAL SOURCE MODEL; PHASE-SPACE; QUANTITATIVE-EVALUATION; BEAM; RADIOTHERAPY; DISTRIBUTIONS; METAANALYSIS; SIMULATION; VALIDATION	Purpose To introduce a new method of deriving a virtual source model (VSM) of a linear accelerator photon beam from a phase space file (PSF) for Monte Carlo (MC) dose calculation. Materials and methods A PSF of a 6 MV photon beam was generated by simulating the interactions of primary electrons with the relevant geometries of a Synergy linear accelerator (Elekta AB, Stockholm, Sweden) and recording the particles that reach a plane 16 cm downstream the electron source. Probability distribution functions (PDFs) for particle positions and energies were derived from the analysis of the PSF. These PDFs were implemented in the VSM using inverse transform sampling. To model particle directions, the phase space plane was divided into a regular square grid. Each element of the grid corresponds to an area of 1 mm 2 in the phase space plane. The average direction cosines, Pearson correlation coefficient (PCC) between photon energies and their direction cosines, as well as the PCC between the direction cosines were calculated for each grid element. Weighted polynomial surfaces were then fitted to these 2D data. The weights are used to correct for heteroscedasticity across the phase space bins. The directions of the particles created by the VSM were calculated from these fitted functions. The VSM was validated against the PSF by comparing the doses calculated by the two methods for different square field sizes. The comparisons were performed with profile and gamma analyses. Results The doses calculated with the PSF and VSM agree to within 3%/1 mm (>95% pixel pass rate) for the evaluated fields. Conclusion A new method of deriving a virtual photon source model of a linear accelerator from a PSF file for MC dose calculation was developed. Validation results show that the doses calculated with the VSM and the PSF agree to within 3%/1 mm.	[Nwankwo, Obioma; Wenz, Frederik; Fleckenstein, Jens] Heidelberg Univ, Med Fac Mannheim, Dept Radiat Oncol, Mannheim, Germany; [Nwankwo, Obioma; Glatting, Gerhard] Heidelberg Univ, Med Fac Mannheim, Med Radiat Phys Radiat Protect, Mannheim, Germany; [Glatting, Gerhard] Ulm Univ, Dept Nucl Med, Med Radiat Phys, Ulm, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ulm University	Nwankwo, O (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Radiat Oncol, Mannheim, Germany.; Nwankwo, O (corresponding author), Heidelberg Univ, Med Fac Mannheim, Med Radiat Phys Radiat Protect, Mannheim, Germany.	Charles.Nwankwo@medma.uni-heidelberg.de	Glatting, Gerhard/ABF-2506-2020	Glatting, Gerhard/0000-0001-7916-1576; Nwankwo, Obioma/0000-0002-3190-8885	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing	We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Bonate PL, 2011, PHARMACOKINETIC-PHARMACODYNAMIC MODELING AND SIMULATION, SECOND EDITION, P1, DOI 10.1007/978-1-4419-9485-1; Chen JT, 2005, EUR J OPER RES, V167, P226, DOI 10.1016/j.ejor.2003.12.027; Chetty I, 2000, MED PHYS, V27, P166, DOI 10.1118/1.598881; Chetty IJ, 2007, MED PHYS, V34, P4818, DOI 10.1118/1.2795842; Clausen S, 2012, Z MED PHYS; Deng J, 2004, PHYS MED BIOL, V49, P1689, DOI 10.1088/0031-9155/49/9/007; Deng J, 2000, PHYS MED BIOL, V45, P411, DOI 10.1088/0031-9155/45/2/311; Depuydt T, 2002, RADIOTHER ONCOL, V62, P309, DOI 10.1016/S0167-8140(01)00497-2; Fedewa MV, 2014, AM J PREV MED, V47, P641, DOI 10.1016/j.amepre.2014.07.035; Fippel M, 2003, MED PHYS, V30, P301, DOI 10.1118/1.1543152; Fix MK, 2004, MED PHYS, V31, P3106, DOI 10.1118/1.1803431; Fix MK, 2000, MED PHYS, V27, P2739, DOI 10.1118/1.1318220; Fix MK, 2001, PHYS MED BIOL, V46, P1407, DOI 10.1088/0031-9155/46/5/307; Fleckenstein J, 2013, Z MED PHYS, V23, P33, DOI 10.1016/j.zemedi.2012.08.002; Giles M., 2011, GPU COMPUTING GEMS, P109; Grevillot L, 2011, PHYS MED BIOL, V56, P903, DOI 10.1088/0031-9155/56/4/002; Havranek T, 2010, REV WORLD ECON, V146, P241, DOI 10.1007/s10290-010-0050-1; Kletting P, 2013, MED PHYS, V40, DOI 10.1118/1.4820367; Lewis JB, 2005, POLIT ANAL, V13, P345, DOI 10.1093/pan/mpi026; Libby B, 1999, MED PHYS, V26, P1476, DOI 10.1118/1.598643; Low DA, 1998, MED PHYS, V25, P656, DOI 10.1118/1.598248; Ma CM, 1998, RADIAT PHYS CHEM, V53, P329, DOI 10.1016/S0969-806X(98)00113-3; Martinez WL, 2015, COMPUTATIONAL STAT H; Mathworks, 2017, RAND NUMB SPEC RANG; Nelson JP, 2006, INT REV LAW ECON, V26, P195, DOI 10.1016/j.irle.2006.08.005; Nelson J, 2009, ENVIRON RESOUR ECON, V42, P345, DOI 10.1007/s10640-008-9253-5; Nwankwo O, 2013, PHYS MED BIOL, V58, P2363, DOI 10.1088/0031-9155/58/7/2363; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; SAXONHOUSE GR, 1976, AM ECON REV, V66, P178; Sempau J, 2001, PHYS MED BIOL, V46, P1163, DOI 10.1088/0031-9155/46/4/318; Siebers JV, 1999, PHYS MED BIOL, V44, P3009, DOI 10.1088/0031-9155/44/12/311; Sikora M, 2007, PHYS MED BIOL, V52, P4449, DOI 10.1088/0031-9155/52/15/006; Sikora M, 2009, PHYS MED BIOL, V54, P7329, DOI 10.1088/0031-9155/54/24/006; Spezi E, 2011, MED PHYS, V38, P5254, DOI 10.1118/1.3626574; Spezi E, 2008, RADIAT PROT DOSIM, V131, P123, DOI 10.1093/rpd/ncn277; von Wittenau AES, 1999, MED PHYS, V26, P1196, DOI 10.1118/1.598613; Weisstein E. W, 2017, MATHWORLD WOLFRAM WE; WILLEMAIN TR, 1993, J STAT COMPUT SIM, V45, P23; Zorn ME, 1997, ANAL CHEM, V69, P3069, DOI 10.1021/ac970082i	40	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183486	10.1371/journal.pone.0183486	http://dx.doi.org/10.1371/journal.pone.0183486			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886048	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100025
J	Zamparo, P; Carrara, S; Cesari, P				Zamparo, Paola; Carrara, Stefano; Cesari, Paola			Movement evaluation of front crawl swimming: Technical skill versus aesthetic quality	PLOS ONE			English	Article							PROPELLING EFFICIENCY; ACTION ANTICIPATION; BASKETBALL PLAYERS; BIOLOGICAL MOTION; VISUAL-PERCEPTION; RESONANCE	The study aim was to compare expert with non-expert swimmers' rating of the aesthetic and technical qualities of front crawl in video-taped recordings of swimmers with low, middle, and high level proficiency. The results suggest that: i) observers' experience affects their judgment: only the expert observers correctly rated the swimmers' proficiency level; ii) evaluation of movement (technical and aesthetic scores) is correlated with the level of skill as expressed in the kinematics of the observed action (swimming speed, stroke frequency, and stroke length); iii) expert and non-expert observers use different strategies to rate the aesthetic and technical qualities of movement: equating the technical skill with the aesthetic quality is a general rule non-expert observers follow in the evaluation of human movement.	[Zamparo, Paola; Carrara, Stefano; Cesari, Paola] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy	University of Verona	Zamparo, P (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.	paola.zamparo@univr.it	Zamparo, Paola/AAF-7700-2020	Zamparo, Paola/0000-0002-6919-6721; Cesari, Paola/0000-0002-1705-6065				Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; Best D., 1974, BRIT J AESTHET, V14, P197, DOI DOI 10.1093/BJAESTHETICS/14.3.197; CRAIG AB, 1979, MED SCI SPORT EXER, V11, P278; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Lan C, 2008, EXERCISE INTENSITY T, P12; Peterson Silveria R, 2016, INT J SPORT PHYSIOL, V13, P21; SCULLY DM, 1986, HUM MOVEMENT SCI, V5, P185, DOI 10.1016/0167-9457(86)90024-2; Tomeo E, 2013, CEREB CORTEX, V23, P2765, DOI 10.1093/cercor/bhs279; TOUSSAINT HM, 1988, J APPL PHYSIOL, V65, P2506, DOI 10.1152/jappl.1988.65.6.2506; TOUSSAINT HM, 1992, SPORTS MED, V13, P8, DOI 10.2165/00007256-199213010-00002; TOUSSAINT HM, 1990, MED SCI SPORT EXER, V22, P409; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Zamparo P, 2005, EUR J APPL PHYSIOL, V94, P134, DOI 10.1007/s00421-004-1281-4; Zamparo P, 2011, EUR J APPL PHYSIOL, V111, P367, DOI [10.1007/s00421-010-1433-7, 10.1007/s00421-010-1396-8]; Zamparo P, PLOS ONE, V10	16	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184171	10.1371/journal.pone.0184171	http://dx.doi.org/10.1371/journal.pone.0184171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886063	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100075
J	Zhu, Q; Liao, BY; Li, P; Li, JC; Deng, XM; Hu, XS; Chen, XY				Zhu, Qin; Liao, Bo-Yong; Li, Pei; Li, Jun-Cheng; Deng, Xiao-Mei; Hu, Xin-Sheng; Chen, Xiao-Yang			Phylogeographic pattern suggests a general northeastward dispersal in the distribution of Machilus pauhoi in South China	PLOS ONE			English	Article							MICROSATELLITE LOCI; GENETIC-STRUCTURE; TEMPERATE PLANTS; EAST-ASIA; LAURACEAE; DISTANCE; POPULATIONS; DIVERSITY; MARKERS; PALAEOVEGETATION	Machilus pauhoi Kanehira is an important timber species in China. A provenance trial was recently set up to evaluate the growth performance of trees from different localities, with the aim of designing seed transfer guidelines. Here, we tested twelve nuclear microsatellite markers derived from other species of the Lauraceae family and investigated population genetic structure in M. pauhoi. Both the number of observed alleles per locus (N-a) and the polymorphic information content (PIC) significantly decreased against the latitude, but showed an insignificant decrease against the longitude. Heterozygosity (Ho) and gene diversity (h) exhibited a weak correlation with geographic location. Private alleles were present in multiple populations, and a moderate level of population genetic differentiation was detected (G(st) = 0.1691). The joint pattern of genetic diversity (N-a, PIC, H-o, and h) suggests that general northeastward dispersal led to the current distribution of M. pauhoi. Significant but weak effects of isolation-by-distance (IBD) occurred, implicating the mountain ranges as the major barrier to gene flow. Both STRUCTURE and hierarchical clustering analyses showed three distinct groups of populations related to the physical connectivity among mountain ranges. A priority in designing genetic conservation should be given to the populations at the southwest side of the species' distribution. This conservation strategy can also be combined with the pattern of adaptive genetic variation from the provenance trial for comprehensive genetic resource management of native M. pauhoi.	[Zhu, Qin; Li, Pei; Li, Jun-Cheng; Deng, Xiao-Mei; Hu, Xin-Sheng; Chen, Xiao-Yang] South China Agr Univ, Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou, Guangdong, Peoples R China; [Zhu, Qin; Li, Pei; Li, Jun-Cheng; Deng, Xiao-Mei; Hu, Xin-Sheng; Chen, Xiao-Yang] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Coll Forestry & Landscape Architecture, Guangzhou, Guangdong, Peoples R China; [Zhu, Qin] Jiaying Univ, Sch Life Sci, Meizhou, Peoples R China; [Liao, Bo-Yong] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Liao, Bo-Yong] Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resources, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University; Jiaying University; Sun Yat Sen University; Sun Yat Sen University	Hu, XS; Chen, XY (corresponding author), South China Agr Univ, Guangdong Key Lab Innovat Dev & Utilizat Forest P, Guangzhou, Guangdong, Peoples R China.; Hu, XS; Chen, XY (corresponding author), South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Coll Forestry & Landscape Architecture, Guangzhou, Guangdong, Peoples R China.	xinsheng@scau.edu.cn; xychen@scau.edu.cn		Hu, Xin-Sheng/0000-0002-8049-9491	National Science & Technology Pillar Program [2012BAD01B04]; Forestry Science and Technology Innovation Project of Guangdong Province [2011KJCX002]; South China Agricultural University [4400-K16013]	National Science & Technology Pillar Program; Forestry Science and Technology Innovation Project of Guangdong Province; South China Agricultural University	The authors acknowledge the funding by the National Science & Technology Pillar Program during the Twelfth Five-Year Plan Period (2012BAD01B04) and Forestry Science and Technology Innovation Project of Guangdong Province (2011KJCX002) to XYC, and the startup funding from South China Agricultural University (4400-K16013) to XSH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrizani RC, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200516; [Anonymous], [No title captured]; [Anonymous], 1994, J TROP SUBTROP BOT; Borrone JW, 2007, MOL ECOL NOTES, V7, P439, DOI 10.1111/j.1471-8286.2006.01611.x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Carpenter RJ, 2010, J BIOGEOGR, V37, P1202, DOI 10.1111/j.1365-2699.2010.02279.x; Chanderbali AS, 2001, ANN MO BOT GARD, V88, P104, DOI 10.2307/2666133; Chen Dong-Mei, 2011, Bulletin of Botanical Research, V31, P623; Chung MG, 2000, HEREDITY, V85, P490, DOI 10.1046/j.1365-2540.2000.00781.x; Ci XQ, 2008, PLANT SYST EVOL, V273, P237, DOI 10.1007/s00606-008-0012-4; Cui ZJ, 1984, J GLACIOL GEOCRYOL, V6, P77; Danieli-Silva A, 2013, PLANT SPEC BIOL, V28, P31, DOI 10.1111/j.1442-1984.2011.00354.x; DRINNAN AN, 1990, BOT GAZ, V151, P370, DOI 10.1086/337838; Ennos RA, 1998, FORESTRY, V71, P1, DOI 10.1093/forestry/71.1.1-a; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Gibson JP, 1996, AM J BOT, V83, P890, DOI 10.2307/2446266; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Gross-German E, 2013, TREE GENET GENOMES, V9, P539, DOI 10.1007/s11295-012-0577-5; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Guo XiaoMin, 1999, Acta Agriculturae Universitatis Jiangxiensis, V21, P391; Guo ZT, 2002, NATURE, V416, P159, DOI 10.1038/416159a; HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Harrison SP, 2001, NATURE, V413, P129, DOI 10.1038/35093166; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hu Xin-sheng, 2001, Forest Research, V14, P1; Hu XinSheng, 2001, Forest Genetics, V8, P225; Kameyama Y, 2012, AM J BOT, V99, pE1, DOI 10.3732/ajb.1100231; Kaneko Y, 2012, AM J BOT, V99, pE265, DOI 10.3732/ajb.1100560; Kumar P, 2009, PLANT OMICS, V2, P141; Li HongYing, 2011, Journal of Northeast Forestry University, V39, P28; Li X., 2016, THESIS; Li XW, 2000, HIGHER PLANTS CHINA, V3, p282 ; Li YJ, 2016, J GUANGXI TEACHERS E, V37, P67; Liu L, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200549; Mantel N., 1967, CANCER RES, V27, P109; Martins E, 2015, CONSERV GENET, V16, P1, DOI 10.1007/s10592-014-0635-7; Martins EM, 2014, GENET MOL RES, V13, P5138, DOI 10.4238/2014.July.7.6; Moraes Pedro Luís Rodrigues de, 2002, Biota Neotrop., V2, P1, DOI [10.1590/S1676-06032002000100005, 10.1590/S1676-06032002000200005]; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Poole I, 2000, IAWA J, V21, P463, DOI 10.1163/22941932-90000262; Pritchard JK, 2000, GENETICS, V155, P945; Qi C, 1992, J CENTRAL S FORESTRY, V12, P1; Qian H, 2001, NATURE, V413, P130, DOI 10.1038/35093169; Salmela MJ, 2010, FORESTRY, V83, P535, DOI 10.1093/forestry/cpq036; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takahashi M, 2014, SYST BOT, V39, P715, DOI 10.1600/036364414X681464; Tsuneki S, 2009, CONSERV GENET, V10, P2009, DOI 10.1007/s10592-009-9881-5; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang GuoPing, 2014, Journal of South China Agricultural University, V35, P56; Wang ZS, 2005, ANN BOT-LONDON, V95, P305, DOI 10.1093/aob/mci027; Watanabe S, 2016, PLANT SPEC BIOL, V31, P29, DOI 10.1111/1442-1984.12078; Wattier R, 1998, MOL ECOL, V7, P1569, DOI 10.1046/j.1365-294x.1998.00477.x; Weir BS, 1996, GENETIC DATA ANALYSI; Wen SF, 2008, GUANGDONG FORESTRY S, V24, P115; WHEELWRIGHT NT, 1991, BIOTROPICA, V23, P29, DOI 10.2307/2388685; Wu GX, 2008, JIANGXI FORESTRY SCI, V4, p14 ; Xiong B, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1600088; Xu F, 2003, GUANGDONG FORESTRY S, V19, P61; [杨彦伶 Yang Yanling], 2008, [分子植物育种, Molecular Plant Breeding], V6, P1134; Yeh F.C., 1999, MICROSOFT WINDOWS BA; YING JS, 2001, BIODIVERSITY SCI, V9, P393, DOI DOI 10.17520/BI0DS.2001058; Zhang R, 2012, BIOCHEM SYST ECOL, V44, P317, DOI 10.1016/j.bse.2012.06.007; Zhao HM, 2005, JIANGXI FORESTRY SCI, V4, P8; Zhong QuanLin, 2008, Acta Agriculturae Universitatis Jiangxiensis, V30, P257	68	7	10	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184456	10.1371/journal.pone.0184456	http://dx.doi.org/10.1371/journal.pone.0184456			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886133	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100126
J	Bester-van der Merwe, AE; Bitalo, D; Cuevas, JM; Ovenden, J; Hernandez, S; da Silva, C; McCord, M; Roodt-Wilding, R				Bester-van der Merwe, Aletta E.; Bitalo, Daphne; Cuevas, Juan M.; Ovenden, Jennifer; Hernandez, Sebastian; da Silva, Charlene; McCord, Meaghen; Roodt-Wilding, Rouvay			Population genetics of Southern Hemisphere tope shark (Galeorhinus galeus): Intercontinental divergence and constrained gene flow at different geographical scales	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; SCHOOL SHARK; MICROSATELLITE LOCI; DEMOGRAPHIC HISTORY; MUSTELUS-HENLEI; PHYLOGEOGRAPHY; SOFTWARE; ATLANTIC; IDENTIFICATION; PERFORMANCE	The tope shark (Galeorhinus galeus Linnaeus, 1758) is a temperate, coastal hound shark found in the Atlantic and Indo-Pacific oceans. In this study, the population structure of Galeorhinus galeus was determined across the entire Southern Hemisphere, where the species is heavily targeted by commercial fisheries, as well as locally, along the South African coastline. Analysis was conducted on a total of 185 samples using 19 microsatellite markers and a 671 bp fragment of the NADH dehydrogenase subunit 2 (ND2) gene. Across the Southern Hemisphere, three geographically distinct clades were recovered, including one from South America (Argentina, Chile), one from Africa (all the South African collections) and an Australia-New Zealand clade. Nuclear data revealed significant population subdivisions (F-ST = 0.192 to 0.376, p<0.05) indicating limited gene flow for tope sharks across ocean basins. Marked population connectivity was however evident across the Indian Ocean based on Bayesian clustering analysis. More locally in South Africa, F-statistics and multivariate analysis supported moderate to high gene flow across the Atlantic/Indian Ocean boundary (F-ST = 0.035 to 0.044, p<0.05), with exception of samples from Struisbaai and Port Elizabeth which differed significantly from the rest. Discriminant and Bayesian clustering analysis indicated admixture in all sampling populations, decreasing from west to east, corroborating possible restriction to gene flow across regional oceanographic barriers. Mitochondrial sequence data recovered seven haplotypes (h = 0.216, pi = 0.001) for South Africa, with one major haplotype shared by 87% of the individuals and at least one private haplotype for each sampling location except Port Elizabeth. As with many other coastal shark species with cosmopolitan distribution, this study confirms the lack of both historical dispersal and inter-oceanic gene flow while also implicating contemporary factors such as oceanic currents and thermal fronts to drive local genetic structure of G. galeus on a smaller spatial scale.	[Bester-van der Merwe, Aletta E.; Bitalo, Daphne; Roodt-Wilding, Rouvay] Stellenbosch Univ, Dept Genet, Stellenbosch, South Africa; [Cuevas, Juan M.] UNLP, Div Zool Vertebrados, Museo La Plata, La Plata, Buenos Aires, Argentina; [Ovenden, Jennifer] Queensland Govt, Mol Fisheries Lab, St Lucia, Qld, Australia; [Hernandez, Sebastian] Univ Catolica Norte, Fac Ciencias Mar, Sala Colecc Biol, Coquimbo, Chile; [Hernandez, Sebastian] Veritas Univ, Ctr Int Programs, Mol Biol Lab, San Jose, Costa Rica; [da Silva, Charlene] Dept Agr Forestry & Fisheries, Fisheries Res, Cape Town, South Africa; [McCord, Meaghen] Old Harbour Museum, South African Shark Conservancy, Hermanus, South Africa	Stellenbosch University; National University of La Plata; Museo La Plata; Universidad Catolica del Norte	Bester-van der Merwe, AE (corresponding author), Stellenbosch Univ, Dept Genet, Stellenbosch, South Africa.	aeb@sun.ac.za	Bitalo, Daphne/Q-4350-2018; der Merwe, Bester-van/AAL-6644-2021; Ovenden, Jenny/A-3717-2010	Bitalo, Daphne/0000-0002-3396-5920; Ovenden, Jenny/0000-0001-7538-1504; van der Merwe, Aletta/0000-0002-0332-7864; Roodt-Wilding, Rouvay/0000-0002-3528-7932; Cuevas, juan/0000-0003-0086-5963	National Research Foundation of South Africa	National Research Foundation of South Africa(National Research Foundation - South Africa)	This study was funded by the National Research Foundation of South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the following individuals, organisations and institutions for providing biological samples: Jayson Semmens from Australia, South African Department of Agriculture, Forestry and Fisheries (DAFF), and the Viking Fishing Group. Simo Maduna is especially thanked for assistance with clustering analyses as well as two anonymous reviewers for many helpful comments on an earlier draft of this manuscript. This study was funded by the National Research Foundation of South Africa.	Andreotti S, 2016, J BIOGEOGR, V43, P328, DOI 10.1111/jbi.12641; Ashe JL, 2015, MAR ECOL PROG SER, V520, P203, DOI 10.3354/meps11069; Benavides MT, 2011, MAR FRESHWATER RES, V62, P861, DOI 10.1071/MF10236; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernard AM, 2016, MOL ECOL, V25, P5312, DOI 10.1111/mec.13845; Best LN, 2013, AFR ZOOL, V48, P201, DOI 10.3377/004.048.0201; Bitalo DN, 2015, FISH RES, V172, P190, DOI 10.1016/j.fishres.2015.07.003; BRIGGS J C, 1974, P475; Briggs JC., 1995, GLOBAL BIOGEOGRAPHY, V14; Camargo SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155623; Chabot CL, 2015, J FISH BIOL, V87, P371, DOI 10.1111/jfb.12727; Chabot CL, 2009, MOL ECOL, V18, P545, DOI 10.1111/j.1365-294X.2008.04047.x; Chabot CL, 2015, ECOL EVOL, V5, P1585, DOI 10.1002/ece3.1458; Chabot CL, 2012, CONSERV GENET RESOUR, V4, P23, DOI 10.1007/s12686-011-9464-x; Chabot CL, 2011, CONSERV GENET RESOUR, V3, P553, DOI 10.1007/s12686-011-9402-y; Chapman DD, 2015, ANNU REV MAR SCI, V7, P547, DOI 10.1146/annurev-marine-010814-015730; Chiaramonte GE, 1998, MAR FRESHWATER RES, V49, P601, DOI 10.1071/MF97136; Chiaramonte GE., 2015, THESIS; Clarke CR, 2015, MAR BIOL, V162, P945, DOI 10.1007/s00227-015-2636-6; Coates AG, 2004, GEOL SOC AM BULL, V116, P11; COMPAGNO L J V, 1984, FAO (Food and Agriculture Organization of the United Nations) Fisheries Synopsis, P1; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; Cuevas JM, 2014, ANIM BIOTELEM, V2, P1; Cunha RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049196; da Silva C, 2015, AFR J MAR SCI, V37, P233, DOI 10.2989/1814232X.2015.1044471; Ferrette BLD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117549; Daly-Engel TS, 2012, PLOS ONE, V7, P279, DOI 10.1371/journal.pone.0029986; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Duncan KM, 2006, MOL ECOL, V15, P2239, DOI 10.1111/j.1365-294X.2006.02933.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elias I, 2004, J NW ATL FISH SCI, V37, P261; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farrell ED, 2009, ICES J MAR SCI, V66, P561, DOI 10.1093/icesjms/fsn218; Feutry P, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0232-x; Francis MP, 2010, NZ FISHERIES ASSESSM, V2010, P1; Fu YX, 1997, GENETICS, V147, P915; Garcia G., 2012, PHYLOGEOGRAPHY S W A; Geraghty PT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075169; Giresi M, 2012, CONSERV GENET RESOUR, V4, P101, DOI 10.1007/s12686-011-9484-6; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hernandez S, 2015, FISH RES, V167, P132, DOI 10.1016/j.fishres.2015.02.010; Hernandez S, 2010, REV BIOL MAR OCEANOG, V45, P695, DOI 10.4067/S0718-19572010000400013; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Keeney DB, 2006, MOL ECOL, V15, P3669, DOI 10.1111/j.1365-294X.2006.03036.x; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lucifora LO, 2004, ENVIRON BIOL FISH, V71, P199, DOI 10.1007/s10641-004-0305-6; Maduna SN, 2017, ECOL EVOL, V7, P1462, DOI 10.1002/ece3.2770; Maduna SN, 2016, MAR ECOL PROG SER, V544, P183, DOI 10.3354/meps11596; McCord M.E., 2005, ASPECTS ECOLOGY MANA; Musick JA, 2004, CRC MAR BIOL SER, P33; Naylor GJP, 2012, B AM MUS NAT HIST, P1; Ovenden JR, 2015, FISH FISH, V16, P125, DOI 10.1111/faf.12052; Ovenden JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-40; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piola A.R., 2001, ENCY OCEAN SCI, P340; Portnoy DS, 2016, ICES J MAR SCI, V73, P2322, DOI 10.1093/icesjms/fsw098; Pritchard JK, 2000, GENETICS, V155, P945; Punt AE, 2000, MAR FRESHWATER RES, V51, P205, DOI 10.1071/MF99124; Punt Andre E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P387; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Schrey AW, 2003, CAN J FISH AQUAT SCI, V60, P670, DOI 10.1139/F03-064; Schultz JK, 2008, MOL ECOL, V17, P5336, DOI 10.1111/j.1365-294X.2008.04000.x; Sebastian H, 2008, J FISH BIOL, V73, P2293, DOI 10.1111/j.1095-8649.2008.02016.x; Spaet JLY, 2015, ECOL EVOL, V5, P2317, DOI 10.1002/ece3.1515; Stadler T, 2009, GENETICS, V182, P205, DOI 10.1534/genetics.108.094904; Taguchi M, 2015, MAR FRESHWATER RES, V66, P267, DOI 10.1071/MF14075; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Teske PR, 2011, S AFR J SCI, V107, P43, DOI 10.4102/sajs.v107i5/6.514; Tillett J, 2012, J FISH BIOL, V80, P2140, DOI 10.1111/j.1095-8649.2012.03228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; von Bonde C., 1934, INVESTIGATIONAL REPO, V2, P1; Walker T., 1999, GALEORHINUS GALEUS F; Walker T. I., 2006, IUCN RED LIST THREAT; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	84	28	28	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184481	10.1371/journal.pone.0184481	http://dx.doi.org/10.1371/journal.pone.0184481			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880905	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200074
J	Nyaoke, BA; Mutua, GN; Sajabi, R; Nyasani, D; Mureithi, MW; Anzala, OA				Nyaoke, Borna A.; Mutua, Gaudensia N.; Sajabi, Rose; Nyasani, Delvin; Mureithi, Marianne W.; Anzala, Omu A.			Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya	PLOS ONE			English	Article							EXPERIENCES	Background 1.5 million Kenyans are living with HIV/AIDS as per 2015 estimates. Though there is a notable decline in new HIV infections, continued effort is still needed to develop an efficacious, accessible and affordable HIV vaccine. HIV vaccine clinical trials bear risks, hence a need to understand volunteer motivators for enrolment, retention and follow-up. Understanding the factors that motivate volunteers to participate in a clinical trial can help to strategize, refine targeting and thus increase enrolment of volunteers in future HIV vaccine clinical trials. The health belief model classifies motivators into social benefits such as 'advancing research' and collaboration with science, and personal benefits such as health benefits and financial interests. Method A thematic analysis was carried out on data obtained from four HIV clinical trials conducted at KAVI-Institute of Clinical Research in Nairobi Kenya from 2009 to 2015. Responses were obtained from a Questionnaire administered to the volunteers during their screening visit at the research site. Results Of the 281 healthy, HIV-uninfected volunteers participating in this study; 38% were motivated by personal benefits including, 31% motivated by health benefits and 7% motivated by possible financial gains. In addition, 62% of the volunteers were motivated by social benefits with 20% of who were seeking to help their family/society/world while 42% were interested in advancing research. Conclusion The majority of volunteers in the HIV vaccine trials at our site were motivated by social benefits, suggesting that altruism can be a major contributor to participation in HIV vaccine studies. Personal benefits were a secondary motivator for the volunteers. The motivators to volunteer in HIV clinical trials were similar across ages, education level and gender.	[Nyaoke, Borna A.; Mutua, Gaudensia N.; Sajabi, Rose; Nyasani, Delvin; Mureithi, Marianne W.; Anzala, Omu A.] Univ Nairobi, ICR, KAVI, Nairobi, Kenya	University of Nairobi	Nyaoke, BA (corresponding author), Univ Nairobi, ICR, KAVI, Nairobi, Kenya.	bnyaoke@kaviuon.org			International AIDS Vaccine Initiative (IAVI); Bill & Melinda Gates Foundation; Ministry of Foreign Affairs of the Netherlands; Irish Aid; Government of Japan; European Union; United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID); KAVI-ICR	International AIDS Vaccine Initiative (IAVI); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Foreign Affairs of the Netherlands; Irish Aid(CGIAR); Government of Japan; European Union(European Commission); United Kingdom Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); KAVI-ICR	The HIV vaccine studies were funded by the International AIDS Vaccine Initiative (IAVI) and its donors. IAVI's work is made possible by generous support from many donors including: the Bill & Melinda Gates Foundation; the Ministry of Foreign Affairs of the Netherlands; Irish Aid; Government of Japan; the Ministry of Foreign Affairs of the Netherlands; European Union; the United Kingdom Department for International Development (DFID), and the United States Agency for International Development (USAID). The full list of IAVI donors is available at www.iavi.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the volunteers who took part in the HIV clinical trials at the KAVI-ICR sites; all of whom were already involved in clinical trials but were still willing to contribute to further HIV research by participating in this sub-study. We would also like to thank all the staff of KAVI-ICR with a special mention to the Kangemi staff for their diligent work in conducting the HIV vaccine trials and International AIDS Vaccine Initiative (IAVI) for providing KAVI-ICR with funding and support to conduct the trials.	African Population and Health Research Center (APHRC), 2014, REP NAIR CROSS SECT; Almeida L, 2007, EUR J CLIN PHARMACOL, V63, P1085, DOI 10.1007/s00228-007-0368-3; Andanda P, 2007, MAJENGO HIV AIDS RES; Bass SB, 2016, AIDS CARE, V28, P528, DOI 10.1080/09540121.2015.1112352; Bhutta ZA, 2002, B WORLD HEALTH ORGAN, V80, P114; Center for Disease Control, 2015, CTR DIS CONTR PREV K; Chakrapani V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051080; Dhalla S, 2014, AIDS BEHAV, V18, P263, DOI 10.1007/s10461-013-0519-8; Dong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111321; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; Greco Dirceu, 2008, J Int Bioethique, V19, P143; Isler MR, 2012, AIDS BEHAV, V16, P1895, DOI 10.1007/s10461-012-0151-z; Kass NE, 2007, CLIN PHARMACOL THER, V82, P219, DOI 10.1038/sj.clpt.6100192; Kochhar S, 2013, HUM VACC IMMUNOTHER, V9, P924, DOI 10.4161/hv.23405; Krueger R. A., 2015, FOCUS GROUPS PRACTIC; Liamputtong P, 2015, J HIV-AIDS SOC SERV, V14, P239, DOI 10.1080/15381501.2014.912175; Linkedin Corporation, 2015, 2014 CHIN WORKPL STR; Mehrotra P, 2009, AIDS EDUC PREV, V21, P39, DOI 10.1521/aeap.2009.21.1.39; Nappo SA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-19; National AIDS and STI control Programme Ministry of Health, 2009, HIV AIDS DEC GUID; National AIDS Control Council Ministry of Health, 2014, KEN AIDS STRAT FRAM; National AIDS Control Council of Kenya, 2014, KEN AIDS RESP PROGR; Rimer B, 1997, THEORY GLANCE GUIDE; Ryan G.W., 2003, FIELD METHOD, V15, P85, DOI DOI 10.1177/1525822X02239569; Sahay S, 2014, HUM VACC IMMUNOTHER, V10, P485, DOI 10.4161/hv.26799; Stunkel L, 2011, CONTEMP CLIN TRIALS, V32, P342, DOI 10.1016/j.cct.2010.12.003; Suhadev M, 2006, INDIAN J MED RES, V124, P631; Tarimo EAM, 2016, BMC PUBLIC HEALTH, P16; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Volk JE, 2014, INT J STD AIDS, V25, P332, DOI 10.1177/0956462413506892	30	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183788	10.1371/journal.pone.0183788	http://dx.doi.org/10.1371/journal.pone.0183788			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880880	Green Submitted, gold, Green Published			2022-12-27	WOS:000409467200025
J	Suarez, R; Paolino, A; Kozulin, P; Fenlon, LR; Morcom, LR; Englebright, R; O'Hara, PJ; Murray, PJ; Richards, LJ				Suarez, Rodrigo; Paolino, Annalisa; Kozulin, Peter; Fenlon, Laura R.; Morcom, Laura R.; Englebright, Robert; O'Hara, Patricia J.; Murray, Peter J.; Richards, Linda J.			Development of body, head and brain features in the Australian fat-tailed dunnart (Sminthopsis crassicaudata; Marsupialia: Dasyuridae); A postnatal model of forebrain formation	PLOS ONE			English	Article							WALLABY MACROPUS-EUGENII; EUTHERIAN MAMMALS; INTERHEMISPHERIC MIDLINE; ANTERIOR COMMISSURE; OLFACTORY SYSTEM; TAMMAR WALLABY; HETEROCHRONY; EVOLUTION; MOUSE; SEQUENCES	Most of our understanding of forebrain development comes from research of eutherian mammals, such as rodents, primates, and carnivores. However, as the cerebral cortex forms largely prenatally, observation and manipulation of its development has required invasive and/or ex vivo procedures. Marsupials, on the other hand, are born at comparatively earlier stages of development and most events of forebrain formation occur once attached to the teat, thereby permitting continuous and non-invasive experimental access. Here, we take advantage of this aspect of marsupial biology to establish and characterise a resourceful laboratory model of forebrain development: the fat-tailed dunnart (Sminthopsis crassicaudata), a mouse-sized carnivorous Australian marsupial. We present an anatomical description of the postnatal development of the body, head and brain in dunnarts, and provide a staging system compatible with human and mouse developmental stages. As compared to eutherians, the orofacial region develops earlier in dunnarts, while forebrain development is largely protracted, extending for more than 40 days versus ca. 15 days in mice. We discuss the benefits of fat-tailed dunnarts as laboratory animals in studies of developmental biology, with an emphasis on how their accessibility in the pouch can help address new experimental questions, especially regarding mechanisms of brain development and evolution.	[Suarez, Rodrigo; Paolino, Annalisa; Kozulin, Peter; Fenlon, Laura R.; Morcom, Laura R.; Richards, Linda J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Englebright, Robert; O'Hara, Patricia J.; Murray, Peter J.] Univ Queensland, Sch Agr & Food Sci, Gatton, Qld, Australia; [Richards, Linda J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Suarez, R; Richards, LJ (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.; Richards, LJ (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia.	rsuarezsaa@gmail.com; richards@uq.edu.au	Murray, Peter/AAO-5884-2021; Murray, Peter J/D-3628-2013; Suarez, Rodrigo/J-1529-2014; Fenlon, Laura/N-6719-2017; Kozulin, Peter/B-7238-2011; Richards AO, Linda/P-6372-2014	Murray, Peter/0000-0003-1143-1706; Suarez, Rodrigo/0000-0001-5153-5652; Paolino, Annalisa/0000-0002-2117-2819; Fenlon, Laura/0000-0002-5132-2419; Kozulin, Peter/0000-0002-7872-9884; Morcom, Laura/0000-0001-6683-4356; Richards AO, Linda/0000-0002-7590-7390	National Health and Medical Research Council (NHMRC) Principal Research Fellowship [1005751]; Australian Research Council (ARC) Discovery Project [160103958]; ARC Discovery Early Career Researcher Award Fellowship [160101394]; NHMRC CJ Martin Early Career Fellowship; Australian Postgraduate Award; UQ-QBI Doctoral scholarship	National Health and Medical Research Council (NHMRC) Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Discovery Project(Australian Research Council); ARC Discovery Early Career Researcher Award Fellowship(Australian Research Council); NHMRC CJ Martin Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); UQ-QBI Doctoral scholarship	This work was funded by the National Health and Medical Research Council (NHMRC) Principal Research Fellowship 1005751 (LJR); Australian Research Council (ARC) Discovery Project 160103958 (LJR, RS); ARC Discovery Early Career Researcher Award Fellowship 160101394 (RS); NHMRC CJ Martin Early Career Fellowship (PK); Australian Postgraduate Award (LRF, LRM); UQ-QBI Doctoral scholarship (AP). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of any of the funding bodies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboitiz F, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00402; Ashwell KWS, 2008, BRAIN BEHAV EVOLUT, V71, P216, DOI 10.1159/000119711; Ashwell KWS, 1996, J COMP NEUROL, V366, P478; Ashwell KWS, 1996, BRAIN BEHAV EVOLUT, V47, P8, DOI 10.1159/000113225; Chew KY, 2014, DEV DYNAM, V243, P324, DOI 10.1002/dvdy.24062; Conhaim J, 2011, J PHYSIOL-LONDON, V589, P2529, DOI 10.1113/jphysiol.2010.202382; Cummings DM, 1997, J NEUROBIOL, V32, P403; Darlington RB, 1999, J COMP NEUROL, V411, P359; de Frutos CA, 2016, NEURON, V92, P435, DOI 10.1016/j.neuron.2016.09.020; DREHER B, 1988, BRAIN BEHAV EVOLUT, V31, P369, DOI 10.1159/000116602; Dunlop SA, 1997, J COMP NEUROL, V384, P26; Dunlop SA, 1996, EXP NEUROL, V137, P294, DOI 10.1006/exnr.1996.0028; Easton CR, 2014, J NEUROSCI, V34, P3854, DOI 10.1523/JNEUROSCI.3811-13.2014; Gobius I, 2017, NEURAL DEV, V12, DOI 10.1186/s13064-017-0086-1; Gobius I, 2016, CELL REP, V17, P735, DOI 10.1016/j.celrep.2016.09.033; Godfrey GK, 1971, INT ZOO YB, V11, P33, DOI [10.1111/J.1748-1090.1971.TB01839.X, DOI 10.1111/J.1748-1090.1971.TB01839.X]; Goswami A, 2016, INTEGR COMP BIOL, V56, P404, DOI 10.1093/icb/icw039; Halley AC, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0219; Halley AC, 2016, BRAIN BEHAV EVOLUT, V88, P14, DOI 10.1159/000447254; Jeffery JE, 2002, SYST BIOL, V51, P478, DOI 10.1080/10635150290069904; Kelly EM, 2011, J MAMMAL, V92, P1038, DOI 10.1644/10-MAMM-A-425.1; Keyte AL, 2014, SEMIN CELL DEV BIOL, V34, P99, DOI 10.1016/j.semcdb.2014.06.015; McCrady E., 1938, American Anatomical Memoir Philadelphia (Wistar Inst), Vno. 16, P1; Meisami E, 1998, MICROSC RES TECHNIQ, V43, P476, DOI 10.1002/(SICI)1097-0029(19981215)43:6<476::AID-JEMT2>3.3.CO;2-M; Molnar Z, 1998, J COMP NEUROL, V398, P491; Morton SR, 1978, AUST WILDLIFE RES, V5, P183; NELSON JE, 1992, ANAT EMBRYOL, V185, P335; O'Rahilly R., 1987, DEV STAGES HUMAN EMB; Oelschlager HA, 1987, ANN NY ACAD SCI, V519, P447, DOI DOI 10.1111/J.1749-6632.1987.TB36316.X; PASSINGHAM RE, 1985, BRAIN BEHAV EVOLUT, V26, P167, DOI 10.1159/000118773; POILEY S. M., 1960, PROC ANIMAL CARE PANEL, V10, P159; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Ramachandran VS., 2014, CLAUSTRUM STRUCTURAL, P119, DOI [10.1016/B978-0-12-404566-8.00004-0, DOI 10.1016/B978-0-12-404566-8.00004-0]; RENFREE MB, 1982, BRAIN BEHAV EVOLUT, V20, P57, DOI 10.1159/000121581; Rowe TB, 2016, J COMP NEUROL, V524, P471, DOI 10.1002/cne.23802; Rowe TB, 2011, SCIENCE, V332, P955, DOI 10.1126/science.1203117; SACHER GA, 1974, AM NAT, V108, P593, DOI 10.1086/282938; Sanchez-Villagra MR, 2002, J EXP ZOOL, V294, P264, DOI 10.1002/jez.10147; Schneider NY, 2009, REPRODUCTION, V138, P849, DOI 10.1530/REP-09-0145; Shang F, 1997, J COMP NEUROL, V387, P507, DOI 10.1002/(SICI)1096-9861(19971103)387:4<507::AID-CNE3>3.0.CO;2-6; Smith KK, 2001, BIOL J LINN SOC, V73, P169, DOI 10.1006/bijl.2001.0535; Smith KK, 1997, EVOLUTION, V51, P1663, DOI 10.1111/j.1558-5646.1997.tb01489.x; Streeter G., 1957, DEV HORIZONS HUMAN E; Suarez R., 2017, EVOLUTION NERVOUS SY, P205, DOI 10.1016/B978-0-12-804042-3.00042-7; Suarez R, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00497; Suarez R, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00050; Thieler K., 1989, HOUSE MOUSE ATLAS EM; Watson C, 2017, J COMP NEUROL, V525, P1499, DOI 10.1002/cne.24034; Weisbecker V, 2008, EVOLUTION, V62, P2027, DOI 10.1111/j.1558-5646.2008.00424.x; Weisbecker V, 2010, P NATL ACAD SCI USA, V107, P16216, DOI 10.1073/pnas.0906486107; Werneburg I, 2013, J ANAT, V222, P2, DOI 10.1111/j.1469-7580.2012.01509.x; Werneburg I, 2011, ACTA ZOOL-STOCKHOLM, V92, P75, DOI 10.1111/j.1463-6395.2009.00447.x; Workman AD, 2013, J NEUROSCI, V33, P7368, DOI 10.1523/JNEUROSCI.5746-12.2013	53	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184450	10.1371/journal.pone.0184450	http://dx.doi.org/10.1371/journal.pone.0184450			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880940	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000409467200071
J	Galbraith, NJ; Burton, J; Ekman, MB; Kenney, J; Walker, SP; Manek, S; Bishop, C; Carter, JV; Gardner, SA; Polk, HC				Galbraith, Norman James; Burton, James; Ekman, Mathew Brady; Kenney, Joseph; Walker, Samuel Patterson; Manek, Stephen; Bishop, Campbell; Carter, Jane Victoria; Gardner, Sarah Appel; Polk, Hiram C.			I kappa K-16 decreases miRNA-155 expression and attenuates the human monocyte inflammatory response	PLOS ONE			English	Article							KAPPA-B KINASE; ENDOTOXIN TOLERANCE; GENE-EXPRESSION; SEPSIS; INHIBITION; INJURY; MICRORNA-155; DYSFUNCTION; MIR-155; PATHWAY	Excessive inflammatory responses in the surgical patient may result in cellular hypo-responsiveness, which is associated with an increased risk of secondary infection and death. microRNAs (miRNAs), such as miR-155, are powerful regulators of inflammatory signalling pathways including nuclear factor kappa B (NF kappa B). Our objective was to determine the effect of I kappa K-16, a selective blocker of inhibitor of kappa-B kinase (I kappa K), on miRNA expression and the monocyte inflammatory response. In a model of endotoxin tolerance using primary human monocytes, impaired monocytes had decreased p65 expression with suppressed TNF-alpha and IL-10 production (P < 0.05). miR-155 and miR-138 levels were significantly upregulated at 17 h in the impaired monocyte (P < 0.05). Notably, I kappa K-16 decreased miR-155 expression with a corresponding dose-dependent decrease in TNF-alpha and IL-10 production (P < 0.05), and impaired monocyte function was associated with increased miR-155 and miR-138 expression. In the context of I kappa K-16 inhibition, miR-155 mimics increased TNF-alpha production, while miR-155 antagomirs decreased both TNF-alpha and IL-10 production. These data demonstrate that I kappa K-16 treatment attenuates the monocyte inflammatory response, which may occur through a miR-155-mediated mechanism, and that I kappa K-16 is a promising approach to limit the magnitude of an excessive innate inflammatory response to LPS.	[Galbraith, Norman James; Burton, James; Ekman, Mathew Brady; Kenney, Joseph; Walker, Samuel Patterson; Manek, Stephen; Bishop, Campbell; Carter, Jane Victoria; Gardner, Sarah Appel; Polk, Hiram C.] Univ Louisville, Sch Med, Hiram C Polk Jr MD Dept Surg, Price Inst Surg Res, Louisville, KY 40292 USA	University of Louisville	Polk, HC (corresponding author), Univ Louisville, Sch Med, Hiram C Polk Jr MD Dept Surg, Price Inst Surg Res, Louisville, KY 40292 USA.	hcpolk01@louisville.edu	Carter, Jane/AAU-7945-2020	Carter, Jane/0000-0002-1203-1889; Galbraith, Norman/0000-0002-6354-6946	John W. Price and Barbara Thruston Atwood Price Trust; James and Emmeline Ferguson Research Fellowship Trust; Dizney Family Foundation; Mary K. Oxley Foundation	John W. Price and Barbara Thruston Atwood Price Trust; James and Emmeline Ferguson Research Fellowship Trust; Dizney Family Foundation; Mary K. Oxley Foundation	This publication was funded by the John W. Price and Barbara Thruston Atwood Price Trust, by the James and Emmeline Ferguson Research Fellowship Trust, by the Dizney Family Foundation, and by the Mary K. Oxley Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors would like to acknowledge the use of equipment from Jason Smith, MD PhD.; This work was funded by the John W. Price and Barbara Thruston Atwood Price Trust, by the James and Emmeline Ferguson Research Fellowship Trust, by the Dizney Family Foundation, and by the Mary K. Oxley Foundation. We would like to acknowledge the use of equipment from Jason Smith, MD, PhD.	Almahmoud K, 2015, SHOCK, V44, P101, DOI 10.1097/SHK.0000000000000395; Billeter AT, 2016, ANN SURG, V263, P601, DOI 10.1097/SLA.0000000000001175; Billeter AT, 2014, FASEB J, V28, P5322, DOI 10.1096/fj.14-258335; Billeter AT, 2012, SURGERY, V151, P1, DOI 10.1016/j.surg.2011.08.006; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Carter JV, 2016, ANN SURG, V264, P575, DOI 10.1097/SLA.0000000000001873; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen J, 2016, J AM SOC NEPHROLOGY; Christopher Ajay Francis, 2016, Perspect Clin Res, V7, P68, DOI 10.4103/2229-3485.179431; Coldewey SM, 2013, DIS MODEL MECH, V6, P1031, DOI 10.1242/dmm.012435; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Elton TS, 2013, GENE, V532, P1, DOI 10.1016/j.gene.2012.12.009; Frede S, 2009, J IMMUNOL, V182, P6470, DOI 10.4049/jimmunol.0802378; Galbraith N, 2016, SURG INFECT, V17, P563, DOI 10.1089/sur.2016.014; Galbraith N, 2016, SURG INFECT, V17, P303, DOI 10.1089/sur.2015.245; Gatto G, 2008, NUCLEIC ACIDS RES, V36, P6608, DOI 10.1093/nar/gkn666; Guo K, 2013, J MOL NEUROSCI, V51, P941, DOI 10.1007/s12031-013-9958-y; Lahiri R, 2016, ANN SURG, V263, P1028, DOI 10.1097/SLA.0000000000001248; Laudanski K, 2006, P NATL ACAD SCI USA, V103, P15564, DOI 10.1073/pnas.0607028103; Li H, 2013, MEDIAT INFLAMM, V2013; Liu JQ, 2015, INT J INFECT DIS, V40, P135, DOI 10.1016/j.ijid.2015.09.016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Lv X, 2015, MOL MED REP, V12, P6013, DOI 10.3892/mmr.2015.4188; Marshall JC, 2014, TRENDS MOL MED, V20, P195, DOI 10.1016/j.molmed.2014.01.007; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Park SH, 2011, NAT IMMUNOL, V12, P607, DOI 10.1038/ni.2043; Polinder S, 2012, BRIT J SURG, V99, P114, DOI 10.1002/bjs.7708; POLK HC, 1986, ANN SURG, V204, P282; Sen A, 2014, FEBS LETT, V588, P906, DOI 10.1016/j.febslet.2014.01.033; Shu YS, 2014, J TRAUMA ACUTE CARE, V76, P1417, DOI 10.1097/TA.0000000000000229; Sordi R, 2015, MOL MED, V21, P563, DOI 10.2119/molmed.2015.00049; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Vachharajani VT, 2014, J LEUKOCYTE BIOL, V96, P785, DOI 10.1189/jlb.3MA0114-034RR; Wang H, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.80; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; Wu XY, 2014, J CELL BIOCHEM, V115, P1928, DOI 10.1002/jcb.24864; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zhou JH, 2015, CYTOKINE, V71, P89, DOI 10.1016/j.cyto.2014.09.003; Zhou X, 2016, J DENT RES, V95, P230, DOI 10.1177/0022034515613043	43	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183987	10.1371/journal.pone.0183987	http://dx.doi.org/10.1371/journal.pone.0183987			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910312	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200026
J	Simieli, L; Gobbi, LTB; Orcioli-Silva, D; Beretta, VS; Santos, PCR; Baptista, AM; Barbieri, FA				Simieli, Lucas; Bucken Gobbi, Lilian Teresa; Orcioli-Silva, Diego; Beretta, Victor Spiandor; Rocha Santos, Paulo Cezar; Baptista, Andre Macari; Barbieri, Fabio Augusto			The variability of the steps preceding obstacle avoidance (approach phase) is dependent on the height of the obstacle in people with Parkinson's disease	PLOS ONE			English	Article							POSTURAL INSTABILITY; GAIT VARIABILITY; DUAL TASKING; WALKING; INTEGRATION; ATTENTION; NETWORKS; PATTERNS; STRIDE; ADULTS	Gait variability may serve as a sensitive and clinically relevant parameter to quantify adjustments in walking and the changes with aging and neurological disease. Variability of steps preceding obstacle avoidance (approach phase) are important for efficiency in the task, especially in people with Parkinson's disease (PD). However, variability of gait during the approach phase to obstacle avoidance in people with PD has been rarely reported, particularly when ambulating obstacles of different heights. The aim of the present study was to investigate the effects of obstacle height on step-to-step variability (step-to-step variability provides information on the variation between the "equivalent steps" for all trials, and walking variability (indicates the within-step variability of each, providing information about the modulations between the steps performed. of spatial-temporal parameters during the approach phase to obstacle avoidance in people with PD and neurologically healthy older people. Twenty-eight older people; 15 with PD and 13 neurologically healthy individuals (control group), participated in the study. Participants were instructed to walk at their preferred speed until the end of the pathway and to avoid the obstacle when it was present. Each subject performed 10 trials of the following tasks: unobstructed walking, low obstacle avoidance (3cm length, height equal ankle's height, 60 cm wide), intermediate obstacle (3cm length, low plus high obstacle height divided by 2, 60 cm wide) avoidance and high obstacle avoidance (3cm length, knee's height, 60 cm wide). The obstacle was positioned 4m from to the start position. The step-to-step and walking variability of the spatial-temporal parameters (acquiring with GAITRite (R)) of the four steps before obstacle avoidance were analyzed. MANOVAs were used to compare the data. PD group showed the characteristic gait deficits associated with PD. The obstacle increased the spatial-temporal variability (step-to-step and walking variability) during the approach phase to the obstacle. Specifically, both groups increased i) the step-to-step variability of the step length during low obstacle avoidance when compared to the other conditions; ii) the variability during low obstacle avoidance in the last step before obstacle (n-1) compared to higher obstacle avoidance; iii) variability during higher obstacle avoidance in further steps (n-3 and n-4). In conclusion, the presence of the obstacle during walking increased the variability of spatialtemporal parameters in older people with PD and the control group during the steps preceding obstacle avoidance. In addition motor planning (and motor adaptations) was initiated much earlier in the approach phase for the higher obstacle conditions compared to the low obstacle condition.	[Simieli, Lucas; Baptista, Andre Macari; Barbieri, Fabio Augusto] UNESP Univ Estadual Paulista, Fac Ciencias, Dept Educ Fis, Human Movement Res Lab, Bauru, SP, Brazil; [Bucken Gobbi, Lilian Teresa; Orcioli-Silva, Diego; Beretta, Victor Spiandor; Rocha Santos, Paulo Cezar] UNESP Univ Estadual Paulista, Inst Biociencias, Dept Educ Fis, Posture & Gait Studies Lab, Rio Claro, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Simieli, L (corresponding author), UNESP Univ Estadual Paulista, Fac Ciencias, Dept Educ Fis, Human Movement Res Lab, Bauru, SP, Brazil.	lucassimieli@hotmail.com	Barbieri, Fabio A./G-8721-2013; dos Santos, Paulo Cezar Rocha/AAR-6161-2021; SIMIELI, L./M-6087-2014; Beretta, Victor S/D-4511-2017; Orcioli-Silva, Diego/I-4108-2016; Gobbi, Lilian T B/C-9879-2010	Barbieri, Fabio A./0000-0002-3678-8456; dos Santos, Paulo Cezar Rocha/0000-0001-7378-1897; SIMIELI, L./0000-0001-5025-4613; Beretta, Victor S/0000-0002-4640-7733; Orcioli-Silva, Diego/0000-0002-2278-8092; Gobbi, Lilian T B/0000-0003-3984-3403	FAPESP [2013-21841-3]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-scholarship) [2013/21841-3]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-scholarship)	The authors thank FAPESP (# 2013-21841-3) for financial support.; We would like to thanks to FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo-scholarship #2013/21841-3).	Almeida QJ, 2005, NEUROSCIENCE, V134, P283, DOI 10.1016/j.neuroscience.2005.02.050; Barbieri FA, 2013, GAIT POSTURE, V37, P542, DOI 10.1016/j.gaitpost.2012.09.015; Bloem BR, 2001, ADV NEUROL, V87, P209; BROTCHIE P, 1991, NEUROSCI LETT, V131, P33, DOI 10.1016/0304-3940(91)90330-V; Brucki SMD, 2003, ARQ NEURO-PSIQUIAT, V61, P777, DOI 10.1590/S0004-282X2003000500014; Buckley JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019079; Camicioli R, 2006, J NEUROL SCI, V248, P205, DOI 10.1016/j.jns.2006.05.013; CHEN HC, 1991, J GERONTOL, V46, pM196, DOI 10.1093/geronj/46.6.M196; Dirnberger G, 2013, J NEUROPSYCHOL, V7, P193, DOI 10.1111/jnp.12028; Fahn S., 1987, RECENT DEV PARKINSON, V2, P153; GABELL A, 1984, J GERONTOL, V39, P662, DOI 10.1093/geronj/39.6.662; Goetz C, 2004, MOVEMENT DISORD, V19, P605, DOI 10.1002/mds.20105; Hausdorff JM, 2007, EUR J NEUROSCI, V26, P2369, DOI 10.1111/j.1460-9568.2007.05810.x; Hausdorff JM, 2006, EXP AGING RES, V32, P411, DOI 10.1080/03610730600875817; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 2005, J AM GERIATR SOC, V53, pS7; Hoehn M.M., 1967, NEUROLOGY, V17; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jantzen KJ, 2005, NEUROIMAGE, V25, P1031, DOI 10.1016/j.neuroimage.2004.12.029; LEE DN, 1982, J EXP PSYCHOL HUMAN, V8, P448; Lirani-Silva Ellen, 2015, Motriz: rev. educ. fis., V21, P244, DOI 10.1590/S1980-65742015000300004; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Miller L, 2015, JOVE-J VIS EXP, V15, P283; MORRIS ME, 1994, BRAIN, V117, P1169, DOI 10.1093/brain/117.5.1169; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Nagy A, 2006, EUR J NEUROSCI, V24, P917, DOI 10.1111/j.1460-9568.2006.04942.x; Patla AE, 2006, NEUROSCI LETT, V397, P110, DOI 10.1016/j.neulet.2005.12.016; Pieruccini-Faria F, 2006, Braz. J. Phys. Ther., V10, P233, DOI 10.1590/S1413-35552006000200015; Pieruccini-Faria F, 2013, J MOTOR BEHAV, V45, P369, DOI 10.1080/00222895.2013.810139; Rochester L, 2008, MOVEMENT DISORD, V23, P2312, DOI 10.1002/mds.22219; Schenkman M, 2001, GERONTOLOGIST, V41, P282; Simieli L, 2015, J ALZHEIMERS DIS, V43, P435, DOI 10.3233/JAD-140807; Stegemoller EL, 2012, ARCH PHYS MED REHAB, V93, P703, DOI 10.1016/j.apmr.2011.11.004; Stolze H, 2004, J NEUROL, V251, P79, DOI 10.1007/s00415-004-0276-8; Thaut MH, 2003, ANN NY ACAD SCI, V999, P364, DOI 10.1196/annals.1284.044; Vitorio R., 2011, INT SCHOLARLY RES NO, V2011; Vitorio R, 2010, GAIT POSTURE, V31, P143, DOI 10.1016/j.gaitpost.2009.09.011; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Yogev-Seligmann G, 2012, MOVEMENT DISORD, V27, P765, DOI 10.1002/mds.24963; Zelaznik HN, 2005, J MOTOR BEHAV, V37, P395, DOI 10.3200/JMBR.37.5.395-403	40	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184134	10.1371/journal.pone.0184134	http://dx.doi.org/10.1371/journal.pone.0184134			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910314	gold, Green Submitted, Green Published			2022-12-27	WOS:000410859200034
J	Hucker, SM; Ardern, Z; Goldberg, T; Schafferhans, A; Bernhofer, M; Vestergaard, G; Nelson, CW; Schloter, M; Rost, B; Scherer, S; Neuhaus, K				Huecker, Sarah M.; Ardern, Zachary; Goldberg, Tatyana; Schafferhans, Andrea; Bernhofer, Michael; Vestergaard, Gisle; Nelson, Chase W.; Schloter, Michael; Rost, Burkhard; Scherer, Siegfried; Neuhaus, Klaus			Discovery of numerous novel small genes in the intergenic regions of the Escherichia coli O157:H7 Sakai genome	PLOS ONE			English	Article							RIBOSOME PROFILING EXPERIMENTS; SMALL MEMBRANE-PROTEINS; FRAME-ENCODED PEPTIDES; OPEN READING FRAMES; TRANSCRIPTION TERMINATION; DARK-MATTER; HUMAN-CELLS; RNA-SEQ; TRANSLATION; SEQUENCE	In the past, short protein-coding genes were often disregarded by genome annotation pipelines. Transcriptome sequencing (RNAseq) signals outside of annotated genes have usually been interpreted to indicate either ncRNA or pervasive transcription. Therefore, in addition to the transcriptome, the translatome (RIBOseq) of the enteric pathogen Escherichia coli O157: H7 strain Sakai was determined at two optimal growth conditions and a severe stress condition combining low temperature and high osmotic pressure. All intergenic open reading frames potentially encoding a protein of >= 30 amino acids were investigated with regard to coverage by transcription and translation signals and their translatability expressed by the ribosomal coverage value. This led to discovery of 465 unique, putative novel genes not yet annotated in this E. coli strain, which are evenly distributed over both DNA strands of the genome. For 255 of the novel genes, annotated homologs in other bacteria were found, and a machine-learning algorithm, trained on small protein-coding E. coli genes, predicted that 89% of these translated open reading frames represent bona fide genes. The remaining 210 putative novel genes without annotated homologs were compared to the 255 novel genes with homologs and to 250 short annotated genes of this E. coli strain. All three groups turned out to be similar with respect to their translatability distribution, fractions of differentially regulated genes, secondary structure composition, and the distribution of evolutionary constraint, suggesting that both novel groups represent legitimate genes. However, the machine-learning algorithm only recognized a small fraction of the 210 genes without annotated homologs. It is possible that these genes represent a novel group of genes, which have unusual features dissimilar to the genes of the machine-learning algorithm training set.	[Huecker, Sarah M.; Ardern, Zachary; Scherer, Siegfried; Neuhaus, Klaus] Tech Univ Munich, Chair Microbial Ecol, Freising Weihenstephan, Germany; [Huecker, Sarah M.; Ardern, Zachary; Scherer, Siegfried] Tech Univ Munich, ZIEL Inst Food & Hlth, Freising Weihenstephan, Germany; [Goldberg, Tatyana; Schafferhans, Andrea; Bernhofer, Michael; Rost, Burkhard] Tech Univ Munich, Dept Informat Bioinformat, Garching, Germany; [Goldberg, Tatyana; Schafferhans, Andrea; Bernhofer, Michael; Rost, Burkhard] Tech Univ Munich, TUM IAS, Garching, Germany; [Vestergaard, Gisle; Schloter, Michael] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Neuherberg, Germany; [Nelson, Chase W.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Neuhaus, Klaus] Tech Univ Munich, Core Facil Microbiome NGS, ZIEL Inst Food & Hlth, Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; American Museum of Natural History (AMNH); Technical University of Munich	Neuhaus, K (corresponding author), Tech Univ Munich, Chair Microbial Ecol, Freising Weihenstephan, Germany.; Neuhaus, K (corresponding author), Tech Univ Munich, Core Facil Microbiome NGS, ZIEL Inst Food & Hlth, Freising Weihenstephan, Germany.	neuhaus@tum.de	Schloter, 1Michael/H-9151-2013; Scherer, Siegfried/I-1320-2013; Ardern, Zachary/AAV-7375-2020; Schafferhans, Andrea/C-9985-2009	Ardern, Zachary/0000-0002-9008-0897; Schafferhans, Andrea/0000-0002-5569-6186; Hucker, Sarah/0000-0002-6167-0265; Vestergaard, Gisle/0000-0003-2541-4974; Nelson, Chase/0000-0001-6287-1598; Scherer, Siegfried/0000-0002-0394-9890; Neuhaus, Klaus/0000-0002-6020-2814; Bernhofer, Michael/0000-0001-6103-3306	Deutsche Forschungsgemeinschaft DFG [SCHE316/3-2, KE740/13-2, SPP 1395]; Alexander von Humboldt foundation through the German Ministry for Research and Education (Bundesministerium fur Bildung and Forschung BMBF); Gerstner Family Foundation at the American Museum of Natural History	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Alexander von Humboldt foundation through the German Ministry for Research and Education (Bundesministerium fur Bildung and Forschung BMBF); Gerstner Family Foundation at the American Museum of Natural History	This work was supported by the Deutsche Forschungsgemeinschaft DFG (SCHE316/3-2, KE740/13-2) within SPP 1395 InKoMBio to S.M.H., Z.A., S.S., and K.N., by Alexander von Humboldt foundation through the German Ministry for Research and Education (Bundesministerium fur Bildung and Forschung BMBF) to T.G., A.B., M.B., and B.R., and by a Gerstner Scholars Fellowship from the Gerstner Family Foundation at the American Museum of Natural History to C.W.N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschimann F, 2015, METHODS; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aspden JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03528; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baek J, 2017, G3-GENES GENOM GENET, V7, P983, DOI 10.1534/g3.116.036939; Banerjee S, 2006, J MICROBIOL, V44, P11; Baumgartner D, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0896-z; Bazzini AA, 2014, EMBO J, V33, P981, DOI 10.1002/embj.201488411; Bernhofer M, 2016, PROTEINS, V84, P1706, DOI 10.1002/prot.25155; Bitard-Feildel T, 2017, SCI REP-UK, V7, DOI 10.1038/srep41425; Boekhorst J, 2011, MICROB BIOTECHNOL, V4, P308, DOI 10.1111/j.1751-7915.2011.00261.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Brylinski M, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-47; Byrgazov K, 2013, CURR OPIN MICROBIOL, V16, P133, DOI 10.1016/j.mib.2013.01.009; Calviello L, 2016, NAT METHODS, V13, P165, DOI [10.1038/NMETH.3688, 10.1038/nmeth.3688]; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carlevaro-Fita J, 2016, RNA, V22, P867, DOI 10.1261/rna.053561.115; Carver T, 2010, BIOINFORMATICS, V26, P676, DOI 10.1093/bioinformatics/btq010; Cassidy L, 2016, J PROTEOME RES, V15, P3773, DOI 10.1021/acs.jproteome.6b00569; Ceroni A, 2006, NUCLEIC ACIDS RES, V34, pW177, DOI 10.1093/nar/gkl266; Cho BK, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-4; Dar D, 2016, SCIENCE, V352, DOI 10.1126/science.aad9822; de Castro BG, 2013, REV BRAS PARASITOL V, V22, P318, DOI 10.1590/S1984-29612013000200052; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dornenburg JE, 2010, MBIO, V1; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Flaherty BL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-332; Gerashchenko MV, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw822; Gerashchenko MV, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku671; Goldberg T, 2014, NUCLEIC ACIDS RES, V42, pW350, DOI 10.1093/nar/gku396; Graur D, 2013, GENOME BIOL EVOL, V5, P578, DOI 10.1093/gbe/evt028; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hemm MR, 2008, MOL MICROBIOL, V70, P1487, DOI 10.1111/j.1365-2958.2008.06495.x; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hou Z, 2013, FOOD MICROBIOL, V35, P136, DOI 10.1016/j.fm.2013.03.002; Hsu PY, 2016, P NATL ACAD SCI US; Hucker SM, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnw262; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; Hwang JY, 2017, NUCLEIC ACIDS RES, V45, P327, DOI 10.1093/nar/gkw944; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jeong Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11605; Ji Z, 2015, ELIFE, V4, DOI 10.7554/eLife.08890; Junier T, 2010, BIOINFORMATICS, V26, P1669, DOI 10.1093/bioinformatics/btq243; Kans J., 2017, ENTREZ DIRECT E UTIL; Kemp G, 2014, BIOL CHEM, V395, P1365, DOI 10.1515/hsz-2014-0213; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Landstorfer R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-353; Lasa I, 2011, P NATL ACAD SCI USA, V108, P20172, DOI 10.1073/pnas.1113521108; Latif H, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00821-14; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Lewis SB, 2015, INFECT IMMUN, V83, P942, DOI 10.1128/IAI.02928-14; Lim JY, 2010, J MICROBIOL BIOTECHN, V20, P5, DOI 10.4014/jmb.0908.08007; Lin YF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-620; Liu XQ, 2013, P NATL ACAD SCI USA, V110, P11928, DOI 10.1073/pnas.1309739110; Ma J, 2002, J BACTERIOL, V184, P5733, DOI 10.1128/JB.184.20.5733-5745.2002; Ma JC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023191; Marks J, 2016, P NATL ACAD SCI USA, V113, P12150, DOI 10.1073/pnas.1613055113; Mohammad F, 2016, CELL REP, V14, P686, DOI 10.1016/j.celrep.2015.12.073; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; Neme R, 2016, ELIFE, V5, DOI 10.7554/eLife.09977; Neuhaus K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3586-9; Neuhaus K, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2456-1; O'Connor PBF, 2013, BIOINFORMATICS, V29, P1488, DOI 10.1093/bioinformatics/btt184; OhEigeartaigh SS, 2014, J BACTERIOL, V196, P2030, DOI 10.1128/JB.01368-13; Perdigao N, 2015, P NATL ACAD SCI USA, V112, P15898, DOI 10.1073/pnas.1508380112; Perkins TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000569; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Ruiz-Orera J, 2014, ELIFE, V3, DOI 10.7554/eLife.03523; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schlessinger A, 2007, BIOINFORMATICS, V23, P2376, DOI 10.1093/bioinformatics/btm349; Schubert Mikkel, 2016, BMC Res Notes, V9, P88, DOI 10.1186/s13104-016-1900-2; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Smith JE, 2014, CELL REP, V7, P1858, DOI 10.1016/j.celrep.2014.05.023; Solovyev VV, 2011, GENOME MED, V3, DOI 10.1186/gm264; Storz G, 2014, ANNU REV BIOCHEM, V83, P753, DOI 10.1146/annurev-biochem-070611-102400; Tatarinova TV, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-015-0104-3; Trachtman H, 2012, NAT REV NEPHROL, V8, P658, DOI 10.1038/nrneph.2012.196; Vimberg V, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-100; Wade JT, 2014, NAT REV MICROBIOL, V12, P647, DOI 10.1038/nrmicro3316; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Warren AS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-131; Wilson BA, 2011, GENOME BIOL EVOL, V3, P1245, DOI 10.1093/gbe/evr099; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; Xue SF, 2012, NAT REV MOL CELL BIO, V13, P355, DOI 10.1038/nrm3359; Yomtovian I, 2010, BIOINFORMATICS, V26, P996, DOI 10.1093/bioinformatics/btq093; Zhang W, 2006, GENOME RES, V16, P757, DOI 10.1101/gr.4759706; Zheng XB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-361; Zur H, 2016, SCI REP, P6	98	14	14	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184119	10.1371/journal.pone.0184119	http://dx.doi.org/10.1371/journal.pone.0184119			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902868	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200026
J	Verbeurgt, C; Veithen, A; Carlot, S; Tarabichi, M; Dumont, JE; Hassid, S; Chatelain, P				Verbeurgt, Christophe; Veithen, Alex; Carlot, Sebastien; Tarabichi, Maxime; Dumont, Jacques E.; Hassid, Sergio; Chatelain, Pierre			The human bitter taste receptor T2R38 is broadly tuned for bacterial compounds	PLOS ONE			English	Article							SOLITARY CHEMOSENSORY CELLS; PHENYLTHIOCARBAMIDE; SENSITIVITY; FAMILY	T2R38 has been shown to be a specific bacterial detector implicated in innate immune defense mechanism of human upper airway. Several clinical studies have demonstrated that this receptor is associated with the development of chronic rhinosinusitis (CRS). T2R38 was previously reported to bind to homoserine lactones (HSL), quorum sensing molecules specific of Pseudomonas Aeruginosa and other gram negative species. Nevertheless, these bacteria are not the major pathogens found in CRS. Here we report on the identification of bacterial metabolites acting as new agonists of T2R38 based on a single cell calcium imaging study. Two quorum sensing molecules (Agr D1 thiolactone from Staphylococcus Aureus and CSP-1 from Streptococcus Pneumoniae) and a list of 32 bacterial metabolites from pathogens frequently implicated in CRS were tested. First, we observed that HSL failed to activate T2R38 in our experimental system, but that the dimethylsulfoxide (DMSO), used as a solvent for these lactones may, by itself, account for the agonistic effect previously described. Secondly, we showed that both Agr D1 thiolactone and CSP-1 are inactive but that at least 7 bacterial metabolites (acetone, 2-butanone, 2-pentanone, 2-methylpropanal, dimethyl disulfide, methylmercaptan, gamma-butyrolactone) are able to specifically trigger this receptor. T2R38 is thus much more broadly tuned for bacterial compounds than previously thought.	[Verbeurgt, Christophe; Carlot, Sebastien; Hassid, Sergio] Free Univ Brussels, Erasme Univ Hosp, Dept Otorhinolaryngol, Brussels, Belgium; [Veithen, Alex; Chatelain, Pierre] ChemCom SA, Brussels, Belgium; [Tarabichi, Maxime; Dumont, Jacques E.] Free Univ Brussels, Inst Interdisciplinary Res Human & Mol Biol, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Verbeurgt, C (corresponding author), Free Univ Brussels, Erasme Univ Hosp, Dept Otorhinolaryngol, Brussels, Belgium.	christophe.verbeurgt@erasme.ulb.ac.be	Tarabichi, Maxime/ABA-9246-2020	Tarabichi, Maxime/0000-0002-1635-2348	Fonds Erasme	Fonds Erasme	Two authors (AV and PC) are employed by the commercial company Chemcom S.A., Brussels. The funder, Fonds Erasme, provided support in the form of salaries for author [CV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adappa ND, 2015, INT FORUM ALLERGY RH; Adappa ND, 2016, INT FORUM ALLERGY RH, V6, P25, DOI 10.1002/alr.21666; Adappa ND, 2014, INT FORUM ALLERGY RH, V4, P3, DOI 10.1002/alr.21253; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Atsumi S, 2009, NAT BIOTECHNOL, V27, P1177, DOI 10.1038/nbt.1586; Avau B, 2015, ACTA PHYSL OXF; Bandara HMHN, 2012, CRIT REV MICROBIOL, V38, P217, DOI 10.3109/1040841X.2011.652065; Barham HP, 2013, INT FORUM ALLERGY RH, V3, P450, DOI 10.1002/alr.21149; Baumler DJ, 2007, EXTREMOPHILES, V11, P841, DOI 10.1007/s00792-007-0108-8; Behrens M, 2013, CHEM SENSES, V38, P475, DOI 10.1093/chemse/bjt016; Bos LDJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003311; Braun T, 2011, RHINOLOGY, V49, P507, DOI 10.4193/Rhino.11.121; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; EBERHARD A, 1981, BIOCHEMISTRY-US, V20, P2444, DOI 10.1021/bi00512a013; Farquhar DR, 2015, INT FORUM ALLERGY RH, V5, P111, DOI 10.1002/alr.21437; Filipiak W, 2012, MICROBIOL-SGM, V158, P3044, DOI 10.1099/mic.0.062687-0; Filipiak W, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-113; Finger TE, 2003, P NATL ACAD SCI USA, V100, P8981, DOI 10.1073/pnas.1531172100; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gaida MM, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw004; Hadad I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056007; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; Jacob Stanley W., 2015, TRAUMA AND DIS; Kim UK, 2003, SCIENCE, V299, P1221, DOI 10.1126/science.1080190; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; LEWIS HL, 1970, J GEN MICROBIOL, V63, P203, DOI 10.1099/00221287-63-2-203; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Maurer S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00369; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Preti G, 2009, J CHROMATOGR B, V877, P2011, DOI 10.1016/j.jchromb.2009.05.028; Sanz G, 2005, CHEM SENSES, V30, P69, DOI 10.1093/chemse/bji002; Sbarbati A, 2009, ANAT REC, V292, P439, DOI 10.1002/ar.20866; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Ueda T, 2003, J NEUROSCI, V23, P7376; Verbeurgt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096333; Wiener A, 2012, NUCLEIC ACIDS RES, V40, pD413, DOI 10.1093/nar/gkr755	39	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0181302	10.1371/journal.pone.0181302	http://dx.doi.org/10.1371/journal.pone.0181302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902853	gold, Green Published, Green Submitted			2022-12-27	WOS:000410669200003
J	Zeidan, AM; Long, JB; Wang, R; Hu, X; Yu, JB; Huntington, SF; Abel, GA; Mougalian, SS; Podoltsev, NA; Gore, SD; Gross, CP; Ma, XM; Davidoff, AJ				Zeidan, Amer M.; Long, Jessica B.; Wang, Rong; Hu, Xin; Yu, James B.; Huntington, Scott F.; Abel, Gregory A.; Mougalian, Sarah S.; Podoltsev, Nikolai A.; Gore, Steven D.; Gross, Cary P.; Ma, Xiaomei; Davidoff, Amy J.			Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study	PLOS ONE			English	Article							MYELODYSPLASTIC SYNDROMES; RADIATION-THERAPY; ADJUVANT BREAST; LEUKEMIA; SURVIVAL; MODEL	Background There are inconsistent and limited data regarding the risk of myeloid neoplasms (MN) among breast cancer survivors who received radiotherapy (RT) in the absence of chemotherapy. Concern about subsequent MN might influence the decision to use adjuvant RT for women with localized disease. As patients with therapy-related MN have generally poor outcomes, the presumption of subsequent MN being therapy-related could affect treatment recommendations. Methods We used the Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database to study older women with in-situ or stage 1-3 breast cancer diagnosed 2001-2009 who received surgery. Chemotherapy and RT were ascertained using Medicare claims, and new MN diagnoses were captured using both SEER registry and Medicare claims. We excluded women who received chemotherapy for initial treatment, and censored at receipt of subsequent chemotherapy. Competing-risk survival analysis was used to assess the association between RT and risk of subsequent MN adjusting for relevant characteristics. Results Median follow-up for 60,426 eligible patients was 68 months (interquartile range, 46 to 92 months), with 47.6% receiving RT. In total, 316 patients (0.52%) were diagnosed with MN; the cumulative incidence per 10,000 person-years was 10.6 vs 9.0 among RT-treated vs non-RT-treated women, respectively (p = .004); the increased risk of subsequent MN persisted in the adjusted analysis (hazard ratio = 1.36, 95% confidence interval: 1.03-1.80). The results were consistent in multiple sensitivity analyses. Conclusions Our data suggest that RT is associated with a significant risk of subsequent MN among older breast cancer survivors, though the absolute risk increase is very small. These findings suggest the benefits of RT outweigh the risks of development of subsequent MN.	[Zeidan, Amer M.; Huntington, Scott F.; Mougalian, Sarah S.; Podoltsev, Nikolai A.; Gore, Steven D.; Gross, Cary P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Zeidan, Amer M.; Long, Jessica B.; Wang, Rong; Hu, Xin; Yu, James B.; Huntington, Scott F.; Mougalian, Sarah S.; Gross, Cary P.; Ma, Xiaomei; Davidoff, Amy J.] Yale Univ, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA; [Wang, Rong; Ma, Xiaomei] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA; [Yu, James B.] Yale Univ, Dept Therapeut Radiol, New Haven, CT USA; [Abel, Gregory A.] Dana Farber Canc Inst, Dept Med Oncol, Div Populat Sci, Boston, MA 02115 USA; [Davidoff, Amy J.] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University; Harvard University; Dana-Farber Cancer Institute; Yale University	Zeidan, AM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.; Zeidan, AM (corresponding author), Yale Univ, Canc Outcomes Publ Policy & Effectiveness Res COP, New Haven, CT USA.	amer.zeidan@yale.edu	HU, XIN/G-7183-2018	HU, XIN/0000-0003-1097-3300; Zeidan, Amer/0000-0001-7017-8160; Yu, James/0000-0002-3119-3226	Dennis Cooper Hematology Young Investigator Award; National Cancer Institute [P30 CA016359]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER	Dennis Cooper Hematology Young Investigator Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partly funded by the Dennis Cooper Hematology Young Investigator Award, and a P30 CA016359 from the National Cancer Institute (https://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V366, P2087; Bach PB, 2002, MED CARE, V40; Braithwaite D, 2016, CLIN INTERV AGING, V11, P111, DOI 10.2147/CIA.S65304; Cogle CR, 2011, BLOOD, V117, P7121, DOI 10.1182/blood-2011-02-337964; Craig BM, 2012, CANCER EPIDEM BIOMAR, V21, P474, DOI 10.1158/1055-9965.EPI-11-1087; CURTIS RE, 1992, NEW ENGL J MED, V326, P1745, DOI 10.1056/NEJM199206253262605; Davidoff AJ, 2013, J GERIATR ONCOL, V4, P157, DOI 10.1016/j.jgo.2012.12.005; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gale RP, 2014, LEUKEMIA RES, V38, P1162, DOI 10.1016/j.leukres.2014.08.002; Grantzau T, 2013, RADIOTHER ONCOL, V106, P42, DOI 10.1016/j.radonc.2013.01.002; Jagsi R, 2012, CANCER-AM CANCER SOC, V118, P333, DOI 10.1002/cncr.26295; Kaplan H, 2013, BREAST CANCER RES TR, V137, P863, DOI 10.1007/s10549-012-2386-9; Kaplan HG, 2013, BREAST CANCER RES TR, V142, P629, DOI 10.1007/s10549-013-2773-x; Kaplan HG, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-260; Kaplan HG, 2004, CANCER, V101, P1529, DOI 10.1002/cncr.20475; Martin MG, 2009, BREAST CANCER RES TR, V118, P593, DOI 10.1007/s10549-009-0376-3; Nardi V, 2012, J CLIN ONCOL, V30, P2340, DOI 10.1200/JCO.2011.38.7340; Ornstein MC, 2014, AM J HEMATOL, V89, P168, DOI 10.1002/ajh.23605; Roberts KB, 2013, INT J RADIAT ONCOL, V85, P1186, DOI 10.1016/j.ijrobp.2012.10.009; Smith RE, 2003, J CLIN ONCOL, V21, P1195, DOI 10.1200/JCO.2003.03.114; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wang R, 2017, PROSTATE, V77, P437, DOI 10.1002/pros.23281; Warren JL, 2002, MED CARE, V40, P3; Warren JL, 2002, J CLIN ONCOL, V20, P307, DOI 10.1200/JCO.20.1.307; Wolff AC, 2015, J CLIN ONCOL, V33, P340, DOI 10.1200/JCO.2013.54.6119; Yu GP, 2006, CANCER CAUSE CONTROL, V17, P411, DOI 10.1007/s10552-005-0338-y; Zeidan AM, 2013, CANCER-AM CANCER SOC, V119, P3870, DOI 10.1002/cncr.28298	29	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184747	10.1371/journal.pone.0184747	http://dx.doi.org/10.1371/journal.pone.0184747			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902882	gold, Green Published, Green Submitted			2022-12-27	WOS:000410669200060
J	Gebreegziabher, T; Stoecker, BJ				Gebreegziabher, Tafere; Stoecker, Barbara J.			Iron deficiency was not the major cause of anemia in rural women of reproductive age in Sidama zone, southern Ethiopia: A cross-sectional study	PLOS ONE			English	Article							BIOMARKERS REFLECTING INFLAMMATION; NUTRITIONAL DETERMINANTS; BRINDA PROJECT; BIOAVAILABILITY; PREVALENCE; ZINC; HEMOGLOBIN; PREGNANCY; CHILDREN; PHYTATE	Background Anemia, which has many etiologies, is a moderate/severe public health problem in young children and women of reproductive age in many developing countries. The aim of this study was to investigate prevalence of iron deficiency, anemia, and iron deficiency anemia using multiple biomarkers and to evaluate their association with food insecurity and food consumption patterns in non-pregnant women from a rural area of southern Ethiopia. Methods A cross-sectional study was conducted in 202 rural women of reproductive age in southern Ethiopia. Anthropometrics and socio-demographic data were collected. A venipuncture blood sample was analyzed for hemoglobin (Hb) and for biomarkers of iron status. Biomarkers were skewed and were log transformed before analysis. Mean, median, Pearson's correlations and ordinary least-squares regressions were calculated. Results Median (IQR) Hb was 138 (127, 151) g/L. Based on an altitude-adjusted (1708 m) cutoff of 125 g/L for Hb, 21.3% were anemic. Plasma ferritin was < 15 mu g/L in 18.6% of the women. Only one woman had alpha-1-acid glycoprotein (AGP) > 1.0 g/L; four women (2%) had > 5 mg/L of C-reactive protein (CRP). Of the 43 women who were anemic, 23.3% (10 women) had depleted iron stores based on plasma ferritin. Three of these had elevated soluble transferrin receptors (sTfR). Hemoglobin (Hb) concentration was negatively correlated with sTfR (r = -0.24, p = 0.001), and positively correlated with ferritin (r = 0.17, p = 0.018), plasma iron (r = 0.15, p = 0.046), transferrin saturation (TfS) (r = 0.15, p = 0.04) and body iron (r = 0.14, p = 0.05). Overall prevalence of iron deficiency anemia was only 5%. Conclusion Iron deficiency anemia was not prevalent in the study population, despite the fact that anemia would be classified as a moderate public health problem.	[Gebreegziabher, Tafere] Hawassa Univ, Sch Nutr Food Sci & Technol, Hawassa, Ethiopia; [Gebreegziabher, Tafere] Cent Washington Univ, Dept Hlth Sci, Ellensburg, WA 98926 USA; [Stoecker, Barbara J.] Oklahoma State Univ, Dept Nutr Sci, Stillwater, OK 74078 USA	Hawassa University; Central Washington University; Oklahoma State University System; Oklahoma State University - Stillwater	Gebreegziabher, T (corresponding author), Hawassa Univ, Sch Nutr Food Sci & Technol, Hawassa, Ethiopia.; Gebreegziabher, T (corresponding author), Cent Washington Univ, Dept Hlth Sci, Ellensburg, WA 98926 USA.	tafere.bl@gmail.com			Hawassa University, Hawassa Ethiopia; Oklahoma Agricultural Experiment Station [W3002]; Hawassa University	Hawassa University, Hawassa Ethiopia; Oklahoma Agricultural Experiment Station; Hawassa University	This work was supported by Hawassa University, Hawassa Ethiopia and W3002 Multistate Project - Oklahoma Agricultural Experiment Station. The funders had no role in study design, data collections and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the study participants for their time and willingness to take part in the study and Mr. Keneni Fufa for his contributions in sample collection. This study was supported by Hawassa University and Oklahoma Agricultural Experiment Station Multi State Project W3002.	Abebe Y, 2006, PUBLIC HEALTH NUTR, V11, P379; Abebe Y, 2007, J FOOD COMPOS ANAL, V20, P161, DOI 10.1016/j.jfca.2006.09.003; Alemayehu AA, 2011, NUTRITION, V27, P919, DOI 10.1016/j.nut.2010.10.015; Assefa Selomon, 2014, BMC Hematol, V14, P3, DOI 10.1186/2052-1839-14-3; Baye K, 2014, INT J FOOD SCI TECH, V49, P174, DOI 10.1111/ijfs.12295; Baynes RD, 1996, CLIN BIOCHEM, V29, P209, DOI 10.1016/0009-9120(96)00010-K; Bekele A, 2016, ANEMIA, V2016, DOI 10.1155/2016/1073192; Central Statistical Agency and ICF International, 2012, ADD AB ETH CALV; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Cusick SE, 2008, AM J CLIN NUTR, V88, P1611, DOI 10.3945/ajcn.2008.25926; de Benoist B, 2008, WHO GLOBAL DATABASE; Deitchler M, 2011, INTRO SIMPLE MEASURE, V12; Ethiopian Public Health Institute, 2016, ETH NAT MICR SURV RE; FerroLuzzi A, 1996, BRIT J NUTR, V75, P3, DOI 10.1079/BJN19960105; Fishman SM, 2000, PUBLIC HEALTH NUTR, V3, P125, DOI 10.1017/S1368980000000173; Gashu D, 2016, PUBLIC HEALTH NUTR, V19, P1834, DOI 10.1017/S1368980015003626; GEBREMEDHIN M, 1976, SCAND J HAEMATOL, V16, P168; Gebremedhin S, 2014, AFR J REPROD HEALTH, V18, P44; Gibson R, 2005, PRINCIPLES NUTR ASSE; Gibson RS, 2008, J NUTR, V138, P581, DOI 10.1093/jn/138.3.581; Gibson RS, 2010, FOOD NUTR BULL, V31, pS134, DOI 10.1177/15648265100312S206; Haidar Jemal A, 2009, BMC Blood Disord, V9, P7, DOI 10.1186/1471-2326-9-7; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112858; Hofvander Y., 1968, ACTA MED SCAND, V494, P1; Mei ZG, 2017, AM J CLIN NUTR, V106, p383S, DOI 10.3945/ajcn.116.142307; Melaku Umeta, 2008, Ethiopian Journal of Health Development, V22, P252; Namaste SML, 2017, AM J CLIN NUTR, V106, p359S, DOI 10.3945/ajcn.116.141762; Pynaert I, 2005, EUR J CLIN NUTR, V59, P826, DOI 10.1038/sj.ejcn.1602149; Regassa N., 2011, ETHIOP J ENV STUD MA, V4; Regassa N, 2012, PUBLIC HEALTH NUTR, V15, P1276, DOI 10.1017/S1368980011003119; Sullivan KM, 2008, TROP MED INT HEALTH, V13, P1267, DOI 10.1111/j.1365-3156.2008.02143.x; Thurnham DI, 2015, J NUTR, V145, p1137S, DOI 10.3945/jn.114.194712; WHO, 2011, SER FERR CONC ASS IR; WHO/ UNICEF/ UNU, 1996, IND ASS DEF STRAT IT; Who/unicef/unu ed, 2001, WHONHD013 UNICEFUNU; World Health Organization, 2006, GLOB DAT BOD MASS IN; World Health Organization Centers for Disease Control and Prevention, 2007, ASS IR STAT POP; Yigzaw Y, 2001, LATHYRUS LATHYRISM N, V2	39	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184742	10.1371/journal.pone.0184742	http://dx.doi.org/10.1371/journal.pone.0184742			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898272	Green Submitted, Green Published, gold			2022-12-27	WOS:000410449500046
J	Kyaw, KWY; Oo, MM; Kyaw, NTT; Phyo, KH; Aung, TK; Mya, T; Aung, N; Oo, HN; Isaakidis, P				Kyaw, Khine Wut Yee; Oo, Myo Minn; Kyaw, Nang Thu Thu; Phyo, Khaing Hnin; Aung, Thet Ko; Mya, Theingi; Aung, Nilar; Oo, Htun Nyunt; Isaakidis, Petros			Low mother-to-child HIV transmission rate but high loss-to-follow-up among mothers and babies in Mandalay, Myanmar; a cohort study	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PREVENTION	Introduction Loss-to-follow-up (LTFU) throughout the Prevention of Mother-To-Child Transmission (PMTCT) cascade remains one of the major threats to the success of PMTCT programs. In this study, we aimed to determine the mother-to-child transmission rate in a programmatic setting and to determine factors associated with LTFU among enrolled mothers and unfavorable outcomes among HIV-exposed babies which includes being HIV positive, death and LTFU. Methods A retrospective cohort study reviewing routinely collected data in an Integrated HIV care program, Mandalay, Myanmar in June 2016. LTFU means mother/infant missing appointed visit for more than three months. Results Of 678 pregnant women enrolled in PMTCT program between March 2011 and June 2014, one stillbirth and 607 live births were recorded in this cohort. Of 457 HIV-exposed babies with HIV-test recorded at the end of the intervention, nine (2%) were HIV-positive. Pregnant women's and exposed-babies' LTFU rate was 7 per 1000 person-years, and 10 per 1000 person-years respectively. PMTCT option B protocol was found to be significantly associate with maternal LTFU [adjusted Hazard Ratio (aHR) 95% CI: 3.52 (1.38-8.96)] when compare to mothers receiving option B+/lifelong antiretroviral therapy (ART). Weight <2.5 Kg at enrolment, receiving mixed-feeding, vaginal delivery and option B PMTCT protocol were significantly associated with unfavorable outcomes among exposed babies [aHR(95% CI): 5.40 (1.66-17.53), 5.91(1.68-20.84), 2.27 (1.22-4.22) and 2.33 (1.16-4.69) respectively]. Conclusion Mother-to-child HIV transmission rate in this public hospital-based program was lower than the 5% national target, which indicates a successful PMTCT intervention. However, a high proportion of HIV-infected mothers and exposed babies LTFU was recorded. Lifelong ART provision to HIV-positive pregnant women was shown to reduce exposed babies' LTFU, death and transmission rate (unfavorable outcomes) in this setting. Lessons learned from this program could be used to inform policy and practice in the country, while the programmatic challenge of LTFU should be urgently addressed.	[Kyaw, Khine Wut Yee; Oo, Myo Minn; Kyaw, Nang Thu Thu] Int Union TB & Lung Dis Union, Dept Operat Res, Mandalay, Myanmar; [Phyo, Khaing Hnin; Aung, Thet Ko] Int Union TB & Lung Dis Union, HIV Unit, Mandalay, Myanmar; [Mya, Theingi] Cent Women Hosp, Dept Obstet & Gynecol, Mandalay, Myanmar; [Aung, Nilar] Cent Women Hosp, Neonatol Unit, Mandalay, Myanmar; [Oo, Htun Nyunt] Minist Hlth & Sports, Dept Publ Hlth, Natl AIDS Program, Nay Pyi Taw, Myanmar; [Isaakidis, Petros] Medecins Sans Frontieres MSF Doctors Borders, Dept Operat Res, Bombay, Maharashtra, India		Kyaw, KWY (corresponding author), Int Union TB & Lung Dis Union, Dept Operat Res, Mandalay, Myanmar.	dr.khinewutyeekyaw2015@gmail.com	Oo, Myo Minn/P-3720-2018; Kyaw, Khine Wut Yee/K-4130-2019	Oo, Myo Minn/0000-0003-4089-016X; Kyaw, Khine Wut Yee/0000-0003-0709-484X; Isaakidis, Petros/0000-0002-7881-1554	Department for International Development (DFID), UK; National AIDS program (NAP); Medical Superintendent Professor and Head of Obstetrics and Gynecology Department of Central Women Hospital; HIV unit (The Union); PLHIV network	Department for International Development (DFID), UK; National AIDS program (NAP); Medical Superintendent Professor and Head of Obstetrics and Gynecology Department of Central Women Hospital; HIV unit (The Union); PLHIV network	The training program was funded by the Department for International Development (DFID), UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the support of National AIDS program (NAP), Medical Superintendent Professor and Head of Obstetrics and Gynecology Department of Central Women Hospital, HIV unit (The Union), PLHIV network and all PLHIV and exposed babies included in this study. This research was conducted through the Structured Operational Research and Training Initiative (SORT IT), a global partnership led by the Special Program for Research and Training in Tropical Diseases at the World Health Organization (WHO/TDR). The model is based on a course developed jointly by the International Union Against Tuberculosis and Lung Disease (The Union) and Medecins sans Frontieres (MSF/Doctors Without Borders). The specific SORT IT program which resulted in this publication was jointly developed and implemented by: The Union South-East Asia Office, New Delhi, India; the Centre for Operational Research, The Union, Paris, France; The Union, Mandalay, Myanmar; the Operational Research Unit (LUXOR), MSF Brussels Operational Center, Luxembourg; Department of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India; Department of Community Medicine, Government T.D Medical College, Alappuzha, India; College of Life and Environmental Sciences, Exeter University, UK; Velammal Medical College Hospital & Research Institute, Madurai, India; and Institute of Medicine, University of Chester, UK.	Altan AMD, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.72.7958; Anoje C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-184; Chetty T, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-146; Chintu N, 2013, NIH PUBLIC ACCESS, V58, P224; Duff P, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-37; Geldsetzer P, 2016, J INT AIDS SOC, P19; Giuliano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068950; Iroezi Ngozi D, 2013, Afr J Reprod Health, V17, P118; Js R, 2007, EFFICACY SAFETY CESA, P1; Kalembo FW, 2013, CHINESE MED J-PEKING, V126, P3172, DOI 10.3760/cma.j.issn.0366-6999.20123475; Kristine SF, 2016, AIDS BEHAV, P2602; Landers DV, 1999, NEW ENGL J MED, V341, P205; National AIDS Program, 2015, NAT STRAT PLAN HIV A; National AIDS Program, 2014, GLOB AIDS RESP PROGR; National AIDS Program, 2015, GLOB AIDS RESP PROGR; Nduati EW, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2355-4; Noubiap JJN, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.65.2551; Phillips T, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19242; Sibanda EL, 2013, AIDS, V27, P2787, DOI 10.1097/QAD.0000000000000027; Thida A, 2014, PLOS ONE, P9; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; UNAIDS, 2013, HIV AS PAS, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2014, GAP REP 2014; UNAIDS, 2016, GAP REPRT 2016; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zhou ZQ, 2010, JAIDS-J ACQ IMM DEF, V53, pS15, DOI 10.1097/QAI.0b013e3181c7d47b	29	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184426	10.1371/journal.pone.0184426	http://dx.doi.org/10.1371/journal.pone.0184426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886165	Green Submitted, gold, Green Published			2022-12-27	WOS:000410001100118
J	Schultz, DJ; Muluhngwi, P; Alizadeh-Rad, N; Green, MA; Rouchka, EC; Waigel, SJ; Klinge, CM				Schultz, David J.; Muluhngwi, Penn; Alizadeh-Rad, Negin; Green, Madelyn A.; Rouchka, Eric C.; Waigel, Sabine J.; Klinge, Carolyn M.			Genome-wide miRNA response to anacardic acid in breast cancer cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; DOWN-REGULATION; MESSENGER-RNA; LUNG-CANCER; PROSTATE-CANCER; GENE-EXPRESSION; UP-REGULATION; MESENCHYMAL TRANSITION; INHIBITS PROLIFERATION; MIR-1247 FUNCTIONS	MicroRNAs are biomarkers and potential therapeutic targets for breast cancer. Anacardic acid (AnAc) is a dietary phenolic lipid that inhibits both MCF-7 estrogen receptor alpha (ER alpha) positive and MDA-MB-231 triple negative breast cancer (TNBC) cell proliferation with IC(50)s of 13.5 and 35 mu M, respectively. To identify potential mediators of AnAc action in breast cancer, we profiled the genome-wide microRNA transcriptome (microRNAome) in these two cell lines altered by the AnAc 24: 1n5 congener. Whole genome expression profiling (RNAseq) and subsequent network analysis in MetaCore Gene Ontology (GO) algorithm was used to characterize the biological pathways altered by AnAc. In MCF-7 cells, 69 AnAc-responsive miRNAs were identified, e.g., increased let-7a and reduced miR-584. Fewer, i.e., 37 AnAc-responsive miRNAs were identified in MDA-MB-231 cells, e.g., decreased miR23b and increased miR-1257. Only two miRNAs were increased by AnAc in both cell lines: miR-612 and miR-20b; however, opposite miRNA arm preference was noted: miR-20b-3p and miR-20b-5p were upregulated in MCF-7 and MDA-MB-231, respectively. miR-20b-5p target EFNB2 transcript levels were reduced by AnAc in MDA-MB-231 cells. AnAc reduced miR-378g that targets VIM (vimentin) and VIM mRNA transcript expression was increased in AnAc-treated MCF-7 cells, suggesting a reciprocal relationship. The top three enriched GO terms for AnAc-treated MCF-7 cells were B cell receptor signaling pathway and ribosomal large subunit biogenesis and S-adenosylmethionine metabolic process for AnActreated MDA-MB-231 cells. The pathways modulated by these AnAc-regulated miRNAs suggest that key nodal molecules, e.g., Cyclin D1, MYC, c-FOS, PPAR., and SIN3, are targets of AnAc activity.	[Schultz, David J.] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Muluhngwi, Penn; Alizadeh-Rad, Negin; Green, Madelyn A.; Klinge, Carolyn M.] Univ Louisville, Sch Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [Rouchka, Eric C.] Dept Comp Engn & Comp Sci, Bioinformat & Biomed Comp Lab, Louisville, KY USA; [Waigel, Sabine J.] Univ Louisville, Sch Med, Dept Med, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville	Klinge, CM (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Genet, Louisville, KY 40292 USA.	carolyn.klinge@louisville.edu		Klinge, Carolyn/0000-0002-3358-4378	University of Louisville Center for Genetics and Molecular Medicine (CGeMM) Next Generation Pilot; University of Louisville School of Medicine; University of Louisville Executive Vice President for Research and Innovation; National Institutes of Health [P20GM103436]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436] Funding Source: NIH RePORTER	University of Louisville Center for Genetics and Molecular Medicine (CGeMM) Next Generation Pilot; University of Louisville School of Medicine; University of Louisville Executive Vice President for Research and Innovation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by a grant from the University of Louisville Center for Genetics and Molecular Medicine (CGeMM) Next Generation Pilot Grant to D.J.S.; a grant from the University of Louisville School of Medicine to C.M.K., and by a University of Louisville Executive Vice President for Research and Innovation grant to C.M.K. Bioinformatics support for this work by E.C.R. and S.J.W. was provided by National Institutes of Health grants P20GM103436 (Kentucky IDeA Networks of Biomedical Research Excellence, Nigel Cooper, PI).; We thank Brandie N. Radde for performing the cell treatments and isolating the RNA for RNA seq. This research was funded by a grant from the University of Louisville Center for Genetics and Molecular Medicine (CGeMM) Next Generation Pilot Grant to D.J.S.; a grant from the University of Louisville School of Medicine to C.M.K., and by a University of Louisville Executive Vice President for Research and Innovation grant to C.M.K. Bioinformatics support for this work by E.C.R. and S.J.W. was provided by National Institutes of Health grants P20GM103436 (Kentucky IDeA Networks of Biomedical Research Excellence, Nigel Cooper, PI).	Abedi N, 2015, TUMOR BIOL, V36, P9895, DOI 10.1007/s13277-015-3738-y; Adachi S, 2014, NUCLEIC ACIDS RES, V42, P10037, DOI 10.1093/nar/gku652; Andrews S., 2014, FASTQC QUALITY CONTR; Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Antolin S, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1238-5; Ao X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.367; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bao YZ, 2017, CLIN EXP MED, V17, P51, DOI 10.1007/s10238-015-0398-6; Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolser DM, 2012, NUCLEIC ACIDS RES, V40, pD1250, DOI 10.1093/nar/gkr1099; Borrelli N, 2017, MODERN PATHOL, V30, P39, DOI [10.1038/nnodpathol.2016.157, 10.1038/modpathol.2016.157]; Bose M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12200; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Caussy C, 2016, ATHEROSCLEROSIS, V246, P280, DOI 10.1016/j.atherosclerosis.2016.01.010; Chen B, 2015, BIOMED PHARMACOTHER, V75, P1, DOI 10.1016/j.biopha.2015.08.012; Chen G, 2016, BIOCHEM BIOPH RES CO, V473, P1144, DOI 10.1016/j.bbrc.2016.04.030; Chen MT, 2015, SCI REP-UK, V5, DOI 10.1038/srep16229; Chen WC, 2012, EXP THER MED, V3, P1039, DOI 10.3892/etm.2012.531; Chen XD, 2014, TUMOR BIOL, V35, P11081, DOI 10.1007/s13277-014-2405-z; Cho JG, 2016, ONCOTARGET, V7, P31177, DOI 10.18632/oncotarget.8870; Chong GO, 2015, ANTICANCER RES, V35, P2611; Chowdhari S, 2014, J CELL PHYSIOL, V229, P1630, DOI 10.1002/jcp.24608; Cimino D, 2013, FASEB J, V27, P1223, DOI 10.1096/fj.12-214692; Cinegaglia NC, 2016, ONCOTARGET, V7, P28920, DOI 10.18632/oncotarget.8713; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Debeb BG, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw026; Deng ZQ, 2013, J BIOL CHEM, V288, P319, DOI 10.1074/jbc.M112.418830; Dimri M, 2015, J BIOL CHEM, V290, P3033, DOI 10.1074/jbc.M114.615179; Ding Z, 2015, MEDICINE, V94, pe1327; Drake KM, 2009, CLIN CANCER RES, V15, P5985, DOI 10.1158/1078-0432.CCR-09-1065; Duan H, 2009, MOL ENDOCRINOL, V23, P497, DOI 10.1210/me.2008-0296; Ell B, 2014, J BIOL CHEM, V289, P21888, DOI 10.1074/jbc.M114.582866; Feng M, 2011, ONCOGENE, V30, P2242, DOI 10.1038/onc.2010.602; Finlay-Schultz J, 2015, ONCOGENE, V34, P3676, DOI 10.1038/onc.2014.298; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gerhauser C, 2013, TOP CURR CHEM, V329, P73, DOI 10.1007/128_2012_360; Gerin I, 2010, AM J PHYSIOL-ENDOC M, V299, pE198, DOI 10.1152/ajpendo.00179.2010; Gertz J, 2012, GENOME RES, V22, P2153, DOI 10.1101/gr.135681.111; Giraud-Triboult K, 2011, PHYSIOL GENOMICS, V43, P77, DOI 10.1152/physiolgenomics.00077.2010; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2011, EMBO REP, V12, P172, DOI 10.1038/embor.2010.191; Hah N, 2014, MOL CELL ENDOCRINOL, V382, P652, DOI 10.1016/j.mce.2013.06.021; Haldrup C, 2014, DRUG DELIV TRANSL RE, V4, P19, DOI 10.1007/s13346-013-0169-4; Hannafon BN, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0400-7; Hayes EL, 2015, BREAST CANCER RES, V17, P542; He J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013558; Hemshekhar M, 2012, BASIC CLIN PHARMACOL, V110, P122, DOI 10.1111/j.1742-7843.2011.00833.x; Hinske LC, 2014, DATABASE, V2014; Hisaoka M, 2012, AM J PATHOL, V180, P2076, DOI 10.1016/j.ajpath.2012.01.042; Honegger A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004712; Hong SB, 2016, THYROID, V26, P1733, DOI 10.1089/thy.2015.0578; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; Hu W, 2015, CARDIOVASC RES, V107, P534, DOI 10.1093/cvr/cvv160; Huang WZ, 2016, BIOMED PHARMACOTHER, V81, P431, DOI 10.1016/j.biopha.2016.04.034; Iorio MV, 2012, CARCINOGENESIS, V33, P1126, DOI 10.1093/carcin/bgs140; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jarret A, 2016, NAT MED, V22, P1475, DOI 10.1038/nm.4211; Jiao L, 2014, J CELL PHYSIOL, V229, P834, DOI 10.1002/jcp.24510; Kalabus JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048622; Kanlikilicer P, 2016, CANCER RES, V76, P7194, DOI 10.1158/0008-5472.CAN-16-0714; Kim JW, 2010, CANCER RES, V70, P4820, DOI 10.1158/0008-5472.CAN-10-0659; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Klinge CM, 2015, MOL CELL ENDOCRINOL, V418, P273, DOI 10.1016/j.mce.2015.01.035; Krist B, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/281756; Landais S, 2007, CANCER RES, V67, P5699, DOI 10.1158/0008-5472.CAN-06-4478; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee YM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3059; Li DP, 2013, ONCOTARGET, V4, P1373, DOI 10.18632/oncotarget.1165; Li J, 2017, AM J TRANSL RES, V9, P146; Li P, 2017, CANCER MED-US, V6, P662, DOI 10.1002/cam4.1024; Li TS, 2015, ONCOTARGET, V6, P21428, DOI 10.18632/oncotarget.4077; Li XB, 2016, ONCOTARGET, V7, P45385, DOI 10.18632/oncotarget.9978; Litchfield LM, 2014, MOL CELL ENDOCRINOL, V382, P358, DOI 10.1016/j.mce.2013.10.010; Liu CH, 2015, J CANCER RES CLIN, V141, P431, DOI 10.1007/s00432-014-1836-7; Liu JB, 2015, TUMOR BIOL, V36, P219, DOI 10.1007/s13277-014-2622-5; Liu K, 2015, INT J ONCOL, V46, P2526, DOI 10.3892/ijo.2015.2949; Liu W, 2010, ONCOGENE, V29, P4914, DOI 10.1038/onc.2010.237; Liu Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.282; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Ma F, 2017, ONCOTARGET; Ma F, 2010, J IMMUNOL, V184, P6053, DOI 10.4049/jimmunol.0902308; Madhavan D, 2016, CARCINOGENESIS, V37, P461, DOI 10.1093/carcin/bgw008; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Mammoto A, 2000, J BIOL CHEM, V275, P13167, DOI 10.1074/jbc.C000096200; Marrale M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090947; Martinez-Sanchez A, 2013, J BIOL CHEM, V288, P30802, DOI 10.1074/jbc.M113.496729; McGuire A, 2015, CANCER METAST REV, V34, P145, DOI 10.1007/s10555-015-9551-7; Meijer HA, 2014, BIOCHEM SOC T, V42, P1135, DOI 10.1042/BST20140142; Misund K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076234; Mody HR, 2016, MOL CANCER RES, V14, P1124, DOI 10.1158/1541-7786.MCR-16-0083; Muluhngwi P, 2017, CANCER LETT, V388, P230, DOI 10.1016/j.canlet.2016.12.007; Munari E, 2014, HUM PATHOL, V45, P1130, DOI 10.1016/j.humpath.2014.01.013; Nakazawa K, 2014, FEBS J, V281, P2937, DOI 10.1111/febs.12831; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Ono M, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005231; Othman N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081735; Oztemur Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126837; Pan JA, 2010, ONCOL REP, V24, P105, DOI 10.3892/or_00000834; Paris O, 2012, ONCOGENE, V31, P4196, DOI 10.1038/onc.2011.583; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Pellegrino Loredana, 2013, Bioarchitecture, V3, P119; Pellegrino L, 2013, NUCLEIC ACIDS RES, V41, P5400, DOI 10.1093/nar/gkt245; Pennanen PI, 2009, STEROIDS, V74, P404, DOI 10.1016/j.steroids.2008.12.005; Pieper LA, 2017, BIOTECHNOL BIOENG, V114, P1310, DOI 10.1002/bit.26263; Pignot G, 2013, INT J CANCER, V132, P2479, DOI 10.1002/ijc.27949; Pinweha P, 2016, COMPUT STRUCT BIOTEC, V14, P223, DOI 10.1016/j.csbj.2016.05.005; Planel S, 2010, ONCOGENE, V29, P5989, DOI 10.1038/onc.2010.341; Radde B. N., 2016, J CELL BIOCH; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roy SS, 2014, ONCOGENE, V33, P3707, DOI 10.1038/onc.2013.332; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Scaravilli M, 2015, PROSTATE, V75, P798, DOI 10.1002/pros.22961; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schultz DJ, 2006, J AGR FOOD CHEM, V54, P7522, DOI 10.1021/jf061481u; Schultz David J., 2006, V40, P131; Schultz DJ, 2010, MOL CANCER THER, V9, P594, DOI 10.1158/1535-7163.MCT-09-0978; Shen ZY, 2016, J ORAL PATHOL MED, V45, P523, DOI 10.1111/jop.12404; Sheng L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.184; Shi S, 2014, CURR MOL MED, V14, P316, DOI 10.2174/1566524014666140228120014; Shi XG, 2015, ONCOTARGET, V6, P19043, DOI 10.18632/oncotarget.4232; Shimomura A, 2016, CANCER SCI, V107, P326, DOI 10.1111/cas.12880; Sripada L, 2017, J MOL MED, V95, P641, DOI 10.1007/s00109-017-1517-5; Tan ZY, 2016, ONCOTARGET, V7, P24076, DOI 10.18632/oncotarget.8119; Tang J, 2014, BIOCHEM BIOPH RES CO, V447, P210, DOI 10.1016/j.bbrc.2014.03.135; Tao ZH, 2013, J EXP MED, V210, P789, DOI 10.1084/jem.20120153; Tili E, 2010, CARCINOGENESIS, V31, P1561, DOI 10.1093/carcin/bgq143; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsuno S, 2014, SCI REP-UK, V4, DOI 10.1038/srep03852; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; van Kampen JGM, 2017, CANCER RES, V77, P2008, DOI 10.1158/0008-5472.CAN-16-2609; van Schooneveld E, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0526-y; Vejdovszky K, 2017, TOXICOL LETT, V267, P45, DOI 10.1016/j.toxlet.2016.12.011; Vignudelli T, 2010, MOL BIOL CELL, V21, P3340, DOI 10.1091/mbc.E10-01-0040; Vilquin P, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0515-1; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wang B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164105; Wang C, 2011, MOL CELL BIOCHEM, V352, P197, DOI 10.1007/s11010-011-0755-z; Wang P, 2017, BIOCHEM BIOPH RES CO, V482, P935, DOI 10.1016/j.bbrc.2016.11.136; Wang W, 2012, J CLIN ENDOCR METAB, V97, pE1051, DOI 10.1210/jc.2011-3131; Wang Y, 2013, CANCER GENET-NY, V206, P340, DOI 10.1016/j.cancergen.2013.09.005; Ward A, 2013, ONCOGENE, V32, P1173, DOI 10.1038/onc.2012.128; Wei XF, 2016, RNA BIOL, V13, P1300, DOI 10.1080/15476286.2016.1239008; Wei ZT, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0842-9; Weng ZH, 2011, EXP THER MED, V2, P951, DOI 10.3892/etm.2011.288; Wolter M, 2016, BRAIN PATHOL, V26, P344, DOI 10.1111/bpa.12294; Wu Q, 2015, J CELL MOL MED, V19, P2874, DOI 10.1111/jcmm.12681; Xin JX, 2017, ONCOTARGETS THER, V10, P1, DOI 10.2147/OTT.S124201; Xing F, 2015, ONCOGENE, V34, P4890, DOI 10.1038/onc.2014.412; Xu K, 2013, MOL CARCINOGEN, V52, P70, DOI 10.1002/mc.21832; Xu YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065123; Xue TM, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/325176; Yan L, 2015, AM J CANCER RES, V5, P1447; Yang FL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100031, 10.1371/journal.pone.0076458]; Yang HY, 2016, TUMOR BIOL, V37, P1051, DOI 10.1007/s13277-015-3898-9; Yang HP, 2013, J CLIN INVEST, V123, P285, DOI 10.1172/JCI63861; Yang Y, 2015, INT J CLIN EXP MED, V8, P18123; Yao TT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-175; Yao YS, 2015, ONCOL REP, V33, P2504, DOI 10.3892/or.2015.3866; Yoo JK, 2012, STEM CELLS DEV, V21, P2049, DOI 10.1089/scd.2011.0500; Yoon S, 2014, MOL CELLS, V37, P314, DOI 10.14348/molcells.2014.2360; Yu S, 2016, ONCOTARGET, V7, P84165, DOI 10.18632/oncotarget.12389; Zawada AM, 2017, IMMUNOBIOLOGY, V222, P587, DOI 10.1016/j.imbio.2016.11.006; Zekavati A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102625; Zhan Y, 2016, MOL ONCOL, V10, P838, DOI 10.1016/j.molonc.2016.02.002; Zhang GQ, 2016, ONCOL RES, V24, P233, DOI 10.3727/096504016X14648701447977; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406; Zhang J, 2016, INT J OPHTHALMOL-CHI, V9, P1, DOI 10.18240/ijo.2016.01.01; Zhang WC, 2014, TUMOR BIOL, V35, P6235, DOI 10.1007/s13277-014-2202-8; Zhang Y, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2350-x; Zhao FY, 2015, INT J CLIN EXP PATHO, V8, P1451; Zhou Y, 2016, CANCER RES, V76, P5777, DOI 10.1158/0008-5472.CAN-15-2936; Zhu H, 2015, BIOCHEM BIOPH RES CO, V459, P340, DOI 10.1016/j.bbrc.2015.02.116	179	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184471	10.1371/journal.pone.0184471	http://dx.doi.org/10.1371/journal.pone.0184471			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886127	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100133
J	Topalovic, V; Krstic, A; Schwirtlich, M; Dolfini, D; Mantovani, R; Stevanovic, M; Mojsin, M				Topalovic, Vladanka; Krstic, Aleksandar; Schwirtlich, Marija; Dolfini, Diletta; Mantovani, Roberto; Stevanovic, Milena; Mojsin, Marija			Epigenetic regulation of human SOX3 gene expression during early phases of neural differentiation of NT2/D1 cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; RETINOIC ACID; HISTONE ACETYLATION; DNA METHYLATION; TRANSCRIPTION FACTORS; CHROMATIN-STRUCTURE; RESPONSE ELEMENT; CHICKEN SOX2; CPG ISLANDS; IN-VITRO	Sox3/SOX3 is one of the earliest neural markers in vertebrates. Together with the Sox1/SOX1 and Sox2/SOX2 genes it is implicated in the regulation of stem cell identity. In the present study, we performed the first analysis of epigenetic mechanisms (DNA methylation and histone marks) involved in the regulation of the human SOX3 gene expression during RA-induced neural differentiation of NT2/D1 cells. We show that the promoter of the human SOX3 gene is extremely hypomethylated both in undifferentiated NT2/D1 cells and during the early phases of RA-induced neural differentiation. By employing chromatin immunopre-cipitation, we analyze several histone modifications across different regions of the SOX3 gene and their dynamics following initiation of differentiation. In the same timeframe we investigate profiles of selected histone marks on the promoters of human SOX1 and SOX2 genes. We demonstrate differences in histone signatures of SOX1, SOX2 and SOX3 genes. Considering the importance of SOXB1 genes in the process of neural differentiation, the present study contributes to a better understanding of epigenetic mechanisms implicated in the regulation of pluripotency maintenance and commitment towards the neural lineage.	[Topalovic, Vladanka; Schwirtlich, Marija; Stevanovic, Milena; Mojsin, Marija] Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia; [Krstic, Aleksandar] Univ Coll Dublin, Syst Biol Ireland, Dublin, Ireland; [Dolfini, Diletta; Mantovani, Roberto] Univ Milan, Dept Biosci, Milan, Italy; [Stevanovic, Milena] Univ Belgrade, Fac Biol, Belgrade, Serbia; [Stevanovic, Milena] Serbian Acad Arts & Sci, Belgrade, Serbia	University of Belgrade; University College Dublin; University of Milan; University of Belgrade; Serbian Academy of Sciences & Arts	Mojsin, M (corresponding author), Univ Belgrade, Inst Mol Genet & Genet Engn, Belgrade, Serbia.	mojsin@imgge.bg.ac.rs		Mojsin, Marija/0000-0001-8775-0522; Schwirtlich, Marija/0000-0002-2183-0164; DOLFINI, DILETTA/0000-0002-5346-6096; Krstic, Aleksandar/0000-0002-7128-5707; Stevanovic, Milena/0000-0003-4286-7334	Ministry of Education, Science and Technological Development, Republic of Serbia [173051]	Ministry of Education, Science and Technological Development, Republic of Serbia	This experimental work was supported by Ministry of Education, Science and Technological Development, Republic of Serbia (Grant No 173051, http://www.mon.gov.rs/). Authors who received this funding were A.K., M.S. and M.M. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Ministry of Education, Science and Technological Development, Republic of Serbia (Grant No 173051). We thank Prof. Paul J. Scotting (University of Nottingham, UK) for excellent technical assistance with pyrosequencing and valuable input during the preparation of the manuscript. We thank Prof. Peter W. Andrews (University of Sheffield, UK) for NT2/D1 cells and dr Natasa Anastasov (Helmholtz Zentrum Munchen, Munich, Germany) for anti-caspase-3 antibody.	Abello G, 2010, DEV BIOL, V339, P166, DOI 10.1016/j.ydbio.2009.12.027; Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Amaral PP, 2009, RNA, V15, P2013, DOI 10.1261/rna.1705309; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; ANDREWS PW, 1990, DIFFERENTIATION, V43, P131, DOI 10.1111/j.1432-0436.1990.tb00439.x; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Baharvand H, 2007, INT J DEV BIOL, V51, P371, DOI 10.1387/ijdb.072280hb; Barrand S, 2010, BIOCHEM BIOPH RES CO, V391, P762, DOI 10.1016/j.bbrc.2009.11.134; Bergsland M, 2011, GENE DEV, V25, P2453, DOI 10.1101/gad.176008.111; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brunelli S, 2003, GENESIS, V36, P12, DOI 10.1002/gene.10193; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Collignon J, 1996, DEVELOPMENT, V122, P509; Cruickshank MN, 2010, AMINO ACIDS, V39, P1087, DOI 10.1007/s00726-010-0530-6; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Fei T, 2010, GENOME RES, V20, P36, DOI 10.1101/gr.092114.109; Goodfellow CE, 2011, J NEUROSCI RES, V89, P1685, DOI 10.1002/jnr.22692; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Grujicic NK, 2005, GENE, V344, P287, DOI 10.1016/j.gene.2004.11.006; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Guan Z, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-257; Hara K, 2008, PROG NEUROBIOL, V85, P318, DOI 10.1016/j.pneurobio.2008.04.005; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Kimura A, 2005, J BIOCHEM, V138, P647, DOI 10.1093/jb/mvi184; Kovacevic-Grujicic N, 2014, BMB REP, V47, P197, DOI 10.5483/BMBRep.2014.47.4.084; Krstic A, 2007, ARCH BIOCHEM BIOPHYS, V467, P163, DOI 10.1016/j.abb.2007.08.029; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liao RQ, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0135-3; Lin YW, 2013, GYNECOL ONCOL, V131, P174, DOI 10.1016/j.ygyno.2013.07.111; Lindeman LC, 2010, INT J DEV BIOL, V54, P803, DOI 10.1387/ijdb.103081ll; McAninch D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113361; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Milivojevic Milena N G, 2010, ARCH BIOL SCI, V62, P199; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Mojsin M, 2006, NEUROSCI RES, V56, P409, DOI 10.1016/j.neures.2006.08.010; Mojsin M, 2015, HISTOCHEM CELL BIOL, V144, P429, DOI 10.1007/s00418-015-1352-0; Mojsin M, 2010, BIOCHEM J, V425, P107, DOI 10.1042/BJ20090694; Musch T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010726; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nardini M, 2013, CELL, V152, P132, DOI 10.1016/j.cell.2012.11.047; Nettersheim D, 2011, EPIGENETICS-US, V6, P114, DOI 10.4161/epi.6.1.13433; Nikcevic G, 2011, PHYSIOL RES, V60, pS83, DOI 10.33549/physiolres.932184; Nikcevic G, 2008, J NEUROCHEM, V107, P1206, DOI 10.1111/j.1471-4159.2008.05670.x; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okitsu CY, 2010, MOL CELL BIOL, V30, P2933, DOI 10.1128/MCB.01478-09; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; Olynik Brendan M., 2012, Frontiers in Genetics, V3, P81, DOI 10.3389/fgene.2012.00081; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Popovic J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091852; Przyborski SA, 2000, EUR J NEUROSCI, V12, P3521, DOI 10.1046/j.1460-9568.2000.00230.x; Rahmatpanah FB, 2009, EPIGENOMICS-UK, V1, P39, DOI 10.2217/EPI.09.10; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Rogers CD, 2009, MECH DEVELOP, V126, P42, DOI 10.1016/j.mod.2008.10.005; Rogers N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095356; Rogers N, 2013, GENE EXPR PATTERNS, V13, P240, DOI 10.1016/j.gep.2013.04.004; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Saunders A, 2013, STEM CELLS, V31, P1227, DOI 10.1002/stem.1384; Shahryari A, 2014, STEM CELLS, V32, P126, DOI 10.1002/stem.1542; Sikorska M, 2008, J NEUROSCI RES, V86, P1680, DOI 10.1002/jnr.21635; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Stevanovic M, 2003, MOL BIOL REP, V30, P127, DOI 10.1023/A:1023961009869; STEVANOVIC M, 1993, HUM MOL GENET, V2, P2013, DOI 10.1093/hmg/2.12.2013; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; TAYLOR SM, 1982, J MOL BIOL, V162, P679, DOI 10.1016/0022-2836(82)90395-3; Terranova C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123380; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Topalovic V, 2017, BIOCHEMISTRY-MOSCOW+, V82, P715, DOI 10.1134/S0006297917060086; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; Tsao CM, 2012, HEPATOLOGY, V56, P2277, DOI 10.1002/hep.25933; Uchikawa M, 2003, DEV CELL, V4, P509, DOI 10.1016/S1534-5807(03)00088-1; UWANOGHO D, 1995, MECH DEVELOP, V49, P23, DOI 10.1016/0925-4773(94)00299-3; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Wegner M, 2010, INT J BIOCHEM CELL B, V42, P381, DOI 10.1016/j.biocel.2009.07.006; Wiebe MS, 2000, GENE, V246, P383, DOI 10.1016/S0378-1119(00)00086-X; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Zentner GE, 2013, NAT STRUCT MOL BIOL, V20, P259, DOI 10.1038/nsmb.2470	91	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184099	10.1371/journal.pone.0184099	http://dx.doi.org/10.1371/journal.pone.0184099			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886103	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100067
J	van Berlaer, G; Elsafti, AM; Al Safadi, M; Saeed, SS; Buyl, R; Debacker, M; Redwan, A; Hubloue, I				van Berlaer, Gerlant; Elsafti, Abdallah Mohamed; Al Safadi, Mohammad; Saeed, Saad Souhil; Buyl, Ronald; Debacker, Michel; Redwan, Atef; Hubloue, Ives			Diagnoses, infections and injuries in Northern Syrian children during the civil war: A crosssectional study	PLOS ONE			English	Article							ASYLUM SEEKERS; CHRONIC DISEASES; IRAQI REFUGEES; HEALTH; JORDAN; IMPACT; RISK; EMERGENCIES; ASSISTANCE; SPECTRUM	Background The civil war in Syria including the deliberate targeting of healthcare services resulted in a complex humanitarian emergency, seriously affecting children's health. The objectives of this study are to document diagnoses and disease categories in Northern Syrian children after four years of conflict, and to document infectious diseases and injuries in this vulnerable population. Methods In a prospective cross-sectional observational sample study conducted in May 2015, healthcare workers registered demographics, comorbidities, and diagnoses (categorised according to the International Classification of Diseases version 10) in children visited at home and in internally displaced persons camps in four Syrian governorates. Results Of 1080 filled-out records, 1002 were included. Children originated from Aleppo (41%), Idleb (36%), Hamah (15%) and Lattakia (8%). Median age was 6 years (0-15; IQR 3-11), 61% were boys, 40% were younger than 5 years old. Children suffered from respiratory (29%), neurological (19%), digestive (17%), eye (5%) and skin (5%) diseases. Clinical malnutrition was seen in 4%, accidental injury in 3%, intentional injury in 1%, and mental disorders in 2%. Overall, 64% had features of infectious diseases (OR 0.635; CI 0.605-0.665). Most common comorbidities were chronic respiratory diseases (14, malnutrition (5%), acute flaccid paralysis (5%), and epilepsy (4%). Logistic regression analysis indicated that the risk for children to have communicable diseases was higher in Aleppo than in Idleb (OR 1.7; CI 1.2-2.3), Hamah (OR 4.9; CI 3.3-7.5), or Lattakia (OR 5.5; CI 3.3-9.3). Children in Aleppo and Lattakia were more at risk to be injured than in Idleb (OR 5.6; CI 2.1-14.3), or in Hamah (OR 5.9; CI 1.4-25.6), but more often from intentional violence in Lattakia. Mental problems were more prominent in Hamah. Conclusions Four years far in the conflict, 64% of the studied children in four Northern Syrian governorates suffer from infections, mostly from respiratory, neurological and digestive origin, while 4% was injured or victim of intentional aggression. Substandard living conditions and the lack of paediatric healthcare put Syrian children at risk for serious infections, epidemics and morbidity, and ask for urgent international humanitarian relief efforts.	[van Berlaer, Gerlant; Debacker, Michel; Hubloue, Ives] Univ Ziekenhuis Brussel, Dept Emergency Med, Brussels, Belgium; [van Berlaer, Gerlant; Debacker, Michel; Hubloue, Ives] Vrije Univ Brussel, Res Grp Emergency & Disaster Med, Brussels, Belgium; [Elsafti, Abdallah Mohamed] Hamad Med Corp, Dept Emergency Med, Doha, Qatar; [Al Safadi, Mohammad] Turkey Mission, Med Off Turkey & Syria, Qatar Red Crescent, Doha, Qatar; [Saeed, Saad Souhil] Hamad Gen Hosp, Dept Paediat Cardiol, Doha, Qatar; [Buyl, Ronald] Vrije Univ Brussel, Dept Publ Hlth, Biostat & Med Informat Res Grp, Brussels, Belgium; [Redwan, Atef] Zagazig Univ, Fac Med, Dept Crit Care, Zagazig, Egypt	University Hospital Brussels; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Hamad Medical Corporation; Hamad Medical Corporation; Hamad General Hospital; Vrije Universiteit Brussel; Egyptian Knowledge Bank (EKB); Zagazig University	van Berlaer, G (corresponding author), Univ Ziekenhuis Brussel, Dept Emergency Med, Brussels, Belgium.; van Berlaer, G (corresponding author), Vrije Univ Brussel, Res Grp Emergency & Disaster Med, Brussels, Belgium.	gerlant.vanberlaer@uzbrussel.be	Hubloue, Ives/GYR-0901-2022; Buyl, Ronald/F-3862-2015	Buyl, Ronald/0000-0002-6598-9505; van Berlaer, Gerlant/0000-0003-3674-9083; Debacker, Michel/0000-0003-1901-6865				Abou-Zeid AHA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-133; Al-Assil B, 2013, AM J INFECT CONTROL, V41, P597, DOI 10.1016/j.ajic.2012.09.016; Alberer M, 2016, DEUT MED WOCHENSCHR, V141, pE8, DOI 10.1055/s-0041-106907; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P193; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; [Anonymous], JOINT STAT OV 20 MIL; Bellos Anna, 2010, Confl Health, V4, P3, DOI 10.1186/1752-1505-4-3; Ben Taleb Z, 2015, INT J PUBLIC HEALTH, V60, pS63, DOI 10.1007/s00038-014-0586-2; Bilukha OO, 2014, MMWR-MORBID MORTAL W, V63, P638; Bischoff A, 2009, EUR J PUBLIC HEALTH, V19, P59, DOI 10.1093/eurpub/ckn113; Bottcher S, 2015, INT J MED MICROBIOL, V305, P601, DOI 10.1016/j.ijmm.2015.08.008; Burnett A, 2001, BRIT MED J, V322, P544, DOI 10.1136/bmj.322.7285.544; Celikel A, 2015, J FORENSIC LEG MED, V34, P1, DOI 10.1016/j.jflm.2015.04.021; Connolly MA, 2004, LANCET, V364, P1974, DOI 10.1016/S0140-6736(04)17481-3; Connolly MA, 2005, COMMUNICABLE DIS CON, P204; Debacker M., 2012, PLOS CURRENTS DISAST, DOI [DOI 10.1371/4F6CF3E8DF15A, 10.1371/4f6cf3e8df15a]; Devakumar D, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0061-6; Doganay M, 2016, HEALTH SECUR, V14, P220, DOI 10.1089/hs.2016.0054; Doocy S, 2016, INT J HEALTH PLAN M, V31, P97, DOI 10.1002/hpm.2336; Doocy S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2429-3; Doocy Shannon, 2015, Confl Health, V9, P33, DOI 10.1186/s13031-015-0060-7; Doocy S, 2011, SOC SCI MED, V72, P273, DOI 10.1016/j.socscimed.2010.10.023; Elfaituri SS, 2016, INT J DERMATOL, V55, P1000, DOI 10.1111/ijd.13115; Elsafti AM, 2016, DISASTER MED PUBLIC, V10, P874, DOI 10.1017/dmp.2016.165; Escobio F, 2015, LANCET, V386, P2475, DOI 10.1016/S0140-6736(15)01240-4; Gammouh OS, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140424; Guha-Sapir D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4736; Institute for Health Metrics and Evaluation, GLOBAL BURDEN OF DIS; Kassem DF, 2017, EMERG INFECT DIS, V23, P166, DOI 10.3201/eid2301.161204; Kherallah Mazen, 2012, Avicenna J Med, V2, P51; Lam E, 2015, HUM VACC IMMUNOTHER, V11, P2627, DOI 10.1080/21645515.2015.1096457; Marquardt L, 2016, TROP MED INT HEALTH, V21, P210, DOI 10.1111/tmi.12649; Mateen FJ, 2012, B WORLD HEALTH ORGAN, V90, P444, DOI 10.2471/BLT.11.097048; McKenzie ED, 2015, CONFL HEALTH, V9, DOI 10.1186/s13031-015-0038-5; Mockenhaupt FP, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.10.30160; Moss WJ, 2006, B WORLD HEALTH ORGAN, V84, P58, DOI 10.2471/BLT.04.019570; North CS, 2013, JAMA-J AM MED ASSOC, V310, P507, DOI 10.1001/jama.2013.107799; Petersen E, 2013, INT J INFECT DIS, V17, pE666, DOI 10.1016/j.ijid.2013.06.001; Pfortmueller CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148196; Ratnayake Ruwan, 2014, Confl Health, V8, P7, DOI 10.1186/1752-1505-8-7; Roberts L, 2014, SCIENCE, V343, P1302, DOI 10.1126/science.343.6177.1302; Saroufim M, 2014, EMERG INFECT DIS, V20, P1712, DOI 10.3201/eid2010.140288; Sen K, 2013, INT J HEALTH PLAN M, V28, P290, DOI 10.1002/hpm.2193; Sharara SL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004438; Sirin S, 2015, YOUNG CHILD IN PRESS; Tabbaa D, 2013, VET ITAL, V49, P19; The Sphere Project, 2011, SPH HDB; Touma J, 2016, CHILDREN SYRIA REPOR; UNHCR, 2014, GLANC HLTH DAT SYR R; van Berlaer G, 2016, EUR J EMERG MED; van Berlaer G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013963; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Watson JT, 2007, EMERG INFECT DIS, V13, P1, DOI 10.3201/eid1301.060779; World Health Organisation, SYR AR REP WHO STAT; World Health Organization, 2016, E MED REG FRAM HLTH; World Health Organization, 2010, INT STAT CLASS DIS H; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yaman H, 2002, SCAND J PRIM HEALTH, V20, P85, DOI 10.1080/02813430215550	58	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182770	10.1371/journal.pone.0182770	http://dx.doi.org/10.1371/journal.pone.0182770			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886038	Green Submitted, gold, Green Published			2022-12-27	WOS:000410001100011
J	Zhang, R; Yao, EJ; Yang, Y				Zhang, Rui; Yao, Enjian; Yang, Yang			Degradable transportation network with the addition of electric vehicles: Network equilibrium analysis	PLOS ONE			English	Article							HETEROGENEOUS USERS; TIME RELIABILITY; CHOICE BEHAVIOR; ROAD NETWORK; MODEL; DEMAND; ROUTE; ASSIGNMENT; CAPACITY; GASOLINE	Introducing electric vehicles (EVs) into urban transportation network brings higher requirement on travel time reliability and charging reliability. Specifically, it is believed that travel time reliability is a key factor influencing travelers' route choice. Meanwhile, due to the limited cruising range, EV drivers need to better learn about the required energy for the whole trip to make decisions about whether charging or not and where to charge (i.e., charging reliability). Since EV energy consumption is highly related to travel speed, network uncertainty affects travel time and charging demand estimation significantly. Considering the network uncertainty resulted from link degradation, which influences the distribution of travel demand on transportation network and the energy demand on power network, this paper aims to develop a reliability-based network equilibrium framework for accommodating degradable road conditions with the addition of EVs. First, based on the link travel time distribution, the mean and variance of route travel time and monetary expenses related to energy consumption are deduced, respectively. And the charging time distribution of EVs with charging demand is also estimated. Then, a nested structure is considered to deal with the difference of route choice behavior derived by the different uncertainty degrees between the routes with and without degradable links. Given the expected generalized travel cost and a psychological safety margin, a traffic assignment model with the addition of EVs is formulated. Subsequently, a heuristic solution algorithm is developed to solve the proposed model. Finally, the effects of travelers' risk attitude, network degradation degree, and EV penetration rate on network performance are illustrated through an example network. The numerical results show that the difference of travelers' risk attitudes does have impact on the route choice, and the widespread adoption of EVs can cut down the total system travel cost effectively when the transportation network is more reliable.	[Zhang, Rui; Yao, Enjian; Yang, Yang] Beijing Jiaotong Univ, Sch Traff & Transportat, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing, Peoples R China	Beijing Jiaotong University	Yao, EJ (corresponding author), Beijing Jiaotong Univ, Sch Traff & Transportat, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing, Peoples R China.	enjyao@bjtu.edu.cn			National Natural Science Foundation of China [71210001]; Fundamental Research Funds for the Central Universities [2016YJS090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by National Natural Science Foundation of China (No. 71210001) and Fundamental Research Funds for the Central Universities (No. 2016YJS090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by National Natural Science Foundation of China (No. 71210001) and Fundamental Research Funds for the Central Universities (No. 2016YJS090).	Bae S, 2012, IEEE T SMART GRID, V3, P394, DOI 10.1109/TSG.2011.2159278; Botsford C., 2009, INT BATT HYBR FUEL C; Chen A, 2012, TRANSPORT RES A-POL, V46, P1343, DOI 10.1016/j.tra.2012.04.003; Gardner LM, 2013, TRANSPORT RES A-POL, V49, P76, DOI 10.1016/j.tra.2013.01.031; He F, 2014, TRANSPORT RES B-METH, V67, P306, DOI 10.1016/j.trb.2014.05.010; Jiang N, 2013, 92 TRANSP RES BOARD; Jiang N, 2014, EURO J TRANSP LOGIST, V3, P55, DOI 10.1007/s13676-013-0021-5; Liu BQ, 2016, APPL MATH MODEL, V40, P3483, DOI 10.1016/j.apm.2015.09.052; Liu HX, 2017, TRANSPORT RES B-METH, V103, P30, DOI 10.1016/j.trb.2017.01.005; Liu HX, 2009, NETW SPAT ECON, V9, P485, DOI 10.1007/s11067-007-9023-x; Lo HK, 2003, TRANSPORT RES B-METH, V37, P345, DOI 10.1016/S0191-2615(02)00017-6; Lo HK, 2006, TRANSPORT RES B-METH, V40, P792, DOI 10.1016/j.trb.2005.10.003; Meng M, 2012, J COMPUT, V7, P3005, DOI 10.4304/jcp.7.12.3005-3012; NGUYEN S, 1984, TRANSPORT SCI, V18, P185, DOI 10.1287/trsc.18.2.185; Nie Y, 2011, TRANSPORT RES B-METH, V45, P1641, DOI 10.1016/j.trb.2011.06.001; Pineda C, 2016, TRANSPORT RES C-EMER, V71, P86, DOI 10.1016/j.trc.2016.06.021; Siu BWY, 2008, EUR J OPER RES, V191, P166, DOI 10.1016/j.ejor.2007.08.026; Sun XH, 2015, TRANSPORT RES D-TR E, V37, P97, DOI 10.1016/j.trd.2015.04.007; Wang JYT, 2013, PROCD SOC BEHV, V80, P266, DOI 10.1016/j.sbspro.2013.05.016; Wang JYT, 2014, TRANSPORT RES B-METH, V66, P4, DOI 10.1016/j.trb.2013.10.007; Wang XL, 2012, TRANSPORT RES E-LOG, V48, P426, DOI 10.1016/j.tre.2011.10.007; Xu M, 2017, TRANSPORT RES B-METH, V99, P138, DOI 10.1016/j.trb.2017.01.009; Yan CY, 2015, TRANSPORT RES C-EMER, V56, P94, DOI 10.1016/j.trc.2015.03.042; Yang Y, 2015, 94 TRANSP RES BOARD; Yang Y, 2016, TRANSPORT RES C-EMER, V65, P190, DOI 10.1016/j.trc.2015.09.008; Yao EJ, 2013, ADV MECH ENG, DOI 10.1155/2013/435721; Yao EJ, 2013, J INTELL TRANSPORT S, V17, P42, DOI 10.1080/15472450.2013.747822; Yao J, 2015, TRANSPORT RES C-EMER, V60, P36, DOI 10.1016/j.trc.2015.08.005; Zhang HM, 2005, NETW SPAT ECON, V5, P71, DOI 10.1007/s11067-005-6662-7; Zhang J., 2011, PROCEDIA COMPUTER SC, V20, P313; Zhang KL, 2013, TRANSPORT RES C-EMER, V27, P189, DOI 10.1016/j.trc.2012.05.001; Zhang R, 2015, TRANSPORT RES D-TR E, V41, P177, DOI 10.1016/j.trd.2015.10.010	32	0	0	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184693	10.1371/journal.pone.0184693	http://dx.doi.org/10.1371/journal.pone.0184693			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886167	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100178
J	Andrade, AL; Afonso, ET; Minamisava, R; Bierrenbach, AL; Cristo, EB; Morais-Neto, OL; Policena, GM; Domingues, CMAS; Toscano, CM				Andrade, Ana Lucia; Afonso, Eliane T.; Minamisava, Ruth; Bierrenbach, Ana Luiza; Cristo, Elier B.; Morais-Neto, Otaliba L.; Policena, Gabriela M.; Domingues, Carla M. A. S.; Toscano, Cristiana M.			Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; SYSTEMATIC ANALYSIS; NATIONAL CAUSES; LATIN-AMERICA; CHILDREN; ADMISSIONS; MORTALITY; DISEASE; SURVEILLANCE; IMMUNIZATION		[Andrade, Ana Lucia; Afonso, Eliane T.; Bierrenbach, Ana Luiza; Morais-Neto, Otaliba L.; Policena, Gabriela M.; Toscano, Cristiana M.] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Afonso, Eliane T.] Univ Fed Goias, Fac Med, Goiania, Go, Brazil; [Afonso, Eliane T.] Pontifical Catholic Univ Goias, Dept Med, Goiania, Go, Brazil; [Minamisava, Ruth] Univ Fed Goias, Sch Nursing, Goiania, Go, Brazil; [Cristo, Elier B.] Minist Hlth, Brasilia, DF, Brazil; [Domingues, Carla M. A. S.] Minist Hlth, Secretariat Hlth Surveillance, Natl Immunizat Program, Brasilia, DF, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Andrade, AL (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.	alssandrade@gmail.com	Toscano, Cristiana Maria/N-4019-2014; B. Cristo, Elier/L-3512-2017; Bierrenbach, Ana L/F-3185-2014	B. Cristo, Elier/0000-0003-2233-1313; Bierrenbach, Ana L/0000-0002-6837-0636; Minamisava, Ruth/0000-0001-9352-5567; TOSCANO, CRISTIANA/0000-0002-9453-2643	Ministry of Health of Brazil, National Immunization Program [01/2012]; Brazilian National Council for Scientific and Technological Development (CNPq) [313286/2014-0, 312532/2014-8]	Ministry of Health of Brazil, National Immunization Program; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This investigation was supported by the Ministry of Health of Brazil, National Immunization Program (grant #01/2012). ALA (#313286/2014-0) and CMT (#312532/2014-8) receive scientific productivity scholarships from the Brazilian National Council for Scientific and Technological Development (CNPq).	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; Andrade AL, 2012, PEDIATR INFECT DIS J, V31, P1312, DOI 10.1097/INF.0b013e31826a8ee5; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brazil. DATASUS, 2016, EP MORB; Brazil. DATASUS, 2017, HLTH INF VACC COV; Brazil. DATASUS, 2015, SIGTAP SYST MAN TABL; Brazil. DATASUS, 2017, FIL TRANSF SERV; Brazil. DATASUS. BPS. Health care price database, 2016, HLTH CAR PRIC DAT; Brazil. IBGE, 2017, STAT BRAZ CENS; Brazil. IBGE, 2016, NAT IND PRIC CONS BR; Brazil. Ministry of health, 2010, NAT IMM PROGR TECHN; Brazilian Institute of Geography and Statistics-IBGE, 2013, NAT HLTH RES 2013 AC; Bruhn CAW, 2017, P NATL ACAD SCI USA, V114, P1524, DOI 10.1073/pnas.1612833114; Pirez MC, 2011, PEDIATR INFECT DIS J, V30, P669, DOI 10.1097/INF.0b013e3182152bf1; Cui YDA, 2017, HUM VACC IMMUNOTHER, V13, P1229, DOI 10.1080/21645515.2016.1277300; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Drummond MF, 2005, J MENTAL HLTH POLICY; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Grijalva CG, 2007, LANCET, V369, P1179, DOI 10.1016/S0140-6736(07)60564-9; Hortal M, 2014, PLOS ONE, P9; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; Jit M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0446-9; Koshy E, 2010, THORAX, V65, P770, DOI 10.1136/thx.2010.137802; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Menzies RI, 2015, CLIN INFECT DIS, V61, P927, DOI 10.1093/cid/civ429; Montgomery D. C., 2015, INTRO TIME SERIES AN; Morettin P., 2006, ANALISE SERIES TEMPO; Nair H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1693-x; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; Nelson JC, 2008, VACCINE, V26, P4947, DOI 10.1016/j.vaccine.2008.07.016; Nunes S, 2013, VALUE HEALTH, V16, pA724, DOI 10.1016/j.jval.2013.08.2261; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Panik, 2012, STAT INFERENCE SHORT; Poolman JT, 2013, EXPERT REV VACCINES, V12, P1379; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Scotta MC, 2014, VACCINE, V32, P4495, DOI 10.1016/j.vaccine.2014.06.042; Sgambatti S, 2015, EPIDEMIOL INFECT, V143, P334, DOI 10.1017/S0950268814000922; Sgambatti S, 2016, VACCINE, V34, P663, DOI 10.1016/j.vaccine.2015.12.007; Simonsen L, 2014, LANCET RESP MED, V2, P387, DOI 10.1016/S2213-2600(14)70032-3; Simonsen L, 2011, MBIO, V2, DOI 10.1128/mBio.00309-10; Sinha A, 2008, REV PANAM SALUD PUBL, V24, P304, DOI 10.1590/S1020-49892008001100002; Smith PJ, 2007, PEDIATRICS, V120, pE1165, DOI 10.1542/peds.2007-0037; Snedecor GW, 1980, STAT METHODS, V7th; Toscano C, 2016, 10 INT S PNEUM PNEUM; van der Putten IM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1638-0; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; WHO Publication, 2012, VACCINE, V30, P4717, DOI 10.1016/j.vaccine.2012.04.093; World bank, 2016, THE WORLD BANK; World Health Organization, 2016, INT CLASS DIS ICD 10; Zhang S, 2016, J GLOB HEALTH, P6	50	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184204	10.1371/journal.pone.0184204	http://dx.doi.org/10.1371/journal.pone.0184204			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880953	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200040
J	Berghuijs, HNC; Yin, XY; Ho, QT; Retta, MA; Verboven, P; Nicolai, BM; Struik, PC				Berghuijs, Herman N. C.; Yin, Xinyou; Ho, Q. Tri; Retta, Moges A.; Verboven, Pieter; Nicolai, Bart M.; Struik, Paul C.			Localization of (photo) respiration and CO2 re-assimilation in tomato leaves investigated with a reaction-diffusion model	PLOS ONE			English	Article							COMBINED GAS-EXCHANGE; MESOPHYLL CONDUCTANCE; CHLOROPHYLL FLUORESCENCE; PHOTORESPIRATORY CO2; ISOTOPE DISCRIMINATION; PHOTOSYNTHESIS MODEL; LEAF PHOTOSYNTHESIS; 3-DIMENSIONAL MODEL; CRITICAL-APPRAISAL; C-3 PLANTS	The rate of photosynthesis depends on the CO2 partial pressure near Rubisco, C-c, which is commonly calculated by models using the overall mesophyll resistance. Such models do not explain the difference between the CO2 level in the intercellular air space and Cc mechanistically. This problem can be overcome by reaction-diffusion models for CO2 transport, production and fixation in leaves. However, most reaction-diffusion models are complex and unattractive for procedures that require a large number of runs, like parameter optimisation. This study provides a simpler reaction-diffusion model. It is parameterized by both leaf physiological and leaf anatomical data. The anatomical data consisted of the thickness of the cell wall, cytosol and stroma, and the area ratios of mesophyll exposed to the intercellular air space to leaf surfaces and exposed chloroplast to exposed mesophyll surfaces. The model was used directly to estimate photosynthetic parameters from a subset of the measured light and CO2 response curves; the remaining data were used for validation. The model predicted light and CO2 response curves reasonably well for 15 days old tomato (cv. Admiro) leaves, if (photo) respiratory CO2 release was assumed to take place in the inner cytosol or in the gaps between the chloroplasts. The model was also used to calculate the fraction of CO2 produced by (photo) respiration that is re-assimilated in the stroma, and this fraction ranged from 56 to 76%. In future research, the model should be further validated to better understand how the re-assimilation of (photo) respired CO2 is affected by environmental conditions and physiological parameters.	[Berghuijs, Herman N. C.; Yin, Xinyou; Retta, Moges A.; Struik, Paul C.] Wageningen Univ & Res, Ctr Crop Syst Anal, Droevendaalsesteeg 1, Wageningen, Netherlands; [Berghuijs, Herman N. C.; Yin, Xinyou; Struik, Paul C.] BioSolar Cells, Wageningen, Netherlands; [Berghuijs, Herman N. C.; Ho, Q. Tri; Retta, Moges A.; Verboven, Pieter; Nicolai, Bart M.] Katholieke Univ Leuven, Flanders Ctr Postharvest Technol BIOSYST MeBioS, Willem de Croylaan 42, Leuven, Belgium	Wageningen University & Research; KU Leuven	Berghuijs, HNC (corresponding author), Wageningen Univ & Res, Ctr Crop Syst Anal, Droevendaalsesteeg 1, Wageningen, Netherlands.; Berghuijs, HNC (corresponding author), BioSolar Cells, Wageningen, Netherlands.; Berghuijs, HNC (corresponding author), Katholieke Univ Leuven, Flanders Ctr Postharvest Technol BIOSYST MeBioS, Willem de Croylaan 42, Leuven, Belgium.	herman.berghuijs@wur.nl	; Nicolai, Bart/L-6129-2013	Ho, Quang Tri/0000-0003-3766-0283; Yin, Xinyou/0000-0001-8273-8022; Nicolai, Bart/0000-0001-5267-1920; Struik, Paul/0000-0003-2196-547X; Berghuijs, Herman/0000-0002-1754-5061; Verboven, Pieter/0000-0001-9542-8285	BioSolar Cells programme (project C3B3); Research Council of the KU Leuven [C16/16/002]	BioSolar Cells programme (project C3B3); Research Council of the KU Leuven(KU Leuven)	Wageningen-based authors thank the BioSolar Cells programme (project C3B3) for financial support. Leuven-based authors thank the Research Council of the KU Leuven (project C16/16/002) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto T, 2002, PLANT CELL ENVIRON, V25, P1399, DOI 10.1046/j.0016-8025.2002.00906.x; Aalto T, 2001, BOREAL ENVIRON RES, V6, P53; Aalto T, 1999, J THEOR BIOL, V196, P115, DOI 10.1006/jtbi.1998.0820; Berghuijs HNC, 2016, PLANT SCI, V252, P62, DOI 10.1016/j.plantsci.2016.05.016; Berghuijs HNC, 2015, PLANT SCI, V238, P297, DOI 10.1016/j.plantsci.2015.06.022; Busch FA, 2013, PLANT CELL ENVIRON, V36, P200, DOI 10.1111/j.1365-3040.2012.02567.x; Ethier GJ, 2004, PLANT CELL ENVIRON, V27, P137, DOI 10.1111/j.1365-3040.2004.01140.x; Evans JR, 2009, J EXP BOT, V60, P2235, DOI 10.1093/jxb/erp117; EVANS JR, 1994, AUST J PLANT PHYSIOL, V21, P475, DOI 10.1071/PP9940475; Fanta SW, 2012, J FOOD ENG, V108, P393, DOI 10.1016/j.jfoodeng.2011.09.010; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Flexas J, 2008, PLANT CELL ENVIRON, V31, P602, DOI 10.1111/j.1365-3040.2007.01757.x; Flexas J, 2007, PLANT CELL ENVIRON, V30, P1284, DOI 10.1111/j.1365-3040.2007.01700.x; Flexas J, 2012, PLANT SCI, V193, P70, DOI 10.1016/j.plantsci.2012.05.009; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gielwanowska I, 2015, ARCT ANTARCT ALP RES, V47, P17, DOI 10.1657/AAAR0014-019; Gu JF, 2012, J EXP BOT, V63, P5137, DOI 10.1093/jxb/ers170; Gu LH, 2014, PLANT CELL ENVIRON, V37, P1231, DOI 10.1111/pce.12232; HARLEY PC, 1992, PLANT PHYSIOL, V98, P1429, DOI 10.1104/pp.98.4.1429; Hatakeyama Y, 2016, PLANT PROD SCI, V19, P540, DOI 10.1080/1343943X.2016.1212667; Haupt-Herting S, 2001, PLANT PHYSIOL, V126, P388, DOI 10.1104/pp.126.1.388; Ho QT, 2010, J EXP BOT, V61, P2071, DOI 10.1093/jxb/erq026; Juurola E, 2005, NEW PHYTOL, V166, P205, DOI 10.1111/j.1469-8137.2004.01317.x; KOK B., 1948, ENZYMOLOGIA [HAGUE], V13, P1; KOK B, 1949, BIOCHIM BIOPHYS ACTA, V3, P625, DOI 10.1016/0006-3002(49)90136-5; Laisk A.K., 1977, KINETICS PHOTOSYNTHE; LEUNING R, 1995, PLANT CELL ENVIRON, V18, P339, DOI 10.1111/j.1365-3040.1995.tb00370.x; Loreto F, 1999, AUST J PLANT PHYSIOL, V26, P733, DOI 10.1071/PP99096; Moser T, 2015, PLANT CELL ENVIRON, V38, P1347, DOI 10.1111/pce.12483; Niinemets U, 2009, J EXP BOT, V60, P2271, DOI 10.1093/jxb/erp063; Nobel PS, 2009, PHYSICOCHEMICAL AND ENVIRONMENTAL PLANT PHYSIOLOGY, 4TH EDITION, P1; Pachepsky LB, 1995, J BIOGEOGR, V22, P209, DOI 10.2307/2845912; PARKHURST DF, 1977, J THEOR BIOL, V67, P471, DOI 10.1016/0022-5193(77)90050-9; PARKHURST DF, 1990, PLANT PHYSIOL, V94, P1024, DOI 10.1104/pp.94.3.1024; Parnik T, 2007, PHYSIOL PLANTARUM, V129, P34, DOI 10.1111/j.1399-3054.2006.00824.x; Pons TL, 2009, J EXP BOT, V60, P2217, DOI 10.1093/jxb/erp081; Ho QT, 2016, PLANT CELL ENVIRON, V39, P50, DOI 10.1111/pce.12590; Ho QT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048376; Retta M, 2016, PLANT SCI, V246, P37, DOI 10.1016/j.plantsci.2016.02.003; Sage TL, 2009, PLANT CELL PHYSIOL, V50, P756, DOI 10.1093/pcp/pcp033; SHARKEY TD, 1985, BOT REV, V51, P53, DOI 10.1007/BF02861058; Terashima I, 2006, J EXP BOT, V57, P343, DOI 10.1093/jxb/erj014; THAIN JF, 1983, J EXP BOT, V34, P87, DOI 10.1093/jxb/34.1.87; Tholen D, 2014, PLANT CELL ENVIRON, V37, P2456, DOI 10.1111/pce.12401; Tholen D, 2012, PLANT CELL ENVIRON, V35, P2087, DOI 10.1111/j.1365-3040.2012.02538.x; Tholen D, 2011, PLANT PHYSIOL, V156, P90, DOI 10.1104/pp.111.172346; Tomas M, 2013, J EXP BOT, V64, P2269, DOI 10.1093/jxb/ert086; Tosens T, 2012, J EXP BOT, V63, P5105, DOI 10.1093/jxb/ers171; Van Riel N, MATLAB IMPLEMENTATIO; Vesala T, 1996, NEW PHYTOL, V132, P235, DOI 10.1111/j.1469-8137.1996.tb01843.x; von Caemmerer S, 2013, PLANT CELL ENVIRON, V36, P1617, DOI 10.1111/pce.12098; Walker BJ, 2016, PLANT CELL ENVIRON, V39, P1198, DOI 10.1111/pce.12722; Watte R, 2015, OPT EXPRESS, V23, P17467, DOI 10.1364/OE.23.017467; Yin XY, 2017, PHOTOSYNTH RES, V132, P211, DOI 10.1007/s11120-017-0340-8; Yin XY, 2011, J EXP BOT, V62, P3489, DOI 10.1093/jxb/err038; Yin XY, 2009, PLANT CELL ENVIRON, V32, P1513, DOI 10.1111/j.1365-3040.2009.02016.x; Yin XY, 2009, PLANT CELL ENVIRON, V32, P448, DOI 10.1111/j.1365-3040.2009.01934.x	58	11	11	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183746	10.1371/journal.pone.0183746	http://dx.doi.org/10.1371/journal.pone.0183746			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880924	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200024
J	Rose, J; Rillich, J; Stevenson, PA				Rose, Jacqueline; Rillich, Jan; Stevenson, Paul A.			Chronic social defeat induces long-term behavioral depression of aggressive motivation in an invertebrate model system	PLOS ONE			English	Article							GRYLLUS-BIMACULATUS ORTHOPTERA; FIELD CRICKET; AGONISTIC BEHAVIOR; EXPERIENCE; OCTOPAMINE; FIGHT; STRESS; COMPETITION; ENCOUNTERS; MODULATION	Losing a fight against a conspecific male (social defeat) induces a period of suppressed aggressiveness and general behaviour, often with symptoms common to human psychiatric disorders. Agonistic experience is also discussed as a potential cause of consistent, behavioral differences between individuals (animal "personality"). In non-mammals, however, the impact of single agonistic encounters typically last only hours, but then again studies of repeated intermittent defeat (chronic social defeat) are seldom. We report the effect of chronic social defeat in adult male crickets (Gryllus bimaculatus), for which all known behavioral effects of defeat last only 3 h. Firstly, after 48 h social isolation, crickets that experienced 5 defeats at 24 h intervals against the same, weight-matched opponent exhibited suppressed aggressiveness lasting > 24 h, which was still evident when the animals were matched against an unfamiliar opponent at the last trial. Secondly, this longer-term depression of aggression also occurred in 48 h isolated crickets that lost 6 fights at 1 h intervals against unfamiliar opponents at each trial. Thirdly, crickets isolated as larvae until adult maturity (> 16 days) were significantly more aggressive, and less variable in their aggressiveness at their very first fight than 48 h isolates, and also significantly more resilient to the effects of chronic social defeat. We conclude that losing an aggressive encounter in crickets has a residual effect, lasting at least 24 h, that accumulates when repeated defeats are experienced, and leads to a prolonged depression of aggressive motivation in subordinates. Furthermore, our data indicate that social interactions between young adults and possibly larvae can have even longer, possibly lifelong influences on subsequent behavior. Social subjugation is thus likely to be a prime determinant of inter-individual behavioral differences in crickets. Our work also opens new avenues for investigating proximate mechanisms underlying depression-like phenomena.	[Rose, Jacqueline; Rillich, Jan; Stevenson, Paul A.] Univ Leipzig, Inst Biol, Talstr, Leipzig, Germany	Leipzig University	Stevenson, PA (corresponding author), Univ Leipzig, Inst Biol, Talstr, Leipzig, Germany.	stevenson@rz.uni-leipzig.de	Stevenson, Paul A/A-2048-2010	Stevenson, Paul Anthony/0000-0002-3232-5155	Deutsche Forschungsgemeinschaft [STE 714/4-1];  [RI 2728/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was funded by the Deutsche Forschungsgemeinschaft, grant STE 714/4-1; J. Rillich is funded by grant RI 2728/2. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO SA, 1995, J EXP BIOL, V198, P1691; ADAMO SA, 1995, ANIM BEHAV, V49, P1491, DOI 10.1016/0003-3472(95)90070-5; Adamo SA, 2013, J EXP BIOL, V216, P4608, DOI 10.1242/jeb.094482; Adamo SA, 2011, HORM BEHAV, V60, P478, DOI 10.1016/j.yhbeh.2011.07.015; Adamo Shelley A., 2008, ISJ, V5, P12; Alexander R.D., 1961, BEHAVIOUR, V17, P130; BARNARD CJ, 1979, J THEOR BIOL, V81, P65, DOI 10.1016/0022-5193(79)90081-X; Breithaupt T, 2002, J EXP BIOL, V205, P1221; Briffa M, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.1007; Carnevali L, 2012, PHYSIOL BEHAV, V106, P142, DOI 10.1016/j.physbeh.2012.01.022; Chichinadze K, 2014, BIOL REV, V89, P1005, DOI 10.1111/brv.12091; DIXON KA, 1986, ANIM BEHAV, V34, P340, DOI 10.1016/S0003-3472(86)80102-6; Dreier S, 2007, BIOL LETTERS, V3, P459, DOI 10.1098/rsbl.2007.0224; Ghosal K, 2010, ARCH INSECT BIOCHEM, V74, P38, DOI 10.1002/arch.20360; Ghosal K, 2009, J EXP BIOL, V212, P2044, DOI 10.1242/jeb.026682; Hack MA, 1997, BEHAV ECOL, V8, P28, DOI 10.1093/beheco/8.1.28; Hofmann HA, 2000, NATURE, V403, P613, DOI 10.1038/35001137; Hofmann HA, 2001, ANIM BEHAV, V62, P337, DOI 10.1006/anbe.2001.1746; Hollis F, 2014, ILAR J, V55, P221, DOI 10.1093/ilar/ilu002; Hsu YY, 2006, BIOL REV, V81, P33, DOI 10.1017/S146479310500686X; Huhman KL, 2006, HORM BEHAV, V50, P640, DOI 10.1016/j.yhbeh.2006.06.022; Iwasaki M, 2008, COMP BIOCHEM PHYS A, V149, P306, DOI 10.1016/j.cbpa.2008.01.008; Iwasaki M, 2006, ZOOL SCI, V23, P863, DOI 10.2108/zsj.23.863; Khazraie K, 1999, BEHAV PROCESS, V44, P341, DOI 10.1016/S0376-6357(98)00058-8; Koolhaas JM, 1997, NEUROSCI BIOBEHAV R, V21, P775, DOI 10.1016/S0149-7634(96)00057-7; Kortet R, 2007, BIOL J LINN SOC, V91, P475, DOI 10.1111/j.1095-8312.2007.00812.x; KOYAMA S, 1993, J ETHOL, V11, P117, DOI 10.1007/BF02350045; PARMIGIANI S, 1983, BEHAV PROCESS, V8, P45, DOI 10.1016/0376-6357(83)90042-6; Pfluger HJ, 2005, ARTHROPOD STRUCT DEV, V34, P379, DOI 10.1016/j.asd.2005.04.004; Rillich J, 2007, ANIM BEHAV, V74, P823, DOI 10.1016/j.anbehav.2006.11.022; Rillich J, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00050; Rillich J, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00095; Rillich J, 2014, HORM BEHAV, V66, P696, DOI 10.1016/j.yhbeh.2014.09.012; Rillich J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028891; Rillich J, 2011, P ROY SOC B-BIOL SCI, V278, P1873, DOI 10.1098/rspb.2010.2099; Rose J, 2017, ANIM BEHAV, V123, P441, DOI 10.1016/j.anbehav.2016.11.021; Rudin FS, 2017, BEHAV ECOL, V28, P270, DOI 10.1093/beheco/arw151; Rutte C, 2006, TRENDS ECOL EVOL, V21, P16, DOI 10.1016/j.tree.2005.10.014; Sayed S, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-015-0623-8; Sheehan MJ, 2008, CURR BIOL, V18, pR851, DOI 10.1016/j.cub.2008.07.032; Sheehan MJ, 2011, SCIENCE, V334, P1272, DOI 10.1126/science.1211334; SIMMONS LW, 1986, ANIM BEHAV, V34, P567, DOI 10.1016/S0003-3472(86)80126-9; SIMMONS LW, 1987, J ANIM ECOL, V56, P1015, DOI 10.2307/4963; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Stevenson PA, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500060; Stevenson PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074965; Thomas ML, 2009, BEHAV ECOL, V20, P1118, DOI 10.1093/beheco/arp105; Trannoy S, 2016, P NATL ACAD SCI USA, V113, P4818, DOI 10.1073/pnas.1520953113; Tregenza T, 1997, ANIM BEHAV, V54, P979, DOI 10.1006/anbe.1997.0500; Urszan TJ, 2015, ECOL EVOL, V5, pS847, DOI 10.1002/ece3.1804; Verlinden H, 2010, J INSECT PHYSIOL, V56, P854, DOI 10.1016/j.jinsphys.2010.05.018; Yu WC, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00110	53	7	7	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184121	10.1371/journal.pone.0184121	http://dx.doi.org/10.1371/journal.pone.0184121			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910319	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200033
J	Woitke, F; Ceanga, M; Rudolph, M; Niv, F; Witte, OW; Redecker, C; Kunze, A; Keiner, S				Woitke, Florus; Ceanga, Mihai; Rudolph, Max; Niv, Fanny; Witte, Otto W.; Redecker, Christoph; Kunze, Albrecht; Keiner, Silke			Adult hippocampal neurogenesis poststroke: More new granule cells but aberrant morphology and impaired spatial memory	PLOS ONE			English	Article							COGNITIVE DECLINE; DENTATE GYRUS; PATTERN SEPARATION; STATUS EPILEPTICUS; NEURONS; STROKE; PERSPECTIVES; CONTRIBUTES; INFARCTS	Stroke significantly stimulates neurogenesis in the adult dentate gyrus, though the functional role of this postlesional response is mostly unclear. Recent findings suggest that newborn neurons generated in the context of stroke may fail to correctly integrate into pre-existing networks. We hypothesized that increased neurogenesis in the dentate gyrus following stroke is associated with aberrant neurogenesis and impairment of hippocampus-dependent memory. To address these questions we used the middle cerebral artery occlusion model (MCAO) in mice. Animals were housed either under standard conditions or with free access to running wheels. Newborn granule cells were labelled with the thymidine analoque EdU and retroviral vectors. To assess memory performance, we employed a modified version of the Morris water maze (MWM) allowing differentiation between hippocampus dependent and independent learning strategies. Newborn neurons were morphologically analyzed using confocal microscopy and Neurolucida system at 7 weeks. We found that neurogenesis was significantly increased following MCAO. Animals with MCAO needed more time to localize the platform and employed less hippocampus-dependent search strategies in MWM versus controls. Confocal studies revealed an aberrant cell morphology with basal dendrites and an ectopic location (e. g. hilus) of new granule cells born in the ischemic brain. Running increased the number of new neurons but also enhanced aberrant neurogenesis. Running, did not improve the general performance in the MWM but slightly promoted the application of precise spatial search strategies. In conclusion, ischemic insults cause hippocampal-dependent memory deficits which are associated with aberrant neurogenesis in the dentate gyrus indicating ischemia-induced maladaptive plasticity in the hippocampus.	[Woitke, Florus; Ceanga, Mihai; Rudolph, Max; Niv, Fanny; Witte, Otto W.; Redecker, Christoph; Kunze, Albrecht; Keiner, Silke] Jena Univ Hosp, Hans Berger Dept Neurol, Klinikum 1, Jena, Germany	Friedrich Schiller University of Jena	Kunze, A (corresponding author), Jena Univ Hosp, Hans Berger Dept Neurol, Klinikum 1, Jena, Germany.	albrecht.kunze@med.uni-jena.de	Witte, Otto/P-4127-2018; Keiner, Silke/A-5405-2018	Witte, Otto/0000-0003-2101-4105; 	BMBF program [01GN0977]; Interdisciplinary Center for Clinical Research (IZKF) Jena	BMBF program(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Center for Clinical Research (IZKF) Jena	Financial support was received from the BMBF program "Cell-based, regenerative therapies," 01GN0977; and the Interdisciplinary Center for Clinical Research (IZKF) Jena.	Austin JE, 2004, J COMP NEUROL, V476, P205, DOI 10.1002/cne.20182; Blum S, 2012, NEUROLOGY, V78, P38, DOI 10.1212/WNL.0b013e31823ed0cc; Brainin M, 2015, EUR J NEUROL, V22, P229, DOI 10.1111/ene.12626; Cho KO, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7606; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Garthe A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00063; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Geibig CS, 2012, NEUROBIOL DIS, V46, P431, DOI 10.1016/j.nbd.2012.02.007; Jessberger S, 2015, COLD SPRING HARB PER; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kunze A, 2009, P NATL ACAD SCI USA, V106, P11336, DOI 10.1073/pnas.0813160106; Myers CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068208; Niv F, 2012, STROKE, V43, P2468, DOI 10.1161/STROKEAHA.112.660977; Parent JM, 1997, J NEUROSCI, V17, P3727; Patel LS, 2004, J NEUROSCI, V24, P9005, DOI 10.1523/JNEUROSCI.2943-04.2004; Prins ND, 2005, BRAIN, V128, P2034, DOI 10.1093/brain/awh553; Rangel LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4181; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Scharfman H, 2007, DEV NEUROSCI-BASEL, V29, P14, DOI 10.1159/000096208; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Shapiro LA, 2008, EPILEPSIA, V49, P13, DOI 10.1111/j.1528-1167.2008.01633.x; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616	27	40	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183463	10.1371/journal.pone.0183463	http://dx.doi.org/10.1371/journal.pone.0183463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910298	Green Submitted, gold, Green Published			2022-12-27	WOS:000410859200011
J	Wong, KLM; Benova, L; Campbell, OMR				Wong, Kerry L. M.; Benova, Lenka; Campbell, Oona M. R.			A look back on how far to walk: Systematic review and meta-analysis of physical access to skilled care for childbirth in Sub-Saharan Africa	PLOS ONE			English	Review							OBSTETRIC CARE; NEWBORN HEALTH; DELIVERY CARE; MEDICAL-CARE; SERVICES; COVERAGE; WOMEN; BIRTH; ACCESSIBILITY; FACILITIES	Objectives To (i) summarize the methods undertaken to measure physical accessibility as the spatial separation between women and health services, and (ii) establish the extent to which distance to skilled care for childbirth affects utilization in Sub-Saharan Africa. Method We defined spatial separation as the distance/travel time between women and skilled care services. The use of skilled care at birth referred to either the location or attendant of childbirth. The main criterion for inclusion was any quantification of the relationship between spatial separation and use of skilled care at birth. The approaches undertaken to measure distance/travel time were summarized in a narrative format. We obtained pooled adjusted odds ratios (aOR) from studies that controlled for financial means, education and (perceived) need of care in a meta-analysis. Results 57 articles were included (40 studied distance and 25 travel time), in which distance/travel time were found predominately self-reported or estimated in a geographic information system based on geographic coordinates. Approaches of distance/travel time measurement were generally poorly detailed, especially for self-reported data. Crucial features such as start point of origin and the mode of transportation for travel time were most often unspecified. Meta-analysis showed that increased distance to maternity care had an inverse association with utilization (n = 10, pooled aOR = 0.90/1km, 95% CI = 0.85-0.94). Distance from a hospital for rural women showed an even more pronounced effect on utilization (n = 2, pooled aOR = 0.58/1km increase, 95% CI = 0.31,1.09). The effect of spatial separation appears to level off beyond critical point when utilization was generally low. Conclusion Although the reporting and measurements of spatial separation in low-resource settings needs further development, we found evidence that a lack of geographic access impedes use. Utilization is conditioned on access, researchers and policy makers should therefore prioritize quality data for the evidence-base to ensure that women everywhere have the potential to access obstetric care.	[Wong, Kerry L. M.; Benova, Lenka; Campbell, Oona M. R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London, England	University of London; London School of Hygiene & Tropical Medicine	Wong, KLM (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London, England.	kerry.wong@lshtm.ac.uk	Dangal, Ganesh/O-1989-2017	Dangal, Ganesh/0000-0002-5834-5525; Campbell, Oona/0000-0002-9311-0115; Wong, Kerry/0000-0002-4400-2257				Abikar R A, 2013, East Afr Med J, V90, P365; Ahmed T, 2009, REPROD HEALTH MATTER, V17, P45, DOI 10.1016/S0968-8080(09)33446-1; Alkema Leontine, 2016, Lancet, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; Amano A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-105; Anastasi E, 2015, BMC; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; [Anonymous], 2012, IMPROVING ACCESS SKI; [Anonymous], 2015, MILL DEV GOALS REP; [Anonymous], 2017, FOREST OBSERVATIONS; [Anonymous], MONITORING BIRTH PRE; [Anonymous], 2000, NON TRADITIONAL REF; [Anonymous], 2017, MATERNAL NEWBORN HLT; Anyait A, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-132; Campbell OMR, 2016, TROP MED INT HEALTH, V21, P486, DOI 10.1111/tmi.12681; Celi LAG, GLOBAL HLTH INFORM P; Chen SCC, 2011, J MIDWIFERY WOM HEAL, V56, P68, DOI 10.1111/j.1542-2011.2010.00005.x; Chong S, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-46; Cummins S, 2007, SOC SCI MED, V65, P1825, DOI 10.1016/j.socscimed.2007.05.036; De Groot A, 1993, INT J; Ebener S, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0012-x; Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735; Esimai O, 2001, UTILIZATION APPROVED; Essien E, 1997, GYNECOL; Evans DB, 2013, B WORLD HEALTH ORGAN, V91, P546, DOI 10.2471/BLT.13.125450; Fogliati P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139460; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gebru T, 2014, ETHIOP J; Gething PW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-991; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Hailu D, 2014, MIDWIFERY; Hounton S, 2008, TROP MED INT HEALTH, V13, P44, DOI 10.1111/j.1365-3156.2008.02086.x; Joharifard S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1049; Johnson FA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120556; Kante AM, 2016, TROP MED INT HEALTH, V21, P504, DOI 10.1111/tmi.12672; Kawakatsu Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-265; Kelly C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013059; Kenny A, 2015, REMOTENESS MATERNAL; Kirby R, 2017, ANN EPIDEMIOL; Kruger C, 2011, WHERE DO WOMEN GIVE; Kruk M, 2015, TROP MED; Kruk ME, 2009, HEALTH POLICY PLANN, V24, P279, DOI 10.1093/heapol/czp011; Kyei-Nimakoh M, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0503-x; Masters S, 2013, SOC SCI; McLaughlin CG, 2002, HEALTH SERV RES, V37, P1441, DOI 10.1111/1475-6773.12171; Mills S, 2008, MATERN CHILD HLTH J, V12, P509, DOI 10.1007/s10995-007-0288-y; Molla YB, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1199-y; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Mwaliko E, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-212; Myers B, 2015, DEFINING REMOTENESS; National Institutes of Health, QUAL ASS TOOL OBS CO; Nesbitt RC, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-25; Nuwaha F, 1999, AFR J REPROD HLTH; Nwakoby B., 1992, HLTH POLICY PLAN; O'Donnell O, 2007, CAD SAUDE PUBLICA, V23, P2820, DOI 10.1590/S0102-311X2007001200003; Otun OW, 2017, ETHIOP J ENV STUD MA, V9, P829; Rai PK, 2017, GEOINFORMATICS HLTH; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Salazar M, 2016, GLOB HLTH ACTION; Samai O, 1997, INT J GYNECOL; Shah R, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1848-x; Spangler S, 2010, SOC SCI MED; Sudhof L, 2013, TROP MED INT HEALTH, V18, P18, DOI 10.1111/tmi.12016; Tatem AJ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-2; Teferra AS, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-74; USAID, 2020, MAT NEON CHILD HLTH; Van Eijk A, 2006, USE ANTENATAL SERVIC; Van Lerberghe W, REDUCING MATERNAL MO; Voils CI, 2011, J EVAL CLIN PRACT, V17, P429, DOI 10.1111/j.1365-2753.2010.01444.x; Wado YD, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-36; WHO OHCHR, 2007, THE RIGHT TO HLTH; Wild K, 2012, B WORLD; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735	73	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184432	10.1371/journal.pone.0184432	http://dx.doi.org/10.1371/journal.pone.0184432			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910302	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000410859200047
J	Yadav, DK; Arora, R; Jain, A				Yadav, Dinesh Kumar; Arora, Reena; Jain, Anand			Classification and conservation priority of five Deccani sheep ecotypes of Maharashtra, India	PLOS ONE			English	Article							ALLELE FREQUENCY DATA; SEMI ARID ZONE; GENETIC DIVERSITY; MICROSATELLITE MARKERS; POPULATION-STRUCTURE; MORPHOLOGICAL TRAITS; MULTIVARIATE CHARACTERIZATION; FIELD CONDITIONS; BREEDS; MUNJAL	Characterization of Indian livestock breeds has mostly been limited to single breed/population focused on either physical description of traditionally recognized breeds/populations or to their genetic description. Usually, morphological and genetic characterization has taken place in isolation. A parallel morphological characterization of genetically identified breeds or genetic characterization of morphologically described breeds is mostly missing, and their conservation priorities have largely been based on solely considering degree of endangerment. This study uses parallel approach based on morphometric and genetic differentiation for classification of five sheep ecotypes of Maharashtra state, and sets their conservation priority using threat parameters, current utilities/merits and contribution to genetic diversity. A total of 1101 animals were described for 7 body measurements for morphometric characterization. From this sample set, 456 animals were genotyped for 25 microsatellite markers for genetic characterization. Conservation priorities were assessed combining genetic and non-genetic factors. All studied traits varied significantly among ecotypes (p<0.05). All morphometric traits exhibited substantial sexual dimorphism except ear length. Males were 42% heavier than females. Madgyal sheep were the largest amongst the five ecotypes. In the stepwise discriminant analysis, all measured traits were significant and were found to have potential discriminatory power. Tail length was the most discriminatory trait. The Maha-lanobis distance of the morphological traits between Kolhapuri and Madgyal was maximum (12.07) while the least differentiation was observed between Madgyal and Solapuri (1.50). Discriminant analysis showed that 68.12% sheep were classified into their source population. The Sangamneri sheep showed least assignment error (22%) whilst Solapuri exhibited maximum error level (41%). A total of 407 alleles were observed, with an average of 16.28 alleles per locus. Sufficient levels of genetic diversity were observed in all the ecotypes with observed heterozygosity values exceeding 0.47 and gene diversity values exceeding 0.76. About 6% of the total genetic variation was explained by population differences (F-ST = 0.059). Pairwise F-ST values indicated least differentiation between Solapuri and Madgyal (0.025). In terms of genetic distances, Kolhapuri and Lonand were most closely related (Ds = 0.177). The most probable structure clustering of the five studied populations was at K = 5. The study showed a fair congruence between the dendrogram constructed on the basis of Mahalanobis distances and Nei's as well as Reynolds genetic distances. The findings gave highest conservation priority to Lonand and least to Solapuri ecotype.	[Yadav, Dinesh Kumar; Arora, Reena; Jain, Anand] ICAR Natl Bur Anim Genet Resources, Karnal, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Animal Genetic Resources	Yadav, DK (corresponding author), ICAR Natl Bur Anim Genet Resources, Karnal, Haryana, India.	dkyadav66@gmail.com	ARORA, REENA/AAK-6892-2021; Arora, Reena/AAR-2240-2021		Indian Council of Agricultural Research	Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	The authors received no specific funding for this work. The project was part of institute funding by Indian Council of Agricultural Research.	ACHARYA RM, 1982, 30 FAO AN PROD HLTH; Agaviezor BO, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-38; [Anonymous], 2012, STAT AN SYST; Arora R, 2011, ANIM GENET, V42, P242, DOI 10.1111/j.1365-2052.2010.02147.x; Arora R, 2011, LIVEST SCI, V135, P193, DOI 10.1016/j.livsci.2010.07.008; Arora R, 2009, ASIAN AUSTRAL J ANIM, V22, P1; Arora RJ, 2011, TROP ANIM HEALTH PRO, V43, P401, DOI 10.1007/s11250-010-9706-z; Baumung R, 2006, J ANIM BREED GENET, V123, P265, DOI 10.1111/j.1439-0388.2006.00583.x; Ben Sassi-Zaidy Y, 2014, SMALL RUMINANT RES, V119, P52, DOI 10.1016/j.smallrumres.2014.02.005; Bhatia S, 2005, ASIAN AUSTRAL J ANIM, V18, P1387, DOI 10.5713/ajas.2005.1387; Birteeb P T, 2012, TROP ANIM HLTH PROD, V12, P23; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bradley D G, 1997, REPORT ADVISORY GROU, P1; Carneiro H, 2010, SMALL RUMINANT RES, V94, P58, DOI 10.1016/j.smallrumres.2010.07.001; Cornuet JM, 1996, GENETICS, V144, P2001; d'Arnoldi CT, 1998, GENET SEL EVOL, V30, P149, DOI 10.1051/gse:19980204; Dalvit C, 2008, SMALL RUMINANT RES, V80, P45, DOI 10.1016/j.smallrumres.2008.09.005; Derban S., 2002, WEITZPRO SOFTWARE AN; Di Stasio L, 2001, PANELS MARKERS PAREN; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2007, OB PLAN ACT AN GEN R; Gaouar SBS, 2016, SMALL RUMINANT RES, V144, P23, DOI 10.1016/j.smallrumres.2016.07.021; Gaouar SBS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122667; Ghanekar V M., 1983, WOOL WOOLLENS INDIA, V20, P51; Gizaw S, 2007, ANIM GENET, V38, P621, DOI 10.1111/j.1365-2052.2007.01659.x; Gizaw S, 2008, GENET SEL EVOL, V40, P433, DOI 10.1051/gse:2008012; Gokhale S B., 2003, EVALUATION CHARACTER, P5; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gurmej Singh, 2007, Indian Journal of Animal Sciences, V77, P1158; Hedrick PW, 2013, J HERED, V104, P298, DOI 10.1093/jhered/ess139; Herrera M, 1996, SMALL RUMINANT RES, V22, P39, DOI 10.1016/0921-4488(96)00863-2; Jyotsana B, 2010, SMALL RUMINANT RES, V93, P57, DOI 10.1016/j.smallrumres.2010.03.008; LANGELLA O, 2002, POPULATIONS 1 2 28; Legaz E, 2008, SMALL RUMINANT RES, V80, P39, DOI 10.1016/j.smallrumres.2008.09.001; Legaz E, 2011, SMALL RUMINANT RES, V100, P122, DOI 10.1016/j.smallrumres.2011.06.005; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reist-Marti SB, 2003, CONSERV BIOL, V17, P1299, DOI 10.1046/j.1523-1739.2003.01587.x; REYNOLDS J, 1983, GENETICS, V105, P767; Riva J, 2004, SMALL RUMINANT RES, V55, P221, DOI 10.1016/j.smallrumres.2003.12.010; Ruane J, 2000, CONSERV BIOL, V14, P1385, DOI 10.1046/j.1523-1739.2000.99276.x; Sahana G, 2004, ANIMAL GENETIC RESOU, V34, P67; Simianer H, 2003, ECOL ECON, V45, P377, DOI 10.1016/S0921-8009(03)00092-2; Spanish Assaf, 2008, SMALL RUMINANT RES, V80, P39; Traore A, 2008, SMALL RUMINANT RES, V80, P62, DOI 10.1016/j.smallrumres.2008.09.011; Waghmode P. S., 2008, Indian Journal of Small Ruminants, V14, P127; WEITZMAN ML, 1992, Q J ECON, V107, P363, DOI 10.2307/2118476; Yadav D. K., 2014, Indian Journal of Small Ruminants, V20, P91; Yadav D K, 2015, MONOGRAPH, V91, P5; Yadav DK, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-29; Yadav DK, 2014, INDIAN J ANIM SCI, V84, P527; Yadav DK, 2012, INDIAN J ANIM SCI, V82, P216; Yadav DK, 2011, INDIAN J ANIM SCI, V81, P943; Yadav DK, 2009, INDIAN J ANIM SCI, V79, P1242; Yakubu A, 2011, ITAL J ANIM SCI, V10, P83, DOI 10.4081/ijas.2011.e17; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Yilmaz O, 2014, ANIM GENET, V45, P604, DOI 10.1111/age.12173	63	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184691	10.1371/journal.pone.0184691	http://dx.doi.org/10.1371/journal.pone.0184691			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910329	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200079
J	Fuller, AW; Young, P; Pierce, BD; Kitson-Finuff, J; Jain, P; Schneider, K; Lazar, S; Taran, O; Palmer, AG; Lynn, DG				Fuller, Alexandra W.; Young, Phoebe; Pierce, B. Daniel; Kitson-Finuff, Jamie; Jain, Purvi; Schneider, Karl; Lazar, Stephen; Taran, Olga; Palmer, Andrew G.; Lynn, David G.			Redox-mediated quorum sensing in plants	PLOS ONE			English	Article							KIN RECOGNITION; RHIZOSPHERE MICROBIOME; MOLECULAR-OXYGEN; STRIGA-ASIATICA; CROSS-TALK; HOST; CHEMISTRY; OXIDATION; CALCIUM; CA2+	The rhizosphere, the narrow zone of soil around plant roots, is a complex network of interactions between plants, bacteria, and a variety of other organisms. The absolute dependence on host-derived signals, or xenognosins, to regulate critical developmental checkpoints for host commitment in the obligate parasitic plants provides a window into the rhizosphere's chemical dynamics. These sessile intruders use H2O2 in a process known as semagenesis to chemically modify the mature root surfaces of proximal host plants and generate p-benzoquinones (BQs). The resulting redox-active signaling network regulates the spatial and temporal commitments necessary for host attachment. Recent evidence from non-parasites, including Arabidopsis thaliana, establishes that reactive oxygen species (ROS) production regulates similar redox circuits related to root recognition, broadening xenognosins' role beyond the parasites. Here we compare responses to the xenognosin dimethoxybenzoquinone (DMBQ) between the parasitic plant Striga asiatica and the non-parasitic A. thaliana. Exposure to DMBQ simulates the proximity of a mature root surface, stimulating an increase in cytoplasmic Ca2+ concentration in both plants, but leads to remarkably different phenotypic responses in the parasite and non-parasite. In S. asiatica, DMBQ induces development of the host attachment organ, the haustorium, and decreases ROS production at the root tip, while in A. thaliana, ROS production increases and further growth of the root tip is arrested. Obstruction of Ca2+ channels and the addition of antioxidants both lead to a decrease in the DMBQ response in both parasitic and non-parasitic plants. These results are consistent with Ca2+ regulating the activity of NADPH oxidases, which in turn sustain the autocatalytic production of ROS via an external quinone/hydroquinone redox cycle. Mechanistically, this chemistry is similar to black and white photography with the emerging dynamic reaction-diffusion network laying the foundation for the precise temporal and spatial control underlying rhizosphere architecture.	[Fuller, Alexandra W.; Young, Phoebe; Pierce, B. Daniel; Taran, Olga; Lynn, David G.] Emory Univ, Dept Biol & Chem, Atlanta, GA 30322 USA; [Pierce, B. Daniel] Univ Richmond, Gottwald Sci Ctr, Richmond, VA 23173 USA; [Kitson-Finuff, Jamie; Jain, Purvi; Schneider, Karl; Lazar, Stephen; Palmer, Andrew G.] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA	Emory University; University of Richmond; Florida Institute of Technology	Taran, O; Lynn, DG (corresponding author), Emory Univ, Dept Biol & Chem, Atlanta, GA 30322 USA.; Palmer, AG (corresponding author), Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA.	otarani@emory.edu; apalmer@fit.edu; dlynn2@emory.edu		Taran, Olga/0000-0003-1994-0847; Pierce, B Daniel/0000-0002-0004-2054; Palmer, Andrew/0000-0001-6506-5292; Young, Phoebe/0000-0001-9408-912X	Emory University; Florida Institute of Technology; NIH; Emory University's Department of Neurology	Emory University; Florida Institute of Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University's Department of Neurology	We thank Emory University for undergraduate student research fellowships to AWF and PY, the Florida Institute of Technology for graduate fellowship support of SL, the NIH FIRST Fellowship to BDP, and Emory University's Department of Neurology for fellowship support to OT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bhatt MV, 2011, NEW PHYTOL, V189, P1135, DOI 10.1111/j.1469-8137.2010.03548.x; Biedrzycki ML, 2011, PLANT SIGNAL BEHAV, V6, P1515, DOI 10.4161/psb.6.10.16525; Biedrzycki ML, 2014, COMMUN INTEGR BIOL, V3, P28; Binns A. N., 1993, Advances in molecular genetics of plant-microbe interactions. Vol. 2. Proceedings of the 6th International Symposium of Molecular Plant-Microbe Interactions, Seattle, Washington, USA, July 1992., P51; CARLSON BW, 1985, J AM CHEM SOC, V107, P479, DOI 10.1021/ja00288a035; Casper BB, 1997, ANNU REV ECOL SYST, V28, P545, DOI 10.1146/annurev.ecolsys.28.1.545; CHANG M, 1986, J AM CHEM SOC, V108, P7858, DOI 10.1021/ja00284a074; Depuydt S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00614; Dorr I, 1997, ANN BOT-LONDON, V79, P463, DOI 10.1006/anbo.1996.0385; Dudley SA, 2007, BIOLOGY LETT, V3, P435, DOI 10.1098/rsbl.2007.0232; Egamberdieva D, 2008, ENVIRON MICROBIOL, V10, P1, DOI 10.1111/j.1462-2920.2007.01424.x; El-Shemy, 2015, PLANTS FUTURE, P135; Fang F, 2015, CHEMBIOCHEM, V16, P2183, DOI 10.1002/cbic.201500334; FATE G, 1990, PLANT PHYSIOL, V93, P201, DOI 10.1104/pp.93.1.201; Fate GD, 1996, J AM CHEM SOC, V118, P11369, DOI 10.1021/ja961395i; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gechev TS, 2005, J CELL BIOL, V168, P17, DOI 10.1083/jcb.200409170; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Golisz A, 2011, PLANTA, V233, P231, DOI 10.1007/s00425-010-1294-7; Gonzalez JE, 2003, MICROBIOL MOL BIOL R, V67, P574, DOI 10.1128/MMBR.67.4.574-592.2003; Hogan DA, 2006, EUKARYOT CELL, V5, P613, DOI 10.1128/EC.5.4.613-619.2006; Hood ME, 1998, PHYTOPATHOLOGY, V88, P70, DOI 10.1094/PHYTO.1998.88.1.70; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Keyes WJ, 2007, PLANT J, V51, P707, DOI 10.1111/j.1365-313X.2007.03171.x; Keyes WJ, 2001, PLANT PHYSL, V127; Kim DJ, 1998, CHEM BIOL, V5, P103, DOI 10.1016/S1074-5521(98)90144-2; Kimura S, 2012, BBA-MOL CELL RES, V1823, P398, DOI 10.1016/j.bbamcr.2011.09.011; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Liang LiZhi, 2016, American Journal of Plant Sciences, V7, P1275; Lohar DP, 2007, NEW PHYTOL, V173, P39, DOI 10.1111/j.1469-8137.2006.01901.x; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; LYNN DG, 1990, ANNU REV PLANT PHYS, V41, P497, DOI 10.1146/annurev.pp.41.060190.002433; Mazars C, 2010, MOL PLANT, V3, P706, DOI 10.1093/mp/ssq024; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Monshausen GB, 2008, PLANT PHYSIOL, V147, P1690, DOI 10.1104/pp.108.123638; Murphy GP, 2009, AM J BOT, V96, P1990, DOI 10.3732/ajb.0900006; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Palmer AG, 2004, ANNU REV PHYTOPATHOL, V42, P439, DOI 10.1146/annurev.phyto.41.052002.095701; Palmer AG, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2016.1224045; Palmer AG, 2014, ACS CHEM BIOL, V9, P1834, DOI 10.1021/cb500191a; Palmer AG, 2008, PLANT SIGNAL BEHAV, V3, P560, DOI 10.4161/psb.3.8.5703; Palmer AG, 2009, PEST MANAG SCI, V65, P512, DOI 10.1002/ps.1717; Panayotaros J-GC, 2015, J PHYS A, V48, P75102; Potocky M, 2007, NEW PHYTOL, V174, P742, DOI 10.1111/j.1469-8137.2007.02042.x; Roginsky V, 2000, J CHEM SOC PERK T 2, P1575, DOI 10.1039/b000538j; Roginsky VA, 1999, J CHEM SOC PERK T 2, P871, DOI 10.1039/a807650b; Roginsky VA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P200; Sella E, 2013, ORG BIOMOL CHEM, V11, P5074, DOI 10.1039/c3ob40962g; Smertenko A, 2014, J EXP BOT, V65, P1343, DOI 10.1093/jxb/eru005; SMITH CE, 1990, PLANT PHYSIOL, V93, P208, DOI 10.1104/pp.93.1.208; Smith CE, 1996, P NATL ACAD SCI USA, V93, P6986, DOI 10.1073/pnas.93.14.6986; Song Y, 2010, FREE RADICAL BIO MED, V49, P919, DOI 10.1016/j.freeradbiomed.2010.05.009; Soumen Bhattacharjee, 2012, Journal of Botany, V2012, P985298; Stacy A, 2014, P NATL ACAD SCI USA, V111, P7819, DOI 10.1073/pnas.1400586111; Steinbock O, 1995, NAVIGATING COMPLEX L; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Tschiersch H, 2012, NEW PHYTOL, V196, P926, DOI 10.1111/j.1469-8137.2012.04295.x; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x; Yoder JI, 2001, CURR OPIN PLANT BIOL, V4, P359, DOI 10.1016/S1369-5266(00)00185-0; Zeng ZX, 1996, J AM CHEM SOC, V118, P1233, DOI 10.1021/ja950372l; Zhang DJ, 2010, ECOL RES, V25, P13, DOI 10.1007/s11284-009-0627-0; Zhou LL, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/951210; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	68	10	11	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0182655	10.1371/journal.pone.0182655	http://dx.doi.org/10.1371/journal.pone.0182655			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902851	gold, Green Published, Green Submitted			2022-12-27	WOS:000410669200005
J	Isaksen, JL; Mohebbi, A; Puthusserypady, S				Isaksen, Jonas L.; Mohebbi, Ali; Puthusserypady, Sadasivan			Optimal pseudorandom sequence selection for online c-VEP based BCI control applications	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; PERFORMANCES	Background In a c-VEP BCI setting, test subjects can have highly varying performances when different pseudorandom sequences are applied as stimulus, and ideally, multiple codes should be supported. On the other hand, repeating the experiment with many different pseudorandom sequences is a laborious process. Aims This study aimed to suggest an efficient method for choosing the optimal stimulus sequence based on a fast test and simple measures to increase the performance and minimize the time consumption for research trials. Methods A total of 21 healthy subjects were included in an online wheelchair control task and completed the same task using stimuli based on the m-code, the gold-code, and the Barker-code. Correct/incorrect identification and time consumption were obtained for each identification. Subject-specific templates were characterized and used in a forward-step first-order model to predict the chance of completion and accuracy score. Results No specific pseudorandom sequence showed superior accuracy on the group basis. When isolating the individual performances with the highest accuracy, time consumption per identification was not significantly increased. The Accuracy Score aids in predicting what pseudorandom sequence will lead to the best performance using only the templates. The Accuracy Score was higher when the template resembled a delta function the most and when repeated templates were consistent. For completion prediction, only the shape of the template was a significant predictor. Conclusions The simple and fast method presented in this study as the Accuracy Score, allows c-VEP based BCI systems to support multiple pseudorandom sequences without increase in trial length. This allows for more personalized BCI systems with better performance to be tested without increased costs.	[Isaksen, Jonas L.; Mohebbi, Ali; Puthusserypady, Sadasivan] Tech Univ Denmark, Dept Elect Engn, Lyngby, Denmark; [Isaksen, Jonas L.] Univ Copenhagen, Dept Biomed Sci, Lab Expt Cardiol, Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen	Isaksen, JL (corresponding author), Tech Univ Denmark, Dept Elect Engn, Lyngby, Denmark.; Isaksen, JL (corresponding author), Univ Copenhagen, Dept Biomed Sci, Lab Expt Cardiol, Copenhagen, Denmark.	rbv188@alumni.ku.dk	Puthusserypady, Sadasivan/AAU-6190-2020; Isaksen, Jonas L/J-8167-2015; Puthusserypady, Sadasivan/N-3551-2015	Puthusserypady, Sadasivan/0000-0001-7564-2612; Isaksen, Jonas L/0000-0003-3227-1131; Puthusserypady, Sadasivan/0000-0001-7564-2612				ACKROYD MH, 1972, IEEE T AERO ELEC SYS, VAES8, P2, DOI 10.1109/TAES.1972.309459; Amiri S, 2013, ADV HUM-COMPUT INTER, V2013, DOI 10.1155/2013/187024; Berger T. W., 2008, BRAIN COMPUTER INTER; Bianchi L, 2007, IEEE T NEUR SYS REH, V15, P207, DOI 10.1109/TNSRE.2007.897024; Bin GY, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025015; Bin GY, 2009, IEEE COMPUT INTELL M, V4, P22, DOI 10.1109/MCI.2009.934562; Colwell K, 2014, IEEE T NEUR SYS REH, V22, P921, DOI 10.1109/TNSRE.2014.2324892; Dal Seno B, 2010, IEEE T NEUR SYS REH, V18, P20, DOI 10.1109/TNSRE.2009.2032642; Nicolas-Alonso LF, 2012, SENSORS-BASEL, V12, P1211, DOI 10.3390/s120201211; GOLOMB SW, 1965, IEEE T INFORM THEORY, V11, P533, DOI 10.1109/TIT.1965.1053828; Golomb SW, 1982, SHIFT REGISTER SEQUE, pX; Hassanien AE, 2015, INTEL SYST REF LIBR, V74, pVII; Isaksen J, 2016, IEEE ENG MED BIO, P1512, DOI 10.1109/EMBC.2016.7590997; Kapeller C, 2013, IEEE ENG MED BIO, P5254, DOI 10.1109/EMBC.2013.6610734; Kasami T, 1966, R285 COORD SCI LAB; LaFleur K, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046003; Meng JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38565; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; Mohebbi A, 2015, IEEE ENG MED BIO, P602, DOI 10.1109/EMBC.2015.7318434; Quitadamo LR, 2012, J NEUROSCI METH, V203, P361, DOI 10.1016/j.jneumeth.2011.10.010; Rao R., 2013, BRAIN COMPUTER INTER; SARWATE DV, 1980, P IEEE, V68, P593, DOI 10.1109/PROC.1980.11697; Sato J, 2015, IEEE ENG MED BIO, P562, DOI 10.1109/EMBC.2015.7318424; Shih JJ, 2012, MAYO CLIN PROC, V87, P268, DOI 10.1016/j.mayocp.2011.12.008; Spuler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051077; Standage D, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00236; Thielen J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133797; Wei QG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156416; Wolpaw J R, 1998, IEEE Trans Rehabil Eng, V6, P326, DOI 10.1109/86.712231; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, DOI [10.1093/acprof:oso/9780195388855.001.0001, DOI 10.1093/ACPROF:OSO/9780195388855.001.0001]; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Zhu Danhua, 2010, Comput Intell Neurosci, P702357, DOI 10.1155/2010/702357	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184785	10.1371/journal.pone.0184785	http://dx.doi.org/10.1371/journal.pone.0184785			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902895	Green Submitted, gold, Green Published			2022-12-27	WOS:000410669200067
J	Li, Y; Khalafalla, AI; Paden, CR; Yusof, MF; Eltahir, YM; Al Hammadi, ZM; Tao, Y; Queen, K; Al Hosani, F; Gerber, SI; Hall, AJ; Al Muhairi, S; Tong, SX				Li, Yan; Khalafalla, Abdelmalik Ibrahim; Paden, Clinton R.; Yusof, Mohammed F.; Eltahir, Yassir M.; Al Hammadi, Zulaikha M.; Tao, Ying; Queen, Krista; Al Hosani, Farida; Gerber, Susan I.; Hall, Aron J.; Al Muhairi, Salama; Tong, Suxiang			Identification of diverse viruses in upper respiratory samples in dromedary camels from United Arab Emirates	PLOS ONE			English	Article							CONGO HEMORRHAGIC-FEVER; CORONAVIRUS MERS-COV; MIDDLE-EAST; SAUDI-ARABIA; MOLECULAR CHARACTERIZATION; METAGENOMIC ANALYSIS; VIROME REVEALS; VIRAL GENOMES; DNA VIRUSES; ABU-DHABI	Camels are known carriers for many viral pathogens, including Middle East respiratory syndrome coronavirus (MERS-CoV). It is likely that there are additional, as yet unidentified viruses in camels with the potential to cause disease in humans. In this study, we performed metagenomic sequencing analysis on nasopharyngeal swab samples from 108 MERS-CoV-positive dromedary camels from a live animal market in Abu Dhabi, United Arab Emirates. We obtained a total of 846.72 million high-quality reads from these nasopharyngeal swab samples, of which 2.88 million (0.34%) were related to viral sequences while 512.63 million (60.5%) and 50.87 million (6%) matched bacterial and eukaryotic sequences, respectively. Among the viral reads, sequences related to mammalian viruses from 13 genera in 10 viral families were identified, including Coronaviridae, Nairoviridae, Paramyxoviridae, Parvoviridae, Polyomaviridae, Papillomaviridae, Astroviridae, Picornaviridae, Poxviridae, and Genomoviridae. Some viral sequences belong to known camel or human viruses and others are from potentially novel camel viruses with only limited sequence similarity to virus sequences in GenBank. A total of five potentially novel virus species or strains were identified. Co-infection of at least two recently identified camel coronaviruses was detected in 92.6% of the camels in the study. This study provides a comprehensive survey of viruses in the virome of upper respiratory samples in camels that have extensive contact with the human population.	[Li, Yan; Paden, Clinton R.; Tao, Ying; Queen, Krista; Gerber, Susan I.; Hall, Aron J.; Tong, Suxiang] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA 30329 USA; [Khalafalla, Abdelmalik Ibrahim; Yusof, Mohammed F.; Eltahir, Yassir M.; Al Hammadi, Zulaikha M.; Al Muhairi, Salama] Abu Dhabi Food Control Author, Anim Wealth Sect, Abu Dhabi, U Arab Emirates; [Paden, Clinton R.; Queen, Krista] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Al Hosani, Farida] Hlth Author Abu Dhabi, Abu Dhabi, U Arab Emirates	Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Tong, SX (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Div Viral Dis, Atlanta, GA 30329 USA.; Al Muhairi, S (corresponding author), Abu Dhabi Food Control Author, Anim Wealth Sect, Abu Dhabi, U Arab Emirates.	salama.almuhairi@adfca.ae; sot1@cdc.gov	Khalafalla, Abdelmalik Ibrahim/GLT-3730-2022	Khalafalla, Abdelmalik Ibrahim/0000-0001-9156-1361; Alhosani, Farida/0000-0002-4901-0280				Abou Zaid A, 2001, J EGYPT VET VET ASSU, V61, P15; AFZAL M, 1994, REV SCI TECH OIE, V13, P787, DOI 10.20506/rst.13.3.794; Al Hammadi ZM, 2015, EMERG INFECT DIS, V21, P2197, DOI 10.3201/eid2112.151132; Al Muhairi S, 2016, VIRUS GENES, V52, P848, DOI 10.1007/s11262-016-1367-1; Al-Ruwaili MA, 2012, SAUDI J BIOL SCI, V19, P35, DOI 10.1016/j.sjbs.2011.10.001; Anthony SJ, 2017, MBIO, V8, DOI [10.1128/mBio.00373-17, 10.1128/mbio.00373-17]; Buck CB, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005574; Calvignac-Spencer S, 2016, ARCH VIROL, V161, P1739, DOI 10.1007/s00705-016-2794-y; Champour M, 2016, J ARTHROPOD-BORNE DI, V10, P168; Champour M, 2014, J VECTOR DIS, V51, P62; Corman VM, 2016, P NATL ACAD SCI USA, V113, P9864, DOI 10.1073/pnas.1604472113; Assis MRD, 2016, FOOD ENVIRON VIROL, V8, P305, DOI 10.1007/s12560-016-9254-4; Dacheux L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087194; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; de Wit E, 2016, NAT REV MICROBIOL, V14, P523, DOI 10.1038/nrmicro.2016.81; Du ZG, 2014, ARCH VIROL, V159, P1527, DOI 10.1007/s00705-013-1890-5; Fawaz M, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0113-5; Halary S, 2016, EMERG INFECT DIS, V22, P1839, DOI 10.3201/eid2210.160052; Huang CP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005883; Intisar KS, 2010, J VIROL METHODS, V163, P82, DOI 10.1016/j.jviromet.2009.08.017; Intisar KS, 2009, ACTA TROP, V111, P243, DOI 10.1016/j.actatropica.2009.05.001; Johne R, 2011, ARCH VIROL, V156, P1627, DOI 10.1007/s00705-011-1008-x; Khalafalla AI, 2017, VECTOR-BORNE ZOONOT, V17, P281, DOI 10.1089/vbz.2016.2070; Khalafalla AI, 2010, ACTA TROP, V116, P161, DOI 10.1016/j.actatropica.2010.08.002; Khan AS, 1997, AM J TROP MED HYG, V57, P519, DOI 10.4269/ajtmh.1997.57.519; Krupovic M, 2016, ARCH VIROL, V161, P2633, DOI 10.1007/s00705-016-2943-3; Lager KM, 2012, J VET DIAGN INVEST, V24, P1177, DOI 10.1177/1040638712463212; Lau SKP, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.129; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li LL, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-54; Li LL, 2010, J VIROL, V84, P6955, DOI 10.1128/JVI.00501-10; Li PE, 2017, NUCLEIC ACIDS RES, V45, P67, DOI 10.1093/nar/gkw1027; MAURICE PY, 1968, REV ELEV MED VET PAY, V21, P443; Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113; Ng TFF, 2014, P NATL ACAD SCI USA, V111, P16842, DOI 10.1073/pnas.1410429111; Ng TFF, 2014, VET MICROBIOL, V171, P102, DOI 10.1016/j.vetmic.2014.04.005; Perera RA, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.36.20574; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Sabir JSM, 2016, SCIENCE, V351, P81, DOI 10.1126/science.aac8608; Saeed IK, 2015, TROP ANIM HEALTH PRO, V47, P995, DOI 10.1007/s11250-015-0798-3; Sasaki M, 2015, J GEN VIROL, V96, P440, DOI 10.1099/vir.0.071209-0; SINGH KV, 1967, VET REC, V81, P84, DOI 10.1136/vr.81.3.84; Steel O, 2016, INFECT GENET EVOL, V43, P151, DOI 10.1016/j.meegid.2016.05.008; Tao Y, 2017, J VIROL, V91, DOI 10.1128/JVI.01953-16; Tao Y, 2013, J GEN VIROL, V94, P738, DOI 10.1099/vir.0.047928-0; Telmadarraiy Z, 2010, SCAND J INFECT DIS, V42, P137, DOI 10.3109/00365540903362501; Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; Phan TG, 2015, VIROLOGY, V482, P98, DOI 10.1016/j.virol.2015.03.011; Uch R, 2015, EMERG INFECT DIS, V21, P2096, DOI 10.3201/eid2111.150486; Ure AE, 2011, J GEN VIROL, V92, P1769, DOI 10.1099/vir.0.031039-0; Varsani A, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vew037; Wernery U, 1999, J VET MED B, V46, P131, DOI 10.1111/j.0931-1793.1999.00250.x; Wernery U, 2014, INFECT DISORDERS CAM; Wernery U, 2008, J GEN VIROL, V89, P660, DOI 10.1099/vir.0.82215-0; WHO, 2016, MERS COV GLOB SUMM R; Woo PCY, 2006, J VIROL, V80, P7136, DOI 10.1128/JVI.00509-06; Woo PCY, 2015, J GEN VIROL, V96, P2697, DOI 10.1099/jgv.0.000233; Woo PCY, 2015, J GEN VIROL, V96, P1723, DOI 10.1099/vir.0.000131; Woo PCY, 2014, VIROLOGY, V471, P117, DOI 10.1016/j.virol.2014.09.020; Woo PCY, 2014, EMERG INFECT DIS, V20, P560, DOI 10.3201/eid2004.131769; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Woo PC, 2017, J GEN VIROLOGY; World Health Organization (WHO), 2019, MIDDLE E RESP SYNDRO; YAM BAZ, 2015, RES J AGR ENV MANAGE, V4, P496; Yousif A.A., 2004, ARAB J BIOTECHNOL, V7, P8; Yu X, 2010, P NATL ACAD SCI USA, V107, P8387, DOI 10.1073/pnas.0913535107; Yusof MF, 2015, VIRUS GENES, V50, P509, DOI 10.1007/s11262-015-1174-0; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang W, 2016, TRANSFUSION, V56, P2248, DOI 10.1111/trf.13692; Zhou CL, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0431-0; Zivcec M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040106	74	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184718	10.1371/journal.pone.0184718	http://dx.doi.org/10.1371/journal.pone.0184718			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902913	gold, Green Published, Green Submitted			2022-12-27	WOS:000410669200056
J	Zhang, WD; Randell, EW; Sun, G; Likhodii, S; Liu, M; Furey, A; Zhai, GJ				Zhang, Weidong; Randell, Edward W.; Sun, Guang; Likhodii, Sergei; Liu, Ming; Furey, Andrew; Zhai, Guangju			Hyperglycemia-related advanced glycation end-products is associated with the altered phosphatidylcholine metabolism in osteoarthritis patients with diabetes	PLOS ONE			English	Article							COMPLICATION-FREE PATIENTS; SYNOVIAL-FLUID; METHYLGLYOXAL; METFORMIN; GLUCOSE; RAGE; PIOGLITAZONE; RESPONSES; PROTEOME; RECEPTOR	To test whether type 2 diabetic patients have an elevated level of advanced glycation end-products (AGEs) and responsible for altered phosphatidylcholine metabolism, which we recently found to be associated with osteoarthritis (OA) and diabetes mellitus (DM), synovial fluid (SF) and plasma samples were collected from OA patients with and without DM. Hyperglycemia-related AGEs including methylglyoxal (MG), free methylglyoxal-derived hydroimidazolone (MG-H1), and protein bound N-(Carboxymethyl) lysine (CML) and N-(Carboxyethyl) lysine (CEL) levels were measured in both SF and plasma samples using liquid chromatography coupled tandem mass spectrometry methodology. The correlation between these AGEs and phosphatidylcholine acyl-alkyl C34: 3 (PC ae C34: 3) and C36:3 (PC ae C36: 3) were examined. Eighty four patients with knee OA, including 46 with DM and 38 without DM, were included in the study. There was no significant difference in plasma levels of MG, MG-H1, CML, and CEL between OA patients with and without DM. However, the levels of MG and MG-H1, but not CML and CEL in SF were significantly higher in OA patients with DM than in those without (all p <= 0.04). This association strengthened after adjustment for age, body mass index (BMI), sex and hexose level (p<0.02). Moreover, the levels of MG-H1 in SF was negatively and significantly correlated with PC ae C34: 3 (rho = -0.34; p = 0.02) and PC ae C36: 3 (rho = -0.39; P = 0.03) after the adjustment of age, BMI, sex and hexose level. Our data indicated that the production of non-protein bound AGEs was increased within the OA-affected joint of DM patients. This is associated with changes in phosphatidylcholine metabolism and might be responsible for the observed epidemiological association between OA and DM.	[Zhang, Weidong; Liu, Ming; Zhai, Guangju] Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada; [Zhang, Weidong] Jilin Univ, Sch Pharmaceut Sci, Changchun, Jilin, Peoples R China; [Randell, Edward W.; Likhodii, Sergei] Mem Univ Newfoundland, Fac Med, Dept Lab Med, St John, NF, Canada; [Sun, Guang] Mem Univ Newfoundland, Fac Med, Discipline Med, St John, NF, Canada; [Furey, Andrew] Mem Univ Newfoundland, Fac Med, Dept Surg, St John, NF, Canada; [Zhai, Guangju] Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia	Memorial University Newfoundland; Jilin University; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; University of Tasmania; Menzies Institute for Medical Research	Zhai, GJ (corresponding author), Mem Univ Newfoundland, Fac Med, Discipline Genet, St John, NF, Canada.; Zhai, GJ (corresponding author), Univ Tasmania, Menzies Res Inst, Hobart, Tas, Australia.	guangju.zhai@med.mun.ca			Canadian Institutes of Health Research (CIHR) [RNL-132178]; Newfoundland & Labrador Research and Development Corporation; Memorial University of Newfoundland (MUN)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Newfoundland & Labrador Research and Development Corporation; Memorial University of Newfoundland (MUN)	This work was supported by the Canadian Institutes of Health Research (CIHR); Grant number:RNL-132178, GJZ (http://webapps. cihr-irsc.gc.ca/cfdd/db_search); the Newfoundland & Labrador Research and Development Corporation and Memorial University of Newfoundland (MUN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072128; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; BASKARAN S, 1990, INDIAN J BIOCHEM BIO, V27, P13; Bennike T, 2014, J PROTEOME RES, V13, P4377, DOI 10.1021/pr500587x; Chen Yi, 2007, J Orthop Surg Res, V2, P14, DOI 10.1186/1749-799X-2-14; Chen YJ, 2016, J ORTHOP RES, V34, P791, DOI 10.1002/jor.23083; Di Marco Elyse, 2013, Front Endocrinol (Lausanne), V4, P68, DOI 10.3389/fendo.2013.00068; Diamanti-Kandarakis E, 2007, METABOLISM, V56, P129, DOI 10.1016/j.metabol.2006.09.006; Eymard F, 2015, OSTEOARTHR CARTILAGE, V23, P851, DOI 10.1016/j.joca.2015.01.013; Freitas C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155741; Garg S, 2013, CLIN J PAIN, V29, P717, DOI 10.1097/AJP.0b013e318272ebec; Glyn-Jones S, 2015, LANCET, V386, P376, DOI 10.1016/S0140-6736(14)60802-3; GROOP LC, 1992, DIABETES CARE, V15, P737, DOI 10.2337/diacare.15.6.737; Han Y, 2007, MOL CELL BIOCHEM, V305, P123, DOI 10.1007/s11010-007-9535-1; Han YC, 2009, CLIN BIOCHEM, V42, P562, DOI 10.1016/j.clinbiochem.2008.12.016; HILLS BA, 1990, LYMPHOLOGY, V23, P39; Hirose H, 2002, METABOLISM, V51, P314, DOI 10.1053/meta.2002.30506; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Karimi J, 2011, DIABETES RES CLIN PR, V91, P61, DOI 10.1016/j.diabres.2010.09.024; Kender Z, 2014, EXP CLIN ENDOCR DIAB, V122, P316, DOI 10.1055/s-0034-1371818; Kiho T, 2005, CLIN CHIM ACTA, V358, P139, DOI 10.1016/j.cccn.2005.02.012; King KB, 2015, OSTEOARTHR CARTILAGE, V23, P841, DOI 10.1016/j.joca.2015.03.031; Kontomanolis EN, 2016, CLIN EXP OBSTET GYN, V43, P276; LAL S, 1995, ARCH BIOCHEM BIOPHYS, V318, P191, DOI 10.1006/abbi.1995.1220; Li WG, 2008, EXP BIOL MED, V233, P176, DOI 10.3181/0705-BC-131; Li Y, 2016, OSTEOARTHR CARTILAGE, V24, P307, DOI 10.1016/j.joca.2015.08.001; Lv X, 2016, CHIN J NAT MEDICINES, V14, P844, DOI 10.1016/S1875-5364(16)30101-7; Magnusson CD, 2011, CHEM PHYS LIPIDS, V164, P315, DOI 10.1016/j.chemphyslip.2011.04.010; Magnusson K, 2015, ARTHRIT CARE RES, V67, P187, DOI 10.1002/acr.22460; Miranda C, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1228-z; Oloyede A, 2004, CONNECT TISSUE RES, V45, P86, DOI 10.1080/03008200490442653; Prasad A, 2012, CARDIOL REV, V20, P177, DOI 10.1097/CRD.0b013e318244e57c; Rabbani N, 2014, BIOCHEM SOC T, V42, P425, DOI 10.1042/BST20140018; Rabbani N, 2014, DIABETES, V63, P50, DOI 10.2337/db13-1606; Rahbar S, 2000, CLIN CHIM ACTA, V301, P65, DOI 10.1016/S0009-8981(00)00327-2; Rahman MM, 2014, INT J RHEUMATOL, V2014, DOI 10.1155/2014/620920; Schett G, 2013, DIABETES CARE, V36, P403, DOI 10.2337/dc12-0924; Schmidt AM, 1996, DIABETES, V45, pS77, DOI 10.2337/diab.45.3.S77; SZWERGOLD BS, 1990, SCIENCE, V247, P451, DOI 10.1126/science.2300805; Teerlink T, 2004, CLIN CHEM, V50, P1222, DOI 10.1373/clinchem.2004.031286; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yamagishi S, 2008, CURR PHARM DESIGN, V14, P939, DOI 10.2174/138161208784139756; Zhang WD, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0937-x; Zhang WD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006286	46	28	28	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184105	10.1371/journal.pone.0184105	http://dx.doi.org/10.1371/journal.pone.0184105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898260	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000410449500013
J	Bjelland, EK; Owe, KM; Nordeng, HME; Engdahl, BL; Kristiansson, P; Vangen, S; Eberhard-Gran, M				Bjelland, Elisabeth Krefting; Owe, Katrine Mari; Nordeng, Hedvig Marie Egeland; Engdahl, Bo Lars; Kristiansson, Per; Vangen, Siri; Eberhard-Gran, Malin			Does progestin-only contraceptive use after pregnancy affect recovery from pelvic girdle pain? A prospective population study	PLOS ONE			English	Article							HORMONAL CONTRACEPTION; INTRAUTERINE SYSTEM; NORWEGIAN MOTHER; CHILD COHORT; WOMEN; PREVALENCE; DELIVERY; MENARCHE; HEALTH; RISK	Objective To estimate associations of progestin-only contraceptives with persistent pelvic girdle pain 18 months after delivery. Methods Prospective population based cohort study during the years 2003-2011. We included 20,493 women enrolled in the Norwegian Mother and Child Cohort Study who reported pelvic girdle pain in pregnancy week 30. Data were obtained by 3 self-administered questionnaires and the exposure was obtained by linkage to the Prescription Database of Norway. The outcome was pelvic girdle pain 18 months after delivery. Results Pelvic girdle pain 18 months after delivery was reported by 9.7% (957/9830) of women with dispense of a progestin-only contraceptive and by 10.5% (1114/10,663) of women without dispense (adjusted odds ratio 0.93; 95% CI 0.84-1.02). In sub-analyses, long duration of exposure to a progestin intrauterine device or progestin-only oral contraceptives was associated with reduced odds of persistent pelvic girdle pain (P-trend = 0.021 and P-trend = 0.005). Conversely, long duration of exposure to progestin injections and/or a progestin implant was associated with modest increased odds of persistent pelvic girdle pain (P-trend = 0.046). Early timing of progestin-only contraceptive dispense following delivery (<= 3 months) was not significantly associated with persistent pelvic girdle pain. Conclusions Our findings suggest a small beneficial effect of progestin intrauterine devices and progestin-only oral contraceptives on recovery from pelvic girdle pain. We cannot completely rule out an opposing adverse effect of exposure to progestin injections and/or progestin implants. However, the modest increased odds of persistent pelvic girdle pain among these users could be a result of unmeasured confounding.	[Bjelland, Elisabeth Krefting; Eberhard-Gran, Malin] Akershus Univ Hosp, Hlth Serv Res Unit, Lorenskog, Norway; [Bjelland, Elisabeth Krefting; Engdahl, Bo Lars] Norwegian Inst Publ Hlth, Dept Hlth & Aging, Oslo, Norway; [Bjelland, Elisabeth Krefting] Akershus Univ Hosp, Dept Obstet & Gynecol, Lorenskog, Norway; [Owe, Katrine Mari; Vangen, Siri] Natl Hosp Norway, Oslo Univ Hosp, Norwegian Natl Advisory Unit Womens Hlth, Oslo, Norway; [Owe, Katrine Mari; Nordeng, Hedvig Marie Egeland; Eberhard-Gran, Malin] Norwegian Inst Publ Hlth, Dept Child Hlth, Oslo, Norway; [Nordeng, Hedvig Marie Egeland] Univ Oslo, Sch Pharm, PharmacoEpidemiol & Drug Safety Res Grp, Oslo, Norway; [Kristiansson, Per] Uppsala Univ, Dept Publ Hlth & Caring Sci, Uppsala, Sweden; [Eberhard-Gran, Malin] Univ Oslo, Inst Clin Med, Campus Ahus, Lorenskog, Norway	University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo; National Hospital Norway; Norwegian Institute of Public Health (NIPH); University of Oslo; Uppsala University; University of Oslo	Bjelland, EK (corresponding author), Akershus Univ Hosp, Hlth Serv Res Unit, Lorenskog, Norway.; Bjelland, EK (corresponding author), Norwegian Inst Publ Hlth, Dept Hlth & Aging, Oslo, Norway.; Bjelland, EK (corresponding author), Akershus Univ Hosp, Dept Obstet & Gynecol, Lorenskog, Norway.	Elisabeth.Krefting.Bjelland@ahus.no	Bjelland, Elisabeth Krefting/Q-5531-2016; Engdahl, Bo/ABC-6923-2020; Owe, Katrine M/I-1909-2017	Bjelland, Elisabeth Krefting/0000-0003-3206-524X; Engdahl, Bo/0000-0002-9166-5782; 	South-Eastern Norway Regional Health Authority [2013073]; Norwegian Ministry of Health; Ministry of Education and Research, NIH/NIEHS [N01-ES-75558]; NIH/NINDS [1 UO1 NS 047537-01, 2 UO1 NS 047537-06A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047537] Funding Source: NIH RePORTER	South-Eastern Norway Regional Health Authority; Norwegian Ministry of Health; Ministry of Education and Research, NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The present study was supported by the South-Eastern Norway Regional Health Authority [grant no. 2013073]. The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research, NIH/NIEHS [contract no. N01-ES-75558], NIH/NINDS [grant no. 1 UO1 NS 047537-01 and grant no. 2 UO1 NS 047537-06A1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert H, 2001, ACTA OBSTET GYN SCAN, V80, P505, DOI 10.1034/j.1600-0412.2001.080006505.x; Bjelland EK, 2013, HUM REPROD, V28, P3134, DOI 10.1093/humrep/det301; Bjelland EK, 2011, BJOG-INT J OBSTET GY, V118, P1646, DOI 10.1111/j.1471-0528.2011.03099.x; Bjelland EK, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.040; Bjorklund K, 2000, ACTA OBSTET GYN SCAN, V79, P979, DOI 10.3109/00016340009169246; Casper RF, 2017, FERTIL STERIL, V107, P533, DOI 10.1016/j.fertnstert.2017.01.003; d'Arcangues C, 2006, CONTRACEPTION, V73, P443, DOI 10.1016/j.contraception.2006.01.002; Fotoohi AK, 2010, J OBSTET GYNAECOL RE, V36, P1142, DOI 10.1111/j.1447-0756.2010.01291.x; Fraser IS, 2013, CONTRACEPTION, V87, P273, DOI 10.1016/j.contraception.2012.08.039; Furu K., 2008, Norsk Epidemiologi, V18, P129; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Hubacher D, 2006, HUM REPROD, V21, P1467, DOI 10.1093/humrep/del029; Kirkeby MJ, 2013, J OBSTET GYNAECOL RE, V39, P1037, DOI 10.1111/jog.12008; Kovacs CS, 2015, OSTEOPOROSIS INT, V26, P2223, DOI 10.1007/s00198-015-3149-3; Kristiansson P, 1999, AM J OBSTET GYNECOL, V180, P128, DOI 10.1016/S0002-9378(99)70162-6; Kumle Merethe, 2004, BMC Pregnancy Childbirth, V4, P11, DOI 10.1186/1471-2393-4-11; Lanza LL, 2013, OBSTET GYNECOL, V121, P593, DOI 10.1097/AOG.0b013e318283d1a1; Larsen EC, 1999, ACTA OBSTET GYN SCAN, V78, P105, DOI 10.1034/j.1600-0412.1999.780206.x; Lindh I, 2013, HUM REPROD, V28, P1953, DOI 10.1093/humrep/det101; Lopez LM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006033.pub5; Lopez LM, 2015, COCHRANE DB SYST REV, V3; Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029; Maximo MM, 2015, FERTIL STERIL, V104, P1182, DOI 10.1016/j.fertnstert.2015.07.1165; Mogren IM, 2009, OPEN EPIDEMIOL J, V2, P26; Nielsen LL, 2010, ACTA OBSTET GYN SCAN, V89, P1187, DOI 10.3109/00016349.2010.501853; Sverdrup B, 2004, ACTA OBSTET GYN SCAN, V83, P316, DOI 10.1111/j.0001-6349.2004.0089d.x; VanderWeele TJ, 2015, EXPLANATION CAUSAL I, P66; Vleeming A, 2008, EUR SPINE J, V17, P794, DOI 10.1007/s00586-008-0602-4; World Health Organization, PROG ONL CONTR US DU	29	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184071	10.1371/journal.pone.0184071	http://dx.doi.org/10.1371/journal.pone.0184071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892506	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000410243200009
J	Domingo, A; Jimenez, S; Abreu, M; Forselledo, R; Yates, O				Domingo, Andres; Jimenez, Sebastian; Abreu, Martin; Forselledo, Rodrigo; Yates, Oliver			Effectiveness of tori line use to reduce seabird bycatch in pelagic longline fishing	PLOS ONE			English	Article							DIVING BEHAVIOR; FISHERIES; ALBATROSSES; MITIGATION; TUNA; MORTALITY; PETRELS; DEPTHS; TRAWL	Industrial longline fisheries cause the death of large numbers of seabirds annually. Various mitigation measures have been proposed, including the use of tori lines. In this study the efficiency of a single tori line to reduce seabird bycatch was tested on pelagic longline vessels (25-37m length). Thirteen fishing trips were carried out in the area and season of the highest bycatch rates recorded in the southwest Atlantic (2009-2011). We deployed two treatments in random order: sets with a tori line and without a tori line (control treatment). The use of a tori line significantly reduced seabird bycatch rates. Forty three and seven birds were captured in the control (0.85 birds/1,000 hooks, n = 49 sets) and in the tori line treatment (0.13 birds/1,000 hooks, n = 51 sets), respectively. In 47% of the latter sets the tori line broke either because of entanglement with the longline gear or by tension. This diminished the tori line effectiveness; five of the seven captures during sets where a tori line was deployed were following ruptures. Nine additional trips were conducted with a tori line that was modified to reduce entanglements (2012-2016). Seven entanglements were recorded in 73 longline sets. The chance of a rupture on these trips was 4% (95% c. l. = 1-18%) of that during 2009-2011. This work shows that the use of a tori line reduces seabird bycatch in pelagic longline fisheries and is a practice suitable for medium size vessels (similar to 25-40m length). Because the study area has historically very high bycatch rates at global level, this tori line design is potentially useful to reduce seabird bycatch in many medium size pelagic longline vessel fishing in the southern hemisphere.	[Domingo, Andres; Jimenez, Sebastian; Forselledo, Rodrigo] Direcc Nacl Recursos Acuat, Lab Recursos Pelag, Montevideo, Uruguay; [Jimenez, Sebastian; Abreu, Martin] Ctr Invest & Conservac Marina CICMAR, Albatross Task Force, Proyecto Albatros & Petreles Uruguay, Canelones, Uruguay; [Yates, Oliver] RSPB, BirdLife Int Marine Programme, Sandy, Beds, England	BirdLife International; Royal Society for Protection of Birds	Domingo, A; Jimenez, S (corresponding author), Direcc Nacl Recursos Acuat, Lab Recursos Pelag, Montevideo, Uruguay.; Jimenez, S (corresponding author), Ctr Invest & Conservac Marina CICMAR, Albatross Task Force, Proyecto Albatros & Petreles Uruguay, Canelones, Uruguay.	adomingo@dinara.gub.uy; jimenezpsebastian@gmail.com	Fennell, Hannah/AAI-1408-2019	Jimenez, Sebastian/0000-0003-3945-4619	Royal Society for the Protection of Birds (RSPB); BirdLife International; Direccion Nacional de Recursos Acuaticos (DINARA); RSPB	Royal Society for the Protection of Birds (RSPB); BirdLife International; Direccion Nacional de Recursos Acuaticos (DINARA); RSPB	The Royal Society for the Protection of Birds (RSPB) and BirdLife International funded the Albatross Task Force-Uruguay of the Proyecto Albatros y Petreles-Uruguay (PAP-U) to conduct a large part of this work. Research trips in the RN Aldebaran were funded by Direccion Nacional de Recursos Acuaticos (DINARA). SJ was funded by the RSPB to write this paper. The publication fee for this article was provided by RSPB.	ACAP, 2016, REP SEAB BYC WORK GR; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boggs CH, 2001, SEABIRD BYCATCH TREN; Brothers N, 1999, BIOL CONSERV, V88, P85, DOI 10.1016/S0006-3207(98)00085-8; BROTHERS N, 1991, BIOL CONSERV, V55, P255, DOI 10.1016/0006-3207(91)90031-4; Brothers N.P., 1999, INCIDENTAL CATCH SEA; Bull LS, 2007, FISH FISH, V8, P31, DOI 10.1111/j.1467-2979.2007.00234.x; Domingo A, 2012, B MAR SCI, V88, P499, DOI 10.5343/bms.2011.1069; HUIN N, 1994, CONDOR, V96, P1111, DOI 10.2307/1369125; Jimenez S, 2015, REVISION PLANES ACCI, P11; Jimenez S, 2009, POLAR BIOL, V32, P187, DOI 10.1007/s00300-008-0519-8; Jimenez S, 2014, BIOL CONSERV, V171, P9, DOI 10.1016/j.biocon.2013.12.035; Jimenez S, 2012, AQUAT CONSERV, V22, P436, DOI 10.1002/aqc.2242; Jimenez S, 2010, AQUAT LIVING RESOUR, V23, P49, DOI 10.1051/alr/2010002; Lokkeborg S, 2011, MAR ECOL PROG SER, V435, P285, DOI 10.3354/meps09227; Melvin EF, 2014, FISH RES, V149, P5, DOI 10.1016/j.fishres.2013.07.012; Melvin EF, 2013, FISH RES, V147, P72, DOI 10.1016/j.fishres.2013.04.015; Melvin EF, 2004, CCAMLR SCI, V11, P189; Murray T.E., 1993, BIRD CONSERV INT, V3, P181, DOI DOI 10.1017/S0959270900000897; Neves T, 2008, MEDIDAS MITIGADORAS; Phillips RA, 2016, BIOL CONSERV, V201, P169, DOI 10.1016/j.biocon.2016.06.017; PRINCE PA, 1994, ANTARCT SCI, V6, P353, DOI 10.1017/S0954102094000532; Robertson G, 2013, AQUAT CONSERV, V23, P885, DOI 10.1002/aqc.2346; Rollinson DP, 2014, POLAR BIOL, V37, P1301, DOI 10.1007/s00300-014-1521-y; Ronconi RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015508; Sato N, 2014, AQUATIC CONSERVATION; Sato N, 2013, FISH RES, V140, P14, DOI 10.1016/j.fishres.2012.11.007; Sato N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037546; Stagi A, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P220; Yokota K, 2011, FISHERIES SCI, V77, P479, DOI 10.1007/s12562-011-0357-4	31	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184465	10.1371/journal.pone.0184465	http://dx.doi.org/10.1371/journal.pone.0184465			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886183	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100129
J	Duboz, P; Boetsch, G; Gueye, L; Macia, E				Duboz, Priscilla; Boetsch, Gilles; Gueye, Lamine; Macia, Enguerran			Self-rated health in Senegal: A comparison between urban and rural areas	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; GENDER-DIFFERENCES; LIFE SATISFACTION; OLDER-ADULTS; MORTALITY; INCOME; OUAGADOUGOU; SUPPORT; DAKAR; AGE	Introduction Although the relationship between mortality and self-rated health has been demonstrated in sub-Saharan Africa, information in this area is rudimentary. In Senegal, no study has been undertaken comparing self-rated health between urban and rural areas. The objective of this study is therefore to compare self-rated health and its main predictors in Dakar and in a rural isolated area, Tessekere municipality, taking into account socio-demographic and economic factors, social relations, as well as measures of physical and mental health. Material and methods This study was carried out in 2015 on a population sample of 1000 individuals living in Dakar and 500 individuals living in the municipality of Tessekere, constructed using the quota method. Self-rated health, health variables, psychosocial, sociodemographic and economic characteristics were collected during face-to-face interviews. Statistical analyses used were Chi-square tests and binary logistic regressions. Results Results show that self-rated health in Senegalese urban area (Dakar) is better than in rural area (Tessekere), but the determinants of self-rated health partly differ between these two environments. Age and gender play a fundamental role in self-rated health as much in Dakar as in Tessekere but diabetes and social support play a role in self-rated health only in urban environment, whereas economic well-being is associated to self-rated health only in rural area. Conclusion The analyses carried out in these two environments show that despite the existence of common determinants (age, gender, stress), the determinants for formulating an answer to the question of self-rated health differ. People's social and cultural environments thus play a fundamental role in the process of rating one's health and, in the short and long term, in the mortality rate.	[Duboz, Priscilla; Boetsch, Gilles; Gueye, Lamine; Macia, Enguerran] Univ Cheikh Anta Diop Dakar UCAD, Fac Med Pharm & Odontostomatol, CNRS, UGB,USTTB,CNRST,UMI ESS 3189, Dakar, Senegal; [Duboz, Priscilla; Boetsch, Gilles] Univ Cheikh Anta Diop Dakar UCAD, Fac Med Pharm & Odontostomatol, Tessekere Int Human Environm Observ, Labex DRIIHM,INEE,CNRS, Dakar, Senegal	University Cheikh Anta Diop Dakar; University Cheikh Anta Diop Dakar	Duboz, P (corresponding author), Univ Cheikh Anta Diop Dakar UCAD, Fac Med Pharm & Odontostomatol, CNRS, UGB,USTTB,CNRST,UMI ESS 3189, Dakar, Senegal.; Duboz, P (corresponding author), Univ Cheikh Anta Diop Dakar UCAD, Fac Med Pharm & Odontostomatol, Tessekere Int Human Environm Observ, Labex DRIIHM,INEE,CNRS, Dakar, Senegal.	priscilla.duboz@gmail.com			French National Center of Scientific Research (CNRS, PEPS ECOSAN, INEE)	French National Center of Scientific Research (CNRS, PEPS ECOSAN, INEE)	PD and EM are respectively project partner and project leader of this study and wrote the funding request. Their research was funded by the French National Center of Scientific Research (CNRS, PEPS ECOSAN, INEE): http//www.cnrs.fr/inee/outils/PEPS.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addai I, 2014, APPL RES QUAL LIFE, V9, P233, DOI 10.1007/s11482-013-9220-3; Agence Nationale de la Statistique et de la De A mographie, 2011, PAUVR COND VIE NAG; Ardington C, 2014, DEV SO AFR, V31, P127, DOI 10.1080/0376835X.2013.853611; Arokiasamy P, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0402-8; Australian Institute of Health and Welfare, 2007, RURAL HLTH SERIES, V8; Barger SD, 2006, J HUM HYPERTENS, V20, P117, DOI 10.1038/sj.jhh.1001950; Baron-Epel O, 2005, SOC SCI MED, V61, P1256, DOI 10.1016/j.socscimed.2005.01.022; Canadian Institute for Health I, 2006, HLTH AR RUR CAN ASS; Cantrelle P, 1982, JOURNEES MED DAKAR; Chandola T, 2000, ETHNIC HEALTH, V5, P151, DOI 10.1080/713667451; Chin B, 2010, DEMOGR RES, V23, P997, DOI 10.4054/DemRes.2010.23.35; Chola L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071085; Cohen E., THESIS, DOI [10.16/i.diabet.2012.02.011, DOI 10.16/i.diabet.2012.02.011]; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Coume A M, 2014, CAHIERS ANNE GERONTO, V6, P90; Cramm JM, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-51; Crimmins EM, 2011, EUR J PUBLIC HEALTH, V21, P81, DOI 10.1093/eurpub/ckq022; Darviri C, 2012, INT J ENV RES PUB HE, V9, P943, DOI 10.3390/ijerph9030943; Debpuur C, 2010, GLOBAL HEALTH ACTION, V3, P54, DOI 10.3402/gha.v3i0.2151; Desquelles AF, 2009, SOC SCI MED, V68, P1124; Diener E, 2011, APPL PSYCHOL-HLTH WE, V3, P1, DOI 10.1111/j.1758-0854.2010.01045.x; Diouf AB, 2014, J NEUROL SCI, V333, pe663; Duboz P, 2012, DIABETES METAB, V38, P332, DOI 10.1016/j.diabet.2012.02.011; Eberhardt MS, 2001, URBAN RURAL HLTH CHA; Ellaway A, 2000, AM J PUBLIC HEALTH, V90, P988; Frankenberg E, 2004, J HEALTH SOC BEHAV, V45, P441, DOI 10.1177/002214650404500406; Gilbert L, 2003, HEALTH PLACE, V9, P193, DOI 10.1016/S1353-8292(02)00039-4; Hosseinpoor AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034799; IDLER EL, 1995, J GERONTOL B-PSYCHOL, V50, pS344, DOI 10.1093/geronb/50B.6.S344; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kuate-Defo B, 2005, CAH QUE DEMOGR, V34, P1, DOI 10.7202/012515ar; Kumar S, 2012, SOC SCI MED, V74, P696, DOI 10.1016/j.socscimed.2011.11.017; Lankila T, 2012, INT J PUBLIC HEALTH, V57, P525, DOI 10.1007/s00038-011-0286-0; Lee JA, 2015, INT J ENV RES PUB HE, V12, P14329, DOI 10.3390/ijerph121114329; Macia E, DIMENSIONS QUALITE Q; Macia E, 2015, J CROSS-CULT GERONTO, V30, P377, DOI 10.1007/s10823-015-9275-8; Macia E, 2012, EUR J AGEING, V9, P243, DOI 10.1007/s10433-012-0227-7; Tomas JM, 2012, ARCH GERONTOL GERIAT, V55, P605, DOI 10.1016/j.archger.2012.06.010; Mauss M., 1924, SOCIOLOGIE ANTHR, P280; Nyamwaya D, 2003, HEALTH PROMOT INT, V18, P85, DOI 10.1093/heapro/18.2.85; Obare F, 2007, AFR POPUL STUD, V22, P57; Oksuzyan A, 2008, AGING CLIN EXP RES, V20, P91; Onadja Y, 2013, ARCH GERONTOL GERIAT, V57, P311, DOI 10.1016/j.archger.2013.06.007; Onadja Y, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-15; Pampalon R, 2006, HEALTH PLACE, V12, P421, DOI 10.1016/j.healthplace.2005.04.002; Patrick D. L., 1993, HLTH STATUS HLTH POL; Poortinga W, 2006, SOC SCI MED, V63, P255, DOI 10.1016/j.socscimed.2005.11.039; Rahman MO, 2003, GERONTOLOGIST, V43, P856, DOI 10.1093/geront/43.6.856; Ramlagan S, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-100; Razafindrakoto M, 2007, AFRIQUE CONT, V4, P191, DOI [10.3917/afco.220.0191, DOI 10.3917/AFCO.220.0191]; RINGEN S, 1995, ACTA SOCIOL, V38, P3, DOI 10.1177/000169939503800102; Salmon P, 2004, BRIT J GEN PRACT, V54, P171; Senegal's national statistical office, 2013, AGR BREED REP; Spiers N, 2003, GERONTOLOGIST, V43, P406, DOI 10.1093/geront/43.3.406; Tabutin D, 2004, POPULATION, V59, P521, DOI 10.2307/3654994; Udofia EA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-244; United Nations, 2015, HUM DEV REP 2015; World Health Organization, 2006, CONST WORLD HLTH ORG, V4	59	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184416	10.1371/journal.pone.0184416	http://dx.doi.org/10.1371/journal.pone.0184416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886107	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100113
J	Fletcher, TE; Gulzhan, A; Ahmeti, S; Al-Abri, SS; Asik, Z; Atilla, A; Beeching, NJ; Bilek, H; Bozkurt, I; Christova, I; Duygu, F; Esen, S; Khanna, A; Kader, C; Mardani, M; Mahmood, F; Mamuchishvili, N; Pshenichnaya, N; Sunbul, M; Yalcin, TY; Leblebicioglu, H				Fletcher, Tom E.; Gulzhan, Abuova; Ahmeti, Salih; Al-Abri, Seif S.; Asik, Zahide; Atilla, Aynur; Beeching, Nick J.; Bilek, Heval; Bozkurt, Ilkay; Christova, Iva; Duygu, Fazilet; Esen, Saban; Khanna, Arjun; Kader, Cigdem; Mardani, Masoud; Mahmood, Faisal; Mamuchishvili, Nana; Pshenichnaya, Natalia; Sunbul, Mustafa; Yalcin, Tugba Y.; Leblebicioglu, Hakan			Infection prevention and control practice for Crimean-Congo hemorrhagic fever - A multicenter cross-sectional survey in Eurasia	PLOS ONE			English	Article							HEALTH-CARE WORKERS; NOSOCOMIAL OUTBREAK; VIRUS	Background Crimean Congo Hemorrhagic Fever (CCHF) is a life threatening acute viral infection that presents significant risk of nosocomial transmission to healthcare workers. Aim Evaluation of CCHF infection prevention and control (IP&C) practices in healthcare facilities that routinely manage CCHF cases in Eurasia. Methods A cross-sectional CCHF IP&C survey was designed and distributed to CCHF centers in 10 endemic Eurasian countries in 2016. Results Twenty-three responses were received from centers in Turkey, Pakistan, Russia, Georgia, Kosovo, Bulgaria, Oman, Iran, India and Kazakhstan. All units had dedicated isolation rooms for CCHF, with cohorting of confirmed cases in 15/23 centers and cohorting of suspect and confirmed cases in 9/23 centers. There was adequate personal protective equipment (PPE) in 22/23 facilities, with 21/23 facilities reporting routine use of PPE for CCHF patients. Adequate staffing levels to provide care reported in 14/23 locations. All centers reported having a high risk CCHFV nosocomial exposure in last five years, with 5 centers reporting more than 5 exposures. Education was provided annually in most centers (13/23), with additional training requested in PPE use (11/23), PPE donning/doffing (12/23), environmental disinfection (12/23) and waste management (14/23). Conclusions Staff and patient safety must be improved and healthcare associated CCHF exposure and transmission eliminated. Improvements are recommended in isolation capacity in healthcare facilities, use of PPE and maintenance of adequate staffing levels. We recommend further audit of IP& C practice at individual units in endemic areas, as part of national quality assurance programs.	[Fletcher, Tom E.; Beeching, Nick J.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Fletcher, Tom E.; Bozkurt, Ilkay; Esen, Saban; Sunbul, Mustafa; Leblebicioglu, Hakan] Ondokuz Mayis Univ, Sch Med, Dept Clin Microbiol & Infect Dis, Samsun, Turkey; [Gulzhan, Abuova] South Kazakhstan State Pharmaceut Acad, Shymkent, Kazakhstan; [Ahmeti, Salih] Univ Prishtina Hasan Prishtina, Med Fac, Infect Dis Clin, Prishtina, Kosovo; [Al-Abri, Seif S.] Royal Hosp, Infect Dis, Muscat, Oman; [Asik, Zahide] Tokat State Hosp, Infect Dis & Clin Microbiol, Tokat, Turkey; [Atilla, Aynur] Samsun Res & Training Hosp, Dept Infect Dis & Clin Microbiol, Samsun, Turkey; [Bilek, Heval] Siirt State Hosp, Dept Infect Dis, Siirt, Turkey; [Christova, Iva] Natl Ctr Infect & Parasit Dis, Dept Microbiol, Sofia, Bulgaria; [Duygu, Fazilet] AY Ankara Oncol Res & Training Hosp, Dept Infect Dis, Ankara, Turkey; [Khanna, Arjun] Metro Multispecial Hosp, Metro Ctr Resp Dis, Noida, Uttar Pradesh, India; [Kader, Cigdem] Bozok Univ, Dept Infect Dis & Clin Microbiol, Yozgat, Turkey; [Mardani, Masoud] Shahid Beheshti Univ Med Sci, Infect Dis Dept, Fac Med, Tehran, Iran; [Mahmood, Faisal] Aga Khan Univ Hosp, Dept Med, Infect Dis, Karachi, Pakistan; [Mamuchishvili, Nana] Natl Ctr Dis Control & Publ Hlth, Tbilisi, Georgia; [Pshenichnaya, Natalia] Rostov State Med Univ, Dept Infect Dis, Rostov Na Donu, Russia; [Yalcin, Tugba Y.] Sivas Numune Hosp, Dept Infect Dis, Sivas, Turkey	Liverpool School of Tropical Medicine; Ondokuz Mayis University; M. Auezov South Kazakhstan State University; The Royal Hospital, Sultanate of Oman; Tokat State Hospital; Samsun Training & Research Hospital; Siirt State Hospital; Ministry of Health Bulgaria; National Centre of Infectious & Parasitic Diseases; Bozok University; Shahid Beheshti University Medical Sciences; Aga Khan University; National Center for Disease Control & Public Health - Georgia; Rostov State Medical University; Sivas Numune Hospital	Leblebicioglu, H (corresponding author), Ondokuz Mayis Univ, Sch Med, Dept Clin Microbiol & Infect Dis, Samsun, Turkey.	hakanomu@yahoo.com	Bilek, Heval Can/AAS-4133-2020; MARDANI, MASOUD/AAV-9931-2020; Pshenichcnaya, Natalia Y/Q-2352-2016; Leblebicioglu, Hakan/A-3960-2016; Yalçın, Tuğba Yanık/AAO-7924-2021; yalcın, tugba yanık/AAA-4708-2022	Bilek, Heval Can/0000-0002-4330-3293; Pshenichcnaya, Natalia Y/0000-0003-2570-711X; Leblebicioglu, Hakan/0000-0002-6033-8543; yalcın, tugba yanık/0000-0001-5996-8639; atilla, aynur/0000-0001-8027-1991; Mardani, Masoud/0000-0001-6082-072X; Fletcher, Tom/0000-0002-3712-415X; Kilic, Suleyman sirri/0000-0003-1255-9939	Wellcome Trust [104480/Z/14/Z]; UK Ministry of Defence; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections; University of Liverpool, Liverpool School of Tropical Medicine and Public Health England (PHE)	Wellcome Trust(Wellcome TrustEuropean Commission); UK Ministry of Defence; National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections; University of Liverpool, Liverpool School of Tropical Medicine and Public Health England (PHE)	There was no specific funding for this study. TF is funded by Wellcome Trust (104480/Z/14/Z) and the UK Ministry of Defence. NJB is partially supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections, a partnership between the University of Liverpool, Liverpool School of Tropical Medicine and Public Health England (PHE). The views expressed are those of the author(s) and not necessarily those of their respective institutions or Ministries of Health.; There was no specific funding for this study. TF is funded by Wellcome Trust (104480/Z/14/Z) and the UK Ministry of Defence. NJB is partially supported by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emerging and Zoonotic Infections, a partnership between the University of Liverpool, Liverpool School of Tropical Medicine and Public Health England (PHE). The views expressed are those of the author(s) and not necessarily those of their respective institutions or Ministries of Health.	Advisory Committee on Dangerous Pathogens, VIR HAEM FEV ACDP AL; Akinci E, 2013, VECTOR-BORNE ZOONOT, V13, P429, DOI 10.1089/vbz.2012.1061; Beeching NJ, 2010, INT J ANTIMICROB AG, V36, pS26, DOI 10.1016/j.ijantimicag.2010.06.017; BURNEY MI, 1980, AM J TROP MED HYG, V29, P941, DOI 10.4269/ajtmh.1980.29.941; Ergonul O, 2007, INT J INFECT DIS, V11, P48, DOI 10.1016/j.ijid.2005.10.009; European Centre for Disease Prevention and Control, 2016, CRIM CONG HAEM FEV S; Gozel MG, 2013, INT J INFECT DIS, V17, pE1046, DOI 10.1016/j.ijid.2013.05.005; Leblebicioglu H, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.11.024; Leblebicioglu H, 2016, ANTIVIR RES, V126, P21, DOI 10.1016/j.antiviral.2015.12.003; Leblebicioglu H, 2015, T ROY SOC TROP MED H, V109, P676, DOI 10.1093/trstmh/trv083; Leblebicioglu H, 2012, VECTOR-BORNE ZOONOT, V12, P805, DOI 10.1089/vbz.2011.0896; Mardani M, 2007, AM J TROP MED HYG, V76, P443, DOI 10.4269/ajtmh.2007.76.443; Mardani M, 2009, AM J TROP MED HYG, V81, P675, DOI 10.4269/ajtmh.2009.09-0051; Nabeth P, 2004, EMERG INFECT DIS, V10, P2143, DOI 10.3201/eid1012.040535; Naderi HR, 2011, EPIDEMIOL INFECT, V139, P862, DOI 10.1017/S0950268810002001; Osterholm MT, 2015, MBIO, V6, DOI 10.1128/mBio.00137-15; PARLAK E, 2015, J MICROBIOL INFECT D, V5, P5, DOI DOI 10.5799/ALUNJS.02.2015.01.0166; Pshenichnaya NY, 2015, INT J INFECT DIS, V33, P120, DOI 10.1016/j.ijid.2014.12.047; Rahnavardi M, 2008, J HOSP INFECT, V69, P77, DOI 10.1016/j.jhin.2008.02.007; Rodriguez LL, 1997, AM J TROP MED HYG, V57, P512, DOI 10.4269/ajtmh.1997.57.512; Shears P, 2015, J HOSP INFECT, V90, P1, DOI 10.1016/j.jhin.2015.01.002; Sunbul M, 2016, J INFECTION, V72, P253, DOI 10.1016/j.jinf.2015.10.005; World Health Organization, 2014, INT INF PREV CONTR G	23	18	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182315	10.1371/journal.pone.0182315	http://dx.doi.org/10.1371/journal.pone.0182315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886039	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100007
J	Fujita, K; Nishimoto, S; Fujiwara, T; Sotsuka, Y; Tonooka, M; Kawai, K; Kakibuchi, M				Fujita, Kazutoshi; Nishimoto, Soh; Fujiwara, Toshihiro; Sotsuka, Yohei; Tonooka, Maki; Kawai, Kenichiro; Kakibuchi, Masao			A new rabbit model of impaired wound healing in an X-ray-irradiated field	PLOS ONE			English	Article							PLATELET-RICH PLASMA; BONE-MARROW ASPIRATE; INJURY MODEL; RADIATION; SKIN; THERAPY; REPAIR	Radiation is an important therapy for cancer with many benefits; however, its side effects, such as impaired wound healing, are a major problem. While many attempts have been made to overcome this particular disadvantage, there are few effective treatments for impaired wound healing in an X-ray-irradiated field. One reason for this deficiency is the lack of experimental models, especially animal models. We have previously reported a mouse model of impaired wound healing in which the irradiation area was restricted to the hindlimbs. In this mouse model, due to the size of the animal, a diameter of five millimeters was considered the largest wound size suitable for the model. In addition, the transplanted cells had to be harvested from other inbred animals. To investigate larger wounds and the impact of autologous specimen delivery, a rabbit model was developed. Rabbits were kept in a special apparatus to shield the body and hindlimbs while the irradiation field was exposed to radiation. Six weeks after irradiation, a 2 x 2 cm, full-thickness skin defect was made inside the irradiation field. Then, the wound area was observed over time. The wound area after irradiation was larger than that without irradiation at all time points. Both angiogenesis and collagen formation were reduced. For further study, as an example of using this model, the effect of autologous platelet-rich plasma (PRP) was observed. Autologous PRP from peripheral blood (pb-PRP) and bone marrow aspirate (bm-PRP) was processed and injected into the wounds in the irradiated field. Two weeks later, the wounds treated with bm-PRP were significantly smaller than those treated with phosphate buffer vehicle controls. In contrast, the wounds treated with pb-PRP were not significantly different from the controls. This rabbit model is useful for investigating the mechanism of impaired wound healing in an X-ray-irradiated field.	[Fujita, Kazutoshi; Nishimoto, Soh; Fujiwara, Toshihiro; Sotsuka, Yohei; Tonooka, Maki; Kawai, Kenichiro; Kakibuchi, Masao] Hyogo Coll Med, Dept Plast Surg, Nishinomiya, Hyogo, Japan	Hyogo College of Medicine	Nishimoto, S (corresponding author), Hyogo Coll Med, Dept Plast Surg, Nishinomiya, Hyogo, Japan.	nishimot@hyo-med.ac.jp	Fujita, Kazutoshi/AAQ-4428-2020	Fujita, Kazutoshi/0000-0002-6774-7497; Nishimoto, Soh/0000-0002-0165-1273				Bey E, 2010, WOUND REPAIR REGEN, V18, P50, DOI 10.1111/j.1524-475X.2009.00562.x; BUJKO K, 1993, SURG GYNECOL OBSTET, V176, P124; Fernberg JO, 2001, MED ONCOL, V18, P231, DOI 10.1385/mo:18:3:231; Forcheron F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031694; Hilmi AM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/795458; Kim JW, 2013, J RADIAT RES, V54, P823, DOI 10.1093/jrr/rrt016; Koenig TR, 2001, AM J ROENTGENOL, V177, P3, DOI 10.2214/ajr.177.1.1770003; Kronowitz SJ, 2009, PLAST RECONSTR SURG, V124, P395, DOI 10.1097/PRS.0b013e3181aee987; Kunisada T, 2002, EUR J SURG ONCOL, V28, P75, DOI 10.1053/ejso.2001.1213; Lataillade JJ, 2007, REGEN MED, V2, P785, DOI 10.2217/17460751.2.5.785; Mapara Manjeet, 2012, Dent Res J (Isfahan), V9, P111, DOI 10.4103/1735-3327.92960; Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4; Meng J, 2003, B AM MUS NAT HIST, P1; MILLER SH, 1990, CLIN PLAST SURG, V17, P503; Nishimoto S, 2007, WOUND REPAIR REGEN, V15, P156, DOI 10.1111/j.1524-475X.2006.00196.x; Nishimoto S, 2013, J PLAST SURG HAND SU, V47, P169, DOI 10.3109/2000656X.2012.752739; Nishimoto S, 2012, INDIAN J PLAST SURG, V45, P109, DOI 10.4103/0970-0358.96599; Rifkin LH, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-68; Rodgers KE, 2016, INT J RADIAT BIOL, V92, P434, DOI 10.1080/09553002.2016.1186302; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Tsumano T, 2013, J PLAST SURG HAND SU, V47, P83, DOI 10.3109/2000656X.2012.731000; WANG Q, 1994, BRIT J DERMATOL, V130, P551, DOI 10.1111/j.1365-2133.1994.tb13098.x; Zheng K, 2015, MOL MED REP, V12, P7065, DOI 10.3892/mmr.2015.4270; Zisch AH, 2004, CURR OPIN BIOTECH, V15, P424, DOI 10.1016/j.copbio.2004.08.005	24	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184534	10.1371/journal.pone.0184534	http://dx.doi.org/10.1371/journal.pone.0184534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886194	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100151
J	Shah, DD; Singh, SM; Dzieciatkowska, M; Mallela, KMG				Shah, Dinen D.; Singh, Surinder M.; Dzieciatkowska, Monika; Mallela, Krishna M. G.			Biophysical analysis of the effect of chemical modification by 4-oxononenal on the structure, stability, and function of binding immunoglobulin protein (BiP)	PLOS ONE			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; GLUCOSE-REGULATED PROTEINS; FREE-ENERGY CHANGES; HEAVY-CHAIN; IN-VITRO; LINEAR EXTRAPOLATION; MOLECULAR CHAPERONES; CITRATE SYNTHASE; ATPASE ACTIVITY; M-VALUES	Binding immunoglobulin protein (BiP) is a molecular chaperone important for the folding of numerous proteins, which include millions of immunoglobulins in human body. It also plays a key role in the unfolded protein response (UPR) in the endoplasmic reticulum. Free radical generation is a common phenomenon that occurs in cells under healthy as well as under stress conditions such as ageing, inflammation, alcohol consumption, and smoking. These free radicals attack the cell membranes and generate highly reactive lipid peroxidation products such as 4-oxononenal (4-ONE). BiP is a key protein that is modified by 4-ONE. In this study, we probed how such chemical modification affects the biophysical properties of BiP. Upon modification, BiP shows significant tertiary structural changes with no changes in its secondary structure. The protein loses its thermodynamic stability, particularly, that of the nucleotide binding domain (NBD) where ATP binds. In terms of function, the modified BiP completely loses its ATPase activity with decreased ATP binding affinity. However, modified BiP retains its immunoglobulin binding function and its chaperone activity of suppressing non-specific protein aggregation. These results indicate that 4-ONE modification can significantly affect the structure-function of key proteins such as BiP involved in cellular pathways, and provide a molecular basis for how chemical modifications can result in the failure of quality control mechanisms inside the cell.	[Shah, Dinen D.; Singh, Surinder M.; Mallela, Krishna M. G.] Univ Colorado Anschutz Med Campus, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA; [Dzieciatkowska, Monika] Univ Colorado Anschutz Med Campus, Biol Mass Spectrometry Facil, Sch Med, Aurora, CO USA; [Mallela, Krishna M. G.] Univ Colorado Anschutz Med Campus, Program Struct Biol & Biochem, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Mallela, KMG (corresponding author), Univ Colorado Anschutz Med Campus, Dept Pharmaceut Sci, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO 80045 USA.; Mallela, KMG (corresponding author), Univ Colorado Anschutz Med Campus, Program Struct Biol & Biochem, Aurora, CO 80045 USA.	krishna.mallela@ucdenver.edu		Mallela, Krishna/0000-0001-8308-5318				Arakawa A, 2011, PROTEIN SCI, V20, P1367, DOI 10.1002/pro.663; Arthur KK, 2015, J PHARM SCI-US, V104, P1548, DOI 10.1002/jps.24313; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P1586, DOI 10.1021/bi00220a020; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cai J., 2008, ADV COMPUT MATH, P1; Carbone DL, 2005, J PHARMACOL EXP THER, V315, P8, DOI 10.1124/jpet.105.088088; Daugherty DL, 1998, J BIOL CHEM, V273, P33961, DOI 10.1074/jbc.273.51.33961; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005; Feng JA, 2011, ANAL BIOCHEM, V409, P144, DOI 10.1016/j.ab.2010.10.025; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Fritz KS, 2013, FREE RADICAL BIO MED, V59, P85, DOI 10.1016/j.freeradbiomed.2012.06.025; Fritz KS, 2011, CHEM RES TOXICOL, V24, P1411, DOI 10.1021/tx200169n; Galligan JJ, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/207594; Galligan JJ, 2014, FREE RADICAL BIO MED, V73, P411, DOI 10.1016/j.freeradbiomed.2014.06.002; Galligan JJ, 2012, CHEM RES TOXICOL, V25, P1012, DOI 10.1021/tx300002q; GAUT JR, 1993, J BIOL CHEM, V268, P7248; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Gersting SW, 2008, AM J HUM GENET, V83, P5, DOI 10.1016/j.ajhg.2008.05.013; Gething MJ, 1995, COLD SPRING HARB SYM, V60, P417, DOI 10.1101/SQB.1995.060.01.046; Gorbatyuk MS., 2013, J GENET SYNDR GENE T, V4; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Halliwell B, 1988, Agents Actions Suppl, V26, P223; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; HENDERSHOT L, 1987, IMMUNOL TODAY, V8, P111, DOI 10.1016/0167-5699(87)90861-9; Katanasaka Y, 2010, INT J CANCER, V127, P2685, DOI 10.1002/ijc.25276; KNARR G, 1995, J BIOL CHEM, V270, P27589, DOI 10.1074/jbc.270.46.27589; KNITTLER MR, 1992, EMBO J, V11, P1573, DOI 10.1002/j.1460-2075.1992.tb05202.x; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lamb HK, 2006, J BIOL CHEM, V281, P8796, DOI 10.1074/jbc.M503964200; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; Li ZW, 2012, BBA-REV CANCER, V1826, P13, DOI 10.1016/j.bbcan.2012.02.001; Lin D, 2008, ADV BIOACTIVATION RE, P1; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mayer M, 2003, J MOL BIOL, V330, P137, DOI 10.1016/S0022-2836(03)00556-4; MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020; Naidoo N, 2009, AGEING RES REV, V8, P150, DOI 10.1016/j.arr.2009.03.001; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Pace C N, 1986, Methods Enzymol, V131, P266; Park KW, 2017, SCI REP-UK, V7, DOI 10.1038/srep44723; Petersen DR, 2004, FREE RADICAL BIO MED, V37, P937, DOI 10.1016/j.freeradbiomed.2004.06.012; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Pham-Huy Lien Ai, 2008, Int J Biomed Sci, V4, P89; Roede JR, 2008, CHEM RES TOXICOL, V21, P2289, DOI 10.1021/tx800244u; Rosenes Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044927; SANTORO MM, 1992, BIOCHEMISTRY-US, V31, P4901, DOI 10.1021/bi00135a022; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Shao F, 2000, J BIOL CHEM, V275, P13349, DOI 10.1074/jbc.275.18.13349; Smathers RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038459; Smathers RL, 2011, CHEM-BIOL INTERACT, V192, P107, DOI 10.1016/j.cbi.2011.02.021; Soulages JL, 1998, BIOPHYS J, V75, P484, DOI 10.1016/S0006-3495(98)77537-X; Stevens FJ, 1999, SEMIN CELL DEV BIOL, V10, P443, DOI 10.1006/scdb.1999.0315; Stronge VS, 2001, J BIOL CHEM, V276, P39779, DOI 10.1074/jbc.M107091200; TANFORD C, 1962, J AM CHEM SOC, V84, P4240, DOI 10.1021/ja00881a009; TOLEDO H, 1993, P NATL ACAD SCI USA, V90, P2505, DOI 10.1073/pnas.90.6.2505; Tran TM, 2004, J IMMUNOL, V172, P5110, DOI 10.4049/jimmunol.172.8.5110; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; WEI JY, 1995, J BIOL CHEM, V270, P26677, DOI 10.1074/jbc.270.44.26677; Wen J, 2012, J PHARM SCI-US, V101, P955, DOI 10.1002/jps.22820; Xu GZ, 1999, CHEM RES TOXICOL, V12, P862, DOI 10.1021/tx9900573; Yang J, 2015, STRUCTURE, V23, P2191, DOI 10.1016/j.str.2015.10.012; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec	72	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183975	10.1371/journal.pone.0183975	http://dx.doi.org/10.1371/journal.pone.0183975			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886061	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100050
J	Walve, R; Salmela, L; Makinen, V				Walve, Riku; Salmela, Leena; Makinen, Veli			Variant genotyping with gap filling	PLOS ONE			English	Article								Although recent developments in DNA sequencing have allowed for great leaps in both the quality and quantity of genome assembly projects, de novo assemblies still lack the efficiency and accuracy required for studying genetic variation of individuals. Thus, efficient and accurate methods for calling and genotyping genetic variants are fundamental to studying the genomes of individuals. We study the problem of genotyping insertion variants. We assume that the location of the insertion is given, and the task is to find the insertion sequence. Insertions are the hardest structural variant to genotype, because the insertion sequence must be assembled from the reads, whereas genotyping other structural variants only requires transformations of the reference genome. The current methods for constructing insertion variants are mostly linked to variation calling methods and are only able to construct small insertions. A sub-problem in genome assembly, the gap filling problem, provides techniques that are readily applicable to insertion genotyping. Gap filling takes the context and length of a missing sequence in a genome assembly and attempts to assemble the intervening sequence. In this paper we show how tools and methods for gap filling can be used to assemble insertion variants by modeling the problem of insertion genotyping as filling gaps in the reference genome. We further give a general read filtering scheme to make the method scalable to large data sets. Our results show that gap filling methods are competitive against insertion genotyping tools. We further show that read filtering improves performance of insertion genotyping especially for long insertions. Our experiments show that on long insertions the new proposed method is the most accurate one, whereas on short insertions it has comparable performance as compared against existing tools.	[Walve, Riku; Salmela, Leena; Makinen, Veli] Univ Helsinki, Helsinki Inst Informat Technol, Dept Comp Sci, Helsinki, Finland	University of Helsinki	Salmela, L (corresponding author), Univ Helsinki, Helsinki Inst Informat Technol, Dept Comp Sci, Helsinki, Finland.	leena.salmela@cs.helsinki.fi		Makinen, Veli/0000-0003-4454-1493; Salmela, Leena/0000-0002-0756-543X; Walve, Riku Mikael/0000-0003-0397-003X	Academy of Finland [284598]	Academy of Finland(Academy of Finland)	This work was funded by the Academy of Finland (http://www.aka.fi/en) [grant 284598 (Center of Excellence in Cancer Genetics Research) to VM]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boetzer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r56; Bradnam KR, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-10; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Huang W, 2011, BIOINFORMATICS; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Nielsen R, 2011, NAT REV GENET, V12, P443, DOI 10.1038/nrg2986; Paulino D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0663-4; Rizk G, 2014, BIOINFORMATICS; Salmela L, 2016, LNBI, V9838; Salmela L, 2016, J COMPUT BIOL, V23, P347, DOI 10.1089/cmb.2015.0197; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Vergara IA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-255; Ye K, 2009, BIOINFORMATICS	15	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184608	10.1371/journal.pone.0184608	http://dx.doi.org/10.1371/journal.pone.0184608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886164	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100166
J	Huang, JYX; Wang, RW; Gao, YT; Yuan, JM				Huang, Joyce Yongxu; Wang, Renwei; Gao, Yu-Tang; Yuan, Jian-Min			ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study	PLOS ONE			English	Article							HUMAN GASTRIC EPITHELIUM; GENOME-WIDE ASSOCIATION; HELICOBACTER-PYLORI; GROUP ANTIGENS; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; EXPRESSION; BLADDER; LESIONS; TAIWAN	ABO blood type is an inherited characteristic. The associations between ABO blood type and risk of all cancer and specific cancers were examined in a prospective cohort study of 18,244 Chinese men enrolled in 1986. During the 25 years of follow-up, 3,973 men developed cancer including 964 lung cancers, 624 colorectal cancers, 560 gastric cancers, 353 liver cancers, and 172 urinary bladder cancers. Hazard ratios (HR) for all cancer and specific cancers by ABO blood type were calculated using Cox proportional hazards models. Compared with blood type A, blood type B was associated with statistically significant reduced risk of all cancers (HR, 0.91, 95% CI:0.84, 0.99). Both blood types B and AB were associated with significantly lower risk of gastrointestinal cancer and colorectal cancer, respectively. Blood type B was also associated with significantly lower risk of stomach cancer and bladder cancer, while blood type AB was associated with significantly increased risk of liver cancer. By histological type, blood types B and AB were associated with lower risk of epidermoid carcinoma and adenocarcinoma, but were not associated with risk of sarcoma, lymphoma, leukemia or other cell types of cancer. The findings of this study support a role of genetic traits related to ABO blood type in the development of cancers in the gastrointestinal and urinary tracts.	[Huang, Joyce Yongxu; Wang, Renwei; Yuan, Jian-Min] Univ Pittsburgh, Canc Inst, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA; [Huang, Joyce Yongxu; Yuan, Jian-Min] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Gao, Yu-Tang] Shanghai Jiao Tong Univ, Shanghai Canc Inst, Dept Epidemiol, Shanghai, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Shanghai Jiao Tong University	Yuan, JM (corresponding author), Univ Pittsburgh, Canc Inst, Div Canc Control & Populat Sci, Pittsburgh, PA 15260 USA.; Yuan, JM (corresponding author), Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA.	yuanj@upmc.edu	Gao, Y./GWZ-3665-2022; gao, yi/HCI-8298-2022; Gao, Yu/HGE-1937-2022	Yuan, Jian-Min/0000-0002-4620-3108	United States National Institutes of Health [R01CA144034, R01 CA043092, UM1 CA182876]	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the United States National Institutes of Health (R01CA144034, R01 CA043092, and UM1 CA182876) to J.-M.Y. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; AIRD I, 1954, Br Med J, V2, P315; Alkout AM, 1997, GASTROENTEROLOGY, V112, P1179, DOI 10.1016/S0016-5085(97)70129-X; Alkout AM, 2000, J INFECT DIS, V181, P1364, DOI 10.1086/315375; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Berg JW, 1996, CANC EPIDEMIOLOGY PR, P28; BOREN T, 1993, SCIENCE, V262, P1892, DOI 10.1126/science.8018146; Edgren G, 2010, AM J EPIDEMIOL, V172, P1280, DOI 10.1093/aje/kwq299; FALK P, 1993, P NATL ACAD SCI USA, V90, P2035, DOI 10.1073/pnas.90.5.2035; Garratty G, 2004, TRANSFUSION, V44, P703, DOI 10.1111/j.1537-2995.2004.03338.x; Hakomori S, 1999, BBA-GEN SUBJECTS, V1473, P247, DOI 10.1016/S0304-4165(99)00183-X; Harmening Denise M., 1994, P86; Hsiao LT, 2015, ASIA-PAC J CLIN ONCO, V11, pE31, DOI 10.1111/ajco.12253; Iwamoto S, 1999, GLYCOCONJUGATE J, V16, P659, DOI 10.1023/A:1007085202379; LABARRIERE N, 1994, CANCER RES, V54, P6275; MELDGAARD P, 1995, INT J CANCER, V63, P341, DOI 10.1002/ijc.2910630306; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; NEWMAN E, 1961, BRIT MED J, V1, P92, DOI 10.1136/bmj.1.5219.92; Nieters A, 2005, CANCER, V103, P740, DOI 10.1002/cncr.20842; OKADA Y, 1987, CANCER-AM CANCER SOC, V60, P345, DOI 10.1002/1097-0142(19870801)60:3<345::AID-CNCR2820600311>3.0.CO;2-T; OKADA Y, 1987, J NATL CANCER I, V78, P19, DOI 10.1093/jnci/78.1.19; Orlow I, 1998, INT J CANCER, V75, P819, DOI 10.1002/(SICI)1097-0215(19980316)75:6<819::AID-IJC1>3.0.CO;2-Y; Reid ME, 2004, SEMIN HEMATOL, V41, P93, DOI 10.1053/j.seminhematol.2004.01.001; ROSS RK, 1992, LANCET, V339, P943, DOI 10.1016/0140-6736(92)91528-G; Su M, 2001, WORLD J GASTROENTERO, V7, P657; Sun WJ, 2015, CANCER EPIDEMIOL, V39, P150, DOI 10.1016/j.canep.2014.12.006; VOGEL F, 1970, AM J HUM GENET, V22, P464; Whitlock SA, 2010, IMMUNOHEMATOLOGY MED, P87; Wolpin BM, 2009, J NATL CANCER I, V101, P424, DOI 10.1093/jnci/djp020; YAMADA T, 1991, CANCER, V67, P1661, DOI 10.1002/1097-0142(19910315)67:6<1661::AID-CNCR2820670630>3.0.CO;2-E; You WC, 2000, INT J EPIDEMIOL, V29, P405, DOI 10.1093/ije/29.3.405; Yuan JM, 2006, JNCI-J NATL CANCER I, V98, P482, DOI 10.1093/jnci/djj104; Yuan JM, 1996, JAMA-J AM MED ASSOC, V275, P1646, DOI 10.1001/jama.275.21.1646; Yuan X, 2008, AM J HUM GENET, V83, P520, DOI 10.1016/j.ajhg.2008.09.012; Zhang SL, 1997, INT J CANCER, V73, P50, DOI 10.1002/(SICI)1097-0215(19970926)73:1<50::AID-IJC9>3.3.CO;2-O	35	12	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184295	10.1371/journal.pone.0184295	http://dx.doi.org/10.1371/journal.pone.0184295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880901	gold, Green Published, Green Submitted			2022-12-27	WOS:000409467200047
J	Lin, JS; Jeon, JS; Fan, QF; Wong, HN; Palmer, MB; Holzman, LB				Lin, Jamie S.; Jeon, Jin Seok; Fan, Qingfeng; Wong, Hetty N.; Palmer, Matthew B.; Holzman, Lawrence B.			ARF6 mediates nephrin tyrosine phosphorylation-induced podocyte cellular dynamics	PLOS ONE			English	Article							ADP-RIBOSYLATION FACTOR; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; CONGENITAL NEPHROTIC SYNDROME; GTP-BINDING PROTEINS; SLIT DIAPHRAGM; DOWNSTREAM ACTIVATION; ACTIN CYTOSKELETON; GLOMERULAR PODOCYTES; DIABETIC-NEPHROPATHY; PLASMA-MEMBRANE	ADP-ribosylation factor 6 (ARF6) is a small GTPase necessary for regulating cellular structure, motility, and vesicle trafficking. In several cellular systems, ARF6 was shown to regulate actin dynamics in coordination with Rac1, a Rho small GTPase. We examined the function of ARF6 in the kidney podocyte because Rac1 was implicated in kidney diseases involving this cell. We found that ARF6 expression was enriched in human podocytes and that it modulated podocyte cytoskeletal dynamics through a functional interaction with nephrin, an intercellular junction protein necessary for podocyte injury-induced signaling requiring activation by tyrosine phosphorylation of its cytoplasmic domain. ARF6 was necessary for nephrin activation-induced ruffling and focal adhesion turnover, possibly by altering Rac1 activity. In podocyte-specific Arf6 (ARF6_PodKO) knockout mice, ARF6 deficiency did not result in a spontaneous kidney developmental phenotype or proteinuria after aging. However, ARF6_PodKO mice exhibited distinct phenotypes in two in vivo glomerular injury models. In the protamine sulfate perfusion model, which induced acute podocyte effacement, ARF6_PodKO mice were protected from podocyte effacement. In the nephrotoxic serum nephritis model, which induced immune-complex mediated injury, ARF6_PodKO mice exhibited aggravated proteinuria. Together, these observations suggest that while ARF6 is necessary for nephrin tyrosine phosphorylation-induced cytoskeletal dynamics in cultured podocytes, ARF6 has pleotropic podocyte roles in vivo, where glomerular injury-specific mechanisms might activate distinct signaling pathways that dictate whether ARF6 activity is beneficial or deleterious for maintaining the integrity of the glomerular filtration barrier.	[Lin, Jamie S.] Univ Texas MD Anderson Canc Ctr, Nephrol Sect, Dept Emergency Med, Div Internal Med, Houston, TX 77030 USA; [Jeon, Jin Seok] Soonchunhyang Univ Hosp, Div Nephrol, Dept Med, Seoul, South Korea; [Fan, Qingfeng; Wong, Hetty N.; Holzman, Lawrence B.] Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Palmer, Matthew B.] Hosp Univ Penn, Dept Pathol & Lab Med, 3400 Spruce St, Philadelphia, PA 19104 USA	University of Texas System; UTMD Anderson Cancer Center; Soonchunhyang University; Soonchunhyang University Hospital; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Holzman, LB (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA.	lholzman@mail.med.upenn.edu	; Lin, Jamie/F-4278-2015	Holzman, Lawrence/0000-0002-8961-234X; Fan, Qingfeng/0000-0002-7100-7766; Lin, Jamie/0000-0002-7073-9658	National Institute of Diabetes and Digestive and Kidney Diseases [DK080751-11, DK007006-43, DK108566-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007006, R01DK080751, F32DK108566] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases: DK080751-11 (LBH); DK007006-43 (LBH, JSL); DK108566-01(JSL); https://www.niddk.nih.gov gov/.	Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Akiyama M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5744; Akiyama M, 2010, DEV DYNAM, V239, P3416, DOI 10.1002/dvdy.22481; Attias O, 2010, NEPHRON EXP NEPHROL, V114, pE93, DOI 10.1159/000262317; Auguste David, 2016, Small GTPases, V7, P107, DOI 10.1080/21541248.2015.1113353; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Beltcheva O, 2001, HUM MUTAT, V17, P368, DOI 10.1002/humu.1111; Blattner SM, 2013, KIDNEY INT, V84, P920, DOI 10.1038/ki.2013.175; Bollee G, 2011, NAT MED, V17, P1242, DOI 10.1038/nm.2491; Boshans RL, 2000, MOL CELL BIOL, V20, P3685, DOI 10.1128/MCB.20.10.3685-3694.2000; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Chen PW, 2013, J BIOL CHEM, V288, P5849, DOI 10.1074/jbc.M112.415778; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Chugh SS, 2012, AM J KIDNEY DIS, V59, P284, DOI 10.1053/j.ajkd.2011.07.024; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; D'SOUZA-SCHOREY C, 1995, SCIENCE, V267, P1175, DOI 10.1126/science.7855600; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; DONALDSON JG, 1994, CURR OPIN CELL BIOL, V6, P527, DOI 10.1016/0955-0674(94)90072-8; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Doublier S, 2003, DIABETES, V52, P1023, DOI 10.2337/diabetes.52.4.1023; East MP, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.417477; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Eng DG, 2015, KIDNEY INT, V88, P999, DOI 10.1038/ki.2015.152; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Garg P, 2010, J BIOL CHEM, V285, P22676, DOI 10.1074/jbc.M110.122929; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; George B, 2014, KIDNEY INT, V85, P1382, DOI 10.1038/ki.2013.556; George B, 2012, J CLIN INVEST, V122, P674, DOI 10.1172/JCI60070; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Hongu Tsunaki, 2014, Advances in Biological Regulation, V54, P59, DOI 10.1016/j.jbior.2013.09.014; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Hu ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035542; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Huber TB, 2003, MOL CELL BIOL, V23, P4917, DOI 10.1128/MCB.23.14.4917-4928.2003; Ichikawa L, 2005, CURR OPIN NEPHROL HY, V14, P205; Jones N, 2006, NATURE, V440, P818, DOI 10.1038/nature04662; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Kawaguchi K, 2014, J BIOL CHEM, V289, P9675, DOI 10.1074/jbc.M113.546051; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Koo TH, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-29; Lahdenpera J, 2003, KIDNEY INT, V64, P404, DOI 10.1046/j.1523-1755.2003.00097.x; Li H, 2004, J AM SOC NEPHROL, V15, P3006, DOI 10.1097/01.ASN.0000146689.88078.80; Li XZ, 2015, J AM SOC NEPHROL, V26, P2361, DOI 10.1681/ASN.2014040405; Lin JS, 2015, J PATHOLOGY; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Oh J, 2004, PEDIATR NEPHROL, V19, P130, DOI 10.1007/s00467-003-1367-y; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Radhakrishna H, 1999, J CELL SCI, V112, P855; Robins R, 2017, RAC1 ACTIVATION PODO; Rudiger F, 1999, KIDNEY INT, V56, P1700, DOI 10.1046/j.1523-1755.1999.00729.x; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; SEILER MW, 1975, SCIENCE, V189, P390, DOI 10.1126/science.1145209; Simons M, 2001, AM J PATHOL, V159, P1069, DOI 10.1016/S0002-9440(10)61782-8; Subramanian B, 2016, KIDNEY INT, V90, P363, DOI 10.1016/j.kint.2016.04.020; Tian XF, 2016, NEPHROL DIAL TRANSPL, V31, P1577, DOI 10.1093/ndt/gfw021; Topham PS, 1999, J CLIN INVEST, V104, P1549, DOI 10.1172/JCI7707; Venkatareddy M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028710; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Verma R, 2016, MOL CELL BIOL, V36, P596, DOI 10.1128/MCB.00956-15; Wehrle-Haller B, 2002, TRENDS CELL BIOL, V12, P382, DOI 10.1016/S0962-8924(02)02321-8; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Wolfenson H, 2009, CELL MOTIL CYTOSKEL, V66, P1017, DOI 10.1002/cm.20410; Yu HY, 2013, MOL CELL BIOL, V33, P4755, DOI 10.1128/MCB.00730-13; Zhu J, 2008, KIDNEY INT, V73, P556, DOI 10.1038/sj.ki.5002691	79	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184575	10.1371/journal.pone.0184575	http://dx.doi.org/10.1371/journal.pone.0184575			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880939	Green Submitted, gold, Green Published			2022-12-27	WOS:000409467200078
J	Wu, F; Ma, JX; Meng, YQ; Zhang, DY; Muvunyi, BP; Luo, K; Di, HY; Guo, WL; Wang, YR; Feng, BC; Zhang, JY				Wu, Fan; Ma, Jinxing; Meng, Yuqin; Zhang, Daiyu; Muvunyi, Blaise Pascal; Luo, Kai; Di, Hongyan; Guo, Wenli; Wang, Yanrong; Feng, Baochang; Zhang, Jiyu			Potential DNA barcodes for Melilotus species based on five single loci and their combinations (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							GENUS; IDENTIFY; REGION; IDENTIFICATION; DIVERSITY; PRIMERS; NUCLEAR	Melilotus, an annual or biennial herb, belongs to the tribe Trifolieae (Leguminosae) and consists of 19 species. As an important green manure crop, diverse Melilotus species have different values as feed and medicine. To identify different Melilotus species, we examined the efficiency of five candidate regions as barcodes, including the internal transcribed spacer (ITS) and two chloroplast loci, rbcL and matK, and two non-coding loci, trnH-psbA and trnL-F. In total, 198 individuals from 98 accessions representing 18 Melilotus species were sequenced for these five potential barcodes. Based on inter-specific divergence, we analysed sequences and confirmed that each candidate barcode was able to identify some of the 18 species. The resolution of a single barcode and its combinations ranged from 33.33% to 88.89%. Analysis of pairwise distances showed that matK+rbcL+trnL-F+trnH-psbA+ITS (MRTPI) had the greatest value and rbcL the least. Barcode gap values and similarity value analyses confirmed these trends. The results indicated that an ITS region, successfully identifying 13 of 18 species, was the most appropriate single barcode and that the combination of all five potential barcodes identified 16 of the 18 species. We conclude that MRTPI is the most effective tool for Melilotus species identification. Taking full advantage of the barcode system, a clear taxonomic relationship can be applied to identify Melilotus species and enhance their practical production.	[Wu, Fan; Zhang, Daiyu; Muvunyi, Blaise Pascal; Luo, Kai; Di, Hongyan; Guo, Wenli; Wang, Yanrong; Zhang, Jiyu] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China; [Ma, Jinxing; Feng, Baochang] Minist Agr, Natl Qual Control Inspect Ctr Grassland Ind Prod, Natl Anim Husb Serv, Beijing, Peoples R China; [Meng, Yuqin] China Agr Veterinarian Biol Sci & Technol Co Ltd, Lanzhou, Gansu, Peoples R China	Lanzhou University; Ministry of Agriculture & Rural Affairs	Zhang, JY (corresponding author), Lanzhou Univ, Coll Pastoral Agr Sci & Technol, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China.; Feng, BC (corresponding author), Minist Agr, Natl Qual Control Inspect Ctr Grassland Ind Prod, Natl Anim Husb Serv, Beijing, Peoples R China.	bcfeng@163.com; zhangjy@lzu.edu.cn	Zhang, Jiyu/AAG-3452-2021	Zhang, Jiyu/0000-0002-3642-373X; , Fan/0000-0002-3230-8996	National Basic Research Program (973) of China [2014CB138704]; Special Fund for Agro-scientific Research in the Public Interest [20120304205]; National Natural Science Foundation of China [31572453]; 111 project [B12002]; State Key Laboratory of Grassland Agroecosystems [SKLGAE201702]; Program for Changjiang Scholars and Innovative Research Team in University [IRT_17R50]	National Basic Research Program (973) of China(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project(Ministry of Education, China - 111 Project); State Key Laboratory of Grassland Agroecosystems; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	Funded by National Basic Research Program (973) of China (2014CB138704), Special Fund for Agro-scientific Research in the Public Interest (20120304205), National Natural Science Foundation of China (31572453), the 111 project (B12002), State Key Laboratory of Grassland Agroecosystems (SKLGAE201702), and Program for Changjiang Scholars and Innovative Research Team in University (IRT_17R50). We thank the National Plant Germplasm System (NPGS, US) and National Gene Bank of Forage Germplasm (NGBFG, China) for providing experimental materials used in our study. Yanrong Wang, Baochang Feng and Jinxing Ma secured financial support. Yanrong Wang and Jiyu Zhang decided to publish the manuscript.; This work was supported by National Basic Research Program (973) of China (2014CB138704), Special Fund for Agro-scientific Research in the Public Interest (20120304205), National Natural Science Foundation of China (31572453), the 111 project (B12002), State Key Laboratory of Grassland Agro-ecosystems (SKLGAE201702), and Program for Changjiang Scholars and Innovative Research Team in University (IRT_17R50). Additionally, we thank the National Plant Germplasm System (NPGS, US) and National Gene Bank of Forage Germplasm (NGBFG, China) for providing experimental materials used in our study. We also thank the reviewers for reviewing our manuscript.	ABOEL-ATTA ABDEL-MONEIM IBRAHEIM, 2009, ACAD J PLANT SCI, V2, P113; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Castro C., 2015, American Journal of Plant Sciences, V6, P95, DOI 10.4236/ajps.2015.61011; Chao Z, 2014, PHYTOMEDICINE, V21, P1767, DOI 10.1016/j.phymed.2014.09.001; Chen SL, 2015, PLOS ONE, V10, P1903; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Cong JM, 2012, J ANHUI AGR SCI, V5, P155; Costion CM, 2016, DIVERSITY-BASEL, V8, DOI 10.3390/d8010005; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; Di HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132596; Di HY, 2014, ACTA BOT BOREALI-OCC; Dong R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00649; Dong WP, 2014, MOL ECOL RESOUR, V14, P336, DOI 10.1111/1755-0998.12185; Evans PM, 2003, AUST J EXP AGR, V43, P349, DOI 10.1071/EA02079; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Fu YM, 2011, J SYST EVOL, V49, P237, DOI 10.1111/j.1759-6831.2011.00126.x; Gao T, 2013, BIOL PHARM BULL, V36, P1975, DOI 10.1248/bpb.b13-00611; Gong XY, 2016, J EXP BOT; Guo XR, 2011, BIOL PHARM BULL, V34, P1198, DOI 10.1248/bpb.34.1198; Guo X, 2011, J SYST EVOL, V49, P203, DOI 10.1111/j.1759-6831.2011.00130.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; [骆凯 Luo Kai], 2014, [草业科学, Pratacultural Science], V31, P2125; Moon BC, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15017064; Moussavi S., 2001, SPECIES MELILOTUS IR, V2; Musa MA, 2008, CURR MED CHEM, V15, P2664, DOI 10.2174/092986708786242877; Muscarella R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112843; Nadia Z, 2014, BIOCHEM SYST ECOL, V55, P296, DOI 10.1016/j.bse.2014.03.016; Nair RM, NZ J AGR; Nitta JH, 2008, TAXON, V57, P725, DOI 10.1002/tax.573006; Parnmen S, 2016, J TOXICOL SCI, V41, P65, DOI 10.2131/jts.41.65; Rogers ME, 2008, PLANT SOIL, V304, P89, DOI 10.1007/s11104-007-9523-y; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Rubinoff D, 2006, TRENDS ECOL EVOL, V21, P1, DOI 10.1016/j.tree.2005.10.019; Sakiroglu M, 2011, TURK J BOT, V35, P509, DOI 10.3906/bot-1002-47; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; [单志 SHAN Zhi], 2011, [广东农业科学, Guangdong Agricultural Sciences], V38, P113; Shi SL, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7010001; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wiersema J. H., 2013, WORLD EC PLANTS STAN; Wu F, 2016, IND CROP PROD, V85, P84, DOI 10.1016/j.indcrop.2016.02.055; Xue CY, 2011, J SYST EVOL, V49, P267, DOI 10.1111/j.1759-6831.2011.00127.x; Yamaguchi A, 2006, PHYCOL RES, V54, P317, DOI 10.1111/j.1440-1835.2006.00438.x; Yan LJ, 2015, MOL ECOL RESOUR, V15, P932, DOI 10.1111/1755-0998.12353; Yu J, 2011, J SYST EVOL, V49, P176, DOI 10.1111/j.1759-6831.2011.00134.x; Zhang DQ, 2014, BIOCHEM SYST ECOL, V52, P14, DOI 10.1016/j.bse.2013.10.004; Zuo YJ, 2011, PLANTA MED, V77, P182, DOI 10.1055/s-0030-1250166	57	12	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0182693	10.1371/journal.pone.0182693	http://dx.doi.org/10.1371/journal.pone.0182693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910286	Green Submitted, gold, Green Published			2022-12-27	WOS:000410859200004
J	Zebende, GF; Oliveira, FM; Cruz, JAL				Zebende, Gilney Figueira; Oliveira Filho, Florencio Mendes; Leyva Cruz, Juan Alberto			Auto-correlation in the motor/imaginary human EEG signals: A vision about the F-DFA fluctuations	PLOS ONE			English	Article							MEMORY	In this paper we analyzed, by the F-DFA root mean square fluctuation (rms) function, the motor/imaginary human activity produced by a 64-channel electroencephalography (EEG). We utilized the Physionet on-line databank, a publicly available database of human EEG signals, as a standardized reference database for this study. Herein, we report the use of detrended fluctuation analysis (DFA) method for EEG analysis. We show that the complex time series of the EEG exhibits characteristic fluctuations depending on the analyzed channel in the scalp-recorded EEG. In order to demonstrate the effectiveness of the proposed technique, we analyzed four distinct channels represented here by F(3)32, F(6)37 (frontal region of the head) and P(3)49, P(6)54 (parietal region of the head). We verified that the amplitude of the F-DFA rms function is greater for the frontal channels than for the parietal. To tabulate this information in a better way, we define and calculate the difference between F-DFA (in log scale) for the channels, thus defining a new path for analysis of EEG signals. Finally, related to the studied EEG signals, we obtain the auto-correlation exponent, alpha(DFA) by DFA method, that reveals self-affinity at specific time scale. Our results shows that this strategy can be applied to study the human brain activity in EEG processing.	[Zebende, Gilney Figueira; Leyva Cruz, Juan Alberto] State Univ Feira de Santana, Dept Phys, Feira De Santana, BA, Brazil; [Oliveira Filho, Florencio Mendes] Estacio de Sa Univ, Gilberto Gil Campus, Salvador, BA, Brazil; [Oliveira Filho, Florencio Mendes] SENAI CIMATEC, Computat Modeling Program, Salvador, BA, Brazil	Universidade Estadual de Feira de Santana; Faculdade de Tecnologia Senai Cimatec	Zebende, GF (corresponding author), State Univ Feira de Santana, Dept Phys, Feira De Santana, BA, Brazil.	gfzebende@hotmail.com	Cruz, Juan Alberto Leyva/AAP-8764-2021; Zebende, Gilney Figueira/AAZ-6135-2020; Filho, Florêncio MO/P-3141-2018	Cruz, Juan Alberto Leyva/0000-0003-4019-4463; Zebende, Gilney Figueira/0000-0003-2420-9805; Oliveira Filho, Florencio Mendes/0000-0002-8675-6444	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [309288/2013-4]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico) [309288/2013-4]; Brazilian agency	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian agency	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, grant 309288/2013-4, GFZ.; Gilney F. Zebende thanks the CNPq (Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico) (Grant 309288/2013-4), Brazilian agency.	[Anonymous], 2004, BCI2000 GEN PURPOSE; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Galaska R, 2007, J ELECTROCARDIOL S1, V40, pS41; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Hardstone R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00450; Heneghan C, 2000, PHYS REV E, V62, P6103, DOI 10.1103/PhysRevE.62.6103; Hu K, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011114; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Lee JM, 2002, COMPUT BIOL MED, V32, P37, DOI 10.1016/S0010-4825(01)00031-2; Lee JS, 2017, CLIN NEUROPHYSIOL, V118, P2489; Marton LF, 2014, PROC TECH, V12, P125, DOI 10.1016/j.protcy.2013.12.465; Mirzayof D, 2010, PHYSICA A, V389, P5573, DOI 10.1016/j.physa.2010.08.035; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Romine CB, 2004, NEUROPSYCHOL REV, V14, P43, DOI 10.1023/B:NERV.0000026648.94811.32; Schalk G, 2004, IEEE T BIO-MED ENG, V51, P1034, DOI 10.1109/TBME.2004.827072; Swartz BE, 1998, ELECTROEN CLIN NEURO, V106, P113, DOI 10.1016/S0013-4694(97)00113-2; Walleczek J., 2000, SELF ORGANIZED BIOLO; William O., 2014, HDB EEG INTERPRETATI; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, DOI [10.1093/acprof:oso/9780195388855.001.0001, DOI 10.1093/ACPROF:OSO/9780195388855.001.0001]; Yang S., 2015, USE EEG SIGNALS BIOM; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305; Zebende GF, 2017, MON NOT R ASTRON SOC, V464, P2638, DOI 10.1093/mnras/stw2611	24	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183121	10.1371/journal.pone.0183121	http://dx.doi.org/10.1371/journal.pone.0183121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910294	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200006
J	Kaneko, M; Takanashi, S; Thongprachum, A; Hanaoka, N; Fujimoto, T; Nagasawa, K; Kimura, H; Okitsu, S; Mizuguchi, M; Ushijima, H				Kaneko, Mei; Takanashi, Sayaka; Thongprachum, Aksara; Hanaoka, Nozomu; Fujimoto, Tsuguto; Nagasawa, Koo; Kimura, Hirokazu; Okitsu, Shoko; Mizuguchi, Masashi; Ushijima, Hiroshi			Identification of vaccine-derived rotavirus strains in children with acute gastroenteritis in Japan, 2012-2015	PLOS ONE			English	Article							LESS-THAN-5 YEARS; UNITED-STATES; RT-PCR; PENTAVALENT; DIARRHEA; MONOVALENT; DS-1-LIKE; COVERAGE; INFANTS; ASSAY	Two live attenuated oral rotavirus vaccines, Rotarix and RotaTeq, have been introduced as voluntary vaccination in Japan since 2011 and 2012, respectively. Effectiveness of the vaccines has been confirmed, whereas concerns such as shedding of the vaccine strains and gastroenteritis cases caused by vaccine strains are not well assessed. We aimed to identify the vaccine strains in children with acute gastroenteritis (AGE) to investigate the prevalence of AGE caused by vaccination or horizontal transmission of vaccine strains. A total of 1,824 stool samples were collected from children with AGE at six outpatient clinics in 2012-2015. Among all, 372 group A rotavirus (RVA) positive samples were screened for vaccine components by real-time RT-PCR which were designed to differentiate vaccine strains from rotavirus wild-type strains with high specificity. For samples possessing both vaccine and wildtype strains, analyses by next-generation sequencing (NGS) were conducted to characterize viruses existed in the intestine. As a result, Rotarix-derived strains were identified in 6 of 372 (1.6%) RVA positive samples whereas no RotaTeq strain was detected. Among six samples, four possessed Rotarix-derived strains while two possessed both Rotarix-derived strains and wild-type strains. In addition, other pathogens such as norovirus, enterovirus and E. coli were detected in four samples. The contribution of these vaccine strains to each patient's symptoms was unclear as all of the cases were vaccinated 2-14 days before sample collection. Proportion of average coverage for each segmented gene by NGS strongly suggested the concurrent infection of the vaccine-derived strain and the wild-type strain rather than reassortment of these two strains in one sample. This is the first study to report the prevalence of vaccine-derived strains in patients with RVA AGE in Japan as 1.6% without evidence of horizontal transmission. The results emphasized the importance of continuous monitoring on vaccine strains and their clinical impacts on children.	[Kaneko, Mei; Takanashi, Sayaka; Okitsu, Shoko; Mizuguchi, Masashi; Ushijima, Hiroshi] Univ Tokyo, Dept Dev Med Sci, Grad Sch Med, Tokyo, Japan; [Thongprachum, Aksara; Okitsu, Shoko; Ushijima, Hiroshi] Nihon Univ, Sch Med, Div Microbiol, Dept Pathol & Microbiol, Tokyo, Japan; [Hanaoka, Nozomu; Fujimoto, Tsuguto; Nagasawa, Koo; Kimura, Hirokazu] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan	University of Tokyo; Nihon University; National Institute of Infectious Diseases (NIID)	Takanashi, S (corresponding author), Univ Tokyo, Dept Dev Med Sci, Grad Sch Med, Tokyo, Japan.	sayat@m.u-tokyo.ac.jp	Nagasawa, Koo/I-3723-2019; hanaoka, nozomu/L-7717-2019; Fujimoto, Tsuguto/AAG-8675-2019	Fujimoto, Tsuguto/0000-0002-4861-4349; hanaoka, nozomu/0000-0002-1039-6278	Japan Society for the Promotion of Science (JSPS) [24390266, 16H05360]; Public Foundation of the Vaccination Research Center [2015-34]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Public Foundation of the Vaccination Research Center	This work was supported by Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (Grant number: 24390266, 16H05360) and Public Foundation of the Vaccination Research Center (2015-34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; Araki K, 2015, HUM VACC IMMUNOTHER, V12, P1; Boom JA, 2012, J INFECT DIS, V206, P1275, DOI 10.1093/infdis/jis490; Committee for Immunization and vaccines, 2015, 13 MIN HLTH LAB WELF; Donato CM, 2012, J INFECT DIS, V206, P377, DOI 10.1093/infdis/jis361; Elfving K, 2014, J CLIN MICROBIOL, V52, P916, DOI 10.1128/JCM.02697-13; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Fujii Y, 2012, MICROBIOL IMMUNOL, V56, P630, DOI 10.1111/j.1348-0421.2012.00479.x; Gautam R, 2014, HUM VACC IMMUNOTHER, V10, P767, DOI 10.4161/hv.27388; Hacimustafaoglu M, 2013, J PEDIATR INFECT, V7, P13, DOI 10.5152/ced.2013.04; Hall T., 2011, GERF B BIOSCI, V2, P60; Hashizume Masahiro, 2015, Trop Med Health, V43, P177, DOI 10.2149/tmh.2015-23; Hill HA, 2015, MMWR-MORBID MORTAL W, V64, P889, DOI 10.15585/mmwr.mm6433a1; Hsieh YC, 2014, VACCINE, V32, P1199, DOI 10.1016/j.vaccine.2013.08.041; Jothikumar N, 2009, J VIROL METHODS, V155, P126, DOI 10.1016/j.jviromet.2008.09.025; Kageyama T, 2003, J CLIN MICROBIOL, V41, P1548, DOI 10.1128/JCM.41.4.1548-1557.2003; Kaplon J, 2015, PEDIATR INFECT DIS J, V34, P326, DOI 10.1097/INF.0000000000000560; Kawada J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33452; Kirkwood CD, 2010, J INFECT DIS, V202, pS43, DOI 10.1086/653548; Klinkenberg D, 2015, PEDIATR INFECT DIS J, V34, P114, DOI 10.1097/INF.0000000000000507; Leshem E, 2014, PEDIATRICS, V134, P15, DOI 10.1542/peds.2013-3849; Loharikar A, 2016, MMWR-MORBID MORTAL W, V65, P1136, DOI 10.15585/mmwr.mm6541a3; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007; Matthijnssens J, 2010, VIROLOGY, V403, P111, DOI 10.1016/j.virol.2010.04.004; Nijhuis M, 2002, J CLIN MICROBIOL, V40, P3666, DOI 10.1128/JCM.40.10.3666-3670.2002; Payne DC, 2013, CLIN INFECT DIS, V57, P13, DOI 10.1093/cid/cit164; Payne DC, 2010, PEDIATRICS, V125, pE438, DOI 10.1542/peds.2009-1901; Sabbe M, 2016, EUROSURVEILLANCE, V21, P19, DOI 10.2807/1560-7917.ES.2016.21.27.30273; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Thongprachum A, 2017, J MED VIROL, V89, P818, DOI 10.1002/jmv.24711; Velazquez RF, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0771-y; Ward RL, 2009, CLIN INFECT DIS, V48, P222, DOI 10.1086/595702; Werther RL, 2009, J ALLERGY CLIN IMMUN, V124, P600, DOI 10.1016/j.jaci.2009.07.005; Yamamoto SP, 2014, EMERG INFECT DIS, V20, P1030, DOI 10.3201/eid2006.131326; Yamashita A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00032; Zeller M, 2015, GENOME BIOL EVOL, V7, P2473, DOI 10.1093/gbe/evv157	40	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184067	10.1371/journal.pone.0184067	http://dx.doi.org/10.1371/journal.pone.0184067			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902863	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200025
J	Naidoo, K; Hassan-Moosa, R; Yende-Zuma, N; Govender, D; Padayatchi, N; Dawood, H; Adams, RN; Govender, A; Chinappa, T; Abdool-Karim, S; Abdool-Karim, Q				Naidoo, Kogieleum; Hassan-Moosa, Razia; Yende-Zuma, Nonhlanhla; Govender, Dhineshree; Padayatchi, Nesri; Dawood, Halima; Adams, Rochelle Nicola; Govender, Aveshen; Chinappa, Tilagavathy; Abdool-Karim, Salim; Abdool-Karim, Quarraisha			High mortality rates in men initiated on anti-retroviral treatment in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							GENDER-DIFFERENCES; RURAL DISTRICT; HIV-INFECTION; THERAPY; COHORT; HEALTH; OUTCOMES; WOMEN; RETENTION; MALAWI	In attaining UNAIDS targets of 90-90-90 to achieve epidemic control, understanding who the current utilizers of HIV treatment services are will inform efforts aimed at reaching those not being reached. A retrospective chart review of CAPRISA AIDS Treatment Program (CAT) patients between 2004 and 2013 was undertaken. Of the 4043 HIV-infected patients initiated on ART, 2586 (64.0%) were women. At ART initiation, men, compared to women, had significantly lower median CD4+ cell counts (113 vs 131 cells/mm(3), p < 0.001), lower median body mass index (BMI) (21.0 vs 24.2 kg/m(2), p< 0.001), higher mean log viral load (5.0 vs 4.9 copies/ml, p< 0.001) and were significantly older (median age: 35 vs. 32 years, p< 0.001). Men had higher mortality rates compared to women, 6.7 per 100 person-years (p-y), (95% CI: 5.8-7.8) vs. 4.4 per 100 p-y, (95% CI: 3.8-5.0); mortality rate ratio: 1.54, (95% CI: 1.27-1.87), p < 0.001. Age-standardised mortality rate was 7.9 per 100 p-y (95% CI: 4.1-11.7) for men and 5.7 per 100 p-y (95% CI: 2.7 to 8.6) for women (standardised mortality ratio: 1.38 (1.15 to 1.70)). Mean CD4+ cell count increases post-ART initiation were lower in men at all follow-up time points. Men presented later in the course of their HIV disease for ART initiation with more advanced disease and experienced a higher mortality rate compared to women.	[Naidoo, Kogieleum; Hassan-Moosa, Razia; Yende-Zuma, Nonhlanhla; Govender, Dhineshree; Padayatchi, Nesri; Dawood, Halima; Adams, Rochelle Nicola; Govender, Aveshen; Chinappa, Tilagavathy; Abdool-Karim, Salim; Abdool-Karim, Quarraisha] CAPRISA, Durban, Kwazulu Natal, South Africa; [Naidoo, Kogieleum; Yende-Zuma, Nonhlanhla; Padayatchi, Nesri; Abdool-Karim, Salim] Univ KwaZulu Natal, MRC CAPRISA HIV TB Pathogenesis & Treatment Res U, Doris Duke Med Res Inst, Durban, Kwazulu Natal, South Africa; [Abdool-Karim, Salim] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA	University of Kwazulu Natal; Columbia University	Naidoo, K; Hassan-Moosa, R (corresponding author), CAPRISA, Durban, Kwazulu Natal, South Africa.; Naidoo, K (corresponding author), Univ KwaZulu Natal, MRC CAPRISA HIV TB Pathogenesis & Treatment Res U, Doris Duke Med Res Inst, Durban, Kwazulu Natal, South Africa.	Kogie.Naidoo@caprisa.org; Razia.Hassan-Moosa@caprisa.org	Abdool Karim, Quarraisha/GVS-1160-2022; padayatchi, nesri/Q-2780-2019; Karim, Salim Abdool/AAE-7118-2019; Karim, Salim Abdool/P-3117-2019; Dawood, Halima/AAO-6963-2020; Dawood, Halima/AAF-6045-2020	Abdool Karim, Quarraisha/0000-0002-0985-477X; padayatchi, nesri/0000-0003-2543-9071; Karim, Salim Abdool/0000-0002-4986-2133; Dawood, Halima/0000-0001-8180-6791; Naidoo, Kogieleum/0000-0002-8874-6661	US President's Emergency Plan for AIDS Relief (PEPFAR); Global Fund to fight AIDS, Tuberculosis and Malaria; National Institutes of Health Comprehensive International Program of Research on AIDS [UM1A1069469]; Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP) [D43 TW000231]; FOGARTY INTERNATIONAL CENTER [D43TW000231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069469] Funding Source: NIH RePORTER	US President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Global Fund to fight AIDS, Tuberculosis and Malaria; National Institutes of Health Comprehensive International Program of Research on AIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the US President's Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to fight AIDS, Tuberculosis and Malaria and the National Institutes of Health Comprehensive International Program of Research on AIDS (UM1A1069469). K.N. and N.P. were supported by the Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP, Grant D43 TW000231). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the US President's Emergency Plan for AIDS Relief (PEPFAR), the Global Fund to fight AIDS, Tuberculosis and Malaria and the National Institutes of Health Comprehensive International Program of Research on AIDS (UM1AI069469). K.N. and N.P. were supported by the Columbia University-South Africa Fogarty AIDS International Training and Research Program (AITRP, Grant D43 TW000231).	Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Boulle C, 2015, JAIDS-J ACQ IMM DEF, V69, P355, DOI 10.1097/QAI.0000000000000604; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cescon A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083649; Cornell M, 2013, S AFR J HIV MED, V14, P12, DOI 10.7196/SAJHIVMED.894; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cornell M, 2011, TROP MED INT HEALTH, V16, P828, DOI 10.1111/j.1365-3156.2011.02767.x; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Giles ML, 2016, SEX HEALTH, V13, P155, DOI 10.1071/SH15124; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Harling G, 2014, JAIDS-J ACQ IMM DEF, V66, P443, DOI 10.1097/QAI.0000000000000198; Ikuabe P. O., 2015, J MED, V24, P103; Karim QA, 2010, CLIN INFECT DIS, V50, pS122, DOI 10.1086/651483; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn S, 2012, AIDS, V26; Lee MP, 2015, AIDS PATIENT CARE ST, V29, P229, DOI 10.1089/apc.2014.0232; Maskew M, 2013, J WOMENS HEALTH, V22, P113, DOI 10.1089/jwh.2012.3585; Menzaghi B, 2014, BIOMED PHARMACOTHER, V68, P385, DOI 10.1016/j.biopha.2014.01.007; Naidoo K, 2014, JAIDS-J ACQ IMM DEF, V65, P438, DOI 10.1097/QAI.0000000000000060; Naranbhai V, 2012, LANCET, V380, P1907, DOI 10.1016/S0140-6736(12)62110-2; Nash D, 2008, AIDS, V22, P2291, DOI 10.1097/QAD.0b013e3283121ca9; Norheim OF, 2015, LANCET, V385, P239, DOI 10.1016/S0140-6736(14)61591-9; Ramkissoon A, 2011, JAIDS-J ACQ IMM DEF, V58, pE138, DOI 10.1097/QAI.0b013e3182381171; Rosin C, 2015, HIV MED, V16, P319, DOI 10.1111/hiv.12203; Rudatsikira E, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-176; Saunders P, 2016, HIV MED, V17, P18, DOI 10.1111/hiv.12272; STATISTICS SOUTH AFRICA, 2015, MID POP EST; Takarinda KC, 2015, INT J INFECT DIS, V30, P98, DOI 10.1016/j.ijid.2014.11.009; Taylor-Smith K, 2010, MALAWI MED J, V22, P49; Thorsteinsson K, 2012, SCAND J INFECT DIS, V44, P766, DOI 10.3109/00365548.2012.684220; Yende-Zuma N, 2016, J ACQUIRED IMMUNE DE; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832	35	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184124	10.1371/journal.pone.0184124	http://dx.doi.org/10.1371/journal.pone.0184124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902869	Green Published, gold			2022-12-27	WOS:000410669200027
J	Zhang, X; Han, DD; Yang, RQ; Zhang, ZQ				Zhang, Xin; Han, Ding-Ding; Yang, Ruiqi; Zhang, Ziqiao			Users' participation and social influence during information spreading on Twitter	PLOS ONE			English	Article							DIRECTED NETWORKS; ONLINE	Online Social Networks generate a prodigious wealth of real-time information at an incessant rate. In this paper we study the empirical data that crawled from Twitter to describe the topology and information spreading dynamics of Online Social Networks. We propose a measurement with three measures to state the efforts of users on Twitter to get their information spreading, based on the unique mechanisms for information retransmission on Twitter. It is noticed that small fraction of users with special performance on participation can gain great influence, while most other users play a role as middleware during the information propagation. Thus a community analysis is performed and four categories of users are found with different kinds of participation that cause the information dissemination dynamics. These suggest that exiting topological measures alone may reflect little about the influence of individuals and provide new insights for information spreading.	[Zhang, Xin; Han, Ding-Ding; Yang, Ruiqi; Zhang, Ziqiao] East China Normal Univ, Sch Informat Sci & Technol, Shanghai Key Lab Multidimens Informat Proc, Shanghai, Peoples R China	East China Normal University	Han, DD (corresponding author), East China Normal Univ, Sch Informat Sci & Technol, Shanghai Key Lab Multidimens Informat Proc, Shanghai, Peoples R China.	ddhan@ee.ecnu.edu.cn			National Natural Science Foundation of China [11421505]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported in part by the National Natural Science Foundation of China under contract Nos. 11421505.	Asur S., 2011, SSRN ELECT J; Barzel B., 2014, P NATL ACAD SCI USA, V111, P10411; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Borondo J, 2015, CHAOS SOLITON FRACT, V72, P90, DOI 10.1016/j.chaos.2014.12.023; Boyd D., 2010, 43 HAW INT C SYST SC, V2010, P1, DOI DOI 10.1109/HICSS.2010.412; Cha M., 2010, INT AAAI C WEB SOC M, P30, DOI DOI 10.1016/J.IPM.2016.04.003; Chen Q, 2016, J APPL ANAL COMPUT, V6, P30; Chen Q, 2014, INT J MOD PHYS C, V25, DOI 10.1142/S0129183114400129; Chen YL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/815981; Cui AX, 2011, ACTA PHYS SIN-CH ED, V60, DOI 10.7498/aps.60.038901; Galuba Wojciech, 2010, WOSN, V10, P3, DOI 10.5555/1863190.1863193; Gayo-Avello D, 2013, INFORM PROCESS MANAG, V49, P1250, DOI 10.1016/j.ipm.2013.06.003; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gleeson JP, 2014, P NATL ACAD SCI USA, V111, P10411, DOI 10.1073/pnas.1313895111; Goncalves B, 2011, PLOS ONE, V6; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; Gruzd A, 2011, AM BEHAV SCI, V55, P1294, DOI 10.1177/0002764211409378; Kleineberg KK, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031046; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lai DR, 2010, PHYSICA A, V389, P2443, DOI 10.1016/j.physa.2010.02.014; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Lewis K, 2008, SOC NETWORKS, V30, P330, DOI 10.1016/j.socnet.2008.07.002; Li Y, 2015, INFORM SCIENCES, V293, P383, DOI 10.1016/j.ins.2014.09.019; Lymperopoulos IN, 2015, INFORM SCIENCES, V320, P26, DOI 10.1016/j.ins.2015.05.004; Malliaros FD, 2013, PHYS REP, V533, P95, DOI 10.1016/j.physrep.2013.08.002; Manaman HS, 2016, COMPUT HUM BEHAV, V54, P94, DOI 10.1016/j.chb.2015.07.061; Morales AJ, 2014, SOC NETWORKS, V39, P1, DOI 10.1016/j.socnet.2014.03.007; Morales AJ, 2012, PHYSICA A, V391, P5244, DOI 10.1016/j.physa.2012.05.015; Newman MEJ, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.036122; Qian JH, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.062808; Qian JH, 2012, PHYSICA A, V391, P5146, DOI 10.1016/j.physa.2012.05.038; Ranco G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138441; Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701; Romero D.M., 2010, SSRN ELECT J, V6913, P18, DOI DOI 10.1007/978-3-642-23808-6_2; Small TA, 2011, INFORM COMMUN SOC, V14, P872, DOI 10.1080/1369118X.2011.554572; Tafti A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159226; Wang P, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/18005; Wang P, 2010, PHYS STAT MECH ITS A, V398, P145; Weng L, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00335; Zafarani R, 2014, SOCIAL MEDIA MINING, P197; Zhang ZK, 2016, PHYS REP, V651, P1, DOI 10.1016/j.physrep.2016.07.002; Zhao Z. D., 2013, SCI REP, V3, P324; Zhao ZD, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.050802; Zhao ZD, 2012, PHYSICA A, V391, P3308, DOI 10.1016/j.physa.2012.01.008	45	14	15	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183290	10.1371/journal.pone.0183290	http://dx.doi.org/10.1371/journal.pone.0183290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902906	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200011
J	Haaland, OA; Jugessur, A; Gjerdevik, M; Romanowska, J; Shi, M; Beaty, TH; Marazita, ML; Murray, JC; Wilcox, AJ; Lie, RT; Gjessing, HK				Haaland, Oystein A.; Jugessur, Astanand; Gjerdevik, Miriam; Romanowska, Julia; Shi, Min; Beaty, Terri H.; Marazita, Mary L.; Murray, Jeffrey C.; Wilcox, Allen J.; Lie, Rolv T.; Gjessing, Hakon K.			Genome-wide analysis of parent-of-origin interaction effects with environmental exposure (PoOxE): An application to European and Asian cleft palate trios	PLOS ONE			English	Article							POPULATION-BASED COHORT; OROFACIAL CLEFTS; ORAL CLEFTS; RISK; RECURRENCE; ASSOCIATION; LIP; PREVALENCE; EXPRESSION; RELATIVES	Cleft palate only is a common birth defect with high heritability. Only a small fraction of this heritability is explained by the genetic variants identified so far, underscoring the need to investigate other disease mechanisms, such as gene-environment (GxE) interactions and parent-of-origin (PoO) effects. Furthermore, PoO effects may vary across exposure levels (PoOxE effects). Such variation is the focus of this study. We upgraded the R-package Haplin to enable direct tests of PoOxE effects at the genome-wide level. From a previous GWAS, we had genotypes for 550 case-parent trios, of mainly European and Asian ancestry, and data on three maternal exposures (smoking, alcohol, and vitamins). Data were analyzed for Europeans and Asians separately, and also for all ethnicities combined. To account for multiple testing, a false discovery rate method was used, where q-values were generated from the p-values. In the Europeans-only analyses, interactions with maternal smoking yielded the lowest q-values. Two SNPs in the 'Interactor of little elongation complex ELL subunit 1' (ICE1) gene had a q-value of 0.14, and five of the 20 most significant SNPs were in the 'N-acetylated alpha-linked acidic dipeptidase-like 2' (NAALADL2) gene. No evidence of PoOxE effects was found in the other analyses. The connections to ICE1 and NAALADL2 are novel and warrant further investigation. More generally, the new methodology presented here is easily applicable to other traits and exposures in which a family-based study design has been implemented.	[Haaland, Oystein A.; Jugessur, Astanand; Gjerdevik, Miriam; Romanowska, Julia; Lie, Rolv T.; Gjessing, Hakon K.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Jugessur, Astanand; Gjerdevik, Miriam] NIPH, Dept Genet & Bioinformat, Oslo, Norway; [Jugessur, Astanand; Gjessing, Hakon K.] Norwegian Inst Publ Hlth, Ctr Fertil & Hlth CeFH, Oslo, Norway; [Shi, Min] NIEHS, Biostat & Computat Biol Branch, NIH, Durham, NC USA; [Beaty, Terri H.] Johns Hopkins Univ, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Marazita, Mary L.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Wilcox, Allen J.] NIEHS, Epidemiol Branch, NIH, Durham, NC USA; [Lie, Rolv T.] Norwegian Inst Publ Hlth, Dept Hlth Registries, Oslo, Norway	University of Bergen; Norwegian Institute of Public Health (NIPH); Norwegian Institute of Public Health (NIPH); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Norwegian Institute of Public Health (NIPH)	Haaland, OA (corresponding author), Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.	oystein.haaland@uib.no	Wilcox, Allen J/C-7723-2019; Gjerdevik, Miriam/ABE-4722-2021; Shi, Min/GXM-3977-2022	Wilcox, Allen J/0000-0002-3376-1311; Romanowska, Julia/0000-0001-6733-1953; Haaland, Oystein Ariansen/0000-0001-5288-7879	Bergen Medical Research Foundation [807191]; National Institute of Environmental Health Sciences, National Institutes of Health (NIH/NIEHS); NIH [DE08559]; Research Council of Norway through Centres of Excellence [262700]; National Institute of Environmental Health Sciences, NIH/NIEHS; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES044003] Funding Source: NIH RePORTER	Bergen Medical Research Foundation; National Institute of Environmental Health Sciences, National Institutes of Health (NIH/NIEHS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Council of Norway through Centres of Excellence; National Institute of Environmental Health Sciences, NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Bergen Medical Research Foundation, grant 807191, in part by the Intramural Program of the National Institute of Environmental Health Sciences, National Institutes of Health (NIH/NIEHS), by NIH grant DE08559, and partly by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Bergen Medical Research Foundation, grant 807191 (AJ, HKG, RTL), in part by the Intramural Program of the National Institute of Environmental Health Sciences, NIH/NIEHS (AJW), by NIH grant DE08559 (JCM), and by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700 (HKG, AJ).	Beaty TH, 2011, GENET EPIDEMIOL, V35, P469, DOI 10.1002/gepi.20595; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Blanton SH, 2011, BIRTH DEFECTS RES A, V91, P50, DOI 10.1002/bdra.20740; Borg K, 2005, HUM GENET, V118, P267, DOI 10.1007/s00439-005-0021-0; Christensen K, 1996, AM J HUM GENET, V58, P182; Corcos Laurent, 2012, Drug Metabolism and Drug Interactions, V27, P63, DOI [10.1515/DMDI-2011-0037, 10.1515/dmdi-2011-0037]; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Du J, 2014, BIOTECH HISTOCHEM, V89, P14, DOI 10.3109/10520295.2013.795661; Du J, 2011, ACTA HISTOCHEM, V113, P636, DOI 10.1016/j.acthis.2010.08.001; Gjessing HK, 2006, ANN HUM GENET, V70, P382, DOI 10.1111/j.1469-1809.2005.00218.x; Grosen D, 2011, EPIDEMIOLOGY, V22, P313, DOI 10.1097/EDE.0b013e3182125f9c; Grosen D, 2010, AM J MED GENET A, V152A, P2468, DOI 10.1002/ajmg.a.33608; Grosen D, 2010, J MED GENET, V47, P162, DOI 10.1136/jmg.2009.069385; Hager R, 2008, GENETICS, V178, P1755, DOI 10.1534/genetics.107.080697; Jugessur A, 2009, ORAL DIS, V15, P437, DOI 10.1111/j.1601-0825.2009.01577.x; Jugessur A., 2012, NORSK EPIDEMIOLOGI, V21, P251, DOI DOI 10.5324/NJE.V21I2.1503; Krey KF, 2002, EXP TOXICOL PATHOL, V54, P69, DOI 10.1078/0940-2993-00235; Lawson HA, 2013, NAT REV GENET, V14, P608, DOI 10.1038/nrg3543; LIE RT, 1994, NEW ENGL J MED, V331, P1, DOI 10.1056/NEJM199407073310101; Marazita ML, 2012, ANN REV GENOMICS HUM; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Mossey P., 2003, GLOBAL REGISTRY DATA; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2015, R LANG ENV STAT COMP; Rahimov F, 2012, CLEFT PALATE-CRAN J, V49, P73, DOI 10.1597/10-178; Romanovska J, 2017, ANN HUM GENET; Sharp GC, 2017, CLEFT PALATE CRANIOF; Sharp GC, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-017-0362-2; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Skare O, 2012, ANN HUM GENET, V76, P221, DOI 10.1111/j.1469-1809.2012.00707.x; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Wang S, 2011, HUM HERED, V71, P196, DOI 10.1159/000328006; Whitaker HC, 2014, ONCOGENE, V33, P5274, DOI 10.1038/onc.2013.464; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	37	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184358	10.1371/journal.pone.0184358	http://dx.doi.org/10.1371/journal.pone.0184358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898263	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000410449500023
J	Moreno-Fernandez, MM; Blanco, F; Matute, H				Manuela Moreno-Fernandez, Maria; Blanco, Fernando; Matute, Helena			Causal illusions in children when the outcome is frequent	PLOS ONE			English	Article							BIAS BLIND SPOT; CONTINGENCY JUDGMENTS; DEVELOPMENTAL DIFFERENCES; PERCEIVED CONTROL; BINARY VARIABLES; WORKING-MEMORY; DENSITY BIAS; INFORMATION; AGE; COVARIATION	Causal illusions occur when people perceive a causal relation between two events that are actually unrelated. One factor that has been shown to promote these mistaken beliefs is the outcome probability. Thus, people tend to overestimate the strength of a causal relation when the potential consequence (i.e. the outcome) occurs with a high probability (outcome-density bias). Given that children and adults differ in several important features involved in causal judgment, including prior knowledge and basic cognitive skills, developmental studies can be considered an outstanding approach to detect and further explore the psychological processes and mechanisms underlying this bias. However, the outcome density bias has been mainly explored in adulthood, and no previous evidence for this bias has been reported in children. Thus, the purpose of this study was to extend outcome-density bias research to childhood. In two experiments, children between 6 and 8 years old were exposed to two similar setups, both showing a non-contingent relation between the potential cause and the outcome. These two scenarios differed only in the probability of the outcome, which could either be high or low. Children judged the relation between the two events to be stronger in the high probability of the outcome setting, revealing that, like adults, they develop causal illusions when the outcome is frequent.	[Manuela Moreno-Fernandez, Maria; Blanco, Fernando; Matute, Helena] Univ Deusto, Dept Fundamentos & Metodos Psicol, Bilbao, Spain	University of Deusto	Moreno-Fernandez, MM (corresponding author), Univ Deusto, Dept Fundamentos & Metodos Psicol, Bilbao, Spain.	manuela.moreno@deusto.es	Moreno-Fernandez, María Manuela/D-8654-2015; Matute, Helena/A-8256-2011; Blanco, Fernando/E-8941-2010; FERNANDEZ, MARIA MANUELA MORENO/U-3060-2019	Blanco, Fernando/0000-0003-1283-8313; FERNANDEZ, MARIA MANUELA MORENO/0000-0002-1747-4128	Agencia Estatal de Investigacion of the Spanish Government (AEI) [PSI2016-78818-R AEI/FEDER]; Fondo Europeo de Desarrollo Regional (FEDER); Basque Government [IT955-16]	Agencia Estatal de Investigacion of the Spanish Government (AEI); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Basque Government(Basque Government)	Support for this research was provided by Grant PSI2016-78818-R AEI/FEDER from Agencia Estatal de Investigacion of the Spanish Government (AEI) and Fondo Europeo de Desarrollo Regional (FEDER), as well as Grant IT955-16 from the Basque Government, both granted to Helena Matute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN LG, 1983, LEARN MOTIV, V14, P381, DOI 10.1016/0023-9690(83)90024-3; ALLAN LG, 1980, CAN J PSYCHOL, V34, P1, DOI 10.1037/h0081013; Allan LG, 2005, LEARN BEHAV, V33, P250; ALLAN LG, 1980, B PSYCHONOMIC SOC, V15, P147; ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Barberia I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071303; Blanco F., 2012, PLOS ONE, V7; Blanco F, 2017, CONSCIOUS COGN, V50, P56, DOI 10.1016/j.concog.2016.08.012; Blanco F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084084; Blanco F, 2013, LEARN BEHAV, V41, P333, DOI 10.3758/s13420-013-0108-8; Blanco F, 2011, Q J EXP PSYCHOL, V64, P1290, DOI 10.1080/17470218.2011.552727; Blanco F, 2010, PSYCHON B REV, V17, P117, DOI 10.3758/PBR.17.1.117; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; CAREY S, 1977, SCIENCE, V195, P312, DOI 10.1126/science.831281; Carey S., 1994, VIS COGN, V1, P253, DOI [DOI 10.1080/13506289408402302, 10.1080/13506289408402302]; Chambers CT, 2002, J PEDIATR PSYCHOL, V27, P27, DOI 10.1093/jpepsy/27.1.27; CHAPMAN LJ, 1967, J ABNORM PSYCHOL, V72, P193, DOI 10.1037/h0024670; Crump MJC, 2007, Q J EXP PSYCHOL, V60, P753, DOI 10.1080/17470210701257685; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Elashi FB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141809; Farah MJ, 1998, PSYCHOL REV, V105, P482, DOI 10.1037/0033-295X.105.3.482; Gallagher MW, 2014, COGNITIVE THER RES, V38, P571, DOI 10.1007/s10608-014-9624-x; Gathercole SE, 1999, TRENDS COGN SCI, V3, P410, DOI 10.1016/S1364-6613(99)01388-1; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 2000, J EDUC PSYCHOL, V92, P377, DOI 10.1037//0022-0663.92.2.377; Gathercole SE, 1998, J CHILD PSYCHOL PSYC, V39, P3, DOI 10.1111/1469-7610.00301; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gopnik A, 2001, DEV PSYCHOL, V37, P620, DOI 10.1037//0012-1649.37.5.620; Gopnik A, 2015, CURR DIR PSYCHOL SCI, V24, P87, DOI 10.1177/0963721414556653; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1234, DOI 10.1073/pnas.0409314102; JENKINS HM, 1965, PSYCHOL MONOGR, V79, P1, DOI 10.1037/h0093874; KAO SF, 1993, J EXP PSYCHOL LEARN, V19, P1363, DOI 10.1037/0278-7393.19.6.1363; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; Larrick R.P., 2004, BLACKWELL HDB JUDGME, P316, DOI [DOI 10.1002/9780470752937.CH16, 10.1002/9780470752937.ch16]; Lewandowsky S, 2012, PSYCHOL SCI PUBL INT, V13, P106, DOI 10.1177/1529100612451018; Lilienfeld SO, 2009, PERSPECT PSYCHOL SCI, V4, P390, DOI 10.1111/j.1745-6924.2009.01144.x; Lucas CG, 2014, COGNITION, V131, P284, DOI 10.1016/j.cognition.2013.12.010; Mandel DR, 2009, Q J EXP PSYCHOL, V62, P2388, DOI 10.1080/17470210902794148; MATUTE H, 1995, Q J EXP PSYCHOL-B, V48, P142; Matute H, 1996, PSYCHOL SCI, V7, P289, DOI 10.1111/j.1467-9280.1996.tb00376.x; Matute H, 2015, FRONT PSYCHOL, V6, P1; Matute H, 2011, BRIT J PSYCHOL, V102, P392, DOI 10.1348/000712610X532210; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Meltzoff AN, 2012, DEV PSYCHOL, V48, P1215, DOI 10.1037/a0027440; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; Moreno-Fernandez MM, 2017, OPEN SCI FRAMEWORK; Morris SC, 2000, DEV PSYCHOL, V36, P582, DOI 10.1037/0012-1649.36.5.582; Msetfi RM, 2017, ACTA PSYCHOL, V178, P1, DOI 10.1016/j.actpsy.2017.05.003; Msetfi RM, 2016, Q J EXP PSYCHOL, V69, P1073, DOI 10.1080/17470218.2016.1138134; Msetfi RM, 2005, J EXP PSYCHOL GEN, V134, P10, DOI 10.1037/0096-3445.134.1.10; Mueller SM, 2013, ACTA PSYCHOL, V144, P472, DOI 10.1016/j.actpsy.2013.08.004; Muller-Lyer FC., 1889, ARCHIV F R ANATOMIE, V2, P263; Musca SC, 2010, CONNECT SCI, V22, P177, DOI 10.1080/09540091003623797; MUTTER SA, 1994, PSYCHOL AGING, V9, P53, DOI 10.1037/0882-7974.9.1.53; Mutter SA, 1996, J GERONTOL B-PSYCHOL, V51, pP70, DOI 10.1093/geronb/51B.2.P70; Mutter SA, 2007, MEM COGNITION, V35, P875, DOI 10.3758/BF03193462; Nakabayashi K, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00831; Parr WV, 1998, CAN J EXP PSYCHOL, V52, P147, DOI 10.1037/h0087288; Perales JC, 2005, J EXP PSYCHOL LEARN, V31, P1105, DOI 10.1037/0278-7393.31.5.1105; Piaget J, 1930, CHILDS CONCEPTION PH; Pronin E, 2004, PSYCHOL REV, V111, P781, DOI 10.1037/0033-295X.111.3.781; Pronin E, 2002, PERS SOC PSYCHOL B, V28, P369, DOI 10.1177/0146167202286008; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Reuven-Magril O, 2008, J ABNORM PSYCHOL, V117, P334, DOI 10.1037/0021-843X.117.2.334; SANDERSON WC, 1989, ARCH GEN PSYCHIAT, V46, P157; Scopelliti I, 2015, MANAGE SCI, V61, P2468, DOI 10.1287/mnsc.2014.2096; SHANKS DR, 1987, PSYCHOL LEARN MOTIV, V21, P229; SHANKS DR, 1991, MEM COGNITION, V19, P353, DOI 10.3758/BF03197139; SHANKS DR, 1991, PSYCHOL SCI, V2, P341, DOI 10.1111/j.1467-9280.1991.tb00163.x; Vadillo MA, 2016, EXP PSYCHOL, V63, P3, DOI 10.1027/1618-3169/a000309; Vallee-Tourangeau F, 2005, Q J EXP PSYCHOL-B, V58, P177, DOI 10.1080/02724990444000104; Waismeyer A, 2015, DEVELOPMENTAL SCI, V18, P175, DOI 10.1111/desc.12208; Waldmann MR, 2001, COGNITION, V82, P27, DOI 10.1016/S0010-0277(01)00141-X; Waldmann MR, 1996, PSYCHOL LEARN MOTIV, V34, P47, DOI 10.1016/S0079-7421(08)60558-7; Wann D. L., 2013, Athletic Insight: The Online Journal of Sport Psychology, V15, punpaginated; WASSERMAN EA, 1990, J EXP PSYCHOL LEARN, V16, P509, DOI 10.1037/0278-7393.16.3.509; WASSERMAN EA, 1990, PSYCHOL LEARN MOTIV, V26, P27, DOI DOI 10.1016/S0079-7421(08)60051-1; White PA, 2009, MEM COGNITION, V37, P500, DOI 10.3758/MC.37.4.500; WONG PTP, 1982, SEX ROLES, V8, P381; Yarritu I, 2015, BRIT J PSYCHOL, V106, P597, DOI 10.1111/bjop.12119; Yarritu I, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00389; Yarritu I, 2014, EXP PSYCHOL, V61, P38, DOI 10.1027/1618-3169/a000225	83	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184707	10.1371/journal.pone.0184707	http://dx.doi.org/10.1371/journal.pone.0184707			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG6AR	28898294	Green Published, gold, Green Submitted			2022-12-27	WOS:000410449500045
J	Cenik, B; Cenik, C; Snyder, MP; Brown, ES				Cenik, Basar; Cenik, Can; Snyder, Michael P.; Brown, E. Sherwood			Plasma sterols and depressive symptom severity in a population-based cohort	PLOS ONE			English	Article							16-ITEM QUICK INVENTORY; REPORT QIDS-SR; MAJOR DEPRESSION; LIPID RAFTS; CHOLESTEROL; EPIDEMIOLOGY; ASSOCIATION; PREVALENCE; OXYSTEROLS; METABOLISM	Convergent evidence strongly suggests major depressive disorder is heterogeneous in its etiology and clinical characteristics. Depression biomarkers hold potential for identifying etiological subtypes, improving diagnostic accuracy, predicting treatment response, and personalization of treatment. Human plasma contains numerous sterols that have not been systematically studied. Changes in cholesterol concentrations have been implicated in suicide and depression, suggesting plasma sterols may be depression biomarkers. Here, we investigated associations between plasma levels of 34 sterols (measured by mass spectrometry) and scores on the Quick Inventory of Depressive Symptomatology-Self Report (QIDS-SR16) scale in 3117 adult participants in the Dallas Heart Study, an ethnically diverse, population-based cohort. We built a random forest model using feature selection from a pool of 43 variables including demographics, general health indicators, and sterol concentrations. This model comprised 19 variables, 13 of which were sterol concentrations, and explained 15.5% of the variation in depressive symptoms. Desmosterol concentrations below the fifth percentile (1.9 ng/mL, OR 1.9, 95% CI 1.2-2.9) were significantly associated with depressive symptoms of at least moderate severity (QIDS-SR16 score >= 10.5). This is the first study reporting a novel association between plasma concentrations cholesterol precursors and depressive symptom severity.	[Cenik, Basar; Brown, E. Sherwood] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Cenik, Can; Snyder, Michael P.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Stanford University	Brown, ES (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA.	sherwood.brown@utsouthwestern.edu		Snyder, Michael/0000-0003-0784-7987; Cenik, Can/0000-0001-6370-0889	NATIONAL CANCER INSTITUTE [K99CA204522] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001105] Funding Source: Medline; NCI NIH HHS [K99 CA204522] Funding Source: Medline; NIMH NIH HHS [R25 MH101078] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Anglin RES, 2013, BRIT J PSYCHIAT, V202, P100, DOI 10.1192/bjp.bp.111.106666; Beasley CL, 2005, BIPOLAR DISORD, V7, P449, DOI 10.1111/j.1399-5618.2005.00239.x; Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016; Bjorkholm C, 2016, NEUROPHARMACOLOGY, V102, P72, DOI 10.1016/j.neuropharm.2015.10.034; Boscarino JA, 2009, J PSYCHIATR RES, V43, P848, DOI 10.1016/j.jpsychires.2008.11.007; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, MACH LEARN, V45, P5; Cantarelli MD, 2014, PSYCHIAT RES, V220, P745, DOI 10.1016/j.psychres.2014.10.017; Dubrovsky BO, 2005, PROG NEURO-PSYCHOPH, V29, P169, DOI 10.1016/j.pnpbp.2004.11.001; Fiedorowicz JG, 2007, PSYCHIAT RES, V152, P11, DOI 10.1016/j.psychres.2006.09.003; Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6; Hasin DS, 2005, ARCH GEN PSYCHIAT, V62, P1097, DOI 10.1001/archpsyc.62.10.1097; Hasler G, 2010, WORLD PSYCHIATRY, V9, P155; Hastie T., 2016, R PACKAGE VERSION 1; Huang TL, 2015, ADV CLIN CHEM, V68, P177, DOI 10.1016/bs.acc.2014.11.003; Javitt NB, 2008, STEROIDS, V73, P149, DOI 10.1016/j.steroids.2007.10.004; Korade Z, 2017, SCHIZOPHR RES; Kuhn M., 2016, CARET CLASSIFICATION; Lalovic A, 2007, INT J NEUROPSYCHOPH, V10, P159, DOI 10.1017/S1461145706006663; Lauth M, 2010, MOL PHARMACOL, V78, P486, DOI 10.1124/mol.110.066431; Linsenbardt AJ, 2014, NEUROPHARMACOLOGY, V85, P232, DOI 10.1016/j.neuropharm.2014.05.027; McDonald JG, 2012, J LIPID RES, V53, P1399, DOI 10.1194/jlr.D022285; MORGAN RE, 1993, LANCET, V341, P75, DOI 10.1016/0140-6736(93)92556-9; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nowaczyk MJM, 2012, AM J MED GENET C, V160C, P250, DOI 10.1002/ajmg.c.31343; Partonen T, 1999, BRIT J PSYCHIAT, V175, P259, DOI 10.1192/bjp.175.3.259; Patten SB, 2006, CAN J PSYCHIAT, V51, P84, DOI 10.1177/070674370605100204; Paul SM, 2013, J NEUROSCI, V33, P17290, DOI 10.1523/JNEUROSCI.2619-13.2013; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Raeder MB, 2006, NEUROSCI LETT, V395, P185, DOI 10.1016/j.neulet.2005.10.096; Reilly TJ, 2015, J PSYCHIATR RES, V60, P132, DOI 10.1016/j.jpsychires.2014.09.008; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Rush AJ, 2004, CONTROL CLIN TRIALS, V25, P119, DOI 10.1016/S0197-2456(03)00112-0; Rush AJ, 1996, PSYCHOL MED, V26, P477, DOI 10.1017/S0033291700035558; Singh P, 2011, BBA-BIOMEMBRANES, V1808, P2428, DOI 10.1016/j.bbamem.2011.06.022; Steegmans PHA, 2000, PSYCHOSOM MED, V62, P205, DOI 10.1097/00006842-200003000-00009; Stiles AR, 2014, P NATL ACAD SCI USA, V111, pE4006, DOI 10.1073/pnas.1413561111; Trivedi MH, 2004, PSYCHOL MED, V34, P73, DOI 10.1017/S0033291703001107; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Vega GL, 2006, J CLIN ENDOCR METAB, V91, P4459, DOI 10.1210/jc.2006-0814; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Weaver A, 2015, JAMA PSYCHIAT, V72, P576, DOI 10.1001/jamapsychiatry.2015.10; Wellington CL, 2016, CURR OPIN LIPIDOL, V27, P225, DOI 10.1097/MOL.0000000000000291; Weston S., 2015, R PACKAGE VERSION 1; Wu SQ, 2016, J PSYCHIATR NEUROSCI, V41, P56, DOI 10.1503/jpn.150079; Zhang J, 2015, PROTEIN CELL, V6, P254, DOI 10.1007/s13238-014-0131-3	46	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184382	10.1371/journal.pone.0184382	http://dx.doi.org/10.1371/journal.pone.0184382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886149	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100106
J	Eitas, TK; Stepp, W; Sjeklocha, L; Long, C; Riley, C; Callahan, J; Sanchez, Y; Gough, P; Knowlin, L; van Duin, D; Ortiz-Pujols, S; Jones, S; Maile, R; Hong, Z; Berger, S; Cairns, B				Eitas, Timothy K.; Stepp, Wesley; Sjeklocha, Lucas; Long, Clayton; Riley, Caitlin; Callahan, James; Sanchez, Yolanda; Gough, Peter; Knowlin, Laquanda; van Duin, David; Ortiz-Pujols, Shiara; Jones, Samuel; Maile, Robert; Hong, Zhi; Berger, Scott; Cairns, Bruce			Differential regulation of innate immune cytokine production through pharmacological activation of Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) in burn patient immune cells and monocytes	PLOS ONE			English	Article							CHEMOATTRACTANT PROTEIN-1 MCP-1; FAILURE ASSESSMENT SCORE; ACUTE KIDNEY INJURY; BARDOXOLONE METHYL; INFLAMMASOME ACTIVATION; CDDO-ME; POLYMORPHISMS; PREVENTION; EXPRESSION; BIOMARKERS	Burn patients suffer from immunological dysfunction for which there are currently no successful interventions. Similar to previous observations, we find that burn shock patients (>= 15% Total Burn Surface Area (TBSA) injury) have elevated levels of the innate immune cytokines Interleukin-6 (IL-6) and Monocyte Chemoattractant Protein-1 (MCP-1)/CC-motif Chemokine Ligand 2(CCL2) early after hospital admission (0-48 Hours Post-hospital Admission (HPA). Functional immune assays with patient Peripheral Blood Mononuclear Cells (PBMCs) revealed that burn shock patients (>= 15% TBSA) produced elevated levels of MCP-1/CCL2 after innate immune stimulation ex vivo relative to mild burn patients. Interestingly, treatment of patient PBMCs with the Nuclear Factor-Erythroid-2-Related Factor 2 (NRF2) agonist, CDDO-Me(bardoxolone methyl), reduced MCP-1 production but not IL-6 or Interleukin-10 (IL-10) secretion. In enriched monocytes from healthy donors, CDDO-Me (bardoxolone methyl) also reduced LPS-induced MCP1/CCL2 production but did not alter IL-6 or IL-10 secretion. Similar immunomodulatory effects were observed with Compound 7, which activates the NRF2 pathway through a different and non-covalent Mechanism Of Action (MOA). Hence, our findings with CDDO-Me(bardoxolone methyl) and Compound 7 are likely to reflect a generalizable aspect of NRF2 activation. These observed effects were not specific to LPS-induced immune responses, as NRF2 activation also reduced MCP1/CCL2 production after stimulation with IL-6. Pharmacological NRF2 activation reduced Mcp-1/Ccl2 transcript accumulation without inhibiting either II-6 or II-10 transcript levels. Hence, we describe a novel aspect of NRF2 activation that may contribute to the beneficial effects of NRF2 agonists during disease. Our work also demonstrates that the NRF2 pathway is retained and can be modulated to regulate important immunomodulatory functions in burn patient immune cells.	[Eitas, Timothy K.; Gough, Peter; Berger, Scott] GlaxoSmithKline, Infect Dis Therapy Area Unit, Host Def Discovery Performance Unit, Collegeville, PA 19426 USA; [Stepp, Wesley; Sjeklocha, Lucas; Long, Clayton; Riley, Caitlin; Knowlin, Laquanda; Ortiz-Pujols, Shiara; Jones, Samuel; Maile, Robert; Cairns, Bruce] Univ North Carolina Chapel Hill, Dept Surg, Chapel Hill, NC 27599 USA; [Callahan, James; Sanchez, Yolanda] GlaxoSmithKline, Resp Therapy Area Unit, Stress & Repair Discovery Performance Unit, Upper Merion, PA USA; [van Duin, David] Univ North Carolina Chapel Hill, Div Infect Dis, Chapel Hill, NC USA; [Hong, Zhi] GlaxoSmithKline, Infect Dis Therapy Area Unit, Durham, NC USA	GlaxoSmithKline; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; GlaxoSmithKline; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; GlaxoSmithKline	Berger, S (corresponding author), GlaxoSmithKline, Infect Dis Therapy Area Unit, Host Def Discovery Performance Unit, Collegeville, PA 19426 USA.; Cairns, B (corresponding author), Univ North Carolina Chapel Hill, Dept Surg, Chapel Hill, NC 27599 USA.	scott.b.berger@gsk.com; bruce_cairns@med.unc.edu	van Duin, David/AAH-7085-2019	van Duin, David/0000-0003-4784-3227; Sjeklocha, Lucas/0000-0003-0658-3377; Stepp, Wesley/0000-0003-2213-1872; Maile, Robert/0000-0002-9126-4188	GlaxoSmithKline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008450, K08GM109106] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The project was funded by GlaxoSmithKline. The funder provided support in the form of salaries for authors (TKE, JC, YS, PG, ZH, SB), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Biswas P, 1998, BLOOD, V91, P258, DOI 10.1182/blood.V91.1.258.258_258_265; Brenner D, 2006, STROKE, V37, P1691, DOI 10.1161/01.STR.0000226565.76113.6c; Chen Z, 2016, ONCOTARGET, P8189; Davies TG, 2016, J MED CHEM, V59, P3991, DOI 10.1021/acs.jmedchem.6b00228; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Eba S, 2013, AM J RESP CELL MOL, V49, P324, DOI 10.1165/rcmb.2011-0396OC; Franz MG, 2007, CURR PROB SURG, V44, P691, DOI 10.1067/j.cpsurg.2007.07.001; Furukawa K, 2002, ANN SURG, V236, P112, DOI 10.1097/00000658-200207000-00017; Gopal S, 2017, MULT SCLER; Grunwell JR, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1052-0; Hong DS, 2012, CLIN CANCER RES, V18, P3396, DOI 10.1158/1078-0432.CCR-11-2703; Ishikawa T, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00383; Jeschke MG, 2014, ANN SURG, V259, P814, DOI 10.1097/SLA.0b013e31828dfbf1; JESCHKE MG, 2007, CRIT CARE, V11, P45501; Jones AE, 2009, CRIT CARE MED, V37, P1649, DOI 10.1097/CCM.0b013e31819def97; Kitamura T, 2015, J EXP MED, V212, P1043, DOI 10.1084/jem.20141836; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Maile R, 2015, AM J PHYSIOL-LUNG C, V308, pL855, DOI 10.1152/ajplung.00321.2014; Martin-Ventura JL, 2009, REV ESP CARDIOL, V62, P677, DOI 10.1016/S0300-8932(09)71335-1; Marzec JM, 2007, FASEB J, V21, P2237, DOI 10.1096/fj.06-7759com; Noel S, 2014, SHOCK, V42, P392, DOI 10.1097/SHK.0000000000000236; Pandharipande PP, 2009, CRIT CARE MED, V37, P1317, DOI 10.1097/CCM.0b013e31819cefa9; Peck M, 2009, B WORLD HEALTH ORGAN, V87, P802, DOI 10.2471/BLT.08.059733; Pienta KJ, 2013, INVEST NEW DRUG, V31, P760, DOI 10.1007/s10637-012-9869-8; Ramnath RD, 2008, INT IMMUNOPHARMACOL, V8, P810, DOI 10.1016/j.intimp.2008.01.033; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Rosseau S, 2000, AM J PHYSIOL-LUNG C, V279, pL25, DOI 10.1152/ajplung.2000.279.1.L25; Rowan MP, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0961-2; Ruiz-Castilla M, 2016, SHOCK, V45, P117, DOI 10.1097/SHK.0000000000000497; Ruotsalainen AK, 2013, CARDIOVASC RES, V98, P107, DOI 10.1093/cvr/cvt008; Shelton LM, 2013, KIDNEY INT, V84, P1090, DOI 10.1038/ki.2013.248; Shimoyama Y, 2014, INT J MED SCI, V11, P726, DOI 10.7150/ijms.8590; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Wakabayashi N, 2010, ANTIOXID REDOX SIGN, V13, P1649, DOI 10.1089/ars.2010.3216; Walsh J, 2014, J PROTEOMICS, V108, P171, DOI 10.1016/j.jprot.2014.05.007; Wang YY, 2014, DRUG DES DEV THER, V8, P2075, DOI 10.2147/DDDT.S68872; Wise RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163716; Wu J, 2014, TOXICOLOGY, V318, P22, DOI 10.1016/j.tox.2014.01.008; Yeh FL, 2000, BURNS, V26, P454, DOI 10.1016/S0305-4179(99)00174-6; Yore MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022862; YOSHIMURA T, 1989, FEBS LETT, V244, P487, DOI 10.1016/0014-5793(89)80590-3; Zhao CC, 2014, J BIOL CHEM, V289, P17020, DOI 10.1074/jbc.M114.563114	47	13	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184164	10.1371/journal.pone.0184164	http://dx.doi.org/10.1371/journal.pone.0184164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886135	gold, Green Submitted, Green Published			2022-12-27	WOS:000410001100073
J	Estrada-Aviles, R; Rodriguez, G; Zarain-Herzberg, A				Estrada-Aviles, Rafael; Rodriguez, Gabriela; Zarain-Herzberg, Angel			The cardiac calsequestrin gene transcription is modulated at the promoter by NFAT and MEF-2 transcription factors	PLOS ONE			English	Article							SKELETAL-MUSCLE DEVELOPMENT; SARCOPLASMIC-RETICULUM; HEART-FAILURE; OVEREXPRESSING CALSEQUESTRIN; RYANODINE RECEPTOR; CALCINEURIN; EXPRESSION; CALCIUM; HYPERTROPHY; PROTEINS	Calsequestrin-2 (CASQ2) is the main Ca2+-binding protein inside the sarcoplasmic reticulum of cardiomyocytes. Previously, we demonstrated that MEF-2 and SRF binding sites within the human CASQ2 gene (hCASQ2) promoter region are functional in neonatal cardiomyocytes. In this work, we investigated if the calcineurin/NFAT pathway regulates hCASQ2 expression in neonatal cardiomyocytes. The inhibition of NFAT dephosphorylation with CsA or INCA-6, reduced both the luciferase activity of hCASQ2 promoter constructs (-3102/+176 bp and -288/+176 bp) and the CASQ2 mRNA levels in neonatal rat cardiomyocytes. Additionally, NFATc1 and NFATc3 over-expressing neonatal cardiomyocytes showed a 2-3-fold increase in luciferase activity of both hCASQ2 promoter constructs, which was prevented by CsA treatment. Site-directed mutagenesis of the -133 bp MEF-2 binding site prevented trans-activation of hCASQ2 promoter constructs induced by NFAT overexpression. Chromatin Immunoprecipitation (ChIP) assays revealed NFAT and MEF-2 enrichment within the -288 bp to +76 bp of the hCASQ2 gene promoter. Besides, a direct interaction between NFAT and MEF-2 proteins was demonstrated by protein co-immunoprecipitation experiments. Taken together, these data demonstrate that NFAT interacts with MEF-2 bound to the -133 bp binding site at the hCASQ2 gene promoter. In conclusion, in this work, we demonstrate that the Ca2+-calcineurin/NFAT pathway modulates the transcription of the hCASQ2 gene in neonatal cardiomyocytes.	[Estrada-Aviles, Rafael; Rodriguez, Gabriela; Zarain-Herzberg, Angel] Univ Nacl Autonoma Mexico, Sch Med, Dept Biochem, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Zarain-Herzberg, A (corresponding author), Univ Nacl Autonoma Mexico, Sch Med, Dept Biochem, Mexico City, DF, Mexico.	zarain@unam.mx		Zarain-Herzberg, Angel/0000-0002-1916-4780	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [164413]; CONACyT [57838]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was funded by Consejo Nacional de Ciencia y Tecnologia (CONACYT) grant 164413 to A.Z.-H. and by a Scholarship CONACyT No. 57838 to R.E.-A. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; ARAI M, 1991, GENE, V109, P275, DOI 10.1016/0378-1119(91)90621-H; ARAI M, 1992, AM J PHYSIOL, V262, pC614, DOI 10.1152/ajpcell.1992.262.3.C614; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Beard NA, 2009, CLIN EXP PHARMACOL P, V36, P340, DOI 10.1111/j.1440-1681.2008.05094.x; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Birkeland JA, 2005, SCAND CARDIOVASC J, V39, P13, DOI 10.1080/14017430410004632; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Bosc LVG, 2005, J BIOL CHEM, V280, P26113, DOI 10.1074/jbc.M411972200; Chopra N, 2009, J CARDIOVASC ELECTR, V20, P1179, DOI 10.1111/j.1540-8167.2009.01531.x; CLAYCOMB WC, 1981, EXP CELL RES, V131, P231, DOI 10.1016/0014-4827(81)90423-7; Doevendans PA, 1996, INT J BIOCHEM CELL B, V28, P387, DOI 10.1016/1357-2725(95)00145-X; Frank KF, 2001, BASIC RES CARDIOL, V96, P636, DOI 10.1007/s003950170016; Gyorke S, 2009, J PHYSIOL-LONDON, V587, P3091, DOI 10.1113/jphysiol.2009.172049; Haddad R, 2013, CAN J PHYSIOL PHARM, V91, P741, DOI 10.1139/cjpp-2013-0014; Hanninen SL, 2010, CARDIOVASC RES, V88, P75, DOI 10.1093/cvr/cvq180; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ihara Y, 2002, CELL CALCIUM, V32, P21, DOI 10.1016/S0143-4160(02)00096-9; Im SH, 2004, MOL CELLS, V18, P1; Jones LR, 1998, J CLIN INVEST, V101, P1385, DOI 10.1172/JCI1362; Kasneci A, 2009, CARDIOVASC RES, V81, P695, DOI 10.1093/cvr/cvn357; Kiarash A, 2004, CARDIOVASC RES, V63, P264, DOI 10.1016/j.cardiores.2004.04.001; Korzick DH, 2003, ADV PHYSIOL EDUC, V27, P192, DOI 10.1152/advan.00028.2003; Kubalova Z, 2005, P NATL ACAD SCI USA, V102, P14104, DOI 10.1073/pnas.0504298102; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; Kuwahara K, 2010, ENDOCR J, V57, P555, DOI 10.1507/endocrj.K10E-150; Lee D, 2010, BMB REP, V43, P151, DOI 10.5483/BMBRep.2010.43.3.151; Lehnart SE, 1998, ANN NY ACAD SCI, V853, P220, DOI 10.1111/j.1749-6632.1998.tb08270.x; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; Meissner JD, 2007, J CELL PHYSIOL, V211, P138, DOI 10.1002/jcp.20916; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Musaro A, 1999, NATURE, V400, P581, DOI 10.1038/23060; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Protasi F, 2011, J MUSCLE RES CELL M, V32, P257, DOI 10.1007/s10974-011-9277-2; Reyes-Juarez JL, 2007, J BIOL CHEM, V282, P35554, DOI 10.1074/jbc.M707788200; Rinne A, 2010, AM J PHYSIOL-HEART C, V298, pH2001, DOI 10.1152/ajpheart.01072.2009; Roehrl MHA, 2004, P NATL ACAD SCI USA, V101, P7554, DOI 10.1073/pnas.0401835101; Rossi AE, 2006, MUSCLE NERVE, V33, P715, DOI 10.1002/mus.20512; Rossi D, 2008, TRAFFIC, V9, P1044, DOI 10.1111/j.1600-0854.2008.00717.x; Sanchez EJ, 2012, J BIOL CHEM, V287, P11592, DOI 10.1074/jbc.M111.335075; Sato Y, 1998, J BIOL CHEM, V273, P28470, DOI 10.1074/jbc.273.43.28470; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Schwinger RHG, 1999, J MOL CELL CARDIOL, V31, P479, DOI 10.1006/jmcc.1998.0897; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Wada H, 2002, J CELL BIOL, V156, P983, DOI 10.1083/jcb.200106057; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zima AV, 2014, PFLUG ARCH EUR J PHY, V466, P1129, DOI 10.1007/s00424-014-1469-3	50	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184724	10.1371/journal.pone.0184724	http://dx.doi.org/10.1371/journal.pone.0184724			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886186	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100180
J	Guan, WJ; Yuan, JJ; Huang, Y; Li, HM; Chen, RC; Zhong, NS				Guan, Wei-jie; Yuan, Jing-jing; Huang, Yan; Li, Hui-min; Chen, Rong-chang; Zhong, Nan-shan			Residual volume/total lung capacity ratio confers limited additive significance to lung clearance index for assessment of adults with bronchiectasis	PLOS ONE			English	Article							INERT-GAS WASHOUT; PULMONARY-FUNCTION; CYSTIC-FIBROSIS; COPD PATIENTS; HYPERINFLATION; CHILDREN; DISEASE; RESPONSIVENESS; TESTS; FLOW	Background Mosaicism and hyperinflation are common pathophysiologic features of bronchiectasis. The magnitude of ventilation heterogeneity might have been affected by the degree of hyperinflation. Some studies have evaluated the discriminative performance of lung clearance index (LCI) in bronchiectasis patients, but the additive diagnostic value of hyperinflation metrics to LCI is unknown. Objective To compare LCI and the ratio of residual volume to total lung capacity (RV/TLC), along with the LCI normalized with RV/TLC, in terms of discriminative performance, correlation and concordance with clinical variables in adults with bronchiectasis. Methods Measurement items included chest high-resolution computed tomography, multiple-breath nitrogen washout test, spirometry, and sputum culture. We analyzed bronchodilator responses by stratifying LCI and RV/TLC according to their median levels (LCIHigh/RV/TLCHigh, LCILow/RV/TLCHigh, LCIHigh/RV/TLCLow, and LCILow/RV/TLCLow). Results Data from 127 adults with clinically stable bronchiectasis were analyzed. LCI had greater diagnostic value than RV/TLC in discriminating moderate-to-severe from mild bronchiectasis, had greater concordance in reflecting clinical characteristics (including the number of bronchiectatic lobes, radiological severity score, and the presence of cystic bronchiectasis). Normalization of LCI with RV/TLC did not contribute to greater discriminative performance or concordance with clinical variables. The LCI, before and after normalization with RV/TLC, correlated statistically with age, sex, HRCT score, Pseudomonas aeruginosa colonization, cystic bronchiectasis, and ventilation heterogeneity (all P < 0.05). Different bronchodilator responses were not significant among the four subgroups of bronchiectasis patients, including those with discordant LCI and RV/TLC levels. Conclusion LCI is superior to RV/TLC for bronchiectasis assessment. Normalization with RV/TLC is not required. Stratification of LCI and RV/TLC is not associated with significantly different bronchodilator responses.	[Guan, Wei-jie; Yuan, Jing-jing; Huang, Yan; Li, Hui-min; Chen, Rong-chang; Zhong, Nan-shan] Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China; [Guan, Wei-jie] Guangzhou Med Univ, Sino French Hoffmann Inst, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University	Guan, WJ; Chen, RC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Natl Clin Res Ctr Resp Dis, State Key Lab Resp Dis,Guangzhou Inst Resp Dis, Guangzhou, Guangdong, Peoples R China.; Guan, WJ (corresponding author), Guangzhou Med Univ, Sino French Hoffmann Inst, Guangzhou, Guangdong, Peoples R China.	battery203@.163.com; chenrc@vip.163.com	Guan, Wei-jie/K-8257-2019		National Natural Science Foundation [81400010, 81500006]; Pearl River S&T Nova Program of Guangzhou [201710010097]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Changjiang Scholars and Innovative Research Team in University [ITR0961]; National Key Technology R&D Program of the 12th National Five-year Development Plan [2012BAI05B01]; National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer [2013BAI09B09]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Pearl River S&T Nova Program of Guangzhou; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Key Technology R&D Program of the 12th National Five-year Development Plan(National Key Technology R&D Program); National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer	This study was supported by National Natural Science Foundation no. 81400010, Pearl River S&T Nova Program of Guangzhou no. 201710010097, and Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme 2017 (to Dr. Guan), National Natural Science Foundation no. 81500006 (to Dr. Gao), Changjiang Scholars and Innovative Research Team in University ITR0961, The National Key Technology R&D Program of the 12th National Five-year Development Plan 2012BAI05B01 and National Key Scientific & Technology Support Program: Collaborative innovation of Clinical Research for chronic obstructive pulmonary disease and lung cancer no. 2013BAI09B09 (to Profs. Zhong and Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrill J, 2001, AM J RESP CRIT CARE, V164, P1628, DOI 10.1164/ajrccm.164.9.2105083; Chalmers JD, 2014, AM J RESP CRIT CARE, V189, P576, DOI 10.1164/rccm.201309-1575OC; Chen CL, 2016, INT J CHRONIC OBSTR, V11, P2519, DOI 10.2147/COPD.S110021; Davies G, 2006, EUR RESPIR J, V28, P974, DOI 10.1183/09031936.06.00074605; Gonem S, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-59; Grillo L, 2015, EUR RESPIR J, V46, P1645, DOI 10.1183/13993003.00152-2015; Guan WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28467; Guan WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113373; Gustafsson PM, 2008, THORAX, V63, P129, DOI 10.1136/thx.2007.077784; Haidopoulou K, 2012, RESP PHYSIOL NEUROBI, V180, P247, DOI 10.1016/j.resp.2011.11.016; Irving SJ, 2013, AM J RESP CRIT CARE, V188, P545, DOI 10.1164/rccm.201304-0800OC; Kraemer R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-138; Martinez-Garcia MA, 2007, RESP MED, V101, P2248, DOI 10.1016/j.rmed.2007.06.028; McCartney CT, 2016, RESP CARE, V61, P1505, DOI 10.4187/respcare.04323; O'Neill K, 2016, CHEST, V150, P1323, DOI 10.1016/j.chest.2016.06.029; Owens CM, 2011, THORAX, V66, P481, DOI 10.1136/thx.2010.150375; REIFF DB, 1995, AM J ROENTGENOL, V165, P261, DOI 10.2214/ajr.165.2.7618537; Roberts HR, 2000, THORAX, V55, P198, DOI 10.1136/thorax.55.3.198; Robinson PD, 2013, EUR RESPIR J, V41, P507, DOI 10.1183/09031936.00069712; Rossi A, 2015, RESP MED, V109, P785, DOI 10.1016/j.rmed.2015.03.010; Rowan SA, 2014, AM J RESP CRIT CARE, V189, P586, DOI 10.1164/rccm.201310-1747OC; Stahl M, 2017, AM J RESP CRIT CARE, V195, P349, DOI 10.1164/rccm.201604-0893OC; Verbanck S, 2012, J APPL PHYSIOL, V112, P782, DOI 10.1152/japplphysiol.01221.2011; Zhang W, 2015, RESPIROLOGY, V20, P618, DOI 10.1111/resp.12504; Zheng JP, 2002, CHINESE MED J-PEKING, V115, P50; Zheng L, 2002, EUR RESPIR J, V20, P170, DOI 10.1183/09031936.02.00282402	26	3	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183779	10.1371/journal.pone.0183779	http://dx.doi.org/10.1371/journal.pone.0183779			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886040	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100038
J	Lackermair, K; Clauss, S; Voigt, T; Klier, I; Summo, C; Hildebrand, B; Nickel, T; Estner, L; Kaab, S; Wakili, R; Wilbert-Lampen, U				Lackermair, K.; Clauss, S.; Voigt, T.; Klier, I.; Summo, C.; Hildebrand, B.; Nickel, T.; Estner, L.; Kaeaeb, S.; Wakili, R.; Wilbert-Lampen, U.			Alteration of Endothelin 1, MCP-1 and Chromogranin A in patients with atrial fibrillation undergoing pulmonary vein isolation	PLOS ONE			English	Article							WORLD-CUP SOCCER; AUTONOMIC DENERVATION; ARRHYTHMOGENIC ACTION; CATHETER ABLATION; HEART-FAILURE; STRESS; TRIAL; ASSOCIATION; PREDICTOR; DISEASE	Background The relation between arrhythmias and stress is known. The aim of our current study was to elucidate whether plasma levels of previously described stress parameters are altered in highly symptomatic patients with atrial fibrillation (AF) per se and in patients undergoing ablation therapy by pulmonary vein isolation (PVI). Methods 96 patients with AF undergoing PVI were recruited. Plasma levels of Endothelin-1 (ET-1), MCP-1 and Chromogranin-A (CGA) were measured before and three months after ablation completed with clinical follow-up with respect to AF recurrence. Additionally, we examined 40 healthy age-and sex-matched volunteers as a reference. Results Symptomatic AF patients showed increased levels of ET-1 compared to healthy controls (2.62pg/ml vs. 1.57pg/ml; p<0.01). Baseline levels of ET-1 were higher in patients presenting with AF after PVI (2.96pg/ml vs. 2.57pg/ml; p = 0.02). The temporal comparison revealed decreased ET-1 levels in patients without (2.57pg/ml vs. 2.33pg/ml; p< 0.01) and unchanged ET-1 levels in patients with AF after PVI. Baseline MCP-1 was increased in AF patients vs. controls (268pg/ml vs. 227 pg/ml; p = 0.03). Both groups, with and without AF after PVI, showed an increase of MCP-1 compared to baseline (268pg/ml vs. 349pg/ml; p< 0.01; 281pg/ml vs. 355pg/ml; p = 0.03). CGA was lower in AF patients compared to healthy controls (13.8ng/ml vs. 25.6ng/ml; p< 0.01). Over time patients without AF after PVI showed an increase of CGA (14.2ng/ml vs. 20.7ng/ml; p< 0.01). No change was observed in patients with AF after PVI. Conclusion Our study demonstrated dysregulated levels of ET-1, MCP-1 and CGA in symptomatic AF patients. We could demonstrate an association between ET-1 to presence or absence of AF. Furthermore, we could show that a decrease of ET-1 as well as an increase of CGA after PVI, representing a trend towards control cohort levels, were both associated with restoration of sinus rhythm. These results provide new insights into the role of stress-related biomarkers in AF and AF treatment by ablation therapy.	[Lackermair, K.; Clauss, S.; Voigt, T.; Klier, I.; Summo, C.; Hildebrand, B.; Nickel, T.; Estner, L.; Kaeaeb, S.; Wakili, R.; Wilbert-Lampen, U.] Univ Munich LMU, Dept Med 1, Klinikum Grosshadern, Munich, Germany; [Clauss, S.; Wakili, R.] DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Partner Site Munich, Munich, Germany; [Wakili, R.] Univ Duisburg Essen, Univ Essen, Dept Cardiol & Vasc Med, West German Heart & Vasc Ctr Essen,Med Sch, Essen, Germany	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Duisburg Essen	Wakili, R (corresponding author), Univ Munich LMU, Dept Med 1, Klinikum Grosshadern, Munich, Germany.; Wakili, R (corresponding author), DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Partner Site Munich, Munich, Germany.; Wakili, R (corresponding author), Univ Duisburg Essen, Univ Essen, Dept Cardiol & Vasc Med, West German Heart & Vasc Ctr Essen,Med Sch, Essen, Germany.	reza.wakili@uk-essen.de	Carmine, Summo/ABC-6239-2021; Clauss, Sebastian/HDL-7189-2022	Clauss, Sebastian/0000-0002-5675-6128	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [PIOF-GA-2012-328352]; German Centre for Cardiovascular Research (DZHK) [81X2600210, 81X2600204]; European Union's Horizon research and innovation programme [633193]	Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme; German Centre for Cardiovascular Research (DZHK); European Union's Horizon research and innovation programme	Dr. Clauss was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (PIOF-GA-2012-328352). Dres. Clauss, Wakili and Kaab were supported by the German Centre for Cardiovascular Research (DZHK; 81X2600210, 81X2600204). Dres. Wakili and Kaab received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 633193 (CATCH ME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Clauss was supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (PIOF-GA-2012-328352). Dres. Clauss, Wakili and Ka E a E b were supported by the German Centre for Cardiovascular Research (DZHK; 81X2600210, 81X2600204). Dres. Wakili and Ka E a E b received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 633193 (CATCH ME).	Afzal MR, 2017, EXPERT REV CARDIOVAS, V15, P227, DOI 10.1080/14779072.2017.1294064; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Burg MM, 2011, MOL MED, V17, P495, DOI 10.2119/molmed.2010.00083; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Ceconi C, 2002, EUR HEART J, V23, P967, DOI 10.1053/euhj.2001.2977; COUMEL P, 1994, EUR HEART J, V15, P9, DOI 10.1093/eurheartj/15.suppl_A.9; COUMEL P, 1994, ARCH MAL COEUR VAISS, V87, P55; Di Comite G, 2011, J HYPERTENS, V29, P409, DOI 10.1097/HJH.0b013e328341a429; Endoh M, 1998, LIFE SCI, V62, P1485, DOI 10.1016/S0024-3205(98)00094-0; Engelhardt E, 1998, AM J PATHOL, V153, P1849, DOI 10.1016/S0002-9440(10)65699-4; Fabritz L, 2016, NAT REV CARDIOL, V13, P230, DOI 10.1038/nrcardio.2015.194; Hansson Anders, 2004, BMC Cardiovasc Disord, V4, P13, DOI 10.1186/1471-2261-4-13; Katritsis DG, 2013, J AM COLL CARDIOL, V62, P2318, DOI 10.1016/j.jacc.2013.06.053; Katritsis DG, 2011, HEART RHYTHM, V8, P672, DOI 10.1016/j.hrthm.2010.12.047; Katritsis GD, 2014, ARRHYTH ELECTROPHYSI, V3, P113, DOI 10.15420/aer.2014.3.2.113; Kurotobi T, 2015, HEART RHYTHM, V12, P470, DOI 10.1016/j.hrthm.2014.11.033; Lau DH, 2016, EUR HEART J, V37, P1573, DOI 10.1093/eurheartj/ehv375; Lewicka E, 2014, INT J CARDIOL; Low QEH, 2001, AM J PATHOL, V159, P457, DOI 10.1016/S0002-9440(10)61717-8; Lyman GH, 2016, NEW ENGL J MED, V375, P4, DOI 10.1056/NEJMp1604033; Maryniak A, 2006, KARDIOL POL, V64; Maryniak Agnieszka, 2006, Kardiol Pol, V64, P1102; Mattioli AV, 2005, EUROPACE, V7, P211, DOI 10.1016/j.eupc.2004.02.006; Mayyas F, 2010, CIRC-ARRHYTHMIA ELEC, V3, P369, DOI 10.1161/CIRCEP.109.924985; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Merkely B, 2000, CARDIOVASC RES, V48, P357, DOI 10.1016/S0008-6363(00)00200-5; Merkely B, 2000, J CARDIOVASC PHARM, V36, pS314; Miyazaki S, 2016, HEART RHYTHM, V13, P1010, DOI 10.1016/j.hrthm.2015.12.031; Modlin IM, 2010, ANN SURG ONCOL, V17, P2427, DOI 10.1245/s10434-010-1006-3; Nakazawa Y, 2009, HEART RHYTHM, V6, P725, DOI 10.1016/j.hrthm.2009.02.027; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; Nickel T, 2012, ATHEROSCLEROSIS, V220, P219, DOI 10.1016/j.atherosclerosis.2011.09.036; Pieroni M, 2007, EUR HEART J, V28, P1117, DOI 10.1093/eurheartj/ehm022; Pugazhendhi Vijayaraman SAW, 2016, J INTERVENTIONAL CAR, V45, P246; Qin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164989; Rosjo H, 2010, EUR J HEART FAIL, V12, P549, DOI 10.1093/eurjhf/hfq055; Sarah Worsnick P, 2016, GEISINGER HLTH SYSTE, pS48; Schonfelder A RP, 2006, SCHWEIZ MED FORUM, P45; Trautmann A, 2000, J PATHOL, V190, P100, DOI 10.1002/(SICI)1096-9896(200001)190:1<100::AID-PATH496>3.0.CO;2-Q; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Wakili R, 2016, ONE YEAR CLIN OUT CO; Wakili R, 2014, CLIN RES CARDIOL, V103, P97, DOI 10.1007/s00392-013-0625-7; Wakili R, 2011, J CLIN INVEST, V121, P2955, DOI 10.1172/JCI46315; Wang H, 2012, HERZ, V37, P919, DOI 10.1007/s00059-012-3626-9; Wilbert-Lampen U, 2008, NEW ENGL J MED, V358, P475, DOI 10.1056/NEJMoa0707427; Wilbert-Lampen U, 2010, J AM COLL CARDIOL, V55, P637, DOI 10.1016/j.jacc.2009.07.073; Workman AJ, 2010, N-S ARCH PHARMACOL, V381, P235, DOI 10.1007/s00210-009-0474-0; Wozakowska-Kaplon B, 2010, CARDIOL J, V17, P471; Xu FQ, 2017, PACING CLIN ELECTROP; YORIKANE R, 1991, J CARDIOVASC PHARM, V17, pS159, DOI 10.1097/00005344-199100177-00044	51	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184337	10.1371/journal.pone.0184337	http://dx.doi.org/10.1371/journal.pone.0184337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886122	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100099
J	Lietman, CD; Segedy, AK; Li, B; Fazio, S; Atkinson, JB; Linton, MF; Young, PP				Lietman, Caressa D.; Segedy, Amanda K.; Li, Bin; Fazio, Sergio; Atkinson, James B.; Linton, MacRae F.; Young, Pampee P.			Loss of SPRR3 in ApoE(-/-) mice leads to atheroma vulnerability through Akt dependent and independent effects in VSMCs	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; APOE-DEFICIENT MICE; PLAQUE RUPTURE; MATRIX METALLOPROTEINASES; SIGNAL-TRANSDUCTION; CORNIFIED ENVELOPE; CORONARY-ARTERIES; GROWTH-FACTOR; ATHEROSCLEROSIS; EXPRESSION	Vascular smooth muscle cells (VSMCs) represent important modulators of plaque stability in advanced lesions. We previously reported that loss of small proline-rich repeat protein 3 (Sprr3), leads to VSMC apoptosis in a PI3K/Akt-dependent manner and accelerates lesion progression. Here, we investigated the role of Sprr3 in modulating plaque stability in hyperlipidemic ApoE(-/-) mice. We show that loss of Sprr3 increased necrotic core size and reduced cap collagen content of atheromas in brachiocephalic arteries with evidence of plaque rupture and development of intraluminal thrombi. Moreover, Sprr3(-/-) ApoE(-/-) mice developed advanced coronary artery lesions accompanied by intraplaque hemorrhage and left ventricle microinfarcts. SPRR3 is known to reduce VSMC survival in lesions by promoting their apoptosis. In addition, we demonstrated that Sprr3(-/-) VSMCs displayed reduced expression of procollagen in a PI3K/Akt dependent manner. SPRR3 loss also increased MMP gelatinase activity in lesions, and increased MMP2 expression, migration and contraction of VSMCs independently of PI3K/Akt. Consequently, Sprr3 represents the first described VSMC modulator of each of the critical features of cap stability, including VSMC numbers, collagen type I synthesis, and protease activity through Akt dependent and independent pathways.	[Lietman, Caressa D.; Segedy, Amanda K.; Li, Bin; Atkinson, James B.; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA; [Fazio, Sergio] Oregon Hlth & Sci Univ, Ctr Prevent Cardiol, Knight Cardiovasc Inst, Portland, OR 97201 USA; [Atkinson, James B.; Young, Pampee P.] Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Linton, MacRae F.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37235 USA; [Linton, MacRae F.; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA	Vanderbilt University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University	Young, PP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37235 USA.; Young, PP (corresponding author), Vet Affairs Med Ctr, Nashville, TN 37212 USA.; Young, PP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA.	pampee.young@vanderbilt.edu		Lietman, Caressa/0000-0003-3863-2751	Department of Veterans Affairs [BX002337]; National Institutes of Health [R21 EB019509]; National Institutes of Health, National Heart Lung and Blood Institute [057986]; National Heart Lung and Blood Institute [HL116263]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL116263] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Merit Award from the Department of Veterans Affairs BX002337 (PPY) [https://www.va.gov/] and National Institutes of Health R21 EB019509 (PPY) [https://www.nih.gov/]. SF was supported by the National Institutes of Health, National Heart Lung and Blood Institute 057986 [https://www.nhlbi.nih.gov/]. MFL was supported by the National Heart Lung and Blood Institute HL116263 [https://www.nhlbi.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeyrathna P, 2014, FASEB J S, V28; Babaev VR, 2014, J LIPID RES, V55, P2296, DOI 10.1194/jlr.M050633; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Cabral A, 2001, J BIOL CHEM, V276, P19231, DOI 10.1074/jbc.M100336200; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chen CCA, 2007, FASEB J, V21, pA520; Cho DH, 2010, MOL MED, V16, P271, DOI 10.2119/molmed.2009.00187; Clarke MCH, 2008, CIRC RES, V102, P1529, DOI 10.1161/CIRCRESAHA.108.175976; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Cullen P, 2003, ARTERIOSCLER THROMB, V23, P529; da Cunha V, 2006, J VASC SURG, V44, P364, DOI 10.1016/j.jvs.2006.04.033; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; DAVIES MJ, 1984, NEW ENGL J MED, V310, P1137, DOI 10.1056/NEJM198405033101801; Durante W, 2001, CIRCULATION, V103, P1121, DOI 10.1161/01.CIR.103.8.1121; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Fernandez-Hernando C, 2007, CELL METAB, V6, P446, DOI 10.1016/j.cmet.2007.10.007; Fernandez-Hernando C, 2009, ARTERIOSCL THROM VAS, V29, P2033, DOI 10.1161/ATVBAHA.109.196394; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Gough PJ, 2006, J CLIN INVEST, V116, P59, DOI 10.1172/JCI25074; Ikedo H, 2003, INT J MOL MED, V11, P645; Jackson CL, 2007, ARTERIOSCL THROM VAS, V27, P714, DOI 10.1161/01.ATV.0000261873.86623.e1; Johnson JL, 2014, CARDIOVASC RES, V103, P452, DOI 10.1093/cvr/cvu171; Johnson JL, 2001, ATHEROSCLEROSIS, V154, P399, DOI 10.1016/S0021-9150(00)00515-3; Kenagy RD, 1997, CIRCULATION, V96, P3555; Kim JC, 2012, BREAST CANCER RES TR, V133, P909, DOI 10.1007/s10549-011-1868-5; Kobayashi E, 2000, INTERV NEURORADIOL, V6, P165, DOI 10.1177/15910199000060S125; Kusuhara M, 1998, CIRC RES, V83, P824, DOI 10.1161/01.RES.83.8.824; Kuzuya M, 2006, ARTERIOSCL THROM VAS, V26, P1120, DOI 10.1161/01.ATV.0000218496.60097.e0; Lee R, 2012, EUR HEART J, V33, P1039, DOI 10.1093/eurheartj/ehs028; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Liu Q, 2013, ONCOLOGY LETT, V7, P427; Matoba T, 2013, CURR OPIN LIPIDOL, P24; Matoba T, 2013, CURR OPIN LIPIDOL, V24, P419, DOI 10.1097/MOL.0b013e3283646e4d; Matsui T, 2005, J MOL CELL CARDIOL, V38, P63, DOI 10.1016/j.yjmcc.2004.11.005; Mughal MM, 2011, EXPERT REV CARDIOVAS, V9, P1315, DOI [10.1586/erc.11.120, 10.1586/ERC.11.120]; Pradervand S, 2004, EMBO J, V23, P4517, DOI 10.1038/sj.emboj.7600454; Pyle AL, 2008, AM J PATHOL, V173, P1577, DOI 10.2353/ajpath.2008.080042; Pyle AL, 2010, AM J PATHOL, V177, P4, DOI 10.2353/ajpath.2010.090615; Pyle Amy L, 2010, Cardiovasc Pathol, V19, pe13, DOI 10.1016/j.carpath.2008.12.006; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Rodella LF, 2007, ACTA HISTOCHEM, V109, P45, DOI 10.1016/j.acthis.2006.08.002; Rotllan N, 2015, CIRC RES, V116, P1744, DOI 10.1161/CIRCRESAHA.116.305895; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; Sato K, 2012, J ATHEROSCLER THROMB, V19, P986, DOI 10.5551/jat.13391; Scherberich A, 1998, ARTERIOSCL THROM VAS, V18, P1691, DOI 10.1161/01.ATV.18.11.1691; Schwartz SM, 2007, ARTERIOSCL THROM VAS, V27, P705, DOI 10.1161/01.ATV.0000261709.34878.20; Seasholtz TM, 1999, CIRC RES, V84, P1186, DOI 10.1161/01.RES.84.10.1186; Segedy AK, 2014, ARTERIOSCL THROM VAS, V34, P2527, DOI 10.1161/ATVBAHA.114.303644; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Silvestre-Roig C, 2014, CIRC RES, V114, P214, DOI 10.1161/CIRCRESAHA.114.302355; STARY HC, 1994, CIRCULATION, V89, P2462, DOI 10.1161/01.CIR.89.5.2462; STARY HC, 1994, BASIC RES CARDIOL, V89, P17; Travis JA, 2001, CIRC RES, V88, P77, DOI 10.1161/01.RES.88.1.77; Watanabe Noboru, 2004, Curr Atheroscler Rep, V6, P112, DOI 10.1007/s11883-004-0099-1; Yokoyama K, 2012, GRAEF ARCH CLIN EXP, V250, P15, DOI 10.1007/s00417-011-1766-x; Young PP, 2005, CIRCULATION, V111, P2382, DOI 10.1161/01.CIR.0000164235.26339.78; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	59	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184620	10.1371/journal.pone.0184620	http://dx.doi.org/10.1371/journal.pone.0184620			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886156	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100171
J	Marangu, D; Mwaniki, H; Nduku, S; Maleche-Obimbo, E; Jaoko, W; Babigumira, J; John-Stewart, G; Rao, D				Marangu, Diana; Mwaniki, Hannah; Nduku, Salome; Maleche-Obimbo, Elizabeth; Jaoko, Walter; Babigumira, Joseph; John-Stewart, Grace; Rao, Deepa			Stakeholder perspectives for optimization of tuberculosis contact investigation in a high-burden setting	PLOS ONE			English	Article							CHILD CONTACTS	Introduction Optimal tuberculosis contact investigation impacts TB prevention, timely case finding and linkage to care, however data on routine implementation in high burden contexts is limited. Materials and methods In a multi-method qualitative study based on individual interviews with TB patients, facility observations and focus group discussions with health workers (HWs) in 13 public health facilities, and key informant interviews with governmental and non-governmental experts, we describe TB contact investigation in the context of an urban setting in Kenya and identify opportunities for optimization. Results Invitation of TB patients to bring close contacts by HWs was key for all patient decisions that led to contact screening in addition to patients' understanding of TB transmission and desire to avoid contacts suffering from TB. Sub-optimal HW enquiry of TB patients and contacts presenting at the facility were missed opportunities which stemmed from lack of standardized operational procedures, documentation tools and HW training. Stakeholders proposed provision of fast tracked and holistic health packages for contacts seeking TB screening, and sustainable government led funding for the requisite infrastructure and workforce. Conclusion TB contact invitation by HWs leading to contact screening occurs in this context. Stake-holder perspectives inform the design of an operational framework for optimized delivery.	[Marangu, Diana; Maleche-Obimbo, Elizabeth] Univ Nairobi, Dept Paediat & Child Hlth, Nairobi, Kenya; [Marangu, Diana] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [Mwaniki, Hannah] Univ Nairobi, Populat Studies & Res Inst, Nairobi, Kenya; [Nduku, Salome] Semant Africa Ltd, Nairobi, Kenya; [Jaoko, Walter] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Babigumira, Joseph; John-Stewart, Grace; Rao, Deepa] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [John-Stewart, Grace] Univ Washington, Dept Allergy & Infect Dis, Seattle, WA 98195 USA; [John-Stewart, Grace] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [John-Stewart, Grace] Univ Washington, Dept Paediat, Seattle, WA 98195 USA; [Rao, Deepa] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Nairobi; University of Nairobi; University of Nairobi; University of Nairobi; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Marangu, D (corresponding author), Univ Nairobi, Dept Paediat & Child Hlth, Nairobi, Kenya.; Marangu, D (corresponding author), Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya.	dmarangu@uonbi.ac.ke	Jaoko, Walter/AAN-5048-2020; Babigumira, Joseph/T-4208-2019; John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019	Marangu, Diana/0000-0003-3895-2210; John-Stewart, Grace/0000-0002-4301-1573; Jaoko, Walter/0000-0002-7134-6581	International AIDS Research Training Program (IARTP); Fogarty International Centre, National Institutes of Health (NIH) [1 D43 TW009580]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009580] Funding Source: NIH RePORTER	International AIDS Research Training Program (IARTP); Fogarty International Centre, National Institutes of Health (NIH); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Diana Marangu is a recipient of the International AIDS Research Training Program (IARTP) MPH-PhD Implementation Science Scholarship funded by the Fogarty International Centre, National Institutes of Health (NIH) (1 D43 TW009580). Grace John-Stewart holds an NIH K24 Mentoring Award (K24 HD54314). Hannah Mwaniki and Salome Nduku received funding from the study budget as research assistants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, KEN NAT STRAT PLAN T; [Anonymous], 2015, GLOB TUB REP; [Anonymous], 2011, GUID INT TUB CAS FIN; [Anonymous], 2016, GLOB TUB REP; Assefa D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129135; Faccini M, 2015, EPIDEMIOLOGY INFECT; Fair E, 2015, INT J TUBERC LUNG D, V19, P269, DOI 10.5588/ijtld.14.0512; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Galgalo T, 2008, INT J TUBERC LUNG D, V12, P949; Gerald LB, 2003, INT J TUBERC LUNG D, V7, pS369; Jaganath D, 2013, CLIN INFECT DIS, V57, P1685, DOI 10.1093/cid/cit645; Khaparde Kshitij, 2015, Tuberc Res Treat, V2015, P670167, DOI 10.1155/2015/670167; Kumwenda M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154103; Mandalakas AM, 2013, THORAX, V68, P247, DOI 10.1136/thoraxjnl-2011-200933; Marangu D, 2016, ADAPTING STIGMA SCAL; Matsumoto Kenji, 2014, Kekkaku, V89, P515; Ottmani S., 2009, Eastern Mediterranean Health Journal, V15, P494; Thanh THT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-713; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, 2012, REC INV CONT PERS IN; Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55	21	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183749	10.1371/journal.pone.0183749	http://dx.doi.org/10.1371/journal.pone.0183749			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886072	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100035
J	Nishimukai, A; Inoue, N; Kira, A; Takeda, M; Morimoto, K; Araki, K; Kitajima, K; Watanabe, T; Hirota, S; Katagiri, T; Nakamori, S; Akazawa, K; Miyoshi, Y				Nishimukai, Arisa; Inoue, Natsuko; Kira, Ayako; Takeda, Masashi; Morimoto, Koji; Araki, Kazuhiro; Kitajima, Kazuhiro; Watanabe, Takahiro; Hirota, Seiichi; Katagiri, Toyomasa; Nakamori, Shoji; Akazawa, Kouhei; Miyoshi, Yasuo			Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of F-18-deoxyglucose levels on positron emission tomography for breast cancers	PLOS ONE			English	Article							NEOADJUVANT CHEMOTHERAPY; F-18-FDG PET/CT; PATHOLOGICAL RESPONSE; GLUCOSE-METABOLISM; EARLY PREDICTION; PROGNOSIS; PATHWAY; KI-67	It has been well established that maximum standardized uptake value (SUVmax) for F-18-fluorodeoxyglucose positron-emission tomography/computed tomography (FDG PET/CT) is clinically useful for evaluating treatment efficacy as well as predicting prognosis of breast cancer patients. Although SUVmax reflects increased glucose uptake and metabolism possibly induced by activation of growth factor signaling or TP53 dysfunction, tumor characteristics of SUVmax-high breast cancers remain to be elucidated. For the present study, we used immunohistochemical staining to investigate expressions of phospho-ribosomal protein S6 (pS6, downstream molecule of phosphatidyl inositol 3-kinase/Akt/mammalian target of the rapamycin/S6K pathway) and phosphor-p44/42 mitogen-activated protein kinase (pMAPK). Expression levels of TP53 and proliferative marker geminin as well as Ki67 were also examined by means of immunostaining in 163 invasive breast cancers. Cutoff values were set at 10% for pS6, 20% for pMAPK and TP53, and 4% for geminin. The SUVmax levels were significantly higher in the pS6-positive (p = 0.0173), TP53-positive (p = 0.0207) and geminin-high cancers (p<0.0001), but there was no significant association between pMAPK expression levels and SUVmax levels. Multivariable analysis showed that a high geminin level (odds ratio: 6.497, 95% confidence interval: 2.427-19.202, p = 0.0001) and large tumor size (6.438, 2.224-20.946, p = 0.0005) were significantly and independently associate d with SUVmax-high. Univariable but not multivariable analysis indicated that Ki67-high significantly correlated with SUVmax-high. Twenty of 23 (87.0%) breast cancers with tumor size >2cm and geminin-high showed SUVmax-high, while only 6 of 49 (12.2%) breast cancers <= 2cm in size and with low geminin levels were SUVmax-high. In conclusion, we could determine that breast cancers with a large tumor and a geminin-high rather than Ki67-high proliferative marker were significantly associated with high levels of SUVmax. These findings may signify that SUVmax reflects tumor characteristics with high proliferative activity but not activation of mTOR/S6K and MAPK pathways or increased glucose metabolism due to dysfunction of TP53.	[Nishimukai, Arisa; Inoue, Natsuko; Kira, Ayako; Araki, Kazuhiro; Miyoshi, Yasuo] Hyogo Coll Med, Dept Surg, Div Breast & Endocrine, Nishinomiya, Hyogo, Japan; [Takeda, Masashi] Yao Municipal Hosp, Dept Pathol, Yao, Osaka, Japan; [Morimoto, Koji] Osaka Womens Jr Coll, Dept Sci Living, Fujiidera City, Osaka, Japan; [Morimoto, Koji; Nakamori, Shoji] Natl Hosp Org, Osaka Natl Hosp, Dept Surg, Chuo Ku, Osaka, Japan; [Kitajima, Kazuhiro] Hyogo Coll Med, Dept Nucl Med, Nishinomiya, Hyogo, Japan; [Kitajima, Kazuhiro] Hyogo Coll Med, PET Ctr, Nishinomiya, Hyogo, Japan; [Watanabe, Takahiro; Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo, Japan; [Katagiri, Toyomasa] Tokushima Univ, Inst Genome Res, Div Genome Med, Kuramoto Cho, Tokushima, Japan; [Akazawa, Kouhei] Niigata Univ Med & Dent Hosp, Dept Med Informat, Niigata, Japan	Hyogo College of Medicine; Osaka National Hospital; Hyogo College of Medicine; Hyogo College of Medicine; Hyogo College of Medicine; Niigata University	Miyoshi, Y (corresponding author), Hyogo Coll Med, Dept Surg, Div Breast & Endocrine, Nishinomiya, Hyogo, Japan.	ymiyoshi@hyo-med.ac.jp	Araki, kazuhiro/AAD-5658-2019; Miyoshi, Yasuo/AAI-6321-2020	Araki, kazuhiro/0000-0001-7623-7715; Miyoshi, Yasuo/0000-0001-8535-4008	Ministry of Education, Culture, Sports, Science, and Technology of Japan [26461963]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 26461963) (https://www.jsps.go.jp/english/index.html).	Ahn SG, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0502-y; Avril S, 2016, J NUCL MED, V57, p34S, DOI 10.2967/jnumed.115.157875; Chang JS, 2016, CANCER RES TREAT, V48, P508, DOI 10.4143/crt.2015.172; Crippa F, 2015, EUR J NUCL MED MOL I, V42, P818, DOI 10.1007/s00259-015-2995-8; Evangelista L, 2015, EUR J NUCL MED MOL I, V42, P1648, DOI 10.1007/s00259-015-3088-4; Gao D, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160122; Garami Z, 2012, EJSO-EUR J SURG ONC, V38, P31, DOI 10.1016/j.ejso.2011.09.002; Gonzalez MA, 2004, J PATHOL, V204, P121, DOI 10.1002/path.1625; Groheux D, 2016, EUR J NUCL MED MOL I, V43, P983, DOI 10.1007/s00259-015-3295-z; Groheux D, 2015, J NUCL MED, V56, P824, DOI 10.2967/jnumed.115.154138; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Higuchi T, 2016, BREAST, V30, P5, DOI 10.1016/j.breast.2016.08.003; Kadoya T, 2013, BREAST CANCER RES TR, V141, P269, DOI 10.1007/s10549-013-2687-7; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kitajima K, 2016, JPN J RADIOL, V34, P220, DOI 10.1007/s11604-015-0515-1; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koo HR, 2015, EUR RADIOL, V25, P3314, DOI 10.1007/s00330-015-3734-z; Lee HW, 2016, J NUCL MED, V57, P1183, DOI 10.2967/jnumed.115.166322; Lee JH, 2013, SEMIN NUCL MED, V43, P294, DOI 10.1053/j.semnuclmed.2013.04.001; Loddo M, 2009, BRIT J CANCER, V100, P959, DOI 10.1038/sj.bjc.6604924; Mizuno T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1097-0; Nguyen QD, 2011, TRANSL ONCOL, V4, P241, DOI 10.1593/tlo.11118; Sakamoto Goi, 2005, Breast Cancer, V12 Suppl, pS1; Schwarz JK, 2012, CLIN CANCER RES, V18, P1464, DOI 10.1158/1078-0432.CCR-11-2485; Shimoda Wataru, 2007, Breast Cancer, V14, P260, DOI 10.2325/jbcs.14.260; Son SH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-585; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Stanton KJ, 2003, AM J SURG, V186, P486, DOI 10.1016/j.amjsurg.2003.07.002; Tchou J, 2010, MOL IMAGING BIOL, V12, P657, DOI 10.1007/s11307-009-0294-0; Tegnebratt T, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0034-6; Yagi T, 2016, BREAST CANCER-TOKYO, V23, P224, DOI 10.1007/s12282-014-0556-9; Yanai A, 2015, CLIN BREAST CANCER, V15, P197, DOI 10.1016/j.clbc.2014.12.002; Zhao K, 2014, ONCOL LETT, V7, P984, DOI 10.3892/ol.2014.1877	33	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184508	10.1371/journal.pone.0184508	http://dx.doi.org/10.1371/journal.pone.0184508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886153	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100142
J	Ostermann, AI; Waindok, P; Schmidt, MJ; Chiu, CY; Smyl, C; Rohwer, N; Weylandt, KH; Schebb, NH				Ostermann, Annika I.; Waindok, Patrick; Schmidt, Moritz J.; Chiu, Cheng-Ying; Smyl, Christopher; Rohwer, Nadine; Weylandt, Karsten-H.; Schebb, Nils Helge			Modulation of the endogenous omega-3 fatty acid and oxylipin profile in vivo-A comparison of the fat-1 transgenic mouse with C57BL/6 wildtype mice on an omega-3 fatty acid enriched diet	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; EPOXIDE HYDROLASE INHIBITORS; ALPHA-LINOLENIC ACID; DOCOSAHEXAENOIC ACID; LIPID MEDIATORS; CYTOCHROME-P450 ENZYMES; QUANTITATIVE-ANALYSIS; OMEGA-3 INDEX; HUMAN PLASMA; RISK-FACTOR	Dietary intervention and genetic fat-1 mice are two models for the investigation of effects associated with omega-3 polyunsaturated fatty acids (n3-PUFA). In order to assess their power to modulate the fatty acid and oxylipin pattern, we thoroughly compared fat-1 and wild-type C57BL/6 mice on a sunflower oil diet with wild-type mice on the same diet enriched with 1% EPA and 1% DHA for 0, 7, 14, 30 and 45 days. Feeding led after 14-30 days to a high steady state of n3-PUFA in all tissues at the expense of n6-PUFAs. Levels of n3-PUFA achieved by feeding were higher compared to fat-1 mice, particularly for EPA (max. 1.7% in whole blood of fat-1 vs. 7.8% following feeding). Changes in PUFAs were reflected in most oxylipins in plasma, brain and colon: Compared to wild-type mice on a standard diet, arachidonic acid metabolites were overall decreased while EPA and DHA oxylipins increased with feeding more than in fat-1 mice. In plasma of n3-PUFA fed animals, EPA and DHA metabolites from the lipoxygenase and cytochrome P450 pathways dominated over ARA derived counterparts. Fat-1 mice show n3-PUFA level which can be reached by dietary interventions, supporting the applicability of this model in n3-PUFA research. However, for specific questions, e.g. the role of EPA derived mediators or concentration dependent effects of (individual) PUFA, feeding studies are necessary.	[Ostermann, Annika I.; Waindok, Patrick; Schmidt, Moritz J.; Schebb, Nils Helge] Univ Vet Med Hannover, Inst Food Toxicol, Hannover, Germany; [Ostermann, Annika I.; Schebb, Nils Helge] Univ Wuppertal, Fac Math & Nat Sci, Food Chem, Wuppertal, Germany; [Waindok, Patrick] Univ Vet Med Hannover, Inst Parasitol, Ctr Infect Med, Hannover, Germany; [Chiu, Cheng-Ying; Smyl, Christopher; Rohwer, Nadine; Weylandt, Karsten-H.] Charite, Div Hepatol & Gastroenterol Including Metab Dis, Med Dept, Campus Virchow Klinikum, Berlin, Germany; [Weylandt, Karsten-H.] Charite, Expt & Clin Res Ctr, Campus Buch, Berlin, Germany; [Weylandt, Karsten-H.] Brandenburg Med Sch, Div Gastroenterol Oncol Hematol Rheumatol & Diabe, Med Dept, Ruppiner Kliniken, Neuruppin, Germany	University of Veterinary Medicine Hannover, Foundation; University of Wuppertal; University of Veterinary Medicine Hannover, Foundation; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruppiner Kliniken GmbH	Schebb, NH (corresponding author), Univ Vet Med Hannover, Inst Food Toxicol, Hannover, Germany.; Schebb, NH (corresponding author), Univ Wuppertal, Fac Math & Nat Sci, Food Chem, Wuppertal, Germany.	nils@schebb-web.de		Chiu, Cheng-Ying/0000-0002-7075-1446; Rohwer, Nadine/0000-0001-6170-1327; Schmidt, Moritz Jonathan/0000-0001-9719-6967; Schebb, Nils Helge/0000-0003-1299-6629	German Research Foundation (DFG) [SCHE 1801]; KHW [WE 2908]	German Research Foundation (DFG)(German Research Foundation (DFG)); KHW	This study was supported by grants of the German Research Foundation (DFG) to NHS (SCHE 1801) and KHW (WE 2908).	Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Astarita G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096221; Bellenger J, 2011, DIABETES, V60, P1090, DOI 10.2337/db10-0901; Bousquet M, 2008, FASEB J, V22, P1213, DOI 10.1096/fj.07-9677com; Bousquet M, 2011, J LIPID RES, V52, P263, DOI 10.1194/jlr.M011692; Brossard N, 1996, AM J CLIN NUTR, V64, P577, DOI 10.1093/ajcn/64.4.577; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Camuesco D, 2005, J NUTR, V135, P687, DOI 10.1093/jn/135.4.687; Chiu CY, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010009; CRASKE JD, 1988, J AM OIL CHEM SOC, V65, P1190; Fischer R, 2014, J LIPID RES, V55, P1150, DOI 10.1194/jlr.M047357; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Gravaghi C, 2011, J NUTR BIOCHEM, V22, P360, DOI 10.1016/j.jnutbio.2010.03.003; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Harris TR, 2016, J NUTR BIOCHEM, V38, P93, DOI 10.1016/j.jnutbio.2016.08.010; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hudert CA, 2006, P NATL ACAD SCI USA, V103, P11276, DOI 10.1073/pnas.0601280103; Inceoglu B, 2012, P NATL ACAD SCI USA, V109, P11390, DOI 10.1073/pnas.1208708109; Inceoglu B, 2011, P NATL ACAD SCI USA, V108, P5093, DOI 10.1073/pnas.1101073108; Jia Q, 2008, CANCER RES, V68, P3985, DOI 10.1158/0008-5472.CAN-07-6251; Kang JX, 2007, PROSTAG LEUKOTR ESS, V77, P263, DOI 10.1016/j.plefa.2007.10.010; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Keenan AH, 2012, J LIPID RES, V53, P1662, DOI 10.1194/jlr.P025577; Kelton D, 2013, PROSTAG LEUKOTR ESS, V89, P169, DOI [10.1016/j.plefa.201, 10.1016/j.plefa.2013.08.002]; Kutzner L, 2017, J AGR FOOD CHEM, V65, P139, DOI 10.1021/acs.jafc.6b03745; Morisseau C, 2005, ANNU REV PHARMACOL, V45, P311, DOI 10.1146/annurev.pharmtox.45.120403.095920; Morisseau C, 2010, J LIPID RES, V51, P3481, DOI 10.1194/jlr.M006007; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Nieto N, 2002, J NUTR, V132, P11, DOI 10.1093/jn/132.1.11; Nowak J, 2007, CARCINOGENESIS, V28, P1991, DOI 10.1093/carcin/bgm166; Olson MV, 2013, INFLAMM RES, V62, P1003, DOI 10.1007/s00011-013-0658-4; Ostermann AI, 2017, FOOD FUNCT, V8, P2355, DOI [10.1039/c7fo00403f, 10.1039/C7FO00403F]; Ostermann AI, 2015, ANAL BIOANAL CHEM, V407, P1403, DOI 10.1007/s00216-014-8377-4; Ostermann AI, 2014, PROSTAG LEUKOTR ESS, V91, P235, DOI 10.1016/j.plefa.2014.10.002; Panigrahy D, 2011, CANCER METAST REV, V30, P525, DOI 10.1007/s10555-011-9315-y; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; Schebb NH, 2014, PROSTAG OTH LIPID M, V113, P21, DOI 10.1016/j.prostaglandins.2014.05.002; Schmocker C, 2007, HEPATOLOGY, V45, P864, DOI 10.1002/hep.21626; Schuchardt JP, 2014, PROSTAG OTH LIPID M, V109, P23, DOI 10.1016/j.prostaglandins.2014.03.001; Schuchardt JP, 2014, PROSTAG LEUKOTR ESS, V90, P27, DOI 10.1016/j.plefa.2013.12.008; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Ulu A, 2013, J CARDIOVASC PHARM, V62, P285, DOI 10.1097/FJC.0b013e318298e460; Volker DH, 2000, J NUTR, V130, P559, DOI 10.1093/jn/130.3.559; von Schacky C, 2011, PROSTAG OTH LIPID M, V96, P94, DOI 10.1016/j.prostaglandins.2011.06.008; Wang W, 2016, PROSTAGLANDINS OTHER; Wang WC, 2014, PROSTAG OTH LIPID M, V113, P13, DOI 10.1016/j.prostaglandins.2014.07.002; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Westphal C, 2015, ADV EXP MED BIOL, V851, P151, DOI 10.1007/978-3-319-16009-2_6; Weylandt K. H., 2015, BIOMED RES INT, V2015, DOI [10.1155/2015/143109, DOI 10.1155/2015/143109]; Weylandt KH, 2012, PROSTAG OTH LIPID M, V97, P73, DOI 10.1016/j.prostaglandins.2012.01.005; Weylandt KH, 2011, CARCINOGENESIS, V32, P897, DOI 10.1093/carcin/bgr049; Weylandt KH, 2008, BBA-MOL BASIS DIS, V1782, P634, DOI 10.1016/j.bbadis.2008.08.011; Willenberg I, 2016, INFLAMM RES, V65, P133, DOI 10.1007/s00011-015-0897-7; Willenberg I, 2015, ANAL BIOANAL CHEM, V407, P2675, DOI 10.1007/s00216-014-8369-4; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103; Zhang GD, 2013, P NATL ACAD SCI USA, V110, P6530, DOI 10.1073/pnas.1304321110	63	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184470	10.1371/journal.pone.0184470	http://dx.doi.org/10.1371/journal.pone.0184470			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886129	Green Accepted, gold, Green Published			2022-12-27	WOS:000410001100132
J	Tevik, K; Selbaek, G; Engedal, K; Seim, A; Krokstad, S; Helvik, AS				Tevik, Kjerstin; Selbaek, Geir; Engedal, Knut; Seim, Arnfinn; Krokstad, Steinar; Helvik, Anne-S.			Use of alcohol and drugs with addiction potential among older women and men in a population-based study. The Nord-Trondelag Health Study 2006-2008 (HUNT3)	PLOS ONE			English	Article							BENZODIAZEPINE USE; PSYCHOTROPIC-DRUGS; DRINKING PATTERNS; CONCOMITANT USE; RISK DRINKING; CHRONIC PAIN; AGED 75; ADULTS; CONSUMPTION; PREVALENCE	Background Little is known about the consumption habits of older adults in Norway with respect to alcohol and the use of drugs with addiction potential, such as benzodiazepines, z-hypnotics and opioids, among regular drinkers. We studied the prevalence of self-reported consumption of alcohol on a regular basis in community-living older men and women (>= 65 years). Furthermore, we investigated the prevalence of dispensed prescribed drugs with addiction potential in older men and women who were regular drinkers. Methods We used data from the Nord-Trondelag Health Study 2006-2008 (HUNT3). Of 12,361 older adults in the HUNT3 study, 11,545 had answered the alcohol consumption item and were included in our study. Regular drinkers were defined as consuming alcohol one or more days a week. Data on dispensed drugs with addiction potential were drawn from the Norwegian Prescription Database. Addiction potential was defined as at least one prescription for benzodiazepines, z-hypnotics or opioids during one year for a minimum of two consecutive years. Results In total 28.2% of older Norwegian adults were regular drinkers. Men in the study were more likely to be regular drinkers than women. Drugs with addiction potential were used by 32.4% of participants, and were more commonly used by women. Nearly 12% of participants used benzodiazepines, 19% z-hypnotics and 12.4% opioids. Among regular drinkers, 29% used drugs with addiction potential, which was also more common among women. Adjusted for age, gender and living situation, use of z-hypnotics was associated with regular alcohol intake, while use of opioids was associated with no regular alcohol intake. Conclusion The prevalence of the use of drugs with addiction potential was high in a Norwegian population of older adults who reported regular consumption of alcohol. Strategies should be developed to reduce or prevent alcohol consumption among older adults who use drugs with addiction potential.	[Tevik, Kjerstin; Selbaek, Geir; Engedal, Knut; Helvik, Anne-S.] Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway; [Tevik, Kjerstin; Seim, Arnfinn; Helvik, Anne-S.] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Publ Hlth & Gen Practice, Trondheim, Norway; [Selbaek, Geir] Innlandet Hosp Trust, Res Ctr Old Age Psychiat Res, Ottestad, Norway; [Selbaek, Geir] Univ Oslo, Inst Hlth & Soc, Fac Med, Oslo, Norway; [Engedal, Knut] Oslo Univ Hosp, Dept Geriatr Med, Oslo, Norway; [Krokstad, Steinar] Norwegian Univ Sci & Technol NTNU, Fac Med, HUNT Res Ctr, Dept Publ Hlth & Gen Practice, Levanger, Norway; [Krokstad, Steinar] Nord Trondelag Hosp Trust, Levanger Hosp, Psychiat Dept, Levanger, Norway; [Helvik, Anne-S.] St Olavs Univ Hosp, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Innlandet Hospital Trust; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Tevik, K (corresponding author), Vestfold Hosp Trust, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway.; Tevik, K (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Publ Hlth & Gen Practice, Trondheim, Norway.	kjtev@online.no		Tevik, Kjerstin/0000-0002-9810-8276; Krokstad, Steinar/0000-0002-2932-6675; Selbaek, Geir/0000-0001-6511-8219	Norwegian Extra Foundation for Health and Rehabilitation through The Norwegian Council for Mental Health [2015/F05044]; Norwegian National Advisory Unit on Ageing and Health; Vestfold Hospital Trust	Norwegian Extra Foundation for Health and Rehabilitation through The Norwegian Council for Mental Health; Norwegian National Advisory Unit on Ageing and Health; Vestfold Hospital Trust	This project has been made possible by the Norwegian Extra Foundation for Health and Rehabilitation (hops://www.extrastiftelsen.no/) through The Norwegian Council for Mental Health (http://www.psykiskhelse.no/) (2015/F05044). In addition, the project has been funded partly by the Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust (http://www.aldringoghelse.no/). KT is a phd-fellow in this project and she received the funding. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Adams WL, 1995, INT J ADDICT, V30, P1903, DOI 10.3109/10826089509071060; Aira M, 2005, INT J GERIATR PSYCH, V20, P680, DOI 10.1002/gps.1340; Aira M, 2008, FAM PRACT, V25, P445, DOI 10.1093/fampra/cmn065; Arndt S, 2002, J FAM PRACTICE, V51, P41; Bazin F, 2012, INT J GERIATR PSYCH, V27, P716, DOI 10.1002/gps.2773; BLENNOW G, 1994, AM J PUBLIC HEALTH, V84, P242, DOI 10.2105/AJPH.84.2.242; Booth BM, 2006, AM J DRUG ALCOHOL AB, V32, P561, DOI 10.1080/00952990600920409; Bratberg G, 2012, USE ALCOHOL DRUGS OL; Bratberg GH, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3384-3; Breslow RA, 2015, ALCOHOL CLIN EXP RES, V39, P371, DOI 10.1111/acer.12633; Cousins G, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-57; D'Amico EJ, 2005, MED CARE, V43, P229, DOI 10.1097/00005650-200503000-00005; Del Rio MC, 2002, ALCOHOL, V26, P31, DOI 10.1016/S0741-8329(01)00195-1; Dixon MA, 2016, ALCOHOL RES-CURR REV, V38, P69; Du Y, 2008, PHARMACOPSYCHIATRY, V41, P242, DOI 10.1055/s-0028-1083791; Du Y, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012182; Ekholm O, 2009, EUR J PAIN, V13, P606, DOI 10.1016/j.ejpain.2008.07.006; Fang SY, 2009, DRUG ALCOHOL DEPEN, V104, P140, DOI 10.1016/j.drugalcdep.2009.04.017; Fleming MF, 1999, J FAM PRACTICE, V48, P378; Forster L E, 1993, J Community Health, V18, P225, DOI 10.1007/BF01324433; Gell L, 2015, ALCOHOL ALCOHOLISM, V50, P1, DOI 10.1093/alcalc/agu082; Glymour M.M., 2008, MODERN EPIDEMIOLOGY, P183; Hajat S, 2004, AGE AGEING, V33, P170, DOI 10.1093/ageing/afh046; Hallgren M, 2009, ALCOHOL CONSUMPTION; Hartz I, 2011, LONG TERM USE BZD KO, V4, P24; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; HOYER G, 1995, ADDICTION, V90, P539, DOI 10.1111/j.1360-0443.1995.tb02188.x; Ilomaki J, 2013, ANN PHARMACOTHER, V47, P257, DOI 10.1345/aph.1R449; Ilomaki J, 2008, ALCOHOL, V42, P261, DOI 10.1016/j.alcohol.2008.02.002; Immonen S, 2011, J NUTR HEALTH AGING, V15, P789, DOI 10.1007/s12603-011-0115-4; Immonen S, 2013, SCAND J PRIM HEALTH, V31, P73, DOI 10.3109/02813432.2013.788272; Jalbert JJ, 2008, J GEN INTERN MED, V23, P1318, DOI 10.1007/s11606-008-0639-4; Johannesen A., 2015, QUAL PRIM CARE, V23, P134; Johannessen A, 2016, SCAND J CARING SCI, V30, P586, DOI 10.1111/scs.12282; Johannessen A, 2015, SCAND J CARING SCI, V29, P325, DOI 10.1111/scs.12166; John U, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-337; Jyrkama J, 2008, ALDRER ALKOHOL NORDI; Kerr WC, 2009, ADDICTION, V104, P27, DOI 10.1111/j.1360-0443.2008.02391.x; Knudsen AK, 2010, AM J EPIDEMIOL, V172, P1306, DOI 10.1093/aje/kwq257; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Kuerbis A, 2013, SUBST ABUS-RES TREAT, V7, P13, DOI 10.4137/SART.S7865; Lagnaoui R, 2001, BRIT J CLIN PHARMACO, V52, P455, DOI 10.1046/j.0306-5251.2001.01456.x; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; McEvoy LK, 2013, J AM GERIATR SOC, V61, P1303, DOI 10.1111/jgs.12366; Merrick EL, 2008, J AM GERIATR SOC, V56, P214, DOI 10.1111/j.1532-5415.2007.01539.x; Moore AA, 2005, AM J PUBLIC HEALTH, V95, P458, DOI 10.2105/AJPH.2003.019471; Moore Alison A, 2007, Am J Geriatr Pharmacother, V5, P64, DOI 10.1016/j.amjopharm.2007.03.006; Mura T, 2013, EUR NEUROPSYCHOPHARM, V23, P212, DOI 10.1016/j.euroneuro.2012.05.004; Nordfjaern T, 2014, NORD J PSYCHIAT, V68, P107, DOI 10.3109/08039488.2013.775342; Nordfjaern T, 2013, HUM PSYCHOPHARM CLIN, V28, P248, DOI 10.1002/hup.2316; Pringle KE, 2005, J AM GERIATR SOC, V53, P1930, DOI 10.1111/j.1532-5415.2005.00474.x; Qato DM, 2015, J AM GERIATR SOC, V63, P2324, DOI 10.1111/jgs.13787; Rush CR, 1998, PHARMACOL BIOCHEM BE, V61, P253, DOI 10.1016/S0091-3057(98)00102-6; Skurtveit S, 2014, USE ADDICTIVE DRUGS; Skurtveit S, 2008, PHARMACOEPIDEM DR S, V17, P926, DOI 10.1002/pds.1616; sterberg O E, COLLECTION COUNTRY R; Sulander T, 2004, PREV MED, V39, P413, DOI 10.1016/j.ypmed.2004.02.049; Torvik FA, 2012, SOC PSYCH PSYCH EPID, V47, P805, DOI 10.1007/s00127-011-0387-3; van Ojik AL, 2012, DRUG AGING, V29, P615, DOI 10.2165/11632620-000000000-00000; Veldhuizen S, 2009, PHARMACOEPIDEM DR S, V18, P203, DOI 10.1002/pds.1702; Wang YP, 2013, CURR OPIN PSYCHIATR, V26, P343, DOI 10.1097/YCO.0b013e328360eafd; Weathermon R, 1999, ALCOHOL RES HEALTH, V23, P40; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Zandstra SM, 2002, SOC PSYCH PSYCH EPID, V37, P139, DOI 10.1007/s001270200006	64	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184428	10.1371/journal.pone.0184428	http://dx.doi.org/10.1371/journal.pone.0184428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886172	Green Submitted, gold, Green Published			2022-12-27	WOS:000410001100120
J	Wang, JJ; Chen, P; Xi, B; Liu, JY; Zhang, Y; Yu, SJ				Wang, Jianji; Chen, Pei; Xi, Bao; Liu, Jianyi; Zhang, Yi; Yu, Shujian			Fast sparse fractal image compression	PLOS ONE			English	Article							CLASSIFICATION; SCHEME; RECOGNITION; DICTIONARY; SET	As a structure-based image compression technology, fractal image compression (FIC) has been applied not only in image coding but also in many important image processing algorithms. However, two main bottlenecks restrained the develop and application of FIC for a long time. First, the encoding phase of FIC is time-consuming. Second, the quality of the reconstructed images for some images which have low structure-similarity is usually unacceptable. Based on the absolute value of Pearson's correlation coefficient (APCC), we had proposed an accelerating method to significantly speed up the encoding of FIC. In this paper, we make use of the sparse searching strategy to greatly improve the quality of the reconstructed images in FIC. We call it the sparse fractal image compression (SFIC). Furthermore, we combine both the APCC-based accelerating method and the sparse searching strategy to propose the fast sparse fractal image compression (FSFIC), which can effectively improve the two main bottlenecks of FIC. The experimental results show that the proposed algorithm greatly improves both the efficiency and effectiveness of FIC.	[Wang, Jianji; Chen, Pei; Liu, Jianyi] Xi An Jiao Tong Univ, Inst Artificial Intelligence & Robot, Xian, Shaanxi, Peoples R China; [Wang, Jianji; Chen, Pei; Liu, Jianyi] Xi An Jiao Tong Univ, Natl Engn Lab Visual Informat Proc & Applicat, Xian, Shaanxi, Peoples R China; [Xi, Bao] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China; [Zhang, Yi] Shandong Univ Sci & Technol, Coll Mech & Elect Engn, Qingdao, Shandong, Peoples R China; [Yu, Shujian] Univ Florida, Computat NeuroEngn Lab, Gainesville, FL USA	Xi'an Jiaotong University; Xi'an Jiaotong University; Chinese Academy of Sciences; Institute of Automation, CAS; Shandong University of Science & Technology; State University System of Florida; University of Florida	Wang, JJ (corresponding author), Xi An Jiao Tong Univ, Inst Artificial Intelligence & Robot, Xian, Shaanxi, Peoples R China.; Wang, JJ (corresponding author), Xi An Jiao Tong Univ, Natl Engn Lab Visual Informat Proc & Applicat, Xian, Shaanxi, Peoples R China.	wangjianji@xjtu.edu.cn	Wang, Jianji/T-8813-2019; Xi, Bao/W-9854-2019	Wang, Jianji/0000-0002-4284-3933	National Natural Science Foundation of China [61401351]; China Postdoctoral Science Foundation [2014M560782]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported in part by the National Natural Science Foundation of China under Grants 61401351 (https://isisn.nsfc.gov.cn), and the China Postdoctoral Science Foundation under Grants 2014M560782 (http://jj.chinapostdoctor.org.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNSLEY MF, 1988, P SOC PHOTO-OPT INS, V1001, P122; Du SL, 2015, IEEE SIGNAL PROC LET, V22, P499, DOI 10.1109/LSP.2014.2363689; Fisher Y., 1992, Image and text compression, P35; Fisher Y., 1995, FRACTAL IMAGE COMPRE; Ghazel M, 2003, IEEE T IMAGE PROCESS, V12, P1560, DOI 10.1109/TIP.2003.818038; Ghazel M, 2006, IEEE T IMAGE PROCESS, V15, P2669, DOI 10.1109/TIP.2006.877377; [何传江 HE Chuanjiang], 2005, [计算机仿真, Computer Simulation], V22, P60; JACQUIN AE, 1993, P IEEE, V81, P1451, DOI 10.1109/5.241507; Jacquin AE, 1992, IEEE T IMAGE PROCESS, V1, P18, DOI 10.1109/83.128028; Jiang WM, 2016, IEEE T IND INFORM, V12, P248, DOI 10.1109/TII.2015.2496272; Kovacs T, 2008, IMAGE VISION COMPUT, V26, P1129, DOI 10.1016/j.imavis.2007.12.008; Li LY, 2014, IMAGE VISION COMPUT, V32, P814, DOI 10.1016/j.imavis.2014.02.007; Li S, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P2155; Lin KT, 2012, OPT COMMUN, V285, P2335, DOI 10.1016/j.optcom.2012.01.028; Lu J, 2013, IEEE T IMAGE PROCESS, V22, P134, DOI 10.1109/TIP.2012.2215619; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Nappi M, 2007, IET IMAGE PROCESS, V1, P363, DOI 10.1049/iet-ipr:20070071; Ni BB, 2015, IEEE T PATTERN ANAL, V37, P1615, DOI 10.1109/TPAMI.2014.2362935; Nodehi A, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-112; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; PATI YC, 1993, CONFERENCE RECORD OF THE TWENTY-SEVENTH ASILOMAR CONFERENCE ON SIGNALS, SYSTEMS & COMPUTERS, VOLS 1 AND 2, P40, DOI 10.1109/ACSSC.1993.342465; Qian Zhang, 2013, 2013 IEEE Digital Signal Processing and Signal Processing Education Meeting (DSP/SPE), P1, DOI 10.1109/DSP-SPE.2013.6642555; Schwartz WR, 2011, INT J IMAGE GRAPH, V11, P571, DOI 10.1142/S0219467811004251; Sun YY, 2015, IET IMAGE PROCESS, V9, P173, DOI 10.1049/iet-ipr.2014.0224; Sun YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101697; Tang XT, 2010, BELL LABS TECH J, V15, P209, DOI 10.1002/bltj.20433; Tong CS, 2003, SIGNAL PROCESS-IMAGE, V18, P483, DOI 10.1016/S0923-5965(03)00037-7; Wang JJ, 2014, CHINESE SCI BULL, V59, P1597, DOI 10.1007/s11434-014-0226-5; Wang JJ, 2013, IEEE T IMAGE PROCESS, V22, P3690, DOI 10.1109/TIP.2013.2268977; Wang JJ, 2013, SIGNAL PROCESS-IMAGE, V28, P681, DOI 10.1016/j.image.2012.12.006; Wang J, 2014, IEEE T CYBERNETICS, V44, P2368, DOI 10.1109/TCYB.2014.2307067; Wang JJ, 2011, P ICIP BRUSS SEPT, P245; Wohlberg B, 1999, IEEE T IMAGE PROCESS, V8, P1716, DOI 10.1109/83.806618; Zhang Z, 2016, IEEE T SIGNAL PROCES, V64, P3790, DOI 10.1109/TSP.2016.2550016; Zhang Z, 2016, IEEE T IMAGE PROCESS, V25, P2429, DOI 10.1109/TIP.2016.2547180; Zhang Z, 2015, ACM T INTEL SYST TEC, V6, DOI 10.1145/2601408	37	4	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184408	10.1371/journal.pone.0184408	http://dx.doi.org/10.1371/journal.pone.0184408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886137	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100109
J	Yuan, YH; Tsai, SB; Dai, CY; Chen, HM; Chen, WF; Wu, CH; Li, GD; Wang, JT				Yuan, Yu-Hsi; Tsai, Sang-Bing; Dai, Chien-Yun; Chen, Hsiao-Ming; Chen, Wan-Fei; Wu, Chia-Huei; Li, Guodong; Wang, Jiangtao			An empirical research on relationships between subjective judgement, technology acceptance tendency and knowledge transfer	PLOS ONE			English	Article							CORPORATE SOCIAL-RESPONSIBILITY; INFORMATION-SYSTEMS; USER ACCEPTANCE; PERCEIVED EASE; INTRINSIC MOTIVATION; GROWTH TRENDS; MANAGEMENT; MODEL; ADOPTION; EXPERIENCE	The purpose of this study was to explore the relationships among employees' usage intention pertaining to mobile information devices, focusing on subjective judgement, technology acceptance tendency, information sharing behavior and information transfer. A research model was established to verify several hypotheses. The research model based on integrated concepts of knowledge management and technology acceptance modeling. Participants were employees of enterprises in Taiwan, selected by combining snowball and convenience sampling. Data obtained from 779 e-surveys. Multiple-regression analysis was employed for hypothesis verification. The results indicate that perceived ease-of-use of mobile devices was affected by computer self-efficacy and computer playfulness directly; meanwhile, perceived ease-of-use directly affects perceived usefulness. In addition, perceived ease-of-use and perceived usefulness can predict information-sharing behavior in a positive manner, and impact knowledge transfer as well. Based on the research findings, it suggested that enterprises should utilize mobile information devices to create more contact with customers and enrich their service network. In addition, it is recommended that managers use mobile devices to transmit key information to their staff and that they use these devices for problem-solving and decision-making. Further, the staff's skills pertaining to the operation of mobile information devices and to fully implement their features are reinforced in order to inspire the users' knowledge transfer. Enhancing the playfulness of the interface is also important. In general, it is useful to promote knowledge transfer behavior within an organization by motivating members to share information and ideas via mobile information devices. In addition, a well-designed interface can facilitate employees' use of these devices.	[Yuan, Yu-Hsi] Yuanpei Univ Med Technol, Dept Business Adm, Hsinchu, Taiwan; [Tsai, Sang-Bing; Wang, Jiangtao] Univ Elect Sci & Technol China, Zhongshan Inst, Zhongshan, Guangdong, Peoples R China; [Tsai, Sang-Bing] Foshan Univ, Business & Law Sch, Foshan, Guangdong, Peoples R China; [Tsai, Sang-Bing; Li, Guodong] Civil Aviat Univ China, Econ & Management Coll, Tianjin, Peoples R China; [Dai, Chien-Yun; Chen, Hsiao-Ming; Chen, Wan-Fei] Natl Taiwan Normal Univ, Dept Ind Educ, Taipei, Taiwan; [Wu, Chia-Huei] MingHsin Univ Sci & Technol, Inst Serv Ind & Management, Hsinchu, Taiwan	University of Electronic Science & Technology of China; Foshan University; Civil Aviation University of China; National Taiwan Normal University	Tsai, SB; Wang, JT (corresponding author), Univ Elect Sci & Technol China, Zhongshan Inst, Zhongshan, Guangdong, Peoples R China.; Tsai, SB (corresponding author), Foshan Univ, Business & Law Sch, Foshan, Guangdong, Peoples R China.; Tsai, SB; Li, GD (corresponding author), Civil Aviat Univ China, Econ & Management Coll, Tianjin, Peoples R China.; Wu, CH (corresponding author), MingHsin Univ Sci & Technol, Inst Serv Ind & Management, Hsinchu, Taiwan.	sangbing@hotmail.com; chiahuei530@gmail.com; 369890684@qq.com; jiangtao-w@foxmail.com	Tsai, Sang-Bing/C-2978-2014	Tsai, Sang-Bing/0000-0001-6988-5829; Yuan, Yu-Hsi/0000-0003-4614-9671	Tianjin philosophy and social science planning project [TJGL13-028]; Fundamental Research Funds for the Central Universities [ZXH2012N002]	Tianjin philosophy and social science planning project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Tianjin philosophy and social science planning project (No. TJGL13-028), The Fundamental Research Funds for the Central Universities (No. ZXH2012N002). Provincial Nature Science Foundation of Guangdong (No. 2015A030310271 and 2015A030313679), Academic Scientific Research Foundation for High-level Researcher, University of Electronic Science Technology of China, Zhongshan Institute (No. 415YKQ08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.	ADAMS DA, 1992, MIS QUART, V16, P227, DOI 10.2307/249577; ADAMSON I, 2003, TECHNOL ANAL STRATEG, V15, P441, DOI DOI 10.1080/093373203000136033; Ahn T., 2004, ELECT COMM RES APPL, V3, P405, DOI [DOI 10.1016/J.ELERAP.2004.05.001, 10.1016/j.elerap.2004.05.001]; Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-3_2; ANDERSON JC, 1988, PSYCHOL BULL, V103, P411, DOI 10.1037/0033-2909.103.3.411; [Anonymous], 1996, KNOWL BAS EC; APQC, 1999, KNOWL MAN EX SUMM CO; Arnindon D., 1997, CREATING KNOWLEDGE B; Asian Productivity Organization, 2004, TRAIN KNOWL WORK; Atkinson M, 1997, DATA BASE ADV INF SY, V28, P53; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Brown I, 2009, ELECT J INFORM SYSTE, V11, P167; Chan I, 2008, COMMUN ACM, V51, P83, DOI 10.1145/1330311.1330328; Chen CW, 2013, HUM FACTOR ERGON MAN, V23, P95, DOI 10.1002/hfm.20300; COMPEAU DR, 1995, INFORM SYST RES, V6, P118, DOI 10.1287/isre.6.2.118; Davenport T. H., 1998, WORKING KNOWLEDGE OR, DOI DOI 10.1109/EMR.2003.1267012; Davenport TH, 1998, CALIF MANAGE REV, V40, P195, DOI 10.2307/41165950; David E, 2006, CACCI J, V1, P1; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; Davis FD, 2004, IEEE T ENG MANAGE, V51, P31, DOI 10.1109/TEM.2003.822468; DAVIS FD, 1992, J APPL SOC PSYCHOL, V22, P1111, DOI 10.1111/j.1559-1816.1992.tb00945.x; DeVellis R., 2003, SCALE DEV THEORY APP; Drucker PF, 1999, CALIF MANAGE REV, V41, P79, DOI 10.2307/41165987; du Plessis M, 2008, INT J INFORM MANAGE, V28, P61, DOI 10.1016/j.ijinfomgt.2007.05.002; Edvardsson I. R., 2006, Knowledge Management Research & Practice, V4, P275, DOI 10.1057/palgrave-kmrp.8500111; Eighmey J, 1998, J BUS RES, V41, P187, DOI 10.1016/S0148-2963(97)00061-1; Erdelez S., 2000, New Review of Information Behaviour Research, V1, P219; Fishbein M., 1975, BELIEF ATTITUDE INTE; Frolick MN, 1994, INFORM SYSTEMS MANAG, V21, P53; Gilbert M, 1996, TECHNOVATION, V16, P301, DOI 10.1016/0166-4972(96)00012-0; Goodhue DL, 1995, MANAGE SCI, V41, P1827, DOI 10.1287/mnsc.41.12.1827; Gorelick C., 2004, PERFORMANCE LEARNING; Guo JJ, 2015, S AFR J IND ENG, V26, P56, DOI 10.7166/26-2-956; Guo WF, 2015, INT J PROD RES, V53, P665, DOI 10.1080/00207543.2014.972525; Hackbarth G, 2003, INFORM MANAGEMENT, V40; Henderson R, 1998, INTERACT COMPUT, V10, P385, DOI 10.1016/S0953-5438(98)00037-X; Hong S, 2006, DECISION SUPPORT SYS, V42; Hsiao RL, 2006, ORGAN STUD, V27, P1289, DOI 10.1177/0170840606064108; Huang IC, 2003, CHINESE PUBLIC ADM R, V12, P27; Hubert, 2011, NEW EDGE KNOWLEDGE K; Igbaria M., 1996, Journal of Management Information Systems, V13, P127; Jaccard J., 1996, LISREL APPROACHES IN, DOI DOI 10.4135/9781412984782; Jackson CM, 1997, DECISION SCI, V28, P357, DOI 10.1111/j.1540-5915.1997.tb01315.x; Jung Y, 2009, COMPUT HUM BEHAV, V25, P123, DOI 10.1016/j.chb.2008.07.011; Kim SH, 2008, INFORM MANAGE-AMSTER, V45, P387, DOI 10.1016/j.im.2008.05.002; Kimble C., 2016, INFORM SYSTEMS FRONT, P1; Kramer DM, 2005, SCI COMMUN, V26, P428, DOI 10.1177/1075547005275427; Kuan Yew Wong, 2005, Journal of Knowledge Management, V9, P64, DOI 10.1108/13673270510602773; Lambe P, 2011, J KNOWL MANAG, V15, P175, DOI 10.1108/13673271111119646; Lee KC, 2005, INFORM MANAGE-AMSTER, V42, P469, DOI 10.1016/j.im.2004.02.003; Lee MKO, 2007, J AM SOC INF SCI TEC, V58, P2066, DOI 10.1002/asi.20670; Lee YC, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016641011; Lee YC, 2015, P I MECH ENG B-J ENG, V229, P3, DOI 10.1177/0954405414539934; LEONARDBARTON D, 1988, MANAGE SCI, V34, P1252, DOI 10.1287/mnsc.34.10.1252; Liebowitz J., 1999, KNOWL PROCESS MANAG, V6, P37, DOI [DOI 10.1002/(SICI)1099-1441(199903)6:1<37::AID-KPM40>3.0.CO;2-M, 10.1002/(SICI)1099-1441(199903)6:13.0.CO;2-M]; Lopez-Nicolas C, 2008, INFORM MANAGE-AMSTER, V45, P359, DOI 10.1016/j.im.2008.05.001; Maguire S, 2007, BENCHMARKING, V14, P37, DOI 10.1108/14635770710730928; Martina K, 2012, J COMPETITIVENESS, V4, P129, DOI 10.7441/joc.2012.01.10; Ministry of Economic Affairs, 2015, WHIT PAP SMALL MED E; Moon JW, 2001, INFORM MANAGE, V38, P217, DOI 10.1016/S0378-7206(00)00061-6; MUSEN MA, 1992, COMPUT BIOMED RES, V25, P435, DOI 10.1016/0010-4809(92)90003-S; NEWELL A, 1982, ARTIF INTELL, V18, P87, DOI 10.1016/0004-3702(82)90012-1; Nonaka I, 1998, CALIF MANAGE REV, V40, P40, DOI 10.2307/41165942; Nonaka I, 2005, INT J TECHNOL MANAGE, V30, P248, DOI 10.1504/IJTM.2005.006709; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; O'Sullivan KM, SYNERGY MOBILE DEVIC; Ong CS, 2004, INFORM MANAGE-AMSTER, V41, P795, DOI 10.1016/j.im.2003.08.012; Page T., 2013, INT J GREEN COMPUT I, V4, P38; Patnayakuni R, 2007, IEEE T ENG MANAGE, V54, P286, DOI 10.1109/TEM.2007.893997; Paulin Dan, 2012, Electronic Journal of Knowledge Management, V10, P81; Qu Q, MATH PROBLEMS ENG; Quinn JB, 1996, HARVARD BUS REV, V74, P71; Senge P., 1997, EXECUTIVE EXCELLENCE, V14, P17; Snowden D., 2002, Journal of Knowledge Management, V6, P100, DOI 10.1108/13673270210424639; Szelagowski M, 2014, J ENTREP MANAG INNOV, V10, P147, DOI 10.7341/20141016; Talja S, 2006, INFORM SCI KNOWL MAN, V8, P113; Teo TSH, 1999, OMEGA-INT J MANAGE S, V27, P25, DOI 10.1016/S0305-0483(98)00028-0; Thayer G., 2002, PEN COMPUTING, V9, P17; Tsai SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154071; Tsai SB, 2016, CLEAN TECHNOL ENVIR, V18, P563, DOI 10.1007/s10098-015-1017-7; Tsai SB, 2015, P I MECH ENG B-J ENG, V229, P135, DOI 10.1177/0954405414558740; Tsai SB, 2014, P I MECH ENG B-J ENG, V228, P931, DOI 10.1177/0954405413509079; Tsai SB, 2013, APPL MECH MATER, V437, P1012, DOI 10.4028/www.scientific.net/AMM.437.1012; Tsai SB, 2016, RENEWABLE SUSTAINABL; Van den Hooff B., 2004, KNOWLEDGE PROCESS MA, V11, P13, DOI DOI 10.1002/KPM.187; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Venkatesh V, 1996, DECISION SCI, V27, P451, DOI 10.1111/j.1540-5915.1996.tb01822.x; Venkatesh V, 2000, INFORM SYST RES, V11, P342, DOI 10.1287/isre.11.4.342.11872; Venkatesh V., 1999, MIS Q, V23, P218; Venkatesh V, 2008, DECISION SCI, V39, P273, DOI 10.1111/j.1540-5915.2008.00192.x; Verma C, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2003-1; VESSEY I, 1991, DECISION SCI, V22, P219, DOI 10.1111/j.1540-5915.1991.tb00344.x; von Krogh G, 2001, LONG RANGE PLANN, V34, P421, DOI 10.1016/S0024-6301(01)00059-0; Wangpipatwong S., 2008, ELECT J E GOVT, V6, P55; WEBSTER J, 1992, MIS QUART, V16, P201, DOI 10.2307/249576; Whitehill M, 1997, LONG RANGE PLANN, V30, P621, DOI 10.1016/S0024-6301(97)00046-0; Williams D, 2014, J ENTREP MANAG INNOV, V10, P79, DOI 10.7341/20141013; Wong KY, 2005, IND MANAGE DATA SYST, V105, P261, DOI 10.1108/02635570510590101; Wu HL, 2009, J SME DEV, V12, P179; Wu TH, 1996, WORK VALUES INVENTOR; Yan YL, 2013, COMPUT HUM BEHAV, V29, P1923, DOI 10.1016/j.chb.2013.03.007; Yi MY, 2003, INT J HUM-COMPUT ST, V59, P431, DOI 10.1016/S1071-5819(03)00114-9; Yu TK, 2010, COMPUT HUM BEHAV, V26, P32, DOI 10.1016/j.chb.2009.08.002; Zhou J, 2016, IEEE T SYST MAN CYB	106	11	12	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183994	10.1371/journal.pone.0183994	http://dx.doi.org/10.1371/journal.pone.0183994			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886088	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100052
J	Kim, YS; Kim, C; Jung, KH; Kwon, HM; Heo, SH; Kim, BJ; Kim, YD; Kim, JM; Lee, SH				Kim, Young Seo; Kim, Chulho; Jung, Keun-Hwa; Kwon, Hyung-Min; Heo, Sung Hyuk; Kim, Beom Joon; Kim, Young Dae; Kim, Jeong-Min; Lee, Seung-Hoon			Range of glucose as a glycemic variability and 3-month outcome in diabetic patients with acute ischemic stroke	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; ASYMPTOMATIC HYPOGLYCEMIA; POSTSTROKE HYPERGLYCEMIA; INDEPENDENT PREDICTOR; MORTALITY; TRIAL; COMPLICATIONS; ASSOCIATION	Glycemic variability (GV) is reportedly a predictor for poor outcome in various clinical conditions. We aimed to assess whether GV during hospital admission is associated with poor outcomes in patients with acute ischemic stroke (AIS) and diabetes. We prospectively enrolled consecutive patients with AIS from the registry of 6 tertiary hospitals between January 2013 and December 2014. For the GV index, we used a glucose level range that was divided into 4 quartiles. Multivariable binary and ordinal logistic regression analyses were performed to determine the association between GV and the modified Rankin Scale score (3-6) at 3 months. We enrolled 1,504 patients with AIS and diabetes (mean age, 68.1 years; male, 57.2%), of which 35.1% had poor outcomes at 3 months. An increasing glucose range quartile was positively associated with initial neurologic severity and development of hypoglycemia during hospital admission. Multivariable analysis showed that the glucose level range quartile was associated with poor outcomes, even after adjusting for the number of glucose measurement and hypoglycemia (odds ratio [OR] Q2 vs. Q1: 1.50, 95% confidence interval [CI]: 1.02-2.18; OR Q3 vs. Q1: 2.01, 95% CI: 1.34-3.01; OR Q4 vs. Q1: 1.98, 95% CI: 1.22-3.23). These associations remained significant after dichotomization according to glycated hemoglobin levels at admission. An increasing glucose level range as a GV index during hospital admission was associated with poor functional outcomes at 3 months in patients with AIS and diabetes.	[Kim, Young Seo] Hanyang Univ, Dept Neurol, Sch Med, Seoul, South Korea; [Kim, Chulho] Chuncheon Sacred Heart Hosp, Dept Neurol, Chunchon, South Korea; [Jung, Keun-Hwa; Lee, Seung-Hoon] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Kwon, Hyung-Min] Seoul Natl Univ, Dept Neurol, Seoul Metropolitan Govt Boramae Med Ctr, Seoul, South Korea; [Heo, Sung Hyuk] Kyung Hee Univ, Dept Neurol, Sch Med, Seoul, South Korea; [Kim, Beom Joon] Seoul Natl Univ, Dept Neurol, Bundang Hosp, Seongnam, South Korea; [Kim, Beom Joon] Seoul Natl Univ, Cerebrovasc Ctr, Bundang Hosp, Seongnam, South Korea; [Kim, Young Dae] Yonsei Univ, Severance Hosp, Dept Neurol, Coll Med, Seoul, South Korea; [Kim, Jeong-Min] Chung Ang Univ Hosp, Dept Neurol, Seoul, South Korea	Hanyang University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Kyung Hee University; Seoul National University (SNU); Seoul National University (SNU); Yonsei University; Yonsei University Health System; Chung Ang University; Chung Ang University Hospital	Kim, C (corresponding author), Chuncheon Sacred Heart Hosp, Dept Neurol, Chunchon, South Korea.	gumdol52@naver.com	Kim, Jeong-Min/ABH-2469-2021; Kim, Beom Joon/C-2904-2011; Heo, Sung Hyuk/P-3529-2019; Kim, Chulho/AAC-8708-2022	Kim, Beom Joon/0000-0002-2719-3012; Heo, Sung Hyuk/0000-0002-9215-5119; Kim, Chulho/0000-0001-8762-8340; Kim, Young Dae/0000-0001-5750-2616; Kwon, Hyung-Min/0000-0002-6101-7127; Jung, Keun-Hwa/0000-0003-1433-8005; Kim, Jeong-Min/0000-0001-7213-5527	Hallym University Specialization Fund [HRF-S-53]; Cerebrovascular Research Society Fund [2015-01]	Hallym University Specialization Fund; Cerebrovascular Research Society Fund	The present study was supported by research grants from the Hallym University Specialization Fund (HRF-S-53) and from the Cerebrovascular Research Society Fund (2015-01). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation for the manuscript.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Allport L, 2006, DIABETES CARE, V29, P1839, DOI 10.2337/dc06-0204; [Anonymous], 1995, DIABETES, V44, P968; Bragd J, 2008, DIABETES METAB, V34, P612, DOI 10.1016/j.diabet.2008.04.005; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Calderon-Larranaga A, 2016, INT J CARDIOL, V207, P310, DOI 10.1016/j.ijcard.2016.01.069; Camara-Lemarroy CR, 2017, J NEUROL SCI, V373, P242, DOI 10.1016/j.jns.2017.01.015; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Christensen H, 2004, J NEUROL SCI, V217, P175, DOI 10.1016/j.jns.2003.09.013; Cueni-Villoz N, 2011, CRIT CARE MED, V39, P2225, DOI 10.1097/CCM.0b013e31822572c9; DeVries JH, 2013, DIABETES, V62, P1405, DOI 10.2337/db12-1610; Dossett LA, 2008, AM SURGEON, V74, P679; Egi M, 2006, ANESTHESIOLOGY, V105, P244, DOI 10.1097/00000542-200608000-00006; Egi M, 2010, MAYO CLIN PROC, V85, P217, DOI 10.4065/mcp.2009.0394; Engoren M, 2014, J CRIT CARE, V29, P611, DOI 10.1016/j.jcrc.2014.03.014; FEIBEL JH, 1977, JAMA-J AM MED ASSOC, V238, P1374, DOI 10.1001/jama.238.13.1374; Gonzalez-Moreno EI, 2014, TRANSL STROKE RES, V5, P638, DOI 10.1007/s12975-014-0365-7; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Hermanides J, 2010, CRIT CARE MED, V38, P838, DOI 10.1097/CCM.0b013e3181cc4be9; Hirsch IB, 2005, J DIABETES COMPLICAT, V19, P178, DOI 10.1016/j.jdiacomp.2004.10.001; Ishihara M, 2005, AM HEART J, V150, P814, DOI 10.1016/j.ahj.2004.12.020; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kaarisalo MM, 2005, DIABETES RES CLIN PR, V69, P293, DOI 10.1016/j.diabres.2005.02.001; Kim BJ, 2015, J STROKE, V17, P38, DOI 10.5853/jos.2015.17.1.38; Krinsley JS, 2008, CRIT CARE MED, V36, P3008, DOI 10.1097/CCM.0b013e31818b38d2; Kurtz P, 2014, CRIT CARE IN PRESS; Lin BW, 2000, NEUROSCI LETT, V278, P1, DOI 10.1016/S0304-3940(99)00889-7; Lipska KJ, 2012, CIRC-CARDIOVASC QUAL, V5, P550, DOI 10.1161/CIRCOUTCOMES.111.963298; Megherbi SE, 2003, STROKE, V34, P688, DOI 10.1161/01.STR.0000057975.15221.40; Monnier L, 2011, DIABETES TECHNOL THE, V13, P813, DOI 10.1089/dia.2011.0049; ONEILL PA, 1991, STROKE, V22, P842, DOI 10.1161/01.STR.22.7.842; Qu YM, 2012, DIABETES TECHNOL THE, V14, P1008, DOI 10.1089/dia.2012.0099; Ribo M, 2005, STROKE, V36, P1705, DOI 10.1161/01.STR.0000173161.05453.90.9f; Rizk NN, 2005, BRAIN RES, V1053, P1, DOI 10.1016/j.brainres.2005.05.036; Rodbard David, 2012, J Diabetes Sci Technol, V6, P712; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Wang JS, 2016, DIABETES RES CLIN PR, V113, P108, DOI 10.1016/j.diabres.2015.12.010; Weir CJ, 1997, BMJ-BRIT MED J, V314, P1303, DOI 10.1136/bmj.314.7090.1303; Williams LS, 2002, NEUROLOGY, V59, P67, DOI 10.1212/WNL.59.1.67	42	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183894	10.1371/journal.pone.0183894	http://dx.doi.org/10.1371/journal.pone.0183894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880933	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200027
J	Nier, A; Engstler, AJ; Maier, IB; Bergheim, I				Nier, Anika; Engstler, Anna Janina; Maier, Ina Barbara; Bergheim, Ina			Markers of intestinal permeability are already altered in early stages of non-alcoholic fatty liver disease: Studies in children	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; PLASMINOGEN-ACTIVATOR INHIBITOR-1; FRUCTOSE-INDUCED STEATOSIS; INSULIN-RESISTANCE; GUT MICROBIOTA; MICE ROLE; CIRRHOSIS; OBESITY; MODEL; CD14	Background & aims Recent studies have shown that patients with manifest non-alcoholic fatty liver disease (NAFLD), e.g. steatosis grade 3 or steatohepatitis with or without beginning fibrosis frequently show altered fecal microbiota composition and elevated bacterial endotoxin levels. However, if these alterations are signs of a progressing disease or are already found in initial disease stages has not yet been clarified. Methods Twenty children with simple steatosis (grade 1) diagnosed by ultrasound and 29 normal weight healthy control children (age < 10 years) were included in the study (mean age 7.6 +/- 1.1 years). Metabolic parameters, markers of intestinal barrier function and inflammation were determined. Results Activity of alanine aminotransferase, concentrations of some markers of inflammation and insulin resistance were significantly higher in plasma of NAFLD children than in controls. When compared to controls, plasma bacterial endotoxin and lipopolysaccharide-binding protein (LBP) levels were significantly higher in NAFLD children (+ 50% and + 24%, respectively), while soluble CD14 serum and D-lactate plasma levels as well as the prevalence of small intestinal bacterial overgrowth did not differ between groups. Plasma endotoxin and LBP levels were positive associated with proinflammatory markers like plasminogen activator inhibitor-1, c-reactive protein, interleukin-6 and leptin while no associations with markers of insulin resistance were found. Conclusions Taken together, our results indicate that even in juvenile patients with early stages of NAFLD e.g. simple steatosis grade 1, plasma endotoxin concentrations are already elevated further suggesting that intestinal barrier dysfunction might be present already in the initial phases of the disease.	[Nier, Anika; Engstler, Anna Janina; Bergheim, Ina] Univ Vienna, Dept Nutr Sci, Mol Nutr Sci, Vienna, Austria; [Nier, Anika; Engstler, Anna Janina; Bergheim, Ina] Friedrich Schiller Univ Jena, SD Model Syst Mol Nutr, Inst Nutr, Jena, Germany; [Maier, Ina Barbara] Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany	University of Vienna; Friedrich Schiller University of Jena; University Hohenheim	Bergheim, I (corresponding author), Univ Vienna, Dept Nutr Sci, Mol Nutr Sci, Vienna, Austria.; Bergheim, I (corresponding author), Friedrich Schiller Univ Jena, SD Model Syst Mol Nutr, Inst Nutr, Jena, Germany.	ina.bergheim@univie.ac.at			German Ministry of Education and Science (BMBF) [FKZ: 01EA1305]; University of Vienna	German Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); University of Vienna	The work was supported in part by the German Ministry of Education and Science (BMBF), FKZ: 01EA1305 (IB). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Open access funding provided by University of Vienna.	Agiasotelli D, 2017, LIVER INT, V37, P576, DOI 10.1111/liv.13264; Akcam M, 2013, CLIN IMAG, V37, P504, DOI 10.1016/j.clinimag.2012.07.011; Alisi A, 2010, J PEDIATR GASTR NUTR, V50, P645, DOI 10.1097/MPG.0b013e3181c7bdf1; Anderson EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140908; Biedermann L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059260; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356; Campbell DI, 2002, BRIT J NUTR, V88, P499, DOI 10.1079/BJN2002697; Chen YY, 2014, J CHIN MED ASSOC, V77, P68, DOI 10.1016/j.jcma.2013.10.006; de Courten B, 2016, MOL NUTR FOOD RES, V60, P103, DOI 10.1002/mnfr.201500102; Engen PA, 2015, ALCOHOL RES-CURR REV, V37, P223; Engstler AJ, 2016, GUT, V65, P1564, DOI 10.1136/gutjnl-2014-308379; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Guercio Nuzio S, 2016, PEDIAT OBES; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Hocking MP, 1998, DIGEST DIS SCI, V43, P2493, DOI 10.1023/A:1026698602714; Jin CJ, 2017, J GASTROEN HEPATOL, V32, P708, DOI 10.1111/jgh.13488; JOSEPH AEA, 1991, CLIN RADIOL, V43, P26, DOI 10.1016/S0009-9260(05)80350-2; Kanuri G, 2011, LAB INVEST, V91, P885, DOI 10.1038/labinvest.2011.44; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lee H, 2014, APPL ENVIRON MICROB, V80, P5935, DOI 10.1128/AEM.01357-14; Maier IB, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-14; Fernandez-Real JM, 2011, DIABETES, V60, P2179, DOI 10.2337/db10-1210; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Nardone G, 2010, AM J PHYSIOL-GASTR L, V299, pG669, DOI 10.1152/ajpgi.00188.2010; Naska Androniki, 2017, F1000Res, V6, P926, DOI 10.12688/f1000research.10703.1; Nobili V, 2016, ARCH MED SCI; De Loera-Rodriguez CO, 2014, J INFLAMM-LOND, V11, DOI 10.1186/s12950-014-0039-y; Papp M, 2012, LIVER INT, V32, P603, DOI 10.1111/j.1478-3231.2011.02689.x; Ritze Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0101702, 10.1371/journal.pone.0080169]; Ruan Peng, 2004, Hepatobiliary Pancreat Dis Int, V3, P58; Saad RJ, 2014, CLIN GASTROENTEROL H, V12, P1964, DOI 10.1016/j.cgh.2013.09.055; Schafer C, 2002, ALCOHOL ALCOHOLISM, V37, P81, DOI 10.1093/alcalc/37.1.81; Spruss A, 2012, LAB INVEST, V92, P1020, DOI 10.1038/labinvest.2012.75; Thorgersen EB, 2010, FASEB J, V24, P712, DOI 10.1096/fj.09-140798; Thuy S, 2008, J NUTR, V138, P1452, DOI 10.1093/jn/138.8.1452; van den Berg EH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171502; Velayudham A, 2009, HEPATOLOGY, V49, P989, DOI 10.1002/hep.22711; Volynets V, 2013, EUR J NUTR, V52, P527, DOI 10.1007/s00394-012-0355-z; Volynets V, 2010, J LIPID RES, V51, P3414, DOI 10.1194/jlr.M007179; Wagnerberger S, 2013, J NUTR BIOCHEM, V24, P531, DOI 10.1016/j.jnutbio.2012.01.014; Weiss J, 2014, DTSCH ARZTEBL INT, V111, P447, DOI 10.3238/arztebl.2014.0447; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Younossi ZM, 2011, CLIN GASTROENTEROL H, V9, P524, DOI 10.1016/j.cgh.2011.03.020; Zhu JZ, 2016, WORLD J GASTROENTERO, V22, P8226, DOI 10.3748/wjg.v22.i36.8226	47	45	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183282	10.1371/journal.pone.0183282	http://dx.doi.org/10.1371/journal.pone.0183282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880885	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200015
J	Turner, RE; Rabalais, NN; Justic, D				Turner, R. Eugene; Rabalais, Nancy N.; Justic, Dubravko			Trends in summer bottom-water temperatures on the northern Gulf of Mexico continental shelf from 1985 to 2015	PLOS ONE			English	Article							SEDIMENT TRANSPORT; MISSISSIPPI RIVER; CLIMATE-CHANGE; LOUISIANA; HYPOXIA; OCEAN; SEA; CIRCULATION; ECOSYSTEMS; ASSEMBLAGE	We quantified trends in the 1985 to 2015 summer bottom-water temperature on the northern Gulf of Mexico (nGOM) continental shelf for data collected at 88 stations with depths ranging from 3 to 63 m. The analysis was supplemented with monthly data collected from 1963 to 1965 in the same area. The seasonal summer peak in average bottom-water temperature varied concurrently with air temperature, but with a 2- to 5-month lag. The summer bottom-water temperature declined gradually with depth from 30 degrees C at stations closest to the shore, to 20 degrees C at the offshore edge of the study area, and increased an average 0.051 degrees C y(-)1 between1963 and 2015. The bottom-water warming in summer for all stations was 1.9 times faster compared to the rise in local summer air temperatures, and 6.4 times faster than the concurrent increase in annual global ocean sea surface temperatures. The annual rise in average summer bottom-water temperatures on the subtropical nGOM continental shelf is comparable to the few published temperature trend estimates from colder environments. These recent changes in the heat storage on the nGOM continental shelf will affect oxygen and carbon cycling, spatial distribution of fish and shrimp, and overall species diversity.	[Turner, R. Eugene; Rabalais, Nancy N.; Justic, Dubravko] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Rabalais, Nancy N.] Louisiana Univ Marine Consortium, Chauvin, LA 70344 USA	Louisiana State University System; Louisiana State University	Turner, RE (corresponding author), Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	euturne@lsu.edu	Rabalais, Nancy N./AAD-2119-2021	Rabalais, Nancy N./0000-0002-1514-837X	National Oceanic and Atmospheric Administration over the last 3 decades, and most recently through Center for Sponsored Coastal Ocean Research [NA09NOS4780204, NA09NOS4780230]	National Oceanic and Atmospheric Administration over the last 3 decades, and most recently through Center for Sponsored Coastal Ocean Research	Sampling was supported by grants from the National Oceanic and Atmospheric Administration over the last 3 decades, and most recently through Center for Sponsored Coastal Ocean Research (www.cop.noaa gov), under awards NA09NOS4780204 to Louisiana Universities Marine Consortium and award NA09NOS4780230 to Louisiana State University.	Altieri AH, 2015, GLOBAL CHANGE BIOL, V21, P1395, DOI 10.1111/gcb.12754; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Carstensen J, 2014, P NATL ACAD SCI USA, V111, P5628, DOI 10.1073/pnas.1323156111; Cochrane JD, 1986, EOS T AM GEOPHYS UN, V64, P1021; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; DINNEL SP, 1986, CONT SHELF RES, V6, P765, DOI 10.1016/0278-4343(86)90036-1; Dunn D.E., 1996, 964113 US GEOL SURV; Etter PC, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001820; Fodrie FJ, 2010, GLOBAL CHANGE BIOL, V16, P48, DOI 10.1111/j.1365-2486.2009.01889.x; Gore R.H., 1992, GULF MEXICO TREASURY; Hansen J, 2011, ATMOS CHEM PHYS, V11, P13421, DOI 10.5194/acp-11-13421-2011; Hunter-Cevera KR, 2016, SCIENCE, V354, P326, DOI 10.1126/science.aaf8536; Karl TR, 2015, SCIENCE, V348, P1469, DOI 10.1126/science.aaa5632; Kuffner IB, 2015, ESTUAR COAST, V38, P1085, DOI 10.1007/s12237-014-9875-5; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Lyman JM, 2010, NATURE, V465, P334, DOI 10.1038/nature09043; Molinos JG, 2016, NAT CLIM CHANGE, V6, P83, DOI [10.1038/NCLIMATE2769, 10.1038/nclimate2769]; Montagna PA, 2011, COASTAL IMPACTS IMPA; NOAA, 2013, NAT COAST POP REP PO; Notz D, 2016, SCIENCE, V354, P747, DOI 10.1126/science.aag2345; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Pachauri R. K. Team, 2007, CLIMATE CHANGE 2007, P104; Pinsky M, 2015, SCIENCE, V341, P1239; Powell EJ, 2015, J CLIMATE, V28, P1592, DOI 10.1175/JCLI-D-14-00410.1; Quinones-Rivera ZJ, 2007, MAR ECOL PROG SER, V342, P69, DOI 10.3354/meps342069; Rabalais NN, 2007, ESTUAR COAST, V30, P753, DOI 10.1007/BF02841332; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; Santos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050666; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Smith SJ, 2015, NAT CLIM CHANGE, V5, P333, DOI 10.1038/nclimate2552; Strauss BH, 2013, P NATL ACAD SCI USA, V110, P13699, DOI 10.1073/pnas.1312464110; Sydeman WJ, 2015, SCIENCE, V350, P772, DOI 10.1126/science.aac9874; Temple RF, 1977, SSRF707 NOAA NMFS; Turner RE, 2012, MAR POLLUT BULL, V64, P319, DOI 10.1016/j.marpolbul.2011.11.008; Turner RE, 2008, ENVIRON SCI TECHNOL, V42, P2323, DOI 10.1021/es071617k; UNESCO IOC SCOR and IAPSO, 2010, INT THERM EQ SEAW 20; Walker N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017555; Walker ND, 2005, J COASTAL RES, V21, P1228, DOI 10.2112/04-0347.1; Walker ND, 2001, ESTUARIES, V24, P498, DOI 10.2307/1353252; Walker ND, 2000, J COASTAL RES, V16, P996; White DA, 2016, AQUAT BOT, V132, P5, DOI 10.1016/j.aquabot.2016.02.007; Wiseman WJ, 2004, NATO SCI S SS IV EAR, V36, P359; Wiseman WJ, 1997, J MARINE SYST, V12, P237, DOI 10.1016/S0924-7963(96)00100-5	43	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184350	10.1371/journal.pone.0184350	http://dx.doi.org/10.1371/journal.pone.0184350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880893	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200054
J	Droulers, O; Gallopel-Morvan, K; Lacoste-Badie, S; Lajante, M				Droulers, Olivier; Gallopel-Morvan, Karine; Lacoste-Badie, Sophie; Lajante, Mathieu			The influence of threatening visual warnings on tobacco packaging: Measuring the impact of threat level, image size, and type of pack through psychophysiological and self-report methods	PLOS ONE			English	Article							PICTORIAL WARNINGS; CIGARETTE PACKAGES; SMOKING-CESSATION; LABELS; EMOTION; VALENCE	The first aim of this research was to assess the effectiveness, in terms of emotional and behavioral reactions, of moderately vs. highly TVWs (Threatening Visual Warnings) displayed on tobacco packs. Given the key role that emotional reactions play in explaining the effect of TVWs on behaviors, psychophysiological and self-report methods were used-for the first time in this context-to measure the emotions provoked by TVWs. The second aim of this research was to determine whether increasing the size of warnings, and their display on plain packaging (compared with branded packaging) would improve their effectiveness. A within-subjects experiment was conducted. Three variables were manipulated: health warning threat level (high vs. moderate), image size (40% vs. 75%) and pack type (plain vs. branded). A convenience sample of 48 French daily smokers participated. They were exposed to eight different packs of cigarettes in a research lab at the University of Rennes. Smokers' emotions and behavioral intentions were recorded through self-reports. Emotions were also evaluated using psychophysiological measurements: electrodermal activity and facial electromyography. The results revealed that TVWs with a high threat level are the most effective in increasing negative emotions (fear, disgust, valence, arousal) and behavioral intentions conducive to public health (desire to quit, etc.). They also highlight the appeal of increasing the size of the warnings and displaying them on plain packs, because this influences emotions, which is the first step toward behavioral change. Increasing the threat level of TVWs from moderate to high seems beneficial for public health. Our results also confirm the relevance of recent governmental decisions to adopt plain packaging and larger TVWs (in the UK, France, Ireland, Canada, New Zealand, Hungary, etc.).	[Droulers, Olivier] Univ Rennes 1, IGR, UMR 6211, IAE,Grad Sch Management,CREM, Rennes, France; [Gallopel-Morvan, Karine] EHESP, Sch Publ Hlth, EA 7348, MOS, Rennes, France; [Lacoste-Badie, Sophie] Univ Rennes 1, UMR 6211, CREM, IUT,GEA, Rennes, France; [Lajante, Mathieu] Univ Laval, Mkt Dept, Fac Business Adm, Quebec City, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Rennes; Ecole des Hautes Etudes en Sante Publique (EHESP); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Rennes; Laval University	Gallopel-Morvan, K (corresponding author), EHESP, Sch Publ Hlth, EA 7348, MOS, Rennes, France.	karine.gallopel-morvan@ehesp.fr	Lajante, Mathieu/G-7271-2018; Lajante, Mathieu/AAU-4838-2020		French National Cancer Institute [2013-154 I(D)MATREC]	French National Cancer Institute(Institut National du Cancer (INCA) France)	This work was supported by grant no 2013-154 I(D)MATREC from the French National Cancer Institute. This funding source had no role in the design of the study,during its execution, analyses, interpretation of the data, or decision to submit results.	Andler R., 2016, Bulletin Epidemiologique Hebdomadaire, P502; Andrews J. C., 2016, TOB CONTROL; Andrews JC, 2014, J MARKETING RES, V51, P165, DOI 10.1509/jmr.13.0092; Azagba S, 2013, NICOTINE TOB RES, V15, P708, DOI 10.1093/ntr/nts194; Bansal-Travers M, 2011, AM J PREV MED, V40, P674, DOI 10.1016/j.amepre.2011.01.021; Benedek M, 2010, J NEUROSCI METH, V190, P80, DOI 10.1016/j.jneumeth.2010.04.028; Benedek M, 2010, PSYCHOPHYSIOLOGY, V47, P647, DOI 10.1111/j.1469-8986.2009.00972.x; Borland R, 2009, ADDICTION, V104, P669, DOI 10.1111/j.1360-0443.2009.02508.x; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; CACIOPPO JT, 1986, J PERS SOC PSYCHOL, V50, P260, DOI 10.1037/0022-3514.50.2.260; Canadian Cancer Society, 2016, CIG PACK HLTH WARN I; Cho Y, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0147191, 10.1371/journal.pone.0159245]; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Emery LF, 2014, NICOTINE TOB RES, V16, P263, DOI 10.1093/ntr/ntt124; Erceg-Hurn DM, 2011, J APPL SOC PSYCHOL, V41, P219, DOI 10.1111/j.1559-1816.2010.00710.x; Evans AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142879; Farrelly MC, 2012, AM J PREV MED, V43, P475, DOI 10.1016/j.amepre.2012.07.023; Gallopel-Morvan K, 2011, J BUS RES, V64, P7, DOI 10.1016/j.jbusres.2009.09.012; Glock S, 2013, J HEALTH PSYCHOL, V18, P252, DOI 10.1177/1359105312439734; Glock S, 2009, APPL PSYCHOL-HLTH WE, V1, P356, DOI 10.1111/j.1758-0854.2009.01019.x; Goodall C, 2008, HEALTH COMMUN, V23, P117, DOI 10.1080/10410230801967825; Gravely S, 2016, TOB CONTROL, V25, P89, DOI 10.1136/tobaccocontrol-2014-051742; Green Adam E, 2016, Addict Behav Rep, V3, P28; Hammond D, 2007, AM J PREV MED, V32, P202, DOI 10.1016/j.amepre.2006.11.011; Harris PR, 2007, HEALTH PSYCHOL, V26, P437, DOI 10.1037/0278-6133.26.4.437; Hoek J, 2011, TOB CONTROL, V20, P183, DOI 10.1136/tc.2010.037861; Huang JD, 2014, TOB CONTROL, V23, P7, DOI 10.1136/tobaccocontrol-2013-051170; Izard C. E., 1977, HUMAN EMOTIONS; Kees J, 2010, J PUBLIC POLICY MARK, V29, P265, DOI 10.1509/jppm.29.2.265; Kessels LTE, 2014, INT J PSYCHOL, V49, P80, DOI 10.1002/ijop.12036; Lajante M, 2012, J NEUROSCI PSYCHOL E, V5, P238, DOI 10.1037/a0030680; Lajante MMP, 2017, J ADVERTISING RES, V57, P28, DOI 10.2501/JAR-2017-011; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lerner JS, 2015, ANNU REV PSYCHOL, V66, P799, DOI 10.1146/annurev-psych-010213-115043; McCool J, 2012, SOC SCI MED, V74, P1269, DOI 10.1016/j.socscimed.2011.12.043; Monarrez-Espino J, 2014, AM J PUBLIC HEALTH, V104, pE11, DOI 10.2105/AJPH.2014.302129; Morales AC, 2012, J MARKETING RES, V49, P383, DOI 10.1509/jmr.07.0364; Netemeyer RG, 2016, J PUBLIC POLICY MARK, V35, P124, DOI 10.1509/jppm.15.008; Noar SM, 2016, TOB CONTROL, V25, P341, DOI 10.1136/tobaccocontrol-2014-051978; Plutchik R., 1980, EMOTION PSYCHOEVOLUT; Poels K, 2006, J ADVERTISING RES, V46, P18, DOI 10.2501/S0021849906060041; ROGERS RW, 1975, J PSYCHOL, V91, P93, DOI 10.1080/00223980.1975.9915803; Russell, 1974, APPROACH ENV PSYCHOL; Schneider S, 2012, PATIENT EDUC COUNS, V86, P77, DOI 10.1016/j.pec.2011.03.005; Stead M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075919; Strasser AA, 2012, AM J PREV MED, V43, P41, DOI 10.1016/j.amepre.2012.02.026; TASSINARY LG, 1989, PSYCHOPHYSIOLOGY, V26, P1, DOI 10.1111/j.1469-8986.1989.tb03125.x; Thrasher JF, 2016, PREV MED, V88, P59, DOI 10.1016/j.ypmed.2016.03.006; Volchan E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072117; Wakefield M, 2012, ADDICTION, V107, P1159, DOI 10.1111/j.1360-0443.2012.03774.x; Wang AL, 2015, TOB CONTROL, V24, P225, DOI 10.1136/tobaccocontrol-2014-051993; Wang AL, 2015, ADDICT BIOL, V20, P368, DOI 10.1111/adb.12117; WHO, FRAM CONV TOB CONTR; World Health Organization, 2016, TOB FACTS; Zentner M, 2008, EMOTION, V8, P494, DOI 10.1037/1528-3542.8.4.494	55	18	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184415	10.1371/journal.pone.0184415	http://dx.doi.org/10.1371/journal.pone.0184415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910317	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200045
J	Boldinova, EO; Stojkovic, G; Khairullin, R; Wanrooij, S; Makarova, AV				Boldinova, Elizaveta O.; Stojkovic, Gorazd; Khairullin, Rafil; Wanrooij, Sjoerd; Makarova, Alena V.			Optimization of the expression, purification and polymerase activity reaction conditions of recombinant human PrimPol	PLOS ONE			English	Article							TRANSLESION DNA-SYNTHESIS; ESCHERICHIA-COLI; ACCESSORY SUBUNITS; LOW-FIDELITY; REPLICATION; ZETA; PROTEINS; CELLS; POL; CHAPERONES	Human PrimPol is a DNA primase/polymerase involved in DNA damage tolerance and prevents nuclear genome instability. PrimPol is also localized to the mitochondria, but its precise function in mitochondrial DNA maintenance has remained elusive. PrimPol works both as a translesion (TLS) polymerase and as the primase that restarts DNA replication after a lesion. However, the observed biochemical activities of PrimPol vary considerably between studies as a result of different reaction conditions used. To reveal the effects of reaction composition on PrimPol DNA polymerase activity, we tested the polymerase activity in the presence of various buffer agents, salt concentrations, pH values and metal cofactors. Additionally, the enzyme stability was analyzed under various conditions. We demonstrate that the reaction buffer with pH 6-6.5, low salt concentrations and 3 mM Mg2+ or 0.3-3 mM Mn2+ cofactor ions supports the highest DNA polymerase activity of human PrimPol in vitro. The DNA polymerase activity of PrimPol was found to be stable after multiple freeze-thaw cycles and prolonged protein incubation on ice. However, rapid heat-inactivation of the enzyme was observed at 37 degrees C. We also for the first time describe the purification of human PrimPol from a human cell line and compare the benefits of this approach to the expression in Escherichia coli and in Saccharomyces cerevisiae cells. Our results show that active PrimPol can be purified from E. coli and human suspension cell line in high quantities and that the activity of the purified enzyme is similar in both expression systems. Conversely, the yield of full-length protein expressed in S. cerevisiae was considerably lower and this system is therefore not recommended for expression of full-length recombinant human PrimPol.	[Boldinova, Elizaveta O.; Makarova, Alena V.] Russian Acad Sci, Inst Mol Genet, Kurchatov Sq 2, Moscow, Russia; [Boldinova, Elizaveta O.] Moscow State Univ Fine Chem Technol, Vernadsky Prospect 78, Moscow, Russia; [Stojkovic, Gorazd; Khairullin, Rafil; Wanrooij, Sjoerd] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden; [Khairullin, Rafil] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan 18, Russia	Russian Academy of Sciences; MIREA - Russian Technological University; Umea University; Kazan Federal University	Makarova, AV (corresponding author), Russian Acad Sci, Inst Mol Genet, Kurchatov Sq 2, Moscow, Russia.; Wanrooij, S (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.	sjoerd.wanrooij@umu.se; amakarova-img@yandex.ru	Khairullin, Rafil/H-7560-2013; Makarova, Alena Vladimirovna/I-1338-2014; Wanrooij, Sjoerd/J-1367-2019	Khairullin, Rafil/0000-0001-9879-378X; Wanrooij, Sjoerd/0000-0001-6126-4382; Boldinova, Elizaveta/0000-0002-5462-6709	RAS; D. Zimin "Dynasty" Foundation; RFBR [15-04-08398-a]; Wallenberg Foundation; Olle Engkvist Byggmastare foundation	RAS(Russian Academy of SciencesRegione Sardegna); D. Zimin "Dynasty" Foundation; RFBR(Russian Foundation for Basic Research (RFBR)); Wallenberg Foundation(European Commission); Olle Engkvist Byggmastare foundation	This work was supported by the RAS Presidium Program "Molecular and Cellular Biology. New Groups", D. Zimin "Dynasty" Foundation and partially by RFBR (15-04-08398-a) to A.M. and by the Wallenberg Foundation to S.W. G.S. was supported by Olle Engkvist Byggmastare foundation.	Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Brown JA, 2011, ANTIMICROB AGENTS CH, V55, P276, DOI 10.1128/AAC.01229-10; Bylund GO, 2006, METHOD ENZYMOL, V409, P1, DOI 10.1016/S0076-6879(05)09001-4; COPELAND WC, 1993, J BIOL CHEM, V268, P11028; Costa S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00063; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Garg P, 2005, J BIOL CHEM, V280, P23446, DOI 10.1074/jbc.C500173200; Guilliam TA, 2015, NUCLEIC ACIDS RES, V43, P1056, DOI 10.1093/nar/gku1321; Holz Caterina, 2003, Journal of Structural and Functional Genomics, V4, P97, DOI 10.1023/A:1026226429429; Iyer LM, 2005, NUCLEIC ACIDS RES, V33, P3875, DOI 10.1093/nar/gki702; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Kazachenko KY, 2017, DNA REPAIR, V50, P77, DOI 10.1016/j.dnarep.2017.01.001; Keen BA, 2014, NUCLEIC ACIDS RES, V42, P12102, DOI 10.1093/nar/gku879; Keen BA, 2014, NUCLEIC ACIDS RES, V42, P5830, DOI 10.1093/nar/gku214; KLENOW H, 1969, EUR J BIOCHEM, V9, P133, DOI 10.1111/j.1432-1033.1969.tb00586.x; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Makarova AV, 2014, DNA REPAIR, V18, P63, DOI 10.1016/j.dnarep.2014.02.017; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Martinez-Jimenez MI, 2015, DNA REPAIR, V29, P127, DOI 10.1016/j.dnarep.2015.02.013; Mislak AC, 2016, ANTIMICROB AGENTS CH, V60, P561, DOI 10.1128/AAC.02270-15; Mouron S, 2013, NAT STRUCT MOL BIOL, V20, P1383, DOI 10.1038/nsmb.2719; Nishimoto N, 2016, BIOL PHARM BULL, V39, P953, DOI 10.1248/bpb.b15-00900; Porowinska D, 2014, APPL BIOCHEM BIOTECH, V173, P1349, DOI 10.1007/s12010-014-0858-6; Rechkoblit O, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601317; Rudd SG, 2013, MOL CELL, V52, P554, DOI 10.1016/j.molcel.2013.10.034; Schiavone D, 2016, MOL CELL, V61, P161, DOI 10.1016/j.molcel.2015.10.038; Schlieker C, 2002, J BIOTECHNOL, V96, P13, DOI 10.1016/S0168-1656(02)00033-0; Schumann W, 2004, GENET MOL BIOL, V27, P442, DOI 10.1590/S1415-47572004000300022; Shimazaki N, 2002, GENES CELLS, V7, P639, DOI 10.1046/j.1365-2443.2002.00547.x; Stojkovic G, 2016, SCI REP-UK, V6, DOI 10.1038/srep28942; Wan L, 2013, EMBO REP, V14, P1104, DOI 10.1038/embor.2013.159; Zafar MK, 2014, BIOCHEMISTRY-US, V53, P6584, DOI 10.1021/bi501024u; Zhang YB, 2000, NUCLEIC ACIDS RES, V28, P4147, DOI 10.1093/nar/28.21.4147; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	35	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184489	10.1371/journal.pone.0184489	http://dx.doi.org/10.1371/journal.pone.0184489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902865	gold, Green Published, Green Submitted			2022-12-27	WOS:000410669200039
J	Diaz-Rizo, V; Bonilla-Lara, D; Gonzalez-Lopez, L; Sanchez-Mosco, D; Fajardo-Robledo, NS; Perez-Guerrero, EE; Rodriguez-Jimenez, NA; Saldana-Cruz, AM; Vazquez-Villegas, ML; Gomez-Banuelos, E; Vazquez-Del Mercado, M; Cardona-Munoz, EG; Cardona-Muller, D; Trujillo, X; Huerta, M; Salazar-Paramo, M; Gamez-Nava, JI				Diaz-Rizo, Valeria; Bonilla-Lara, David; Gonzalez-Lopez, Laura; Sanchez-Mosco, Dalia; Fajardo-Robledo, Nicte S.; Perez-Guerrero, Edsaul E.; Alejandra Rodriguez-Jimenez, N.; Miriam Saldana-Cruz, A.; Luisa Vazquez-Villegas, M.; Gomez-Banuelos, Eduardo; Vazquez-Del Mercado, Monica; German Cardona-Munoz, E.; Cardona-Muller, David; Trujillo, Xochitl; Huerta, Miguel; Salazar-Paramo, Mario; Gamez-Nava, Jorge I.			Serum levels of adiponectin and leptin as biomarkers of proteinuria in lupus nephritis	PLOS ONE			English	Article							ERYTHEMATOSUS RELATIONSHIP; INSULIN-RESISTANCE; IMMUNE-RESPONSE; ADIPOKINES; INFLAMMATION; DISEASE; ADIPOCYTOKINES; PLASMA; INJURY; INDEX	Introduction There are controversial results about the role of serum leptin and adiponectin levels as biomarkers of the severity of proteinuria in lupus nephritis. Objective The aim of this study was to evaluate the relationship between serum leptin and adiponectin levels with severity of proteinuria secondary to lupus nephritis (LN). Methods In a cross-sectional study, 103 women with systemic lupus erythematosus (SLE) were evaluated for kidney involvement. We compared 30 SLE patients with LN, all of them with proteinuria, versus 73 SLE patients without renal involvement (no LN). A comprehensive set of clinical and laboratory variables was assessed, including serum levels of leptin and adiponectin by ELISA. Multivariate analyses were used to adjust for potential confounders associated with proteinuria in LN. Results We found higher adiponectin levels in the LN group compared with the no LN group (20.4 +/- 10.3 vs 15.6 +/- 7.8 mu g/mL; p = 0.02), whereas no differences were observed in leptin levels (33.3 +/- 31.4 vs 22.5 +/- 25.5 ng/mL; p = 0.07). Severity of proteinuria correlated with an increase in adiponectin levels (r = 0.31; p = 0.001), but no correlation was observed with leptin. Adiponectin levels were not related to anti-dsDNA or anti-nucleosome antibodies. In the logistic regression, adiponectin levels were associated with a high risk of proteinuria in SLE (OR = 1.06; 95% CI 1.01 - 1.12; p = 0.02). Instead, leptin was not associated with LN. Conclusion These findings indicate that adiponectin levels are useful markers associated with proteinuria in LN. Further longitudinal studies are required to identify if these levels are predictive of renal relapse.	[Diaz-Rizo, Valeria; Gamez-Nava, Jorge I.] Hosp Especialidades Ctr Med La Raza, IMSS, CMNO, Unidad Invest Biomed 02, Guadalajara, Jalisco, Mexico; [Diaz-Rizo, Valeria; Sanchez-Mosco, Dalia; Trujillo, Xochitl; Huerta, Miguel] Univ Colima, Programa Posgrad Ciencias Med, Colima, Mexico; [Diaz-Rizo, Valeria; Bonilla-Lara, David; Gonzalez-Lopez, Laura; Perez-Guerrero, Edsaul E.; Alejandra Rodriguez-Jimenez, N.; Gamez-Nava, Jorge I.] Univ Guadalajara, CUCS, Programa Posgrad Farmacol, Guadalajara, Jalisco, Mexico; [Bonilla-Lara, David; Gonzalez-Lopez, Laura; Sanchez-Mosco, Dalia] IMSS, Hosp Gen Reg 110, Dept Med Interna Reumatol, Guadalajara, Jalisco, Mexico; [Fajardo-Robledo, Nicte S.] Univ Guadalajara, Ctr Univ Ciencias Exactas & Ingn, Lab Invest & Desarrollo Farmaceut, Guadalajara, Jalisco, Mexico; [Perez-Guerrero, Edsaul E.] Univ Guadalajara, Ctr Univ Ciencias Exactas & Ingn, Dept Farmacobiol, Guadalajara, Jalisco, Mexico; [Miriam Saldana-Cruz, A.] Univ Guadalajara, Ctr Univ Tonala, Dept Ciencias Biomed, Guadalajara, Jalisco, Mexico; [Luisa Vazquez-Villegas, M.] IMSS, Dept Epidemiol, Unidad Med Familiar 4 & 8, Guadalajara, Jalisco, Mexico; [Luisa Vazquez-Villegas, M.] Univ Guadalajara, Programa Posgrad Salud Publ, CUCS, Guadalajara, Jalisco, Mexico; [Gomez-Banuelos, Eduardo] Univ Guadalajara, Ctr Univ Ciencias Salud, Inst Invest Reumatol & Sistema Musculoesquelet, Guadalajara, Jalisco, Mexico; [Vazquez-Del Mercado, Monica] Hosp Civil Juan I Menchaca, Div Med Marna OPD, Serv Reumatol, Guadalajara, Jalisco, Mexico; [German Cardona-Munoz, E.; Cardona-Muller, David] Univ Guadalajara, CUCS, Dept Fisiol, Inst Terapeut Expt & Clin, Guadalajara, Jalisco, Mexico; [Salazar-Paramo, Mario] Hosp Especialidades Ctr Med La Raza, IMSS, CMNO, Div Invest Salud,Unidad Med Alta Especialidad, Guadalajara, Jalisco, Mexico	Universidad de Colima; Universidad de Guadalajara; Instituto Mexicano del Seguro Social; Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara; Universidad de Guadalajara	Gamez-Nava, JI (corresponding author), Hosp Especialidades Ctr Med La Raza, IMSS, CMNO, Unidad Invest Biomed 02, Guadalajara, Jalisco, Mexico.; Gamez-Nava, JI (corresponding author), Univ Guadalajara, CUCS, Programa Posgrad Farmacol, Guadalajara, Jalisco, Mexico.	drivangamez@prodigy.net.mx	Gomez-Bañuelos, Eduardo/M-2616-2019; del Mercado, Monica Vazquez/F-5856-2017; Huerta, Miguel/AEP-0820-2022; Trujillo, Xóchitl/AHC-2100-2022; Trujillo, Xochitl/P-7020-2017	del Mercado, Monica Vazquez/0000-0002-3823-4676; Huerta, Miguel/0000-0001-8515-0777; Trujillo, Xóchitl/0000-0001-8146-5667; Diaz-Rizo, Valeria/0000-0001-9808-289X; Vazquez-Villegas, Maria Luisa/0000-0003-1399-270X; Perez-Guerrero, Edsaul Emilio/0000-0002-0007-1824; Fajardo-Robledo, Nicte/0000-0002-3471-5835; Gomez-Banuelos, Eduardo/0000-0001-9730-1851; Trujillo, Xochitl/0000-0001-7506-1674; Cardona-Muller, David/0000-0002-9470-2489; Rodriguez Jimenez, Norma Alejandra/0000-0001-7643-6298	Fondo de Investigacion en Salud (FIS) of the Institute Mexicano del Seguro Social (IMSS) [FIS/IMSS/PROT/G11/937]; IMSS; Mexican Institute for Social Security Foundation (Foundation IMSS, A.C.)	Fondo de Investigacion en Salud (FIS) of the Institute Mexicano del Seguro Social (IMSS); IMSS; Mexican Institute for Social Security Foundation (Foundation IMSS, A.C.)	This work was financially supported by a grant of the Fondo de Investigacion en Salud (FIS) of the Institute Mexicano del Seguro Social (IMSS). Grant number: FIS/IMSS/PROT/G11/937, held by the Ph.D. Jorge Ivan Gamez-Nava (JIGN), corresponding of this work. Dr. Gamez-Nava JI, was the supervisor of this work, he received the funding by the IMSS to make this possible. He also contributed in the conceptualization, the formal analysis, investigation, methodology of the manuscript, the project administration, he provided resources, he made part of the validation of the data, the software and supervision and the writing original draft preparation, review and editing the final version.; Also, we wish to thank the Mexican Institute for Social Security Foundation (Foundation IMSS, A.C.) for their support to this research.	Abella V, 2017, NAT REV RHEUMATOL, V13, P100, DOI 10.1038/nrrheum.2016.209; Al M, 2009, RHEUMATOLOGY, V48, P497, DOI 10.1093/rheumatology/kep030; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Cameron JS, 1999, J AM SOC NEPHROL, V10, P413; Choi HM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2844; Chung CP, 2009, LUPUS, V18, P799, DOI 10.1177/0961203309103582; Cohen SS, 2011, ANN EPIDEMIOL, V21, P86, DOI 10.1016/j.annepidem.2010.10.011; De Sanctis JB, 2009, AUTOIMMUNITY, V42, P272, DOI 10.1080/08916930902828031; Salgado AD, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/849684; Faggioni R, 2001, FASEB J, V15, P2565, DOI 10.1096/fj.01-0431rev; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Fantuzzi G, 2008, J ALLERGY CLIN IMMUN, V121, P326, DOI 10.1016/j.jaci.2007.10.018; Fantuzzi G, 2013, CYTOKINE, V64, P1, DOI 10.1016/j.cyto.2013.06.317; Frommer KW, 2012, ANN RHEUM DIS, V71, P1724, DOI 10.1136/annrheumdis-2011-200924; Frommer KW, 2010, ARTHRITIS RHEUM-US, V62, P2886, DOI 10.1002/art.27616; Fujita H, 2006, ENDOCR J, V53, P745, DOI 10.1507/endocrj.K06-016; Garcia-Gonzalez A, 2002, RHEUMATOL INT, V22, P138, DOI 10.1007/s00296-002-0216-9; Gladman D, 1996, J RHEUMATOL, V23, P1953; Hahn BH, 2012, ARTHRIT CARE RES, V64, P797, DOI 10.1002/acr.21664; Hayakawa K, 2009, NEPHROLOGY, V14, P327, DOI 10.1111/j.1440-1797.2008.01047.x; Hutcheson J, 2015, CLIN EXP IMMUNOL, V179, P435, DOI 10.1111/cei.12473; Koo HS, 2016, LUPUS, V25, P3, DOI 10.1177/0961203315595130; Krysiak R, 2012, EUR J NUTR, V51, P513, DOI 10.1007/s00394-012-0370-0; Lago F, 2007, NAT CLIN PRACT RHEUM, V3, P716, DOI 10.1038/ncprheum0674; Landolt-Marticorena C, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1120-0; Lee JH, 2001, INT J OBESITY, V25, P1471, DOI 10.1038/sj.ijo.0801736; Loghman M, 2016, INT J RHEUM DIS, V19, P678, DOI 10.1111/1756-185X.12284; Masaki T, 2004, HEPATOLOGY, V40, P177, DOI 10.1002/hep.20282; Neumann E, 2016, NAT REV RHEUMATOL, V12, P296, DOI 10.1038/nrrheum.2016.49; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Reyes-Thomas J, 2011, CLIN REV ALLERG IMMU, V40, P138, DOI 10.1007/s12016-010-8197-z; Rovin BH, 2006, CLIN IMMUNOL, V120, P99, DOI 10.1016/j.clim.2006.01.010; Rovin BH, 2005, KIDNEY INT, V68, P1825, DOI 10.1111/j.1523-1755.2005.00601.x; Sada KE, 2006, J RHEUMATOL, V33, P1545; Scotece M, 2014, DRUG DISCOV TODAY, V19, P241, DOI 10.1016/j.drudis.2013.07.012; Scotece M, 2014, BASIC CLIN PHARMACOL, V114, P97, DOI 10.1111/bcpt.12109; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Touma Z, 2014, J RHEUMATOL, V41, P688, DOI 10.3899/jrheum.130005; Toussirot E, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/938408; Tsioufis C, 2005, AM J CARDIOL, V96, P946, DOI 10.1016/j.amjcard.2005.05.052; Vadacca M, 2009, J RHEUMATOL, V36, P295, DOI 10.3899/jrheum.080503; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Zoccali C, 2002, J AM SOC NEPHROL, V13, P134, DOI 10.1681/ASN.V131134	45	26	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184056	10.1371/journal.pone.0184056	http://dx.doi.org/10.1371/journal.pone.0184056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898254	gold, Green Published, Green Submitted			2022-12-27	WOS:000410449500012
J	Leftin, A; Ben-Chetrit, N; Klemm, F; Joyce, JA; Koutcher, JA				Leftin, Avigdor; Ben-Chetrit, Nir; Klemm, Florian; Joyce, Johanna A.; Koutcher, Jason A.			Iron imaging reveals tumor and metastasis macrophage hemosiderin deposits in breast cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MAGNETIC-SUSCEPTIBILITY; MICROENVIRONMENTAL REGULATION; BRAIN; ANGIOGENESIS; RELAXATION; FERRITIN; INFILTRATION; CHELATORS; BLOOD	Iron-deposition is a metabolic biomarker of macrophages in both normal and pathological situations, but the presence of iron in tumor and metastasis-associated macrophages is not known. Here we mapped and quantified hemosiderin-laden macrophage ( HLM) deposits in murine models of metastatic breast cancer using iron and macrophage histology, and in vivo MRI. Iron MRI detected high-iron pixel clusters in mammary tumors, lung metastasis, and brain metastasis as well as liver and spleen tissue known to contain the HLMs. Iron histology showed these regions to contain clustered macrophages identified by their common iron status and tissue-intrinsic association with other phenotypic macrophage markers. The in vivo MRI and ex vivo histological images were further processed to determine the frequencies and sizes of the iron deposits, and measure the number of HLMs in each deposit to estimate the in vivo MRI sensitivity for these cells. Hemosiderin accumulation is a macrophage biomarker and intrinsic contrast source for cellular MRI associated with the innate function of macrophages in iron metabolism systemically, and in metastatic cancer.	[Leftin, Avigdor; Koutcher, Jason A.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Ben-Chetrit, Nir; Klemm, Florian; Joyce, Johanna A.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Klemm, Florian; Joyce, Johanna A.] Univ Lausanne, Dept Oncol, Lausanne, Switzerland; [Klemm, Florian; Joyce, Johanna A.] Univ Lausanne, Ludwig Inst Canc Res, Lausanne, Switzerland; [Koutcher, Jason A.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Koutcher, Jason A.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Koutcher, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA.; Koutcher, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Koutcher, JA (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA.	koutchej@mskcc.org		Klemm, Florian/0000-0002-8944-9175	NIH [P01 CA115675, DOD PC120233, P30 CA008748]; Deutsche Forschungsgemeinschaft (DFG) [KL 2491/1-1]; Breast Cancer Research Foundation; MSKCC Evelyn H. Lauder Breast Center [NIH 1F32CA206277]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Breast Cancer Research Foundation; MSKCC Evelyn H. Lauder Breast Center	The authors acknowledge funding support from NIH grants P01 CA115675, DOD PC120233 and P30 CA008748 (Cancer Center Support Grants), Breast and Molecular Imaging Fund at MSKCC Evelyn H. Lauder Breast Center, NIH 1F32CA206277 to A.L., Deutsche Forschungsgemeinschaft (DFG) grant KL 2491/1-1 to F.K., and the Breast Cancer Research Foundation to J.A.J. and J.A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PD, 2000, BBA-MOL BASIS DIS, V1500, P186, DOI 10.1016/S0925-4439(99)00104-0; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; BRITTENHAM GM, 1982, NEW ENGL J MED, V307, P1671, DOI 10.1056/NEJM198212303072703; BROOKS RA, 1995, JMRI-J MAGN RESON IM, V5, P446, DOI 10.1002/jmri.1880050414; Buss JL, 2004, CURR TOP MED CHEM, V4, P1623, DOI 10.2174/1568026043387269; Carneiro A A, 2004, Neurol Clin Neurophysiol, V2004, P85; Daldrup-Link H, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19457; Daldrup-Link HE, 2011, CLIN CANCER RES, V17, P5695, DOI 10.1158/1078-0432.CCR-10-3420; Navarrete MG, 2014, ANN DIAGN PATHOL, V18, P193, DOI 10.1016/j.anndiagpath.2014.01.005; Gammella E, 2014, METALLOMICS, V6, P1336, DOI 10.1039/c4mt00104d; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Garbowski MW, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-40; GILLIS P, 1987, MAGN RESON MED, V5, P323, DOI 10.1002/mrm.1910050404; GOMORI JM, 1987, J COMPUT ASSIST TOMO, V11, P684, DOI 10.1097/00004728-198707000-00025; Gwak JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125728; Haacke EM, 2005, MAGN RESON IMAGING, V23, P1, DOI 10.1016/j.mri.2004.10.001; Heath JL, 2013, NUTRIENTS, V5, P2836, DOI 10.3390/nu5082836; Jaiswal S, 2010, TRENDS IMMUNOL, V31, P212, DOI 10.1016/j.it.2010.04.001; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Kleinig TJ, 2013, J CLIN NEUROSCI, V20, P919, DOI 10.1016/j.jocn.2012.12.002; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Leek RD, 1996, CANCER RES, V56, P4625; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2006, CANCER RES, V66, P11238, DOI 10.1158/0008-5472.CAN-06-1278; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Neuwelt A, 2015, AM J ROENTGENOL, V204, pW302, DOI 10.2214/AJR.14.12733; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Recalcati S, 2012, AUTOIMMUN REV, V11, P883, DOI 10.1016/j.autrev.2012.03.003; RICHTER GW, 1960, J EXP MED, V112, P551, DOI 10.1084/jem.112.4.551; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Ruffell B, 2015, CANCER CELL, V27, P462, DOI 10.1016/j.ccell.2015.02.015; Sage D, 2012, IMAGESJ US DEV C 201; Schenck JF, 1996, MED PHYS, V23, P815, DOI 10.1118/1.597854; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shree T, 2011, GENE DEV, V25, P2465, DOI 10.1101/gad.180331.111; Takada S, 2011, NEUROL MED-CHIR, V51, P275, DOI 10.2176/nmc.51.275; THULBORN KR, 1990, AM J ROENTGENOL, V154, P1053, DOI 10.2214/ajr.154.5.2108542; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Valkovic T, 2002, VIRCHOWS ARCH, V440, P583, DOI 10.1007/s004280100458; Weissleder R, 2014, NAT MATER, V13, P125, DOI [10.1038/nmat3780, 10.1038/NMAT3780]; Westra C, 2014, AM J ROENTGENOL, V202, pW183, DOI 10.2214/AJR.13.11266; Wood JC, 2015, MAGN RESON IN PRESS; Yuan ZY, 2014, ONCOTARGETS THER, V7, P1, DOI 10.2147/OTT.S61838; Zeisberger SM, 2006, BRIT J CANCER, V95, P272, DOI 10.1038/sj.bjc.6603240; Zhang YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069715; ZHOU XH, 1993, MAGNET RESON MED, V30, P92, DOI 10.1002/mrm.1910300114	50	21	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184765	10.1371/journal.pone.0184765	http://dx.doi.org/10.1371/journal.pone.0184765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898277	Green Published, Green Submitted, gold			2022-12-27	WOS:000410449500048
J	Cao, XD; MacNaughton, P; Laurent, JC; Allen, JG				Cao, Xiaodong; MacNaughton, Piers; Laurent, Jose Cedeno; Allen, Joseph G.			Radon-induced lung cancer deaths may be overestimated due to failure to account for confounding by exposure to diesel engine exhaust in BEIR VI miner studies	PLOS ONE			English	Article							INDOOR RADON; RESIDENTIAL RADON; TRUCKING INDUSTRY; RISK; METAANALYSIS	Background EPA reported that radon is the second leading cause of lung cancer in the United States, killing 21,100 people per year. EPA relies on the BEIR VI models, based on an evaluation of radon exposure and lung cancer risk in studies of miners. But these models did not account for co-exposure to diesel exhaust, a known human carcinogen recently classified by IARC. It is probable then that a portion of the lung cancer deaths in the miner cohorts are originally attributable to the exposure to diesel rather than radon. Objective To re-evaluate EPA's radon attributable lung cancer estimates accounting for diesel exposure information in the miner cohorts. Methods We used estimates of historical diesel concentrations, combined with diesel exposure-response functions, to estimate the risks of lung cancer attributable to diesel engine exhaust (DEE) exposure in the miner studies. We re-calculated the fatal lung cancer risk attributable to radon after accounting for risk from diesel and re-estimated the number of U.S. deaths associated with radon in the U.S. using EPA's methodology. Results Considering the probable confounding with DEE exposure and using the same estimate of baseline mortality from 1989-91 that the EPA currently uses in their calculations, we estimate that radon-induced lung cancer deaths per year are 15,600 (95% CI: 14,300, 17,000)-19,300 (95% CI: 18,800, 20,000) in the U.S. population, a reduction of 9%-26%. The death estimates would be 12,900-15,900 using 2014 baseline vital statistics. Conclusions We recommend further research on re-evaluating the health effects of exposure to radon that accounts for new information on diesel exhaust carcinogenicity in BEIR VI models, up-to-date vital statistics and new epidemiological evidence from residential studies.	[Cao, Xiaodong; MacNaughton, Piers; Laurent, Jose Cedeno; Allen, Joseph G.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Allen, JG (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	jgallen@hsph.harvard.edu	Cao, Xiaodong/AAO-8483-2021	Cao, Xiaodong/0000-0002-0890-3306	post-doctoral fellowship at Harvard; NIEHS environmental epidemiology training grant [5T32ES007069-35]; Marilyn Hoffman program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007069] Funding Source: NIH RePORTER	post-doctoral fellowship at Harvard; NIEHS environmental epidemiology training grant; Marilyn Hoffman program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank Yan Chen for partially supporting a post-doctoral fellowship at Harvard for Xiaodong Cao. Piers MacNaughton's time was supported by NIEHS environmental epidemiology training grant 5T32ES007069-35. Jose Cedeno Laurent's funding is provided by the Marilyn Hoffman program. Joseph G. Allen's funding for this project comes from his faculty startup funds.; We thank the anonymous peer-reviewers for their excellent comments that have enhanced the manuscript. We thank Yan Chen for partially supporting a post-doctoral fellowship at Harvard for Xiaodong Cao. Piers MacNaughton's time was supported by NIEHS environmental epidemiology training grant 5T32ES007069-35. Jose Cedeno Laurent's funding is provided by the Marilyn Hoffman program. Joseph G. Allen's funding for this project comes from his faculty startup funds.We thank the anonymous peer-reviewers for their excellent comments that have enhanced the manuscript. We thank Yan Chen for partially supporting a post-doctoral fellowship at Harvard for Xiaodong Cao. Piers MacNaughton's time was supported by NIEHS environmental epidemiology training grant 5T32ES007069-35. Jose Cedeno Laurent's funding is provided by the Marilyn Hoffman program. Joseph G. Allen's funding for this project comes from his faculty startup funds.	Barros-Dios JM, 2012, CANC EPIDEMIOLOGY PR; Baysson H, 2004, EPIDEMIOLOGY, V15, P709, DOI 10.1097/01.ede.0000142150.60556.b8; Benbrahim-Tallaa L, 2012, LANCET ONCOL, V13, P663, DOI 10.1016/S1470-2045(12)70280-2; BLOT WJ, 1990, J NATL CANCER I, V82, P1025, DOI 10.1093/jnci/82.12.1025; Castorina R, 2003, ENVIRON HEALTH PERSP, V111, P1318, DOI 10.1289/ehp.6185; Catelinois O, 2006, ENVIRON HEALTH PERSP, V114, P1361, DOI 10.1289/ehp.9070; Cavallo AJ, 2000, J ENVIRON RADIOACTIV, V51, P99, DOI 10.1016/S0265-931X(00)00047-3; CDC, 2016, CDC WONDER HOM; Crump K, 2012, CRIT REV TOXICOL, V42, P599, DOI 10.3109/10408444.2012.689755; Darby S, 2005, BMJ-BRIT MED J, V330, P223, DOI 10.1136/bmj.38308.477650.63; Duan P, 2015, EUR J CANCER PREV, V24, P267, DOI 10.1097/CEJ.0000000000000066; EPA, EPA402K120022012; Garshick E, 2012, ENVIRON HEALTH PERSP, V120, P1301, DOI 10.1289/ehp.1204989; James AC, 2004, RADIAT PROT DOSIM, V108, P3, DOI 10.1093/rpd/nch007; Kim SH, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0093-4; Kreuzer M, 2002, INT J CANCER, V100, P706, DOI 10.1002/ijc.10549; Krewski D, 2006, J TOXICOL ENV HEAL A, V69, P533, DOI 10.1080/15287390500260945; Krewski D, 2005, EPIDEMIOLOGY, V16, P137, DOI 10.1097/01.ede.0000152522.80261.e3; Lagarde F, 2001, EPIDEMIOLOGY, V12, P396, DOI 10.1097/00001648-200107000-00009; Lubin JH, 1994, RADON LUNG CANC RISK; MARCINOWSKI F, 1994, HEALTH PHYS, V66, P699, DOI 10.1097/00004032-199406000-00009; Morfeld P, 2015, J OCCUP MED TOXICOL, V10, DOI 10.1186/s12995-015-0073-6; MSHA, 2006, 064494 MSHA; NRC (National Research Council), 1999, HLTH EFF EXP RAD BEI; Robert E., 2014, FY2015 APPROPRIATION; Sandler DP, 2006, J TOXICOL ENV HEAL A, V69, P633, DOI 10.1080/15287390500261117; Sheen S, 2016, ANN OCCUP ENVIRON ME, V28, DOI 10.1186/s40557-016-0094-3; Silverman DT, 2012, JNCI-J NATL CANCER I, V104, P855, DOI 10.1093/jnci/djs034; Steenland K, 1998, AM J IND MED, V34, P220, DOI 10.1002/(SICI)1097-0274(199809)34:3<220::AID-AJIM3>3.0.CO;2-Z; Stewart PA, 2010, ANN OCCUP HYG, V54, P728, DOI 10.1093/annhyg/meq022; Turner MC, 2011, CANCER EPIDEM BIOMAR, V20, P438, DOI 10.1158/1055-9965.EPI-10-1153; USEPA Environmental Protection Agency, 2003, EPA ASS RISKS RAD HO; USHHS, 2014, HLTH CONS SMOK 50 YE; Verma DK, 2015, J ENV OCCUPATIONAL S, V4, P70; Vermeulen R, 2014, ENVIRON HEALTH PERSP, V122, P172, DOI 10.1289/ehp.1306880; Vermeulen R, 2010, ANN OCCUP HYG, V54, P774, DOI 10.1093/annhyg/meq025; Wang ZY, 2002, AM J EPIDEMIOL, V155, P554, DOI 10.1093/aje/155.6.554; Wichmann HE, 2005, HEALTH PHYS, V88, P71, DOI 10.1097/01.HP.0000142497.31627.86; Wilcox HB, 2008, RADIAT PROT DOSIM, V128, P169, DOI 10.1093/rpd/ncm330; World Health Organization (WHO), 2009, WHO HDB INDOOR RADON	40	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184298	10.1371/journal.pone.0184298	http://dx.doi.org/10.1371/journal.pone.0184298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886109	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100094
J	Huang, L; Liao, L; Wu, CH				Huang, Lei; Liao, Li; Wu, Cathy H.			Evolutionary analysis and interaction prediction for protein-protein interaction network in geometric space	PLOS ONE			English	Article								Prediction of protein-protein interaction (PPI) remains a central task in systems biology. With more PPIs identified, forming PPI networks, it has become feasible and also imperative to study PPIs at the network level, such as evolutionary analysis of the networks, for better understanding of PPI networks and for more accurate prediction of pairwise PPIs by leveraging the information gained at the network level. In this work we developed a novel method that enables us to incorporate evolutionary information into geometric space to improve PPI prediction, which in turn can be used to select and evaluate various evolutionary models. The method is tested with cross-validation using human PPI network and yeast PPI network data. The results show that the accuracy of PPI prediction measured by ROC score is increased by up to 14.6%, as compared to a baseline without using evolutionary information. The results also indicate that our modified evolutionary model DANEOsf-combining a gene duplication/neofunctionalization model and scale-free model-has a better fitness and prediction efficacy for these two PPI networks. The improved PPI prediction performance may suggest that our DANEOsf evolutionary model can uncover the underlying evolutionary mechanism for these two PPI networks better than other tested models. Consequently, of particular importance is that our method offers an effective way to select evolutionary models that best capture the underlying evolutionary mechanisms, evaluating the fitness of evolutionary models from the perspective of PPI prediction on real PPI networks.	[Huang, Lei; Liao, Li] Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA; [Wu, Cathy H.] Univ Delaware, Ctr Bioinformat & Computat Biol, Newark, DE USA	University of Delaware; University of Delaware	Liao, L (corresponding author), Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA.	liliao@udel.edu		Wu, Cathy/0000-0001-6379-8601	Delaware INBRE program; National Institutes of Health [8P20GM103446-13]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	Delaware INBRE program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Delaware INBRE program supported by the grant 8P20GM103446-13 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Delaware INBRE program supported by the grant 8P20GM103446-13 from the National Institutes of Health. The authors thank the anonymous reviewers for their constructive comments and suggestions.	Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bishop C. M, 2006, PATTERN RECOGNITION; Cannistraci CV, 2013, BIOINFORMATICS, V29, P199, DOI 10.1093/bioinformatics/btt208; Cannistraci CV, 2010, BIOINFORMATICS, V26, pi531, DOI 10.1093/bioinformatics/btq376; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Hase T, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000550; Higham DJ, 2008, BIOINFORMATICS, V24, P1093, DOI 10.1093/bioinformatics/btn079; Hinton G., 2003, ADV NEURAL INFORM PR, P857; Huang L, 2015, IEEE ACM T COMPUT BI, V12, P622, DOI 10.1109/TCBB.2014.2366748; Ispolatov I, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/145; Ispolatov I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061911; Jain S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-562; Jin YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058134; Kuchaiev O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000454; Milenkovic T, 2008, CANCER INFORM, V6, P257; Peterson GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039052; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; PRIM RC, 1957, AT&T TECH J, V36, P1389, DOI 10.1002/j.1538-7305.1957.tb01515.x; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Trevor F Cox MAAC, 1994, MULTIDIMENSIONAL SCA; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vazquez Alexei, 2003, ComPlexUs, V1, P38, DOI 10.1159/000067642; You ZH, 2010, BIOINFORMATICS, V26, P2744, DOI 10.1093/bioinformatics/btq510; Zhang A., 2009, PROT INT NETW COMP; Zhu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058368	28	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183495	10.1371/journal.pone.0183495	http://dx.doi.org/10.1371/journal.pone.0183495			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886027	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100027
J	Pelaez-Garcia, A; Yebenes, L; Berjon, A; Angulo, A; Zamora, P; Sanchez-Mendez, JI; Espinosa, E; Redondo, A; Heredia-Soto, V; Mendiola, M; Feliu, J; Hardisson, D				Pelaez-Garcia, Alberto; Yebenes, Laura; Berjon, Alberto; Angulo, Antonia; Zamora, Pilar; Sanchez-Mendez, Jose Ignacio; Espinosa, Enrique; Redondo, Andres; Heredia-Soto, Victoria; Mendiola, Marta; Feliu, Jaime; Hardisson, David			Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer	PLOS ONE			English	Article							RECURRENCE SCORE; GENE-EXPRESSION; DISTANT RECURRENCE; PAM50 RISK; ER; CHEMOTHERAPY; TARGETPRINT; CONCORDANCE; INFORMATION; BENEFIT	Purpose To compare the concordance in risk classification between the EndoPredict and the MammaPrint scores obtained for the same cancer samples on 40 estrogen-receptor positive/HER2-negative breast carcinomas. Methods Formalin-fixed, paraffin-embedded invasive breast carcinoma tissues that were previously analyzed with MammaPrint as part of routine care of the patients, and were classified as high-risk (20 patients) and low-risk (20 patients), were selected to be analyzed by the EndoPredict assay, a second generation gene expression test that combines expression of 8 genes (EP score) with two clinicopathological variables (tumor size and nodal status, EPclin score). Results The EP score classified 15 patients as low-risk and 25 patients as high-risk. EPclin re-classified 5 of the 25 EP high-risk patients into low-risk, resulting in a total of 20 high-risk and 20 low-risk tumors. EP score and MammaPrint score were significantly correlated (p = 0.008). Twelve of 20 samples classified as low-risk by MammaPrint were also low-risk by EP score (60%). 17 of 20 MammaPrint high-risk tumors were also high-risk by EP score. The overall concordance between EP score and MammaPrint was 72.5% (k = 0.45, (95% CI, 0.182 to 0.718)). EPclin score also correlated with MammaPrint results (p = 0.004). Discrepancies between both tests occurred in 10 cases: 5 MammaPrint low-risk patients were classified as EPclin high-risk and 5 high-risk MammaPrint were classified as low-risk by EPclin and overall concordance of 75%(k = 0.5, ( 95% CI, 0.232 to 0.768)). Conclusions This pilot study demonstrates a limited concordance between MammaPrint and EndoPredict. Differences in results could be explained by the inclusion of different gene sets in each platform, the use of different methodology, and the inclusion of clinicopathological parameters, such as tumor size and nodal status, in the EndoPredict test.	[Pelaez-Garcia, Alberto; Yebenes, Laura; Berjon, Alberto; Mendiola, Marta; Hardisson, David] Hosp Univ La Paz, Dept Pathol, IdiPAZ, Madrid, Spain; [Pelaez-Garcia, Alberto; Yebenes, Laura; Berjon, Alberto; Sanchez-Mendez, Jose Ignacio; Heredia-Soto, Victoria; Mendiola, Marta; Hardisson, David] Hosp Univ La Paz, Mol Pathol & Therapeut Targets Grp, IdiPAZ, Madrid, Spain; [Pelaez-Garcia, Alberto; Heredia-Soto, Victoria; Mendiola, Marta; Hardisson, David] Hosp Univ La Paz, INGEMM, IdiPAZ, Mol Pathol Diagnost Unit, Madrid, Spain; [Angulo, Antonia] Myriad Genet Espana SLU, Madrid, Spain; [Zamora, Pilar; Espinosa, Enrique; Redondo, Andres; Feliu, Jaime] Hosp Univ La Paz, IdiPAZ, Dept Med Oncol, Madrid, Spain; [Zamora, Pilar; Sanchez-Mendez, Jose Ignacio; Espinosa, Enrique; Redondo, Andres; Feliu, Jaime; Hardisson, David] Univ Autonoma Madrid, Fac Med, Madrid, Spain; [Zamora, Pilar; Espinosa, Enrique; Redondo, Andres; Feliu, Jaime] Hosp Univ La Paz, Translat Oncol Grp, IdiPAZ, Madrid, Spain; [Sanchez-Mendez, Jose Ignacio] Hosp Univ La Paz, Dept Obstet & Gynecol, IdiPAZ, Breast Canc Unit, Madrid, Spain; [Espinosa, Enrique; Heredia-Soto, Victoria; Feliu, Jaime] Minist Econ Ind & Competitividad, Inst Salud Carlos III, Ctr Invest Biorned Red Canc CIBERONC, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz; Autonomous University of Madrid; Hospital Universitario La Paz; Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Instituto de Salud Carlos III; Spanish Ministry of Economy & Competitiveness	Hardisson, D (corresponding author), Hosp Univ La Paz, Dept Pathol, IdiPAZ, Madrid, Spain.; Hardisson, D (corresponding author), Hosp Univ La Paz, Mol Pathol & Therapeut Targets Grp, IdiPAZ, Madrid, Spain.; Hardisson, D (corresponding author), Hosp Univ La Paz, INGEMM, IdiPAZ, Mol Pathol Diagnost Unit, Madrid, Spain.; Hardisson, D (corresponding author), Univ Autonoma Madrid, Fac Med, Madrid, Spain.	david.hardisson@salud.madrid.org	Méndez, José Ignacio Sánchez/M-8025-2019; Hardisson, David/A-6259-2011; Hardisson, David/AAN-3833-2020; Hardisson, David/E-2832-2010; Zamora, Pilar/AAM-9336-2021	Méndez, José Ignacio Sánchez/0000-0003-2559-2500; Hardisson, David/0000-0002-2183-3699; Berjon, Alberto/0000-0002-3467-106X; Heredia-Soto, Victoria/0000-0002-0704-7958; Espinosa Arranz, Enrique/0000-0001-6562-7902; Redondo Sanchez, Andres/0000-0002-7257-5642	company Myriad Genetic Espana SLU	company Myriad Genetic Espana SLU	The study was supported by the company Myriad Genetic Espana SLU. The funder provided support in the form of salaries for author AA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the author contributions section.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Bartlett JMS, 2016, JNCI-J NATL CANCER I, V108, P1, DOI DOI 10.1093/JNCI/DJW05; Buus R, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw149; Cardoso F, 2016, NEW ENGL J MED, V375, P717, DOI 10.1056/NEJMoa1602253; Denkert C, 2012, VIRCHOWS ARCH, V460, P251, DOI 10.1007/s00428-012-1204-4; Dowsett M, 2013, J CLIN ONCOL, V31, P2783, DOI 10.1200/JCO.2012.46.1558; Dubsky P, 2013, BRIT J CANCER, V109, P2959, DOI 10.1038/bjc.2013.671; Dubsky P, 2013, ANN ONCOL, V24, P640, DOI 10.1093/annonc/mds334; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Filipits M, 2011, CLIN CANCER RES, V17, P6012, DOI 10.1158/1078-0432.CCR-11-0926; Gyorffy B, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0514-2; Hagemann IS, 2016, ARCH PATHOL LAB MED, V140, P815, DOI 10.5858/arpa.2016-0051-RA; Henry LR, 2009, INFLUENCE GENE EXPRE, P319; Kelly CM, 2012, ONCOLOGIST, V17, P492, DOI 10.1634/theoncologist.2012-0007; Kronenwett R, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-456; Martin M, 2016, BREAST CANCER RES TR, V156, P81, DOI 10.1007/s10549-016-3725-z; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Roepman P, 2009, CLIN CANCER RES, V15, P7003, DOI 10.1158/1078-0432.CCR-09-0449; Stein RC, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20100; Tang G, 2011, J CLIN ONCOL, V29, P4365, DOI 10.1200/JCO.2011.35.3714; Varga Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058483; Viale G, 2014, ANN ONCOL, V25, P816, DOI 10.1093/annonc/mdu026; Viale G, 2016, BREAST CANCER RES TR, V155, P463, DOI 10.1007/s10549-016-3690-6; Wesseling J, 2016, VIRCHOWS ARCH, V469, P297, DOI 10.1007/s00428-016-1979-9	25	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183452	10.1371/journal.pone.0183452	http://dx.doi.org/10.1371/journal.pone.0183452			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886093	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100022
J	Ramos-Morales, E; de la Fuente, G; Nash, RJ; Braganca, R; Duval, S; Bouillon, ME; Lahmann, M; Newbold, CJ				Ramos-Morales, Eva; de la Fuente, Gabriel; Nash, Robert J.; Braganca, Radek; Duval, Stephane; Bouillon, Marc E.; Lahmann, Martina; Newbold, C. Jamie			Improving the antiprotozoal effect of saponins in the rumen by combination with glycosidase inhibiting iminosugars or by modification of their chemical structure	PLOS ONE			English	Article							STEVIA-REBAUDIANA; BACTERIAL PROTEIN; HEDERA-HELIX; TEA SAPONIN; FERMENTATION; BERTONI	The antiprotozoal effect of saponins is transitory, as when saponins are deglycosylated to sapogenins by rumen microorganisms they become inactive. We hypothesised that the combination of saponins with glycosidase-inhibiting iminosugars might potentially increase the effectiveness of saponins over time by preventing their deglycosylation in the rumen. Alternatively, modifying the structure of the saponins by substituting the sugar moiety with other small polar residues might maintain their activity as the sugar substitute would not be enzymatically cleaved. The aim of this in vitro study was to evaluate the acute antiprotozoal effect and the stability of this effect over a 24 h incubation period using ivy saponins, a stevia extract rich in iminosugars, ivy saponins with stevia extract, and a chemically modified ivy saponin, hederagenin bis-succinate (HBS). The effects on fermentation parameters and rumen bacterial communities were also studied. Ivy saponins with stevia and HBS had a greater antiprotozoal effect than ivy saponins, and this effect was maintained after 24 h of incubation (P<0.001). The combination of ivy and stevia extracts was more effective in shifting the fermentation pattern towards higher propionate (+39%) and lower butyrate (-32%) and lower ammonia concentration (-64%) than the extracts incubated separately. HBS caused a decrease in butyrate (-45%) and an increase in propionate (+43%) molar proportions. However, the decrease in ammonia concentration (-42%) observed in the presence of HBS was less than that caused by ivy saponins, either alone or with stevia. Whereas HBS and stevia impacted on bacterial population in terms of community structure, only HBS had an effect in terms of biodiversity (P<0.05). It was concluded that ivy saponins with stevia and the modified saponin HBS had a strong antiprotozoal effect, although they differed in their effects on fermentation parameters and bacteria communities. Ivy saponins combined with an iminosugar-rich stevia extract and/or HBS should be evaluated to determine their antiprotozoal effect in vivo.	[Ramos-Morales, Eva; de la Fuente, Gabriel; Newbold, C. Jamie] Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales; [Nash, Robert J.] PhytoQuest Ltd, Aberystwyth, Dyfed, Wales; [Braganca, Radek] Bangor Univ, BioComposites Ctr, Bangor, Gwynedd, Wales; [Duval, Stephane] DSM Nutr Prod Ltd, Ctr Rech Nutr Anim, St Louis, France; [Bouillon, Marc E.; Lahmann, Martina] Bangor Univ, Sch Chem, Bangor, Gwynedd, Wales; [de la Fuente, Gabriel] Univ Lleida, Dept Ciencia Anim, Lleida, Spain; [Newbold, C. Jamie] Scotlands Rural Coll, Edinburgh, Midlothian, Scotland	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Aberystwyth University; Bangor University; DSM NV; Bangor University; Universitat de Lleida; Scotland's Rural College	Ramos-Morales, E; Newbold, CJ (corresponding author), Aberystwyth Univ, Inst Biol Environm & Rural Sci, Aberystwyth, Dyfed, Wales.; Newbold, CJ (corresponding author), Scotlands Rural Coll, Edinburgh, Midlothian, Scotland.	evr1@aber.ac.uk; Jamie.Newbold@sruc.ac.uk	Nash, Robert/ABE-3575-2020; de la Fuente Oliver, Gabriel/M-6981-2019; Ramos-Morales, Eva/ABD-3707-2021; de la Fuente Oliver, Gabriel/B-3793-2015; Lahmann, Martina/A-3090-2010	de la Fuente Oliver, Gabriel/0000-0003-0083-776X; Ramos-Morales, Eva/0000-0002-7056-9097; de la Fuente Oliver, Gabriel/0000-0003-0083-776X; Lahmann, Martina/0000-0002-8513-1952; Nash, Robert/0000-0002-3272-640X	Innovate UK project "Ivy for ruminants" [101091]; Biotechnology and Biological Sciences Research Council, UK [BB/J0013/1]; Biotechnology and Biological Sciences Research Council [BBS/E/W/10964A01B] Funding Source: researchfish; BBSRC [BBS/E/W/10964A01B] Funding Source: UKRI	Innovate UK project "Ivy for ruminants"(UK Research & Innovation (UKRI)Innovate UK); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was financed by the Innovate UK project "Ivy for ruminants" Ref: 101091. SD (DSM Nutritional Products Ltd.) and RN (PhytoQuest Ltd.) were part of the project consortium and they contributed to the conceptualization of the project as well as to the funding acquisition and revision of the manuscript (as described in the author's contributions section). The before mentioned institutions did not provide any further funding. CJN acknowledges the support of the Biotechnology and Biological Sciences Research Council, UK via grant number BB/J0013/1.	Asano N, 2003, CURR TOP MED CHEM, V3, P471, DOI 10.2174/1568026033452438; Atteh JO, 2008, J ANIM PHYSIOL AN N, V92, P640, DOI 10.1111/j.1439-0396.2007.00760.x; Belanche A, 2012, J ANIM SCI, V90, P4495, DOI 10.2527/jas.2012-5118; Belanche A, 2016, J SCI FOOD AGR, V96, P3069, DOI 10.1002/jsfa.7481; Belanche A, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv160; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; De la Fuente Gabriel, 2006, Zootaxa, V1377, P47; Debnath M, 2008, J MED PLANTS RES, V2, P45; Dehority BA, 1993, LABORATORY MANUAL FO; Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725; Ghias Uddin, 2011, Middle East Journal of Scientific Research, V8, P198; Guo YQ, 2008, LETT APPL MICROBIOL, V47, P421, DOI 10.1111/j.1472-765X.2008.02459.x; Hill TCJ, 2003, FEMS MICROBIOL ECOL, V43, P1, DOI 10.1111/j.1574-6941.2003.tb01040.x; Hongoh Y, 2003, FEMS MICROBIOL LETT, V221, P299, DOI 10.1016/S0378-1097(03)00218-0; Hu WL, 2005, ANIM FEED SCI TECH, V120, P333, DOI 10.1016/j.anifeedsci.2005.02.029; Jayanegara A, 2014, ASIAN AUSTRAL J ANIM, V27, P1426, DOI 10.5713/ajas.2014.14086; KOHDA H, 1976, PHYTOCHEMISTRY, V15, P981, DOI 10.1016/S0031-9422(00)84384-8; Lutsenko Y., 2010, Herba Polonica, V56, P83; Menke K.H, 1988, ANIM RES DEV, V28, P7, DOI DOI 10.1016/S0301-6226(01)00298-6.PALMQUIST; Michalik A, 2010, PHYTOCHEM LETT, V3, P136, DOI 10.1016/j.phytol.2010.04.004; Morgavi DP, 2004, FOOD ADDIT CONTAM A, V21, P871, DOI [10.1080/02652030400002188, 10.1080/0265-2030400002188]; Moss AR, 2000, ANN ZOOTECH, V49, P231, DOI 10.1051/animres:2000119; NASH RJ, 1986, J CHROMATOGR, V366, P431, DOI 10.1016/S0021-9673(01)93497-1; Nash RJ, 2011, FUTURE MED CHEM, V3, P1513, DOI [10.4155/FMC.11.117, 10.4155/fmc.11.117]; Newbold CJ, 2010, IN VITRO SCREENING OF PLANT RESOURCES FOR EXTRA-NUTRITIONAL ATTRIBUTES IN RUMINANTS: NUCLEAR AND RELATED METHODOLOGIES, P47, DOI 10.1007/978-90-481-3297-3_4; Newbold CJ, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01313; Newbold CJ, 1997, BRIT J NUTR, V78, P237, DOI 10.1079/BJN19970143; Parvu M, 2015, NOT BOT HORTI AGROBO, V43, P53, DOI 10.15835/nbha4319644; Patra AK, 2009, NUTR RES REV, V22, P204, DOI 10.1017/S0954422409990163; Patra K. A., 2009, ANTON LEEUW INT J G, V96, P363, DOI [10.1007/s10482-009-9364-1, DOI 10.1007/S10482-009-9364-1]; Pielartzik H, 1985, METHODEN DER ORGANIS, P656; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Ramos-Morales E, 2016, UK patent application number, Patent No. [1620438.0, 1620438]; Ramos-Morales E, 2016, Patent PCT/ EP, Patent No. 2016062383; Ramos-Morales E, 2014, VITRO EFFECT OF THE, P116; Ramos-Morales E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00399; Seymour WM, 2005, ANIM FEED SCI TECH, V119, P155, DOI 10.1016/j.anifeedsci.2004.10.001; Skrivanova E, 2010, VET MICROBIOL, V144, P334, DOI 10.1016/j.vetmic.2010.01.013; STEWART CS, 1985, J GEN MICROBIOL, V131, P427; Sumit Ghosh, 2008, International Journal of Integrative Biology, V2, P27; Tedeschi LO, 2000, P CORN NUTR C FEED M; Tomita T, 1997, MICROBIOL IMMUNOL, V41, P1005, DOI 10.1111/j.1348-0421.1997.tb01961.x; Torres M, 2015, Compend. cienc. vet, V5, P32, DOI 10.18004/compend.cienc.vet.2015.05.02.32-37; Wallace RJ, 2007, J LIPID RES, V48, P2247, DOI 10.1194/jlr.M700271-JLR200; WALLACE RJ, 1987, BRIT J NUTR, V58, P313, DOI 10.1079/BJN19870098; Wang LS, 2014, ANIM FEED SCI TECH, V187, P104, DOI 10.1016/j.anifeedsci.2013.10.014; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Williams A.G., 1992, RUMEN PROTOZOA; Wina E, 2005, J AGR FOOD CHEM, V53, P8093, DOI 10.1021/jf048053d	50	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184517	10.1371/journal.pone.0184517	http://dx.doi.org/10.1371/journal.pone.0184517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886130	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100145
J	Coplan, JD; Gupta, NK; Karim, A; Rozenboym, A; Smith, ELP; Kral, JG; Rosenblum, LA				Coplan, Jeremy D.; Gupta, Nishant K.; Karim, Asif; Rozenboym, Anna; Smith, Eric L. P.; Kral, John G.; Rosenblum, Leonard A.			Maternal hypothalamic-pituitary-adrenal axis response to foraging uncertainty: A model of individual vs. social allostasis and the "Superorganism Hypothesis"	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CEREBROSPINAL-FLUID; NONHUMAN-PRIMATES; STRESS; ANXIETY; CORTISOL; RANK; FEAR; PATHOPHYSIOLOGY; GLUCOCORTICOIDS	Introduction Food insecurity is a major global contributor to developmental origins of adult disease. The allostatic load of maternal food uncertainty from variable foraging demand (VFD) activates corticotropin-releasing factor (CRF) without eliciting hypothalamic-pituitary-adrenal (HPA) activation measured on a group level. Individual homeostatic adaptations of the HPA axis may subserve second-order homeostasis, a process we provisionally term "social allostasis." We postulate that maternal food insecurity induces a "superorganism" state through coordination of individual HPA axis response. Methods Twenty-four socially-housed bonnet macaque maternal-infant dyads were exposed to 16 weeks of alternating two-week epochs of low or high foraging demand shown to compromise normative maternal-infant rearing. Cerebrospinal fluid (CSF) CRF concentrations and plasma cortisol were measured pre-and post-VFD. Dyadic distance was measured, and blinded observers performed pre-VFD social ranking assessments. Results Despite marked individual cortisol responses (mean change = 20%) there was an absence of maternal HPA axis group mean response to VFD (0%). Whereas individual CSF CRF concentrations change = 56%, group mean did increase 25% (p = 0.002). Our "dyadic vulnerability" index (low infant weight, low maternal weight, subordinate maternal social status and reduced dyadic distance) predicted maternal cortisol decreases (p < 0.0001) whereas relatively "advantaged" dyads exhibited maternal cortisol increases in response to VFD exposure. Comment In response to a chronic stressor, relative dyadic vulnerability plays a significant role in determining the directionality and magnitude of individual maternal HPA axis responses in the service of maintaining a "superorganism" version of HPA axis homeostasis, provisionally termed "social allostasis."	[Coplan, Jeremy D.; Smith, Eric L. P.; Rosenblum, Leonard A.] Suny Downstate Med Ctr, Biol Sci Unit, Dept Psychiat & Behav Sci, Brooklyn, NY 11203 USA; [Gupta, Nishant K.; Karim, Asif] Suny Downstate Med Ctr, Coll Med, Brooklyn, NY 11203 USA; [Rozenboym, Anna] Kingsborough Community Coll, Brooklyn, NY USA; [Kral, John G.] Suny Downstate Med Ctr, Dept Internal Med, Brooklyn, NY 11203 USA; [Kral, John G.] Suny Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; City University of New York (CUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Coplan, JD (corresponding author), Suny Downstate Med Ctr, Biol Sci Unit, Dept Psychiat & Behav Sci, Brooklyn, NY 11203 USA.	Jeremy.Coplan@downstate.edu			National Institute of Mental Health grant [R01MH59990A]	National Institute of Mental Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health grant R01MH59990A (JDC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTEMUS M, 1994, ARCH GEN PSYCHIAT, V51, P794; ANDREWS MW, 1991, CHILD DEV, V62, P686, DOI 10.1111/j.1467-8624.1991.tb01562.x; [Anonymous], 2008, ADAPTATION NATURAL S; BALTES PB, 1968, HUM DEV, V11, P145, DOI 10.1159/000270604; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Bjorntorp P, 2000, NUTRITION, V16, P924, DOI 10.1016/S0899-9007(00)00422-6; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Bremner JD, 1997, AM J PSYCHIAT, V154, P624; Cairney J, 2003, SOC PSYCH PSYCH EPID, V38, P442, DOI 10.1007/s00127-003-0661-0; Cavigelli SA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0103; Conrad CD, 1999, BEHAV NEUROSCI, V113, P902, DOI 10.1037/0735-7044.113.5.902; Coplan JD, 1997, PSYCHOPHARMACOL BULL, V33, P193; Coplan JD, 2005, CNS SPECTRUMS, V10, P530, DOI 10.1017/S109285290001018X; Coplan JD, 1996, P NATL ACAD SCI USA, V93, P1619, DOI 10.1073/pnas.93.4.1619; Coplan JD, 2014, FRONTIERS BEHAV NEUR, V8; Coplan JD, 1995, PSYCHIAT CLIN N AM; Coplan JD, 2006, ANN NY ACAD SCI, V1071, P525, DOI 10.1196/annals.1364.057; Coplan JD, 2006, PSYCHIAT RES-NEUROIM, V147, P27, DOI 10.1016/j.pscychresns.2005.12.011; Coplan JD, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00100; Coplan JD, 2010, NEUROSCI LETT, V480, P93, DOI 10.1016/j.neulet.2010.06.012; Czoty PW, 2009, J NEUROENDOCRINOL, V21, P68, DOI 10.1111/j.1365-2826.2008.01800.x; Dallman MF, 2004, ENDOCRINOLOGY, V145, P2633, DOI 10.1210/en.2004-0037; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; Gardner A, 2009, J EVOLUTION BIOL, V22, P659, DOI 10.1111/j.1420-9101.2008.01681.x; Ginzburg K, 2008, PSYCHOSOMATICS, V49, P407, DOI 10.1176/appi.psy.49.5.407; JARETT LR, 1984, PSYCHONEUROENDOCRINO, V9, P21, DOI 10.1016/0306-4530(84)90018-0; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; KALIN NH, 1984, PROG NEURO-PSYCHOPH, V8, P459, DOI 10.1016/0278-5846(84)90122-2; Karatsoreos IN, 2010, ENDOCRINOLOGY, V151, P2117, DOI 10.1210/en.2009-1436; Kohn JN, 2016, PSYCHONEUROENDOCRINO, V74, P179, DOI 10.1016/j.psyneuen.2016.09.005; McDonnell MN, 2013, J APPL PHYSIOL, V114, P1174, DOI 10.1152/japplphysiol.01378.2012; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McEwen BS, 1998, ANN NY ACAD SCI, V840, P33, DOI 10.1111/j.1749-6632.1998.tb09546.x; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Nanni V, 2014, AM J PSYCHIAT; Okasha S, 2012, J EVOLUTION BIOL, V25, P1127, DOI 10.1111/j.1420-9101.2012.02501.x; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Pornpattananangkul N., 2014, PSYCHOL SOCIAL STATU, P303; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Rakic P, 1995, CORTICOGENESIS HUMAN; Reiner W, 2014, INFLUENCE MATERNAL G; ROSENBLUM LA, 1984, CHILD DEV, V55, P305, DOI 10.1111/j.1467-8624.1984.tb00293.x; Rosenblum LA, 2002, PSYCHONEUROENDOCRINO, V27, P651, DOI 10.1016/S0306-4530(01)00056-7; Rosenblum LA, 1967, LAB OBSERVATIONS EAR; Sanchez MM, 2001, DEV PSYCHOPATHOL, V13, P419, DOI 10.1017/S0954579401003029; SAPOLSKY RM, 1992, PSYCHONEUROENDOCRINO, V17, P701, DOI 10.1016/0306-4530(92)90029-7; Scharf BA, 1999, TOXICOL METHOD, V9, P25, DOI 10.1080/105172399242799; Schulkin J, 1998, PSYCHONEUROENDOCRINO, V23, P219, DOI 10.1016/S0306-4530(97)00099-1; Schulkin J, 2003, RETHINKING HOMEOSTAS; Shively CA, 1997, BIOL PSYCHIAT, V41, P871, DOI 10.1016/S0006-3223(96)00185-0; SILK J B, 1980, Primates, V21, P100, DOI 10.1007/BF02383827; SILK JB, 1988, AM NAT, V132, P1, DOI 10.1086/284834; Snyder-Mackler N, 2016, ANIM BEHAV, V111, P307, DOI 10.1016/j.anbehav.2015.10.033; STANTON ME, 1985, PSYCHONEUROENDOCRINO, V10, P125, DOI 10.1016/0306-4530(85)90050-2; Sterling P., 1988, HDB LIFE STRESS COGN; Syed SA, 2017, NEUROSCI LETT, V647, P20, DOI 10.1016/j.neulet.2017.03.017; Weinbauer GF, 2008, TOXICOL PATHOL, V36, p7S, DOI 10.1177/0192623308327412; Wenseleers Tom, 2010, P132; YEHUDA R, 1990, J NERV MENT DIS, V178, P366, DOI 10.1097/00005053-199006000-00004	63	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184340	10.1371/journal.pone.0184340	http://dx.doi.org/10.1371/journal.pone.0184340			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880949	Green Published, gold			2022-12-27	WOS:000409467200051
J	Kovacs, JL; Wolf, C; Voisin, D; Wolf, S				Kovacs, Jennifer L.; Wolf, Candice; Voisin, Dene; Wolf, Seth			Aphid secondary symbionts do not affect prey attractiveness to two species of predatory lady beetles	PLOS ONE			English	Article							PEA APHID; CONFERRED PROTECTION; ACYRTHOSIPHON-PISUM; PARASITISM; INFECTION	Heritable symbionts have been found to mediate interactions between host species and their natural enemies in a variety of organisms. Aphids, their facultative symbionts, and their potential fitness effects have been particularly well-studied. For example, the aphid facultative symbiont Regiella can protect its host from infection from a fungal pathogen, and aphids with Hamiltonella are less likely to be parasitized by parasitic wasps. Recent work has also found there to be negative fitness effects for the larvae of two species of aphidophagous lady beetles that consumed aphids with facultative symbionts. In both species, larvae that consumed aphids with secondary symbionts were significantly less likely to survive to adulthood. In this study we tested whether adult Harmonia axyridis and Hippodamia convergens lady beetles avoided aphids with symbionts in a series of choice experiments. Adults of both lady beetle species were as likely to choose aphids with symbionts as those without, despite the potential negative fitness effects associated with consuming aphids with facultative symbionts. This may suggest that under natural conditions aphid secondary symbionts are not a significant source of selection for predatory lady beetles.	[Kovacs, Jennifer L.] Spelman Coll, Dept Biol, Atlanta, GA 30314 USA; [Wolf, Candice; Wolf, Seth] Univ Vermont, Larner Coll Med, Burlington, VT USA; [Voisin, Dene] Georgia State Univ, Inst Neurosci, Atlanta, GA 30303 USA	Spelman College; University of Vermont; University System of Georgia; Georgia State University	Kovacs, JL (corresponding author), Spelman Coll, Dept Biol, Atlanta, GA 30314 USA.	jkovacs@spelman.edu		Kovacs, Jennifer/0000-0002-9130-176X; Voisin, Dene/0000-0003-2523-1756	Spelman College; NSF HBCU-UP ASPIRE Project through Spelman College [0714553]; HHMI's SMART Scholars program at Spelman College	Spelman College; NSF HBCU-UP ASPIRE Project through Spelman College; HHMI's SMART Scholars program at Spelman College	JK was supported by start-up funds by Spelman College. CNGW was supported by NSF HBCU-UP ASPIRE Project Award #0714553 through Spelman College. DV was supported by HHMI's SMART Scholars program at Spelman College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cayetano L, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2333; Cayetano L, 2015, ECOL ENTOMOL, V40, P85, DOI 10.1111/een.12161; Chen DQ, 2000, ENTOMOL EXP APPL, V95, P315, DOI 10.1023/A:1004083324807; Cohen J., 1977, CONCEPTS POWER ANAL, P1; Costopoulos K, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-5; Dunbar HE, 2007, PLOS BIOL, V5, P1006, DOI 10.1371/journal.pbio.0050096; Erdfelder E, 1994, GPOWER GEN POWER ANA; Ferrari J, 2012, EVOLUTION, V66, P375, DOI 10.1111/j.1558-5646.2011.01436.x; Hansen AK, 2007, APPL ENVIRON MICROB, V73, P7531, DOI 10.1128/AEM.01672-07; Kovacs JL, 2017, BMC ECOL, V17, DOI 10.1186/s12898-017-0136-x; Laughton AM, 2016, J INSECT PHYSIOL, V86, P17, DOI 10.1016/j.jinsphys.2015.12.005; Loxdale HD, 2008, AGR FOREST ENTOMOL, V10, P81, DOI 10.1111/j.1461-9563.2008.00364.x; Martinez AJ, 2014, MOL ECOL, V23, P1594, DOI 10.1111/mec.12550; McCornack BP, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.1001; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Oliver KM, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-11; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Oliver KM, 2009, MYCOL SER, V27, P129; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Oliver KM, 2014, FUNCT ECOL; Polin S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143728; Polin S, 2014, ECOL EVOL, V4, P826, DOI 10.1002/ece3.991; Russell JA, 2006, P ROY SOC B-BIOL SCI, V273, P603, DOI 10.1098/rspb.2005.3348; Russell JA, 2013, MOL ECOL, V22, P2045, DOI 10.1111/mec.12211; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Tsuchida T, 2004, SCIENCE, V303, P1989, DOI 10.1126/science.1094611	27	1	1	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184150	10.1371/journal.pone.0184150	http://dx.doi.org/10.1371/journal.pone.0184150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880922	gold, Green Published, Green Submitted			2022-12-27	WOS:000409467200036
J	Pehrson, S; Devaney, L; Bryan, D; Blaylock, DL				Pehrson, Samuel; Devaney, Lee; Bryan, Dominic; Blaylock, Danielle L.			Beyond group engagement: Multiple pathways from encounters with the police to cooperation and compliance in Northern Ireland	PLOS ONE			English	Article							PROCEDURAL-JUSTICE; PUBLIC CONFIDENCE; SOCIAL IDENTITY; LEGITIMACY; MODEL; CRIME; POWER; IDENTIFICATION; PERSPECTIVES; PERCEPTIONS	In a sample of young people in Northern Ireland (N = 819), we examine the relationships between the quality of experience with police officers and police legitimacy. We examine potential pathways through which experiences may either support or undermine the legitimacy of the police, and thus cooperation and compliance with them. We find evidence that perceptions of the police as having goals that align with those of wider society, and as being fair in general, mediate relations between the quality of encounters and legitimacy, which in turn mediates the relation with cooperation and compliance. Identification with wider society was not a reliable mediator, contrary to our predictions based on the Group Engagement Model. Moreover, our analysis of the structure of police fairness perceptions finds no support for the distinction between procedural and distributive police fairness as usually conceived. Implications for the social psychological understanding of legitimate authority are discussed.	[Pehrson, Samuel] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland; [Devaney, Lee] Queens Univ Belfast, Sch Psychol, Belfast, Antrim, North Ireland; [Bryan, Dominic] Queens Univ Belfast, Inst Irish Studies, Belfast, Antrim, North Ireland; [Blaylock, Danielle L.] Queens Univ Belfast, Sch Social Sci Educ & Social Work, Belfast, Antrim, North Ireland	University of St Andrews; Queens University Belfast; Queens University Belfast; Queens University Belfast	Pehrson, S (corresponding author), Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland.	sdp21@st-andrews.ac.uk			Office of the First Minister and Deputy First Minister of Northern Ireland	Office of the First Minister and Deputy First Minister of Northern Ireland	The survey was funded by a grant from the Office of the First Minister and Deputy First Minister of Northern Ireland. A steering group advised on survey design on behalf of the funder. The funder had no role in the analyses reported in the manuscript, the decision to publish or preparation of the manuscript.	Ambrose ML, 2009, J APPL PSYCHOL, V94, P491, DOI 10.1037/a0013203; [Anonymous], 2003, POLICING ACCOUNTABIL; Blackwood L, 2013, ETHNIC RACIAL STUD, V36, P1090, DOI 10.1080/01419870.2011.645845; Blader SL, 2009, J APPL PSYCHOL, V94, P445, DOI 10.1037/a0013935; Blaylock D, 2016, FOCUS GROUPS INTERVI; Bradford B., 2010, SOCIAL SCI RES NETWO; Bradford B, 2014, BRIT J CRIMINOL, V54, P527, DOI 10.1093/bjc/azu021; Bradford B, 2014, POLIC SOC, V24, P22, DOI 10.1080/10439463.2012.724068; Bradford B, 2009, POLIC SOC, V19, P20, DOI 10.1080/10439460802457594; Byrne J, 2011, YOUTH SOC, V43, P433, DOI 10.1177/0044118X10383542; De Cremer D, 2006, EUR J SOC PSYCHOL, V36, P211, DOI 10.1002/ejsp.290; Ellison G, 2013, CRIMINOL CRIM JUSTIC, V13, P552, DOI 10.1177/1748895812462597; Engel RS, 2005, J RES CRIME DELINQ, V42, P445, DOI 10.1177/0022427804272725; Haslam SA, 2011, NEW PSYCHOLOGY OF LEADERSHIP: IDENTITY, INFLUENCE, AND POWER, P1; Hauenstein N., 2001, EMPLOY RESPONSIB RIG, V13, P39, DOI [DOI 10.1023/A:1014482124497, https://doi.org/10.1023/A:1014482124497]; Hopkins N, 2011, J COMMUNITY APPL SOC, V21, P215, DOI 10.1002/casp.1088; Huq AH, BR J CRIMIN IN PRESS; Independent Commission on Policing for Northern Ireland Patten C, 1999, NEW BEGINN POL N IR; Jackson J., 2010, PRISON SERV J, V191, P4; Jackson J, 2007, BRIT J CRIMINOL, V47, P214, DOI 10.1093/bjc/azl031; Jackson J, 2010, POLIC-J POLICY PRACT, V4, P241, DOI 10.1093/police/paq020; Jackson J, 2009, POLIC-J POLICY PRACT, V3, P100, DOI 10.1093/police/pan079; Jackson J, 2009, BRIT J SOCIOL, V60, P493, DOI 10.1111/j.1468-4446.2009.01253.x; Kane RJ, 2005, CRIMINOLOGY, V43, P469, DOI 10.1111/j.0011-1348.2005.00014.x; Kelloway E. K., 1998, USING LISREL STRUCTU; Leach CW, 2008, J PERS SOC PSYCHOL, V95, P144, DOI 10.1037/0022-3514.95.1.144; Levi M, 2009, AM BEHAV SCI, V53, P354, DOI 10.1177/0002764209338797; Lind E. A., 2001, ADV ORG JUSTICE, V56, P88; Reicher SD, 2012, PERSPECT PSYCHOL SCI, V7, P315, DOI 10.1177/1745691612448482; Reisig MD, 2007, CRIM JUSTICE BEHAV, V34, P1005, DOI 10.1177/0093854807301275; Simon B, 2006, HUM RELAT, V59, P105, DOI 10.1177/0018726706062760; Subasic E, 2008, PERS SOC PSYCHOL REV, V12, P330, DOI 10.1177/1088868308323223; Sunshine J, 2003, SOC PSYCHOL QUART, V66, P153, DOI 10.2307/1519845; Sunshine J, 2003, LAW SOC REV, V37, P513, DOI 10.1111/1540-5893.3703002; Tankebe J, 2013, CRIMINOLOGY, V51, P103, DOI 10.1111/j.1745-9125.2012.00291.x; Turner JC, 2005, EUR J SOC PSYCHOL, V35, P1, DOI 10.1002/ejsp.244; Tyler, 2005, POLICE Q, V8, P322, DOI [10.1177/1098611104271105, DOI 10.1177/1098611104271105]; Tyler T, 1996, J PERS SOC PSYCHOL, V70, P913, DOI 10.1037/0022-3514.70.5.913; Tyler T.R., 1990, WHY PEOPLE OBEY LAW; Tyler TR, 2010, LAW SOC REV, V44, P365, DOI 10.1111/j.1540-5893.2010.00405.x; Tyler Tom R., 2008, OHIO ST J CRIM L, V6, P233, DOI DOI 10.2139/SSRN.887737; Tyler Tom R, 2002, TRUST LAW ENCOURAGIN; Tyler TR, 2001, BEHAV SCI LAW, V19, P215, DOI 10.1002/bsl.438; Tyler TR, 2006, ANNU REV PSYCHOL, V57, P375, DOI 10.1146/annurev.psych.57.102904.190038; Tyler TR, 2004, CRIMINOLOGY, V42, P253, DOI 10.1111/j.1745-9125.2004.tb00520.x; Tyler TR, 2003, PERS SOC PSYCHOL REV, V7, P349, DOI 10.1207/S15327957PSPR0704_07; Weber M., 1946, M WEBER ESSAYS SOCIO	47	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184436	10.1371/journal.pone.0184436	http://dx.doi.org/10.1371/journal.pone.0184436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880946	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200069
J	Hu, LH; Huang, X; You, CJ; Li, JX; Hong, K; Li, P; Wu, YQ; Wu, QH; Wang, ZW; Gao, RL; Bao, HH; Cheng, XS				Hu, Lihua; Huang, Xiao; You, Chunjiao; Li, Juxiang; Hong, Kui; Li, Ping; Wu, Yanqing; Wu, Qinhua; Wang, Zengwu; Gao, Runlin; Bao, Huihui; Cheng, Xiaoshu			Prevalence of overweight, obesity, abdominal obesity and obesity-related risk factors in southern China	PLOS ONE			English	Article							BODY-MASS INDEX; ALCOHOL-CONSUMPTION; HYPERTENSION; ADULTS; HEALTH; TRENDS; AGE	Objectives The purpose of this study is to assess the prevalence of overweight/obesity, abdominal obesity and obesity-related risk factors in southern China. Methods A cross-sectional survey of 15,364 participants aged 15 years and older was conducted from November 2013 to August 2014 in Jiangxi Province, China, using questionnaire forms and physical measurements. The physical measurements included body height, weight, waist circumference (WC), body fat percentage (BFP) and visceral adipose index (VAI). Multivariate logistic regression analysis was performed to evaluate the risk factors for overweight/obesity and abdominal obesity. Results The prevalence of overweight was 25.8% (25.9% in males and 25.7% in females), while that of obesity was 7.9% (8.4% in males and 7.6% in females). The prevalence of abdominal obesity was 10.2% (8.6% in males and 11.3% in females). The prevalence of overweight/obesity was 37.1% in urban residents and 30.2% in rural residents, and this difference was significant (P < 0.001). Urban residents had a significantly higher prevalence of abdominal obesity than rural residents (11.6% vs 8.7%, P < 0.001). Among the participants with an underweight/normal body mass index (BMI), 1.3% still had abdominal obesity, 16.1% had a high BFP and 1.0% had a high VAI. Moreover, among obese participants, 9.7% had a low/normal WC, 0.8% had a normal BFP and 15.9% had a normal VAI. Meanwhile, the partial correlation analysis indicated that the correlation coefficients between VAI and BMI, VAI and WC, and BMI and WC were 0.700, 0.666, and 0.721, respectively. A multivariate logistic regression analysis indicated that being female and having a high BFP and a high VAI were significantly associated with an increased risk of overweight/obesity and abdominal obesity. In addition, living in an urban area and older age correlated with overweight/obesity. Conclusion This study revealed that obesity and abdominal obesity, which differed by gender and age, are epidemic in southern China. Moreover, there was a very high, significant, positive correlation between WC, BMI and VAI. However, further studies are needed to explore which indicator of body fat could be used as the best marker to indirectly reflect cardiometabolic risk.	[Hu, Lihua; Huang, Xiao; You, Chunjiao; Li, Juxiang; Hong, Kui; Li, Ping; Wu, Yanqing; Wu, Qinhua; Bao, Huihui; Cheng, Xiaoshu] Nanchang Univ, Affiliated Hosp 2, Dept Cardiovas Med, Nanchang, Jiangxi, Peoples R China; [Wang, Zengwu] Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovas Dis, Div Prevent & Community Hlth, Beijing, Peoples R China; [Wang, Zengwu; Gao, Runlin] Chinese Acad Med Sci, Beijing, Peoples R China; [Gao, Runlin] Peking Union Med Coll, Fuwai Hosp, Beijing, Peoples R China	Nanchang University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Bao, HH; Cheng, XS (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Cardiovas Med, Nanchang, Jiangxi, Peoples R China.	huihui_bao77@126.com; xiaoshumenfan126@163.com	Huang, Xiao/ABB-9211-2020; wang, zengwu/AAS-9504-2021	wang, Zengwu/0000-0003-1613-5076	Chinese Ministry of Science and Technology [2011BAI11B01, 2014ZX09303305]; National Natural Science Foundation of China [81260023, 81560051]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key R&D Program in the Twelfth Five-year Plan (no. 2011BAI11B01 and 2014ZX09303305) from the Chinese Ministry of Science and Technology and National Natural Science Foundation of China (81260023, and 81560051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MC, 2010, DIABETES CARE, V33, P920, DOI 10.2337/dc09-1825; Amato MC, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/730827; Bluher S, 2013, J CLIN ENDOCR METAB, V98, P3384, DOI 10.1210/jc.2013-1389; Borruel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114112; Cai L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098744; Du T, 2014, INT J OBESITY, V38, P840, DOI 10.1038/ijo.2013.181; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Franzosi MG, 2006, LANCET, V368, P624, DOI 10.1016/S0140-6736(06)69222-2; Hong SY, 2012, EUR J CANCER PREV, V21, P523, DOI 10.1097/CEJ.0b013e328351c775; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; Hu LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170238; Jaacks LM, 2013, INT J EPIDEMIOL, V42, P828, DOI 10.1093/ije/dyt052; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kim J.-H., 2012, INT J PHOTOENERGY, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0051280; Lao XQ, 2014, INT J OBES LOND, V39, P288, DOI DOI 10.1038/IJ0.2014.95; Lindstrom M, 2003, EUR J PUBLIC HEALTH, V13, P306, DOI 10.1093/eurpub/13.4.306; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI [10.1001/jama.289.1.76, DOI 10.1001/JAMA.289.1.76]; Nguyen HN, 2013, CIRC J, V77, P2851, DOI 10.1253/circj.CJ-13-1292; Stepien M, 2014, ANGIOLOGY, V65, P333, DOI 10.1177/0003319713485807; Sternfeld B, 2005, MED SCI SPORT EXER, V37, P1195, DOI 10.1249/01.mss.0000170083.41186.b1; Thomson CA, 2012, INT J OBESITY, V36, P1158, DOI 10.1038/ijo.2012.84; Wang H, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-967, 10.1186/1471-2407-12-528]; Wang K, 2015, PLOS ONE, V10; Wang L, 2010, ARCH INTERN MED, V170, P453, DOI 10.1001/archinternmed.2009.527; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wang ZW, 2014, INT J CARDIOL, V174, P721, DOI 10.1016/j.ijcard.2014.03.117; Wildman RP, 2008, OBESITY, V16, P1448, DOI 10.1038/oby.2008.208; Wu Yang-feng, 2005, Zhonghua Yufang Yixue Zazhi, V39, P316; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Yang L, 2016, PLOS ONE, V11; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	33	83	94	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183934	10.1371/journal.pone.0183934	http://dx.doi.org/10.1371/journal.pone.0183934			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910301	gold, Green Published, Green Submitted			2022-12-27	WOS:000410859200024
J	Lee, M; Um, H; Van Dyke, MW				Lee, Minwoo; Um, Hyejin; Van Dyke, Michael W.			Identification and characterization of preferred DNA-binding sites for the Thermus thermophilus transcriptional regulator FadR	PLOS ONE			English	Article							COMBINATORIAL METHOD REPSA; ESCHERICHIA-COLI; SEQUENCE SPECIFICITY; COMPARATIVE GENOMICS; PROTEIN COMPLEXES; GENE-EXPRESSION; HB8; METABOLISM; SELECTION; DATABASE	One of the primary transcriptional regulators of fatty acid homeostasis in many prokaryotes is the protein FadR. To better understand its biological function in the extreme thermophile Thermus thermophilus HB8, we sought to first determine its preferred DNA-binding sequences in vitro using the combinatorial selection method Restriction Endonuclease Protection, Selection, and Amplification (REPSA) and then use this information to bioinformatically identify potential regulated genes. REPSA determined a consensus FadR-binding sequence 5'-TTRNACYNRGTNYAA-3', which was further characterized using quantitative electrophoretic mobility shift assays. With this information, a search of the T. thermophilus HB8 genome found multiple operons potentially regulated by FadR. Several of these were identified as encoding proteins involved in fatty acid biosynthesis and degradation; however, others were novel and not previously identified as targets of FadR. The role of FadR in regulating these genes was validated by physical and functional methods, as well as comparative genomic approaches to further characterize regulons in related organisms. Taken together, our study demonstrates that a systematic approach involving REPSA, biophysical characterization of protein-DNA binding, and bioinformatics can be used to postulate biological roles for potential transcriptional regulators.	[Lee, Minwoo; Um, Hyejin; Van Dyke, Michael W.] Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA	University System of Georgia; Kennesaw State University	Van Dyke, MW (corresponding author), Kennesaw State Univ, Dept Chem & Biochem, Kennesaw, GA 30144 USA.	mvandyk2@kennesaw.edu	Van Dyke, Michael W./AAY-6751-2020	Van Dyke, Michael W./0000-0003-0306-4002	US National Institutes of Health [1R15GM104833-01]; US National Science Foundation [DBI 1624654, MCB 1714778]; Kennesaw State University Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM104833] Funding Source: NIH RePORTER; Direct For Biological Sciences [1624654] Funding Source: National Science Foundation	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Science Foundation(National Science Foundation (NSF)); Kennesaw State University Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the US National Institutes of Health ([http://]www.nih.gov, Grant 1R15GM104833-01, MVD), the US National Science Foundation ([http://]www.nsf.gov, Grant DBI 1624654 and Grant MCB 1714778, MVD), and the Kennesaw State University Foundation ([http://] www.kennesaw.edu/foundation/, Foundation Fellow in Biochemistry, MVD). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agari Y, 2008, MOL MICROBIOL, V70, P60, DOI 10.1111/j.1365-2958.2008.06388.x; Agari Y, 2013, PROTEINS, V81, P1166, DOI 10.1002/prot.24266; Agari Y, 2012, J BACTERIOL, V194, P4630, DOI 10.1128/JB.00668-12; Agari Y, 2011, MICROBIOL-SGM, V157, P1589, DOI 10.1099/mic.0.048017-0; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; BECK CF, 1988, MICROBIOL REV, V52, P318, DOI 10.1128/MMBR.52.3.318-326.1988; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Charoensawan V, 2010, NUCLEIC ACIDS RES, V38, P7364, DOI 10.1093/nar/gkq617; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Gama-Castro S, 2016, NUCLEIC ACIDS RES, V44, pD133, DOI 10.1093/nar/gkv1156; Gopal YNV, 2003, BIOCHEMISTRY-US, V42, P6891, DOI 10.1021/bi027373s; Hardenbol P, 1996, P NATL ACAD SCI USA, V93, P2811, DOI 10.1073/pnas.93.7.2811; Hardenbol P, 1997, NUCLEIC ACIDS RES, V25, P3339, DOI 10.1093/nar/25.16.3339; Hardenbol P, 1997, BIOCONJUGATE CHEM, V8, P617, DOI 10.1021/bc970066s; Iwanaga N, 2014, EXTREMOPHILES, V18, P995, DOI 10.1007/s00792-014-0669-2; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Khodursky AB, 2000, P NATL ACAD SCI USA, V97, P12170, DOI 10.1073/pnas.220414297; Mao XZ, 2014, NUCLEIC ACIDS RES, V42, pD654, DOI 10.1093/nar/gkt1048; McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774; McGuire AM, 2000, NUCLEIC ACIDS RES, V28, P4523, DOI 10.1093/nar/28.22.4523; Novichkov PS, 2010, NUCLEIC ACIDS RES, V38, pW299, DOI 10.1093/nar/gkq531; Perez-Rueda E, 2015, COMPUT BIOL CHEM, V58, P93, DOI 10.1016/j.compbiolchem.2015.06.002; Perez-Rueda Ernesto, 2012, Science Progress, V95, P315, DOI 10.3184/003685012X13420097673409; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Sakamoto K, 2011, J BACTERIOL, V193, P4388, DOI 10.1128/JB.05203-11; Sakamoto K, 2010, MICROBIOL-SGM, V156, P1993, DOI 10.1099/mic.0.037382-0; Shen J, 2001, BIOORGAN MED CHEM, V9, P2285, DOI 10.1016/S0968-0896(01)00146-8; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Solovjev V, 2011, METAGENOMICITAPP, P61; Sunavala-Dossabhoy G, 2005, BIOCHEMISTRY-US, V44, P2510, DOI 10.1021/bi047877l; SZYBALSKI W, 1991, GENE, V100, P13, DOI 10.1016/0378-1119(91)90345-C; Taboada B, 2012, NUCLEIC ACIDS RES, V40, pD627, DOI 10.1093/nar/gkr1020; Takano H, 2014, MICROBIOL-SGM, V160, P2650, DOI 10.1099/mic.0.082263-0; Takano H, 2011, J BACTERIOL, V193, P2451, DOI 10.1128/JB.01125-10; Tonthat NK, 2011, EMBO J, V30, P154, DOI 10.1038/emboj.2010.288; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Van Dyke MW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159408; Yokoyama S, 2000, NAT STRUCT BIOL, V7, P943, DOI 10.1038/80712; Zhang YM, 2009, J LIPID RES, V50, pS115, DOI 10.1194/jlr.R800046-JLR200; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	47	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184796	10.1371/journal.pone.0184796	http://dx.doi.org/10.1371/journal.pone.0184796			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902898	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200070
J	Waeber, PO; Gardner, CJ; Lourenco, WR; Wilme, L				Waeber, Patrick O.; Gardner, Charlie J.; Lourenco, Wilson R.; Wilme, Lucienne			On specimen killing in the era of conservation crisis - A quantitative case for modernizing taxonomy and biodiversity inventories	PLOS ONE			English	Article							NATIONAL-DHISTOIRE-NATURELLE; MOUSE LEMURS MICROCEBUS; OF-NATURAL-HISTORY; RODENTS MUROIDEA; MAMMALIAN FAUNA; MADAGASCAR; COLLECTIONS; DIVERSITY; BIRDS; NESOMYINAE	Background to the work For centuries taxonomy has relied on dead animal specimens, a practice that persists today despite the emergence of innovative biodiversity assessment methods. Taxonomists and conservationists are engaged in vigorous discussions over the necessity of killing animals for specimen sampling, but quantitative data on taxonomic trends and specimen sampling over time, which could inform these debates, are lacking. Methods We interrogated a long-term research database documenting 2,723 land vertebrate and 419 invertebrate taxa from Madagascar, and their associated specimens conserved in the major natural history museums. We further compared specimen collection and species description rates for the birds, mammals and scorpions over the last two centuries, to identify trends and links to taxon descriptions. Results We located 15,364 specimens documenting endemic mammals and 11,666 specimens documenting endemic birds collected between 1820 and 2010. Most specimens were collected at the time of the Mission Zoologique Franco-Anglo-Ame A ricaine (MZFAA) in the 1930s and during the last two decades, with major differences according to the groups considered. The small mammal and bat collections date primarily from recent years, and are paralleled by the description of new species. Lemur specimens were collected during the MZFAA but the descriptions of new taxa are recent, with the type series limited to non-killed specimens. Bird specimens, particularly of non-passerines, are mainly from the time of the MZFAA. The passerines have also been intensely collected during the last two decades; the new material has been used to solve the phylogeny of the groups and only two new endemic taxa of passerine birds have been described over the last two decades. Conclusions Our data show that specimen collection has been critical for advancing our understanding of the taxonomy of Madagascar's biodiversity at the onset of zoological work in Madagascar, but less so in recent decades. It is crucial to look for alternatives to avoid killing animals in the name of documenting life, and encourage all efforts to share the information attached to historical and recent collections held in natural history museums. In times of conservation crisis and the advancement in digital technologies and open source sharing, it seems obsolete to kill animals in well-known taxonomic groups for the sake of enriching natural history collections around the world.	[Waeber, Patrick O.] ETH, Dept ITES, Forest Management & Dev ForDev Grp, Univ Str 16, Zurich, Switzerland; [Gardner, Charlie J.] Univ Kent, DICE, Canterbury, Kent, England; [Lourenco, Wilson R.] UPMC, Muse Natl Hist Nat, Sorbonne Univ,MNHN,EPHE, Inst Systemat Evolut Biodiversite ISYEB,UMR7205,C, CP 53,57 Rue Cuvier, Paris, France; [Wilme, Lucienne] Missouri Bot Garden, Madagascar Res & Conservat Program, Antananarivo 101, Madagascar; [Wilme, Lucienne] World Resources Inst, Washington, DC 20006 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Kent; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Missouri Botanical Gardens	Waeber, PO (corresponding author), ETH, Dept ITES, Forest Management & Dev ForDev Grp, Univ Str 16, Zurich, Switzerland.; Wilme, L (corresponding author), Missouri Bot Garden, Madagascar Res & Conservat Program, Antananarivo 101, Madagascar.; Wilme, L (corresponding author), World Resources Inst, Washington, DC 20006 USA.	patrick.waeber@usys.ethz.ch; lucienne.wilme@mobot-mg.org	Waeber, Patrick O./A-3649-2016; Wilmé, Lucienne/AAQ-6653-2020; Wilmé, Lucienne/A-3818-2016	Waeber, Patrick O./0000-0002-3229-0124; Wilmé, Lucienne/0000-0002-8344-1957; Wilmé, Lucienne/0000-0002-8344-1957; Gardner, Charlie/0000-0002-2750-3690				ANDRIANTOMPOHAV.R, 2007, SPECIAL PUBLICATIONS, V51, P1; Bartlett Edward, 1875, Proceedings of the Zoological Society, P62; BENGTSON SA, 1984, AUK, V101, P1; BENSON C W, 1970, Bulletin of the British Ornithologists' Club, V90, P168; BENSON C W, 1971, Bulletin of the British Ornithologists' Club, V91, P1; Benson CW, 1999, B BRIT ORNITHOLOGIST; Berner PO, 1997, AKONNY ALA, V20, P2; Blagoderov V, 2012, ZOOKEYS, P133, DOI 10.3897/zookeys.209.3178; Buettner-Janusch J, 1985, AM MUS NOVIT, V2834, P1; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; CARLETON M D, 1990, American Museum Novitates, P1; Carleton MD, 2014, P BIOL SOC WASH, V126, P414, DOI 10.2988/0006-324X-126.4.414; Carleton Michael D., 1996, Fieldiana Zoology, V85, P231; Carleton Michael D., 1994, American Museum Novitates, V3087, P1; Ceriaco LMP, 2016, ZOOTAXA, V4196, P435, DOI 10.11646/zootaxa.4196.3.9; Cianferoni F, 2016, ZOOTAXA, V4139, P128, DOI 10.11646/zootaxa.4139.1.8; Cibois A, 2010, ZOOTAXA, P65, DOI 10.11646/zootaxa.2554.1.6; Collen Ben, 2013, P71; Dekker R.W.R.J., 2003, NNM Technical Bulletin, V6, P1; DELACOUR J., 1932, OISEAU ET REV FRANC ORNITHOL, V2, P1; Filardi C. E., 2015, WHY I COLLECTED MOUS; Fontaine B, 2012, CURR BIOL, V22, pR943, DOI 10.1016/j.cub.2012.10.029; Frasier Cynthia L., 2016, Primate Conservation, V30, P59; Goodman SM, 1996, FIELDIANA ZOOLOGY, V85, P1; Goodman Steven M., 2000, Fieldiana Zoology, V97, P1; Goodman Steven M., 2009, Bonner Zoologische Beitraege, V56, P133; Gray GR, 1869, TRUSTEES BRIT MUSEUM, Vi-xx, P1; Gray GR, 1871, TRUSTEES BRIT MUSEUM, p[i, 1]; Gray GR, 1870, TRUSTEES BRIT MUSEUM, Vi-xv, P1; Gutierrez EE, 2017, SCIENCE, V355, P1275, DOI 10.1126/science.aan0926; HABERMAN Karen L., 2015, J NATURAL HIST ED EX, V9, P8; Hebert P. D., 2013, PLOS ONE, V10; Helgen KM, 2011, SCIENCE, V334, P458, DOI 10.1126/science.1214544; HELLMAYR C. E., 1928, AUK, V45, P293; Hertu O, 2001, BIODIVERSITE BIOTYPO, P361; Hotaling S, 2016, MOL ECOL, V25, P2029, DOI 10.1111/mec.13604; Ito Ryo, 2013, Madagascar Conservation & Development, V8, P45; IUCN, 2021, WIKIPEDIA; Jenkins P.D., 1987, CATALOGUE PRIMATES B; Jenkins PD, 2005, J NAT HIST, V39, P1779, DOI 10.1080/00222930400023719; Jenkins Richard K.B., 2008, Madagascar Conservation & Development, V3, P22; Jiguet Frederic, 2002, Bulletin of the British Ornithologists' Club, V122, P50; Kappeler P.M., 2005, Primate Report, V71, P3; Krell FT, 2014, SCIENCE, V344, P815, DOI 10.1126/science.344.6186.815; LeCroy M, 2005, B AM MUS NAT HIST, P1; LeCroy M, 2003, B AM MUS NAT HIST, P1; Lei Runhua, 2015, Primate Conservation, V29, P43; Lei Runhua, 2008, Texas Tech University Museum Special Publications, V53, P1; Lesson RP, 1831, ANN SCI NATURELLES, V22, P421; Lobl Ivan, 2016, Bulletin of Zoological Nomenclature, V73, P83; LONNBERG EINAR, 1926, AUK, V43, P434; Louis Jr E.E., 2006, SPECIAL PUBLICATIONS, V49, P1; Lourenco W. R., 2010, Entomologische Mitteilungen aus dem Zoologischen Museum Hamburg, V15, P173; Lourenco Wilson R., 2003, Entomologische Mitteilungen aus dem Zoologischen Museum Hamburg, V14, P129; Lourenco WR, 1996, MUSEUM NATL HIST NAT; Lourenco WR, 2016, COMPTES RENDUS BIOL, V339, P427; Menegaux MA, 1907, B MUSEUM HIST NATURE, V13, P104; Mercier J.-R., 2006, MADAGASCAR CONSERVAT, V1, P50, DOI [10.4314/mcd.v1i1.44122, DOI 10.4314/MCD.V1I1.44122]; MILON PH, 1951, NAT MALGACHE, V3, P167; Minteer BA, 2014, SCIENCE, V344, P260, DOI 10.1126/science.1250953; Moratelli R, 2014, ZOOLOGIA-CURITIBA, V31, P413, DOI 10.1590/S1984-46702014000500001; Ostende Hoek, 1997, NATL NATUURHIST MUS, V1, P1; Pape T, 2016, NATURE, V537, P307, DOI 10.1038/537307b; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Pucheran J., 1849, REV MAGASIN ZOOLOGIE, V12, P17; Radespiel U, 2008, AM J PRIMATOL, V70, P1033, DOI 10.1002/ajp.20592; Rand A. L., 1936, Bulletin of the American Museum of Natural History, V72, P143; Rasoloarison RM, 2000, INT J PRIMATOL, V21, P963, DOI 10.1023/A:1005511129475; Richmond CW, 1897, P US NATL MUS, V19, P677; Rocha LA, 2014, SCIENCE, V344, P814, DOI 10.1126/science.344.6186.814; Rodriguez-Estrella R, 2006, BIODIVERS CONSERV, V15, P1621, DOI 10.1007/s10531-004-4308-6; Rosauer DF, 2015, GLOBAL ECOL BIOGEOGR, V24, P168, DOI 10.1111/geb.12237; Roselaar C. S., 2003, Bulletin of the British Ornithologists' Club, V123A, P253; Garraffoni ARS, 2017, SCIENCE, V355, P805, DOI 10.1126/science.aam7686; Seregin AP, 2016, TAXON, V65, P206; Tattersall I, 2007, EVOL ANTHROPOL, V16, P12, DOI 10.1002/evan.20126; Tattersall Ian, 2013, Madagascar Conservation & Development, V8, P7; Thalmann U, 2000, INT J PRIMATOL, V21, P915, DOI 10.1023/A:1005507028567; Thiele D, 2013, MOL PHYLOGENET EVOL, V69, P593, DOI 10.1016/j.ympev.2013.07.019; Umetsu F, 2006, J MAMMAL, V87, P757, DOI 10.1644/05-MAMM-A-285R2.1; Voisin C., 1991, Oiseau et la Revue Francaise d'Ornithologie, V61, P341; Voisin C, 1999, MAMMALIA, V63, P535; Voisin C, 2008, ZOOSYSTEMA, V30, P463; Voisin Claire, 1993, Oiseau et la Revue Francaise d'Ornithologie, V63, P45; Voisin Claire, 2008, Journal of the National Museum Prague Natural History Series, V177, P1; Voisin Claire, 2001, Zoosystema, V23, P173; Waeber PO, 2015, INT FOREST REV, V17, P127, DOI 10.1505/146554815815834822; Waeber PO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161115; Wakeham-Dawson Andrew, 2002, Bulletin of Zoological Nomenclature, V59, P282; Wilme L, 1996, COLLOQ SEMI, P349; WILME L, 1994, BIOL CONSERV, V69, P15, DOI 10.1016/0006-3207(94)90324-7; Wilme Lucienne, 2012, Madagascar Conservation &  Development, V7, P30, DOI 10.4314/mcd.v7i1.6; Wilson D. E., 2005, MAMMAL SPECIES WORLD; World Wide Fund for Nature, 2016, LIV PLAN REP 2016; WOZENCRAFT WC, 1986, J MAMMAL, V67, P561, DOI 10.2307/1381288	95	13	13	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183903	10.1371/journal.pone.0183903	http://dx.doi.org/10.1371/journal.pone.0183903			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902889	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000410669200023
J	Romo-Munoz, RA; Cabas-Monje, JH; Garrido-Henrriquez, HM; Gil, JM				Alejandro Romo-Munoz, Rodrigo; Hernan Cabas-Monje, Juan; Manuel Garrido-Henrriquez, Hector; Maria Gil, Jose			Heterogeneity and nonlinearity in consumers' preferences: An application to the olive oil shopping behavior in Chile	PLOS ONE			English	Article							WILLINGNESS-TO-PAY; CHOICE EXPERIMENTS; QUALITY; PURCHASE; PRICE; INFERENCE; ORIGIN; LABELS	In relatively unknown products, consumers use prices as a quality reference. Under such circumstances, the utility function can be non-negative for a specific price range and generate an inverted U-shaped function. The extra virgin olive oil market in Chile is a good example. Although domestic production and consumption have increased significantly in the last few years, consumer knowledge of this product is still limited. The objective of this study was to analyze Chilean consumer preferences and willingness to pay for extra virgin olive oil attributes. Consumers were segmented taking into account purchasing frequency. A Random Parameter Logit model was estimated for preference heterogeneity. Results indicate that the utility function is nonlinear allowing us to differentiate between two regimes. In the first regime, olive oil behaves as a conspicuous good, that is, higher utility is assigned to higher prices and consumers prefer foreign products in smaller containers. Under the second regime, Chilean olive oil in larger containers is preferred.	[Alejandro Romo-Munoz, Rodrigo; Hernan Cabas-Monje, Juan; Manuel Garrido-Henrriquez, Hector] Univ Bio Bio, Business Management Dept, Agribusiness Res Grp, Chillan, Chile; [Maria Gil, Jose] Ctr Agrofood Econ & Dev CREDA UPC IRTA, Parc Mediterrani Tecnol,Edifici ESAB, Barcelona, Spain	Universidad del Bio-Bio; IRTA	Gil, JM (corresponding author), Ctr Agrofood Econ & Dev CREDA UPC IRTA, Parc Mediterrani Tecnol,Edifici ESAB, Barcelona, Spain.	chema.gil@upc.edu	GIL, Jose M./B-2699-2012	GIL, Jose M./0000-0003-3313-9052; Romo Munoz, Rodrigo/0000-0001-6839-8834; Garrido Henriquez, Hector Manuel/0000-0002-9560-8267	University of Bio Bio	University of Bio Bio	This work was supported by the Research Council at the University of Bio Bio.	Alfnes F, 2006, AM J AGR ECON, V88, P1050, DOI 10.1111/j.1467-8276.2006.00915.x; Bernabeu R, 2009, GRASAS ACEITES, V60, P525, DOI 10.3989/gya.053409; Camarena D. M., 2004, Economia Agraria y Recursos Naturales, V4, P105; Campbell J, 2014, INT J HOSP MANAG, V42, P39, DOI 10.1016/j.ijhm.2014.05.014; Chan-Halbrendt C, 2010, INT FOOD AGRIBUS MAN, V13, P55; Chang JB, 2009, AM J AGR ECON, V91, P518, DOI 10.1111/j.1467-8276.2008.01242.x; Cicia G., 2011, International Journal on Food System Dynamics, V2, P106; Costanigro M, 2014, FOOD QUAL PREFER, V31, P81, DOI 10.1016/j.foodqual.2013.08.002; Cronley ML, 2005, J CONSUM PSYCHOL, V15, P159, DOI 10.1207/s15327663jcp1502_8; de-Magistris T, 2014, SPAN J AGRIC RES, V12, P529, DOI 10.5424/sjar/2014123-4499; Del Giudice T, 2015, AGR FOOD EC, DOI [10.1186/s40100-015-0034-5, DOI 10.1186/S40100-015-0034-5]; dell'Olio L, 2011, TRANSPORT RES C-EMER, V19, P1060, DOI 10.1016/j.trc.2011.06.004; Denver S, 2014, FOOD QUAL PREFER, V31, P129, DOI 10.1016/j.foodqual.2013.08.014; Ding M, 2005, J MARKETING RES, V42, P67, DOI 10.1509/jmkr.42.1.67.56890; Fotopoulos C, 2001, J INT FOOD AGRIBUS M, V12, P1, DOI 10.1300/J047v12n01_01; Grunert KG, 2015, FOOD QUAL PREFER, V42, P37, DOI 10.1016/j.foodqual.2015.01.001; Hensher D., 2005, APPL CHOICE ANAL PRI, DOI 10.1017/CBO9780511610356; INE, 2011, SANTIAGO; Jimenez-Guerrero J, INTECH, DOI DOI 10.5772/30390; Johnson R. L., 1988, ADV CONSUM RES, V15, P316; Judd VC, 2000, J FOOD PROD MARK, V6, P11, DOI 10.1300/J038v06n01_02; Kallas Z, 2012, APPETITE, V58, P285, DOI 10.1016/j.appet.2011.09.017; Kallas Z, 2011, FOOD QUAL PREFER, V22, P181, DOI 10.1016/j.foodqual.2010.09.010; Kapaj A, 2013, J FOOD AGRIC ENVIRON, V11, P76; Krystallis A., 2005, INT FOOD AGRIBUS MAN, V8, P62, DOI [10.22004/ag.econ.8161, DOI 10.22004/AG.ECON.8161]; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lancsar E, 2013, SOC SCI MED, V76, P74, DOI 10.1016/j.socscimed.2012.10.007; Loomis JB, 2014, J AGR RESOUR ECON, V39, P34; Lusk J.L., 2007, EXPT AUCTIONS METHOD; Lusk JL, 2004, AM J AGR ECON, V86, P467, DOI 10.1111/j.0092-5853.2004.00592.x; Marian L, 2014, FOOD QUAL PREFER, V37, P52, DOI 10.1016/j.foodqual.2014.05.001; Martinez MG, 2002, AGRIBUSINESS, V18, P163, DOI DOI 10.1002/(ISSN)1520-6297; McFadden D., 1974, J PUBLIC ECON, V3, P303, DOI [10.1016/0047-2727(74)90003-6, DOI 10.1016/0047-2727(74)90003-6]; Menapace L, 2011, EUR REV AGRIC ECON, V38, P193, DOI 10.1093/erae/jbq051; Mtimet N, 2011, INT C AUG 30 SEP 2 2; Mtimet N, 2006, AGRIBUSINESS, V22, P343, DOI 10.1002/agr.20090; Obermiller C., 1988, ADV CONSUM RES, V15, P304; Panico T., 2014, Agricultural Economics Review, V15, P100; RAO AR, 1989, J MARKETING RES, V26, P351, DOI 10.2307/3172907; Santibanez F, 2008, ANALISIS VULNERABILI; Scarpa R., 2004, Journal of Agricultural & Food Industrial Organization, V2, P7, DOI 10.2202/1542-0485.1080; Scarpa R., 2005, Agribusiness (New York), V21, P329, DOI 10.1002/agr.20051; Scarpa R, 2011, AM J AGR ECON, V93, P809, DOI 10.1093/ajae/aaq174; Scozzafava G, 2016, APPETITE, V96, P70, DOI 10.1016/j.appet.2015.09.004; Sporleder EM, 2014, INT FOOD AGRIBUS MAN, V17, P59; Street D. J., 2007, CONSTRUCTION OPTIMAL; Sundt S, 2015, ENERG ECON, V51, P1, DOI 10.1016/j.eneco.2015.06.005; Tempesta T, 2013, FOOD QUAL PREFER, V27, P35, DOI 10.1016/j.foodqual.2012.06.005; Tempesta T., 2013, INT AGR POLICY, V2, P33; van der Lans IA, 2001, EUR REV AGRIC ECON, V28, P451, DOI 10.1093/erae/28.4.451; Van Loo EJ, 2011, FOOD QUAL PREFER, V22, P603, DOI 10.1016/j.foodqual.2011.02.003; Ward R. W., 2003, Agribusiness (New York), V19, P393, DOI 10.1002/agr.10068; Wu LH, 2015, CHINA ECON REV, V35, P121, DOI 10.1016/j.chieco.2015.07.001; Yangui A, 2016, FOOD QUAL PREFER, V51, P27, DOI 10.1016/j.foodqual.2016.02.012	54	16	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184585	10.1371/journal.pone.0184585	http://dx.doi.org/10.1371/journal.pone.0184585			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG4OS	28892516	Green Submitted, Green Published, gold			2022-12-27	WOS:000410243200018
J	Buhrmann, M; Wiedemann, BM; Muller, MP; Hardick, J; Ecke, M; Rauh, D				Buehrmann, Mike; Wiedemann, Bianca M.; Mueller, Matthias P.; Hardick, Julia; Ecke, Maria; Rauh, Daniel			Structure-based design, synthesis and crystallization of 2-arylquinazolines as lipid pocket ligands of p38 alpha MAPK	PLOS ONE			English	Article							KINASE; INHIBITORS; PROTEIN; BINDING; HYDROPHOBICITY; NUCLEOTIDE; TOOL	In protein kinase research, identifying and addressing small molecule binding sites other than the highly conserved ATP-pocket are of intense interest because this line of investigation extends our understanding of kinase function beyond the catalytic phosphotransfer. Such alternative binding sites may be involved in altering the activation state through subtle conformational changes, control cellular enzyme localization, or in mediating and disrupting protein-protein interactions. Small organic molecules that target these less conserved regions might serve as tools for chemical biology research and to probe alternative strategies in targeting protein kinases in disease settings. Here, we present the structure-based design and synthesis of a focused library of 2-arylquinazoline derivatives to target the lipophilic C-terminal binding pocket in p38 alpha MAPK, for which a clear biological function has yet to be identified. The interactions of the ligands with p38 alpha MAPK was analyzed by SPR measurements and validated by protein X-ray crystallography.	[Buehrmann, Mike; Wiedemann, Bianca M.; Mueller, Matthias P.; Hardick, Julia; Ecke, Maria; Rauh, Daniel] TU Dortmund Univ, Fac Chem & Chem Biol, Dortmund, Germany	Dortmund University of Technology	Rauh, D (corresponding author), TU Dortmund Univ, Fac Chem & Chem Biol, Dortmund, Germany.	daniel.rauh@tu-dortmund.de		Muller, Matthias/0000-0002-1529-8933	German Federal Ministry for Education and Research (NGFNPlus); German Federal Ministry for Education and Research (e:Med) [BMBF 01GS08104, 01ZX1303C]; Deutsche Forschungsgemeinschaft (DFG); European Union [EFRE-800400]; German federal state North Rhine Westphalia (NRW)	German Federal Ministry for Education and Research (NGFNPlus); German Federal Ministry for Education and Research (e:Med); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union(European Commission); German federal state North Rhine Westphalia (NRW)	This work was co-funded by the German Federal Ministry for Education and Research (NGFNPlus and e:Med) (Grant No. BMBF 01GS08104, 01ZX1303C) and by the Deutsche Forschungsgemeinschaft (DFG). https://www.bmbf.de/en/index.html; http://mv.dtp.de/. DR thanks the German federal state North Rhine Westphalia (NRW) and the European Union (European Regional Development Fund: Investing In Your Future) (EFRE-800400).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Biffinger JC, 2004, CHEMBIOCHEM, V5, P622, DOI 10.1002/cbic.200300910; Buehrmann M, 2017, ANGEW CHEM INT EDIT, V56, P13232, DOI 10.1002/anie.201706345; Bukhtiyarova M, 2004, PROTEIN EXPRES PURIF, V37, P154, DOI 10.1016/j.pep.2004.05.017; Cheng R, 2013, SYNTHESIS-STUTTGART, V45, P8; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Comess KM, 2011, ACS CHEM BIOL, V6, P234, DOI 10.1021/cb1002619; Cox KJ, 2011, FUTURE MED CHEM, V3, P29, DOI 10.4155/FMC.10.272; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Diskin R, 2008, J MOL BIOL, V375, P70, DOI 10.1016/j.jmb.2007.09.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel J, 2015, J MED CHEM, V58, P6844, DOI 10.1021/acs.jmedchem.5b01082; Getlik M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039713; Giet R, 2001, J CELL SCI, V114, P2095; HIDAKA H, 1984, BIOCHEMISTRY-US, V23, P5036, DOI 10.1021/bi00316a032; Hour MJ, 2000, J MED CHEM, V43, P4479, DOI 10.1021/jm000151c; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karplus PA, 1997, PROTEIN SCI, V6, P1302; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Lata S, 2005, J AM CHEM SOC, V127, P10205, DOI 10.1021/ja050690c; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Garcia-Martinez JM, 2010, CELL SIGNAL, V22, P415, DOI 10.1016/j.cellsig.2009.10.013; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; Moe ST, 2009, BIOORGAN MED CHEM, V17, P3072, DOI 10.1016/j.bmc.2009.03.013; Nouira I, 2008, TETRAHEDRON LETT, V49, P7033, DOI 10.1016/j.tetlet.2008.09.135; Perry JJP, 2009, J MOL BIOL, V391, P1, DOI 10.1016/j.jmb.2009.06.005; Rauch J, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-23; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Sawyers CL, 2003, GENE DEV, V17, P2998, DOI 10.1101/gad.1152403; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shen ZL, 2011, TETRAHEDRON, V67, P1665, DOI 10.1016/j.tet.2010.12.067; Simard JR, 2010, J AM CHEM SOC, V132, P4152, DOI 10.1021/ja908083e; Simard JR, 2009, J AM CHEM SOC, V131, P18478, DOI 10.1021/ja907795q; Tzarum N, 2012, J MOL BIOL, V424, P339, DOI 10.1016/j.jmb.2012.10.007; Weisner J, 2015, ANGEW CHEM INT EDIT, V54, P10313, DOI 10.1002/anie.201502142; Wilcken R, 2012, J AM CHEM SOC, V134, P6810, DOI 10.1021/ja301056a; Yang JS, 2011, CHEM BIOL, V18, P177, DOI 10.1016/j.chembiol.2010.12.013; Zhang WX, 2005, ANAL BIOCHEM, V343, P76, DOI 10.1016/j.ab.2005.05.011	40	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184627	10.1371/journal.pone.0184627	http://dx.doi.org/10.1371/journal.pone.0184627			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892510	Green Published, Green Submitted, gold			2022-12-27	WOS:000410243200020
J	Dagnall, CL; Hicks, B; Teshome, K; Hutchinson, AA; Gadalla, SM; Khincha, PP; Yeager, M; Savage, SA				Dagnall, Casey L.; Hicks, Belynda; Teshome, Kedest; Hutchinson, Amy A.; Gadalla, Shahinaz M.; Khincha, Payal P.; Yeager, Meredith; Savage, Sharon A.			Effect of pre-analytic variables on the reproducibility of qPCR relative telomere length measurement	PLOS ONE			English	Article							DNA EXTRACTION METHOD; EPIDEMIOLOGIC RESEARCH; QUANTITATIVE PCR; DISEASE; RISK; CANCER; HEALTH; IMPACT; VARIES	Telomeres, long nucleotide repeats and a protein complex at chromosome ends, shorten with each cell division and are susceptible to oxidative damage. Quantitative PCR (qPCR) is a widely-used technique to measure relative telomere length (RTL) in DNA samples but is challenging to optimize and significant lab-to-lab variability has been reported. In this study, we evaluated factors that may contribute to qPCR RTL measurement variability including DNA extraction methods, methods used for removing potential residual PCR inhibitors, sample storage conditions, and sample location in the PCR plate. Our results show that the DNA extraction and purification techniques, as well as sample storage conditions introduce significant variability in qPCR RTL results. We did not find significant differences in results based on sample location in the PCR plate or qPCR instrument used. These data suggest that lack of reproducibility in published association studies of RTL could be, in part, due to methodological inconsistencies. This study illustrates the importance of uniform sample handling, from DNA extraction through data generation and analysis, in using qPCR to determine RTL.	[Dagnall, Casey L.; Hicks, Belynda; Teshome, Kedest; Hutchinson, Amy A.; Gadalla, Shahinaz M.; Khincha, Payal P.; Yeager, Meredith; Savage, Sharon A.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Dagnall, Casey L.; Hicks, Belynda; Teshome, Kedest; Hutchinson, Amy A.; Yeager, Meredith] Leidos Biomed Res Inc, Canc Genom Res Lab, Frederick Natl Lab Canc Res, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Savage, SA (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	savagesh@mail.nih.gov	Gadalla, Shahinaz/U-2848-2019; Savage, Sharon/AAB-5160-2019; Savage, Sharon A/B-9747-2015; Gadalla, Shahinaz M/C-4005-2015; Yeager, Meredith/AAA-5322-2020	Savage, Sharon/0000-0001-6006-0740; Savage, Sharon A/0000-0001-6006-0740; Gadalla, Shahinaz M/0000-0002-3255-8143; 	Division of Cancer Epidemiology and Genetics, National Cancer Institute; Frederick National Laboratory for Cancer Research; National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010190] Funding Source: NIH RePORTER	Division of Cancer Epidemiology and Genetics, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the intramural research program of the Division of Cancer Epidemiology and Genetics, National Cancer Institute. Authors CLD, BH, KT, AAH, and MY are employees of Leidos Biomedical Research, Inc. a subsidiary of Leidos dedicated to a single contract to the Frederick National Laboratory for Cancer Research, which is sponsored by the National Cancer Institute (https.//www.leidos.cam/about/subsidiaries/leidos-biomedical-research). Leidos Biomedical Research, Inc., did not play a role in study design, data collection or analysis, or preparation of the manuscript.	Alter BP, 2012, HAEMATOL-HEMATOL J, V97, P353, DOI 10.3324/haematol.2011.055269; Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Aubert G, 2012, MUTAT RES-FUND MOL M, V730, P59, DOI 10.1016/j.mrfmmm.2011.04.003; Aviv A, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr634; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Callicott RJ, 2006, COMPARATIVE MED, V56, P17; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cunningham JM, 2013, CANCER EPIDEM BIOMAR, V22, P2047, DOI 10.1158/1055-9965.EPI-13-0409; Denham Joshua, 2014, BMC Res Notes, V7, P877, DOI 10.1186/1756-0500-7-877; Eisenberg DTA, 2015, AM J HUM BIOL, V27, P570, DOI 10.1002/ajhb.22690; Elbers CC, 2014, J GERONTOL A-BIOL, V69, P527, DOI 10.1093/gerona/glt121; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Gutierrez-Rodrigues F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113747; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hofmann JN, 2014, CANCER EPIDEM BIOMAR, V23, P1129, DOI 10.1158/1055-9965.EPI-14-0145; Koppelstaetter C, 2005, MECH AGEING DEV, V126, P1331, DOI 10.1016/j.mad.2005.08.003; Martin-Ruiz CM, 2015, INT J EPIDEMIOLOGY; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Montpetit AJ, 2014, NURS RES, V63, P289, DOI 10.1097/NNR.0000000000000037; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Raschenberger J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25398; Roder B, 2010, J CLIN MICROBIOL, V48, P4260, DOI 10.1128/JCM.01230-10; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Seeker LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164046; Tolios A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143889; van der Harst P, 2007, J AM COLL CARDIOL, V49, P1459, DOI 10.1016/j.jacc.2007.01.027; Willeit P, 2010, JAMA-J AM MED ASSOC, V304, P69, DOI 10.1001/jama.2010.897	31	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184098	10.1371/journal.pone.0184098	http://dx.doi.org/10.1371/journal.pone.0184098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886139	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100066
J	Gasco, S; Zaragoza, P; Garcia-Redondo, A; Calvo, AC; Osta, R				Gasco, Samanta; Zaragoza, Pilar; Garcia-Redondo, Alberto; Calvo, Ana C.; Osta, Rosario			Inflammatory and non-inflammatory monocytes as novel prognostic biomarkers of survival in SOD1G93A mouse model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CCR2; HEMATOPOIETIC STEM; PROTEIN ABUNDANCE; MESSENGER-RNA; EXPRESSION; DIFFERENTIATION; MACROPHAGE; SUBSETS; MCP-1; NEUROPROTECTION	Amyotrophic Lateral Sclerosis (ALS) has lately become a suitable scenario to study the interplay between the hematopoietic system and disease progression. Recent studies in C9orf72 null mice have demonstrated that C9orf72 is necessary for the normal function of myeloid cells. In this study, we aimed to analyze in depth the connection between the hematopoietic system and secondary lymphoid (spleen) and non-lymphoid (liver and skeletal muscle) organs and tissues along the disease progression in the transgenic SOD1G93A mice. Our findings suggested that the inflammatory response due to the neurodegeneration in this animal model affected all three organs and tissues, especially the liver and the skeletal muscle. However, the liver was able to compensate this inflammatory response by means of the action of non-inflammatory monocytes, while in the skeletal muscle inflammatory monocytes prompted a further inflammation process until the terminal state of the animals. Interestingly, in blood, a positive correlation was found between non-inflammatory monocytes and survival of the transgenic SOD1G93A mice, while the contrary (a negative correlation) was found in the case of inflammatory monocytes, supporting their potential role as biomarkers of disease progression and survival in this animal model. These findings could prompt future translational studies in ALS patients, promoting the identification of new reliable biomarkers of disease progression.	[Gasco, Samanta; Zaragoza, Pilar; Calvo, Ana C.; Osta, Rosario] Univ Zaragoza, Vet Fac Zaragoza, Hlth Res Inst Aragon IIS, Inst Agroalimentario Aragon,CITA,LAGENBIO, Zaragoza, Spain; [Garcia-Redondo, Alberto] October 12th Hosp, Hlth Res Inst, CIBERER U 723, Biochem Dept, Madrid, Spain	University of Zaragoza; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Gasco, S (corresponding author), Univ Zaragoza, Vet Fac Zaragoza, Hlth Res Inst Aragon IIS, Inst Agroalimentario Aragon,CITA,LAGENBIO, Zaragoza, Spain.	samantagasco@gmail.com	Osta, Rosario/R-5410-2019; REDONDO, ALBERTO GARCÍA/AAD-9453-2020; zaragoza, pilar/AAN-9479-2021; Calvo, Ana/L-2826-2017	Gasco, Samanta/0000-0002-3318-4286; Calvo, Ana/0000-0001-5193-7782; Osta, Rosario/0000-0001-5687-6704	FIS [PI14/00947]; Institute de Salud Carlos III; FEDER	FIS(Instituto de Salud Carlos III); Institute de Salud Carlos III(Instituto de Salud Carlos III); FEDER(European Commission)	This work was supported by the Grant FIS (PI14/00947); Institute de Salud Carlos III and FEDER Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajroud-Driss S, 2015, BBA-MOL BASIS DIS, V1852, P679, DOI 10.1016/j.bbadis.2014.08.010; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Banerjee R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002740; Bellavance MA, 2015, BRAIN STRUCT FUNCT, V220, P1759, DOI 10.1007/s00429-014-0759-z; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Breslin WL, 2013, J IMMUNOL METHODS, V390, P1, DOI 10.1016/j.jim.2011.03.005; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Carri MT, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00041; Chao MP, 2008, COLD SH Q B, V73, P439, DOI 10.1101/sqb.2008.73.031; Chiu IM, 2009, P NATL ACAD SCI USA, V106, P20960, DOI 10.1073/pnas.0911405106; Dimitrijevic OB, 2007, STROKE, V38, P1345, DOI 10.1161/01.STR.0000259709.16654.8f; Eckert C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00179; Engel DR, 2008, J IMMUNOL, V181, P5579, DOI 10.4049/jimmunol.181.8.5579; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Fantuzzi L, 1999, BLOOD, V94, P875, DOI 10.1182/blood.V94.3.875.415k28_875_883; Finkelstein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022374; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Gupta PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038382; Henkel JS, 2006, MOL CELL NEUROSCI, V31, P427, DOI 10.1016/j.mcn.2005.10.016; Hu ZT, 2015, J IMMUNOL, V194, P2746, DOI 10.4049/jimmunol.1401928; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jaiswal Manoj Kumar, 2014, Mol Cell Ther, V2, P26, DOI 10.1186/2052-8426-2-26; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Jung HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128387; Kan X, 2015, CARDIOVASCULAR RES; King AE, 2016, EXP NEUROL, V275, P162, DOI 10.1016/j.expneurol.2015.09.019; Laferriere F, 2015, SWISS MED WKLY, V145, DOI 10.4414/smw.2015.14054; Liaskou E, 2013, HEPATOLOGY, V57, P385, DOI 10.1002/hep.26016; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Massberg S, 2009, ANN NY ACAD SCI, V1176, P87, DOI 10.1111/j.1749-6632.2009.04609.x; Mehra A, 2003, BIOTECHNOL BIOENG, V84, P822, DOI 10.1002/bit.10860; Michaud JP, 2013, CELL REP, V5, P646, DOI 10.1016/j.celrep.2013.10.010; Murdock BJ, 2015, NEUROBIOL DIS, V77, P1, DOI 10.1016/j.nbd.2015.02.017; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Narni-Mancinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002457; O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064; Philips T, 2015, CURRENT PROTOCOLS PH, V69; Redler RL, 2012, PROG MOL BIOL TRANSL, V107, P215, DOI 10.1016/B978-0-12-385883-2.00002-3; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shi P, 2010, BBA-MOL BASIS DIS, V1802, P707, DOI 10.1016/j.bbadis.2010.05.008; Strauss-Ayali D, 2007, J LEUKOCYTE BIOL, V82, P244, DOI 10.1189/jlb.0307191; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; Vaknin I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026921; Van den Bosch L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/348765; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang CQ, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-6; Wang HZ, 2014, AM J PATHOL, V184, P1167, DOI 10.1016/j.ajpath.2013.12.020; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Zarei Sara, 2015, Surg Neurol Int, V6, P171, DOI 10.4103/2152-7806.169561; Zhang RZ, 2006, J NEUROIMMUNOL, V179, P87, DOI 10.1016/j.jneuroim.2006.06.008; Zhao WH, 2013, J NEUROIMMUNE PHARM, V8, P888, DOI 10.1007/s11481-013-9489-x	58	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184626	10.1371/journal.pone.0184626	http://dx.doi.org/10.1371/journal.pone.0184626			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886177	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100172
J	Franzo, G; Massi, P; Tucciarone, CM; Barbieri, I; Tosi, G; Fiorentini, L; Ciccozzi, M; Lavazza, A; Cecchinato, M; Moreno, A				Franzo, Giovanni; Massi, Paola; Tucciarone, Claudia Maria; Barbieri, Ilaria; Tosi, Giovanni; Fiorentini, Laura; Ciccozzi, Massimo; Lavazza, Antonio; Cecchinato, Mattia; Moreno, Ana			Think globally, act locally: Phylodynamic reconstruction of infectious bronchitis virus (IBV) QX genotype (GI-19 lineage) reveals different population dynamics and spreading patterns when evaluated on different epidemiological scales	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; AVIAN CORONAVIRUS; MUTATION-RATES; STRAIN; RECOMBINATION; CIRCULATION; EMERGENCE; VACCINE; PATHOGENICITY; PERFORMANCE	Infectious bronchitis virus (IBV) represents one of the poultry industry major threats, particularly in high density producing countries. The emergence and spread of new IBV genotypes have frustrated the various disease control efforts implemented over time. Despite that, few comprehensive and large scale studies have been performed to understand the international and local spreading dynamics of this virus. In the present work, these phenomena were evaluated by implementing a Bayesian phylodynamic approach to reconstruct the epidemiological patterns and population history of the QX genotype (currently renamed GI-19 lineage), the most relevant IBV lineage of the Old-World. Our analysis, based on 807 partial S1 sequences of strains collected from 18 countries between 1993 and 2015, demonstrates that this genotype originated in China well before its first identification. After a prolonged local circulation, it started spreading to other European, Asian and Middle East countries in successive waves, which were mirrored by concomitant fluctuations in viral population size. Interestingly, the within-Europe spread was characterized by a higher estimated migration rate compared with the inter-continental one, potentially reflecting the closer geographic and economic relationships among these countries. Nevertheless, the colonization of new states by the GI-19 lineage appeared to occur mostly by single introduction events in both intra and inter-continental spread, likely because of epidemiological factor and health policy combination which seems to prevent the frequent introduction and mixing of different strains. On the other hand, the within Italy QX circulation reconstruction showed a much more intricate connection network among different locations, evidencing the difficulty in controlling IBV spread especially in highly densely poultry populated areas. The presence of several well supported epidemiological links among distantly related Italian regions testifies that animal transportation and indirect transmission routes rather than local airborne diffusion contribute to the QX success and persistence at local scale. Globally, the spreading dynamics and evolution of the QX genotype were reconstructed from its very origin to nowadays, demonstrating the need of more effective direct control measures, particularly within each country. Unfortunately, the incompleteness of available molecular epidemiology data represents an insurmountable limit which leaves many questions currently unsolved, thus highlighting the compulsoriness of a structured monitoring and data sharing system implementation.	[Franzo, Giovanni; Tucciarone, Claudia Maria; Cecchinato, Mattia] Univ Padua, Dept Anim Med Prod & Hlth MAPS, Padua, Italy; [Massi, Paola; Tosi, Giovanni; Fiorentini, Laura] Ist Sperimentale Lombardia & Emilia Romagna, Sez Forli, Forli, Forli Cesena, Italy; [Barbieri, Ilaria; Lavazza, Antonio; Moreno, Ana] Ist Sperimentale Lombardia & Emilia Romagna, Dept Virol, Brescia, Italy; [Ciccozzi, Massimo] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Rome, Italy	University of Padua; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS)	Franzo, G (corresponding author), Univ Padua, Dept Anim Med Prod & Hlth MAPS, Padua, Italy.; Moreno, A (corresponding author), Ist Sperimentale Lombardia & Emilia Romagna, Dept Virol, Brescia, Italy.	giovanni.franzo@unipd.it; anamaria.morenomartin@izsler.it	Moreno, Ana/Q-2173-2019; Ciccozzi, Massimo/AAC-3271-2022	Moreno, Ana/0000-0002-8497-9708; Ciccozzi, Massimo/0000-0003-3866-9239; Cecchinato, Mattia/0000-0002-2269-7879; Tucciarone, Claudia Maria/0000-0002-0340-8920; Franzo, Giovanni/0000-0003-2991-217X	Ministry of Health (Italy): Progetto di Ricerca Corrente [PCR2015009]	Ministry of Health (Italy): Progetto di Ricerca Corrente	The study was partially funded by the Ministry of Health (Italy): Progetto di Ricerca Corrente PCR2015009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abdel-Moneim AS, S1 GENE SEQUENCE ANA; Abro SH, 2012, VET MICROBIOL, V155, P237, DOI 10.1016/j.vetmic.2011.09.022; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Baele GFAU, 2012, MOL BIOL EVOLUTION J; Banks J, 2001, ARCH VIROL, V146, P963, DOI 10.1007/s007050170128; Beato MS, 2005, VET REC, V156, P720, DOI 10.1136/vr.156.22.720; Benyeda Z, 2009, AVIAN PATHOL, V38, P449, DOI 10.1080/03079450903349196; Bielejec F, 2016, MOL BIOL EVOL, V33, P2167, DOI 10.1093/molbev/msw082; Bochkov YA, 2006, AVIAN PATHOL, V35, P379, DOI 10.1080/03079450600921008; Bozorgmehri-Fard M. H., 2013, IRANIAN J VIROL, V7, P57, DOI DOI 10.21859/isv.7.1.2.57; Cavanagh D, 1999, AVIAN PATHOL, V28, P593, DOI 10.1080/03079459994399; Chu DKW, 2011, J VIROL, V85, P12815, DOI 10.1128/JVI.05838-11; Cook JKA, 2012, AVIAN PATHOL, V41, P239, DOI 10.1080/03079457.2012.680432; Cook JKA, 1999, AVIAN PATHOL, V28, P477, DOI 10.1080/03079459994506; CRINION RAP, 1971, AVIAN DIS, V15, P42, DOI 10.2307/1588386; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Wit J.J., 2017, AVIAN PATHOLOGY; de Wit JJ, 2011, AVIAN PATHOL, V40, P223, DOI 10.1080/03079457.2011.566260; Dolz R., 2009, VI International Symposium on Avian Corona- and Pneumoviruses and Complicating Pathogens, Rauischholzhausen, Germany, 14-17 June 2009., P27; Domanska-Blicharz K, 2014, AVIAN PATHOL, V43, P406, DOI 10.1080/03079457.2014.949619; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Elena SF, 2005, J VIROL, V79, P11555, DOI 10.1128/JVI.79.18.11555-11558.2005; Franzo G, 2016, VACCINE; Franzo G, 2016, MOL PHYLOGENET EVOL, V100, P269, DOI 10.1016/j.ympev.2016.04.028; Franzo G, 2014, VACCINE, V32, P6765, DOI 10.1016/j.vaccine.2014.10.006; Geerligs HJ, 2011, AVIAN PATHOL, V40, P93, DOI 10.1080/03079457.2010.542742; Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265; Gough RE, 2008, VET REC, V162, P99, DOI 10.1136/vr.162.3.99; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall MD, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew003; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Holmes E., 2009, EVOLUTION EMERGENCE; Holmes EC, 2009, ANNU REV ECOL EVOL S, V40, P353, DOI 10.1146/annurev.ecolsys.110308.120248; Hong S-M, 2017, ARCH VIROL; Jackwood MW, 2012, AVIAN DIS, V56, P634, DOI 10.1637/10227-043012-Review.1; Jackwood MW, 2012, INFECT GENET EVOL, V12, P1305, DOI 10.1016/j.meegid.2012.05.003; JONES RC, 1987, VET REC, V120, P617, DOI 10.1136/vr.120.26.617; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kiss I, 2015, ACTA VET HUNG, V63, P382, DOI 10.1556/004.2015.036; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Krapez U, 2010, VIRUS GENES; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Little C, 2010, VET REC, V167, P879, DOI 10.1136/vr.c6702; Maroney Susan A, 2007, Vet Ital, V43, P723; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; McKinley ET, 2011, VIRUS RES, V158, P225, DOI 10.1016/j.virusres.2011.04.006; Moreno A, 2016, AVIAN PATHOL, p1 ; Munster VJ, 2006, GLOBAL PATTERNS INFL, V312, p384 ; Muradrasoli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013640; Naqi S, 2003, AVIAN DIS, V47, P594, DOI 10.1637/6087; Ovchinnikova EV, 2011, AVIAN PATHOL, V40, P507, DOI 10.1080/03079457.2011.605782; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rambaut A., 2016, VIRUS EVOL, V2; Seger W, 2016, ARCH VIROL, V161, P1229, DOI 10.1007/s00705-016-2790-2; Team RC, 2016, R LANG ENV STAT COMP; Terregino C, 2008, AVIAN PATHOL, V37, P487, DOI 10.1080/03079450802356938; Thor SW, 2011, VIRUSES-BASEL, V3, P1777, DOI 10.3390/v3091777; Valastro V, 2016, INFECT GENET EVOL, V39, P349, DOI 10.1016/j.meegid.2016.02.015; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059449; Worthington KJ, 2008, AVIAN PATHOL, V37, P247, DOI 10.1080/03079450801986529; Yu L, 2001, AVIAN DIS, V45, P416, DOI 10.2307/1592981; YuDong W, 1998, CHINESE J ANIMAL QUA, V15, P1	63	35	36	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184401	10.1371/journal.pone.0184401	http://dx.doi.org/10.1371/journal.pone.0184401			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880958	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200065
J	Gainer, PJ; Pound, HL; Larkin, AA; LeCleir, GR; DeBruyn, JM; Zinser, ER; Johnson, ZI; Wilhelm, SW				Gainer, P. Jackson; Pound, Helena L.; Larkin, Alyse A.; LeCleir, Gary R.; DeBruyn, Jennifer M.; Zinser, Erik R.; Johnson, Zackary I.; Wilhelm, Steven W.			Contrasting seasonal drivers of virus abundance and production in the North Pacific Ocean	PLOS ONE			English	Article							DEEP-SEA SEDIMENTS; 16S RIBOSOMAL-RNA; WESTERN PACIFIC; MICROBIAL COMMUNITIES; SARGASSO SEA; AQUATIC ENVIRONMENTS; CONTINENTAL-SHELF; DIEL PERIODICITY; VIRAL PRODUCTION; COASTAL WATERS	The North Pacific Ocean (between approximately 0 degrees N and 50 degrees N) contains the largest continuous ecosystem on Earth. This region plays a vital role in the cycling of globally important nutrients as well as carbon. Although the microbial communities in this region have been assessed, the dynamics of viruses (abundances and production rates) remains understudied. To address this gap, scientific cruises during the winter and summer seasons (2013) covered the North Pacific basin to determine factors that may drive virus abundances and production rates. Along with information on virus particle abundance and production, we collected a spectrum of oceanographic metrics as well as information on microbial diversity. The data suggest that both biotic and abiotic factors affect the distribution of virus particles. Factors influencing virus dynamics did not vary greatly between seasons, although the abundance of viruses was almost an order of magnitude greater in the summer. When considered in the context of microbial community structure, our observations suggest that members of the bacterial phyla Proteobacteria, Planctomycetes, and Bacteroidetes were correlated to both virus abundances and virus production rates: these phyla have been shown to be enriched in particle associated communities. The findings suggest that environmental factors influence virus community functions (e.g., virion particle degradation) and that particle-associated communities may be important drivers of virus activity.	[Gainer, P. Jackson; Pound, Helena L.; LeCleir, Gary R.; Zinser, Erik R.; Wilhelm, Steven W.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA; [Larkin, Alyse A.; Johnson, Zackary I.] Duke Univ, Marine Lab, Environm & Biol Dept, Nicholas Sch, Beaufort, NC 28516 USA; [DeBruyn, Jennifer M.] Univ Tennessee, Biosyst Engn & Soil Sci, Knoxville, TN USA	University of Tennessee System; University of Tennessee Knoxville; Duke University; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Wilhelm, SW (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	wilhelm@utk.edu	DeBruyn, Jennifer M./A-8813-2010; Wilhelm, Steven W/B-8963-2008	DeBruyn, Jennifer M./0000-0002-2993-4144; Wilhelm, Steven W/0000-0001-6283-8077; Johnson, Zackary/0000-0003-0793-8512; LeCleir, Gary/0000-0002-0228-7557; Larkin, Alyse/0000-0003-4466-0791	National Science Foundation [OCE 1030518]; ZIJ [OCE 1031064, OCE14 16665]; Kenneth and Blaire Mossman Endowment; Division Of Ocean Sciences [1416665] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); ZIJ; Kenneth and Blaire Mossman Endowment; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by grants from the National Science Foundation to ERZ and SWW (OCE 1030518) and ZIJ (OCE 1031064 and OCE14 16665). Further support was provided by the Kenneth and Blaire Mossman Endowment to the University of Tennessee (SWW).	Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Bettarel Y, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnv216; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Brussaard CPD, 2008, ISME J, V2, P575, DOI 10.1038/ismej.2008.31; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; Crespo BG, 2013, MICROBIOLOGYOPEN, V2, P541, DOI 10.1002/mbo3.92; Culley AI, 2002, LIMNOL OCEANOGR, V47, P1508, DOI 10.4319/lo.2002.47.5.1508; Danovaro R, 2000, APPL ENVIRON MICROB, V66, P1857, DOI 10.1128/AEM.66.5.1857-1861.2000; Fontanez KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00469; Fu G., 1998, P 4 PAC OC REM SENS, P73; Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144; Gobler CJ, 1997, LIMNOL OCEANOGR, V42, P1492, DOI 10.4319/lo.1997.42.7.1492; Hagino K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081749; Hara S, 1996, MAR ECOL PROG SER, V145, P269, DOI 10.3354/meps145269; HARDING LW, 1981, MAR BIOL, V61, P95, DOI 10.1007/BF00386649; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; HOLMHANSEN O, 1978, OIKOS, V30, P438, DOI 10.2307/3543338; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; JIANG SC, 1994, MAR ECOL PROG SER, V104, P163, DOI 10.3354/meps104163; Johnson ZI, 2010, J MAR RES, V68, P283, DOI 10.1357/002224010793721433; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Jover LF, 2014, NAT REV MICROBIOL, V12, P519, DOI 10.1038/nrmicro3289; Kirchman D, 2001, METHOD MICROBIOL, V30, P227, DOI 10.1016/S0580-9517(01)30047-8; KRAMER JG, 1993, APPL ENVIRON MICROB, V59, P2430, DOI 10.1128/AEM.59.8.2430-2436.1993; Larkin AA, 2016, ISME J, V10, P1555, DOI 10.1038/ismej.2015.244; LeCleir GR, 2014, FEMS MICROBIOL ECOL, V87, P153, DOI 10.1111/1574-6941.12213; LENSKI RE, 1984, J THEOR BIOL, V108, P319, DOI 10.1016/S0022-5193(84)80035-1; Li Y, 2014, BIOGEOSCIENCES, V11, P2531, DOI 10.5194/bg-11-2531-2014; Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997; MATHIAS CB, 1995, APPL ENVIRON MICROB, V61, P3734, DOI 10.1128/AEM.61.10.3734-3740.1995; Matteson AR, 2010, JOVE-J VIS EXP, V43, pe2196; Matteson AR, 2013, FEMS MICROBIOL ECOL, V84, P223, DOI 10.1111/1574-6941.12060; Matteson AR, 2012, FEMS MICROBIOL ECOL, V79, P709, DOI 10.1111/j.1574-6941.2011.01251.x; Middelboe M, 2006, DEEP-SEA RES PT I, V53, P1, DOI 10.1016/j.dsr.2005.09.008; Middelboe M, 2002, AQUAT MICROB ECOL, V27, P187, DOI 10.3354/ame027187; Mojica KDA, 2014, FEMS MICROBIOL ECOL, V89, P495, DOI 10.1111/1574-6941.12343; Needham DM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.5, 10.1038/nmicrobiol.2016.5]; Nelson CE, 2014, ENVIRON MICROBIOL, V16, P871, DOI 10.1111/1462-2920.12241; Noble RT, 1997, APPL ENVIRON MICROB, V63, P77, DOI 10.1128/AEM.63.1.77-83.1997; O'Malley MA, 2007, NAT REV MICROBIOL, V5, P647, DOI 10.1038/nrmicro1711; Ortmann Alice C., 2009, V501, P87, DOI 10.1007/978-1-60327-164-6_10; OWENS TG, 1980, MAR BIOL, V59, P71, DOI 10.1007/BF00405456; Parsons RJ, 2012, ISME J, V6, P273, DOI 10.1038/ismej.2011.101; Payet JP, 2008, J MARINE SYST, V74, P933, DOI 10.1016/j.jmarsys.2007.11.002; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rappe MS, 1997, LIMNOL OCEANOGR, V42, P811, DOI 10.4319/lo.1997.42.5.0811; Rowe JM, 2008, AQUAT MICROB ECOL, V52, P233, DOI 10.3354/ame01231; Rowe JM, 2012, FEMS MICROBIOL ECOL, V79, P359, DOI 10.1111/j.1574-6941.2011.01223.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SUTTLE CA, 1994, MICROBIAL ECOL, V28, P237, DOI 10.1007/BF00166813; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Tsai AY, 2013, BIOGEOSCIENCES, V10, P3055, DOI 10.5194/bg-10-3055-2013; WATERBURY JB, 1993, APPL ENVIRON MICROB, V59, P3393, DOI 10.1128/AEM.59.10.3393-3399.1993; WEINBAUER MG, 1995, MICROBIAL ECOL, V30, P25, DOI 10.1007/BF00184511; Weitz JS, 2015, ISME J, V9, P1352, DOI 10.1038/ismej.2014.220; Weitz Joshua S, 2012, F1000 Biol Rep, V4, P17; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Welsh EA, 2008, P NATL ACAD SCI USA, V105, P15094, DOI 10.1073/pnas.0805418105; Wilhelm SW, 2002, MICROBIAL ECOL, V43, P168, DOI 10.1007/s00248-001-1021-9; Wilhelm SW, 1999, BIOSCIENCE, V49, P781, DOI 10.2307/1313569; Winget DM, 2005, AQUAT MICROB ECOL, V41, P221, DOI 10.3354/ame041221	62	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184371	10.1371/journal.pone.0184371	http://dx.doi.org/10.1371/journal.pone.0184371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880951	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200060
J	Goods, BA; Hernandez, AL; Lowther, DE; Lucca, LE; Lerner, BA; Gunel, M; Raddassi, K; Coric, V; Hafler, DA; Love, JC				Goods, Brittany A.; Hernandez, Amanda L.; Lowther, Daniel E.; Lucca, Liliana E.; Lerner, Benjamin A.; Gunel, Murat; Raddassi, Khadir; Coric, Vlad; Hafler, David A.; Love, J. Christopher			Functional differences between PD-1(+) and PD-1(-) CD4(+) effector T cells in healthy donors and patients with glioblastoma multiforme	PLOS ONE			English	Article							TUMOR; CD8(+); LYMPHOCYTES; EXPRESSION; EPIDEMIOLOGY; DYSFUNCTION; ANTI-PD-1; SAFETY; GLIOMA	Immune checkpoint inhibitors targeting programmed cell death protein 1 (PD-1) have been highly successful in the treatment of cancer. While PD-1 expression has been widely investigated, its role in CD4(+) effector T cells in the setting of health and cancer remains unclear, particularly in the setting of glioblastoma multiforme (GBM), the most aggressive and common form of brain cancer. We examined the functional and molecular features of PD1 (+)CD4(+)CD25(-)CD127(+)Foxp3(-) effector cells in healthy subjects and in patients with GBM. In healthy subjects, we found that PD-1(+)CD4(+) effector cells are dysfunctional: they do not proliferate but can secrete large quantities of IFN gamma. Strikingly, blocking antibodies against PD-1 did not rescue proliferation. RNA-sequencing revealed features of exhaustion in PD1 (+) CD4 effectors. In the context of GBM, tumors were enriched in PD-1(+)CD4(+) effectors that were similarly dysfunctional and unable to proliferate. Furthermore, we found enrichment of PD-1(+)TIM-3(+)CD4(+) effectors in tumors, suggesting that co-blockade of PD-1 and TIM-3 in GBM may be therapeutically beneficial. RNA-sequencing of blood and tumors from GBM patients revealed distinct differences between CD4(+) effectors from both compartments with enrichment in multiple gene sets from tumor infiltrating PD-1(-)CD4(+) effectors cells. Enrichment of these gene sets in tumor suggests a more metabolically active cell state with signaling through other co-receptors. PD-1 expression on CD4 cells identifies a dysfunctional subset refractory to rescue with PD-1 blocking antibodies, suggesting that the influence of immune checkpoint inhibitors may involve recovery of function in the PD-1(-)CD4(+) T cell compartment. Additionally, co-blockade of PD-1 and TIM-3 in GBM may be therapeutically beneficial.	[Goods, Brittany A.; Love, J. Christopher] MIT, Dept Biol Engn, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Goods, Brittany A.; Love, J. Christopher] MIT, Dept Chem Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Hernandez, Amanda L.; Lowther, Daniel E.; Lucca, Liliana E.; Lerner, Benjamin A.; Raddassi, Khadir; Hafler, David A.] Yale Sch Med, Dept Neurol, New Haven, CT USA; [Hernandez, Amanda L.; Lowther, Daniel E.; Lucca, Liliana E.; Lerner, Benjamin A.; Raddassi, Khadir; Hafler, David A.] Yale Sch Med, Dept Immunobiol, New Haven, CT USA; [Gunel, Murat] Yale Sch Med, Dept Genet, New Haven, CT USA; [Gunel, Murat] Yale Sch Med, Dept Neurosurg, New Haven, CT USA; [Coric, Vlad] Bristol Myers Squibb, Wallingford, CT USA; [Hafler, David A.; Love, J. Christopher] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Yale University; Yale University; Yale University; Yale University; Bristol-Myers Squibb; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Love, JC (corresponding author), MIT, Dept Biol Engn, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Love, JC (corresponding author), MIT, Dept Chem Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Love, JC (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	clove@mit.edu	Lucca, Liliana/ABA-9188-2021	Love, John/0000-0003-0921-3144; Lucca, Liliana Elisa/0000-0002-5109-0128; /0000-0002-5962-9570	Britstol-Myers Squib; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI073748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	Britstol-Myers Squib; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A portion of this research was funded by Britstol-Myers Squib. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Berghoff AS, 2015, NEURO-ONCOLOGY, V17, P1064, DOI 10.1093/neuonc/nou307; Cao Y, 2015, SCI TRANSL MED, V7; Chang CH, 2016, NAT IMMUNOL, V17, P364, DOI 10.1038/ni.3415; Chauvin JM, 2015, J CLIN INVEST, V125, P2046, DOI 10.1172/JCI80445; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Crawford A, 2009, CURR OPIN IMMUNOL, V21, P179, DOI 10.1016/j.coi.2009.01.010; Croci DO, 2007, CANCER IMMUNOL IMMUN, V56, P1687, DOI 10.1007/s00262-007-0343-y; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Han S, 2014, BRIT J CANCER, V110, P2560, DOI 10.1038/bjc.2014.162; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Igarashi H, 2008, BIOCHEM BIOPH RES CO, V369, P1134, DOI 10.1016/j.bbrc.2008.03.024; Jacobs JFM, 2010, J NEUROIMMUNOL, V225, P195, DOI 10.1016/j.jneuroim.2010.05.020; Kang CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep15659; Learn CA, 2006, CLIN CANCER RES, V12, P7306, DOI 10.1158/1078-0432.CCR-06-1727; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li YX, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-104; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lowther DE, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85935; Mischel PS, 2002, TARGETED MOL THERAPY, P1; Motzer RJ, 2015, J CLIN ONCOL, V33, P1430, DOI 10.1200/JCO.2014.59.0703; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Ray S, 2014, ARCH APPL MECH, P1; Razavi SM, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00011; Riley JL, 2009, IMMUNOL REV, V229, P114, DOI 10.1111/j.1600-065X.2009.00767.x; Ronchetti S, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/171520; Rutledge WC, 2013, CLIN CANCER RES, V19, P4951, DOI 10.1158/1078-0432.CCR-13-0551; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Tirosh I, 2016, DISSECTING MULTICELL, P1; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2829, DOI 10.1172/JCI28941E1; Wainwright DA, 2014, CLIN CANCER RES, V20, P5290, DOI 10.1158/1078-0432.CCR-14-0514; Walker DG, 2006, J NEUROIMMUNOL, V175, P59, DOI 10.1016/j.jneuroim.2006.03.006; Wei B, 2014, TUMOR BIOL, V35, P2923, DOI 10.1007/s13277-013-1376-9; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yang ZZ, 2012, J CLIN INVEST, V122, P1271, DOI 10.1172/JCI59806; Zhang Y, 2010, CELL MOL IMMUNOL, V7, P389, DOI 10.1038/cmi.2010.28; Zhu C, 2011, CURR TOP MICROBIOL, V350, P1, DOI 10.1007/82_2010_84	43	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0181538	10.1371/journal.pone.0181538	http://dx.doi.org/10.1371/journal.pone.0181538			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880903	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200005
J	Shiraya, T; Kato, S; Araki, F; Ueta, T; Abe, H; Asai, N				Shiraya, Tomoyasu; Kato, Satoshi; Araki, Fumiyuki; Ueta, Takashi; Abe, Hitoshi; Asai, Nobuharu			Experimental verification of subthreshold laser therapy using conventional pattern scan laser	PLOS ONE			English	Article							DIABETIC MACULAR EDEMA; RETINAL PHOTOCOAGULATION	Purpose Leading-edge therapeutic laser technologies are not available at every medical facility; therefore, alternative approaches incorporating novel advances in digital and laser technology into more readily available conventional methods have generated significant research interest. Using a rabbit model, this study investigated whether the algorithm used in the Endpoint Management (EM) software system of the latest devices could enable subthreshold laser treatment in conventional retinal tissue laser therapy systems. Materials and methods Two types of devices were used, the PASCAL Streamline 577 and the MC 500-Vixi T, and the laser method was classified into three categories: EM; single-shot using PASCAL with arbitrary energy settings (PSS-SDM); and MC500-Vixi TM (VX-SDM), which were performed in eight eyes from four Dutch-Belted rabbits. In EM, 100mW (100%) was set as a landmark, and the laser energy parameters were gradually decreased to 80%, 60%, 50%, 40%, 30%, 20%, and 10%, using a 2 x 3 square pattern. In PSS-SDM and VX-SDM, as control, the laser energy was gradually decreased to 100, 80, 60, 50, 40, 30, 20, and 10 mW. The laser settings were fixed at 200 mu m, 20 ms, and a wavelength of 577 mu m. To identify and compare the extent of tissue damage at each spot size, optical coherence tomography (OCT) and histological findings were used to construct a three-dimensional histopathology image using a confocal laser scanning fluorescence microscope. Results The spot size at 50% setting on EM was 7183 mu m(2); PSS-SDM required 50mW (5503 mu m(2)) to 60mW(10279 mu m(2)) and VX-SDM required 50mW(7423 mu m(2)) to create the approximate spot size. Furthermore, at 50mW of PSS-SDM and VX-SDM, the extent of tissue damage in all three methods was generally in accord with the outer nuclear layer by OCT and inner nuclear layer by histopathological imaging. Conclusion These findings suggest that it may be possible to perform subthreshold laser therapy using approximations from the EM algorithm.	[Shiraya, Tomoyasu; Kato, Satoshi; Araki, Fumiyuki; Ueta, Takashi] Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Abe, Hitoshi; Asai, Nobuharu] NIDEK Co Ltd, Gamagori, Japan	Nidek Co., Ltd	Kato, S (corresponding author), Grad Sch Med, Dept Ophthalmol, Tokyo, Japan.	katou-s@ka2.so-net.ne.jp			JSPS KAKENHI [JP16K20305]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI, Grant Number JP16K20305 (https://www.jsps.go.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blumenkranz MS, 2006, RETINA-J RET VIT DIS, V26, P370, DOI 10.1097/00006982-200603000-00024; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Fong DS, 2007, ARCH OPHTHALMOL-CHIC, V125, P469; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; KLEIN R, 1984, OPHTHALMOLOGY, V91, P1464; Koinzer S, 2013, ACTA OPHTHALMOL, V91, pE603, DOI 10.1111/aos.12188; Lavinsky D, 2011, INVEST OPHTH VIS SCI, V52, P4314, DOI 10.1167/iovs.10-6828; Muqit MMK, 2011, INVEST OPHTH VIS SCI, V52, P994, DOI 10.1167/iovs.10-6309; Ohkoshi K, 2010, AM J OPHTHALMOL, V149, P133, DOI 10.1016/j.ajo.2009.08.010; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Paulus YM, 2008, INVEST OPHTH VIS SCI, V49, P5540, DOI 10.1167/iovs.08-1928; ROIDER J, 1992, ARCH OPHTHALMOL-CHIC, V110, P1786, DOI 10.1001/archopht.1992.01080240126045; Roider J, 1999, Semin Ophthalmol, V14, P19, DOI 10.3109/08820539909056059; SCHATZ H, 1991, ARCH OPHTHALMOL-CHIC, V109, P1549, DOI 10.1001/archopht.1991.01080110085041; Sher A, 2013, J NEUROSCI, V33, P6800, DOI 10.1523/JNEUROSCI.1044-12.2013; Shiraya T, 2014, ACTA OPHTHALMOL, V92, pe585, DOI 10.1111/aos.12393; Vujosevic S, 2010, RETINA-J RET VIT DIS, V30, P908, DOI 10.1097/IAE.0b013e3181c96986	17	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184392	10.1371/journal.pone.0184392	http://dx.doi.org/10.1371/journal.pone.0184392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880961	gold, Green Published, Green Submitted			2022-12-27	WOS:000409467200063
J	Jia, B; McNeil, LK; Dupont, CD; Tsioris, K; Barry, RM; Scully, IL; Ogunniyi, AO; Gonzalez, C; Pride, MW; Gierahn, TM; Liberator, PA; Jansen, KU; Love, JC				Jia, Bin; McNeil, Lisa K.; Dupont, Christopher D.; Tsioris, Konstantinos; Barry, Rachel M.; Scully, Ingrid L.; Ogunniyi, Adebola O.; Gonzalez, Christopher; Pride, Michael W.; Gierahn, Todd M.; Liberator, Paul A.; Jansen, Kathrin U.; Love, J. Christopher			Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; CAPSULAR POLYSACCHARIDE; SOMATIC HYPERMUTATION; NAIVE ADULTS; VACCINATION; RESPONSES; IMMUNOGENICITY; SAFETY; OLDER; REVACCINATION	Background The efficacy of protein-conjugated pneumococcal polysaccharide vaccines has been well characterized for children. The level of protection conferred by unconjugated polysaccharide vaccines remains less clear, particularly for elderly individuals who have had prior antigenic experience through immunization with unconjugated polysaccharide vaccines or natural exposure to Streptococcus pneumoniae. Methods We compared the magnitude, diversity and genetic biases of antigen-specific memory B cells in two groups of adult cynomolgus macaques that were immunized with a 7-valent conjugated vaccine and boosted after five years with either a 13-valent pneumococcal polysaccharide conjugate vaccine (13vPnC) or a 23-valent unconjugated pneumococcal polysaccharide vaccine (23vPS) using microengraving (a single-cell analysis method) and single-cell RT-PCR. Results Seven days after boosting, the mean frequency of antigen-specific memory B cells was significantly increased in macaques vaccinated with 13vPnC compared to those receiving 23vPS. The 13vPnC-vaccinated macaques also exhibited a more even distribution of antibody specificities to four polysaccharides in the vaccine (PS4, 6B, 14, 23F) that were examined. However, single-cell analysis of the antibody variable region sequences from antigen-specific B cells elicited by unconjugated and conjugated vaccines indicated that both the germline gene segments forming the heavy chains and the average lengths of the Complementary Determining Region 3 (CDR3) were similar. Conclusions Our results confirm that distinctive differences can manifest between antigen-specific memory B cell repertoires in nonhuman primates immunized with conjugated and unconjugated pneumococcal polysaccharide vaccines. The study also supports the notion that the conjugated vaccines have a favorable profile in terms of both the frequency and breadth of the anamnestic response among antigen-specific memory B cells.	[Jia, Bin; Dupont, Christopher D.; Tsioris, Konstantinos; Barry, Rachel M.; Ogunniyi, Adebola O.; Gonzalez, Christopher; Gierahn, Todd M.; Love, J. Christopher] MIT, Dept Chem Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [McNeil, Lisa K.; Scully, Ingrid L.; Pride, Michael W.; Liberator, Paul A.; Jansen, Kathrin U.] Pfizer Vaccine Res & Early Dev, Pearl River, NY USA; [Love, J. Christopher] MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); Pfizer; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute	Love, JC (corresponding author), MIT, Dept Chem Engn, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA.; Love, JC (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA USA.	clove@mit.edu		Love, John/0000-0003-0921-3144	Pfizer; National Institute of Allergy and Infectious Disease [F32AI112359]; National Cancer Institute [P30CA140514]	Pfizer(Pfizer); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by Pfizer, and in part by grants from the National Institute of Allergy and Infectious Disease (Grant F32AI112359) and the National Cancer Institute (P30CA140514). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Pfizer provided support in the form of salaries for authors LKM, ILS, MWP, PAL and KUJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Alamyar E., 2012, IMMUNOME RES, V8, P1, DOI [10.4172/1745-7580.1000056, DOI 10.4172/1745-7580.1000056]; Baxendale HE, 2000, EUR J IMMUNOL, V30, P1214, DOI 10.1002/(SICI)1521-4141(200004)30:4<1214::AID-IMMU1214>3.0.CO;2-D; Baxendale HE, 2010, VACCINE, V28, P4763, DOI 10.1016/j.vaccine.2010.04.103; Bradshaw EM, 2008, CLIN IMMUNOL, V129, P10, DOI 10.1016/j.clim.2008.06.009; Brezinschek HP, 1998, J IMMUNOL, V160, P4762; Brezinschek HP, 1997, J CLIN INVEST, V99, P2488, DOI 10.1172/JCI119433; Choi JH, 2010, BIOTECHNOL PROGR, V26, P888, DOI 10.1002/btpr.374; Clutterbuck EA, 2012, J INFECT DIS, V205, P1408, DOI 10.1093/infdis/jis212; DAVIDSON M, 1994, ARCH INTERN MED, V154, P2209, DOI 10.1001/archinte.154.19.2209; de Roux A, 2008, CLIN INFECT DIS, V46, P1015, DOI 10.1086/529142; Feldman C, 2014, J INFECT; Gierahn TM, 2014, J PROTEOME RES; Goldblatt D, 2000, CLIN EXP IMMUNOL, V119, P1, DOI 10.1046/j.1365-2249.2000.01109.x; Greenberg RN, 2014, VACCINE, V32, P2364, DOI 10.1016/j.vaccine.2014.02.002; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Han Q, 2010, LAB CHIP, V10, P1391, DOI 10.1039/b926849a; Hausdorff WP, 2005, LANCET INFECT DIS, V5, P83, DOI 10.1016/S1473-3099(05)01280-6; Huss A, 2009, CAN MED ASSOC J, V180, P48, DOI 10.1503/cmaj.080734; Jackson LA, 2013, VACCINE, V31, P3594, DOI 10.1016/j.vaccine.2013.04.084; Jackson LA, 2013, VACCINE, V31, P3577, DOI 10.1016/j.vaccine.2013.04.085; Jackson LA, 2013, VACCINE, V31, P3585, DOI 10.1016/j.vaccine.2013.05.010; Jahnmatz M, 2013, J IMMUNOL METHODS, V391, P50, DOI 10.1016/j.jim.2013.02.009; Jiang N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004794; Juergens C, 2014, HUM VACCINES IMMUNOT, V10; KONRADSEN HB, 1995, CLIN INFECT DIS, V21, P616, DOI 10.1093/clinids/21.3.616; Kroger AT, GEN RECOMMENDATIONS; Kuwata T, 2011, AIDS RES HUM RETROV, V27, P487, DOI 10.1089/aid.2010.0191; Leggat DJ, 2013, VACCINE, V31, P4632, DOI 10.1016/j.vaccine.2013.07.030; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; MacIntyre CR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094578; McDaniel LS, 2004, INFECT DIS CLIN PRAC, V12, P93, DOI [10.1016/S0140-6736(09)61114-4, DOI 10.1016/S0140-6736(09)61114-4]; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; Melegaro A, 2006, J INFECTION, V52, P37, DOI 10.1016/j.jinf.2005.02.008; Musher DM, 2010, J INFECT DIS, V201, P516, DOI 10.1086/649839; Nuorti JP, 2010, PREV PNEUM DIS INF C; OBrien KL, 1996, PEDIATR INFECT DIS J, V15, P425, DOI 10.1097/00006454-199605000-00009; Ogunniyi AO, 2014, VACCINE, V32, P2866, DOI 10.1016/j.vaccine.2014.02.020; Ogunniyi AO, 2009, NAT PROTOC, V4, P767, DOI 10.1038/nprot.2009.40; Pinna D, 2009, EUR J IMMUNOL, V39, P1260, DOI 10.1002/eji.200839129; Sankilampi U, 1997, J INFECT DIS, V176, P1100, DOI 10.1086/516521; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Smith K, 2013, IMMUNOBIOLOGY, V218, P745, DOI 10.1016/j.imbio.2012.08.278; Story CM, 2008, P NATL ACAD SCI USA, V105, P17902, DOI 10.1073/pnas.0805470105; Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340; Tomczyk S, USE 13 VALENT PNEUMO; Torling J, VACCINE; Tsioris K, 2015, INTEGR BIOL-UK, V7, P1587, DOI [10.1039/c5ib00169b, 10.1039/C5IB00169B]; Wang XW, 2000, J IMMUNOL METHODS, V244, P217, DOI 10.1016/S0022-1759(00)00260-X; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wu Y, 2012, ADV MATER RES-SWITZ, V528, P3, DOI 10.4028/www.scientific.net/AMR.528.3; Zhou JH, 2002, INFECT IMMUN, V70, P4083, DOI 10.1128/IAI.70.8.4083-4091.2002	52	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183738	10.1371/journal.pone.0183738	http://dx.doi.org/10.1371/journal.pone.0183738			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910279	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200015
J	Liu, ZZ; Qu, HJ; Tian, ZL; Han, MJ; Fan, Y; Ge, LZ; Zang, YF; Zhang, H				Liu, Zan-Zan; Qu, Hui-Jie; Tian, Zhuo-Ling; Han, Meng-Jian; Fan, Yi; Ge, Lie-Zhong; Zang, Yu-Feng; Zhang, Hang			Reproducibility of frequency-dependent low frequency fluctuations in reaction time over time and across tasks	PLOS ONE			English	Article							INTRA-SUBJECT VARIABILITY; DEFICIT-HYPERACTIVITY-DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TEST-RETEST RELIABILITY; SUSTAINED ATTENTION; HUMAN BRAIN; RESPONSE VARIABILITY; ADHD; CHILDREN; MRI	Objective Increased levels of reaction time variability (RTV) are characteristics of sustained attention deficits. The clinical significance of RTV has been widely recognized. However, the reliability of RTV measurements has not been widely studied. The present study aimed to assess the test-retest reliability of RTV conventional measurements, e.g., the standard deviation (SD), the coefficient of variation (CV), and a new measurement called the amplitude of low frequency fluctuation (ALFF) of RT. In addition, we aimed to assess differences and similarities of these measurements between different tasks. Method Thirty-seven healthy college students participated in 2 tasks, i.e., an Eriksen flanker task (EFT) and a simple reaction task (SRT), twice over a mean interval of 56 days. Conventional measurements of RTV including RT-SD and RT-CV were assessed first. Then the RT time series were converted into frequency domains, and RT-ALFF was further calculated for the whole frequency band (0.0023-0.167 Hz) and for a few sub-frequency bands including Slow-6(< 0.01 Hz), Slow-5 (0.01-0.027 Hz), Slow-4 (0.027-0.073 Hz), and Slow-3 (0.073-0.167 Hz). The test-retest reliability of these measurements was evaluated through intra-class correlation (ICC) tests. Differences and correlations between each EFT and SRT measurement were further examined during both visits. Results 1) The RT-ALFF of the Slow-5/4/3 and conventional measurements of RT-SD and RT-CV showed moderate to high levels of test-retest reliability. EFT RT-ALFF patterns generated slightly higher ICC values than SRT values in higher frequency bands (Slow-3), but SRT RT-ALFF values showed slightly higher ICC values than EFT values in lower frequency bands (Slow-5 and Slow-4). 2) RT-ALFF magnitudes in each sub-frequency band were greater for the SRT than those for the EFT. 3) The RT-ALFF in the Slow-4 of the EFT was found to be correlated with the RT-ALFF in the Slow-5 of the SRT for both two visits, but no consistently significant correlation was found between the same frequency bands. Conclusions These findings reveal good test-retest reliability for conventional measurements and for the RT-ALFF of RTV. The RT-ALFF presented frequency-dependent similarities across tasks. All of our results reveal the presence of different frequency structures between the two tasks, and thus the frequency-dependent characteristics of different tasks deserve more attention in future studies.	[Liu, Zan-Zan; Qu, Hui-Jie; Ge, Lie-Zhong] Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China; [Tian, Zhuo-Ling; Fan, Yi; Zang, Yu-Feng] Hangzhou Normal Univ, Inst Psychol Sci, Hangzhou, Zhejiang, Peoples R China; [Tian, Zhuo-Ling; Fan, Yi; Zang, Yu-Feng] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China; [Tian, Zhuo-Ling; Fan, Yi; Zang, Yu-Feng] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Han, Meng-Jian] Zhejiang Sci Tech Univ, Dept Phys, Hangzhou, Zhejiang, Peoples R China; [Zhang, Hang] Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China	Zhejiang Sci-Tech University; Hangzhou Normal University; Hangzhou Normal University; Zhejiang Sci-Tech University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Zang, YF (corresponding author), Hangzhou Normal Univ, Inst Psychol Sci, Hangzhou, Zhejiang, Peoples R China.; Zang, YF (corresponding author), Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China.; Zang, YF (corresponding author), Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China.; Zhang, H (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen, Peoples R China.	zangyf@gmail.com; kevinhangbnu@foxmail.com	ZANG, Yu-Feng/J-1558-2012	ZANG, Yu-Feng/0000-0003-1833-8010	National Natural Science Foundation of China [81271652, 81520108016, 31471084, 81401481]; Natural Science Foundation of Zhejiang Province, China [LY16C090006]; Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province [20146030301013]; Qian Jiang Distinguished Professor	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province, China(Natural Science Foundation of Zhejiang Province); Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province; Qian Jiang Distinguished Professor	This study was supported by the National Natural Science Foundation of China (81271652, 81520108016, 31471084), recipient: Yu-Feng Zang; the National Natural Science Foundation of China (81401481), recipient: Hang Zhang; the Natural Science Foundation of Zhejiang Province, China (LY16C090006), recipient: Lie-Zhong Ge; Key Laboratory for Magnetic Resonance and Multimodality Imaging of Guangdong Province (20146030301013), recipient: Xin Liu and Dr. Yu-Feng Zang is partly supported through the "Qian Jiang Distinguished Professor" program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jin-Xuan Cheng for her help with recruiting subjects. Dr. Yu-Feng Zang is partly supported through the "Qian Jiang Distinguished Professor" program. We wish to acknowledge the two anonymous reviewers' careful reviews and helpful suggestions.	Adamo N, 2014, EUR CHILD ADOLES PSY, V23, P69, DOI 10.1007/s00787-013-0428-4; Adamo N, 2014, J ATTEN DISORD, V18, P434, DOI 10.1177/1087054712439419; Anastasi A., 1997, PSYCHOL TESTING; Andellini M, 2015, J NEUROSCI METH, V253, P183, DOI 10.1016/j.jneumeth.2015.05.020; Bastiaansen JA, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.03.005; Bellgrove MA, 2005, NEUROPSYCHOLOGIA, V43, P1847, DOI 10.1016/j.neuropsychologia.2005.03.011; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bora E, 2006, PROG NEURO-PSYCHOPH, V30, P1097, DOI 10.1016/j.pnpbp.2006.04.016; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Buyck I, 2015, NEUROPSYCHOLOGY, V29, P433, DOI 10.1037/neu0000148; Castellanos FX, 2005, BIOL PSYCHIAT, V57, P1416, DOI 10.1016/j.biopsych.2004.12.005; Di Martino A, 2008, BIOL PSYCHIAT, V64, P607, DOI 10.1016/j.biopsych.2008.03.008; Epstein JN, 2011, NEUROPSYCHOLOGY, V25, P427, DOI 10.1037/a0022155; Epstein JN, 2010, J INT NEUROPSYCH SOC, V16, P138, DOI 10.1017/S1355617709991111; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Esterman M, 2014, J NEUROSCI, V34, P1724, DOI 10.1523/JNEUROSCI.2658-13.2014; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hahn E, 2011, SCHIZOPHR RES, V133, P218, DOI 10.1016/j.schres.2011.09.026; Helps SK, 2011, NEUROPSYCHOLOGY, V25, P711, DOI 10.1037/a0024479; Hervey AS, 2006, CHILD NEUROPSYCHOL, V12, P125, DOI 10.1080/09297040500499081; Johnson KA, 2008, NEUROPSYCHOLOGIA, V46, P1532, DOI 10.1016/j.neuropsychologia.2008.01.002; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P2234, DOI 10.1016/j.neuropsychologia.2007.02.019; Karalunas SL, 2013, J CHILD PSYCHOL PSYC, V54, P536, DOI 10.1111/jcpp.12028; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Klein C, 2006, BIOL PSYCHIAT, V60, P1088, DOI 10.1016/j.biopsych.2006.04.003; Klotz JM, 2012, CHILD NEUROPSYCHOL, V18, P576, DOI 10.1080/09297049.2011.625356; Kuntsi J, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-40; Leth-Steensen C, 2000, ACTA PSYCHOL, V104, P167, DOI 10.1016/S0001-6918(00)00019-6; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Rosch KS, 2013, J ABNORM CHILD PSYCH, V41, P485, DOI 10.1007/s10802-012-9690-z; Saville CWN, 2011, PERS INDIV DIFFER, V51, P148, DOI 10.1016/j.paid.2011.03.034; Scheres A, 2003, J ABNORM CHILD PSYCH, V31, P105, DOI 10.1023/A:1021729501230; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Tamm L, 2012, NEUROTHERAPEUTICS, V9, P500, DOI 10.1007/s13311-012-0138-5; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Wostmann NM, 2013, BRAIN COGNITION, V81, P82, DOI 10.1016/j.bandc.2012.09.010; Yue Y, 2015, BIOMED RES INT, V2015; YUE YY, 2015, BIOMED RES INT, DOI DOI 10.1155/2015/505479; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	42	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184476	10.1371/journal.pone.0184476	http://dx.doi.org/10.1371/journal.pone.0184476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910331	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200049
J	Mao, LP; Wang, YG; Wang, DL; Han, G; Fu, SZ; Wang, JX				Mao, Liping; Wang, Yueguo; Wang, Delin; Han, Gang; Fu, Shouzhong; Wang, Jianxin			TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma	PLOS ONE			English	Article							TIE2-EXPRESSING MONOCYTES; EXPRESSION	Background & aims Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) is prevalent worldwide. Despite its limitations, serum alpha-fetoprotein (AFP) remains the most widely-used bio-marker for the diagnosis of HCC. This study aimed to assess whether measurement of peripheral plasma Dickkopf-1 (DKK1) and Tie2-expressing monocytes (TEMs) could overcome the limitations of AFP and improve the diagnostic accuracy of HCC. Methods Plasma DKK1 level and the percentage of TEMs in peripheral CD14+CD16+monocytes from HCC patients (n = 82), HBV-related liver cirrhosis (LC) patients (n = 29), chronic hepatitis B (CHB) infected patients (n = 28) and healthy volunteers (n = 31) were analyzed by ELISA and flow cytometry. Receiver operating characteristic (ROC) curves were used to analyze a single biomarker, or a combination of two or three biomarkers. Univariate and multivariate analyses were performed to assess the significance of each marker in prediction of HCC and AFP-negative HCC from LC patients. Results The percentage of TEMs in peripheral CD14+CD16+monocytes and plasma level of DKK1 in HCC group were significantly higher than those in LC, CHB and healthy control groups (all P-values < 0.05). The percentage of TEMs alone was also significantly higher in AFP-negative HCC group than that in LC, CHB and healthy control groups (all P-values < 0.05). Plasma DKK1 level alone could not distinguish between AFP-negative HCC and LC patients. ROC curves showed that the optimal diagnostic cutoff value was 550.93 ng/L for DKK1 and 4.95% for TEMs. There was no significant difference in AUC of DKK1, TEMs and AFP in HCC diagnosis between the four groups (all P>0.05). A combination of DKK1, TEMs and AFP measurements increased the AUC for HCC diagnosis as compared with either marker alone (0.833; 95% CI 0.768-0.886). The AUC for TEMs was 0.692 (95% CI 0.564-0.819) in differentiating AFP-negative HCC from LC, with a sensitivity of 80.0% and a specificity of 65.52%. Only TEMs prevailed as a significant predictor for AFP-negative HCC differentiating from LC patients in univariate and multivariate analyses (P = 0.016, P = 0.023). Conclusions TEMs and DKK1 may prove to be potential complementary biomarkers for AFP in the diagnosis of HCC. TEMs rather than DKK1 could serve as a complementary biomarker for AFP in the differential diagnosis of AFP-negative HCC versus LC patients.	[Mao, Liping; Wang, Delin; Han, Gang] Nantong Univ, Affiliated Nantong Hosp 3, Dept Lab Med, Nantong, Jiangsu, Peoples R China; [Wang, Yueguo] Nantong Univ, Lab Med Ctr, Affiliated Hosp, Nantong, Jiangsu, Peoples R China; [Fu, Shouzhong] Nantong Univ, Affiliated Nantong Hosp 3, Dept Intervent, Nantong, Jiangsu, Peoples R China; [Wang, Jianxin] Nantong Univ, Affiliated Nantong Hosp 3, Dept Liver & Gall Surg, Nantong, Jiangsu, Peoples R China	Nantong University; Nantong University; Nantong University; Nantong University	Wang, YG (corresponding author), Nantong Univ, Lab Med Ctr, Affiliated Hosp, Nantong, Jiangsu, Peoples R China.	yueguowang@163.com			Project of "226 Project" of Nantong City [CR201401]	Project of "226 Project" of Nantong City	This study was funded by the Project of "226 Project" of Nantong City in 2014 (CR201401).	Chaiteerakij R, 2015, CLIN GASTROENTEROL H, V13, P237, DOI 10.1016/j.cgh.2013.10.038; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Daniele B, 2004, GASTROENTEROLOGY, V127, pS108, DOI 10.1053/j.gastro.2004.09.023; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; He YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143657; Jang ES, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151069; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Matsubara T, 2013, HEPATOLOGY, V57, P1416, DOI 10.1002/hep.25965; Ministry of Health of the People's Republic of China, 2011, J CLIN HEPATOL, V27, P1141; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Qian EN, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0332-3; Schauer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044450; Shen QJ, 2012, LANCET ONCOL, V13, P817, DOI 10.1016/S1470-2045(12)70233-4; Tanaka F, 2002, CANCER RES, V62, P7124; Ueland T, 2009, ARTERIOSCL THROM VAS, V29, P1228, DOI 10.1161/ATVBAHA.109.189761; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; Voorzanger-Rousselot N, 2009, BRIT J HAEMATOL, V145, P264, DOI 10.1111/j.1365-2141.2009.07587.x; Zhu WW, 2013, CLIN CANCER RES, V19, P3944, DOI 10.1158/1078-0432.CCR-12-3363	18	13	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183880	10.1371/journal.pone.0183880	http://dx.doi.org/10.1371/journal.pone.0183880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902891	gold, Green Published, Green Submitted			2022-12-27	WOS:000410669200022
J	Barreto-Vieira, DF; Jacome, FC; da Silva, MAN; Caldas, GC; de Filippis, AMB; de Sequeira, PC; de Souza, EM; Andrade, AA; Manso, PPD; Trindade, GF; Lima, SMB; Barth, OM				Barreto-Vieira, Debora Ferreira; Jacome, Fernanda Cunha; Nunes da Silva, Marcos Alexandre; Caldas, Gabriela Cardoso; Bispo de Filippis, Ana Maria; de Sequeira, Patricia Carvalho; de Souza, Elen Mello; Andrade, Audrien Alves; de Abreu Manso, Pedro Paulo; Trindade, Gisela Freitas; Barbosa Lima, Sheila Maria; Barth, Ortrud Monika			Structural investigation of C6/36 and Vero cell cultures infected with a Brazilian Zika virus	PLOS ONE			English	Article							DENGUE VIRUS; REPLICATION; VIROPLASM; FACTORIES	Zika virus (ZIKV) is a member of the flavivirus genus, and its genome is approximately 10.8 kilobases of positive-strand RNA enclosed in a capsid and surrounded by a membrane. Studies on the replication dynamics of ZIKV are scarce, which limits the development of antiviral agents and vaccines directed against ZIKV. In this study, Aedes albopictus mosquito lineage cells (C6/36 cells) and African green monkey kidney epithelial cells (Vero cells) were inoculated with a ZIKV sample isolated from a Brazilian patient, and the infection was characterized by immunofluorescence staining, phase contrast light microscopy, transmission electron microscopy and real-time RT-PCR. The infection was observed in both cell lineages, and ZIKV particles were observed inside lysosomes, the rough endoplasmic reticulum and viroplasm-like structures. The susceptibility of C6/36 and Vero cells to ZIKV infection was demonstrated. Moreover, this study showed that part of the replicative cycle may occur within viroplasm-like structures, which has not been previously demonstrated in other flaviviruses.	[Barreto-Vieira, Debora Ferreira; Jacome, Fernanda Cunha; Nunes da Silva, Marcos Alexandre; Caldas, Gabriela Cardoso; de Souza, Elen Mello; Andrade, Audrien Alves; Barth, Ortrud Monika] Fiocruz MS, Inst Oswaldo Cruz, Lab Morphol & Viral Morphogenesis, Ave Brasil, Rio De Janeiro, RJ, Brazil; [Bispo de Filippis, Ana Maria; de Sequeira, Patricia Carvalho] Fiocruz MS, Inst Oswaldo Cruz, Lab Flavivirus, Ave Brasil, Rio De Janeiro, RJ, Brazil; [de Abreu Manso, Pedro Paulo] Fiocruz MS, Inst Oswaldo Cruz, Lab Pathol, Ave Brasil, Rio De Janeiro, RJ, Brazil; [Trindade, Gisela Freitas; Barbosa Lima, Sheila Maria] Biomanguinhos, Lab Virol Technol, Ave Brasil, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Barreto-Vieira, DF (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Morphol & Viral Morphogenesis, Ave Brasil, Rio De Janeiro, RJ, Brazil.	barreto@ioc.fiocruz.br	de Abreu Manso, Pedro Paulo/M-7326-2018	de Abreu Manso, Pedro Paulo/0000-0002-7255-0429; Trindade, Gisela/0000-0002-1630-4143	Institute Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj; European Union's Horizon program [734857]; Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj	Institute Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj; European Union's Horizon program; Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj	This study was funded by Institute Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj, and Ana Maria Bispo de Filippis is supported by the European Union's Horizon 2020 program under grant agreement No. 734857. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Jose Farias Filho and Arthur da Costa Rasinhas for technical assistance, to the Electron Microscopy Platform of the Biology Institute, Universidade Federal Fluminense and to the Microscopy Platform of Rudolf Barth, Instituto Oswaldo Cruz, Fiocruz. Ana Maria Bispo de Filippis is supported by the European Union's Horizon 2020 program under grant agreement No. 734857.; Financial Support: Instituto Oswaldo Cruz, Fundacao Oswaldo Cruz, Faperj.	Altman LK, 2007, NY TIMES; Armstrong Najealicka, 2017, World J Virol, V6, P1, DOI 10.5501/wjv.v6.i1.1; Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107; Bak A, 2013, J VIROL, V87, P12207, DOI 10.1128/JVI.01883-13; Barreto-Vieira DF, 2015, INDIAN J APPL RES, V5, P44; Barreto-Vieira DF, 2016, MEM I O CRUZ, V111, P1; Barth O. M., 1999, Journal of Submicroscopic Cytology and Pathology, V31, P407; Barth OM, 1996, MEM I OSWALDO CRUZ, V91, P255, DOI 10.1590/S0074-02761996000200025; Barth OM, 2000, ATLAS DENGUE VIRUSES; Barth OM, 2016, MEM I OSWALDO CRUZ, V111, P411, DOI 10.1590/0074-02760150433; Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049; Calvet G, 2016, LANCET INFECT DIS; CHAN JFW, 2016, EMERG MICROBES INFEC, V5; Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014; Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Eichwald C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047947; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894; Grief C, 1997, ARCH VIROL, V142, P2347, DOI 10.1007/s007050050247; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332; Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049; Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217; Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016; Lindenbach B.D., 2007, FLAVIVIRIDAE VIRUSES; MAJEROWICZ S, 1994, MEM I OSWALDO CRUZ, V89, P395, DOI 10.1590/S0074-02761994000300018; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021; Netherton CL, 2011, CURR OPIN VIROL, V1, P381, DOI 10.1016/j.coviro.2011.09.008; Nikolay A, 2017, VACCINE; Novoa RR, 2005, BIOL CELL, V97, P147, DOI 10.1042/BC20040058; Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002; Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016; Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740; Sesso A., 2007, MANUAL TECNICAS BASI, P13; Sharma M, 2014, AUTOPHAGY, V10, P1637, DOI 10.4161/auto.29455; SINGH KRP, 1967, CURR SCI INDIA, V36, P506; Szajner P, 2001, J VIROL, V75, P5752, DOI 10.1128/JVI.75.13.5752-5761.2001; Tang BL, 2016, ARCH MICROBIOL, V13; Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0; Wei T, 2006, ARCH VIROL, V151, P1701, DOI 10.1007/s00705-006-0757-4; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; World Health Organization (WHO), 2016, HIST ZIK VIR; XIONG C, 1982, EMBO J, V1, P971, DOI 10.1002/j.1460-2075.1982.tb01280.x; Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206	53	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184397	10.1371/journal.pone.0184397	http://dx.doi.org/10.1371/journal.pone.0184397			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898286	gold, Green Published, Green Submitted			2022-12-27	WOS:000410449500025
J	Clark, A; Black, R; Tate, J; Roose, A; Kotloff, K; Lam, D; Blackwelder, W; Parashar, U; Lanata, C; Kang, G; Troeger, C; Platts-Mills, J; Mokdad, A; Sanderson, C; Lamberti, L; Levine, M; Santosham, M; Steele, D				Clark, Andrew; Black, Robert; Tate, Jacqueline; Roose, Anna; Kotloff, Karen; Lam, Diana; Blackwelder, William; Parashar, Umesh; Lanata, Claudio; Kang, Gagandeep; Troeger, Christopher; Platts-Mills, James; Mokdad, Ali; Sanderson, Colin; Lamberti, Laura; Levine, Myron; Santosham, Mathuram; Steele, Duncan		Global Rotavirus Surveillance	Estimating global, regional and national rotavirus deaths in children aged < 5 years: Current approaches, new analyses and proposed improvements	PLOS ONE			English	Article							ENTERIC MULTICENTER; DEVELOPING-COUNTRIES; DIARRHEAL DISEASE; YOUNG-CHILDREN; MORTALITY; BURDEN; GEMS; INFANTS	Background Rotavirus is a leading cause of diarrhoeal mortality in children but there is considerable disagreement about how many deaths occur each year. Methods and findings We compared CHERG, GBD and WHO/CDC estimates of age under 5 years (U5) rotavirus deaths at the global, regional and national level using a standard year (2013) and standard list of 186 countries. The global estimates were 157,398 (CHERG), 122,322 (GBD) and 215,757 (WHO/CDC). The three groups used different methods: (i) to select data points for rotavirus-positive proportions; (ii) to extrapolate data points to individual countries; (iii) to account for rotavirus vaccine coverage; (iv) to convert rotavirus-positive proportions to rotavirus attributable fractions; and (v) to calculate uncertainty ranges. We conducted new analyses to inform future estimates. We found that acute watery diarrhoea was associated with 87% (95% CI 83-90%) of U5 diarrhoea hospitalisations based on data from 84 hospital sites in 9 countries, and 65% (95% CI 57-74%) of U5 diarrhoea deaths based on verbal autopsy reports from 9 country sites. We reanalysed data from the Global Enteric Multicenter Study (GEMS) and found 44% (55% in Asia, and 32% in Africa) rotavirus-positivity among U5 acute watery diarrhoea hospitalisations, and 28% rotavirus-positivity among U5 acute watery diarrhoea deaths. 97% (95% CI 95-98%) of the U5 diarrhoea hospitalisations that tested positive for rotavirus were entirely attributable to rotavirus. For all clinical syndromes combined the rotavirus attributable fraction was 34% (95% CI 31-36%). This increased by a factor of 1.08 (95% CI 1.02-1.14) when the GEMS results were reanalysed using a more sensitive molecular test. Conclusions We developed consensus on seven proposals for improving the quality and transparency of future rotavirus mortality estimates.	[Clark, Andrew; Sanderson, Colin] London Sch Hyg & Trop Med, London, England; [Black, Robert; Santosham, Mathuram] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Tate, Jacqueline; Parashar, Umesh] Ctr Dis Control & Prevent, Atlanta, GA USA; [Roose, Anna; Kotloff, Karen; Lam, Diana; Blackwelder, William; Levine, Myron] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Lanata, Claudio] Inst Invest Nutr, Lima, Peru; [Lanata, Claudio] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Kang, Gagandeep] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Troeger, Christopher; Mokdad, Ali] Inst Hlth Metr & Evaluat, Seattle, WA USA; [Platts-Mills, James] Univ Virginia, Charlottesville, VA USA; [Global Rotavirus Surveillance] WHO, Geneva, Switzerland; [Lamberti, Laura; Steele, Duncan] Bill & Melinda Gates Fdn, Seattle, WA USA	University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; University System of Maryland; University of Maryland Baltimore; Vanderbilt University; Christian Medical College & Hospital (CMCH) Vellore; Institute for Health Metrics & Evaluation; University of Virginia; World Health Organization; Bill & Melinda Gates Foundation	Clark, A (corresponding author), London Sch Hyg & Trop Med, London, England.	andrew.clark@lshtm.ac.uk	Mokdad, Ali H./AAD-1232-2022; Sanderson, Colin F/O-9877-2014; kotloff, karen l/E-7768-2012	Mokdad, Ali H./0000-0002-4994-3339; kotloff, karen l/0000-0003-1808-6431; Steele, Andrew Duncan/0000-0002-4946-037X; Sanderson, Colin/0000-0002-4838-6112	Bill and Melinda Gates Foundation [OPP1147721]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	n We acknowledge funding from the Bill and Melinda Gates Foundation-www.gatesfoundation.org (Investment Code OPP1147721). ADS and LML were involved in the preparation of the manuscript and decision to publish.	Agocs M.M., 2014, MMWR-MORBID MORTAL W, V25. 63, P634; Alkema L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001288; BHANDARI N, 1992, ACTA PAEDIATR, V81, P3, DOI 10.1111/j.1651-2227.1992.tb12363.x; Blackwelder WC, 2012, CLIN INFECT DIS, V55, pS246, DOI 10.1093/cid/cis788; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; IHME, MORT EST PROC; IHME. GBD, 2013, CSV FIL IHME GBD 201; IHME. GBD, 2013, CSV FIL ROT CO UNPUB; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; Kovacs SD, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0728-4; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Liu J, 2016, LANCET, V388, P1291, DOI 10.1016/S0140-6736(16)31529-X; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Rahman AE, 2014, B WORLD HEALTH ORGAN, V92, P664, DOI 10.2471/BLT.13.134809; StataCorp, 2015, STAT STAT SOFTW REL; Stevens GA, 2016, LANCET; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Vos Theo B R, AUTHORS REPLY CORRES; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1	21	54	58	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0183392	10.1371/journal.pone.0183392	http://dx.doi.org/10.1371/journal.pone.0183392			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892480	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000410243200004
J	Flanagan, J; Bissot, T; Hours, MA; Moreno, B; Feugier, A; German, AJ				Flanagan, John; Bissot, Thomas; Hours, Marie-Anne; Moreno, Bernabe; Feugier, Alexandre; German, Alexander J.			Success of a weight loss plan for overweight dogs: The results of an international weight loss study	PLOS ONE			English	Article							OBESE DOGS; BODY-COMPOSITION; HIGH-PROTEIN; FOOD-INTAKE; RESTRICTION; MAINTENANCE; PROGRAMS; IMPROVES; LIFE	Introduction Obesity is a global concern in dogs with an increasing prevalence, and effective weight loss solutions are required that work in different geographical regions. The main objective was to conduct an international, multi-centre, weight loss trial to determine the efficacy of a dietary weight loss intervention in obese pet dogs. Methods A 3-month prospective observational cohort study of weight loss in 926 overweight dogs was conducted at 340 veterinary practices in 27 countries. Commercially available dry or wet weight loss diets were used, with the initial energy allocation being 250-335 kJ/kg target body weight 0.75/day (60-80 kcal/kg target body weight 0.75/day) depending on sex and neuter status. The primary outcome measure was percentage weight loss; the main secondary outcomes were changes in activity, quality of life, and food-seeking behaviour, which were subjectively determined from owner descriptions. Results At baseline, median (range) age was 74 (12 to 193) months and median body condition score was 8 (range 7-9). 896 of the 926 dogs (97%) lost weight, with mean weight loss being 11.4 +/- 5.84%. Sexually intact dogs lost more weight than neutered dogs (P = 0.001), whilst female dogs lost more weight than male dogs (P = 0.007), with the difference being more pronounced in North and South American dogs (median [Q1, Q3]: female: 11.5% [8.5%, 14.5%]; male: 9.1% [6.3%, 12.1%], P = 0.053) compared with those from Europe (female: 12.3% [8.9%, 14.9%]; male: 10.9% [8.6%, 15.4%]). Finally, subjective scores for activity (P<0.001) and quality of life (P<0.001) increased sequentially, whilst scores for food-seeking behaviour decreased sequentially (P<0.001) during the study. Conclusion This is the largest international multi-centre weight loss study conducted to date in obese dogs. Most dogs lost a clinically significant amount of weight, although there were notable differences between dogs of different sex, neuter status and in different geographical locations.	[Flanagan, John; Bissot, Thomas; Hours, Marie-Anne; Moreno, Bernabe; Feugier, Alexandre] Royal Canin Res Ctr, Aimargues, France; [German, Alexander J.] Univ Liverpool, Inst Ageing & Chron Dis, Neston, Cheshire, England; [German, Alexander J.] Univ Liverpool, Inst Vet Sci, Neston, Cheshire, England; [Bissot, Thomas] Montpellier Business Sch, Montpellier, France; [Moreno, Bernabe] IDEXX Europe BV, Hoofddorp, Netherlands	University of Liverpool; University of Liverpool; Montpellier Business School	German, AJ (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Neston, Cheshire, England.; German, AJ (corresponding author), Univ Liverpool, Inst Vet Sci, Neston, Cheshire, England.	ajgerman@liverpool.ac.uk		German, Alexander/0000-0002-3017-7988	Royal Canin	Royal Canin	The study was funded by Royal Canin to conduct the study. The funder provided support in the form of salaries for authors (JF, MAH, BM, AF) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions section.; AJG's academic post at the University of Liverpool is financially supported by Royal Canin. The authors acknowledge the assistance of Royal Canin staff and veterinary clinics involved in this study for their assistance in IT support, recruitment and follow-up of the enrolled dogs.	[Anonymous], 1985, THEORY PRACTICE ECON; Blanchard G, 2004, J NUTR, V134, p2148S, DOI 10.1093/jn/134.8.2148S; Brady RB, 2013, AM J VET RES, V74, P757, DOI 10.2460/ajvr.74.5.757; Butterwick RF, 1996, VET REC, V138, P354, DOI 10.1136/vr.138.15.354; Diez M, 2002, J NUTR, V132, p1685S, DOI 10.1093/jn/132.6.1685S; Floerchinger AM, 2015, JAVMA-J AM VET MED A, V247, P375, DOI 10.2460/javma.247.4.375; Gant P, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0642-7; German AJ, 2015, J VET INTERN MED, V29, P1547, DOI 10.1111/jvim.13629; German AJ, 2012, VET J, V192, P428, DOI 10.1016/j.tvjl.2011.09.015; German AJ, 2009, DOMEST ANIM ENDOCRIN, V37, P214, DOI 10.1016/j.domaniend.2009.07.001; German AJ, 2009, RES VET SCI, V87, P249, DOI 10.1016/j.rvsc.2009.02.007; German AJ, 2007, J VET INTERN MED, V21, P1174, DOI 10.1892/06-280.1; German AJ, 2006, J NUTR, V136, p1940S, DOI 10.1093/jn/136.7.1940S; German AJ, 2016, ACTA VET SCAND, V58, DOI 10.1186/s13028-016-0238-z; German AJ, 2010, VET J, V183, P294, DOI 10.1016/j.tvjl.2008.12.004; HOUPT KA, 1979, J AM VET MED ASSOC, V174, P1083; Hours MA, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0899-x; Jeusette I, 2004, J ANIM PHYSIOL AN N, V88, P117, DOI 10.1111/j.1439-0396.2003.00467.x; Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315; Laflamme D, 1997, CANINE PRACT, V22, P10; LAFLAMME DP, 1995, NUTR RES, V15, P1019, DOI 10.1016/0271-5317(95)00063-O; Marshall WG, 2010, VET RES COMMUN, V34, P241, DOI 10.1007/s11259-010-9348-7; Morrison R, 2014, J SMALL ANIM PRACT, V55, P566, DOI 10.1111/jsap.12273; Morrison R, 2013, J SMALL ANIM PRACT, V54, P570, DOI 10.1111/jsap.12142; Mosing M, 2013, VET J, V198, P367, DOI 10.1016/j.tvjl.2013.08.008; Saengsoi W, 2017, P 27 EUR COLL VET IN; Sargen H., 2016, BSAVA Congress 2016 Proceedings, 7-10 April 2016, Birmingham, UK, P471; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Tvarijonaviciute A, 2013, J VET INTERN MED, V27, P31, DOI 10.1111/jvim.12029; Tvarijonaviciute A, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-147; Vitger AD, 2016, JAVMA-J AM VET MED A, V248, P174, DOI 10.2460/javma.248.2.174; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Weber M, 2007, J VET INTERN MED, V21, P1203, DOI 10.1892/07-016.1; Yaissle JE, 2004, JAVMA-J AM VET MED A, V224, P1932, DOI 10.2460/javma.2004.224.1932; Yam PS, 2016, PREV VET MED, V127, P64, DOI 10.1016/j.prevetmed.2016.03.013	35	20	20	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184199	10.1371/journal.pone.0184199	http://dx.doi.org/10.1371/journal.pone.0184199			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886096	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100078
J	Krogsgaard, LW; Vestergaard, CH; Plana-Ripoll, O; Lutzen, TH; Vestergaard, M; Fenger-Gron, M; Bech, BH; Rytter, D				Krogsgaard, Lene Wulff; Vestergaard, Claus Hostrup; Plana-Ripoll, Oleguer; Lutzen, Tina Hovgaard; Vestergaard, Mogens; Fenger-Gron, Morten; Bech, Bodil Hammer; Rytter, Dorte			Health care utilization in general practice after HPV vaccination-A Danish nationwide register-based cohort study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINES; DENMARK; SYSTEM	Objective The Human Papillomavirus (HPV) vaccine has increasingly been suspected of adverse effects in Denmark since 2013. By using consultations with the general practitioner (GP) as an indicator for morbidity, this study aims to examine the association between HPV vaccination and morbidity in girls in the Danish childhood immunization program. Methods The study is a nationwide register-based cohort study. Both the HPV and the Measles, Mumps and Rubella (MMR) vaccines were offered to 12-year-old girls in Denmark in the study period (2008-2015). Therefore, both vaccines were included as exposures to allow differentiation between potential effects. This resulted in four exposure groups: HPV only vaccinated, HPV+MMR vaccinated, MMR only vaccinated, and Non-vaccinated girls. Outcomes were: daytime consultation rates and frequent GP attendance (>7 annual GP consultations). We estimated consultation rates by negative binomial regressions analysis and frequent GP attendance by logistic regression analysis. Both analyses were stratified on the years 2008-2013 versus 2014. Results The study included 214,240 girls born in 1996-2002. All vaccinated groups consulted the GP more often than the non-vaccinated group, both before and after the vaccination. After the vaccination, an increase in consultations was observed for all three vaccinated groups; most distinct for girls vaccinated in 2014. For girls vaccinated before 2014, we found a slightly higher risk of frequent GP attendance after vaccination in the HPV only group compared to the non-vaccinated group, whereas in 2014, frequent GP attendance was seen for all three vaccinated groups; most substantial for the MMR only vaccinated group. Conclusion In this study, no exclusive increase in health care utilization was detected after HPV vaccination. However, a general difference in the health care utilization pattern was found between vaccinated and non-vaccinated girls, which increased after the time of vaccination, primarily for girls vaccinated after 2013.	[Krogsgaard, Lene Wulff; Vestergaard, Claus Hostrup; Vestergaard, Mogens; Fenger-Gron, Morten; Bech, Bodil Hammer] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark; [Krogsgaard, Lene Wulff; Lutzen, Tina Hovgaard; Bech, Bodil Hammer; Rytter, Dorte] Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, Aarhus, Denmark; [Plana-Ripoll, Oleguer] Aarhus Univ, Aarhus BSS, Natl Ctr Register Based Res, Aarhus, Denmark; [Vestergaard, Mogens] Aarhus Univ, Dept Publ Hlth, Sect Gen Med Practice, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Krogsgaard, LW (corresponding author), Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark.; Krogsgaard, LW (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Epidemiol, Aarhus, Denmark.	l.krogsgaard@ph.au.dk	Bech, Bodil Hammer/B-9646-2016; Randrup, Tina/GWV-3271-2022; Plana-Ripoll, Oleguer/E-1448-2015	Bech, Bodil Hammer/0000-0002-0287-3687; Plana-Ripoll, Oleguer/0000-0002-6470-7465; Vestergaard, Claus Hostrup/0000-0003-2916-1548; Krogsgaard, Lene/0000-0002-3936-6240; Rytter, Dorte/0000-0003-1518-0975; Fenger-Gron, Morten/0000-0002-6354-5871; Lutzen, Tina/0000-0002-5384-2557	Program for Clinical Research Infrastructure (PROCRIN)	Program for Clinical Research Infrastructure (PROCRIN)	This work was supported by the Program for Clinical Research Infrastructure (PROCRIN), which was established by the Lundbeck Foundation and Novo Nordisk Foundation and administrated by Danish Regions. The funder had no role in study design, data Collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; [Anonymous], 2015, WKLY EPIDEMIOL REC, V91, P21; Brinth L, 2015, DAN MED J, V62; Brinth LS, 2015, VACCINE, V33, P2602, DOI 10.1016/j.vaccine.2015.03.098; Christiansen T, 2002, HEALTH POLICY, V59, P107, DOI 10.1016/S0168-8510(01)00201-9; Danish Health and Medicines Authority, 2015, REP DAN HLTH MED AUT; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Garland SM, 2016, CLIN INFECT DIS, V63, P519, DOI 10.1093/cid/ciw354; Geier DA, 2016, IMMUNOL RES; Hequet D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172906; Holt N, 2017, DAN MED J, V64; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pedersen KM, 2012, J AM BOARD FAM MED, V25, pS34, DOI 10.3122/jabfm.2012.02.110216; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Stanley M, 2012, VACCINE, V30, pF83, DOI 10.1016/j.vaccine.2012.04.106; Stanley Margaret, 2010, Infect Agent Cancer, V5, P19, DOI 10.1186/1750-9378-5-19; Statens Serum Institut, 2008, HPV VACC CHILDH VACC; Stillo M, 2015, EXPERT OPIN DRUG SAF, V14, P697, DOI 10.1517/14740338.2015.1013532; Svahn MF, 2016, SCAND J PUBLIC HEALT, V44, P551, DOI 10.1177/1403494816653669; The Danish Health Authority, 2017, DAN CHILDH VACC PROG; Vichnin M, 2015, PEDIATR INFECT DIS J, V34, P983, DOI 10.1097/INF.0000000000000793; WHO, 2016, HUMAN PAPILLOMAVIRUS, DOI 10.12968/indn.2020.2.20; WHO, 2016, GLOB ADV COMM VACC S; Willame C, 2016, HUM VACCIN IMMUNOTHE, V18	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184658	10.1371/journal.pone.0184658	http://dx.doi.org/10.1371/journal.pone.0184658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886180	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100174
J	Liu, HQ; Zhang, CS; Fan, XX; Duan, YN; Xiao, TQ; Du, GH; Fu, YN; Liu, HG; Wen, H				Liu, Huiqiang; Zhang, Chuanshan; Fan, Xiaoxi; Duan, Yingni; Xiao, Tiqiao; Du, Guohao; Fu, Yanan; Liu, Haigang; Wen, Hao			Robust phase-retrieval-based X-ray tomography for morphological assessment of early hepatic echinococcosis infection in rats	PLOS ONE			English	Article							ALVEOLAR ECHINOCOCCOSIS; CONTRAST TOMOGRAPHY; ATTENUATION DUALITY; FRESNEL REGION; MICROTOMOGRAPHY; HOLOTOMOGRAPHY; OPTIMIZATION; ULTRASOUND; LIVER; IMAGE	Propagation-based phase-contrast computed micro-tomography (PPCT) dominates the non-destructive, three-dimensional inner-structure measurement in synchrotron-based biomedical research due to its simple experimental setup. To quantitatively visualize tiny density variations in soft tissues and organs closely related to early pathological morphology, an experimental study of synchrotron-based X-ray PPCT combined with generalized phase and attenuation duality (PAD) phase retrieval was implemented with the hepatic echinococcosis (HE) infection rat model at different stages. We quantitatively analyzed and evaluated the different pathological characterizations of hepatic echinococcosis during the development of this disease via our PAD-based PPCT and especially provided evidence that hepatic alveolar echinococcosis invades the liver tissue and spreads through blood flow systems with abundant blood supply in the early stage. Additionally, the infiltration of tiny vesicles in HE lesions can be clearly observed by our PAD-PPCT technique due to the striking contrast-to-noise ratio (CNR) and mass density resolution, which cannot be found by the medical imaging techniques, such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound, in hospitals. The results demonstrated that our PAD-PPCT technique has a great potential for indicating the subtle structural information of pathological changes in soft biomedical specimens, especially helpful for the research of early micromorphology of diseases.	[Liu, Huiqiang; Fan, Xiaoxi; Duan, Yingni] Xinjiang Med Univ, Coll Med Engn & Technol, Urumqi, Peoples R China; [Zhang, Chuanshan; Wen, Hao] Xinjiang Med Univ, State Key Lab Incubat Base Xinjiang Major Dis Res, Affiliated Hosp 1, Urumqi, Peoples R China; [Xiao, Tiqiao; Du, Guohao; Fu, Yanan; Liu, Haigang] Chinese Acad Sci, Shanghai Inst Appl Phys, SSRF, Shanghai, Peoples R China	Xinjiang Medical University; Xinjiang Medical University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Liu, HQ (corresponding author), Xinjiang Med Univ, Coll Med Engn & Technol, Urumqi, Peoples R China.; Wen, H (corresponding author), Xinjiang Med Univ, State Key Lab Incubat Base Xinjiang Major Dis Res, Affiliated Hosp 1, Urumqi, Peoples R China.; Liu, HG (corresponding author), Chinese Acad Sci, Shanghai Inst Appl Phys, SSRF, Shanghai, Peoples R China.	hqliu@xjmu.edu.cn; liuhaiguang@sinap.ac.cn; dr.wenhao@163.com			National Natural Science Foundation of China [81660306]; Postdoctoral Science Foundation of Xinjiang Medical University; Technology Foundation for Selected Overseas Chinese Scholar	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Science Foundation of Xinjiang Medical University; Technology Foundation for Selected Overseas Chinese Scholar	This work was supported by the National Natural Science Foundation of China (Grant No. 81660306) to HQL, Postdoctoral Science Foundation of Xinjiang Medical University, and the Technology Foundation for Selected Overseas Chinese Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi A, 2015, ABDOM IMAGING, V40, P56, DOI 10.1007/s00261-014-0183-0; Bech M, 2010, Z MED PHYS, V20, P7, DOI 10.1016/j.zemedi.2009.11.003; Bresson-Hadni S, 2006, PARASITOL INT, V55, pS267, DOI 10.1016/j.parint.2005.11.053; Caoduro C, 2013, J NUCL MED, V54, P358, DOI 10.2967/jnumed.112.109942; Ceballos L, 2008, PARASITOL RES, V103, P355, DOI 10.1007/s00436-008-0980-x; Cloetens P, 1999, APPL PHYS LETT, V75, P2912, DOI 10.1063/1.125225; Cloetens P, 2006, P NATL ACAD SCI USA, V103, P14626, DOI 10.1073/pnas.0603490103; Coskun A, 2004, ACTA RADIOL, V45, P492, DOI 10.1080/02841850410005912; Czermak BV, 2001, AM J ROENTGENOL, V176, P1207, DOI 10.2214/ajr.176.5.1761207; Donald PM, 2011, PARASITE VECTOR, V4, P196; Engelhardt M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2743928; Groso A, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2207221; Groso A, 2006, OPT EXPRESS, V14, P8103, DOI 10.1364/OE.14.008103; Guigay JP, 2007, OPT LETT, V32, P1617, DOI 10.1364/OL.32.001617; Gureyev TE, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2226794; Gureyev TE, 2004, OPT COMMUN, V231, P53, DOI 10.1016/j.optcom.2003.12.020; Kern P, 2003, EMERG INFECT DIS, V9, P343, DOI 10.3201/eid0903.020341; Lang S, 2014, J APPL PHYS, V116, DOI 10.1063/1.4897225; Langer M, 2010, IEEE T IMAGE PROCESS, V19, P2428, DOI 10.1109/TIP.2010.2048608; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Liu HQ, 2015, MED PHYS, V42, P5595, DOI 10.1118/1.4929551; Liu HQ, 2015, APPL OPTICS, V54, P5610, DOI 10.1364/AO.54.005610; Liu HQ, 2012, CHIN OPT LETT, V10, DOI 10.3788/COL201210.121101; Liu Y, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/49/494001; Lovric G, 2014, OPT EXPRESS, V22, P2745, DOI 10.1364/OE.22.002745; Myers GR, 2007, J OPT SOC AM A, V24, P2516, DOI 10.1364/JOSAA.24.002516; Nesterets YI, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.2038107; Paganin D, 2002, J MICROSC-OXFORD, V206, P33, DOI 10.1046/j.1365-2818.2002.01010.x; Pfeiffer F, 2008, NAT MATER, V7, P134, DOI 10.1038/nmat2096; Pfeiffer F, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168101; Piscaglia F, 2010, ULTRASOUND MED BIOL, V36, P531, DOI 10.1016/j.ultrasmedbio.2010.01.004; Reuter S, 2008, NUKLEARMED-NUCL MED, V47, P147, DOI 10.3413/nukmed-0139; Revol V, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3465334; Satoshi T, 2007, APPL PHYS LETT, V90; Thuering T, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3618672; Wu XZ, 2003, J X-RAY SCI TECHNOL, V11, P33; Wu XZ, 2009, OPT EXPRESS, V17, P11187, DOI 10.1364/OE.17.011187; Wu XZ, 2008, EUR J RADIOL, V68, pS8, DOI 10.1016/j.ejrad.2008.04.027; Wu XZ, 2005, OPT LETT, V30, P379, DOI 10.1364/OL.30.000379; Yang YR, 2007, TROP MED INT HEALTH, V12, P637, DOI 10.1111/j.1365-3156.2007.01834.x; Zanette I, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4848595; Zeng HC, 2012, ULTRASOUND MED BIOL, V38, P1982, DOI 10.1016/j.ultrasmedbio.2012.07.007; Zhou T, 2014, P SOC PHOTO-OPT INS, V9033, P131	43	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183396	10.1371/journal.pone.0183396	http://dx.doi.org/10.1371/journal.pone.0183396			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886025	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100020
J	Quinn, KM; Kan, WT; Watson, KA; Liddicoat, BJ; Swan, NG; McQuilten, H; Denton, AE; Li, J; Chen, W; Brown, LE; Jackson, DC; Reading, PC; Doherty, PC; Kedzierska, K; Kedzierski, L; Turner, SJ; La Gruta, NL				Quinn, Kylie M.; Kan, Wan-Ting; Watson, Katherine A.; Liddicoat, Brian J.; Swan, Natasha G.; McQuilten, Hayley; Denton, Alice E.; Li, Jasmine; Chen, Weisan; Brown, Lorena E.; Jackson, David C.; Reading, Patrick C.; Doherty, Peter C.; Kedzierska, Katherine; Kedzierski, Lukasz; Turner, Stephen J.; La Gruta, Nicole L.			Extrinsically derived TNF is primarily responsible for limiting antiviral CD8+T cell response magnitude	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CD8(+) T-CELLS; INFLUENZA INFECTION; DEFICIENT MICE; ALPHA; IMMUNOPATHOLOGY; CYTOKINE; LUNG; INFLAMMATION; LYMPHOTOXIN	TNF is a pro-inflammatory cytokine produced by both lymphoid and non-lymphoid cells. As a consequence of the widespread expression of its receptors (TNFR1 and 2), TNF plays a role in many important biological processes. In the context of influenza A virus (IAV) infection, TNF has variably been implicated in mediating immunopathology as well as suppression of the immune response. Although a number of cell types are able to produce TNF, the ability of CD8(+) T cells to produce TNF following viral infection is a hallmark of their effector function. As such, the regulation and role of CD8(+) T cell-derived TNF following viral infection is of great interest. Here, we show that the biphasic production of TNF by CD8(+) T cells following in vitro stimulation corresponds to distinct patterns of epigenetic modifications. Further, we show that a global loss of TNF during IAV infection results in an augmentation of the peripheral virus-specific CD8+ T cell response. Subsequent adoptive transfer experiments demonstrated that this attenuation of the CD8(+) T cell response was largely, but not exclusively, conferred by extrinsic TNF, with intrinsically-derived TNF making only modest contributions. In conclusion, TNF exerts an immunoregulatory role on CD8(+) T cell responses following IAV infection, an effect that is largely mediated by extrinsically-derived TNF.	[Quinn, Kylie M.; Li, Jasmine; Turner, Stephen J.; La Gruta, Nicole L.] Monash Univ, Infect & Immun Program, Clayton, Vic, Australia; [Quinn, Kylie M.; Li, Jasmine; Turner, Stephen J.; La Gruta, Nicole L.] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia; [Kan, Wan-Ting; Watson, Katherine A.; Liddicoat, Brian J.; Swan, Natasha G.; McQuilten, Hayley; Denton, Alice E.; Brown, Lorena E.; Jackson, David C.; Reading, Patrick C.; Doherty, Peter C.; Kedzierska, Katherine; Turner, Stephen J.; La Gruta, Nicole L.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia; [Chen, Weisan] La Trobe Univ, Sch Mol Sci, T Cell Lab, Bundoora, Vic, Australia; [Doherty, Peter C.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Kedzierski, Lukasz] Univ Melbourne, Fac Vet & Agr Sci, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia; [Watson, Katherine A.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Liddicoat, Brian J.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Denton, Alice E.] Babraham Inst, Babraham Res Campus, Cambridge, England	Monash University; Monash University; University of Melbourne; La Trobe University; St Jude Children's Research Hospital; University of Melbourne; Walter & Eliza Hall Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	La Gruta, NL (corresponding author), Monash Univ, Infect & Immun Program, Clayton, Vic, Australia.; La Gruta, NL (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia.; La Gruta, NL (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia.	Nicole.la.gruta@monash.edu	Quinn, Kylie/AAJ-5066-2021; Turner, Stephen/GXM-4654-2022	Reading, Patrick/0000-0002-8860-5308; Jackson, David/0000-0001-7255-270X; Brown, Lorena/0000-0001-9342-909X; La Gruta, Nicole/0000-0001-5358-9363; Denton, Alice/0000-0002-4580-3443; Turner, Stephen/0000-0002-1002-0000; Quinn, Kylie/0000-0002-0417-3625; Kedzierska, Katherine/0000-0001-6141-335X; McQuilten, Hayley/0000-0002-7089-5300	Australian National Health and Medical Research Council (NHMRC) [APP1071916]; Sylvia and Charles Viertel Senior Medical Research Fellowship	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Senior Medical Research Fellowship	This work was supported by Australian National Health and Medical Research Council (NHMRC) funding (APP1071916). and a Sylvia and Charles Viertel Senior Medical Research Fellowship awarded to N.L.L.G.; This work was supported by Australian National Health and Medical Research Council (NHMRC) funding (APP1071916). and a Sylvia and Charles Viertel Senior Medical Research Fellowship awarded to N.L.L.G.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; ALLAN W, 1990, J IMMUNOL, V144, P3980; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; Damjanovic D, 2011, AM J PATHOL, V179, P2963, DOI 10.1016/j.ajpath.2011.09.003; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; DeBerge MP, 2014, J IMMUNOL, V192, P5839, DOI 10.4049/jimmunol.1302729; Denton AE, 2011, P NATL ACAD SCI USA, V108, P15306, DOI 10.1073/pnas.1112520108; Gaeta ML, 2000, LAB INVEST, V80, P1185, DOI 10.1038/labinvest.3780126; Grell M, 1996, J INFLAMM, V47, P8; Hussell T, 2001, EUR J IMMUNOL, V31, P2566, DOI 10.1002/1521-4141(200109)31:9<2566::AID-IMMU2566>3.0.CO;2-L; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Kuprash DV, 2002, MOL CELL BIOL, V22, P8626, DOI 10.1128/MCB.22.24.8626-8634.2002; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; MARASKOVSKY E, 1992, INT IMMUNOL, V4, P475, DOI 10.1093/intimm/4.4.475; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Matikainen S, 2006, J VIROL, V80, P3515, DOI 10.1128/JVI.80.7.3515-3522.2006; Morty RE, 2007, INTENS CARE MED, V33, P1229, DOI 10.1007/s00134-007-0662-7; Muller S, 2009, EUR J IMMUNOL, V39, P3171, DOI 10.1002/eji.200939554; Nolz JC, 2015, CELL MOL LIFE SCI, V72, P2461, DOI 10.1007/s00018-015-1835-0; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; PEPER RL, 1995, MICROB PATHOGENESIS, V19, P175, DOI 10.1006/mpat.1995.0056; Pfeffer K, 2003, CYTOKINE GROWTH F R, V14, P185, DOI 10.1016/S1359-6101(03)00022-4; Richter MV, 2007, J IMMUNOL, V179, P5054, DOI 10.4049/jimmunol.179.8.5054; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; SARIN A, 1995, J IMMUNOL, V155, P3716; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Singh A, 2007, J LEUKOCYTE BIOL, V82, P1201, DOI 10.1189/jlb.0407240; Szretter KJ, 2007, J VIROL, V81, P2736, DOI 10.1128/JVI.02336-06; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Turner SJ, 2004, P NATL ACAD SCI USA, V101, P3545, DOI 10.1073/pnas.0307347101; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wortzman ME, 2013, PLOS ONE, V8; Xu LM, 2004, J IMMUNOL, V173, P721, DOI 10.4049/jimmunol.173.2.721	36	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184732	10.1371/journal.pone.0184732	http://dx.doi.org/10.1371/journal.pone.0184732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886201	Green Published, gold			2022-12-27	WOS:000410001100184
J	Wang, Z; Chang, HH; Gao, YL; Zhang, R; Guo, YM; Holschneider, DP; Rodriguez, LV				Wang, Zhuo; Chang, Harriet H.; Gao, Yunliang; Zhang, Rong; Guo, Yumei; Holschneider, Daniel P.; Rodriguez, Larissa V.			Effects of water avoidance stress on peripheral and central responses during bladder filling in the rat: A multidisciplinary approach to the study of urologic chronic pelvic pain syndrome (MAPP) research network study	PLOS ONE			English	Article							CEREBRAL BLOOD-FLOW; FUNCTIONAL CONNECTIVITY; RESTING-STATE; INTERSTITIAL CYSTITIS; URINARY-BLADDER; INDICATOR FRACTIONATION; SENSORIMOTOR CORTEX; BARRINGTONS NUCLEUS; OVERACTIVE BLADDER; REFLEX MICTURITION	Stress plays a role in the exacerbation and possibly the development of functional lower urinary tract disorders. Chronic water avoidance stress (WAS) in rodents is a model with high construct and face validity to bladder hypersensitive syndromes, such as interstitial cystitis/bladder pain syndrome (IC/BPS), characterized by urinary frequency and bladder hyperalgesia and heightened stress responsiveness. Given the overlap of the brain circuits involved in stress, anxiety, and micturition, we evaluated the effects chronic stress has on bladder function, as well as its effects on regional brain activation during bladder filling. Female Wistar-Kyoto rats were exposed to WAS (10 days) or sham paradigms. One day thereafter, cystometrograms were obtained during titrated bladder dilation, with visceromotor responses (VMR) recorded simultaneously. Cerebral perfusion was assessed during passive bladder distension (20-cmH(2)O) following intravenous administration of [C-14]-iodoantipyrine. Regional cerebral blood flow was quantified by autoradiography and analyzed in 3-dimensionally reconstructed brains with statistical parametric mapping. WAS animals compared to controls demonstrated a decreased pressure threshold and visceromotor threshold triggering the voiding phase. At 20-cmH(2)O, VMR was significantly greater in WAS animals compared to controls. WAS animals showed greater activation in cortical regions of the central micturition circuit, including the posterior cingulate, anterior retrosplenial, somatosensory, posterior insula, orbital, and anterior secondary ("supplementary") motor cortices, as well as in the thalamus, anterior hypothalamus, parabrachial and Barrington nuclei, and striatum. Seed analysis showed increased functional connectivity of WAS compared to control animals of the posterior cingulate cortex to the pontine parabrachial nucleus; of the Barrington nucleus to the anterior dorsal midline and ventrobasilar thalamus and somatosensory and retrosplenial cortices; and of the posterior insula to anterior secondary motor cortex. Our findings show a visceral hypersensitivity during bladder filling in WAS animals, as well as increased engagement of portions of the micturition circuit responsive to urgency, viscerosensory perception and its relay to motor regions coordinating imminent bladder contraction. Results are consistent with recent findings in patients with interstitial cystitis, suggesting that WAS may serve as an animal model to elucidate the mechanisms leading to viscerosensitive brain phenotypes in humans with IC/BPS.	[Wang, Zhuo; Guo, Yumei; Holschneider, Daniel P.] Univ Southern Calif, Dept Psychiat & Behav Sci, Los Angeles, CA 90007 USA; [Chang, Harriet H.; Gao, Yunliang; Zhang, Rong; Rodriguez, Larissa V.] Univ Southern Calif, Dept Urol, Los Angeles, CA USA; [Gao, Yunliang] Cent S Univ, Xiangya Hosp 2, Dept Urol, Changsha, Hunan, Peoples R China	University of Southern California; University of Southern California; Central South University	Holschneider, DP (corresponding author), Univ Southern Calif, Dept Psychiat & Behav Sci, Los Angeles, CA 90007 USA.; Rodriguez, LV (corresponding author), Univ Southern Calif, Dept Urol, Los Angeles, CA USA.	lrodriguez@med.usc.edu; holschne@usc.edu		Wang, Zhuo/0000-0003-1531-8065; Holschneider, Daniel/0000-0002-4297-8280	MAPP Research Network grant from the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH) [U01 DK082370]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK082370] Funding Source: NIH RePORTER	MAPP Research Network grant from the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by a MAPP Research Network grant (U01 DK082370) from the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH).	Ackerman AL, 2016, AM J PHYSIOL-RENAL, V310, pF628, DOI 10.1152/ajprenal.00297.2015; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Asavasopon S, 2014, J NEUROSCI, V34, P13811, DOI 10.1523/JNEUROSCI.2073-14.2014; Baek K, 2016, BRAIN STRUCT FUNCT, V221, P2801, DOI 10.1007/s00429-015-1073-0; Blok BFM, 1998, BRAIN, V121, P2033, DOI 10.1093/brain/121.11.2033; Brett M, 2002, NEUROIMAGE; Rodriguez MAB, 2013, J UROLOGY, V189, pS66, DOI 10.1016/j.juro.2012.11.019; Cagnie B, 2014, SEMIN ARTHRITIS RHEU, V44, P68, DOI 10.1016/j.semarthrit.2014.01.001; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; CHEN SY, 1993, AM J PHYSIOL, V265, pF520, DOI 10.1152/ajprenal.1993.265.4.F520; Clemens JQ, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-57; Clemens JQ, 2005, J UROLOGY, V173, P98, DOI 10.1097/01.ju.0000146114.53828.82; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; de Groat WC, 2013, ACTA PHYSIOL, V207, P66, DOI 10.1111/apha.12014; de Groat William C, 2015, Handb Clin Neurol, V130, P61, DOI 10.1016/B978-0-444-63247-0.00005-5; Deen B, 2011, CEREB CORTEX, V21, P1498, DOI 10.1093/cercor/bhq186; Deutsch G, 2016, J UROLOGY, V196, P902, DOI 10.1016/j.juro.2016.03.135; Duval ER, 2015, THER CLIN RISK MANAG, V11, P115, DOI 10.2147/TCRM.S48528; Friston K and the Methodology group at the Wellcome Dept. of Cognitive Neurology, 1999, STATISTICAL PARAMETR; GOLDMAN H, 1973, AM J PHYSIOL, V224, P122, DOI 10.1152/ajplegacy.1973.224.1.122; Griffiths D, 2005, J UROLOGY, V174, P1862, DOI 10.1097/01.ju.0000177450.34451.97; Griffiths Derek, 2015, Handb Clin Neurol, V130, P121, DOI 10.1016/B978-0-444-63247-0.00007-9; Hampson JP, 2013, J PAIN, V14, P579, DOI 10.1016/j.jpain.2013.01.767; Herms AMRD, 2006, NEUROIMAGE, V29, P267, DOI 10.1016/j.neuroimage.2005.07.018; Holschneider DP, 2002, AM J PHYSIOL-HEART C, V283, pH1713, DOI 10.1152/ajpheart.00362.2002; JONES SC, 1991, J CEREBR BLOOD F MET, V11, P236, DOI 10.1038/jcbfm.1991.55; Jung SC, 2004, NEUROREPORT, V15, P1405, DOI 10.1097/01.wnr.0000131008.36444.2d; Kalthoff D, 2013, NMR BIOMED, V26, P638, DOI 10.1002/nbm.2908; Kilpatrick LA, 2014, J UROLOGY, V192, P947, DOI 10.1016/j.juro.2014.03.093; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; KRUSE MN, 1990, BRAIN RES, V532, P182, DOI 10.1016/0006-8993(90)91758-9; Kuhtz-Buschbeck JP, 2007, NEUROIMAGE, V35, P449, DOI 10.1016/j.neuroimage.2006.12.032; Kuhtz-Buschbeck JR, 2009, NEUROIMAGE, V47, P18, DOI 10.1016/j.neuroimage.2009.04.020; Kutch JJ, 2015, NEUROIMAGE-CLIN, V8, P493, DOI 10.1016/j.nicl.2015.05.013; Lai H, 2015, UROLOGY, V85, P1454, DOI 10.1016/j.urology.2015.03.007; Lee UJ, 2015, PHYSIOL BEHAV, V139, P541, DOI 10.1016/j.physbeh.2014.11.045; Legrain V, 2011, PROG NEUROBIOL, V93, P111, DOI 10.1016/j.pneurobio.2010.10.005; Levinthal DJ, 2012, J NEUROSCI, V32, P6726, DOI 10.1523/JNEUROSCI.0406-12.2012; Lim JR, 2007, SCAND J UROL NEPHROL, V41, P403, DOI 10.1080/00365590701303702; LUMB BM, 1987, BRAIN RES, V435, P363, DOI 10.1016/0006-8993(87)91626-X; Lutgendorf SK, 2000, J UROLOGY, V164, P1265, DOI 10.1016/S0022-5347(05)67152-2; MACAULAY AJ, 1987, BRIT MED J, V294, P540, DOI 10.1136/bmj.294.6571.540; Magnuson ME, 2014, NMR BIOMED, V27, P291, DOI 10.1002/nbm.3062; MALLORY BS, 1991, BRAIN RES, V546, P310, DOI 10.1016/0006-8993(91)91495-M; Martin C, 2006, NEUROIMAGE, V32, P33, DOI 10.1016/j.neuroimage.2006.02.021; Martucci KT, 2015, PAIN, V156, P1755, DOI 10.1097/j.pain.0000000000000238; Mayer EA, 2001, AM J PHYSIOL-GASTR L, V280, pG519, DOI 10.1152/ajpgi.2001.280.4.G519; Mayer EA, 2015, PAIN, V156, pS50, DOI 10.1097/j.pain.0000000000000106; Melzack R., 2005, PAIN PRACT, V5, P85, DOI DOI 10.1111/J.1533-2500.2005.05203.X; Monconduit L, 1999, J NEUROSCI, V19, P9063, DOI 10.1523/JNEUROSCI.19-20-09063.1999; Nardos R, 2014, NEUROUROL URODYNAM, V33, P493, DOI 10.1002/nau.22458; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE FOR THE CARE A; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Ness TJ, 2001, J UROLOGY, V165, P968, DOI 10.1016/S0022-5347(05)66586-X; Nguyen PT, 2004, NEUROIMAGE, V23, P252, DOI 10.1016/j.neuroimage.2004.05.014; Nickel JC, 2010, J UROLOGY, V184, P1358, DOI 10.1016/j.juro.2010.06.005; Nickel JC, 2010, J UROLOGY, V183, P167, DOI 10.1016/j.juro.2009.08.133; Nickel JC, 2009, J UROLOGY, V182, P155, DOI 10.1016/j.juro.2009.02.122; Otake K, 1996, NEUROSCI LETT, V209, P97, DOI 10.1016/0304-3940(96)12609-4; PATLAK CS, 1984, J CEREBR BLOOD F MET, V4, P47, DOI 10.1038/jcbfm.1984.7; Paxinos G., 2007, THE RAT BRAIN IN STE; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Robbins MT, 2006, J PAIN, V7, P218, DOI 10.1016/j.jpain.2005.10.012; Rogers R, 2008, INT UROGYNECOL J, V19, P1551, DOI 10.1007/s00192-008-0688-6; Rothrock NE, 2001, UROLOGY, V57, P422, DOI 10.1016/S0090-4295(00)00988-2; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Sadler KE, 2016, J UROL; SAKURADA O, 1978, AM J PHYSIOL, V234, pH59, DOI 10.1152/ajpheart.1978.234.1.H59; Seseke S, 2006, NEUROIMAGE, V31, P1399, DOI 10.1016/j.neuroimage.2006.02.012; SIEVERT CF, 1986, BRAIN RES, V381, P15, DOI 10.1016/0006-8993(86)90684-0; Smith AL, 2011, UROLOGY, V78, DOI 10.1016/j.urology.2011.06.041; Tadic SD, 2010, J UROLOGY, V183, P221, DOI 10.1016/j.juro.2009.08.155; Tai CF, 2009, J NEUROPHYSIOL, V102, P2719, DOI 10.1152/jn.00700.2009; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Valentino RJ, 1995, J COMP NEUROL, V363, P402, DOI 10.1002/cne.903630306; VANUITERT RL, 1978, STROKE, V9, P67, DOI 10.1161/01.STR.9.1.67; Vertes RP, 2015, NEUROSCI BIOBEHAV R, V54, P89, DOI 10.1016/j.neubiorev.2015.01.014; Wang Z, 2009, PAIN, V145, P120, DOI 10.1016/j.pain.2009.05.025; Zeng JW, 2012, J UROLOGY, V188, P1027, DOI 10.1016/j.juro.2012.04.101; Zhang H, 2005, NEUROIMAGE, V24, P174, DOI 10.1016/j.neuroimage.2004.08.027	80	29	30	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182976	10.1371/journal.pone.0182976	http://dx.doi.org/10.1371/journal.pone.0182976			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886046	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100014
J	Olsen, JR; Mitchell, R; Ogilvie, D				Olsen, Jonathan R.; Mitchell, Richard; Ogilvie, David		M74 Study Team	Effect of a new motorway on social-spatial patterning of road traffic accidents: A retrospective longitudinal natural experimental study	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; ENVIRONMENTAL JUSTICE; TEMPORAL ANALYSIS; CASUALTIES; CRASHES; IDENTIFICATION; BEHAVIOR; ENGLAND; WALES	Background The World Health Organisation reports that road traffic accidents (accidents) could become the seventh leading cause of death globally by 2030. Accidents often occur in spatial clusters and, generally, there are more accidents in less advantaged areas. Infrastructure changes, such as new roads, can affect the locations and magnitude of accident clusters but evidence of impact is lacking. A new 5-mile motorway extension was opened in 2011 in Glasgow, Scotland. Previous research found no impact on the number of accidents but did not consider their spatial location or socio-economic setting. We evaluated impacts on these, both locally and city-wide. Methods We used STATS19 data covering the period 2008 to 2014 and describing the location and details of all reported accidents involving a personal injury. Poisson-based continuous scan statistics were used to detect spatial clusters of accidents and any change in these over time. Change in the socio-economic distribution of accident cluster locations during the study period was also assessed. Results In each year accidents were strongly clustered, with statistically significant clusters more likely to occur in socio-economically deprived areas. There was no significant shift in the magnitude or location of accident clusters during motorway construction or following opening, either locally or city-wide. There was also no impact on the socio-economic patterning of accident cluster locations. Conclusions Although urban infrastructure changes occur constantly, all around the world, this is the first study to evaluate the impact of such changes on road accident clusters. Despite expectations to the contrary from both proponents and opponents of the M74 extension, we found no beneficial or adverse change in the socio-spatial distribution of accidents associated with its construction, opening or operation. Our approach and findings can help inform urban planning internationally.	[Olsen, Jonathan R.; Mitchell, Richard] Univ Glasgow, Inst Hlth & Wellbeing, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Olsen, Jonathan R.; Mitchell, Richard] Univ Glasgow, CRESH, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Ogilvie, David] Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Cambridge, England; [Ogilvie, David] Univ Cambridge, UKCRC Ctr Diet & Act Res CEDAR, Sch Clin Med, Cambridge, England	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Glasgow; University of Cambridge; University of Cambridge	Olsen, JR (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.; Olsen, JR (corresponding author), Univ Glasgow, CRESH, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	jonathan.olsen@glasgow.ac.uk		Olsen, Jonathan/0000-0002-5356-8615; Ogilvie, David/0000-0002-0270-4672	NIHR Public Health Research programme [11/3005/07]; National Institute for Health Research (NIHR); Medical Research Council (MRC), Neighbourhoods and Communities Programme of the MRC/CSO Social and Public Health Sciences Research Unit [MC_UU_12017/8]; Physical Activity and Public Health Programme of the MRC Epidemiology Unit [MC_UU_12015/6]; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UP_1001/1, MR/K023187/1, MC_UU_12017/8, MC_UU_12015/6, MC_UU_12017/10, G106/1203] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [G106/1203, MC_UU_12017/10, MC_UU_12017/8, MC_UU_12015/6, MR/K023187/1, MC_UP_1001/1] Funding Source: researchfish; National Institute for Health Research [11/3005/07] Funding Source: researchfish; Chief Scientist Office [SPHSU10] Funding Source: researchfish	NIHR Public Health Research programme; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Medical Research Council (MRC), Neighbourhoods and Communities Programme of the MRC/CSO Social and Public Health Sciences Research Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Physical Activity and Public Health Programme of the MRC Epidemiology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Chief Scientist Office	This study was funded by the NIHR Public Health Research programme (project number 11/3005/07: see http://www.nets.nihr.ac.uk.projects/phr/11300507). This article presents independent research funded by the National Institute for Health Research (NIHR). The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the NIHR PHR programme or the Department of Health. The researchers were independent of the funders; the funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript. JO, RM and DO are also funded by the Medical Research Council (MRC) as part of the Neighbourhoods and Communities Programme (MC_UU_12017/8) of the MRC/CSO Social and Public Health Sciences Research Unit and the Physical Activity and Public Health Programme (MC_UU_12015/6) of the MRC Epidemiology Unit.	Aeron-Thomas A, 2005, COCHRANE DB SYST REV, V2; Anderson TK, 2009, ACCIDENT ANAL PREV, V41, P359, DOI 10.1016/j.aap.2008.12.014; Bil M, 2013, ACCIDENT ANAL PREV, V55, P265, DOI 10.1016/j.aap.2013.03.003; Blazquez CA, 2013, ACCIDENT ANAL PREV, V50, P304, DOI 10.1016/j.aap.2012.05.001; Cairns J, 2015, J PUBLIC HEALTH-UK, V37, P515, DOI 10.1093/pubmed/fdu067; Campbell M, 2014, PUBLIC HEALTH, V128, P350, DOI 10.1016/j.puhe.2013.12.014; Chini F, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-21; Department for Transport, 2014, REP ROAD CAS GREAT B; Duncan D.T., 2016, AM J DRUG ALCOHOL AB, P1; Elvik R, 2009, HANDBOOK OF ROAD SAFETY MEASURES, 2ND EDITION, P1; Environmental Resources Management, 2003, M74 COMPL ENV STAT; Penna MLF, 2009, LEPROSY REV, V80, P332; Foley L, 2016, COMMUNITY ENGAGEMENT; Fujii S, 2006, TRANSPORT POLICY, V13, P339, DOI 10.1016/j.tranpol.2005.12.007; Goniewicz K, 2015, EUR J TRAUMA EMERG S, P1; Goungounga JA, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0228-x; Greene SK, 2016, EMERG INFECT DIS, V22, P1808, DOI 10.3201/eid2210.160097; Grundy C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4469; Jones AP, 2008, HEALTH PLACE, V14, P519, DOI 10.1016/j.healthplace.2007.10.001; Kingham S, 2007, TRANSPORT RES D-TR E, V12, P254, DOI 10.1016/j.trd.2007.02.004; Knoflacher H, 2017, ADV CIV IND ENG BOOK, P270, DOI 10.4018/978-1-5225-2116-7.ch012; Kulldorff, 2010, SATSCAN SOFTWARE SPA; Truong LT, 2011, J PUBLIC TRANSPORT, V14, P99, DOI 10.5038/2375-0901.14.1.6; Lyons RA, 2008, ACCIDENT ANAL PREV, V40, P1406, DOI 10.1016/j.aap.2008.03.011; Mitchell G, 2003, ENVIRON PLANN A, V35, P909, DOI 10.1068/a35240; Olsen JR, 2016, J EPIDEMIOL COMMUN H, V70, P1088, DOI 10.1136/jech-2016-207378; Petticrew M, 2005, PUBLIC HEALTH, V119, P751, DOI 10.1016/j.puhe.2004.11.008; Plug C, 2011, ACCIDENT ANAL PREV, V43, P1937, DOI 10.1016/j.aap.2011.05.007; Prato CG, 2012, ACCIDENT ANAL PREV, V44, P56, DOI 10.1016/j.aap.2010.12.022; Rodriguez-Morales B, 2013, ACCIDENT ANAL PREV, V60, P121, DOI 10.1016/j.aap.2013.07.032; Roth D, 2016, SOC SCI MED, V168, P214, DOI 10.1016/j.socscimed.2016.06.047; Scottish Government, 2012, SIMD BACKGR METH; Slaughter Dekeya R, 2014, J Trauma Acute Care Surg, V76, P1103, DOI 10.1097/TA.0000000000000176; Soole DW, 2013, ACCIDENT ANAL PREV, V54, P46, DOI 10.1016/j.aap.2013.01.018; Sparks R., 2012, OPEN J SAFETY SCI TE, V2, P98, DOI DOI 10.4236/OJSST.2012.23013; Sparks R, 2011, SAFETY SCI, V49, P794, DOI 10.1016/j.ssci.2010.06.007; Steinbach R, 2015, J EPIDEMIOL COMMUN H, V69, P1118, DOI 10.1136/jech-2015-206012; Transport Scotland, 2015, M74 COMPL SCHEM ON Y; WHO, 2015, ROAD TRAFF INJ; Zhang X, 2017, HIV MED, V18, P141, DOI 10.1111/hiv.12408	40	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184047	10.1371/journal.pone.0184047	http://dx.doi.org/10.1371/journal.pone.0184047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880956	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000409467200031
J	Ong, J; Timens, W; Rajendran, V; Algra, A; Spira, A; Lenburg, ME; Campbell, JD; van den Berge, M; Postma, DS; van den Berg, A; Kluiver, J; Brandsma, CA				Ong, Jennie; Timens, Wim; Rajendran, Vijay; Algra, Arjan; Spira, Avrum; Lenburg, Marc E.; Campbell, Joshua D.; van den Berge, Maarten; Postma, Dirkje S.; van den Berg, Anke; Kluiver, Joost; Brandsma, Corry-Anke			Identification of transforming growth factorbeta-lregulated microRNAs and the microRNAtargetomes in primary lung fibroblasts	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; GENE-EXPRESSION; INHIBITION; TARGETS; REPAIR; AIRWAY; COPD	Background Lung fibroblasts are involved in extracellular matrix homeostasis, which is mainly regulated by transforming growth factor-beta (TGF-beta), and are therefore crucial in lung tissue repair and remodeling. Abnormal repair and remodeling has been observed in lung diseases like COPD. As miRNA levels can be influenced by TGF-beta, we hypothesized that TGF-beta influences miRNA expression in lung fibroblasts, thereby affecting their function. Materials and methods We investigated TGF-beta 1-induced miRNA expression changes in 9 control primary parenchymal lung fibroblasts using miRNA arrays. TGF-beta 1-induced miRNA expression changes were validated and replicated in an independent set of lung fibroblasts composted of 10 controls and 15 COPD patients using qRT-PCR. Ago2-immunoprecipitation followed by mRNA expression profiling was used to identify the miRNA-targetomes of unstimulated and TGF-beta 1-stimulated primary lung fibroblasts (n = 2). The genes affected by TGF-beta 1-modulated miRNAs were identified by comparing the miRNA targetomes of unstimulated and TGF-beta 1stimulated fibroblasts. Results Twenty-nine miRNAs were significantly differentially expressed after TGF-beta 1 stimulation (FDR< 0.05). The TGF-beta 1-induced miR-455-3p and miR-21-3p expression changes were validated and replicated, with in addition, lower miR-455-3p levels in COPD (p< 0.05). We identified 964 and 945 genes in the miRNA-targetomes of unstimulated and TGF-beta 1-stimulated lung fibroblasts, respectively. The TGF-beta and Wnt pathways were significantly enriched among the Ago2-IP enriched and predicted targets of miR-455-3p and miR-21-3p. The miR-455-3p target genes HN1, NGF, STRADB, DLD and ANO3 and the miR-21-3p target genes HHEX, CHORDC1 and ZBTB49 were consistently more enriched after TGF-beta 1 stimulation. Conclusion Two miRNAs, miR-455-3p and miR-21-3p, were induced by TGF-beta 1 in lung fibroblasts. The significant Ago2-IP enrichment of targets of these miRNAs related to the TGF-beta and/or Wnt pathways ( NGF, DLD, HHEX) in TGF-beta 1-stimulated fibroblasts suggest a role for these miRNAs in lung diseases by affecting lung fibroblast function.	[Ong, Jennie; Timens, Wim; Rajendran, Vijay; Algra, Arjan; van den Berg, Anke; Kluiver, Joost; Brandsma, Corry-Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Ong, Jennie; Timens, Wim; Rajendran, Vijay; van den Berge, Maarten; Postma, Dirkje S.; Brandsma, Corry-Anke] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands; [Spira, Avrum; Lenburg, Marc E.; Campbell, Joshua D.] Boston Univ, Sch Med, Dept Med, Sect Computat Biomed, Boston, MA USA; [van den Berge, Maarten; Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands	University of Groningen; University of Groningen; Boston University; University of Groningen	Brandsma, CA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands.; Brandsma, CA (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma & COPD GRIAC, Groningen, Netherlands.	c.a.brandsma@umcg.nl	Lenburg, Marc/B-8027-2008; Kluiver, Joost/G-6406-2014; van den Berg, Anke/H-1718-2011; Timens, Wim/K-5570-2013	Lenburg, Marc/0000-0002-5760-4708; Kluiver, Joost/0000-0001-7650-2937; van den Berg, Anke/0000-0002-8894-2638; Timens, Wim/0000-0002-4146-6363; van den Berge, Maarten/0000-0002-9336-7340	 [3.2.12.044]		This work was supported by Grant number: 3.2.12.044, https://www.longfonds.nl/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Baarsma HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025450; Brandsma CA, 2015, THORAX, V70, P21, DOI 10.1136/thoraxjnl-2014-205091; Brandsma CA, 2013, AM J PHYSIOL-LUNG C, V305, pL582, DOI 10.1152/ajplung.00152.2013; Butz H, 2012, TRENDS PHARMACOL SCI, V33, P382, DOI 10.1016/j.tips.2012.04.003; Cao MR, 2012, INT J ONCOL, V41, P869, DOI 10.3892/ijo.2012.1535; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Cui HC, 2016, AM J RESP CELL MOL, V54, P843, DOI 10.1165/rcmb.2015-0205OC; Das S, 2014, AM J RESP CELL MOL, V50, P882, DOI 10.1165/rcmb.2013-0195OC; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Eickelberg O, 1999, AM J PHYSIOL-LUNG C, V276, pL814, DOI 10.1152/ajplung.1999.276.5.L814; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Fernandes Lynette B, 2007, Ther Adv Respir Dis, V1, P25, DOI 10.1177/1753465807080740; Ferretti R, 2010, DEV CELL, V18, P486, DOI 10.1016/j.devcel.2009.12.020; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gray LR, 2014, CELL MOL LIFE SCI, V71, P2577, DOI 10.1007/s00018-013-1539-2; Huang SL, 2008, INT J CANCER, V123, P972, DOI 10.1002/ijc.23580; Jeon BN, 2014, NUCLEIC ACIDS RES, V42, P11447, DOI 10.1093/nar/gku857; Kluiver Joost, 2013, Methods Mol Biol, V971, P265, DOI 10.1007/978-1-62703-269-8_15; Kohyama T, 2002, J LAB CLIN MED, V140, P329, DOI 10.1067/mlc.2002.128347; Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898; Milosevic J, 2012, AM J RESP CELL MOL, V47, P879, DOI 10.1165/rcmb.2011-0377OC; Noordhoek JA, 2003, EXP LUNG RES, V29, P291, DOI 10.1080/01902140303789; Noordhoek Jacobien A, 2005, COPD, V2, P17; Osei ET, 2015, EUR RESPIR J, V46, P807, DOI 10.1183/13993003.02139-2014; Pandit KV, 2010, AM J RESP CRIT CARE, V182, P220, DOI 10.1164/rccm.200911-1698OC; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Renzoni EA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-24; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Slezak-Prochazka I, 2016, ONCOTARGET, V7, P2391, DOI 10.18632/oncotarget.6165; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swingler TE, 2012, ARTHRITIS RHEUM-US, V64, P1909, DOI 10.1002/art.34314; Takizawa H, 2001, AM J RESP CRIT CARE, V163, P1476, DOI 10.1164/ajrccm.163.6.9908135; Tan LP, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp715; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Wang MY, 2016, CLIN RESPIR J, V10, P104, DOI 10.1111/crj.12194; Wen YC, 2015, ONCOTARGET, V6, P21120, DOI 10.18632/oncotarget.4229; Zandvoort A, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-83; Zhang WJ, 2002, J BIOL CHEM, V277, P45435, DOI 10.1074/jbc.M208056200	41	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183815	10.1371/journal.pone.0183815	http://dx.doi.org/10.1371/journal.pone.0183815			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910321	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200018
J	Sokunbi, OJ; Ekure, EN; Temiye, EO; Anyanwu, R; Okoromah, CAN				Sokunbi, Ogochukwu J.; Ekure, Ekanem N.; Temiye, Edamisan O.; Anyanwu, Roosevelt; Okoromah, Christy A. N.			Pulmonary hypertension among 5 to 18 year old children with sickle cell anaemia in Nigeria	PLOS ONE			English	Article							REGURGITANT JET VELOCITY; YOUNG-ADULTS; DISEASE; DEATH; RISK; PREVALENCE; DIAGNOSIS; HEMOLYSIS	Background Pulmonary hypertension (PHT) is a significant cause of mortality in patients with sickle cell disease (SCD). Few studies on PHT in SCD have been carried out in children. This study aimed to estimate the prevalence of PHT in children with sickle cell anaemia (SCA) and determine its clinical and laboratory correlates. Methods In this cross sectional study, evaluation involved obtaining bio-data, history and physical examination findings in 175 SCA subjects with haemoglobin genotype SS aged 5 to 18 years and 175 age and sex matched controls with haemoglobin genotype AA. PHT was determined using peak Tricuspid Regurgitant Velocity (TRV) obtained from echocardiography as a marker. Complete blood count (CBC), lactate dehydrogenase (LDH) assay, reticulocyte count, foetal haemoglobin (HbF) estimation as well as Human Immunodeficiency Virus (HIV) I and II, Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) screening were done for patients with SCA. Results The mean peak TRV of subjects with SCA and controls was 2.2 +/- 0.4 m/s and 1.9 +/- 0.3 m/s respectively and prevalence of PHT among children with SCA and controls was 22.9% and 2.3% respectively. PHT in SCA correlated negatively with body mass index, haematocrit and haemoglobin. Conclusion This study affirms that PHT prevalence is high in children with SCA in Nigeria. Cardiovascular examination for signs of PHT is recommended for children with SCA and if required, further echocardiographic assessment from as early as five years.	[Sokunbi, Ogochukwu J.] Lagos Univ, Teaching Hosp, Dept Paediat, Lagos, Nigeria; [Ekure, Ekanem N.; Temiye, Edamisan O.; Okoromah, Christy A. N.] Univ Lagos, Coll Med, Dept Paediat, Lagos, Nigeria; [Anyanwu, Roosevelt] Univ Lagos, Coll Med, Cent Res Lab, Lagos, Nigeria	University of Lagos; University of Lagos	Sokunbi, OJ (corresponding author), Lagos Univ, Teaching Hosp, Dept Paediat, Lagos, Nigeria.	ogosokunbi@gmail.com		Sokunbi, Ogochukwu/0000-0002-6543-2600; Ekure, Ekanem/0000-0002-8257-1864; OKOROMAH, CHRISTY/0000-0001-9623-604X				Akgul F, 2007, ACTA HAEMATOL-BASEL, V118, P1, DOI 10.1159/000100929; Aliyu ZY, 2008, AM J HEMATOL, V83, P485, DOI 10.1002/ajh.21162; Ambrusko SJ, 2006, PEDIATR BLOOD CANCER, V47, P907, DOI 10.1002/pbc.20791; [Anonymous], 2015, SICKLE CELL DIS PREV; Ataga KI, 2006, BRIT J HAEMATOL, V134, P109, DOI 10.1111/j.1365-2141.2006.06110.x; Ataga KI, 2004, AM J MED, V117, P665, DOI 10.1016/j.amjmed.2004.03.034; Barst RJ, 2004, J AM COLL CARDIOL, V43, p40S, DOI 10.1016/j.jacc.2004.02.032; Bunn HF, 2010, BLOOD, V116, P687, DOI 10.1182/blood-2010-02-268193; Caughey MC, 2012, AM J CARDIOL, V109, P1353, DOI 10.1016/j.amjcard.2011.11.067; Colombatti R, 2010, BRIT J HAEMATOL, V150, P601, DOI 10.1111/j.1365-2141.2010.08269.x; Dahoui HA, 2010, PEDIATR BLOOD CANCER, V54, P398, DOI 10.1002/pbc.22306; De Castro LM, 2008, AM J HEMATOL, V83, P19, DOI 10.1002/ajh.21058; Lobo CLD, 2013, BRIT J HAEMATOL, V161, P852, DOI 10.1111/bjh.12323; Dosunmu Adedoyin O, 2014, Niger Med J, V55, P161, DOI 10.4103/0300-1652.129661; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Gladwin MT, 2008, NEW ENGL J MED, V359, P2254, DOI 10.1056/NEJMra0804411; Gladwin MT, 2010, AM J RESP CRIT CARE, V181, P1020, DOI 10.1164/rccm.201002-0235UP; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; HEATH D, 1958, CIRCULATION, V18, P533, DOI 10.1161/01.CIR.18.4.533; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2007, PEDIATR HEMAT ONCOL, V24, P159, DOI 10.1080/08880010601185892; Klings ES, 2014, AM J RESP CRIT CARE, V189, P727, DOI 10.1164/rccm.201401-0065ST; Lee MT, 2009, BRIT J HAEMATOL, V146, P437, DOI 10.1111/j.1365-2141.2009.07779.x; Liem RI, 2007, HAEMATOLOGICA, V92, P1549, DOI 10.3324/haematol.11576; Manci EA, 2003, BRIT J HAEMATOL, V123, P359, DOI 10.1046/j.1365-2141.2003.04594.x; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Nelson SC, 2007, J PEDIAT HEMATOL ONC, V29, P334, DOI 10.1097/MPH.0b013e31805d8f32; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; POWARS DR, 1984, BLOOD, V63, P921, DOI 10.1182/blood.V63.4.921.921; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X	31	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184287	10.1371/journal.pone.0184287	http://dx.doi.org/10.1371/journal.pone.0184287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910308	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200037
J	Huang, P; Lan, M; Peng, AF; Yu, QF; Chen, WZ; Liu, ZL; Liu, JM; Huang, SH				Huang, Ping; Lan, Min; Peng, Ai-Fen; Yu, Qing-Fu; Chen, Wen-Zhao; Liu, Zhi-Li; Liu, Jia-Ming; Huang, Shan-Hu			Serum calcium, alkaline phosphotase and hemoglobin as risk factors for bone metastases in bladder cancer	PLOS ONE			English	Article							SKELETAL METASTASES; PROSTATE-CANCER; LUNG-CANCER; PHOSPHATASE; DIAGNOSIS; BREAST; MANAGEMENT; CARCINOMA; PROGNOSIS; EFFICACY	Early detection of bone metastases is helpful for the treatment of bladder cancer (BC). In this study, we investigated the potential risk factors for bone metastasis in newly diagnosed patients with BC. A total of 902 patients diagnosed with BC between January 2000 and August 2016 were retrospectively reviewed. Of these patient, 50 (5.5%) were identified with bone metastasis. The serum levels of alkaline phosphatase (ALP) and calcium were significantly higher in patients with bone metastases than those without bone metastases (P = 0.015 and P<0.001). And the concentration of hemoglobin (HB) was significant lower in bone metastatic patients compared with non bone metastatic patients (P = 0.009). Multivariate logistic regression analysis indicated that ALP, HB and calcium were independent risk factors for bone metastases in patients with BC. The cut off values of ALP, HB and calcium were 116 U/L, 37.5g/L and 2.54 mmol/L according to the receiver operating characteristic (ROC) curves analysis. And combined ALP, HB with calcium had the highest diagnostic accuracy for predicting bone metastases in BC patients (AUC = 0.760, P<0.001). Therefore, for newly diagnosed patients with BC, the concentrations of ALP > 116 U/L, HB < 37.5 g/Land calcium > 2.54 mmol/L were the risk factors for developing bone metastases. Combined ALP, HB with calcium was more useful to diagnose the bone metastases.	[Huang, Ping] Nanchang Univ, Affiliated Hosp 1, Dept Nutr, Nanchang, Jiangxi, Peoples R China; [Lan, Min; Yu, Qing-Fu; Chen, Wen-Zhao; Liu, Zhi-Li; Liu, Jia-Ming; Huang, Shan-Hu] Nanchang Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Nanchang, Jiangxi, Peoples R China; [Peng, Ai-Fen] Jiangxi Univ Tradit Chinese Med, Sch Humanities, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Jiangxi University of Traditional Chinese Medicine	Liu, JM; Huang, SH (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Orthopaed Surg, Nanchang, Jiangxi, Peoples R China.	liujiamingdr@hotmail.com; hsh869@126.com			Department of Science and Technology Program of Jiangxi Province, China [20162BCB22022, 20162BCB23057]	Department of Science and Technology Program of Jiangxi Province, China	This work was supported by the Department of Science and Technology Program of Jiangxi Province, China (no. 20162BCB22022, 20162BCB23057).	Bienz M, 2015, CURR OPIN SUPPORT PA, V9, P261, DOI 10.1097/SPC.0000000000000157; CORRIE D, 1988, CANCER, V61, P2453, DOI 10.1002/1097-0142(19880615)61:12<2453::AID-CNCR2820611211>3.0.CO;2-P; Glas AS, 2003, J UROLOGY, V169, P1975, DOI 10.1097/01.ju.0000067461.30468.6d; HANNISDAL E, 1993, RADIOTHER ONCOL, V27, P117, DOI 10.1016/0167-8140(93)90131-Q; Joeckel E, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-42; Kawai N, 2001, CANCER LETT, V171, P201, DOI 10.1016/S0304-3835(01)00595-X; Le Bricon T, 2010, J CLIN LAB ANAL, V24, P20, DOI 10.1002/jcla.20357; Leeming DJ, 2006, CANCER EPIDEM BIOMAR, V15, P32, DOI 10.1158/1055-9965.EPI-05-0492; Lim SM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2415-x; MICHEL F, 1991, THORAX, V46, P469, DOI 10.1136/thx.46.7.469; Mihai R, 2006, EJSO, V32, P511, DOI 10.1016/j.ejso.2006.02.009; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Rosen LS, 2004, CANCER, V100, P2613, DOI 10.1002/cncr.20308; Saylor PJ, 2013, EUR UROL, V63, P309, DOI 10.1016/j.eururo.2012.10.007; Selvaggi G, 2005, CRIT REV ONCOL HEMAT, V56, P365, DOI 10.1016/j.critrevonc.2005.03.011; Taher Azza N, 2006, J Egypt Natl Canc Inst, V18, P203; Yang L, 2004, BRIT J CANCER, V90, P2157, DOI 10.1038/sj.bjc.6601813; Zhao H, 2011, MED SCI MONITOR, V17, pCR626, DOI 10.12659/MSM.882047	18	37	37	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183835	10.1371/journal.pone.0183835	http://dx.doi.org/10.1371/journal.pone.0183835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902911	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200020
J	Osland, MJ; Griffith, KT; Larriviere, JC; Feher, LC; Cahoon, DR; Enwright, NM; Oster, DA; Tirpak, JM; Woodrey, MS; Collini, RC; Baustian, JJ; Breithaupt, JL; Cherry, JA; Conrad, JR; Cormier, N; Coronado-Molina, CA; Donoghue, JF; Graham, SA; Harper, JW; Hester, MW; Howard, RJ; Krauss, KW; Kroes, DE; Lane, RR; McKee, KL; Mendelssohn, IA; Middleton, BA; Moon, JA; Piazza, SC; Rankin, NM; Sklar, FH; Steyer, GD; Swanson, KM; Swarzenski, CM; Vervaeke, WC; Willis, JM; Van Wilson, K				Osland, Michael J.; Griffith, Kereen T.; Larriviere, Jack C.; Feher, Laura C.; Cahoon, Donald R.; Enwright, Nicholas M.; Oster, David A.; Tirpak, John M.; Woodrey, Mark S.; Collini, Renee C.; Baustian, Joseph J.; Breithaupt, Joshua L.; Cherry, Julia A.; Conrad, Jeremy R.; Cormier, Nicole; Coronado-Molina, Carlos A.; Donoghue, Joseph F.; Graham, Sean A.; Harper, Jennifer W.; Hester, Mark W.; Howard, Rebecca J.; Krauss, Ken W.; Kroes, Daniel E.; Lane, Robert R.; McKee, Karen L.; Mendelssohn, Irving A.; Middleton, Beth A.; Moon, Jena A.; Piazza, Sarai C.; Rankin, Nicole M.; Sklar, Fred H.; Steyer, Greg D.; Swanson, Kathleen M.; Swarzenski, Christopher M.; Vervaeke, William C.; Willis, Jonathan M.; Van Wilson, K.			Assessing coastal wetland vulnerability to sea-level rise along the northern Gulf of Mexico coast: Gaps and opportunities for developing a coordinated regional sampling network	PLOS ONE			English	Article							HIGH-PRECISION MEASUREMENTS; RIVER DELTAIC PLAIN; SALT-MARSH; SURFACE ELEVATION; MANGROVE FORESTS; SEDIMENT ELEVATION; SPARTINA-ALTERNIFLORA; MISSISSIPPI DELTA; TIDAL WETLANDS; CLIMATE-CHANGE	Coastal wetland responses to sea-level rise are greatly influenced by biogeomorphic processes that affect wetland surface elevation. Small changes in elevation relative to sea level can lead to comparatively large changes in ecosystem structure, function, and stability. The surface elevation table-marker horizon (SET-MH) approach is being used globally to quantify the relative contributions of processes affecting wetland elevation change. Historically, SET-MH measurements have been obtained at local scales to address site-specific research questions. However, in the face of accelerated sea-level rise, there is an increasing need for elevation change network data that can be incorporated into regional ecological models and vulnerability assessments. In particular, there is a need for long-term, high-temporal resolution data that are strategically distributed across ecologically-relevant abiotic gradients. Here, we quantify the distribution of SET-MH stations along the northern Gulf of Mexico coast (USA) across political boundaries (states), wetland habitats, and ecologically-relevant abiotic gradients (i.e., gradients in temperature, precipitation, elevation, and relative sea-level rise). Our analyses identify areas with high SET-MH station densities as well as areas with notable gaps. Salt marshes, intermediate elevations, and colder areas with high rainfall have a high number of stations, while salt flat ecosystems, certain elevation zones, the mangrove-marsh ecotone, and hypersaline coastal areas with low rainfall have fewer stations. Due to rapid rates of wetland loss and relative sea-level rise, the state of Louisiana has the most extensive SET-MH station network in the region, and we provide several recent examples where data from Louisiana's network have been used to assess and compare wetland vulnerability to sea-level rise. Our findings represent the first attempt to examine spatial gaps in SET-MH coverage across abiotic gradients. Our analyses can be used to transform a broadly disseminated and unplanned collection of SET-MH stations into a coordinated and strategic regional network. This regional network would provide data for predicting and preparing for the responses of coastal wetlands to accelerated sea-level rise and other aspects of global change.	[Osland, Michael J.; Feher, Laura C.; Enwright, Nicholas M.; Cormier, Nicole; Howard, Rebecca J.; Krauss, Ken W.; McKee, Karen L.; Middleton, Beth A.; Steyer, Greg D.; Vervaeke, William C.] US Geol Survey, Lafayette, LA USA; [Griffith, Kereen T.] US Geol Survey, Griffith Consulting Serv, Lafayette, LA USA; [Larriviere, Jack C.] Five Rivers Serv, Lafayette, LA USA; [Cahoon, Donald R.] US Geol Survey, Patuxent River, MD USA; [Oster, David A.; Tirpak, John M.] US Fish & Wildlife Serv, Lafayette, LA USA; [Woodrey, Mark S.] Grand Bay Natl Estuarine Res Reserve, Moss Point, MS USA; [Collini, Renee C.] Northern Gulf Mexico Sentinel Site Cooperat, Dauphin Isl, AL USA; [Baustian, Joseph J.] Nature Conservancy, Baton Rouge, LA USA; [Breithaupt, Joshua L.] Univ S Florida, St Petersburg, FL USA; [Cherry, Julia A.] Univ Alabama, Tuscaloosa, AL USA; [Conrad, Jeremy R.] US Fish & Wildlife Serv, Sanibel, FL USA; [Coronado-Molina, Carlos A.; Sklar, Fred H.] South Florida Water Management Dist, W Palm Beach, FL USA; [Donoghue, Joseph F.] Univ Cent Florida, Orlando, FL 32816 USA; [Graham, Sean A.] Nicholls State Univ, Thibodaux, LA 70310 USA; [Harper, Jennifer W.] Apalachicola Natl Estuarine Res Reserve, Eastpoint, FL USA; [Hester, Mark W.; Willis, Jonathan M.] Univ Louisiana Lafayette, Lafayette, LA 70504 USA; [Kroes, Daniel E.; Piazza, Sarai C.; Swarzenski, Christopher M.] US Geol Survey, Baton Rouge, LA USA; [Lane, Robert R.; Mendelssohn, Irving A.] Louisiana State Univ, Baton Rouge, LA USA; [Moon, Jena A.] US Fish & Wildlife Serv, Winnie, TX USA; [Rankin, Nicole M.] US Fish & Wildlife Serv, Awendaw, SC USA; [Swanson, Kathleen M.] Mission Aransas Natl Estuarine Res Reserve, Port Aransas, TX USA; [Van Wilson, K.] US Geol Survey, Jackson, MS USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; US Fish & Wildlife Service; Nature Conservancy; State University System of Florida; University of South Florida; University of Alabama System; University of Alabama Tuscaloosa; United States Department of the Interior; US Fish & Wildlife Service; South Florida Water Management District; State University System of Florida; University of Central Florida; University of Louisiana System; Nicholls State University; University of Louisiana Lafayette; United States Department of the Interior; United States Geological Survey; Louisiana State University System; Louisiana State University; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey	Osland, MJ (corresponding author), US Geol Survey, Lafayette, LA USA.	mosland@usgs.gov	Vervaeke, William/AAS-3293-2020; Breithaupt, Joshua L./G-9841-2012; McKee, Karen L/D-1365-2014; Osland, Michael J./D-1814-2014	Vervaeke, William/0000-0002-1518-5197; Breithaupt, Joshua L./0000-0003-0963-3253; McKee, Karen L/0000-0001-7042-670X; Osland, Michael J./0000-0001-9902-8692; Cherry, Julia/0000-0003-2854-4731; Kroes, Daniel/0000-0001-9104-9077; Cormier, Nicole/0000-0003-2453-9900; Tirpak, John/0000-0003-1937-9754	USFWS; USGS Ecosystems Mission Area, USGS Climate and Land Use Change; USGS Greater Everglades Priority Ecosystems Science	USFWS(US Fish & Wildlife Service); USGS Ecosystems Mission Area, USGS Climate and Land Use Change; USGS Greater Everglades Priority Ecosystems Science	This inventory was the result of an effort between individuals at the USGS Wetland and Aquatic Research Center and the NOM Northern Gulf of Mexico Sentinel Site Cooperative, who worked with scientists from other state, federal, and academic organizations to compile this information. The participation of David Oster was supported by the USFWS Directorate Resource Assistant Fellows Program. We thank the Gulf Coastal Plains and Ozarks Landscape Conservation Cooperative for hosting the inventory results on their conservation planning atlas. This research was partially funded by the USGS Ecosystems Mission Area, USGS Climate and Land Use Change R&D Program, and the USGS Greater Everglades Priority Ecosystems Science Program.	Alizad K, 2016, EARTHS FUTURE, V4, P483, DOI 10.1002/2016EF000385; Alizad K, 2016, ECOL MODEL, V327, P29, DOI 10.1016/j.ecolmodel.2016.01.013; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2012, GLOBAL CHANGE FUNCTI, DOI DOI 10.1007/978-94-007-4494-3_2; [Anonymous], 2013, 20131163 US GEOL SUR; Asbridge E, 2015, CURR FOR REP, V1, P178, DOI 10.1007/s40725-015-0018-4; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Baustian JJ, 2012, GLOBAL CHANGE BIOL, V18, P3377, DOI 10.1111/j.1365-2486.2012.02792.x; Blum MD, 2009, NAT GEOSCI, V2, P488, DOI 10.1038/ngeo553; BOUMANS RMJ, 1993, ESTUARIES, V16, P375, DOI 10.2307/1352509; Breithaupt JL, 2014, J GEOPHYS RES-BIOGEO, V119, P2032, DOI 10.1002/2014JG002715; BUCHER D, 1994, AQUAT CONSERV, V4, P1, DOI 10.1002/aqc.3270040102; Buffington KJ, 2016, REMOTE SENS ENVIRON, V186, P616, DOI 10.1016/j.rse.2016.09.020; Cahoon D. R., 1997, MANGROVES SALT MARSH, V1, P173, DOI [10.1023/A:1009904816246, DOI 10.1023/A:1009904816246]; Cahoon DR, 2006, ECOL STUD-ANAL SYNTH, V190, P271; Cahoon DR, 2015, ESTUAR COAST, V38, P1077, DOI 10.1007/s12237-014-9872-8; Cahoon DR, 2003, J ECOL, V91, P1093, DOI 10.1046/j.1365-2745.2003.00841.x; Cahoon DR, 2002, J SEDIMENT RES, V72, P734, DOI 10.1306/020702720734; Cahoon DR, 2002, J SEDIMENT RES, V72, P730, DOI 10.1306/020702720730; CAHOON DR, 1995, MAR GEOL, V128, P1, DOI 10.1016/0025-3227(95)00087-F; Callaway JC, 1997, J COASTAL RES, V13, P181; Callaway JC, 2013, SSSA BOOK S, V10, P901, DOI 10.2136/sssabookser10.c46; Cavanaugh KC, 2015, GLOBAL CHANGE BIOL, V21, P1928, DOI 10.1111/gcb.12843; Cavanaugh KC, 2014, P NATL ACAD SCI USA, V111, P723, DOI 10.1073/pnas.1315800111; Center for International Earth Science Information Network (CIESIN) Columbia University, 2018, GRIDDED POPULATION W, DOI DOI 10.1023/A:1009900724172; Cherry JA, 2015, METHODS ECOL EVOL, V6, P1443, DOI 10.1111/2041-210X.12441; Comeaux RS, 2012, ESTUAR COAST SHELF S, V96, P81, DOI 10.1016/j.ecss.2011.10.003; Cooper HM, 2013, PROG PHYS GEOG, V37, P745, DOI 10.1177/0309133313496835; Couvillion BR, 2013, J COASTAL RES, P29, DOI 10.2112/SI_67_3; Cowardin LM., 2005, WATER ENCY; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Day JW, 2007, SCIENCE, V315, P1679, DOI 10.1126/science.1137030; DELAUNE RD, 1978, NATURE, V275, P532, DOI 10.1038/275532a0; Doyle TW, 2010, FOREST ECOL MANAG, V259, P770, DOI 10.1016/j.foreco.2009.10.023; Duke NC, 2017, MAR FRESHW RES; ELEUTERIUS LN, 1979, B MAR SCI, V29, P394; Engle VD, 2011, WETLANDS, V31, P179, DOI 10.1007/s13157-010-0132-9; Enwright NM, 2016, FRONT ECOL ENVIRON, V14, P307, DOI 10.1002/fee.1282; Eslami-Andargoli L, 2009, ESTUAR COAST SHELF S, V85, P292, DOI 10.1016/j.ecss.2009.08.011; Fagherazzi S, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000359; Gabler CA, 2017, NAT CLIM CHANGE, V7, P142, DOI [10.1038/nclimate3203, 10.1038/NCLIMATE3203]; Graham SA, 2014, ECOLOGY, V95, P3271, DOI 10.1890/14-0196.1; Howard RJ, 2017, RESTOR ECOL, V25, P471, DOI 10.1111/rec.12452; Jankowski KL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14792; Kidwell DM, 2017, EARTHS FUTURE, V5, P2, DOI 10.1002/2016EF000493; Kintisch E, 2013, SCIENCE, V341, P480, DOI 10.1126/science.341.6145.480; Kirwan ML, 2007, P NATL ACAD SCI USA, V104, P6118, DOI 10.1073/pnas.0700958104; Kirwan ML, 2016, NAT CLIM CHANGE, V6, P253, DOI 10.1038/NCLIMATE2909; Kirwan ML, 2015, ECOSYSTEMS, V18, P903, DOI 10.1007/s10021-015-9870-0; Kirwan ML, 2013, NATURE, V504, P53, DOI 10.1038/nature12856; Krauss KW, 2008, AQUAT BOT, V89, P105, DOI 10.1016/j.aquabot.2007.12.014; Krauss KW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01224-2; Krauss KW, 2014, NEW PHYTOL, V202, P19, DOI 10.1111/nph.12605; Krauss KW, 2010, ECOSYSTEMS, V13, P129, DOI 10.1007/s10021-009-9307-8; Lane RR, 2006, WETLANDS, V26, P1130, DOI 10.1672/0277-5212(2006)26[1130:WSEVAA]2.0.CO;2; Langley JA, 2013, GLOBAL CHANGE BIOL, V19, P1495, DOI 10.1111/gcb.12147; Longley W.L., 1995, IMPACT GLOBAL WARMIN, P88; Lovelock CE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01927-6; Lovelock CE, 2015, NATURE, V526, P559, DOI 10.1038/nature15538; Lugo A.E., 1974, ECOLOGY MANGROVES, V5, P39; LYNCH JC, 1989, ESTUARIES, V12, P284, DOI 10.2307/1351907; Lynch JC., 2015, NPSNCBNNRR20151078; Marcy D, 2011, SOLUTIONS COASTAL DI, P474, DOI [DOI 10.1061/41185(417)42, 10.1061/9780784411858]; McKee KL, 2011, ESTUAR COAST SHELF S, V91, P475, DOI 10.1016/j.ecss.2010.05.001; Medeiros S, 2015, REMOTE SENS-BASEL, V7, P3507, DOI 10.3390/rs70403507; MENDELSSOHN IA, 1980, ESTUAR COAST MAR SCI, V11, P27, DOI 10.1016/S0302-3524(80)80027-2; Mendelssohn IA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P59; Montagna P.A., 2007, CHANGING CLIMATE S T, P57; Morris J. T., 2007, Principles and standards for measuring primary production, P106; Morris JT, 2007, HYDROBIOLOGIA, V577, P161, DOI 10.1007/s10750-006-0425-4; Morris JT, 2016, EARTHS FUTURE, V4, P110, DOI 10.1002/2015EF000334; Morris JT, 2013, OCEANOGRAPHY, V26, P78, DOI 10.5670/oceanog.2013.48; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; NYMAN JA, 1990, ESTUAR COAST SHELF S, V31, P57, DOI 10.1016/0272-7714(90)90028-P; ODUM WE, 1982, FWSOBS8124 OFF BIOL; Osland MJ, 2017, ECOL MONOGR, V87, P341, DOI 10.1002/ecm.1248; Osland MJ, 2017, ECOLOGY, V98, P125, DOI 10.1002/ecy.1625; Osland MJ, 2016, GLOBAL CHANGE BIOL, V22, P1, DOI 10.1111/gcb.13084; Osland MJ, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00042.1; Osland MJ, 2014, ECOLOGY, V95, P2789, DOI 10.1890/13-1269.1; Osland MJ, 2013, GLOBAL CHANGE BIOL, V19, P1482, DOI 10.1111/gcb.12126; Parker BB, 2003, J COASTAL RES, P44; PARKINSON RW, 1994, J COASTAL RES, V10, P1077; Passeri DL, 2015, EARTHS FUTURE, V3, P159, DOI 10.1002/2015EF000298; Perillo G. M. E., 2009, COASTAL WETLANDS INT; Raposa KB, 2016, BIOL CONSERV, V204, P263, DOI 10.1016/j.biocon.2016.10.015; Rasser MK, 2013, WETLANDS, V33, P575, DOI 10.1007/s13157-013-0398-9; RICHARDSON CJ, 1994, WETLANDS, V14, P1, DOI 10.1007/BF03160616; Rogers K., 2005, Wetlands Ecology and Management, V13, P587, DOI 10.1007/s11273-004-0003-3; Ross MS, 2009, GLOBAL CHANGE BIOL, V15, P1817, DOI 10.1111/j.1365-2486.2009.01900.x; Schile LM, 2017, ECOL EVOL, V7, P1276, DOI 10.1002/ece3.2758; SCHOLL DW, 1964, MAR GEOL, V1, P344, DOI 10.1016/0025-3227(64)90020-9; Schoot PM, 1982, SEDIMENTATIE EROSIE; Smith TJ, 2009, WETLANDS, V29, P24, DOI 10.1672/08-40.1; Snedden GA, 2015, ECOL ENG, V81, P133, DOI 10.1016/j.ecoleng.2015.04.035; Stagg CL, 2011, ECOL APPL, V21, P1731, DOI 10.1890/09-2128.1; Steyer GD, 2003, ENVIRON MONIT ASSESS, V81, P107, DOI 10.1023/A:1021368722681; Su J, 2006, PHOTOGRAMM ENG REM S, V72, P1265, DOI 10.14358/PERS.72.11.1265; Thieler ER, 2000, 00179 US GULF MEX CO; Turner RE, 2006, ESTUAR COAST SHELF S, V69, P352, DOI 10.1016/j.ecss.2006.05.005; Twilley RR, 2016, SUSTAIN SCI, V11, P711, DOI 10.1007/s11625-016-0374-4; VANEERDT MM, 1985, VEGETATIO, V62, P367; Ward Raymond D., 2016, Ecosystem Health and Sustainability, V2, pe01211, DOI 10.1002/ehs2.1211; Webb EL, 2013, NAT CLIM CHANGE, V3, P458, DOI [10.1038/NCLIMATE1756, 10.1038/nclimate1756]; Whelan KRT, 2009, WETLANDS, V29, P16, DOI 10.1672/08-125.1; Whelan KRT, 2005, ESTUARIES, V28, P833, DOI 10.1007/BF02696013; Withers Kim, 2002, P114; Woodroffe CD, 2016, ANNU REV MAR SCI, V8, P243, DOI 10.1146/annurev-marine-122414-034025; WOODROFFE CD, 1991, J BIOGEOGR, V18, P479, DOI 10.2307/2845685	109	27	27	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183431	10.1371/journal.pone.0183431	http://dx.doi.org/10.1371/journal.pone.0183431			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902904	Green Published, gold			2022-12-27	WOS:000410669200012
J	Ren, S; Wang, Y; Xian, L; Toyama, T; Jardine, M; Li, GS; Perkovic, V; Hong, DQ				Ren, Song; Wang, Ying; Xian, Li; Toyama, Tadashi; Jardine, Meg; Li, Guisen; Perkovic, Vlado; Hong, Daqing			Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis	PLOS ONE			English	Article							NEPHROTIC SYNDROME; CONTROLLED-TRIAL; MYCOPHENOLATE-MOFETIL; NATURAL-HISTORY; RENAL-FUNCTION; TACROLIMUS; CYCLOPHOSPHAMIDE; CORTICOSTEROIDS; CHLORAMBUCIL; GLOMERULOPATHY	Background Immunosuppressive agents in general are shown to prevent renal progression and all-cause mortality in idiopathic membranous nephropathy (IMN) patients with nephrotic syndrome. However, the efficacy and safety of different immunosuppressive treatments have not been systematic assessed and compared. A network meta-analysis was performed to compare different immunosuppressive treatment in IMN. Methods Cochrane library, MEDLINE, EMBASE and trial register system were searched for randomized controlled trials reporting the treatments for IMN to May 3, 2016. Composite endpoint of mortality or end-stage kidney disease (ESKD), complete or partial proteinuria remission and withdrawal because of treatment adverse events were compared combing direct and indirect comparison using network meta-analysis. Ranking different immunosuppressive treatments in the outcomes were analyzed by using surface under the cumulative ranking curve (SUCRA). Results Total 36 randomized controlled trials (n = 2018) covering 11 kinds of treatments were included. Compared with non-immunosuppressive treatment, only cyclophosphamide (CTX) and chlorambucil significantly reduced the risk of composite outcome of mortality or ESKD while combining the direct and indirect comparison (OR = 0.31, 95% CI: 0.12-0.81 and OR = 0.33, 95% CI: 0.12-0.92). CTX increased the composite outcome of complete remission (CR) or partial remission (PR) (OR = 4.29, 95% CI: 2.30-8.00) but chlorambucil did not (OR = 1.58, 95% CI: 0.80-3.12) as compared with non-immunosuppressive treatment. Chlorambucil also significantly increased the withdrawal risk (OR = 3.34, 95% CI: 1.37-8.17) as compared to CTX. Both tacrolimus (OR = 3.10, 95% CI: 1.36-7.09) and cyclosporine (CsA) (OR = 2.81, 95% CI: 1.08-7.32) also significantly increased the rate of CR or PR as compared with non-immunosuppressive treatment (without significant difference as compared with CTX), while ranking results showed that cyclosporine or tacrolimus was with less possibility of drug withdrawal as compared to CTX. Conclusions Cyclophosphamide and chlorambucil reduce risk of ESKD or death in IMN with nephrotic range proteinuria, but carry substantial toxicity that may be lower for cyclophosphamide. Tacrolimus and cyclosporine increase the possibility of proteinuria remission with less drug withdrawal, but the effects on kidney failure remain uncertain.	[Ren, Song; Xian, Li; Li, Guisen; Hong, Daqing] Sichuan Acad Med Sci, Renal Div, Chengdu, Sichuan, Peoples R China; [Ren, Song; Xian, Li; Li, Guisen; Hong, Daqing] Sichuan Acad Med Sci, Inst Nephrol, Chengdu, Sichuan, Peoples R China; [Ren, Song; Xian, Li; Li, Guisen; Hong, Daqing] Univ Elect Sci & Technol China, Sch Med, Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Wang, Ying; Toyama, Tadashi; Jardine, Meg; Perkovic, Vlado; Hong, Daqing] Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia; [Toyama, Tadashi] Kanazawa Univ Hosp, Div Nephrol, Kanazawa, Ishikawa, Japan; [Jardine, Meg] Concord Repatriat Gen Hosp, Concord, Australia	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; George Institute for Global Health; University of Sydney; Kanazawa University; Concord Repatriation General Hospital	Li, GS; Hong, DQ (corresponding author), Sichuan Acad Med Sci, Renal Div, Chengdu, Sichuan, Peoples R China.; Li, GS; Hong, DQ (corresponding author), Sichuan Acad Med Sci, Inst Nephrol, Chengdu, Sichuan, Peoples R China.; Li, GS; Hong, DQ (corresponding author), Univ Elect Sci & Technol China, Sch Med, Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China.; Perkovic, V; Hong, DQ (corresponding author), Univ Sydney, George Inst Global Hlth, Sydney, NSW, Australia.	guisenli@163.com; VPerkovic@georgeinstitute.org.au; hongdaqing11@126.com	Jardine, Meg/AFR-1699-2022; Jardine, Meg/AAS-1864-2020; Perkovic, Vlado/AAY-1933-2021; Li, Guisen/AAS-9461-2021	Jardine, Meg/0000-0002-0160-2375; Jardine, Meg/0000-0002-0160-2375; Li, Guisen/0000-0003-1970-9979; Wang, Ying/0000-0001-9753-6888; Wang, Ying/0000-0002-0367-6677	National Basic Research Program of China 973 [2012CB517600, 2012CB517604]; National Science and Technology Support Program [2013BA109b04]; Youth Science and Technology Creative Research Groups of Sichuan Province [2015TD0013]; John Chalmers Servier Post-doctoral fellowship	National Basic Research Program of China 973(National Basic Research Program of China); National Science and Technology Support Program; Youth Science and Technology Creative Research Groups of Sichuan Province; John Chalmers Servier Post-doctoral fellowship	This study was supported in part by National Basic Research Program of China 973 No. 2012CB517600 (No. 2012CB517604), National Science and Technology Support Program (2013BA109b04) and Youth Science and Technology Creative Research Groups of Sichuan Province (2015TD0013). Ying Wang was supported by John Chalmers Servier Post-doctoral fellowship.	Ahmed S, 1994, BANGLADESH RENAL J, V13, P51; [Anonymous], 1976, Can Med Assoc J, V115, P1209; [Anonymous], 2011, BMJ-BRIT MED J, V343, pd4949; Arnadottir M, 2006, J AM SOC NEPHROL, V17, p571A; Austin H. A., 1996, Journal of the American Society of Nephrology, V7, P1327; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Branten AJW, 1998, QJM-MON J ASSOC PHYS, V91, P359, DOI 10.1093/qjmed/91.5.359; Braun N, 2004, 41 C EUR REN ASS EUR; Burroughs TE, 2007, CLIN J AM SOC NEPHRO, V2, P517, DOI 10.2215/CJN.00620206; CAMERON JS, 1990, Q J MED, V74, P133, DOI 10.1093/oxfordjournals.qjmed.a068422; Cattran DC, 2001, CYCLOSPORINE PATIENT; Cattran DC, 1995, CONTROLLED TRIAL CYC; Cattran DC, 1989, RANDOMIZED CONTROLLE; Chan TM, 2007, PROSPECTIVE CONTROLL; Chen M, 2010, AM J MED SCI, V339, P233, DOI 10.1097/MAJ.0b013e3181ca3a7d; Chen YZ, 2013, CLIN J AM SOC NEPHRO, V8, P787, DOI 10.2215/CJN.07570712; COGGINS CH, 1979, NEW ENGL J MED, V301, P1301; DAVISON AM, 1984, CLIN NEPHROL, V22, P61; DONADIO JV, 1974, KIDNEY INT, V6, P431, DOI 10.1038/ki.1974.129; Drachenberg CB, 1999, TRANSPLANTATION, V68, P396, DOI 10.1097/00007890-199908150-00012; Dussol B, 2008, AM J KIDNEY DIS, V52, P699, DOI 10.1053/j.ajkd.2008.04.013; Dyadyk A. I., 2001, Nephrology Dialysis Transplantation, V16, pA64; FALK RJ, 1992, ANN INTERN MED, V116, P438, DOI 10.7326/0003-4819-116-6-438; Haas M, 1997, AM J KIDNEY DIS, V30, P621, DOI 10.1016/S0272-6386(97)90485-6; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hladunewich MA, 2009, CLIN J AM SOC NEPHRO, V4, P1417, DOI 10.2215/CJN.01330209; Hofstra JM, 2012, NEPHROL DIAL TRANSPL, V27, P6, DOI 10.1093/ndt/gfr371; Howman A, 2013, LANCET, V381, P744, DOI 10.1016/S0140-6736(12)61566-9; Hoxha E, 2017, J AM SOC NEPHROL, V28, P520, DOI 10.1681/ASN.2016010050; Iwakura T., 2015, PLOS ONE, V1, P10, DOI [10.1371/journal, DOI 10.1371/J0URNAL.P0NE.0138841]; Jha V, 2007, J AM SOC NEPHROL, V18, P1899, DOI 10.1681/ASN.2007020166; KDIGO, KIDNEY INT S, V2, P186; Koshisawa S, 1993, JIN TOHSEKI, V34, P631; Kosmadakis G, 2010, RENAL FAILURE, V32, P566, DOI 10.3109/08860221003728754; Larsen CP, 2016, MODERN PATHOL, V29, P421, DOI 10.1038/modpathol.2016.32; Liu S, 2015, HONG KONG J NEPHROLO, V17, pS64; Liu SS, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0199-x; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Moher D., 1999, HEALTH TECHNOL ASSES, V3, pi, DOI [DOI 10.3310/HTA3120, 10.3310/hta3120]; MURPHY BF, 1992, CLIN NEPHROL, V37, P229; Naumovic R, 2011, BIOMED PHARMACOTHER, V65, P105, DOI 10.1016/j.biopha.2010.10.009; Nayagam LS, 2008, NEPHROL DIAL TRANSPL, V23, P1926, DOI 10.1093/ndt/gfm538; Pahari D K, 1993, J Assoc Physicians India, V41, P350; Peng L, 2016, J FORMOS MED ASSOC, V115, P11, DOI 10.1016/j.jfma.2015.07.021; PONTICELLI C, 1995, KIDNEY INT, V48, P1600, DOI 10.1038/ki.1995.453; Ponticelli C, 1998, RANDOMIZED STUDY COM; Ponticelli C, 1992, METHYLPREDNISOLONE P; Praga M, 2007, KIDNEY INT, V71, P924, DOI 10.1038/sj.ki.5002215; Qiu TT, 2016, AUTOIMMUN REV; Ramachandran R, 2016, NEPHROLOGY, V21, P139, DOI 10.1111/nep.12569; REICHERT LJM, 1994, ANN INTERN MED, V121, P328, DOI 10.7326/0003-4819-121-5-199409010-00003; Shibasaki Toshiaki, 2004, Clin Exp Nephrol, V8, P117; Tiller DJCA, 1981, ADV BAS CLIN NEPHR 8; Tomas NM, 2014, NEW ENGL J MED, V371, P2277, DOI 10.1056/NEJMoa1409354; Xu J, 2013, CONTRIB NEPHROL, V181, P152, DOI 10.1159/000348475	56	14	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184398	10.1371/journal.pone.0184398	http://dx.doi.org/10.1371/journal.pone.0184398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898290	gold, Green Published, Green Submitted			2022-12-27	WOS:000410449500026
J	Mezzasalma, V; Sandionigi, A; Bruni, I; Bruno, A; Lovicu, G; Casiraghi, M; Labra, M				Mezzasalma, Valerio; Sandionigi, Anna; Bruni, Ilaria; Bruno, Antonia; Lovicu, Gianni; Casiraghi, Maurizio; Labra, Massimo			Grape microbiome as a reliable and persistent signature of field origin and environmental conditions in Cannonau wine production	PLOS ONE			English	Article							RNA GENES DIFFERENTIATION; SOIL BACTERIAL DIVERSITY; FERMENTATION; CULTIVARS; TERROIR; POPULATION; SEQUENCES; VINEYARDS; DATABASE; MARKERS	Grape berries harbor a wide range of microbes originating from the vineyard environment, many of which are recognized for their role in the must fermentation process shaping wine quality. To better clarify the contribution of the microbiome of grape fruits during wine fermentation, we used high-throughput sequencing to identify bacterial and fungi communities associated with berries and musts of Cannonau. This is the most important cultivar-wine of Sardinia (Italy) where most vineyards are cultivated without phytochemical treatments. Results suggested that microbiomes of berries collected at four different localities share a core composition characterized by Enterobacteriales, Pseudomonadales, Bacillales, and Rhodospirillales. However, any area seems to enrich berries microbiome with peculiar microbial traits. For example, berries belonging to the biodynamic vineyards of Mamoiada were rich in Bacillales typical of manure (i.e. Lysinibacillus, Bacillus, and Sporosarcina), whereas in the Santadi locality, berries showed soil bacteria such as Pasteurellales and Bacteroidales as well as Rhodospirillales and Lactobacillales which are commonly involved in wine fermentation. In the case of fungi, the most abundant taxa were Dothioraceae, Pleosporaceae, and Saccharomycodaceae, and although the proportion of these families varied among localities, they occurred ubiquitously in all vineyards. During vinification processes performed at the same wine cellar under controlled conditions and without using any yeast starter, more than 50% of bacteria groups of berries reached musts, and each locality had its own private bacteria signature, even if Saccharomyces cerevisiae represented the most abundant fungal species. This work suggests that natural berries microbiome could be influenced by pedoclimatic and anthropologic conditions (e.g., farming management), and the fruits' microorganisms persist during the fermentation process. For these reasons, a reliable wine genotyping should include the entire holobiont (plant and all its symbionts), and bioprospecting activities on grape microbiota could lead to improved viticulture yields and wine quality.	[Mezzasalma, Valerio; Sandionigi, Anna; Bruni, Ilaria; Bruno, Antonia; Casiraghi, Maurizio; Labra, Massimo] Univ Milano Bicocca, Dept Biotechnol & Biosci, Zooplantlab, Milan, Italy; [Mezzasalma, Valerio] FEM2 Ambiente Srl, Milan, Italy; [Lovicu, Gianni] Agr Res Agcy Sardinia AGRIS, Sassari, Italy	University of Milano-Bicocca	Labra, M (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Zooplantlab, Milan, Italy.	massimo.labra@unimib.it	Sandionigi, Anna/H-8815-2016; Bruno, Antonia/ABB-7605-2020; Casiraghi, Maurizio/E-7273-2011; Mezzasalma, Valerio/B-3753-2016	Sandionigi, Anna/0000-0002-5257-0027; Bruno, Antonia/0000-0002-1929-6652; Casiraghi, Maurizio/0000-0002-2733-2094; Mezzasalma, Valerio/0000-0001-7651-4567; Bruni, Ilaria/0000-0002-9947-0963	SardegnaRicerche [CUP B81H11001320002]; FEM2-Ambiente	SardegnaRicerche(Regione Sardegna); FEM2-Ambiente	This work was supported by SardegnaRicerche (www.sardegnamerche.it) in the framework of the project AKINAS (CUP B81H11001320002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. FEM2-Ambiente s.r.l. provided support in the form of a salary for author Valerio Mezzasalma but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of research materials. The specific roles of this author is articulated in the 'author contributions' section.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Arbizu PM, 2016, RESEARCHGATE; Barata A, 2012, INT J FOOD MICROBIOL, V153, P243, DOI 10.1016/j.ijfoodmicro.2011.11.025; Belda I, INBIO WEB C, V9; Belda I, 2017, MOLECULES, V22, DOI 10.3390/molecules22020189; Bell SJ, 2005, AUST J GRAPE WINE R, V11, P242, DOI 10.1111/j.1755-0238.2005.tb00028.x; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Bokulich NA, 2016, MBIO, V7, DOI 10.1128/mBio.00631-16; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bokulich NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066437; Bruno A, 2017, SCI REPORTS, P7; Bruno A, 2016, MICROBIOLOGYOPEN; Bulgari D, 2009, J MICROBIOL, V47, P393, DOI 10.1007/s12275-009-0082-1; Burns KN, 2016, SOIL BIOL BIOCHEM, V103, P337, DOI 10.1016/j.soilbio.2016.09.007; Burns KN, 2015, SOIL BIOL BIOCHEM, V91, P232, DOI 10.1016/j.soilbio.2015.09.002; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Capozzi V, 2015, MICROBIOL RES, V181, P75, DOI 10.1016/j.micres.2015.10.005; Ciani M, 2016, FRONTIERS MICROBIOLO, P7; Ciani M, 2010, FEMS YEAST RES, V10, P123, DOI 10.1111/j.1567-1364.2009.00579.x; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Compant S, 2011, MICROB ECOL, V62, P188, DOI 10.1007/s00248-011-9883-y; De Mattia F, 2009, J HORTIC SCI BIOTECH, V84, P65, DOI 10.1080/14620316.2009.11512481; De Mattia F, 2007, J INT SCI VIGNE VIN, V41, P175; De Mattia F, 2008, REND LINCEI-SCI FIS, V19, P223, DOI 10.1007/s12210-008-0016-6; de Oliveira AF, 2016, AUST J GRAPE WINE R, V22, P96, DOI 10.1111/ajgw.12174; Portillo MD, 2016, INT J FOOD MICROBIOL, V219, P56, DOI 10.1016/j.ijfoodmicro.2015.12.002; Ding Guo-Chun, 2014, PLoS One, V9, pe92958, DOI 10.1371/journal.pone.0092958; du Toit M, 2011, FOOD BIOPROCESS TECH, V4, P876, DOI 10.1007/s11947-010-0448-8; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faissal AZ, 2017, SAUDI J BIOL SCI; Fleet GH, 2008, FEMS YEAST RES, V8, P979, DOI 10.1111/j.1567-1364.2008.00427.x; Fossati T, 2001, THEOR APPL GENET, V102, P200, DOI 10.1007/s001220051636; Garofalo C, 2015, J APPL MICROBIOL, V118, P1395, DOI 10.1111/jam.12789; Genomics BE, CALCULATE DRAW CUSTO; Gilbert JA, 2014, P NATL ACAD SCI USA, V111, P5, DOI 10.1073/pnas.1320471110; Green SJ, 2004, FEMS MICROBIOL LETT, V233, P115, DOI 10.1016/j.femsle.2004.01.049; Jolly N. P., 2006, SOUTH AFRICAN JOURNAL OF ENOLOGY AND VITICULTURE, V27, P15; Klindworth Anna, 2013, Nucleic Acids Res, V41, pe1, DOI 10.1093/nar/gks808; Lasik M, 2013, EUR FOOD RES TECHNOL, V237, P843, DOI 10.1007/s00217-013-2083-x; Leveau JHJ, 2011, ACTA HORTIC, V905, P31; Lovanh N, 2007, POULTRY SCI, V86, P1840, DOI 10.1093/ps/86.9.1840; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Martinez-Luscher J, 2015, PLANT SCI, V232, P13, DOI 10.1016/j.plantsci.2014.12.013; Martins G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073013; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Meng B., 2017, GRAPEVINE VIRUSES MO, DOI [10.1007/978-3-319-57706-7, DOI 10.1007/978-3-319-57706-7_2]; Oksanen J., 2007, COMMUNITY ECOLOGY PA, V10, P719; Patrignani F, 2017, ANN MICROBIOL, V67, P99, DOI 10.1007/s13213-016-1241-3; Pinheiro JC, 2012, NLME LINEAR NONLINEA, P1; Pinto C, 2016, BIOCONTROL, V61, P243, DOI 10.1007/s10526-016-9725-4; Pinto C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00905; Pinto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085622; Rana A, 2011, ANN MICROBIOL, V61, P893, DOI 10.1007/s13213-011-0211-z; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Santamaria P, 2005, INT J FOOD MICROBIOL, V103, P49, DOI 10.1016/j.ijfoodmicro.2004.11.024; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Styger G, 2011, J IND MICROBIOL BIOT, V38, P1145, DOI 10.1007/s10295-011-1018-4; Swiegers JH, 2005, ADV APPL MICROBIOL, V57, P131, DOI 10.1016/S0065-2164(05)57005-9; Van Leeuwen Cornelis, 2006, Journal of Wine Research, V17, P1, DOI 10.1080/09571260600633135; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; West ER, 2010, CAN J MICROBIOL, V56, P209, DOI [10.1139/w10-004, 10.1139/W10-004]; Zarraonaindia I, 2015, MBIO, V6, DOI 10.1128/mBio.02527-14; Zecca G, 2010, PLANT BIOLOGY, V12, P558, DOI 10.1111/j.1438-8677.2009.00226.x	64	57	59	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184615	10.1371/journal.pone.0184615	http://dx.doi.org/10.1371/journal.pone.0184615			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892512	Green Submitted, Green Published, gold			2022-12-27	WOS:000410243200019
J	Chandler, MR; Keene, KS; Tuomela, JM; Forero-Torres, A; Desmond, R; Vuopala, KS; Harris, KW; Merner, ND; Selander, KS				Chandler, Madison R.; Keene, Kimberly S.; Tuomela, Johanna M.; Forero-Torres, Andres; Desmond, Renee; Vuopala, Katri S.; Harris, Kevin W.; Merner, Nancy D.; Selander, Katri S.			Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-9; PROSTATE-CANCER; CELLULAR INVASION; ADAPTIVE IMMUNITY; 9 EXPRESSION; POLYMORPHISMS; AGONISTS; CELLS; DNA; INFLAMMATION	Introduction Toll-like receptor 9 (TLR9) is an innate immune system DNA-receptor that regulates tumor invasion and immunity in vitro. Low tumor TLR9 expression has been associated with poor survival in Caucasian patients with triple negative breast cancer (TNBC). African American (AA) patients with TNBC have worse prognosis than Caucasians but whether this is due to differences in tumor biology remains controversial. We studied the prognostic significance of tumor Toll like receptor-9 (TLR9) protein expression among African American (AA) triple negative breast cancer (TNBC) patients. Germline TLR9 variants in European Americans (EAs) and AAs were investigated, to determine their contribution to AA breast cancer risk. Methods TLR9 expression was studied with immunohistochemistry in archival tumors. Exome Variant Server and The Cancer Genome Atlas were used to determine the genetic variation in the general EA and AA populations, and AA breast cancer cases. Minor allele frequencies (MAFs) were compared between EAs (n = 4300), AAs (n = 2203), and/or AA breast cancer cases (n = 131). Results Thirty-two TLR9 variants had a statistically significant MAF difference between general EAs and AAs. Twenty-one of them affect a CpG site. Rs352140, a variant previously associated with protection from breast cancer, is more common in EAs than AAs (p = 2.20E-16). EAs had more synonymous alleles, while AAs had more rare coding alleles. Similar analyses comparing AA breast cancer cases with AA controls did not reveal any variant class differences; however, three previously unreported TLR9 variants were associated with late onset breast cancer. Although not statistically significant, rs352140 was observed less frequently in AA cases compared to controls. Tumor TLR9 protein expression was not associated with prognosis. Conclusions Tumor TLR9 expression is not associated with prognosis in AA TNBC. Significant differences were detected in TLR9 variant MAFs between EAs and AAs. They may affect TLR9 expression and function. Rs352140, which may protect from breast cancer, is 1.6 X more common among EAs. These findings call for a detailed analysis of the contribution of TLR9 to breast cancer pathophysiology and health disparities.	[Chandler, Madison R.] Auburn Univ, Harrison Sch Pharm, Auburn, AL 36849 USA; [Keene, Kimberly S.] Univ Alabama Birmingham, Dept Radiat Oncol, Birmingham, AL USA; [Tuomela, Johanna M.] Univ Turku, Inst Biomed, Dept Cell Biol & Anat, Turku, Finland; [Forero-Torres, Andres; Harris, Kevin W.] Univ Alabama Birmingham, Dept Med, Div Hematol & Oncol, Birmingham, AL 35294 USA; [Forero-Torres, Andres; Desmond, Renee; Harris, Kevin W.; Selander, Katri S.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA; [Desmond, Renee] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; [Vuopala, Katri S.; Selander, Katri S.] Lapland Cent Hosp, Dept Pathol, Rovaniemi, Finland; [Harris, Kevin W.] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA; [Merner, Nancy D.] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA; [Selander, Katri S.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA	Auburn University System; Auburn University; University of Alabama System; University of Alabama Birmingham; University of Turku; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; Auburn University System; Auburn University; University of Alabama System; University of Alabama Birmingham	Selander, KS (corresponding author), Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA.; Selander, KS (corresponding author), Lapland Cent Hosp, Dept Pathol, Rovaniemi, Finland.; Selander, KS (corresponding author), Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA.	Katriselander@uabmc.edu	Selander, Katri/GWM-8685-2022	Selander, Katri/0000-0003-4812-294X; Merner, Nancy/0000-0002-8954-0155; Tuomela, Johanna/0000-0003-4390-4563	Breast Cancer Research Foundation of Alabama; Maud Kuistila memorial foundation; Orion-Farmos Research foundation; Turku University foundation; Finnish Cultural foundation; Jane and Aatos Erkko Foundation; K. Albin Johansson foundation	Breast Cancer Research Foundation of Alabama; Maud Kuistila memorial foundation; Orion-Farmos Research foundation; Turku University foundation; Finnish Cultural foundation(Finnish Cultural FoundationFinnish IT center for science); Jane and Aatos Erkko Foundation; K. Albin Johansson foundation	This study was supported by grants from Breast Cancer Research Foundation of Alabama (K.S.S.), Maud Kuistila memorial foundation (J.T), Orion-Farmos Research foundation (J.T), Turku University foundation (J.T), Finnish Cultural foundation (J.T), Jane and Aatos Erkko Foundation (J.T.) and K. Albin Johansson foundation (J.T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from Breast Cancer Research Foundation of Alabama (K.S.S.), Maud Kuistila memorial foundation (J.T), Orion-Farmos Research foundation (J.T), Turku University foundation (J.T), Finnish Cultural foundation (J.T), Jane and Aatos Erkko Foundation (J.T.) and K. Albin Johansson foundation (J.T). The results shown here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/.	Adzhubei I, 2013, CURR PROTOC HUM GENE; Anders CK, 2009, CLIN BREAST CANCER, V9, pS73, DOI 10.3816/CBC.2009.s.008; Berger R, 2010, CANCER SCI, V101, P1059, DOI 10.1111/j.1349-7006.2010.01491.x; Carotenuto P, 2010, CRIT REV EUKAR GENE, V20, P17, DOI 10.1615/CritRevEukarGeneExpr.v20.i1.20; Carvalho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028256; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen KH, 2011, BRIT J SURG, V98, P1252, DOI 10.1002/bjs.7532; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Di JM, 2009, CANCER GENET CYTOGEN, V192, P60, DOI 10.1016/j.cancergencyto.2009.03.006; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hoque R, 2012, PANCREAS, V41, P353, DOI 10.1097/MPA.0b013e3182321500; Hyslop T, 2013, BIOMARK MED, V7, P11, DOI [10.2217/bmm.12.114, 10.2217/BMM.12.114]; Ilvesaro JM, 2008, MOL CANCER RES, V6, P1534, DOI 10.1158/1541-7786.MCR-07-2005; Ilvesaro JM, 2007, PROSTATE, V67, P774, DOI 10.1002/pros.20562; Jukkola-Vuorinen A, 2009, J INNATE IMMUN, V1, P59, DOI 10.1159/000151602; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Karody V, 2016, J MATERN-FETAL NEO M, V29, P2210, DOI 10.3109/14767058.2015.1081590; Kauppila JH, 2011, HISTOPATHOLOGY, V59, P643, DOI 10.1111/j.1365-2559.2011.03991.x; Korvala J, 2014, J ORAL PATHOL MED; Kubarenko AV, 2010, J BIOL CHEM, V285, P36486, DOI 10.1074/jbc.M110.117200; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; Lamphier MS, 2006, ANN NY ACAD SCI, V1082, P31, DOI 10.1196/annals.1348.005; Lange NE, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-26; Lazarus R, 2003, GENOMICS, V81, P85, DOI 10.1016/S0888-7543(02)00022-8; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Leppanen J, 2017, VIRCHOWS ARCH; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Lim JS, 2016, BIOCHEM BIOPH RES CO, V481, P219, DOI 10.1016/j.bbrc.2016.10.105; Long MD, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010015; Loo LWM, 2011, BREAST CANCER RES TR, V127, P297, DOI 10.1007/s10549-010-1297-x; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meng YX, 2008, J NEURO-ONCOL, V88, P19, DOI 10.1007/s11060-008-9536-2; Merrell MA, 2006, MOL CANCER RES, V4, P437, DOI 10.1158/1541-7786.MCR-06-0007; Meseure D, 2016, CANCER MICROENVIRON, V9, P107, DOI 10.1007/s12307-016-0186-1; Mukherjee S, 2014, J INFLAMM RES, V7, P89, DOI 10.2147/JIR.S61365; Nurmenniemi S, 2010, EXP CELL RES, V316, P2676, DOI 10.1016/j.yexcr.2010.05.024; Ogden A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42289; Omar AH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-168; Paul WE, 2011, CELL, V147, P1212, DOI 10.1016/j.cell.2011.11.036; Ronkainen H, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-84; Sandholm J, 2014, ONCOL LETT, V8, P266, DOI 10.3892/ol.2014.2095; Stewart PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082460; Sturtz LA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-62; Takala H, 2011, J INNATE IMMUN, V3, P631, DOI 10.1159/000329115; Tuomela J, 2013, BREAST CANCER RES TR, V142, P477, DOI 10.1007/s10549-013-2762-0; Tuomela J, 2012, BREAST CANCER RES TR, V135, P481, DOI 10.1007/s10549-012-2181-7; U. S. Department of Health and Human Services NIoH National Cancer Institute USA. gov, GDC DATA TRANSFER TO; U. S. Department of Health and Human Services NIoH National Cancer Institute USA. gov, GENOMIC DATA COMMONS; Vaisanen MR, 2013, ONCOL LETT, V5, P1659, DOI 10.3892/ol.2013.1204; Vaisanen MR, 2010, PROSTATE, V70, P817, DOI 10.1002/pros.21115; Wagner H, 2002, CURR OPIN MICROBIOL, V5, P62, DOI 10.1016/S1369-5274(02)00287-4; Wan GX, 2014, ASIAN PAC J CANCER P, V15, P8279, DOI 10.7314/APJCP.2014.15.19.8279; Wang XH, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15037641; Zhang LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071785; Zhang PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42796; Zhang YB, 2009, MOL BIOL REP, V36, P1475, DOI 10.1007/s11033-008-9338-9	58	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183832	10.1371/journal.pone.0183832	http://dx.doi.org/10.1371/journal.pone.0183832			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886076	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100040
J	Fernandes, LDD; Netto, EBF; Coutinho, R				de Almeida Fernandes, Lohengrin Dias; Fagundes Netto, Eduardo Barros; Coutinho, Ricardo		PELD-RECA	Inter-annual cascade effect on marine food web: A benthic pathway lagging nutrient supply to pelagic fish stock	PLOS ONE			English	Article							CABO FRIO BRAZIL; TOP-DOWN; SOUTHWESTERN ATLANTIC; TROPHIC STRUCTURE; UPWELLING SYSTEM; BOTTOM-UP; PHYTOPLANKTON; PLANKTON; SOUTH; CLIMATE	Currently, spatial and temporal changes in nutrients availability, marine planktonic, and fish communities are best described on a shorter than inter-annual (seasonal) scale, primarily because the simultaneous year-to-year variations in physical, chemical, and biological parameters are very complex. The limited availability of time series datasets furnishing simultaneous evaluations of temperature, nutrients, plankton, and fish have limited our ability to describe and to predict variability related to short-term process, as species-specific phenology and environmental seasonality. In the present study, we combine a computational time series analysis on a 15-year (1995-2009) weekly-sampled time series (high-resolution long-term time series, 780 weeks) with an Autoregressive Distributed Lag Model to track non-seasonal changes in 10 potentially related parameters: sea surface temperature, nutrient concentrations (NO2, NO3, NH4 and PO4), phytoplankton biomass (as in situ chlorophyll a biomass), meroplankton (barnacle and mussel larvae), and fish abundance (Mugil liza and Caranx latus). Our data demonstrate for the first time that highly intense and frequent upwelling years initiate a huge energy flux that is not fully transmitted through classical size-structured food web by bottom-up stimulus but through additional ontogenetic steps. A delayed inter-annual sequential effect from phytoplankton up to top predators as carnivorous fishes is expected if most of energy is trapped into benthic filter feeding organisms and their larval forms. These sequential events can explain major changes in ecosystem food web that were not predicted in previous short-term models.	[de Almeida Fernandes, Lohengrin Dias; Coutinho, Ricardo] Brazilian Navy, Inst Estudos Mar Almirante Paulo Moreira IEAPM, Dept Biotechnol, Arraial Do Cabo, RJ, Brazil; [de Almeida Fernandes, Lohengrin Dias; Fagundes Netto, Eduardo Barros; Coutinho, Ricardo] Marine Biotechnol Postgrad Program, Arraial Do Cabo, RJ, Brazil; [Fagundes Netto, Eduardo Barros] Brazilian Navy, Dept Oceanog, Inst Estudos Mar Almirante Paulo Moreira IEAPM, Arraial Do Cabo, RJ, Brazil; [de Almeida Fernandes, Lohengrin Dias] Inst Estudos Mar Almirante Paulo Moreira, Arraial Do Cabo, RJ, Brazil		Fernandes, LDD (corresponding author), Brazilian Navy, Inst Estudos Mar Almirante Paulo Moreira IEAPM, Dept Biotechnol, Arraial Do Cabo, RJ, Brazil.; Fernandes, LDD (corresponding author), Marine Biotechnol Postgrad Program, Arraial Do Cabo, RJ, Brazil.; Fernandes, LDD (corresponding author), Inst Estudos Mar Almirante Paulo Moreira, Arraial Do Cabo, RJ, Brazil.	lohengrin@marinha.mil.br	coutinho, ricardo/AAW-2458-2020; DA Fernandes, Lohengrin/C-2334-2009	coutinho, ricardo/0000-0001-5430-2176; DA Fernandes, Lohengrin/0000-0002-8579-2363	Fundacao Carlos Chagas Filho de Amparo a Ciencia [FAPERJ - E26/110.220/2011]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through "Programa de Pesquisa Ecologica de Longa Duracao PELD - RECA" [441525/2016-4]	Fundacao Carlos Chagas Filho de Amparo a Ciencia; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through "Programa de Pesquisa Ecologica de Longa Duracao PELD - RECA"	Financial support was provided by Fundacao Carlos Chagas Filho de Amparo a Ciencia (FAPERJ - E26/110.220/2011) (LDAF) through the "Estrutura e Dinamica Trofica em Assembleias Micropelagicas Marinhas em Area de Ressurgencia no Norte Fluminense" project, and also by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through "Programa de Pesquisa Ecologica de Longa Duracao PELD - RECA" (RC). (Proc. 441525/2016-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; BAKUN A, 1991, ICES J MAR SCI, V48, P343, DOI 10.1093/icesjms/48.3.343; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2010, GLOBAL CHANGE BIOL, V16, P1268, DOI 10.1111/j.1365-2486.2009.02063.x; Behrenfeld MJ, 2014, ANNU REV MAR SCI, V6, P167, DOI 10.1146/annurev-marine-052913-021325; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Carbonel CAA, 1999, ECOL MODEL, V116, P135, DOI 10.1016/S0304-3800(98)00201-4; Carvalho W.F., 2004, BRAZ J OCEANOGR, V52, P35; CGFAP/ DBFLO/ IBAMA, 2007, EST PESCA 2007; Chassot E, 2010, ECOL LETT, V13, P495, DOI 10.1111/j.1461-0248.2010.01443.x; Cibic T, 2009, J EXP MAR BIOL ECOL, V370, P144, DOI 10.1016/j.jembe.2008.12.006; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CLOERN JE, 1982, MAR ECOL PROG SER, V9, P191, DOI 10.3354/meps009191; Coelho-Souza SA, 2012, J OCEANOGR, V60, P353; Corbisier TN, 2014, MAR ECOL PROG SER, V512, P23, DOI 10.3354/meps10947; DALLAGNOLO R., 2010, BRAZILIAN J AQUATIC, V14, P95; Darriba S, 2005, ICES J MAR SCI, V62, P886, DOI 10.1016/j.icesjms.2005.02.010; Fernandes LDD, 2012, J PLANKTON RES, V34, P236, DOI 10.1093/plankt/fbr106; Desai DV, 2006, MAR BIOL, V149, P1431, DOI 10.1007/s00227-006-0315-3; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Frank KT, 2011, NATURE, V477, P86, DOI 10.1038/nature10285; FRECHETTE M, 1989, LIMNOL OCEANOGR, V34, P19, DOI 10.4319/lo.1989.34.1.0019; Geider RJ, 2001, GLOBAL CHANGE BIOL, V7, P849, DOI 10.1046/j.1365-2486.2001.00448.x; Gigliotti ES, 2010, J FISH BIOL, V77, P2248, DOI 10.1111/j.1095-8649.2010.02802.x; GONZALEZRODRIGUEZ E, 1994, HYDROBIOLOGIA, V294, P145, DOI 10.1007/BF00016855; Guenther M, 2008, OECOLOGIA BRASILIENS, V12, P172, DOI DOI 10.4257/0EC0.2008.1201.15; Guenther M, 2008, MAR ECOL PROG SER, V363, P109, DOI 10.3354/meps07458; Haimovici M., 1991, ATLANTICA RIO GRANDE, V13, P189; Halpern BS, 2006, SCIENCE, V312, P1230, DOI 10.1126/science.1128613; Hamilton J.D., 1994, TIME SERIES ANAL, V2, DOI 10.2307/j.ctv14jx6sm; Highfield JM, 2010, J PLANKTON RES, V32, P681, DOI 10.1093/plankt/fbp139; Horn H, 2008, LIMNOLOGICA, V38, P302, DOI 10.1016/j.limno.2008.05.007; Isangedighi IA, 2009, J AGR FOOD ENV, V5, P10; Jablonski S, 2004, SCI MAR, V68, P385, DOI 10.3989/scimar.2004.68n3385; Ji RB, 2010, J PLANKTON RES, V32, P1355, DOI 10.1093/plankt/fbq062; Kerimoglu O, 2013, OIKOS, V122, P223, DOI 10.1111/j.1600-0706.2012.20603.x; Landry MR, 2004, ICES J MAR SCI, V61, P501, DOI 10.1016/j.icesjms.2004.03.011; Le Moigne FAC, 2013, BIOGEOSCIENCES, V10, P281, DOI 10.5194/bg-10-281-2013; Levinton JS, 2013, PROCESSES OPEN SEA, P225; Lopez-Urrutia A, 2015, LIMNOL OCEANOGR, V60, P733, DOI 10.1002/lno.10049; Manriquez K, 2009, J PLANKTON RES, V31, P1075, DOI 10.1093/plankt/fbp053; Matsuura Y, 1996, S AFR J MARINE SCI, V17, P29; McManus GB, 2007, HYDROBIOLOGIA, V575, P69, DOI 10.1007/s10750-006-0279-9; Memery L, 2000, PROG OCEANOGR, V47, P69, DOI 10.1016/S0079-6611(00)00032-X; Modou S. S., 2014, International Journal of Agricultural Policy and Research, V2, P125; Monteiro-Ribas W., 2006, Braz. J. Biol., V66, P109, DOI 10.1590/S1519-69842006000100014; Mousing EA, 2014, MAR ECOL PROG SER, V497, P25, DOI 10.3354/meps10583; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pesaran M.H., 1998, EC SOC MONOGR, V31, P371, DOI DOI 10.1017/CCOL521633230.011; Rueda PS, 2002, REV BIOL TROP, V50, P245; SAZIMA I, 1986, J FISH BIOL, V29, P53, DOI 10.1111/j.1095-8649.1986.tb04926.x; Skinner LF, 2011, BRAZ J OCEANOGR, V59, P349, DOI 10.1590/S1679-87592011000400005; Skogen MD, 2007, ICES J MAR SCI, V64, P889, DOI 10.1093/icesjms/fsm063; SMITH SV, 1984, LIMNOL OCEANOGR, V29, P1149, DOI 10.4319/lo.1984.29.6.1149; Soares LSH, 2014, MAR ECOL PROG SER, V512, P9, DOI 10.3354/meps10948; Sommer U, 2002, ECOL RES, V17, P161, DOI 10.1046/j.1440-1703.2002.00476.x; Steinberg DK, 2017, ANNU REV MAR SCI, V9, P413, DOI 10.1146/annurev-marine-010814-015924; Straile D, 2007, CLIM RES, V34, P259, DOI 10.3354/cr00702; Thompson SA, 2012, PROG OCEANOGR, V101, P106, DOI 10.1016/j.pocean.2012.02.001; VALENTIN JL, 1986, ANN I OCEANOGR PARIS, V62, P117; Valentin JL, 2001, ECOL STU AN, V144, P97; VALENTIN JL, 1990, ECOL MODEL, V52, P103, DOI 10.1016/0304-3800(90)90011-5; VALENTIN JL, 1984, HYDROBIOLOGIA, V113, P183, DOI 10.1007/BF00026607; VELLEMAN PF, 1980, J AM STAT ASSOC, V75, P609, DOI 10.2307/2287657; VILLALOBOS CR, 1979, REV BIOL TROP, V27, P293	69	5	5	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184512	10.1371/journal.pone.0184512	http://dx.doi.org/10.1371/journal.pone.0184512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886162	Green Published, gold			2022-12-27	WOS:000410001100143
J	Jeong, S; Kim, J; Park, W; Jeon, H; Kim, N				Jeong, Seongmun; Kim, Jiwoong; Park, Won; Jeon, Hongmin; Kim, Namshin			SEXCMD: Development and validation of sex marker sequences for whole-exome/genome and RNA sequencing	PLOS ONE			English	Article							ASSOCIATION	Over the last decade, a large number of nucleotide sequences have been generated by next-generation sequencing technologies and deposited to public databases. However, most of these datasets do not specify the sex of individuals sampled because researchers typically ignore or hide this information. Male and female genomes in many species have distinctive sex chromosomes, XX/XY and ZW/ZZ, and expression levels of many sex-related genes differ between the sexes. Herein, we describe how to develop sex marker sequences from syntenic regions of sex chromosomes and use them to quickly identify the sex of individuals being analyzed. Array-based technologies routinely use either known sex markers or the B-allele frequency of X or Z chromosomes to deduce the sex of an individual. The same strategy has been used with whole-exome/genome sequence data; however, all reads must be aligned onto a reference genome to determine the B-allele frequency of the X or Z chromosomes. SEXCMD is a pipeline that can extract sex marker sequences from reference sex chromosomes and rapidly identify the sex of individuals from whole-exome/genome and RNA sequencing after training with a known dataset through a simple machine learning approach. The pipeline counts total numbers of hits from sex-specific marker sequences and identifies the sex of the individuals sampled based on the fact that XX/ZZ samples do not have Y or W chromosome hits. We have successfully validated our pipeline with mammalian (Homo sapiens; XY) and avian (Gallus gallus; ZW) genomes. Typical calculation time when applying SEXCMD to human whole-exome or RNA sequencing datasets is a few minutes, and analyzing human whole-genome datasets takes about 10 minutes. Another important application of SEXCMD is as a quality control measure to avoid mixing samples before bioinformatics analysis. SEXCMD comprises simple Python and R scripts and is freely available at https://github. com/lovemun/SEXCMD.	[Jeong, Seongmun; Park, Won; Jeon, Hongmin; Kim, Namshin] Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon, South Korea; [Kim, Jiwoong] Univ Texas Southwestern Med Ctr Dallas, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Texas System; University of Texas Southwestern Medical Center Dallas	Kim, N (corresponding author), Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon, South Korea.	deepreds@kribb.re.kr	Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X; Jeong, Seongmun/0000-0002-0038-461X	National Research Foundation of Korea [NRF-2011-0030049, NRF-2014M3C9A3064552]; Korea Research Institute of Bioscience and Biotechnology; KRIBB Initiative program	National Research Foundation of Korea(National Research Foundation of Korea); Korea Research Institute of Bioscience and Biotechnology; KRIBB Initiative program	This work was supported by grants from the National Research Foundation of Korea, Grant NRF-2011-0030049, NRF-2014M3C9A3064552 (http://www.nrf.re.kr/) and the Korea Research Institute of Bioscience and Biotechnology, NK., KRIBB Initiative program (http://www.kribb.re.kr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Research Foundation of Korea (NRF-2011-0030049, NRF-2014M3C9A3064552) and the KRIBB Initiative program.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Chaveerach A, 2015, FORENS SCI INT-GEN S, V5, pE390, DOI 10.1016/j.fsigss.2015.09.154; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Grady BJ, 2010, BIOCOMPUT-PAC SYM, P315; Harris RS, 2007, IMPROVED PAIRWISE AL, DOI DOI 10.1093/molbev/msx116; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li H., 2013, 13033997V1 ARXIV; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian DC, 2017, BIOINFORMATICS, V33, P561, DOI 10.1093/bioinformatics/btw696; Qu Conghui, 2011, Frontiers in Genetics, V2, P31, DOI 10.3389/fgene.2011.00031; Tzvetkov MV, 2010, PHARMACOGENOMICS, V11, P449, DOI [10.2217/pgs.10.14, 10.2217/PGS.10.14]	14	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184087	10.1371/journal.pone.0184087	http://dx.doi.org/10.1371/journal.pone.0184087			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886064	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100065
J	Soeria-Atmadja, S; Osterberg, E; Gustafsson, LL; Dahl, ML; Eriksen, J; Rubin, J; Naver, L				Soeria-Atmadja, Sandra; Osterberg, Emma; Gustafsson, Lars L.; Dahl, Marja-Liisa; Eriksen, Jaran; Rubin, Johanna; Naver, Lars			Genetic variants in CYP2B6 and CYP2A6 explain interindividual variation in efavirenz plasma concentrations of HIV-infected children with diverse ethnic origin	PLOS ONE			English	Article							AFRICAN HIV/AIDS PATIENTS; POPULATION PHARMACOKINETICS; HIV-1-INFECTED CHILDREN; ANTIRETROVIRAL THERAPY; POLYMORPHISMS; VARIABILITY; METABOLISM; PHARMACOGENETICS; GUIDELINES; NEVIRAPINE	Background Approximately 2.6 million children live with HIV globally, and efavirenz (EFV) is one of the most widely used antiretroviral agents for HIV treatment in children and adults. There are concerns about the appropriateness of current EFV dosing and it has been discussed whether EFV dosing should be adapted according to genotype in children as suggested for adults. Aim To investigate if pediatric EFV dosing should be guided by genetic variation in drug metabolizing enzymes rather than by body weight. Method EFV plasma concentrations measured for clinical purposes from all children less than 18 years old at Karolinska University Hospital, Stockholm, Sweden, treated with EFV were collected retrospectively. They were genotyped for eleven polymorphisms in genes coding for drug-metabolizing enzymes and P-glycoprotein, of potential importance for EFV disposition. Data on country of origin, sex, age, weight, HIV RNA, viral resistance patterns, CD4 cells, adherence to treatment, subjective health status and adverse events were collected from their medical records. Results Thirty-six patients and 182 (mean 5 samples/patient) EFV plasma concentration measurements from children of African, Asian and Latin American origin were included. EFV plasma concentration varied 21-fold between measurements (n = 182) (0.85 - 19.3 mg/L) and 9-fold measured as mean EFV plasma concentration across the subjects (1.55-13.4 mg/L). A multivariate mixed-effects restricted maximum likelihood regression model, including multiple gene polymorphisms, identified CYP2B6*6 T/T (p < 0.0005), CYP2B6*11 G/G (p < 0.0005), CYP2A6*9 A/C (p = 0.001) genotypes, age at treatment initiation (p = 0.002) and time from treatment initiation (p < 0.0005) as independent factors significantly related to log(e) concentration/(dose/weight). The contribution of the model to the intra-and interindividual variation were 6 and 75%, respectively (Bryk/Raudenbush R-squared level). Conclusion Genetic polymorphisms in CYP2B6 and CYP2A6 explained a significant proportion of variability in EFV plasma concentration in HIV-infected children in a multi-ethnic outpatient clinic. Knowledge about individual variants in key drug metabolizing enzyme genes could improve clinical safety and genotype directed dosing could achieve more predictable EFV plasma concentrations in HIV-infected children.	[Soeria-Atmadja, Sandra; Osterberg, Emma; Rubin, Johanna; Naver, Lars] Karolinska Univ Hosp, Dept Pediat, Stockholm, Sweden; [Soeria-Atmadja, Sandra; Rubin, Johanna; Naver, Lars] Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden; [Gustafsson, Lars L.; Dahl, Marja-Liisa; Eriksen, Jaran] Karolinska Univ Hosp, Karolinska Inst, Div Clin Pharmacol, Dept Lab Med, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Naver, L (corresponding author), Karolinska Univ Hosp, Dept Pediat, Stockholm, Sweden.; Naver, L (corresponding author), Karolinska Inst, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden.	lars.naver@ki.se	Navér, Lars/E-5085-2013	Eriksen, Jaran/0000-0003-1146-5615; Naver, Lars/0000-0001-6027-0211	Swedish Order of Freemason Foundation for Children; Samariten Foundation; Jerring Foundation; Karolinska Institutet Funds [2013tobi37895]; Swedish Research Council [2011-3440, VR-Link 2012-3466]	Swedish Order of Freemason Foundation for Children; Samariten Foundation; Jerring Foundation; Karolinska Institutet Funds; Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was supported by grants from the Swedish Order of Freemason Foundation for Children (LN), the Samariten Foundation (SSA), the Jerring Foundation (LN), Karolinska Institutet Funds (2013tobi37895) (LN) and the Swedish Research Council (2011-3440 and VR-Link 2012-3466) (LLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by grants from the Swedish Order of Freemason Foundation for Children (LN), the Samariten Foundation (SSA), the Jerring Foundation (LN), Karolinska Institutet Funds (LN) and the Swedish Research Council (2011-3440 and VR-Link 20123466) (LLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin J, 2015, LANCET INFECT DIS, V15, P793, DOI 10.1016/S1473-3099(15)70060-5; Barrett JS, 2002, INT J CLIN PHARM TH, V40, P507; BRYK AS, 1988, PSYCHOL BULL, V104, P396, DOI 10.1037/0033-2909.104.3.396; Burger D, 2006, BRIT J CLIN PHARMACO, V61, P148, DOI 10.1111/j.1365-2125.2005.02536.x; Dalgaard LS, 2012, SCAND J INFECT DIS, V44, P108, DOI 10.3109/00365548.2011.616223; Elens L, 2010, PHARMACOGENOMICS, V11, P1223, DOI 10.2217/PGS.10.94; Fillekes Q, 2011, JAIDS-J ACQ IMM DEF, V58, P392, DOI 10.1097/QAI.0b013e318235e560; Gutierrez F, 2005, CLIN INFECT DIS, V41, P1648, DOI 10.1086/497835; Hirt D, 2009, ANTIMICROB AGENTS CH, V53, P4407, DOI 10.1128/AAC.01594-08; Holzinger ER, 2012, PHARMACOGENET GENOM, V22, P858, DOI 10.1097/FPC.0b013e32835a450b; Hoody Dorie W, 2003, Semin Pediatr Infect Dis, V14, P286, DOI 10.1053/j.spid.2003.09.004; Kwara A, 2009, AIDS, V23, P2101, DOI 10.1097/QAD.0b013e3283319908; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Luo M, 2016, ANTIMICROB AGENTS CH, V60, P3676, DOI 10.1128/AAC.02678-15; Marzolini C, 2001, AIDS, V15, P71, DOI 10.1097/00002030-200101050-00011; Mirghani RA, 2006, PHARMACOGENET GENOM, V16, P637, DOI 10.1097/01.fpc.0000230411.89973.1b; Moore CB, 2017, AIDS, V31, P1129, DOI 10.1097/QAD.0000000000001463; Mukonzo JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086919; Mukonzo JK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-261; Mukonzo JK, 2009, BRIT J CLIN PHARMACO, V68, P690, DOI 10.1111/j.1365-2125.2009.03516.x; Mutwa PR, 2012, JAIDS-J ACQ IMM DEF, V60, P400, DOI 10.1097/QAI.0b013e3182569f57; Naidoo P, 2014, EUR J CLIN PHARMACOL, V70, P379, DOI 10.1007/s00228-013-1634-1; Ngaimisi E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067946; Pfister M, 2003, ANTIMICROB AGENTS CH, V47, P130, DOI 10.1128/AAC.47.1.130-137.2003; Pinillos F, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1381-x; Puthanakit T, ANTIVIR THER; Ren Y, 2007, JAIDS-J ACQ IMM DEF, V45, P133, DOI 10.1097/QAI.0b013e31805c9d52; Ribaudo HJ, 2010, J INFECT DIS, V202, P717, DOI 10.1086/655470; Rodriguez-Novoa S, 2005, CLIN INFECT DIS, V40, P1358, DOI 10.1086/429327; Saitoh A, 2007, JAIDS-J ACQ IMM DEF, V45, P280; Salem AH, 2014, ANTIMICROB AGENTS CH, V58, P136, DOI 10.1128/AAC.01738-13; Sharland M, 2004, HIV MED, V5, P61, DOI 10.1111/j.1468-1293.2004.00227.x; Shubber Z, 2013, AIDS, V27, P1403, DOI 10.1097/QAD.0b013e32835f1db0; Sinxadi PZ, 2015, BRIT J CLIN PHARMACO, V80, P146, DOI 10.1111/bcp.12590; Smith RL, 2021, J INFECT DIS; Stahle L, 2004, THER DRUG MONIT, V26, P267, DOI 10.1097/00007691-200406000-00008; Stohr W, 2008, ANTIVIR THER, V13, P675; Sukasem C, 2014, INFECTION, V42, P469, DOI 10.1007/s15010-013-0560-6; Swart M, 2013, PHARMACOGENET GENOM, V23, P415, DOI 10.1097/FPC.0b013e328363176f; Swart Marelize, 2012, Frontiers in Genetics, V3, P236, DOI 10.3389/fgene.2012.00236; Heine R, 2008, ANTIVIR THER, V13, P779; Usach I, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18567; Van Leth F, 2006, AIDS RES HUM RETROV, V22, P232, DOI 10.1089/aid.2006.22.232; Viljoen M, 2012, EUR J CLIN PHARMACOL, V68, P339, DOI 10.1007/s00228-011-1148-7; Ward BA, 2003, J PHARMACOL EXP THER, V306, P287, DOI 10.1124/jpet.103.049601; WHO, CONS US ANT DRUGS TR	46	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0181316	10.1371/journal.pone.0181316	http://dx.doi.org/10.1371/journal.pone.0181316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886044	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100002
J	Wang, W; Li, K; Yue, SW; Yin, CP; Wei, N				Wang, Wei; Li, Ke; Yue, Shouwei; Yin, Cuiping; Wei, Na			Associations between lower-limb muscle activation and knee flexion in post-stroke individuals: A study on the stance-to-swing phases of gait	PLOS ONE			English	Article							RECTUS FEMORIS; CEREBRAL-PALSY; CHRONIC STROKE; WALKING; EXERCISE; CLASSIFICATION; COORDINATION; HEMIPARESIS; KINEMATICS; STRATEGIES	Reduced knee flexion is a leading feature of post-stroke gait, but the causes have not been well understood. The purpose of this study was to investigate the relationship between the knee flexion and the lower-limb muscle activation within the stance-to-swing phases of gait cycle in the post-stroke hemiplegic patients. Ten stroke patients and 10 age- and gender-matched healthy subjects participated in the experiment. The lower-limb kinematic signals and the surface electromyography (sEMG) signals of the left and right rectus femoris (RF), biceps femoris (BF) and lateral gastrocnemius (GS) were recorded during walking. The angle range (AR) of knee flexion, the root mean square (RMS) and the mean frequency (MNF) of sEMG signals were calculated from the terminal stance (TSt) to the initial swing (ISw) phases of gait cycle. Stroke patients showed lower bilateral AR of knee flexion and lower RMS of GS on the paretic side, but higher MNF of RF on the non-paretic side compared with the controls. Within the stroke patients, significant differences were found between their paretic and non-paretic limbs in the AR of knee flexion, as well as in the RMS and MNF of GS (p < 0.05). Regression analysis showed that the RMS of BF, MNF of BF and MNF of GS explained 82.1% of variations in AR of knee flexion on paretic side (r(2) = 0.821). But the RMS and MNF of all the muscles (including the RF, GS and BF) could explain 65.6% of AR of knee flexion variations on the non-paretic side (r(2) = 0.656), and 45.2% of variations for the healthy subjects (r(2) = 0.452). The reduced knee flexion during gait was associated with altered magnitude and frequency of muscle contractions and with simplified muscle synergy in the post-stroke hemiplegic patients. Identifying the muscles that are responsible for knee stiffness may facilitate improvement of rehabilitation strategy for post-stroke gait.	[Wang, Wei; Li, Ke] Shandong Univ, Sch Control Sci & Engn, Inst Biomed Engn, Lab Motor Control & Rehabil, Jinan, Shandong, Peoples R China; [Yue, Shouwei; Yin, Cuiping] Shandong Univ, Qilu Hosp, Dept Phys Med & Rehabil, Jinan, Shandong, Peoples R China; [Wei, Na] Shandong Univ, Qilu Hosp, Dept Geriatr, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Li, K (corresponding author), Shandong Univ, Sch Control Sci & Engn, Inst Biomed Engn, Lab Motor Control & Rehabil, Jinan, Shandong, Peoples R China.	kli@sdu.edu.cn		Li, Ke/0000-0002-8660-0116	National Natural Science Foundation of China [31200744]; Key Research & Development Programs of Shandong Province [KL 2015GSF118127, 2015GSF118127]; China Postdoctoral Science Foundation [KL 2014M560558, 2015T80723, 2014M560558]; Postdoctoral Innovation Foundation of Shandong Province [KL 201401012, 201401012]; Shandong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research & Development Programs of Shandong Province; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Postdoctoral Innovation Foundation of Shandong Province; Shandong University	Funded by 31200744, http://www.nsfc.gov.cn/, National Natural Science Foundation of China, KL 2015GSF118127, http://www.sdstc.gov.cn/, Key Research & Development Programs of Shandong Province, KL 2014M560558, 2015T80723, http://jj.chinapostdoctor.org.cn/V1/Program3/Default.aspx, China Postdoctoral Science Foundation, KL 201401012, http://www.sdhrss.gov.cn/, Postdoctoral Innovation Foundation of Shandong Province, KL NA, http://www.sdu.edu.cn, Young Scholars Program of Shandong University, KL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Natural Science Foundation of China (31200744), Key Research & Development Programs of Shandong Province (2015GSF118127), China Postdoctoral Science Foundation (2014M560558, 2015T80723), Postdoctoral Innovation Foundation of Shandong Province (201401012), Young Scholars Program of Shandong University. The authors give thanks to all the stroke patients and healthy subjects for their participation in the experiment.	Alcan V, 2017, TURK J MED SCI, V47, P148, DOI 10.3906/sag-1512-65; Allen JL, 2014, CLIN BIOMECH, V29, P780, DOI 10.1016/j.clinbiomech.2014.06.001; Anderson FC, 2004, J BIOMECH, V37, P731, DOI 10.1016/j.jbiomech.2003.09.018; Boudarham J, 2013, J ELECTROMYOGR KINES, V23, P1036, DOI 10.1016/j.jelekin.2013.07.002; Boudarham J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094138; Burpee JL, 2015, CLIN BIOMECH, V30, P1102, DOI 10.1016/j.clinbiomech.2015.08.018; Chen IH, 2014, CHINESE J PHYSIOL, V57, P128, DOI 10.4077/CJP.2014.BAC204; Cruz AI, 2011, J PEDIATR ORTHOPED, V31, P541, DOI 10.1097/BPO.0b013e31821f818d; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Drefus LC, 2014, GAIT POSTURE, V40, P145, DOI 10.1016/j.gaitpost.2014.03.017; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Francis CA, 2013, GAIT POSTURE, V38, P993, DOI 10.1016/j.gaitpost.2013.05.009; George-Reichley DG, 2010, J APPL BIOMECH, V26, P180, DOI 10.1123/jab.26.2.180; Gray VL, 2015, J ELECTROMYOGR KINES, V25, P959, DOI 10.1016/j.jelekin.2015.09.003; Hill E, 2016, CONCENTRIC MUSCLE AC, V4; Jung H, 2015, INT J PRECIS ENG MAN, V16, P2219, DOI 10.1007/s12541-015-0286-8; Knuppe AE, 2013, GAIT POSTURE, V37, P345, DOI 10.1016/j.gaitpost.2012.07.034; Lamontagne A, 2000, J ELECTROMYOGR KINES, V10, P407, DOI 10.1016/S1050-6411(00)00028-6; Lewek MD, 2014, J APPL BIOMECH, V30, P31, DOI 10.1123/jab.2012-0208; Li JM, 2007, J AM PODIAT MED ASSN, V97, P447, DOI 10.7547/0970447; Lo J, 2017, GAIT POSTURE, V53, P110, DOI 10.1016/j.gaitpost.2017.01.010; Nadiv Y, 2012, J APPL BIOMECH, V28, P139, DOI 10.1123/jab.28.2.139; Ostadal M, 2007, ACTA CHIR ORTHOP TR, V74, P388; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Sarre G, 2005, ACTA PHYSIOL SCAND, V185, P321, DOI 10.1111/j.1365-201X.2005.01490.x; Tennant LM, 2014, J ELECTROMYOGR KINES, V24, P711, DOI 10.1016/j.jelekin.2014.06.011; Wonsetler E.C., 2017, TOP STROKE REHABIL, V21, P1; Wonsetler EC, 2017, TOP STROKE REHABIL, V24, P394, DOI 10.1080/10749357.2017.1282413	28	21	26	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183865	10.1371/journal.pone.0183865	http://dx.doi.org/10.1371/journal.pone.0183865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886079	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100042
J	Zhang, CL; Acosta-Sampson, L; Yu, VY; Cate, JHD				Zhang, Chenlu; Acosta-Sampson, Ligia; Yu, Vivian Yaci; Cate, Jamie H. D.			Screening of transporters to improve xylodextrin utilization in the yeast Saccharomyces cerevisiae	PLOS ONE			English	Article							DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; GLUCOSE TRANSPORTERS; BIOFUEL PRODUCTION; D-XYLOSE; BIOTECHNOLOGY; CONSUMPTION; ENZYMES; BIOMASS	The economic production of cellulosic biofuel requires efficient and full utilization of all abundant carbohydrates naturally released from plant biomass by enzyme cocktails. Recently, we reconstituted the Neurospora crassa xylodextrin transport and consumption system in Saccharomyces cerevisiae, enabling growth of yeast on xylodextrins aerobically. However, the consumption rate of xylodextrin requires improvement for industrial applications, including consumption in anaerobic conditions. As a first step in this improvement, we report analysis of orthologues of the N. crassa transporters CDT-1 and CDT-2. Transporter ST16 from Trichoderma virens enables faster aerobic growth of S. cerevisiae on xylodextrins compared to CDT-2. ST16 is a xylodextrin-specific transporter, and the xylobiose transport activity of ST16 is not inhibited by cellobiose. Other transporters identified in the screen also enable growth on xylodextrins including xylotriose. Taken together, these results indicate that multiple transporters might prove useful to improve xylodextrin utilization in S. cerevisiae. Efforts to use directed evolution to improve ST16 from a chromosomally-integrated copy were not successful, due to background growth of yeast on other carbon sources present in the selection medium. Future experiments will require increasing the baseline growth rate of the yeast population on xylodextrins, to ensure that the selective pressure exerted on xylodextrin transport can lead to isolation of improved xylodextrin transporters.	[Zhang, Chenlu] Tsinghua Univ, Dept Life Sci, Beijing, Peoples R China; [Acosta-Sampson, Ligia; Yu, Vivian Yaci; Cate, Jamie H. D.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Cate, Jamie H. D.] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA	Tsinghua University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Cate, JHD (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Cate, JHD (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging, Berkeley, CA 94720 USA.	jcate@lbl.gov		Cate, Jamie/0000-0001-5965-7902	Energy Biosciences Institute; China Scholarship Council	Energy Biosciences Institute; China Scholarship Council(China Scholarship Council)	This work was supported by Energy Biosciences Institute (ttp://energybiosciencesinstitute.org/); China Scholarship Council (http://en.csc.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank British Petroleum for the library of CDT-1 and CDT-2 orthologues. This work was supported by the Energy Biosciences Institute. C.Z. was supported by the China Scholarship Council.	Berlin A, 2007, BIOTECHNOL BIOENG, V97, P287, DOI 10.1002/bit.21238; Cai PL, 2015, J BIOL CHEM, V290, P788, DOI 10.1074/jbc.M114.609875; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dougherty MJ, 2009, CURR OPIN BIOTECH, V20, P486, DOI 10.1016/j.copbio.2009.08.005; Esvelt KM, 2011, NATURE, V472, P499, DOI 10.1038/nature09929; Farwick A, 2014, P NATL ACAD SCI USA, V111, P5159, DOI 10.1073/pnas.1323464111; Galazka JM, 2010, SCIENCE, V330, P84, DOI 10.1126/science.1192838; Henderson PJF, 2013, NAT STRUCT MOL BIOL, V20, P654, DOI 10.1038/nsmb.2604; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; HOSAKA K, 1992, J BIOCHEM-TOKYO, V111, P352, DOI 10.1093/oxfordjournals.jbchem.a123761; Katahira S, 2004, APPL ENVIRON MICROB, V70, P5407, DOI 10.1128/AEM.70.9.5407-5414.2004; Kell DB, 2015, TRENDS BIOTECHNOL, V33, P237, DOI 10.1016/j.tibtech.2015.02.001; Kim SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057048; Lee ME, 2015, ACS SYNTH BIOL, V4, P975, DOI 10.1021/sb500366v; Lemieux MJ, 2007, MOL MEMBR BIOL, V24, P333, DOI 10.1080/09687680701496507; Li HB, 2016, APPL MICROBIOL BIOT, V100, P10215, DOI 10.1007/s00253-016-7879-8; Li X, 2015, ELIFE, P4; Lin YP, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0126-6; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; Nijland JG, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0168-9; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Sen A, 2016, APPL ENVIRON MICROB, V82, P7074, DOI 10.1128/AEM.02148-16; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Wei N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3580	31	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184730	10.1371/journal.pone.0184730	http://dx.doi.org/10.1371/journal.pone.0184730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886200	gold, Green Submitted, Green Published			2022-12-27	WOS:000410001100183
J	Illera, JC; Lopez, G; Garcia-Padilla, L; Moreno, A				Carlos Illera, Juan; Lopez, Guillermo; Garcia-Padilla, Laura; Moreno, Angel			Factors governing the prevalence and richness of avian haemosporidian communities within and between temperate mountains	PLOS ONE			English	Article							PIPIT ANTHUS-BERTHELOTII; LEAST-SQUARES REGRESSION; NEVADA SOUTHERN SPAIN; EUROPA NATIONAL-PARK; CLIMATE-CHANGE; MALARIA TRANSMISSION; BLOOD PARASITES; SIERRA-NEVADA; HAPLOTYPE RECONSTRUCTION; LAST DEGLACIATION	Mountains are well-suited systems to disentangle the factors driving distribution of parasites due to their heterogeneity of climatic and habitat conditions. However, the information about the relative importance of environmental factors governing the distribution of avian haemosporidians on temperate mountains is very limited. The main goal of the present study is to identify the factors determining prevalence and richness in avian haemosporidians ( Plasmodium, Haemoproteus and Leucocytozoon) at the community level along elevational gradients on two mountain ranges located around the northern and southern limits of the Iberian Peninsula (Spain). We used samples from 68 avian species and 1,460 breeding individuals caught over widespread woodland and open habitats. Our findings confirmed the importance of climatic variables explaining prevalence and richness on Iberian mountains. However, landscape variables and other factors named host richness and migration behaviour explained more variation than climatic ones. Plasmodium genus preferred open and warm habitats. Water sources were also important for the southern but not for the northern mountain. Haemoproteus and Leucocytozoon showed affinities for woodland areas. Climatic conditions for Haemoproteus and Leucocytozoon were dependent on the mountain range suggesting some adaptation of avian haemosporidian and their invertebrate vectors to the climatic particularities of both mountain massifs. In contrast to Plasmodium and Haemoproteus genera, Leucocytozoon prevalence and richness values were significantly higher in the southern mountain range. Overall, our findings at the community level has enriched the relative weight and effect direction of environmental factors governing the distribution and prevalence of the avian haemosporidian community. Also, our results provide a caution message about the precision of predictive models on parasite distributions based on climatic variables, since such predictions could overestimate the effect of climate change scenarios on the transmission of the haemosporidians.	[Carlos Illera, Juan; Garcia-Padilla, Laura] Oviedo Univ, Res Unit Biodivers, Mieres, Asturias, Spain; [Lopez, Guillermo] Inst Biol Conservac, Malaga, Spain; [Moreno, Angel] Vice Council Environm, Serv Environm Impact, Las Palmas Gran Canaria, Canary Islands, Spain		Illera, JC (corresponding author), Oviedo Univ, Res Unit Biodivers, Mieres, Asturias, Spain.	illerajuan@uniovi.es	Illera, Juan Carlos/C-6583-2014	Illera, Juan Carlos/0000-0002-4389-0264	Spanish Administration of National Parks; Spanish Minister of Agriculture, Food and Environment [375/2011]	Spanish Administration of National Parks; Spanish Minister of Agriculture, Food and Environment	This study was funded by the Spanish Administration of National Parks, Spanish Minister of Agriculture, Food and Environment (Ref.: 375/2011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Anderson RS, 2011, QUATERNARY SCI REV, V30, P1615, DOI 10.1016/j.quascirev.2011.03.005; Rojo MA, 2013, BIRD STUDY, V60, P247, DOI 10.1080/00063657.2012.744807; Asghar M, 2015, SCIENCE, V347, P436, DOI 10.1126/science.1261121; Atkinson CT, 2014, GLOBAL CHANGE BIOL, V20, P2426, DOI 10.1111/gcb.12535; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bruford Michael W., 1998, P287; Illera JC, 2015, J BIOGEOGR, V42, P1858, DOI 10.1111/jbi.12548; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Christiansen-Jucht C, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0489-3; Clark NJ, 2017, MOL ECOL, V26, P3074, DOI 10.1111/mec.14101; Clark NJ, 2014, INT J PARASITOL, V44, P329, DOI 10.1016/j.ijpara.2014.01.004; Currie DC, 2008, HYDROBIOLOGIA, V595, P469, DOI 10.1007/s10750-007-9114-1; Dulle HI, 2016, DIVERS DISTRIB, V22, P288, DOI 10.1111/ddi.12405; Ellisa VA, 2015, P NATL ACAD SCI USA, V112, P11294, DOI 10.1073/pnas.1515309112; Garamszegi LZ, 2011, GLOBAL CHANGE BIOL, V17, P1751, DOI 10.1111/j.1365-2486.2010.02346.x; Gonzalez AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100695; Gonzalez-Quevedo C, 2014, J ANIM ECOL, V83, P1091, DOI 10.1111/1365-2656.12214; Goudie Andrew, 2013, HUMAN IMPACT NATURAL; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Gutierrez D, 2004, BIOL CONSERV, V115, P379, DOI 10.1016/S0006-3207(03)00154-X; Gutierrez-Lopez R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1903-9; H?skuldsson A., 1988, J CHEMOMETR, V2, P211, DOI DOI 10.1002/CEM.1180020306; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Harrigan RJ, 2014, EVOL APPL, V7, P799, DOI 10.1111/eva.12176; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Illera JC, 2008, PARASITOL RES, V103, P1435, DOI 10.1007/s00436-008-1153-7; Ishtiaq F, 2010, J BIOGEOGR, V37, P120, DOI 10.1111/j.1365-2699.2009.02189.x; Kebede A, 2005, AM J TROP MED HYG, V73, P676, DOI 10.4269/ajtmh.2005.73.676; Krizanauskiene A, 2006, J PARASITOL, V92, P1319, DOI 10.1645/GE-873R.1; Laiolo P, 2013, J EVOLUTION BIOL, V26, P2171, DOI 10.1111/jeb.12213; Laiolo P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1808; Laiolo P, 2015, AM NAT, V185, P169, DOI 10.1086/679348; Liao W, 2015, GLOBAL CHANGE BIOL, V21, P4342, DOI 10.1111/gcb.13005; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loiseau C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01126; Martinez-de la Puente J, 2011, MOL ECOL, V20, P3275, DOI 10.1111/j.1365-294X.2011.05136.x; Martins IS, 2014, ACTA OECOL, V61, P41, DOI 10.1016/j.actao.2014.10.005; Melendez L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101942; Melendez L, 2014, IBIS, V156, P276, DOI 10.1111/ibi.12127; Menendez R, 2014, GLOBAL ECOL BIOGEOGR, V23, P646, DOI 10.1111/geb.12142; Moens MAJ, 2016, J ANIM ECOL, V85, P1234, DOI 10.1111/1365-2656.12550; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Moreno A, 2010, J QUATERNARY SCI, V25, P1076, DOI 10.1002/jqs.1265; Outlaw DC, 2016, PARASITOLOGY, V8, P1; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Padilla DP, 2017, INT J PARASITOL, V47, P225, DOI 10.1016/j.ijpara.2016.11.008; Palacios D, 2016, QUATERNARY SCI REV, V150, P110, DOI 10.1016/j.quascirev.2016.08.012; Perez-Rodriguez A, 2014, GLOBAL CHANGE BIOL, V20, P2406, DOI 10.1111/gcb.12542; Perez-Rodriguez A, 2013, GLOBAL CHANGE BIOL, V19, P3245, DOI 10.1111/gcb.12226; Perez-Tris J, 2005, TRENDS PARASITOL, V21, P209, DOI 10.1016/j.pt.2005.03.001; Ploquin EF, 2013, OECOLOGIA, V173, P1649, DOI 10.1007/s00442-013-2731-7; Pointing SB, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.145, 10.1038/NMICROBIOL.2016.145]; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; Santiago-Alarcon D, 2012, BIOL REV, V87, P928, DOI 10.1111/j.1469-185X.2012.00234.x; Scordato ESC, 2014, J ANIM ECOL, V83, P1387, DOI 10.1111/1365-2656.12246; Sehgal RNM, 2011, P ROY SOC B-BIOL SCI, V278, P1025, DOI 10.1098/rspb.2010.1720; Sehgal RNM, 2015, INT J PARASITOL-PAR, V4, P421, DOI 10.1016/j.ijppaw.2015.09.001; Spurgin LG, 2012, OECOLOGIA, V168, P691, DOI 10.1007/s00442-011-2149-z; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Valkinas G., 2005, AVIAN MALARIA PARASI; Ya'cob Z, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1492-7; Young HS, 2017, TRENDS ECOL EVOL, V32, P41, DOI 10.1016/j.tree.2016.09.008; Zamora R, 2015, ARDEOLA, V62, P3, DOI 10.13157/arla.62.1.2015.3; Zamora-Vilchis I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039208	67	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184587	10.1371/journal.pone.0184587	http://dx.doi.org/10.1371/journal.pone.0184587			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880919	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200079
J	Deshpande, CN; Xin, V; Lu, Y; Savage, T; Anderson, GJ; Jormakka, M				Deshpande, Chandrika N.; Xin, Vicky; Lu, Yan; Savage, Tom; Anderson, Gregory J.; Jormakka, Mika			Large scale expression and purification of secreted mouse hephaestin	PLOS ONE			English	Article							RECOMBINANT HUMAN HEPHAESTIN; NUCLEAR POLYHEDROSIS-VIRUS; FERROXIDASE ACTIVITY; INSECT CELLS; IRON EFFLUX; NEURODEGENERATIVE DISORDERS; MULTICOPPER OXIDASE; FET3 PROTEIN; BRAIN IRON; CERULOPLASMIN	Hephaestin is a large membrane-anchored multicopper ferroxidase involved in mammalian iron metabolism. Newly absorbed dietary iron is exported across the enterocyte basolateral membrane by the ferrous iron transporter ferroportin, but hephaestin increases the efficiency of this process by oxidizing the transported iron to its ferric form and promoting its release from ferroportin. Deletion or mutation of the hephaestin gene leads to systemic anemia with iron accumulation in the intestinal epithelium. The crystal structure of human ceruloplasmin, another multicopper ferroxidase with 50% sequence identity to hephaestin, has provided a framework for comparative analysis and modelling. However, detailed structural information for hephaestin is still absent, leaving questions relating to metal coordination and binding sites unanswered. To obtain structural information for hephaestin, a reliable protocol for large-scale purification is required. Here, we present an expression and purification protocol of soluble mouse hephaestin, yielding milligram amounts of enzymatically active, purified protein using the baculovirus/insect cell system.	[Deshpande, Chandrika N.; Xin, Vicky; Jormakka, Mika] Centenary Inst, Struct Biol Program, Sydney, NSW, Australia; [Deshpande, Chandrika N.; Xin, Vicky; Jormakka, Mika] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Lu, Yan; Anderson, Gregory J.] QIMR Berghofer Med Res Inst, Iron Metab Lab, Brisbane, Qld, Australia; [Savage, Tom] Univ Sydney, Sch Geosci, Sydney, NSW, Australia; [Anderson, Gregory J.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia	University of Sydney; Centenary Institute; University of Sydney; QIMR Berghofer Medical Research Institute; University of Sydney; University of Queensland	Jormakka, M (corresponding author), Centenary Inst, Struct Biol Program, Sydney, NSW, Australia.; Jormakka, M (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	m.jormakka@centenary.org.au	; Anderson, Gregory/G-4148-2013	Deshpande, Chandrika/0000-0002-5557-519X; Anderson, Gregory/0000-0002-8814-5866	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK107309]; National Health and Medical Research Council (NHMRC) [APP1083536]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107309] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported primarily by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01 DK107309 and by the National Health and Medical Research Council (NHMRC) (grant No. APP1083536) (to M. J.). The content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the NIDDK, the National Institutes of Health, and NHMRC.	Bruinzeel W, 2002, PROTEIN EXPRES PURIF, V26, P139, DOI 10.1016/S1046-5928(02)00516-8; Chen HJ, 2006, J NUTR, V136, P1236, DOI 10.1093/jn/136.5.1236; Chen HJ, 2009, J CELL BIOCHEM, V107, P803, DOI 10.1002/jcb.22178; deSilva D, 1997, J BIOL CHEM, V272, P14208, DOI 10.1074/jbc.272.22.14208; DEXTER DT, 1993, ADV NEUROL, V60, P273; Fuqua BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098792; GRANADOS RR, 1994, J INVERTEBR PATHOL, V64, P260, DOI 10.1016/S0022-2011(94)90400-6; Griffiths TAM, 2005, BIOCHEMISTRY-US, V44, P14725, DOI 10.1021/bi051559k; Hancock K, 2008, J IMMUNOL METHODS, V330, P130, DOI 10.1016/j.jim.2007.08.002; Harris ZL, 1999, P NATL ACAD SCI USA, V96, P10812, DOI 10.1073/pnas.96.19.10812; Hassett RF, 1998, J BIOL CHEM, V273, P23274, DOI 10.1074/jbc.273.36.23274; Heppner DE, 2014, J AM CHEM SOC, V136, P17788, DOI 10.1021/ja509150j; JARVIS DL, 1993, J BIOL CHEM, V268, P16754; Jiang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep39470; Jiang RW, 2015, J NUTR, V145, P1003, DOI 10.3945/jn.114.207316; Krammer F, 2010, BIOTECHNOL J, V5, P17, DOI 10.1002/biot.200900267; Lindley PF, 1997, J BIOL INORG CHEM, V2, P454, DOI 10.1007/s007750050156; McCarthy RC, 2013, J BIOL CHEM, V288, P17932, DOI 10.1074/jbc.M113.455428; Nittis T, 2004, J BIOL CHEM, V279, P25696, DOI 10.1074/jbc.M401151200; Ponka P, 2004, ANN NY ACAD SCI, V1012, P267, DOI 10.1196/annals.1306.022; Price KA, 2011, INORG CHEM, V50, P9594, DOI 10.1021/ic201334q; Ranganathan PN, 2012, P NATL ACAD SCI USA, V109, P3564, DOI 10.1073/pnas.1120833109; Ranganathan PN, 2011, BLOOD, V118, P3146, DOI 10.1182/blood-2011-05-352112; Sambrook J., 2001, MOL CLONING LAB MANU; Schipper HM, 2012, BBA-MOL BASIS DIS, V1822, P350, DOI 10.1016/j.bbadis.2011.06.016; Seismann H, 2010, MOL IMMUNOL, V47, P799, DOI 10.1016/j.molimm.2009.10.005; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Syed BA, 2002, PROTEIN ENG, V15, P205, DOI 10.1093/protein/15.3.205; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Vashchenko G, 2012, J BIOL INORG CHEM, V17, P1187, DOI 10.1007/s00775-012-0932-x; Vashchenko G, 2011, ARCH BIOCHEM BIOPHYS, V514, P50, DOI 10.1016/j.abb.2011.07.010; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; VOLKMAN LE, 1986, CURR TOP MICROBIOL, V131, P103; Ward R, 2014, LANCET NEUROL, V13, P1045, DOI 10.1016/S1474-4422(14)70117-6; Wessling-Resnick M, 2006, AM J PHYSIOL-GASTR L, V290, pG1, DOI 10.1152/ajpgi.00415.2005; WHITFORD M, 1989, J VIROL, V63, P1393, DOI 10.1128/JVI.63.3.1393-1399.1989; WICKHAM TJ, 1993, BIOTECHNOL PROGR, V9, P25, DOI 10.1021/bp00019a004; YEHUDA S, 1989, AM J CLIN NUTR, V50, P618, DOI 10.1093/ajcn/50.3.618; Zaitseva I, 1996, J BIOL INORG CHEM, V1, P15, DOI 10.1007/s007750050018; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	40	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184366	10.1371/journal.pone.0184366	http://dx.doi.org/10.1371/journal.pone.0184366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880952	gold, Green Published, Green Submitted			2022-12-27	WOS:000409467200059
J	Maes, ME; Schlamp, CL; Nickells, RW				Maes, Margaret E.; Schlamp, Cassandra L.; Nickells, Robert W.			Live-cell imaging to measure BAX recruitment kinetics to mitochondria during apoptosis	PLOS ONE			English	Article							CYTOCHROME-C; BCL-2 FAMILY; MEMBRANE PERMEABILIZATION; PROAPOPTOTIC BAX; OUTER-MEMBRANE; BH3 DOMAINS; PORES; PROTEINS; CYTOSOL; RELEASE	The pro-apoptotic BCL2 gene family member, BAX, plays a pivotal role in the intrinsic apoptotic pathway. Under cellular stress, BAX recruitment to the mitochondria occurs when activated BAX forms dimers, then oligomers, to initiate mitochondria outer membrane permeabilization (MOMP), a process critical for apoptotic progression. The activation and recruitment of BAX to form oligomers has been studied for two decades using fusion proteins with a fluorescent reporter attached in-frame to the BAX N-terminus. We applied highspeed live cell imaging to monitor the recruitment of BAX fusion proteins in dying cells. Data from time-lapse imaging was validated against the activity of endogenous BAX in cells, and analyzed using sigmoid mathematical functions to obtain detail of the kinetic parameters of the recruitment process at individual mitochondrial foci. BAX fusion proteins behave like endogenous BAX during apoptosis. Kinetic studies show that fusion protein recruitment is also minimally affected in cells lacking endogenous BAK or BAX genes, but that the kinetics are moderately, but significantly, different with different fluorescent tags in the fusion constructs. In experiments testing BAX recruitment in 3 different cell lines, our results show that regardless of cell type, once activated, BAX recruitment initiates simultaneously within a cell, but exhibits varying rates of recruitment at individual mitochondrial foci. Very early during BAX recruitment, pro-apoptotic molecules are released in the process of MOMP, but different molecules are released at different times and rates relative to the time of BAX recruitment initiation. These results provide a method for BAX kinetic analysis in living cells and yield greater detail of multiple characteristics of BAX-induced MOMP in living cells that were initially observed in cell free studies.	[Maes, Margaret E.; Schlamp, Cassandra L.; Nickells, Robert W.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; [Maes, Margaret E.] Univ Wisconsin, Sch Med & Publ Hlth, Cellular & Mol Pathol Grad Program, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Nickells, RW (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA.	nickells@wisc.edu		Nickells, Robert/0000-0002-2998-5494; Maes, Margaret/0000-0001-9642-1085	National Eye Institute [R01EY012223, P30 EY016665]; National Institutes of Health [T32GM081061]; Senior Scientist Research Award; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [P30EY016665, R01EY012223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM081061] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Senior Scientist Research Award; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from R01EY012223 and Vision Core Grant P30 EY016665 from the National Eye Institute, the National Institutes of Health grant T32GM081061, and a Senior Scientist Research Award and an unrestricted funding grant from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Bardwell PD, 2009, J IMMUNOL, V182, P7482, DOI 10.4049/jimmunol.0802813; Bleicken S, 2014, MOL CELL, V56, P496, DOI 10.1016/j.molcel.2014.09.022; Bleicken S, 2013, J BIOL CHEM, V288, P33241, DOI 10.1074/jbc.M113.512087; Capano M, 2002, BIOCHEM J, V367, P169, DOI 10.1042/BJ20020805; Chang LK, 2002, BIOCHIMIE, V84, P223, DOI 10.1016/S0300-9084(02)01372-X; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Edlich F, 2011, CELL, V145, P104, DOI 10.1016/j.cell.2011.02.034; Gavathiotis E, 2010, MOL CELL, V40, P481, DOI 10.1016/j.molcel.2010.10.019; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; Gillies LA, 2015, MOL BIOL CELL, V26, P339, DOI 10.1091/mbc.E13-11-0638; Gillies LA, 2014, J CELL BIOCHEM, V115, P632, DOI 10.1002/jcb.24709; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Grosse L, 2016, EMBO J, V35, P402, DOI 10.15252/embj.201592789; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2016, SCI REP-UK, V6, DOI 10.1038/srep27299; Lartigue L, 2008, J CELL SCI, V121, P3515, DOI 10.1242/jcs.029587; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Mahajan NP, 1998, NAT BIOTECHNOL, V16, P547, DOI 10.1038/nbt0698-547; McDowall LM, 2006, AM J PHYSIOL-HEART C, V291, pH2003, DOI 10.1152/ajpheart.00219.2006; Munoz-Pinedo C, 2006, P NATL ACAD SCI USA, V103, P11573, DOI 10.1073/pnas.0603007103; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Rehm M, 2003, J CELL BIOL, V162, P1031, DOI 10.1083/jcb.200303123; Rehm M, 2009, CELL DEATH DIFFER, V16, P613, DOI 10.1038/cdd.2008.187; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Ros U, 2015, J MEMBRANE BIOL, V248, P545, DOI 10.1007/s00232-015-9820-y; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Salvador-Gallego R, 2016, EMBO J, V35, P389, DOI 10.15252/embj.201593384; Schinzel A, 2004, J CELL BIOL, V164, P1021, DOI 10.1083/jcb.200309013; Semaan SJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-554; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Valentijn AJ, 2008, CELL DEATH DIFFER, V15, P1243, DOI 10.1038/cdd.2008.39; Volkmann N, 2014, CELL DEATH DIFFER, V21, P206, DOI 10.1038/cdd.2013.153; Wang C, 2012, ONCOGENE, V31, P3177, DOI 10.1038/onc.2011.497; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xu XP, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.210; Zhang Z, 2016, EMBO J, V35, P208, DOI 10.15252/embj.201591552	47	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184434	10.1371/journal.pone.0184434	http://dx.doi.org/10.1371/journal.pone.0184434			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880942	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200068
J	Muire, PJ; Hanson, LA; Wills, R; Petrie-Hanson, L				Muire, Preeti J.; Hanson, Larry A.; Wills, Robert; Petrie-Hanson, Lora			Differential gene expression following TLR stimulation in rag1(-/-) mutant zebrafish tissues and morphological descriptions of lymphocyte-like cell populations	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DOUBLE-STRANDED-RNA; HUMAN NK CELLS; INTERFERON-GAMMA GENES; TOLL-LIKE-RECEPTOR; IMMUNE-RESPONSES; IFN-GAMMA; RAINBOW-TROUT; BETA-GLUCANS; T-BET	In the absence of lymphocytes, rag1(-/)-mutant zebrafish develop protective immunity to bacteria. In mammals, induction of protection by innate immunity can be mediated by macrophages or natural killer (NK) cells. To elucidate potential responsive cell populations, we morphologically characterized lymphocyte-like cells (LLCs) from liver, spleen and kidney hematopoietic tissues. In fish, these cells include NK cells and Non-specific cytotoxic cells (NCCs). We also evaluated the transcriptional expression response of select genes that are important indicators of NK and macrophage activation after exposure to specific TLR ligands. The LLC cell populations could be discriminated by size and further discriminated by the presence of cytoplasmic granules. Expression levels of mx, tnfa, ifny, t-bet and nitr9 demonstrated dynamic changes in response to intra-coelomically administered beta glucan (a TLR2/6 ligand), Poly I: C (a TLR3 ligand) and resiquimod (R848) (a TLR7/8 ligand). Following TLR 2/6 stimulation, there was a greater than 100 fold increase in ifn. in liver, kidney and spleen and moderate increases in tnfa in liver and kidney. TLR3 stimulation caused broad up regulation of mx, down-regulation of tnfa in kidney and spleen tissues and up regulation of nitr9 in the kidney. Following TLR 7/8 stimulation, there was a greater than 100 fold increase in ifn. in liver and kidney and t-bet in liver. Our gene expression findings suggest that LLCs and macrophages are stimulated following beta glucan exposure. Poly I: C causes type I interferon response and mild induction of LLC in the kidney and R-848 exposure causes the strongest LLC stimulation. Overall, the strongest NK like gene expression occurred in the liver. These differential effects of TLR ligands in rag1 (-/-)mutant zebrafish shows strong NK cell-like gene expression responses, especially in the liver, and provides tools to evaluate the basis for protective immunity mediated by the innate immune cells of fish.	[Muire, Preeti J.; Hanson, Larry A.; Petrie-Hanson, Lora] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA; [Wills, Robert] Mississippi State Univ, Coll Vet Med, Dept Pathobiol & Populat Med, Mississippi State, MS 39762 USA	Mississippi State University; Mississippi State University	Petrie-Hanson, L (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	lora@cvm.msstate.edu		Hanson, Larry/0000-0001-9362-7416	Office of Research and Graduate Studies; Department of Basic Sciences, College of Veterinary Medicine, MSU; College of Veterinary Medicine; Mississippi State University	Office of Research and Graduate Studies; Department of Basic Sciences, College of Veterinary Medicine, MSU; College of Veterinary Medicine; Mississippi State University	This work was funded by the Office of Research and Graduate Studies and the Department of Basic Sciences, College of Veterinary Medicine, MSU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Nitr9 monoclonal antibody 90.10.5 was provided by Dr. J. Yoder. Myxovirus resistance A (Mx) NM_182942.4 primers and probe sequences were designed using Beacon Design software (BioRad) and kindly provided by Dr. Du Ngoc Nguyen. This research was funded by the College of Veterinary Medicine and Mississippi State University.	Adib-Conquy M, 2014, IMMUNOL CELL BIOL, V92, P256, DOI 10.1038/icb.2013.99; Albeituni SH, 2013, ANTI-CANCER AGENT ME, V13, P689, DOI 10.2174/1871520611313050003; Albuquerque A, 2008, FISH SHELLFISH IMMUN, P24; Andersson M, 1996, VET IMMUNOL IMMUNOP, V54, P123, DOI 10.1016/S0165-2427(96)05677-2; [Anonymous], 2004, AZ QUANT PCR; Bowdish DME, 2007, MICROBES INFECT, V9, P1680, DOI 10.1016/j.micinf.2007.09.002; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; Das BK, 2009, FISH SHELLFISH IMMUN, V26, P40, DOI 10.1016/j.fsi.2008.03.009; DIRENZO L, 1991, EUR J IMMUNOL, V21, P1755, DOI 10.1002/eji.1830210726; Dong ZJ, 2004, J HEPATOL, V41, P966, DOI 10.1016/j.jhep.2004.08.021; Elibol-Fleming B., 2006, THESIS; Estepa A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135483; Falco A, 2014, FISH SHELLFISH IMMUN, V36, P494, DOI 10.1016/j.fsi.2013.12.005; Fernandez-Trujillo A, 2008, FISH SHELLFISH IMMUN, V24, P279, DOI 10.1016/j.fsi.2007.11.008; Fischer S, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-69; Fischer U, 2013, FISH SHELLFISH IMMUN, V35, P197, DOI 10.1016/j.fsi.2013.04.018; Garcia-Castillo J, 2002, IMMUNOGENETICS, V54, P200, DOI 10.1007/s00251-002-0451-y; Garcia-Valtanen P, 2017, MULTIGENE FAMILIES I, P8; Gorski KS, 2006, INT IMMUNOL, V18, P1115, DOI 10.1093/intimm/dxl046; HARRIS DT, 1992, DEV COMP IMMUNOL, V16, P395, DOI 10.1016/0145-305X(92)90041-A; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hida TH, 2009, INFLAMM RES, V58, P9, DOI 10.1007/s00011-008-8141-3; Hohn C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044451; Janeway C., 2008, JANEWAY IMMUNOBIOL; Ju BS, 1999, DEV GENET, V25, P158, DOI 10.1002/(SICI)1520-6408(1999)25:2&lt;158::AID-DVG10&gt;3.0.CO;2-6; Jurk M, 2002, NAT IMMUNOL, V3, P499, DOI 10.1038/ni0602-499; Kim JO, 2012, FISH PATHOL, V47, P137, DOI 10.3147/jsfp.47.137; Korkea-aho TL, 2012, J APPL MICROBIOL, V113, P24, DOI 10.1111/j.1365-2672.2012.05325.x; Krishnavajhala A, 2017, INT J IMMUNOLOGY, V5, P20; Kumari J, 2015, FRONT IMMUNOL, P6; Leong J, 1988, VACCINATION INFECT H, P193; Lugo-Villarino G, 2010, P NATL ACAD SCI USA, V107, P15850, DOI 10.1073/pnas.1000494107; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; Meijer AH, 2004, MOL IMMUNOL, V40, P773, DOI 10.1016/j.molimm.2003.10.003; Milev-Milovanovic I, 2006, IMMUNOGENETICS, V58, P70, DOI 10.1007/s00251-006-0081-x; Mitra S, 2010, FEBS J, V277, P128, DOI 10.1111/j.1742-4658.2009.07460.x; Moss LD, 2009, DEV COMP IMMUNOL, V33, P1077, DOI 10.1016/j.dci.2009.05.009; Mulero I, 2007, AQUACULTURE, V268, P244, DOI 10.1016/j.aquaculture.2007.04.046; Netea MG, 2013, EUR J CLIN INVEST, V43, P881, DOI 10.1111/eci.12132; Overturf K, 2006, J FISH DIS, V29, P215, DOI 10.1111/j.1365-2761.2006.00707.x; Palti Y, 2010, DEV COMP IMMUNOL, V34, P219, DOI 10.1016/j.dci.2009.10.002; Palti Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-462; Parhi J, AQUACULTURE REPORTS; Petrie-Hanson L, 1999, FISH SHELLFISH IMMUN, V9, P579, DOI 10.1006/fsim.1999.0215; Petrie-Hanson L, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-8; Phelan PE, 2005, J VIROL, V79, P1842, DOI 10.1128/JVI.79.3.1842-1852.2005; Pisegna S, 2004, BLOOD, V104, P4157, DOI 10.1182/blood-2004-05-1860; Pressley ME, 2005, DEV COMP IMMUNOL, V29, P501, DOI 10.1016/j.dci.2004.10.007; Purcell MK, 2006, COMP BIOCHEM PHYS D, V1, P77, DOI 10.1016/j.cbd.2005.07.003; Purcell MK, 2004, FISH SHELLFISH IMMUN, V17, P447, DOI 10.1016/j.fsi.2004.04.017; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Roca FJ, 2008, J IMMUNOL, V181, P5071, DOI 10.4049/jimmunol.181.7.5071; Rodriguez I, 2009, FISH SHELLFISH IMMUN, V27, P369, DOI 10.1016/j.fsi.2009.02.007; ROERS A, 1994, J INFECT DIS, V169, P807, DOI 10.1093/infdis/169.4.807; Saint-Jean SR, 2007, FISH SHELLFISH IMMUN, V23, P390, DOI 10.1016/j.fsi.2006.11.012; Schmidt KN, 2004, J IMMUNOL, V172, P138, DOI 10.4049/jimmunol.172.1.138; Sepulcre MP, 2007, MOL IMMUNOL, V44, P2009, DOI 10.1016/j.molimm.2006.09.022; Shah RN, 2012, ADV HEMATOLOGY, P2012; Sieger D, 2009, DIS MODEL MECH, V2, P571, DOI 10.1242/dmm.003509; Stolte EH, 2008, DEV COMP IMMUNOL, V32, P1467, DOI 10.1016/j.dci.2008.06.012; Strandskog G, 2008, VACCINE, V26, P4704, DOI 10.1016/j.vaccine.2008.06.054; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Svingerud T, 2012, J IMMUNOL, V189, P5912, DOI 10.4049/jimmunol.1201188; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tomai MA, 2000, CELL IMMUNOL, V203, P55, DOI 10.1006/cimm.2000.1673; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vetvicka Vaclav, 2013, N Am J Med Sci, V5, P580, DOI 10.4103/1947-2714.120792; Vojtech LN, 2009, INFECT IMMUN, V77, P914, DOI 10.1128/IAI.01201-08; Wang J, 2005, CELL MOL IMMUNOL, V2, P449; Wang L, 2013, FISH PHYSIOL BIOCHEM, V39, P793, DOI 10.1007/s10695-012-9741-y; Wei S, 2007, IMMUNOGENETICS, V59, P813, DOI 10.1007/s00251-007-0250-6; Wu JJ, 2004, ANTIVIR RES, V64, P79, DOI 10.1016/j.antiviral.2004.07.002; Zhou ZX, 2015, DEV COMP IMMUNOL, V49, P113, DOI 10.1016/j.dci.2014.11.018; Zou J, 2005, J IMMUNOL, V175, P2484, DOI 10.4049/jimmunol.175.4.2484	80	9	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184077	10.1371/journal.pone.0184077	http://dx.doi.org/10.1371/journal.pone.0184077			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910320	gold, Green Submitted, Green Published			2022-12-27	WOS:000410859200029
J	Hancock, AM; Frostig, RD				Hancock, Aneeka M.; Frostig, Ron D.			Testing the effects of sensory stimulation as a collateral-based therapeutic for ischemic stroke in C57BL/6J and CD1 mouse strains	PLOS ONE			English	Article							BLOOD-FLOW; MICROCIRCULATION; ARCHITECTURE; DETERMINANT; CHLORIDE; ANATOMY; BRAIN; MICE	Utilizing a rat model of ischemic stroke, we have previously shown that sensory stimulation can completely protect rats from impending ischemic damage of cortex if this treatment is delivered within the first two hours post-permanent middle cerebral artery occlusion (pMCAo). The current study sought to extend our findings in rats to mice, which would allow new avenues of research not available in rats. Thus, young adult C57BL/6J and CD1 mice were tested for protection from ischemic stroke with the same protective sensory stimulation-based treatment. Cortical activity and blood flow were assessed with intrinsic signal optical imaging (ISOI) and laser speckle imaging (LSI), respectively, and histological analysis (TTC) was performed at the completion of the experiments. Standing in stark contrast to the positive results observed in rats, in both strains we found that there were no differences between treated and untreated mice at 24 hours post-pMCAo in terms of infarct volume, negative functional imaging results, and major reduction in retrograde collateral blood flow as compared to pre-pMCAo baseline and surgical controls. Also, no differences were found between the strains in terms of theses variables. Potential reasons for the differences between rats and mice are discussed.	[Hancock, Aneeka M.; Frostig, Ron D.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Frostig, Ron D.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA; [Frostig, Ron D.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Frostig, RD (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.; Frostig, RD (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92717 USA.; Frostig, RD (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.	rfrostig@uci.edu			National Institute of Neurological Disorders and Stroke [NS-066001]; Fondation Leducq [15CVD02]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fondation Leducq(Leducq Foundation)	This work was supported by the following funding sources: The National Institute of Neurological Disorders and Stroke (NS-066001 to RDF; https://www.ninds.nih.gov/), and Fondation Leducq (15CVD02 to RDF; https://www.fondationleducq.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang OY, 2008, J NEUROL NEUROSUR PS, V79, P625, DOI 10.1136/jnnp.2007.132100; Bang OY, 2011, STROKE, V42, P693, DOI 10.1161/STROKEAHA.110.595256; Baran U, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.2.025006; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Brozici M, 2003, STROKE, V34, P2750, DOI 10.1161/01.STR.0000095791.85737.65; Carmichael S Thomas, 2005, NeuroRx, V2, P396; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Chalothorn D, 2010, J MOL CELL CARDIOL, V49, P251, DOI 10.1016/j.yjmcc.2010.03.014; Chalothorn D, 2009, CIRC RES, V105, P89, DOI 10.1161/CIRCRESAHA.109.197145; Chen-Bee CH, 2007, J NEUROSCI, V27, P4572, DOI 10.1523/JNEUROSCI.0326-07.2007; Choi B, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2341196; Christoforidis GA, 2005, AM J NEURORADIOL, V26, P1789; Cristofaro B, 2013, DEVELOPMENT, V140, P1720, DOI 10.1242/dev.092304; Davis MF, 2013, JOVE-J VIS EXP, DOI 10.3791/50418; Davis MF, 2011, STROKE, V42, P792, DOI 10.1161/STROKEAHA.110.607135; Doyle KP, 2012, J NEUROSCI METH, V207, P31, DOI 10.1016/j.jneumeth.2012.03.003; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195, DOI 10.1097/00004647-200103000-00002; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GIBO H, 1981, J NEUROSURG, V54, P151, DOI 10.3171/jns.1981.54.2.0151; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Hussein HM, 2010, AM J NEURORADIOL, V31, P454, DOI 10.3174/ajnr.A2006; IADECOLA C, 1993, TRENDS NEUROSCI, V16, P206, DOI 10.1016/0166-2236(93)90156-G; Kochanek KD, 2013, NCHS DATA BRIEF, V2014, P1; Lay CC, 2014, EUR J NEUROSCI, P1, DOI DOI 10.1111/EJN.12387; Lay CC, 2013, EUR J NEUROSCI, V38, P2445, DOI 10.1111/ejn.12217; Lay CC, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001255; Lay CC, 2011, J NEUROSCI, V31, P11495, DOI 10.1523/JNEUROSCI.1741-11.2011; LEE RMKW, 1995, PHARMACOL THERAPEUT, V66, P149, DOI 10.1016/0163-7258(94)00071-A; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Liebeskind DS, 2008, STROKE, V39, pE187, DOI 10.1161/STROKEAHA.108.522888; Lima FO, 2010, STROKE, V41, P2316, DOI 10.1161/STROKEAHA.110.592303; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; McColl BW, 2004, BRAIN RES, V997, P15, DOI 10.1016/j.brainres.2003.10.028; Meier P, 2007, CIRCULATION, V116, P975, DOI 10.1161/CIRCULATIONAHA.107.703959; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Segal SS, 2005, MICROCIRCULATION, V12, P33, DOI 10.1080/10739680590895028; Shih AY, 2009, J CEREBR BLOOD F MET, V29, P738, DOI 10.1038/jcbfm.2008.166; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Urban A, 2015, NAT METHODS, V12, P873, DOI [10.1038/nmeth.3482, 10.1038/NMETH.3482]; Wang SL, 2010, CIRC RES, V107, P558, DOI 10.1161/CIRCRESAHA.110.224634; Wang-Fischer Y, 2009, MANUAL STROKE MODELS; Winship IR, 2015, MICROCIRCULATION, V22, P228, DOI 10.1111/micc.12177; Zhang H, 2010, J CEREBR BLOOD F MET, V30, P923, DOI 10.1038/jcbfm.2010.10	44	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183909	10.1371/journal.pone.0183909	http://dx.doi.org/10.1371/journal.pone.0183909			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902897	Green Submitted, gold, Green Published			2022-12-27	WOS:000410669200024
J	Kaida, A; Iritani, N; Yamamoto, SP; Kanbayashi, D; Hirai, Y; Togawa, M; Amo, K; Kohdera, U; Nishigaki, T; Shiomi, M; Asai, S; Kageyama, T; Kubo, H				Kaida, Atsushi; Iritani, Nobuhiro; Yamamoto, Seiji P.; Kanbayashi, Daiki; Hirai, Yuki; Togawa, Masao; Amo, Kiyoko; Kohdera, Urara; Nishigaki, Toshinori; Shiomi, Masashi; Asai, Sadasaburo; Kageyama, Tsutomu; Kubo, Hideyuki			Distinct genetic clades of enterovirus D68 detected in 2010, 2013, and 2015 in Osaka City, Japan	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; CHILDREN; NETHERLANDS; EMERGENCE; OUTBREAK	The first upsurge of enterovirus D68 (EV-D68), a causative agent of acute respiratory infections (ARIs), in Japan was reported in Osaka City in 2010. In this study, which began in 2010, we surveyed EV-D68 in children with ARIs and analyzed sequences of EV-D68 strains detected. Real-time PCR of 19 respiratory viruses or subtypes of viruses, including enterovirus, was performed on 2,215 specimens from ARI patients (< 10 years of age) collected between November 2010 and December 2015 in Osaka City, Japan. EV-D68 was identified in 18 enterovirus-positive specimens (n = 4 in 2013, n = 1 in 2014, and n = 13 in 2015) by analysis of viral protein 1 (VP1) or VP4 sequences, followed by a BLAST search for similar sequences. All EV-D68 strains were detected between June and October (summer to autumn), except for one strain detected in 2014. A phylogenetic analysis of available VP1 sequences revealed that the Osaka strains detected in 2010, 2013, and 2015 belonged to distinct clusters (Clades C, A, and B [Subclade B3], respectively). Comparison of the 50 untranslated regions of these viruses showed that Osaka strains in Clades A, B (Subclade B3), and C commonly had deletions at nucleotide positions 681-703 corresponding to the prototype Fermon strain. Clades B and C had deletions from nucleotide positions 713-724. Since the EV-D68 epidemic in 2010, EV-D68 re-emerged in Osaka City, Japan, in 2013 and 2015. Results of this study indicate that distinct clades of EV-D68 contributed to re-emergences of this virus in 2010, 2013, and 2015 in this limited region.	[Kaida, Atsushi; Iritani, Nobuhiro; Yamamoto, Seiji P.; Kanbayashi, Daiki; Hirai, Yuki; Kubo, Hideyuki] Osaka Inst Publ Hlth, Div Microbiol, Osaka, Japan; [Togawa, Masao; Amo, Kiyoko] Osaka City Gen Hosp, Osaka, Japan; [Kohdera, Urara] Nakano Childrens Hosp, Osaka, Japan; [Nishigaki, Toshinori] Osaka Police Hosp, Osaka, Japan; [Shiomi, Masashi] Aizenbashi Hosp, Osaka, Japan; [Asai, Sadasaburo] Asai Childrens Clin, Osaka, Japan; [Kageyama, Tsutomu] Natl Inst Infect Dis, Influenza Virus Res Ctr, Tokyo, Japan	Osaka Prefectural Institute of Public Health; Osaka City General Hospital; Osaka Police Hospital; National Institute of Infectious Diseases (NIID)	Kaida, A (corresponding author), Osaka Inst Publ Hlth, Div Microbiol, Osaka, Japan.	a-kaida@iph.osaka.jp	Iritani, Nobuhiro/ABI-1062-2020	Kanbayashi, Daiki/0000-0002-9526-2411	JSPS KAKENHI [26460819]; Japan Agency for Medical Research and Development	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was partially supported by JSPS KAKENHI Grant Number 26460819 to AK and the Japan Agency for Medical Research and Development to TK.	Bottcher S, 2016, EUROSURVEILLANCE, V21, P16, DOI 10.2807/1560-7917.ES.2016.21.19.30227; De Jesus N, 2005, J VIROL, V79, P14235, DOI 10.1128/JVI.79.22.14235-14243.2005; Du J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144208; Dunn JJ, 2003, J INFECT DIS, V187, P1552, DOI 10.1086/374877; Fields B. N., 2007, FIELDS VIROLOGY; Gong YN, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004416; Greninger AL, 2015, LANCET INFECT DIS, V15, P671, DOI 10.1016/S1473-3099(15)70093-9; Ikeda T, 2012, MICROBIOL IMMUNOL, V56, P139, DOI 10.1111/j.1348-0421.2012.00411.x; Imamura T, 2015, REV MED VIROL, V25, P102, DOI 10.1002/rmv.1820; Imamura T, 2014, J VIROL, V88, P2374, DOI 10.1128/JVI.03070-13; Ishiko H, 2002, INTERVIROLOGY, V45, P136, DOI 10.1159/000065866; Kaida A, 2014, JPN J INFECT DIS, V67, P469, DOI 10.7883/yoken.67.469; Kaida A, 2011, EMERG INFECT DIS, V17, P1494, DOI 10.3201/eid1708.110028; Katayama K, 2002, VIROLOGY, V299, P225, DOI 10.1006/viro.2002.1568; Khetsuriani N, 2006, MMWR-MORBID MORTAL W, V55, P1; Kira R., 2016, CLIN VIROLOGY, V44, P107; Knoester M, 2017, EMERG INFECT DIS, V23, P140, DOI 10.3201/eid2301.161313; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lang M, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.44.20952; Lau SKP, 2016, SCI REP-UK, V6, DOI 10.1038/srep25147; Levy A, 2015, J CLIN VIROL, V69, P117, DOI 10.1016/j.jcv.2015.06.079; Linsuwanon P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035190; Maloney JA, 2015, AM J NEURORADIOL, V36, P245, DOI 10.3174/ajnr.A4188; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; Meijer A, 2014, EUROSURVEILLANCE, P19; Meijer A, 2012, VIROLOGY, V423, P49, DOI 10.1016/j.virol.2011.11.021; Messacar K, 2015, LANCET, V385, P1662, DOI 10.1016/S0140-6736(14)62457-0; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Opanda SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102866; Pallansch M.A., 2007, FIELDS VIROLOGY, V6th, P490; Pfeiffer HC, 2015, EUROSURVEILLANCE, V20, DOI 10.2807/1560-7917.ES2015.20.10.21062; SCHIEBLE JH, 1967, AM J EPIDEMIOL, V85, P297, DOI 10.1093/oxfordjournals.aje.a120693; Tan Y, 2016, J VIROL, V90, P1997, DOI 10.1128/JVI.02418-15; Taya K., 2016, CLIN VIROLOGY, V44, P101; Tokarz R, 2012, J GEN VIROL, V93, P1952, DOI 10.1099/vir.0.043935-0; Xiang ZC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27800	36	21	21	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184335	10.1371/journal.pone.0184335	http://dx.doi.org/10.1371/journal.pone.0184335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902862	Green Submitted, Green Published, gold			2022-12-27	WOS:000410669200031
J	Leal, MF; dos Santos, LC; de Oliveira, AM; Belangero, PS; Figueiredo, EA; Cohen, C; Alves, FD; Yanaguizawa, WH; Andreoli, CV; Pochini, AD; Ejnisman, B; Smith, MC; Alves, MTD; Cohen, M				Leal, Mariana Ferreira; dos Santos, Leonardo Caires; de Oliveira, Adrielle Martins; Belangero, Paulo Santoro; Figueiredo, Eduardo Antonio; Cohen, Carina; Alves, Felipe de Seixas; Yanaguizawa, Wania Hiromi; Andreoli, Carlos Vicente; Pochini, Alberto de Castro; Ejnisman, Benno; Smith, Marilia Cardoso; de Seixas Alves, Maria Teresa; Cohen, Moises			Epigenetic regulation of metalloproteinases and their inhibitors in rotator cuff tears	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE; SUPRASPINATUS TENDINOPATHY; GENE-EXPRESSION; DNA METHYLATION; TENDON; TISSUE; DEGENERATION; DISEASE; INFLAMMATION; COLLAGEN	Rotator cuff tear is a common orthopedic condition. Metalloproteinases (MMP) and their inhibitors (TIMP) seem to play a role in the development of joint injuries and in the failure of tissue healing. However, the mechanisms of regulation of gene expression in tendons are still unknown. Epigenetic mechanisms, such as DNA methylation and microRNAs regulation, are involved in the dynamic control of gene expression. Here, the mRNA expression and DNA methylation status of MMPs (MMP1, MMP2, MMP3, MMP9, MMP13, and MMP14) and TIMPs (TIMP1-3) and the expression of miR-29 family members in ruptured supraspinatus tendons were compared with non-injured tendons of individuals without this lesion. Additionally, the gene expression and methylation status at the edge of the ruptured tendon were compared with macroscopically non-injured rotator cuff tendon samples from the anterior and posterior regions of patients with tendon tears. Moreover, the possible associations between the molecular alterations and the clinical and histologic characteristics were investigated. Dysregulated expression and DNA methylation of MMP and TIMP genes were found across the rotator cuff tendon samples of patients with supraspinatus tears. These alterations were influenced at least in part by age at surgery, sex, smoking habit, tear size, and duration of symptoms. Alterations in the studied MMP and TIMP genes may contribute to the presence of microcysts, fissures, necrosis, and neovascularization in tendons and may thus be involved in the tendon healing process. In conclusion, MMPs and their inhibitors are regulated by epigenetic modifications and may play a role in rotator cuff tears.	[Leal, Mariana Ferreira; de Oliveira, Adrielle Martins; Belangero, Paulo Santoro; Figueiredo, Eduardo Antonio; Cohen, Carina; Alves, Felipe de Seixas; Yanaguizawa, Wania Hiromi; Andreoli, Carlos Vicente; Pochini, Alberto de Castro; Ejnisman, Benno; Cohen, Moises] Univ Fed Sao Paulo, Dept Ortopedia & Traumatol, Sao Paulo, SP, Brazil; [Leal, Mariana Ferreira; dos Santos, Leonardo Caires; de Oliveira, Adrielle Martins; Smith, Marilia Cardoso] Univ Fed Sao Paulo, Disciplina Genet, Dept Morfol & Genet, Sao Paulo, SP, Brazil; [Alves, Felipe de Seixas; Yanaguizawa, Wania Hiromi; de Seixas Alves, Maria Teresa] Univ Fed Sao Paulo, Dept Patol, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Leal, MF (corresponding author), Univ Fed Sao Paulo, Dept Ortopedia & Traumatol, Sao Paulo, SP, Brazil.; Leal, MF (corresponding author), Univ Fed Sao Paulo, Disciplina Genet, Dept Morfol & Genet, Sao Paulo, SP, Brazil.	mariana.morf@epm.br	Leal, Mariana/C-4010-2012; Chen, Elizabeth/G-1598-2012; Andreoli, Carlos Vicente/AAW-1228-2021; Belangero, Paulo/AAD-8299-2021; Ejnisman, Benno/J-1556-2015; Smith, Marilia/C-4397-2012	Leal, Mariana/0000-0003-4375-2563; Chen, Elizabeth/0000-0002-3573-0164; Martins de Oliveira, Adrielle/0000-0003-0173-6872; Seixas Alves, Maria Teresa/0000-0002-5268-7612; Ejnisman, Benno/0000-0002-3301-1457; Smith, Marilia/0000-0002-1441-1033	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/22548-2, 2012/14768-5, 2016/01392-8, 2016/15785-1, 2013/10691-0, 2013/10791-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was supported by: Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) as grant #2011/22548-2 (PI: MFL) and fellowships #2012/14768-5 (MFL), #2016/01392-8 (AMO), #2016/15785-1 (AMO), #2013/10691-0 (FSA), #2013/10791-5 (WHY) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq): fellowship to MC and MCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alvarez K, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-431; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bell CG, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1051-8; Blevins FT, 1997, ORTHOP CLIN N AM, V28, P1, DOI 10.1016/S0030-5898(05)70260-1; Boot-Handford RP, 2003, BIOESSAYS, V25, P142, DOI 10.1002/bies.10230; Chaudhury S, 2016, J SHOULDER ELBOW SUR; Cheung EV, 2010, CLIN ORTHOP RELAT R, V468, P1476, DOI 10.1007/s11999-010-1323-7; COFIELD RH, 1982, SURG GYNECOL OBSTET, V154, P667; Creemers EEJM, 2001, CIRC RES, V89, P201, DOI 10.1161/hh1501.094396; Dean BJF, 2012, BONE JOINT RES, V1, P158, DOI 10.1302/2046-3758.17.2000115; Dines JS, 2007, J SHOULDER ELB SURG, V16, p204S, DOI 10.1016/j.jse.2007.03.004; Farlik M, 2015, CELL REP, V10, P1386, DOI 10.1016/j.celrep.2015.02.001; Fuchs B, 1999, J SHOULDER ELB SURG, V8, P599, DOI 10.1016/S1058-2746(99)90097-6; Gotoh M, 1997, J ORTHOP RES, V15, P33, DOI 10.1002/jor.1100150106; Hart DA, 1998, CLIN ORTHOP RELAT R, P44; Hashimoto K, 2013, J BIOL CHEM, V288, P10061, DOI 10.1074/jbc.M112.421156; Klatte-Schulz F, 2015, INT J MOL SCI, V16, P13141, DOI 10.3390/ijms160613141; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Lakemeier S, 2011, KNEE SURG SPORT TR A, V19, P1760, DOI 10.1007/s00167-010-1367-y; Lakemeier S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-271; Leal MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118821; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lichtenberg, 2006, CLASSIFICATIONS SCOR; Lo IKY, 2004, AM J SPORT MED, V32, P1223, DOI 10.1177/0363546503262200; Loiselle AE, 2009, J ORTHOP RES, V27, P833, DOI 10.1002/jor.20769; Millar NL, 2009, J BONE JOINT SURG BR, V91B, P417, DOI 10.1302/0301-620X.91B3.21652; Millar NL, 2008, CLIN ORTHOP RELAT R, V466, P1569, DOI 10.1007/s11999-008-0265-9; Mittal R, 2016, J CELL PHYSIOL, V231, P2599, DOI 10.1002/jcp.25430; NEER CS, 1970, J BONE JOINT SURG AM, VA 52, P1077, DOI 10.2106/00004623-197052060-00001; Nho SJ, 2008, AM J SPORT MED, V36, P987, DOI 10.1177/0363546508317344; Oliva Francesco, 2014, Muscles Ligaments Tendons J, V4, P309; Oliva Francesco, 2013, Muscles Ligaments Tendons J, V3, P201; OPDENAKKER G, 1992, CYTOKINE, V4, P251, DOI 10.1016/1043-4666(92)90064-X; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Rees JD, 2014, BRIT J SPORT MED, V48, P1553, DOI 10.1136/bjsports-2012-091957; Reuther KE, 2013, J BIOMECH, V46, P1818, DOI 10.1016/j.jbiomech.2013.05.007; Riley GP, 2002, MATRIX BIOL, V21, P185, DOI 10.1016/S0945-053X(01)00196-2; Riley GP, 1996, AM J PATHOL, V149, P933; Shindle MK, 2011, J SHOULDER ELB SURG, V20, P917, DOI 10.1016/j.jse.2011.02.015; Shirachi I, 2011, ARTHROSCOPY, V27, P1173, DOI 10.1016/j.arthro.2011.03.078; Slusarz A, 2015, J CARDIOVASC MED, V16, P480, DOI 10.2459/JCM.0000000000000246; Tillander B, 2002, J ORTHOP RES, V20, P1358, DOI 10.1016/S0736-0266(02)00057-8; White JJE, 2014, BONE JOINT J, V96B, P350, DOI 10.1302/0301-620X.96B3.32336; Xu YH, 2008, CLIN ORTHOP RELAT R, V466, P1528, DOI 10.1007/s11999-008-0286-4; Yamamoto A, 2010, J SHOULDER ELB SURG, V19, P116, DOI 10.1016/j.jse.2009.04.006; Yuan J, 2003, CLIN SPORT MED, V22, P693, DOI 10.1016/S0278-5919(03)00049-8	46	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184141	10.1371/journal.pone.0184141	http://dx.doi.org/10.1371/journal.pone.0184141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902861	gold, Green Submitted, Green Published			2022-12-27	WOS:000410669200028
J	Li, X; Jan, S; Yan, LL; Hayes, A; Chu, YB; Wang, HJ; Feng, XX; Niu, WY; He, FJ; Ma, J; Han, YB; MacGregor, GA; Wu, YF				Li, Xian; Jan, Stephen; Yan, Lijing L.; Hayes, Alison; Chu, Yunbo; Wang, Haijun; Feng, Xiangxian; Niu, Wenyi; He, Feng J.; Ma, Jun; Han, Yanbo; MacGregor, Graham A.; Wu, Yangfeng			Cost and cost-effectiveness of a school-based education program to reduce salt intake in children and their families in China	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; BLOOD-PRESSURE; SODIUM-INTAKE; DIETARY-SODIUM; HYPERTENSION; POPULATION; STROKE; INTERVENTIONS; STRATEGIES; INFARCTION	Objective The School-based Education Program to Reduce Salt Intake in Children and Their Families study was a cluster randomized control trial among grade five students in 28 primary schools and their families in Changzhi, China. It achieved a significant effect in lowering systolic blood pressure (SBP) in all family adults by 2.3 mmHg and in elderlies (aged > = 60 years) by 9.5 mmHg. The aim of this study was to assess the cost-effectiveness of this salt reduction program. Methods Costs of the intervention were assessed using an ingredients approach to identify resource use. A trial-based incremental cost-effectiveness ratio (ICER) was estimated based on the observed effectiveness in lowering SBP. A Markov model was used to estimate the long-term cost-effectiveness of the intervention, and then based on population data, extrapolated to a scenario where the program is scaled up nationwide. Findings were presented in terms of an incremental cost per quality-adjusted life year (QALY). The perspective was that of the health sector. Results The intervention cost Int$19.04 per family and yielded an ICER of Int$2.74 (90% CI: 1.17-12.30) per mmHg reduction of SBP in all participants (combining children and adult participants together) compared with control group. If scaled up nationwide for 10 years and assumed deterioration in treatment effect of 50% over this period, it would reach 165 million families and estimated to avert 42,720 acute myocardial infarction deaths and 107,512 stroke deaths in China. This would represent a gain of 635,816 QALYs over 10-year time frame, translating into Int$1,358 per QALY gained. Conclusion Based on WHO-CHOICE criteria, our analysis demonstrated that the proposed salt reduction strategy is highly cost-effective, and if scaled up nationwide, the benefits could be substantial.	[Li, Xian; Yan, Lijing L.; Chu, Yunbo; Wu, Yangfeng] Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China; [Jan, Stephen] George Inst Global Hlth, Sydney, NSW, Australia; [Hayes, Alison] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Wang, Haijun; Niu, Wenyi; Ma, Jun] Peking Univ, Hlth Sci Ctr, Inst Child & Adolescent Hlth, Beijing, Peoples R China; [Feng, Xiangxian; Han, Yanbo] Changzhi Med Coll, Changzhi, Shanxi, Peoples R China; [He, Feng J.; MacGregor, Graham A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, London, England; [Wu, Yangfeng] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Wu, Yangfeng] Peking Univ, Clin Res Inst, Beijing, Peoples R China; [Yan, Lijing L.] Duke Kunshan Univ, Global Hlth Res Ctr, Kunshan, Jiangsu, Peoples R China	Peking University; George Institute for Global Health; University of Sydney; University of Sydney; Peking University; Changzhi Medical College; University of London; Queen Mary University London; Peking University; Peking University; Duke Kunshan University	Wu, YF (corresponding author), Peking Univ, Hlth Sci Ctr, George Inst Global Hlth, Beijing, Peoples R China.; Wu, YF (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China.; Wu, YF (corresponding author), Peking Univ, Clin Res Inst, Beijing, Peoples R China.	ywu@georgeinstitute.org.cn	Jan, Stephen/AAG-3333-2021; He, Feng/HHS-6457-2022; Wang, Haijun/AAD-1302-2021	He, Feng/0000-0002-1996-0744; Wang, Haijun/0000-0003-0849-2903; Jan, Stephen/0000-0003-2839-1405; Li, Xian/0000-0001-5445-4022; He, Feng/0000-0003-2807-4119; MacGregor, Graham/0000-0001-9206-4500	UK Medical Research Council as a part of the GACD (Global Alliance for Chronic Disease) Hypertension Programme [MR/J015903/1]; Medical Research Council [MR/J015903/1] Funding Source: researchfish; MRC [MR/J015903/1] Funding Source: UKRI	UK Medical Research Council as a part of the GACD (Global Alliance for Chronic Disease) Hypertension Programme; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the UK Medical Research Council (MR/J015903/1, http://www.mrc.ac.uk/), as a part of the GACD (Global Alliance for Chronic Disease) Hypertension Programme. The funders of the study had no role in study design, the collection, analysis, and interpretation of the data, preparation of the manuscript, and decision to publish. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; [Anonymous], 2011, 1 GLOB MIN C HLTH LI; [Anonymous], 2011, CHINA GUIDELINES PHA; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Basu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044037; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Collins M, 2014, VALUE HEALTH, V17, P517, DOI 10.1016/j.jval.2014.03.1722; Dalal PM, 2006, INT J STROKE, V1, P164, DOI 10.1111/j.1747-4949.2006.00051.x; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Du SF, 2014, AM J CLIN NUTR, V99, P334, DOI 10.3945/ajcn.113.059121; EFRON B, 1994, J AM STAT ASSOC, V89, P463, DOI 10.2307/2290846; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Glanz K, 2008, HLTH BEHAV HLTH ED T, P169; Gu DF, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001860; He FJ, 2006, HYPERTENSION, V48, P861, DOI 10.1161/01.HYP.0000245672.27270.4a; He FJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h770; He FJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004549; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; He FJ, 2013, BMJ OPEN, V3; Joffres MR, 2007, CAN J CARDIOL, V23, P437, DOI 10.1016/S0828-282X(07)70780-8; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Li Q, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/1471-2261-15-9; Mason H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084445; McEwan PJ, 2012, J DEV EFFECT, V4, P189, DOI 10.1080/19439342.2011.649044; Moran Andrew, 2008, BMC Public Health, V8, P394, DOI 10.1186/1471-2458-8-394; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; National Health and Family Planning Commission of China, 2015, CHIN HLTH FAM PLANN; National Institute for Health and Clinical Excellence (NICE), 2010, GUID PREV CARD LAR D; Nghiem N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123915; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Selmer RM, 2000, J EPIDEMIOL COMMUN H, V54, P697, DOI 10.1136/jech.54.9.697; Singh GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065174; Smith-Spangler CM, 2010, ANN INTERN MED, V152, P481, DOI 10.7326/0003-4819-152-8-201004200-00212; Stamler J, 1997, AM J CLIN NUTR, V65, P626, DOI 10.1093/ajcn/65.2.626S; Sun Jia-Yi, 2007, Zhonghua Nei Ke Za Zhi, V46, P362; Tengs TO, 2000, MED CARE, V38, P583, DOI 10.1097/00005650-200006000-00004; The People's Republic of China National Health and Family Planning Commission, 2012, CHINA NATL PLAN NCD; The World Bank, DAT CHIN GDP POP 201; Tu F, 2002, HEALTH POLICY, V59, P243, DOI 10.1016/S0168-8510(01)00182-8; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; Webster J, 2014, NUTRIENTS, V6, P3274, DOI 10.3390/nu6083274; World Health Organization, 2013, CHOOS INT AR COST EF; Yang Li, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P349, DOI 10.1586/14737167.8.4.349; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Zhai F., 2006, REPORT CHINESE NATL; Zhao D, 2008, STROKE, V39, P1668, DOI 10.1161/STROKEAHA.107.502807; Zhou MG, 2016, LANCET, V387, P251, DOI 10.1016/S0140-6736(15)00551-6; 2003, J HYPERTENS, V21, P707, DOI DOI 10.1097/01.HJH.0000052492.18130.07	50	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183033	10.1371/journal.pone.0183033	http://dx.doi.org/10.1371/journal.pone.0183033			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902880	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200009
J	Afshari, P; Yao, WD; Middleton, FA				Afshari, Parisa; Yao, Wei-Dong; Middleton, Frank A.			Reduced Slc1a1 expression is associated with neuroinflammation and impaired sensorimotor gating and cognitive performance in mice: Implications for schizophrenia	PLOS ONE			English	Article							NEURONAL GLUTAMATE TRANSPORTER; OBSESSIVE-COMPULSIVE DISORDER; INCREASED OXIDATIVE STRESS; FAMILY-BASED ASSOCIATION; WORKING-MEMORY; PREFRONTAL CORTEX; GLUTATHIONE SYNTHESIS; GENE SLC1A1; APOPTOTIC MECHANISMS; PYRAMIDAL NEURONS	We previously reported a 84-Kb hemi-deletion copy number variant at the SLC1A1 gene locus that reduces its expression and appeared causally linked to schizophrenia. In this report, we characterize the in vivo and in vitro consequences of reduced expression of Slc1a1 in mice. Heterozygous (HET) Slc1a1(+/-) mice, which more closely model the hemi-deletion we found in human subjects, were examined in a series of behavioral, anatomical and biochemical assays. Knockout (KO) mice were also included in the behavioral studies for comparative purposes. Both HET and KO mice exhibited evidence of increased anxiety-like behavior, impaired working memory, decreased exploratory activity and impaired sensorimotor gating, but no changes in overall locomotor activity. The magnitude of changes was approximately equivalent in the HET and KO mice suggesting a dominant effect of the haploinsufficiency. Behavioral changes in the HET mice were accompanied by reduced thickness of the dorsomedial prefrontal cortex. Whole transcriptome RNA-Seq analysis detected expression changes of genes and pathways involved in cytokine signaling and synaptic functions in both brain and blood. Moreover, the brains of Slc1a1(+/-) mice displayed elevated levels of oxidized glutathione, a trend for increased oxidative DNA damage, and significantly increased levels of cytokines. This latter finding was further supported by SLC1A1 knockdown and overexpression studies in differentiated human neuroblastoma cells, which led to decreased or increased cytokine expression, respectively. Taken together, our results suggest that partial loss of the Slc1a1 gene in mice causes haploinsufficiency associated with behavioral, histological and biochemical changes that reflect an altered redox state and may promote the expression of behavioral features and inflammatory states consistent with those observed in schizophrenia.	[Afshari, Parisa; Yao, Wei-Dong; Middleton, Frank A.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Yao, Wei-Dong; Middleton, Frank A.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA.; Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA.; Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	middletf@upstate.edu		Middleton, Frank/0000-0002-3107-7188	National Institutes of Health [DA032283, MH106489, RR026761]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA032283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	WDY is supported by grants from the National Institutes of Health (DA032283, MH106489 and RR026761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriano F, 2012, NEUROSCIENTIST, V18, P180, DOI 10.1177/1073858410395147; Afshari Parisa, 2015, Mol Neuropsychiatry, V1, P125, DOI 10.1159/000433599; Antonova E, 2004, SCHIZOPHR RES, V70, P117, DOI 10.1016/j.schres.2003.12.002; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Aoyama K, 2015, MOLECULES, V20, P8742, DOI 10.3390/molecules20058742; Aoyama K, 2013, INT J MOL SCI, V14, P21021, DOI 10.3390/ijms141021021; Aoyama K, 2013, AMINO ACIDS, V45, P133, DOI 10.1007/s00726-013-1481-5; Aoyama K, 2012, INT J MOL SCI, V13, P12017, DOI 10.3390/ijms130912017; Aoyama K, 2012, NEUROBIOL DIS, V45, P973, DOI 10.1016/j.nbd.2011.12.016; Aoyama K, 2008, J PHARMACOL SCI, V108, P227, DOI 10.1254/jphs.08R01CR; Arion D, 2015, MOL PSYCHIATR, V20, P1397, DOI 10.1038/mp.2014.171; Arnold PD, 2006, ARCH GEN PSYCHIAT, V63, P769, DOI 10.1001/archpsyc.63.7.769; BANNAI S, 1980, J BIOL CHEM, V255, P2372; Barch DM, 2008, BIOL PSYCHIAT, V64, P11, DOI 10.1016/j.biopsych.2008.03.003; Berman AE, 2011, ANN NEUROL, V69, P509, DOI 10.1002/ana.22162; Bicks LK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01805; Black JE, 2004, AM J PSYCHIAT, V161, P742, DOI 10.1176/appi.ajp.161.4.742; BOGERTS B, 1990, PSYCHIAT RES-NEUROIM, V35, P1; Bonilha L, 2008, SCHIZOPHR RES, V101, P142, DOI 10.1016/j.schres.2007.11.023; Boskovic M, 2011, CURR NEUROPHARMACOL, V9, P301, DOI 10.2174/157015911795596595; Braff DL, 2007, SCHIZOPHRENIA BULL, V33, P21, DOI 10.1093/schbul/sbl049; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Broadbent NJ, 2010, LEARN MEMORY, V17, P794, DOI 10.1101/lm.1650110; Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361; Buckley PF, 2009, SCHIZOPHRENIA BULL, V35, P383, DOI 10.1093/schbul/sbn135; Bumb JM, 2015, EXPERT OPIN PHARMACO, V16, P1049, DOI 10.1517/14656566.2015.1032248; Cannon TD, 2002, P NATL ACAD SCI USA, V99, P3228, DOI 10.1073/pnas.052023499; Cao L, 2012, NEUROSCIENCE, V220, P85, DOI 10.1016/j.neuroscience.2012.06.044; Chen YM, 2003, J NEUROCHEM, V84, P1332, DOI 10.1046/j.1471-4159.2003.01630.x; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; Cooper AJL, 1997, BIOL CHEM, V378, P793; Copoglu US, 2015, PSYCHIAT RES, V229, P200, DOI 10.1016/j.psychres.2015.07.036; Costain G, 2014, AM J MED GENET B, V165, P337, DOI 10.1002/ajmg.b.32236; Costain G, 2013, HUM MOL GENET, V22, P4485, DOI 10.1093/hmg/ddt297; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Dickel DE, 2006, ARCH GEN PSYCHIAT, V63, P778, DOI 10.1001/archpsyc.63.7.778; Doorduin J, 2009, J NUCL MED, V50, P1801, DOI 10.2967/jnumed.109.066647; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Ehrlich S, 2012, SCHIZOPHRENIA BULL, V38, P1050, DOI 10.1093/schbul/sbr018; Emiliani FE, 2014, CURR OPIN PSYCHIATR, V27, P185, DOI 10.1097/YCO.0000000000000054; Escartin C, 2011, J NEUROSCI, V31, P7392, DOI 10.1523/JNEUROSCI.6577-10.2011; Gadani SP, 2012, J IMMUNOL, V189, P4213, DOI 10.4049/jimmunol.1202246; GADOW KD, 2010, J AUTISM DEV DISORD, V40, DOI DOI 10.1007/s10803-010-0959-1; Ganzola R, 2014, SCHIZOPHR RES, V156, P76, DOI 10.1016/j.schres.2014.03.030; GILBERT HF, 1984, METHOD ENZYMOL, V107, P330; Girgis RR, 2014, BIOL PSYCHIAT, V75, P292, DOI 10.1016/j.biopsych.2013.12.002; Glantz LA, 2006, SCHIZOPHR RES, V81, P47, DOI 10.1016/j.schres.2005.08.014; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Grados MA, 2013, EXPERT OPIN DRUG DIS, V8, P1515, DOI 10.1517/17460441.2013.845553; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Gu F, 2015, CURR OPIN CLIN NUTR, V18, P89, DOI 10.1097/MCO.0000000000000134; Hanna GL, 2002, AM J MED GENET, V114, P541, DOI 10.1002/ajmg.10519; Harrison PJ, 1999, BRAIN, V122, P593, DOI 10.1093/brain/122.4.593; Harrison PJ, 2004, PSYCHOPHARMACOLOGY, V174, P151, DOI 10.1007/s00213-003-1761-y; Holmseth S, 2012, J NEUROSCI, V32, P6000, DOI 10.1523/JNEUROSCI.5347-11.2012; Horiuchi Y, 2012, AM J MED GENET B, V159B, P30, DOI 10.1002/ajmg.b.31249; Jarskog LF, 2000, BIOL PSYCHIAT, V48, P641, DOI 10.1016/S0006-3223(00)00988-4; Jarskog LF, 2006, CURR OPIN PSYCHIATR, V19, P307, DOI 10.1097/01.yco.0000218603.25346.8f; Jarskog LF, 2005, PROG NEURO-PSYCHOPH, V29, P846, DOI 10.1016/j.pnpbp.2005.03.010; Jarskog LF, 2004, AM J PSYCHIAT, V161, P109, DOI 10.1176/appi.ajp.161.1.109; Jones CA, 2011, BRIT J PHARMACOL, V164, P1162, DOI 10.1111/j.1476-5381.2011.01386.x; Jorgensen A, 2013, PSYCHIAT RES, V209, P417, DOI 10.1016/j.psychres.2013.01.033; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Khandaker GM, 2015, LANCET PSYCHIAT, V2, P258, DOI 10.1016/S2215-0366(14)00122-9; Kiryu-Seo S, 2006, EMBO J, V25, P3411, DOI 10.1038/sj.emboj.7601225; Klein JA, 2003, J CLIN INVEST, V111, P785, DOI 10.1172/JCI200318182; Komada M, 2008, J VIS EXP, Vpii, P1088; Lane MC, 2014, NEUROCHEM INT, V73, P152, DOI 10.1016/j.neuint.2013.11.013; Lawrie SM, 1999, LANCET, V353, P30, DOI 10.1016/S0140-6736(98)06244-8; Leckman JF, 2006, ARCH GEN PSYCHIAT, V63, P717, DOI 10.1001/archpsyc.63.7.717; Lee S, 2012, J PHARM PHARMACOL, V64, P302, DOI 10.1111/j.2042-7158.2011.01404.x; Lett TA, 2014, BIOL PSYCHIAT, V75, P361, DOI 10.1016/j.biopsych.2013.07.026; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Lewis DA, 2012, EUR J NEUROSCI, V35, P1871, DOI 10.1111/j.1460-9568.2012.08156.x; Li LL, 2011, J CEREBR BLOOD F MET, V31, P1283, DOI 10.1038/jcbfm.2010.222; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Muller Jacqueline E, 2004, Curr Psychiatry Rep, V6, P255, DOI 10.1007/s11920-004-0074-0; Myles-Worsley M, 2013, AM J MED GENET B, V162B, P87, DOI 10.1002/ajmg.b.32125; Nielsen J, 2015, SCHIZOPHRENIA BULL, V41, P764, DOI 10.1093/schbul/sbu118; Nishioka N, 2004, AM J GERIAT PSYCHIAT, V12, P167, DOI 10.1176/appi.ajgp.12.2.167; Pastore A, 2003, CLIN CHIM ACTA, V333, P19, DOI 10.1016/S0009-8981(03)00200-6; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Perry W, 2001, SCHIZOPHRENIA BULL, V27, P157, DOI 10.1093/oxfordjournals.schbul.a006854; Porsolt RD, 2010, J PHARMACOL EXP THER, V333, P632, DOI 10.1124/jpet.110.166710; Porton B, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.35; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P19, DOI 10.1093/schbul/sbn162; Powell SB, 2009, BEHAV BRAIN RES, V204, P282, DOI 10.1016/j.bbr.2009.04.021; Priebe L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064035; Qing H, 2003, EUR J NEUROSCI, V17, P1563, DOI 10.1046/j.1460-9568.2003.02590.x; Rajkowska G, 2002, SCHIZOPHR RES, V57, P127, DOI 10.1016/S0920-9964(02)00339-0; Rajkowska G, 1998, ARCH GEN PSYCHIAT, V55, P215, DOI 10.1001/archpsyc.55.3.215; Rees E, 2014, HUM MOL GENET, V23, P1669, DOI 10.1093/hmg/ddt540; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; SAGARA J, 1993, J NEUROCHEM, V61, P1672, DOI 10.1111/j.1471-4159.1993.tb09802.x; Samuels J, 2011, AM J MED GENET B, V156B, P472, DOI 10.1002/ajmg.b.31184; Scimemi A, 2009, J NEUROSCI, V29, P14581, DOI 10.1523/JNEUROSCI.4845-09.2009; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Shugart YY, 2009, AM J MED GENET B, V150B, P886, DOI 10.1002/ajmg.b.30914; Smyth AM, 2013, CLIN PSYCHOPHARM NEU, V11, P107, DOI 10.9758/cpn.2013.11.3.107; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steullet P, 2016, SCHIZOPHR RES, V176, P41, DOI 10.1016/j.schres.2014.06.021; Stewart LR, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-154; Stewart SE, 2007, AM J MED GENET B, V144B, P1027, DOI 10.1002/ajmg.b.30533; Strekalova T, 2004, NEUROPSYCHOPHARMACOL, V29, P2007, DOI 10.1038/sj.npp.1300532; Upthegrove R, 2014, SCHIZOPHR RES, V155, P101, DOI 10.1016/j.schres.2014.03.005; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; van den Buuse M, 2010, SCHIZOPHRENIA BULL, V36, P246, DOI 10.1093/schbul/sbp132; Watabe M, 2007, MOL PHARMACOL, V72, P1103, DOI 10.1124/mol.107.039461; Watanabe Y, 2010, PSYCHIAT CLIN NEUROS, V64, P217, DOI 10.1111/j.1440-1819.2010.02094.x; Willour VL, 2004, AM J HUM GENET, V75, P508, DOI 10.1086/423899; Won SJ, 2010, J NEUROSCI, V30, P15409, DOI 10.1523/JNEUROSCI.2084-10.2010; Yoon T, 2008, LEARN MEMORY, V15, P97, DOI 10.1101/lm.850808; Zerangue N, 1996, J PHYSIOL-LONDON, V493, P419, DOI 10.1113/jphysiol.1996.sp021393; Zhang JP, 2014, 8TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICAL ENGINEERING (ICBBE 2014), P1	122	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183854	10.1371/journal.pone.0183854	http://dx.doi.org/10.1371/journal.pone.0183854			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886095	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100041
J	Seminati, E; Talamas, DC; Young, M; Twiste, M; Dhokia, V; Bilzon, JLJ				Seminati, Elena; Talamas, David Canepa; Young, Matthew; Twiste, Martin; Dhokia, Vimal; Bilzon, James L. J.			Validity and reliability of a novel 3D scanner for assessment of the shape and volume of amputees' residual limb models	PLOS ONE			English	Article							CONTEMPORARY CAD/CAM SYSTEM; TRANSTIBIAL AMPUTATION; BODY-COMPOSITION; PRECISION; ACCURACY; PROSTHETICS; AGREEMENT; PEOPLE	Background Objective assessment methods to monitor residual limb volume following lower-limb amputation are required to enhance practitioner-led prosthetic fitting. Computer aided systems, including 3D scanners, present numerous advantages and the recent Artec Eva scanner, based on laser free technology, could potentially be an effective solution for monitoring residual limb volumes. Purpose The aim of this study was to assess the validity and reliability of the Artec Eva scanner (practical measurement) against a high precision laser 3D scanner (criterion measurement) for the determination of residual limb model shape and volume. Methods Three observers completed three repeat assessments of ten residual limb models, using both the scanners. Validity of the Artec Eva scanner was assessed (mean percentage error <2%) and Bland-Altman statistics were adopted to assess the agreement between the two scanners. Intra and inter-rater reliability (repeatability coefficient <5%) of the Artec Eva scanner was calculated for measuring indices of residual limb model volume and shape (i.e. residual limb cross sectional areas and perimeters). Results Residual limb model volumes ranged from 885 to 4399 ml. Mean percentage error of the Artec Eva scanner (validity) was 1.4% of the criterion volumes. Correlation coefficients between the Artec Eva and the Romer determined variables were higher than 0.9. Volume intra-rater and inter-rater reliability coefficients were 0.5% and 0.7%, respectively. Shape percentage maximal error was 2% at the distal end of the residual limb, with intra-rater reliability coefficients presenting the lowest errors (0.2%), both for cross sectional areas and perimeters of the residual limb models. Conclusion The Artec Eva scanner is a valid and reliable method for assessing residual limb model shapes and volumes. While the method needs to be tested on human residual limbs and the results compared with the current system used in clinical practice, it has the potential to quantify shape and volume fluctuations with greater resolution.	[Seminati, Elena; Bilzon, James L. J.] Univ Bath, Dept Hlth, Bath, Avon, England; [Seminati, Elena; Young, Matthew; Bilzon, James L. J.] Univ Bath, CAMERA Ctr, Bath, Avon, England; [Talamas, David Canepa; Dhokia, Vimal] Univ Bath, Dept Mech Engn, Bath, Avon, England; [Twiste, Martin] Univ Salford, Sch Hlth Sci, Salford, Lancs, England; [Twiste, Martin] Univ Salford, UNIPOD, Salford, Lancs, England	University of Bath; University of Bath; University of Bath; University of Salford; University of Salford	Bilzon, JLJ (corresponding author), Univ Bath, Dept Hlth, Bath, Avon, England.; Bilzon, JLJ (corresponding author), Univ Bath, CAMERA Ctr, Bath, Avon, England.	j.bilzon@bath.ac.uk		Young, Matthew/0000-0003-4868-3878; Dhokia, Vimal/0000-0002-6343-6958; Bilzon, James/0000-0002-6701-7603; Seminati, Elena/0000-0002-6736-893X	Engineering and Physical Sciences Research Council UKs Impact Acceleration Account [RC-FH1136]; Engineering and Physical Sciences Research Council [EP/M023281/1] Funding Source: researchfish; EPSRC [EP/M023281/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council UKs Impact Acceleration Account(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was funded by the Engineering and Physical Sciences Research Council UKs Impact Acceleration Account (RC-FH1136).	Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bolt A, 2010, AM J PHYS MED REHAB, V89, P376, DOI 10.1097/PHM.0b013e3181d3ea94; Buis AWP, 2006, J REHABIL RES DEV, V43, P883, DOI 10.1682/JRRD.2005.08.0145; Coltman CE, 2016, ERGONOMICS IN PRESS, P1; Colyer SL, 2016, PHYSIOL MEAS, V37, P596, DOI 10.1088/0967-3334/37/4/596; Commean PK, 1996, ARCH PHYS MED REHAB, V77, P477, DOI 10.1016/S0003-9993(96)90037-4; Commean PK, 1998, ARCH PHYS MED REHAB, V79, P772, DOI 10.1016/S0003-9993(98)90355-0; de Boer-Wilzing VG, 2011, ARCH PHYS MED REHAB, V92, P941, DOI 10.1016/j.apmr.2011.01.007; Dickinson AS, 2016, J REHABIL RES DEV, V53, P207, DOI 10.1682/JRRD.2014.10.0272; FERNIE GR, 1982, ARCH PHYS MED REHAB, V63, P162; Geil MD, 2007, J REHABIL RES DEV, V44, P515, DOI 10.1682/JRRD.2006.08.0088; Golbranson F L, 1988, J Rehabil Res Dev, V25, P11; He P, 1999, J REHABIL RES DEV, V36, P86; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG, SPREADSHEET ANAL VAL; Hopkins WG, PRECISION MEASUREMEN; Johansson S, 1998, J REHABIL RES DEV, V35, P27; Karmarkar AM, 2009, J REHABIL RES DEV, V46, P567, DOI 10.1682/JRRD.2008.08.0102; LILJA M, 1995, J REHABIL RES DEV, V32, P141; Lilja M., 1997, JPO J PROSTHET ORTHO, V9, P90, DOI [10.1097/00008526-199700920-00009, DOI 10.1097/00008526-199700920-00009]; McGarry T, 2008, PROSTHET ORTHOT INT, V32, P145, DOI 10.1080/03093640802015920; McGarry T, 2007, PROSTHET ORTHOT INT, V31, P27, DOI 10.1080/03093640600942101; McGarry T, 2005, PROSTHET ORTHOT INT, V29, P221, DOI 10.1080/03093640500199497; Menditto A, 2007, ACCREDIT QUAL ASSUR, V12, P45, DOI 10.1007/s00769-006-0191-z; Mirtich B., 1996, J GRAPH TOOLS, V1, P31, DOI DOI 10.1080/10867651.1996.10487458; Modabber A, 2016, J CRANIOMAXILLOFAC S; Nana A, 2013, MED SCI SPORT EXER, V45, P178, DOI 10.1249/MSS.0b013e31826c9cfd; OBERG K, 1989, J PROSTHET ORTHOT, V1, P139; Paulus S, 2014, BIOSYST ENG, V121, P1, DOI 10.1016/j.biosystemseng.2014.01.010; Portney LG., 2014, FDN CLIN RES APPL PR; Sanders JE, 2005, J BIOMECH, V38, P1566, DOI 10.1016/j.jbiomech.2004.08.008; Sanders JE, 2011, J REHABIL RES DEV, V48, P949, DOI 10.1682/JRRD.2010.09.0189; Sanders JE, 2009, PROSTHET ORTHOT INT, V33, P378, DOI 10.3109/03093640903214067; Schreiner R. E., 1995, IEEE Transactions on Rehabilitation Engineering, V3, P242, DOI 10.1109/86.413197; SUKUL DMKSK, 1993, J BIOMED ENG, V15, P477, DOI 10.1016/0141-5425(93)90062-4; Tantua AT, 2014, J REHABIL RES DEV, V51, P1119, DOI 10.1682/JRRD.2013.11.0243; Yamamoto S, 2016, J ORAL MAXIL SURG OF; Zachariah SC, 2004, J REHABIL RES DEV, V41, P683, DOI 10.1682/JRRD.2003.10.0153; Zachariah SG, 2005, IEEE T NEUR SYS REH, V13, P551, DOI 10.1109/TNSRE.2005.858459; Zheng YP, 2001, J REHABIL RES DEV, V38, P487	40	32	32	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184498	10.1371/journal.pone.0184498	http://dx.doi.org/10.1371/journal.pone.0184498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886154	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100140
J	Wu, L; Lin, HD; Gao, J; Li, XM; Xia, MF; Wang, D; Aleteng, Q; Ma, H; Pan, BS; Gao, X				Wu, Li; Lin, Huandong; Gao, Jian; Li, Xiaoming; Xia, Mingfeng; Wang, Dan; Aleteng, Qiqige; Ma, Hui; Pan, Baishen; Gao, Xin			Effect of age on the diagnostic efficiency of HbA1c for diabetes in a Chinese middle-aged and elderly population: The Shanghai Changfeng Study	PLOS ONE			English	Article							GLYCATED HEMOGLOBIN; GLYCOSYLATED HEMOGLOBIN; PREVALENCE; HBA(1C); MELLITUS; TRENDS; ADULTS; ERYTHROCYTES; INDIVIDUALS; PEOPLE	Background and aims Glycated hemoglobin A1c (HbA1c) >= 6.5% (or 48mmol/mol) has been recommended as a new diagnostic criterion for diabetes; however, limited literature is available regarding the effect of age on the HbA1c for diagnosing diabetes and the causes for this age effect remain unknown. In this study, we investigated whether and why age affects the diagnostic efficiency of HbA1c for diabetes in a community-based Chinese population. Methods In total, 4325 participants without previously known diabetes were enrolled in this study. Participants were stratified by age. Receiver operating characteristic curve (ROC) was plotted for each age group and the area under the curve (AUC) represented the diagnostic efficiency of HbA1c for diabetes defined by the plasma glucose criteria. The area under the ROC curve in each one-year age group was defined as AUCage. Multiple regression analyses were performed to identify factors inducing the association between age and AUCage based on the changes in the beta and P values of age. Results The current threshold of HbA1c (>= 6.5% or 48mmol/mol) showed low sensitivity (35.6%) and high specificity (98.9%) in diagnosing diabetes. ROC curve analyses showed that the diagnostic efficiency of HbA1c in the >= 75 years age group was significantly lower than that in the 45-54 years age group (AUC: 0.755 vs. 0.878; P<0.001). Pearson correlation analysis showed that the AUCage of HbA1c was negatively correlated with age (r = -0.557, P = 0.001). When adjusting the red blood cell (RBC) count in the multiple regression model, the negative association between age and AUCage disappeared, with the regression coefficient of age reversed to 0.001 and the P value increased to 0.856. Conclusions The diagnostic efficiency of HbA1c for diabetes decreased with aging, and this age effect was induced by the decreasing RBC count with age. HbA1c is unsuitable for diagnosing diabetes in elderly individuals because of their physiologically decreased RBC count.	[Wu, Li; Lin, Huandong; Li, Xiaoming; Xia, Mingfeng; Wang, Dan; Aleteng, Qiqige; Ma, Hui; Gao, Xin] Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Wu, Li; Lin, Huandong; Xia, Mingfeng; Gao, Xin] Fudan Inst Metab Dis, Shanghai, Peoples R China; [Lin, Huandong] Fudan Univ, Res Ctr Aging & Med, Shanghai, Peoples R China; [Gao, Jian] Fudan Univ, Zhongshan Hosp, Dept Clin Nutr, Shanghai, Peoples R China; [Pan, Baishen] Fudan Univ, Zhongshan Hosp, Dept Lab Med, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Gao, X (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China.; Gao, X (corresponding author), Fudan Inst Metab Dis, Shanghai, Peoples R China.	happy20061208@126.com	Xia, Ming-Feng/AAL-1403-2020	Xia, Ming-Feng/0000-0002-5650-0165; Gao, Xin/0000-0003-1864-7796	Shanghai Science and Technology Committee (STCSM) Foundation [16411954800]; Shanghai Health and Family Planning Commission Foundation [2013ZYJB0802, 15GWZK0801]	Shanghai Science and Technology Committee (STCSM) Foundation; Shanghai Health and Family Planning Commission Foundation	This work was supported by grants from Shanghai Science and Technology Committee (STCSM) Foundation (16411954800 to Xin Gao), the Shanghai Health and Family Planning Commission Foundation (Grant No. 2013ZYJB0802 to Xin Gao and 15GWZK0801 to Xin Gao and Huandong Lin). 2013ZYJB0802. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, TURK J ENDOCRINOL ME, V14, P11; ARAKI K, 1980, J GERONTOL, V35, P499, DOI 10.1093/geronj/35.4.499; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; BROSCHE T, 1990, EXP GERONTOL, V25, P23, DOI 10.1016/0531-5565(90)90005-M; Committee C, 2007, DIABETOLOGIA, V50, P2042, DOI 10.1007/s00125-007-0789-7; Davidson MB, 2010, DIABETES RES CLIN PR, V87, P415, DOI 10.1016/j.diabres.2009.12.013; Drawz P, 2015, ANN INTERN MED, V162, DOI 10.7326/AITC201506020; Ferrucci L, 2006, ARCH INTERN MED, V166, P1380, DOI 10.1001/archinte.166.13.1380; Gao X, 2010, EUR J EPIDEMIOL, V25, P885, DOI 10.1007/s10654-010-9525-6; GERSHON H, 1988, BLOOD CELLS, V14, P93; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; HASHIMOTO Y, 1995, DIABETES CARE, V18, P1337, DOI 10.2337/diacare.18.10.1337; Huang H, 2013, PREV MED, V57, P345, DOI 10.1016/j.ypmed.2013.06.012; Inaba M, 2007, J AM SOC NEPHROL, V18, P896, DOI 10.1681/ASN.2006070772; Ji CJ, 2015, CLIN LAB, V61, P1831, DOI 10.7754/Clin.Lab.2015.150423; Kramer CK, 2010, DIABETES CARE, V33, P101, DOI 10.2337/dc09-1366; Lahousen T, 2004, WORLD J GASTROENTERO, V10, P2284; Lee H, 2013, DIABETES RES CLIN PR, V99, P231, DOI 10.1016/j.diabres.2012.09.030; Lin H, 2016, EUROPEAN J EPIDEMIOL; [吕雪梅 Lv Xuemei], 2013, [中国糖尿病杂志, Chinese Journal of Diabetes], V21, P686; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; Mueller SM, 2001, J CELL BIOCHEM, V82, P583, DOI 10.1002/jcb.1174; MULKERRIN EC, 1992, AGE AGEING, V21, P175, DOI 10.1093/ageing/21.3.175; Nakagami T, 2007, DIABETES RES CLIN PR, V76, P251, DOI 10.1016/j.diabres.2006.09.015; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; NATHAN DM, 1984, NEW ENGL J MED, V310, P341, DOI 10.1056/NEJM198402093100602; Nuttall FQ, 1999, J LAB CLIN MED, V134, P451, DOI 10.1016/S0022-2143(99)90165-8; Organization WH, 2008, WORLD HLTH REP 2008, V25, P617; Pani LN, 2008, DIABETES CARE, V31, P1991, DOI 10.2337/dc08-0577; Rohlfing CL, 2000, DIABETES CARE, V23, P187, DOI 10.2337/diacare.23.2.187; Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498; WHO Guidelines Approved by the Guidelines Review Committee, 2011, US GLYC HAEM HBA1C D; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yang LY, 2015, CLIN ENDOCRINOL, V82, P205, DOI 10.1111/cen.12494; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang YC, 1997, DIABETES CARE, V20, P988, DOI 10.2337/diacare.20.6.988	37	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184607	10.1371/journal.pone.0184607	http://dx.doi.org/10.1371/journal.pone.0184607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886160	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100165
J	Sewell, DK; Rayner, PJ; Shank, DB; Guy, S; Lilburn, SD; Saber, S; Kashima, Y				Sewell, David K.; Rayner, Peter J.; Shank, Daniel B.; Guy, Sophie; Lilburn, Simon D.; Saber, Saam; Kashima, Yoshihisa			Causal knowledge promotes behavioral self-regulation: An example using climate change dynamics	PLOS ONE			English	Article							DECISION-MAKING; MENTAL MODELS; PEOPLE KNOW; EDUCATED LAYPEOPLE; CARBON-CYCLE; MISPERCEPTIONS; ACCUMULATION; FEEDBACK; POLICIES; INTERVENTIONS	Adopting successful climate change mitigation policies requires the public to choose how to balance the sometimes competing goals of managing CO2 emissions and achieving economic growth. It follows that collective action on climate change depends on members of the public to be knowledgeable of the causes and economic ramifications of climate change. The existing literature, however, shows that people often struggle to correctly reason about the fundamental accumulation dynamics that drive climate change. Previous research has focused on using analogy to improve people's reasoning about accumulation, which has been met with some success. However, these existing studies have neglected the role economic factors might play in shaping people's decisions in relation to climate change. Here, we introduce a novel iterated decision task in which people attempt to achieve a specific economic goal by interacting with a causal dynamic system in which human economic activities, CO2 emissions, and warming are all causally interrelated. We show that when the causal links between these factors are highlighted, people's ability to achieve the economic goal of the task is enhanced in a way that approaches optimal responding, and avoids dangerous levels of warming.	[Sewell, David K.; Shank, Daniel B.; Guy, Sophie; Lilburn, Simon D.; Saber, Saam; Kashima, Yoshihisa] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia; [Sewell, David K.] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Rayner, Peter J.] Univ Melbourne, Sch Earth Sci, Melbourne, Vic, Australia; [Shank, Daniel B.] Missouri Univ Sci & Technol, Dept Psychol Sci, Rolla, MO USA; [Guy, Sophie] Univ South Australia, Sch Hlth Sci, Adelaide, SA, Australia	University of Melbourne; University of Queensland; University of Melbourne; University of Missouri System; Missouri University of Science & Technology; University of South Australia	Sewell, DK (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.; Sewell, DK (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld, Australia.	d.sewell@uq.edu.au		Kashima, Yoshihisa/0000-0003-3627-3273; Sewell, David/0000-0002-9966-8232	Australian Research Council Discovery Project Grant [DP130102229]; Australian Research Council Discovery Early Career Research Award fellowship [DE140100772]	Australian Research Council Discovery Project Grant(Australian Research Council); Australian Research Council Discovery Early Career Research Award fellowship(Australian Research Council)	This research was supported by an Australian Research Council Discovery Project Grant (www.arc.gov.au; DP130102229) awarded to Yoshihisa Kashima, Angela Paladino, and David Sewell. David Sewell was supported by an Australian Research Council Discovery Early Career Research Award fellowship (www.arc.gov.au; DE140100772). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain PG, 2012, NAT CLIM CHANGE, V2, P600, DOI 10.1038/NCLIMATE1532; Bodman R, 2013, NAT CLIM CHANGE, V3, P725, DOI [10.1038/nclimate1903, 10.1038/NCLIMATE1903]; Bord RJ, 2000, PUBLIC UNDERST SCI, V9, P205, DOI 10.1088/0963-6625/9/3/301; BOSTROM A, 1994, RISK ANAL, V14, P959, DOI 10.1111/j.1539-6924.1994.tb00065.x; Bostrom A, 2012, GLOBAL ENVIRON CHANG, V22, P210, DOI 10.1016/j.gloenvcha.2011.09.012; Brulle RJ, 2012, CLIMATIC CHANGE, V114, P169, DOI 10.1007/s10584-012-0403-y; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Burns BD, 2002, Q J EXP PSYCHOL-A, V55, P241, DOI 10.1080/02724980143000262; Clark D., 2013, P 35 ANN M COGN SCI, P2070; Cronin MA, 2009, ORGAN BEHAV HUM DEC, V108, P116, DOI 10.1016/j.obhdp.2008.03.003; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; DIEHL E, 1995, ORGAN BEHAV HUM DEC, V62, P198, DOI 10.1006/obhd.1995.1043; DORNER D, 1990, PHILOS T ROY SOC B, V327, P463, DOI 10.1098/rstb.1990.0089; Dutt V, 2012, CLIMATIC CHANGE, V111, P497, DOI 10.1007/s10584-011-0202-x; Dutt V, 2012, J ENVIRON PSYCHOL, V32, P19, DOI 10.1016/j.jenvp.2011.10.003; Fernbach PM, 2013, PSYCHOL SCI, V24, P939, DOI 10.1177/0956797612464058; Gonzalez C, 2003, COGNITIVE SCI, V27, P591, DOI 10.1016/S0364-0213(03)00031-4; Guy S, 2014, EUR J SOC PSYCHOL, V44, P421, DOI 10.1002/ejsp.2039; Guy S, 2013, CLIMATIC CHANGE, V121, P579, DOI 10.1007/s10584-013-0949-3; Hagmayer Y., 2010, OPEN PSYCHOL J, V3, P145, DOI DOI 10.2174/18743501010030; Hagmayer Y, 2013, J EXP PSYCHOL LEARN, V39, P33, DOI 10.1037/a0028643; Kahn ME, 2011, CLIM CHANG ECON, V2, P257, DOI 10.1142/S2010007811000292; Keil FC, 2003, TRENDS COGN SCI, V7, P368, DOI 10.1016/S1364-6613(03)00158-X; KEMPTON W, 1991, GLOBAL ENVIRON CHANG, V1, P183, DOI 10.1016/0959-3780(91)90042-R; Lagnado DA, 2004, J EXP PSYCHOL LEARN, V30, P856, DOI 10.1037/0278-7393.30.4.856; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Moxnes E, 2000, SYST DYNAM REV, V16, P325, DOI 10.1002/sdr.201; Moxnes E, 2009, CLIMATIC CHANGE, V93, P15, DOI 10.1007/s10584-008-9465-2; Newell BR, 2016, TOP COGN SCI, V8, P138, DOI 10.1111/tops.12176; Newell BR, 2014, ANNU REV ENV RESOUR, V39, P443, DOI 10.1146/annurev-environ-010713-094623; O'Connor RE, 2002, SOC SCI QUART, V83, P1, DOI 10.1111/1540-6237.00067; O'Connor RE, 1999, RISK ANAL, V19, P461, DOI 10.1111/j.1539-6924.1999.tb00421.x; Osman M, 2010, PSYCHOL BULL, V136, P65, DOI 10.1037/a0017815; Pidgeon N, 2011, NAT CLIM CHANGE, V1, P35, DOI [10.1038/NCLIMATE1080, 10.1038/nclimate1080]; Ranney M.A., 2012, P 34 ANN M COGN SCI, P2228; READ D, 1994, RISK ANAL, V14, P971, DOI 10.1111/j.1539-6924.1994.tb00066.x; Reynolds TW, 2010, RISK ANAL, V30, P1520, DOI 10.1111/j.1539-6924.2010.01448.x; Rogelj J, 2013, NATURE, V493, P79, DOI 10.1038/nature11787; Rottman BM, 2012, COGNITIVE PSYCHOL, V64, P93, DOI 10.1016/j.cogpsych.2011.10.003; Rottman BM, 2014, PSYCHOL BULL, V140, P109, DOI 10.1037/a0031903; Rozenblit L, 2002, COGNITIVE SCI, V26, P521, DOI 10.1016/S0364-0213(02)00078-2; Sloman Steven A., 2011, Information.Knowledge.Systems Management, V10, P85, DOI 10.3233/IKS-2012-0187; STERMAN JD, 1989, MANAGE SCI, V35, P321, DOI 10.1287/mnsc.35.3.321; Sterman JD, 2002, SYST DYNAM REV, V18, P501, DOI 10.1002/sdr.261; Sterman JD, 2008, SCIENCE, V322, P532, DOI 10.1126/science.1162574; Sterman JD, 2007, CLIMATIC CHANGE, V80, P213, DOI 10.1007/s10584-006-9107-5; Steyvers M, 2003, COGNITIVE SCI, V27, P453, DOI 10.1016/S0364-0213(03)00010-7; Sweeney LB, 2000, SYST DYNAM REV, V16, P249, DOI 10.1002/sdr.198; Waldmann MR, 2001, PSYCHON B REV, V8, P600, DOI 10.3758/BF03196196; Weber EU, 2011, AM PSYCHOL, V66, P315, DOI 10.1037/a0023253	50	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184480	10.1371/journal.pone.0184480	http://dx.doi.org/10.1371/journal.pone.0184480			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880945	gold, Green Accepted, Green Published			2022-12-27	WOS:000409467200073
J	Zhang, W; Zhang, XL; Zhao, JJ; Qiang, Y; Tian, Q; Tang, XX				Zhang, Wei; Zhang, Xiaolong; Zhao, Juanjuan; Qiang, Yan; Tian, Qi; Tang, Xiaoxian			A segmentation method for lung nodule image sequences based on superpixels and density-based spatial clustering of applications with noise	PLOS ONE			English	Article							RAY-COMPUTED-TOMOGRAPHY; NEURAL-NETWORKS; ALGORITHM; DISTANCE; ENTROPY	The fast and accurate segmentation of lung nodule image sequences is the basis of subsequent processing and diagnostic analyses. However, previous research investigating nodule segmentation algorithms cannot entirely segment cavitary nodules, and the segmentation of juxta-vascular nodules is inaccurate and inefficient. To solve these problems, we propose a new method for the segmentation of lung nodule image sequences based on superpixels and density-based spatial clustering of applications with noise (DBSCAN). First, our method uses three-dimensional computed tomography image features of the average intensity projection combined with multi-scale dot enhancement for preprocessing. Hexagonal clustering and morphological optimized sequential linear iterative clustering (HMSLIC) for sequence image oversegmentation is then proposed to obtain superpixel blocks. The adaptive weight coefficient is then constructed to calculate the distance required between superpixels to achieve precise lung nodules positioning and to obtain the subsequent clustering starting block. Moreover, by fitting the distance and detecting the change in slope, an accurate clustering threshold is obtained. Thereafter, a fast DBSCAN superpixel sequence clustering algorithm, which is optimized by the strategy of only clustering the lung nodules and adaptive threshold, is then used to obtain lung nodule mask sequences. Finally, the lung nodule image sequences are obtained. The experimental results show that our method rapidly, completely and accurately segments various types of lung nodule image sequences.	[Zhang, Wei; Zhao, Juanjuan; Qiang, Yan] Taiyuan Univ Technol, Coll Comp Sci & Technol, Jinzhong, Shanxi, Peoples R China; [Zhang, Xiaolong] Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA; [Tian, Qi] Univ Texas San Antonio, Dept Comp Sci, San Antonio, TX USA; [Tang, Xiaoxian] Shanxi Prov Peoples Hosp, Dept PET, CT Ctr, Taiyuan, Shanxi, Peoples R China	Taiyuan University of Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas at San Antonio (UTSA); Shanxi People's Hospital	Zhao, JJ (corresponding author), Taiyuan Univ Technol, Coll Comp Sci & Technol, Jinzhong, Shanxi, Peoples R China.	zhaojuanjuan@tyut.edu.cn		Zhang, Xiaolong/0000-0002-6828-4930	ARO [W911NF-15-1-0290]; NEC Laboratories of America; Blippar; National Science Foundation of China (NSFC) [61429201]; National Natural Science Foundation of China [61373100]; State Key Laboratory of Virtual Reality Technology and Systems, Beihang University [BUAA-VR-17KF-14, BUAA-VR-17KF-15]; Shanxi Scholarship Council of China [2016-038]	ARO; NEC Laboratories of America; Blippar; National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Virtual Reality Technology and Systems, Beihang University; Shanxi Scholarship Council of China	This work was supported in part to Dr. Qi Tian by ARO grant W911NF-15-1-0290 and Faculty Research Gift Awards by NEC Laboratories of America and Blippar, National Science Foundation of China (NSFC) (61429201), National Natural Science Foundation of China (61373100), the open funding project of the State Key Laboratory of Virtual Reality Technology and Systems, Beihang University (Grant No. BUAA-VR-17KF-14,BUAA-VR-17KF-15) and Research Project Supported by Shanxi Scholarship Council of China (2016-038).	Achanta R., 2010, EPFL; Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; Armato SG, 2011, MED PHYS, V38, P915, DOI 10.1118/1.3528204; Chen K, 2014, BIO-MED MATER ENG, V24, P539, DOI 10.3233/BME-130840; CHEN W, 2009, CHIN J CANCER RES, V25, P10, DOI DOI 10.3978/J.ISSN.1000-9604.2012.12.04; Chen Y, 2017, PHYS MED BIOL, V62, P2103, DOI 10.1088/1361-6560/aa5c24; Chen Y, 2016, IEEE T IMAGE PROCESS, V25, P988, DOI 10.1109/TIP.2015.2496279; Chen Y, 2014, IEEE T MED IMAGING, V33, P2271, DOI 10.1109/TMI.2014.2336860; Deng Y., 2016, IEEE T FUZZY SYST, P1; Doi K, 2014, BR J RADIOL; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; HEIJMANS HJAM, 1990, COMPUT VISION GRAPH, V50, P245, DOI 10.1016/0734-189X(90)90148-O; Kalender WA, 2006, PHYS MED BIOL, V51, pR29, DOI 10.1088/0031-9155/51/13/R03; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Kong YY, 2015, IEEE SIGNAL PROC LET, V22, P573, DOI 10.1109/LSP.2014.2364612; Kuntimad G, 1999, IEEE T NEURAL NETWOR, V10, P591, DOI 10.1109/72.761716; Lee KH, 2008, J DIGIT IMAGING, V21, P422, DOI 10.1007/s10278-007-9067-y; Liang J, 2006, INT J GEN SYST, V35, P641, DOI 10.1080/03081070600687668; Liao XL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160556; Liu YC, 2012, LECT NOTES COMPUT SC, V7208, P221; Lusic H, 2013, CHEM REV, V113, P1641, DOI 10.1021/cr200358s; Martin D, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL II, PROCEEDINGS, P416, DOI 10.1109/ICCV.2001.937655; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Ren XF, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P10; Sander J, 2011, DENSITY BASED CLUSTE, P270; Sivakumar S, 2012, PROCEDIA ENGINEER, V38, P3064, DOI 10.1016/j.proeng.2012.06.357; Sun SS, 2014, IEEE J BIOMED HEALTH, V18, P1355, DOI 10.1109/JBHI.2014.2303511; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Unnikrishnan R., 2005, 2005 IEEE COMP VIS P, P34, DOI [DOI 10.1109/CVPR.2005.390, 10.1109/CVPR.2005.390]; Wei Y, 2012, J CENT SOUTH UNIV, V19, P3500, DOI 10.1007/s11771-012-1435-1; Xu N, 2002, P SOC PHOTO-OPT INS, V4684, P666, DOI 10.1117/12.467209; Zhao JJ, 2015, INT J BIO-INSPIR COM, V7, P62, DOI 10.1504/IJBIC.2015.067999; Zinoveva O, 2011, LECT NOTES COMPUT SC, V6754, P21, DOI 10.1007/978-3-642-21596-4_3	36	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184290	10.1371/journal.pone.0184290	http://dx.doi.org/10.1371/journal.pone.0184290			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880916	Green Submitted, Green Published, gold			2022-12-27	WOS:000409467200046
J	Abe, M; Hamano, T; Wada, A; Nakai, S; Masakane, I				Abe, Masanori; Hamano, Takayuki; Wada, Atsushi; Nakai, Shigeru; Masakane, Ikuto		Renal Data Registry Comm; Japanese Soc Dialysis Therapy	Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry	PLOS ONE			English	Article							SERUM BETA(2)-MICROGLOBULIN LEVEL; THERAPY CLINICAL GUIDELINE; PREDICT MORTALITY; ASSOCIATION; SOCIETY; BETA-2-MICROGLOBULIN; INFLAMMATION; MORBIDITY; QUALITY; SYSTEM	Background Little information is available regarding which type of dialyzer membrane results in good prognosis in patients on chronic hemodialysis. Therefore, we conducted a cohort study from a nationwide registry of hemodialysis patients in Japan to establish the association between different dialyzer membranes and mortality rates. Methods We followed 142,412 patients on maintenance hemodialysis (female, 39.1%; mean age, 64.8 +/- 12.3 years; median dialysis duration, 7[4-12] years) for a year from 2008 to 2009. We included patients treated with seven types of high-flux dialyzer membranes at baseline, including cellulose triacetate (CTA), ethylene vinyl alcohol (EVAL), polyacrylonitrile (PAN), polyester polymer alloy (PEPA), polyethersulfone (PES), polymethylmethacrylate (PMMA), and polysulfone (PS). Cox regression was used to estimate the association between baseline dialyzers and all-cause mortality as hazard ratios (HRs) and 95% confidence intervals for 1-year mortality adjusting for potential confounders, and propensity score matching analysis was performed. Results The distribution of patients treated with each membrane was as follows: PS (56.0%), CTA (17.3%), PES (12.0%), PEPA (7.5%), PMMA (4.9%), PAN (1.2%), and EVAL (1.1%). When data were adjusted using basic factors, with PS as a reference group, the mortality rate was significantly higher in all groups except for the PES group. When data were further adjusted groups. When the data were further adjusted for nutrition-and inflammation-related factors, HRs were significantly lower for the PMMA and PES groups compared with the PS group. After propensity score matching, HRs were significantly lower for the PMMA group than for the PS group. Conclusion The results suggest that the use of different membrane types may affect mortality in hemodialysis patients. However, further long-term prospective studies are needed to clarify these findings, including whether the use of the PMMA membrane can improve prognosis.	[Abe, Masanori] Nihon Univ, Sch Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Japan; [Hamano, Takayuki] Osaka Univ, Grad Sch Med, Dept Comprehens Kidney Dis Res, Osaka, Japan; [Wada, Atsushi] Kitasaito Hosp, Dept Nephrol, Asahikawa, Hokkaido, Japan; [Nakai, Shigeru] Fujita Hlth Univ, Dept Clin Engn, Toyoake, Aichi, Japan; [Masakane, Ikuto] Yabuki Hosp, Yamagata, Japan; [Abe, Masanori] Nihon Univ, Sch Med, Dept Internal Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Japan	Nihon University; Osaka University; Fujita Health University; Nihon University	Abe, M (corresponding author), Nihon Univ, Sch Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Japan.; Abe, M (corresponding author), Nihon Univ, Sch Med, Dept Internal Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Japan.	abe.masanori@nihon-u.ac.jp	Hamano, TAKAYUKI/AAZ-4837-2021	Hamano, TAKAYUKI/0000-0002-2100-9106				Aucella F, 2007, NEPHROL DIAL TRANSPL, V22, P8, DOI 10.1093/ndt/gfm293; Aucella F, 2013, BLOOD PURIFICAT, V35, P42, DOI 10.1159/000350847; Cheung AK, 2008, CLIN J AM SOC NEPHRO, V3, P69, DOI 10.2215/CJN.02340607; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; COLLINS AJ, 1994, AM J KIDNEY DIS, V23, P272, DOI 10.1016/S0272-6386(12)80984-X; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; HAKIM RM, 1994, AM J KIDNEY DIS, V23, P661, DOI 10.1016/S0272-6386(12)70276-7; Higuchi T, 2015, SLEEP MED, V16, P941, DOI 10.1016/j.sleep.2015.03.025; Iseki K, 2011, NEPHROL DIAL TRANSPL, V26, P963, DOI 10.1093/ndt/gfq507; Koda Y, 1997, KIDNEY INT, V52, P1096, DOI 10.1038/ki.1997.434; Kopple JD, 1999, KIDNEY INT, V56, P1136, DOI 10.1046/j.1523-1755.1999.00615.x; Kreusser W, 2010, CLIN KIDNEY J, V3, pI12, DOI 10.1093/ndtplus/sfq032; Lin YC, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0380-7; Lin YK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/234245; Liu CT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00080-4; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; LOWRIE EG, 1981, NEW ENGL J MED, V305, P1176, DOI 10.1056/NEJM198111123052003; MacLeod A.M., 2005, COCHRANE DB SYST REV, V3, P1, DOI DOI 10.1002/14651858.CD003234.PUB2; Masakane I, 2015, THER APHER DIAL, V19, P540, DOI 10.1111/1744-9987.12378; Masakane I, 2010, CLIN KIDNEY J, V3, pI28, DOI 10.1093/ndtplus/sfq034; Masakane I, 2009, BLOOD PURIFICAT, V27, P11, DOI 10.1159/000213491; Nakai S, 2001, AM J KIDNEY DIS, V38, pS212, DOI 10.1053/ajkd.2001.27449; Nakai S, 2012, THER APHER DIAL, V16, P483, DOI 10.1111/j.1744-9987.2012.01143.x; Nakai S, 2012, THER APHER DIAL, V16, P11, DOI 10.1111/j.1744-9987.2011.01050.x; Nakai S, 2010, THER APHER DIAL, V14, P505, DOI 10.1111/j.1744-9987.2010.00893.x; National Kidney Foundation, 2006, AM J KIDNEY DIS, V48, ps12; Okuno S, 2009, NEPHROL DIAL TRANSPL, V24, P571, DOI 10.1093/ndt/gfn521; Saito A, 2011, CONTRIB NEPHROL, V173, P1, DOI 10.1159/000328938; Sakai Y, 2011, CONTRIB NEPHROL, V173, P137, DOI 10.1159/000329052; Santoro A, 2013, BLOOD PURIFICAT, V35, P5, DOI 10.1159/000350837; Schiffl H, 2001, NEPHROL DIAL TRANSPL, V17, P1814; SHINZATO T, 1994, NEPHRON, V67, P280, DOI 10.1159/000187980; Shinzato T, 1997, NEPHROL DIAL TRANSPL, V12, P884, DOI 10.1093/ndt/12.5.884; Shinzato T, 1997, ARTIF ORGANS, V21, P864; Shoji T, 2011, CLIN J AM SOC NEPHRO, V6, P1112, DOI 10.2215/CJN.09961110; Stenvinkel P, 1999, KIDNEY INT, V55, P1899, DOI 10.1046/j.1523-1755.1999.00422.x; Tattersall J, 2007, NEPHROL DIAL TRANSPL, V22, P5, DOI 10.1093/ndt/gfm022; Traut M, 2007, BLOOD PURIFICAT, V25, P432, DOI 10.1159/000110069; Watanabe Y, 2015, THER APHER DIAL, V19, P67, DOI 10.1111/1744-9987.12294; Watanabe Y, 2015, THER APHER DIAL, V19, P93, DOI 10.1111/1744-9987.12293; Yamashita AC, 2011, CONTRIB NEPHROL, V173, P95, DOI 10.1159/000328946	41	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184424	10.1371/journal.pone.0184424	http://dx.doi.org/10.1371/journal.pone.0184424			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910324	gold, Green Submitted, Green Published			2022-12-27	WOS:000410859200046
J	DiMarzio, M; Rusconi, B; Yennawar, NH; Eppinger, M; Patterson, AD; Dudley, EG				DiMarzio, Michael; Rusconi, Brigida; Yennawar, Neela H.; Eppinger, Mark; Patterson, Andrew D.; Dudley, Edward G.			Identification of a mouse Lactobacillus johnsonii strain with deconjugase activity against the FXR antagonist T-beta-MCA	PLOS ONE			English	Article							BILE-SALT HYDROLASE; BIFIDOBACTERIUM-LONGUM; FUNCTIONAL-ANALYSIS; WEIGHT-GAIN; ACIDS; MICROBIOME; BACTERIA; METABOLISM; GENOMES	Bile salt hydrolase (BSH) activity against the bile acid tauro-beta-muricholic acid (T-beta-MCA) was recently reported to mediate host bile acid, glucose, and lipid homeostasis via the farnesoid X receptor (FXR) signaling pathway. An earlier study correlated decreased Lactobacillus abundance in the cecum with increased concentrations of intestinal T-beta-MCA, an FXR antagonist. While several studies have characterized BSHs in lactobacilli, deconjugation of T-beta-MCA remains poorly characterized among members of this genus, and therefore it was unclear what strain(s) were responsible for this activity. Here, a strain of L. johnsonii with robust BSH activity against T-beta-MCA in vitro was isolated from the cecum of a C57BL/6J mouse. A screening assay performed on a collection of 14 Lactobacillus strains from nine different species identified BSH substrate specificity for T-beta-MCA only in two of three L. johnsonii strains. Genomic analysis of the two strains with this BSH activity revealed the presence of three bsh genes that are homologous to bsh genes in the previously sequenced humanassociated strain L. johnsonii NCC533. Heterologous expression of several bsh genes in E. coli followed by enzymatic assays revealed broad differences in substrate specificity even among closely related bsh homologs, and suggests that the phylogeny of these enzymes does not closely correlate with substrate specificity. Predictive modeling allowed us to propose a potential mechanism driving differences in BSH activity for T-beta-MCA in these homologs. Our data suggests that L. johnsonii regulates T-beta-MCA levels in the mouse intestinal environment, and that this species may play a central role in FXR signaling in the mouse.	[DiMarzio, Michael; Dudley, Edward G.] Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA; [Rusconi, Brigida; Eppinger, Mark] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Rusconi, Brigida; Eppinger, Mark] Univ Texas San Antonio, South Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [Yennawar, Neela H.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Patterson, Andrew D.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Dudley, EG (corresponding author), Penn State Univ, Dept Food Sci, University Pk, PA 16802 USA.	egd100@psu.edu	Patterson, Andrew/ABF-1575-2020	Patterson, Andrew/0000-0003-2073-0070	U.S Department of Agriculture [2012-38420-19284]; Swiss National Science Foundation [2012-38420-19284]	U.S Department of Agriculture(United States Department of Agriculture (USDA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by U.S Department of Agriculture (WWW.usda.gov); 2012-38420-19284, to MD; Swiss National Science Foundation (WWW.snf.ch). 2012-38420-19284, to BR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bathena SPR, 2013, J CHROMATOGR B, V942, P53, DOI 10.1016/j.jchromb.2013.10.019; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Berger B, 2007, J BACTERIOL, V189, P1311, DOI 10.1128/JB.01393-06; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; CHIKAI T, 1987, LIPIDS, V22, P669, DOI 10.1007/BF02533948; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; DE MAN J. C., 1960, JOUR APPL BACT, V23, P130, DOI 10.1111/j.1365-2672.1960.tb00188.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geng W, 2016, ANIM HEALTH RES REV, V17, P148, DOI 10.1017/S1466252316000153; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gonzalez FJ, 2016, GASTROENTEROLOGY, V151, P845, DOI 10.1053/j.gastro.2016.08.057; Hamilton JP, 2007, AM J PHYSIOL-GASTR L, V293, pG256, DOI 10.1152/ajpgi.00027.2007; Han J, 2015, ANAL CHEM, V87, P1127, DOI 10.1021/ac503816u; HOFMANN AF, 1984, HEPATOLOGY, V4, pS4, DOI 10.1002/hep.1840040803; Jamroz M, 2013, NUCLEIC ACIDS RES, V41, pW427, DOI 10.1093/nar/gkt332; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111; Kant R, 2011, MICROB BIOTECHNOL, V4, P323, DOI 10.1111/j.1751-7915.2010.00215.x; KAYAHARA T, 1994, LIPIDS, V29, P289, DOI 10.1007/BF02536334; Killer J, 2014, INT J SYST EVOL MICR, V64, P1526, DOI 10.1099/ijs.0.054924-0; Kim GB, 2004, J DAIRY SCI, V87, P258, DOI 10.3168/jds.S0022-0302(04)73164-1; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kumar RS, 2006, J BIOL CHEM, V281, P32516, DOI 10.1074/jbc.M604172200; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lambert JM, 2008, APPL ENVIRON MICROB, V74, P4719, DOI 10.1128/AEM.00137-08; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3384; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Matsubara T, 2013, MOL CELL ENDOCRINOL, V368, P17, DOI 10.1016/j.mce.2012.05.004; McAuliffe O, 2005, APPL ENVIRON MICROB, V71, P4925, DOI 10.1128/AEM.71.8.4925-4929.2005; Million M, 2013, CLIN MICROBIOL INFEC, V19, P305, DOI 10.1111/1469-0691.12172; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pridmore RD, 2004, P NATL ACAD SCI USA, V101, P2512, DOI 10.1073/pnas.0307327101; Rissman AI, 2009, BIOINFORMATICS, V25, P2071, DOI 10.1093/bioinformatics/btp356; ROGOSA M, 1951, J BACTERIOL, V62, P132, DOI 10.1128/JB.62.1.132-133.1951; Rossocha M, 2005, BIOCHEMISTRY-US, V44, P5739, DOI 10.1021/bi0473206; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka H, 1999, J DAIRY SCI, V82, P2530, DOI 10.3168/jds.S0022-0302(99)75506-2; Tanaka H, 2000, APPL ENVIRON MICROB, V66, P2502, DOI 10.1128/AEM.66.6.2502-2512.2000; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uchida K, 1999, LIPIDS, V34, P269, DOI 10.1007/s11745-999-0363-y; Young VB, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j831; Zhang LM, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00070-16; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	54	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183564	10.1371/journal.pone.0183564	http://dx.doi.org/10.1371/journal.pone.0183564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910295	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200012
J	Amaral, KB; Silva, TP; Dias, FF; Malta, KK; Rosa, FM; Costa-Neto, SF; Gentile, R; Melo, RCN				Amaral, Katia B.; Silva, Thiago P.; Dias, Felipe F.; Malta, Kassia K.; Rosa, Florence M.; Costa-Neto, Socrates F.; Gentile, Rosana; Melo, Rossana C. N.			Histological assessment of granulomas in natural and experimental Schistosoma mansoni infections using whole slide imaging	PLOS ONE			English	Article							NECTOMYS-SQUAMIPES; MURINE SCHISTOSOMIASIS; HELMINTH INFECTION; EOSINOPHILS; PATHOLOGY; MICE; PERSPECTIVES; EGGS	The pathology of schistosomiasis mansoni, a neglected tropical disease of great clinical and socioeconomic importance, results from the parasite eggs that become trapped in host tissues, particularly in the liver and intestines. Continuous antigenic stimulation from these eggs leads to recruitment of inflammatory cells to the sites of infection with formation of periovular granulomas. These complex structures have variable size and composition and are the most striking histopathological feature of schistosomiasis mansoni. However, evaluation of granulomas by conventional microscopy methods is time-consuming and limited, especially in large-scale studies. Here, we used high resolution Whole Slide Imaging (WSI), which allows fast scanning of entire histological slides, and multiple morphometric evaluations, to assess the granulomatous response elicited in target organs (liver, small and large intestines) of two models of schistosomiasis mansoni. One of the advantages of WSI, also termed virtual microscopy, is that it generates images that simultaneously offer high resolution and a wide field of observation. By using a model of natural (Nectomys squamipes, a wild reservoir captured from endemic areas in Brazil) and experimental (Swiss mouse) infection with Schistosoma mansoni, we provided the first detailed WSI characterization of granulomas and other pathological aspects. WSI and quantitative analyses enabled a fast and reliable assessment of the number, evolutional types, frequency and areas of granulomas and inflammatory infiltrates and revealed that target organs are differentially impacted by inflammatory responses in the natural and experimental infections. Remarkably, high-resolution analysis of individual eosinophils, key cells elicited by this helminthic infection, showed a great difference in eosinophil numbers between the two infections. Moreover, features such as the intestinal egg path and confluent granulomas were uncovered. Thus, WSI may be a suitable tool for detailed and precise histological analysis of granulomas and other pathological aspects for clinical and research studies of schistosomiasis.	[Amaral, Katia B.; Silva, Thiago P.; Dias, Felipe F.; Malta, Kassia K.; Melo, Rossana C. N.] Fed Univ Juiz De Fora UFJF, Dept Biol, Lab Cellular Biol, Juiz De Fora, MG, Brazil; [Rosa, Florence M.] Fed Univ Juiz De Fora UFJF, Dept Parasitol Microbiol & Immunol, Lab Parasitol, Juiz De Fora, MG, Brazil; [Costa-Neto, Socrates F.; Gentile, Rosana] Fundacao Oswaldo Cruz, Lab Biol & Parasitol Wild Reservoir Mammals, Rio De Janeiro, RJ, Brazil	Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora; Fundacao Oswaldo Cruz	Melo, RCN (corresponding author), Fed Univ Juiz De Fora UFJF, Dept Biol, Lab Cellular Biol, Juiz De Fora, MG, Brazil.	rossana.melo@ufjf.edu.br	Dias, Felipe F/P-1324-2016; Gentile, Rosana/C-3101-2013; Malta, Kássia K./A-7938-2019; Dias, Felipe Ferraz/K-4549-2019; Silva, Thiago/B-3293-2018; Melo, Rossana C. N./B-8248-2013	Dias, Felipe F/0000-0002-3493-6929; Gentile, Rosana/0000-0001-9160-1204; Malta, Kássia K./0000-0003-2203-2719; Dias, Felipe Ferraz/0000-0002-3493-6929; Silva, Thiago/0000-0001-7122-3015; Melo, Rossana C. N./0000-0003-1736-0806; Amaral, Katia/0000-0001-9812-8093	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil); Fundacao Oswaldo Cruz (FIOCRUZ, Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Oswaldo Cruz (FIOCRUZ, Brazil)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazil), Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG, Brazil), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, Brazil) and Fundacao Oswaldo Cruz (FIOCRUZ, Brazil).	Abdul-Ghani RA, 2010, PARASITOL RES, V107, P1, DOI 10.1007/s00436-010-1855-5; Al-Janabi S, 2012, HUM PATHOL, V43, P2318, DOI 10.1016/j.humpath.2012.03.027; Al-Janabi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082576; Al-Janabi S, 2012, HISTOPATHOLOGY, V61, P1, DOI 10.1111/j.1365-2559.2011.03814.x; Amaral KB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166979; Andrade ZA, 2009, PARASITE IMMUNOL, V31, P656, DOI 10.1111/j.1365-3024.2009.01157.x; Lins RAB, 2008, REV SOC BRAS MED TRO, V41, P173, DOI 10.1590/S0037-86822008000200008; Burkholder Tanya, 2012, Curr Protoc Mouse Biol, V2, P145; Cheever AW, 2002, MEM I OSWALDO CRUZ, V97, P917, DOI 10.1590/S0074-02762002000700002; Chuah C, 2014, TRENDS PARASITOL, V30, P141, DOI 10.1016/j.pt.2013.12.009; Costa-Silva M, 2002, MEM I OSWALDO CRUZ, V97, P129, DOI 10.1590/S0074-02762002000900026; D'Andrea PS, 2000, PARASITOLOGY, V120, P573, DOI 10.1017/S0031182099005892; Dee FR, 2009, HUM PATHOL, V40, P1112, DOI 10.1016/j.humpath.2009.04.010; Fabrino DL, 2011, J INNATE IMMUN, V3, P71, DOI 10.1159/000320641; Farris AB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161019; Gentile R, 2006, MEM I OSWALDO CRUZ, V101, P111, DOI 10.1590/S0074-02762006000900018; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hams E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00089; Hoffman WA, 1934, PUERTO RICO J PUB HL, V9, P283; HSU SYL, 1972, J RETICULOENDOTH SOC, V12, P418; Huang L, 2016, TRENDS PARASITOL, V32, P798, DOI 10.1016/j.pt.2016.05.004; JUNQUEIRA LCU, 1986, ANN TROP MED PARASIT, V80, P27, DOI 10.1080/00034983.1986.11811981; Kawano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058344; Lambertucci JR, 2010, MEM I OSWALDO CRUZ, V105, P422, DOI 10.1590/S0074-02762010000400012; Lenzi HL, 2006, MEM I OSWALDO CRUZ, V101, P219, DOI 10.1590/S0074-02762006000900034; Lenzi HL, 1997, MEM I OSWALDO CRUZ, V92, P19, DOI 10.1590/S0074-02761997000800005; LENZI HL, 1987, BRAZ J MED BIOL RES, V20, P433; Lenzi HL, 1998, MEM I OSWALDO CRUZ, V93, P141, DOI 10.1590/S0074-02761998000700020; Raso P, 2012, REV SOC BRAS MED TRO, V45, P627, DOI 10.1590/S0037-86822012000500016; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Ross AGP, 2002, NEW ENGL J MED, V346, P1212, DOI 10.1056/NEJMra012396; Shin MH, 2009, KOREAN J PARASITOL, V47, pS125, DOI 10.3347/kjp.2009.47.S.S125; Silva LM, 2000, MEM I OSWALDO CRUZ, V95, P353, DOI 10.1590/S0074-02762000000300010; SILVA RRE, 1992, MEM I OSWALDO CRUZ, V87, P271, DOI 10.1590/S0074-02761992000500051; SILVA TMC, 1989, MEM I OSWALDO CRUZ, V84, P227, DOI 10.1590/S0074-02761989000200011; SMITHERS SR, 1965, PARASITOLOGY, V55, P701, DOI 10.1017/S003118200008625X; Souza ALS, 2011, INFECT IMMUN, V79, P1741, DOI 10.1128/IAI.00502-10; Tweyongyere R, 2016, PARASITE IMMUNOL, V38, P516, DOI 10.1111/pim.12336; WEINSTOCK JV, 1983, J IMMUNOL, V130, P418; WHO, 2020, SCHISTOSOMIASIS; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014	41	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184696	10.1371/journal.pone.0184696	http://dx.doi.org/10.1371/journal.pone.0184696			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902908	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200054
J	Maraz, A; Borbala, H; Urban, R; Demetrovics, Z				Maraz, Aniko; Borbala Hende; Urban, Robert; Demetrovics, Zsolt			Pathological grooming: Evidence for a single factor behind trichotillomania, skin picking and nail biting	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; HAIR PULLING DISORDER; BRIEF SYMPTOM INVENTORY; MOTOR INHIBITION; COMORBIDITY; PERSONALITY; IMPULSIVITY; MODEL; ONYCHOPHAGIA; BEHAVIORS	Although trichotillomania (TTM), skin picking (SP), and nail biting (NB) have been receiving growing scientific attention, the question as to whether these disorders can be regarded as separate entities or they are different manifestations of the same underlying tendency is unclear. Data were collected online in a community survey, yielding a sample of 2705 participants (66% women, mean age: 29.1, SD:8.6). Hierarchical factor analysis was used to identify a common latent factor and the multiple indicators and multiple causes (MIMIC) modelling was applied to test the predictive effect of borderline personality disorder symptoms, impulsivity, distress and self-esteem on pathological grooming. Pearson correlation coefficients between TTM, SP and NB were between 0.13 and 0.29 (p < 0.01). The model yielded an excellent fit to the data (CFI = 0.992, TLI = 0.991, chi(2) = 696.65, p < 0.001, df = 222, RMSEA = 0.030, Cfit of RMSEA = 1.000), supporting the existence of a latent factor. The MIMIC model indicated an adequate fit (CFI = 0.993, TLI = 0.992, chi(2) = 655.8, p < 0.001, df = 307, RMSEA = 0.25, CI: 0.022-0.028, pclose = 1.000). TTM, SP and NB each were loaded significantly on the latent factor, indicating the presence of a general grooming factor. Impulsivity, psychiatric distress and contingent self-esteem had significant predictive effects, whereas borderline personality disorder had a nonsignificant predictive effect on the latent factor. We found evidence that the category of pathological grooming is meaningful and encompasses three symptom manifestations: trichotillomania, skin picking and nail biting. This latent underlying factor is not better explained by indicators of psychopathology, which supports the notion that the urge to self-groom, rather than general psychiatric distress, impulsivity, self-esteem or borderline symptomatology, is what drives individual grooming behaviours.	[Maraz, Aniko; Borbala Hende; Urban, Robert; Demetrovics, Zsolt] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Borbala Hende] Eotvos Lorand Univ, Doctoral Sch Psychol, Budapest, Hungary	Eotvos Lorand University; Eotvos Lorand University	Maraz, A (corresponding author), Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary.	aniko.maraz@ppk.elte.hu	Demetrovics, Zsolt/F-8613-2010	Demetrovics, Zsolt/0000-0001-5604-7551; Maraz, Aniko/0000-0002-0846-0728	Hungarian National Research, Development and Innovation Office [K111938]	Hungarian National Research, Development and Innovation Office	This work was supported by Hungarian National Research, Development and Innovation Office (Grant number: K111938). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DIAGN STAT MAN MENT; Arnold LM, 2001, CNS DRUGS, V15, P351, DOI 10.2165/00023210-200115050-00002; Baumeister R.F., 1997, REV GEN PSYCHOL, V1, P145, DOI [10.1037/1089-2680.1.2.145, DOI 10.1037/1089-2680.1.2.145]; Bertsch K, 2013, HORM BEHAV, V63, P424, DOI 10.1016/j.yhbeh.2012.11.013; Bienvenu OJ, 2009, AM J MED GENET B, V150B, P710, DOI 10.1002/ajmg.b.30897; Bijl RV, 1998, SOC PSYCH PSYCH EPID, V33, P587, DOI 10.1007/s001270050098; Blasco-Fontecilla H, 2016, FRONTIERS PSYCHIAT, V7; Bohne A, 2002, BEHAV MODIF, V26, P320, DOI 10.1177/0145445502026003002; Bohne A, 2008, J PSYCHIATR RES, V42, P141, DOI 10.1016/j.jpsychires.2006.11.008; Bohne Antje, 2005, Ann Clin Psychiatry, V17, P227, DOI 10.1080/10401230500295354; Bray N., 2016, NATURE REV NEUROSCIE, V17, P138; Brown T.A., 2006, CONFIRMATORY FACTOR, V1st; Burkett JP, 2016, SCIENCE, V351, P375, DOI 10.1126/science.aac4785; Chamberlain SR, 2008, BRIT J PSYCHIAT, V193, P216, DOI 10.1192/bjp.bp.107.048314; Chamberlain SR, 2006, AM J PSYCHIAT, V163, P1282, DOI 10.1176/appi.ajp.163.7.1282; Cheng H, 2003, PERS INDIV DIFFER, V34, P921, DOI 10.1016/S0191-8869(02)00078-8; Christenson GA, 1991, J CLIN PSYCHIAT; COHEN LJ, 1995, J CLIN PSYCHIAT, V56, P319; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Diamantopoulos A, 2011, MIS QUART, V35, P335; du Toit PL, 2001, COMPR PSYCHIAT, V42, P291, DOI 10.1053/comp.2001.24586; Feusner JD, 2009, CNS SPECTRUMS, V14, P503, DOI 10.1017/S1092852900023567; Finney SJ, 2006, QUANT METH EDUC BEHA, P269; Flessner CA, 2012, PSYCHIAT RES, V199, P151, DOI 10.1016/j.psychres.2012.03.039; Franklin ME, 2008, J DEV BEHAV PEDIATR, V29, P493, DOI 10.1097/DBP.0b013e31818d4328; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; Hollander E, 2003, NEUROPSYCHOPHARMACOL, V28, P193, DOI 10.1038/sj.npp.1300021; Johnson M., 2007, INDIVIDUAL DIFFERENC, V5, P300; Jokinen J, 2012, PSYCHONEUROENDOCRINO, V37, P482, DOI 10.1016/j.psyneuen.2011.07.016; JOLLES J, 1979, BEHAV NEURAL BIOL, V25, P563, DOI 10.1016/S0163-1047(79)90362-5; JORESKOG KG, 1975, J AM STAT ASSOC, V70, P631, DOI 10.2307/2285946; Kaburu SSK, 2012, AFR ZOOL, V47, P74, DOI 10.3377/004.047.0111; Keuthen NJ, 2000, PSYCHOSOMATICS, V41, P210, DOI 10.1176/appi.psy.41.3.210; KEUTHEN NJ, 1995, PSYCHOTHER PSYCHOSOM, V64, P141, DOI 10.1159/000289003; Lawrence KA, 2010, J PERS DISORD, V24, P785, DOI 10.1521/pedi.2010.24.6.785; Lee JA, 2010, PROG NEURO-PSYCHOPH, V34, P1250, DOI 10.1016/j.pnpbp.2010.06.031; LENANE MC, 1992, J CHILD PSYCHOL PSYC, V33, P925, DOI 10.1111/j.1469-7610.1992.tb01966.x; LEONARD HL, 1991, ARCH GEN PSYCHIAT, V48, P821; LEUNG AKC, 1990, CLIN PEDIATR, V29, P690, DOI 10.1177/000992289002901201; Lochner C, 2002, DEPRESS ANXIETY, V15, P83, DOI 10.1002/da.10034; MAESTRIPIERI D, 1992, ANIM BEHAV, V44, P967, DOI 10.1016/S0003-3472(05)80592-5; Mueller A, 2011, COMPR PSYCHIAT, V52, P420, DOI 10.1016/j.comppsych.2010.09.001; Muthen B., 2010, MPLUS USERS GUIDE; NEALE MC, 1995, AM J HUM GENET, V57, P935; Novak CE, 2009, AM J MED GENET B, V150B, P944, DOI 10.1002/ajmg.b.30922; Odlaug BL, 2008, GEN HOSP PSYCHIAT, V30, P61, DOI 10.1016/j.genhosppsych.2007.07.009; Odlaug BL, 2007, J CLIN PSYCHOPHARM, V27, P227, DOI 10.1097/01.jcp.0000264976.86990.00; Odlaug BL, 2010, J ANXIETY DISORD, V24, P823, DOI 10.1016/j.janxdis.2010.06.004; Odlaug BL, 2008, ANN CLIN PSYCHIATRY, V20, P57, DOI 10.1080/10401230802017027; Offord DR, 1996, CAN J PSYCHIAT, V41, P559, DOI 10.1177/070674379604100904; Pacan P, 2009, ACTA DERM-VENEREOL, V89, P278, DOI 10.2340/00015555-0646; Park HJ, 2010, PERS INDIV DIFFER, V48, P469, DOI 10.1016/j.paid.2009.11.024; PENNINGTON LA, 1945, AM J PSYCHIAT, V102, P241, DOI 10.1176/ajp.102.2.241; Penzel F, 2003, HAIR PULLING PROBLEM; Reise SP, 2010, J PERS ASSESS, V92, P544, DOI 10.1080/00223891.2010.496477; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Silva-Netto R, 2014, REV BRAS PSIQUIATR, V36, P98, DOI 10.1590/1516-4446-2013-1154; Simeon D, 1997, J NERV MENT DIS, V185, P117, DOI 10.1097/00005053-199702000-00009; Snorrason I, 2012, CLIN PSYCHOL REV, V32, P618, DOI 10.1016/j.cpr.2012.05.008; Snorrason I, 2011, BEHAV THER, V42, P521, DOI 10.1016/j.beth.2010.12.002; Stein DJ, 2006, CNS SPECTRUMS, V11, P824, DOI 10.1017/S1092852900014978; Stein DJ, 2010, DEPRESS ANXIETY, V27, P611, DOI 10.1002/da.20700; STEIN DJ, 1992, J CLIN PSYCHIAT, V53, P123; STEIN DJ, 1995, J CLIN PSYCHIAT, V56, P28; SWEDO SE, 1989, NEW ENGL J MED, V321, P497, DOI 10.1056/NEJM198908243210803; Tanaka OM, 2008, AM J ORTHOD DENTOFAC, V134, P305, DOI 10.1016/j.ajodo.2006.06.023; Urban R, 2014, BEHAV RES METHODS, V46, P488, DOI 10.3758/s13428-013-0391-5; Urban R, 2014, PSYCHIAT RES, V216, P146, DOI 10.1016/j.psychres.2014.01.027; Varga G., 2015, BARRATT IMPULS UNPUB; Vazire S, 2006, PERS SOC PSYCHOL REV, V10, P154, DOI 10.1207/s15327957pspr1002_4; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Wilhelm S, 1999, J CLIN PSYCHIAT, V60, P454, DOI 10.4088/JCP.v60n0707; Woods DW, 2006, PSYCHIAT CLIN N AM, V29, P487, DOI 10.1016/j.psc.2006.02.009; Zanarini MC, 2003, AM J PSYCHIAT, V160, P274, DOI 10.1176/appi.ajp.160.2.274	74	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183806	10.1371/journal.pone.0183806	http://dx.doi.org/10.1371/journal.pone.0183806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902896	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200019
J	Sbracia, M; McKinnon, B; Scarpellini, F; Marconi, D; Rossi, G; Simmilion, C; Mueller, MD; Barnea, ER; Mueller, M				Sbracia, Marco; McKinnon, Brett; Scarpellini, Fabio; Marconi, Daniela; Rossi, Gabriele; Simmilion, Cedric; Mueller, Michael D.; Barnea, Eytan R.; Mueller, Martin			PreImplantation Factor in endometriosis: A potential role in inducing immune privilege for ectopic endometrium	PLOS ONE			English	Article							REGULATORY T-CELLS; ACTIVATING PEPTIDE-78 ENA-78; STROMAL CELLS; TNF-ALPHA; EPITHELIAL-CELLS; PATHOGENESIS; RECEPTOR; NEUROPROTECTION; CIRCULATION; SURVIVAL	Endometriosis is a chronic inflammatory condition characterised by the growth of endometrial epithelial and stromal cells outside the uterine cavity. In addition to Sampson's theory of retrograde menstruation, endometriosis pathogenesis is facilitated by a privileged inflammatory microenvironment, with T regulatory FoxP3(+) expressing T cells (Tregs) being a significant factor. PreImplantation Factor (PIF) is a peptide essential for pregnancy recognition and development. An immune modulatory function of the synthetic PIF analog (sPIF) has been successfully confirmed in multiple animal models. We report that PIF is expressed in the epithelial ectopic cells in close proximity to FoxP3(+) stromal cells. We provide evidence that PIF interacts with FoxP3(+) cells and modulates cell viability, dependent on cell source and presence of inflammatory mediators. Our finding represent a novel PIF-based mechanism in endometriosis that has potential for novel therapeutics.	[Sbracia, Marco; Scarpellini, Fabio] Hungaria Ctr Endocrinol & Reprod Med, Rome, Italy; [McKinnon, Brett; Simmilion, Cedric; Mueller, Michael D.; Mueller, Martin] Univ Bern, Dept Clin Res, Bern, Switzerland; [Marconi, Daniela; Rossi, Gabriele] Univ Roma Tor Vergata, Dept Obstet & Gynecol, Rome, Italy; [Mueller, Michael D.; Mueller, Martin] Univ Hosp Bern, Dept Obstet & Gynecol, Bern, Switzerland; [Barnea, Eytan R.] SIEP, Cherry Hill, NJ 08003 USA; [Barnea, Eytan R.] BioIncept LLC, Dept Res & Dev, Cherry Hill, NJ 08003 USA; [Mueller, Martin] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA	University of Bern; University of Rome Tor Vergata; University of Bern; University Hospital of Bern; Yale University	Mueller, M (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.; Mueller, M (corresponding author), Univ Hosp Bern, Dept Obstet & Gynecol, Bern, Switzerland.; Barnea, ER (corresponding author), SIEP, Cherry Hill, NJ 08003 USA.; Barnea, ER (corresponding author), BioIncept LLC, Dept Res & Dev, Cherry Hill, NJ 08003 USA.; Mueller, M (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.	eytan.barnea@bioincept.com; martin.mueller@insel.ch	Barnea, Eytan/AAC-9910-2021; Barnea, Eytan/AAK-9467-2021; Mueller, Martin/J-9682-2019; McKinnon, Brett/I-5125-2013	Barnea, Eytan/0000-0003-4677-4370; Mueller, Martin/0000-0001-5594-0532; McKinnon, Brett/0000-0002-9881-1252	Biolncept	Biolncept	Dr. Eytan R. Barnea is the (uncompensated) Chief Scientist for Biolncept, LLC. Martin Mueller received an unrestricted grant from Biolncept. This grant aims to prepare PIF clinical trial in the field of neonatal brain injuries. Biolncept, LLC did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the authors is articulated in the 'author contributions' section.	Azar Y, 2013, BIOL BLOOD MARROW TR, V19, P519, DOI 10.1016/j.bbmt.2012.12.011; Barnea ER, 2015, PHARMACOL THERAPEUT, V156, P10, DOI 10.1016/j.pharmthera.2015.10.008; Barnea ER, 2016, IMMUNOBIOLOGY, V221, P778, DOI 10.1016/j.imbio.2016.02.004; Barnea ER, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.07.017; Barnea ER, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-50; Barnea ER, 2012, AM J OBSTET GYNECOL, V206, pS36, DOI 10.1016/j.ajog.2011.10.083; Berbic M, 2011, J REPROD IMMUNOL, V88, P149, DOI 10.1016/j.jri.2010.11.004; Berbic M, 2010, HUM REPROD, V25, P900, DOI 10.1093/humrep/deq020; Bergmann C, 2011, EUR J IMMUNOL, V41, P3564, DOI 10.1002/eji.201141532; Bersinger NA, 2008, FERTIL STERIL, V89, P1530, DOI 10.1016/j.fertnstert.2007.05.075; Bersinger NA, 2011, ARCH GYNECOL OBSTET, V283, P1291, DOI 10.1007/s00404-010-1520-3; Bono Y, 2012, BRIT J CANCER, V106, P1205, DOI 10.1038/bjc.2012.26; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Budiu RA, 2009, DIS MODEL MECH, V2, P593, DOI 10.1242/dmm.002535; Canis M, 1997, FERTIL STERIL, V67, P817; Chen YC, 2016, THROMB HAEMOSTASIS, V115, P1010, DOI 10.1160/TH15-08-0640; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Di Simone N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180642; Duzyj CM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.060; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Han SJ, 2015, CELL, V163, P960, DOI 10.1016/j.cell.2015.10.034; Hornung D, 1997, J CLIN ENDOCR METAB, V82, P1621, DOI 10.1210/jc.82.5.1621; Kocbek V, 2016, MOL HUM REPROD, V22, P768, DOI 10.1093/molehr/gaw054; Kyo S, 2003, AM J PATHOL, V163, P2259, DOI 10.1016/S0002-9440(10)63583-3; Li MQ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.414; Macer ML, 2012, OBSTET GYN CLIN N AM, V39, P535, DOI 10.1016/j.ogc.2012.10.002; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; McKinnon B, 2012, FERTIL STERIL, V97, P373, DOI 10.1016/j.fertnstert.2011.11.011; McKinnon BD, 2015, TRENDS ENDOCRIN MET, V26, P1, DOI 10.1016/j.tem.2014.10.003; McKinnon BD, 2013, J CLIN ENDOCR METAB, V98, P2469, DOI 10.1210/jc.2013-1019; Migliara G, 2017, ONCOTARGET, V8, P21834, DOI 10.18632/oncotarget.15662; Moindjie H, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119156; Mueller M, 2015, CELL DEATH DIFFER, V22, P2078, DOI 10.1038/cdd.2015.55; Mueller M, 2014, P NATL ACAD SCI USA, V111, P13882, DOI 10.1073/pnas.1411674111; Nakahashi-Oda C, 2016, NAT IMMUNOL, V17, P441, DOI 10.1038/ni.3345; Olkowska-Truchanowicz J, 2013, HUM REPROD, V28, P119, DOI 10.1093/humrep/des346; Paidas MJ, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.024; Ramu S, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-105; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sampson JA, 1927, AM J PATHOL, V3, P93; Santi A, 2011, FERTIL STERIL, V96, P663, DOI 10.1016/j.fertnstert.2011.06.039; Sbracia M, 2016, REPROD SCI, V23, P81, DOI 10.1177/1933719115594019; Shainer R, 2016, ONCOTARGET; Stamatkin CW, 2011, REPROD BIOMED ONLINE, V23, P517, DOI 10.1016/j.rbmo.2011.06.009; Stamatkin CW, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-63; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Tagashira Y, 2009, FERTIL STERIL, V91, P2185, DOI 10.1016/j.fertnstert.2008.04.052; Tang QZ, 2006, IMMUNOL REV, V212, P217, DOI 10.1111/j.0105-2896.2006.00421.x; Wang W, 2012, INT J CANCER, V131, pE928, DOI 10.1002/ijc.27613; Weiss L, 2012, J NEUROL SCI, V312, P146, DOI 10.1016/j.jns.2011.07.050; Weiss L, 2011, ENDOCRINE, V40, P41, DOI 10.1007/s12020-011-9438-5	53	8	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184399	10.1371/journal.pone.0184399	http://dx.doi.org/10.1371/journal.pone.0184399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902871	gold, Green Submitted, Green Published			2022-12-27	WOS:000410669200035
J	Wijeratne, PA; Hipwell, JH; Hawkes, DJ; Stylianopoulos, T; Vavourakis, V				Wijeratne, Peter A.; Hipwell, John H.; Hawkes, David J.; Stylianopoulos, Triantafyllos; Vavourakis, Vasileios			Multiscale biphasic modelling of peritumoural collagen microstructure: The effect of tumour growth on permeability and fluid flow	PLOS ONE			English	Article							SOLID STRESS; VASCULAR NORMALIZATION; MECHANICAL-BEHAVIOR; CANCER MODEL; PRESSURE; INVASION; MURINE; ARRAYS; DRUG	We present an in-silico model of avascular poroelastic tumour growth coupled with a multi-scale biphasic description of the tumour-host environment. The model is specified to in-vitro data, facilitating biophysically realistic simulations of tumour spheroid growth into a dense collagen hydrogel. We use the model to first confirm that passive mechanical remodelling of collagen fibres at the tumour boundary is driven by solid stress, and not fluid pressure. The model is then used to demonstrate the influence of collagen microstructure on peritumoural permeability and interstitial fluid flow. Our model suggests that at the tumour periphery, remodelling causes the peritumoural stroma to become more permeable in the circumferential than radial direction, and the interstitial fluid velocity is found to be dependent on initial collagen alignment. Finally we show that solid stresses are negatively correlated with peritumoural permeability, and positively correlated with interstitial fluid velocity. These results point to a heterogeneous, microstructure-dependent force environment at the tumour-peritumoural stroma interface.	[Wijeratne, Peter A.] UCL, Dept Comp Sci, London, England; [Hipwell, John H.; Hawkes, David J.; Vavourakis, Vasileios] UCL, Dept Med Phys & Biomed Engn, London, England; [Stylianopoulos, Triantafyllos] Univ Cyprus, Dept Mech & Mfg Engn, Nicosia, Cyprus	University of London; University College London; University of London; University College London; University of Cyprus	Wijeratne, PA (corresponding author), UCL, Dept Comp Sci, London, England.	p.wijeratne@ucl.ac.uk	Stylianopoulos, Triantafyllos/AGF-9544-2022	Stylianopoulos, Triantafyllos/0000-0002-3093-1696; Vavourakis, Vasileios/0000-0002-4102-2084; Wijeratne, Peter/0000-0002-4885-6241	EPSRC [EP/K020439/1]; EU [601040]; Marie-Curie Fellowship [627025]; European Research Council [336839]; Engineering and Physical Sciences Research Council [EP/K020439/1, EP/H046410/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10143] Funding Source: researchfish; EPSRC [EP/H046410/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EU(European Commission); Marie-Curie Fellowship(European Commission); European Research Council(European Research Council (ERC)European Commission); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	PAW, JHH, DJH received funding from EPSRC grant "MIMIC": EP/K020439/1 and EU FP7 Virtual Physiological Human grant: "VPH-PRISM" (FP7-ICT-2011-9, 601040). W received funding from Marie-Curie Fellowship (FP7-PEOPLE-2013-IEF, 627025). TS received funding from the European Research Council (FP7/2007-2013)/ERC Grant No. 336839-ReEngineeringCancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida EDGARD S., 1997, Comput Methods Biomech Biomed Engin, V1, P25, DOI 10.1080/01495739708936693; Balay S, 1997, MODERN SOFTWARE TOOLS FOR SCIENTIFIC COMPUTING, P163; Baldock AL, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00062; Bathe K.-J., 2006, FINITE ELEMENT PROCE; BOUCHER Y, 1990, CANCER RES, V50, P4478; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chandran PL, 2008, MULTISCALE MODEL SIM, V7, P22, DOI 10.1137/070689504; Charoen KM, 2014, BIOMATERIALS, V35, P2264, DOI 10.1016/j.biomaterials.2013.11.038; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; de Sampaio PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030753; Detournay E, 1993, FUNDAMENTALS POROELA, P113, DOI DOI 10.1016/B978-0-08-040615-2.50011-3; DRUMMOND JE, 1984, INT J MULTIPHAS FLOW, V10, P515, DOI 10.1016/0301-9322(84)90079-X; Frieboes HB, 2011, CANCER RES, V71, P298, DOI 10.1158/0008-5472.CAN-10-2676; Frieboes HB, 2010, J THEOR BIOL, V264, P1254, DOI 10.1016/j.jtbi.2010.02.036; Girard YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075345; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Hori M, 1999, MECH MATER, V31, P667, DOI 10.1016/S0167-6636(99)00020-4; Jackson TL, 2002, MATH BIOSCI, V180, P307; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Jain RK, 2014, ANNU REV BIOMED ENG, V16, P321, DOI 10.1146/annurev-bioeng-071813-105259; Kam Y, 2012, J CELL PHYSIOL, V227, P431, DOI 10.1002/jcp.22766; Kirk BS, 2006, ENG COMPUT-GERMANY, V22, P237, DOI 10.1007/s00366-006-0049-3; Leu AJ, 2000, CANCER RES, V60, P4324; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Mohamed A, 2005, LECT NOTES COMPUT SC, V3749, P400; Mpekris F, 2015, BIOMECH MODEL MECHAN; Netti PA, 2000, CANCER RES, V60, P2497; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Ricketts KPM, 2014, SMALL, V10, P3954, DOI 10.1002/smll.201400194; Roose T, 2003, MICROVASC RES, V66, P204, DOI 10.1016/S0026-2862(03)00057-8; SANGANI AS, 1982, INT J MULTIPHAS FLOW, V8, P193, DOI 10.1016/0301-9322(82)90029-5; Sciume G, 2013, ARCH COMPUT METHOD E, V20, P327, DOI 10.1007/s11831-013-9090-8; Stylianopoulos T, 2007, J BIOMECH ENG-T ASME, V129, P611, DOI 10.1115/1.2746387; Stylianopoulos T, 2007, COMPUT METHOD APPL M, V196, P2981, DOI 10.1016/j.cma.2006.06.019; Stylianopoulos T, 2013, CANCER RES, V73, P3833, DOI 10.1158/0008-5472.CAN-12-4521; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Stylianopoulos T, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.3021477; Sugii Y, 2005, MEAS SCI TECHNOL, V16, P1126, DOI 10.1088/0957-0233/16/5/011; Tong RT, 2004, CANCER RES, V64, P3731, DOI 10.1158/0008-5472.CAN-04-0074; Vavourakis V, 2017, PLOS COMPUTATIONAL B; Voutouri C, 2014, PLOS ONE, P9; Wijeratne PA, 2016, BIOMECH MODEL MECHAN, V15, P1079, DOI 10.1007/s10237-015-0745-2; Wise SM, 2008, J THEOR BIOL, V253, P524, DOI 10.1016/j.jtbi.2008.03.027; Xu J, 2016, PLOS ONE, V11; Zheng X, 2005, B MATH BIOL, V67, P211, DOI 10.1016/j.bulm.2004.08.001	46	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184511	10.1371/journal.pone.0184511	http://dx.doi.org/10.1371/journal.pone.0184511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902902	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200041
J	Hajjar, R; Bassatne, A; Cheaito, MA; El Dine, RN; Traboulsy, S; Haddadin, F; Honein-AbouHaidar, G; Aki, EA				Hajjar, Rima; Bassatne, Aya; Cheaito, Mohamad Ali; El Dine, Rabie Naser; Traboulsy, Sarah; Haddadin, Fadi; Honein-AbouHaidar, Gladys; Aki, Elie A.			Characterizing the interaction between physicians, pharmacists and pharmaceutical representatives in a middle-income country: A qualitative study	PLOS ONE			English	Article							DRUG PROMOTION; PAYMENTS; HEALTH; SALES	Background Studies around the world have shown that interactions between pharmaceutical companies, pharmacists and physicians have a great influence on prescribing and drug dispensing practices. In middle-income countries, the nature and extent of these interactions have not been well researched. Our objectives were to qualitatively explore the nature of the interactions between pharmaceutical companies, physicians and pharmacists, their impact on drug prescription and dispensing practices in Lebanon. Methods and findings We used grounded theory approach as well as the known sponsor, purposive, and snowballing sampling strategies to identify interviewees from the three respective groups: physicians, pharmacists, and pharmaceutical representatives. We conducted semi-structured and analyzed transcripts thematically. This study encompassed 6 pharmaceutical representatives, 13 physicians and 13 pharmacists. The following themes emerged: purpose and driver for the interactions, nature of the interactions, incentives, impact on prescription practices, ethical considerations, and suggestions for managing the interactions. The main purposes for the interaction were educational, promotional, and monitoring prescription practices and dispensing, while the main drivers for these interactions were market potential and neighborhood socio-economic status. Physicians, pharmacists and pharmaceutical representatives who engage in these interactions benefit from a variety of incentives, some of which were characterized as unethical. It appears that pharmaceutical companies give prominence to selected physicians within their communities. Although members of the three interviewed groups refer to some of the interactions as being problematic, they described a culture of acceptance of gift giving. We developed a framework that depicts the prevailing politico-cultural environment, the interactions between the three professional groups, and their impact on drug prescription. Underreporting is the main limitation of this study. Conclusion Interactions between physicians, pharmacists and pharmaceutical representatives are frequent. Although these interactions can be beneficial, they still have a substantial effect on drug prescription and dispensing practices. Hence, the need for new policies that regulate these interactions and penalize any misconduct.	[Hajjar, Rima; Bassatne, Aya; Cheaito, Mohamad Ali; El Dine, Rabie Naser; Traboulsy, Sarah; Haddadin, Fadi; Aki, Elie A.] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Honein-AbouHaidar, Gladys] Amer Univ Beirut, Hariri Sch Med, Beirut, Lebanon	American University of Beirut; American University of Beirut	Aki, EA (corresponding author), Amer Univ Beirut, Fac Med, Beirut, Lebanon.	ea32@aub.edu.lb	Akl, Elie/K-5269-2019; Honein-AbouHaidar, Gladys N./M-4308-2013; Akl, Elie A./R-2079-2016	Honein-AbouHaidar, Gladys N./0000-0001-6208-7859; Cheaito, Mohamad Ali/0000-0001-6653-8848; Traboulsy, Sarah/0000-0001-6876-1066; Akl, Elie A./0000-0002-3444-8618				Agrawal S, 2016, NEW ENGL J MED, V374, P906, DOI 10.1056/NEJMp1509103; Alssageer MA, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.132.2598; Blominvest Bank, 2016, PHARM HEALTHC LEB NU; Brax H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175493; Buchman S, 2012, CAN FAM PHYSICIAN, V58, P229; DeAngelis CD, 2014, MILBANK Q, V92, P195, DOI 10.1111/1468-0009.12052; El-Jardali F, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0556-1; Francer J, 2014, PHILOS ETHICS HUM ME, V9, DOI 10.1186/1747-5341-9-7; Fugh-Berman A, 2008, J GEN INTERN MED, V23, P1277, DOI 10.1007/s11606-008-0630-0; Ghaith A., 2013, EUR J SOCIAL SCI, V36, P528; Goodley S., 2014, GUARDIAN; Grouse L, 2014, J THORAC DIS, V6, P558, DOI 10.3978/j.issn.2072-1439.2014.01.25; Kamal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140457; Lai Taavi, 2013, HLTH SYSTEMS TRANSIT, V15; Lakoff A, 2004, SOC STUD SCI, V34, P247, DOI 10.1177/0306312704042624; Lotfi T, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1299-4; Mello MM, 2011, NEW ENGL J MED, V365, P1248, DOI 10.1056/NEJMhle1107678; Mikhael E., 2014, PHARM PHARMACOL-RUSS, V5, P705, DOI [10.4236/pp.2014.57080, DOI 10.4236/PP.2014.57080]; Ministry of Public Health, 2016, COD ETH MED PROD PRO; Oldani MJ, 2004, MED ANTHROPOL Q, V18, P325, DOI 10.1525/maq.2004.18.3.325; Pham-Kanter G, 2017, J GEN INTERN MED, V32, P767, DOI 10.1007/s11606-017-4012-3; Publishing O, 2013, HLTH GLANC 2013; Rothman DJ, 2014, MILBANK Q, V92, P471, DOI 10.1111/1468-0009.12074; Strauss A., 1998, BASICS QUALITATIVE R; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Zaki NM, 2014, SAUDI PHARM J, V22, P528, DOI 10.1016/j.jsps.2014.02.008	26	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184662	10.1371/journal.pone.0184662	http://dx.doi.org/10.1371/journal.pone.0184662			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG6AR	28898296	Green Published, Green Submitted, gold			2022-12-27	WOS:000410449500041
J	Sulli, M; Mandolino, G; Sturaro, M; Onofri, C; Diretto, G; Parisi, B; Giuliano, G				Sulli, Maria; Mandolino, Giuseppe; Sturaro, Monica; Onofri, Chiara; Diretto, Gianfranco; Parisi, Bruno; Giuliano, Giovanni			Molecular and biochemical characterization of a potato collection with contrasting tuber carotenoid content	PLOS ONE			English	Article							TOMATO FRUIT; XANTHOPHYLL ESTERIFICATION; ACCUMULATION; STORAGE; L.; BIOSYNTHESIS; CULTIVARS; REVEALS; SUBERIN; PLANTS	After wheat and rice, potato is the third most important staple food worldwide. A collection of ten tetraploid )Solanum tuberosum) and diploid )S. phureja and S. chacoense) genotypes with contrasting carotenoid content was subjected to molecular characterization with respect to candidate carotenoid loci and metabolic profiling using LC-HRMS. Irrespective of ploidy and taxonomy, tubers of these genotypes fell into three groups: yellow-fleshed, characterized by high levels of epoxy-xanthophylls and xanthophyll esters and by the presence of at least one copy of a dominant allele of the beta-Carotene Hydroxylase 2 )CHY2) gene; white-fleshed, characterized by low carotenoid levels and by the presence of recessive chy2 alleles; and orange-fleshed, characterized by high levels of zeaxanthin but low levels of xanthophyll esters, and homozygosity for a Zeaxanthin Epoxidase )ZEP) recessive allele. Novel CHY2 and ZEP alleles were identified in the collection. Multivariate analysis identified several groups of co-regulated non-polar compounds, and resulted in the grouping of the genotypes according to flesh color, suggesting that extensive cross-talk exists between the carotenoid pathway and other metabolite pathways in tubers. Postharvest traits like tuber dormancy and weight loss during storage showed little correlation with tuber carotenoid content, with the exception of zeaxanthin and its esters. Other tuber metabolites, such as glucose, monogalactosyldiacyglycerol )a glycolipid), or suberin precursors, showed instead significant correlations with both traits.	[Sulli, Maria; Diretto, Gianfranco; Giuliano, Giovanni] ENEA, Casaccia Res Ctr, Via Anguillarese 301, Rome, Italy; [Sulli, Maria] Scuola Super Sant Anna, Piazza Martin della Liberta 33, Pisa, Italy; [Mandolino, Giuseppe; Onofri, Chiara; Parisi, Bruno] CREA Ctr Cerealicoltura & Colture Ind, Sede Bologna, Via Corticella 133, Bologna, Italy; [Sturaro, Monica] CREA Ctr Cerealicoltura & Colture Ind, Sede Bergamo, Via Stezzano 24, Bergamo, Italy	Italian National Agency New Technical Energy & Sustainable Economics Development; Scuola Superiore Sant'Anna	Giuliano, G (corresponding author), ENEA, Casaccia Res Ctr, Via Anguillarese 301, Rome, Italy.	giovanni.giuliano@enea.it	Diretto, Gianfranco/L-9279-2017; Mandolino, Giuseppe/H-7915-2019; Giuliano, Giovanni/A-2701-2012	Diretto, Gianfranco/0000-0002-1441-0233; Mandolino, Giuseppe/0000-0003-1956-7392; Giuliano, Giovanni/0000-0002-2486-0510; Sulli, Maria/0000-0002-6875-2546	Italian Ministry of Agriculture (ALISAL project); Italian Ministry of Agriculture (NUTRISOL project); European Commission (G2P-SOL project) [677379]; Scuola Superiore San-t'Anna (Pisa)	Italian Ministry of Agriculture (ALISAL project); Italian Ministry of Agriculture (NUTRISOL project); European Commission (G2P-SOL project); Scuola Superiore San-t'Anna (Pisa)	This work was supported by the Italian Ministry of Agriculture (ALISAL and NUTRISOL projects), the European Commission (G2P-SOL project, contract n. 677379) and benefited from the networking activities within the European Cooperation in Science and Technology Action CM 5136 (EUROCAROTEN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Italian Ministry of Agriculture (ALISAL and NUTRISOL projects), the European Commission (G2P-SOL project, contract n. 677379) and benefited from the networking activities within the European Cooperation in Science and Technology Action CA15136 (EUROCAROTEN). Maria Sulli acknowledges the Scuola Superiore San-t'Anna (Pisa) for a doctoral fellowship and Prof. Enrico Pe for supervision of her thesis work.	Alboresi  A., 2016, PLANT PHYSIOL; Ariizumi T, 2014, PLANT J, V79, P453, DOI 10.1111/tpj.12570; Aversano R, 2017, PHYTOCHEMISTRY, V137, P42, DOI 10.1016/j.phytochem.2017.02.011; Bernards MA, 2001, PHYTOCHEMISTRY, V57, P1115, DOI 10.1016/S0031-9422(01)00046-2; Biemelt S, 2000, POTATO RES, V43, P371, DOI 10.1007/BF02360541; Breithaupt DE, 2002, J AGR FOOD CHEM, V50, P7175, DOI 10.1021/jf0257953; Brown CR, 2006, AM J POTATO RES, V83, P365, DOI 10.1007/BF02872013; BROWN CR, 1993, J AM SOC HORTIC SCI, V118, P145, DOI 10.21273/JASHS.118.1.145; Burgos G, 2009, J FOOD COMPOS ANAL, V22, P503, DOI 10.1016/j.jfca.2008.08.008; Campbell R, 2014, THEOR APPL GENET, V127, P1917, DOI 10.1007/s00122-014-2349-0; Carputo D, 2005, ANN APPL BIOL, V146, P71, DOI 10.1111/j.1744-7348.2005.04070.x; D'Esposito D, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1008-4; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Diretto G, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-13; Diretto G, 2010, PLANT PHYSIOL, V154, P899, DOI 10.1104/pp.110.159368; Fantini E, 2013, PLANT PHYSIOL, V163, P986, DOI 10.1104/pp.113.224733; Fasano C, 2016, NEW PHYTOLOGIST; Fernandez-Orozco R, 2013, FOOD CHEM, V141, P2864, DOI 10.1016/j.foodchem.2013.05.016; Fiedor J, 2014, NUTRIENTS, V6, P466, DOI 10.3390/nu6020466; Fiore A, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-50; Ghislain M, 2006, THEOR APPL GENET, V113, P1515, DOI 10.1007/s00122-006-0399-7; Giuliano G, 2008, TRENDS BIOTECHNOL, V26, P139, DOI 10.1016/j.tibtech.2007.12.003; Giuliano G, 2017, CURR OPIN BIOTECH, V44, P169, DOI 10.1016/j.copbio.2017.02.001; Giuliano G, 2014, CURR OPIN PLANT BIOL, V19, P111, DOI 10.1016/j.pbi.2014.05.006; Gomez-Gomez L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010076; Graca J, 2010, PHYTOCHEM REV, V9, P85, DOI 10.1007/s11101-009-9138-4; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kloosterman B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-158; Liu MC, 2014, NEW PHYTOL, V203, P206, DOI 10.1111/nph.12771; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez AB, 2008, J EXP BOT, V59, P213, DOI 10.1093/jxb/erm299; Maalekuu K, 2006, POSTHARVEST BIOL TEC, V42, P248, DOI 10.1016/j.postharvbio.2006.06.012; Morris WL, 2004, J EXP BOT, V55, P975, DOI 10.1093/jxb/erh121; Nesterenko S, 2003, HORTSCIENCE, V38, P1173, DOI 10.21273/HORTSCI.38.6.1173; Norkus EP, 2010, J AM COLL NUTR, V29, P575, DOI 10.1080/07315724.2010.10719896; Rodriguez-Amaya D.B., 2001, GUIDE CAROTENOID ANA; Romer S, 2002, METAB ENG, V4, P263, DOI 10.1006/mben.2002.0234; Schweiggert U, 2007, EUR FOOD RES TECHNOL, V225, P261, DOI 10.1007/s00217-006-0413-y; Sonnewald U, 2001, TRENDS PLANT SCI, V6, P333, DOI 10.1016/S1360-1385(01)02020-9; Spooner DM, 2010, AM J BOT, V97, P2049, DOI 10.3732/ajb.1000277; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Su LY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0495-4; Suttle JC, 2004, AM J POTATO RES, V81, P253, DOI 10.1007/BF02871767; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Vreugdenhil D., 2007, Potato Research, V50, P371, DOI 10.1007/s11540-008-9068-3; Wolters AMA, 2010, PLANT MOL BIOL, V73, P659, DOI 10.1007/s11103-010-9647-y	47	28	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184143	10.1371/journal.pone.0184143	http://dx.doi.org/10.1371/journal.pone.0184143			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898255	Green Published, Green Submitted, gold			2022-12-27	WOS:000410449500014
J	Abplanalp, W; DeJarnett, N; Riggs, DW; Conklin, DJ; McCracken, JP; Srivastava, S; Xie, ZZ; Rai, S; Bhatnagar, A; O'Toole, TE				Abplanalp, Wesley; DeJarnett, Natasha; Riggs, Daniel W.; Conklin, Daniel J.; McCracken, James P.; Srivastava, Sanjay; Xie, Zhengzhi; Rai, Shesh; Bhatnagar, Aruni; O'Toole, Timothy E.			Benzene exposure is associated with cardiovascular disease risk	PLOS ONE			English	Article							PARTICULATE AIR-POLLUTION; ENDOTHELIAL PROGENITOR CELLS; VOLATILE ORGANIC-COMPOUNDS; ERYTHROID-DIFFERENTIATION; IN-UTERO; ACROLEIN; METABOLITES; INFLAMMATION; MORTALITY; MECHANISM	Benzene is a ubiquitous, volatile pollutant present at high concentrations in toxins (e.g. tobacco smoke) known to increase cardiovascular disease (CVD) risk. Despite its prevalence, the cardiovascular effects of benzene have rarely been studied. Hence, we examined whether exposure to benzene is associated with increased CVD risk. The effects of benzene exposure in mice were assessed by direct inhalation, while the effects of benzene exposure in humans was assessed in 210 individuals with mild to high CVD risk by measuring urinary levels of the benzene metabolite trans, trans-muconic acid (t, t-MA). Generalized linear models were used to assess the association between benzene exposure and CVD risk. Mice inhaling volatile benzene had significantly reduced levels of circulating angiogenic cells (Flk1 (+)/Sca-1(+)) as well as an increased levels of plasma low-density lipoprotein (LDL) compared with control mice breathing filtered air. In the human cohort, urinary levels of t, t-MA were inversely associated several populations of circulating angiogenic cells (CD31(+)/34(+)/45(+), CD31(+)/34(+)/45(+)/AC133(-), CD34(+)/45(+)/AC133(+)). Although t, t-MA was not associated with plasma markers of inflammation or thrombosis, t, t-MA levels were higher in smokers and in individuals with dyslipidemia. In smokers, t, t-MA levels were positively associated with urinary metabolites of nicotine (cotinine) and acrolein (3-hydroxymercapturic acid). Levels of t, t-MA were also associated with CVD risk as assessed using the Framingham Risk Score and this association was independent of smoking. Thus, benzene exposure is associated with increased CVD risk and deficits in circulating angiogenic cells in both smokers and nonsmokers.	[Abplanalp, Wesley; DeJarnett, Natasha; Riggs, Daniel W.; Conklin, Daniel J.; McCracken, James P.; Srivastava, Sanjay; Xie, Zhengzhi; Bhatnagar, Aruni; O'Toole, Timothy E.] Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40292 USA; [Abplanalp, Wesley; Riggs, Daniel W.; Conklin, Daniel J.; McCracken, James P.; Srivastava, Sanjay; Xie, Zhengzhi; Bhatnagar, Aruni; O'Toole, Timothy E.] Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA; [DeJarnett, Natasha] Univ Louisville, Dept Environm & Occupat Hlth Sci, Louisville, KY 40292 USA; [Rai, Shesh] Univ Louisville, Dept Bioinformat & Biostat, Louisville, KY 40292 USA; [Rai, Shesh] Univ Louisville, JG Brown Canc Ctr, Biostat Shared Facil, Louisville, KY 40292 USA; [Abplanalp, Wesley] Goethe Univ, Inst Cardiovasc Regenerat, Frankfurt, Germany; [DeJarnett, Natasha] Amer Publ Hlth Assoc, Washington, DC USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University of Louisville; Goethe University Frankfurt	O'Toole, TE (corresponding author), Univ Louisville, Diabet & Obes Ctr, Louisville, KY 40292 USA.; O'Toole, TE (corresponding author), Univ Louisville, Inst Mol Cardiol, Louisville, KY 40292 USA.	tim.otoole@louisville.edu		Abplanalp, Wesley/0000-0001-5996-8997; DeJarnett, Natasha/0000-0003-2638-5028; Riggs, Daniel/0000-0002-3503-0600	 [ES0119217];  [P50 HL120163-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL120163, R01HL122676, P50HL120163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019217] Funding Source: NIH RePORTER	; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by ES0119217 and P50 HL120163-01, www.nih.gov.	Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; [Anonymous], 2015, EUR HEART J, V36, P1779; APPEL BR, 1990, AM J PUBLIC HEALTH, V80, P560, DOI 10.2105/AJPH.80.5.560; ATSDR, 2005, REG AFTSAD; Badham HJ, 2010, TOXICOL APPL PHARM, V244, P273, DOI 10.1016/j.taap.2010.01.002; Badham HJ, 2010, TOXICOL SCI, V113, P207, DOI 10.1093/toxsci/kfp242; Bard D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100307; BLANK IH, 1985, J INVEST DERMATOL, V85, P522, DOI 10.1111/1523-1747.ep12277325; Charbotel B, 2014, CRIT REV ONCOL HEMAT, V90, P99, DOI 10.1016/j.critrevonc.2013.12.004; Choi YH, 2014, SCI TOTAL ENVIRON, V482, P260, DOI 10.1016/j.scitotenv.2014.02.121; Chow PW, 2015, TOXICOL APPL PHARM, V284, P8, DOI 10.1016/j.taap.2015.01.016; Clayton CA, 1999, J EXPO ANAL ENV EPID, V9, P381, DOI 10.1038/sj.jea.7500055; DeJarnett N, 2015, ARTERIOSCL THROM VAS, V35, P2468, DOI 10.1161/ATVBAHA.115.305724; DeJarnett N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000934; Fraser MP, 1998, ENVIRON SCI TECHNOL, V32, P2051, DOI 10.1021/es970916e; Friedrich EB, 2006, CIRC RES, V98, pE20, DOI 10.1161/01.RES.0000205765.28940.93; HATTEMERFREY HA, 1990, ENVIRON RES, V53, P221, DOI 10.1016/S0013-9351(05)80120-3; Inventory TR, 2016, TOX REL INV TRI DAT; Jacob P, 2013, CANCER EPIDEM BIOMAR, V22, P765, DOI 10.1158/1055-9965.EPI-12-1422; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; LINDSTROM AB, 1994, J EXPO ANAL ENV EPID, V4, P183; Man CN, 2006, J CHROMATOGR B, V844, P322, DOI 10.1016/j.jchromb.2006.07.029; Mansi A, 2012, TOXICOL LETT, V213, P57, DOI 10.1016/j.toxlet.2011.02.001; Matsunaga N, 2008, HEPATOLOGY, V48, P240, DOI 10.1002/hep.22304; Mohamed MF, 2002, CHEMOSPHERE, V47, P863, DOI 10.1016/S0045-6535(02)00107-8; Morello-Frosch RA, 2000, RISK ANAL, V20, P273, DOI 10.1111/0272-4332.202026; Newby DE, 2015, EUR HEART J, V36, P83, DOI 10.1093/eurheartj/ehu458; O'Toole TE, 2010, CIRC RES, V107, P200, DOI 10.1161/CIRCRESAHA.110.222679; Pope CA, 2016, CIRC RES, V119, P1204, DOI 10.1161/CIRCRESAHA.116.309279; Pope CA, 2015, CIRC RES, V116, P108, DOI 10.1161/CIRCRESAHA.116.305060; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; ROBERTS BJ, 1995, J BIOL CHEM, V270, P29632; Ruppert T, 1997, INT ARCH OCC ENV HEA, V69, P247, DOI 10.1007/s004200050143; Sarkar M, 2013, ENVIRON TOXICOL PHAR, V36, P108, DOI 10.1016/j.etap.2013.03.001; Schnatter AR, 2012, J NATL CANCER I, V104, P1724, DOI 10.1093/jnci/djs411; Snyder R, 2012, INT J ENV RES PUB HE, V9, P2875, DOI 10.3390/ijerph9082875; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Uchida K, 1999, TRENDS CARDIOVAS MED, V9, P109, DOI 10.1016/S1050-1738(99)00016-X; Waidyanatha S, 2004, ANAL BIOCHEM, V327, P184, DOI 10.1016/j.ab.2004.01.008; Weisel CP, 2010, CHEM-BIOL INTERACT, V184, P58, DOI 10.1016/j.cbi.2009.12.030; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Wheat LA, 2011, ARTERIOSCL THROM VAS, V31, P1598, DOI 10.1161/ATVBAHA.111.227124; Wiwanitkit Viroj, 2007, Cardiovasc J Afr, V18, P264; Wu XR, 2011, TOXICOL LETT, V203, P190, DOI 10.1016/j.toxlet.2011.03.012	45	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183602	10.1371/journal.pone.0183602	http://dx.doi.org/10.1371/journal.pone.0183602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886060	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100030
J	Aoki, T; Inoue, M				Aoki, Takuya; Inoue, Machiko			Association between health literacy and patient experience of primary care attributes: A cross-sectional study in Japan	PLOS ONE			English	Article							MEDICARE MANAGED CARE; ASSESSMENT-TOOL; COMMUNICATION; ORGANIZATIONS; ENROLLEES; BEHAVIOR; ADULTS	Primary care is regarded as a setting that potentially mitigate patient health literacy (HL) related inequalities. However, there is a lack of evidence about influence of patient HL on the patients' perception of quality of primary care. We aimed to examine the association between HL and patient experience of primary care attributes. We conducted a cross-sectional survey, and sent questionnaires to adult residents who were randomly selected from a basic resident register in Yugawara Town, Kanagawa, Japan. We assessed HL using a 14-item Health Literacy Scale (HLS-14) and patient experience of primary care attributes using a Japanese version of Primary Care Assessment Tool (JPCAT), which comprises six domains: first contact, longitudinality, coordination, comprehensiveness (services available), comprehensiveness (services provided), and community orientation. We used a multivariable linear regression analyses to adjust individual covariates. Data were analyzed for 381 residents who had a usual source of care. After adjustment for patients' sociodemographic and health characteristics, patient HL was positively associated with the JPCAT total score (B = 4.49, 95% confidence interval: 0.27 to 8.65 for HLS-14 total score highest quartile, compared with the lowest quartile). Among primary care attributes, HL had significant associations with longitudinality and comprehensiveness (service provided). We found that HL was positively associated with patient experience of primary care attributes in Japanese people. Our findings indicated that greater efforts might be needed to improve patient-centered and tailored primary care to those with low HL.	[Aoki, Takuya] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Kyoto, Japan; [Inoue, Machiko] Hamamatsu Univ Sch Med, Dept Family & Community Med, Hamamatsu, Shizuoka, Japan	Kyoto University; Hamamatsu University School of Medicine	Aoki, T (corresponding author), Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Kyoto, Japan.	taku5924@gmail.com	Inoue, Machiko/T-4884-2019	Inoue, Machiko/0000-0002-0799-5894; Aoki, Takuya/0000-0002-8232-2155	Japan Science and Technology Agency; Research Institute of Science and Technology for Society; Designing a Sustainable Society through Intergenerational Co-creation; Evaluation of Effectiveness of Intergenerational Co-creative Community on ME-BYO	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Research Institute of Science and Technology for Society; Designing a Sustainable Society through Intergenerational Co-creation; Evaluation of Effectiveness of Intergenerational Co-creative Community on ME-BYO	The Japan Science and Technology Agency, Research Institute of Science and Technology for Society, Designing a Sustainable Society through Intergenerational Co-creation, Evaluation of Effectiveness of Intergenerational Co-creative Community on ME-BYO, Project Director: Kenji Watanabe (http://ristex.jst.go.jp/i-gene/en/projects/projects.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2009, AUST FAM PHYSICIAN, V38, P144; ALTIN SV, 2015, BMC FAM PRACT, V16; Aoki T, 2016, FAM PRACT, V33, P112, DOI 10.1093/fampra/cmv087; Baker DW, 2007, ARCH INTERN MED, V167, P1503, DOI 10.1001/archinte.167.14.1503; Baker DW, 2002, AM J PUBLIC HEALTH, V92, P1278, DOI 10.2105/AJPH.92.8.1278; Browne K, 2010, HEALTH AFFAIR, V29, P921, DOI 10.1377/hlthaff.2010.0238; Cho YI, 2008, SOC SCI MED, V66, P1809, DOI 10.1016/j.socscimed.2008.01.003; Feinstein A., 1966, MULTIVARIABLE ANAL I, P226; Haggerty J, 2007, ANN FAM MED, V5, P336, DOI 10.1370/afm.682; Howard DH, 2005, AM J MED, V118, P371, DOI 10.1016/j.amjmed.2005.01.010; Inoue M, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-40; Institute of Medicine, 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; Lied TR, 2003, HEALTH CARE FINANC R, V25, P55; Ministry of Internal Affairs and Communications, 2015, 2015 POP CENS JAP; National Research Council, 2004, HLTH LITERACY PRESCR; Nutbeam D, 2000, HEALTH PROMOT INT, V15, P259, DOI 10.1093/heapro/15.3.259; Paddison CAM, 2013, AM J KIDNEY DIS, V61, P440, DOI 10.1053/j.ajkd.2012.10.009; Peterson NB, 2007, J NATL MED ASSOC, V99, P1105; Saultz John W, 2003, Ann Fam Med, V1, P134, DOI 10.1370/afm.23; Shea JA, 2007, INT J QUAL HEALTH C, V19, P45, DOI 10.1093/intqhc/mzl068; Shi LY, 2001, J FAM PRACTICE, V50, P161; Shrank WH, 2007, HEALTH AFFAIR, V26, P731, DOI 10.1377/hlthaff.26.3.731; Starfield B, 1998, PRIMARY CARE BALANCI; Sturmberg JP, 2011, J EVAL CLIN PRACT, V17, P525, DOI 10.1111/j.1365-2753.2011.01671.x; Suka M, 2013, ENVIRON HEALTH PREV, V18, P407, DOI 10.1007/s12199-013-0340-z; United Nations Educational Scientific and Research Organisation (UNESCO), 2012, EFF LIT PRACT PROGR; von Wagner C, 2007, J EPIDEMIOL COMMUN H, V61, P1086, DOI 10.1136/jech.2006.053967; Warren FC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2040; Williams MV, 2002, FAM MED, V34, P383; Wynia MK, 2010, J HEALTH COMMUN, V15, P102, DOI 10.1080/10810730.2010.499981	30	11	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184565	10.1371/journal.pone.0184565	http://dx.doi.org/10.1371/journal.pone.0184565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886146	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100157
J	Chen, XJ; Utheim, OA; Xiao, JX; Adil, MY; Stojanovic, A; Tashbayev, B; Jensen, JL; Utheim, TP				Chen, Xiangjun; Utheim, Oygunn Aass; Xiao, Jiaxin; Adil, Muhammed Yasin; Stojanovic, Aleksandar; Tashbayev, Behzod; Jensen, Janicke Liaaen; Utheim, Tor Paaske			Meibomian gland features in a Norwegian cohort of patients with primary Sjogren 's syndrome	PLOS ONE			English	Article							DRY EYE DISEASE; NONCONTACT INFRARED MEIBOGRAPHY; TEAR FILM; INTERNATIONAL WORKSHOP; DYSFUNCTION REPORT; OCULAR SURFACE; RISK-FACTORS; LIPID LAYER; POPULATION; SUBCOMMITTEE	Purpose To assess the tear film and meibomian gland (MG) features in a Norwegian cohort of patients with primary Sjogren's syndrome (pSS) and in age-and gender-matched control subjects. Methods Thirty-four female patients with pSS (age 52.9 +/- 11.9 years) and 32 female control subjects (age 49.0 +/- 11.5 years) were recruited. After completion of Ocular Surface Disease Index (OSDI) questionnaire and McMonnies Dry Eye Questionaire, participants underwent measurements of tear osmolarity, tear break-up time (TBUT), ocular surface and corneal staining, Schirmer I test, corneal sensitivity, MG expressibility evaluations, and lid margin morphology examination using slitlamp microscopy. Non-contact infrared meibography images were assessed by computer-assisted analysis. The MG loss, calculated as (tarsal area-MG area)/tarsal area, was evaluated in both upper (UL) and lower lids (LL). Results Compared to the control group, pSS patients demonstrated higher MG loss in both UL (33.8 +/- 13.2% vs. 24.4 +/- 8.5%, p<0.01) and LL (52.5 +/- 15.7% vs. 43.0 +/- 9.6%, p<0.05), as well as higher lid abnormality score (0.8 +/- 0.8 vs. 0.2 +/- 0.6, p<0.01). Furthermore, pSS patients showed higher OSDI and McMonnies questionnaire scores, elevated osmolarity, shorter TBUT, shorter blink interval, less wetting in Schirmer I test, more ocular surface staining and more corneal staining. MG loss in UL correlated negatively with TBUT (r = -0.386, p = 0.029) in the pSS group, whereas MG loss in LL correlated negatively with TBUT (r = -0.380, p = 0.035) in the control group. Conclusions Significantly elevated dry eye symptoms and signs were found in the pSS group compared with the control group, which might be attributed to both decreased aqueous tear production and increased tear evaporation.	[Chen, Xiangjun] Vestre Viken Hosp Trust, Dept Ophthalmol, Drammen, Norway; [Utheim, Oygunn Aass] Oslo Univ Hosp, Dept Ophthalmol, Oslo, Norway; [Xiao, Jiaxin; Adil, Muhammed Yasin; Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Xiao, Jiaxin; Adil, Muhammed Yasin] Univ Oslo, Fac Med, Oslo, Norway; [Stojanovic, Aleksandar] Univ Hosp North Norway, Dept Ophthalmol, Tromso, Norway; [Tashbayev, Behzod; Jensen, Janicke Liaaen] Univ Oslo, Dept Oral Surg & Oral Med, Fac Dent, Oslo, Norway; [Utheim, Tor Paaske] Univ Oslo, Dept Oral Biol, Fac Dent, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo; University of Oslo	Chen, XJ (corresponding author), Vestre Viken Hosp Trust, Dept Ophthalmol, Drammen, Norway.	chenxiangjun1101@gmail.com	Stojanovic, Aleksandar/AAG-9933-2019; Tashbayev, Behzod/AAZ-6268-2020	Chen, Xiangjun/0000-0003-0331-9028; Tashbayev, Behzod/0000-0003-2566-8800; Jensen, Janicke Liaaen/0000-0003-4276-9611	Faculty of Dentistry, University of Oslo	Faculty of Dentistry, University of Oslo	The project is funded by the Faculty of Dentistry, University of Oslo. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, OCULAR SURFACE, V5, P93; Argueso P, 2002, INVEST OPHTH VIS SCI, V43, P1004; Arita R, 2008, OPHTHALMOLOGY, V115, P911, DOI 10.1016/j.ophtha.2007.06.031; Baek J, 2015, CORNEA, V34, P1209, DOI 10.1097/ICO.0000000000000575; Baudouin C, 2001, SURV OPHTHALMOL, V45, pS211, DOI 10.1016/S0039-6257(00)00200-9; Baudouin C, 2013, OCUL SURF, V11, P246, DOI 10.1016/j.jtos.2013.07.003; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Bron AJ, 2007, OCUL SURF, V5, P108; Caffery B, 2010, OPTOMETRY VISION SCI, V87, P742, DOI 10.1097/OPX.0b013e3181f32196; Danjo Y, 1997, GRAEF ARCH CLIN EXP, V235, P761, DOI 10.1007/BF02332860; Den S, 2006, CORNEA, V25, P651, DOI 10.1097/01.ico.0000227889.11500.6f; Eom Y, 2013, AM J OPHTHALMOL, V155, P1104, DOI 10.1016/j.ajo.2013.01.008; Finis D, 2015, CURR EYE RES, V40, P982, DOI 10.3109/02713683.2014.971929; Goto E, 2007, AM J OPHTHALMOL, V144, P81, DOI 10.1016/j.ajo.2007.03.055; Greiner JV, 1998, ADV EXP MED BIOL, V438, P339; Guo Y, 2016, J OPHTHALMOLOGY, V2016; Jester JV, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0132-x; JESTER JV, 1981, INVEST OPHTH VIS SCI, V20, P537; Johnson ME, 2009, OCUL SURF, V7, P199, DOI 10.1016/S1542-0124(12)70187-8; Kim KT, 2015, GRAEF ARCH CLIN EXP, V253, P1355, DOI 10.1007/s00417-015-3080-5; Knop E, 2011, INVEST OPHTH VIS SCI, V52, P1938, DOI 10.1167/iovs.10-6997c; Kozak I, 2007, CORNEA, V26, P610, DOI 10.1097/ICO.0b013e318041f0d2; Lemp MA, 2007, OCUL SURF, V5, P75; Li JY, 2015, EYE CONTACT LENS, V41, P44, DOI 10.1097/ICL.0000000000000064; Liu HX, 2009, INVEST OPHTH VIS SCI, V50, P3671, DOI 10.1167/iovs.08-2689; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; MATHERS WD, 1993, OPHTHALMOLOGY, V100, P347; McMonnies C W, 1987, J Am Optom Assoc, V58, P588; Menzies KL, 2015, INVEST OPHTH VIS SCI, V56, P836, DOI 10.1167/iovs.14-13864; Nichols KK, 2004, CORNEA, V23, P365, DOI 10.1097/00003226-200405000-00010; NORN MS, 1966, ACTA OPHTHALMOL, V44, P948; Ousler GW, 2008, CORNEA, V27, P509, DOI 10.1097/ICO.0b013e31816583f6; Pflugfelder SC, 2015, INVEST OPHTH VIS SCI, V56, P7545, DOI 10.1167/iovs.15-17627; Pult H, 2012, OPTOMETRY VISION SCI, V89, pE310, DOI 10.1097/OPX.0b013e318244e487; Qin BD, 2015, ANN RHEUM DIS, V74, P1983, DOI 10.1136/annrheumdis-2014-205375; Ramos-Casals M, 2015, AUTOIMMUN REV, V14, P670, DOI 10.1016/j.autrev.2015.03.008; Schaumberg DA, 2011, INVEST OPHTH VIS SCI, V52, P1994, DOI 10.1167/iovs.10-6997e; Schein OD, 1997, OPHTHALMOLOGY, V104, P1395, DOI 10.1016/S0161-6420(97)30125-0; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Shimazaki J, 1998, OPHTHALMOLOGY, V105, P1485, DOI 10.1016/S0161-6420(98)98033-2; Srinivasan S, 2012, OPTOMETRY VISION SCI, V89, P788, DOI 10.1097/OPX.0b013e318253de93; Stapleton F, 2017, OCUL SURF, V15, P334, DOI 10.1016/j.jtos.2017.05.003; Sullivan BD, 2014, ACTA OPHTHALMOL, V92, P161, DOI 10.1111/aos.12012; Sullivan DA, 2003, J RHEUMATOL, V30, P2413; Sullivan DA, 2002, ANN NY ACAD SCI, V966, P211, DOI 10.1111/j.1749-6632.2002.tb04217.x; Tomlinson A, 2005, OCUL SURF, V3, P81, DOI 10.1016/S1542-0124(12)70157-X; Tomlinson A, 2006, INVEST OPHTH VIS SCI, V47, P4309, DOI 10.1167/iovs.05-1504; Tomlinson A, 2011, INVEST OPHTH VIS SCI, V52, P2006, DOI 10.1167/iovs.10-6997f; Uchino M, 2006, OPTOMETRY VISION SCI, V83, P797, DOI 10.1097/01.opx.0000232814.39651.fa; Villani E, 2011, INVEST OPHTH VIS SCI, V52, P933, DOI 10.1167/iovs.10-5995; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Wan KH, 2016, EYE, V30, P1558, DOI 10.1038/eye.2016.186; Whitcher JP, 2010, AM J OPHTHALMOL, V149, P405, DOI 10.1016/j.ajo.2009.09.013; Yu DF, 2008, EXP EYE RES, V86, P403, DOI 10.1016/j.exer.2007.11.013	54	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184284	10.1371/journal.pone.0184284	http://dx.doi.org/10.1371/journal.pone.0184284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886085	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100091
J	Cheng, SHC; Huang, TT; Cheng, YH; Tan, TBK; Horng, CF; Wang, YA; Brian, NS; Shih, LS; Yu, BL				Cheng, Skye Hung-Chun; Huang, Tzu-Ting; Cheng, Yu-Hao; Tan, Tee Benita Kiat; Horng, Chen-Fang; Wang, Yong Alison; Brian, Nicholas Shannon; Shih, Li-Sun; Yu, Ben-Long			Validation of the 18-gene classifier as a prognostic biomarker of distant metastasis in breast cancer	PLOS ONE			English	Article							LOCOREGIONAL RECURRENCE; ADJUVANT CHEMOTHERAPY; PREDICTION; PATTERNS; THERAPY; TUMORS; TRIAL; RISK	We validated an 18-gene classifier (GC) initially developed to predict local/regional recurrence after mastectomy in estimating distant metastasis risk. The 18-gene scoring algorithm defines scores as: < 21, low risk; >= 21, high risk. Six hundred eighty-three patients with primary operable breast cancer and fresh frozen tumor tissues available were included. The primary outcome was the 5-year probability of freedom from distant metastasis (DMFP). Two external datasets were used to test the predictive accuracy of 18-GC. The 5-year rates of DMFP for patients classified as low-risk (n = 146, 21.7%) and high-risk (n = 537, 78.6%) were 96.2% (95% CI, 91.1% -98.8%) and 80.9% (74.6%-81.9%), respectively (median follow-up interval, 71.8 months). The 5-year rates of DMFP of the low-risk group in stage I (n = 62, 35.6%), stage II (n = 66, 20.1%), and stage III (n = 18, 10.3%) were 100%, 94.2% (78.5%-98.5%), and 90.9% (50.8% -98.7%), respectively. Multivariate analysis revealed that 18-GC is an independent prognostic factor of distant metastasis (adjusted hazard ratio, 5.1; 95% CI, 1.8-14.1; p = 0.0017) for scores of >= 21. External validation showed that the 5-year rate of DMFP in the low-and high-risk patients was 94.1% (82.9% -100%) and 80.3% (70.7%-89.9%, p = 0.06) in a Singapore dataset, and 89.5% (81.9%-94.1%) and 73.6% (67.2%-79.0%, p = 0.0039) in the GEO-GSE20685 dataset, respectively. In conclusion, 18-GC is a viable prognostic biomarker for breast cancer to estimate distant metastasis risk.	[Cheng, Skye Hung-Chun] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Radiat Oncol, Taipei, Taiwan; [Cheng, Skye Hung-Chun; Huang, Tzu-Ting; Horng, Chen-Fang] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Res, Taipei, Taiwan; [Cheng, Yu-Hao] Cathy Gen Hosp, Dept Med, Taipei, Taiwan; [Tan, Tee Benita Kiat] Natl Canc Ctr Singapore, Singapore, Singapore; [Tan, Tee Benita Kiat] Singapore Gen Hosp, Dept Gen Surg, Singapore, Singapore; [Tan, Tee Benita Kiat; Brian, Nicholas Shannon] Natl Univ Singapore, Duke NUS Grad Med Sch, Singapore, Singapore; [Wang, Yong Alison] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Med, Taipei, Taiwan; [Wang, Yong Alison] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Shih, Li-Sun] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Lab & Pathol, Taipei, Taiwan; [Yu, Ben-Long] Koo Fdn, Sun Yat Sen Canc Ctr, Dept Surg, Taipei, Taiwan	National Cancer Centre Singapore (NCCS); Singapore General Hospital; National University of Singapore; National Yang Ming Chiao Tung University	Cheng, SHC (corresponding author), Koo Fdn, Sun Yat Sen Canc Ctr, Dept Radiat Oncol, Taipei, Taiwan.; Cheng, SHC (corresponding author), Koo Fdn, Sun Yat Sen Canc Ctr, Dept Res, Taipei, Taiwan.	skye@kfsyscc.org		Cheng, Skye Hung Chun/0000-0002-5331-6688	Ministry of Science and Technology of the Republic of China (Taiwan) [NSC 102-3114-Y-368-001]	Ministry of Science and Technology of the Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of the Republic of China (Taiwan) (https://www.most.gov.tm/en/public), grant number NSC 102-3114-Y-368-001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Arvold ND, 2011, J CLIN ONCOL, V29, P3885, DOI 10.1200/JCO.2011.36.1105; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Cheng SH, 2006, J CLIN ONCOL, V24, P4594, DOI 10.1200/JCO.2005.02.5676; Cheng SH, 2016, EBIOMEDICINE, V5, P74, DOI 10.1016/j.ebiom.2016.02.022; Dabbs DJ, 2011, J CLIN ONCOL, V29, P4279, DOI 10.1200/JCO.2011.34.7963; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dubsky P, 2013, BRIT J CANCER, V109, P2959, DOI 10.1038/bjc.2013.671; Esserman LJ, 2013, JAMA-J AM MED ASSOC, V310, P797, DOI 10.1001/jama.2013.108415; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; FISHER B, 1989, NEW ENGL J MED, V320, P473, DOI 10.1056/NEJM198902233200801; Francis PA, 2015, NEW ENGL J MED, V372, P436, DOI 10.1056/NEJMoa1412379; Grantzau T, 2014, RADIOTHER ONCOL, V111, P366, DOI 10.1016/j.radonc.2014.05.004; Harris LN, 2016, J CLIN ONCOLOGY; HPAMOHAW TAIWAN, 2012, TAIPEI2015, P68; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Katz SJ, 2013, CANCER-AM CANCER SOC, V119, P3584, DOI 10.1002/cncr.28260; Mook S, 2009, BREAST CANCER RES TR, V116, P295, DOI 10.1007/s10549-008-0130-2; Naoi Y, 2015, BREAST CANC; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Porter ME, 2010, HARVARD BUSINESS SCH; Ragaz J, 2005, JNCI-J NATL CANCER I, V97, P116, DOI 10.1093/jnci/djh297; Rampurwala MM, 2014, BREAST CANCER-BASIC, V8, P125, DOI 10.4137/BCBCR.S9454; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Shibuta K, 2011, BREAST CANCER-TOKYO, V18, P292, DOI 10.1007/s12282-010-0209-6; Sohal D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002965; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sparano JA, 2015, NEW ENGL J MED, V373, P2005, DOI 10.1056/NEJMoa1510764; Teschendorff AE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2138; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1	35	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184372	10.1371/journal.pone.0184372	http://dx.doi.org/10.1371/journal.pone.0184372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886126	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100104
J	Kawada, Y; Asahara, S; Sugiura, Y; Sato, A; Furubayashi, A; Kawamura, M; Bartolome, A; Terashi-Suzuki, E; Takai, T; Kanno, A; Koyanagi-Kimura, M; Matsuda, T; Hashimoto, N; Kido, Y				Kawada, Yukina; Asahara, Shun-ichiro; Sugiura, Yumiko; Sato, Ayaka; Furubayashi, Ayuko; Kawamura, Mao; Bartolome, Alberto; Terashi-Suzuki, Emi; Takai, Tomoko; Kanno, Ayumi; Koyanagi-Kimura, Maki; Matsuda, Tomokazu; Hashimoto, Naoko; Kido, Yoshiaki			Histone deacetylase regulates insulin signaling via two pathways in pancreatic beta cells	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; MASS; GROWTH; RESISTANCE; SECRETION; MICE; HYPERINSULINEMIA; TRANSCRIPTION; ACETYLATION; DYSFUNCTION	Recent studies demonstrated that insulin signaling plays important roles in the regulation of pancreatic beta cell mass, the reduction of which is known to be involved in the development of diabetes. However, the mechanism underlying the alteration of insulin signaling in pancreatic beta cells remains unclear. The involvement of epigenetic control in the onset of diabetes has also been reported. Thus, we analyzed the epigenetic control of insulin receptor substrate 2 (IRS2) expression in the MIN6 mouse insulinoma cell line. We found concomitant IRS2 up-regulation and enhanced insulin signaling in MIN6 cells, which resulted in an increase in cell proliferation. The H3K9 acetylation status of the Irs2 promoter was positively associated with IRS2 expression. Treatment of MIN6 cells with histone deacetylase inhibitors led to increased IRS2 expression, but this occurred in concert with low insulin signaling. We observed increased IRS2 lysine acetylation as a consequence of histone deacetylase inhibition, a modification that was coupled with a decrease in IRS2 tyrosine phosphorylation. These results suggest that insulin signaling in pancreatic beta cells is regulated by histone dea-cetylases through two novel pathways affecting IRS2: the epigenetic control of IRS2 expression by H3K9 promoter acetylation, and the regulation of IRS2 activity through protein modification. The identification of the histone deacetylase isoform(s) involved in these mechanisms would be a valuable approach for the treatment of type 2 diabetes.	[Kawada, Yukina; Sugiura, Yumiko; Kido, Yoshiaki] Kobe Univ, Grad Sch Hlth Sci, Div Metab & Dis, Dept Biophys, Kobe, Hyogo, Japan; [Asahara, Shun-ichiro; Terashi-Suzuki, Emi; Takai, Tomoko; Kanno, Ayumi; Koyanagi-Kimura, Maki; Matsuda, Tomokazu; Hashimoto, Naoko; Kido, Yoshiaki] Kobe Univ, Div Diabet & Endocrinol, Dept Internal Med, Grad Sch Med, Kobe, Hyogo, Japan; [Sato, Ayaka; Furubayashi, Ayuko; Kawamura, Mao] Kobe Univ, Med Technol Major, Fac Hlth Sci Major, Grad Sch Med, Kobe, Hyogo, Japan; [Bartolome, Alberto] Columbia Univ, Dept Med, Med Ctr, New York, NY USA	Kobe University; Kobe University; Kobe University; Columbia University	Kido, Y (corresponding author), Kobe Univ, Grad Sch Hlth Sci, Div Metab & Dis, Dept Biophys, Kobe, Hyogo, Japan.; Kido, Y (corresponding author), Kobe Univ, Div Diabet & Endocrinol, Dept Internal Med, Grad Sch Med, Kobe, Hyogo, Japan.	kido@med.kobe-u.ac.jp	Bartolome, Alberto/AAV-1735-2020; Asahara, Shun-ichiro/I-6645-2019	Bartolome, Alberto/0000-0002-3382-0553; Asahara, Shun-ichiro/0000-0001-6661-9402	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26461382]; Uehara Memorial Foundation; Takeda Science Foundation; Suzuken Memorial Foundation; Yamaguchi Endocrine Research Foundation; Honjo International Scholarship Foundation; Hyogo Science and Technology Association; Grants-in-Aid for Scientific Research [16K16277] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Yamaguchi Endocrine Research Foundation; Honjo International Scholarship Foundation(Honjo International Scholarship Foundation); Hyogo Science and Technology Association; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to Shun-ichiro Asahara (S.A.) Grant number: 26461382; Uehara Memorial Foundation to Yoshiaki Kido (Y.K.) http://www.ueharazadan.or.jp; Takeda Science Foundation to Naoko Hashimoto (N.H.) http://www.takeda-sci.or.jp; Suzuken Memorial Foundation to Naoko Hashimoto (N.H.) http://www.suzukenzaidan.or.jp; Yamaguchi Endocrine Research Foundation to Naoko Hashimoto (N.H.) http://www.yamaguchi-endocrine.org; Honjo International Scholarship Foundation to Shun-ichiro Asahara (S.A.) http://www.hisf.or.jp; and Hyogo Science and Technology Association to Shun-ichiro Asahara (S. A.) http://hyogosta.jp/reconstruction/jyosei.	Asahara S, 2013, DIABETOLOGIA, V56, P1088, DOI 10.1007/s00125-013-2849-5; Asahara S, 2015, P NATL ACAD SCI USA, V112, P8332, DOI 10.1073/pnas.1422104112; Asahara S, 2009, BIOCHEM BIOPH RES CO, V381, P367, DOI 10.1016/j.bbrc.2009.02.047; Cheng K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040868; Costes S, 2013, DIABETES, V62, P327, DOI 10.2337/db12-1326; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Daneshpajooh M, 2017, DIABETOLOGIA, V60, P116, DOI 10.1007/s00125-016-4113-2; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Doi T, 2013, INT J CLIN ONCOL, V18, P87, DOI 10.1007/s10147-011-0348-6; Festa A, 2008, DIABETES, V57, P1638, DOI 10.2337/db07-0954; Funato H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018950; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Giannini C, 2012, DIABETES, V61, P606, DOI 10.2337/db11-1111; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Inoue T, 2009, BIOMED RES-TOKYO, V30, P325, DOI 10.2220/biomedres.30.325; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kanno A, 2015, BIOCHEM BIOPH RES CO, V458, P681, DOI 10.1016/j.bbrc.2015.02.024; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; Kubota N, 2004, J CLIN INVEST, V114, P917, DOI 10.1172/JCI200421484; Lee HB, 2007, KIDNEY INT, V72, pS61, DOI 10.1038/sj.ki.5002388; Lenoir O, 2011, DIABETES, V60, P2861, DOI 10.2337/db11-0440; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016096; Lundh M, 2012, DIABETOLOGIA, V55, P2421, DOI 10.1007/s00125-012-2615-0; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Meng Z, 2016, ONCOGENE, V35, P2333, DOI 10.1038/onc.2015.293; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Nakamura A, 2012, DIABETOLOGIA, V55, P1745, DOI 10.1007/s00125-012-2521-5; Neelankal John A, 2017, J NEUROENDOCRINOL, P29; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Noh H, 2009, AM J PHYSIOL-RENAL, V297, pF729, DOI 10.1152/ajprenal.00086.2009; O'Driscoll L, 2006, J ENDOCRINOL, V191, P665, DOI 10.1677/joe.1.06894; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; PHIPPS K, 1993, DIABETOLOGIA, V36, P225, DOI 10.1007/BF00399954; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Wang J, 2014, DIABETES, V63, P645, DOI 10.2337/db13-1063; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Yamato E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061211; Yoshida Y, 2014, DIABETOL INT, V5, P43, DOI 10.1007/s13340-013-0127-x	49	17	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184435	10.1371/journal.pone.0184435	http://dx.doi.org/10.1371/journal.pone.0184435			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886131	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100122
J	Petoumenos, K; Huang, R; Hoy, J; Bloch, M; Templeton, DJ; Baker, D; Giles, M; Law, MG; Cooper, DA				Petoumenos, Kathy; Huang, Robin; Hoy, Jennifer; Bloch, Mark; Templeton, David J.; Baker, David; Giles, Michelle; Law, Matthew G.; Cooper, David A.			Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years-The Australian Positive & Peers Longevity Evaluation Study (APPLES)	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BONE-MINERAL DENSITY; CD4 CELL COUNT; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; RISK-FACTORS; CARDIOVASCULAR-DISEASE; LIFE EXPECTANCY; MYOCARDIAL-INFARCTION; POPULATION-IMPACT	In Australia, almost half of HIV-positive people are now aged over 50 and are predominately gay and bisexual men (GBM). Compared to the general HIV-negative population, GBM engage more in behaviours that may increase the risk of age-related comorbidities, including smoking, high alcohol consumption and recreational drug use. The objective of APPLES was to compare comorbidities and risk factors in HIV-positive older GBM with an appropriate control group of HIV-negative GBM. We undertook a prospectively recruited cross-sectional sample of HIV-positive and HIV-negative GBM >= 55 years. Detailed data collection included clinic data, a health and lifestyle survey, and blood sample collection. We report key demographic, laboratory markers and self-reported comorbidities by HIV status. For selected comorbidities we also adjust HIV status a priori for age, smoking and body mass index. Over 16 months 228 HIV-positive and 218 HIV-negative men were recruited. Median age was 63 years (IQR: 59-67). Although more HIV-positive men reported having ever smoked, smoking status was not statistically different between HIV positive and HIV negative men (p = 0.081). Greater alcohol use was reported by HIV-negative men (p = 0.002), and recreational drug use reported more often by HIV-positive men (p<0.001). After adjustment, HIV-positive men had significantly increased odds of diabetes (adjusted Odds ratio (aOR): 1.97, p = 0.038), thrombosis (aOR: 3.08, p = 0.007), neuropathy (aOR: 34.6, P<0.001), and non-significantly increased odds for heart-disease (aOR: 1.71, p = 0.077). In conclusion, HIV-positive GBM have significantly increased odds for key self-reported comorbidities. This study underscores the importance of an appropriate HIV-negative control group for more accurate evaluation of the risk and attribution of age-related comorbidities in HIV-positive people.	[Petoumenos, Kathy; Huang, Robin; Bloch, Mark; Templeton, David J.; Law, Matthew G.; Cooper, David A.] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Hoy, Jennifer] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Hoy, Jennifer] Monash Univ, Melbourne, Vic, Australia; [Bloch, Mark] Holdsworth House Med Practice, Darlinghurst, NSW, Australia; [Templeton, David J.] Univ Sydney, Sydney Local Hlth Dist & Cent Clin Sch, RPA Sexual Hlth, Camperdown, NSW, Australia; [Baker, David] East Sydney Doctors, Darlinghurst, NSW, Australia; [Giles, Michelle] Monash Hlth, Dept Infect Dis, Melbourne, Vic, Australia	University of New South Wales Sydney; Kirby Institute; Florey Institute of Neuroscience & Mental Health; Monash University; University of Sydney	Petoumenos, K (corresponding author), UNSW Sydney, Kirby Inst, Sydney, NSW, Australia.	kpetoumenos@kirby.unsw.edu.au	Hoy, Jennifer/AAK-7968-2020	Giles, Michelle/0000-0003-3007-1822; Law, Matthew/0000-0002-3540-8837; Petoumenos, Kathy/0000-0001-7534-7154; Hoy, Jennifer/0000-0002-6948-7086; Templeton, David/0000-0003-2157-9587	Gilead Sciences Australia	Gilead Sciences Australia(Gilead Sciences)	This study was funded by an unrestricted research grant by Gilead Sciences Australia. The funder had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2015, CLIN INFECT DIS, V60, P627, DOI 10.1093/cid/ciu869; Australian HIV Observational Database, 2002, HIV Med, V3, P28; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Chaisson RE, 2000, JAMA-J AM MED ASSOC, V284, P3128, DOI 10.1001/jama.284.24.3128; Correll PK, 1998, MED J AUSTRALIA, V169, P469, DOI 10.5694/j.1326-5377.1998.tb123370.x; De Francesco D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1970-8; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Dore GJ, 2003, AIDS, V17, P1539, DOI 10.1097/00002030-200307040-00015; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Egger S, 2009, JAIDS-J ACQ IMM DEF, V50, P513, DOI 10.1097/QAI.0b013e31819906d3; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Glass TR, 2006, HIV MED, V7, P404, DOI 10.1111/j.1468-1293.2006.00400.x; Grierson J, 2004, MONOGRAPH SERIES, V48; Grierson J, 2009, MONOGRAPH SERIES, V74; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Gueler A, 2017, AIDS, V31, P427, DOI 10.1097/QAD.0000000000001335; Helleberg M, 2015, AIDS, V29, P221, DOI 10.1097/QAD.0000000000000540; Helleberg M, 2014, AIDS, V28, P1499, DOI 10.1097/QAD.0000000000000283; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Jain MK, 2003, CLIN INFECT DIS, V36, P1030, DOI 10.1086/368186; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kooij KW, 2015, J INFECT DIS, V211, P539, DOI 10.1093/infdis/jiu499; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Law MG, 2000, AIDS, V14, P197, DOI 10.1097/00002030-200001280-00016; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V71, P413, DOI 10.1097/QAI.0000000000000881; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Mocroft A, 2002, AIDS, V16, P1663, DOI 10.1097/00002030-200208160-00012; Moore AL, 2001, AIDS, V15, P1731, DOI 10.1097/00002030-200109070-00019; Murray JM, 2009, SEX HEALTH, V6, P83, DOI 10.1071/SH08063; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Petoumenos K, 2016, CURR OPIN HIV AIDS, V11, P514, DOI 10.1097/COH.0000000000000306; Phillips AN, 2010, AIDS, V24, P1561, DOI 10.1097/QAD.0b013e32833a6056; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Prestage G, 2009, J SEX MED, V6, P2311, DOI 10.1111/j.1743-6109.2009.01323.x; Rasmussen L, 2015, LANCET HIV; Rose H, 2006, METABOLISM, V55, P90, DOI 10.1016/j.metabol.2005.07.012; Schouten J, 2012, 19 INT AIDS C JUL 22; Schouten J, 2014, CLIN INFECT DIS, V59, P1787, DOI 10.1093/cid/ciu701; Smith CJ, 2004, HIV MED, V5, P88, DOI 10.1111/j.1468-1293.2004.00191.x; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Tebas P, 2000, AIDS, V14, pF63, DOI 10.1097/00002030-200003100-00005; Teeraananchai S, 2017, HIV MED, V18, P256, DOI 10.1111/hiv.12421; Templeton DJ, 2014, SEX HEALTH, V11, P217, DOI 10.1071/SH14003; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Trickey A, LANCET HIV; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632	52	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184583	10.1371/journal.pone.0184583	http://dx.doi.org/10.1371/journal.pone.0184583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886173	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100163
J	Raedle-Hurst, T; Mueller, M; Meinitzer, A; Maerz, W; Dschietzig, T				Raedle-Hurst, Tanja; Mueller, Marieke; Meinitzer, Andreas; Maerz, Winfried; Dschietzig, Thomas			Homoarginine-A prognostic indicator in adolescents and adults with complex congenital heart disease?	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; NITRIC-OXIDE; ARGININE; DIMETHYLARGININE; DYSFUNCTION; EXPRESSION; BIOMARKERS; MORTALITY; ARGINASE; SYNTHASE	Background Homoarginine (hArg) has been shown to be of prognostic value in patients with chronic left heart failure. The present study aims to assess the clinical utility and prognostic value of hArg levels in patients with complex congenital heart disease (CHD). Methods Plasma hArg levels were measured in 143 patients with complex CHD and compared to clinical status, echocardiographic and laboratory parameters as well as the occurrence of adverse cardiac events. Results Median hArg levels were 1.5 mu mol/l in CHD patients as compared to 1.70 mu mol/l in healthy controls (p = 0.051). Median hArg levels were lowest in patients with Fontan palliation (1.27 mu mol/l) and Eisenmenger physiology (0.99 mu mol/l) and decreased with the severity of adverse cardiac events with lowest values found in patients prior to death or overt heart failure (0.89 mu mol/l). According to ROC analysis, the most important predictors of adverse cardiac events were hArg levels (AUC 0.837, p< 0.001, CI 0.726-0.947), NYHA class (AUC 0.800, p< 0.001, CI 0.672-0.928) and NT-proBNP levels (AUC 0.780, p< 0.001, CI 0.669-0.891). The occurrence of overt heart failure or death due to progressive heart failure were best predicted by NYHA class (AUC 0.945, p< 0.001, CI 0.898-0.992), hArg levels (AUC 0.911, p< 0.001, CI 0.850-0.971) and NT-proBNP levels (AUC 0.877, p< 0.001, CI 0.791-0.962), respectively. Conclusion In patients with complex CHD, hArg levels can predict adverse cardiac events as reliably as or even better than NT-proBNP levels and thus might be of prognostic value in this subset of patients.	[Raedle-Hurst, Tanja; Mueller, Marieke] Saarland Univ, Med Ctr, Dept Pediat Cardiol, Homburg, Germany; [Meinitzer, Andreas] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria; [Maerz, Winfried] Heidelberg Univ, Med Clin Nephrol Hypertensiol Rheumatol Endocrino, Med Fac Mannheim, Mannheim, Germany; [Maerz, Winfried] Synlab Holding Deutschland GmbH, Synlab Acad, Mannheim, Germany; [Maerz, Winfried] Synlab Holding Deutschland GmbH, Synlab Acad, Augsburg, Germany; [Dschietzig, Thomas] Charite, Med Clin Cardiol & Angiol, Campus Mitte, Berlin, Germany; [Dschietzig, Thomas] Immundiagnost GmbH, Bensheim, Germany	Universitatsklinikum des Saarlandes; Medical University of Graz; Ruprecht Karls University Heidelberg; SYNLAB Group; SYNLAB Group; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Raedle-Hurst, T (corresponding author), Saarland Univ, Med Ctr, Dept Pediat Cardiol, Homburg, Germany.	tanja.raedle-hurst@uks.eu		Dschietzig, Thomas Bernd/0000-0003-1186-8713				Alonso-Gonzalez R, 2013, EXPERT REV CARDIOVAS, V11, P773, DOI [10.1586/ERC.13.14, 10.1586/erc.13.14]; Alsaied T, 2015, HEART, V101, P1731, DOI 10.1136/heartjnl-2015-307930; Atzler D, 2015, CURR OPIN CLIN NUTR, V18, P83, DOI 10.1097/MCO.0000000000000123; Atzler D, 2013, INT J CARDIOL, V168, P4907, DOI 10.1016/j.ijcard.2013.07.099; Cullen ME, 2006, CIRCULATION, V114, pI16, DOI 10.1161/CIRCULATIONAHA.105.000448; Drechsler C, 2011, EUR J HEART FAIL, V13, P852, DOI 10.1093/eurjhf/hfr056; Giannakoulas G, 2015, HEART, V101, P1523, DOI 10.1136/heartjnl-2015-308045; Giannakoulas G, 2010, AM J CARDIOL, V105, P869, DOI 10.1016/j.amjcard.2009.11.041; Henaine R, 2013, J THORAC CARDIOV SUR, V146, P522, DOI 10.1016/j.jtcvs.2012.11.031; Hopkins WE, 2004, CIRCULATION, V109, P2872, DOI 10.1161/01.CIR.0000129305.25115.80; HRABAK A, 1994, BIOCHEM BIOPH RES CO, V198, P206, DOI 10.1006/bbrc.1994.1029; Huynh NN, 2006, CLIN EXP PHARMACOL P, V33, P1, DOI 10.1111/j.1440-1681.2006.04316.x; Khambadkone S, 2003, CIRCULATION, V107, P3204, DOI 10.1161/01.CIR.0000074210.49434.40; Levy M, 2003, J THORAC CARDIOV SUR, V125, P1083, DOI 10.1067/mtc.2003.193; Marz W, 2010, CIRCULATION, V122, P967, DOI 10.1161/CIRCULATIONAHA.109.908988; Massion PB, 2003, CIRC RES, V93, P388, DOI 10.1161/01.RES.0000088351.58510.21; Meinitzer A, 2007, CLIN CHIM ACTA, V384, P141, DOI 10.1016/j.cca.2007.07.006; Nir A, 2012, BIOMARK MED, V6, P827, DOI [10.2217/BMM.12.73, 10.2217/bmm.12.73]; Oechslin E, 2005, CIRCULATION, V112, P1106, DOI 10.1161/CIRCULATIONAHA.105.534073; Ohuchi H, 2004, CIRCULATION, V110, P2601, DOI 10.1161/01.CIR.0000145545.83564.51; Paulus WJ, 2004, AM J PHYSIOL-HEART C, V287, pH8, DOI 10.1152/ajpheart.01147.2003; Popelova JR, 2015, AM J CARDIOL, V116, P1425, DOI 10.1016/j.amjcard.2015.07.070; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; SHREENIWAS R, 1991, J CELL PHYSIOL, V146, P8, DOI 10.1002/jcp.1041460103; Tsutamoto T, 2006, J AM COLL CARDIOL, V47, P582, DOI 10.1016/j.jacc.2005.10.038; Tutarel O, 2013, INT J CARDIOL, V168, P4415, DOI 10.1016/j.ijcard.2013.05.030; Tutarel O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033795; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; WYATT HL, 1980, AM HEART J, V100, P821, DOI 10.1016/0002-8703(80)90062-9	30	5	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184333	10.1371/journal.pone.0184333	http://dx.doi.org/10.1371/journal.pone.0184333			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886170	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100098
J	Shimizu, T; Fujibayashi, S; Yamaguchi, S; Otsuki, B; Okuzu, Y; Matsushita, T; Kokubo, T; Matsuda, S				Shimizu, Takayoshi; Fujibayashi, Shunsuke; Yamaguchi, Seiji; Otsuki, Bungo; Okuzu, Yaichiro; Matsushita, Tomiharu; Kokubo, Tadashi; Matsuda, Shuichi			In vivo experimental study of anterior cervical fusion using bioactive polyetheretherketone in a canine model	PLOS ONE			English	Article							LUMBAR INTERBODY FUSION; FOLLOW-UP; TITANIUM; SPINE; ARTHRODESIS; IMPLANT; CAGES; DISKECTOMY; NONUNION	Background Polyetheretherketone (PEEK) is a widely accepted biomaterial, especially in the field of spinal surgery. However, PEEK is not able to directly integrate with bone tissue, due to its bioinertness. To overcome this drawback, various studies have described surface coating approaches aimed at increasing the bioactivity of PEEK surfaces. Among those, it has been shown that the recently developed sol-gel TiO2 coating could provide PEEK with the ability to bond with bone tissue in vivo without the use of a bone graft. Objective This in vivo experimental study using a canine model determined the efficacy of bioactive TiO2-coated PEEK for anterior cervical fusion. Methods Sol-gel-derived TiO2 coating, which involves sandblasting and acid treatment, was used to give PEEK bone-bonding ability. The cervical interbody spacer, which was designed to fit the disc space of a beagle, was fabricated using bioactive TiO2-coated PEEK. Both uncoated PEEK (control) and TiO2-coated PEEK spacers were implanted into the cervical intervertebral space of beagles (n = 5 for each type). After the 3-month survival period, interbody fusion success was evaluated based on mu-CT imaging, histology, and manual palpation analyses. Results Manual palpation analyses indicated a 60% (3/5 cases) fusion (no gap between bone and implants) rate for the TiO2-coated PEEK group, indicating clear advantage over the 0% (0/5 cases) fusion rate for the uncoated PEEK group. The bony fusion rate of the TiO2-coated PEEK group was 40% according to mu CT imaging; however, it was 0% of for the uncoated PEEK group. Additionally, the bone-implant contact ratio calculated using histomorphometry demonstrated a better contact ratio for the TiO2-coated PEEK group than for the uncoated PEEK group (mean, 32.6% vs 3.2%; p = 0.017). Conclusions The TiO2-coated bioactive PEEK implant demonstrated better fusion rates and bone-bonding ability than did the uncoated PEEK implant in the canine anterior cervical fusion model. Bioactive PEEK, which has bone-bonding ability, could contribute to further improvements in clinical outcomes for spinal interbody fusion.	[Shimizu, Takayoshi; Fujibayashi, Shunsuke; Otsuki, Bungo; Okuzu, Yaichiro; Matsuda, Shuichi] Kyoto Univ, Dept Orthoped Surg, Grad Sch Med, Kyoto, Japan; [Shimizu, Takayoshi] Columbia Univ, Med Ctr, Spine Hosp, New York Presbyterian Healthcare Syst, New York, NY USA; [Yamaguchi, Seiji; Matsushita, Tomiharu; Kokubo, Tadashi] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi, Japan	Kyoto University; Columbia University; NewYork-Presbyterian Hospital; Chubu University	Shimizu, T (corresponding author), Kyoto Univ, Dept Orthoped Surg, Grad Sch Med, Kyoto, Japan.; Shimizu, T (corresponding author), Columbia Univ, Med Ctr, Spine Hosp, New York Presbyterian Healthcare Syst, New York, NY USA.	takayosh@kuhp.kyoto-u.ac.jp	Matsushita, Tomiharu/AAG-2432-2021		DVM	DVM	We greatly appreciate the technical support of DVM. Masashi Imamura for animal treatment.	[Anonymous], 2014, 233172014 ISO; BAGBY GW, 1988, ORTHOPEDICS, V11, P931; Bishop RC, 1996, J NEUROSURG, V85, P206, DOI 10.3171/jns.1996.85.2.0206; BOHLMAN HH, 1993, J BONE JOINT SURG AM, V75A, P1298, DOI 10.2106/00004623-199309000-00005; Chen Y, 2008, J SPINAL DISORD TECH, V21, P489, DOI 10.1097/BSD.0b013e318158de22; COOK SD, 1994, SPINE, V19, P1856, DOI 10.1097/00007632-199408150-00011; Devine DM, 2013, J BIOMED MATER RES B, V101B, P591, DOI 10.1002/jbm.b.32861; Drespe IH, 2005, THE SPINE JOURNAL OF, V5, p209s; Fujibayashi S, 2012, SPINE, V37, pE1197, DOI 10.1097/BRS.0b013e31825d26d7; Johnson JA, 2011, VET SURG, V40, P720, DOI 10.1111/j.1532-950X.2011.00853.x; Kersten RFMR, 2015, SPINE J, V15, P1446, DOI 10.1016/j.spinee.2013.08.030; Khoury J, 2013, NUCL INSTRUM METH B, V307, P630, DOI 10.1016/j.nimb.2012.11.087; Kizuki T, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5359-1; Kurtz SM, 2007, BIOMATERIALS, V28, P4845, DOI 10.1016/j.biomaterials.2007.07.013; Kuslich SD, 1998, SPINE, V23, P1267, DOI 10.1097/00007632-199806010-00019; McAfee PC, 1999, J BONE JOINT SURG AM, V81A, P859, DOI 10.2106/00004623-199906000-00014; MOSDAL C, 1984, ACTA NEUROCHIR, V70, P207, DOI 10.1007/BF01406650; Olivares-Navarrete R, 2015, SPINE, V40, P399, DOI 10.1097/BRS.0000000000000778; Patsi ME, 1998, J SOL-GEL SCI TECHN, V11, P55, DOI 10.1023/A:1008684815735; Rokkum M, 2003, J BONE JOINT SURG BR, V85B, P440, DOI 10.1302/0301-620X.85B3.12834; SHIMA T, 1979, J NEUROSURG, V51, P533, DOI 10.3171/jns.1979.51.4.0533; Shimizu T, 2016, ACTA BIOMATER, V35, P305, DOI 10.1016/j.actbio.2016.02.007; SMITH GW, 1958, J BONE JOINT SURG AM, V40, P607, DOI 10.2106/00004623-195840030-00009; Takemoto M, 2007, J NEUROSURG-SPINE, V7, P435, DOI 10.3171/SPI-07/10/435; Tanida S, 2016, SPINE, V41, pE1216, DOI 10.1097/BRS.0000000000001605; Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011; Vadapalli S, 2006, SPINE, V31, P2189, DOI 10.1097/01.brs.0000232720.23748.ce; Walsh WR, 2015, SPINE J, V15, P1041, DOI 10.1016/j.spinee.2014.12.018; Weiner BK, 1998, SPINE, V23, P634, DOI 10.1097/00007632-199803010-00020; Wieling A. G. R., 2009, EUR CELLS MATER, V17, P10; Wu GM, 2009, SURF COAT TECH, V203, P2755, DOI 10.1016/j.surfcoat.2009.02.115; Zdeblick TA, 1997, J BONE JOINT SURG AM, V79A, P523, DOI 10.2106/00004623-199704000-00007	32	22	22	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184495	10.1371/journal.pone.0184495	http://dx.doi.org/10.1371/journal.pone.0184495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886118	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100139
J	Xu, WT; Chen, TM; Dong, XC; Kong, M; Lv, XZ; Li, L				Xu, Wenti; Chen, Tianmu; Dong, Xiaochun; Kong, Mei; Lv, Xiuzhi; Li, Lin			Outbreak detection and evaluation of a school-based influenza-like-illness syndromic surveillance in Tianjin, China	PLOS ONE			English	Article							TRANSMISSION; CHANGSHA; DISEASE; VIRUS	School-based influenza-like-illness (ILI) syndromic surveillance can be an important part of influenza community surveillance by providing early warnings for outbreaks and leading to a fast response. From September 2012 to December 2014, syndromic surveillance of ILI was carried out in 4 county-level schools. The cumulative sum methods(CUSUM) was used to detect abnormal signals. A susceptible-exposed-infectious/asymptomatic-recovered (SEIAR) model was fit to the influenza outbreak without control measures and compared with the actual influenza outbreak to evaluate the effectiveness of early control efforts. The ILI incidence rates in 2014 (14.51%) was higher than the incidence in 2013 (5.27%) and 2012 (3.59%). Ten school influenza outbreaks were detected by CUSUM. Each outbreak had high transmissibility with a median R-unc of 4.62. The interventions in each outbreak had high effectiveness and all R-con were 0. The early intervention had high effectiveness within the school-based ILI syndromic surveillance. Syndromic surveillance within schools can play an important role in controlling influenza outbreaks.	[Xu, Wenti; Dong, Xiaochun; Kong, Mei; Li, Lin] Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China; [Chen, Tianmu] Changsha Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Lv, Xiuzhi] Hangu Ctr Dis Control & Prevent, Tianjin, Peoples R China	Tianjin Center for Disease Control & Prevention	Xu, WT (corresponding author), Tianjin Ctr Dis Control & Prevent, Tianjin, Peoples R China.	wenti_xwt@163.com			Tianjin Health and Family Planning Commission [2009kz043]	Tianjin Health and Family Planning Commission	This work was supported by Tianjin Health and Family Planning Commission (Research Grant number 2009kz043): http://www.tjwsj.gov.cn/html/wsjn/portal/index/index.htm. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Burkom HS, 2004, MMWR-MORBID M      S, V53, pS67; Chan TC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1500-4; Chen SC, 2013, EPIDEMIOL INFECT, V141, P2581, DOI 10.1017/S0950268813000423; Chen SL, 2017, EPIDEMIOL INFECT, V145, P368, DOI 10.1017/S0950268816002338; Chen TM, 2017, EPIDEMIOL INFECT, V145, P424, DOI [10.1017/S0950268816002508, 10.1017/s0950268816002508]; Chen TM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3716-3; Chen TM, 2014, TRAVEL MED INFECT DI, V12, P650, DOI 10.1016/j.tmaid.2014.10.015; Chen TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095006; Crowe S, 2015, MMWR-MORBID MORTAL W, V64, P70; Fan YZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112255; Hiller KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073832; Hutwagner L, 2005, EMERG INFECT DIS, V11, P314, DOI 10.3201/eid1102.040587; Lamunu M, 2004, INT J INFECT DIS, V8, P27, DOI 10.1016/j.ijid.2003.04.001; Li J, 2015, INT J INFECT DIS, V40, P17, DOI 10.1016/j.ijid.2015.09.013; Liu CD, 2016, 2016 INTERNATIONAL CONFERENCE ON COMPUTER ENGINEERING, INFORMATION SCIENCE AND INTERNET TECHNOLOGY (CII 2016), P111; Liu RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132588; Lober William B, 2014, Online J Public Health Inform, V5, P224, DOI 10.5210/ojphi.v5i3.4938; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; May L, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-242; Miller B, 2004, EMERG INFECT DIS, V10, P1806, DOI 10.3201/eid1010.030789; Nelesone T, 2006, TROP MED INT HEALTH, V11, P17, DOI 10.1111/j.1365-3156.2005.01534.x; Paterson BJ, 2013, J EPIDEMIOL GLOB HEA, V3, P41, DOI 10.1016/j.jegh.2012.12.005; Rosenkotter N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-905; Siegrist David, 2004, MMWR Suppl, V53, P152; Tan L, 2014, PUBLIC HEALTH, V128, P792, DOI 10.1016/j.puhe.2014.06.004; Timpka T, 2014, EUROSURVEILLANCE, V19, P24, DOI 10.2807/1560-7917.ES2014.19.46.20966	27	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184527	10.1371/journal.pone.0184527	http://dx.doi.org/10.1371/journal.pone.0184527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886143	Green Submitted, gold, Green Published			2022-12-27	WOS:000410001100147
J	Ikari, J; Nelson, AJ; Obaid, J; Giron-Martinez, A; Ikari, K; Makino, F; Iwasawa, S; Gunji, Y; Farid, M; Wang, XQ; Basma, H; Demeo, D; Feghali-Bostwick, C; Holz, O; Rabe, K; Liu, XD; Rennard, SI				Ikari, Jun; Nelson, Amy J.; Obaid, Jannah; Giron-Martinez, Alvaro; Ikari, Kumiko; Makino, Fumihiko; Iwasawa, Shunichiro; Gunji, Yoko; Farid, Maha; Wang, Xingqi; Basma, Hesham; Demeo, Dawn; Feghali-Bostwick, Carol; Holz, Olaf; Rabe, Klaus; Liu, Xiangde; Rennard, Stephen I.			Reduced microRNA-503 expression augments lung fibroblast VEGF production in chronic obstructive pulmonary disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROSTAGLANDIN E-2; E-PROSTANOID-2 RECEPTOR; CIGARETTE-SMOKE; EMPHYSEMA; COPD; ANGIOGENESIS; MECHANISMS; ASTHMA; INFLAMMATION	Alterations in microRNA (miRNA) expression may contribute to COPD pathogenesis. In COPD, lung fibroblast repair functions are altered in multiple ways, including extracellular mediator release. Our prior study revealed miR-503 expression is decreased in COPD lung fibroblasts, although the exact role played by miR-503 is undetermined. The current study examined a role of miR-503 in cytokine, growth factor and fibronectin production by lung fibroblasts from patients with and without COPD. Primary adult lung fibroblasts were isolated from patients with or without COPD. MiR-503 expression and interleukin (IL)-6, -8, PGE(2), HGF, KGF, VEGF and fibronectin release were examined with or without inflammatory cytokines, IL-1 beta and tumor necrosis factor (TNF)-alpha. MiR-503 expression was decreased in COPD lung fibroblasts. The expression of miR-503 was positively correlated with %FVC, % FEV1, and % DLco as well as IL-6, -8, PGE(2), HGF, KGF, and VEGF in the absence or presence of IL-1 beta/TNF-alpha. In addition, IL-8 and VEGF release from COPD lung fibroblasts were increased compared to those from control. Exogenous miR-503 inhibited VEGF release from primary adult and fetal lung fibroblasts but not IL-8 release. As expected, COPD fibroblasts proliferated more slowly than control fibroblasts. MiR-503 did not affect proliferation of either control or COPD lung fibroblasts. MiR-503 inhibition of VEGF protein production and mRNA was mediated by direct binding to the 3' untranslated region of VEGF mRNA. Endogenous miR-503 was differently regulated by exogenous stimulants associated with COPD pathogenesis, including IL-1 beta/TNF-alpha, TGF-beta 1 and PGE(2). Endogenous miR-503 inhibition augmented VEGF release by IL-1 beta/TNF-alpha and TGF-beta 1 but not by PGE(2), demonstrating selectivity of miR-503 regulation of VEGF. In conclusions, reduced miR-503 augments VEGF release from lung fibroblasts from patients with COPD.	[Ikari, Jun; Nelson, Amy J.; Obaid, Jannah; Giron-Martinez, Alvaro; Ikari, Kumiko; Makino, Fumihiko; Iwasawa, Shunichiro; Gunji, Yoko; Farid, Maha; Wang, Xingqi; Basma, Hesham; Liu, Xiangde; Rennard, Stephen I.] Univ Nebraska Med Ctr, Pulm Crit Care Sleep & Allergy Med, Omaha, NE 68198 USA; [Ikari, Jun] Chiba Univ, Grad Sch Med, Respirol, Chiba, Japan; [Demeo, Dawn] Harvard Med Sch, Channing Lab, Boston, MA USA; [Feghali-Bostwick, Carol] Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC USA; [Holz, Olaf] Fraunhofer ITEM, Hannover, Germany; [Holz, Olaf] BREATH, German Ctr Lung Res DZL, Hannover, Germany; [Rabe, Klaus] Lungen Clin Grosshansdorf, ARCN, Grosshansdorf, Germany; [Rabe, Klaus] German Ctr Lung Res, Grosshansdorf, Germany	University of Nebraska System; University of Nebraska Medical Center; Chiba University; Harvard University; Harvard Medical School; Medical University of South Carolina; Grosshansdorf Hospital	Rennard, SI (corresponding author), Univ Nebraska Med Ctr, Pulm Crit Care Sleep & Allergy Med, Omaha, NE 68198 USA.	srennard@unmc.edu	Farid, Maha Mohamed AlAzab Hassan/HDO-0741-2022; Rabe, Klaus F./AAW-6296-2021	Farid, Maha Mohamed AlAzab Hassan/0000-0002-7692-1661; Rabe, Klaus F./0000-0002-7020-1401	AstraZeneca	AstraZeneca(AstraZeneca)	During the completion of this work, Dr. Rennard was an employee of AstraZeneca, which thus provided support financial support in the form of salary, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Angulo M, 2012, ARCH BRONCONEUMOL, V48, P325, DOI 10.1016/j.arbres.2012.04.011; Annoni R, 2012, EUR RESPIR J, V40, P1362, DOI 10.1183/09031936.00192611; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Barnes PJ, 2015, J ALLERGY CLIN IMMUN, V136, P531, DOI 10.1016/j.jaci.2015.05.052; Barnes PJ, 2014, CHEST, V146, P1135, DOI 10.1378/chest.14-1194; Birk DM, 2008, VASC ENDOVASC SURG, V42, P517, DOI 10.1177/1538574408322755; Caporali A, 2011, TRENDS CARDIOVAS MED, V21, P162, DOI 10.1016/j.tcm.2012.05.003; Chen Y, 2008, RESPIROLOGY, V13, P1014, DOI 10.1111/j.1440-1843.2008.01365.x; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Dagouassat M, 2013, AM J RESP CRIT CARE, V187, P703, DOI 10.1164/rccm.201208-1361OC; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Horowitz JC, 2009, COPD, V6, P201, DOI 10.1080/15412550902905953; Ikari J, 2015, IN VITRO CELL DEV-AN, V51, P390, DOI 10.1007/s11626-014-9820-8; Ikari J, 2013, AM J RESP CELL MOL, V49, P571, DOI 10.1165/rcmb.2013-0004OC; Izzotti A, 2009, FASEB J, V23, P3243, DOI 10.1096/fj.09-135251; Kamio K, 2008, AM J PHYSIOL-LUNG C, V294, pL1226, DOI 10.1152/ajplung.00129.2007; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040; Kobayashi T, 2005, BIOCHEM BIOPH RES CO, V327, P393, DOI 10.1016/j.bbrc.2004.12.032; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Kranenburg AR, 2005, THORAX, V60, P106, DOI 10.1136/thx.2004.023986; Montuschi P, 2003, THORAX, V58, P585, DOI 10.1136/thorax.58.7.585; Nakanishi M, 2012, AM J RESP CELL MOL, V46, P217, DOI 10.1165/rcmb.2010-0115OC; Nana-Sinkam SP, 2009, AM J RESP CRIT CARE, V179, P4, DOI 10.1164/rccm.200807-1042PP; Plantier Laurent, 2007, Int J Chron Obstruct Pulmon Dis, V2, P463; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; Profita M, 2010, AM J PHYSIOL-LUNG C, V298, pL261, DOI 10.1152/ajplung.90593.2008; Puxeddu I, 2005, J ALLERGY CLIN IMMUN, V116, P531, DOI 10.1016/j.jaci.2005.06.007; Rennard Stephen I, 2011, Pneumonol Alergol Pol, V79, P132; Rupani H, 2013, EUR RESPIR J, V41, P695, DOI 10.1183/09031936.00212011; Santos S, 2003, AM J RESP CRIT CARE, V167, P1250, DOI 10.1164/rccm.200210-1233OC; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Schanen BC, 2011, GENOMICS, V97, P1, DOI 10.1016/j.ygeno.2010.10.005; Togo S, 2008, AM J RESP CRIT CARE, V178, P248, DOI 10.1164/rccm.200706-929OC; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P673, DOI 10.1513/pats.200605-124SF; Van Pottelberge GR, 2011, AM J RESP CRIT CARE, V183, P898, DOI 10.1164/rccm.201002-0304OC; Wen FQ, 2003, J ALLERGY CLIN IMMUN, V111, P1307, DOI 10.1067/mai.2003.1455; White ES, 2005, AM J RESP CELL MOL, V32, P135, DOI 10.1165/rcmb.2004-0126OC; Yin KJ, 2012, J BIOL CHEM, V287, P27055, DOI 10.1074/jbc.M112.364414; Zhou BS, 2013, CANCER LETT, V333, P159, DOI 10.1016/j.canlet.2013.01.028	46	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184039	10.1371/journal.pone.0184039	http://dx.doi.org/10.1371/journal.pone.0184039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880936	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200030
J	Matthews, LT; Burns, BF; Bajunirwe, F; Kabakyenga, J; Bwana, M; Ng, C; Kastner, J; Kembabazi, A; Sanyu, N; Kusasira, A; Haberer, JE; Bangsberg, DR; Kaida, A				Matthews, Lynn T.; Burns, Bridget F.; Bajunirwe, Francis; Kabakyenga, Jerome; Bwana, Mwebesa; Ng, Courtney; Kastner, Jasmine; Kembabazi, Annet; Sanyu, Naomi; Kusasira, Adrine; Haberer, Jessica E.; Bangsberg, David R.; Kaida, Angela			Beyond HIV-serodiscordance: Partnership communication dynamics that affect engagement in safer conception care	PLOS ONE			English	Article							ANTIRETROVIRAL PREEXPOSURE PROPHYLAXIS; REPRODUCTIVE HEALTH-SERVICES; RANDOMIZED CONTROLLED-TRIAL; DISCORDANT COUPLES; SEROSTATUS DISCLOSURE; RELATIONSHIP CONTEXT; CONTRACEPTIVE USE; FERTILITY DESIRE; DECISION-MAKING; RISK REDUCTION	Introduction We explored acceptability and feasibility of safer conception methods among HIV-affected couples in Uganda. Methods We recruited HIV-positive men and women on antiretroviral therapy (ART) ('index') from the Uganda Antiretroviral Rural Treatment Outcomes cohort who reported an HIV-negative or unknown-serostatus partner ('partner'), HIV-serostatus disclosure to partner, and personal or partner desire for a child within two years. We conducted in-depth interviews with 40 individuals from 20 couples, using a narrative approach with tailored images to assess acceptability of five safer conception strategies: ART for the infected partner, pre-exposure prophylaxis (PrEP) for the uninfected partner, condomless sex timed to peak fertility, manual insemination, and male circumcision. Translated and transcribed data were analyzed using thematic analysis. Results 11/20 index participants were women, median age of 32.5 years, median of 2 living children, and 80% had HIV-RNA < 400 copies/mL. Awareness of HIV prevention strategies beyond condoms and abstinence was limited and precluded opportunity to explore or validly assess acceptability or feasibility of safer conception methods. Four key partnership communication challenges emerged as primary barriers to engagement in safer conception care, including: (1) HIV-serostatus disclosure: Although disclosure was an inclusion criterion, partners commonly reported not knowing the index partner's HIV status. Similarly, the partner's HIV- serostatus, as reported by the index, was frequently inaccurate. (2) Childbearing intention: Many couples had divergent childbearing intentions and made incorrect assumptions about their partner's desires. (3) HIV risk perception: Participants had disparate understandings of HIV transmission and disagreed on the acceptable level of HIV risk to meet reproductive goals. (4) Partnership commitment: Participants revealed significant discord in perceptions of partnership commitment. All four types of partnership miscommunication introduced constraints to autonomous reproductive decision-making, particularly for women. Such miscommunication was common, as only 2 of 20 partnerships in our sample were mutuallydisclosed with agreement across all four communication themes. Conclusions Enthusiasm for safer conception programming is growing. Our findings highlight the importance of addressing gendered partnership communication regarding HIV disclosure, reproductive goals, acceptable HIV risk, and commitment, alongside technical safer conception advice. Failing to consider partnership dynamics across these domains risks limiting reach, uptake, adherence to, and retention in safer conception programming.	[Matthews, Lynn T.; Burns, Bridget F.; Haberer, Jessica E.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Matthews, Lynn T.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Bajunirwe, Francis; Kabakyenga, Jerome; Bwana, Mwebesa; Kembabazi, Annet; Sanyu, Naomi; Kusasira, Adrine] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Ng, Courtney] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Kastner, Jasmine] McGill Univ, Hlth Ctr, Res Inst, Montreal, PQ, Canada; [Haberer, Jessica E.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Bangsberg, David R.] OHSU PSU Sch Publ Hlth, Portland, OR USA; [Kaida, Angela] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Mbarara University of Science & Technology; Harvard University; Harvard T.H. Chan School of Public Health; McGill University; Harvard University; Massachusetts General Hospital; Simon Fraser University	Matthews, LT (corresponding author), Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA.; Matthews, LT (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.	ltmatthews@mgh.harvard.edu	Haberer, Jessica/AAH-7976-2019	Haberer, Jessica/0000-0001-5845-3190	NIH/NICHD [R21-HD069194]; NIH/NIMH [R01-MH54907]; Canada Sub-Saharan Africa AIDS Network; Sullivan Family Foundation;  [K-23 MH095655];  [K-24 MH87227]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Canada Sub-Saharan Africa AIDS Network; Sullivan Family Foundation; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by NIH/NICHD R21-HD069194 (Kaida), NIH/NIMH R01-MH54907 (Bangsberg), and the Canada Sub-Saharan Africa AIDS Network (Bajunirwe). The work was also supported by K-23 MH095655 (Matthews), K-24 MH87227 (Bangsberg), and the Sullivan Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia IB, 1999, J WOMEN HEALTH GEN-B, V8, P587, DOI 10.1089/jwh.1.1999.8.587; ALLAN G, 1980, J MARRIAGE FAM, V42, P205, DOI 10.2307/351948; Allen S, 2003, AIDS, V17, P733, DOI 10.1097/00002030-200303280-00012; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Barker G, 2010, GLOB PUBLIC HEALTH, V5, P539, DOI 10.1080/17441690902942464; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Bhatia D, 2017, FRONTIERS P IN PRESS; Bott S, 2013, SAHARA J-J SOC ASP H, V10, pS5, DOI 10.1080/02664763.2012.755319; Brubaker SG, 2011, HIV MED, V12, P316, DOI 10.1111/j.1468-1293.2010.00884.x; Campbell JI, 2016, J GEN INTERN MED, V31, P338, DOI 10.1007/s11606-015-3502-4; Cohen MS, 2011, N ENGL J MED; Colombini M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20766; Conroy AA, 2016, SOC SCI MED, V153, P1, DOI 10.1016/j.socscimed.2016.01.035; Conroy AA, 2015, SOC SCI MED, V144, P28, DOI 10.1016/j.socscimed.2015.09.007; Crankshaw TL, 2016, SOC SCI MED, V166, P169, DOI 10.1016/j.socscimed.2016.08.020; Crankshaw Tamaryn L, 2012, Reprod Health Matters, V20, P50, DOI 10.1016/S0968-8080(12)39639-0; Crankshaw TL, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18832; Darbes LA, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-64; Drake AL, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001608; Dyer S, 2008, HUM REPROD, V23, P352, DOI 10.1093/humrep/dem279; Goggin K, 2015, AIDS PATIENT CARE ST, V29, P651, DOI 10.1089/apc.2015.0089; Grabbe K, 2009, J WOMENS HEALTH, V18, P1449, DOI 10.1089/jwh.2008.1160; Greig A, 2008, GENDER AIDS TIME ACT, V22, pS35; GROSSKURTH H, 1995, LANCET, V346, P530, DOI 10.1016/S0140-6736(95)91380-7; Guthrie BL, 2010, AIDS BEHAV, V14, P1066, DOI 10.1007/s10461-010-9716-x; Heffron R, 2016, CURR HIV AIDS REP; Heffron R, 2016, PREP ART REDUCE HIV; Hertz R., 1995, QUALITATIVE INQUIRY, V1; Higgins JA, 2014, AM J PUBLIC HEALTH, V104, P612, DOI 10.2105/AJPH.2013.301670; Homsy J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004149; Jiwatram-Negron T, 2014, AIDS BEHAV, V18, P1864, DOI 10.1007/s10461-014-0827-7; Kaida A, 2016, HIGH PLANNED PARTNER; Kaida A, 2014, AIDS RES HUM RETROV, V30, pA61, DOI 10.1089/aid.2014.5110.abstract; Kastner J, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/626120; Kennedy CE, 2015, J INT AIDS SOC, V18, P74, DOI 10.7448/IAS.18.6.20292; Khidir H, 2017, AIDS BEHAV; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; Lewis MA, 2006, SOC SCI MED, V62, P1369, DOI 10.1016/j.socscimed.2005.08.006; Maier M, 2009, AIDS BEHAV, V13, pS28, DOI 10.1007/s10461-008-9371-7; Marston M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151877; Matovu JKB, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0272-3; Matthews LT, 2015, AIDS BEHAV, V19, P1666, DOI 10.1007/s10461-015-1026-x; Matthews LT, 2017, AIDS BEHAV; Matthews LT, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4195762; Matthews LT, 2014, JAIDS-J ACQ IMM DEF, V67, pS210, DOI 10.1097/QAI.0000000000000374; Matthews LT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-843; Matthews LT, 2013, AIDS BEHAV, V17, P461, DOI 10.1007/s10461-011-0068-y; Matthews LT, 2009, AIDS BEHAV, V13, pS5, DOI 10.1007/s10461-009-9551-0; Medley A, 2004, B WORLD HEALTH ORGAN, V82, P299; Mmeje O, 2016, HIV INFERTILITY PRAG; Mmeje O, 2016, AIDS CARE, V28, P750, DOI 10.1080/09540121.2016.1153592; Mmeje O, 2015, AIDS CARE, V27, P10, DOI 10.1080/09540121.2014.946385; Muhindo R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2526-3; Musinguzi N, 2017, AIDS BEHAV, V21, P1735, DOI 10.1007/s10461-016-1447-1; Myer L, 2007, AIDS PATIENT CARE ST, V21, P278, DOI 10.1089/apc.2006.0108; Nakayiwa S, 2006, AIDS BEHAV, V10, pS95, DOI 10.1007/s10461-006-9126-2; Ngure K, 2016, AIDS PATIENT CARE ST, V30, P78, DOI 10.1089/apc.2015.0259; Nieves CI, 2015, CONTRACEPTION, V92, P152, DOI 10.1016/j.contraception.2015.04.011; NORMAN GR, 1992, ACAD MED, V67, P557, DOI 10.1097/00001888-199209000-00002; Obermeyer CM, 2011, AM J PUBLIC HEALTH, V101, P1011, DOI 10.2105/AJPH.2010.300102; Phiri S, 2016, J FAM PLAN REPROD H, V42, P17, DOI 10.1136/jfprhc-2013-100816; Pintye J, 2015, AIDS PATIENT CARE ST, V29, P510, DOI 10.1089/apc.2015.0063; Rao A, 2016, FUTURE PREGNANCY INT; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; SCHWARTZ S, 2011, AIDS BEHAV; Schwartz SR, 2014, AIDS, V28, pS277, DOI 10.1097/QAD.0000000000000330; Schwartz SR, 2015, INT J STD AIDS; Siegfried N, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003362.pub2; Stephenson R, 2011, J WOMENS HEALTH, V20, P567, DOI 10.1089/jwh.2010.2113; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Ugandan Ministry of Health, 2016, CONS GUID PREV TRAEA; Ujiji OA, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-13; Vernazza PL, 2011, AIDS, V25, P2005, DOI 10.1097/QAD.0b013e32834a36d0; Wall KM, 2017, SEX TRANSM INFECT, V93, P259, DOI 10.1136/sextrans-2016-052743; Wanyenze RK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-98; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; Wawer MJ, 1998, AIDS, V12, P1211, DOI 10.1097/00002030-199810000-00014; West N, 2016, AIDS CARE, V28, P390, DOI 10.1080/09540121.2015.1093596; Whetham J, 2014, AIDS CARE, V26, P332, DOI 10.1080/09540121.2013.819406; WHO (World Health Organization), 2010, POL APPR ENG MEN BOY; World Health Organization, 2009, INT GEND HIV AIDS PR; World Health Organization, 2007, ENG MEN BOYS CHANG G; World Health Organization, 2012, GUID OR PREEXP PROPH; Zafer M, 2016, FERTIL STERIL, V105, P645, DOI 10.1016/j.fertnstert.2015.11.028	84	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183131	10.1371/journal.pone.0183131	http://dx.doi.org/10.1371/journal.pone.0183131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880892	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200014
J	Theisen, S; Palm, HW; Al-Jufaili, SH; Kleinertz, S				Theisen, Stefan; Palm, Harry W.; Al-Jufaili, Sarah H.; Kleinertz, Sonja			Pseudempleurosoma haywardi sp nov (Monogenea: Ancyrocephalidae (sensu lato) Bychowsky & Nagibina, 1968): An endoparasite of croakers (Teleostei: Sciaenidae) from Indonesia	PLOS ONE			English	Article							URINARY-BLADDER; BRAZIL; DACTYLOGYRIDAE; CICHLIDAE; COAST	An endoparasitic monogenean was identified for the first time from Indonesia. The oesophagus and anterior stomach of the croakers Nibea soldado (Lacepede) and Otolithes ruber (Bloch & Schneider) (n = 35 each) sampled from the South Java coast in May 2011 and Johnius amblycephalus (Bleeker) (n = 2) (all Sciaenidae) from Kedonganan fish market, South Bali coast, in November 2016, were infected with Pseudempleurosoma haywardi sp. nov. Prevalences in the first two croakers were 63% and 46%, respectively, and the two J. amblycephalus harboured three and five individuals. All three croakers represent new hosts for this monogenean genus. We provide infection rates, light microscopical observations, 3D confocal microscopical illustrations, and a morphometric comparison with all congeners. The new species differs in body size, the position and shape of the ovary and testes, and especially in the composition of the dorsal anchor complex, with the dorsal bar being anteriorly concave rather than planar or convex as in its congeners. The dorsal and ventral anchors of this new species are the longest in the genus, whereas the male copulatory organ is the smallest. The first DNA sequences for a member of this genus demonstrate the greatest similarity with endoparasitic freshwater monogeneans from African cichlid fishes. This suggests a freshwater origin for these marine endoparasitic monogeneans.	[Theisen, Stefan; Palm, Harry W.; Al-Jufaili, Sarah H.; Kleinertz, Sonja] Univ Rostock, Aquaculture & Sea Ranching, Rostock, Germany; [Palm, Harry W.] Udayana Univ, Ctr Studies Anim Dis, Badung Denpasar, Badung Denpasar, Bali, Indonesia; [Al-Jufaili, Sarah H.] Minist Agr & Fisheries Wealth, Fishery Qual Control Ctr, Lab Microbiol Anal, Al Bustan, Oman	University of Rostock; Universitas Udayana	Theisen, S (corresponding author), Univ Rostock, Aquaculture & Sea Ranching, Rostock, Germany.	Stefan.Theisen@uni-rostock.de			German Academic Exchange Service (DAAD); HIBAH competitive grant; German Federal Ministry for Education and Science (BMBF) [03F0641D]; Deutsche Forschungsgemeinschaft (DFG)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); HIBAH competitive grant; German Federal Ministry for Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by a two year Ph.D. scholarship (ST) from the German Academic Exchange Service (DAAD (https://www.daad.de/en/), budgetary title: 332 4 04 101, code digit: D/09/48018), and the HIBAH competitive grant. Financial support was also provided by the German Federal Ministry for Education and Science (BMBF [https://www.bmbf.de/en/index.html], Grant No. 03F0641D) (SK, HWP) within the framework of the joint Indonesian-German research program SPICE III-MABICO (Science for the Protection of Indonesian Coastal Marine Ecosystems). Open access article processing charge was paid by the open access publication fund of Rostock University, funded by the Deutsche Forschungsgemeinschaft (DFG).	Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Bychowsky B. E, 1970, Parazitologiya, V4, P451; Cepeda PB, 2011, ACTA PARASITOL, V56, P270, DOI 10.2478/s11686-011-0055-5; Cribb TH, 2002, INT J PARASITOL, V32, P321, DOI 10.1016/S0020-7519(01)00333-2; de Carvalho Adriano Reder, 2012, Acta Scientiarum Biological Sciences, V34, P359, DOI 10.4025/actascibiolsci.v34i3.10360; Froese R, FISHBASE WORLD WIDE; Galli P, 2006, J PARASITOL, V92, P395, DOI 10.1645/GE-3544RN.1; Gerasev P.I., 1987, Parazitologicheskii Sbornik, V34, P192; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hayward CJ, 1997, FOLIA PARASIT, V44, P173; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Madanire-Moyo GN, 2015, AFR ZOOL, V50, P175, DOI 10.1080/15627020.2015.1048729; Marchiori NC, 2015, FOLIA PARASIT, V62; Mendlova M, 2010, PARASITOL RES, V107, P1405, DOI 10.1007/s00436-010-2008-6; Mendoza-Franco EF, 2011, J PARASITOL, V97, P1020, DOI 10.1645/GE-2727.1; Nematoda Riemann F., 1988, INTRO STUDY MEIOFAUN, P293; Nguyen V. P., 2011, THESIS; PALM H.W., 2014, MARINE FISH PARASITO; Rehulkova A E, 2009, 6 INT S MON; Reimer L., 1990, WISSENSCHAFTLICHE Z, V1, P27; Santos CP, 2001, MEM I OSWALDO CRUZ, V96, P215, DOI 10.1590/S0074-02762001000200013; Stunkard H. W., 1924, Parasitology Cambridge, V16, P436, DOI 10.1017/S0031182000020333; VAUCHER C, 1990, J PARASITOL, V76, P501, DOI 10.2307/3282828; Whittington I. D., 2008, Fish diseases, Volume 2, P683; Wu XY, 2005, FOLIA PARASIT, V52, P231, DOI 10.14411/fp.2005.031; YAMAGUTI SATYU, 1965, PACIFIC SCI, V19, P55	26	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184376	10.1371/journal.pone.0184376	http://dx.doi.org/10.1371/journal.pone.0184376			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880928	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200061
J	Yang, SJ; Yang, C; Liao, Q; Zhai, WW; Yu, G; Xiao, L; Wang, QX; Gong, YH; Zhang, SH; Yao, YN; Wang, K; Wang, J; Bian, SC; Liu, Q				Yang, Shujuan; Yang, Chao; Liao, Qiang; Zhai, Wenwen; Yu, Gang; Xiao, Lin; Wang, Qixing; Gong, Yuhan; Zhang, Suhua; Yao, Yongna; Wang, Ke; Wang, Ju; Bian, Shaochao; Liu, Qian			Analysis of HIV prevalence among pregnant women in Liangshan Prefecture, China, from 2009 to 2015	PLOS ONE			English	Article							INJECTION-DRUG USERS; SICHUAN PROVINCE	Background Yi people make up about 50% of the population in Liangshan Prefecture, Sichuan Province, China, but accounted for 88.07% of new HIV cases in the prefecture from 2011 to 2013. This study evaluated HIV prevalence in pregnant women of Liangshan Prefecture using HIV sentinel surveillance (HSS) data over the period of 2009 to 2015. Methods Xichang, Zhaojue County, and Butuo County were selected as HSS sites. We investigated the temporal trends in HIV prevalence in these areas, and the association between demographic and behavioral characteristics and risk of HIV infection. Results Data on a total of 2797 pregnant women in Xichang and 3983 pregnant women in Zhaojue and Butuo was collected for the period 2009 to 2015. There was a fluctuating HIV prevalence among pregnant women of Xichang, with a rate of 0.75% in 2015 (chi(2) (trend) = 2.27, P = 0.13). HIV prevalence among pregnant women of Zhaojue and Butuo was consistently high, varying between 3.4% (9/267, 2011) and 10.3% (82/796, 2012) over the period of 2010 to 2015 (chi(2) (trend) = 0.12, P = 0.73). In Xichang, we found that Yi ethnicity (OR = 11.37, 95% CI = 2.92-44.25) and a husband who used drugs (OR = 32.13, 95% CI = 5.33-193.67) were significantly associated with HIV risk in pregnant women. For Zhaojue and Butuo, we observed that pregnant women had a higher risk of HIV infection when they were over 30 years old (OR = 1.72, 95% CI = 1.17-2.52), when they had a higher number of previous births, when their husbands had a history of migrating for work (OR = 1.56, 95% CI = 1.16- 2.08),and when they had a history of other sexually transmitted infections (OR = 2.19, 95% CI = 1.16-2.08). Compared to those with a primary school education or below, pregnant women with a secondary or high school education level had a lower risk of HIV infection (OR = 0.28, 95% CI = 0.09-0.89). Conclusion Our results indicate that there is a serious HIV epidemic among pregnant Yi women, especially for those with less education, more past births, or a husband with a history of out-migrating for work or STD infection.	[Yang, Shujuan; Zhai, Wenwen; Zhang, Suhua; Yao, Yongna] Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Related Social & Behav Sci, Chengdu, Sichuan, Peoples R China; [Yang, Chao] Southwest Med Univ, Sch Publ Hlth, Dept Epidemiol & Stat, Luzhou, Peoples R China; [Liao, Qiang; Yu, Gang; Xiao, Lin; Wang, Qixing; Gong, Yuhan; Wang, Ke; Wang, Ju; Bian, Shaochao; Liu, Qian] Liangshan Prefecture Ctr Dis Control & Prevent, Xichang, Peoples R China	Sichuan University; Southwest Medical University	Yang, SJ (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Hlth Related Social & Behav Sci, Chengdu, Sichuan, Peoples R China.	rekiny@126.com			Liangshan HIV/AIDS Prevention project [H161236]; Health and Family Planning Commission of Sichuan Province [16PJ259]; Evaluation Model of AIDS Infections in Liangshan Prefecture [2014LSCDC002]	Liangshan HIV/AIDS Prevention project; Health and Family Planning Commission of Sichuan Province; Evaluation Model of AIDS Infections in Liangshan Prefecture	This research was supported by grant funding from the Liangshan HIV/AIDS Prevention project (H161236), the Health and Family Planning Commission of Sichuan Province (16PJ259) and the Evaluation Model of AIDS Infections in Liangshan Prefecture (2014LSCDC002).	CDC LP, 2008, SURV REP HIV AIDS LI; Chen LanXin, 2013, China Tropical Medicine, V13, P1323; China. MoHotPsRo UNAIDS WHO, 2012, CHINESE J AIDS STD, V18, P1; Dai W, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2385-y; Gong Y., 2014, CHINESE J DIS CONTRO, V18, P1132; Li L, 2015, AIDS RES HUM RETROV, V31, P479, DOI [10.1089/AID.2014.0120, 10.1089/aid.2014.0120]; Liang L, 2013, J PREV MED INF, V29, P453; Liu G, 2002, J PREV MED INF, V18, P211; Liu L, 2014, CHIN J DIS CONTROL P, V18, P702; Lu Juan, 2012, Bulletin of Disease Control and Prevention, V27, P6; Man ZK, 2013, EXPLORING ED DEV, P33; Qumu A., STUDY PROBLEM POVERT; Ruan YH, 2005, JAIDS-J ACQ IMM DEF, V39, P459, DOI 10.1097/01.qai.0000152398.47025.0f; Ruan YH, 2004, SEX TRANSM DIS, V31, P623; Tang XJ, 2014, CHIN J AIDS STD, V20, P176; Tuan Z, 2016, CHIN J AIDS STD, V22, P917; Wang Lan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P20; Wang Q., 2008, CHIN J AIDS STD, V14, P351; Wu H., 2009, J PREVENTION MED INF, V25, P638; Wu Z, 1999, GLOB RES NETW M HIV; Yang C, 2010, SEX TRANSM INFECT, V86, P559, DOI 10.1136/sti.2009.041731; Yang SJ, 2017, CHINESE J AIDS STD, V23, P271, DOI DOI 10.13419/J.CNKI.AIDS.2017.03.28; Yang Y, 2011, MED SOC, V24, P41; Zhang S H, 2017, Zhonghua Liu Xing Bing Xue Za Zhi, V38, P486, DOI 10.3760/cma.j.issn.0254-6450.2017.04.015; Zhao HY, 2015, CHIN J DERM VENEREOL, V29, P1265; Zhao J, 2011, LIFE SCI J, V8, P27; Zhou RN, 2012, OPEN TIMES, V2, P145; Zhou Y, 2012, CHIN J AIDS STD, V18, P319; Zhou YB, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0073-x; Zhou YB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-134	30	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183418	10.1371/journal.pone.0183418	http://dx.doi.org/10.1371/journal.pone.0183418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880917	Green Submitted, gold, Green Published			2022-12-27	WOS:000409467200017
J	Wroblewska-Seniuk, K; Greczka, G; Dabrowski, P; Szyfter-Harris, J; Mazela, J				Wroblewska-Seniuk, Katarzyna; Greczka, Grazyna; Dabrowski, Piotr; Szyfter-Harris, Joanna; Mazela, Jan			Hearing impairment in premature newborns-Analysis based on the national hearing screening database in Poland	PLOS ONE			English	Article							NEONATAL INTENSIVE-CARE; INTERVENTION PROGRAMS; AUDITORY FUNCTION; RISK-FACTORS; FOLLOW-UP; INFANTS; CHILDREN; PREVALENCE	Objectives The incidence of sensorineural hearing loss is between 1 and 3 per 1000 in healthy neonates and 2-4 per 100 in high-risk infants. The national universal neonatal hearing screening carried out in Poland since 2002 enables selection of infants with suspicion and/or risk factors of hearing loss. In this study, we assessed the incidence and risk factors of hearing impairment in infants <= 33 weeks' gestational age (wga). Methods We analyzed the database of the Polish Universal Newborns Hearing Screening Program from 2010 to 2013. The study group involved 11438 infants born before 33 wga, the control group-1487730 infants. Screening was performed by means of transient evoked otoacoustic emissions. The risk factors of hearing loss were recorded. Infants who failed the screening test and/or had risk factors were referred for further audiological evaluation. Results Hearing deficit was diagnosed in 11% of infants <= 25 wga, 5% at 26-27 wga, 3.46% at 28 wga and 2-3% at 29-32 wga. In the control group the incidence of hearing deficit was 0.2% (2.87% with risk factors). The most important risk factors were craniofacial malformations, very low birth weight, low Apgar score and mechanical ventilation. Hearing screening was positive in 22.42% newborns <= 28 wga and 10% at 29-32 wga and in the control group. Conclusions Hearing impairment is a severe consequence of prematurity. Its prevalence is inversely related to the maturity of the baby. Premature infants have many concomitant risk factors which influence the occurrence of hearing deficit.	[Wroblewska-Seniuk, Katarzyna; Mazela, Jan] Poznan Univ Med Sci, Dept Newborns Infect Dis, Poznan, Poland; [Greczka, Grazyna; Dabrowski, Piotr; Szyfter-Harris, Joanna] Poznan Univ Med Sci, Dept Otolaryngol & Oncol Laryngol, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences	Wroblewska-Seniuk, K (corresponding author), Poznan Univ Med Sci, Dept Newborns Infect Dis, Poznan, Poland.	kwroblewska@post.pl	Wróblewska-Seniuk, Katarzyna/U-3292-2019	Wroblewska-Seniuk, Katarzyna/0000-0003-3908-6617				Antoni M, 2016, EUR ANN OTORHINOLARY, V133, P95, DOI 10.1016/j.anorl.2015.10.001; Biernath KR, 2010, AM FAM PHYSICIAN, V81, P124; Bolisetty S, 2014, PEDIATRICS, V133, P55, DOI 10.1542/peds.2013-0372; Borkoski-Barreiro SA, 2013, ACTA OTORRINOLAR ESP, V64, P403, DOI 10.1016/j.otorri.2013.05.002; Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333; Coenraad S, 2010, INT J PEDIATR OTORHI, V74, P999, DOI 10.1016/j.ijporl.2010.05.024; Cristobal R, 2008, ARCH DIS CHILD-FETAL, V93, P1462, DOI 10.1136/adc.2007.124214; D'Agostino Jo Ann, 2004, Adv Neonatal Care, V4, P344, DOI 10.1016/j.adnc.2004.09.007; DEVRIES LS, 1987, EARLY HUM DEV, V15, P269, DOI 10.1016/0378-3782(87)90050-8; Fausti SA, 1999, EAR HEARING, V20, P497, DOI 10.1097/00003446-199912000-00005; Finitzo T, 2000, PEDIATRICS, V106, P798, DOI 10.1044/1059-0889(2000/005); Greczka G, 2017, ANAL FOLLOW DIAGNOST; HAUPT H, 1993, EUR ARCH OTO-RHINO-L, V250, P396; Helfand M., 2001, NEWBORN HEARING SCRE; Hille ETM, 2007, ACTA PAEDIATR, V96, P1155, DOI 10.1111/j.1651-2227.2007.00398.x; Konkle D F, 1993, J Am Acad Audiol, V4, P351; Le Prell CG, 2007, HEARING RES, V226, P22, DOI 10.1016/j.heares.2006.10.006; Mehl AL, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.1.e4; Meyer C, 1999, PEDIATRICS, V104, P900, DOI 10.1542/peds.104.4.900; Norton SJ, 2000, EAR HEAR, V21; Ohl C, 2009, INT J PEDIATR OTORHI, V73, P1691, DOI 10.1016/j.ijporl.2009.08.027; Robertson CMT, 2009, PEDIATRICS, V123, pE797, DOI 10.1542/peds.2008-2531; Shapiro SM, 2001, J PERINATOL S1, V21, pS59, DOI DOI 10.1038/SJ.JP.7210635; Sokol Jennifer, 2002, Pediatr Rev, V23, P155, DOI 10.1542/pir.23-5-155; Steel KP, 2001, NAT GENET, V27, P143, DOI 10.1038/84758; Szyfter W, 2013, EPIDEMIOLOGY, V24, P333, DOI 10.1097/EDE.0b013e31827b23a3; White KR, 2010, SEMIN PERINATOL, V34, P170, DOI 10.1053/j.semperi.2009.12.009; Wrobel MJ, 2014, INT J PEDIATR OTORHI, V78, P209, DOI 10.1016/j.ijporl.2013.10.052; Wroblewska-Seniuk K, 2005, INT J PEDIATR OTORHI, V69, P1351, DOI 10.1016/j.ijporl.2005.03.023; Yoon PJ, 2003, INT J PEDIATR OTORHI, V67, P353, DOI 10.1016/S0165-5876(02)00400-7; Yoshinaga-Itano C, 1999, OTOLARYNG CLIN N AM, V32, P1089, DOI 10.1016/S0030-6665(05)70196-1	31	30	34	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184359	10.1371/journal.pone.0184359	http://dx.doi.org/10.1371/journal.pone.0184359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910311	gold, Green Published, Green Submitted			2022-12-27	WOS:000410859200042
J	Fresquet-Corrales, S; Roque, E; Sarrion-Perdigones, A; Rochina, M; Lopez-Gresa, MP; Diaz-Mula, HM; Belles, JM; Tomas-Barberan, F; Beltran, JAP; Canas, LA				Fresquet-Corrales, Sandra; Roque, Edelin; Sarrion-Perdigones, Alejandro; Rochina, Maricruz; Lopez-Gresa, Maria P.; Diaz-Mula, Huertas M.; Belles, Jose M.; Tomas-Barberan, Francisco; Beltran, Jose A. P.; Canas, Luis A.			Metabolic engineering to simultaneously activate anthocyanin and proanthocyanidin biosynthetic pathways in Nicotiana spp.	PLOS ONE			English	Article							R2R3-MYB TRANSCRIPTION FACTOR; TRANSGENIC TOBACCO PLANTS; SECRETORY ANTIBODIES; MEDICAGO-TRUNCATULA; CONDENSED TANNINS; EXPRESSION; GENES; PIGMENTATION; ARABIDOPSIS; REDUCTASE	Proanthocyanidins (PAs), or condensed tannins, are powerful antioxidants that remove harmful free oxygen radicals from cells. To engineer the anthocyanin and proanthocyanidin biosynthetic pathways to de novo produce PAs in two Nicotiana species, we incorporated four transgenes to the plant chassis. We opted to perform a simultaneous transformation of the genes linked in a multigenic construct rather than classical breeding or retransformation approaches. We generated a GoldenBraid 2.0 multigenic construct containing two Antirrhinum majus transcription factors (AmRosea1 and AmDelila) to upregulate the anthocyanin pathway in combination with two Medicago truncatula genes (MtLAR and MtANR) to produce the enzymes that will derivate the biosynthetic pathway to PAs production. Transient and stable transformation of Nicotiana benthamiana and Nicotiana tabacum with the multigenic construct were respectively performed. Transient expression experiments in N. benthamiana showed the activation of the anthocyanin pathway producing a purple color in the agroinfiltrated leaves and also the effective production of 208.5 nmol (-) catechin/g FW and 228.5 nmol (-) epicatechin/g FW measured by the p-dimethylaminocinnamaldehyde (DMACA) method. The integration capacity of the four transgenes, their respective expression levels and their heritability in the second generation were analyzed in stably transformed N. tabacum plants. DMACA and phoroglucinolysis/HPLC-MS analyses corroborated the activation of both pathways and the effective production of PAs in T0 and T1 transgenic tobacco plants up to a maximum of 3.48 mg/g DW. The possible biotechnological applications of the GB2.0 multigenic approach in forage legumes to produce "bloatsafe" plants and to improve the efficiency of conversion of plant protein into animal protein (ruminal protein bypass) are discussed.	[Fresquet-Corrales, Sandra; Roque, Edelin; Sarrion-Perdigones, Alejandro; Rochina, Maricruz; Lopez-Gresa, Maria P.; Belles, Jose M.; Beltran, Jose A. P.; Canas, Luis A.] CSIC UPV, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Sarrion-Perdigones, Alejandro] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Diaz-Mula, Huertas M.; Tomas-Barberan, Francisco] CSIC, CEBAS, Res Grp Qual Safety & Bioact Plant Foods, Murcia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Baylor College of Medicine; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS)	Canas, LA (corresponding author), CSIC UPV, Inst Biol Mol & Celular Plantas, Valencia, Spain.	lcanas@ibmcp.upv.es	Roque, Edelin/K-7576-2015; Tomás-Barberán, Francisco/D-6686-2011; Diaz-Mula, Huertas Maria/L-4559-2013; Gresa, María Pilar López/N-8830-2013; Cañas, Luis A./F-7147-2015	Roque, Edelin/0000-0002-2422-8128; Tomás-Barberán, Francisco/0000-0002-0790-1739; Diaz-Mula, Huertas Maria/0000-0002-9289-2856; Gresa, María Pilar López/0000-0001-9251-0160; Canas, Luis/0000-0003-4177-4777; ROCHINA PENALVER, MARI CRUZ/0000-0002-7327-0437	Spanish Ministry of Economy and Competitiveness (MINECO) [BIO2012-39849-C02-01, BIO2016-75485-R]; JAE-CSIC	Spanish Ministry of Economy and Competitiveness (MINECO); JAE-CSIC	This work was supported by grants BIO2012-39849-C02-01 and BIO2016-75485-R from the Spanish Ministry of Economy and Competitiveness (MINECO) (http://www.idi.mineco.gob.es/portal/site/MICINN) to LAC and a fellowship of the JAE-CSIC program to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts RJ, 1999, AGR ECOSYST ENVIRON, V75, P1, DOI 10.1016/S0167-8809(99)00062-6; Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; Albert NW, 2011, PLANT J, V65, P771, DOI 10.1111/j.1365-313X.2010.04465.x; Barry TN, 1999, BRIT J NUTR, V81, P263, DOI 10.1017/S0007114599000501; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; BINNS AN, 1988, ANNU REV MICROBIOL, V42, P575, DOI 10.1146/annurev.mi.42.100188.003043; Buendia B, 2010, J AGR FOOD CHEM, V58, P3916, DOI 10.1021/jf9030597; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Capell T, 2004, CURR OPIN BIOTECH, V15, P148, DOI 10.1016/j.copbio.2004.01.009; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; Dafny-Yelin M, 2007, PLANT PHYSIOL, V145, P1118, DOI 10.1104/pp.107.106104; Datta K, 2002, THEOR APPL GENET, V106, P1, DOI 10.1007/s00122-002-1014-1; de Pascual-Teresa S, 1998, J AGR FOOD CHEM, V46, P4209, DOI 10.1021/jf980255k; DELCOUR JA, 1985, J I BREWING, V91, P37, DOI 10.1002/j.2050-0416.1985.tb04303.x; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Dixon RA, 2005, NEW PHYTOL, V165, P9, DOI 10.1111/j.1469-8137.2004.01217.x; Dixon RA, 2012, CURR OPIN BIOTECH, V24, P1; Dixon RA, 2010, PLANT PHYSIOL, V154, P453, DOI 10.1104/pp.110.161430; Du H, 2010, APPL MICROBIOL BIOT, V86, P1293, DOI 10.1007/s00253-010-2512-8; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; FISHER DK, 1995, PLANT MOL BIOL REP, V13, P278, DOI 10.1007/BF02670906; Gong ZZ, 1999, PLANT MOL BIOL, V41, P33, DOI 10.1023/A:1006237529040; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; HALL JW, 1994, CAN VET J, V35, P702; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Halpin C, 2001, PLANT MOL BIOL, V47, P295, DOI 10.1023/A:1010604120234; Hewitt E., 1966, SAND WATER CULTURE M, V187-237, P430; HORSCH RB, 1984, SCIENCE, V223, P496, DOI 10.1126/science.223.4635.496; Jobling SA, 2002, NAT BIOTECHNOL, V20, P295, DOI 10.1038/nbt0302-295; Kennedy JA, 2001, J AGR FOOD CHEM, V49, P1740, DOI 10.1021/jf001030o; Kim HU, 1998, MOL CELLS, V8, P310; Kitamura S., 2006, SCI FLAVONOIDS, P123; Laitinen RAE, 2008, J EXP BOT, V59, P3691, DOI 10.1093/jxb/ern216; Lapierre C, 1999, PLANT PHYSIOL, V119, P153, DOI 10.1104/pp.119.1.153; Li HH, 2007, PLANTA, V226, P1243, DOI 10.1007/s00425-007-0573-4; Li PH, 2016, NEW PHYTOL, V210, P905, DOI 10.1111/nph.13816; Li YG, 1996, J SCI FOOD AGR, V70, P89, DOI 10.1002/(SICI)1097-0010(199601)70:1&lt;89::AID-JSFA470&gt;3.0.CO;2-N; Liu CG, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.182, 10.1038/nplants.2016.182]; Liu CG, 2014, PLANT PHYSIOL, V165, P1424, DOI 10.1104/pp.114.241877; Liu Y, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-202; LLOYD AM, 1992, SCIENCE, V258, P1773, DOI 10.1126/science.1465611; MA JKC, 1995, SCIENCE, V268, P716, DOI 10.1126/science.7732380; Magnani E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-46; McMahon LR, 2000, CAN J PLANT SCI, V80, P469, DOI 10.4141/P99-050; Modolo LV, 2007, PLANT MOL BIOL, V64, P499, DOI 10.1007/s11103-007-9167-6; Muir AD, 2000, BASIC LIFE SCI, V66, P867; Nakatsuka T, 2008, PLANT CELL PHYSIOL, V49, P1818, DOI 10.1093/pcp/pcn163; Niezen JH, 1998, VET PARASITOL, V80, P15, DOI 10.1016/S0304-4017(98)00202-7; NIEZEN JH, 1995, J AGR SCI, V125, P281, DOI 10.1017/S0021859600084422; Orzaez D, 2009, PLANT PHYSIOL, V150, P1122, DOI 10.1104/pp.109.139006; Pang YZ, 2007, PLANT PHYSIOL, V145, P601, DOI 10.1104/pp.107.107326; Pang YZ, 2013, PLANT PHYSIOL, V161, P1103, DOI 10.1104/pp.112.212050; Paolocci F, 2007, PLANT PHYSIOL, V143, P504, DOI 10.1104/pp.106.090886; Park KI, 2007, PLANT J, V49, P641, DOI 10.1111/j.1365-313X.2006.02988.x; Peel GJ, 2009, PLANT J, V59, P136, DOI 10.1111/j.1365-313X.2009.03885.x; Polturak G, 2016, NEW PHYTOL, V210, P269, DOI 10.1111/nph.13796; Qi BX, 2004, NAT BIOTECHNOL, V22, P739, DOI 10.1038/nbt972; Ramsay NA, 2003, PLANT MOL BIOL, V52, P679, DOI 10.1023/A:1024852021124; Robbins MP, 2003, J EXP BOT, V54, P239, DOI 10.1093/jxb/erg022; Sarrion-Perdigones A, 2014, DNA CLONING ASSEMBLY, V1116; Sarrion-Perdigones A, 2013, PLANT PHYSIOL, V162, P1618; Sarrion-Perdigones A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021622; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Tanner GJ, 2003, J BIOL CHEM, V278, P31647, DOI 10.1074/jbc.M302783200; Vafaee Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110222; Vallejo F, 2012, FOOD CHEM, V130, P485, DOI 10.1016/j.foodchem.2011.07.032; Vazquez-Vilar M, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0101-2; Verdier J, 2012, P NATL ACAD SCI USA, V109, P1766, DOI 10.1073/pnas.1120916109; WAGHORN GC, 1990, MICROBIAL PLANT OPPO, P137; Wieland WH, 2006, J BIOTECHNOL, V122, P382, DOI 10.1016/j.jbiotec.2005.12.020; Xie DY, 2006, PLANT J, V45, P895, DOI 10.1111/j.1365-313X.2006.02655.x; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Xie DY, 2004, ARCH BIOCHEM BIOPHYS, V422, P91, DOI 10.1016/j.abb.2003.12.011; ZAMBRYSKI P, 1988, ANNU REV GENET, V22, P1, DOI 10.1146/annurev.ge.22.120188.000245; Zhang YJ, 2015, MOLECULES, V20, P21138, DOI 10.3390/molecules201219753; Zhou ML, 2015, APPL MICROBIOL BIOT, V99, P3797, DOI 10.1007/s00253-015-6533-1	78	12	14	6	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184839	10.1371/journal.pone.0184839	http://dx.doi.org/10.1371/journal.pone.0184839			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902886	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200071
J	Salazar, CL; Reyes, C; Atehortua, S; Sierra, P; Correa, MM; Paredes-Sabja, D; Best, E; Fawley, WN; Wilcox, M; Gonzalez, A				Lina Salazar, Clara; Reyes, Catalina; Atehortua, Santiago; Sierra, Patricia; Maria Correa, Margarita; Paredes-Sabja, Daniel; Best, Emma; Fawley, Warren N.; Wilcox, Mark; Gonzalez, Angel			Molecular, microbiological and clinical characterization of Clostridium difficile isolates from tertiary care hospitals in Colombia	PLOS ONE			English	Article							RIO-DE-JANEIRO; RISK-FACTORS; INFECTION; DIARRHEA; EPIDEMIOLOGY; INPATIENTS; DIAGNOSIS; STILL	In Colombia, the epidemiology and circulating genotypes of Clostridium difficile have not yet been described. Therefore, we molecularly characterized clinical isolates of C.difficile from patients with suspicion of C.difficile infection (CDI) in three tertiary care hospitals. C.difficile was isolated from stool samples by culture, the presence of A/B toxins were detected by enzyme immunoassay, cytotoxicity was tested by cell culture and the antimicrobial susceptibility determined. After DNA extraction, tcdA, tcdB and binary toxin (CDTa/CDTb) genes were detected by PCR, and PCR-ribotyping performed. From a total of 913 stool samples collected during 2013-2014, 775 were included in the study. The frequency of A/B toxins-positive samples was 9.7% (75/775). A total of 143 isolates of C.difficile were recovered from culture, 110 (76.9%) produced cytotoxic effect in cell culture, 100 (69.9%) were tcdA +/tcdB+, 11 (7.7%) tcdA-/tcdB+, 32 (22.4%) tcdA-/tcdB-and 25 (17.5%) CDTa+/CDTb+. From 37 ribotypes identified, ribotypes 591 (20%), 106 (9%) and 002 (7.9%) were the most prevalent; only one isolate corresponded to ribotype 027, four to ribotype 078 and four were new ribotypes (794,795, 804,805). All isolates were susceptible to vancomycin and metronidazole, while 85% and 7.7% were resistant to clindamycin and moxifloxacin, respectively. By multivariate analysis, significant risk factors associated to CDI were, staying in orthopedic service, exposure to third-generation cephalosporins and staying in an ICU before CDI symptoms; moreover, steroids showed to be a protector factor. These results revealed new C. difficile ribotypes and a high diversity profile circulating in Colombia different from those reported in America and European countries.	[Lina Salazar, Clara] Univ Antioquia, Sch Microbiol, Res Grp Anaerob Bacteria GIBA, Medellin, Colombia; [Reyes, Catalina; Gonzalez, Angel] Univ Antioquia, Basic & Appl Microbiol Res Grp MICROBA, Sch Microbiol, Medellin, Colombia; [Atehortua, Santiago] Univ Hosp, San Vicente Fdn, Medellin, Colombia; [Sierra, Patricia] Univ Antioquia, IPS Univ, Clin Leon XIII, Medellin, Colombia; [Maria Correa, Margarita] Univ Antioquia, Sch Microbiol, Mol Microbiol Grp, Medellin, Colombia; [Paredes-Sabja, Daniel] Univ Andres Bello, Dept Ciencias Biol, Microbiota Host Interact & Clostridia Res Grp, Santiago, Chile; [Best, Emma; Fawley, Warren N.; Wilcox, Mark] Leeds Teaching Hosp NHS Trust, Dept Microbiol, Leeds, W Yorkshire, England	Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidad de Antioquia; Universidad Andres Bello; University of Leeds	Gonzalez, A (corresponding author), Univ Antioquia, Basic & Appl Microbiol Res Grp MICROBA, Sch Microbiol, Medellin, Colombia.	angel.gonzalez@udea.edu.co	Paredes-Sabja, Daniel/ABI-4293-2020; Gonzalez, Angel/ABG-7914-2020	Gonzalez, Angel/0000-0002-7052-7938	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia [485-2012, 1115569344410]; Estrategia para la Sostenibilidad de Grupos de Investigacion, UdeA, Universidad de Antioquia [ES84160123]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia; Estrategia para la Sostenibilidad de Grupos de Investigacion, UdeA, Universidad de Antioquia	This work was supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia, Project 485-2012 (Code number 1115569344410). MMC received funding from Estrategia para la Sostenibilidad de Grupos de Investigacion 2016-2017, UdeA, code No. ES84160123, Universidad de Antioquia. The funders had no role in study design, analysis and interpretation of experiments, decision to publish, or preparation of the manuscript.	Ashwin H, 2014, 24 EUR C CLIN MICR I; Balassiano IT, 2012, J MED MICROBIOL, V61, P169, DOI 10.1099/jmm.0.037077-0; Balassiano IT, 2011, ANTON LEEUW INT J G, V99, P249, DOI 10.1007/s10482-010-9483-8; Balassiano IT, 2009, ANAEROBE, V15, P61, DOI 10.1016/j.anaerobe.2008.12.007; Becerra María Gabriela, 2011, Infect., V15, P220; Bloomfield MG, 2012, J HOSP INFECT, V82, P1, DOI 10.1016/j.jhin.2012.05.008; Chia JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075471; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Crabtree T, 2007, ANN THORAC SURG, V83, P1396, DOI 10.1016/j.athoracsur.2006.10.067; Davies KA, 2016, EUROSURVEILLANCE, V21, P37, DOI 10.2807/1560-7917.ES.2016.21.29.30294; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Dong DF, 2013, INT J ANTIMICROB AG, V41, P80, DOI 10.1016/j.ijantimicag.2012.08.011; Dudukgian H, 2010, J GASTROINTEST SURG, V14, P315, DOI 10.1007/s11605-009-1093-2; Eastwood K, 2009, J CLIN MICROBIOL, V47, P3211, DOI 10.1128/JCM.01082-09; Elliott B, 2009, ANAEROBE, V15, P249, DOI 10.1016/j.anaerobe.2009.08.006; Faleck DM, 2016, AM J GASTROENTEROL, V111, P1641, DOI 10.1038/ajg.2016.343; Fawley WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118150; Feher C, 2016, INFECT DIS THER, V5, P207, DOI 10.1007/s40121-016-0122-1; Foster N F, 2014, New Microbes New Infect, V2, P64, DOI 10.1002/nmi2.43; Foster NF, 2012, PATHOLOGY, V44, P354, DOI 10.1097/PAT.0b013e328353a235; Freeman J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.017; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Gutierrez J, 2016, PREVALENCIA FACTORES; Halstead DC, 2016, J INFECT DEV COUNTR, V10, P62, DOI 10.3855/jidc.6634; Hecht DW, 2007, ANTIMICROB AGENTS CH, V51, P2716, DOI 10.1128/AAC.01623-06; Hensgens MPM, 2012, J ANTIMICROB CHEMOTH, V67, P742, DOI 10.1093/jac/dkr508; Hernandez-Rocha C, 2013, DIAGN MICR INFEC DIS, V75, P361, DOI 10.1016/j.diagmicrobio.2012.12.010; Karanika S, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofv186; KATO N, 1991, J CLIN MICROBIOL, V29, P33, DOI 10.1128/JCM.29.1.33-37.1991; Kim HB, 2016, J MICROBIOL BIOTECHN, V26, P567, DOI 10.4014/jmb.1512.12017; Krutova M, 2016, INT J MED MICROBIOL, V306, P479, DOI 10.1016/j.ijmm.2016.07.003; Kuehne SA, 2011, GUT MICROBES, V2, P711; Legaria MC, 2003, ANAEROBE, V9, P113, DOI 10.1016/S1075-9964(03)00088-X; Leibovitz A, 2016, AM J INFECT CONTROL, V44, P1158, DOI 10.1016/j.ajic.2016.03.069; Lopardo G, 2015, BRAZ J INFECT DIS, V19, P8, DOI 10.1016/j.bjid.2014.07.004; Lopez-Urena D, 2014, J MED MICROBIOL, V63, P322, DOI 10.1099/jmm.0.066399-0; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Marston HD, 2016, JAMA-J AM MED ASSOC, V316, P1193, DOI 10.1001/jama.2016.11764; Monteiro AD, 2014, BRAZ J INFECT DIS, V18, P672, DOI 10.1016/j.bjid.2014.08.004; Slimings C, 2014, J ANTIMICROB CHEMOTH, V69, P881, DOI 10.1093/jac/dkt477; Smits WK, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.20, 10.1128/microbiolspec.EI10-0007-2015]; Sunkesula VCK, 2013, CLIN INFECT DIS, V57, P494, DOI 10.1093/cid/cit286; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Terhes G, 2004, J CLIN MICROBIOL, V42, P4316, DOI 10.1128/JCM.42.9.4316-4318.2004; Tickler IA, 2014, ANTIMICROB AGENTS CH, V58, P4214, DOI 10.1128/AAC.02775-13; Tleyjeh IM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050836; Wijarnpreecha K, 2016, DIGEST LIVER DIS, V48, P468, DOI 10.1016/j.dld.2016.01.012; Wilcox MH, 2017, J ANTIMICROB CHEMOTH, V72, P1, DOI 10.1093/jac/dkw385; Wilkins TD, 2003, J CLIN MICROBIOL, V41, P531, DOI 10.1128/JCM.41.2.531-534.2003	49	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184689	10.1371/journal.pone.0184689	http://dx.doi.org/10.1371/journal.pone.0184689			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902923	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200053
J	Fausther, M; Lavoie, EG; Dranoff, JA				Fausther, Michel; Lavoie, Elise G.; Dranoff, Jonathan A.			Liver myofibroblasts of murine origins express mesothelin: Identification of novel rat mesothelin splice variants	PLOS ONE			English	Article							MOLECULAR-CLONING; FIBROTIC LIVER; CANCER; FIBROSIS; CHOLANGIOCARCINOMA; IMMUNOTHERAPY; TRANSCRIPTION; PROGRESSION; PROGNOSIS; CARCINOMA	Liver myofibroblasts are specialized effector cells that drive hepatic fibrosis, a hallmark process of chronic liver diseases, leading to progressive scar formation and organ failure. Liver myofibroblasts are increasingly recognized as heterogeneous with regards to their origin, phenotype, and functions. For instance, liver myofibroblasts express cell markers that are universally represented such as, ItgaV and Pdgfr beta, or restricted to a given subpopulation such as, Lrat exclusively expressed in hepatic stellate cells, and Gpm6a in mesothelial cells. To study liver myofibroblasts in vitro, we have previously generated and characterized a SV40-immortalized polyclonal rat activated portal fibroblast cell line called RGF-N2 expressing multiple mesothelin mRNA transcripts. Mesothelin, a cell-surface molecule expressed in normal mesothelial cells and overexpressed in several cancers such as, mesothelioma and cholangiocarcinoma, was recently identified as a key regulator of portal myofibroblast proliferation, and fibrosis progression in the setting of chronic cholestatic liver disease. Here, we identify novel mesothelin splice variants expressed in rat activated portal fibroblasts. RGF-N2 portal fibroblast cDNA was used as template for insertion of hemagglutinin tag consensus sequence into the complete open reading frame of rat mesothelin variant coding sequences by extension PCR. Purified amplicons were subsequently cloned into an expression vector for in vitro translation and transfection in monkey COS7 fibroblasts, before characterization of fusion proteins by immunoblot and immunofluorescence. We show that rat activated portal fibroblasts, hepatic stellate cells, and cholangiocarcinoma cells express wild-type mesothelin and additional splice variants, while mouse activated hepatic stellate cells appear to only express wild-type mesothelin. Notably, rat mesothelin splice variants differ from the wild-type isoform by their protein properties and cellular distribution in transfected COS7 fibroblasts. We conclude that mesothelin is a marker of activated murine liver myofibroblasts. Mesothelin gene expression and regulation may be critical in liver myofibroblasts functions and fibrosis progression.	[Fausther, Michel; Lavoie, Elise G.; Dranoff, Jonathan A.] Univ Arkansas Med Sci, Dept Internal Med, Div Gastroenterol & Hepatol, Little Rock, AR 72205 USA; [Fausther, Michel; Lavoie, Elise G.; Dranoff, Jonathan A.] Cent Arkansas Vet Adm Hlth Syst, Res Serv, Little Rock, AR 72114 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System	Fausther, M (corresponding author), Univ Arkansas Med Sci, Dept Internal Med, Div Gastroenterol & Hepatol, Little Rock, AR 72205 USA.; Fausther, M (corresponding author), Cent Arkansas Vet Adm Hlth Syst, Res Serv, Little Rock, AR 72114 USA.	mfausther@uams.edu		Fausther, Michel/0000-0002-5673-9360	NCATS NIH HHS [UL1 TR000039] Funding Source: Medline; NIDDK NIH HHS [R56 DK076735] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Einama Takahiro, 2016, World J Gastrointest Pathophysiol, V7, P218, DOI 10.4291/wjgp.v7.i2.218; Fausther M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121161; Fausther M, 2012, AM J PHYSIOL-GASTR L, V303, pG904, DOI 10.1152/ajpgi.00015.2012; Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697; Hassan R, 2016, J CLIN ONCOL, V34, P4171, DOI 10.1200/JCO.2016.68.3672; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Hucl T, 2007, CANCER RES, V67, P9055, DOI 10.1158/0008-5472.CAN-07-0474; Iwaisako K, 2014, P NATL ACAD SCI USA, V111, pE3297, DOI 10.1073/pnas.1400062111; Kawamata F, 2012, INT J ONCOL, V41, P2109, DOI 10.3892/ijo.2012.1662; Kisseleva T, 2017, HEPATOLOGY, V65, P1039, DOI 10.1002/hep.28948; KOJIMA T, 1995, J BIOL CHEM, V270, P21984, DOI 10.1074/jbc.270.37.21984; Koyama Y, 2017, J CLIN INVEST, V127, P1254, DOI 10.1172/JCI88845; Lee YA, 2015, GUT, V64, P1337, DOI 10.1136/gutjnl-2014-306842corr1; Leshem Y, 2017, CANCER IMMUNOL RES, V5, P685, DOI 10.1158/2326-6066.CIR-16-0330; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Lua I, 2016, J HEPATOL, V64, P1137, DOI 10.1016/j.jhep.2016.01.010; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Meurer SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056116; Nomura R, 2013, INT SURG, V98, P164, DOI 10.9738/INTSURG-D-13-00001.1; Pastan I, 2014, CANCER RES, V74, P2907, DOI 10.1158/0008-5472.CAN-14-0337; Prieve Mary G, 2003, BMC Dev Biol, V3, P2, DOI 10.1186/1471-213X-3-2; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Sirica AE, 2008, HEPATOLOGY, V47, P1178, DOI 10.1002/hep.22088; Tang ZW, 2013, ANTI-CANCER AGENT ME, V13, P276, DOI 10.2174/1871520611313020014; Thomas A, 2015, ONCOTARGET, V6, P11694, DOI 10.18632/oncotarget.3429; Vogel S, 2000, J LIPID RES, V41, P882; Yu LP, 2010, J CANCER, V1, P141; Zhang JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104388	36	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184499	10.1371/journal.pone.0184499	http://dx.doi.org/10.1371/journal.pone.0184499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898276	Green Published, Green Submitted, gold			2022-12-27	WOS:000410449500031
J	Marin, MM; Schober, R; Gingras, B; Leder, H				Marin, Manuela M.; Schober, Raphaela; Gingras, Bruno; Leder, Helmut			Misattribution of musical arousal increases sexual attraction towards opposite-sex faces in females	PLOS ONE			English	Article							MATE PREFERENCES; CONCEPTION; ABILITY; LOVE	Several theories about the origins of music have emphasized its biological and social functions, including in courtship. Music may act as a courtship display due to its capacity to vary in complexity and emotional content. Support for music's reproductive function comes from the recent finding that only women in the fertile phase of the reproductive cycle prefer composers of complex melodies to composers of simple ones as short-term sexual partners, which is also in line with the ovulatory shift hypothesis. However, the precise mechanisms by which music may influence sexual attraction are unknown, specifically how music may interact with visual attractiveness cues and affect perception and behaviour in both genders. Using a crossmodal priming paradigm, we examined whether listening to music influences ratings of facial attractiveness and dating desirability of opposite-sex faces. We also tested whether misattribution of arousal or pleasantness underlies these effects, and explored whether sex differences and menstrual cycle phase may be moderators. Our sample comprised 64 women in the fertile or infertile phase (no hormonal contraception use) and 32 men, carefully matched for mood, relationship status, and musical preferences. Musical primes (25 s) varied in arousal and pleasantness, and targets were photos of faces with neutral expressions (2 s). Group-wise analyses indicated that women, but not men, gave significantly higher ratings of facial attractiveness and dating desirability after having listened to music than in the silent control condition. High-arousing, complex music yielded the largest effects, suggesting that music may affect human courtship behaviour through induced arousal, which calls for further studies on the mechanisms by which music affects sexual attraction in real-life social contexts.	[Marin, Manuela M.; Schober, Raphaela; Leder, Helmut] Univ Vienna, Dept Basic Psychol Res & Res Methods, Vienna, Austria; [Gingras, Bruno] Univ Innsbruck, Dept Psychol, Innsbruck, Austria	University of Vienna; University of Innsbruck	Marin, MM (corresponding author), Univ Vienna, Dept Basic Psychol Res & Res Methods, Vienna, Austria.	manuela.marin@uibk.ac.at	Marin, Manuela M/G-8693-2012; Marin, Manuela M./Q-4496-2017	Marin, Manuela M./0000-0002-9657-1507	University of Vienna	University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna. The Open Access Fund pays for the publication cost.; This article was supported by the Open Access Publishing Fund of the University of Vienna.	Becker J., 2010, HDB MUSIC EMOTION TH, P127; Blacking J. D, 1973, HOW MUSICAL IS MAN; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; CANTOR JR, 1973, J GEN PSYCHOL, V89, P97, DOI 10.1080/00221309.1973.9710822; Caplan P., 1987, CULTURAL CONSTRUCTIO, P1; Charlton BD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0403; Charlton BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035626; Chivers ML, 2017, ARCH SEX BEHAV, V46, P1161, DOI 10.1007/s10508-016-0897-x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Darwin C, 2006, SO SIMPLE BEGINNING; Dissanayake E, 2000, ORIGINS OF MUSIC, P389; DUTTON DG, 1974, J PERS SOC PSYCHOL, V30, P510, DOI 10.1037/h0037031; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fisher H., 2016, THE ANATOMY OF LOVE; Foster CA, 1998, J PERS SOC PSYCHOL, V74, P86, DOI 10.1037/0022-3514.74.1.86; Gangestad SW, 2007, J PERS SOC PSYCHOL, V92, P151, DOI 10.1037/0022-3514.92.1.151; Gangestad SW, 2016, EVOL HUM BEHAV, V37, P85, DOI 10.1016/j.evolhumbehav.2015.09.001; Garza R, 2017, EVOL PSYCHOL-US, V15, DOI 10.1177/1474704917690741; Gerdes ABM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01351; Gildersleeve K, 2014, PSYCHOL BULL, V140, P1205, DOI 10.1037/a0035438; Gingras B, 2014, Q J EXP PSYCHOL, V67, P1428, DOI 10.1080/17470218.2013.863954; Gueguen N, 2014, PSYCHOL MUSIC, V42, P545, DOI 10.1177/0305735613482025; Herdt Gilbert, 1999, SAMBIA SEXUAL CULTUR; Higham T, 2012, J HUM EVOL, V62, P664, DOI 10.1016/j.jhevol.2012.03.003; Jones BC, 2007, J EVOL PSYCHOL, V5, P119, DOI DOI 10.1556/JEP.2007.1001; Kamiyama KS, 2013, NEUROPSYCHOLOGIA, V51, P500, DOI 10.1016/j.neuropsychologia.2012.11.031; Lakens Daniel, 2013, Front Psychol, V4, P863, DOI 10.3389/fpsyg.2013.00863; Little AC, 2014, WIRES COGN SCI, V5, P621, DOI 10.1002/wcs.1316; Marin MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072412; Marin MM, 2012, EMOTION, V12, P618, DOI 10.1037/a0025020; MAY J L, 1980, Motivation and Emotion, V4, P217, DOI 10.1007/BF00995420; Meston CM, 2003, ARCH SEX BEHAV, V32, P537, DOI 10.1023/A:1026037527455; Miller G, 2000, ORIGINS OF MUSIC, P329; Mosing MA, 2015, EVOL HUM BEHAV, V36, P359, DOI 10.1016/j.evolhumbehav.2015.02.004; Patel A.D., 2010, EMERGING DISCIPLINES, P41; Reddy PG, 2009, INDIAN J SEXOLOGY, V1, P10; Rentfrow PJ, 2012, SOC PERSONAL PSYCHOL, V6, P402, DOI 10.1111/j.1751-9004.2012.00434.x; Roder S, 2016, PERS INDIV DIFFER, V101, P1, DOI 10.1016/j.paid.2016.05.025; ROEDERER JG, 1984, MUSIC PERCEPT, V1, P350; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schacht A, 2008, COGN AFFECT BEHAV NE, V8, P132, DOI 10.3758/CABN.8.2.132; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Singh J, 2012, RES J, V6, P37; Sluming VA, 2000, EVOL HUM BEHAV, V21, P1; Steyer R., 1994, DIAGNOSTICA, V40, P320; Sychareun V, 2011, CULT HEALTH SEX, V13, pS249, DOI 10.1080/13691058.2011.634924; Talle A, 2007, AFRICA, V77, P351, DOI 10.1353/afr.2007.0062; Tifferet S., 2012, LETT EVOLUTIONARY BE, V3, P4, DOI DOI 10.5178/LEBS.2012.18; TURINO T, 1983, LAT AM MUSIC REV, V4, P81, DOI 10.2307/780281; Watkins CD, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160955; WHITE GL, 1981, J PERS SOC PSYCHOL, V41, P56, DOI 10.1037/0022-3514.41.1.56; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3; Wood W, 2014, PSYCHOL BULL, V140, P1265, DOI 10.1037/a0036722; Wood W, 2014, EMOT REV, V6, P229, DOI 10.1177/1754073914523073; ZILLMANN D, 1971, J EXP SOC PSYCHOL, V7, P419, DOI 10.1016/0022-1031(71)90075-8	55	18	19	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0183531	10.1371/journal.pone.0183531	http://dx.doi.org/10.1371/journal.pone.0183531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG4OS	28892486	Green Published, Green Submitted, gold			2022-12-27	WOS:000410243200005
J	Rozenkrantz, L; Mayo, AE; Ilan, T; Hart, Y; Noy, L; Alon, U				Rozenkrantz, Liron; Mayo, Avraham E.; Ilan, Tomer; Hart, Yuval; Noy, Lior; Alon, Uri			Placebo can enhance creativity	PLOS ONE			English	Article							SELF-DETERMINATION THEORY; DIVERGENT THINKING; COGNITIVE PERFORMANCE; DISCRIMINANT VALIDITY; PHYSICAL PERFORMANCE; ERGOGENIC AID; ALCOHOL; FACILITATION; EXPECTANCY; ACTIVATION	Background The placebo effect is usually studied in clinical settings for decreasing negative symptoms such as pain, depression and anxiety. There is interest in exploring the placebo effect also outside the clinic, for enhancing positive aspects of performance or cognition. Several studies indicate that placebo can enhance cognitive abilities including memory, implicit learning and general knowledge. Here, we ask whether placebo can enhance creativity, an important aspect of human cognition. Methods Subjects were randomly assigned to a control group who smelled and rated an odorant (n = 45), and a placebo group who were treated identically but were also told that the odorant increases creativity and reduces inhibitions (n = 45). Subjects completed a recently developed automated test for creativity, the creative foraging game (CFG), and a randomly chosen subset (n = 57) also completed two manual standardized creativity tests, the alternate uses test (AUT) and the Torrance test (TTCT). In all three tests, participants were asked to create as many original solutions and were scored for originality, flexibility and fluency. Results The placebo group showed higher originality than the control group both in the CFG (p<0.04, effect size = 0.5) and in the AUT (p<0.05, effect size = 0.4), but not in the Torrance test. The placebo group also found more shapes outside of the standard categories found by a set of 100 CFG players in a previous study, a feature termed out-of-the-boxness (p<0.01, effect size = 0.6). Conclusions The findings indicate that placebo can enhance the originality aspect of creativity. This strengthens the view that placebo can be used not only to reduce negative clinical symptoms, but also to enhance positive aspects of cognition. Furthermore, we find that the impact of placebo on creativity can be tested by CFG, which can quantify multiple aspects of creative search without need for manual coding. This approach opens the way to explore the behavioral and neural mechanisms by which placebo might amplify creativity.	[Rozenkrantz, Liron; Mayo, Avraham E.; Ilan, Tomer; Hart, Yuval; Noy, Lior; Alon, Uri] Weizmann Inst Sci, Theater Lab, Rehovot, Israel; [Rozenkrantz, Liron; Mayo, Avraham E.; Hart, Yuval; Noy, Lior; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Rozenkrantz, Liron] Weizmann Inst Sci, Dept Neurosci, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Noy, L; Alon, U (corresponding author), Weizmann Inst Sci, Theater Lab, Rehovot, Israel.; Noy, L; Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.	lior.noy@weizmann.ac.il; urialon@weizmann.ac.il	mayo, avi/N-3756-2019; Hart, Yuval/HGD-6424-2022; Noy, Lior/GQZ-3657-2022	mayo, avi/0000-0002-4479-3423; Rozenkrantz, Liron/0000-0002-6496-4592	Braginsky Center for the Interface between Science and the Humanities, at the Weizmann Institute of Science	Braginsky Center for the Interface between Science and the Humanities, at the Weizmann Institute of Science	We thank the Braginsky Center for the Interface between Science and the Humanities, at the Weizmann Institute of Science, for support.; We thank the Braginsky Center for the Interface between Science and the Humanities, at the Weizmann Institute of Science, for support. Uri Alon is the incumbent of the Abisch-Frenkel Professorial Chair.	Almeida LS, 2008, THINK SKILLS CREAT, V3, P53, DOI 10.1016/j.tsc.2008.03.003; AMABILE TM, 1990, CONTEMP PSYCHOL, V35, P451, DOI 10.1037/028582; AMABILE TM, 1979, J PERS SOC PSYCHOL, V37, P221, DOI 10.1037/0022-3514.37.2.221; AMABILE TM, 1983, J PERS SOC PSYCHOL, V45, P357, DOI 10.1037/0022-3514.45.2.357; Amabile TM, 1998, HARVARD BUS REV, V76, P76; Amabile TM, 1983, MOTIVATION CREATIVIT; Amanzio M, 2001, PAIN, V90, P205, DOI 10.1016/S0304-3959(00)00486-3; BAER J, 1994, CREATIVITY RES J, V7, P35, DOI 10.1080/10400419409534507; BARTIS S, 1988, PERS SOC PSYCHOL B, V14, P242, DOI 10.1177/0146167288142003; Beedie CJ, 2007, INT J SPORT NUTR EXE, V17, P259, DOI 10.1123/ijsnem.17.3.259; Beedie CJ, 2006, MED SCI SPORT EXER, V38, P2159, DOI 10.1249/01.mss.0000233805.56315.a9; Beedie CJ, 2009, SPORTS MED, V39, P313, DOI 10.2165/00007256-200939040-00004; Ben-Shaanan TL, 2016, NAT MED, V22, P940, DOI 10.1038/nm.4133; Benedetti F, 2007, J NEUROSCI, V27, P11934, DOI 10.1523/JNEUROSCI.3330-07.2007; Benedetti F, 2011, PATIENT EDUC COUNS, V84, P413, DOI 10.1016/j.pec.2011.04.034; BRUNKE M, 1992, PSYCHOL REP, V71, P651, DOI 10.2466/pr0.1992.71.2.651; Chrysikou EG, 2013, COGN NEUROSCI-UK, V4, P81, DOI 10.1080/17588928.2013.768221; Clapham MM, 2004, EDUC PSYCHOL MEAS, V64, P828, DOI 10.1177/0013164404263883; Clark VR, 2000, MED SCI SPORT EXER, V32, P1642; Colagiuri B, 2011, PSYCHON B REV, V18, P399, DOI 10.3758/s13423-010-0041-1; Crum AJ, 2011, HEALTH PSYCHOL, V30, P424, DOI 10.1037/a0023467; Czerniak E, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00874; de la Fuente-Fernandez R, 2001, SCIENCE, V293, P1164, DOI 10.1126/science.1060937; DECI EL, 1980, PSYCHOPHYSIOLOGY, V17, P321; DECI EL, 1985, J RES PERS, V19, P109, DOI 10.1016/0092-6566(85)90023-6; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Green AE, 2015, HUM BRAIN MAPP, V36, P923, DOI 10.1002/hbm.22676; Guilford J, 1978, PSYCHOL SERVICES; Hart Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182133; Hennessey, 2003, SCAND J EDUC RES, V47, P253, DOI [10.1080/00313830308601, DOI 10.1080/00313830308601]; Hennessey BA, 2010, ANNU REV PSYCHOL, V61, P569, DOI 10.1146/annurev.psych.093008.100416; HOCEVAR D, 1979, EDUC PSYCHOL MEAS, V39, P917, DOI 10.1177/001316447903900427; Jarosz AF, 2012, CONSCIOUS COGN, V21, P487, DOI 10.1016/j.concog.2012.01.002; Johnstone Keith, 1987, IMPRO IMPROVISATION; Kapur N, 1996, BRAIN, V119, P1775, DOI 10.1093/brain/119.5.1775; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; LOWE G, 1994, PSYCHOL REP, V75, P1635, DOI 10.2466/pr0.1994.75.3f.1635; Magalhaes De Saldanha da Gama PA, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0075701; Mayseless N, 2015, NEUROSCIENCE, V291, P167, DOI 10.1016/j.neuroscience.2015.01.061; McClung M, 2007, J SPORT EXERCISE PSY, V29, P382, DOI 10.1123/jsep.29.3.382; MEICHENBAUM D, 1975, AM EDUC RES J, V12, P129, DOI 10.3102/00028312012002129; Oken BS, 2008, J CLIN EXP NEUROPSYC, V30, P7, DOI 10.1080/13803390701775428; Parker S, 2011, MEMORY, V19, P606, DOI 10.1080/09658211.2011.592500; Pollo A, 2001, PAIN, V93, P77, DOI 10.1016/S0304-3959(01)00296-2; Pollo A, 2008, EUR J NEUROSCI, V28, P379, DOI 10.1111/j.1460-9568.2008.06344.x; Pollo A, 2011, PHILOS T R SOC B, V366, P1790, DOI 10.1098/rstb.2010.0381; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Raudenbush B., 2009, N AM J PSYCHOL; Raz A, 2006, PSYCHOL SCI, V17, P91, DOI 10.1111/j.1467-9280.2006.01669.x; RUNCO MA, 1986, GIFTED CHILD QUART, V30, P78, DOI 10.1177/001698628603000207; RUNCO MA, 1995, EDUC PSYCHOL REV, V7, P243, DOI 10.1007/BF02213373; Runco MA, 2004, ANNU REV PSYCHOL, V55, P657, DOI 10.1146/annurev.psych.55.090902.141502; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037/0003-066X.55.1.68; Scott DJ, 2007, NEURON, V55, P325, DOI 10.1016/j.neuron.2007.06.028; Sternberg R.J., 1999, HDB CREAT, V1, P3; Stewart-Williams S, 2004, PSYCHOL BULL, V130, P324, DOI 10.1037/0033-2909.130.2.324; SZYMANSKI K, 1992, PERS SOC PSYCHOL B, V18, P259, DOI 10.1177/0146167292183001; Thomas D., 2011, INVESTIGATION EFFECT; Torrance E. P, 1968, TORRANCE TESTS CREAT; Torrance EP, 1974, TORRANCE TESTS CREAT; Weger UW, 2013, Q J EXP PSYCHOL, V66, P23, DOI 10.1080/17470218.2012.751117; Weinberger AB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150773; Wieth MB, 2011, THINK REASONING, V17, P387, DOI 10.1080/13546783.2011.625663; Won AS, 2014, J NONVERBAL BEHAV, V38, P389, DOI 10.1007/s10919-014-0186-0; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Zoladz P. R., 2005, N AM J PSYCHOL, V7, P125	66	11	11	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0182466	10.1371/journal.pone.0182466	http://dx.doi.org/10.1371/journal.pone.0182466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG4OS	28892513	Green Published, Green Submitted, gold			2022-12-27	WOS:000410243200002
J	Betensky, RA; Chiou, SH				Betensky, Rebecca A.; Chiou, Sy Han			Correlation among baseline variables yields non-uniformity of p-values	PLOS ONE			English	Article								A recent paper in Neurology used statistical techniques to investigate the integrity of the randomization in 33 clinical trials conducted by a group of investigators. Without justification, the approach assumed that there would be no impact of correlation among baseline variables. We investigated the impact of correlation on the conclusions of the approach in several large-scale simulation studies that replicated the sample sizes and baseline variables of the clinical trials in question and utilized proper randomization. Additionally, we considered scenarios with larger numbers of baseline variables. We found that, with even moderate correlation, there can be substantial inflation of the type I error of statistical tests of randomization integrity. This is also the case under no correlation, in the presence of some discrete baseline variables, with a large number of variables. Thus, statistical techniques for assessing randomization integrity should be applied with extreme caution given that very low p-values, which are taken as evidence against valid randomization, can arise even in the case of valid randomization, in the presence of correlation. More generally, the use of tests of goodness of fit to uniformity for the purpose of testing a global null hypothesis is not advisable in the presence of correlation.	[Betensky, Rebecca A.; Chiou, Sy Han] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Betensky, RA (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.	betensky@hsph.harvard.edu		Betensky, Rebecca/0000-0002-3793-1437	Harvard NeuroDiscovery Center NIH; Harvard Clinical and Translational Science Center NIH [UL1 TR001102]; NIH [NS094610, NS048005]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	Harvard NeuroDiscovery Center NIH; Harvard Clinical and Translational Science Center NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Harvard NeuroDiscovery Center, the Harvard Clinical and Translational Science Center NIH UL1 TR001102, NIH NS094610, and NIH NS048005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolland MJ, 2016, NEUROLOGY, V87, P2391, DOI 10.1212/WNL.0000000000003387; Gross RA, 2016, NEUROLOGY, V86, P1; Richmond SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071529	3	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184531	10.1371/journal.pone.0184531	http://dx.doi.org/10.1371/journal.pone.0184531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886190	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100149
J	Bobrowiec, PED; Tavares, VD				Bobrowiec, Paulo Estefano D.; Tavares, Valearia da Cunha			Establishing baseline biodiversity data prior to hydroelectric dam construction to monitoring impacts to bats in the Brazilian Amazon	PLOS ONE			English	Article							ASSEMBLAGE STRUCTURE; SPECIES-DIVERSITY; FOREST ISLANDS; FRAGMENTATION; MORPHOLOGY; PATTERNS; CLUTTER; SCALE	The modification of Amazonian rivers by the construction of megaprojects of hydroelectric dams has widely increased over the last decade. Robust monitoring programs have been rarely conducted prior to the establishment of dams to measure to what extent the fauna, and its associated habitats may be affected by upcoming impacts. Using bats as models, we performed analyses throughout the area under the influence of the Santo Antonio hydroelectric dam, Southwestern Brazilian Amazonia before its construction to estimate how the fauna and its associated habitats would be affected by the upcoming impacts. We surveyed bats in 49 plots distributed along the areas going to be inundated by the dam and those remaining dry. As predictors for the species distribution, we tested the variables of vegetation structure and topography. Species composition largely differed between the dry plots and the plots located in areas that will be flooded, and this was strongly associated with the variables of forest basal area and elevation. Vegetation-related variables also had strong influence on the guilds distribution. The flooding of lower elevations areas is expected to negatively affect the species number and abundance of frugivorous species. In contrast, it is likely that animalivores will be less vulnerable to dam-induced flooding, since they were abundant in the areas not expect to be inundated. We urge for the implementation of studies to predict impacts caused by large hydroelectric dams, including tests of the influence of the local conditions that shape diversity to avoid massive losses of the biota, and to build preventive monitoring and management actions.	[Bobrowiec, Paulo Estefano D.] INPA, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil; [Tavares, Valearia da Cunha] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Belo Horizonte, MG, Brazil; [Tavares, Valearia da Cunha] INPA, Programa Posgrad Genet Conservacao & Biol Evolut, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Universidade Federal de Minas Gerais; Institute Nacional de Pesquisas da Amazonia	Bobrowiec, PED (corresponding author), INPA, Coordenacao Biodiversidade, Manaus, Amazonas, Brazil.	paulobobro@gmail.com	Bobrowiec, Paulo Estefano D./A-2630-2013; Tavares, Valeria/G-4654-2012	Tavares, Valeria/0000-0003-0966-0139; Dineli Bobrowiec, Paulo Estefano/0000-0002-8945-6105	Institute Nacional de Pesquisas da Amazonia; Santo Antonio Energia; Fundacao Amazonica de Defesa da Biosfera; Fundacao de Amparo a Pesquisa do Estado do Amazonas (PEDB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PEDB)	Institute Nacional de Pesquisas da Amazonia; Santo Antonio Energia; Fundacao Amazonica de Defesa da Biosfera; Fundacao de Amparo a Pesquisa do Estado do Amazonas (PEDB); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PEDB)	This work was supported by Institute Nacional de Pesquisas da Amazonia, Santo Antonio Energia, Fundacao Amazonica de Defesa da Biosfera, Fundacao de Amparo a Pesquisa do Estado do Amazonas (PEDB), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (PEDB).	[Anonymous], 2014, R LANG ENV STAT COMP; Arlettaz R, 2001, NATURE, V414, P742, DOI 10.1038/414742a; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Barton K., 2015, MUMIN MULTIMODEL INF; Bates D., 2015, LME4 LINEAR MIXED EF; Benchimol M, 2015, BIOL CONSERV, V187, P61, DOI 10.1016/j.biocon.2015.04.005; Benchimol M, 2015, J ECOL, V103, P408, DOI 10.1111/1365-2745.12371; Bernardes C, 2011, BIOTA NEOTROP, V11, P83, DOI 10.1590/S1676-06032011000300006; Bobrowiec PED, 2010, ANIM CONSERV, V13, P204, DOI 10.1111/j.1469-1795.2009.00322.x; Bobrowiec PED, 2014, BIOTROPICA, V46, P312, DOI 10.1111/btp.12102; Costa FRC, 2010, NAT CONSERVACAO, V8, P3, DOI 10.4322/natcon.00801001; Caras T, 2009, J TROP ECOL, V25, P97, DOI 10.1017/S0266467408005671; Charles-Dominique P., 2001, PATRIMOINES NATURELS, V49, P1; Cintra Renato, 2012, International Journal of Ecology, P1; Cisneros LM, 2015, DIVERS DISTRIB, V21, P523, DOI 10.1111/ddi.12277; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cosson JF, 1999, J TROP ECOL, V15, P515, DOI 10.1017/S026646749900098X; Daws MI, 2002, PLANT SOIL, V238, P79, DOI 10.1023/A:1014289930621; de Oliveira LQ, 2015, J MAMMAL, V96, P1036, DOI 10.1093/jmammal/gyv108; Dias-Terceiro RG, 2015, BIOTROPICA, V47, P259, DOI 10.1111/btp.12197; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Farneda FZ, 2015, J APPL ECOL, V52, P1381, DOI 10.1111/1365-2664.12490; Fearnside PM, 2013, WATER ALTERN, V6, P313; Fearnside PM, 2014, WATER ALTERN, V7, P256; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; Fox J, 2016, PACKAGECAR, DOI DOI 10.1177/0049124105277200; Gardner A.L., 2008, MAMMALS S AM MARSUPI; Goulding M, 2003, SMITHSONIAN ATLAS AM; Haugaasen T, 2005, AM J PRIMATOL, V67, P243, DOI 10.1002/ajp.20180; Haugaasen T, 2005, J TROP ECOL, V21, P133, DOI 10.1017/s026646740400207X; IBAMA, 2011, PROGR CONS WILDL FIN; IBGE, 2013, POP RES ENV TRIB CON; Kalko EKV, 1998, ZOOL-ANAL COMPLEX SY, V101, P281; Lees AC, 2016, BIODIVERS CONSERV, V25, P451, DOI 10.1007/s10531-016-1072-3; Lim BK, 2001, BIODIVERS CONSERV, V10, P613, DOI 10.1023/A:1016660123189; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Marciente R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129560; Marinello MM, 2014, CAN J ZOOL, V92, P141, DOI 10.1139/cjz-2013-0127; McCain CM, 2007, GLOBAL ECOL BIOGEOGR, V16, P1, DOI 10.1111/j.1466-8238.2006.00263.x; Medellin RA, 2000, CONSERV BIOL, V14, P1666, DOI [10.1046/j.1523-1739.2000.99068.x, 10.1111/j.1523-1739.2000.99068.x]; Meyer CFJ, 2008, DIVERS DISTRIB, V14, P644, DOI 10.1111/j.1472-4642.2007.00462.x; Meyer CFJ, 2008, J APPL ECOL, V45, P381, DOI 10.1111/j.1365-2664.2007.01389.x; Michalski LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126114; Moser P, 2014, BIOTROPICA, V46, P367, DOI 10.1111/btp.12111; Moulatlet GM, 2014, BIOTROPICA, V46, P395, DOI 10.1111/btp.12117; Nogueira Marcelo Rodrigues, 2014, Check List, V10, P808; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; Oksanen J., 2019, VEGAN COMMUNITY ECOL; Pansonato MP, 2013, BIOTROPICA, V45, P299, DOI 10.1111/btp.12008; Pottmaier D, 2013, RENEW SUST ENERG REV, V19, P678, DOI 10.1016/j.rser.2012.11.063; Rainho A, 2010, J APPL ECOL, V47, P850, DOI 10.1111/j.1365-2664.2010.01820.x; Pereira MJR, 2009, J ANIM ECOL, V78, P1163, DOI 10.1111/j.1365-2656.2009.01591.x; Rebelo Hugo, 2009, Endangered Species Research, V8, P61, DOI 10.3354/esr00100; Ritter CD, 2017, BIOL CONSERV, V206, P161, DOI 10.1016/j.biocon.2016.12.031; Robert A, 2003, ECOL MODEL, V167, P287, DOI 10.1016/S0304-3800(03)00200-X; Rocha R, 2016, LANDSCAPE E IN PRESS; ROSENZWEIG ML, 1981, ECOLOGY, V62, P327, DOI 10.2307/1936707; Schietti J, 2014, PLANT ECOL DIVERS, V7, P241, DOI 10.1080/17550874.2013.783642; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Tavares VD, 2017, ACTA CHIROPTEROL, V19, P93, DOI 10.3161/15081109ACC2017.19.1.007; Tavares Valeria da C., 2013, Chiroptera Neotropical, V19, P57; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; WALSH C., 2013, HIER PART HIERARCHIC; Wu JG, 2004, FRONT ECOL ENVIRON, V2, P241, DOI 10.1890/1540-9295(2004)002[0241:TTGDAE]2.0.CO;2	66	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183036	10.1371/journal.pone.0183036	http://dx.doi.org/10.1371/journal.pone.0183036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886029	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100016
J	Britto-Borges, T; Barton, GJ				Britto-Borges, Thiago; Barton, Geoffrey J.			A study of the structural properties of sites modified by the O-linked 6-N-acetylglucosamine transferase	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; GLCNAC TRANSFERASE; INSULIN-RESISTANCE; X-CHROMOSOME; GLCNACYLATION; PREDICTION; PHOSPHORYLATION; IDENTIFICATION; GLYCOSYLATION; RECOGNITION	Protein O-GlcNAcylation (O-GlcNAc) is an essential post-translational modification (PTM) in higher eukaryotes. The O-linked beta-N-acetylglucosamine transferase (OGT), targets specific Serines and Threonines (S/T) in intracellular proteins. However, unlike phosphorylation, fewer than 25% of known O-GlcNAc sites match a clear sequence pattern. Accordingly, the three-dimensional structures of O-GlcNAc sites were characterised to investigate the role of structure in molecular recognition. From 1,584 O-GlcNAc sites in 620 proteins, 143 were mapped to protein structures determined by X-ray crystallography. The modified S/T were 1.7 times more likely to be annotated in the REM465 field which defines missing residues in a protein structure, while 7 O-GlcNAc sites were solvent inaccessible and unlikely to be targeted by OGT. 132 sites with complete backbone atoms clustered into 10 groups, but these were indistinguishable from clusters from unmodified S/T. This suggests there is no prevalent three-dimensional motif for OGT recognition. Predicted features from the 620 proteins were compared to unmodified S/T in O-GlcNAcylated proteins and globular proteins. The Jpred4 predicted secondary structure shows that modified S/T were more likely to be coils. 5/6 methods to predict intrinsic disorder indicated O-GlcNAcylated S/T to be significantly more disordered than unmodified S/T. Although the analysis did not find a pattern in the site three-dimensional structure, it revealed the residues around the modification site are likely to be disordered and suggests a potential role of secondary structure elements in OGT site recognition.	[Britto-Borges, Thiago; Barton, Geoffrey J.] Univ Dundee, Sch Life Sci, Div Computat Biol, Dundee, Scotland	University of Dundee	Barton, GJ (corresponding author), Univ Dundee, Sch Life Sci, Div Computat Biol, Dundee, Scotland.	g.j.barton@dundee.ac.uk	Barton, Geoffrey J/C-6267-2011	Britto Borges, Thiago/0000-0002-6218-4429; Barton, Geoffrey John/0000-0002-9014-5355	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES process) [1529/12-9]; Wellcome Trust Strategic Awards [WT097945, WT092340, 098439/Z/12/Z]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES process); Wellcome Trust Strategic Awards	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES process 1529/12-9; studentship to T.B.B). Website: http://www.capes.gov.br/. GJB Acknowledges the support of Wellcome Trust Strategic Awards: WT097945, WT092340 and 098439/Z/12/Z. Website https://wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Chen D, 2005, J VIROL, V79, P9381, DOI 10.1128/JVI.79.15.9381-9387.2005; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cuff JA, 2000, PROTEINS, V40, P502, DOI 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Duarte ML, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005412; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hahne H, 2012, MOL CELL PROTEOMICS, V11, P843, DOI 10.1074/mcp.M112.019463; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Jia CZ, 2013, MOL BIOSYST, V9, P2909, DOI 10.1039/c3mb70326f; Jochmann R, 2014, BBA-PROTEINS PROTEOM, V1844, P416, DOI 10.1016/j.bbapap.2013.12.002; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kao HJ, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S18-S10; Kuo M, 2008, FEBS LETT, V582, P829, DOI 10.1016/j.febslet.2008.02.010; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu J, 2007, AM J PHYSIOL-HEART C, V293, pH1391, DOI 10.1152/ajpheart.00285.2007; Liu XY, 2014, FASEB J, V28, P3362, DOI 10.1096/fj.13-246850; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Ma JF, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-8; Mariappa D, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150234; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; McKinney W., 2015, PD TEAM PANDAS POWER, P1625; Nagel AK, 2014, AMINO ACIDS, V46, P2305, DOI 10.1007/s00726-014-1827-7; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; Pathak S, 2015, NAT STRUCT MOL BIOL, V22, P744, DOI 10.1038/nsmb.3063; Rahman AMA, 2013, ACS CHEM BIOL, V8, P2053, DOI 10.1021/cb4004173; ROQUEMORE EP, 1992, J BIOL CHEM, V267, P555; Schimpl M, 2012, NAT CHEM BIOL, V8, P969, DOI [10.1038/nchembio.1108, 10.1038/NCHEMBIO.1108]; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shi J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151085; Trinidad JC, 2012, MOL CELL PROTEOMICS, V11, P215, DOI 10.1074/mcp.O112.018366; Troshin PV, 2011, BIOINFORMATICS, V27, P2001, DOI 10.1093/bioinformatics/btr304; Velankar S., 2011, NUCLEIC ACIDS RES, V39, pD402, DOI [DOI 10.1093/nar/gkq985, 10.1093/nar/gkq985]; Velankar S, 2013, NUCLEIC ACIDS RES, V41, pD483, DOI 10.1093/nar/gks1258; Wang JL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-91; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wu HY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S1; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhao XW, 2015, J THEOR BIOL, V380, P524, DOI 10.1016/j.jtbi.2015.06.026	49	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184405	10.1371/journal.pone.0184405	http://dx.doi.org/10.1371/journal.pone.0184405			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886091	Green Submitted, gold, Green Published			2022-12-27	WOS:000410001100107
J	Carson, S; Shackell, N; Flemming, JM				Carson, Stuart; Shackell, Nancy; Flemming, Joanna Mills			Local overfishing may be avoided by examining parameters of a spatio-temporal model	PLOS ONE			English	Article							COD GADUS-MORHUA; ATLANTIC COD; NORTHERN COD; STOCK ASSESSMENT; GAUSSIAN MODELS; FISH; ABUNDANCE; FISHERIES; DYNAMICS; DENSITY	Spatial erosion of stock structure through local overfishing can lead to stock collapse because fish often prefer certain locations, and fisheries tend to focus on those locations. Fishery managers are challenged to maintain the integrity of the entire stock and require scientific approaches that provide them with sound advice. Here we propose a Bayesian hierarchical spatio-temporal modelling framework for fish abundance data to estimate key parameters that define spatial stock structure: persistence (similarity of spatial structure over time), connectivity (coherence of temporal pattern over space), and spatial variance (variation across the seascape). The consideration of these spatial parameters in the stock assessment process can help identify the erosion of structure and assist in preventing local overfishing. We use Atlantic cod (Gadus morhua) in eastern Canada as a case study an examine the behaviour of these parameters from the height of the fishery through its collapse. We identify clear signals in parameter behaviour under circumstances of destructive stock erosion as well as for recovery of spatial structure even when combined with a non-recovery in abundance. Further, our model reveals the spatial pattern of areas of high and low density persists over the 41 years of available data and identifies the remnant patches. Models of this sort are crucial to recovery plans if we are to identify and protect remaining sources of recolonization for Atlantic cod. Our method is immediately applicable to other exploited species.	[Carson, Stuart; Flemming, Joanna Mills] Dalhousie Univ, Dept Math & Stat, Halifax, NS B3H 3J5, Canada; [Shackell, Nancy] Fisheries & Oceans Canada, Bedford Inst Oceanog, POB 1035, Dartmouth, NS B2Y 4T3, Canada	Dalhousie University; Bedford Institute of Oceanography; Fisheries & Oceans Canada	Carson, S (corresponding author), Dalhousie Univ, Dept Math & Stat, Halifax, NS B3H 3J5, Canada.	st925638@dal.ca	Shackell, Nancy L/AAF-8209-2019	Shackell, Nancy L/0000-0001-5128-948X; Mills Flemming, Joanna/0000-0002-3517-3089	National Sciences and Engineering Research Council (NSERC) of Canada [NETGP 375118-08]	National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by National Sciences and Engineering Research Council (NSERC) of Canada Research Grant (NETGP 375118-08).	Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Cadrin S. X., 2014, STOCK IDENTIFICATION; Cameletti M, 2013, ASTA-ADV STAT ANAL, V97, P109, DOI 10.1007/s10182-012-0196-3; Cameletti M, 2011, ENVIRONMETRICS, V22, P985, DOI 10.1002/env.1139; Campana SE, 1995, CAN J FISH AQUAT SCI, V52, P2445, DOI 10.1139/f95-835; Carson S, 2014, ECOL MODEL, V291, P175, DOI 10.1016/j.ecolmodel.2014.07.022; Ciannelli L, 2013, MAR ECOL PROG SER, V480, P227, DOI 10.3354/meps10067; Corten A, 2013, ICES J MAR SCI, V70, P1, DOI 10.1093/icesjms/fss187; Cosandey-Godin A, 2015, CAN J FISH AQUAT SCI, V72, P186, DOI 10.1139/cjfas-2014-0159; Cressie N. A. C., 2011, STAT SPATIO TEMPORAL; Erisman BE, 2011, CAN J FISH AQUAT SCI, V68, P1705, DOI 10.1139/F2011-090; Fisher JAD, 2004, MAR ECOL PROG SER, V279, P201, DOI 10.3354/meps279201; Frank KT, 2000, CAN J FISH AQUAT SCI, V57, P513, DOI 10.1139/cjfas-57-3-513; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Fu CH, 2001, CAN J FISH AQUAT SCI, V58, P1613, DOI 10.1139/f01-095; Gaston K.J., 2000, PATTERN PROCESS MACR, DOI [10.1002/9780470999592, DOI 10.1002/9780470999592]; Gaston KJ, 2000, J APPL ECOL, V37, P39, DOI 10.1046/j.1365-2664.2000.00485.x; GEISSER S, 1979, J AM STAT ASSOC, V74, P153, DOI 10.2307/2286745; Pennino MG, 2014, J SEA RES, V90, P44, DOI 10.1016/j.seares.2014.03.001; Pennino MG, 2013, J SEA RES, V83, P209, DOI 10.1016/j.seares.2013.03.005; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; Hedger R, 2004, FISH RES, V70, P17, DOI 10.1016/j.fishres.2004.07.002; Hendrichsen D.K., 2012, J ENV STAT, V3; Horsman TL, 2009, DFO CAN TECH REP FIS, V2835; HUTCHINGS JA, 1994, CAN J FISH AQUAT SCI, V51, P2126, DOI 10.1139/f94-214; Hutchings JA, 1996, CAN J FISH AQUAT SCI, V53, P943, DOI 10.1139/f96-097; Kerr LA, 2010, ECOL APPL, V20, P497, DOI 10.1890/08-1382.1; Lindgren F, 2015, J STAT SOFTWARE, V63; Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x; Maury O, 2001, AQUAT LIVING RESOUR, V14, P203, DOI 10.1016/S0990-7440(01)01115-9; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Munoz F, 2013, STOCH ENV RES RISK A, V27, P1171, DOI 10.1007/s00477-012-0652-3; Myers RA, 1997, ECOL APPL, V7, P91, DOI 10.1890/1051-0761(1997)007[0091:WDFSCT]2.0.CO;2; OBIS, 2014, DFO STOT SUMM RES TR; Paradinas I, 2015, MAR ECOL PROG SER, V528, P245, DOI 10.3354/meps11281; Quiroz ZC, 2014, BIOMETRICS; R Core Team, 2021, R LANGUAGE ENV STAT; Reubens JT, 2013, MAR ENVIRON RES, V90, P128, DOI 10.1016/j.marenvres.2013.07.001; Reuchlin-Hugenholtz E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120500; Ricard D, 2013, DFO CAN TECH REP FIS, V3012; Rose GA, 2000, CAN J FISH AQUAT SCI, V57, P644, DOI 10.1139/cjfas-57-3-644; Rose GA, 1999, CAN J FISH AQUAT SCI, V56, P118, DOI 10.1139/cjfas-56-S1-118; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Ruzzante DE, 2006, P ROY SOC B-BIOL SCI, V273, P1459, DOI 10.1098/rspb.2005.3463; Safina C, 2005, SCIENCE, V309, P707, DOI 10.1126/science.1113725; Shackell NL, 1997, ICES J MAR SCI, V54, P383, DOI 10.1006/jmsc.1996.0173; Shackell NL, 2005, ECOL APPL, V15, P1440, DOI 10.1890/04-0642; Shelton AO, 2014, CAN J FISH AQUAT SCI, V71, P1655, DOI 10.1139/cjfas-2013-0508; Simpson D. P., 2015, PENALISING MODEL COM; Simpson D, 2012, SPAT STAT-NETH, V1, P16, DOI 10.1016/j.spasta.2012.02.003; Simpson D, 2012, ENVIRONMETRICS, V23, P65, DOI 10.1002/env.1137; Smith CD, 2013, CDN MANUSCRIPT RPT F, V3013; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Svedang H, 2003, ICES J MAR SCI, V60, P32, DOI 10.1006/jmsc.2002.1330; SWAIN DP, 1993, CAN J FISH AQUAT SCI, V50, P725, DOI 10.1139/f93-083; Tamdrari H, 2010, ICES J MAR SCI, V67, P1676, DOI 10.1093/icesjms/fsq108; Taylor BM, 2012, INLA MCMC TUTORIAL C; Thorson JT, 2014, ICES J MARINE SCI; Walters C, 1996, REV FISH BIOL FISHER, V6, P125; Wright PJ, 2006, FISH RES, V77, P148, DOI 10.1016/j.fishres.2005.10.008; Zuur Alain F., 2009, P1	62	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184427	10.1371/journal.pone.0184427	http://dx.doi.org/10.1371/journal.pone.0184427			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886179	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100119
J	Collin, J; Hill, SE; Eltanani, MK; Plotnikova, E; Ralston, R; Smith, KE				Collin, Jeff; Hill, Sarah E.; Eltanani, Mor Kandlik; Plotnikova, Evgeniya; Ralston, Rob; Smith, Katherine E.			Can public health reconcile profits and pandemics? An analysis of attitudes to commercial sector engagement in health policy and research	PLOS ONE			English	Article							GLOBAL HEALTH; INDUSTRY DOCUMENTS; BIG TOBACCO; ALCOHOL; FOOD; UK	Background Public health's terms of engagement with unhealthy commodity industries (alcohol, tobacco and ultra-processed food and drinks) have become increasingly contested in policy and research. We sought to identify approaches that could attract consensus support within and across policy domains. Methods Using snowball sampling, we undertook an online survey of 335 health researchers, advocates and policymakers, in 40 countries, assessing responses to stated principles, claims and recommendations for engaging with unhealthy commodity industries in relation to key policy and research initiatives. Results Most respondents identified a fundamental conflict between industry interests and public health objectives for all three industries, with agreement greatest in relation to tobacco and weakest for food. This pattern was replicated across diverse questions regarding potential forms of engagement, including in rejecting voluntarism and partnership approaches to health policy. While awareness of tobacco industry tactics to influence policy and research was higher than for alcohol and food, most respondents rejected the view that the influence of the latter was less significant for public health. Proposals that health and research organisations should divest their funds attracted less support with respect to food, while restricting publication of industry-funded research in academic journals was the issue that most divided opinion. Respondents reported most difficulty in answering questions about the food industry. Conclusions The strong consensus around restricting interactions with the tobacco industry supports increased implementation of the WHO Framework Convention on Tobacco Control's conflict of interest provisions. There is strong support for the extension of such practices to the alcohol industry, challenging current norms. More mixed responses indicate a need for greater clarity in defining the food industry, and for research analyzing links, similarities and differences across different types of unhealthy commodity producers. Partnership approaches to addressing non-communicable diseases seem incapable of attracting widespread support across public health, challenging practice in many contexts.	[Collin, Jeff; Hill, Sarah E.; Plotnikova, Evgeniya; Ralston, Rob; Smith, Katherine E.] Univ Edinburgh, Sch Social & Polit Sci, Global Publ Hlth Unit, Social Policy, Edinburgh, Midlothian, Scotland; [Eltanani, Mor Kandlik] NHS Natl Serv Scotland, Informat Serv Div, Gyle Sq,1 South Gyle Crescent, Edinburgh, Midlothian, Scotland	University of Edinburgh; NHS National Services Scotland	Collin, J (corresponding author), Univ Edinburgh, Sch Social & Polit Sci, Global Publ Hlth Unit, Social Policy, Edinburgh, Midlothian, Scotland.	jeff.collin@ed.ac.uk		Hill, Sarah/0000-0003-3555-433X; Smith, Katherine/0000-0002-1060-4102	ESRC [ES/L001284/1]; School of Social and Political Science (SPS), University of Edinburgh [JC-LG-15-16-SRSF]; Economic and Social Research Council [ES/L001284/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); School of Social and Political Science (SPS), University of Edinburgh; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This editorial builds on discussions in the ESRC seminar series 'Tobacco and Alcohol: Policy challenges for public and global health' (grant No ES/L001284/1; esrc.ac.uk), in which JC, SEH and KES are co-investigators. The development of this paper was supported by funding from the School of Social and Political Science (SPS), University of Edinburgh (JC-LG-15-16-SRSF; sps.ed.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, BBC; Bero L, 2003, ANNU REV PUBL HEALTH, V24, P267, DOI 10.1146/annurev.publhealth.24.100901.140813; Bond L, 2009, AUSTRALAS MED J, V2, DOI 10.4066/AMJ.2009.43; Brownell KD, 2009, MILBANK Q, V87, P259, DOI 10.1111/j.1468-0009.2009.00555.x; Cancer Research UK, 2015, COD PRACT TOB IND FU; Casswell S, 2009, LANCET, V373, P2247, DOI 10.1016/S0140-6736(09)60745-5; Chapman S, 2007, PUBLIC HEALTH ADVOCACY AND TOBACCO CONTROL: MAKING SMOKING HISTORY, P1, DOI 10.1002/9780470692479; Collin J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6087; Collin J, 2012, TOB CONTROL, V21, P274, DOI 10.1136/tobaccocontrol-2011-050418; Gilmore AB, 2011, J PUBLIC HLTH; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Limb M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4590; Lincoln P, 2011, LANCET, V378, pE6, DOI 10.1016/S0140-6736(11)61463-3; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; PLoS Medicine Editors, 2010, PLOS MED, V7; Richter Judith, 2012, SOCIAL MED, V6, P141; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Smith KE, 2015, J PUBLIC HEALTH-UK, V37, P6, DOI 10.1093/pubmed/fdu057; UK Department of Health, 2015, RESP DEAL CEL EV; Ulucanlar S, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001629; UN Secretary General, ROAD DIGN 2030 END P; UNESCAP, 2006, WHAT IS GOOD GOV; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; WHO Framework Convention on Tobacco Control, 2008, GUID IMPL ART 5 3 GU; World Health Organization, 2015, A68ACONF3REV1 WORLD; World Health Organization, 2014, 2014 GLOB PROGR REP; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization, 2009, TOB IND INT TOB CONT; World Nutrition Development team, 2014, WORLD NUTR, V5, P511	29	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182612	10.1371/journal.pone.0182612	http://dx.doi.org/10.1371/journal.pone.0182612			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886049	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000410001100009
J	Desvars-Larrive, A; Pascal, M; Gasqui, P; Cosson, JF; Benoit, E; Lattard, V; Crespin, L; Lorvelec, O; Pisanu, B; Teynie, A; Vayssier-Taussat, M; Bonnet, S; Marianneau, P; Lacote, S; Bourhy, P; Berny, P; Pavio, N; Le Poder, S; Gilot-Fromont, E; Jourdain, E; Hammed, A; Fourel, I; Chikh, F; Vourc'h, G				Desvars-Larrive, Amelie; Pascal, Michel; Gasqui, Patrick; Cosson, Jean-Francois; Benoit, Etienne; Lattard, Virginie; Crespin, Laurent; Lorvelec, Olivier; Pisanu, Benoit; Teynie, Alexandre; Vayssier-Taussat, Muriel; Bonnet, Sarah; Marianneau, Philippe; Lacote, Sandra; Bourhy, Pascale; Berny, Philippe; Pavio, Nicole; Le Poder, Sophie; Gilot-Fromont, Emmanuelle; Jourdain, Elsa; Hammed, Abdessalem; Fourel, Isabelle; Chikh, Farid; Vourc'h, Gwenael			Population genetics, community of parasites, and resistance to rodenticides in an urban brown rat (Rattus norvegicus) population	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; NORWAY RATS; ANTICOAGULANT RODENTICIDES; COMPUTER-PROGRAM; LEPTOSPIRA; DIFFERENTIATION; IDENTIFICATION; EVOLUTIONARY; CONSEQUENCES; TRANSMISSION	Brown rats are one of the most widespread urban species worldwide. Despite the nuisances they induce and their potential role as a zoonotic reservoir, knowledge on urban rat populations remains scarce. The main purpose of this study was to characterize an urban brown rat population from Chanteraines park (Hauts-de-Seine, France), with regards to haematology, population genetics, immunogenic diversity, resistance to anticoagulant rodenticides, and community of parasites. Haematological parameters were measured. Population genetics was investigated using 13 unlinked microsatellite loci. Immunogenic diversity was assessed for Mhc-Drb. Frequency of the Y139F mutation (conferring resistance to rodenticides) and two linked microsatellites were studied, concurrently with the presence of anticoagulant residues in the liver. Combination of microscopy and molecular methods were used to investigate the occurrence of 25 parasites. Statistical approaches were used to explore multiple parasite relationships and model parasite occurrence. Eighty-six rats were caught. The first haematological data for a wild urban R. norvegicus population was reported. Genetic results suggested high genetic diversity and connectivity between Chanteraines rats and surrounding population(s). We found a high prevalence (55.8%) of the mutation Y139F and presence of rodenticide residues in 47.7% of the sampled individuals. The parasite species richness was high (16). Seven potential zoonotic pathogens were identified, together with a surprisingly high diversity of Leptospira species (4). Chanteraines rat population is not closed, allowing gene flow and making eradication programs challenging, particularly because rodenticide resistance is highly prevalent. Parasitological results showed that co-infection is more a rule than an exception. Furthermore, the presence of several potential zoonotic pathogens, of which four Leptospira species, in this urban rat population raised its role in the maintenance and spread of these pathogens. Our findings should stimulate future discussions about the development of a long-term rat-control management program in Chanteraines urban park.	[Desvars-Larrive, Amelie] Univ Vet Med, Res Inst Wildlife Ecol, Conservat Med, Vienna, Austria; [Pascal, Michel; Lorvelec, Olivier] INRA, Agrocampus Ouest, ESE, JRU, Rennes, France; [Gasqui, Patrick; Crespin, Laurent; Teynie, Alexandre; Jourdain, Elsa; Vourc'h, Gwenael] VetAgro Sup, INRA, Epidemiol Malad Anim & Zoonot EPIA, JRU, St Genes Champanelle, France; [Cosson, Jean-Francois; Vayssier-Taussat, Muriel; Bonnet, Sarah] ENVA, INRA, Agence Natl Securite Sanit Alimentat Environm & T, Biol Mol & Immunol Parasitaire BIPAR,JRU, Maisons Alfort, France; [Cosson, Jean-Francois] SupAgro Montpellier, IRD, INRA, Ctr Cooperat Int & Rech Agronom Dev CIRAD,CBGP,JR, Montpellier, France; [Benoit, Etienne; Lattard, Virginie; Berny, Philippe; Hammed, Abdessalem; Fourel, Isabelle] Lyon Univ, INRA, VetAgro Sup, Rongeurs Sauvages Risques Sanit & Gest Populat RS, Marcy Letoile, France; [Pisanu, Benoit] CNRS, MNHN, AFB, Unite Mixte Serv UMS Patrimoine Nat 2006, Paris, France; [Marianneau, Philippe; Lacote, Sandra] Agence Natl Securite Sanit Alimentat Environm & T, Virol Unit, Lyon, France; [Bourhy, Pascale] Inst Pasteur, Natl Reference Ctr, Biol Spirochetes Unit, Paris, France; [Bourhy, Pascale] WHO Collaborating Ctr Leptospirosis, Paris, France; [Pavio, Nicole; Le Poder, Sophie] ENVA, INRA, Agence Natl Securite Sanit Alimentat Environm & T, JRU Virol, Maisons Alfort, France; [Gilot-Fromont, Emmanuelle] Univ Claude Bernard Lyon 1, CNRS, LBBE, JRU, Marcy Letoile, France; [Chikh, Farid] Conseil Dept Hauts de Seine, Parc Chanteraines, Paris, France	University of Veterinary Medicine Vienna; INRAE; Institut Agro; Agrocampus Ouest; INRAE; VetAgro Sup; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; VetAgro Sup; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Vourc'h, G (corresponding author), VetAgro Sup, INRA, Epidemiol Malad Anim & Zoonot EPIA, JRU, St Genes Champanelle, France.	gwenael.vourch@inra.fr	Berny, Philippe/C-6945-2019; Berny, Philippe/AAU-2581-2020; Bonnet, Sarah I/AAD-4191-2020; Fourel, Isabelle/AAI-1564-2020	Berny, Philippe/0000-0001-5007-3820; Berny, Philippe/0000-0001-5007-3820; Bonnet, Sarah I/0000-0002-6365-6117; Fourel, Isabelle/0000-0001-5470-612X; Le Poder, Sophie/0000-0001-8642-8187; Gilot-Fromont, Emmanuelle/0000-0003-0011-7519; Desvars-Larrive, Amelie/0000-0001-7671-696X; Crespin, Laurent/0000-0001-8930-215X	Institut National de la Recherche Agronomique (INRA Grant); Agence Nationale de la Recherche (RODENT programme) [ANR-2009-CESA-008]	Institut National de la Recherche Agronomique (INRA Grant); Agence Nationale de la Recherche (RODENT programme)(French National Research Agency (ANR))	This project was supported by Conseil Departmental des Hauts-de-Seine, research funds from the Institut National de la Recherche Agronomique (INRA Grant), and the Agence Nationale de la Recherche (RODENT programme, ANR-2009-CESA-008).	Abdelkrim J, 2005, CONSERV BIOL, V19, P1509, DOI 10.1111/j.1523-1739.2005.00206.x; Anderson R. C., 2009, KEYS NEMATODE PARASI; Aplin KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026357; BARNETT SA, 1953, J HYG-CAMBRIDGE, V51, P16, DOI 10.1017/S002217240001545X; Barnett Samuel A., 1976, RAT STUDY BEHAV; Battersby SA., 2008, PUBLIC HLTH SIGNIFIC, P387; Beaucournu JC, 1990, FRANCE BASSIN MEDITE; Belkhir K, 2001, LOGICIEL SOUS WINDOW, Vv; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berthier K, 2006, MOL ECOL, V15, P2665, DOI 10.1111/j.1365-294X.2006.02959.x; Biek R, 2010, MOL ECOL, V19, P3515, DOI 10.1111/j.1365-294X.2010.04679.x; Bonnet S, 2007, PARASITOLOGY, V134, P197, DOI 10.1017/S0031182006001545; BOYLE CM, 1960, NATURE, V188, P517, DOI 10.1038/188517a0; Calhoun J. B, 1963, ECOLOGY SOCIOLOGY NO; Casanova JC, 2001, PARASITOL RES, V87, P439, DOI 10.1007/s004360100379; Centers for Disease Control and Prevention, 2006, INT PEST MAN COND UR; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Clapperton B. K., 2006, REV CURRENT KNOWLEDG; Cornuet JM, 1996, GENETICS, V144, P2001; Courchamp F, 2003, BIOL REV, V78, P347, DOI 10.1017/S1464793102006061; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; DAVIS DE, 1948, J MAMMAL, V29, P207, DOI 10.2307/1375387; del Rosario Robles Maria, 2008, Comparative Parasitology, V75, P145, DOI 10.1654/4277.1; Desvars A, 2012, AM J TROP MED HYG, V87, P134, DOI 10.4269/ajtmh.2012.12-0102; Durette-Desset MC, 1923, ANN PARASITOL HUM CO, V45, P818; Easterbrook JD, 2007, EPIDEMIOL INFECT, V135, P1192, DOI 10.1017/S0950268806007746; Easterbrook JD, 2005, VECTOR-BORNE ZOONOT, V5, P296, DOI 10.1089/vbz.2005.5.296; Ellegren H, 2016, NAT REV GENET, V17, P422, DOI 10.1038/nrg.2016.58; Feng AYT, 2014, URBAN ECOSYST, V17, P149, DOI 10.1007/s11252-013-0305-4; Firth C, 2014, MBIO, V5, DOI 10.1128/mBio.01933-14; Fourel I, 2017, J CHROMATOGR B, V1041, P120, DOI 10.1016/j.jchromb.2016.12.028; Galan M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-296; GARDNER SL, 1985, CAN J ZOOL, V63, P1463, DOI 10.1139/z85-219; Gardner-Santana LC, 2009, MOL ECOL, V18, P2766, DOI 10.1111/j.1365-294X.2009.04232.x; Grandemange A, 2010, PEST MANAG SCI, V66, P270, DOI 10.1002/ps.1869; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guernier V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004733; Guivier E, 2011, MOL ECOL, V20, P3569, DOI 10.1111/j.1365-294X.2011.05199.x; Hall SA, 2006, J URBAN HEALTH, V83, P162, DOI 10.1007/s11524-005-9016-3; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Heiberg AC, 2012, WILDLIFE RES, V39, P202, DOI 10.1071/WR11149; Higgins JA, 2000, AM J TROP MED HYG, V62, P310, DOI 10.4269/ajtmh.2000.62.310; Himsworth CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091654; HOMBERGER FR, 1991, J CLIN MICROBIOL, V29, P2789, DOI 10.1128/JCM.29.12.2789-2793.1991; HUGOT JP, 1985, B MUS NATL HIST NA A, V4, P383; Johne R, 2010, J GEN VIROL, V91, P750, DOI 10.1099/vir.0.016584-0; Kajdacsi B, 2013, MOL ECOL, V22, P5056, DOI 10.1111/mec.12455; Kampfmann I, 2012, VET CLIN PATH, V41, P228, DOI 10.1111/j.1939-165X.2012.00427.x; Khalil LF, 1994, KEYS CESTODE PARASIT; Klimpel S, 2007, PARASITOL RES, V100, P867, DOI 10.1007/s00436-006-0368-8; Kramski M, 2007, CLIN CHEM, V53, P1899, DOI 10.1373/clinchem.2007.093245; Lehmann JS, 2014, PATHOGENS, V3, P280, DOI 10.3390/pathogens3020280; Lenz TL, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-57; Lorvelec O, 2005, BIOL INVASIONS, V7, P135, DOI 10.1007/s10530-004-9643-8; Mackenstedt U, 2015, INT J PARASITOL-PAR, V4, P71, DOI 10.1016/j.ijppaw.2015.01.006; Makarikov AA, 2013, ACTA PARASITOL, V58, P37, DOI 10.2478/s11686-013-0115-0; MARCONI RT, 1992, J CLIN MICROBIOL, V30, P2830, DOI 10.1128/JCM.30.11.2830-2834.1992; McGuire B, 2006, AM MIDL NAT, V155, P221, DOI 10.1674/0003-0031(2006)155[0221:GEOARP]2.0.CO;2; McKinney ML, 2002, BIOSCIENCE, V52, P883, DOI 10.1641/0006-3568(2002)052[0883:UBAC]2.0.CO;2; Meade TM, 2014, J AM ASSOC LAB ANIM, V53, P661; Meerburg BG, 2009, CRIT REV MICROBIOL, V35, P221, DOI 10.1080/10408410902989837; MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219; Michelet L, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00103; NEI M, 1978, GENETICS, V89, P583; NELSON L, 1973, J MAMMAL, V54, P295, DOI 10.2307/1378903; Ninove L, 2009, EMERG INFECT DIS, V15, P781, DOI 10.3201/eid1505.090235; NORMAN AF, 1995, J CLIN MICROBIOL, V33, P1797, DOI 10.1128/JCM.33.7.1797-1803.1995; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Parola P, 2000, T ROY SOC TROP MED H, V94, P707, DOI 10.1016/S0035-9203(00)90243-8; Pascal M, 2006, INVASIONS BIOLOGIQUE; Pelz HJ, 2005, GENETICS, V170, P1839, DOI 10.1534/genetics.104.040360; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pojmanska T., 2002, VVolume 1, P31, DOI 10.1079/9780851995472.0031; Postic D, 2000, RES MICROBIOL, V151, P333, DOI 10.1016/S0923-2508(00)00156-X; Psaroulaki A, 2010, T ROY SOC TROP MED H, V104, P733, DOI 10.1016/j.trstmh.2010.08.005; QGIS Development Team, 2016, QGIS GEOGR INF SYST, V2; R Development Core Team, 2016, R LANG ENV STAT COMP; Rats Pascal M., 2011, ENCY BIOL INVASIONS, P571; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Ribas A, 2013, ACTA PARASITOL, V58, P389, DOI 10.2478/s11686-013-0156-4; Richardson JL, 2017, EVOL APPL, V10, P323, DOI 10.1111/eva.12449; Rose N, 2011, COMP IMMUNOL MICROB, V34, P419, DOI 10.1016/j.cimid.2011.07.003; Scialfa E, 2010, REV ARGENT MICROBIOL, V42, P126, DOI 10.1590/S0325-75412010000200012; Seed, 2001, PARASITISM DIVERSITY; Singleton GR, 1999, MONOGRAPH, V59; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Smith HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156180; Smith MJ, 2009, P NATL ACAD SCI USA, V106, P7905, DOI 10.1073/pnas.0809145106; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; STAHL WALTER, 1963, KEIO JOUR MED, V12, P55, DOI 10.2302/kjm.12.55; Storz JF, 2001, EVOLUTION, V55, P1215; Theuerkauf J, 2011, ANN ZOOL FENN, V48, P308, DOI 10.5735/086.048.0505; Tollenaere C, 2016, TRENDS PLANT SCI, V21, P80, DOI 10.1016/j.tplants.2015.10.014; Traweger D, 2006, J PEST SCI, V79, P113, DOI 10.1007/s10340-006-0123-z; TURTON JA, 1989, LAB ANIM, V23, P295, DOI 10.1258/002367789780746006; Vandenbroucke V, 2008, J VET PHARMACOL THER, V31, P437, DOI 10.1111/j.1365-2885.2008.00979.x; Vaumourin E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1167-9; Vaumourin E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00062; Villanueva SYAM, 2010, AM J TROP MED HYG, V82, P889, DOI 10.4269/ajtmh.2010.09-0711; Wang J., 2002, GENETICS, V160; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	104	29	30	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184015	10.1371/journal.pone.0184015	http://dx.doi.org/10.1371/journal.pone.0184015			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886097	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100054
J	Locke, SM; Landy, MS				Locke, Shannon M.; Landy, Michael S.			Temporal causal inference with stochastic audiovisual sequences	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; SYNCHRONY; DETERMINANTS; PERCEPTION; NEURONS; SIGNALS; WINDOW; MODEL; RATS	Integration of sensory information across multiple senses is most likely to occur when signals are spatiotemporally coupled. Yet, recent research on audiovisual rate discrimination indicates that random sequences of light flashes and auditory clicks are integrated optimally regardless of temporal correlation. This may be due to 1) temporal averaging rendering temporal cues less effective; 2) difficulty extracting causal-inference cues from rapidly presented stimuli; or 3) task demands prompting integration without concern for the spatiotemporal relationship between the signals. We conducted a rate-discrimination task (Exp 1), using slower, more random sequences than previous studies, and a separate causal-judgement task (Exp 2). Unisensory and multisensory rate-discrimination thresholds were measured in Exp 1 to assess the effects of temporal correlation and spatial congruence on integration. The performance of most subjects was indistinguishable from optimal for spatiotemporally coupled stimuli, and generally sub-optimal in other conditions, suggesting observers used a multisensory mechanism that is sensitive to both temporal and spatial causal-inference cues. In Exp 2, subjects reported whether temporally uncorrelated (but spatially co-located) sequences were perceived as sharing a common source. A unified percept was affected by click-flash pattern similarity and the maximum temporal offset between individual clicks and flashes, but not on the proportion of synchronous click-flash pairs. A simulation analysis revealed that the stimulus-generation algorithms of previous studies is likely responsible for the observed integration of temporally independent sequences. By combining results from Exps 1 and 2, we found better rate-discrimination performance for sequences that are more likely to be integrated than those that are not. Our results support the principle that multisensory stimuli are optimally integrated when spatiotemporally coupled, and provide insight into the temporal features used for coupling in causal inference.	[Locke, Shannon M.; Landy, Michael S.] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Landy, Michael S.] NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Locke, SM (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	shannon.m.locke@nyu.edu	Locke, Shannon/AAP-3302-2020	Locke, Shannon/0000-0003-1787-3345; Landy, Michael/0000-0002-2079-4552	NIH [EY08266]; National Science Foundation-Collaborative Research in Computational Neuroscience [1420262]; NATIONAL EYE INSTITUTE [P30EY013079, R01EY008266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation-Collaborative Research in Computational Neuroscience(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH Grant EY08266 and National Science Foundation-Collaborative Research in Computational Neuroscience Grant 1420262. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Stephanie Badde, Elyse Norton, and Pascal Mamassian for helpful comments. This work was supported by NIH Grant EY08266 and National Science Foundation-Collaborative Research in Computational Neuroscience Grant 1420262.	Alais D, 2004, COGNITIVE BRAIN RES, V19, P185, DOI 10.1016/j.cogbrainres.2003.11.011; Arrighi R, 2006, J VISION, V6, P260, DOI 10.1167/6.3.6; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brunton BW, 2013, SCIENCE, V340, P95, DOI 10.1126/science.1233912; Calvert G., 2004, HDB MULTISENSORY PRO; Carpenter B, 2016, J STAT SOFTW, P20; Chandrasekaran C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000436; Collier GL, 2000, MEM COGNITION, V28, P529, DOI 10.3758/BF03201243; Colonius H, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00011; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Denison RN, 2013, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00619; DIXON NF, 1980, PERCEPTION, V9, P719, DOI 10.1068/p090719; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Goldberg H, 2015, I-PERCEPTION, V6, DOI 10.1177/2041669515599332; Guttman SE, 2005, PSYCHOL SCI, V16, P228, DOI 10.1111/j.0956-7976.2005.00808.x; Hanks TD, 2006, BAYESIAN BRAIN PROBA, P209, DOI [10.7551/mitpress/9780262042383.003.0010, DOI 10.7551/MITPRESS/9780262042383.003.0010]; Innes-Brown H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006450; JACK CE, 1973, PERCEPT MOTOR SKILL, V37, P967, DOI 10.2466/pms.1973.37.3.967; King AJ, 2005, CURR BIOL, V15, pR339, DOI 10.1016/j.cub.2005.04.022; Kleiner M, 2007, PERCEPTION, V36, P14; Kording KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000943; Lewald J, 2001, BEHAV BRAIN RES, V121, P69, DOI 10.1016/S0166-4328(00)00386-7; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; MEREDITH MA, 1987, J NEUROSCI, V7, P3215; Meredith MA, 1996, J NEUROPHYSIOL, V75, P1843, DOI 10.1152/jn.1996.75.5.1843; MEREDITH MA, 1986, BRAIN RES, V365, P350; Noesselt T, 2007, J NEUROSCI, V27, P11431, DOI 10.1523/JNEUROSCI.2252-07.2007; Noesselt T, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00064; Odegaard B, 2016, PSYCHOL SCI, V27, P583, DOI 10.1177/0956797616628860; Otto TU, 2012, CURR BIOL, V22, P1391, DOI 10.1016/j.cub.2012.05.031; Parise CV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11543; Parise CV, 2013, MULTISENS RES, V26, P307, DOI 10.1163/22134808-00002417; Parise CV, 2012, CURR BIOL, V22, P46, DOI 10.1016/j.cub.2011.11.039; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; Raposo D, 2012, J NEUROSCI, V32, P3726, DOI 10.1523/JNEUROSCI.4998-11.2012; Recanzone GH, 2003, J NEUROPHYSIOL, V89, P1078, DOI 10.1152/jn.00706.2002; REGAN D, 1977, PERCEPTION, V6, P133, DOI 10.1068/p060133; Rohde M, 2016, MULTISENS RES, V29, P279, DOI 10.1163/22134808-00002510; Shen Y, 2015, BEHAV RES METHODS, V47, P13, DOI 10.3758/s13428-014-0450-6; Sheppard JP, 2013, J VISION, V13, DOI 10.1167/13.6.4; SHIPLEY T, 1964, SCIENCE, V145, P1328, DOI 10.1126/science.145.3638.1328; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Spence C, 2013, ANN NY ACAD SCI, V1296, P31, DOI 10.1111/nyas.12121; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Stephan KE, 2009, NEUROIMAGE, V46, P1004, DOI 10.1016/j.neuroimage.2009.03.025; Stevenson RA, 2012, J EXP PSYCHOL HUMAN, V38, P1517, DOI 10.1037/a0027339; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Van der Burg E, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3083; Van der Burg E, 2013, J NEUROSCI, V33, P14633, DOI 10.1523/JNEUROSCI.1182-13.2013; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Varghese L, 2017, J ACOUST SOC AM, V141, P2474, DOI 10.1121/1.4979470; Vatakis A, 2010, MULTISENSORY OBJECT PERCEPTION IN THE PRIMATE BRAIN, P95, DOI 10.1007/978-1-4419-5615-6_7; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; WELCH RB, 1986, PERCEPT PSYCHOPHYS, V39, P294, DOI 10.3758/BF03204939; Zampini M, 2005, PERCEPT PSYCHOPHYS, V67, P531, DOI 10.3758/BF03193329	56	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183776	10.1371/journal.pone.0183776	http://dx.doi.org/10.1371/journal.pone.0183776			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886035	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100037
J	Mihalitsis, M; Bellwood, DR				Mihalitsis, Michalis; Bellwood, David R.			A morphological and functional basis for maximum prey size in piscivorous fishes	PLOS ONE			English	Article							LIONFISH PTEROIS-VOLITANS; MICROPTERUS-SALMOIDES; LARGEMOUTH BASS; HANDLING TIME; FEEDING MECHANISM; CICHLID FISHES; MARINE FISH; REEF FISHES; HABITAT USE; BODY-SIZE	Fish predation is important in shaping populations and community structure in aquatic systems. These predator-prey interactions can be influenced by environmental, behavioural and morphological factors. Morphological constraints influence the feeding performance of species, and interspecific differences can thus affect patterns of resource use. For piscivorous fishes that swallow prey whole, feeding performance has traditionally been linked to three key morphological constraints: oral gape, pharyngeal gape, and the cleithral gape. However, other constraints may be important. We therefore examine 18 potential morphological constraints related to prey capture and processing, on four predatory species (Cephalopholis urodeta, Paracirrhites forsteri, Pterois volitans, Lates calcarifer). Aquarium-based experiments were then carried out to determine capture and processing behaviour and maximum prey size in two focal species, C. urodeta and P. forsteri. All four species showed a progressive decrease in gape measurements from anterior to posterior with oral gape >= buccal >= pharyngeal >= pectoral girdle >= esophagus >= stomach. C. urodeta was able to process prey with a maximum depth of 27% of the predators' standard length; for P. forsteri it was 20%. C. urodeta captured prey head-first in 79% of successful strikes. In P. forsteri head-first was 16.6%, mid-body 44.4%, and tail-first 38.8%. Regardless of capture mode, prey were almost always swallowed head first and horizontally in both focal species. Most internal measurements appeared too small for prey to pass through. This may reflect the compressibility of prey, i.e. their ability to be dorsoventrally compressed during swallowing movements. Despite examining all known potential morphological constraints on prey size, horizontal maxillary oral gape in a mechanically stretched position appears to be the main morphological variable that is likely to affect maximum prey size and resource use by these predatory species.	[Mihalitsis, Michalis; Bellwood, David R.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Mihalitsis, Michalis; Bellwood, David R.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia	James Cook University; James Cook University	Mihalitsis, M (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.; Mihalitsis, M (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia.	mike.mihalitsis@my.jcu.edu.au	Mihalitsis, Michalis/AAG-8919-2020		Australian Research Council (DRB) [CE140100020]	Australian Research Council (DRB)(Australian Research Council)	This study was funded by the Australian Research Council (DRB: grant number CE140100020. URL: http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Albins MA, 2013, ENVIRON BIOL FISH, V96, P1151, DOI 10.1007/s10641-011-9795-1; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; Bellwood D, 2014, P R SOC B; Bellwood DR, 2017, CURR BIOL, V27, pR13, DOI 10.1016/j.cub.2016.11.018; Burress ED, 2016, ECOL FRESHW FISH, V25, P590, DOI 10.1111/eff.12236; Choat J.H., 1991, P39; Christensen B, 1996, OIKOS, V76, P368, DOI 10.2307/3546209; Feitl KE, 2010, J EXP BIOL, V213, P3131, DOI 10.1242/jeb.045518; Gibran FZ, 2007, NEOTROP ICHTHYOL, V5, P387, DOI 10.1590/S1679-62252007000300018; Gidmark NJ, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1181; Goatley CHR, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1858; Graeb BDS, 2005, CAN J FISH AQUAT SCI, V62, P2010, DOI 10.1139/F05-112; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; HAMBRIGHT KD, 1991, T AM FISH SOC, V120, P500, DOI 10.1577/1548-8659(1991)120<0500:EAOPSB>2.3.CO;2; Hixon M.A., 1991, P475; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; Hobson E.S., 1979, PREDATOR PREY SYSTEM, P231; HOYLE JA, 1987, CAN J ZOOL, V65, P1972, DOI 10.1139/z87-300; HOYLE JA, 1988, CAN J ZOOL, V66, P540, DOI 10.1139/z88-079; Juanes Francis, 1994, Belle W. Baruch Library in Marine Science, V18, P79; Kane C, 2009, ENVIRON BIOL FISH, V84, P1, DOI 10.1007/s10641-008-9377-z; LAWRENCE J. M., 1958, PROC ANN CONF SOUTHEASTERN ASSOC GAME AND FISH COMM, V11, P220; Lesmeister C., 2015, MASTERING MACHINE LE; LIEM KF, 1978, J MORPHOL, V158, P323, DOI 10.1002/jmor.1051580305; LUCZKOVICH JJ, 1995, ENVIRON BIOL FISH, V44, P79, DOI 10.1007/BF00005908; McGee MD, 2015, SCIENCE, V350, P1077, DOI 10.1126/science.aab0800; MITTELBACH GG, 1981, ECOLOGY, V62, P1370, DOI 10.2307/1937300; MOODY RC, 1983, ENVIRON BIOL FISH, V8, P61, DOI 10.1007/BF00004947; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Nilsson PA, 2000, OIKOS, V88, P539, DOI 10.1034/j.1600-0706.2000.880310.x; NILSSON PA, 1995, OECOLOGIA, V104, P291, DOI 10.1007/BF00328363; NORTON SF, 1995, ENVIRON BIOL FISH, V44, P287, DOI 10.1007/BF00005921; OSENBERG CW, 1989, ECOL MONOGR, V59, P405, DOI 10.2307/1943074; REIMCHEN TE, 1991, CAN J ZOOL, V69, P2912, DOI 10.1139/z91-410; RICHARD BA, 1995, J EXP BIOL, V198, P419; Scharf FS, 2000, MAR ECOL PROG SER, V208, P229, DOI 10.3354/meps208229; SHPIGEL M, 1989, ENVIRON BIOL FISH, V24, P67, DOI 10.1007/BF00001611; St John J, 1999, MAR ECOL PROG SER, V180, P233, DOI 10.3354/meps180233; Stewart WJ, 2013, J EXP BIOL, V216, P388, DOI 10.1242/jeb.072751; Therneau Terry., 2017, RPART RECURSIVE PART; Truemper HA, 2005, J FISH BIOL, V66, P135, DOI 10.1111/j.0022-1112.2005.00588.x; Vincent SE, 2006, OECOLOGIA, V147, P204, DOI 10.1007/s00442-005-0258-2; Wainwright P.C., 1994, ECOLOGICAL MORPHOLOG; WAINWRIGHT PC, 1987, J ZOOL, V213, P283, DOI 10.1111/j.1469-7998.1987.tb03704.x; WAINWRIGHT PC, 1991, AM ZOOL, V31, P680; WAINWRIGHT PC, 1988, ECOLOGY, V69, P635, DOI 10.2307/1941012; Wainwright PC, 2004, BIOL J LINN SOC, V82, P1, DOI 10.1111/j.1095-8312.2004.00313.x; Wainwright PC, 2001, J EXP BIOL, V204, P3039; WAINWRIGHT PC, 1995, ENVIRON BIOL FISH, V44, P97, DOI 10.1007/BF00005909; Wainwright PC, 2017, CURR BIOL, V27, pR550, DOI 10.1016/j.cub.2017.03.044; Wainwright Peter C., 2002, P33, DOI 10.1016/B978-012615185-5/50004-9; WERNER EE, 1974, J FISH RES BOARD CAN, V31, P1531, DOI 10.1139/f74-186; WERNER EE, 1977, AM NAT, V111, P553, DOI 10.1086/283184; WESTNEAT MW, 1990, J MORPHOL, V205, P269, DOI 10.1002/jmor.1052050304; Whitfield PE, 2002, MAR ECOL PROG SER, V235, P289, DOI 10.3354/meps235289	57	44	46	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184679	10.1371/journal.pone.0184679	http://dx.doi.org/10.1371/journal.pone.0184679			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886161	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000410001100177
J	Wang, JH; Kong, YM; Fu, T; Stipancic, J				Wang, Junhua; Kong, Yumeng; Fu, Ting; Stipancic, Joshua			The impact of vehicle moving violations and freeway traffic flow on crash risk: An application of plugin development for microsimulation	PLOS ONE			English	Article							SAFETY; SIMULATION; COLLISION; SYSTEMS; TIME	This paper presents the use of the Aimsun microsimulation program to simulate vehicle violating behaviors and observe their impact on road traffic crash risk. Plugins for violations of speeding, slow driving, and abrupt stopping were developed using Aimsun's API and SDK module. A safety analysis plugin for investigating probability of rear- end collisions was developed, and a method for analyzing collision risk is proposed. A Fuzzy C-mean Clustering algorithm was developed to identify high risk states in different road segments over time. Results of a simulation experiment based on the G15 Expressway in Shanghai showed that abrupt stopping had the greatest impact on increasing collision risk, and the impact of violations increased with traffic volume. The methodology allows for the evaluation and monitoring of risks, alerting of road hazards, and identification of hotspots, and could be applied to the operations of existing facilities or planning of future ones.	[Wang, Junhua; Kong, Yumeng] Tongji Univ, Coll Transportat Engn, Shanghai, Peoples R China; [Fu, Ting; Stipancic, Joshua] McGill Univ, Dept Civil Engn & Appl Mech, Montreal, PQ, Canada	Tongji University; McGill University	Fu, T (corresponding author), McGill Univ, Dept Civil Engn & Appl Mech, Montreal, PQ, Canada.	ting.fu@mail.mcgill.ca		Fu, Ting/0000-0002-7097-1262	National Natural Science Foundation [71671126]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the National Natural Science Foundation (71671126) and the Fundamental Research Funds for the Central Universities.	AHTD, 2009, BELL VIST BYP SAF AN; American Automobile Association, 2009, AGGR DRIV RES; [Anonymous], 2010, BULLETIN; Barcelo A, 2014, TECHNICAL NOTES; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Boxill SA, 2000, SWUTC001676021 TEX S; BTS, 2003, BTS0301; Carbaugh J, 1998, TRANSPORT RES C-EMER, V6, P69, DOI 10.1016/S0968-090X(98)00009-6; Chattopadhyay S, 2011, COMPUT INFORM, V30, P701; Chen S, 2015, STUDY TRAFFIC RISK A, P102; Chong LS, 2011, TRANSPORT RES REC, P44, DOI 10.3141/2249-07; Dunn J.C., 1973, J CYBERNETICS, V3, P32, DOI [10.1080/01969727308546046, DOI 10.1080/01969727308546046]; *ETSC, 1999, POL ENF STRAT RED TR; EVANS L, 1982, ACCIDENT ANAL PREV, V14, P57, DOI 10.1016/0001-4575(82)90007-0; Fambro DB, 1998, TRANSPORT RES REC, P1; FHWA (Federal Highway Administration), 2008, SURROGATE SAFETY ASS; Fu T, 2017, NOVEL FRAMEWORK EVAL; Fu T, 2016, TRANSPORT RES REC, P90, DOI 10.3141/2586-10; Fu T, 2015, J MOD TRANSP, V23, P81, DOI 10.1007/s40534-015-0073-3; Gettman D, 2003, FHWARD03050 SIEM GAR; Habtemichael FG, 2014, TRANSPORT RES F-TRAF, V23, P101, DOI 10.1016/j.trf.2013.12.022; Hawick, 2009, RES LETT INFORM MATH, V13, P35; Hourdos JN, 2006, TRANSPORT RES REC, P83, DOI 10.3141/1968-10; JAMES F, 1980, REP PROG PHYS, V43, P1145, DOI 10.1088/0034-4885/43/9/002; Jeannotte K, 2004, TRAFFIC ANAL TOOLBOX; [江周 Jiang Zhou], 2014, [中国安全科学学报, China Safety Science Journal（CSSJ）], V24, P95; Khattak AJ, 1998, TRANSPORT RES REC, P10, DOI 10.3141/1621-02; Koppa, 1997, 400 NCHRP; Kroese DP, 2014, WIRES COMPUT STAT, V6, P386, DOI 10.1002/wics.1314; Li M., 2011, THESIS; Li S., 2016, INT J ENV RES PUBLIC, V13; Li X., 2014, TRANSPORTATION STAND, V42, P7; [卢川 LU Chuan], 2008, [合肥工业大学学报. 自然科学版, Journal of Hefei University of Technology. Natural Science], V31, P683; MA J, 2004, 83 ANN M TRANSP RES; Oh C, 2006, ACCIDENT ANAL PREV, V38, P295, DOI 10.1016/j.aap.2005.09.009; Oh C, 2009, TRANSPORT RES REC, P35, DOI 10.3141/2129-05; Ozbay K, 2008, TRANSPORT RES REC, P105, DOI 10.3141/2083-12; Parker D., 1998, TRANSPORT RES F-TRAF, V1, P11, DOI [DOI 10.1016/S1369-8478(98)00002-3, 10.1016/S1369-8478(98)00002-3]; Piao J, 2008, PROCEEDINGS OF THE 11TH INTERNATIONAL IEEE CONFERENCE ON INTELLIGENT TRANSPORTATION SYSTEMS, P833, DOI 10.1109/ITSC.2008.4732618; Postorino MN, 2003, AET PAPERS REPOSITOR; Punzo V, 2011, IEEE T INTELL TRANSP, V12, P354, DOI 10.1109/TITS.2010.2095846; Rakha H, 2009, TRANSPORT RES REC, P113, DOI 10.3141/2124-11; Saccomanno FF, 2008, TRANSPORT RES REC, P90, DOI 10.3141/2078-12; Shahi Jalil, 2009, Ing. Desarro., P67; Shi J, 2002, SIMULATION TECHNOLOG; Song R, 2016, SIMUL-T SOC MOD SIM, V92, P535, DOI 10.1177/0037549716645197; St-Aubin P, 2013, TRANSPORT RES C-EMER, V36, P284, DOI 10.1016/j.trc.2013.08.015; Tak S, 2015, IEEE T INTELL TRANSP, V16, P2435, DOI 10.1109/TITS.2015.2409374; Tarko A, 2009, ANB20 3 SUBCOMMITTE; Traffic Management Bureau of the Ministry of Public Security PRC, 2015, ROAD TRAFF ACC STAT; Tsao H.-S. J., 1994, IVHS Journal, V1, P261, DOI 10.1080/10248079408903798; TSS, 2011, AIMS MICR API MAN; TSS, 2014, AIMS 8 US MAN; TSS, 1997, AIMS DYN SIM US MAN; Vilarinho C, 2013, P 10 INT C ENV EL EN, P1; Vogel K, 2003, ACCIDENT ANAL PREV, V35, P427, DOI 10.1016/S0001-4575(02)00022-2; Voumard J, 2013, NAT HAZARD EARTH SYS, V13, P2763, DOI 10.5194/nhess-13-2763-2013; Wang D., 2002, TRAFFIC FLOW THEORY, P13; Webster F.V., 1958, ROAD RES LAB TECH PA; [项乔君 XIANG Qiaojun], 2008, [公路交通科技, Journal of Highway and Transportation Research and Development], V25, P128; Yan Ying, 2011, Journal of Traffic and Transportation Engineering, V11, P90; Young W, 2014, ACCIDENT ANAL PREV, V66, P89, DOI 10.1016/j.aap.2014.01.008; Yu RX, 2013, THESIS; Zhang GN, 2013, ACCIDENT ANAL PREV, V59, P18, DOI 10.1016/j.aap.2013.05.004; Zhou J., 2011, J CHONGQING JIAOTONG, V30, P974	65	10	10	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184564	10.1371/journal.pone.0184564	http://dx.doi.org/10.1371/journal.pone.0184564			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886141	Green Submitted, gold, Green Published			2022-12-27	WOS:000410001100156
J	Eichwald, C; Kim, J; Nibert, ML				Eichwald, Catherine; Kim, Jonghwa; Nibert, Max L.			Dissection of mammalian orthoreovirus mu 2 reveals a self-associative domain required for binding to microtubules but not to factory matrix protein mu NS	PLOS ONE			English	Article							REOVIRUS M1 GENE; CORE PROTEIN; TRIPHOSPHATASE ACTIVITIES; CRYOELECTRON MICROSCOPY; ANGSTROM RESOLUTION; INFECTIOUS VIRUS; TOP COMPONENT; RNA-SYNTHESIS; CELL TROPISM; STRANDED-RNA	Mammalian orthoreovirus protein mu 2 is a component of the viral core particle. Its activities include RNA binding and hydrolysis of the.-phosphate from NTPs and RNA 5'-termini, suggesting roles as a cofactor for the viral RNA-dependent RNA polymerase, lambda 3, first enzyme in 5'-capping of viral plus-strand RNAs, and/or prohibitory of RNA-5'-triphosphate-activated antiviral signaling. Within infected cells, mu 2 also contributes to viral factories, cytoplasmic structures in which genome replication and particle assembly occur. By associating with both microtubules (MTs) and viral factory matrix protein mu NS, mu 2 can anchor the factories to MTs, the full effects of which remain unknown. In this study, a protease-hypersensitive region allowed mu 2 to be dissected into two large fragments corresponding to residues 1-282 and 283-736. Fusions with enhanced green fluorescent protein revealed that these aminoand carboxyl-terminal regions of mu 2 associate in cells with either MTs or mu NS, respectively. More exhaustive deletion analysis defined mu 2 residues 1-325 as the minimal contiguous region that associates with MTs in the absence of the self-associating tag. A region involved in mu 2 self-association was mapped to residues 283-325, and self-association involving this region was essential for MT-association as well. Likewise, we mapped that mu NS-binding site in mu 2 relates to residues 290-453 which is independent of mu 2 self-association. These findings suggest that mu 2 monomers or oligomers can bind to MTs and mu NS, but that self-association involving mu 2 residues 283-325 is specifically relevant for MT-association during viral factories formation.	[Eichwald, Catherine; Kim, Jonghwa; Nibert, Max L.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02215 USA; [Eichwald, Catherine] Univ Zurich, Inst Virol, Zurich, Switzerland; [Kim, Jonghwa] Samsung Med Ctr, Lab Gastroenterol, Seoul, South Korea	Harvard University; Harvard Medical School; University of Zurich; Sungkyunkwan University (SKKU); Samsung Medical Center	Eichwald, C (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02215 USA.; Eichwald, C (corresponding author), Univ Zurich, Inst Virol, Zurich, Switzerland.	ceichwald@vetvir.uzh.ch		Eichwald, Catherine/0000-0003-0001-4843	NIH [R01 AI47904, R56 AI067445]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by NIH research grants R01 AI47904 and R56 AI067445 to MLN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Brentano L, 1998, J VIROL, V72, P8354, DOI 10.1128/JVI.72.10.8354-8357.1998; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Broering TJ, 2002, J VIROL, V76, P8285, DOI 10.1128/JVI.76.16.8285-8297.2002; Broering TJ, 2000, J VIROL, V74, P5516, DOI 10.1128/JVI.74.12.5516-5524.2000; Carvalho J, 2007, VIROLOGY, V364, P301, DOI 10.1016/j.virol.2007.03.037; Chandran K, 2003, J VIROL, V77, P13361, DOI 10.1128/JVI.77.24.13361-13375.2003; Chappell JD, 2002, EMBO J, V21, P1, DOI 10.1093/emboj/21.1.1; Coombs KM, 1996, J VIROL, V70, P4237, DOI 10.1128/JVI.70.7.4237-4245.1996; Coombs KM, 1998, VIROLOGY, V243, P218, DOI 10.1006/viro.1998.9061; Criglar JM, 2014, J VIROL, V88, P786, DOI 10.1128/JVI.03022-13; Desmet EA, 2014, MBIO, V5, DOI 10.1128/mBio.01463-14; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Dryden KA, 1998, VIROLOGY, V245, P33, DOI 10.1006/viro.1998.9146; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; Eichwald C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047947; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GARD G, 1970, J VIROL, V6, P100, DOI 10.1128/JVI.6.1.100-106.1970; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; HALLER BL, 1995, J VIROL, V69, P357, DOI 10.1128/JVI.69.1.357-364.1995; Hermann LL, 2004, J VIROL, V78, P6171, DOI 10.1128/JVI.78.12.6171-6179.2004; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Irvin SC, 2012, J VIROL, V86, P2302, DOI 10.1128/JVI.06236-11; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Kiemer L, 2005, BIOINFORMATICS, V21, P1269, DOI 10.1093/bioinformatics/bti130; Kim J, 2004, VIRUS RES, V101, P15, DOI 10.1016/j.virusres.2003.12.003; Kim J, 2004, J BIOL CHEM, V279, P4394, DOI 10.1074/jbc.M308637200; Kobayashi T, 2006, J VIROL, V80, P9053, DOI 10.1128/JVI.00276-06; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; LEMIEUX R, 1984, J VIROL, V51, P215, DOI 10.1128/JVI.51.1.215-222.1984; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; MATOBA Y, 1991, J CLIN INVEST, V87, P1628, DOI 10.1172/JCI115177; MATOBA Y, 1993, J CLIN INVEST, V92, P2883, DOI 10.1172/JCI116910; Mbisa JL, 2000, VIROLOGY, V272, P16, DOI 10.1006/viro.2000.0362; Miller CL, 2007, MOL CELL PROTEOMICS, V6, P1027, DOI 10.1074/mcp.M700056-MCP200; Miller CL, 2010, J VIROL, V84, P867, DOI 10.1128/JVI.01571-09; Miller CL, 2004, J VIROL, V78, P10291, DOI 10.1128/JVI.78.19.10291-10302.2004; Murray KE, 2007, J VIROL, V81, P4572, DOI 10.1128/JVI.02106-06; MUSTOE TA, 1978, VIROLOGY, V89, P594, DOI 10.1016/0042-6822(78)90200-3; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; Nguyen CL, 2007, J VIROL, V81, P13533, DOI 10.1128/JVI.01669-07; Nibert ML, 2004, J VIROL, V78, P5528, DOI 10.1128/JVI.78.10.5528-5530.2004; NIBERT ML, 1991, J VIROL, V65, P1960, DOI 10.1128/JVI.65.4.1960-1967.1991; Noble S, 1997, J VIROL, V71, P7728, DOI 10.1128/JVI.71.10.7728-7735.1997; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olland AM, 2001, EMBO J, V20, P979, DOI 10.1093/emboj/20.5.979; Ooms LS, 2012, J VIROL, V86, P10979, DOI 10.1128/JVI.01172-12; Ooms LS, 2010, J BIOL CHEM, V285, P41604, DOI 10.1074/jbc.M110.176255; Parker JSL, 2002, J VIROL, V76, P4483, DOI 10.1128/JVI.76.9.4483-4496.2002; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; RHIM JS, 1962, VIROLOGY, V17, P342, DOI 10.1016/0042-6822(62)90125-3; Riederer BM, 2007, BRAIN RES BULL, V71, P541, DOI 10.1016/j.brainresbull.2006.11.012; Sagar V, 2014, VIRUS RES, V183, P30, DOI 10.1016/j.virusres.2014.01.018; Schmitz AM, 2009, NAT METHODS, V6, P500, DOI 10.1038/nmeth.1337; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHARPE AH, 1982, VIROLOGY, V120, P399, DOI 10.1016/0042-6822(82)90040-X; Sherry B, 1998, CURR TOP MICROBIOL, V233, P51; SHERRY B, 1989, J VIROL, V63, P4850, DOI 10.1128/JVI.63.11.4850-4856.1989; Sherry B, 1996, J VIROL, V70, P6709, DOI 10.1128/JVI.70.10.6709-6715.1996; Sherry B, 2009, J INTERF CYTOK RES, V29, P559, DOI 10.1089/jir.2009.0072; SMITH RE, 1969, VIROLOGY, V39, P791, DOI 10.1016/0042-6822(69)90017-8; SPENDLOVE RS, 1963, J IMMUNOL, V90, P548; Stebbing RE, 2014, J VIROL, V88, P2572, DOI 10.1128/JVI.02573-13; Su YP, 2006, J VIROL METHODS, V133, P146, DOI 10.1016/j.jviromet.2005.10.031; Swanson MI, 2002, RAPID COMMUN MASS SP, V16, P2317, DOI 10.1002/rcm.866; Tao YZ, 2002, CELL, V111, P733, DOI 10.1016/S0092-8674(02)01110-8; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; Yin P, 1996, J VIROL, V70, P1223, DOI 10.1128/JVI.70.2.1223-1227.1996; Yin P, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-6; Zhang GH, 1996, BIOCHEM BIOPH RES CO, V227, P707, DOI 10.1006/bbrc.1996.1573; Zhang X, 2003, NAT STRUCT BIOL, V10, P1011, DOI 10.1038/nsb1009; Zurney J, 2009, J VIROL, V83, P2178, DOI 10.1128/JVI.01787-08	74	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184356	10.1371/journal.pone.0184356	http://dx.doi.org/10.1371/journal.pone.0184356			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880890	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000409467200057
J	Kydd, E; McGreevy, P				Kydd, Erin; McGreevy, Paul			Sex differences in the herding styles of working sheepdogs and their handlers	PLOS ONE			English	Article							DOGS; OWNERS	Working sheepdog trials test the attributes of dogs as well as the dogmanship and stockmanship skills of handlers. They generally include standard elements such as outrun, lift, fetch, drive, shed, pen and single to test all facets of the work that dogs perform on a farm. While both male and female handlers participate, these trials are traditionally dominated by male handlers. Both male and female dogs compete on equal terms within the same events. Drawing data from files (n = 60) downloaded from YouTube, the current study explores whether behaviours of dogs and their handlers during sheepdog trials differ between handler gender and dog sex at different levels of competition. It compared the stalking, crouching, chasing and stationary behaviours of dogs in open (n = 28 dogs: 10 females, 18 males) and not-open trials (n = 32 dogs: 20 females, 12 males). The dogs in this study had male (n = 38) and female (n = 22) handlers, whose movement and use of vocal cues and arm elevations were also compared. However, the small sample size and limitations of these videos as a data source should be noted before the results are generalised to the broader field of working-dog behaviour. The results of an REstricted Maximum Likelihood test showed that male handlers spent, on average, significantly more time in the fetch and drive elements than female handlers, but this difference between sexes was present only in not-open events (mean time to Fetch, female handler = 44.07s, male handler = 124.00s, P<0.001, mean time to Drive, female handler = 95.8s, male handler = 152.4, P = 0.010). This may suggest that female handlers of less experienced dogs are better at the early training of these elements. The results showed that male dogs spent more time stationary than female dogs, but only in open competition (male dog predicted mean 6.17s, P = 0.014). Revealing differences between men/women, and between dogs/bitches in this context may identify pairings that complement each other and improve selection, training and handling of working dogs. It is also hoped that ultimately, it will lead to improved welfare for dogs and the livestock with which they interact.	[Kydd, Erin; McGreevy, Paul] Univ Sydney, Fac Vet Sci, Sydney, NSW, Australia	University of Sydney	Kydd, E (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW, Australia.	erin.kydd@students.mq.edu.au		McGreevy, Paul/0000-0001-7220-8378				Arnott ER, ANIMAL WELFARE, V23, P189; Daliblard GH, 2009, J VET BEHAV, V4, P19, DOI 10.1016/j.jveb.2008.08.008; Early J, J VET BEHAV CLIN APP, V9, pe17; Early JB, J VET BEHAV CLIN APP, V9, P370; Entin P, 2007, PHYSIOLOGY, V4, P135; GODDARD ME, 1982, THEOR APPL GENET, V62, P97, DOI 10.1007/BF00293339; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Jones AC, 2006, HORM BEHAV, V50, P393, DOI 10.1016/j.yhbeh.2006.04.007; Kilgour R, 1970, NZ SOC ANIM PROD PRO; McGreevy Paul, 2007, CARROTS STICKS PRINC; McGreevy PD, 2008, APPL ANIM BEHAV SCI, V109, P320, DOI 10.1016/j.applanim.2007.04.001; Prato-Previde E, 2006, ETHOLOGY, V112, P64, DOI 10.1111/j.1439-0310.2006.01123.x; Serpell JA, 2005, ANTHROZOOS, V18, P196, DOI 10.2752/089279305785594135; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P157, DOI 10.1016/S0168-1591(02)00120-X; Udell MA, ANIMAL BEHAV, V89, P99; Wells DL, 1999, APPL ANIM BEHAV SCI, V61, P341, DOI 10.1016/S0168-1591(98)00202-0	16	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184072	10.1371/journal.pone.0184072	http://dx.doi.org/10.1371/journal.pone.0184072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910326	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200028
J	Nakayama, M; Itami, N; Suzuki, H; Hamada, H; Osaka, N; Yamamoto, R; Tsunoda, K; Nakano, H; Watanabe, K; Zhu, WJ; Maruyama, Y; Terawaki, H; Kabayama, S; Nakazawa, R; Miyazaki, M; Ito, S				Nakayama, Masaaki; Itami, Noritomo; Suzuki, Hodaka; Hamada, Hiromi; Osaka, Naoyuki; Yamamoto, Ryo; Tsunoda, Kazumasa; Nakano, Hirofumi; Watanabe, Kimio; Zhu, Wan-Jun; Maruyama, Yukio; Terawaki, Hiroyuki; Kabayama, Shigeru; Nakazawa, Ryoichi; Miyazaki, Mariko; Ito, Sadayoshi			Possible clinical effects of molecular hydrogen (H-2) delivery during hemodialysis in chronic dialysis patients: Interim analysis in a 12 month observation	PLOS ONE			English	Article							ELECTROLYZED-REDUCED WATER; RENAL-DISEASE PATIENTS; CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; UREMIC PRURITUS; CARDIOVASCULAR-DISEASE; CONTROLLED-TRIAL; INFLAMMATION; THERAPY; FATIGUE	Background and aim It is supposed that enhanced oxidative stress and inflammation are involved with the poor clinical outcomes in patients on chronic dialysis treatment. Recent studies have shown that molecular hydrogen (H-2) is biologically active as an anti-inflammatory agent. Thus, we developed a novel hemodialysis (E-HD) system which delivers H-2 (30 to 80 ppb)-enriched dialysis solution, to conduct a prospective observational study (UMIN000004857) in order to compare the long-term outcomes between E-HD and conventional-HD (C-HD) in Japan. The present interim analysis aimed to look at potential clinical effects of E-HD during the first 12 months observation. Subjects and method 262 patients (140, E-HD; 122, C-HD) were subjected for analysis for comprehensive clinical profiles. They were all participating in the above mentioned study, and they had been under the respective HD treatment for 12 consecutive months without hospitalization. Collected data, such as, physical and laboratory examinations, medications, and self-assessment questionnaires on subjective symptoms (i. e., fatigue and pruritus) were compared between the two groups. Results In a 12-month period, no clinical relevant differences were found in dialysis-related parameters between the two groups. However, there were differences in the defined daily dose of anti-hypertensive agents, and subjective symptoms, such as severe fatigue, and pruritus, which were all less in the E-HD group. Multivariate analysis revealed E-HD was an independent significant factor for the reduced use of anti-hypertensive agents as well as the absence of severe fatigue and pruritus at 12 months after adjusting for confounding factors. Conclusion The data indicates E-HD could have substantial clinical benefits beyond conventional HD therapy, and support the rationale to conduct clinical trials of H-2 application to HD treatment.	[Nakayama, Masaaki; Watanabe, Kimio; Zhu, Wan-Jun; Kabayama, Shigeru; Miyazaki, Mariko; Ito, Sadayoshi] Tohoku Univ, United Ctr Adv Res & Translat Med, Ctr Adv & Integrated Renal Sci, Sendai, Miyagi, Japan; [Nakayama, Masaaki; Zhu, Wan-Jun; Miyazaki, Mariko] Tohoku Univ Hosp, Res Div Chron Kidney Dis & Dialysis Treatment, Sendai, Miyagi, Japan; [Nakayama, Masaaki; Terawaki, Hiroyuki] Fukushima Med Univ, Dept Nephrol & Hypertens, Fukushima, Japan; [Itami, Noritomo; Hamada, Hiromi] Nikko Memorial Hosp, Kidney Ctr, Muroran, Hokkaido, Japan; [Itami, Noritomo; Hamada, Hiromi] Higashi Muroran Satellite Clin, Muroran, Hokkaido, Japan; [Suzuki, Hodaka] Horai Higashi Clin, Fukushima, Japan; [Osaka, Naoyuki] Gumyoji Jin Clin, Yokohama, Kanagawa, Japan; [Yamamoto, Ryo] Tateishi Jin Clin, Tokyo, Japan; [Tsunoda, Kazumasa] Noboribetsu Mem Hosp, Noboribetsu, Japan; [Nakano, Hirofumi] Kashima Hosp, Dialysis Ctr, Iwaki, Fukushima, Japan; [Zhu, Wan-Jun; Kabayama, Shigeru] Trim Med Inst Co Ltd, Osaka, Japan; [Maruyama, Yukio] Tokyo Jikei Univ, Sch Med, Dept Nephrol & Hypertens, Tokyo, Japan; [Nakazawa, Ryoichi] Tokatsu Clin Mirai, Matsudo, Chiba, Japan; [Miyazaki, Mariko; Ito, Sadayoshi] Tohoku Univ Hosp, Div Blood Purificat, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Fukushima Medical University; Jikei University; Tohoku University	Nakayama, M (corresponding author), Tohoku Univ, United Ctr Adv Res & Translat Med, Ctr Adv & Integrated Renal Sci, Sendai, Miyagi, Japan.; Nakayama, M (corresponding author), Tohoku Univ Hosp, Res Div Chron Kidney Dis & Dialysis Treatment, Sendai, Miyagi, Japan.; Nakayama, M (corresponding author), Fukushima Med Univ, Dept Nephrol & Hypertens, Fukushima, Japan.	masaaki.nakayama.c1@tohoku.ac.jp		Ito, Sadayoshi/0000-0002-5092-3626	Nihon Trim Co. Ltd.; Generalbincorporated association of Electrolyzed Water-Hemodialysis Study group	Nihon Trim Co. Ltd.; Generalbincorporated association of Electrolyzed Water-Hemodialysis Study group	The study was conducted by funds from Nihon Trim Co. Ltd., (www.hihon-trim.co.jp), and Generalbincorporated association of Electrolyzed Water-Hemodialysis Study group (www.ew-hd.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artom M, 2014, KIDNEY INT, V86, P497, DOI 10.1038/ki.2014.86; Aslam S, 2006, KIDNEY INT, V70, P2109, DOI 10.1038/sj.ki.5001983; Boaz M, 2000, LANCET, V356, P1213, DOI 10.1016/S0140-6736(00)02783-5; Bossola M, 2015, J PAIN SYMPTOM MANAG, V49, P578, DOI 10.1016/j.jpainsymman.2014.07.009; Bossola Maurizio, 2009, Blood Purif, V28, P245, DOI 10.1159/000231985; Buchholz BM, 2008, AM J TRANSPLANT, V8, P2015, DOI 10.1111/j.1600-6143.2008.02359.x; Cai JM, 2008, NEUROSCI LETT, V441, P167, DOI 10.1016/j.neulet.2008.05.077; Cardinal JS, 2010, KIDNEY INT, V77, P101, DOI 10.1038/ki.2009.421; Chen H, 2010, BIOCHEM BIOPH RES CO, V393, P308, DOI 10.1016/j.bbrc.2010.02.005; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Huang KC, 2006, KIDNEY INT, V70, P391, DOI 10.1038/sj.ki.5001576; Huang KC, 2003, KIDNEY INT, V64, P704, DOI 10.1046/j.1523-1755.2003.00118.x; Huang KC, 2010, NEPHROL DIAL TRANSPL, V25, P2730, DOI 10.1093/ndt/gfq082; Jhamb M, 2008, AM J KIDNEY DIS, V52, P353, DOI 10.1053/j.ajkd.2008.05.005; Kajiya M, 2009, BIOCHEM BIOPH RES CO, V386, P11, DOI 10.1016/j.bbrc.2009.05.117; Kendrick J, 2008, NAT CLIN PRACT NEPHR, V4, P672, DOI 10.1038/ncpneph0954; Kimmel M, 2006, NEPHROL DIAL TRANSPL, V21, P749, DOI 10.1093/ndt/gfi204; Koyama H, 2010, CLIN J AM SOC NEPHRO, V5, P659, DOI 10.2215/CJN.08151109; Mathur VS, 2010, CLIN J AM SOC NEPHRO, V5, P1410, DOI 10.2215/CJN.00100110; Mettang T, 2002, NEPHROL DIAL TRANSPL, V17, P1558, DOI 10.1093/ndt/17.9.1558; Nagata K, 2009, NEUROPSYCHOPHARMACOL, V34, P501, DOI 10.1038/npp.2008.95; Nakayama M, 2010, NEPHROL DIAL TRANSPL, V25, P3026, DOI 10.1093/ndt/gfq196; Nakayama Masaaki, 2007, Hemodial Int, V11, P322, DOI 10.1111/j.1542-4758.2007.00187.x; Nakayama M, 2009, NEPHRON CLIN PRACT, V112, pC9, DOI 10.1159/000210569; Narita I, 2006, KIDNEY INT, V69, P1626, DOI 10.1038/sj.ki.5000251; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Pisoni RL, 2006, NEPHROL DIAL TRANSPL, V21, P3495, DOI 10.1093/ndt/gfl461; Sela S, 2005, J AM SOC NEPHROL, V16, P2431, DOI 10.1681/ASN.2004110929; Shirahata S, 1997, BIOCHEM BIOPH RES CO, V234, P269, DOI 10.1006/bbrc.1997.6622; Tepel M, 2003, CIRCULATION, V107, P992, DOI 10.1161/01.CIR.0000050628.11305.30; Terawaki H, 2014, HEMODIAL INT, V18, P459, DOI 10.1111/hdi.12112; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Virga G, 2002, NEPHROL DIAL TRANSPL, V17, P2164, DOI 10.1093/ndt/17.12.2164; Weisbord SD, 2005, J AM SOC NEPHROL, V16, P2487, DOI 10.1681/ASN.2005020157; WERTHEIMER A I, 1986, Hospital Pharmacy, V21, P233; Wood KC, 2007, NAT MED, V13, P673, DOI 10.1038/nm0607-673; World Health Organization, 1993, GUID CONS MED PLANTS, P1; Yngman-Uhlin P, 2011, SCAND J UROL NEPHROL, V45, P206, DOI 10.3109/00365599.2011.557025; Zhu WJ, 2013, MED GAS RES, V3, DOI 10.1186/2045-9912-3-26; Zhu WJ, 2011, NEPHROL DIAL TRANSPL, V26, P2112, DOI 10.1093/ndt/gfq727; Zimmermann J, 1999, KIDNEY INT, V55, P648, DOI 10.1046/j.1523-1755.1999.00273.x	42	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184535	10.1371/journal.pone.0184535	http://dx.doi.org/10.1371/journal.pone.0184535			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902900	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200045
J	Weber, IP; Rana, M; Thomas, PBM; Dimov, IB; Franze, K; Rajan, MS				Weber, Isabell P.; Rana, Mrinal; Thomas, Peter B. M.; Dimov, Ivan B.; Franze, Kristian; Rajan, Madhavan S.			Effect of vital dyes on human corneal endothelium and elasticity of Descemet's membrane	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; POSTERIOR LAMELLAR KERATOPLASTY; LENS CAPSULE; TRYPAN BLUE; TRANSPLANTATION; COLLAGENS; REJECTION	The purpose of this study was to evaluate the effects of vital dyes on human Descemet's membranes (DMs) and endothelia. DMs of 25 human cadaveric corneas with research consent were treated with dyes routinely used in Descemet membrane endothelial keratoplasty (DMEK), 0.05% Trypan blue (TB) or a combination of 0.15% Trypan blue, 0.025% Brilliant blue and 4% Polyethylene glycol (commercial name Membrane Blue Dual; MB). The effects of these two dyes on (i) endothelial cell viability, (ii) DM mechanical properties as assessed by atomic force microscopy, and iii) qualitative DM dye retention were tested for two varying exposure times (one or four minutes). No significant differences in cell toxicity were observed between treatments with TB and MB at the two different exposure times (P = 0.21). Further, both dyes led to a significant increase in DM stiffness: exposure to TB and MB for one minute increased the apparent elastic modulus of the DM by 11.2% (P = 8*10(-3)) and 17.7%, respectively (P = 4*10(-6)). A four-minute exposure led to an increase of 8.6% for TB (P = 0.004) and 13.6% for MB (P = 0.03). Finally, at 25 minutes, the dye retention of the DM was considerably better for MB compared to TB. Taken together, a one-minute exposure to MB was found to improve DM visibility compared to TB, with a significant increase in DM stiffness and without detrimental effects on endothelial cell viability. The use of MB could therefore improve (i) visibility of the DM scroll, and (ii) intraoperative unfolding, enhancing the probability of successful DMEK surgery.	[Weber, Isabell P.; Dimov, Ivan B.; Franze, Kristian] Univ Cambridge, Dept Physiol Dev & Neurosci, Anat Bldg, Cambridge, England; [Rana, Mrinal; Thomas, Peter B. M.; Rajan, Madhavan S.] Cambridge Univ Hosp NHS Trust, Addenbrookes Hosp, Dept Ophthalmol, Cambridge, England; [Rajan, Madhavan S.] Anglia Ruskin Univ, VERU, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Anglia Ruskin University	Rajan, MS (corresponding author), Cambridge Univ Hosp NHS Trust, Addenbrookes Hosp, Dept Ophthalmol, Cambridge, England.; Rajan, MS (corresponding author), Anglia Ruskin Univ, VERU, Cambridge, England.	Madhavan.rajan@addenbrookes.nhs.uk		Rajan, Madhavan/0000-0003-2223-5364; Thomas, Peter/0000-0003-1681-7659; Dimov, Ivan/0000-0003-3513-583X; Franze, Kristian/0000-0002-8425-7297	EMBO Long Term Fellowship (European Commission FP7 (Marie Curie Actions)) [ALTF 1263-2015, LTFC0FUND2013, GA-2013-609409]; EPSRC Cambridge NanoDTC [EP/L015978/1]; UK Medical Research Council [G1100312/1]; Human Frontier Science Programme [RGY0074/2013]; Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health [R21HD080585]; MRC [G1100312] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1494601] Funding Source: researchfish; Medical Research Council [G1100312] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD080585] Funding Source: NIH RePORTER	EMBO Long Term Fellowship (European Commission FP7 (Marie Curie Actions)); EPSRC Cambridge NanoDTC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontier Science Programme(Human Frontier Science Program); Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	IPW is a recipient of an EMBO Long Term Fellowship (ALTF 1263-2015; European Commission FP7 (Marie Curie Actions, LTFC0FUND2013, GA-2013-609409)). This work was further supported by the EPSRC Cambridge NanoDTC, EP/L015978/1, UK Medical Research Council (Career Development Award G1100312/1 to KF), the Human Frontier Science Programme (Young Investigator Award RGY0074/2013 to KF) and the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health under Award Number R21HD080585 (to KF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anshu A, 2012, OPHTHALMOLOGY, V119, P536, DOI 10.1016/j.ophtha.2011.09.019; Chaurasia SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037456; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Danielsen CC, 2004, EXP EYE RES, V79, P343, DOI 10.1016/j.exer.2004.05.014; Dapena I, 2011, CORNEA, V30, P1341, DOI 10.1097/ICO.0b013e31820d8540; Dapena I, 2009, CURR OPIN OPHTHALMOL, V20, P299, DOI 10.1097/ICU.0b013e32832b8d18; DUHAMEL RC, 1983, COLLAGEN REL RES, V3, P195; Elsheikh A, 2007, CURR EYE RES, V32, P11, DOI 10.1080/02713680601077145; Franz CM, 2008, CELL MOL BIOENG, V1, P289, DOI 10.1007/s12195-008-0037-3; Franze K, 2011, CURR OPIN GENET DEV, V21, P530, DOI 10.1016/j.gde.2011.07.001; Franze K, 2011, SOFT MATTER, V7, P3147, DOI 10.1039/c0sm01017k; Georgiou CD, 2008, ANAL BIOANAL CHEM, V391, P391, DOI 10.1007/s00216-008-1996-x; Haritoglou C, 2013, J CATARACT REFR SURG, V39, P1749, DOI 10.1016/j.jcrs.2013.02.057; Heinzelmann S, 2014, CORNEA, V33, P644, DOI 10.1097/ICO.0000000000000106; John T, 2016, CORNEA, V35, P1401, DOI 10.1097/ICO.0000000000000986; Last JA, 2012, MICRON, V43, P1293, DOI 10.1016/j.micron.2012.02.014; Last JA, 2009, J STRUCT BIOL, V167, P19, DOI 10.1016/j.jsb.2009.03.012; Majmudar PA, 2017, CORNEA, V36, P217, DOI 10.1097/ICO.0000000000001074; MARSHALL GE, 1993, BRIT J OPHTHALMOL, V77, P515, DOI 10.1136/bjo.77.8.515; Meek KM, 2015, PROG RETIN EYE RES, V49, P1, DOI 10.1016/j.preteyeres.2015.07.001; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Melles GRJ, 1998, CORNEA, V17, P618, DOI 10.1097/00003226-199811000-00010; Melles GRJ, 1999, AM J OPHTHALMOL, V127, P340, DOI 10.1016/S0002-9394(98)00324-9; Melles GRJ, 2002, CORNEA, V21, P325, DOI 10.1097/00003226-200204000-00018; Melles GRJ, 2002, CORNEA, V21, P415, DOI 10.1097/00003226-200205000-00016; Mohr A, 2013, OPHTHALMOLOGICA, V230, P51, DOI 10.1159/000353870; Parker J., 2013, US OPHTHAL REV, V06, P29; Rajan MS, 2014, EYE, V28, P196, DOI 10.1038/eye.2013.279; Saad HA, 2008, CORNEA, V27, P818, DOI 10.1097/ICO.0b013e3181705ca2; Siebelmann S, 2017, CORNEA, V36, P440, DOI 10.1097/ICO.0000000000001140; Terry MA, 2001, CORNEA, V20, P239, DOI 10.1097/00003226-200104000-00001; Terry MA, 2012, CORNEA, V31, P469, DOI 10.1097/ICO.0b013e31823f8ee2; Thomas PBM, 2013, CORNEA, V32, pE173, DOI 10.1097/ICO.0b013e3182912fd2; WILLIAMS KA, 1995, EYE, V9, P219, DOI 10.1038/eye.1995.43; Wollensak G, 2004, J CATARACT REFR SURG, V30, P1526, DOI 10.1016/j.jcrs.2003.11.031	35	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184375	10.1371/journal.pone.0184375	http://dx.doi.org/10.1371/journal.pone.0184375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902856	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200033
J	Bonamigo, T; Campos, JF; Oliveira, AS; Torquato, HFV; Balestieri, JBP; Cardoso, CAL; Paredes-Gamero, EJ; Souza, KD; dos Santos, EL				Bonamigo, Thaliny; Campos, Jaqueline Ferreira; Oliveira, Alex Santos; Vieira Torquato, Heron Fernandes; Perrella Balestieri, Jose Benedito; Lima Cardoso, Claudia Andrea; Paredes-Gamero, Edgar Julian; Souza, Kely de Picoli; dos Santos, Edson Lucas			Antioxidant and cytotoxic activity of propolis of Plebeia droryana and Apis mellifera (Hymenoptera, Apidae) from the Brazilian Cerrado biome	PLOS ONE			English	Article							ACID PHENETHYL ESTER; CHEMICAL-COMPOSITION; BIOLOGICAL-ACTIVITY; ANTICANCER ACTIVITY; CELL-DEATH; CANCER; INHIBITION; APOPTOSIS; DAMAGE	Propolis is a complex bioactive mixture produced by bees, known to have different biological activities, especially in countries where there is a rich biodiversity of plant species. The objective of this study was to determine the chemical composition and evaluate the antioxidant and cytotoxic properties of Brazilian propolis from the species Plebeia droryana and Apis mellifera found in Mato Grosso do Sul, Brazil. In the ethanolic extracts of P. droryana propolis (ExEP-P) and A. mellifera (ExEP-A) acids, phenolic compounds, terpenes and tocopherol were identified as major compounds. Both extracts presented antioxidant activity against the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical, the maximum activities being 500 mu g/mL (ExEP-P) and 300 mu g/mL (ExEP-A). However, only ExEP-A was able to inhibit lipid peroxidation induced by the oxidizing agent 2,2'-azobis(2-amidinopropane) dihydrochloride (AAPH), which inhibited oxidative hemolysis and reduced the levels of malondialdehyde (MDA) in human erythrocytes for 4 h of incubation. The extracts also reduced the cell viability of the K562 erythroleukemia tumour line, with a predominance of necrotic death. Thus, it is concluded that the propolis produced by P. droryana and A. mellifera contain important compounds capable of minimizing the action of oxidizing substances in the organism and reducing the viability of erythroleukemia cells.	[Bonamigo, Thaliny; Campos, Jaqueline Ferreira; Oliveira, Alex Santos; Perrella Balestieri, Jose Benedito; Souza, Kely de Picoli; dos Santos, Edson Lucas] Fed Univ Grande Dourados, Res Grp Biotechnol & Bioprospecting Appl Metab GE, Dourados, MS, Brazil; [Vieira Torquato, Heron Fernandes] Braz Cubes Univ, Fac Pharm, Francisco Rodrigues Filho Ave, Mogi Das Cruzes, SP, Brazil; [Vieira Torquato, Heron Fernandes] Univ Fed Sao Paulo, Dept Biochem, R Tres de Maio 100, Sao Paulo, SP, Brazil; [Lima Cardoso, Claudia Andrea; Paredes-Gamero, Edgar Julian] Univ Estado Mato Grosso, Course Chem, Dourados, MS, Brazil; [Paredes-Gamero, Edgar Julian] Univ Mogi das Cruzes, Ctr Interdisciplinary Res Biochem, Av Dr Candido Xavier de Almeida Souza, Mogi Das Cruzes, SP, Brazil	Universidade Federal da Grande Dourados; Universidade Federal de Sao Paulo (UNIFESP); Universidade do Estado de Mato Grosso; Universidade de Mogi das Cruzes	dos Santos, EL (corresponding author), Fed Univ Grande Dourados, Res Grp Biotechnol & Bioprospecting Appl Metab GE, Dourados, MS, Brazil.	edsonsantosphd@gmail.com	Cardoso, Claudia Andrea Lima/AAK-5578-2020; de Picoli Souza, Kely/I-1248-2015; de Picoli Souza, Kely/AAU-5978-2020; dos Santos, Edson Lucas/AAU-5857-2020; Torquato, Heron/AAQ-2462-2020; Paredes-Gamero, Edgar J/C-4791-2012	Cardoso, Claudia Andrea Lima/0000-0002-4907-0056; de Picoli Souza, Kely/0000-0001-5764-2125; de Picoli Souza, Kely/0000-0001-5764-2125; dos Santos, Edson Lucas/0000-0002-6557-7914; Paredes-Gamero, Edgar J/0000-0003-3686-8402; Oliveira, Alex/0000-0002-2097-6655	Development of Education, Science and Technology of Mato Grosso do Sul State - FUNDECT; Brazilian National Research Council - CNPq; Instituto Nacional de Pesquisa do Pantanal - INPP; Fundacao de Amparo e Desenvolvimento da Pesquisa - Fadesp; FUNDECT; CAPES	Development of Education, Science and Technology of Mato Grosso do Sul State - FUNDECT; Brazilian National Research Council - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Pesquisa do Pantanal - INPP; Fundacao de Amparo e Desenvolvimento da Pesquisa - Fadesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Foundation to Support to Development of Education, Science and Technology of Mato Grosso do Sul State - FUNDECT and Brazilian National Research Council - CNPq, Instituto Nacional de Pesquisa do Pantanal - INPP, and Fundacao de Amparo e Desenvolvimento da Pesquisa - Fadesp. Thaliny Bonamigo was supported by FUNDECT and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Luis Carlos Rossini from Apiarios Carbonari, for assistance in collect of propolis samples from A. mellifera in the state of Mato Grosso do Sul. This work was supported by Grants from Foundation to Support to Development of Education, Science and Technology of Mato Grosso do Sul State-FUNDECT and Brazilian National Research Council-CNPq, Instituto Nacional de Pesquisa do Pantanal-INPP, and Fundacao de Amparo e Desenvolvimento da Pesquisa-Fadesp. Thaliny Bonamigo was supported by FUNDECT and CAPES.	Afrouzan H, 2012, AFR J MICROBIOL RES, V6, P421, DOI 10.5897/AJMR11.1183; Al Shaal L, 2011, INT J PHARMACEUT, V420, P133, DOI 10.1016/j.ijpharm.2011.08.018; Alencar SM, 2007, J ETHNOPHARMACOL, V113, P278, DOI 10.1016/j.jep.2007.06.005; [Anonymous], PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0174888; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Awale S, 2008, BIOORGAN MED CHEM, V16, P181, DOI 10.1016/j.bmc.2007.10.004; Bak MJ, 2017, CANCER PREV RES, V10, P1; Bankova V, 2005, J ETHNOPHARMACOL, V100, P114, DOI 10.1016/j.jep.2005.05.004; Bankova V, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-28; Bao YY, 2013, FUTURE ONCOL, V9, P1353, DOI 10.2217/fon.13.84; Boonstra J, 2004, GENE, V337, P1, DOI 10.1016/j.gene.2004.04.032; Boyle SP, 2000, EUR J CLIN NUTR, V54, P774, DOI 10.1038/sj.ejcn.1601090; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Bueno-Silva B., 2016, NAT PRODUCT RES, P1; Bueno-Silva B, 2013, J AGR FOOD CHEM, V61, P4546, DOI 10.1021/jf305468f; Camargo JMF, 2014, CATALOGUE BEES HYMEN; Campos JF, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/296186; Campos JF, 2014, FOOD CHEM TOXICOL, V65, P374, DOI 10.1016/j.fct.2014.01.008; Carocho M, 2013, ANTI-CANCER AGENT ME, V13, P1236, DOI 10.2174/18715206113139990301; Castaldo S, 2002, FITOTERAPIA, V73, pS1, DOI 10.1016/S0367-326X(02)00185-5; Chang WC, 2010, TAIWAN J OBSTET GYNE, V49, P419, DOI 10.1016/S1028-4559(10)60092-7; Cinegaglia NC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/737386; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cortopassi-Laurino M, 2006, APIDOLOGIE, V37, P275, DOI 10.1051/apido:2006027; Dalle-Donne I, 2006, CLIN CHEM, V52, P601, DOI 10.1373/clinchem.2005.061408; De Marco S, 2017, EVID-BASED COMPL ALT, V2017, P1; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Duthie GG, 2003, P NUTR SOC, V62, P599, DOI 10.1079/PNS2003275; Ewnetu Y, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-269; Franchi GC, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/918956; Funakoshi-Tago M, 2015, INT IMMUNOPHARMACOL, V25, P189, DOI 10.1016/j.intimp.2015.01.012; Gupta D, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-13; Sawaya ACHF, 2007, APIDOLOGIE, V38, P93, DOI 10.1051/apido:2006058; Hong JF, 2016, MOL MED REP, V13, P4541, DOI 10.3892/mmr.2016.5105; Huang SA, 2014, MOLECULES, V19, P19610, DOI 10.3390/molecules191219610; Jin UH, 2008, MOL CELL BIOCHEM, V310, P43, DOI 10.1007/s11010-007-9663-7; Kasai H, 2006, ANTIOXID REDOX SIGN, V8, P981, DOI 10.1089/ars.2006.8.981; Kostova I, 2006, MINI-REV MED CHEM, V6, P365, DOI 10.2174/138955706776361457; Kumazawa S, 2004, FOOD CHEM, V84, P329, DOI 10.1016/S0308-8146(03)00216-4; Kurek-Gorecka A, 2014, MOLECULES, V19, P78, DOI 10.3390/molecules19010078; Lopez BGC, 2015, J APPL MICROBIOL, V119, P677, DOI 10.1111/jam.12874; Lu JM, 2010, J CELL MOL MED, V14, P840, DOI 10.1111/j.1582-4934.2009.00897.x; Machado JL, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/157652; Moraes VWR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.190; Moreira L, 2008, FOOD CHEM TOXICOL, V46, P3482, DOI 10.1016/j.fct.2008.08.025; Paredes-Gamero EJ, 2012, BBA-GEN SUBJECTS, V1820, P1062, DOI 10.1016/j.bbagen.2012.02.015; Queiroz MJRP, 2014, BIOMED RES INT, V2014, P1; Cabral ISR, 2009, QUIM NOVA, V32, P1523, DOI 10.1590/S0100-40422009000600031; Roubik D.W., 1990, ECOLOGY NATURAL HIST, V1st ed., P526, DOI [10.1126/science.248.4958.1026, DOI 10.1126/SCIENCE.248.4958.1026]; Russo A, 2002, FITOTERAPIA, V73, pS21, DOI 10.1016/S0367-326X(02)00187-9; Salatino A, 2005, EVID-BASED COMPL ALT, V2, P33, DOI 10.1093/ecam/neh060; Sawicka D, 2012, FOLIA HISTOCHEM CYTO, V50, P25, DOI [10.5603/FHC.2012.0004, 10.2478/18693]; Scalbert A, 2005, AM J CLIN NUTR, V81, p215S, DOI 10.1093/ajcn/81.1.215S; Srivastava S, 2016, SCI REP-UK, V6, DOI 10.1038/s41598-016-0012-5; Teerasripreecha D, 2012, BMC COMPLEM ALTERN M, V12, P2; Valente MJ, 2011, FOOD CHEM TOXICOL, V49, P86, DOI 10.1016/j.fct.2010.10.001; Velikova M, 2000, Z NATURFORSCH C, V55, P785; Zizic JB, 2013, J SCI FOOD AGR, V93, P3001, DOI 10.1002/jsfa.6132	58	16	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0183983	10.1371/journal.pone.0183983	http://dx.doi.org/10.1371/journal.pone.0183983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898258	Green Submitted, Green Published, gold			2022-12-27	WOS:000410449500009
J	Buti, M; Manzano, ML; Morillas, RM; Garcia-Retortillo, M; Martin, L; Prieto, M; Gutierrez, ML; Suarez, E; Rubio, MG; Lopez, J; Castillo, P; Rodriguez, M; Zozaya, JM; Simon, MA; Morano, LE; Calleja, JL; Yebenes, M; Esteban, R				Buti, Maria; Manzano, Maria L.; Morillas, Rosa M.; Garcia-Retortillo, Montserrat; Martin, Leticia; Prieto, Martin; Gutierrez, Maria L.; Suarez, Emilio; Gomez Rubio, Mariano; Lopez, Javier; Castillo, Pilar; Rodriguez, Manuel; Zozaya, Jose M.; Simon, Miguel A.; Morano, Luis E.; Calleja, Jose L.; Yebenes, Maria; Esteban, Rafael			Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study	PLOS ONE			English	Article							CHEMOTHERAPY; PREVENTION; LYMPHOMA; MANAGEMENT; LAMIVUDINE; ENTECAVIR; EFFICACY; THERAPY; UPDATE	Background Hepatitis B virus (HBV) reactivation in patients with resolved HBV infection (HBsAg negative, antiHBc positive) is uncommon, but potentially fatal. The role of HBV prophylaxis in this setting is uncertain. The aim of this study was to compare the efficacy of tenofovir disoproxil fumarate (TDF) prophylaxis versus close monitoring in antiHBc-positive, HBsAg-negative patients under treatment with rituximab (RTX)-based regimens for hematologic malignancy. Methods PREBLIN is a phase IV, randomized, prospective, open-label, multicenter, parallel-group trial conducted in 17 hospitals throughout Spain. Anti-HBc-positive, HBsAg-negative patients with undetectable HBV DNA were randomized to receive TDF 300 mg once daily (Group I) or observation (Group II). The primary endpoint was the percentage of patients showing HBV reactivation during 18 months following initiation of RTX treatment. Patients with detectable HBV DNA (Group III) received the same dose of TDF and were analyzed together with Group I to investigate TDF safety. Results Sixty-one patients were enrolled in the study, 33 in the TDF treatment group and 28 in the observation group. By ITT analysis, HBV reactivation was 0% (0/33) in the study group and 10.7% (3/28) in the observation group (p = 0.091). None of the patients in either group showed significant differences in liver function parameters between baseline and the last follow-up sample. TDF was generally well tolerated and there were no severe treatment-related adverse events. Conclusion In patients with hematological malignancy and resolved hepatitis B infection receiving RTX-based regimens, HBV reactivation did not occur in patients given TDF prophylaxis.	[Buti, Maria; Esteban, Rafael] Hosp Valle De Hebron, Liver Unit, Barcelona, Spain; [Buti, Maria; Esteban, Rafael] Inst Carlos III, CIBEREHD, Barcelona, Spain; [Manzano, Maria L.] Hosp Doce Octubre, Dept Hepatol, Madrid, Spain; [Morillas, Rosa M.] Hosp Germans Trias i Pujol, Dept Hepatol, Badalona, Barcelona, Spain; [Garcia-Retortillo, Montserrat] Hosp Mar, Dept Hepatol, Barcelona, Spain; [Martin, Leticia] Hosp Donostia, Dept Hepatol, San Sebastian, Spain; [Prieto, Martin] Hosp Univ i Politecn La Fe, Dept Hepatol, Valencia, Spain; [Gutierrez, Maria L.] Fdn Hosp Alcorcon, Dept Hepatol, Madrid, Spain; [Suarez, Emilio] Hosp Nuestra Senora Valme, Dept Hepatol, Seville, Spain; [Gomez Rubio, Mariano] Hosp Getafe, Dept Gastroenterol, Madrid, Spain; [Lopez, Javier] Hosp Ramon & Cajal, Dept Hematol, Madrid, Spain; [Castillo, Pilar] Hosp La Paz, Dept Hepatol, Madrid, Spain; [Rodriguez, Manuel] Hosp Cent Asturias, Dept Hepatol, Oviedo, Spain; [Zozaya, Jose M.] Hosp Navarra, Dept Gastroenterol, Pamplona, Spain; [Simon, Miguel A.] Hosp Clin Lozano Blesa, Dept Hepatol, Zaragoza, Spain; [Morano, Luis E.] Hosp Meixoeiro, Dept Infect Dis, Vigo, Spain; [Calleja, Jose L.] Hosp Puerta Hierro Majadahonda, Dept Gastroenterol, Madrid, Spain; [Yebenes, Maria] Pharmacoecon Outcomes Res Iberia, Madrid, Spain	Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitario 12 de Octubre; Hospital Germans Trias i Pujol; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University Hospital Donostia; Alcorcon Foundation University Hospital; Hospital Valme; Hospital Universitario de Getafe; Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; Central University Hospital Asturias; Servicio Navarro de Salud - Osasunbidea; Lozano Blesa University Clinical Hospital; Complexo Hospitalario Universitario de Vigo; Hospital Puerta de Hierro-Majadahonda	Buti, M (corresponding author), Hosp Valle De Hebron, Liver Unit, Barcelona, Spain.; Buti, M (corresponding author), Inst Carlos III, CIBEREHD, Barcelona, Spain.	mbuti@vhebron.net	Prieto, Martin/ABH-7274-2020; Gutiérrez García, María Luisa/B-4311-2018; Panero, Jose Luis Calleja/A-5351-2010; Rodriguez, Manuel/AAH-9936-2020	Prieto, Martin/0000-0002-8841-0543; Gutiérrez García, María Luisa/0000-0002-0035-9211; Panero, Jose Luis Calleja/0000-0002-2265-6591; Rodriguez, Manuel/0000-0001-5763-7668; esteban, rafael/0000-0001-5280-392X; GARCIA-RETORTILLO, MONTSERRAT/0000-0001-6783-7604; Morano Amado, Luis Enrique/0000-0002-0560-3260; Buti Ferret, Maria/0000-0002-0732-3078	Medical Department of Gilead Sciences	Medical Department of Gilead Sciences	Medical Department of Gilead Sciences supplied the medications used in this study and its funding regardless of the study results. Medical Department of Gilead Sciences had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study authors would like to thank the Medical Department of Gilead Sciences for supplying the medications used in this study and funding regardless of the study results; Miguel Angel Casado, Maria Yebenes, Alvaro Munoz, Fernando de Andres, Eliazar Sabater and Araceli Casado of Pharmacoeconomics & Outcomes Research Iberia (PORIB) for management, coordination and monitoring of the study; Mireia Riera and Jordi Cantoni of BioClever for support and follow-up on the electronic case report forms; Antonio Martinez of Ciencia y Deporte for editorial assistance in the preparation of the manuscript; and the pharmacy services of the participating centers for their collaboration in obtaining dispensation records, with special thanks to Hospital Vall Hebron for its participation in study medications.	Amores-Antequera C., 2015, REV ESP QUIM, V28, P56; Bessone F, 2016, WORLD J HEPATOL, V8, P385, DOI 10.4254/wjh.v8.i8.385; Castelli R, 2016, DIGEST LIVER DIS, V48, P1394, DOI 10.1016/j.dld.2016.08.113; Chen KL, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0015-9; Di Bisceglie AM, 2015, HEPATOLOGY, V61, P703, DOI 10.1002/hep.27609; Dyson JK, 2016, EUR J GASTROEN HEPAT, V28, P1172, DOI 10.1097/MEG.0000000000000689; Etzion Ohad, 2015, Clin Liver Dis (Hoboken), V5, P47, DOI 10.1002/cld.458; European Association For The Study Of The Liver, 2017, J HEPATOL IN PRESS; Evens AM, 2011, ANN ONCOL, V22, P1170, DOI 10.1093/annonc/mdq583; Francisci D, 2010, INFECTION, V38, P58, DOI 10.1007/s15010-009-9019-1; Fung S, 2014, GASTROENTEROLOGY, V146, P980, DOI 10.1053/j.gastro.2013.12.028; Gerada J, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.035; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Hsu C, 2014, HEPATOLOGY, V59, P2092, DOI 10.1002/hep.26718; HUANG H, 2014, JAMA J AM MED ASSOC, V312, P2521; Huang MX, 2015, INT J CLIN EXP MED, V8, P666; Keskin O, 2014, ANTIVIR THER, V19, P543, DOI 10.3851/IMP2732; Koskinas JS, 2014, EUR J INTERN MED, V25, P768, DOI 10.1016/j.ejim.2014.06.028; Kumagai K, 1997, ANN ONCOL, V8, P107, DOI 10.1023/A:1008234807768; Kusumoto S, 2014, HEMATOL-AM SOC HEMAT, P576, DOI 10.1182/asheducation-2014.1.576; Kusumoto S, 2011, J GASTROENTEROL, V46, P9, DOI 10.1007/s00535-010-0331-4; Law MF, 2016, WORLD J GASTROENTERO, V22, P6484, DOI 10.3748/wjg.v22.i28.6484; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; LOK ASF, 1991, GASTROENTEROLOGY, V100, P182, DOI 10.1016/0016-5085(91)90599-G; Markovic S, 1999, HEPATO-GASTROENTEROL, V46, P2925; Matsue K, 2010, CANCER-AM CANCER SOC, V116, P4769, DOI 10.1002/cncr.25253; NICE, 2013, HEP B CHRON DIAGN MA; Nyman HA, 2011, PHARMACOTHERAPY, V31, P1130, DOI 10.1592/phco.31.11.1130; Pattullo V, 2015, WORLD J HEPATOL, V7, P954, DOI 10.4254/wjh.v7.i7.954; Paul S, 2016, ANN INTERN MED, V164, P30, DOI 10.7326/M15-1121; Perrillo RP, 2015, GASTROENTEROLOGY, V148, P221, DOI 10.1053/j.gastro.2014.10.038; Qin L, 2016, MOL CLIN ONCOL, V5, P382, DOI 10.3892/mco.2016.989; Reddy KR, 2015, GASTROENTEROLOGY, V148, P215, DOI 10.1053/j.gastro.2014.10.039; Sampedro B, 2014, HEPATOLOGY, V60, P106, DOI 10.1002/hep.27103; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Seto WK, 2014, J CLIN ONCOL, V32, P3736, DOI 10.1200/JCO.2014.56.7081; Tavakolpour S, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.35810; Terrault NA, 2016, HEPATOLOGY, V63, P261, DOI 10.1002/hep.28156; Uteng M, 2016, TOXICOL SCI; Yeo W, 2000, J MED VIROL, V62, P299, DOI 10.1002/1096-9071(200011)62:3&lt;299::AID-JMV1&gt;3.0.CO;2-0; Yeo WN, 2009, J CLIN ONCOL, V27, P605, DOI 10.1200/JCO.2008.18.0182; Zhang MY, 2016, ONCOTARGET, V7, P30661, DOI 10.18632/oncotarget.8907	42	35	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184550	10.1371/journal.pone.0184550	http://dx.doi.org/10.1371/journal.pone.0184550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898281	gold, Green Submitted, Green Published			2022-12-27	WOS:000410449500032
J	van Ditzhuijzenl, NS; Kurata, M; van den Heuvel, M; Sorop, O; van Duin, RWB; Krabbendam-Peters, I; Ligthart, J; Witberg, K; Murawska, M; Bouma, B; Villiger, M; Garcia-Garcia, HM; Serruys, PW; Zipstra, F; van Soest, G; Duncker, DJ; Regar, E; van Beusekom, HMM				van Ditzhuijzenl, Nienke S.; Kurata, Mie; van den Heuvel, Mieke; Sorop, Oana; van Duin, Richard W. B.; Krabbendam-Peters, Ilona; Ligthart, Jurgen; Witberg, Karen; Murawska, Magdalena; Bouma, Brett; Villiger, Martin; Garcia-Garcia, Hector M.; Serruys, Patrick W.; Zipstra, Felix; van Soest, Gijs; Duncker, Dirk-Jan; Regar, Evelyn; van Beusekom, Heleen M. M.			Neoatherosclerosis development following bioresorbable vascular scaffold implantation in diabetic and non-diabetic swine	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CORONARY-ARTERY MODEL; DRUG-ELUTING STENTS; CHOLESTEROL CRYSTALS; PART I; ABSORB; DYSFUNCTION; DISEASE; SYSTEM; ATHEROSCLEROSIS	Background DM remains a risk factor for poor outcome after stent-implantation, but little is known if and how DM affects the vascular response to BVS. Aim The aim of our study was to examine coronary responses to bioresorbable vascular scaffolds (BVS) in swine with and without diabetes mellitus fed a 'fast-food' diet (FF-DM and FF-NDM, respectively) by sequential optical coherence tomography (OCT)-imaging and histology. Methods Fifteen male swine were evaluated. Eight received streptozotocin-injection to induce DM. After 9 months (M), 32 single BVS were implanted in epicardial arteries with a stent to artery (S/A)-ratio of 1.1:1 under quantitative coronary angiography (QCA) and OCT guidance. Lumen, scaffold, neointimal coverage and composition were assessed by QCA, OCT and near-infrared spectroscopy (NIRS) pre- and/or post-procedure, at 3M and 6M. Additionally, polarization-sensitive (PS)-OCT was performed in 7 swine at 6M. After sacrifice at 3M and 6M, histology and polymer degradation analysis were performed. Results Late lumen loss was high (similar to 60%) within the first 3M after BVS-implantation (P<0.01 FF-DM vs. FF-NDM) and stabilized between 3M and 6M (<5% change in FF-DM, similar to 10% in FF-NDM; P>0.20). Neointimal coverage was highly heterogeneous in all swine ( DM vs. NDM P>0.05), with focal lipid accumulation, irregular collagen distribution and neointimal calcification. Likewise, polymer mass loss was low (similar to 2% at 3M, similar to 5% at 6M; P>0.20) and not associated with DM or inflammation. Conclusion Scaffold coverage showed signs of neo-atherosclerosis in all FF-DM and FF-NDM swine, scaffold polymer was preserved and the vascular response to BVS was not influenced by diabetes.	[van Ditzhuijzenl, Nienke S.; Kurata, Mie; van den Heuvel, Mieke; Sorop, Oana; van Duin, Richard W. B.; Krabbendam-Peters, Ilona; Ligthart, Jurgen; Witberg, Karen; Zipstra, Felix; van Soest, Gijs; Duncker, Dirk-Jan; Regar, Evelyn; van Beusekom, Heleen M. M.] Erasmus Univ, Med Ctr, Dept Cardiol, Thoraxctr,Cardiovasc Res Sch COEUR, Rotterdam, Netherlands; [Murawska, Magdalena] Erasmus Univ, Med Ctr, Dept Biostat, Rotterdam, Netherlands; [Bouma, Brett; Villiger, Martin] Harvard Med Sch, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA USA; [Garcia-Garcia, Hector M.; Serruys, Patrick W.] Cardialysis BV, Rotterdam, Netherlands; [Regar, Evelyn] Univ Hosp Zurich, Dept Cardiovasc Surg, Zurich, Switzerland	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard Medical School; Massachusetts General Hospital; Cardialysis; University of Zurich; University Zurich Hospital	van Beusekom, HMM (corresponding author), Erasmus Univ, Med Ctr, Dept Cardiol, Thoraxctr,Cardiovasc Res Sch COEUR, Rotterdam, Netherlands.	h.vanbeusekom@erasmusmc.nl	Regar, E/ABA-3301-2020; Regar, Evelyn/AAD-8201-2019; van Soest, Gijs/B-4881-2008; Garcia-Garcia, Hector Manuel/AAG-7471-2020	Garcia-Garcia, Hector Manuel/0000-0001-5100-0471; van Duin, Richard/0000-0003-4037-726X; Kurata, Mie/0000-0001-6596-2436; van Soest, Gijs/0000-0001-6474-3100	Abbott Vascular; European commission (FP7, MEDIA)	Abbott Vascular(Abbott Laboratories); European commission (FP7, MEDIA)	This study was supported in part by Abbott Vascular and by the European commission (FP7, MEDIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GUIDE CARE USE LAB A; Berry C, 2007, J AM COLL CARDIOL, V49, P631, DOI 10.1016/j.jacc.2006.09.046; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Dixon JL, 1999, ARTERIOSCL THROM VAS, V19, P2981, DOI 10.1161/01.ATV.19.12.2981; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Gomez-Lara J, 2011, EUR HEART J, V32, P294, DOI 10.1093/eurheartj/ehq458; Ioannou GN, 2013, J LIPID RES, V54, P1326, DOI 10.1194/jlr.M034876; Kang SJ, 2011, CIRCULATION, V123, P2954, DOI 10.1161/CIRCULATIONAHA.110.988436; Karanasos A, 2015, CIRCULATION CARDIOVA, V8; Karanasos A, 2014, J AM COLL CARDIOL, V64, P2343, DOI 10.1016/j.jacc.2014.09.029; Kereiakes DJ, 2017, JACC-CARDIOVASC INTE, V10, P42, DOI 10.1016/j.jcin.2016.10.019; Koopmans SJ, 2006, METABOLISM, V55, P960, DOI 10.1016/j.metabol.2006.03.004; Liu LJ, 2000, BIOMACROMOLECULES, V1, P350, DOI 10.1021/bm000046k; Nadkarni SK, 2007, J AM COLL CARDIOL, V49, P1474, DOI 10.1016/j.jacc.2006.11.040; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Oberhauser James P, 2009, EuroIntervention, V5 Suppl F, pF15, DOI 10.4244/EIJV5IFA3; Onuma Y, 2010, CIRCULATION, V122, P2288, DOI 10.1161/CIRCULATIONAHA.109.921528; Ormiston JA, 2008, LANCET, V371, P899, DOI 10.1016/S0140-6736(08)60415-8; Otsuka F, 2014, CIRC-CARDIOVASC INTE, V7, P330, DOI 10.1161/CIRCINTERVENTIONS.113.000990; Qin SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072710; Raggi P, 2004, J AM COLL CARDIOL, V43, P1663, DOI 10.1016/j.jacc.2003.09.068; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Scheen AJ, 2004, EUR HEART J, V25, P2167, DOI 10.1016/j.ehj.2004.07.041; Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033; Serruys PW, 2010, CIRCULATION, V122, P2301, DOI 10.1161/CIRCULATIONAHA.110.970772; Serruys PW, 2009, LANCET, V373, P897, DOI 10.1016/S0140-6736(09)60325-1; Serruys PW, 2013, EUROINTERVENTION; van Beusekom Heleen M M, 2003, Cardiovasc Radiat Med, V4, P186, DOI 10.1016/j.carrad.2004.02.004; van Beusekom HMM, 1998, J AM COLL CARDIOL, V32, P1109, DOI 10.1016/S0735-1097(98)00348-9; van den Heuvel M, 2012, AM J PHYSIOL-HEART C, V302, pH85, DOI 10.1152/ajpheart.00311.2011; van Ditzhuijzen NS, 2014, INT J CARDIOVAS IMAG, V30, P1013, DOI 10.1007/s10554-014-0447-3; van Soest G, 2011, JACC-CARDIOVASC IMAG, V4, P810, DOI 10.1016/j.jcmg.2011.01.022; VANBEUSEKOM HMM, 1993, J AM COLL CARDIOL, V21, P45, DOI 10.1016/0735-1097(93)90715-D; Waxman S, 2009, JACC-CARDIOVASC IMAG, V2, P858, DOI 10.1016/j.jcmg.2009.05.001	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0183419	10.1371/journal.pone.0183419	http://dx.doi.org/10.1371/journal.pone.0183419			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898243	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000410449500004
J	Witkowska, KJ; Bata, AM; Calzetti, G; Luft, N; Fondi, K; Wozniak, PA; Schmid, D; Schmidl, D; Popa-Cherecheanu, A; Werkmeister, RM; Garhofer, G; Schmetterer, L				Witkowska, Katarzyna J.; Bata, Ahmed M.; Calzetti, Giacomo; Luft, Nikolaus; Fondi, Klemens; Wozniak, Piotr A.; Schmid, Doreen; Bolz, Matthias; Popa-Cherecheanu, Alina; Werkmeister, Rene M.; Garhofer, Gerhard; Schmetterer, Leopold			Optic nerve head and retinal blood flow regulation during isometric exercise as assessed with laser speckle flowgraphy	PLOS ONE			English	Article							OCULAR PERFUSION-PRESSURE; INTRAOCULAR-PRESSURE; COHERENCE TOMOGRAPHY; HEALTHY HUMANS; EXPERIMENTAL GLAUCOMA; DIFFERENT MIXTURES; MICROSPHERE METHOD; DOPPLER FLOWMETRY; FUNDUS PULSATIONS; ACUTE INCREASE	The aim of the present study was to investigate regulation of blood flow (BF) in the optic nerve head (ONH) and a peripapillary region (PPR) during an isometric exercise-induced increase in ocular perfusion pressure (OPP) using laser speckle flowgraphy (LSFG) in healthy subjects. For this purpose, a total of 27 subjects was included in this study. Mean blur rate in tissue (MT) was measured in the ONH and in a PPR as well as relative flow volume (RFV) in retinal arteries (ART) and veins (VEIN) using LSFG. All participants performed isometric exercise for 6 minutes during which MT and mean arterial pressure were measured every minute. From these data OPP and pressure/flow curves were calculated. Isometric exercise increased OPP, MTONH and MTPRR. The relative increase in OPP (78.5 +/- 19.8%) was more pronounced than the increase in BF parameters (MTONH: 18.1 +/- 7.7%, MTPRR: 21.1 +/- 8.3%, RFVART: 16.5 +/- 12.0%, RFVVEIN: 17.7 +/- 12.4%) indicating for an autoregulatory response of the vasculature. The pressure/flow curves show that MTONH, MTPRR, RFVART, RFVVEIN started to increase at OPP levels of 51.2 +/- 2.0%, 58.1 +/- 2.4%, 45.6 +/- 1.9% and 45.6 +/- 1.9% above baseline. These data indicate that ONHBF starts to increase at levels of approx. 50% increase in OPP: This is slightly lower than the values we previously reported from LDF data. Signals from the PPR may have input from both, the retina and the choroid, but the relative contribution is unknown. In addition, retinal BF appears to increase at slightly lower OPP values of approximately 45%. LSFG may be used to study ONH autoregulation in diseases such as glaucoma.	[Witkowska, Katarzyna J.; Bata, Ahmed M.; Luft, Nikolaus; Fondi, Klemens; Wozniak, Piotr A.; Schmid, Doreen; Garhofer, Gerhard; Schmetterer, Leopold] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria; [Calzetti, Giacomo] Univ Parma, Dept Ophthalmol, Parma, Italy; [Luft, Nikolaus; Bolz, Matthias] Kepler Univ Hosp, Dept Ophthalmol, Linz, Austria; [Wozniak, Piotr A.] Med Univ Warsaw, Dept Ophthalmol, Warsaw, Poland; [Popa-Cherecheanu, Alina] Carol Davila Univ Med & Pharm, Bucharest, Romania; [Popa-Cherecheanu, Alina] Emergency Univ Hosp, Dept Ophthalmol, Bucharest, Romania; [Werkmeister, Rene M.; Schmetterer, Leopold] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Schmetterer, Leopold] Singapore Eye Res Inst, Singapore, Singapore; [Schmetterer, Leopold] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore	Medical University of Vienna; University of Parma; Kepler University Hospital; Medical University of Warsaw; Carol Davila University of Medicine & Pharmacy; Medical University of Vienna; National University of Singapore; Singapore National Eye Center; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Schmetterer, L (corresponding author), Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria.; Schmetterer, L (corresponding author), Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria.; Schmetterer, L (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.; Schmetterer, L (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.	leopold.schmetterer@meduniwien.ac.at	Wozniak, Piotr/AAT-7394-2020; Calzetti, Giacomo/AAO-7409-2021; Bata, Ahmed/AAH-1735-2020	Wozniak, Piotr/0000-0002-0944-0438; Calzetti, Giacomo/0000-0003-1391-9510; Bata, Ahmed/0000-0001-5228-762X; Schmetterer, Leopold/0000-0002-7189-1707; Schmidl, Doreen/0000-0001-5664-7768; Popa-Cherecheanu, Alina/0000-0003-4189-6571; Werkmeister, Rene/0000-0002-5147-5714	Austrian Science Fund (Fonds zur Forderung der Wissenschaftlichen Forschung) [21406]	Austrian Science Fund (Fonds zur Forderung der Wissenschaftlichen Forschung)(Austrian Science Fund (FWF))	Financial support from the Austrian Science Fund (Fonds zur Forderung der Wissenschaftlichen Forschung; www.fwf.ac.at) Grant 21406 is gratefully acknowledged. The LSFG instrument was provided for free by Nidek. The company did, however, not provide any additional financial support and did not influence data collection, evaluation or interpretation.	Aizawa N, 2014, INVEST OPHTH VIS SCI, V55, P7991, DOI 10.1167/iovs.14-15373; Aizawa N, 2011, CLIN OPHTHALMOL, V5, P1171, DOI 10.2147/OPTH.S22093; Baumann B, 2011, BIOMED OPT EXPRESS, V2, P1539, DOI 10.1364/BOE.2.001539; Boltz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082351; Boltz A, 2013, J CEREBR BLOOD F MET, V33, P1850, DOI 10.1038/jcbfm.2013.137; Boltz A, 2011, INVEST OPHTH VIS SCI, V52, P4410, DOI 10.1167/iovs.11-7263; Bonner RF, 1990, SHEPHERD AP O BLOOD, P57; Briers D, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.066018; BRIERS JD, 1978, OPT QUANT ELECTRON, V10, P364, DOI 10.1007/BF00620125; Burgoyne CF, 2008, J GLAUCOMA, V17, P318, DOI 10.1097/IJG.0b013e31815a343b; Cherecheanu AP, 2013, CURR OPIN PHARMACOL, V13, P36, DOI 10.1016/j.coph.2012.09.003; Chiquet C, 2014, INVEST OPHTH VIS SCI, V55, P485, DOI 10.1167/iovs.13-12975; Costa VP, 2014, ACTA OPHTHALMOL, V92, pe252, DOI 10.1111/aos.12298; Cull G, 2015, INVEST OPHTH VIS SCI, V56, P7286, DOI 10.1167/iovs.15-17879; Dai CX, 2013, INVEST OPHTH VIS SCI, V54, P7998, DOI 10.1167/iovs.13-12318; Doblhoff-Dier V, 2014, BIOMED OPT EXPRESS, V5, P630, DOI 10.1364/BOE.5.000630; Duncan DD, 2008, J OPT SOC AM A, V25, P9, DOI 10.1364/JOSAA.25.000009; Fitzgerald MEC, 2005, EXP EYE RES, V81, P478, DOI 10.1016/j.exer.2005.03.008; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Flammer J, 2008, CAN J OPHTHALMOL, V43, P317, DOI 10.3129/i08-056; Fuchsjager-Mayrl G, 2003, INVEST OPHTH VIS SCI, V44, P728, DOI 10.1167/iovs.02-0372; Garhofer G, 2005, INVEST OPHTH VIS SCI, V46, P1721, DOI 10.1167/iovs.04-1347; Goodman J. W., 2000, STAT OPTICS, V1; Haindl R, 2016, BIOMED OPT EXPRESS, V7, P287, DOI 10.1364/BOE.7.000287; Hayashi N, 2011, EUR J APPL PHYSIOL, V111, P2601, DOI 10.1007/s00421-011-1880-9; Hayreh SS, 2001, PROG RETIN EYE RES, V20, P563, DOI 10.1016/S1350-9462(01)00004-0; Ikemura T, 2015, PHYSIOL MEAS, V36, P219, DOI 10.1088/0967-3334/36/2/219; Ikemura T, 2012, EUR J APPL PHYSIOL, V112, P3313, DOI 10.1007/s00421-012-2313-0; Ikemura T, 2012, EUR J APPL PHYSIOL, V112, P641, DOI 10.1007/s00421-011-2016-y; Jia YL, 2012, BIOMED OPT EXPRESS, V3, DOI 10.1364/BOE.3.003127; Kiss B, 2000, CURR EYE RES, V21, P757, DOI 10.1076/ceyr.21.4.757.5549; Kiss B, 2001, MICROVASC RES, V61, P1, DOI 10.1006/mvre.2000.2269; Lee B, 2015, INVEST OPHTH VIS SCI, V56, P2522, DOI 10.1167/iovs.14-16119; Li CY, 2010, BRAIN RES, V1358, P123, DOI 10.1016/j.brainres.2010.08.065; Liang Y, 2010, EXP EYE RES, V90, P203, DOI 10.1016/j.exer.2009.10.009; Luft N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168190; Luft N, 2016, INVEST OPHTH VIS SCI, V57, P5417, DOI 10.1167/iovs.16-19896; Luksch A, 2003, INVEST OPHTH VIS SCI, V44, P734, DOI 10.1167/iovs.02-0177; Luksch A, 2002, BRIT J OPHTHALMOL, V86, P1143, DOI 10.1136/bjo.86.10.1143; Movaffaghy A, 1998, EXP EYE RES, V67, P561, DOI 10.1006/exer.1998.0556; Nickla DL, 2010, PROG RETIN EYE RES, V29, P144, DOI 10.1016/j.preteyeres.2009.12.002; Petrig BL, 1999, AM J OPHTHALMOL, V127, P413, DOI 10.1016/S0002-9394(98)00437-1; Pillunat LE, 1997, EXP EYE RES, V64, P737, DOI 10.1006/exer.1996.0263; Piper C, 2013, INVEST OPHTH VIS SCI, V54, P714, DOI 10.1167/iovs.12-9773; Polska E, 2002, CURR EYE RES, V24, P318, DOI 10.1076/ceyr.24.4.318.8413; Pournaras CJ, 2008, PROG RETIN EYE RES, V27, P284, DOI 10.1016/j.preteyeres.2008.02.002; Rabal HJ, 2003, J OPT A-PURE APPL OP, V5, pS381, DOI 10.1088/1464-4258/5/5/396; Riva CE, 1997, INVEST OPHTH VIS SCI, V38, P2338; Riva CE, 2010, ACTA OPHTHALMOL, V88, P622, DOI 10.1111/j.1755-3768.2009.01621.x; ROBINSON F, 1986, INVEST OPHTH VIS SCI, V27, P722; Rose K, 2016, INVEST OPHTH VIS SCI, V57, P188, DOI 10.1167/iovs.15-17908; Schmetterer L, 1996, EXP EYE RES, V63, P351, DOI 10.1006/exer.1996.0125; Schmetterer L, 1995, EXP EYE RES, V61, P685, DOI 10.1016/S0014-4835(05)80019-3; Schmetterer L., 2015, RUSS OPHTHALMOL J, V8, P100; Schmetterer L, 2007, SURV OPHTHALMOL, V52, pS134, DOI 10.1016/j.survophthal.2007.08.008; Schmidl D, 2016, INVEST OPHTHALMOL VI; Schmidl D, 2013, EXP EYE RES, V116, P247, DOI 10.1016/j.exer.2013.09.008; Schmidl D, 2013, INVEST OPHTH VIS SCI, V54, P1964, DOI 10.1167/iovs.12-11406; Schmidl D, 2012, INVEST OPHTH VIS SCI, V53, P4337, DOI 10.1167/iovs.11-9055; Schmidl D, 2012, INVEST OPHTH VIS SCI, V53, P374, DOI 10.1167/iovs.11-8536; Schmidl D, 2011, EXP EYE RES, V93, P141, DOI 10.1016/j.exer.2010.09.002; Shibata M, 2012, INVEST OPHTH VIS SCI, V53, P3726, DOI 10.1167/iovs.11-9316; Shibata M, 2011, INVEST OPHTH VIS SCI, V52, P2153, DOI 10.1167/iovs.10-6605; Shiga Y, 2014, INVEST OPHTH VIS SCI, V55, P3899, DOI 10.1167/iovs.14-14116; Shiga Y, 2013, CURR EYE RES, V38, P691, DOI 10.3109/02713683.2012.758292; SPANSEL WE, 1992, INVEST OPHTH VIS SCI, V33, P1864; Sugiyama T, 1996, JPN J OPHTHALMOL, V40, P339; Sugiyama T, 2014, PHOTONICS, V1, P220, DOI 10.3390/photonics1030220; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Takahashi H, 2013, EXP EYE RES, V108, P10, DOI 10.1016/j.exer.2012.12.003; Takayama J, 2003, INVEST OPHTH VIS SCI, V44, P3977, DOI 10.1167/iovs.03-0024; Told R, 2016, INVEST OPHTH VIS SCI, V57, P1432, DOI 10.1167/iovs.16-19140; Trasischker W, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.11.116010; Venkataraman ST, 2008, EXP EYE RES, V87, P535, DOI 10.1016/j.exer.2008.08.020; Wang L, 2015, CURR EYE RES, V40, P359, DOI 10.3109/02713683.2014.924146; Wang L, 2014, INVEST OPHTH VIS SCI, V55, P3509, DOI 10.1167/iovs.14-14020; Wang L, 2014, INVEST OPHTH VIS SCI, V55, P873, DOI 10.1167/iovs.13-13716; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Wang YM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2772871; Wang YM, 2009, OPT EXPRESS, V17, P4061, DOI 10.1364/OE.17.004061; Werkmeister RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045876; Werkmeister RM, 2012, INVEST OPHTH VIS SCI, V53, P6062, DOI 10.1167/iovs.12-9514; Wozniak PA, 2016, ACTA OPHTHALMOL, V94; Yanagida K, 2015, INVEST OPHTH VIS SCI, V56, P4880, DOI 10.1167/iovs.15-16567; Zhi ZW, 2012, BIOMED OPT EXPRESS, V3, P2220, DOI 10.1364/BOE.3.002220	85	27	27	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184772	10.1371/journal.pone.0184772	http://dx.doi.org/10.1371/journal.pone.0184772			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898284	Green Published, gold			2022-12-27	WOS:000410449500050
J	Bhatt, I				Bhatt, Ishan			Increased medial olivocochlear reflex strength in normal-hearing, noise-exposed humans	PLOS ONE			English	Article							VENTRAL COCHLEAR NUCLEUS; SPEECH-IN-NOISE; AUDITORY-EVOKED POTENTIALS; OTOACOUSTIC EMISSIONS; ACOUSTIC-REFLEX; GUINEA-PIG; EFFERENT SYSTEM; NEURONS; MUSICIANS; TINNITUS	Research suggests that college-aged adults are vulnerable to tinnitus and hearing loss due to exposure to traumatic levels of noise on a regular basis. Recent human studies have associated exposure to high noise exposure background (NEB, i.e., routine noise exposure) with the reduced cochlear output and impaired speech processing ability in subjects with clinically normal hearing sensitivity. While the relationship between NEB and the functions of the auditory afferent neurons are studied in the literature, little is known about the effects of NEB on functioning of the auditory efferent system. The objective of the present study was to investigate the relationship between medial olivocochlear reflex (MOCR) strength and NEB in subjects with clinically normal hearing sensitivity. It was hypothesized that subjects with high NEB would exhibit reduced afferent input to the MOCR circuit which would subsequently lead to reduced strength of the MOCR. In normal-hearing listeners, the study examined (1) the association between NEB and baseline click-evoked otoacoustic emissions (CEOAEs) and (2) the association between NEB and MOCR strength. The MOCR was measured using CEOAEs evoked by 60 dB pSPL linear clicks in a contralateral acoustic stimulation (CAS)-off and CAS-on (a broadband noise at 60 dB SPL) condition. Participants with at least 6 dB signal-to-noise ratio (SNR) in the CAS-off and CAS-on conditions were included for analysis. A normalized CEOAE inhibition index was calculated to express MOCR strength in a percentage value. NEB was estimated using a validated questionnaire. The results showed that NEB was not associated with the baseline CEOAE amplitude (r = -0.112, p = 0.586). Contrary to the hypothesis, MOCR strength was positively correlated with NEB (r = 0.557, p = 0.003). NEB remained a significant predictor of MOCR strength (beta = 2.98, t(19) = 3.474, p = 0.003) after the unstandardized coefficient was adjusted to control for effects of smoking, sound level tolerance (SLT) and tinnitus. These data provide evidence that MOCR strength is associated with NEB. The functional significance of increased MOCR strength is discussed.	[Bhatt, Ishan] No Arizona Univ, Dept Commun Sci & Disorders, Flagstaff, AZ 86011 USA	Northern Arizona University	Bhatt, I (corresponding author), No Arizona Univ, Dept Commun Sci & Disorders, Flagstaff, AZ 86011 USA.	Ishan.Bhatt@nau.edu						Abdala C, 2013, J ACOUST SOC AM, V133, P938, DOI 10.1121/1.4773265; Abdollahi FZ, 2011, IRAN REHABIL J, V9, P22; Alain C, 2014, HEARING RES, V308, P162, DOI 10.1016/j.heares.2013.06.008; Backus B, 2007, P INT S PERF SCI 200, P23; Beim JA, 2016, J ACOUSTICAL SOC AM, V139; Bhatt IS, 2017, INT J AUDIOLOGY 0203, P1; Bidelman GM, 2017, HEARING RES, V344, P275, DOI 10.1016/j.heares.2016.12.001; Bidelman GM, 2014, J ACOUST SOC AM, V136, pEL33, DOI 10.1121/1.4885484; Blaylock J, 2016, J ACOUSTICAL SOC AM, V139; Boh B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021458; Boothalingam S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136906; Boothalingam S, 2015, J ACOUST SOC AM, V137, P724, DOI 10.1121/1.4906250; Brashears Shanda M, 2003, J Am Acad Audiol, V14, P314; Breinbauer HA, 2012, LARYNGOSCOPE, V122, P2549, DOI 10.1002/lary.23596; Brown MC, 2013, JARO-J ASSOC RES OTO, V14, P703, DOI 10.1007/s10162-013-0400-5; Brown MC, 1998, J NEUROPHYSIOL, V79, P3088, DOI 10.1152/jn.1998.79.6.3088; Carter L, 2014, EAR HEARING, V35, P491, DOI 10.1097/01.aud.0000451498.92871.20; Chen GD, 2003, HEARING RES, V177, P81, DOI 10.1016/S0378-5955(02)00802-X; Cody AR, OUTER HAIR CELLS MAM; COLLET L, 1991, ACTA OTO-LARYNGOL, V111, P231, DOI 10.3109/00016489109137380; Cooper NP, 2003, J PHYSIOL-LONDON, V548, P307, DOI 10.1113/jphysiol.2003.039081; Darrow KN, 2012, J COMP NEUROL, V520, P1365, DOI 10.1002/cne.22797; De Venecia RK, 2005, J COMP NEUROL, V487, P345, DOI 10.1002/cne.20550; Feeney MP, 2003, J SPEECH LANG HEAR R, V46, P128, DOI 10.1044/1092-4388(2003/010); Fuente A., 2015, FRONT SYST NEUROSCI, P9; Giraud AL, 1997, NEUROREPORT, V8, P1779, DOI 10.1097/00001756-199705060-00042; Gu JW, 2012, JARO-J ASSOC RES OTO, V13, P819, DOI 10.1007/s10162-012-0344-1; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Guinan JJ, 2014, FRONTIERS SYSTEMS NE; Guinan JJ, 2006, EAR HEARING, V27, P589, DOI 10.1097/01.aud.0000240507.83072.e7; Harkrider Ashley W, 2005, J Am Acad Audiol, V16, P530, DOI 10.3766/jaaa.16.8.2; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Henderson E, 2010, PEDIATRICS; Horvath M, 2003, EUR J NEUROSCI, V18, P1439, DOI 10.1046/j.1460-9568.2003.02870.x; IGARASHI M, 1979, ACTA OTO-LARYNGOL, V87, P429, DOI 10.3109/00016487909126446; Keefe DH, 2010, HEARING RES, V263, P52, DOI 10.1016/j.heares.2009.09.008; Kim S, 2006, SPEECH COMMUN, V48, P855, DOI 10.1016/j.specom.2006.03.004; Knudson IM, 2014, J NEUROPHYSIOL, V112, P3197, DOI 10.1152/jn.00576.2014; Kujawa SG, 1997, J NEUROPHYSIOL, V78, P3095, DOI 10.1152/jn.1997.78.6.3095; Kujawa SG, 2015, HEARING RES, V330, P191, DOI 10.1016/j.heares.2015.02.009; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Kumar UA, 2004, EAR HEARING, V25, P142, DOI 10.1097/01.AUD.0000120363.56591.E6; Liberman MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162726; Liberman MC, 2015, SCI AM, V313, P48, DOI 10.1038/scientificamerican0815-48; Liberman MC, 2014, J NEUROSCI, V34, P4599, DOI 10.1523/JNEUROSCI.4923-13.2014; Maison SF, 2000, J NEUROSCI, V20, P4701, DOI 10.1523/JNEUROSCI.20-12-04701.2000; Megerson SC, THEIS U KANSAS; Meinke DK, 2014, INT J AUDIOL, V53, pS16, DOI 10.3109/14992027.2013.865845; Micheyl C, 1996, J ACOUST SOC AM, V99, P1604, DOI 10.1121/1.414734; Mishra SK, 2016, J ACOUST SOC AM, V140, P1060, DOI 10.1121/1.4960550; Mishra SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085756; Mishra SK, 2013, EAR HEARING, V34, P789, DOI 10.1097/AUD.0b013e3182944c04; Moreno S, 2014, HEARING RES, V308, P84, DOI 10.1016/j.heares.2013.09.012; Mukari SZMS, 2008, AUDIOL NEURO-OTOL, V13, P328, DOI 10.1159/000128978; Mulders WHAM, 2000, HEARING RES, V144, P65, DOI 10.1016/S0378-5955(00)00046-0; Mulders WHAM, 2007, J NEUROPHYSIOL, V97, P3288, DOI 10.1152/jn.01148.2006; Nagaraj V., 2010, AURIS NASUS LARYNX; Nageris BI, 2007, OTOL NEUROTOL, V28, P434, DOI 10.1097/mao.0b013e3180430191; Negandhi J, 2014, HEARING RES, V315, P34, DOI 10.1016/j.heares.2014.06.002; NHANES, AUD DAT DOC; Niskar AS, 2001, PEDIATRICS, V108, P40, DOI 10.1542/peds.108.1.40; Oertel D, 2011, HEARING RES, V276, P61, DOI 10.1016/j.heares.2010.10.018; Otsuka S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146751; Parbery-Clark A, 2009, EAR HEARING, V30, P653, DOI 10.1097/AUD.0b013e3181b412e9; Paschoal Carolina Pamplona, 2009, Braz. j. otorhinolaryngol., V75, P893; Perrot X, 2014, HEARING RES, V308, P27, DOI 10.1016/j.heares.2013.08.010; Phillips SL, 2010, INT J AUDIOL, V49, P309, DOI 10.3109/14992020903470809; RAJAN R, 1988, BRAIN RES, V459, P241, DOI 10.1016/0006-8993(88)90640-3; Rajan R, 2000, J NEUROSCI, V20, P6684, DOI 10.1523/JNEUROSCI.20-17-06684.2000; Rawool V, 2011, OCCUPATIONAL RECREAT; Rawool V. W., 2012, HEARING CONSERVATION; Rawool VW, 2008, NOISE HEALTH, V10, P1, DOI 10.4103/1463-1741.39002; Shahin A, 2003, J NEUROSCI, V23, P5545; Smith SB, 2017, FRONTIERS NEUROSCIEN, P11; Stamper GC, 2015, EAR HEARING, V36, P172, DOI 10.1097/AUD.0000000000000107; Stuart A, 2012, J AM ACAD AUDIOL, V23, P686, DOI 10.3766/jaaa.23.9.3; Sturm JJ, 2015, J NEUROPHYSIOL, V114, P2551, DOI 10.1152/jn.00948.2014; THOMPSON AM, 1995, BRAIN RES, V695, P263, DOI 10.1016/0006-8993(95)00863-L; THOMPSON AM, 1991, J COMP NEUROL, V303, P267, DOI 10.1002/cne.903030209; Tyler RS, 2003, HYPERAKUSIS, V6, P39; Veuillet E, 2001, ACTA OTO-LARYNGOL, V121, P278; Viana LM, 2015, HEARING RES, V327, P78, DOI 10.1016/j.heares.2015.04.014; Vogel I, 2009, MUSIC LISTENING BEHA; Vogel I, 2012, PEDIATRICS, V129, P1097, DOI 10.1542/peds.2011-1948; Vogler DP, 2011, J NEUROSCI, V31, P6639, DOI 10.1523/JNEUROSCI.6538-10.2011; Wagner W, 2005, LARYNGOSCOPE, V115, P2021, DOI 10.1097/01.MLG.0000181463.16591.A7; Wagner W, 2008, ACTA OTO-LARYNGOL, V128, P53, DOI 10.1080/00016480701361954; Washnik NJ, 2016, NOISE HEALTH, V18, P98, DOI 10.4103/1463-1741.178510; Wild DC, 2005, CLIN OTOLARYNGOL, V30, P517, DOI 10.1111/j.1749-4486.2005.01105.x; Wolpert S, 2014, AUDIOL NEURO-OTOL, V19, P31, DOI 10.1159/000354913; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Zhao W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018725	92	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184036	10.1371/journal.pone.0184036	http://dx.doi.org/10.1371/journal.pone.0184036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886123	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100055
J	Chao, YS; Wu, CJ				Chao, Yi-Sheng; Wu, Chao-Jung			Principal component-based weighted indices and a framework to evaluate indices: Results from the Medical Expenditure Panel Survey 1996 to 2011	PLOS ONE			English	Article							FRAILTY; RISK; FRACTURE; ADULTS; HEALTH	Producing indices composed of multiple input variables has been embedded in some data processing and analytical methods. We aim to test the feasibility of creating data-driven indices by aggregating input variables according to principal component analysis (PCA) loadings. To validate the significance of both the theory-based and data-driven indices, we propose principles to review innovative indices. We generated weighted indices with the variables obtained in the first years of the two-year panels in the Medical Expenditure Panel Survey initiated between 1996 and 2011. Variables were weighted according to PCA loadings and summed. The statistical significance and residual deviance of each index to predict mortality in the second years was extracted from the results of discrete-time survival analyses. There were 237,832 surviving the first years of panels, represented 4.5 billion civilians in the United States, of which 0.62% (95% CI = 0.58% to 0.66%) died in the second years of the panels. Of all 134,689 weighted indices, there were 40,803 significantly predicting mortality in the second years with or without the adjustment of age, sex and races. The significant indices in the both models could at most lead to 10,200 years of academic tenure for individual researchers publishing four indices per year or 618.2 years of publishing for journals with annual volume of 66 articles. In conclusion, if aggregating information based on PCA loadings, there can be a large number of significant innovative indices composing input variables of various predictive powers. To justify the large quantities of innovative indices, we propose a reporting and review framework for novel indices based on the objectives to create indices, variable weighting, related outcomes and database characteristics. The indices selected by this framework could lead to a new genre of publications focusing on meaningful aggregation of information.	[Chao, Yi-Sheng] Univ Montreal, CRCHUM, Montreal, PQ, Canada; [Wu, Chao-Jung] Univ Quebec, Dept Informat, Montreal, PQ, Canada	Universite de Montreal; University of Quebec; University of Quebec Montreal	Chao, YS (corresponding author), Univ Montreal, CRCHUM, Montreal, PQ, Canada.	chaoyisheng@post.harvard.edu		Wu, Chao-Jung/0000-0002-8270-5498	Fonds de recherche du Quebec - Sante (FRQS) fellowship	Fonds de recherche du Quebec - Sante (FRQS) fellowship	YSC is financed by the Fonds de recherche du Quebec - Sante (FRQS) fellowship. The granting agencies had no role in this study.	Agency for Healthcare Research and Quality, 2013, AGENCY HEALTHCARE RE, P29; Agency for Healthcare Research and Quality, MEPS HC SAMPL DES CO; Babbie E., 2015, PRACTICE SOCIAL RES, P155; Buuren S., 2011, J STAT SOFTWARE, V45; Center for Financing A and Cost Trends, 2014, MEPS HC 156 PAN 16 L; Cohen JW, 1996, INQUIRY-J HEALTH CAR, V33, P373; Collin C, 1988, Int Disabil Stud, V10, P61; Duffy ME, 2005, STAT METHODS HLTH CA, P33; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; Everitt BS, 2006, HDB STAT ANAL USING, P215; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fukuda-Parr S, 2003, FEM ECON, V9, P301, DOI 10.1080/1354570022000077980; Goff JDC, 2013, J AM COLL CARDIOL, V63; Guyon I, 2003, J MACH LEARN RES, V3, P1157; Hall MA, 1997, FEATURE SUBSET SELEC; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hawken A, 2013, SOC INDIC RES, V111, P801, DOI 10.1007/s11205-012-0035-7; He R, 2010, NEUROCOMPUTING, V73, P1840, DOI 10.1016/j.neucom.2009.12.032; Hubbard RE, 2009, AGE AGEING, V38, P115, DOI 10.1093/ageing/afn252; Hurria A, 2010, HOLLAND FREI CANC ME, P838; Jolliffe I., 2013, PRINCIPAL COMPONENT; Jones JD, 2014, PARKINSONISM RELAT D, V20, P1236, DOI 10.1016/j.parkreldis.2014.09.014; Kennedy CC, 2014, OSTEOPOROSIS INT, V25, P2825, DOI 10.1007/s00198-014-2828-9; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lumley T., 2004, J STAT SOFTW, V9, P1, DOI [10.18637/jss.v009.i08, DOI 10.18637/JSS.V009.I08]; Lumley T., 2010, BASIC TOOLS COMPLEX, P1; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Makizako H, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008462; Mills M., 2011, INTRO SURVIVAL EVENT; Moher D, 2010, INT J SURG, V8, P658, DOI 10.1016/j.ijsu.2010.07.299; Moon JR, 2012, SOC SCI MED, V75, P526, DOI 10.1016/j.socscimed.2012.04.004; Oja H, 2010, MULTIVARIATE NONPARA; Park SH, 1996, STRATEGIC MANAGE J, V17, P109, DOI 10.1002/(SICI)1097-0266(199602)17:2<109::AID-SMJ796>3.3.CO;2-G; Plerou V, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066126; R Development Core Team. R, 2016, LANG ENV STAT COMP; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 2007, J GERONTOL A-BIOL, V62, P722, DOI 10.1093/gerona/62.7.722; Rstudio T, 2020, RSTUDIO INT DEV R; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schulz KF, 2010, OBSTET GYNECOL, V115, P1063, DOI 10.1097/AOG.0b013e3181d9d421; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Song XW, 2004, J AM GERIATR SOC, V52, P1180, DOI 10.1111/j.1532-5415.2004.52319.x; Therneau T.M., 2000, MODELING SURVIVAL DA; United Nations Development Programme (UNDP), 2015, HUM DEV REP 2015 WOR; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; von Elm E, 2007, B WORLD HEALTH ORGAN, V85, P867, DOI 10.2471/BLT.07.045120; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; Ware M, 2012, STM REPORT OVERVIEW	48	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183997	10.1371/journal.pone.0183997	http://dx.doi.org/10.1371/journal.pone.0183997			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886057	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100053
J	Curtis, PD				Curtis, Patrick D.			Stalk formation of Brevundimonas and how it compares to Caulobacter crescentus	PLOS ONE			English	Article							PROTEIN LOCALIZATION; BACTERIAL ORGANELLE; NUTRIENT-UPTAKE; CELL; POLYSACCHARIDE; INHIBITION; BIOGENESIS; REGULATOR; GENE	The Caulobacter crescentus cell extension known as a stalk represents an unusual bacterial morphology. C. crescentus produces stalks under multiple nutrient conditions, but the length of the stalk is increased in response to phosphate starvation. However, the exact function of the stalk is not known, nor is it known how much stalk biogenesis or function is conserved with other stalked bacteria. Work presented here shows that many organisms in the Caulobacter genus and the next closest genus (Brevundimonas) generally do not synthesize stalks in the relatively-rich PYE growth medium, suggesting that the synthesis of a stalk under nutrient-rich conditions by C. crescentus may be the exception instead of the norm among its phylogenetic group. Brevundimonas subvibrioides can be induced to synthesize stalks by genetically mimicking phosphate starvation conditions, indicating stalk synthesis in this organism may be performed on an as-need basis. This mutation, however, does not appear to increase the incidence of holdfast synthesis. While B. subvibrioides stalks appear to be synthesized with the same polarity with respect to holdfast as C. crescentus stalks, evidence is presented that suggests B. subvibrioides may disassemble stalks when they are no longer needed. Many homologs of C. crescentus genes encoding stalk-associated proteins are absent in the B. subvibrioides genome, and B. subvibrioides PstA-GFP as well as C. crescentus StpX-GFP are able to enter the B. subvibrioides stalk compartment, calling into question the level of compartmentalization of the B. subvibrioides stalk. In summary, this work begins to address how much the C. crescentus model for this unusual morphological adaptation can be extended to related organisms.	[Curtis, Patrick D.] Univ Mississippi, Dept Biol, University, MS 38677 USA	University of Mississippi	Curtis, PD (corresponding author), Univ Mississippi, Dept Biol, University, MS 38677 USA.	pdcurtis@olemiss.edu		Curtis, Patrick/0000-0002-4382-7564	United States National Science Foundation CAREER program [1552647]; Direct For Biological Sciences [1552647] Funding Source: National Science Foundation	United States National Science Foundation CAREER program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the United States National Science Foundation CAREER program award 1552647. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari S, 2016, FEMS MICROBIOL REV, V40, P575, DOI 10.1093/femsre/fuw023; Biondi EG, 2006, MOL MICROBIOL, V59, P386, DOI 10.1111/j.1365-2958.2005.04970.x; Brilli M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-52; BRUN YV, 1992, GENE DEV, V6, P2395, DOI 10.1101/gad.6.12a.2395; Curtis PD, 2014, MOL MICROBIOL, V93, P713, DOI 10.1111/mmi.12686; Curtis PD, 2010, MICROBIOL MOL BIOL R, V74, P13, DOI 10.1128/MMBR.00040-09; Gonin M, 2000, J BACTERIOL, V182, P337, DOI 10.1128/JB.182.2.337-347.2000; HAARS EG, 1974, J BACTERIOL, V120, P1409, DOI 10.1128/JB.120.3.1409-1416.1974; Hughes HV, 2013, MOL MICROBIOL, V90, P1162, DOI 10.1111/mmi.12422; Hughes HV, 2010, P NATL ACAD SCI USA, V107, P5599, DOI 10.1073/pnas.0909119107; Ireland MME, 2002, MOL MICROBIOL, V45, P1029, DOI 10.1046/j.1365-2958.2002.03071.x; Janakiraman RS, 1999, J BACTERIOL, V181, P1118, DOI 10.1128/JB.181.4.1118-1125.1999; Jiang C, 2014, NATURE, V506, P489, DOI 10.1038/nature12900; Klein Eric A, 2013, Commun Integr Biol, V6, pe24561, DOI 10.4161/cib.24561; Kuhn J, 2010, EMBO J, V29, P327, DOI 10.1038/emboj.2009.358; Laus MC, 2006, MOL MICROBIOL, V59, P1704, DOI 10.1111/j.1365-2958.2006.05057.x; Marques MDV, 1997, J BACTERIOL, V179, P5502, DOI 10.1128/jb.179.17.5502-5510.1997; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; POINDEXTER JS, 1978, J BACTERIOL, V135, P1141, DOI 10.1128/JB.135.3.1141-1145.1978; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; Schlimpert S, 2012, CELL, V151, P1270, DOI 10.1016/j.cell.2012.10.046; SCHMIDT JM, 1966, J CELL BIOL, V28, P423, DOI 10.1083/jcb.28.3.423; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818; Wagner JK, 2006, P NATL ACAD SCI USA, V103, P11772, DOI 10.1073/pnas.0602047103; WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630; Werner JN, 2009, P NATL ACAD SCI USA, V106, P7858, DOI 10.1073/pnas.0901781106; Xu J, 2013, MOL MICROBIOL, V89, P929, DOI 10.1111/mmi.12321; Xu QP, 2009, J MOL BIOL, V390, P686, DOI 10.1016/j.jmb.2009.05.023; Yakhnina AA, 2013, J BACTERIOL, V195, P4527, DOI 10.1128/JB.00600-13	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184063	10.1371/journal.pone.0184063	http://dx.doi.org/10.1371/journal.pone.0184063			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886080	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100062
J	Erdmann, W; Idzikowski, B; Kowalski, W; Szymanski, B; Kosicki, JZ; Kaczmarek, L				Erdmann, Weronika; Idzikowski, Bogdan; Kowalski, Wojciech; Szymanski, Bogdan; Kosicki, Jakub Z.; Kaczmarek, Lukasz			Can the tardigrade Hypsibius dujardini survive in the absence of the geomagnetic field?	PLOS ONE			English	Article							MAGNETIC-FIELD; MILNESIUM-TARDIGRADUM; RICHTERSIUS-CORONIFER; TOLERANCE; SPACE; EARTH; LIFE; ANHYDROBIOSIS; CRYPTOBIOSIS; DESICCATION	Earth's geomagnetic field has undergone critical changes in the past. Studies on the influence of the magnetic field on Earth's organisms are crucial for the understanding of evolution of life on Earth and astrobiological considerations. Numerous studies conducted both on plants and animals confirmed the significant influence of the geomagnetic field on the metabolism of living organisms. Water bears (Tardigrada), which are a mong the most resistant animals due to their cryptobiotic abilities, show significant resistance to a number of environmental stressors, but the influence of the geomagnetic field on their fitness has not been addressed before. In our studies, we used eutardigrade Hypsibius dujardini to analyse whether isolation from the geomagnetic field had an effect on mortality. We found that Hypsibius dujardini specimens demonstrated relatively high mortality during anhydrobiosis, also in control groups exposed to the normal geomagnetic field. Moreover, similar mortality was observed in anhydrobiotic specimens isolated from the geomagnetic field. However, a significant difference was noted between tardigrade survival and the moment of their isolation from the geomagnetic field. In particular, tardigrade mortality substantially increased in absence of a magnetic field during the process of entering anhydrobiosis and returning to active life. Our results suggest that these processes rely on complex metabolic processes that are critically influenced by the geomagnetic field.	[Erdmann, Weronika; Kaczmarek, Lukasz] Adam Mickiewicz Univ, Fac Biol, Dept Anim Taxon & Ecol, Umultowska 89, Poznan, Poland; [Idzikowski, Bogdan; Kowalski, Wojciech; Szymanski, Bogdan] Polish Acad Sci, Inst Mol Phys, M Smoluchowskiego17, Poznan, Poland; [Kosicki, Jakub Z.] Adam Mickiewicz Univ, Fac Biol, Dept Avian Biol & Ecol, Umultowska 89, Poznan, Poland	Adam Mickiewicz University; Polish Academy of Sciences; Institute of Molecular Physics of the Polish Academy of Sciences; Adam Mickiewicz University	Kosicki, JZ (corresponding author), Adam Mickiewicz Univ, Fac Biol, Dept Avian Biol & Ecol, Umultowska 89, Poznan, Poland.	kubako@amu.edu.pl	Idzikowski, Bogdan/AAE-9311-2021; Kaczmarek, Lukasz/A-2000-2008	Kaczmarek, Lukasz/0000-0002-5260-6253; Kosicki, Jakub/0000-0002-9044-7775; Idzikowski, Bogdan/0000-0003-0159-9839	Diamond Grant program [DI2012 016342]; Polish Ministry of Science and Higher Education via the "Diamond Grant" program [DI2012 016342]	Diamond Grant program; Polish Ministry of Science and Higher Education via the "Diamond Grant" program	Diamond Grant program No: DI2012 016342, "Study of resistance of small invertebrates cryptobiotic (for example Tardigrades). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by the Polish Ministry of Science and Higher Education via the "Diamond Grant" program (grant: DI2012 016342, "Study of resistance of small invertebrates cryptobiotic (for example tardigrades) to the lack of the geomagnetic field and the survivability of terrestrial organisms beyond our planet"). Studies have been conducted in the framework of activities of BARg (Biodiversity and Astrobiology Research group). The authors also wish to thank Professor Diane R. Nelson, Christine Moissl-Eichinger, Justyna Grzesko-wiak, Mark Ordon and Cambridge Proofreading LLC (http://proofreading.org/) for their linguistic assistance.	[Anonymous], B L ACAD POL SC; [Anonymous], 1955, NATURE; Baumann H., 1922, Zoologische Jahrbuecher Jena Abteilungen f Systematik, V45, P501; BECQUEREL P, 1950, CR HEBD ACAD SCI, V231, P261; Beltran-Pardo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133658; Beltran-Pardo EA, 2013, J LIMNOL, V72, P80, DOI 10.4081/jlimnol.2013.s1.e10; Belyavskaya NA, 2001, ADV SPACE RES, V28, P645, DOI 10.1016/S0273-1177(01)00373-8; Blank M, 1997, BIOELECTROMAGNETICS, V18, P111, DOI 10.1002/(SICI)1521-186X(1997)18:2<111::AID-BEM3>3.0.CO;2-5; Boothby TC, 2015, P NATL ACAD SCI USA, V112, P15976, DOI 10.1073/pnas.1510461112; BULLARD EC, 1949, PROC R SOC LON SER-A, V197, P433, DOI 10.1098/rspa.1949.0074; Clegg J.S., 1973, ANHYDROBIOSIS, P141; Conley CC, 1970, TND5902127 NASA, P1; CREMERBARTELS G, 1984, NATURWISSENSCHAFTEN, V71, P567, DOI 10.1007/BF01189180; Dubrov AP, 2014, GEOMAGNETOBIOLOGY, P318; Forster F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-469; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Galland P, 2005, J PLANT RES, V118, P371, DOI 10.1007/s10265-005-0246-y; Grohme MA, 2013, BIOINFORM BIOL INSIG, V7, P153, DOI 10.4137/BBI.S11497; Guidetti R, 2008, J EXP BIOL, V211, P2296, DOI 10.1242/jeb.015131; Guidetti R, 2012, PLANET SPACE SCI, V74, P97, DOI 10.1016/j.pss.2012.05.021; Guidetti R, 2011, J INSECT PHYSIOL, V57, P567, DOI 10.1016/j.jinsphys.2011.03.003; Guidetti R, 2011, ZOOLOGY, V114, P123, DOI 10.1016/j.zool.2010.11.005; Hengherr S, 2009, J EXP BIOL, V212, P802, DOI 10.1242/jeb.025973; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Jonsson KI, 2001, ECOTOX ENVIRON SAFE, V50, P72, DOI 10.1006/eesa.2001.2090; Kondo K, 2015, C MAT 13 INT S TARD, P92; Kopcewicz M, 1999, J APPL PHYS, V85, P4427, DOI 10.1063/1.370363; Lide D.R., 2004, CRC HDB CHEM PHYS, P2475; MARKOV MS, 1994, BIOELECTROCH BIOENER, V35, P57, DOI 10.1016/0302-4598(94)87012-8; Markov MS, 1997, BIOELECTROCH BIOENER, V43, P233, DOI 10.1016/S0302-4598(96)02226-X; Miglierini M, 2002, J PHYS-CONDENS MAT, V14, P1249, DOI 10.1088/0953-8984/14/6/312; Negishi Y, 1999, ADV SPACE RES, V23, P2029, DOI 10.1016/S0273-1177(99)00342-7; NOSSOL B, 1993, BIOELECTROMAGNETICS, V14, P361, DOI 10.1002/bem.2250140408; Ono F, 2008, J PHYS CHEM SOLIDS, V69, P2297, DOI 10.1016/j.jpcs.2008.04.019; R Development Core Team, 2016, R LANG ENV STAT COMP, P499; RAHM P. G., 1926, BIOL ZENTRALBL, V46, P452; Rahm PG, 1924, VERH D ZOOL GES, V29, P106; RAHM PG, 1923, Z ALLG PHYSL, V20, P1; Ramlov H, 2001, ZOOL ANZ, V240, P517, DOI 10.1078/0044-5231-00062; RAMLOV H, 1992, CRYOBIOLOGY, V29, P125, DOI 10.1016/0011-2240(92)90012-Q; Rampelotto Pabulo Henrique, 2013, Life-Basel, V3, P482, DOI 10.3390/life3030482; Rebecchi L, 2007, ISJ-INVERT SURVIV J, V4, P65; Rebecchi L, 2011, 5 NAT M ISSBB SPAZ N, P17; Rebecchi L, 2011, J ZOOL SYST EVOL RES, V49, P98, DOI 10.1111/j.1439-0469.2010.00606.x; Rebecchi L, 2009, ASTROBIOLOGY, V9, P581, DOI 10.1089/ast.2008.0305; Richaud M, 2015, C MAT 13 INT S TARD, P100; Rizzo AM, 2010, COMP BIOCHEM PHYS B, V156, P115, DOI 10.1016/j.cbpb.2010.02.009; Rotronic Instrument Corp, 2005, ROTR HUM HDB, P130; Seki K, 1998, NATURE, V395, P853, DOI 10.1038/27576; Shopf JW, 1999, DISCOVERY EARTHS EAR, P369; Tarduno JA, 2010, SCIENCE, V327, P1238, DOI 10.1126/science.1183445; Tombarkiewicz B, 2008, ENVIRON TOXICOL PHAR, V26, P75, DOI 10.1016/j.etap.2008.02.003; Vansanthan T, 2015, C MAT 13 INT S TARD, P133; Welnicz W, 2011, J INSECT PHYSIOL, V57, P577, DOI 10.1016/j.jinsphys.2011.03.019; Worth RJ, 2013, ASTROBIOLOGY, V13, P1155, DOI 10.1089/ast.2013.1028; Wplyw J., 2004, STYMULACJI MAGNETYCZ, V4, P459; Wright JC, 2001, ZOOL ANZ, V240, P563, DOI 10.1078/0044-5231-00068; WRIGHT JC, 1989, J EXP BIOL, V142, P267; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044209; ZAR JH, 1999, BIOSTAT ANAL, P123	63	10	10	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183380	10.1371/journal.pone.0183380	http://dx.doi.org/10.1371/journal.pone.0183380			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886031	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100018
J	Li, XJ; Jiang, XL; Chen, XD; Song, J; Ren, CC; Xiao, YJ; Gao, XH; Ru, ZG				Li, Xiaojun; Jiang, Xiaoling; Chen, Xiangdong; Song, Jie; Ren, Cuicui; Xiao, Yajuan; Gao, Xiaohui; Ru, Zhengang			Molecular cytogenetic identification of a novel wheat-Agropyron elongatum chromosome translocation line with powdery mildew resistance	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; TRITICUM-AESTIVUM L.; THINOPYRUM-INTERMEDIUM DERIVATIVES; FUSARIUM HEAD BLIGHT; CONFERRING RESISTANCE; MULTICOLOR GISH; COMMON WHEAT; BREAD WHEAT; STEM RUST; PARTIAL AMPHIPLOIDS	Agropyron elongatum (Host.) Neviski (synonym, Thinopyrum ponticum Podp., 2n = 70) has been used extensively as a valuable source for wheat breeding. Numerous chromosome fragments containing valuable genes have been successfully translocated into wheat from A. elongatum. However, reports on the transfer of powdery mildew resistance from A. elongatum to wheat are rare. In this study, a novel wheat-A. elongatum translocation line, 11-20-1, developed and selected from the progenies of a sequential cross between wheat varieties (Lankaoaizaoba, Keyu 818 and BainongAK 58) and A. elongatum, was evaluated for disease resistance and characterized using molecular cytogenetic methods. Cytological observations indicated that 11-20-1 had 42 chromosomes and formed 21 bivalents at meiotic metaphase I. Genomic in situ hybridization analysis using whole genomic DNA from A. elongatum as a probe showed that the short arms of a pair of wheat chromosomes were replaced by a pair of A. elongatum chromosome arms. Fluorescence in situ hybridization, using wheat D chromosome specific sequence pAs1 as a probe, suggested that the replaced chromosome arms of 11-20-1 were 5DS. This was further confirmed by wheat SSR markers specific for 5DS. ESTSSR and EST-STS multiple loci markers confirmed that the introduced A. elongatum chromosome arms belonged to homoeologous group 5. Therefore, it was deduced that 11-20-1 was a wheat-A. elongatum T5DL.5AgS translocation line. Both resistance observation and molecular marker analyses using two specific markers (BE443538 and CD452608) of A. elongatum in a F-2 population from a cross between line 11-20-1 and a susceptible cultivar Yannong 19 verified that the A. elongatum chromosomes were responsible for the powdery mildew resistance. This work suggests that 11-20-1 likely contains a novel resistance gene against powdery mildew. We expect this line to be useful for the genetic improvement of wheat.	[Li, Xiaojun; Jiang, Xiaoling; Chen, Xiangdong; Song, Jie; Ren, Cuicui; Xiao, Yajuan; Gao, Xiaohui; Ru, Zhengang] Henan Inst Sci & Technol, Coll Life Sci & Technol, Collaborat Innovat Ctr Modern Biol Breeding, Xinxiang, Henan, Peoples R China	Henan Institute of Science & Technology	Ru, ZG (corresponding author), Henan Inst Sci & Technol, Coll Life Sci & Technol, Collaborat Innovat Ctr Modern Biol Breeding, Xinxiang, Henan, Peoples R China.	rzgh58@163.com			Natural Science Foundation of China [31571752]; Key Research and Development Plan of China [2017YFD0100705]; Project of Henan Provincial Youth Backbone Teachers	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Plan of China; Project of Henan Provincial Youth Backbone Teachers	This work was supported by the Natural Science Foundation of China (No. 31571752), Key Research and Development Plan of China (No. 2017YFD0100705) and Project of Henan Provincial Youth Backbone Teachers.	An DG, 2013, CHROMOSOME RES, V21, P419, DOI 10.1007/s10577-013-9366-8; Chen GL, 2012, J BIOSCIENCES, V37, P149, DOI 10.1007/s12038-011-9175-1; Chen Q, 1998, GENOME, V41, P580, DOI 10.1139/gen-41-4-580; Ding YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122128; DONG YS, 1992, HEREDITAS, V116, P175, DOI 10.1111/j.1601-5223.1992.tb00224.x; Du WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053921; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; FRIEBE B, 1994, CROP SCI, V34, P400, DOI 10.2135/cropsci1994.0011183X003400020018x; Fu BS, 2013, THEOR APPL GENET, V126, P913, DOI 10.1007/s00122-012-2025-1; Fu SL, 2012, J GENET GENOMICS, V39, P103, DOI 10.1016/j.jgg.2011.11.008; GRIFFEY CA, 1993, PLANT DIS, V77, P618, DOI 10.1094/PD-77-0618; Han FP, 2004, THEOR APPL GENET, V109, P1070, DOI 10.1007/s00122-004-1720-y; Han FP, 2003, GENOME, V46, P490, DOI [10.1139/g03-032, 10.1139/G03-032]; Hao WeiWei, 2012, Scientia Agricultura Sinica, V45, P3240; He F, 2017, J GENET, V96, P165, DOI 10.1007/s12041-017-0754-2; He RL, 2009, THEOR APPL GENET, V118, P1173, DOI 10.1007/s00122-009-0971-z; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Hu LJ, 2011, J APPL GENET, V52, P279, DOI 10.1007/s13353-011-0038-0; Ishikawa G, 2009, THEOR APPL GENET, V118, P499, DOI 10.1007/s00122-008-0916-y; Ji J, 2009, CEREAL RES COMMUN, V37, P217, DOI 10.1556/CRC.37.2009.2.8; Jing Fan, 2015, Journal of Agricultural Biotechnology, V23, P561; Knott D. R., 1987, Wheat and wheat improvement., P462; Li HJ, 2004, GENOME, V47, P215, DOI 10.1139/G03-095; Li HongJie, 2013, Acta Agronomica Sinica, V39, P999, DOI 10.3724/SP.J.1006.2013.00999; Li HJ, 2009, J GENET GENOMICS, V36, P557, DOI 10.1016/S1673-8527(08)60147-2; Li Xiao-Feng, 2012, Chinese Journal of Plant Ecology, V36, P109, DOI 10.3724/SP.J.1258.2012.00109; Lin ZS, 2007, EUPHYTICA, V158, P109, DOI 10.1007/s10681-007-9435-1; Liu Z, 2007, J INTEGR PLANT BIOL, V49, P1080, DOI 10.1111/j.1672-9072.2007.00462.x; Ma HQ, 2011, THEOR APPL GENET, V123, P1099, DOI 10.1007/s00122-011-1651-3; MCINTOSH RA, 1970, EUPHYTICA, V19, P71, DOI 10.1007/BF01904668; Miranda LM, 2007, THEOR APPL GENET, V114, P1451, DOI 10.1007/s00122-007-0530-4; Miranda LM, 2006, THEOR APPL GENET, V113, P1497, DOI 10.1007/s00122-006-0397-9; Monneveux P, 2003, PLANT BREEDING, V122, P379, DOI 10.1046/j.1439-0523.2003.00856.x; Niu Z, 2014, THEOR APPL GENET, V127, P969, DOI 10.1007/s00122-014-2272-4; Oliver RE, 2006, THEOR APPL GENET, V112, P1473, DOI 10.1007/s00122-006-0250-1; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Peng YY, 2005, SCI AGR SIN, V38; Qi LL, 2011, THEOR APPL GENET, V123, P159, DOI 10.1007/s00122-011-1574-z; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Qiu YC, 2006, CEREAL RES COMMUN, V34, P1267, DOI 10.1556/CRC.34.2006.4.268; Sepsi A, 2008, THEOR APPL GENET, V116, P825, DOI 10.1007/s00122-008-0716-4; SHARP PJ, 1988, THEOR APPL GENET, V75, P286, DOI 10.1007/BF00303966; Si Q. M., 1987, Scientia Agricultura Sinica, V20, P64; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Tang ZX, 2008, CEREAL RES COMMUN, V36, P451, DOI 10.1556/CRC.36.2008.3.9; Wang J, 2005, PLANTA, V221, P277, DOI 10.1007/s00425-004-1443-y; Wang RRC, 1995, GENOME, V38, P1221, DOI 10.1139/g95-160; Wu J, 2006, THEOR APPL GENET, V114, P13, DOI 10.1007/s00122-006-0405-0; Zhan HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113455; Zhang XY, 1996, GENOME, V39, P1062, DOI 10.1139/g96-133; Zhang ZY, 2001, GENOME, V44, P1129, DOI 10.1139/gen-44-6-1129; Zhao JX, 2013, EUPHYTICA, V190, P45, DOI 10.1007/s10681-012-0772-3; Zheng Q, 2009, J GENET GENOMICS, V36, P575, DOI 10.1016/S1673-8527(08)60149-6; Zhu ZD, 2006, EUPHYTICA, V150, P149, DOI 10.1007/s10681-006-9103-x; Zou JingWei, 2017, Acta Agronomica Sinica, V43, P332	55	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184462	10.1371/journal.pone.0184462	http://dx.doi.org/10.1371/journal.pone.0184462			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886152	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100127
J	Park, S; Jang, H; Kim, BS; Hwang, C; Jeong, GS; Park, Y				Park, Siwan; Jang, Hwanseok; Kim, Byung Soo; Hwang, Changmo; Jeong, Gi Seok; Park, Yongdoo			Directional migration of mesenchymal stem cells under an SDF-1 alpha gradient on a microfluidic device	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; ENDOTHELIAL-CELLS; PROSTATE-CANCER; RHO-GTPASES; METASTASIS; INHIBITOR; MICE; CHEMOTAXIS; ACTIVATION; PLATFORM	Homing of peripheral stem cells is regulated by one of the most representative homing factors, stromal cell-derived factor 1 alpha (SDF-1 alpha), which specifically binds to the plasma membrane receptor CXCR4 of mesenchymal stem cells (MSCs) in order to initiate the signaling pathways that lead to directional migration and homing of stem cells. This complex homing process and directional migration of stem cells have been mimicked on a microfluidic device that is capable of generating a chemokine gradient within the collagen matrix and embedding endothelial cell (EC) monolayers to mimic blood vessels. On the microfluidic device, stem cells showed directional migration toward the higher concentration of SDF-1 alpha, whereas treatment with the CXCR4 antagonist AMD3100 caused loss of directionality of stem cells. Furthermore, inhibition of stem cell's main migratory signaling pathways, RhoROCK and Rac pathways, caused blockage of actomyosin and lamellipodia formation, decreasing the migration distance but maintaining directionality. Stem cell homing regulated by SDF-1 alpha caused directional migration of stem cells, while the migratory ability was affected by the activation of migration-related signaling pathways.	[Park, Siwan; Jang, Hwanseok; Park, Yongdoo] Korea Univ, Coll Med, Biomed Sci Brain Korea 21, Dept Biomed Engn, Seoul, South Korea; [Kim, Byung Soo] Korea Univ, Grad Sch Med, Dept Biomed Sci, Seoul, South Korea; [Hwang, Changmo; Jeong, Gi Seok] Asan Med Ctr, Asan Inst Life Sci, Biomed Engn Res Ctr, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); University of Ulsan; Asan Medical Center	Park, Y (corresponding author), Korea Univ, Coll Med, Biomed Sci Brain Korea 21, Dept Biomed Engn, Seoul, South Korea.; Jeong, GS (corresponding author), Asan Med Ctr, Asan Inst Life Sci, Biomed Engn Res Ctr, Seoul, South Korea.	gsjeong@amc.seoul.kr; ydpark67@korea.ac.kr	Jeong, Gi Seok/AAB-2830-2021	Park, Yongdoo/0000-0003-3822-4651; Jang, Hwanseok/0000-0002-1700-5962	National Research Foundation of Korea grant - Korean government [NRF-2014R1A2A1A11051879]; Korea University Grant	National Research Foundation of Korea grant - Korean government; Korea University Grant	This work was supported by a National Research Foundation of Korea grant funded by the Korean government (NRF-2014R1A2A1A11051879), (http://www.nrf.re.kr/index) and a Korea University Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson RH, 2002, J PHYSIOL-LONDON, V539, P295, DOI 10.1113/jphysiol.2001.013117; Baumer Y, 2009, J CELL PHYSIOL, V220, P716, DOI 10.1002/jcp.21819; Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Chen YC, 2003, CANCER RES, V63, P4801; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Chung S, 2009, ADV MATER, V21, P4863; Chung S, 2009, LAB CHIP, V9, P269, DOI 10.1039/b807585a; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Gouwy M, 2004, J LEUKOCYTE BIOL, V76, P185, DOI 10.1189/jlb.1003479; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Hatse S, 2002, FEBS LETT, V527, P255, DOI 10.1016/S0014-5793(02)03143-5; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Jeong GS, 2011, ANAL CHEM, V83, P8454, DOI 10.1021/ac202170e; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Li J, 2011, TRENDS CELL BIOL, V21, P489, DOI 10.1016/j.tcb.2011.05.002; Liao YX, 2013, INT J MOL MED, V32, P1239, DOI 10.3892/ijmm.2013.1521; Mark D, 2010, CHEM SOC REV, V39, P1153, DOI 10.1039/b820557b; Matthys P, 2001, J IMMUNOL, P167; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Quesenberry PJ, 1998, P NATL ACAD SCI USA, V95, P15155, DOI 10.1073/pnas.95.26.15155; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rao JN, 2001, AM J PHYSIOL-CELL PH, V280, pC993, DOI 10.1152/ajpcell.2001.280.4.C993; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Somlyo AV, 2000, BIOCHEM BIOPH RES CO, V269, P652, DOI 10.1006/bbrc.2000.2343; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; TAKAI Y, 1992, INT REV CYTOL, V133, P187, DOI 10.1016/S0074-7696(08)61861-6; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tonges L, 2011, ROCKING REGENERATION; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Wong D, 2008, CLIN CANCER RES, V14, P7975, DOI 10.1158/1078-0432.CCR-07-4846; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Yu XF, 2003, J BONE MINER RES, V18, P1404, DOI 10.1359/jbmr.2003.18.8.1404	43	22	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184595	10.1371/journal.pone.0184595	http://dx.doi.org/10.1371/journal.pone.0184595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886159	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100164
J	Tanskanen, A; Taipale, H; Koponen, M; Tolppanen, AM; Hartikainen, S; Ahonen, R; Tiihonen, J				Tanskanen, Antti; Taipale, Heidi; Koponen, Marjaana; Tolppanen, Anna-Maija; Hartikainen, Sirpa; Ahonen, Riitta; Tiihonen, Jari			Drug exposure in register-based research-An expert-opinion based evaluation of methods	PLOS ONE			English	Article							LONG-TERM USE; PRESCRIPTION DURATIONS; ANTIPLATELET DRUGS; CLAIMS DATA; MEDICATION; PERSISTENCE; ADHERENCE; HOSPITALIZATION; DATABASE; FINLAND	Background In register-based pharmacoepidemiological studies, construction of drug exposure periods from drug purchases is a major methodological challenge. Various methods have been applied but their validity is rarely evaluated. Our objective was to conduct an expert-opinion based evaluation of the correctness of drug use periods produced by different methods. Methods Drug use periods were calculated with three fixed methods: time windows, assumption of one Defined Daily Dose (DDD) per day and one tablet per day, and with PRE2DUP that is based on modelling of individual drug purchasing behavior. Expert-opinion based evaluation was conducted with 200 randomly selected purchase histories of warfarin, bisoprolol, simvastatin, risperidone and mirtazapine in the MEDALZ-2005 cohort (28,093 persons with Alzheimer's disease). Two experts reviewed purchase histories and judged which methods had joined correct purchases and gave correct duration for each of 1000 drug exposure periods. Results The evaluated correctness of drug use periods was 70-94% for PRE2DUP, and depending on grace periods and time window lengths 0-73% for tablet methods, 0-41% for DDD methods and 0-11% for time window methods. The highest rate of evaluated correct solutions for each method class were observed for 1 tablet per day with 180 days grace period (TAB_1_180, 43-73%), and 1 DDD per day with 180 days grace period (1-41%). Time window methods produced at maximum only 11% correct solutions. The best performing fixed method TAB_1_180 reached highest correctness for simvastatin 73% (95% CI 65-81%) whereas 89% (95% CI 84-94%) of PRE2DUP periods were judged as correct. Conclusions This study shows inaccuracy of fixed methods and the urgent need for new data-driven methods. In the expert-opinion based evaluation, the lowest error rates were observed with data-driven method PRE2DUP.	[Tanskanen, Antti; Taipale, Heidi; Tiihonen, Jari] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Tanskanen, Antti] Natl Inst Hlth & Welf, Helsinki, Finland; [Tanskanen, Antti; Taipale, Heidi; Tiihonen, Jari] Univ Eastern Finland, Dept Forens Psychiat, Niuvanniemi Hosp, Kuopio, Finland; [Taipale, Heidi; Koponen, Marjaana; Hartikainen, Sirpa] Univ Eastern Finland, Kuopio Res Ctr Geriatr Care, Kuopio, Finland; [Taipale, Heidi; Koponen, Marjaana; Tolppanen, Anna-Maija; Hartikainen, Sirpa; Ahonen, Riitta] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Tolppanen, Anna-Maija] Univ Eastern Finland, Res Ctr Comparat Effectiveness & Patient Safety R, Kuopio, Finland; [Hartikainen, Sirpa] Kuopio Univ Hosp, Psychiat, Kuopio, Finland	Karolinska Institutet; Finland National Institute for Health & Welfare; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Tanskanen, A (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.; Tanskanen, A (corresponding author), Natl Inst Hlth & Welf, Helsinki, Finland.; Tanskanen, A (corresponding author), Univ Eastern Finland, Dept Forens Psychiat, Niuvanniemi Hosp, Kuopio, Finland.	antti.tanskanen@ki.se	Tiihonen, Jari/G-3078-2012	Tiihonen, Jari/0000-0002-0400-6798; Taipale, Heidi/0000-0002-3281-934X	Finnish Cultural Fund; European Regional Development Fund	Finnish Cultural Fund(Finnish Cultural Foundation); European Regional Development Fund(European Commission)	H.T. received funding from the Finnish Cultural Fund. A.-M.T. received funding from the European Regional Development Fund (Regional Council of Pohjois-Savo). The funders did not have a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah-Koolmees H, 2014, ANN PHARMACOTHER, V48, P1415, DOI 10.1177/1060028014544897; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; [Anonymous], DDD DEF GEN CONS; Bakken MS, 2013, AGE AGEING, V42, P514, DOI 10.1093/ageing/aft009; Burden AM, 2015, PHARMACOEPIDEM DR S, V24, P67, DOI 10.1002/pds.3718; Gardarsdottir H, 2010, J CLIN EPIDEMIOL, V63, P422, DOI 10.1016/j.jclinepi.2009.07.001; Gardarsdottir H, 2009, AM J EPIDEMIOL, V170, P280, DOI 10.1093/aje/kwp142; Helin-Salmivaara Arja, 2009, Diabetes Res Clin Pract, V84, pe9, DOI 10.1016/j.diabres.2008.12.015; Helin-Salmivaara A, 2008, CLIN THER, V30, P2228, DOI 10.1016/j.clinthera.2008.12.003; JOHNELL K, EUR J CLIN PHARM, V64, P1119; Meid AD, 2016, PHARMACOEPIDEM DR S, V25, P1434, DOI 10.1002/pds.4091; Nielsen LH, 2008, PHARMACOEPIDEM DR S, V17, P384, DOI 10.1002/pds.1549; Ostergaard K, 2014, EUR J CLIN PHARMACOL, V70, P241, DOI 10.1007/s00228-013-1609-2; Ostergaard K, 2012, EUR J CLIN PHARMACOL, V68, P1631, DOI 10.1007/s00228-012-1293-7; Robinson D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140598; Romppainen T, 2014, EUR J CLIN PHARMACOL, V70, P1275, DOI 10.1007/s00228-014-1737-3; Sjosten N, 2013, J HYPERTENS, V31, P1477, DOI 10.1097/HJH.0b013e32836098d1; Stovring H, 2016, PHARMACOEPIDEM DR S, V25, P1451, DOI 10.1002/pds.4114; Strandberg AY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151910; Stricker BHC, 2010, EUR J EPIDEMIOL, V25, P245, DOI 10.1007/s10654-010-9451-7; Suokas JT, 2013, SOC PSYCH PSYCH EPID, V48, P631, DOI 10.1007/s00127-012-0586-6; Taipale H, 2016, CLIN EPIDEMIOL, V8, P363, DOI 10.2147/CLEP.S116160; Taipale H, 2014, J CLIN PSYCHOPHARM, V34, P435, DOI 10.1097/JCP.0000000000000133; Tanskanen A, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0140-z; Tanskanen Antti, 2014, BMC Res Notes, V7, P796, DOI 10.1186/1756-0500-7-796; Tiihonen J, 2012, ARCH GEN PSYCHIAT, V69, P476, DOI 10.1001/archgenpsychiatry.2011.1532; Tolppanen Anna-Maija, 2013, Clin Epidemiol, V5, P277, DOI 10.2147/CLEP.S46622; Van Wijk BLG, 2006, J CLIN EPIDEMIOL, V59, P11, DOI 10.1016/j.jclinepi.2005.05.005; Weitoft GR, 2014, PHARMACOEPIDEM DR S, V23, P290, DOI 10.1002/pds.3567	29	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184070	10.1371/journal.pone.0184070	http://dx.doi.org/10.1371/journal.pone.0184070			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886089	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100063
J	Farrell, M; Yoneda, Z; Montgomery, J; Crawford, D; Wray, LL; Xu, M; Kolek, MJ; Richardson, T; Lugo, R; Metawee, M; Michaud, G; Estrada, JC; Saavedra, P; Shen, S; Kanagasundram, A; Ellis, CR; Crossley, G; Roden, D; Shoemaker, MB				Farrell, Maureen; Yoneda, Zachary; Montgomery, Jay; Crawford, Diane; Wray, Lauren Lee; Xu, Meng; Kolek, Matthew J.; Richardson, Travis; Lugo, Ricardo; Metawee, Mohamed; Michaud, Greg; Estrada, Juan Carlos; Saavedra, Pablo; Shen, Sharon; Kanagasundram, Arvindh; Ellis, Christopher R.; Crossley, George; Roden, Dan; Shoemaker, M. Benjamin			Non-pulmonary vein mediated atrial fibrillation: A novel sub-phenotype	PLOS ONE			English	Article							CATHETER ABLATION	Background Atrial fibrillation (AF) is a mechanistically heterogeneous disorder, and the ability to identify sub-phenotypes ("endophenotypes") of AF would assist in the delivery of personalized medicine. We used the clinical response to pulmonary vein isolation (PVI) to identify a sub-group of patients with non-PV mediated AF and sought to define the clinical associations. Methods Subjects enrolled in the Vanderbilt AF Ablation Registry who underwent a repeat AF ablation due to arrhythmia recurrence were analyzed on the basis of PV reconnection. Subjects who had no PV reconnection were defined as "non-PV mediated AF". A comparison group of subjects were identified who had AF that was treated with PVI-only and experienced no arrhythmia recurrence >12 months. They were considered a group enriched for "PV-mediated AF". Univariate and multivariable binary logistic regression analysis was performed to investigate clinical associations between the PV and non-PV mediated AF groups. Results Two hundred and twenty nine subjects underwent repeat AF ablation and thirty three (14%) had no PV reconnection. They were compared with 91 subjects identified as having PV-mediated AF. Subjects with non-PV mediated AF were older (64 years [IQR 60,71] vs. 60 [52,67], P = 0.01), more likely to have non-paroxysmal AF (82% [N = 27] vs. 35% [N = 32], P< 0.001), and had a larger left atrium (LA) (4.2cm [3.6,4.8] vs. 4.0 [3.3,4.4], P = 0.04). In univariate analysis, age (per decade: OR 1.56 [95% CI: 1.04 to 2.33], P = 0.03), LA size (per cm: OR 1.8 [1.06 to 3.21], P = 0.03) and non-paroxysmal AF (OR 8.3 [3.10 to 22.19], P< 0.001) were all significantly associated with non-PV mediated AF. However, in multivariable analysis only non-paroxysmal AF was independently associated with non-PV mediated AF (OR 7.47 [95% CI 2.62 to 21.29], P<0.001), when adjusted for age (per decade: OR 1.25 [0.81 to 1.94], P = 0.31), male gender (OR 0.48 [0.18 to 1.28], P = 0.14), and LA size (per 1cm: 1.24 [0.65 to 2.33], P = 0.52). Conclusions Non-paroxysmal AF was the only clinical variable found to be independently associated with non-PV mediated AF. We demonstrated that analysis of AF ablation outcomes data can serve as a tool to successfully identify a sub-phenotype of subjects who have non-PV mediated AF.	[Farrell, Maureen; Yoneda, Zachary; Montgomery, Jay; Crawford, Diane; Wray, Lauren Lee; Kolek, Matthew J.; Richardson, Travis; Lugo, Ricardo; Metawee, Mohamed; Michaud, Greg; Estrada, Juan Carlos; Saavedra, Pablo; Shen, Sharon; Kanagasundram, Arvindh; Ellis, Christopher R.; Crossley, George; Roden, Dan; Shoemaker, M. Benjamin] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA; [Xu, Meng] Vanderbilt Univ, Dept Biostat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Roden, Dan] Vanderbilt Univ, Dept Biomed Informat, 221 Kirkland Hall, Nashville, TN 37235 USA; [Roden, Dan] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Yoneda, Z; Shoemaker, MB (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37235 USA.	moore.b.shoemaker@vanderbilt.edu; moore.b.shoemaker@vanderbilt.edu	Roden, Dan/ABD-5412-2021; Ellis, Christopher Randall/AAL-3749-2020	Ellis, Christopher Randall/0000-0002-7333-5720; Farrell, Maureen/0000-0003-4728-0233	National Institutes of Health [K23 HL127704]; CTSA from the National Center for Advancing Translational Sciences [UL1TR000445]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL127704] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research work was supported in part by the National Institutes of Health grant K23 HL127704 (MBS). The project was also supported by CTSA award UL1TR000445 from the National Center for Advancing Translational Sciences awarded to Vanderbilt University. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldinger Samuel H, 2016, JACC Clin Electrophysiol, V2, P723, DOI 10.1016/j.jacep.2016.05.013; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Kim TH, 2016, EUROPACE; Kornej J, 2015, CLIN RES CARDIOL, V104, P871, DOI 10.1007/s00392-015-0856-x; Nattel S, 2016, NAT REV CARDIOL, V13, P575, DOI 10.1038/nrcardio.2016.118; Nery Pablo B, 2016, JACC Clin Electrophysiol, V2, P474, DOI 10.1016/j.jacep.2016.02.003; Sadek MM, 2016, HEART RHYTHM, V13, P2174, DOI 10.1016/j.hrthm.2016.08.026; Sawhney N, 2010, CIRC-ARRHYTHMIA ELEC, V3, P243, DOI 10.1161/CIRCEP.109.924878; Shah AJ, 2010, CARDIOL RES PRACT, V2010, DOI 10.4061/2010/950763; Shoemaker MB, 2013, AM J CARDIOL, V111, P368, DOI 10.1016/j.amjcard.2012.10.013; Verma A, 2015, NEW ENGL J MED, V372, P1812, DOI 10.1056/NEJMoa1408288; Winkle RA, 2016, HEART RHYTHM, V13, P2119, DOI 10.1016/j.hrthm.2016.07.018	16	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184354	10.1371/journal.pone.0184354	http://dx.doi.org/10.1371/journal.pone.0184354			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880943	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200056
J	Zhou, J; Li, J; Rosenbaum, DM; Zhuang, J; Poon, C; Qin, P; Rivera, K; Lepore, J; Willette, RN; Hu, E; Barone, FC				Zhou, Jin; Li, Jie; Rosenbaum, Daniel M.; Zhuang, Jian; Poon, Carrie; Qin, Pu; Rivera, Katrina; Lepore, John; Willette, Robert N.; Hu, Erding; Barone, Frank C.			The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; ENDOTHELIAL GROWTH-FACTOR; CEREBRAL-ISCHEMIA; STEM-CELLS; HYDROXYLASE INHIBITION; VEGF EXPRESSION; MESSENGER-RNA; HYPOXIA; STROKE; ERYTHROPOIETIN	There is interest in pharmacologic preconditioning for end-organ protection by targeting the HIF system. This can be accomplishe d by inhibition of prolyl 4-hydroxylase (PHD). GSK360A is an orally active PHD inhibitor that has been previously shown to protect the failing heart. We hypothesized that PHD inhibition can also protect the brain from injuries and resulting behavioral deficits that can occur as a result of surgery. Thus, our goal was to investigate the effect of pre-stroke surgery brain protection using a verified GSK360A PHD inhibition paradigm on post-stroke surgery outcomes. Vehicle or an established protective dose (30 mg/kg, p.o.) of GSK360A was administered to male Sprague-Dawley rats. Initially, GSK360A pharmacokinetics and organ distribution were determined, and then PHD-HIF pharmacodynamic markers were measured (i.e., to validate the pharmacological effects of the GSK360A administration regimen). Results obtained using this validated PHD dose-regimen indicated significant improvement by GSK360A (30mg/kg); administered at 18 and 5 hours prior to transient middle cerebral artery occlusion (stroke). GSK360A exposure and plasma, kidney and brain HIF-PHD pharmacodynamics endpoints (e.g., erythropoietin; EPO and Vascular Endothelial Growth Factor; VEGF) were measured. GSK360A provided rapid exposure in plasma (7734 ng/ml), kidney (45-52% of plasma level) and brain (1-4% of plasma level), and increased kidney EPO mRNA (80-fold) and brain VEGF mRNA (2-fold). We also observed that GSK360A increased plasma EPO (300-fold) and VEGF (2-fold). Further assessments indicated that GSK360A reduced post-stroke surgery neurological deficits (47-64%), cognitive dysfunction (60-75%) and brain infarction (30%) 4 weeks later. Thus, PHD inhibition using GSK360A pretreatment produced long-term post-stroke brain protection and improved behavioral functioning. These data support PHD inhibition, specifically by GSK360A, as a potential strategy for pre-surgical use to reduce brain injury and functional decline due to surgery-related cerebral injury.	[Zhou, Jin; Li, Jie; Rosenbaum, Daniel M.; Zhuang, Jian; Poon, Carrie; Barone, Frank C.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Rosenbaum, Daniel M.; Barone, Frank C.] Suny Downstate Med Ctr, Robert F Furchgott Fdn, Brooklyn, NY 11203 USA; [Rosenbaum, Daniel M.; Barone, Frank C.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Qin, Pu; Rivera, Katrina; Lepore, John; Willette, Robert N.; Hu, Erding] GlaxoSmithKline, Heart Failure Discovery Performance Unit, Cardiac Biol, King Of Prussia, PA USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; GlaxoSmithKline	Barone, FC (corresponding author), Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA.; Barone, FC (corresponding author), Suny Downstate Med Ctr, Robert F Furchgott Fdn, Brooklyn, NY 11203 USA.; Barone, FC (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.	frank.barone@downstate.edu			GlaxoSmithKline Pharmaceuticals (GSK)	GlaxoSmithKline Pharmaceuticals (GSK)(GlaxoSmithKline)	This work was funded by GlaxoSmithKline Pharmaceuticals (GSK) to test the "chemical preconditioning protection surgical pretreatment hypothesis" as indicated in this paper. Only the persons listed as authors of this manuscript had roles in the study design, the collection and analysis of data, the decision to publish, and/or the preparation of this paper for publication. The funder (GSK) provided support in the form of salaries for authors [JL for Jie Li], provided the background in vitro and in vivo information on GSK360, collaborated on the study design, completed pharmacokinetic and pharmacodynamic data analysis, and helped in editing of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ansaloni L, 2010, BRIT J SURG, V97, P273, DOI 10.1002/bjs.6843; Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Ban HS, 2010, CANCER LETT, V296, P17, DOI 10.1016/j.canlet.2010.03.010; Bao WK, 2010, J CARDIOVASC PHARM, V56, P147, DOI 10.1097/FJC.0b013e3181e2bfef; Barone FC, 2004, METH MOLEC MED, V104, P105; Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; Barone FC, 2010, NEUROPHARMACOLOGY, V59, P650, DOI 10.1016/j.neuropharm.2010.08.016; Bartels K, 2013, CURR OPIN ANESTHESIO, V26, P91, DOI 10.1097/ACO.0b013e32835bf24c; Bernaudin M, 2002, J CEREBR BLOOD F MET, V22, P393, DOI 10.1097/00004647-200204000-00003; Bernaudin M, 2002, J BIOL CHEM, V277, P39728, DOI 10.1074/jbc.M204619200; Cai Z, 2008, CARDIOVASC RES, V77, P463, DOI 10.1093/cvr/cvm035; Cai ZQ, 2003, CIRCULATION, V108, P79, DOI 10.1161/01.CIR.0000078635.89229.8A; Chavez JC, 2002, J NEUROSCI, V22, P8922; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Chen CH, 2009, NEUROBIOL DIS, V33, P509, DOI 10.1016/j.nbd.2008.12.010; Cimadevilla JM, 2000, NEUROSCI LETT, V285, P53, DOI 10.1016/S0304-3940(00)01019-3; CLARK RK, 1993, BRAIN RES BULL, V31, P565, DOI 10.1016/0361-9230(93)90124-T; DERYCK M, 1989, STROKE, V20, P1383, DOI 10.1161/01.STR.20.10.1383; Ding Y, 2004, NEUROSCIENCE, V123, P667, DOI 10.1016/j.neuroscience.2003.08.031; Dirnagl U, 2003, TRENDS NEUROSCI, V26, P248, DOI 10.1016/S0166-2236(03)00071-7; Dirnagl U, 2009, LANCET NEUROL, V8, P398, DOI 10.1016/S1474-4422(09)70054-7; Dreixler JC, 2009, EXP EYE RES, V89, P782, DOI 10.1016/j.exer.2009.07.006; Eckerich C, 2007, INT J CANCER, V121, P276, DOI 10.1002/ijc.22679; Etz CD, 2015, J THORAC CARDIOV SUR, V149, P1074, DOI 10.1016/j.jtcvs.2014.12.025; Fandrey J, 2004, AM J PHYSIOL-REG I, V286, pR977, DOI 10.1152/ajpregu.00577.2003; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Ghoneim MM, 2012, EUR J ANAESTH, V29, P409, DOI 10.1097/EJA.0b013e328356bd6e; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gidday JM, 2010, TRANSL STROKE RES, V1, P19, DOI 10.1007/s12975-010-0011-y; Harten SK, 2010, ANTIOXID REDOX SIGN, V12, P459, DOI 10.1089/ars.2009.2870; Jin KL, 2000, P NATL ACAD SCI USA, V97, P10242, DOI 10.1073/pnas.97.18.10242; Jung F, 2000, CIRC RES, V86, P319, DOI 10.1161/01.RES.86.3.319; Kahle MP, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/374098; Karuppagounder SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac6008; Karuppagounder SS, 2012, J CEREBR BLOOD F MET, V32, P1347, DOI 10.1038/jcbfm.2012.28; Knowles HJ, 2004, CIRC RES, V95, P162, DOI 10.1161/01.RES.0000134924.89412.70; Kovalska M, 2012, NEUROCHEM RES, V37, P1568, DOI 10.1007/s11064-012-0752-y; Kurapeev DI, 2015, J CARDIOTHORAC SURG, V10, DOI 10.1186/s13019-015-0206-0; Lai TW, 2012, J MOL CELL BIOL, V4, P184, DOI 10.1093/jmcb/mjs009; Lenhard SC, 2008, PHARMACOLOGY, V81, P1, DOI 10.1159/000107661; Li XP, 2010, BLOOD CELL MOL DIS, V45, P9, DOI 10.1016/j.bcmd.2010.03.003; Malhotra S, 2006, J NEUROSCI RES, V83, P19, DOI 10.1002/jnr.20705; Margaritescu O, 2011, ROM J MORPHOL EMBRYO, V52, P1283; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P483, DOI 10.1097/00004647-199705000-00001; Nishimura M, 2003, J CEREBR BLOOD F MET, V23, P1052, DOI 10.1097/01.WCB.0000084251.20114.65; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Prass K, 2003, STROKE, V34, P1981, DOI 10.1161/01.STR.0000080381.76409.B2; Ratan RR, 2007, J MOL MED, V85, P1331, DOI 10.1007/s00109-007-0283-1; Ratan RR, 2004, STROKE, V35, P2687, DOI 10.1161/01.STR.0000143216.85349.9e; Reischl S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084767; Roitbak T, 2008, J CEREBR BLOOD F MET, V28, P1530, DOI 10.1038/jcbfm.2008.38; Ruscher K, 2002, J NEUROSCI, V22, P10291, DOI 10.1523/jneurosci.22-23-10291.2002; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Selvan P, 2017, DRUG FUTURE, V42, P215, DOI 10.1358/dof.2017.042.04.2611806; Siddiq A, 2005, J BIOL CHEM, V280, P41732, DOI 10.1074/jbc.M504963200; Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977; Troen AM, 2012, J RENAL NUTR, V22, P268, DOI 10.1053/j.jrn.2011.07.009; Umschweif G, 2013, J CEREBR BLOOD F MET, V33, P524, DOI 10.1038/jcbfm.2012.193; van den Beucken T, 2009, J BIOL CHEM, V284, P24204, DOI 10.1074/jbc.M109.006510; Virgintino D, 2003, HISTOCHEM CELL BIOL, V119, P227, DOI 10.1007/s00418-003-0510-y; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Wang XK, 2000, J NEUROSCI RES, V59, P238, DOI 10.1002/(SICI)1097-4547(20000115)59:2<238::AID-JNR10>3.0.CO;2-G; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Wu YG, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/537531; Yeh CH, 2010, LIFE SCI, V86, P115, DOI 10.1016/j.lfs.2009.11.022; Zhong Q, 2012, STEM CELLS DEV, V21, P2703, DOI 10.1089/scd.2011.0604; Zhou J, 2005, J CEREBR BLOOD F MET, V25, P878, DOI 10.1038/sj.jcbfm.9600082; Zhou J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057503; Zhou J, 2011, J CEREBR BLOOD F MET, V31, P924, DOI 10.1038/jcbfm.2010.171	71	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184049	10.1371/journal.pone.0184049	http://dx.doi.org/10.1371/journal.pone.0184049			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880966	Green Submitted, gold, Green Published			2022-12-27	WOS:000409467200032
J	Zuidscherwoude, M; Worah, K; van der Schaaf, A; Buschow, SI; van Spriel, AB				Zuidscherwoude, Malou; Worah, Kuntal; van der Schaaf, Alie; Buschow, Sonja I.; van Spriel, Annemiek B.			Differential expression of tetraspanin superfamily members in dendritic cell subsets	PLOS ONE			English	Article							MHC CLASS-II; ANTIGEN PRESENTATION; PLASMA-MEMBRANE; HLA-DR; COMPLEXES; MOLECULES; CD82; MIGRATION; SURFACE; CD63	Dendritic cells (DCs), which are essential for initiating immune responses, are comprised of different subsets. Tetraspanins organize dendritic cell membranes by facilitating protein-protein interactions within the so called tetraspanin web. In this study we analyzed expression of the complete tetraspanin superfamily in primary murine (CD4+, CD8+, pDC) and human DC subsets (CD1c+, CD141+, pDC) at the transcriptome and proteome level. Different RNA and protein expression profiles for the tetraspanin genes across human and murine DC subsets were identified. Although RNA expression levels of CD37 and CD82 were not significantly different between human DC subsets, CD9 RNA was highly expressed in pDCs, while CD9 protein expression was lower. This indicates that relative RNA and protein expression levels are not always in agreement. Both murine CD8 alpha+ DCs and its regarded human counterpart, CD141+ DCs, displayed relatively high protein levels of CD81. CD53 protein was highly expressed on human pDCs in contrast to the relatively low protein expression of most other tetraspanins. This study demonstrates that tetraspanins are differentially expressed by human and murine DC subsets which provides a valuable resource that will aid the understanding of tetraspanin function in DC biology.	[Zuidscherwoude, Malou; Worah, Kuntal; van der Schaaf, Alie; Buschow, Sonja I.; van Spriel, Annemiek B.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, Nijmegen, Netherlands; [Worah, Kuntal] Radboud Univ Nijmegen, Med Ctr, CMBI, Nijmegen, Netherlands; [Buschow, Sonja I.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC	van Spriel, AB (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Tumor Immunol, Nijmegen, Netherlands.	Annemiek.vanSpriel@radboudumc.nl	van Spriel, Annemiek/Q-6044-2019; Buschow, Sonja/AAD-3567-2020; Zuidscherwoude, Malou/AAY-1547-2021	van Spriel, Annemiek/0000-0002-3590-2368; Zuidscherwoude, Malou/0000-0002-5071-9000; Buschow, Sonja/0000-0002-7907-8315	Netherlands Organization (NWO-ALW VIDI) [864.11.006]; Dutch Cancer Society (KWF) [KUN2014-6845, KWO-2009-4402]; European Research Council [724281]; Radboudumc	Netherlands Organization (NWO-ALW VIDI); Dutch Cancer Society (KWF)(KWF Kankerbestrijding); European Research Council(European Research Council (ERC)European Commission); Radboudumc	ABvS is recipient of a Netherlands Organization for Scientific Research Grant (NWO-ALW VIDI grant 864.11.006) http://www.nwo.nl/en/funding/our-funding-instruments/nwo/innovational-research-incentives-scheme/vidi/index.html, a Dutch Cancer Society (KWF) grant (KUN2014-6845) http://www.kwf.nl/english/pages/default.aspx, and was awarded an European Research Council Consolidator Grant (Secret Surface, 724281) https://erc.europa.eu/. KW is supported by a Dutch Cancer Society (KWF) grant KWO-2009-4402. This work is supported by the Radboudumc (PhD Grant to MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrena S, 2005, LEUKEMIA, V19, P1376, DOI 10.1038/sj.leu.2403822; Bassani S, 2012, INT J BIOCHEM CELL B, V44, P703, DOI 10.1016/j.biocel.2012.01.020; Bosch B, 2013, J BIOL CHEM, V288, P13236, DOI 10.1074/jbc.M112.442640; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Cowin AJ, 2006, J INVEST DERMATOL, V126, P680, DOI 10.1038/sj.jid.5700142; Dalgaard J, 2005, J LEUKOCYTE BIOL, V77, P689, DOI 10.1189/jlb.1204711; de Winde CM, 2015, HISTOCHEM CELL BIOL, V144, P133, DOI 10.1007/s00418-015-1326-2; Dutertre CA, 2014, CELL IMMUNOL, V291, P3, DOI 10.1016/j.cellimm.2014.08.006; Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021; Engering A, 2001, INT IMMUNOL, V13, P127, DOI 10.1093/intimm/13.2.127; Ferez M, 2014, J IMMUNOL, V192, P52, DOI 10.4049/jimmunol.1301224; Gartlan KH, 2013, EUR J IMMUNOL, V43, P1208, DOI 10.1002/eji.201242730; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Hammond C, 1998, J IMMUNOL, V161, P3282; Harris J, 2002, TRENDS IMMUNOL, V23, P158, DOI 10.1016/S1471-4906(01)02161-5; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Jones EL, 2016, J IMMUNOL, V196, P978, DOI 10.4049/jimmunol.1500357; Levy S, 2005, NAT REV IMMUNOL, V5, P136, DOI 10.1038/nri1548; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Mantegazza AR, 2004, BLOOD, V104, P1183, DOI 10.1182/blood-2004-01-0104; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Mittelbrunn M, 2002, J IMMUNOL, V169, P6691, DOI 10.4049/jimmunol.169.12.6691; Petersen SH, 2011, EUR J IMMUNOL, V41, P2556, DOI 10.1002/eji.201141438; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; Rubinstein E, 1996, EUR J IMMUNOL, V26, P2657, DOI 10.1002/eji.1830261117; Schlitzer A, 2014, CURR OPIN IMMUNOL, V26, P90, DOI 10.1016/j.coi.2013.11.002; Segura E, 2010, MOL IMMUNOL, V47, P1765, DOI 10.1016/j.molimm.2010.02.028; Sheng KC, 2009, EUR J IMMUNOL, V39, P50, DOI 10.1002/eji.200838798; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Szollosi J, 1996, J IMMUNOL, V157, P2939; Tarrant JM, 2003, TRENDS IMMUNOL, V24, P610, DOI 10.1016/j.it.2003.09.011; Tel J, 2013, BLOOD, V121, P459, DOI 10.1182/blood-2012-06-435644; Manh TPV, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00260; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Unternaehrer JJ, 2007, P NATL ACAD SCI USA, V104, P234, DOI 10.1073/pnas.0609665104; van den Hoorn T, 2012, J CELL SCI, V125, P328, DOI 10.1242/jcs.088047; van Spriel AB, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003113; Vremec D, 2000, J IMMUNOL, V164, P2978, DOI 10.4049/jimmunol.164.6.2978; Worah K, 2016, CELL REP, V16, P2953, DOI 10.1016/j.celrep.2016.08.023; Wright MD, 2004, TISSUE ANTIGENS, V64, P533, DOI 10.1111/j.1399-0039.2004.00321.x; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang XWH, 2012, J CELL SCI, V125, P1478, DOI 10.1242/jcs.093963; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhang JW, 2014, ONCOTARGET, V5, P12083, DOI 10.18632/oncotarget.2499; Zuidscherwoude M, 2013, J LEUKOCYTE BIOL, V95, p1 ; Zuidscherwoude M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12201	52	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184317	10.1371/journal.pone.0184317	http://dx.doi.org/10.1371/journal.pone.0184317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880937	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200049
J	Shinohara, K; Suganuma, AM; Imai, H; Takeshima, N; Hayasaka, Y; Furukawa, TA				Shinohara, Kiyomi; Suganuma, Aya M.; Imai, Hissei; Takeshima, Nozomi; Hayasaka, Yu; Furukawa, Toshi A.			Overstatements in abstract conclusions claiming effectiveness of interventions in psychiatry: A meta-epidemiological investigation	PLOS ONE			English	Article							RANDOMIZED-CONTROLLED-TRIAL; CLINICAL-TRIAL; OUTCOMES; DEPRESSION; SYMPTOMS; EFFICACY; CARE	Objective Abstracts of scientific reports are sometimes criticized for exaggerating significant results when compared to the corresponding full texts. Such abstracts can mislead the readers. We aimed to conduct a systematic review of overstatements in abstract conclusions in psychiatry trials. Methods We searched for randomized controlled trials published in 2014 that explicitly claimed effectiveness of any intervention for mental disorders in their abstract conclusion, using the Cochrane Register of Controlled Trials. Claims of effectiveness in abstract conclusion were categorized into three types: superiority (stating superiority of intervention to control), limited superiority (intervention has limited superiority), and equal efficactiveness (claiming equal effectiveness of intervention with standard treatment control), and full text results into three types: significant (all primary outcomes were statistically significant in favor of the intervention), mixed (primary outcomes included both significant and non-significant results), or all results non-significant. By comparing these classifications, we assessed whether each abstract was overstated. Our primary outcome was the proportion of overstated abstract conclusions. Results We identified and included 60 relevant trials. 20 out of 60 studies (33.3%) showed overstatements. Nine reports reported only significant results although none of their primary outcomes were significant. Large sample size (>300) and publication in high impact factor (IF>10) journals were associated with low occurrence of overstatements. Conclusions We found that one in three psychiatry studies claiming effectiveness in their abstract conclusion, either superior to control or equal to standard treatment, for any mental disorders were overstated in comparison with the full text results. Readers of the psychiatry literature are advised to scrutinize the full text results regardless of the claims in the abstract.	[Shinohara, Kiyomi; Suganuma, Aya M.; Imai, Hissei; Takeshima, Nozomi; Hayasaka, Yu; Furukawa, Toshi A.] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav,Sakyo Ku, Konoe Cho, Kyoto, Japan	Kyoto University	Shinohara, K (corresponding author), Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Hlth Promot & Human Behav,Sakyo Ku, Konoe Cho, Kyoto, Japan.	shinohara.kiyomi.75r@st.kyoto-u.ac.jp	Shinohara, Kiyomi/AAC-6963-2021; Furukawa, Toshi A./B-9259-2011; Imai, Hissei/AFB-5160-2022; Kiyomi, Shinohara/AAB-9504-2021	Shinohara, Kiyomi/0000-0003-3527-4004; Furukawa, Toshi A./0000-0003-2159-3776; Imai, Hissei/0000-0003-3656-5188; 	JSPS KAKENHI [26670314]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by JSPS KAKENHI (Grant-in-Aid for Scientific Research) Grant Number 26670314 to TAF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional internal or external funding received for this study.	Amos AJ., 2014, PRIM CARE COMPANION, V16; Arunachalam L, 2016, ANN SURG; Bastiaansen JA, 2015, BIOL PSYCHIAT, V78, pE35, DOI 10.1016/j.biopsych.2014.12.007; Beglinger LJ, 2014, MOVEMENT DISORD, V29, P401, DOI 10.1002/mds.25750; Boutron I, 2010, JAMA-J AM MED ASSOC, V303, P2058, DOI 10.1001/jama.2010.651; Brigham GS, 2014, DRUG ALCOHOL DEPEN, V138, P240, DOI 10.1016/j.drugalcdep.2014.02.013; Burke DT, 2002, AM J PHYS MED REHAB, V81, P779, DOI 10.1097/00002060-200210000-00011; Campbell ANC, 2014, AM J PSYCHIAT, V171, P683, DOI 10.1176/appi.ajp.2014.13081055; de Vries YA, 2016, PSYCHOL MED, V46, P2971, DOI 10.1017/S0033291716000805; Freund-Levi Y, 2014, AM J GERIAT PSYCHIAT, V22, P341, DOI 10.1016/j.jagp.2013.05.005; Hopewell S, 2008, PLOS MED, V5, P48, DOI 10.1371/journal.pmed.0050020; Hopewell S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4178; Hoyles RK, 2006, ARTHRITIS RHEUM-US, V54, P3962, DOI 10.1002/art.22204; Knuppel H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075995; Kurata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060925; Lazarus C, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0079-x; Lockyer S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-371; Mathieu S, 2012, JOINT BONE SPINE, V79, P262, DOI 10.1016/j.jbspin.2011.05.008; Melville JL, 2014, OBSTET GYNECOL, V123, P1237, DOI 10.1097/AOG.0000000000000231; Mertens JR, 2014, ALCOHOL ALCOHOLISM, V49, P430, DOI 10.1093/alcalc/agu030; Park IU, 2014, NATURE, V506, P93, DOI 10.1038/nature12786; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Shinohara K, 2015, ACTA PSYCHIAT SCAND, V132, P489, DOI 10.1111/acps.12502; Sternfeld B, 2014, MENOPAUSE, V21, P330, DOI 10.1097/GME.0b013e31829e4089; Suganuma AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009832; Sumner P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168217; Vinkers CH, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6467; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8	28	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184786	10.1371/journal.pone.0184786	http://dx.doi.org/10.1371/journal.pone.0184786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902885	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200068
J	Ye, YQ; Li, ZH; Feng, Q; Chen, ZM; Wu, ZG; Wang, JY; Ye, XS; Zhang, DH; Liu, L; Gao, W; Zhang, LH; Wang, B				Ye, Yongqin; Li, Zhihan; Feng, Qi; Chen, Zimin; Wu, Zhouguang; Wang, Jianyao; Ye, Xiaoshuo; Zhang, Dahao; Liu, Lei; Gao, Wei; Zhang, Lihui; Wang, Bin			Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3	PLOS ONE			English	Article							SUSCEPTIBILITY; PROLIFERATION; PATHOGENESIS; HEPATITIS; ADHESION	Background and objectives Biliary atresia (BA) is a pediatric liver disease characterized by fibro-obliteration and obstruction of the extrahepatic biliary system, that invariably leads to cirrhosis and even death, if left untreated for extended time. However, its pathology and etiology still remained unknown. In this study, we tested the expression of adducin 3 (ADD3), the gene identified as a susceptibility gene in BA by GWAS, and uncovered its upstream regulatory microRNA in the pathogenesis of BA. Methods In this study, 14 infants with BA and 14 infants with choledochal cyst (CC) were enrolled as experimental group and control group, respectively. ADD3 and microRNA-145 (miR-145) expression profiles in liver tissues of BA and CC were determined using qPCR. Luciferase reporter assay was performed to verify the direct interaction between miR-145-5p and ADD3 3' Untranslated Regions (3' UTR). The Lentiviral vectors containing miR-145, miR-145-3p inhibitor, miR-145-5p inhibitor, empty vector were transfected into human hepatic stellate cell line (LX-2) to determine the functional effect of miR-145 on ADD3 expression at both mRNA and protein level. Results MiR-145 was shown to be down-regulated in liver tissues of infants with BA compared to CC (p = 0.0267). ADD3, verified as a target of miR-145-5p, was shown to be overexpressed in infants with BA at the mRNA level (p = 0.0118). Transfection of lentiviruses containing miR-145 into LX-2 cells decreased the expression of ADD3 at both mRNA and protein level compared to negative control group, and suppressed the expression of p-Akt at protein level. Conclusions Our study has shown that overexpressed ADD3 and downregulated miR-145 were detected in BA liver tissues. MiR-145-5p was confirmed to target ADD3 by luciferase reporter assay. The downregulation of miR-145 may contribute to liver fibrosis in BA by upregulating the expression of ADD3.	[Ye, Yongqin; Li, Zhihan; Zhang, Dahao] Shantou Univ, Med Coll, Shantou, Guangdong, Peoples R China; [Ye, Yongqin; Li, Zhihan; Feng, Qi; Chen, Zimin; Wu, Zhouguang; Wang, Jianyao; Ye, Xiaoshuo; Zhang, Dahao; Wang, Bin] Shenzhen Childrens Hosp, Dept Gen Surg, Shenzhen, Guangdong, Peoples R China; [Liu, Lei] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Hepatobiliary Dis, Shenzhen, Guangdong, Peoples R China; [Gao, Wei] Tianjin First Ctr Hosp, Dept Organ Transplatat, Tianjin, Peoples R China; [Zhang, Lihui] Shenzhen Childrens Hosp, Dept Tradit Chinese Med, Shenzhen, Guangdong, Peoples R China	Shantou University	Wang, B (corresponding author), Shenzhen Childrens Hosp, Dept Gen Surg, Shenzhen, Guangdong, Peoples R China.; Gao, W (corresponding author), Tianjin First Ctr Hosp, Dept Organ Transplatat, Tianjin, Peoples R China.; Zhang, LH (corresponding author), Shenzhen Childrens Hosp, Dept Tradit Chinese Med, Shenzhen, Guangdong, Peoples R China.	gao-wei@medmail.com.cn; 13602576251@126.com; szwb1967@126.com	Wu, Zhouguang/AAQ-1534-2020; Liu, lei/V-9405-2018	Liu, lei/0000-0001-9612-6844	Shenzhen Science and Technology Innovation Committee [JCYJ20150403100317072, JCYJ20160429174611494]	Shenzhen Science and Technology Innovation Committee	This work is jointly supported by Shenzhen Science and Technology Innovation Committee (Grant numbers: JCYJ20150403100317072 and JCYJ20160429174611494), https//wwwszsti.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado AG, 2016, NEURO-ONCOLOGY, V18, P656, DOI 10.1093/neuonc/nov196; Asai A, 2015, NAT REV GASTRO HEPAT, V12, P342, DOI 10.1038/nrgastro.2015.74; Bai GP, 2016, ONCOL REP, V36, P2902, DOI 10.3892/or.2016.5078; Citterio L, 2003, BIOCHEM BIOPH RES CO, V309, P359, DOI 10.1016/j.bbrc.2003.08.011; Cronin DC, 2013, PEDIATRICS, V131, P141, DOI 10.1542/peds.2012-0567; Dai Yang, 2010, Open Access Bioinformatics, V2, P29; DANKS DM, 1977, ARCH DIS CHILD, V52, P360, DOI 10.1136/adc.52.5.360; Duellman T, 2014, NUCLEIC ACIDS RES, V42, P5518, DOI 10.1093/nar/gku197; Garcia-Barcelo MM, 2010, HUM MOL GENET, V19, P2917, DOI 10.1093/hmg/ddq196; Gradilone SA, 2015, SEMIN LIVER DIS, V35, P26, DOI 10.1055/s-0034-1397346; He Weichun, 2015, Curr Pathobiol Rep, V3, P183; Huang JF, 2011, HEPATOL RES, V41, P430, DOI 10.1111/j.1872-034X.2011.00786.x; Lee M, 2016, MEDICINE, V95, pe2741, DOI 10. 1097/MD. 0000000000002741; MATSUI A, 1994, LANCET, V343, P925, DOI 10.1016/S0140-6736(94)90052-3; Mezina A, 2015, DIGEST DIS, V33, P408, DOI 10.1159/000371694; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Nio M, 2003, J PEDIATR SURG, V38, P997, DOI 10.1016/S0022-3468(03)00178-7; OSHIO C, 1981, SCIENCE, V212, P1041, DOI 10.1126/science.7015506; Panebianco C, 2016, CLIN EXPT MED; Pasquinelli AE, 2012, NAT REV GENET, V13, P271, DOI 10.1038/nrg3162; Petersen C, 2008, EUR J PEDIATR SURG, V18, P111, DOI 10.1055/s-2008-1038479; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Reich M, 2016, GUT, V65, P487, DOI 10.1136/gutjnl-2015-309458; Schmitt MMN, 2014, CIRCULATION, V129, P66, DOI 10.1161/CIRCULATIONAHA.113.004149; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Shteyer E, 2006, J PEDIATR GASTR NUTR, V42, P93, DOI 10.1097/01.mpg.0000189324.80323.a6; Tsai EA, 2014, HUM GENET, V133, P235, DOI 10.1007/s00439-013-1368-2; Varma V, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/121862; Yoon PW, 1997, PEDIATRICS, V99, P376, DOI 10.1542/peds.99.3.376; Zeng SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107977; Zhang XL, 2016, MOL MED REP, V14, P5699, DOI 10.3892/mmr.2016.5960; Zhou DD, 2016, MOL IMMUNOL, V75, P151, DOI 10.1016/j.molimm.2016.05.018	32	16	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0180896	10.1371/journal.pone.0180896	http://dx.doi.org/10.1371/journal.pone.0180896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902846	gold, Green Published, Green Submitted			2022-12-27	WOS:000410669200001
J	Angkasekwinai, P; Sodthawon, W; Jeerawattanawart, S; Hansakon, A; Pattanapanyasat, K; Wang, YH				Angkasekwinai, Pornpimon; Sodthawon, Wichuda; Jeerawattanawart, Siranart; Hansakon, Adithap; Pattanapanyasat, Kovit; Wang, Yui-Hsi			ILC2s activated by IL-25 promote antigen-specific Th2 and Th9 functions that contribute to the control of Trichinella spiralis infection	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; T-CELLS; IMMUNITY; IDENTIFICATION; IL-13; INFLAMMATION; MECHANISMS; EXPRESSION; INDUCTION; RESPONSES	IL-25, an IL-17 family cytokine, derived from epithelial cells was shown to regulate Th2-and Th9-type immune responses. We previously reported that IL-25 was important in promoting efficient protective immunity against T. spiralis infection; however, the cellular targets of IL25 to elicit type-2 immunity during infection have not yet been addressed. Here, we investigated IL-25-responding cells and their involvement in mediating type-2 immune response during T. spiralis infection. ILC2 and CD4(+) Th2 cells residing in the gastrointestinal tract of T. spiralis infected mice were found to express high levels of surface interleukin-17 receptor B ( IL-17RB), a component of the IL-25 receptor. Following T. spiralis infection, activated ILC2s upregulated surface MHCII expression and enhanced capacity of effector T helper cell in producing antigen-specific Th2 and Th9 cytokines through MHCII-dependent interactions. Reciprocally, lack of CD4(+) T helper cells impaired ILC2 function to produce type 2-associated cytokines in responding to IL-25 during T. spiralis infection. Furthermore, mice deficient in IL-17RB showed markedly reduced ILC2 numbers and antigen-specific Th2 and Th9 cytokine production during T. spiralis infection. The Il17rb(-/-)mice failed to mount effective antigen specific Th2 and Th9 functions resulting in diminished goblet cell and mast cell responses, leading to delayed worm expulsion in the intestines and muscles. Thus, our data indicated that ILC2s and CD4 + Th2 cells are the predominant cellular targets of IL-25 following T. spiralis infection and their collaborative interactions may play a key role in mounting effective antigen-specific Th2 and Th9 cytokine responses against T. spiralis infection.	[Angkasekwinai, Pornpimon; Sodthawon, Wichuda; Jeerawattanawart, Siranart; Hansakon, Adithap] Thammasat Univ, Fac Allied Hlth Sci, Dept Med Technol, Pathum Thani, Thailand; [Angkasekwinai, Pornpimon; Jeerawattanawart, Siranart; Hansakon, Adithap] Thammasat Univ, Fac Allied Hlth Sci, Grad Program Biomed Sci, Pathum Thani, Thailand; [Pattanapanyasat, Kovit] Mahidol Univ, Siriraj Hosp, Ctr Excellence Flow Cytometry, Off Res & Dev,Fac Med, Bangkok, Thailand; [Wang, Yui-Hsi] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH USA	Thammasat University; Thammasat University; Mahidol University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Angkasekwinai, P (corresponding author), Thammasat Univ, Fac Allied Hlth Sci, Dept Med Technol, Pathum Thani, Thailand.; Angkasekwinai, P (corresponding author), Thammasat Univ, Fac Allied Hlth Sci, Grad Program Biomed Sci, Pathum Thani, Thailand.	upornpim@tu.ac.th	Angkasekwinai, Pornpimon/AAX-6124-2020	Angkasekwinai, Pornpimon/0000-0003-0303-9544; Hansakon, Adithap/0000-0003-1693-4900	Thailand Research Fund Grant for New Researcher (Thailand Research Fund (TRF)); Thailand Research Fund Grant for New Researcher (Thammasat University) [TRG5780021]; Kovit Pattanapanyasat (Thailand research Fund) [DPG5980001]; Ph.D. Royal Golden Jubilee Scholarship from the Thailand Research Fund (TRF) Grant; Faculty of Allied Health Sciences, Thammasat University; Thammasat university	Thailand Research Fund Grant for New Researcher (Thailand Research Fund (TRF))(Thailand Research Fund (TRF)); Thailand Research Fund Grant for New Researcher (Thammasat University); Kovit Pattanapanyasat (Thailand research Fund)(Thailand Research Fund (TRF)); Ph.D. Royal Golden Jubilee Scholarship from the Thailand Research Fund (TRF) Grant; Faculty of Allied Health Sciences, Thammasat University; Thammasat university	This work was supported by the Thailand Research Fund Grant for New Researcher (co-funded by the Thailand Research Fund (TRF) and Thammasat University, TRG5780021), Kovit Pattanapanyasat (Thailand research Fund, DPG5980001). Siranart Jeerawattanawart receives a Ph.D. Scholarship from Thammasat university and Adithap Hansakon was sponsored by a Ph.D. Royal Golden Jubilee Scholarship from the Thailand Research Fund (TRF) Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Wanchai Maleewong (Department of Parasitology, Faculty of Medicine, Khon Kaen University) and Dr. Wanpen Chaicumpa (Department of Parasitology, Faculty of Medicine Siriraj Hospital, Mahidol University) for providing T. spiralis, the Drug Discovery and Development Center, Thammasat University and Flow Cytometry Laboratory, Department of Pathology, Faculty of Medicine, Ramathibodi Hospital for use of flow cytometry facilities and the Faculty of Allied Health Sciences, Thammasat University for their support.	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Angkasekwinai P, 2013, INFECT IMMUN, V81, P3731, DOI 10.1128/IAI.00646-13; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Chen CY, 2015, IMMUNITY, V43, P788, DOI 10.1016/j.immuni.2015.08.020; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Grencis RK, 2014, IMMUNOL REV, V260, P183, DOI 10.1111/imr.12188; GRENCIS RK, 1985, IMMUNOLOGY, V56, P213; Helmby H, 2002, J IMMUNOL, V169, P2553, DOI 10.4049/jimmunol.169.5.2553; Hoshino K, 1999, J EXP MED, V190, P1541, DOI 10.1084/jem.190.10.1541; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Lee JB, 2016, J ALLERGY CLIN IMMUN, V137, P1216, DOI 10.1016/j.jaci.2015.09.019; Liu B, 2015, J IMMUNOL, V194, P3583, DOI 10.4049/jimmunol.1400951; Mirchandani AS, 2014, J IMMUNOL, V192, P2442, DOI 10.4049/jimmunol.1300974; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; Oliphant CJ, 2014, IMMUNITY, V41, P283, DOI 10.1016/j.immuni.2014.06.016; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Patel N, 2009, INT J PARASITOL, V39, P13, DOI 10.1016/j.ijpara.2008.08.003; POZIO E, 1989, TROP MED PARASITOL, V40, P73; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rickel EA, 2008, J IMMUNOL, V181, P4299, DOI 10.4049/jimmunol.181.6.4299; Scales HE, 2007, PARASITE IMMUNOL, V29, P81, DOI 10.1111/j.1365-3024.2006.00920.x; Scalfone LK, 2013, INFECT IMMUN, V81, P1354, DOI 10.1128/IAI.01307-12; Turner JE, 2013, J EXP MED, V210, P2951, DOI 10.1084/jem.20130071; Vallance BA, 1999, INFECT IMMUN, V67, P6090, DOI 10.1128/IAI.67.11.6090-6097.1999; Vallance BA, 1998, AM J PHYSIOL-GASTR L, V275, pG1157, DOI 10.1152/ajpgi.1998.275.5.G1157; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Zhao AP, 2010, J IMMUNOL, V185, P6921, DOI 10.4049/jimmunol.1000450	34	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184684	10.1371/journal.pone.0184684	http://dx.doi.org/10.1371/journal.pone.0184684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898280	Green Published, gold, Green Submitted			2022-12-27	WOS:000410449500044
J	Bretin, S; Louis, C; Seguin, L; Wagner, S; Thomas, JY; Challal, S; Rogez, N; Albinet, K; Iop, F; Villain, N; Bertrand, S; Krazem, A; Berachochea, D; Billiald, S; Tordjman, C; Cordi, A; Bertrand, D; Lestage, P; Danober, L				Bretin, Sylvie; Louis, Caroline; Seguin, Laure; Wagner, Stephanie; Thomas, Jean-Yves; Challal, Sylvie; Rogez, Nathalie; Albinet, Karine; Iop, Fabrice; Villain, Nadege; Bertrand, Sonia; Krazem, Ali; Berachochea, Daniel; Billiald, Stephanie; Tordjman, Charles; Cordi, Alex; Bertrand, Daniel; Lestage, Pierre; Danober, Laurence			Pharmacological characterisation of S 47445, a novel positive allosteric modulator of AMPA receptors	PLOS ONE			English	Article							SPONTANEOUS-ALTERNATION BEHAVIOR; GLUTAMATE RECEPTORS; POTENTIATORS LY392098; SYNAPTIC PLASTICITY; MOLECULAR-MECHANISM; FUNCTIONAL-ANALYSIS; CELL BIOLOGY; ION-CHANNEL; DRUG DESIGN; IN-VITRO	S 47445 is a novel positive allosteric modulator of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors (AMPA-PAM). S 47445 enhanced glutamate's action at AMPA receptors on human and rat receptors and was inactive at NMDA and kainate receptors. Potentiation did not differ among the different AMPA receptors subtypes (GluA1/2/4 flip and flop variants) (EC50 between 2.5-5.4 mu M), except a higher EC50 value for GluA4 flop (0.7 mu M) and a greater amount of potentiation on GluA1 flop. A low concentration of S 47445 (0.1 mu M) decreased receptor response decay time of GluA1flop/GluA2flip AMPA receptors and increased the sensitivity to glutamate. Furthermore, S 47445 (0.1 and 0.3 mu M) in presence of repetitive glutamate pulses induced a progressive potentiation of the glutamate-evoked currents from the second pulse of glutamate confirming a rapid-enhancing effect of S 47445 at low concentrations. The potentiating effect of S 47445 (1 mu M) was concentration-dependently reversed by the selective AMPA receptor antagonist GYKI52466 demonstrating the selective modulatory effect of S 47445 on AMPA receptors. Using an AMPA-kainate chimera approach, it was confirmed that S 47445 binds to the common binding pocket of AMPA-PAMs. S 47445 did not demonstrate neurotoxic effect against glutamate-mediated excitotoxicity in vitro, in contrast significantly protected rat cortical neurons at 10 mu M. S 47445 was shown to improve both episodic and spatial working memory in adult rodents at 0.3 mg/kg, as measured in the natural forgetting condition of object recognition and T-maze tasks. Finally, no deleterious effect on spontaneous locomotion and general behavior was observed up to 1000 mg/kg of S 47445 given acutely in rodents, neither occurrence of convulsion or tremors. Collectively, these results indicate that S 47445 is a potent and selective AMPA-PAM presenting procognitive and potential neuroprotective properties. This drug is currently evaluated in clinical phase 2 studies in Alzheimer's disease and in Major Depressive Disorder.	[Bretin, Sylvie; Seguin, Laure] Inst Rech Int Servier, Pole Innovat Therapeut Neuropsychiat, Suresnes, France; [Louis, Caroline; Thomas, Jean-Yves; Challal, Sylvie; Rogez, Nathalie; Albinet, Karine; Iop, Fabrice; Villain, Nadege; Lestage, Pierre; Danober, Laurence] Inst Rech Servier, Pole Innovat Therapeut Neuropsychiat, Croissy Sur Seine, France; [Wagner, Stephanie] Neurofit, Illkirch Graffenstaden, France; [Bertrand, Sonia; Bertrand, Daniel] HiQScreen, Vesenaz Geneva, Switzerland; [Krazem, Ali; Berachochea, Daniel] Univ Bordeaux 1, Ctr Neurosci Integrat & Cognit, Talence, France; [Billiald, Stephanie; Tordjman, Charles; Cordi, Alex] Inst Rech Servier, Pole Expertise Rech & Biopharm, Suresnes, France	Servier; Institut de Recherches Internationales Servier; Servier; Institut de Recherches Internationales Servier; UDICE-French Research Universities; Universite de Bordeaux; Servier; Institut de Recherches Internationales Servier	Bretin, S (corresponding author), Inst Rech Int Servier, Pole Innovat Therapeut Neuropsychiat, Suresnes, France.; Danober, L (corresponding author), Inst Rech Servier, Pole Innovat Therapeut Neuropsychiat, Croissy Sur Seine, France.	sylvie.bretin@servier.com; laurence.danober@servier.com		Bretin, Sylvie/0000-0002-4244-3390	Institut de Recherches Internationales Servier; Institut de Recherches Servier; Neurofit; HiQScreen	Institut de Recherches Internationales Servier(Servier); Institut de Recherches Servier; Neurofit; HiQScreen	Institut de Recherches Internationales Servier provided support in the form of salaries for SB and LS. Institut de Recherches Servier provided support in the form of salaries for CL, JYT, SC, NR, KA, FI, NV, SB, CT, CA, PL, and LD. Neurofit provided support in the form of salaries for SW. HiQScreen provided support in the form of salaries for SB and DB. Servier was involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Ahmed AH, 2010, BIOCHEMISTRY-US, V49, P2843, DOI 10.1021/bi1000678; Arai AC, 2000, MOL PHARMACOL, V58, P802, DOI 10.1124/mol.58.4.802; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2005, J BIOL CHEM, V280, P15053, DOI 10.1074/jbc.M408413200; Balannik V, 2005, NEURON, V48, P279, DOI 10.1016/j.neuron.2005.09.024; Baumbarger PJ, 2001, J PHARMACOL EXP THER, V298, P86; Beracochea D, 2007, PSYCHOPHARMACOLOGY, V193, P63, DOI 10.1007/s00213-007-0765-4; BERACOCHEA DJ, 1987, BEHAV NEUROSCI, V101, P187, DOI 10.1037/0735-7044.101.2.187; Bernard K, 2010, CNS NEUROSCI THER, V16, pe193, DOI 10.1111/j.1755-5949.2009.00088.x; Black MD, 2005, PSYCHOPHARMACOLOGY, V179, P154, DOI 10.1007/s00213-004-2065-6; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Brorson JR, 2004, J NEUROSCI, V24, P3461, DOI 10.1523/JNEUROSCI.5023-03.2004; Buisson B, 1996, J NEUROSCI, V16, P7880; Calabrese F, 2017, PHARMACOL RES, V121, P59, DOI 10.1016/j.phrs.2017.04.019; CHOI DW, 1988, J NEUROSCI, V8, P185; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DEMBER WN, 1958, PSYCHOL BULL, V55, P412, DOI 10.1037/h0045446; Dere E, 2005, NEUROBIOL LEARN MEM, V84, P214, DOI 10.1016/j.nlm.2005.07.002; Destot-Wong KD, 2009, NEUROPHARMACOLOGY, V57, P277, DOI 10.1016/j.neuropharm.2009.05.010; Dicou E, 2003, BRAIN RES, V970, P221, DOI 10.1016/S0006-8993(03)02357-6; Donevan SD, 1998, NEUROSCIENCE, V87, P615, DOI 10.1016/S0306-4522(98)00109-2; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fleck MW, 1996, J NEUROPHYSIOL, V75, P2322, DOI 10.1152/jn.1996.75.6.2322; Gates M, 2001, NEUROPHARMACOLOGY, V40, P984, DOI 10.1016/S0028-3908(01)00040-5; Giralt A., 2017, NEUROPHARMACOLOGY; Harms JE, 2013, NEUROPHARMACOLOGY, V64, P45, DOI 10.1016/j.neuropharm.2012.06.008; Henley JM, 2016, NAT REV NEUROSCI, V17, P337, DOI 10.1038/nrn.2016.37; Herguedas B, 2016, SCIENCE, V352, DOI 10.1126/science.aad3873; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Koike M, 2000, J NEUROSCI, V20, P2166; Krieger J, 2015, BIOPHYS J, V109, P1136, DOI 10.1016/j.bpj.2015.06.061; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Lynch G, 2006, TRENDS NEUROSCI, V29, P554, DOI 10.1016/j.tins.2006.07.007; Mellor IR, 2010, FUTURE MED CHEM, V2, P877, DOI [10.4155/fmc.10.27, 10.4155/FMC.10.27]; Miu P, 2001, NEUROPHARMACOLOGY, V40, P976, DOI 10.1016/S0028-3908(01)00027-2; Morrow JA, 2006, CURR OPIN DRUG DISC, V9, P571; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; O'Neill MJ, 2007, IDRUGS, V10, P185; O'Neill MJ, 2004, CNS NEUROL DISORD-DR, V3, P181, DOI 10.2174/1568007043337508; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Parsons CG, 2005, HANDB EXP PHARM, V169, P249; Partin KM, 2015, CURR OPIN PHARMACOL, V20, P46, DOI 10.1016/j.coph.2014.11.002; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1995, NEURON, V14, P833, DOI 10.1016/0896-6273(95)90227-9; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; Pirotte B, 2013, EXPERT OPIN THER PAT, V23, P615, DOI 10.1517/13543776.2013.770840; Quirk JC, 2002, CNS DRUG REV, V8, P255; Robbins TW, 2006, TRENDS PHARMACOL SCI, V27, P141, DOI 10.1016/j.tips.2006.01.009; Sekiguchi M, 1997, J NEUROSCI, V17, P5760; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Simmons DA, 2011, NEUROBIOL DIS, V41, P436, DOI 10.1016/j.nbd.2010.10.015; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Stone TW, 2002, EUR J PHARMACOL, V447, P285, DOI 10.1016/S0014-2999(02)01851-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Timm DE, 2011, MOL PHARMACOL, V80, P267, DOI 10.1124/mol.110.070243; Ward SE, 2010, BRIT J PHARMACOL, V160, P181, DOI 10.1111/j.1476-5381.2010.00726.x; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wilding TJ, MOL PHARM; Wollmuth LP, 2004, TRENDS NEUROSCI, V27, P321, DOI 10.1016/j.tins.2004.04.005; Yamada KA, 1996, BRIT J PHARMACOL, V117, P1663, DOI 10.1111/j.1476-5381.1996.tb15337.x; Zagrebelsky M, 2014, NEUROPHARMACOLOGY, V76, P628, DOI 10.1016/j.neuropharm.2013.05.029; Zhang QG, 2010, HIPPOCAMPUS, V20, P65, DOI 10.1002/hipo.20593; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	67	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184429	10.1371/journal.pone.0184429	http://dx.doi.org/10.1371/journal.pone.0184429			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886144	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100121
J	Dong, YC; Liu, YH				Dong, Yichen; Liu, Yanhong			Response of Korean pine's functional traits to geography and climate	PLOS ONE			English	Article							LEAF ECONOMICS SPECTRUM; DRY-MATTER CONTENT; NORTHEAST CHINA; SPECIES-RICHNESS; PLANT TRAITS; GROWTH FORM; COMMUNITY; LATITUDE; NITROGEN; AREA	This study analyzed the characteristics of Korean pine (Pinus koraiensis) functional trait responses to geographic and climatic factors in the eastern region of Northeast China (41 degrees-48 degrees N) and the linear relationships among Korean pine functional traits, to explore this species' adaptability and ecological regulation strategies under different environmental conditions. Korean pine samples were collected from eight sites located at different latitudes, and the following factors were determined for each site: geographic factors-latitude, longitude, and altitude; temperature factors-mean annual temperature (MAT), growth season mean temperature (GST), and mean temperature of the coldest month (MTCM); and moisture factors-annual precipitation (AP), growth season precipitation (GSP), and potential evapotranspiration (PET). The Korean pine functional traits examined were specific leaf area (SLA), leaf thickness (LT), leaf dry matter content (LDMC), specific root length (SRL), leaf nitrogen content (LNC), leaf phosphorus content (LPC), root nitrogen content (RNC), and root phosphorus content (RPC). The results showed that Korean pine functional traits were significantly correlated to latitude, altitude, GST, MTCM, AP, GSP, and PET. Among the Korean pine functional traits, SLA showed significant linear relationships with LT, LDMC, LNC, LPC, and RPC, and LT showed significant linear relationships with LDMC, SRL, LNC, LPC, RNC, and RPC; the linear relationships between LNC, LPC, RNC, and RPC were also significant. In conclusion, Korean pine functional trait responses to latitude resulted in its adaptation to geographic and climatic factors. The main limiting factors were precipitation and evapotranspiration, followed by altitude, latitude, GST, and MTCM. The impacts of longitude and MAT were not obvious. Changes in precipitation and temperature were most responsible for the close correlation among Korean pine functional traits, reflecting its adaption to habitat variation.	[Dong, Yichen; Liu, Yanhong] Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc Beijing, Beijing, Peoples R China	Beijing Forestry University	Liu, YH (corresponding author), Beijing Forestry Univ, Key Lab Forest Resources & Ecosyst Proc Beijing, Beijing, Peoples R China.	liuyh@bjfu.edu.cn			Key Project of National Key Research and Development Plan Research on protection and restoration of typical small populations of wild plants [2016YFC0503106]; Beijing key disciplines project	Key Project of National Key Research and Development Plan Research on protection and restoration of typical small populations of wild plants; Beijing key disciplines project	The work was supported by Key Project of National Key Research and Development Plan Research on protection and restoration of typical small populations of wild plants (Grant No. 2016YFC0503106); and Beijing key disciplines project.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; [Anonymous], 1992, J NE U; Atkin OK, 2015, NEW PHYTOL, V206, P614, DOI 10.1111/nph.13253; Baraloto C, 2010, ECOL LETT, V13, P1338, DOI 10.1111/j.1461-0248.2010.01517.x; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1106, DOI 10.1111/j.1466-8238.2011.00753.x; Blonder B, 2013, J ECOL, V101, P981, DOI 10.1111/1365-2745.12102; Boucher-Lalonde V, 2016, GLOBAL ECOL BIOGEOGR, V25, P527, DOI 10.1111/geb.12433; Chen YH, 2013, ECOGRAPHY, V36, P178, DOI 10.1111/j.1600-0587.2011.06833.x; Chen Ying-Ting, 2014, Chinese Journal of Plant Ecology, V38, P1135, DOI 10.3724/SP.J.1258.2014.00108; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 1999, J VEG SCI, V10, P651, DOI 10.2307/3237080; Diaz S, 1998, J VEG SCI, V9, P113, DOI 10.2307/3237229; Diaz S, 2016, NATURE, V529, P167, DOI 10.1038/nature16489; Fang J.-Y., 1992, ACTA ECOL SIN, V12, P97; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Freschet GT, 2012, FUNCT ECOL, V26, P56, DOI 10.1111/j.1365-2435.2011.01913.x; Gao G., 1956, GEOGRAPHY RES, V25, P378; Garnier E, 2001, FUNCT ECOL, V15, P688, DOI 10.1046/j.0269-8463.2001.00563.x; Gillman LN, 2015, GLOBAL ECOL BIOGEOGR, V24, P107, DOI 10.1111/geb.12245; Grady KC, 2013, FUNCT ECOL, V27, P428, DOI 10.1111/1365-2435.12060; Han Wei, 2014, Journal of Beijing Forestry University, V36, P47; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Hao Zhan-Qing, 2008, Zhiwu Shengtai Xuebao, V32, P238, DOI 10.3773/j.issn.1005-264x.2008.02.002; Hawkins BA, 2004, ECOGRAPHY, V27, P268, DOI 10.1111/j.0906-7590.2004.03883.x; He J.S., 1997, ACTA ECOL SIN, V17, P91; He JS, 2006, NEW PHYTOL, V170, P835, DOI 10.1111/j.1469-8137.2006.01704.x; [贺伟 He Wei], 2013, [生态学报, Acta Ecologica Sinica], V33, P519; Hodgson JG, 2011, ANN BOT-LONDON, V108, P1337, DOI 10.1093/aob/mcr225; Kattge J, 2011, GLOBAL CHANGE BIOL, V17, P2905, DOI 10.1111/j.1365-2486.2011.02451.x; Li J. Q., 1986, Journal of North-East Forestry University, China, V14, P33; Makoto K, 2007, PHOTOSYNTHETICA, V45, P99, DOI 10.1007/s11099-007-0015-3; [毛伟 Mao Wei], 2012, [中国沙漠, Journal of Desert Research], V32, P33; McIntyre S, 1999, J VEG SCI, V10, P621, DOI 10.2307/3237077; Meng Ting-Ting, 2007, Zhiwu Shengtai Xuebao, V31, P150; Moles AT, 2014, J VEG SCI, V25, P1167, DOI 10.1111/jvs.12190; Price CA, 2014, FUNCT ECOL, V28, P1330, DOI 10.1111/1365-2435.12298; Santiago LS, 2007, FUNCT ECOL, V21, P19, DOI 10.1111/j.1365-2435.2006.01218.x; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; [唐志尧 Tang Zhiyao], 2004, [生物多样性, Chinese Biodiversity], V12, P20; Thompson K, 2005, FUNCT ECOL, V19, P355, DOI [10.1111/j.0269-8463.2005.00936.x, 10.1111/j.1365-2435.2005.00936.x]; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vile D, 2005, ANN BOT-LONDON, V96, P1129, DOI 10.1093/aob/mci264; Wang XP, 2006, J INTEGR PLANT BIOL, V48, P778, DOI 10.1111/j.1744-7909.2006.00294.x; Wang XP, 2008, FOREST ECOL MANAG, V255, P4007, DOI 10.1016/j.foreco.2008.03.055; Wang XP, 2006, FOREST ECOL MANAG, V234, P264, DOI 10.1016/j.foreco.2006.07.007; Wang XP, 2009, ECOGRAPHY, V32, P133, DOI 10.1111/j.1600-0587.2008.05507.x; Wang YJ, 1995, BROADLEAF PINUS KORA; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; [吴晓莆 Wu Xiaofu], 2004, [生物多样性, Chinese Biodiversity], V12, P174; Xu W-D, 1986, ACTA PHYTOECOLOGICA, V10, P254; Yu ZL, 1996, J JILIN FORESTRY U, V12, P235; Zhang H-Q, 1999, ACTA ECOLOGICA SINIC, V19, P932; Zhang S, 2017, ECOLOGY, V98, P425, DOI 10.1002/ecy.1649; Zhang S, 2016, J ECOL, V104, P1089, DOI 10.1111/1365-2745.12588; Zhu JF, 1958, FORESTRY SCI, V4, P355	57	2	3	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184051	10.1371/journal.pone.0184051	http://dx.doi.org/10.1371/journal.pone.0184051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886053	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100059
J	Quilez, MP; Seral, B; Perez, MA				Paz Quilez, Maria; Seral, Belen; Angeles Perez, Maria			Biomechanical evaluation of tibial bone adaptation after revision total knee arthroplasty: A comparison of different implant systems	PLOS ONE			English	Article							RESURFACED FEMORAL-HEAD; METAPHYSEAL SLEEVES; FINITE-ELEMENT; PROXIMAL TIBIA; FIXATION; REPLACEMENT; CEMENTLESS; COMPONENT; DEFECTS; STEMS	The best methods to manage tibial bone defects following total knee arthroplasty remain under debate. Different fixation systems exist to help surgeons reconstruct knee osseous bone loss (such as tantalum cones, cement, modular metal augments, autografts, allografts and porous metaphyseal sleeves) However, the effects of the various solutions on the long-term outcome remain unknown. In the present work, a bone remodeling mathematical model was used to predict bone remodeling after total knee arthroplasty (TKA) revision. Five different types of prostheses were analyzed: one with a straight stem; two with offset stems, with and without supplements; and two with sleeves, with and without stems. Alterations in tibia bone density distribution and implant Von Mises stresses were quantified. In all cases, the bone density decreased in the proximal epiphysis and medullary channels, and an increase in bone density was predicted in the diaphysis and around stem tips. The highest bone resorption was predicted for the offset prosthesis without the supplement, and the highest bone formation was computed for the straight stem. The highest Von Mises stress was obtained for the straight tibial stem, and the lowest was observed for the stemless metaphyseal sleeves prosthesis. The computational model predicted different behaviors among the five systems. We were able to demonstrate the importance of choosing an adequate revision system and that in silico models may help surgeons choose patient-specific treatments.	[Paz Quilez, Maria; Angeles Perez, Maria] Univ Zaragoza, I3A, Dept Ingn Mecan, M2BE, Zaragoza, Spain; [Seral, Belen] Univ Zaragoza, Univ Clin Hosp Lozano Blesa, Aragon Inst Hlth Sci IACS, Zaragoza, Spain	University of Zaragoza; Lozano Blesa University Clinical Hospital; University of Zaragoza	Perez, MA (corresponding author), Univ Zaragoza, I3A, Dept Ingn Mecan, M2BE, Zaragoza, Spain.	angeles@unizar.es	Perez, Maria Angeles/F-7584-2010	Perez, Maria Angeles/0000-0002-2901-4188	Spanish Ministry of Economy and Competitiveness [DPI2014-53401-C2-1-R]; SECOT	Spanish Ministry of Economy and Competitiveness(Spanish Government); SECOT	The authors gratefully acknowledge the support of the Spanish Ministry of Economy and Competitiveness through research project DPI2014-53401-C2-1-R and the SECOT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2013, BONE JOINT J, V95B, P1640, DOI 10.1302/0301-620X.95B12.31190; Alexander GE, 2013, J ARTHROPLASTY, V28, P604, DOI 10.1016/j.arth.2012.08.006; Baldini A, 2015, CURR REV MUSCULOSKE, V8, P383, DOI 10.1007/s12178-015-9294-7; Barink M, 2003, P I MECH ENG H, V217, P325, DOI 10.1243/095441103770802487; Barnett SL, 2014, J ARTHROPLASTY, V29, P1219, DOI 10.1016/j.arth.2013.12.026; BEAUPRE GS, 1990, J ORTHOP RES, V8, P651, DOI 10.1002/jor.1100080506; Caouette C, 2012, MED ENG PHYS, V34, P559, DOI 10.1016/j.medengphy.2011.08.015; Cawley DT, 2012, CLIN BIOMECH, V27, P390, DOI 10.1016/j.clinbiomech.2011.10.011; Chong DYR, 2011, J BIOMECH, V44, P948, DOI 10.1016/j.jbiomech.2010.11.026; Completo A, 2008, J BIOMECH, V41, P560, DOI 10.1016/j.jbiomech.2007.10.006; Completo A, 2007, J BIOMECH ENG-T ASME, V129, P791, DOI 10.1115/1.2768382; Completo A, 2010, CLIN BIOMECH, V25, P159, DOI 10.1016/j.clinbiomech.2009.10.011; Cuckler JM, 2004, J ARTHROPLASTY, V19, P56, DOI 10.1016/j.arth.2004.03.002; Dennis DA, 2007, J ARTHROPLASTY, V22, P32, DOI 10.1016/j.arth.2007.01.001; Derome P, 2014, J ARTHROPLASTY, V29, P122, DOI 10.1016/j.arth.2013.04.033; Doblare M, 2001, J BIOMECH, V34, P1157, DOI 10.1016/S0021-9290(01)00069-0; Duda GN, 2001, J BIOMECH, V34, P639, DOI 10.1016/S0021-9290(00)00237-2; Fischer KJ, 1997, ANN BIOMED ENG, V25, P261, DOI 10.1007/BF02648040; Garijo N, 2014, COMPUT METHOD APPL M, V271, P253, DOI 10.1016/j.cma.2013.12.014; Garijo N, 2014, COMPUT METHOD APPL M, V268, P437, DOI 10.1016/j.cma.2013.10.005; Graichen H, 2015, J ARTHROPLASTY, V30, P2256, DOI 10.1016/j.arth.2015.06.030; HAAS SB, 1995, J BONE JOINT SURG AM, V77A, P1700, DOI 10.2106/00004623-199511000-00009; Hambli R, 2011, FINITE ELEM ANAL DES, V47, P835, DOI 10.1016/j.finel.2011.02.014; Hambli R, 2011, J MECH BEHAV BIOMED, V4, P868, DOI 10.1016/j.jmbbm.2011.03.002; Hambli R, 2011, BIOMECH MODEL MECHAN, V10, P133, DOI 10.1007/s10237-010-0222-x; Huten D, 2013, ORTHOP TRAUMATOL-SUR, V99, pS22, DOI 10.1016/j.otsr.2012.11.009; Jacobs C., 1994, NUMERICAL SIMULATION, P239; Jensen CL, 2012, INT ORTHOP, V36, P1857, DOI 10.1007/s00264-012-1601-y; Kimpton CI, 2013, J ARTHROPLASTY, V28, P971, DOI 10.1016/j.arth.2012.10.007; Kindsfater K, 2014, INT C JOINT REC 2014; Lee Y, 2016, ANN OF JOINT, P1; Mabry TM, 2007, J ARTHROPLASTY, V22, P56, DOI 10.1016/j.arth.2007.02.008; Malinzak RA, 2014, J ARTHROPLASTY, V29, P541, DOI 10.1016/j.arth.2013.08.024; Marton-Hernandez C, 2016, KNEE SURG SPORTS TRA; Mohaghegh K, 2014, COMPUT METHOD APPL M, V273, P255, DOI 10.1016/j.cma.2014.02.003; Moreo P, 2007, COMPUT METHOD APPL M, V196, P3300, DOI 10.1016/j.cma.2007.03.020; Morgan-Jones R, 2015, BONE JOINT J, V97B, P147, DOI 10.1302/0301-620X.97B2.34144; Nyman JS, 2004, J ORTHOPAED RES, V22, P51, DOI 10.1016/S0736-0266(03)00159-1; Perez M, 2010, COMPUT METHOD BIOMEC, V12, P101; Perez MA, 2014, MED ENG PHYS, V36, P185, DOI 10.1016/j.medengphy.2013.10.013; Perez MA, 2013, COMPUT METHOD BIOMEC, V16, P1022, DOI 10.1080/10255842.2011.650635; Perez MA, 2010, ANN BIOMED ENG, V38, P2093, DOI 10.1007/s10439-010-9996-3; Perez MA, 2009, ANN BIOMED ENG, V37, P454, DOI 10.1007/s10439-008-9616-7; Radnay C, 2006, CLIN ORTHOPAEDICS RE, V446; Rothstock S, 2011, J BIOMECH, V44, P1646, DOI 10.1016/j.jbiomech.2011.02.076; Schmitz HCR, 2013, J ARTHROPLASTY, V28, P1556, DOI 10.1016/j.arth.2013.01.028; Small SR, 2013, J ARTHROPLASTY, V28, P179, DOI 10.1016/j.arth.2013.01.004; vanLenthe GH, 1997, J BONE JOINT SURG BR, V79B, P117, DOI 10.1302/0301-620X.79B1.6808; Vasso M, 2014, ARCH ORTHOP TRAUM SU, V134, P543, DOI 10.1007/s00402-014-1941-8; Whittaker JP, 2008, J BONE JOINT SURG BR, V90B, P981, DOI 10.1302/0301-620X.90B8.19948; Wilke BK, 2014, J ARTHROPLASTY, V29, P1005, DOI 10.1016/j.arth.2013.10.025	51	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184361	10.1371/journal.pone.0184361	http://dx.doi.org/10.1371/journal.pone.0184361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886100	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100102
J	Scantlebury, A; Fairhurst, C; Booth, A; McDaid, C; Moran, N; Parker, A; Payne, R; Scott, WJ; Torgerson, D; Webber, M; Hewitt, C				Scantlebury, Arabella; Fairhurst, Caroline; Booth, Alison; McDaid, Catriona; Moran, Nicola; Parker, Adwoa; Payne, Rebecca; Scott, William J.; Torgerson, David; Webber, Martin; Hewitt, Catherine			Effectiveness of a training program for police officers who come into contact with people with mental health problems: A pragmatic randomised controlled trial	PLOS ONE			English	Article								Introduction Police officers frequently come into contact with individuals with mental health problems. Specialist training in this area for police officers may improve how they respond to individuals with mental health problems; however, evidence to support this is sparse. This study evaluated the effectiveness of one bespoke mental health training package for frontline police officers relative to routine training. Design Pragmatic, two-armed cluster randomised controlled trial in one police force in England. Police stations in North Yorkshire were randomised with frontline police officers receiving either a bespoke mental health training package or routine training. The primary outcome was the number of incidents which resulted in a police response reported to the North Yorkshire Police control room up to six months after delivery of training. Secondary outcomes included: likelihood of incidents using Section 136 of the Mental Health Act; likelihood of incidents having a mental health tag applied; and number of individuals with a mental health warning marker involved in incidents. The appropriateness of mental health tags applied to a random sample of incidents was checked by an independent mental health professional. Routinely collected data were used. Results Twelve police stations were recruited and randomised (Intervention group n = 6; Control group n = 6), and 249 officers received the bespoke mental health training intervention. At follow-up, a median of 397 incidents were assigned to trial stations in the intervention group, and 498 in the control group. There was no evidence of a difference in the number of incidents with a police response (adjusted incidence rate ratio (IRR) 0.92, 95% CI 0.61 to 1.38, p = 0.69), or in the number of people with mental health warning markers involved in incidents (adjusted IRR 1.39, 95% CI 0.91 to 2.10, p = 0.13) between the intervention and control groups up to six months following the intervention; however, incidents assigned to stations in the intervention group were more likely to have a mental health tag applied to them than incidents assigned to control stations (adjusted odds ratio 1.41, 95% CI 1.16 to 1.71, p = 0.001). The review of 100 incidents suggests that there may be incidents involving individuals with mental health issues that are not being recorded as such (Kappa coefficient 0.65). There was no statistically significant difference in the likelihood of Section 136 of the Mental Health Act being applied to an incident. Conclusions The bespoke one day mental health training delivered to frontline officers by mental health professionals did not reduce the number of incidents reported to the police control room up to six months after its delivery; however training may have a positive effect on how the police record incidents involving individuals with mental health problems. Our trial has shown that conducting pragmatic trials within the police setting is feasible and acceptable. There is a wealth of routinely collected police data that can be utilised for research and further collaboration between police forces and academia is encouraged.	[Scantlebury, Arabella; Fairhurst, Caroline; Booth, Alison; McDaid, Catriona; Parker, Adwoa; Torgerson, David; Hewitt, Catherine] Univ York, Dept Hlth Sci, York Trials Unit, York, N Yorkshire, England; [Moran, Nicola; Webber, Martin] Univ York, Dept Social Policy & Social Work, York, N Yorkshire, England; [Payne, Rebecca; Scott, William J.] North Yorkshire Police, Newby Wiske Hall, Northallerton, N Yorkshire, England	University of York - UK; University of York - UK	Scantlebury, A (corresponding author), Univ York, Dept Hlth Sci, York Trials Unit, York, N Yorkshire, England.	Arabella.scantlebury@york.ac.uk	Booth, Alison/I-8044-2015; Torgerson, David/L-4566-2019; Webber, Martin P/I-2256-2013	Booth, Alison/0000-0001-7138-6295; Torgerson, David/0000-0002-1667-4275; Webber, Martin P/0000-0003-3604-1376; Hewitt, Catherine Elizabeth/0000-0002-0415-3536; McDaid, Catriona Maria/0000-0002-3751-7260; Scantlebury, Arabella/0000-0003-3518-2740; Parker, Adwoa/0000-0002-2880-3935	Police Knowledge Fund - Home Office [J05]; Police Knowledge Fund - College of Policing [J05]; Police Knowledge Fund - Higher Education Funding Council for England [J05]; Higher Education Funding Council for England; Home Office; University of York	Police Knowledge Fund - Home Office; Police Knowledge Fund - College of Policing; Police Knowledge Fund - Higher Education Funding Council for England; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Home Office; University of York(European Commission)	This work was supported by The Police Knowledge Fund, funded by: The Home Office, The College of Policing and the Higher Education Funding Council for England. Grant number: J05. This project was funded by the Higher Education Funding Council for England and the Home Office and administered by the College of Policing. The University of York acted as sponsor. The funders and administrators played no role in finalising the study design, data collection, data analysis, data interpretation or report writing. The corresponding author has full access to all study data.	Bloom D.E., 2012, GLOBAL EC BURDEN NON; Booth A, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1356-5; Chappell D, 2014, INT J LAW PSYCHIAT, V37, P321, DOI 10.1016/j.ijlp.2014.02.001; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Coleman T, TEMPO POLICE INTERAC; College of Policing, 2015, COLL POL AN EST DEM; Compton MT, 2009, PSYCHIAT SERV, V60, P831, DOI 10.1176/ps.2009.60.6.831; Copas AJ, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0842-7; Hayes RJ, 2009, INTERD STAT, P3; Her Majesty's Inspectorate of Constabulary CQC Her Majesty's Inspectorate of Prisons and Healthcare Inspectorate Wales, 2013, USE POLICE CUSTODY P; HM Government M, 2017, STREET TRIAG PIL ONL; Iacobucci G., 2017, BRIT MED J; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; National Policing Improvement Agency, 2010, GUID RESP PEOPL MENT; Saghaei M., 2011, J BIOMED SCI ENG, V4, P734, DOI [10.4236/jbise.2011.411090, DOI 10.4236/JBISE.2011.411090]; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; SENN S, 1994, STAT MED, V13, P1715, DOI 10.1002/sim.4780131703; Stata Corp, 2013, STAT STAT SOFTW REL	18	14	14	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184377	10.1371/journal.pone.0184377	http://dx.doi.org/10.1371/journal.pone.0184377			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886163	Green Published, gold, Green Accepted			2022-12-27	WOS:000410001100105
J	Maulucci, G; Cordelli, E; Rizzi, A; De Leva, F; Papi, M; Ciasca, G; Samengo, D; Pani, G; Pitocco, D; Soda, P; Ghirlanda, G; Iannello, G; De Spirito, M				Maulucci, Giuseppe; Cordelli, Ermanno; Rizzi, Alessandro; De Leva, Francesca; Papi, Massimiliano; Ciasca, Gabriele; Samengo, Daniela; Pani, Giovambattista; Pitocco, Dario; Soda, Paolo; Ghirlanda, Giovanni; Iannello, Giulio; De Spirito, Marco			Phase separation of the plasma membrane in human red blood cells as a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus	PLOS ONE			English	Article							LIPID-PEROXIDATION; HUMAN-ERYTHROCYTES; FLUIDITY; CHOLESTEROL; COMPLICATIONS	Glycosylation, oxidation and other post-translational modifications of membrane and transmembrane proteins can alter lipid density, packing and interactions, and are considered an important factor that affects fluidity variation in membranes. Red blood cells (RBC) membrane physical state, showing pronounced alterations in Type 1 diabetes mellitus (T1DM), could be the ideal candidate for monitoring the disease progression and the effects of therapies. On these grounds, the measurement of RBC membrane fluidity alterations can furnish a more sensitive index in T1DM diagnosis and disease progression than Glycosylated hemoglobin (HbA1c), which reflects only the information related to glycosylation processes. Here, through a functional two-photon microscopy approach we retrieved fluidity maps at submicrometric scale in RBC of T1DM patients with and without complications, detecting an altered membrane equilibrium. We found that a phase separation between fluid and rigid domains occurs, triggered by systemic effects on membranes fluidity of glycation and oxidation. The phase separation patterns are different among healthy, T1DM and T1DM with complications patients. Blood cholesterol and LDL content are positively correlated with the extent of the phase separation patterns. To quantify this extent a machine learning approach is employed to develop a Decision-Support-System (DSS) able to recognize different fluidity patterns in RBC. Preliminary analysis shows significant differences(p< 0.001) among healthy, T1DM and T1DM with complications patients. The development of an assay based on Phase separation of the plasma membrane of the Red Blood cells is a potential tool for diagnosis and progression monitoring of type 1 diabetes mellitus, and could allow customization and the selection of medical treatments in T1DM in clinical settings, and enable the early detection of complications.	[Maulucci, Giuseppe; Papi, Massimiliano; Ciasca, Gabriele; De Spirito, Marco] Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy; [Cordelli, Ermanno; Soda, Paolo; Iannello, Giulio] Univ Campus Biomed, Fac Dipartimentale Ingn, Unita Sistemi Elaboraz & Bioinformat, Rome, Italy; [Rizzi, Alessandro; De Leva, Francesca; Pitocco, Dario; Ghirlanda, Giovanni] Fdn Policlin Gemelli, Ist Med Interna, Rome, Italy; [Samengo, Daniela; Pani, Giovambattista] Univ Cattolica Sacro Cuore, Ist Patol, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University Campus Bio-Medico - Rome Italy; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Maulucci, G (corresponding author), Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy.	giuseppe.maulucci@unicatt.it	Pani, Giovambattista/AAB-1446-2019; Rizzi, Alessandro AR/K-6721-2016; Ciasca, Gabriele/AAL-4677-2020; Ciasca, Gabriele/D-2447-2013; Papi, Massimiliano/AAC-3657-2022; Rizzi, Alessandro/ABB-8944-2020; Pitocco, Dario/K-4210-2018; De Spirito, Marco/U-3817-2019; Soda, Paolo/K-8126-2016; Maulucci, Giuseppe/C-7400-2009	Rizzi, Alessandro AR/0000-0002-8309-4051; Ciasca, Gabriele/0000-0002-3694-8229; Papi, Massimiliano/0000-0002-0029-1309; De Spirito, Marco/0000-0003-4260-5107; Iannello, Giulio/0000-0003-3864-5800; Pani, Giovambattista/0000-0001-7133-8728; Pitocco, Dario/0000-0002-6220-686X; Soda, Paolo/0000-0003-2621-072X; Maulucci, Giuseppe/0000-0002-2154-319X	Universita Cattolica del Sacro Cuore Linea D1 [R4124500312]; University Cattolica del Sacro Cuore	Universita Cattolica del Sacro Cuore Linea D1; University Cattolica del Sacro Cuore	This work was supported by Universita Cattolica del Sacro Cuore Linea D1 2015 grant number R4124500312.r The authors acknowledge Mario Amici for his excellent Technical support. This work was supported by University Cattolica del Sacro Cuore.	Angelucci C, 2015, BRIT J CANCER, V112, P1675, DOI 10.1038/bjc.2015.135; [Anonymous], 1995, DIABETES, V44, P968; Balogh G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021182; BUCALA R, 1994, P NATL ACAD SCI USA, V91, P9441, DOI 10.1073/pnas.91.20.9441; Catala A, 2009, CHEM PHYS LIPIDS, V157, P1, DOI 10.1016/j.chemphyslip.2008.09.004; Chawla NV, 2013, J GEN INTERN MED, V28, pS660, DOI 10.1007/s11606-013-2455-8; Ciasca G, 2015, NANOSCALE, V7, P17030, DOI 10.1039/c5nr03145a; Cohen G, 2013, FREE RADICAL BIO MED, V65, P978, DOI 10.1016/j.freeradbiomed.2013.08.163; de la Haba C, 2013, BBA-BIOMEMBRANES, V1828, P357, DOI 10.1016/j.bbamem.2012.08.013; Golfetto O, 2013, BIOPHYS J, V104, P1238, DOI 10.1016/j.bpj.2012.12.057; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; Hanson MS, 2008, AM J PHYSIOL-HEART C, V295, pH786, DOI 10.1152/ajpheart.00349.2008; Holzinger A, 2014, INTERACTIVE KNOWLEDG; Holzinger Andreas, 2015, SMART HLTH; Hung KT, 2012, ARTERIOSCL THROM VAS, V32, P1460, DOI 10.1161/ATVBAHA.112.248971; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kumar R, 2011, J DIABETES METAB OMI, P2; Kumar R., INDIAN J MED SCI, V66, P131; LANGE Y, 1983, J BIOL CHEM, V258, P6920; Lind M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004412; Mason RP, 2003, BBA-BIOMEMBRANES, V1610, P198, DOI 10.1016/S0005-2736(03)00018-X; Maulucci G, 2016, FREE RADICAL RES, V50, pS40, DOI 10.1080/10715762.2016.1231403; Maulucci G, 2016, MOL ASPECTS MED, V49, P49, DOI 10.1016/j.mam.2016.03.001; Maulucci G, 2014, BBA-GEN SUBJECTS, V1840, P2192, DOI 10.1016/j.bbagen.2014.04.005; Maulucci G, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.143pl3; MAZZANTI L, 1992, CLIN BIOCHEM, V25, P41, DOI 10.1016/0009-9120(92)80044-H; Murphy RF, 2003, J VLSI SIG PROC SYST, V35, P311, DOI 10.1023/B:VLSI.0000003028.71666.44; Nathan DM, 2008, DIABETES CARE, V31, P1473, DOI 10.2337/dc08-0545; Negre-Salvayre A, 2010, FREE RADICAL RES, V44, P1125, DOI 10.3109/10715762.2010.498478; Nordwall M, 2015, DIABETES CARE, V38, P308, DOI 10.2337/dc14-1203; Nosaka R, 2013, ROTATION INVARIANT C, P15; PILCH PF, 1980, P NATL ACAD SCI-BIOL, V77, P915, DOI 10.1073/pnas.77.2.915; Radin MS, 2014, J GEN INTERN MED, V29, P388, DOI 10.1007/s11606-013-2595-x; RICHTER C, 1987, CHEM PHYS LIPIDS, V44, P175, DOI 10.1016/0009-3084(87)90049-1; Soda P, 2009, IEEE T INF TECHNOL B, V13, P322, DOI 10.1109/TITB.2008.2010855; TESTA I, 1988, J CLIN ENDOCR METAB, V67, P1129, DOI 10.1210/jcem-67-6-1129; The Diabetes Control and Complications Trial Research Group, 1996, AM DIABETES ASS, V45, P1289; Vahalkar GS, 2008, INDIAN J CLIN BIOCHE, V23, P223, DOI 10.1007/s12291-008-0050-2; van Gestel T, 2004, MACH LEARN, V54, P5, DOI 10.1023/B:MACH.0000008082.80494.e0; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wong-Ekkabut J, 2007, BIOPHYS J, V93, P4225, DOI 10.1529/biophysj.107.112565	41	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184109	10.1371/journal.pone.0184109	http://dx.doi.org/10.1371/journal.pone.0184109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880900	gold, Green Submitted, Green Published			2022-12-27	WOS:000409467200034
J	Weinberg, L; Ianno, D; Churilov, L; Chao, I; Scurrah, N; Rachbuch, C; Banting, J; Muralidharan, V; Story, D; Bellomo, R; Christophi, C; Nikfarjam, M				Weinberg, Laurence; Ianno, Damian; Churilov, Leonid; Chao, Ian; Scurrah, Nick; Rachbuch, Clive; Banting, Jonathan; Muralidharan, Vijaragavan; Story, David; Bellomo, Rinaldo; Christophi, Chris; Nikfarjam, Mehrdad			Restrictive intraoperative fluid optimisation algorithm improves outcomes in patients undergoing pancreaticoduodenectomy: A prospective multicentre randomized controlled trial	PLOS ONE			English	Article							INTERNATIONAL STUDY-GROUP; STROKE VOLUME VARIATION; RISK SURGICAL-PATIENTS; PANCREATIC SURGERY; ENHANCED-RECOVERY; PERIOPERATIVE OUTCOMES; MODERATE-RISK; THERAPY; COMPLICATIONS; CANCER	We aimed to evaluate perioperative outcomes in patients undergoing pancreaticoduodenectomy with or without a cardiac output goal directed therapy (GDT) algorithm. We conducted a multicentre randomised controlled trial in four high volume hepatobiliarypancreatic surgery centres. We evaluated whether the additional impact of a intraoperative fluid optimisation algorithm would influence the amount of fluid delivered, reduce fluid related complications, and improve length of hospital stay. Fifty-two consecutive adult patients were recruited. The median (IQR) duration of surgery was 8.6 hours (7.1: 9.6) in the GDT group vs. 7.8 hours (6.8: 9.0) in the usual care group (p = 0.2). Intraoperative fluid balance was 1005mL (475: 1873) in the GDT group vs. 3300mL (2474: 3874) in the usual care group (p< 0.0001). Total volume of fluid administered intraoperatively was also lower in the GDT group: 2050mL (1313: 2700) vs. 4088mL (3400: 4525), p< 0.0001 and vasoactive medications were used more frequently. There were no significant differences in proportions of patients experiencing overall complications (p = 0.179); however, fewer complications occurred in the GDT group: 44 vs. 92 (Incidence Rate Ratio: 0.41; 95% CI 0.24 to 0.69, p = 0.001). Median (IQR) length of hospital stay was 9.5 days (IQR: 7.0, 14.3) in the GDT vs. 12.5 days in the usual care group (IQR: 9.0, 22.3) for an Incidence Rate Ratio 0.64 (95% CI 0.48 to 0.85, p = 0.002). In conclusion, using a surgery-specific, patient-specific goal directed restrictive fluid therapy algorithm in this cohort of patients, can justify using enough fluid without causing oedema, yet as little fluid as possible without causing hypovolaemia i. e. "precision fluid therapy. Our findings support the use of a perioperative haemodynamic optimization plan that prioritizes preservation of cardiac output and organ perfusion pressure by judicious use of fluid therapy, rational use of vasoactive drugs and timely application of inotropic drugs. They also suggest the need for further larger studies to confirm its findings.	[Weinberg, Laurence; Muralidharan, Vijaragavan; Christophi, Chris; Nikfarjam, Mehrdad] Univ Melbourne, Austin Hosp, Dept Surg, Heidelberg, Vic, Australia; [Weinberg, Laurence; Story, David] Univ Melbourne, Anaesthesia & Perioperat & Pain Med Unit, Parkville, Vic, Australia; [Ianno, Damian; Scurrah, Nick; Banting, Jonathan] Austin Hosp, Dept Anaesthesia, Heidelberg, Vic, Australia; [Churilov, Leonid] Melbourne Brain Ctr, Florey Inst Neurosci & Mental Hlth, Stat & Decis Anal Acad Platform, Heidelberg, Vic, Australia; [Chao, Ian; Rachbuch, Clive] Box Hill Hosp, Dept Anaesthesia, Box Hill, Vic, Australia; [Bellomo, Rinaldo] Austin Hosp, Intens Care Unit, Heidelberg, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; Box Hill Hospital; Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Weinberg, L (corresponding author), Univ Melbourne, Austin Hosp, Dept Surg, Heidelberg, Vic, Australia.; Weinberg, L (corresponding author), Univ Melbourne, Anaesthesia & Perioperat & Pain Med Unit, Parkville, Vic, Australia.	laurence.weinberg@austin.org.au	Ianno, Damian/ABE-3780-2020; Chao, Ian/AAZ-1670-2021	Ianno, Damian/0000-0001-7498-1532; Nikfarjam, Mehrdad/0000-0003-4866-276X; Christophi, Christopher/0000-0002-1349-0884; Story, David/0000-0002-6479-1310; Weinberg, Laurence/0000-0001-7403-7680; Bellomo, Rinaldo/0000-0002-1650-8939				Arora RC, 2004, ANN THORAC SURG, V78, P1547, DOI 10.1016/j.athoracsur.2004.04.083; Bassi C, 2001, DIGEST SURG, V18, P453, DOI 10.1159/000050193; Behman R, 2015, AM J SURG, V210, P896, DOI 10.1016/j.amjsurg.2015.04.020; Benes J, 2010, CRIT CARE, V14, DOI 10.1186/cc9070; Bennett-Guerrero E, 1999, ANESTH ANALG, V89, P514, DOI 10.1097/00000539-199908000-00050; Brandstrup B, 2006, BEST PRACT RES-CLIN, V20, P265, DOI 10.1016/j.bpa.2005.10.007; Navarro LHC, 2015, PERIOPER MED, V4, DOI 10.1186/s13741-015-0014-z; Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea; Cannesson M, 2011, ANESTHESIOLOGY, V115, P231, DOI 10.1097/ALN.0b013e318225b80a; CHUNG HM, 1986, ARCH INTERN MED, V146, P333, DOI 10.1001/archinte.146.2.333; Cumberworth A, 2016, BRIT J ANAESTH, V116, P723, DOI 10.1093/bja/aew085; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Eng OS, 2013, J SURG ONCOL, V108, P242, DOI 10.1002/jso.23393; Ferraris VA, 2007, ANN THORAC SURG, V83, P27, DOI 10.1016/j.athoracsur.2007.02.099; Fischer M, 2010, ANN SURG, V252, P952, DOI 10.1097/SLA.0b013e3181ff36b1; Fong Y, 2005, ANN SURG, V242, P540, DOI 10.1097/01.sla.0000184190.20289.4b; Hilton AK, 2008, MED J AUSTRALIA, V189, P509, DOI 10.5694/j.1326-5377.2008.tb02147.x; Holte K, 2002, BRIT J ANAESTH, V89, P622, DOI 10.1093/bja/aef220; Jammer I, 2015, PERIOPER MED-LONDON, V4, DOI 10.1186/s13741-015-0016-x; Jammer I, 2015, EUR J ANAESTH, V32, P88, DOI 10.1097/EJA.0000000000000118; Kagedan DJ, 2015, HPB, V17, P11, DOI 10.1111/hpb.12265; Lassen K, 2012, CLIN NUTR, V31, P817, DOI 10.1016/j.clnu.2012.08.011; Lassen K, 2009, ARCH SURG-CHICAGO, V144, P961, DOI 10.1001/archsurg.2009.170; Li YH, 2012, CRIT CARE, V16, DOI 10.1186/cc11175; Li YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172361; Lobo DN, 2002, LANCET, V359, P1812, DOI 10.1016/S0140-6736(02)08711-1; LOWELL JA, 1990, CRIT CARE MED, V18, P728, DOI 10.1097/00003246-199007000-00010; Mayer J, 2010, CRIT CARE, V14, DOI 10.1186/cc8875; Melis M, 2012, J SURG ONCOL, V105, P81, DOI 10.1002/jso.22048; National Blood Authority, BLOOD MAN GUID MOD 2; Nikfarjam M, 2013, J PANCREAS, V14, P63, DOI 10.6092/1590-8577/1223; Nordstrom J, 2013, BRIT J ANAESTH, V110, P374, DOI 10.1093/bja/aes399; Pearse RM, 2014, JAMA-J AM MED ASSOC, V311, P2181, DOI 10.1001/jama.2014.5305; Peng K, 2014, MED PRIN PRACT, V23, P413, DOI 10.1159/000363573; Pratt WB, 2007, ANN SURG, V245, P443, DOI 10.1097/01.sla.0000251708.70219.d2; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ramsingh DS, 2013, J CLIN MONIT COMPUT, V27, P249, DOI 10.1007/s10877-012-9422-5; Scheeren TWL, 2013, J CLIN MONIT COMPUT, V27, P225, DOI 10.1007/s10877-013-9461-6; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shields Conor J, 2008, Ther Clin Risk Manag, V4, P569; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sutton JM, 2014, J GASTROINTEST SURG, V18, P1575, DOI 10.1007/s11605-014-2567-4; Tan WJH, 2011, HPB, V13, P566, DOI 10.1111/j.1477-2574.2011.00336.x; Vane LA, 2004, ANESTHESIOLOGY, V101, P1136, DOI 10.1097/00000542-200411000-00013; Vos JJ, 2015, CAN J ANESTH, V62, P1153, DOI 10.1007/s12630-015-0464-2; Vretzakis G, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-7; Warrillow SJ, 2010, ANAESTH INTENS CARE, V38, P259, DOI 10.1177/0310057X1003800206; Weinberg L, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-35; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Wright GP, 2014, J SURG ONCOL, V110, P407, DOI 10.1002/jso.23662; Yeo CJ, 1997, ANN SURG, V226, P248, DOI 10.1097/00000658-199709000-00004	51	36	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183313	10.1371/journal.pone.0183313	http://dx.doi.org/10.1371/journal.pone.0183313			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880931	Green Published, gold			2022-12-27	WOS:000409467200016
J	Jayachandran, M; Garovic, VD; Mielke, MM; Bailey, KR; Lahr, BD; Miller, VM				Jayachandran, Muthuvel; Garovic, Vesna D.; Mielke, Michelle M.; Bailey, Kent R.; Lahr, Brian D.; Miller, Virginia M.			Characterization of intravascular cellular activation in relationship to subclinical atherosclerosis in postmenopausal women	PLOS ONE			English	Article							BLOOD-BORNE MICROVESICLES; CIRCULATING MICROPARTICLES; CARDIOVASCULAR RISK; NORMAL-PREGNANCY; HISTORY; PREECLAMPSIA; ESTROGEN	Objective Mechanisms and interactions among intravascular cells contributing to development of subclinical atherosclerosis are poorly understood. In women, both menopausal status and pregnancy history influence progression of atherosclerosis. This study examined activation and interactions among blood elements with subclinical atherosclerosis in menopausal women with known pregnancy histories. Methods Carotid intima-media thickness (CIMT), as a marker of subclinical atherosclerosis, was measured using B-mode ultrasound in age-and parity-matched women [40 with and 40 without a history of preeclampsia] 35 years after the index pregnancy. Interactions among intravascular cells (38 parameters) were measured by flow cytometry in venous blood. Data analysis was by principal component which retained 7 independent dimensions accounting for 63% of the variability among 38 parameters. Results CIMT was significantly greater in women with a history of preeclampsia (P = 0.004). Platelet aggregation and platelet interactions with granulocytes and monocytes positively associated with CIMT in postmenopausal women independent of their pregnancy history (rho = 0.258, P<0.05). However, the association of the number of platelets, platelet activation and mono-cyteplatelet interactions with CIMT differed significantly depending upon pregnancy history (test for interaction, P<0.001). Conclusion Interactions among actived intravascular cells and their association with subclinical atherosclerosis differ in women depending upon their pregnancy histories.	[Jayachandran, Muthuvel; Miller, Virginia M.] Mayo Clin, Dept Surg, Rochester, MN 55905 USA; [Jayachandran, Muthuvel; Miller, Virginia M.] Mayo Clin, Physiol & Biomed Engn, Rochester, MN 55905 USA; [Garovic, Vesna D.] Mayo Clin, Div Nephrol & Hypertens, Gen Internal Med, Rochester, MN USA; [Mielke, Michelle M.; Bailey, Kent R.; Lahr, Brian D.] Mayo Clin, Div Epidemiol, Hlth Sci Res, Rochester, MN USA; [Mielke, Michelle M.] Mayo Clin, Neurol, Rochester, MN USA; [Bailey, Kent R.; Lahr, Brian D.] Mayo Clin, Div Biostat, Hlth Sci Res, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Miller, VM (corresponding author), Mayo Clin, Dept Surg, Rochester, MN 55905 USA.; Miller, VM (corresponding author), Mayo Clin, Physiol & Biomed Engn, Rochester, MN 55905 USA.	miller.virginia@mayo.edu	Jayachandran, Muthuvel/AAG-6532-2019	Jayachandran, Muthuvel/0000-0002-3007-0769; Mielke, Michelle/0000-0001-7177-1185	National Institutes of Health (NIH) [P50 AG044170, R01 AG034676, UL1 TR000135]; Department of Surgery; Mayo Foundation; American Heart Association [12GRNT12050147]; National Center for Advancing Translational Sciences, a component of the National Institutes of Health; NATIONAL INSTITUTE ON AGING [P50AG044170] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Surgery; Mayo Foundation; American Heart Association(American Heart Association); National Center for Advancing Translational Sciences, a component of the National Institutes of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health (NIH) P50 AG044170, R01 AG034676, UL1 TR000135 (a Mayo Clinic Clinical and Translational Science Award), the Department of Surgery, the Mayo Foundation, and the American Heart Association grant 12GRNT12050147. The Mayo Clinic Clinical and Translational Science Award is from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Bretelle F, 2003, THROMB HAEMOSTASIS, V89, P486, DOI 10.1055/s-0037-1613378; Campello E, 2015, THROMB RES, V136, P427, DOI 10.1016/j.thromres.2015.05.029; Cronqvist T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090020; Garcia M, 2016, MAYO CLIN PROC, V91, P226, DOI 10.1016/j.mayocp.2015.11.001; Garovic VD, 2013, CURR HYPERTENS REP, V15, P114, DOI 10.1007/s11906-013-0329-4; Gilani SI, 2016, CURR HYPERTENS REP, V18, DOI 10.1007/s11906-016-0678-x; Goynumer G, 2013, J CLIN ULTRASOUND, V41, P145, DOI 10.1002/jcu.21962; Gustafson CM, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0028-8; Hamad RR, 2009, THROMB RES, V123, P580, DOI 10.1016/j.thromres.2008.03.022; Harman SM, 2014, ANN INTERN MED, V161, P249, DOI 10.7326/M14-0353; Harman SM, 2005, CLIMACTERIC, V8, P3, DOI 10.1080/13697130500042417; Holthe MR, 2005, PLATELETS, V16, P91, DOI 10.1080/09537100400004355; Jayachandran M, 2012, J IMMUNOL METHODS, V375, P207, DOI 10.1016/j.jim.2011.10.012; Jayachandran M, 2011, J CARDIOVASC TRANSL, V4, P811, DOI 10.1007/s12265-011-9296-9; Kim DK, 2015, BIOINFORMATICS, V31, P933, DOI 10.1093/bioinformatics/btu741; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lok CAR, 2009, AM J REPROD IMMUNOL, V61, P346, DOI 10.1111/j.1600-0897.2009.00701.x; Luppi P, 2006, CLIN IMMUNOL, V118, P268, DOI 10.1016/j.clim.2005.11.001; Martin S, 2004, CIRCULATION, V109, P1653, DOI 10.1161/01.CIR.0000124065.31211.6E; McDonald SD, 2013, ATHEROSCLEROSIS, V229, P234, DOI 10.1016/j.atherosclerosis.2013.04.020; Mellembakken JR, 2001, OBSTET GYNECOL, V97, P371, DOI 10.1016/S0029-7844(00)01179-0; Milic NM, 2017, ULTRASOUND OBST GYN, V49, P110, DOI 10.1002/uog.17367; Miller VM, 2007, CLIN EXP PHARMACOL P, V34, P814, DOI 10.1111/j.1440-1681.2007.04685.x; Miller VM, 2016, ATHEROSCLEROSIS, V253, P150, DOI 10.1016/j.atherosclerosis.2016.09.006; Miller VM, 2015, PLATELETS, V27, P1; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Rainger GE, 2015, PLATELETS, V26, P507, DOI 10.3109/09537104.2015.1064881; Redman CWG, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.003; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Tatsumi K, 2015, J ATHEROSCLER THROMB, V22, P543, DOI 10.5551/jat.30940; Toldi G, 2015, AM J REPROD IMMUNOL, V74, P110, DOI 10.1111/aji.12380; White WM, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2016.02.003; Xiong J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025504; Xiong J, 2012, J CARDIOVASC PHARM, V59, P124, DOI 10.1097/FJC.0b013e31820c6254; Zoet GA, 2015, MATURITAS, V82, P153, DOI 10.1016/j.maturitas.2015.07.004	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183159	10.1371/journal.pone.0183159	http://dx.doi.org/10.1371/journal.pone.0183159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910282	gold, Green Submitted, Green Published			2022-12-27	WOS:000410859200007
J	Leiva, A; Contreras-Duarte, S; Amigo, L; Sepulveda, E; Boric, M; Quinones, V; Busso, D; Rigotti, A				Leiva, Andrea; Contreras-Duarte, Susana; Amigo, Ludwig; Sepulveda, Esteban; Boric, Mauricio; Quinones, Veronica; Busso, Dolores; Rigotti, Attilio			Gugulipid causes hypercholesterolemia leading to endothelial dysfunction, increased atherosclerosis, and premature death by ischemic heart disease in male mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; RECEPTOR SR-BI; FARNESOID-X-RECEPTOR; E-DEFICIENT MICE; SCAVENGER RECEPTOR; APOLIPOPROTEIN-E; MYOCARDIAL-INFARCTION; CARDIAC DYSFUNCTION; HDL METABOLISM; CHOLESTEROL	For proper cholesterol metabolism, normal expression and function of scavenger receptor class B type I (SR-BI), a high-density lipoprotein (HDL) receptor, is required. Among the factors that regulate overall cholesterol homeostasis and HDL metabolism, the nuclear farnesoid X receptor plays an important role. Guggulsterone, a bioactive compound present in the natural product gugulipid, is an antagonist of this receptor. This natural product is widely used globally as a natural lipid-lowering agent, although its anti-atherogenic cardiovascular benefit in animal models or humans is unknown. The aim of this study was to determine the effects of gugulipid on cholesterol homeostasis and development of mild and severe atherosclerosis in male mice. For this purpose, we evaluated the impact of gugulipid treatment on liver histology, plasma lipoprotein cholesterol, endothelial function, and development of atherosclerosis and/or ischemic heart disease in wild-type mice; apolipoprotein E knockout mice, a model of atherosclerosis without ischemic complications; and SR-B1 knockout and atherogenic-diet-fed apolipoprotein E hypomorphic (SR-BI KO/ApoER61 h/h) mice, a model of lethal ischemic heart disease due to severe atherosclerosis. Gugulipid administration was associated with histological abnormalities in liver, increased alanine aminotransferase levels, lower hepatic SR-BI content, hypercholesterolemia due to increased HDL cholesterol levels, endothelial dysfunction, enhanced atherosclerosis, and accelerated death in animals with severe ischemic heart disease. In conclusion, our data show important adverse effects of gugulipid intake on HDL metabolism and atherosclerosis in male mice, suggesting potential and unknown deleterious effects on cardiovascular health in humans. In addition, these findings reemphasize the need for rigorous preclinical and clinical studies to provide guidance on the consumption of natural products and regulation of their use in the general population.	[Leiva, Andrea; Contreras-Duarte, Susana] Pontificia Univ Catolica Chile, Sch Med, Div Obstet & Gynaecol, CMPL, Santiago, Chile; [Amigo, Ludwig] Pontificia Univ Catolica Chile, Sch Med, Dept Gastroenterol, Santiago, Chile; [Sepulveda, Esteban; Boric, Mauricio] Pontificia Univ Catolica Chile, Fac Biol Sci, Dept Physiol, Santiago, Chile; [Quinones, Veronica; Busso, Dolores; Rigotti, Attilio] Pontificia Univ Catolica Chile, Dept Nutr Diabet & Metab, Santiago, Chile; [Rigotti, Attilio] Pontificia Univ Catolica Chile, Sch Med, Ctr Mol Nutr & Chron Dis, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Leiva, A (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Div Obstet & Gynaecol, CMPL, Santiago, Chile.; Rigotti, A (corresponding author), Pontificia Univ Catolica Chile, Dept Nutr Diabet & Metab, Santiago, Chile.; Rigotti, A (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Ctr Mol Nutr & Chron Dis, Santiago, Chile.	aaleiva@uc.cl; arigotti@med.puc.cl	Busso, Dolores/K-7375-2012; Boric, Mauricio P/G-1574-2013; Busso, Dolores/AAF-2568-2020	Busso, Dolores/0000-0003-2113-1926; Boric, Mauricio P/0000-0001-6735-6675; Contreras Duarte, Susana/0000-0002-4198-7011	Chilean National Research and Technology Commission (Comision Nacional de Investigacion Cientifica y Tecnologica, CONICYT); Fondo Nacional de Desarrollo Cientifico y Tecnologico [1070634, 1150399, 1150344]; CONICYT Ph.D. fellowships	Chilean National Research and Technology Commission (Comision Nacional de Investigacion Cientifica y Tecnologica, CONICYT); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT Ph.D. fellowships	This work was funded by the Chilean National Research and Technology Commission (Comision Nacional de Investigacion Cientifica y Tecnologica, CONICYT), Fondo Nacional de Desarrollo Cientifico y Tecnologico grant #1070634 (A. Rigotti), #1150399 (A. Rigotti), # 1150344 (A. Leiva) and CONICYT Ph.D. fellowships (A. Leiva, E. Sepulveda). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Amigo L, 2000, GASTROENTEROLOGY, V118, P772, DOI 10.1016/S0016-5085(00)70147-8; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Braun A, 2002, CIRC RES, V90, P270, DOI 10.1161/hh0302.104462; Braun A, 2008, CURR DRUG TARGETS, V9, P217; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Buckley ML, 2015, BBA-MOL BASIS DIS, V1852, P1498, DOI 10.1016/j.bbadis.2015.04.011; Chander Ramesh, 2003, Indian J Clin Biochem, V18, P71, DOI 10.1007/BF02867370; Claudel T, 2005, ARTERIOSCL THROM VAS, V25, P2020, DOI 10.1161/01.ATV.0000178994.21828.a7; Das Gupta R, 1990, J Indian Med Assoc, V88, P346; Morales MG, 2010, LIVER INT, V30, P887, DOI 10.1111/j.1478-3231.2010.02230.x; Ghorai M, 2000, PHYTOTHER RES, V14, P200, DOI 10.1002/(SICI)1099-1573(200005)14:3&lt;200::AID-PTR548&gt;3.0.CO;2-T; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Grieco A, 2009, J HEPATOL, V50, P1273, DOI 10.1016/j.jhep.2009.02.021; Gu XJ, 2000, J BIOL CHEM, V275, P29993, DOI 10.1074/jbc.275.39.29993; Guo Q, 1996, J BIOL CHEM, V271, P11191, DOI 10.1074/jbc.271.19.11191; Hag AMF, 2008, BIOCHEM BIOPH RES CO, V377, P689, DOI 10.1016/j.bbrc.2008.10.037; Hasani-Ranjbar S, 2010, CURR PHARM DESIGN, V16, P2935, DOI 10.2174/138161210793176464; Jain S, 2014, WORLD J PHARM RES, V3, P1616; Kozarsky KF, 1997, NATURE, V387, P414, DOI 10.1038/387414a0; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Lata S, 1991, J Postgrad Med, V37, P132; Leiva A, 2011, ATHEROSCLEROSIS, V217, P299, DOI 10.1016/j.atherosclerosis.2011.05.036; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; Mardones P, 2001, J LIPID RES, V42, P170; Masten SA, 2005, GUM GUGGUL SOME STER, V2, P1; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Moon DO, 2011, BIOCHEM PHARMACOL, V82, P1641, DOI 10.1016/j.bcp.2011.08.019; Nityanand S, 1989, J Assoc Physicians India, V37, P323; Nohr LA, 2009, COMPLEMENT THER MED, V17, P16, DOI 10.1016/j.ctim.2008.07.001; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Russell A, 2000, J PHARMACOL EXP THER, V294, P598; Sairkar PK, 2017, J PHARM BIOALLIED SC, V9, P1, DOI 10.4103/0975-7406.206225; Sane RT, 1990, INDIAN DRUGS, V28, P86; Sarup P, 2015, SCIENTIFICA, V2015, DOI 10.1155/2015/138039; SETH R, 1991, LANCET, V338, P83, DOI 10.1016/0140-6736(91)90077-3; Shah R, 2012, PHYTOTHER RES, V26, P1594, DOI 10.1002/ptr.4647; SINGH RB, 1994, CARDIOVASC DRUG THER, V8, P659, DOI 10.1007/BF00877420; SINGH V, 1990, PHARMACOL RES, V22, P37, DOI 10.1016/1043-6618(90)90741-U; Szapary PO, 2003, JAMA-J AM MED ASSOC, V290, P765, DOI 10.1001/jama.290.6.765; Trigatti B, 1999, P NATL ACAD SCI USA, V96, P9322, DOI 10.1073/pnas.96.16.9322; Trigatti BL, 2003, ARTERIOSCL THROM VAS, V23, P1732, DOI 10.1161/01.ATV.0000091363.28501.84; Ulbricht C, 2005, COMPLEMENT THER MED, V13, P279, DOI 10.1016/j.ctim.2005.08.003; Urizar NL, 2003, ANNU REV NUTR, V23, P303, DOI 10.1146/annurev.nutr.23.011702.073102; Urizar NL, 2002, SCIENCE, V296, P1703, DOI 10.1126/science.1072891; Xu WX, 2017, FEBS J, V284, P114, DOI 10.1111/febs.13956; Xu WX, 2017, TOXICOL APPL PHARM, V315, P23, DOI 10.1016/j.taap.2016.12.001; Yang DF, 2012, J LIPID RES, V53, P529, DOI 10.1194/jlr.M014688; Yesilaltay A, 2006, ENDOCRINOLOGY, V147, P1577, DOI 10.1210/en.2005-1286; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhang SW, 2005, CIRCULATION, V111, P3457, DOI 10.1161/CIRCULATIONAHA.104.523563	55	4	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184280	10.1371/journal.pone.0184280	http://dx.doi.org/10.1371/journal.pone.0184280			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910310	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200036
J	Nonaka, K; Suzuki, H; Murayama, H; Hasebe, M; Koike, T; Kobayashi, E; Fujiwara, Y				Nonaka, Kumiko; Suzuki, Hiroyuki; Murayama, Hiroshi; Hasebe, Masami; Koike, Takashi; Kobayashi, Erika; Fujiwara, Yoshinori			For how many days and what types of group activities should older Japanese adults be involved in to maintain health? A 4-year longitudinal study	PLOS ONE			English	Article							EXPERIENCE CORPS(R); LEISURE ACTIVITIES; SOCIAL NETWORKS; MORTALITY RISK; LATE-LIFE; DEMENTIA; PEOPLE; PARTICIPATION; BENEFITS; PROGRAM	Objective Studies have suggested that frequent participation in social groups contributes to the wellbeing of older people. The primary aim of this study was to identify the number of days older adults should participate in the activities of social groups to maintain their health for 4 years. This study also aimed to examine whether the effective frequency differs by the type of social group activity. Method We examined a prospective cohort of 1,320 community-dwelling older adults over 65 years of age, who responded to both a baseline and a follow-up mail survey, in a suburban city of Tokyo, Japan. The dependent variable was the change in functional competence during 4 years. Logistic regression analyses were conducted to examine the effects of participation in the activities of the 5 most common social groups among older Japanese on maintaining functional competence. Results Nine hundred and ninety-four participants (76.5%) maintained their functional competence for 4 years. The results of the logistic regression analyses showed that participating in alumni groups less than once a month and being an inactive member were associated with higher odds of maintaining functional competence, after controlling for socioeconomic, demographic and baseline health status. Additionally, the odds of maintaining functional competence for 4 years increased upon participating in volunteer groups once a month or more. These results were also confirmed using logistic regression analysis, even after adjustment for the effects of participation in other social groups. Discussion The results indicated the effectiveness of volunteer activities that fulfill a social role in maintaining health. Therefore, older adults should be encouraged to participate in activities of volunteer groups at least once a month. Additionally, older adults can obtain positive health outcomes through less frequent participation in alumni groups, compared with the activities of volunteer groups.	[Nonaka, Kumiko; Suzuki, Hiroyuki; Murayama, Hiroshi; Hasebe, Masami; Kobayashi, Erika; Fujiwara, Yoshinori] Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Itabashi Ku, Tokyo, Japan; [Murayama, Hiroshi] Univ Tokyo, Inst Gerontol, Bunkyo Ku, Tokyo, Japan; [Hasebe, Masami] Seigakuin Univ, Fac Human Welf, Ageo, Saitama, Japan; [Koike, Takashi] Kyushu Sangyo Univ, Fac Int Studies Culture, Higashi Ku, Fukuoka, Japan	Tokyo Metropolitan Institute of Gerontology; University of Tokyo	Nonaka, K; Fujiwara, Y (corresponding author), Tokyo Metropolitan Inst Gerontol, Res Team Social Participat & Community Hlth, Itabashi Ku, Tokyo, Japan.	nonaka@tmig.or.jp; fujiwayo@tmig.or.jp			Health Labor Sciences Research Grant from the Ministry of Health, Labor and Welfare, Japan; Grants-in-Aid for Scientific Research [16KT0119] Funding Source: KAKEN	Health Labor Sciences Research Grant from the Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Health Labor Sciences Research Grant (2008-Research on Policy Planning and Evaluation-012) from the Ministry of Health, Labor and Welfare, Japan to YF.	Anderson ND, 2014, PSYCHOL BULL, V140, P1505, DOI 10.1037/a0037610; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Cabinet Office government of Japan, 2016, HEISEI28NEN KOUR HAK; Carlson MC, 2008, ALZHEIMERS DEMENT, V4, P324, DOI 10.1016/j.jalz.2008.07.002; Carlson MC, 2008, GERONTOLOGIST, V48, P793, DOI 10.1093/geront/48.6.793; Dodge HH, 2008, J GERONTOL A-BIOL, V63, P1193, DOI 10.1093/gerona/63.11.1193; Fratiglioni L, 2000, LANCET, V355, P1315, DOI 10.1016/S0140-6736(00)02113-9; Fujiwara Y., 2003, GERIATR GERONTOL INT, V3, pS63, DOI [DOI 10.1111/J.1444-0594.2003.00097.X, 10.1111/j.1444-0594.2003.00097.x]; Fujiwara Y, 2017, GERIATR GERONTOL INT, V17, P500, DOI 10.1111/ggi.12731; Glass TA, 1999, BRIT MED J, V319, P478, DOI 10.1136/bmj.319.7208.478; Harris AHS, 2005, J HEALTH PSYCHOL, V10, P739, DOI 10.1177/1359105305057310; Hong SI, 2010, SOC SCI MED, V71, P414, DOI 10.1016/j.socscimed.2010.04.009; Kahana E, 2013, J AGING HEALTH, V25, P159, DOI 10.1177/0898264312469665; Konrath S, 2012, HEALTH PSYCHOL, V31, P87, DOI 10.1037/a0025226; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Lawton MP, 1972, RES PLANNING ACTION, P122; Lee JH, 2014, OCCUP THER INT, V21, P124, DOI 10.1002/oti.1371; Minagawa Y, 2015, RES AGING, V37, P481, DOI 10.1177/0164027514545238; Ministry of Health, 2012, LAB WELF KAIG MAN KA; Morrow-Howell Nancy, 2003, J Gerontol B Psychol Sci Soc Sci, V58, pS137; Musick MA, 1999, J GERONTOL B-PSYCHOL, V54, pS173, DOI 10.1093/geronb/54B.3.S173; Musick MA, 2003, SOC SCI MED, V56, P259, DOI 10.1016/S0277-9536(02)00025-4; Norstrand J, 2014, J AGEING RES, V2014, DOI [10.1155/2014/626097, DOI 10.1155/2014/626097]; Oman D, 1999, J Health Psychol, V4, P301, DOI 10.1177/135910539900400301; Parisi JM, 2015, J URBAN HEALTH, V92, P55, DOI 10.1007/s11524-014-9918-z; Poortinga W, 2006, SOC SCI MED, V63, P255, DOI 10.1016/j.socscimed.2005.11.039; Poulin MJ, 2014, HEALTH PSYCHOL, V33, P120, DOI 10.1037/a0031620; STEINBACH U, 1992, J GERONTOL, V47, pS183, DOI 10.1093/geronj/47.4.S183; Takagi D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-701; Thoits PA, 2001, J HEALTH SOC BEHAV, V42, P115, DOI 10.2307/3090173; Van Willigen M, 2000, J GERONTOL B-PSYCHOL, V55, pS308, DOI 10.1093/geronb/55.5.S308; Wang HX, 2002, AM J EPIDEMIOL, V155, P1081, DOI 10.1093/aje/155.12.1081	33	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183829	10.1371/journal.pone.0183829	http://dx.doi.org/10.1371/journal.pone.0183829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910315	Green Submitted, gold, Green Published			2022-12-27	WOS:000410859200020
J	Pan, L; Yang, ZF; Wang, JP; Wang, PX; Ma, X; Zhou, ML; Li, J; Gang, N; Feng, GY; Zhao, JM; Zhang, XQ				Pan, Ling; Yang, Zhongfu; Wang, Jianping; Wang, Pengxi; Ma, Xiao; Zhou, Meiliang; Li, Ji; Gang, Nie; Feng, Guangyan; Zhao, Junming; Zhang, Xinquan			Comparative proteomic analyses reveal the proteome response to short-term drought in Italian ryegrass (Lolium multiflorum)	PLOS ONE			English	Article							ENHANCED TOLERANCE; MONODEHYDROASCORBATE REDUCTASE; OXIDATIVE STRESS; TOBACCO PLANTS; WATER-DEFICIT; LEAVES; SALT; PROLINE; ACCUMULATION; METABOLISM	Drought is a major abiotic stress that impairs growth and productivity of Italian ryegrass. Comparative analysis of drought responsive proteins will provide insight into molecular mechanism in Lolium multiflorum drought tolerance. Using the iTRAQ-based approach, proteomic changes in tolerant and susceptible lines were examined in response to drought condition. A total of 950 differentially accumulated proteins was found to be involved in carbohydrate metabolism, amino acid metabolism, biosynthesis of secondary metabolites, and signal transduction pathway, such as beta-D-xylosidase, beta-D-glucan glucohydrolase, glycerate dehydrogenase, Cobalamin-independent methionine synthase, glutamine synthetase 1a, Farnesyl pyrophosphate synthase, diacylglycerol, and inositol 1, 4, 5-trisphosphate, which might contributed to enhance drought tolerance or adaption in Lolium multiflorum. Interestingly, the two specific metabolic pathways, arachidonic acid and inositol phosphate metabolism including differentially accumulated proteins, were observed only in the tolerant lines. Cysteine protease cathepsin B, Cysteine proteinase, lipid transfer protein and Aquaporin were observed as drought-regulated proteins participating in hydrolysis and transmembrane transport. The activities of phospholipid hydroperoxide glutathione peroxidase, peroxiredoxin, dehydroascorbate reductase, peroxisomal ascorbate peroxidase and monodehydroascorbate reductase associated with alleviating the accumulation of reactive oxygen species in stress inducing environments. Our results showed that drought-responsive proteins were closely related to metabolic processes including signal transduction, antioxidant defenses, hydrolysis, and transmembrane transport.	[Pan, Ling; Yang, Zhongfu; Wang, Pengxi; Ma, Xiao; Li, Ji; Gang, Nie; Feng, Guangyan; Zhao, Junming; Zhang, Xinquan] Sichuan Agr Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Chengdu, Sichuan, Peoples R China; [Wang, Jianping] Univ Florida, Agron Dept, Gainesville, FL USA; [Zhou, Meiliang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China	Sichuan Agricultural University; State University System of Florida; University of Florida; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Zhang, XQ (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Chengdu, Sichuan, Peoples R China.	zhangxq@sicau.edu.cn	Pan, Ling/ABP-1490-2022	Pan, Ling/0000-0003-1371-1672	earmarked fund for Modern Agro-industry Technology Research System [CARS-35-05]; National Basic Research Program (973 program) in China [2014C6138705]; National Natural Science Foundation of China (NSFC) [31372363]	earmarked fund for Modern Agro-industry Technology Research System; National Basic Research Program (973 program) in China(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research work was funded by the earmarked fund for Modern Agro-industry Technology Research System (No. CARS-35-05), the National Basic Research Program (973 program) in China (No. 2014C6138705) and the National Natural Science Foundation of China (NSFC 31372363). XZ is the funder who had role in study design and decision to publish.	Abid G, 2015, PLANT CELL TISS ORG, V121, P367, DOI 10.1007/s11240-014-0707-x; [Anonymous], 2012, J RECEPTORS SIGNAL T, V32, P134; Arsovski AA, 2009, PLANT PHYSIOL, V150, P1219, DOI 10.1104/pp.109.138388; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Budak H, 2013, PLANT MOL BIOL, V83, P89, DOI 10.1007/s11103-013-0024-5; Cameron KD, 2006, PLANT PHYSIOL, V140, P176, DOI 10.1104/pp.105.069724; Caruso G, 2009, PLANT SCI, V177, P570, DOI 10.1016/j.plantsci.2009.08.007; Chen SX, 2006, PROTEOMICS, V6, P5504, DOI 10.1002/pmic.200600143; Claeys H, 2013, PLANT PHYSIOL, V162, P1768, DOI 10.1104/pp.113.220921; Egert M, 2002, ENVIRON EXP BOT, V48, P43, DOI 10.1016/S0098-8472(02)00008-4; Eltayeb AE, 2006, PHYSIOL PLANTARUM, V127, P57, DOI 10.1111/j.1399-3054.2006.00624.x; Eltayeb AE, 2007, PLANTA, V225, P1255, DOI 10.1007/s00425-006-0417-7; Eltelib HA, 2012, S AFR J BOT, V78, P295, DOI 10.1016/j.sajb.2011.08.005; Franca A, 1998, EUR J AGRON, V9, P71, DOI 10.1016/S1161-0301(98)00024-0; FUKUTOKU Y, 1984, PHYSIOL PLANTARUM, V61, P622, DOI 10.1111/j.1399-3054.1984.tb05180.x; Guo RR, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-554; Han KJ, 2013, CROP SCI, V53, P315, DOI 10.2135/cropsci2012.04.0260; Harrak H, 2001, GENOME, V44, P368, DOI 10.1139/gen-44-3-368; Hoch G, 2007, FUNCT ECOL, V21, P823, DOI 10.1111/j.1365-2435.2007.01305.x; Hondorp ER, 2009, J BACTERIOL, V191, P3407, DOI 10.1128/JB.01722-08; HUMPHREYS MW, 1993, PLANT BREEDING, V111, P155, DOI 10.1111/j.1439-0523.1993.tb00622.x; Jaleel CA, 2009, INT J AGRIC BIOL, V11, P100; Ji KX, 2012, J PLANT PHYSIOL, V169, P336, DOI 10.1016/j.jplph.2011.10.010; Jiang Y, 2014, J PROTEOME RES, V13, P1307, DOI 10.1021/pr401292p; Kaneko T, 1997, PLANT CELL PHYSIOL, V38, P1171, DOI 10.1093/oxfordjournals.pcp.a029103; Kirby EG, 2014, DROUGHT STRESS TOLER; Kissoudis C, 2015, PLANT BIOTECHNOL REP, V9, P287, DOI 10.1007/s11816-015-0364-5; Kosmala A, 2012, J EXP BOT, V63, P6161, DOI 10.1093/jxb/ers265; Merchant A, 2006, PLANT CELL ENVIRON, V29, P2017, DOI 10.1111/j.1365-3040.2006.01577.x; Mitton JB, 1998, AM J BOT, V85, P1262, DOI 10.2307/2446636; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Nakai H, 2007, BIOCHIMIE, V89, P49, DOI 10.1016/j.biochi.2006.09.014; Noctor G, 2014, PLANT PHYSIOL, V164, P1636, DOI 10.1104/pp.113.233478; Pan L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00519; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Perlikowski D, 2014, PLANT BIOLOGY, V16, P385, DOI 10.1111/plb.12074; PERLIKOWSKI D, 2016, FRONTIERS PLANT SCI, V7; Qiao JJ, 2013, GENE, V512, P6, DOI 10.1016/j.gene.2012.10.004; Ravanel S, 2004, J BIOL CHEM, V279, P22548, DOI 10.1074/jbc.M313250200; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Roulin S, 2002, PLANTA, V215, P51, DOI 10.1007/s00425-001-0721-1; Rouyi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096712; Sakamoto T, 2014, GENES CELLS, V19, P778, DOI 10.1111/gtc.12175; SCHUBERT S, 1995, J PLANT PHYSIOL, V146, P541, DOI 10.1016/S0176-1617(11)82021-3; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Selmar D, 2013, IND CROP PROD, V42, P558, DOI 10.1016/j.indcrop.2012.06.020; Shiozaki N, 2005, THEOR APPL GENET, V110, P1177, DOI 10.1007/s00122-005-1931-x; Singh N, 2014, MAR BIOTECHNOL, V16, P321, DOI 10.1007/s10126-013-9548-6; Singh R., 2014, INT J ADV RES, V2, P210; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Veeranagamallaiah G, 2007, ENVIRON EXP BOT, V60, P239, DOI 10.1016/j.envexpbot.2006.10.012; Wendelboe-Nelson C, 2012, PROTEOMICS, V12, P3374, DOI 10.1002/pmic.201200154; Wiese S, 2007, PROTEOMICS, V7, P340, DOI 10.1002/pmic.200600422; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yang LM, 2014, INT J MOL SCI, V15, P18892, DOI 10.3390/ijms151018892; Yang YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117475; You J, 2014, PLANT PHYSIOL, V166, P2100, DOI 10.1104/pp.114.251116; ZHANG L, 2008, PRATA CULTURAL SCI, P4; Zhao YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125415; Zhou ML, 2012, GLYCOBIOLOGY, V22, P1775, DOI 10.1093/glycob/cws121; Zhou SY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052439	64	13	15	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184289	10.1371/journal.pone.0184289	http://dx.doi.org/10.1371/journal.pone.0184289			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910323	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200038
J	Li, Q; Hegge, R; Bridges, PJ; Matthews, JC				Li, Qing; Hegge, Raquel; Bridges, Phillip J.; Matthews, James C.			Pituitary genomic expression profiles of steers are altered by grazing of high vs. low endophyte-infected tall fescue forages	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; GROWTH-HORMONE; PROLACTIN SECRETION; GENE-EXPRESSION; PLASMA-CONCENTRATIONS; ORGANIC FORMS; TRANSCRIPTION; ACTIVATION; BINDING; PROTEIN	Consumption of ergot alkaloid-containing tall fescue grass impairs several metabolic, vascular, growth, and reproductive processes in cattle, collectively producing a clinical condition known as "fescue toxicosis." Despite the apparent association between pituitary function and these physiological parameters, including depressed serum prolactin; no reports describe the effect of fescue toxicosis on pituitary genomic expression profiles. To identify candidate regulatory mechanisms, we compared the global and selected targeted mRNA expression patterns of pituitaries collected from beef steers that had been randomly assigned to undergo summer-long grazing (89 to 105 d) of a high-toxic endophyte-infected tall fescue pasture (HE; 0.746 mu g/g ergot alkaloids; 5.7 ha; n = 10; BW = 267 +/- 14.5 kg) or a low-toxic endophyte tall fescue-mixed pasture (LE; 0.023 mu g/g ergot alkaloids; 5.7 ha; n = 9; BW = 266 +/- 10.9 kg). As previously reported, in the HE steers, serum prolactin and body weights decreased and a potential for hepatic gluconeogenesis from amino acid-derived carbons increased. In this manuscript, we report that the pituitaries of HE steers had 542 differentially expressed genes (P < 0.001, false discovery rate <= 4.8%), and the pattern of altered gene expression was dependent (P < 0.001) on treatment. Integrated Pathway Analysis revealed that canonical pathways central to prolactin production, secretion, or signaling were affected, in addition to those related to corticotropin-releasing hormone signaling, melanocyte development, and pigmentation signaling. Targeted RT-PCR analysis corroborated these findings, including decreased (P < 0.05) expression of DRD2, PRL, POU1F1, GAL, and VIP and that of POMC and PCSK1, respectively. Canonical pathway analysis identified HE-dependent alteration in signaling of additional pituitary-derived hormones, including growth hormone and GnRH. We conclude that consumption of endophyte-infected tall fescue alters the pituitary transcriptome profiles of steers in a manner consistent with their negatively affected physiological parameters.	[Li, Qing; Hegge, Raquel; Bridges, Phillip J.; Matthews, James C.] Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40506 USA	University of Kentucky	Matthews, JC (corresponding author), Univ Kentucky, Dept Anim & Food Sci, Lexington, KY 40506 USA.	jmatthew@uky.edu	Matthews, James Clyde/Y-1849-2019	Matthews, James/0000-0003-3219-9758	United States Department of Agriculture-Agricultural Research Service Cooperative Agreement (JCM); National Institute of Food and Agriculture, U.S. Department of Agriculture [KY007095]	United States Department of Agriculture-Agricultural Research Service Cooperative Agreement (JCM); National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA))	This work is supported by a United States Department of Agriculture-Agricultural Research Service Cooperative Agreement (JCM) and by the National Institute of Food and Agriculture, U.S. Department of Agriculture, Hatch project No. KY007095 (JCM, PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Aiken GE, 2013, J ANIM SCI, V91, P2369, DOI 10.2527/jas.2012-5948; ALDRICH CG, 1993, J ANIM SCI, V71, P164, DOI 10.2527/1993.711164x; Beardwell C, 1981, PITUITARY; Ben-Jonathan N, 2006, TRENDS ENDOCRIN MET, V17, P110, DOI 10.1016/j.tem.2006.02.005; BJORO T, 1987, MOL CELL ENDOCRINOL, V49, P119, DOI 10.1016/0303-7207(87)90205-X; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; BREDOW S, 1994, BRAIN RES, V660, P301, DOI 10.1016/0006-8993(94)91303-X; Bridges PJ, 2012, ENDOCRINOLOGY, V153, P1925, DOI 10.1210/en.2011-1900; Brown KR, 2009, J ANIM SCI, V87, P748, DOI 10.2527/jas.2008-1108; Browning R, 1997, J ANIM SCI, V75, P796; Browning R, 1998, J ANIM SCI, V76, P1644; DROUIN J, 1993, EMBO J, V12, P145, DOI 10.1002/j.1460-2075.1993.tb05640.x; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Ezzat S, 2005, MOL ENDOCRINOL, V19, P1004, DOI 10.1210/me.2004-0432; Fitzgerald Peter, 2008, J Psychopharmacol, V22, P12, DOI 10.1177/0269216307087148; Fliss MS, 1999, MOL ENDOCRINOL, V13, P644, DOI 10.1210/me.13.4.644; FOX SR, 1990, MOL ENDOCRINOL, V4, P1069, DOI 10.1210/mend-4-7-1069; FRAWLEY LS, 1981, NEUROENDOCRINOLOGY, V33, P79, DOI 10.1159/000123206; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; GOURDJI D, 1979, FEBS LETT, V104, P165, DOI 10.1016/0014-5793(79)81107-2; Holsboer F, 1999, J PSYCHIATR RES, V33, P181, DOI 10.1016/S0022-3956(98)90056-5; HURLEY WL, 1980, J ANIM SCI, V51, P374, DOI 10.2527/jas1980.512374x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson JJ, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00077; KOSHIYAMA H, 1987, NEUROSCI LETT, V75, P49, DOI 10.1016/0304-3940(87)90073-5; LAMBERTS SWJ, 1990, PHYSIOL REV, V70, P279, DOI 10.1152/physrev.1990.70.2.279; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; Larson BT, 1999, J ANIM SCI, V77, P942; LATCHMAN DS, 1993, INT J EXP PATHOL, V74, P417; Liao SF, 2015, J ANIM SCI, V93, P5659, DOI 10.2527/jas.2015-9193; LIPHAM LB, 1989, J ANIM SCI, V67, P1090, DOI 10.2527/jas1989.6741090x; Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Looper ML, 2010, J ANIM SCI, V88, P4133, DOI 10.2527/jas.2010-3192; Luo Y, 2007, EXP NEUROL, V203, P221, DOI 10.1016/j.expneurol.2006.08.005; MACNAMEE MC, 1986, GEN COMP ENDOCR, V62, P470, DOI 10.1016/0016-6480(86)90057-2; MANGALAM HJ, 1989, GENE DEV, V3, P946, DOI 10.1101/gad.3.7.946; Matthews JC, 2014, ANIM PROD SCI, V54, P1594, DOI 10.1071/AN14274; Matthews JC, 2014, BIOL TRACE ELEM RES, V160, P321, DOI 10.1007/s12011-014-0050-4; Millington GWM, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-18; MURDOCH GH, 1982, NATURE, V300, P192, DOI 10.1038/300192a0; Naef L, 2007, ENDOCRINOLOGY, V148, P5977, DOI 10.1210/en.2007-0442; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673; SAMSON WK, 1980, PEPTIDES, V1, P325, DOI 10.1016/0196-9781(80)90010-8; Schuenemann Gustavo M, 2005, Reprod Biol, V5, P137; Siegel MR, 1994, BIOTECHNOLOGY ENDOPH, P135; STEINFELDER HJ, 1991, P NATL ACAD SCI USA, V88, P3130, DOI 10.1073/pnas.88.8.3130; Strickland JR, 2011, J ANIM SCI, V89, P1603, DOI 10.2527/jas.2010-3478; Thompson IM, 2011, J ANIM SCI, V89, P1338, DOI 10.2527/jas.2010-3559; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; WATERMAN ML, 1988, MOL ENDOCRINOL, V2, P14, DOI 10.1210/mend-2-1-14; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Wynick D, 1998, P NATL ACAD SCI USA, V95, P12671, DOI 10.1073/pnas.95.21.12671	55	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184612	10.1371/journal.pone.0184612	http://dx.doi.org/10.1371/journal.pone.0184612			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902910	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200049
J	del Pozo-Cruz, B; Gant, N; del Pozo-Cruz, J; Maddison, R				del Pozo-Cruz, Borja; Gant, Nicholas; del Pozo-Cruz, Jesus; Maddison, Ralph			Relationships between sleep duration, physical activity and body mass index in young New Zealanders: An isotemporal substitution analysis	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; INSULIN-RESISTANCE; CHILDREN; HEALTH; RISK; TIME; FITNESS; INDICATORS; ADIPOSITY; INTENSITY	Background The evidence regarding the unique effect of sedentary behaviour on obesity among children is unclear. Moreover, the effect of substituting sedentary behaviour with physical activity of different intensities on the body composition of children has received limited empirical study. Objective To examine the mathematical effects on Body Mass Index (BMI) of substituting sedentary behaviours with physical activities of different intensities on children and youth aged 5-14 years old in New Zealand. Methods Secondary analysis of accelerometer data from the National Survey of Children and Young People's Physical Activity and Dietary Behaviours in New Zealand (2008/09) was conducted. A total of 1812 children and youth aged 5-24 years provided accelerometer-derived data on daily sedentary time (SB), light intensity physical activity (LPA) and moderate to vigorous physical activity (MVPA). Sleep time was assessed with a validated computerised use-of-time tool. BMI was assessed using anthropometric measurements. Multiple linear regression models were used to examine the independent associations of SB, Sleep time, LPA, and MVPA on BMI. The isotemporal substitution approach was used to ascertain the mathematical effect of substituting each of the other behaviours on BMI. Analyses were stratified by age groups. Results SB showed a unique (inverse) association with BMI across all age groups (p<0.05) but 20-24 years (p>0.05). Similarly, MVPA was positively associated (p<0.001) across all age groups. Among age groups 5-9 years, 10-14 years and 15-19 years, the estimated impact of replacing 60 min/day of SB with the same amount of MVPA time resulted in decreased BMI for all age groups (p<0.001), ranging from -1.26 (5-9 years) to -1.43 units (15-19 years). Similar results were achieved when SB was replaced with LPA or sleeping time for children (5-19 years). In young people (age group 20-24), the impact of replacing 30 min/day of SB with MVPA resulted in an estimated -1 BMI units decrease (p<0.001). Conclusion MVPA and SB have a unique effect on BMI. Further, substituting SB with LPA or MVPA was associated with a favourable effect on BMI across all age groups; with MVPA having the strongest association.	[del Pozo-Cruz, Borja; Gant, Nicholas] Univ Auckland, Fac Sci, Dept Exercise Sci, TAMAKI Bldg 731,Level 3,Tamaki Campus Gate 1, Auckland, New Zealand; [del Pozo-Cruz, Jesus] Univ Seville, Dept Phys Educ & Sports, Pirotecnia S-N, Seville, Spain; [Maddison, Ralph] Deakin Univ, Fac Hlth Sci, Sch Exercise & Nutr, Geelong, Vic, Australia	University of Auckland; University of Sevilla; Deakin University	del Pozo-Cruz, B (corresponding author), Univ Auckland, Fac Sci, Dept Exercise Sci, TAMAKI Bldg 731,Level 3,Tamaki Campus Gate 1, Auckland, New Zealand.	b.delpozocruz@auckland.acnz	Maddison, Ralph/K-3418-2019; del Pozo-Cruz, Jesus/F-9934-2016	Maddison, Ralph/0000-0001-8564-5518; del Pozo Cruz, Borja/0000-0002-9728-1317; del Pozo-Cruz, Jesus/0000-0002-8553-5818; , Borja/0000-0003-3944-2212	Sport and Recreation New Zealand; Ministry of Health; Ministry of Education; Ministry of Youth; Health Research Council, Sir Charles Hercus Fellowship	Sport and Recreation New Zealand; Ministry of Health; Ministry of Education; Ministry of Youth; Health Research Council, Sir Charles Hercus Fellowship	The current study was not specifically funded. However, The national survey was funded by Sport and Recreation New Zealand, the Ministry of Health, the Ministry of Education and the Ministry of Youth, and was managed by the Clinical Trials Research Unit (now the National Institute for health Innovation), The University of Auckland and Synovate. Professor Maddison was supported by a Health Research Council, Sir Charles Hercus Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggio D, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0249-6; Banda JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150534; Cliff DP, 2016, OBES REV, V17, P330, DOI 10.1111/obr.12371; Dempsey PC, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-014-0522-0; Edelson LR, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2791-9; Foley LS, 2013, PEDIATRICS, V131, P276, DOI 10.1542/peds.2012-1651; Foley LS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-132; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Herzig KH, 2014, INT J OBESITY, V38, P1089, DOI 10.1038/ijo.2013.224; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Leppanen MH, 2016, INT J OBESITY, V40, P1126, DOI 10.1038/ijo.2016.54; Loprinzi PD, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0175-9; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; Mekary RA, 2009, AM J EPIDEMIOL, V170, P519, DOI 10.1093/aje/kwp163; Morrissey B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2913-4; Norton K, 1996, ANTHROPOMETRICA TXB; Poitras VJ, 2016, APPL PHYSIOL NUTR ME, V41, pS197, DOI 10.1139/apnm-2015-0663; Ridley K, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-10; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Sardinha LB, 2016, PEDIAT OBES; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Saunders TJ, 2014, CAN J DIABETES, V38, P53, DOI 10.1016/j.jcjd.2013.08.266; Sluggett L, 2016, CHILD OBES, V12, P325, DOI 10.1089/chi.2015.0214; Steele RM, 2009, AM J CLIN NUTR, V90, P1185, DOI 10.3945/ajcn.2009.28153; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Taveras EM, 2012, PREV MED, V55, P418, DOI 10.1016/j.ypmed.2012.08.016; Thompson DR, 2007, J PEDIATR-US, V150, P18, DOI 10.1016/j.jpeds.2006.09.039; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Trost SG, 1998, MED SCI SPORT EXER, V30, P629, DOI 10.1097/00005768-199804000-00023; Waleh MQ, 2016, PRIMARY CARE, V43, P97, DOI 10.1016/j.pop.2015.08.014; Welk G., 2002, PHYS ACTIVITY ASSESS	31	13	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184472	10.1371/journal.pone.0184472	http://dx.doi.org/10.1371/journal.pone.0184472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898295	Green Published, Green Submitted, gold			2022-12-27	WOS:000410449500029
J	Jordan-Alvarez, S; Santana, E; Casas-Tinto, S; Acebes, A; Ferrus, A				Jordan-Alvarez, Sheila; Santana, Elena; Casas-Tinto, Sergio; Acebes, Angel; Ferrus, Alberto			The equilibrium between antagonistic signaling pathways determines the number of synapses in Drosophila	PLOS ONE			English	Article							REGULATES SYNAPTIC GROWTH; FGF RECEPTOR HOMOLOG; N-TERMINAL KINASE; WISHFUL-THINKING; II-RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; ALZHEIMERS-DISEASE; LOCAL INTERNEURONS; BMP; SYNAPTOGENESIS	The number of synapses is a major determinant of behavior and many neural diseases exhibit deviations in that number. However, how signaling pathways control this number is still poorly understood. Using the Drosophila larval neuromuscular junction, we show here a PI3K-dependent pathway for synaptogenesis which is functionally connected with other previously known elements including the Wit receptor, its ligand Gbb, and the MAPkinases cascade. Based on epistasis assays, we determined the functional hierarchy within the pathway. Wit seems to trigger signaling through PI3K, and Ras85D also contributes to the initiation of synaptogenesis. However, contrary to other signaling pathways, PI3K does not require Ras85D binding in the context of synaptogenesis. In addition to the MAPK cascade, Bsk/JNK undergoes regulation by Puc and Ras85D which results in a narrow range of activity of this kinase to determine normalcy of synapse number. The transcriptional readout of the synaptogenesis pathway involves the Fos/Jun complex and the repressor Cic. In addition, we identified an antagonistic pathway that uses the transcription factors Mad and Medea and the microRNA bantam to down-regulate key elements of the pro-synaptogenesis pathway. Like its counterpart, the anti-synaptogenesis signaling uses small GTPases and MAPKs including Ras64B, Ras-like-a, p38a and Licorne. Bantam downregulates the pro-synaptogenesis factors PI3K, Hiw, Ras85D and Bsk, but not AKT. AKT, however, can suppress Mad which, in conjunction with the reported suppression of Mad by Hiw, closes the mutual regulation between both pathways. Thus, the number of synapses seems to result from the balanced output from these two pathways.	[Jordan-Alvarez, Sheila; Santana, Elena; Casas-Tinto, Sergio; Acebes, Angel; Ferrus, Alberto] Inst Cajal CSIC, Madrid, Spain; [Jordan-Alvarez, Sheila] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Acebes, Angel] Univ La Laguna, Inst Biomed Technol, Ctr Biomed Res Canary Isl, Tenerife, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad de la Laguna	Acebes, A; Ferrus, A (corresponding author), Inst Cajal CSIC, Madrid, Spain.; Acebes, A (corresponding author), Univ La Laguna, Inst Biomed Technol, Ctr Biomed Res Canary Isl, Tenerife, Spain.	aacebesv@ull.es; aferrus@cajal.csic.es	Jordán-Álvarez, Sheila/AAP-3219-2021; Jordan-Alvarez, Sheila/AAA-8006-2020; Casas-Tinto, Sergio/G-8220-2015; Acebes, Angel/I-2127-2015	Jordán-Álvarez, Sheila/0000-0002-7701-4457; Casas-Tinto, Sergio/0000-0002-9589-9981; Acebes, Angel/0000-0003-0020-1913; Santana, Elena/0000-0002-2444-9908; Ferrus, Alberto/0000-0002-0346-0489	Ministry of Economy [BFU2012-3819]; PhD fellowship [BES-2007-1659]; Ramon y Cajal program [RYC-2012-11410]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Ministry of Economy; PhD fellowship; Ramon y Cajal program(Spanish Government); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research was funded by a grant from the Ministry of Economy (BFU2012-3819 to AF) and a PhD fellowship (BES-2007-1659 to SJA). S.C.-T. holds a contract from the Ramon y Cajal program RYC-2012-11410. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Acebes A, 2000, TRENDS NEUROSCI, V23, P557, DOI 10.1016/S0166-2236(00)01646-5; Acebes A, 2012, J NEUROSCI, V32, P417, DOI 10.1523/JNEUROSCI.2921-11.2012; Acebes A, 2011, J NEUROSCI, V31, P2734, DOI 10.1523/JNEUROSCI.5046-10.2011; Aikin R, 2004, ENDOCRINOLOGY, V145, P4522, DOI 10.1210/en.2004-0488; Alexander PB, 2015, FRONT MED-PRC, V9, P134, DOI 10.1007/s11684-015-0396-9; Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; Asha H, 2003, GENETICS, V163, P203; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Ballard SL, 2014, J CELL BIOL, V204, P1157, DOI 10.1083/jcb.201308115; Banerjee S, 2017, MOL CELL NEUROSCI, V78, P9, DOI 10.1016/j.mcn.2016.11.004; Bangi E, 2006, DEVELOPMENT, V133, P3295, DOI 10.1242/dev.02513; Bao H, 2005, J NEUROPHYSIOL, V94, P1888, DOI 10.1152/jn.00080.2005; Baonza A, 2000, DEVELOPMENT, V127, P2383; Baydyuk M, 2015, J NEUROSCI, V35, P4676, DOI 10.1523/JNEUROSCI.2695-14.2015; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Benes FM, 2001, NEUROPSYCHOPHARMACOL, V25, P1, DOI 10.1016/S0893-133X(01)00225-1; Berke B, 2013, J NEUROSCI, V33, P17937, DOI 10.1523/JNEUROSCI.6075-11.2013; Bernardinelli Y, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00123; Borgen M, 2017, GENETICS, V205, P1229, DOI 10.1534/genetics.116.197343; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Budnik V, 2006, FLY NEUROMUSCULAR JU; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Chater TE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00401; Chazeau A, 2015, MOL BIOL CELL, V26, P859, DOI 10.1091/mbc.E14-06-1086; Chen X, 2012, J CELL BIOL, V196, P529, DOI 10.1083/jcb.201109044; Ciapponi L, 2002, MECH DEVELOP, V115, P35, DOI 10.1016/S0925-4773(02)00093-X; Collins CA, 2004, NEURON, V41, P489, DOI 10.1016/S0896-6273(04)00078-9; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Cuesto G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118475; Cuesto G, 2011, J NEUROSCI, V31, P2721, DOI 10.1523/JNEUROSCI.4477-10.2011; Darabid H, 2014, NAT REV NEUROSCI, V15, P703, DOI 10.1038/nrn3821; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; Demontis F, 2014, CELL REP, V7, P1481, DOI 10.1016/j.celrep.2014.05.001; Dobens LL, 2001, DEVELOPMENT, V128, P1845; Dumitriu D, 2010, J NEUROSCI, V30, P7507, DOI 10.1523/JNEUROSCI.6410-09.2010; Eaton BA, 2005, NEURON, V47, P695, DOI 10.1016/j.neuron.2005.08.010; EMORI Y, 1993, FEBS LETT, V332, P111, DOI 10.1016/0014-5793(93)80494-F; Etter PD, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-39; Flores CE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00327; Fouquet W, 2009, J CELL BIOL, V186, P129, DOI 10.1083/jcb.200812150; Fuentes-Medel Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000184; Gallo G, 2011, DEV NEUROBIOL, V71, P201, DOI 10.1002/dneu.20852; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Gass P, 2004, MOL BRAIN RES, V130, P16, DOI 10.1016/j.molbrainres.2004.07.004; Geuking P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007709; Ghosh AC, 2014, P NATL ACAD SCI USA, V111, P5729, DOI 10.1073/pnas.1319116111; Gleason MR, 2003, NAT NEUROSCI, V6, P217, DOI 10.1038/nn1011; Gonda RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042369; Gryzik T, 2004, CURR BIOL, V14, P659, DOI 10.1016/j.cub.2004.03.058; Guo XF, 2005, NEURON, V47, P379, DOI 10.1016/j.neuron.2005.06.027; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Hamanaka Y, 2010, J COMP NEUROL, V518, P1133, DOI 10.1002/cne.22268; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Hipfner DR, 2002, GENETICS, V161, P1527; James RE, 2014, DEV CELL, V31, P586, DOI 10.1016/j.devcel.2014.10.006; James RE, 2011, DEVELOPMENT, V138, P3273, DOI 10.1242/dev.066142; Jimenez G, 2012, J CELL SCI, V125, P1383, DOI 10.1242/jcs.092965; Jordan-Alvarez S, 2012, J CELL SCI, V125, P3621, DOI 10.1242/jcs.102806; Kadam S, 2009, DEVELOPMENT, V136, P739, DOI 10.1242/dev.027904; Karkali K, 2012, BIOCHEM BIOPH RES CO, V418, P301, DOI 10.1016/j.bbrc.2012.01.015; Khalsa O, 1998, DEVELOPMENT, V125, P2723; Kim NC, 2010, DEV DYNAM, V239, P2413, DOI 10.1002/dvdy.22368; Koles K, 2012, J BIOL CHEM, V287, P16820, DOI 10.1074/jbc.M112.342667; KORDYLEWSKI L, 1979, Z MIKROSK ANAT FORSC, V93, P1038; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kwon Y, 2013, SCIENCE, V342, P737, DOI 10.1126/science.1243971; Lalli G, 2009, J CELL SCI, V122, P1499, DOI 10.1242/jcs.044339; Lee-Hoeflich ST, 2005, FEBS LETT, V579, P4615, DOI 10.1016/j.febslet.2005.06.088; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; LEWIS ER, 1980, BRAIN RES, V191, P35, DOI 10.1016/0006-8993(80)90313-3; Li WH, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006062; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Martin-Pena A, 2006, J NEUROSCI, V26, P10199, DOI 10.1523/JNEUROSCI.1223-06.2006; Marucci L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008083; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; Messeant J, 2017, DEVELOPMENT; Michelson AM, 1998, DEVELOPMENT, V125, P4379; Middei S, 2014, NEUROBIOL LEARN MEM, V115, P108, DOI 10.1016/j.nlm.2014.08.001; Nagaoka T, 2014, CELL REP, V6, P916, DOI 10.1016/j.celrep.2014.01.044; Navarro AI, 2014, CURR OPIN NEUROBIOL, V27, P89, DOI 10.1016/j.conb.2014.03.002; Ng SW, 2009, J BIOL CHEM, V284, P24767, DOI 10.1074/jbc.M109.011692; Oh H, 2011, DEV CELL, V20, P109, DOI 10.1016/j.devcel.2010.12.002; Orme MH, 2006, NAT CELL BIOL, V8, P1298, DOI 10.1038/ncb1493; Parker L, 2006, DEVELOPMENT, V133, P4981, DOI 10.1242/dev.02673; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Peled ES, 2014, CURR BIOL, V24, P484, DOI 10.1016/j.cub.2014.01.022; Pfleger CM, 2017, CURR TOP DEV BIOL, V123, P181, DOI 10.1016/bs.ctdb.2016.12.001; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Rallis A, 2010, DEV BIOL, V339, P65, DOI 10.1016/j.ydbio.2009.12.016; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; REICHMANFRIED M, 1995, MECH DEVELOP, V52, P265, DOI 10.1016/0925-4773(95)00407-R; REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Ruiz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067161; Sakuma C, 2016, CELL REP, V16, P2289, DOI 10.1016/j.celrep.2016.07.066; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Seeger G, 2005, J NEURAL TRANSM, V112, P751, DOI 10.1007/s00702-004-0226-8; Sekine Y, 2011, J CELL SCI, V124, P3006, DOI 10.1242/jcs.085902; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SHISHIDO E, 1993, DEVELOPMENT, V117, P751; Spilker C, 2010, EUR J NEUROSCI, V32, P1, DOI 10.1111/j.1460-9568.2010.07273.x; Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404; Sturgill JF, 2009, J NEUROSCI, V29, P12845, DOI 10.1523/JNEUROSCI.1841-09.2009; Szuts D, 2000, P NATL ACAD SCI USA, V97, P5351, DOI 10.1073/pnas.97.10.5351; Teodoro RO, 2013, EMBO J, V32, P2039, DOI 10.1038/emboj.2013.147; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vonhoff F, 2013, DEVELOPMENT, V140, P606, DOI 10.1242/dev.089235; Voskas Daniel, 2010, F1000 Biol Rep, V2, P82, DOI 10.3410/B2-82; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Wang SHJ, 2014, J NEUROSCI, V34, P12745, DOI 10.1523/JNEUROSCI.1280-14.2014; Wharton KA, 1999, GENETICS, V152, P629; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Zhang HY, 2008, DEV CELL, V14, P216, DOI 10.1016/j.devcel.2007.11.020; Zhao HF, 2015, INT J ONCOL, V47, P429, DOI 10.3892/ijo.2015.3052; Zhou YY, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140141	130	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184238	10.1371/journal.pone.0184238	http://dx.doi.org/10.1371/journal.pone.0184238			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892511	gold, Green Published, Green Submitted			2022-12-27	WOS:000410243200012
J	Cieslak, M; Wahli, T; Diserens, N; Haenen, OLM; Schutze, H				Cieslak, Michael; Wahli, Thomas; Diserens, Nicolas; Haenen, Olga L. M.; Schutze, Heike			Phylogeny of the infectious hematopoietic necrosis virus in European aquaculture	PLOS ONE			English	Article							FISH RHABDOVIRUS; RAINBOW-TROUT; SOFTWARE; SEQUENCE; DISEASE; IHNV	Infectious hematopoietic necrosis (IHN)-a highly lethal infectious salmonid disease-has caused substantial economic losses in the European production of rainbow trout (Oncorhynchus mykiss) since the late 1980s. The causal agent of IHN is the IHN virus (IHNV) introduced from overseas. However, until today, its phylogeographic spread in Europe remains poorly understood. We therefore sought to elucidate this unresolved topic by using the largest ever compiled dataset of European IHNV isolates (E isolates) (193 GenBank E isolates and 100 isolates from this study) for the complete glycoprotein (G) gene sequence. Our results clearly revealed that the active trout trade has left its traces in the E phylogeny. For example, the spread by trade of IHNV-infected trout was apparently the cause for the exposure of the E lineage to different local scenarios of selection and genetic drift, and therefore has led to the split of this lineage into various subordinated lineages. Accordingly, we also found evidence for E isolates being mixed Europe-wide by cross-border introduction events. Moreover, there were indications that this propagation of the E lineage within Europe corresponded with an extensive and rapid spread event, already during or shortly after its formation. Finally, in accordance with the high substitution rate of IHNV determined by previous studies, our dataset indicates that the mean period of occurrence of a single E haplotype is typically not longer than one calendar year.	[Cieslak, Michael; Schutze, Heike] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Infectol IMED, Insel Riems, Germany; [Wahli, Thomas; Diserens, Nicolas] Univ Bern, Vetsuisse Fac, Ctr Fish & Wildlife Hlth FIWI, Bern, Switzerland; [Haenen, Olga L. M.] NRL Fish Shellfish & Crustacean Dis, Wageningen Biovet Res, Wageningen, Netherlands	Friedrich Loeffler Institute; University of Bern; Wageningen University & Research	Cieslak, M (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Infectol IMED, Insel Riems, Germany.	cieslak-michael@gmx.de	Diserens, Nicolas/ABC-2030-2021	Diserens, Nicolas/0000-0002-8352-1076; Cieslak, Michael/0000-0002-6111-658X	EMIDA-ERA Net (EU 7th Framework programme); German Federal Office for Agriculture and Food [2811ERA174]; Dutch Ministry of Economic Affairs [1600074-01]	EMIDA-ERA Net (EU 7th Framework programme); German Federal Office for Agriculture and Food; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was supported by EMIDA-ERA Net (EU 7th Framework programme), German Federal Office for Agriculture and Food (2811ERA174), and Dutch Ministry of Economic Affairs (CVI project no. 1600074-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadi M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01306; AMEND DF, 1969, T AM FISH SOC, V98, P796, DOI 10.1577/1548-8659(1969)98[796:AHVDOR]2.0.CO;2; Asl Adel Haghighi Khiabanian, 2007, Pak J Biol Sci, V10, P230, DOI 10.3923/pjbs.2007.230.234; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bootland LM, 1999, FISH DISEASES AND DISORDERS, VOL 3, P57; Bovo G., 1987, Bulletin of the European Association of Fish Pathologists, V7, P124; Breyta R, 2014, DIS AQUAT ORGAN, V112, P17, DOI 10.3354/dao02781; Cieslak M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164475; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Enzmann PJ, 2010, DIS AQUAT ORGAN, V89, P9, DOI 10.3354/dao02182; Foreman MGG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130951; Haenen OLM, 2016, J FISH DIS, V39, P971, DOI 10.1111/jfd.12434; He M, 2013, INFECT GENET EVOL, V18, P145, DOI 10.1016/j.meegid.2013.05.014; Holmes EC, 2002, J VIROL, V76, P460, DOI 10.1128/JVI.76.1.460-462.2002; Humphries EM, 2010, MOL PHYLOGENET EVOL, V54, P88, DOI 10.1016/j.ympev.2009.07.023; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kurath G, 2003, J GEN VIROL, V84, P803, DOI 10.1099/vir.0.18771-0; KURATH G, 1985, J VIROL, V53, P469, DOI 10.1128/JVI.53.2.469-476.1985; Laurencin F.B., 1987, Bulletin of the European Association of Fish Pathologists, V7, P104; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin GN, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S2; MORZUNOV SP, 1995, VIRUS RES, V38, P175, DOI 10.1016/0168-1702(95)00056-V; Niu L, 1988, J FISHERIES CHINA, V1, P351; OIE, 2016, MANUAL DIAGNOSTIC TE; PARK MA, 1993, J FISH DIS, V16, P471, DOI 10.1111/j.1365-2761.1993.tb00880.x; ROSS A. J., 1960, TRANS AMER FISH SOC, V89, P160, DOI 10.1577/1548-8659(1960)89[160:AVDOCS]2.0.CO;2; Rudakova SL, 2007, DIS AQUAT ORGAN, V75, P1, DOI 10.3354/dao075001; Sano T, 1977, Journal Tokyo Univ Fish, V63, P81; SCHUTZE H, 1995, J GEN VIROL, V76, P2519, DOI 10.1099/0022-1317-76-10-2519; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Yu Zh, 2014, AQUAC RES, P1	31	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184490	10.1371/journal.pone.0184490	http://dx.doi.org/10.1371/journal.pone.0184490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886189	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100137
J	Groves, D; Fisher, J; Williams, S				Groves, Dawn; Fisher, John; Williams, Sophie			An in vitro simulation method for the tribological assessment of complete natural hip joints	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; ACETABULAR CARTILAGE; SYNOVIAL JOINTS; HYALURONIC-ACID; LUBRICATION; FRICTION; HEMIARTHROPLASTY; OSTEOARTHRITIS; WEAR; PREVENTION	The use of hip joint simulators to evaluate the tribological performance of total hip replacements is widely reported in the literature, however, in vitro simulation studies investigating the tribology of the natural hip joint are limited with heterogeneous methodologies reported. An in vitro simulation system for the complete natural hip joint, enabling the acetabulum and femoral head to be positioned with different orientations whilst maintaining the correct joint centre of rotation, was successfully developed for this study. The efficacy of the simulation system was assessed by testing complete, matched natural porcine hip joints and porcine hip hemiarthroplasty joints in a pendulum friction simulator. The results showed evidence of biphasic lubrication, with a non-linear increase in friction being observed in both groups. Lower overall mean friction factor values in the complete natural joint group that increased at a lower rate over time, suggest that the exudation of fluid and transition to solid phase lubrication occurred more slowly in the complete natural hip joint compared to the hip hemiarthroplasty joint. It is envisaged that this methodology will be used to investigate morphological risk factors for developing hip osteoarthritis, as well as the effectiveness of early interventional treatments for degenerative hip disease.	[Groves, Dawn; Fisher, John; Williams, Sophie] Univ Leeds, Inst Med & Biol Engn, Sch Mech Engn, Leeds, W Yorkshire, England	University of Leeds	Groves, D (corresponding author), Univ Leeds, Inst Med & Biol Engn, Sch Mech Engn, Leeds, W Yorkshire, England.	d.groves@leeds.ac.uk	Williams, Sophie/D-4591-2015	Williams, Sophie/0000-0002-6963-965X; Groves-Williams, Dawn/0000-0002-4834-8503	Engineering and Physical Sciences Research Council CASE; DePuy Synthes; EPSRC [EP/N02480X/1, EP/N00941X/1, EP/K029592/1, EP/M028143/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/N02480X/1, EP/N00941X/1, EP/M028143/1, EP/K029592/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council CASE(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); DePuy Synthes; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by an Engineering and Physical Sciences Research Council CASE studentship, which was supported by DePuy Synthes. The manuscript was reviewed by DePuy Synthes. The funder provided a contribution to the studentship awarded to DG (CASE studentship) in relation to this study. JF/SW are paid consultants, however, this is not in relation to this study. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ateshian G.A., 2005, BASIC ORTHOPAEDIC BI, P447; Ateshian GA, 2009, J BIOMECH, V42, P1163, DOI 10.1016/j.jbiomech.2009.04.040; Bergmann G, 1999, J BIOMECH, V32, P769, DOI 10.1016/S0021-9290(99)00068-8; BERGMANN G, 1984, J BIOMECH, V17, P907, DOI 10.1016/0021-9290(84)90004-6; Biewener AA., 2003, ANIMAL LOCOMOTION; Bijlsma JWJ, 2007, BEST PRACT RES CL RH, V21, P59, DOI 10.1016/j.berh.2006.08.013; Bitton Ryan, 2009, Am J Manag Care, V15, pS230; Chan FW, 1999, T 45 ANN M ORTH RES; Croft P, 2005, RHEUMATOLOGY, V44, P27, DOI 10.1093/rheumatology/kei058; DALLDORF PG, 1995, J BONE JOINT SURG AM, V77A, P877, DOI 10.2106/00004623-199506000-00008; DEVAS M, 1983, J BONE JOINT SURG BR, V65, P548, DOI 10.1302/0301-620X.65B5.6643556; Felson DT, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2531; Ferguson SJ, 2003, J BIOMECH, V36, P171, DOI 10.1016/S0021-9290(02)00365-2; Forsey RW, 2006, BIOMATERIALS, V27, P4581, DOI 10.1016/j.biomaterials.2006.04.018; Forster H, 1999, P I MECH ENG H, V213, P329, DOI 10.1243/0954411991535167; Forster H, 1996, Proc Inst Mech Eng H, V210, P109, DOI 10.1243/PIME_PROC_1996_210_399_02; Furey M. J., 1997, LUBR SCI, V9, P255, DOI DOI 10.1002/IS.3010090303; GANZ R, 1988, CLIN ORTHOP RELAT R, P26; Groves D., 2015, THESIS; Groves D, 2017, DATA SET ASS IN VITR; Jia LZ, 2013, P I MECH ENG H, V227, P1284, DOI 10.1177/0954411913502156; Katta J, 2007, P I MECH ENG J-J ENG, V221, P175, DOI 10.1243/13506501JET240; Katta J, 2008, MED ENG PHYS, V30, P1349, DOI 10.1016/j.medengphy.2008.09.004; Leunig M, 2014, BONE JOINT J, V96B, P5, DOI 10.1302/0301-620X.96B1.32823; Li JY, 2014, MED ENG PHYS, V36, P1449, DOI 10.1016/j.medengphy.2014.05.014; Lizhang J., 2010, THESIS; Lubbeke A, 2007, J RHEUMATOL, V34, P394; MACIROWSKI T, 1994, J BIOMECH ENG-T ASME, V116, P10, DOI 10.1115/1.2895693; McCann L, 2008, TRIBOL INT, V41, P1126, DOI 10.1016/j.triboint.2008.03.012; McCarthy J, 2003, CLIN ORTHOP RELAT R, P38, DOI 10.1097/01.blo.0000043042.84315.17; McNary SM, 2012, TISSUE ENG PART B-RE, V18, P88, DOI [10.1089/ten.teb.2011.0394, 10.1089/ten.TEB.2011.0394]; Millis MB, 2002, CLIN ORTHOP RELAT R, P108, DOI 10.1097/01.blo.0000038465.05771.02; Mow VC, 1999, CLIN ORTHOP RELAT R, pS204, DOI 10.1097/00003086-199910001-00021; Nuki G, 1999, Z RHEUMATOL, V58, P142, DOI 10.1007/s003930050164; O'Kelly J., 1978, Engineering in Medicine, V7, P73, DOI 10.1243/EMED_JOUR_1978_007_022_02; Palastanga N, 2002, ANATOMY HUMAN MOVEME; Pawaskar SS, 2011, J BIOMECH, V44, P1536, DOI 10.1016/j.jbiomech.2011.02.140; PHILLIPS TW, 1989, J BONE JOINT SURG AM, V71A, P913, DOI 10.2106/00004623-198971060-00016; ROBERTS BJ, 1982, ANN RHEUM DIS, V41, P217, DOI 10.1136/ard.41.3.217; Roter GE, 2002, TRIBOL INTER ENG, V40, P367; Sarma AV, 2001, J ORTHOP RES, V19, P671, DOI 10.1016/S0736-0266(00)00064-4; SCHENAU GJV, 1993, ACTA ANAT, V146, P103, DOI 10.1159/000147429; Simulation Solutions Ltd, 2012, PROSIM FRICT SIM 3 H; Song Y, 2012, J BIOMECH, V45, P524, DOI 10.1016/j.jbiomech.2011.11.044; SWANN DA, 1974, ANN RHEUM DIS, V33, P318, DOI 10.1136/ard.33.4.318; Taylor SD, 2012, P I MECH ENG H, V226, P55, DOI 10.1177/0954411911428717; UNSWORTH A, 1975, J LUBRIC TECH-T ASME, V97, P369, DOI 10.1115/1.3452605; WALKER PS, 1968, ANN RHEUM DIS, V27, P512, DOI 10.1136/ard.27.6.512; Wang A, 1998, TRIBOL INT, V31, P17, DOI 10.1016/S0301-679X(98)00005-X; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6	50	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184226	10.1371/journal.pone.0184226	http://dx.doi.org/10.1371/journal.pone.0184226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886084	Green Published, gold			2022-12-27	WOS:000410001100085
J	Poninska, JK; Samolinski, B; Tomaszewska, A; Raciborski, F; Samel-Kowalik, P; Walkiewicz, A; Lipiec, A; Piekarska, B; Krzych-Falta, E; Namyslowski, A; Kostrzewa, G; Pawlik, A; Jasek, M; Wisniewski, A; Kusnierczyk, P; Majewski, S; Ploski, R				Poninska, Joanna Kinga; Samolinski, Boleslaw; Tomaszewska, Aneta; Raciborski, Filip; Samel-Kowalik, Piotr; Walkiewicz, Artur; Lipiec, Agnieszka; Piekarska, Barbara; Krzych-Falta, Edyta; Namyslowski, Andrzej; Kostrzewa, Grazyna; Pawlik, Andrzej; Jasek, Monika; Wisniewski, Andrzej; Kusnierczyk, Piotr; Majewski, Slawomir; Ploski, Rafal			Haplotype dependent association of rs7927894 (11q13.5) with atopic dermatitis and chronic allergic rhinitis: A study in ECAP cohort	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CHROMOSOME 11Q13.5; IDENTIFIES 4; METAANALYSIS; FILAGGRIN; VARIANTS; ECZEMA; POLYMORPHISM; DISEASE	The T allele of rs7927894 (at 11q13.5) was associated with atopic dermatitis and other allergic diseases. Our purpose was to replicate the association with allergic phenotypes and explore the role of rs7927894 in predisposing to persistent allergic rhinitis and atopic asthma. We also wanted to explore if other SNPs at 11q13.5 contributed to effect of rs7927894. We studied patients with atopic dermatitis (N = 270), atopic asthma (N = 486), persistent allergic rhinitis (N = 589) and controls matched for age, sex and region (N = 540, N = 372 and N = 1178, respectively). We found that rs7927894 T was associated with atopic dermatitis (OR = 1.39, CI:1.12-1.73, P = 0.003) and independently with persistent allergic rhinitis (OR = 1.24, CI:1.07-1.43, P = 0.0043, P-corrected = 0.013) but not atopic asthma. Analysis of additional tagging SNPs (rs7930763, rs2513517, rs7125552) showed that effect of rs7927894 T was limited to haplotypes encoding G at rs7125552. In conclusion, rs7927894 T is associated not only with atopic dermatitis but also persistent allergic rhinitis. Since these effects are haplotype dependent rs7927894 alone does not account for the association between 11q13.5 and atopic dermatitis/persistent allergic rhinitis.	[Poninska, Joanna Kinga] Inst Cardiol, Dept Med Biol, Warsaw, Poland; [Samolinski, Boleslaw; Tomaszewska, Aneta; Raciborski, Filip; Samel-Kowalik, Piotr; Walkiewicz, Artur; Lipiec, Agnieszka; Piekarska, Barbara; Krzych-Falta, Edyta; Namyslowski, Andrzej] Med Univ Warsaw, Dept Prevent Environm Hazards & Allergol, Warsaw, Poland; [Kostrzewa, Grazyna; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Pawlik, Andrzej] Pomeranian Med Univ, Dept Physiol, Szczecin, Poland; [Jasek, Monika; Wisniewski, Andrzej; Kusnierczyk, Piotr] Polish Acad Sci, Ludwik Hirszfeld Inst Immunol & Expt Therapy, Lab Immunogenet, Wroclaw, Poland; [Majewski, Slawomir] Med Univ Warsaw, Dept Dermatol & Venereol, Warsaw, Poland	Institute of Cardiology - Poland; Medical University of Warsaw; Medical University of Warsaw; Pomeranian Medical University; Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences; Medical University of Warsaw	Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.	rploski@wp.pl	Lipiec, Agnieszka/X-7523-2018; Piekarska, Barbara/AAJ-7354-2020; Tomaszewska, Aneta/X-8906-2018; Kusnierczyk, Piotr/ABB-6734-2020; Samel-Kowalik, Piotr/M-3239-2018	Lipiec, Agnieszka/0000-0003-3037-2326; Piekarska, Barbara/0000-0002-6800-7781; Tomaszewska, Aneta/0000-0001-6730-6352; Samel-Kowalik, Piotr/0000-0002-9047-0414; Jasek, Monika/0000-0001-6778-2615; Krzych-Falta, Edyta/0000-0002-9857-7136; Wisniewski, Andrzej/0000-0002-1919-2298; Raciborski, Filip/0000-0003-0562-0260; Pawlik, Andrzej/0000-0001-6557-1208; Kusnierczyk, Piotr/0000-0002-9224-8921; Poninska, Joanna/0000-0002-0890-611X; Ploski, Rafal/0000-0001-6286-5526	Ministry of Science and Higher Education [6 P05 2005 C/06572]; Medical University of Warsaw [1WY/NK1W/2009]; Ministry of Health; Polish Ministry of Science and Higher Education; Ministry of Health [6P052005C/06572]; Warsaw Medical University [1WY/NK1W/2009]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Medical University of Warsaw; Ministry of Health; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Ministry of Health; Warsaw Medical University	Funded by 6 P05 2005 C/06572 - Ministry of Science and Higher Education (http://www.nauka.gov.pl), Ministry of Health (http://www.mz.gov.pl/), 1WY/NK1W/2009 - Medical University of Warsaw (http://www.wum.edu.pl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financed by grants from Polish Ministry of Science and Higher Education, Ministry of Health grant No. 6P052005C/06572, and Warsaw Medical University grant No. 1WY/NK1W/2009.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Asthma. GIfAGSf, 2008, MAN PREV NHLBI WORKS; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baurecht H, 2007, J ALLERGY CLIN IMMUN, V120, P1406, DOI 10.1016/j.jaci.2007.08.067; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bousquet J, 2015, ALLERGY, V70, P1062, DOI 10.1111/all.12637; Bousquet J, 2012, J ALLERGY CLIN IMMUN, V130, P1049, DOI 10.1016/j.jaci.2012.07.053; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147; Dupont WD, 1997, CONTROL CLIN TRIALS, V18, P274, DOI 10.1016/S0197-2456(97)00074-3; Ellinghaus D, 2013, NAT GENET, V45, P808, DOI 10.1038/ng.2642; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garn H, 2007, IMMUNOBIOLOGY, V212, P441, DOI 10.1016/j.imbio.2007.03.006; Greisenegger EK, 2013, EUR J DERMATOL, V23, P142, DOI 10.1684/ejd.2013.1955; Hahn EL, 2005, IMMUNOL ALLERGY CLIN, V25, P231, DOI 10.1016/j.iac.2005.02.004; JM H, 1980, ACTA DERM-VENEREOL, P44; Kim KW, 2015, J ALLERGY CLIN IMMUN, V136, P678, DOI 10.1016/j.jaci.2015.03.030; Li XN, 2012, J ALLERGY CLIN IMMUN, V129, P575, DOI 10.1016/j.jaci.2011.09.040; Manz J, 2016, J INVEST DERMATOL, V136, P2380, DOI 10.1016/j.jid.2016.07.009; Marenholz I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9804; Nomura Y, 2010, J DERMATOL SCI, V59, P210, DOI 10.1016/j.jdermsci.2010.06.010; O'Regan GM, 2010, J ALLERGY CLIN IMMUN, V125, P170, DOI 10.1016/j.jaci.2009.10.046; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Pawlik A, 2007, TISSUE ANTIGENS, V70, P314, DOI 10.1111/j.1399-0039.2007.00908.x; Poninska J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016933; Probst-Kepper M, 2010, CURR MOL MED, V10, P533; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramasamy A, 2011, J ALLERGY CLIN IMMUN, V128, P996, DOI 10.1016/j.jaci.2011.08.030; Rodriguez E, 2009, J ALLERGY CLIN IMMUN, V123, P1361, DOI 10.1016/j.jaci.2009.03.036; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Sleiman PMA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6593; Spergel JM, 2010, IMMUNOL ALLERGY CLIN, V30, P269, DOI 10.1016/j.iac.2010.06.003; Tang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035334; van den Oord RAHM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2433	37	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183922	10.1371/journal.pone.0183922	http://dx.doi.org/10.1371/journal.pone.0183922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886043	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100045
J	Rangrez, AY; Hoppe, P; Kuhn, C; Zille, E; Frank, J; Frey, N; Frank, D				Rangrez, Ashraf Yusuf; Hoppe, Phillip; Kuhn, Christian; Zille, Elisa; Frank, Johanne; Frey, Norbert; Frank, Derk			MicroRNA miR-301a is a novel cardiac regulator of Cofilin-2	PLOS ONE			English	Article							KINASE KNOCKOUT MICE; DILATED CARDIOMYOPATHY; POSITION STATEMENT; TRANSGENIC MICE; RESPONSE FACTOR; WORKING GROUP; CALCINEURIN; HEART; DISRUPTION; EXPRESSION	Calsarcin-1 deficient mice develop dilated cardiomyopathy (DCM) phenotype in pure C57BL/6 genetic background (Cs1-ko) despite severe contractile dysfunction and robust activation of fetal gene program. Here we performed a microRNA microarray to identify the molecular causes of this cardiac phenotype that revealed the dysregulation of several microRNAs including miR-301a, which was highly downregulated in Cs1-ko mice compared to the wild-type littermates. Cofilin-2 (Cfl2) was identified as one of the potential targets of miR-301a using prediction databases, which we validated by luciferase assay and mutation of predicted binding sites. Furthermore, expression of miR-301a contrastingly regulated Cfl2 expression levels in neonatal rat ventricular cardiomyocytes (NRVCM). Along these lines, Cfl2 was significantly upregulated in Cs1-ko mice, indicating the physiological association between miR-301a and Cfl2 in vivo. Mechanistically, we found that Cfl2 activated serum response factor response element (SRF-RE) driven luciferase activity in neonatal rat cardiomyocytes and in C2C12 cells. Similarly, knockdown of miR-301a activated, whereas, its overexpression inhibited the SRF-RE driven luciferase activity, further strengthening physiological interaction between miR-301a and Cfl2. Interestingly, the expression of SRF and its target genes was strikingly increased in Cs1-ko suggesting a possible in vivo correlation between expression levels of Cfl2/miR-301a and SRF activation, which needs to be independently validated. In summary, our data demonstrates that miR-301a regulates Cofilin-2 in vitro in NRVCM, and in vivo in Cs1-ko mice. Our findings provide an additional and important layer of Cfl2 regulation, which we believe has an extended role in cardiac signal transduction and dilated cardiomyopathy presumably due to the reported involvement of Cfl2 in these mechanisms.	[Rangrez, Ashraf Yusuf; Hoppe, Phillip; Kuhn, Christian; Zille, Elisa; Frank, Johanne; Frey, Norbert; Frank, Derk] Univ Med Ctr Kiel, Dept Internal Med Cardiol Angiol Intens Care 3, Kiel, Germany; [Rangrez, Ashraf Yusuf; Kuhn, Christian; Frey, Norbert; Frank, Derk] DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; German Centre for Cardiovascular Research	Frank, D (corresponding author), Univ Med Ctr Kiel, Dept Internal Med Cardiol Angiol Intens Care 3, Kiel, Germany.; Frank, D (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Kiel, Germany.	derk.frank@uksh.de	Rangrez, Ashraf/H-4988-2016; Frey, Norbert/M-7749-2019; Frey, Norbert/A-9695-2010	Rangrez, Ashraf/0000-0003-2630-9754; Frey, Norbert/0000-0001-7611-378X; 	Federal Ministry for Education and Research (BMBF); German Research Foundation (DFG) [FR2554-2]; German Centre for Cardiovascular Research (DZHK); Federal Ministry for Education and Research (eMed SYMBOL-HF)	Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); German Centre for Cardiovascular Research (DZHK); Federal Ministry for Education and Research (eMed SYMBOL-HF)	This work is funded by Federal Ministry for Education and Research (BMBF; eMed SYMBOL-HF, to DF; https://www.bmbf.de/en/), German Research Foundation (DFG; FR2554-2 to DF and NF; www.dfg.de/en/), and support from German Centre for Cardiovascular Research (DZHK; AYR, NF and DF; https://dzhk.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge excellent technical assistance from K. Stiebeling and L. Christen. This work is funded by Federal Ministry for Education and Research (BMBF; eMed SYMBOL-HF, to DF), German Research Foundation (DFG; FR2554-2 to DF and NF), and support from German Centre for Cardiovascular Research (DZHK; AYR, NF and DF).	Agrawal PB, 2012, HUM MOL GENET, V21, P2341, DOI 10.1093/hmg/dds053; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Bamburg James R, 2010, F1000 Biol Rep, V2, P62, DOI 10.3410/B2-62; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bernardo BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090337; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Bueno OF, 2002, CARDIOVASC RES, V53, P806, DOI 10.1016/S0008-6363(01)00493-X; Cakmak HA, 2015, J CARDIOVASC MED, V16, P431, DOI 10.2459/JCM.0000000000000233; Cengiz M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000693; Cui L, 2016, CELL PHYSIOL BIOCHEM, V40, P230, DOI 10.1159/000452540; Damodaran C, 2016, UROL ONCOL, V34, P336, DOI DOI 10.1016/J.UR0L0NC.2016.03.009; Dansky HM, 1999, ARTERIOSCL THROM VAS, V19, P1960, DOI 10.1161/01.ATV.19.8.1960; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; EBERWINE J, 1992, P NATL ACAD SCI USA, V89, P3010, DOI 10.1073/pnas.89.7.3010; El-Armouche A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014263; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Frank D, 2007, CIRCULATION, V116, P2587, DOI 10.1161/CIRCULATIONAHA.107.711317; Frank D, 2014, J MOL CELL CARDIOL, V72, P196, DOI 10.1016/j.yjmcc.2014.03.016; Frank D, 2011, J BIOL CHEM, V286, P9897, DOI 10.1074/jbc.R110.174268; Frey N, 2004, NAT MED, V10, P1336, DOI 10.1038/nm1132; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Grueter CE, 2012, CELL, V149, P671, DOI 10.1016/j.cell.2012.03.029; Gurniak CB, 2014, EUR J CELL BIOL, V93, P252, DOI 10.1016/j.ejcb.2014.01.007; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; Heineke J, 2010, J MOL CELL CARDIOL, V48, P1080, DOI 10.1016/j.yjmcc.2009.10.012; Hodgkinson CP, 2015, CIRC RES, V116, P1700, DOI 10.1161/CIRCRESAHA.116.304377; Kamps JAAM, 2016, WORLD J CARDIOL, V8, P163, DOI 10.4330/wjc.v8.i2.163; Kiper C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070512; Kremneva E, 2014, DEV CELL, V31, P215, DOI 10.1016/j.devcel.2014.09.002; Lakdawala NK, 2013, CIRC-ARRHYTHMIA ELEC, V6, P228, DOI 10.1161/CIRCEP.111.962050; Lee TM, 2014, J MOL MED, V92, P43, DOI 10.1007/s00109-013-1103-4; Li D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106318; Li QL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148480; Liu XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160920; Luk A, 2009, J CLIN PATHOL, V62, P219, DOI 10.1136/jcp.2008.060731; Lygate CA, 2009, J MOL CELL CARDIOL, V46, P93, DOI 10.1016/j.yjmcc.2008.09.710; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Nahrendorf M, 2005, CARDIOVASC RES, V65, P419, DOI 10.1016/j.cardiores.2004.10.006; Ni Z, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027807; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Philippen LE, 2015, MOL THER, V23, P1810, DOI 10.1038/mt.2015.133; Pinto YM, 2016, EUR HEART J, V37, P1850, DOI 10.1093/eurheartj/ehv727; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rangrez AY, 2017, BBA-MOL CELL RES, V1864, P634, DOI 10.1016/j.bbamcr.2017.01.004; Rangrez AY, 2016, J BIOL CHEM, V291, P4128, DOI 10.1074/jbc.M115.689620; Rangrez AY, 2013, J CELL BIOL, V203, P643, DOI 10.1083/jcb.201303052; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rustagi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139359; Sanford LP, 2000, METH MOL B, V158, P217; Schoensiegel F, 2007, COMPARATIVE MED, V57, P546; Schulte C, 2015, CARDIOVASC DIAGN THE, V5, P17, DOI 10.3978/j.issn.2223-3652.2014.12.03; Subramanian K, 2015, J AM COLL CARDIOL, V65, P1199, DOI 10.1016/j.jacc.2015.01.031; Thirion C, 2001, EUR J BIOCHEM, V268, P3473, DOI 10.1046/j.1432-1327.2001.02247.x; Thum T, 2012, EMBO MOL MED, V4, P3, DOI 10.1002/emmm.201100191; van Empel VPM, 2012, CURR HYPERTENS REP, V14, P498, DOI 10.1007/s11906-012-0310-7; Vartiainen MK, 2002, MOL BIOL CELL, V13, P183, DOI 10.1091/mbc.01-07-0331; Wang W, 2016, MED SCI MONITOR, V22, P2126, DOI 10.12659/MSM.896832; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zhu HJ, 2015, AM J TRANSL RES, V7, P2661	65	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183901	10.1371/journal.pone.0183901	http://dx.doi.org/10.1371/journal.pone.0183901			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886070	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100044
J	Hwang, JH; An, SM; Kwon, S; Park, DH; Kim, TW; Kang, DG; Yu, GE; Kim, IS; Park, HC; Ha, J; Kim, CW				Hwang, Jung Hye; An, Sang Mi; Kwon, Seulgi; Park, Da Hye; Kim, Tae Wan; Kang, Deok Gyeong; Yu, Go Eun; Kim, Il-Suk; Park, Hwa Chun; Ha, Jeongim; Kim, Chul Wook			DNA methylation patterns and gene expression associated with litter size in Berkshire pig placenta	PLOS ONE			English	Article							BODY-SPECIFIC METHYLATION; CL-CURRENTS; EFFICIENCY; SELECTION; SWINE; HYPOMETHYLATION; PRODUCTIVITY; METABOLISM; PROMOTER; ENZYMES	Increasing litter size is of great interest to the pig industry. DNA methylation is an important epigenetic modification that regulates gene expression, resulting in livestock phenotypes such as disease resistance, milk production, and reproduction. We classified Berkshire pigs into two groups according to litter size and estimated breeding value: smaller (SLG) and larger (LLG) litter size groups. Genome-wide DNA methylation and gene expression were analyzed using placenta genomic DNA and RNA to identify differentially methylated regions (DMRs) and differentially expressed genes (DEGs) associated with litter size. The methylation levels of CpG dinucleotides in different genomic regions were noticeably different between the groups, while global methylation pattern was similar, and excluding intergenic regions they were found the most frequently in gene body regions. Next, we analyzed RNA-Seq data to identify DEGs between the SLG and LLG groups. A total of 1591 DEGs were identified: 567 were downregulated and 1024 were upregulated in LLG compared to SLG. To identify genes that simultaneously exhibited changes in DNA methylation and mRNA expression, we integrated and analyzed the data from bisulfite-Seq and RNA-Seq. Nine DEGs positioned in DMRs were found. The expression of only three of these genes (PRKG2, CLCA4, and PCK1) was verified by RT-qPCR. Furthermore, we observed the same methylation patterns in blood samples as in the placental tissues by PCR-based methylation analysis. Together, these results provide useful data regarding potential epigenetic markers for selecting hyperprolific sows.	[Hwang, Jung Hye; An, Sang Mi; Kwon, Seulgi; Park, Da Hye; Kim, Tae Wan; Kang, Deok Gyeong; Yu, Go Eun; Ha, Jeongim; Kim, Chul Wook] Gyeongnam Natl Univ Sci & Technol, Swine Sci & Technol Ctr, Jinju, South Korea; [Kim, Il-Suk] Gyeongnam Natl Univ Sci & Technol, Dept Anim Resource Technol, Jinju, South Korea; [Park, Hwa Chun] Dasan Pig Breeding Co, Namwon, South Korea	Gyeongnam National University of Science and Technology; Gyeongnam National University of Science and Technology	Ha, J; Kim, CW (corresponding author), Gyeongnam Natl Univ Sci & Technol, Swine Sci & Technol Ctr, Jinju, South Korea.	jiha@gntech.ac.kr; cwkim@gntech.ac.kr			Priority Research Centers Program through the National Research Foundation of Korea (NRF) [20090093813, 313012-05]; Gyeongnam National University of Science and Technology	Priority Research Centers Program through the National Research Foundation of Korea (NRF); Gyeongnam National University of Science and Technology	This study was supported by grants from the Priority Research Centers Program (no. 20090093813) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, from the Export Promotion Technology Development Program (no. 313012-05) of Ministry of Food, Agriculture, Forestry and Fisheries, Republic of Korea, and from Gyeongnam National University of Science and Technology Grant 2016. The Dasan Pig Breeding Co. provided support in the form of a salary for author HCP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Angermann JE, 2006, J GEN PHYSIOL, V128, P73, DOI 10.1085/jgp.200609507; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Bai Y, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-736, 10.1186/1471-2164-15-653]; Ball MP, 2009, NAT BIOTECHNOL, V27, P8; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Calicchio R, 2014, CURR PHARM DESIGN, V20, P1726, DOI 10.2174/13816128113199990517; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Congras A, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119610; Coster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031825; DIAMANT YZ, 1976, ISRAEL J MED SCI, V12, P243; DIAMANT YZ, 1975, AM J OBSTET GYNECOL, V121, P58, DOI 10.1016/0002-9378(75)90975-8; Distl O, 2007, REPROD DOMEST ANIM, V42, P10, DOI 10.1111/j.1439-0531.2007.00887.x; FABER JJ, 1992, AM ZOOL, V32, P343; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Freking BA, 2016, ANIM REPROD SCI, V167, P16, DOI 10.1016/j.anireprosci.2016.01.018; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hofmann Franz, 2013, Methods Mol Biol, V1020, P17, DOI 10.1007/978-1-62703-459-3_2; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kulis M, 2013, BBA-GENE REGUL MECH, V1829, P1161, DOI 10.1016/j.bbagrm.2013.08.001; Kushwaha G, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0071-5; Kwon SG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153311; Kwong WY, 2007, MOL REPROD DEV, V74, P48, DOI 10.1002/mrd.20606; Lande-Diner L, 2005, NAT REV GENET, V6, P648, DOI 10.1038/nrg1639; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee DG, 2015, BIOSCI BIOTECH BIOCH, V79, P1414, DOI 10.1080/09168451.2015.1039478; Li C, 2007, PLACENTA, V28, P1200, DOI 10.1016/j.placenta.2007.06.011; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lou SK, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0408-0; Mesa H, 2003, J ANIM SCI, V81, P74; Mesa H, 2005, J ANIM SCI, V83, P983; Messerschmidt DM, 2014, GENE DEV, V28, P812, DOI 10.1101/gad.234294.113; Park SJ, 2015, GENE, V558, P152, DOI 10.1016/j.gene.2014.12.052; Plog S, 2012, J HISTOCHEM CYTOCHEM, V60, P45, DOI 10.1369/0022155411426455; Quinton VM, 2006, LIVEST SCI, V99, P69, DOI 10.1016/j.livprodsci.2005.06.002; Rozance PJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE365, DOI 10.1152/ajpendo.00639.2007; Sergeant GP, 2001, J UROLOGY, V166, P1161, DOI 10.1016/S0022-5347(05)65939-3; Singer M, 2015, NUCLEIC ACIDS RES, V43, P3498, DOI 10.1093/nar/gkv153; Singh K, 2012, ANIMAL, V6, P375, DOI 10.1017/S1751731111002564; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Stevenson TJ, 2013, P NATL ACAD SCI USA, V110, P16651, DOI 10.1073/pnas.1310643110; Su JZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks829; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Vaandrager AB, 1997, J BIOL CHEM, V272, P11816, DOI 10.1074/jbc.272.18.11816; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; von der Weid PY, 2008, AM J PHYSIOL-HEART C, V295, pH1989, DOI 10.1152/ajpheart.00007.2008; Wang Y, 2010, C SERIES INTEGRATED; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wilson ME, 2001, J REP FER S, P223; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366; Zhang XY, 2014, J ASSIST REPROD GEN, V31, P1511, DOI 10.1007/s10815-014-0320-2; ZhuGe RH, 1998, J PHYSIOL-LONDON, V513, P711, DOI 10.1111/j.1469-7793.1998.711ba.x	56	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184539	10.1371/journal.pone.0184539	http://dx.doi.org/10.1371/journal.pone.0184539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880934	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200075
J	Bentley, SJ; Boshoff, A				Bentley, Stephen J.; Boshoff, Aileen			Hsp70/J-protein machinery from Glossina morsitans morsitans, vector of African trypanosomiasis	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; EXTENDS LIFE-SPAN; ER DNAJ HOMOLOG; ENDOPLASMIC-RETICULUM; DROSOPHILA-MELANOGASTER; TSETSE-FLIES; MOLECULAR CHAPERONES; MEMBRANE ASSOCIATION; SLEEPING SICKNESS; HSP70 CHAPERONES	Tsetse flies (Glossina spp.) are the sole vectors of the protozoan parasites of the genus Trypanosoma, the causative agents of African Trypanosomiasis. Species of Glossina differ in vector competence and Glossina morsitans morsitans is associated with transmission of Trypanosoma brucei rhodesiense, which causes an acute and often fatal form of African Trypanosomiasis. Heat shock proteins are evolutionarily conserved proteins that play critical roles in proteostasis. The activity of heat shock protein 70 (Hsp70) is regulated by interactions with its J-protein (Hsp40) co-chaperones. Inhibition of these interactions are emerging as potential therapeutic targets. The assembly and annotation of the G. m. morsitans genome provided a platform to identify and characterize the Hsp70s and J-proteins, and carry out an evolutionary comparison to its well-studied eukaryotic counterparts, Drosophila melanogaster and Homo sapiens, as well as Stomoxys calcitrans, a comparator species. In our study, we identified 9 putative Hsp70 proteins and 37 putative J-proteins in G. m. morsitans. Phylogenetic analyses revealed three evolutionarily distinct groups of Hsp70s, with a closer relationship to orthologues from its blood-feeding dipteran relative Stomoxys calcitrans. G. m. morsitans also lacked the high number of heat inducible Hsp70s found in D. melanogaster. The potential localisations, functions, domain organisations and Hsp70/J-protein partnerships were also identified. A greater understanding of the heat shock 70 (Hsp70) and J-protein (Hsp40) families in G. m. morsitans could enhance our understanding of the cell biology of the tsetse fly.	[Bentley, Stephen J.; Boshoff, Aileen] Rhodes Univ, Biotechnol Innovat Ctr, Grahamstown, South Africa	Rhodes University	Boshoff, A (corresponding author), Rhodes Univ, Biotechnol Innovat Ctr, Grahamstown, South Africa.	A.Boshoff@ru.ac.za			National Research Foundation (NRF) [87663]; NRF	National Research Foundation (NRF); NRF	This work was funded by a grant from the National Research Foundation (NRF); grant number 87663. S.J.B. is the recipient of an NRF Doctoral Innovation Scholarship.	Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Ahrendt E, 2010, CHANNELS, V4, P335, DOI 10.4161/chan.4.5.13090; Aksoy S, 2003, VET PARASITOL, V115, P125, DOI 10.1016/S0304-4017(03)00203-6; Alsan M, 2015, AM ECON REV, V105, P382, DOI 10.1257/aer.20130604; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assimon VA, 2013, CURR PHARM DESIGN, V19, P404; Baaklini I, 2012, J BIOL CHEM, V287, P41939, DOI 10.1074/jbc.M112.413278; Barrett MP, 2012, BRIT MED BULL, V104, P175, DOI 10.1093/bmb/lds031; Benoit JB, 2015, ANNU REV ENTOMOL, V60, P351, DOI 10.1146/annurev-ento-010814-020834; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Bronk P, 2005, J NEUROSCI, V25, P2204, DOI 10.1523/JNEUROSCI.3610-04.2005; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Brychzy A, 2003, EMBO J, V22, P3613, DOI 10.1093/emboj/cdg362; Burgoyne RD, 2015, SEMIN CELL DEV BIOL, V40, P153, DOI 10.1016/j.semcdb.2015.03.008; Cheetham ME, 1998, CELL STRESS CHAPERON, V3, P28, DOI 10.1379/1466-1268(1998)003<0028:SFAEOD>2.3.CO;2; Chevalier M, 2000, J BIOL CHEM, V275, P19620, DOI 10.1074/jbc.M001333200; Choi J, 2014, CELL STRESS CHAPERON, V19, P439, DOI 10.1007/s12192-013-0471-6; Christoffels A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003024; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Colinet H, 2013, INSECT BIOCHEM MOLEC, V43, P352, DOI 10.1016/j.ibmb.2013.01.006; CRAIG EA, 1983, DEV BIOL, V99, P418, DOI 10.1016/0012-1606(83)90291-9; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; dos Santos G, 2015, NUCLEIC ACIDS RES, V43, pD690, DOI 10.1093/nar/gku1099; Doumanis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007275; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Edwards KM, 2004, ONCOGENE, V23, P8419, DOI 10.1038/sj.onc.1207732; Elefant F, 1999, MOL BIOL CELL, V10, P2101, DOI 10.1091/mbc.10.7.2101; Fan CY, 2005, J BIOL CHEM, V280, P695, DOI 10.1074/jbc.M410645200; Feder ME, 1998, AM ZOOL, V38, P503; Fitzsimons HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083903; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Fogg PCM, 2014, J BIOL CHEM, V289, P34341, DOI 10.1074/jbc.M114.606392; Freeman BC, 1996, EMBO J, V15, P2969, DOI 10.1002/j.1460-2075.1996.tb00660.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gillis J, 2013, J BIOL CHEM, V288, P17225, DOI 10.1074/jbc.M112.421685; Giraldo-Calderon GI, 2015, NUCLEIC ACIDS RES, V43, pD707, DOI 10.1093/nar/gku1117; Girard M, 2005, J BIOL CHEM, V280, P40135, DOI 10.1074/jbc.M505036200; Girard M, 2008, FEBS LETT, V582, P961, DOI 10.1016/j.febslet.2008.02.042; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Gooding RH, 2005, ANNU REV ENTOMOL, V50, P101, DOI 10.1146/annurev.ento.50.071803.130443; Goodman AG, 2011, VIROLOGY, V417, P27, DOI 10.1016/j.virol.2011.04.020; Gray YHM, 2000, TRENDS GENET, V16, P461, DOI 10.1016/S0168-9525(00)02104-1; Guan J, 2008, MOL REPROD DEV, V75, P1379, DOI 10.1002/mrd.20874; Guo F, 2013, J CELL SCI, V126, P1429, DOI 10.1242/jcs.118182; GUPTA RS, 1994, CURR BIOL, V4, P1104, DOI 10.1016/S0960-9822(00)00249-9; Han CF, 2007, BIOCHEM BIOPH RES CO, V353, P280, DOI 10.1016/j.bbrc.2006.12.013; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hennessy F, 2005, PROTEIN SCI, V14, P1697, DOI 10.1110/ps.051406805; Hoglund A, 2006, BIOINFORMATICS, V22, P1158, DOI 10.1093/bioinformatics/btl002; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Hu C, 2012, PLANT PHYSIOL, V158, P747, DOI 10.1104/pp.111.187674; HUNT C, 1985, P NATL ACAD SCI USA, V82, P6455, DOI 10.1073/pnas.82.19.6455; Iliopoulos I, 1997, BIOL CHEM, V378, P1177; INGOLIA TD, 1982, P NATL ACAD SCI-BIOL, V79, P525, DOI 10.1073/pnas.79.2.525; Iosefson O, 2012, CELL STRESS CHAPERON, V17, P57, DOI 10.1007/s12192-011-0285-3; Jin Y, 2009, BIOCHEMISTRY-US, V48, P41, DOI 10.1021/bi8015923; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kampinga HH, 2009, CELL STRESS CHAPERON, V14, P105, DOI 10.1007/s12192-008-0068-7; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Kaschner LA, 2015, BBA-MOL CELL RES, V1853, P1035, DOI 10.1016/j.bbamcr.2015.01.014; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; KITTEN GT, 1991, J CELL BIOL, V113, P13, DOI 10.1083/jcb.113.1.13; Krafsur ES, 2009, INFECT GENET EVOL, V9, P124, DOI 10.1016/j.meegid.2008.09.010; Kroczynska B, 2004, J BIOL CHEM, V279, P11432, DOI 10.1074/jbc.M310903200; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuo Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.351; KURZIKDUMKE U, 1995, DEV GENET, V16, P64, DOI 10.1002/dvg.1020160110; Lakhotia SC, 2002, J EXP BIOL, V205, P345; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LEAK SGA, 1999, TSETSE BIOL ECOLOGY; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Li WN, 2014, BMC DEV BIOL, V14, DOI 10.1186/s12861-014-0038-5; LIM JK, 1994, BIOESSAYS, V16, P269, DOI 10.1002/bies.950160410; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lindquist S., 1993, TRANSLATIONAL REGULA; Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004; Lo JF, 2004, MOL CELL BIOL, V24, P2226, DOI 10.1128/MCB.24.6.2226-2236.2004; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; Matetovici I, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3283-0; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; McAlpine JF, 1989, MONOGRAPH, V3, P1397; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Nikolaidis N, 2004, MOL BIOL EVOL, V21, P498, DOI 10.1093/molbev/msh041; Niu G, 2015, J BIOL CHEM, V290, P18102, DOI 10.1074/jbc.M115.665950; Odiit M, 1997, E AFR MED J, V74, P792; Oka SI, 2009, J MOL MED, V87, P785, DOI 10.1007/s00109-009-0471-2; Otto H, 2005, P NATL ACAD SCI USA, V102, P10064, DOI 10.1073/pnas.0504400102; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rampelt H, 2011, METHODS MOL BIOL, V787, P83, DOI 10.1007/978-1-61779-295-3_7; Rogers David J., 2004, P139, DOI 10.1079/9780851994758.0139; Rosales-Hernandez A, 2009, CELL STRESS CHAPERON, V14, P71, DOI 10.1007/s12192-008-0056-y; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Severson DW, 2004, INSECT BIOCHEM MOLEC, V34, P715, DOI 10.1016/j.ibmb.2004.03.024; Shen Y, 2002, J BIOL CHEM, V277, P15947, DOI 10.1074/jbc.M112214200; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Sigrist CJA, 2010, NUCLEIC ACIDS RES, V38, pD161, DOI 10.1093/nar/gkp885; Simarro PP, 2008, PLOS MED, V5, P174, DOI 10.1371/journal.pmed.0050055; Skowronek MH, 1999, BIOL CHEM, V380, P1133, DOI 10.1515/BC.1999.142; Sopha P, 2012, CELL STRUCT FUNCT, V37, P177, DOI 10.1247/csf.12017; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Stetina T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128976; Stocker AJ, 2012, G3-GENES GENOM GENET, V2, P287, DOI 10.1534/g3.111.001354; Telleria EL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002649; Terada K, 2005, EMBO J, V24, P611, DOI 10.1038/sj.emboj.7600549; Terada K, 2010, J BIOL CHEM, V285, P16789, DOI 10.1074/jbc.M110.101501; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Uhrigshardt H, 2010, HUM MOL GENET, V19, P3816, DOI 10.1093/hmg/ddq301; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Watanabe J, 2014, SCIENCE, V344, P380, DOI 10.1126/science.1249656; Waterhouse RM, 2008, INSECT MOL BIOL, V17, P1, DOI 10.1111/j.1365-2583.2008.00772.x; Welburn SC, 2009, PARASITOLOGY, V136, P1943, DOI 10.1017/S0031182009006416; Whitaker R, 2013, AGING-US, V5, P682, DOI 10.18632/aging.100599; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052; Yan W, 2002, P NATL ACAD SCI USA, V99, P15920, DOI 10.1073/pnas.252341799; Yu HY, 2015, FEBS LETT, V589, P2825, DOI 10.1016/j.febslet.2015.07.040; Yu M, 2000, J BIOL CHEM, V275, P24984, DOI 10.1074/jbc.M000739200; Zahn M, 2013, J MOL BIOL, V425, P2463, DOI 10.1016/j.jmb.2013.03.041; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013; ZHU JK, 1993, P NATL ACAD SCI USA, V90, P8557, DOI 10.1073/pnas.90.18.8557	133	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183858	10.1371/journal.pone.0183858	http://dx.doi.org/10.1371/journal.pone.0183858			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902917	Green Submitted, Green Published, gold			2022-12-27	WOS:000410669200021
J	Cai, NL; Lau, ATY; Yu, FY; Wu, DD; Dai, LJ; Mo, HY; Lin, CM; Xu, YM				Cai, Na-Li; Lau, Andy T. Y.; Yu, Fei-Yuan; Wu, Dan-Dan; Dai, Li-Juan; Mo, Hai-Ying; Lin, Chang-Min; Xu, Yan-Ming			Purification and characterization of a highly specific polyclonal antibody against human extracellular signal-regulated kinase 8 and its detection in lung cancer	PLOS ONE			English	Article							PROTEIN MAP KINASE; ERK8; PHOSPHORYLATION; ACTIVATION	Extracellular signal-regulated kinase 8 (ERK8), proposed as a novel potential therapeutic target for cancer, has been implicated in cell transformation, apoptosis, the protection of genomic integrity, and autophagy. To facilitate ERK8 research, a highly specific anti-ERK8 antibody is needed. In this article, we use the Immune Epitope Database and Analysis Resource online tool to predict B-cell epitopes of human ERK8 protein, and choose a 28 aa-peptide sequence to generate the GST-ERK8(28aa) fusion protein as the antigen for developing polyclonal antibody against ERK8. The specificity and sensitivity of anti-ERK8 antibody were robustly validated by immunoblotting, immunocytochemical and immunohistochemical analyses; and we found that both the endogenous and ectopically-expressed human ERK8 proteins can be recognized by our anti-ERK8 antibody. This suggested that our characterized anti-ERK8 antibody will be a valuable tool for the elucidation of the distribution of ERK8 at cellular and histological levels. Finally, our tissue array analysis also demonstrated that the ERK8 protein was localized in both the nucleus and cytoplasm of human lung cancers.	[Cai, Na-Li; Lau, Andy T. Y.; Yu, Fei-Yuan; Wu, Dan-Dan; Dai, Li-Juan; Mo, Hai-Ying; Xu, Yan-Ming] Shantou Univ, Med Coll, Dept Cell Biol & Genet, Lab Canc Biol & Epigenet, Shantou, Guangdong, Peoples R China; [Lin, Chang-Min] Shantou Univ, Med Coll, Dept Histol & Embryol, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University	Xu, YM (corresponding author), Shantou Univ, Med Coll, Dept Cell Biol & Genet, Lab Canc Biol & Epigenet, Shantou, Guangdong, Peoples R China.	amyymxu@stu.edu.cn	Lau, Andy Tao Yin/AAX-9980-2021	Lau, Andy Tao Yin/0000-0002-7146-7789; Xu, Yan-Ming/0000-0003-1124-0045; Wu, Dan-Dan/0000-0002-8515-2614	National Natural Science Foundation of China [31271445, 31771582]; Science and Technology Planning Project of Guangdong Province of China [2016A020215144]; Guangdong Natural Science Foundation of China [2017A030313131, S2012030006289]; "Thousand, hundred, and ten" project of The Department of Education of Guangdong Province [124]; Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province of China; Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); "Thousand, hundred, and ten" project of The Department of Education of Guangdong Province; Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases	This work was supported by the grants from the National Natural Science Foundation of China (Nos. 31271445 and 31771582), the Science and Technology Planning Project of Guangdong Province of China (No. 2016A020215144), the Guangdong Natural Science Foundation of China (Nos. 2017A030313131 and S2012030006289), "Thousand, hundred, and ten" project of The Department of Education of Guangdong Province (No.124), and the Department of Education, Guangdong Government under the Top-tier University Development Scheme for Research and Control of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe MK, 2002, J BIOL CHEM, V277, P16733, DOI 10.1074/jbc.M112483200; Bogoyevitch MA, 2004, CELL SIGNAL, V16, P1345, DOI 10.1016/j.cellsig.2004.05.004; Cerone MA, 2011, CANCER RES, V71, P3328, DOI 10.1158/0008-5472.CAN-10-2734; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Colecchia D, 2012, AUTOPHAGY, V8, P1724, DOI 10.4161/auto.21857; Groehler AL, 2010, J CELL BIOL, V190, P575, DOI 10.1083/jcb.201002124; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; Klevernic IV, 2006, BIOCHEM J, V394, P365, DOI 10.1042/BJ20051288; Klevernic IV, 2009, FEBS LETT, V583, P680, DOI 10.1016/j.febslet.2009.01.011; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Peters B, 2005, PLOS BIOL, V3, P379, DOI 10.1371/journal.pbio.0030091; Rossi M, 2011, J BIOL CHEM, V286, P8507, DOI 10.1074/jbc.M110.179523; Saelzler MP, 2006, J BIOL CHEM, V281, P16821, DOI 10.1074/jbc.M512418200; Wu DD, 2017, ONCOTARGET; Xu YM, 2010, CANCER RES, V70, P3218, DOI 10.1158/0008-5472.CAN-09-4306	15	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184755	10.1371/journal.pone.0184755	http://dx.doi.org/10.1371/journal.pone.0184755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902877	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200062
J	Keating, SM; Dodge, JL; Norris, PJ; Heitman, J; Gange, SJ; French, AL; Glesby, MJ; Edlin, BR; Latham, PS; Villacres, MC; Greenblatt, RM; Peters, MG				Keating, Sheila M.; Dodge, Jennifer L.; Norris, Philip J.; Heitman, John; Gange, Stephen J.; French, Audrey L.; Glesby, Marshall J.; Edlin, Brian R.; Latham, Patricia S.; Villacres, Maria C.; Greenblatt, Ruth M.; Peters, Marion G.		Women's Interagency HIV Study	The effect of HIV infection and HCV viremia on inflammatory mediators and hepatic injury-The Women's Interagency HIV Study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SIMPLE NONINVASIVE INDEX; C-VIRUS; LIVER FIBROSIS; T-LYMPHOCYTES; CHEMOKINES; PERSISTENCE; DISEASE; RECRUITMENT; MORTALITY	Hepatitis C virus infection induces inflammation and while it is believed that HIV co-infection enhances this response, HIV control may reduce inflammation and liver fibrosis in resolved or viremic HCV infection. Measurement of systemic biomarkers in co-infection could help define the mechanism of inflammation on fibrosis and determine if HIV control reduces liver pathology. A nested case-control study was performed to explore the relationship of systemic biomarkers of inflammation with liver fibrosis in HCV viremic and/or seropositive women with and without HIV infection. Serum cytokines, chemokines, growth factors and cell adhesion molecules were measured in HIV uninfected (HIV-, n = 18), ART-treated HIVcontrolled (ARTc, n = 20), uncontrolled on anti-retroviral therapy (ARTuc, n = 21) and elite HIV controllers (Elite, n = 20). All were HCV seroreactive and had either resolved (HCV RNA-; <50IU/mL) or had chronic HCV infection (HCV RNA+). In HCV and HIV groups, aspartate aminotransferase to platelet ratio (APRI) was measured and compared to serum cytokines, chemokines, growth factors and cell adhesion molecules. APRI correlated with sVCAM, sICAM, IL-10, and IP-10 levels and inversely correlated with EGF, IL-17, TGF-alpha and MMP-9 levels. Collectively, all HCV RNA+ subjects had higher sVCAM, sICAM and IP-10 compared to HCV RNA-. In the ART-treated HCV RNA+ groups, TNF-alpha, GRO, IP-10, MCP-1 and MDC were higher than HIV-, Elite or both. In ARTuc, FGF-2, MPO, soluble Eselectin, MMP-9, IL-17, GM-CSF and TGF-alpha are lower than HIV-, Elite or both. Differential expression of soluble markers may reveal mechanisms of pathogenesis or possibly reduction of fibrosis in HCV/HIV co-infection.	[Keating, Sheila M.; Norris, Philip J.; Heitman, John] Blood Syst Res Inst, San Francisco, CA 94118 USA; [Keating, Sheila M.; Norris, Philip J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Dodge, Jennifer L.] UCSF, Dept Surg, San Francisco, CA USA; [Norris, Philip J.; Peters, Marion G.] UCSF, Dept Med, San Francisco, CA USA; [Gange, Stephen J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [French, Audrey L.] John H Stroger Jr Hosp Cook Cty, CORE Ctr, Chicago, IL USA; [Glesby, Marshall J.; Edlin, Brian R.] Weill Cornell Med Coll, Dept Med, Div Infect Dis, New York, NY USA; [Edlin, Brian R.] SUNY Downstate, Dept Med, Brooklyn, NY USA; [Latham, Patricia S.] George Washington Univ, Med Ctr, Dept Pathol & Med, Washington, DC 20037 USA; [Villacres, Maria C.] Univ Southern Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Greenblatt, Ruth M.] Univ Calif San Francisco, Dept Pharmacol, San Francisco, CA USA	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; George Washington University; University of Southern California; University of California System; University of California San Francisco	Keating, SM (corresponding author), Blood Syst Res Inst, San Francisco, CA 94118 USA.; Keating, SM (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	skeating@bloodsystems.org	Dodge, Jennifer/AAY-2530-2020; Edlin, Brian R/F-2966-2018; Gange, Stephen/AGY-5004-2022	Edlin, Brian R/0000-0001-8172-8797; Gange, Stephen/0000-0001-7842-512X; Keating, Sheila/0000-0002-8324-3694	National Institutes of Health; UCSF Liver Center [P30 DK026743]; National Institute of Allergy and Infectious Diseases [U01-A1-35004, U01-Al 31834, U01-A1-34994, U01-A1-34989, U01-Al 34993, U01-A1-42590]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01-HD-32632]; National Cancer Institute; National Institute on Drug Abuse; National Institute on Deafness and Other Communication Disorders; National Center for Research Resources (UCSF-CTSI) [UL1 RR024131]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI034989, U01AI031834, U01AI034993, U01AI034994, P30AI027763, U01AI035004, U01AI042590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Liver Center; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Research Resources (UCSF-CTSI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health provided funding to establish the Chicago Early HIV Infection Study. This work was also supported by the Biostatistics Core of the UCSF Liver Center (P30 DK026743). Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS) Collaborative Study Group with centers (Principal Investigators) at New York City/Bronx Consortium (Kathryn Anastos); Brooklyn, NY (Howard Minkoff); Washington DC Metropolitan Consortium (Mary Young); The Connie Wofsy Study Consortium of Northern California (Ruth Greenblatt); Los Angeles County/Southern California Consortium (Alexandra Levine); Chicago Consortium (Mardge Cohen); Data Coordinating Center (Stephen Gange, Elizabeth Golub). The WIHS is funded by the National Institute of Allergy and Infectious Diseases (U01-A1-35004, U01-Al 31834, U01-A1-34994, U01-A1-34989, U01-Al 34993, and U01-A1-42590) and by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (U01-HD-32632). The study is co-funded by the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute on Deafness and Other Communication Disorders. Funding is also provided by the National Center for Research Resources (UCSF-CTSI Grant Number UL1 RR024131). The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.	Aldamiz-Echevarria T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148537; Almodovar S, 2014, VIRAL IMMUNOL, V27, P186, DOI 10.1089/vim.2013.0130; Ansari AWW, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0341-8; Bambha K, 2012, AIDS, V26, P599, DOI 10.1097/QAD.0b013e32834fa121; Barkan SE, 1998, EPIDEMIOLOGY, V9, P117, DOI 10.1097/00001648-199803000-00004; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Bone-Larson CL, 2000, IMMUNOL REV, V177, P8, DOI 10.1034/j.1600-065X.2000.17703.x; Borchers AT, 2009, SEMIN IMMUNOPATHOL, V31, P309, DOI 10.1007/s00281-009-0167-2; CDC, 2013, HIV VIR HEP; Emu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085613; Fausto N, 1995, FASEB J, V9, P1527, DOI 10.1096/fasebj.9.15.8529831; de Castro IF, 2010, AIDS, V24, P2059, DOI 10.1097/QAD.0b013e32833ce54d; Folgori A, 2006, GUT, V55, P1012, DOI 10.1136/gut.2005.080077; Grant AJ, 2001, HEPATOLOGY, V33, P1065, DOI 10.1053/jhep.2001.24231; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Harcourt G, 2006, GUT, V55, DOI 10.1136/gut.2005.083758; Hernando V, 2012, J HEPATOL, V57, P743, DOI 10.1016/j.jhep.2012.06.010; Hillan KJ, 1999, LIVER, V19, P509, DOI 10.1111/j.1478-3231.1999.tb00084.x; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hokeness KL, 2007, J VIROL, V81, P1241, DOI 10.1128/JVI.01937-06; Huang GC, 2012, LAB INVEST, V92, P703, DOI 10.1038/labinvest.2012.3; Jiao JJ, 2012, HEPATOLOGY, V55, P243, DOI 10.1002/hep.24621; Joshi D, 2011, LANCET, V377, P1198, DOI 10.1016/S0140-6736(10)62001-6; Keating SM, 2012, CYTOKINE GROWTH F R, V23, P193, DOI 10.1016/j.cytogfr.2012.05.006; Keating SM, 2011, AIDS, V25, P1823, DOI 10.1097/QAD.0b013e3283489d1f; Kelleher TB, 2005, J HEPATOL, V43, P78, DOI 10.1016/j.jhep.2005.02.025; Kong XN, 2012, HEPATOLOGY, V56, P1150, DOI 10.1002/hep.25744; Konishi H, 2013, HEPATOL RES; Lalor PF, 2002, IMMUNOL CELL BIOL, V80, P52, DOI 10.1046/j.1440-1711.2002.01062.x; Larrubia JR, 2008, WORLD J GASTROENTERO, V14, P7149, DOI 10.3748/wjg.14.7149; Larrubia JR, 2007, J HEPATOL, V47, P632, DOI 10.1016/j.jhep.2007.04.009; Macias J, 2006, GUT, V55, P409, DOI 10.1136/gut.2005.065904; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Meng FL, 2012, GASTROENTEROLOGY, V143, P765, DOI 10.1053/j.gastro.2012.05.049; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Norris PJ, 2006, AIDS RES HUM RETROV, V22, P757, DOI 10.1089/aid.2006.22.757; Ohyama T, 2011, LIVER INT, V31, P572, DOI 10.1111/j.1478-3231.2011.02475.x; Osburn WO, 2013, J VIRAL HEPATITIS, V20, P404, DOI 10.1111/jvh.12052; Peters L, 2014, J CLIN VIROL, V60, P295, DOI 10.1016/j.jcv.2014.03.017; Peters L, 2012, AIDS, V26, P1917, DOI 10.1097/QAD.0b013e3283574e71; Preisser L, 2014, HEPATOLOGY, V60, P1879, DOI 10.1002/hep.27328; Reiberger T, 2008, ANTIVIR THER, V13, P969; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Shields PL, 1999, J IMMUNOL, V163, P6236; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Takemura T, 2013, BIOCHEM BIOPH RES CO, V437, P185, DOI 10.1016/j.bbrc.2013.05.097; Thimme R, 2001, J EXP MED, V194, P1395, DOI 10.1084/jem.194.10.1395; Tural C, 2009, CLIN GASTROENTEROL H, V7, P339, DOI 10.1016/j.cgh.2008.11.019; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Williams JP, 2014, ELIFE, V3, DOI 10.7554/eLife.03821; Williams SK, 2014, J VIRAL HEPATITIS, V21, P251, DOI 10.1111/jvh.12141; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zeremski M, 2009, J INFECT DIS, V200, P1774, DOI 10.1086/646614	55	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0181004	10.1371/journal.pone.0181004	http://dx.doi.org/10.1371/journal.pone.0181004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902848	gold, Green Submitted, Green Published			2022-12-27	WOS:000410669200002
J	Morishita, T; Hilliard, JD; Okun, MS; Neal, D; Nestor, KA; Peace, D; Hozouri, AA; Davidson, MR; Bova, FJ; Sporrer, JM; Oyama, G; Foote, KD				Morishita, Takashi; Hilliard, Justin D.; Okun, Michael S.; Neal, Dan; Nestor, Kelsey A.; Peace, David; Hozouri, Alden A.; Davidson, Mark R.; Bova, Francis J.; Sporrer, Justin M.; Oyama, Genko; Foote, Kelly D.			Postoperative lead migration in deep brain stimulation surgery: Incidence, risk factors, and clinical impact	PLOS ONE			English	Article							HARDWARE-RELATED COMPLICATIONS; MOVEMENT; TERM; DIFFERENTIATION; DISPLACEMENT; DYSTONIA; NUCLEUS; DISEASE	Introduction Deep brain stimulation (DBS) is an effective treatment for multiple movement disorders and shows substantial promise for the treatment of some neuropsychiatric and other disorders of brain neurocircuitry. Optimal neuroanatomical lead position is a critical determinant of clinical outcomes in DBS surgery. Lead migration, defined as an unintended post-operative displacement of the DBS lead, has been previously reported. Despite several reports, however, there have been no systematic investigations of this issue. This study aimed to: 1) quantify the incidence of lead migration in a large series of DBS patients, 2) identify potential risk factors contributing to DBS lead migration, and 3) investigate the practical importance of this complication by correlating its occurrence with clinical outcomes. Methods A database of all DBS procedures performed at UF was queried for patients who had undergone multiple post-operative DBS lead localization imaging studies separated by at least two months. Bilateral DBS implantation has commonly been performed as a staged procedure at UF, with an interval of six or more months between sides. To localize the position of each DBS lead, a head CT is acquired -4 weeks after lead implantation and fused to the pre-operative targeting MRI. The fused targeting images (MR + stereotactic CT) acquired in preparation for the delayed second side lead implantation provide an opportunity to repeat the localization of the first implanted lead. This paradigm offers an ideal patient population for the study of delayed DBS lead migration because it provides a large cohort of patients with localization of the same implanted DBS lead at two time points. The position of the tip of each implanted DBS lead was measured on both the initial post-operative lead localization CT and the delayed CT. Lead tip displacement, intracranial lead length, and ventricular indices were collected and analyzed. Clinical outcomes were characterized with validated rating scales for all cases, and a comparison was made between outcomes of cases with lead migration versus those where migration of the lead did not occur. Results Data from 138 leads in 132 patients with initial and delayed lead localization CT scans were analyzed. The mean distance between initial and delayed DBS lead tip position was 2.2 mm and the mean change in intracranial lead length was 0.45 mm. Significant delayed migration (>3 mm) was observed in 17 leads in 16 patients (12.3% of leads, 12.1% of patients). Factors associated with lead migration were: technical error, repetitive dystonic head movement, and twiddler's syndrome. Outcomes were worse in dystonia patients with lead migration (p = 0.035). In the PD group, worse clinical outcomes trended in cases with lead migration. Conclusions Over 10% of DBS leads in this large single center cohort were displaced by greater than 3 mm on delayed measurement, adversely affecting outcomes. Multiple risk factors emerged, including technical error during implantation of the DBS pulse generator and failure of lead fixation at the burr hole site. We hypothesize that a change in surgical technique and a more effective lead fixation device might mitigate this problem.	[Morishita, Takashi] Fukuoka Univ, Dept Neurosurg, Fukuoka, Japan; [Hilliard, Justin D.; Neal, Dan; Peace, David; Hozouri, Alden A.; Bova, Francis J.; Sporrer, Justin M.; Foote, Kelly D.] Univ Florida, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Okun, Michael S.; Nestor, Kelsey A.] Univ Florida, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Davidson, Mark R.] Univ Florida, Dept Mat Sci & Engn, Gainesville, FL 32611 USA; [Oyama, Genko] Juntendo Univ, Dept Neurol, Tokyo, Japan	Fukuoka University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Juntendo University	Foote, KD (corresponding author), Univ Florida, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA.	foote@neurosurgery.ufl.edu		Foote, Kelly/0000-0002-2436-4138	Center of Excellence Grant - National Parkinson Foundation; Tyler's Hope for a Dystonia Cure; Bahmann-Strauss Dystonia Parkinson Foundation; St. Luke's Life Science Institute of Japan; Japan Society for Promotion of Science; National Parkinson Foundation	Center of Excellence Grant - National Parkinson Foundation; Tyler's Hope for a Dystonia Cure; Bahmann-Strauss Dystonia Parkinson Foundation; St. Luke's Life Science Institute of Japan; Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Parkinson Foundation	This study was supported by the Center of Excellence Grant - National Parkinson Foundation; Tyler's Hope for a Dystonia Cure; Bahmann-Strauss Dystonia Parkinson Foundation; St. Luke's Life Science Institute of Japan (https://cce.luke.ac.jp/subsidy/history/pdf/kako_josei2011.pdf); and Japan Society for Promotion of Science (#17, https://www/jsps.go.jp/j-ab/data/list/h25/08.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a Center of Excellence grant from the National Parkinson Foundation, by Tyler's Hope for a Dystonia Cure, by Bachmann-Strauss Dystonia Parkinson Foundation, by a Grant-in Aid for Clinical Research from St. Luke's Life Science Institute of Japan and by a grant from Japan Society for Promotion of Science.	Benabid AL, 2009, LANCET NEUROL, V8, P67, DOI 10.1016/S1474-4422(08)70291-6; Beric A, 2001, STEREOT FUNCT NEUROS, V77, P73, DOI 10.1159/000064600; Blomstedt P, 2005, ACTA NEUROCHIR, V147, P1061, DOI 10.1007/s00701-005-0576-5; Boviatsis EJ, 2010, ACTA NEUROCHIR, V152, P2053, DOI 10.1007/s00701-010-0749-8; Burdick AP, 2010, STEREOT FUNCT NEUROS, V88, P353, DOI 10.1159/000319039; Carvallo JFB, 2012, STEREOT FUNCT NEUROS, V90, P300, DOI 10.1159/000338222; Chan DTM, 2009, ASIAN J SURG, V32, P258, DOI 10.1016/S1015-9584(09)60404-8; Constantoyannis C, 2005, CAN J NEUROL SCI, V32, P194, DOI 10.1017/S0317167100003966; Contarino MF, 2013, NEUROSURGERY, V73, P681, DOI 10.1227/NEU.0000000000000079; Doshi PK, 2011, STEREOT FUNCT NEUROS, V89, P89, DOI 10.1159/000323372; Ellis TM, 2008, NEUROSURGERY, V63, P754, DOI 10.1227/01.NEU.0000325492.58799.35; Falowski S, 2012, STEREOT FUNCT NEUROS, V90, P173, DOI 10.1159/000338254; Gelabert-Gonzalez M, 2010, ACTA NEUROCHIR, V152, P489, DOI 10.1007/s00701-009-0366-6; Goodman WK, 2010, BIOL PSYCHIAT, V67, P535, DOI 10.1016/j.biopsych.2009.11.028; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; GYLDENSTED C, 1977, NEURORADIOLOGY, V14, P183, DOI 10.1007/BF00496982; Joint C, 2002, MOVEMENT DISORD, V17, pS175, DOI 10.1002/mds.10161; Kenney C, 2007, J NEUROSURG, V106, P621, DOI 10.3171/jns.2007.106.4.621; Kondziolka D, 2002, STEREOT FUNCT NEUROS, V79, P228, DOI 10.1159/000070836; Lyons KE, 2004, NEUROLOGY, V63, P612, DOI 10.1212/01.WNL.0000134650.91974.1A; Morishita T, 2010, PARKINSONISM RELAT D, V16, P153, DOI 10.1016/j.parkreldis.2009.10.003; Morishita T, 2010, J NEUROSURG, V112, P491, DOI 10.3171/2009.7.JNS09150; Morishita T, 2010, NAT REV NEUROL, V6, P52, DOI 10.1038/nrneurol.2009.195; Obuchi T, 2008, NEUROMODULATION, V11, P302, DOI 10.1111/j.1525-1403.2008.00180.x; Oh MY, 2002, NEUROSURGERY, V50, P1268; Okun MS, 2008, PARKINSONISM RELAT D, V14, P532, DOI 10.1016/j.parkreldis.2008.01.001; Okun MS, 2013, JAMA NEUROL, V70, P85, DOI 10.1001/jamaneurol.2013.580; Okun MS, 2012, LANCET NEUROL, V11, P140, DOI 10.1016/S1474-4422(11)70308-8; Ostrem JL, 2008, NEUROTHERAPEUTICS, V5, P320, DOI 10.1016/j.nurt.2008.01.002; Patel NV, 2012, J CLIN NEUROSCI, V19, P1715, DOI 10.1016/j.jocn.2012.02.017; Sudhyadhom Atchar, 2012, Open Neuroimag J, V6, P92, DOI 10.2174/1874440001206010092; Sudhyadhom A, 2009, NEUROIMAGE, V47, pT44, DOI 10.1016/j.neuroimage.2009.04.018; Toma AK, 2011, NEUROSURGERY, V68, P939, DOI 10.1227/NEU.0b013e318208f5e0; Uitti RJ, 2002, NEUROSURGERY, V51, P1423, DOI 10.1097/00006123-200212000-00012; van den Munckhof P, 2010, NEUROSURGERY, V67, P49, DOI 10.1227/01.NEU.0000370597.44524.6D; Voges J, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.081232; Yianni J, 2004, J CLIN NEUROSCI, V11, P243, DOI 10.1016/j.jocn.2003.10.003	37	45	46	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e183711	10.1371/journal.pone.0183711	http://dx.doi.org/10.1371/journal.pone.0183711			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902876	gold, Green Submitted, Green Published			2022-12-27	WOS:000410669200015
J	Cencetti, G; Bagnoli, F; Battistelli, G; Chisci, L; Fanelli, D				Cencetti, Giulia; Bagnoli, Franco; Battistelli, Giorgio; Chisci, Luigi; Fanelli, Duccio			Control of multidimensional systems on complex network	PLOS ONE			English	Article							STABILITY; SYNCHRONIZATION	Multidimensional systems coupled via complex networks are widespread in nature and thus frequently invoked for a large plethora of interesting applications. From ecology to physics, individual entities in mutual interactions are grouped in families, homogeneous in kind. These latter interact selectively, through a sequence of self-consistently regulated steps, whose deeply rooted architecture is stored in the assigned matrix of connections. The asymptotic equilibrium eventually attained by the system, and its associated stability, can be assessed by employing standard nonlinear dynamics tools. For many practical applications, it is however important to externally drive the system towards a desired equilibrium, which is resilient, hence stable, to external perturbations. To this end we here consider a system made up of N interacting populations which evolve according to general rate equations, bearing attributes of universality. One species is added to the pool of interacting families and used as a dynamical controller to induce novel stable equilibria. Use can be made of the root locus method to shape the needed control, in terms of intrinsic reactivity and adopted protocol of injection. The proposed method is tested on both synthetic and real data, thus enabling to demonstrate its robustness and versatility.	[Cencetti, Giulia; Battistelli, Giorgio; Chisci, Luigi] Univ Florence, Dipartimento Ingn Informaz, Via S Marta 3, Florence, Italy; [Cencetti, Giulia; Bagnoli, Franco; Fanelli, Duccio] Univ Florence, Dipartimento Fis & Astron, Via G Sansone 1, Sesto Fiorentino, Italy; [Cencetti, Giulia; Bagnoli, Franco; Fanelli, Duccio] INFN Sez Firenze, Via G Sansone 1, Sesto Fiorentino, Italy	University of Florence; University of Florence; Istituto Nazionale di Fisica Nucleare (INFN)	Cencetti, G (corresponding author), Univ Florence, Dipartimento Ingn Informaz, Via S Marta 3, Florence, Italy.; Cencetti, G (corresponding author), Univ Florence, Dipartimento Fis & Astron, Via G Sansone 1, Sesto Fiorentino, Italy.; Cencetti, G (corresponding author), INFN Sez Firenze, Via G Sansone 1, Sesto Fiorentino, Italy.	giulia.cencetti@unifi.it	Chisci, Luigi/AEU-6598-2022; Cencetti, Giulia/AAW-5852-2021; Bagnoli, Franco/K-6904-2015	Bagnoli, Franco/0000-0002-6293-0305; Cencetti, Giulia/0000-0002-6946-3666				Albert Jaroslav, 2011, Syst Synth Biol, V5, P33, DOI 10.1007/s11693-011-9079-2; [Anonymous], 1991, APPL NONLINEAR CONTR; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Asllani M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5517; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boccaletti S, 2014, PHYS REP, V544, P1, DOI 10.1016/j.physrep.2014.07.001; Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11; Caldarelli G, 2016, DATA SCIENCE AND COMPLEX NETWORKS: REAL CASES STUDIES WITH PYTHON; Cavallaro M, 2014, COMPUT-AIDED CIV INF, V29, P608, DOI 10.1111/mice.12080; Cencetti G, 2017, EUR PHYS J B, V90, DOI 10.1140/epjb/e2016-70465-y; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Dorfler F, 2012, SIAM J CONTROL OPTIM, V50, P1616, DOI 10.1137/110851584; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Evans, 1948, T AIEE, V67, P547, DOI [10.1109/T-AIEE.1948.5059708, DOI 10.1109/T-AIEE.1948.5059708]; Freilich S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1597; Gao JX, 2016, NATURE, V530, P307, DOI 10.1038/nature16948; Grilli J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12031; Hasty J, 2001, NAT REV GENET, V2, P268, DOI 10.1038/35066056; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Kailah T, 1980, LINEAR SYSTEMS; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; Kandel E., 2000, PRINCIPLES NEURAL SC; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lodish H, 2000, MOL CELL BIOL; Luenberger D. G., 1979, INTRO DYNAMIC SYSTEM; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; Murray JD, 2003, MATH BIOL, V3; Nicosia V, 2012, SCI REP-UK, V2, DOI 10.1038/srep00218; Nicosia V, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.174102; Pikovsky A., 2003, SYNCHRONIZATION UNIV, V12; Rohden M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.064101; Rubenstein M, 2014, SCIENCE, V345, P795, DOI 10.1126/science.1254295; Shen TCD, 2015, J CLIN INVEST, V125, P2841, DOI 10.1172/JCI79214; Signaroldi E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10753; Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388; Steinway SN, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004338; Suweis S, 2013, NATURE, V500, P449, DOI 10.1038/nature12438; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tu C. Y., 2016, ARXIV160609630	43	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184431	10.1371/journal.pone.0184431	http://dx.doi.org/10.1371/journal.pone.0184431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892493	Green Published, gold, Green Submitted			2022-12-27	WOS:000410243200014
J	El-Hamoly, T; El-Sharawy, DM; El Refaye, MS; Abd El-Rahman, SS				El-Hamoly, Tarek; El-Sharawy, Dina M.; El Refaye, Marwa S.; Abd El-Rahman, Sahar S.			L-thyroxine modifies nephrotoxicity by regulating the apoptotic pathway: The possible role of CD38/ADP-ribosyl cyclase-mediated calcium mobilization	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; PROXIMAL TUBULAR CELLS; POLY(ADP-RIBOSE) POLYMERASE-1; CISPLATIN NEPHROTOXICITY; THYROID-HORMONE; INJURY; PROTECTS; NEPHROPATHY; EXPRESSION; KIDNEY	Thyroid hormones are well-established as a key regulator of many cellular metabolic pathways developed in various pathogeneses. Here, we dedicated the current work to investigate the role of thyroid hormone analogue (L-thyroxine, L-TH) in regulating the renal cytotoxicity using in vivo and in vitro models. Swiss mice were exposed to gamma radiation (IRR, 6Gy) or treated with cisplatin (CIS, 15 mg/kg, i. p.) for induction of nephrotoxicity. Remarkably, pretreatment with L-TH (1 mu g/kg) ameliorated the elevated kidney function biomarkers, oxidative stress and protected the renal tissue from the subsequent cellular damage. Likewise, L-TH inhibited the apoptotic cascade by down-regulating the extreme consumption of the cellular energy (ATP), the expression of caspase-3 and Bax, and the stimulation of cyclic ADP ribose (cADPR)/calcium mobilization. Moreover, incubation with LTH (120nM/4h) significantly blocked the cytotoxicity of CIS on Vero cells and the depletion of NAD+ content as well as modified the ADP-ribose cyclase (CD38) enzymatic activity. High doses of L-TH (up to30 nM/4h) inversely increased the radiosensitivity of Vero cells towards IRR (up to 6Gy). On the other hand, L-TH did not interfere CIS-induced cytotoxicity of colorectal adenocarcinoma (Caco-2) cell line. In conclusion, pretreatment with L-TH could be a promising protective approach to the renal cellular damage induced during either CIS or IRR therapy by regulating the unbalanced oxidative status, the expression of proapoptotic biomarkers via modulation of cADPR mediated-calcium mobilization.	[El-Hamoly, Tarek] Atom Energy Author, Natl Ctr Radiat Res & Technol, Drug Radiat Res Dept, Cairo, Egypt; [El-Hamoly, Tarek; El-Sharawy, Dina M.; El Refaye, Marwa S.] Atom Energy Author, Ctr Nucl Res, Cyclotron Project, Cairo, Egypt; [Abd El-Rahman, Sahar S.] Cairo Univ, Dept Pathol, Fac Vet Med, Giza, Egypt	Egyptian Knowledge Bank (EKB); Egyptian Atomic Energy Authority (EAEA); National Center for Radiation Research & Technology; Egyptian Knowledge Bank (EKB); Egyptian Atomic Energy Authority (EAEA); Egyptian Knowledge Bank (EKB); Cairo University	Abd El-Rahman, SS (corresponding author), Cairo Univ, Dept Pathol, Fac Vet Med, Giza, Egypt.	saharsamirmah@cu.edu.eg	El-Rahman, Sahar S. Abd/A-1443-2016	Abd El-Rahman, Sahar S/0000-0001-8638-1737				APPENROTH D, 1990, J APPL TOXICOL, V10, P395, DOI 10.1002/jat.2550100603; Arsad SS, 2014, J CYTOL HISTOL, VS4, P1, DOI DOI 10.4172/2157-7099.S4-001; Banchroft J.D., 1996, THEORY PRACTICE HIST; Barker S, 2005, J BIOL CHEM, V280, P33826, DOI 10.1074/jbc.M502477200; Canto C, 2011, COLD SH Q B, V76, P291, DOI 10.1101/sqb.2012.76.010439; Chen CY, 2013, BIOCHIM BIOPHYS ACTA, P11; CHEN SM, 1995, INFECT IMMUN, V63, P647, DOI 10.1128/IAI.63.2.647-655.1995; Davis PJ, 2002, THYROID, V12, P459, DOI 10.1089/105072502760143827; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; GUIDA L, 1995, FEBS LETT, V368, P481, DOI 10.1016/0014-5793(95)00715-L; Guo Y, 2014, NEUROENDOCRINOLOGY L, V35; Ha HC, 2000, NEUROBIOL DIS, V7, P225, DOI 10.1006/nbdi.2000.0324; HARMSEN E, 1982, J CHROMATOGR, V230, P131, DOI 10.1016/S0378-4347(00)81439-5; Higashida H, 2016, J NEURAL TRANSM VIEN, V26, P1; HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816; Johnstone TC, 2014, ANTICANCER RES, V34, P471; Kim J, 2016, PHYSIOL RES, V65, P333, DOI 10.33549/physiolres.932948; Kouvaris JR, 2007, ONCOLOGIST, V12, P738, DOI 10.1634/theoncologist.12-6-738; Kruidering M, 1997, J PHARMACOL EXP THER, V280, P638; Kwakkel J, 2014, ENDOCRINOLOGY, P155; KWON YD, 2014, PLOS ONE, V9; Lakatos P, 2013, BBA-MOL CELL RES, V1833, P743, DOI 10.1016/j.bbamcr.2012.12.003; Laoag-Fernandez JB, 2004, J CLIN ENDOCR METAB, V89, P4069, DOI 10.1210/jc.2003-032208; Lee RH, 2001, BIOCHEM PHARMACOL, V62, P1013; LUCK H, 1963, METHOD ENZYMAT AN, P886; Ma P, 2015, AM J TRANSL RES, V7, P2105; Masaki H, 2004, J INVEST DERMATOL, V14, P50; Mohamed HA, 2015, INT J SCI RES PUBLIC, V5; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Mukhopadhyay P, 2011, FREE RADICAL BIO MED, V51, P1774, DOI 10.1016/j.freeradbiomed.2011.08.006; Pan H., 2015, PLOS ONE, V10; Peng QY, 2016, J SURG RES, V201, P480, DOI 10.1016/j.jss.2015.11.029; Qian W, 2005, AM J PHYSIOL-CELL PH, V289, pC1466, DOI 10.1152/ajpcell.00265.2005; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Ravindra P, 2010, J CELL ANIMAL BIOL, V4, P108; Shang GG, 2013, BBA-MOL BASIS DIS, V1832, P674, DOI 10.1016/j.bbadis.2013.01.023; Shiraishi F, 2000, AM J PHYSIOL-RENAL, V278, pF726, DOI 10.1152/ajprenal.2000.278.5.F726; Sinha RA, 2015, AUTOPHAGY, P23; Sukocheva OA, 2006, J ENDOCRINOL, V191, P447, DOI 10.1677/joe.1.07061; Sung MJ, 2008, KIDNEY INT, V74, P1538, DOI 10.1038/ki.2008.409; Videla LA, 2010, IUBMB LIFE, V62, P460, DOI 10.1002/iub.345; Yang JH, 2015, BIOCHEM BIOPH RES CO, V467, P704, DOI 10.1016/j.bbrc.2015.10.080; Yoshino J, 2013, METHODS MOL BIOL, V1077, P203, DOI 10.1007/978-1-62703-637-5_14	44	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184157	10.1371/journal.pone.0184157	http://dx.doi.org/10.1371/journal.pone.0184157			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892514	gold, Green Published, Green Submitted			2022-12-27	WOS:000410243200010
J	Deng, T; Mai, ZL; Cai, C; Duan, XL; Zhu, W; Zhang, T; Wu, WQ; Zeng, GH				Deng, Tuo; Mai, Zanlin; Cai, Chao; Duan, Xiaolu; Zhu, Wei; Zhang, Tao; Wu, Wenqi; Zeng, Guohua			Influence of weight status on 24-hour urine composition in adults without urolithiasis: A nationwide study based on a Chinese Han population	PLOS ONE			English	Article							STONE; OBESITY; IMPACT; PREVALENCE; OVERWEIGHT; RISK	Objectives This study sought to explore the influence of different body weight statuses on 24-hour urine compositions in adults without urolithiasis based on a nationwide study of a Chinese Han population. Material and methods Twenty-four-hour urine samples from 584 Chinese Han adults without urolithiasis in six cities were analyzed. The participants were divided into four body weight status types according to their body mass indices (BMIs) according to WHO guidelines. The baseline characteristics and 24-hour urine compositions of the standard weight group were compared with those of the underweight, overweight and obese groups. The influences of different body weight statuses on the 24-hour urine compositions were explored using univariate and multivariate logistic regressions. Results The numbers of participants in the underweight, standard weight, overweight and obese status groups were 24, 376, 149 and 35, respectively. The overweight and obese groups suffered significantly higher risks of hypertension and diabetes mellitus than the standard weight group. In the univariate analyses, compared with the standard weight group, the overweight group had significantly higher levels of urine citrate (mean difference [MD] = 0.51 mmol, 95% confidence interval [CI]: 0.15-0.87, P = 0.001), potassium (MD = 6.63 mmol, 95% CI: 1.13-12.14, P = 0.01) and magnesium (MD = 0.38 mmol, 95% CI: 0.08-0.69, P = 0.014). Significant increases in urine citrate (MD = 0.85 mmol, 95% CI: 0.01-1.68, P = 0.046), magnesium (MD = 0.69 mmol, 95% CI: 0.13-1.25, P = 0.016) and phosphate MD = 2.28 mmol, 95% CI: 0.03-4.54, P = 0.047) were found in the obese group. No significant differences were detected between the standard weight and underweight groups. In the multivariate logistic regression analyses, we only observed significantly higher levels of urine potassium (odds ratio [OR] = 1.02, 95% CI: 1.00-1.04, P = 0.03) in the overweight group and phosphate (OR = 1.32, 95% CI: 1.05-1.66, P = 0.018) in the obese group when compared with the standard weight group. Conclusions Nonstone-forming adults with overweight or obese statuses were at higher risks of hypertension and diabetes mellitus. Obese nonstone-formers might have a greater risk of urinary stone formation due to increased urinary phosphate excretion. Additionally, underweight status had no influence on 24-hour urine composition.	[Deng, Tuo; Mai, Zanlin; Cai, Chao; Duan, Xiaolu; Zhu, Wei; Zhang, Tao; Wu, Wenqi; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Deng, Tuo; Mai, Zanlin; Cai, Chao; Duan, Xiaolu; Zhu, Wei; Zhang, Tao; Wu, Wenqi; Zeng, Guohua] Guangzhou Inst Urol, Guangzhou, Guangdong, Peoples R China; [Deng, Tuo; Mai, Zanlin; Cai, Chao; Duan, Xiaolu; Zhu, Wei; Zhang, Tao; Wu, Wenqi; Zeng, Guohua] Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Zeng, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China.; Zeng, GH (corresponding author), Guangzhou Inst Urol, Guangzhou, Guangdong, Peoples R China.; Zeng, GH (corresponding author), Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China.	gzgyzgh@vip.tom.com		Deng, Tuo/0000-0003-0206-2179	China Postdoctoral Science Foundation [2017M612636]; National Natural Science Foundation of China [81370804, 81670643]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Postdoctoral Science Foundation [grant number 2017M612636]; National Natural Science Foundation of China [grant numbers 81370804, 81670643].	Al-Hayek S, 2013, J ENDOUROL, V27, P379, DOI 10.1089/end.2012.0275; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Calvert RC, 2005, CURR OPIN UROL, V15, P113, DOI 10.1097/01.mou.0000160626.36236.22; De Pergola G, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0101-6; Eisner BH, 2010, UROLOGY, V75, P1289, DOI 10.1016/j.urology.2009.09.024; Eisner BH, 2010, J UROLOGY, V183, P2244, DOI 10.1016/j.juro.2010.02.007; Eisner BH, 2010, J UROLOGY, V183, P576, DOI 10.1016/j.juro.2009.10.011; Gyawali P R, 2011, Kathmandu Univ Med J (KUMJ), V9, P54; Hartman C, 2015, UROLOGY, V85, P539, DOI 10.1016/j.urology.2014.12.013; Jaipakdee Sudjai, 2004, Journal of the Medical Association of Thailand, V87, P255; Khand Fateh D., 1994, JPMA (Journal of the Pakistan Medical Association), V44, P179; Liu XL, 2017, J HYPERTENS, V35, P637, DOI 10.1097/HJH.0000000000001203; Lobstein T., 2004, OBESITY REV OFFIC S1, V5, P4, DOI [10.1111/j.1467-789X.2004.00133.x, DOI 10.1111/J.1467-789X.2004.00133.X]; Mydlo JH, 2004, UROL CLIN N AM, V31, P275, DOI 10.1016/j.ucl.2004.01.005; Parvin M, 2011, UROL J, V8, P99; Pierratos A, 2000, J UROLOGY, V164, P1486, DOI 10.1016/S0022-5347(05)67012-7; Pippitt K, 2016, AM FAM PHYSICIAN, V93, P103; Powell CR, 2000, UROLOGY, V55, P825, DOI 10.1016/S0090-4295(99)00617-2; Sarica K, 2009, UROLOGY, V73, P1003, DOI 10.1016/j.urology.2008.11.038; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Siener R, 2004, OBES RES, V12, P106, DOI 10.1038/oby.2004.14; Skolarikos A, 2015, EUR UROL, V67, P750, DOI 10.1016/j.eururo.2014.10.029; Taylor EN, 2005, JAMA-J AM MED ASSOC, V293, P455, DOI 10.1001/jama.293.4.455; Taylor EN, 2006, AM J KIDNEY DIS, V48, P905, DOI 10.1053/j.ajkd.2006.09.004; Tiselius HG, 2002, ENDOCRIN METAB CLIN, V31, P1031, DOI 10.1016/S0889-8529(02)00027-0; Wu WQ, 2014, UROLOGY, V83, P732, DOI 10.1016/j.urology.2013.11.012; Yachantha C, 2009, UROL RES, V37, P311, DOI 10.1007/s00240-009-0220-6; Zhu W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150006	28	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184655	10.1371/journal.pone.0184655	http://dx.doi.org/10.1371/journal.pone.0184655			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886192	Green Submitted, gold, Green Published			2022-12-27	WOS:000410001100173
J	Kimball, HL; Selmants, PC; Moreno, A; Running, SW; Giardina, CP				Kimball, Heather L.; Selmants, Paul C.; Moreno, Alvaro; Running, Steve W.; Giardina, Christian P.			Evaluating the role of land cover and climate uncertainties in computing gross primary production in Hawaiian Island ecosystems	PLOS ONE			English	Article							TERRESTRIAL GROSS; MODIS; VEGETATION; GPP; NPP	Gross primary production (GPP) is the Earth's largest carbon flux into the terrestrial biosphere and plays a critical role in regulating atmospheric chemistry and global climate. The Moderate Resolution Imaging Spectrometer (MODIS)-MOD17 data product is a widely used remote sensing-based model that provides global estimates of spatiotemporal trends in GPP. When the MOD17 algorithm is applied to regional scale heterogeneous landscapes, input data from coarse resolution land cover and climate products may increase uncertainty in GPP estimates, especially in high productivity tropical ecosystems. We examined the influence of using locally specific land cover and high-resolution local climate input data on MOD17 estimates of GPP for the State of Hawaii, a heterogeneous and discontinuous tropical landscape. Replacing the global land cover data input product (MOD12Q1) with Hawaiispecific land cover data reduced statewide GPP estimates by similar to 8%, primarily because the Hawaii-specific land cover map had less vegetated land area compared to the global land cover product. Replacing coarse resolution GMAO climate data with Hawaii-specific high-resolution climate data also reduced statewide GPP estimates by similar to 8% because of the higher spatial variability of photosynthetically active radiation (PAR) in the Hawaii-specific climate data. The combined use of both Hawaii-specific land cover and high-resolution Hawaii climate data inputs reduced statewide GPP by similar to 16%, suggesting equal and independent influence on MOD17 GPP estimates. Our sensitivity analyses within a heterogeneous tropical landscape suggest that refined global land cover and climate data sets may contribute to an enhanced MOD17 product at a variety of spatial scales.	[Kimball, Heather L.] Univ Hawaii, Coll Arts & Sci, Hilo, HI 96720 USA; [Selmants, Paul C.] US Geol Survey, Western Geog Sci Ctr, 345 Middlefield Rd, Menlo Pk, CA 94025 USA; [Moreno, Alvaro; Running, Steve W.] Univ Montana, Numer Terradynam Simulat Grp, Missoula, MT 59812 USA; [Giardina, Christian P.] US Forest Serv, USDA, Inst Pacific Isl Forestry, Hilo, HI USA; [Kimball, Heather L.] Pacific Sci Advocates, Hilo, HI 96720 USA	University of Hawaii System; University Hawaii Hilo; United States Department of the Interior; United States Geological Survey; University of Montana System; University of Montana; United States Department of Agriculture (USDA); United States Forest Service	Kimball, HL (corresponding author), Univ Hawaii, Coll Arts & Sci, Hilo, HI 96720 USA.; Kimball, HL (corresponding author), Pacific Sci Advocates, Hilo, HI 96720 USA.	Hkimball@hawaii.edu	Martínez, Álvaro Moreno/AAA-5778-2019; Giardina, Christian P/C-3120-2011	Martínez, Álvaro Moreno/0000-0003-2990-7768; Giardina, Christian P/0000-0002-3431-5073; Selmants, Paul/0000-0001-6211-3957	U.S. Geological Survey Biological Carbon Sequestration Program [G13PG00084]; USDA Forest Service Pacific Southwest Research Station; NASA Earth Observing System MODIS Project [NNX08AG87A];  [16-JV-11272136-056];  [12-JV- 11272139-047]	U.S. Geological Survey Biological Carbon Sequestration Program; USDA Forest Service Pacific Southwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); NASA Earth Observing System MODIS Project; ; 	This work was funded by the U.S. Geological Survey Biological Carbon Sequestration Program (https://www2.usgs.gov/climate_landuse/land_carbon/) under an Interagency Agreement G13PG00084 to CPG with the USDA Forest Service Pacific Southwest Research Station (https://www.fs.fed.us/psw/). Research Joint Ventures 16-JV-11272136-056 to HK and 12-JV- 11272139-047 were awarded to PS. Funding was provided to AM and SR through the NASA Earth Observing System MODIS Project (https://earthdata.nasa.gov/), grant NNX08AG87A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Anav A, 2015, REV GEOPHYS, V53, P785, DOI 10.1002/2015RG000483; Anderson RG, 2015, AGR ECOSYST ENVIRON, V199, P216, DOI 10.1016/j.agee.2014.09.012; [Anonymous], 2014, PICT ONL; Beer C, 2010, SCIENCE, V329, P834, DOI 10.1126/science.1184984; Belward AS, 1999, PHOTOGRAMM ENG REM S, V65, P1013; Chapin FS., 2011, PRINCIPLES TERRESTRI, V2nd ed.; Cracknell AP, 2013, INT J REMOTE SENS, V34, P7400, DOI 10.1080/01431161.2013.820367; Digital Globe, 2010, QUICKB WORLDVI UNPUB; Dong J, 2017, SCI REPORTS, V7; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Gebremichael M, 2006, REMOTE SENS ENVIRON, V100, P150, DOI 10.1016/j.rse.2005.10.009; Giambelluca T. W., 2014, EVAPOTRANSPIRA UNPUB; Giambelluca TW, 2013, B AM METEOROL SOC, V94, P313, DOI 10.1175/BAMS-D-11-00228.1; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Gilabert MA, 2015, ISPRS J PHOTOGRAMM, V102, P184, DOI 10.1016/j.isprsjprs.2015.01.017; Global Modeling and Assimilation Office, GEOS NEAR REAL TIM D; Gon S., 2006, HAWAII GAP ANAL PROJ; Hashimoto H, 2012, REMOTE SENS-BASEL, V4, P303, DOI 10.3390/rs4010303; Heinsch FA, 2006, IEEE T GEOSCI REMOTE, V44, P1908, DOI 10.1109/TGRS.2005.853936; Jacobi J. D., 2017, BASELINE PROJECTED F, DOI 10.3133/pp1834; Jung M, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001566; Justice CO, 1998, IEEE T GEOSCI REMOTE, V36, P1228, DOI 10.1109/36.701075; Knyazikhin Y, 1998, J GEOPHYS RES ATMOSP, V103; Martinez B, 2013, INT J APPL EARTH OBS, V21, P463, DOI 10.1016/j.jag.2012.06.010; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Milesi C, 2005, GLOBAL PLANET CHANGE, V47, P221, DOI 10.1016/j.gloplacha.2004.10.020; Mitchell JF, 1990, CLIMATE CHANGE IPCC, V131, P172; Moreno A, 2014, REMOTE SENS-BASEL, V6, P8238, DOI 10.3390/rs6098238; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Nightingale JM, 2007, CAN J REMOTE SENS, V33, P278, DOI 10.5589/m07-030; NOAA National Ocean Service Coastal Services Center, 2012, C CAP HAW 2005 LAND; Perez-Hoyos A, 2012, ISPRS J PHOTOGRAMM, V74, P185, DOI 10.1016/j.isprsjprs.2012.09.006; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Rollins MG, 2009, INT J WILDLAND FIRE, V18, P235, DOI 10.1071/WF08088; RUNNING SW, 1994, AMBIO, V23, P77; Running SW, 1999, REMOTE SENS ENVIRON, V70, P108, DOI 10.1016/S0034-4257(99)00061-9; Running SW, 2015, DAILY GPP ANN NPP M; Shim C, 2014, ADV SPACE RES, V54, P2296, DOI 10.1016/j.asr.2014.08.031; Stehman SV, 1997, REMOTE SENS ENVIRON, V62, P77, DOI 10.1016/S0034-4257(97)00083-7; Thornton PE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002868; Turner DP, 2006, REMOTE SENS ENVIRON, V102, P282, DOI 10.1016/j.rse.2006.02.017; U. S. Geological Survey, 2009, LANDFIRE HI 100EVC H; United Nations Framework Convention on Climate Change, 2015, AD AR AGR 21 C PART; Vitousek, 2004, NUTR CYCLING LIMITAT; Wang J, 2017, J GEOPHYS RES BIOGEO; Yan K, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8050359; Zhang YJ, 2009, GLOBAL ECOL BIOGEOGR, V18, P280, DOI 10.1111/j.1466-8238.2008.00442.x; Zhang YQ, 2008, GLOBAL CHANGE BIOL, V14, P757, DOI 10.1111/j.1365-2486.2008.01538.x; Zhao M, 2006, COLLECTION 005 CHANG; Zhao MS, 2005, REMOTE SENS ENVIRON, V95, P164, DOI 10.1016/j.rse.2004.12.011	51	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184466	10.1371/journal.pone.0184466	http://dx.doi.org/10.1371/journal.pone.0184466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886187	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100130
J	Nitkin, CR; Bonfield, TL				Nitkin, Christopher R.; Bonfield, Tracey L.			Balancing anti-inflammatory and anti-oxidant responses in murine bone marrow derived macrophages	PLOS ONE			English	Article							ACUTE LUNG INJURY; BIRTH-WEIGHT INFANTS; PROTEIN-KINASE-C; BRONCHOPULMONARY DYSPLASIA; GENE-EXPRESSION; PPAR-GAMMA; NEONATAL MICE; NRF2 IMPAIRS; NITRIC-OXIDE; ACTIVATION	Rationale The underlying pathophysiology of bronchopulmonary dysplasia includes a macrophagemediated host response orchestrated by anti-inflammatory peroxisome proliferator-activated receptor gamma (PPAR.) and anti-oxidant nuclear factor (erythroid-derived 2)-like 2 (Nrf2). These have not yet been studied in combination. This study tested the hypothesis that combined inflammatory and oxidative stressors would interact and change PPAR.-and Nrf2-regulated gene expression and antioxidant capacity. Therefore, we investigated the effect of dual stimulation with lipopolysaccharide and hyperoxia in murine bone marrowderived macrophages (BMDM). Methods Sub-confluent BMDM from wild-type C57BL/6J mice were treated with lipopolysaccharide (LPS) 1ug/mL for 2 hours followed by room air (21% oxygen) or hyperoxia (95% oxygen) for 24 hours. Taqman real time-polymerase chain reaction gene expression assays, total antioxidant capacity assays, and Luminex assays were performed. Results Supernatants of cultured BMDM contained significant antioxidant capacity. In room air, LPS treatment decreased expression of PPAR. and Nrf2, and increased expression of tumor necrosis factor-alpha and heme oxygenase-1; similar findings were observed under hyperoxic conditions. LPS treatment decreased cellular total antioxidant capacity in room air but not in hyperoxia. Increased expression of sulfiredoxin-1 in response to hyperoxia was not observed in LPS-treated cells. Dual stimulation with LPS treatment and exposure to hyperoxia did not have synergistic effects on gene expression. Cellular total antioxidant capacity was not changed by hyperoxia exposure. Conclusions Our hypothesis was supported and we demonstrate an interaction between inflammatory and oxidative stressors in a model system of bronchopulmonary dysplasia pathogenesis. The protective anti-oxidant effect of cell culture media may have protected the cells from the most deleterious effects of hyperoxia.	[Nitkin, Christopher R.] Rainbow Babies & Childrens Hosp, Dept Pediat, Div Neonatol, Cleveland, OH 44106 USA; [Bonfield, Tracey L.] Case Western Reserve Univ, Dept Pediat, Div Pediat Pulmonol, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University	Bonfield, TL (corresponding author), Case Western Reserve Univ, Dept Pediat, Div Pediat Pulmonol, Cleveland, OH 44106 USA.	tlb7@case.edu	Nitkin, Christopher/R-4862-2019; Nitkin, Christopher/AAJ-3981-2021	Nitkin, Christopher/0000-0001-5718-4523; 	Rainbow Babies & Children's Foundation; Little Giraffe Foundation; David and Virginia Baldwin Fund; NIH [5-T32-HD060537-07]	Rainbow Babies & Children's Foundation; Little Giraffe Foundation; David and Virginia Baldwin Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding provided by the Rainbow Babies & Children's Foundation (http.//www.uhhospitals.org/rainbow/about/rainbow-foundation) (CRN), the Little Giraffe Foundation (http://www.littlegiraffefoundation.org/) (CRN), and the David and Virginia Baldwin Fund (TLB). Dr. Nitkin's fellowship training is supported by NIH 5-T32-HD060537-07 (PI Richard J. Martin). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas K, 2011, FREE RADICAL BIO MED, V51, P107, DOI 10.1016/j.freeradbiomed.2011.03.039; Apopa PL, 2008, J BIOCHEM MOL TOXIC, V22, P63, DOI 10.1002/jbt.20212; Bancalari E, 2015, FANAROFF MARTINS NEO, P1157; BARET A, 1983, MUTAT RES, V121, P293, DOI 10.1016/0165-7992(83)90217-8; Bast A, 2010, FREE RADICAL BIO MED, V49, P1881, DOI 10.1016/j.freeradbiomed.2010.09.015; Billiet L, 2005, J BIOL CHEM, V280, P40310, DOI 10.1074/jbc.M503644200; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Bose CL, 2008, ARCH DIS CHILD-FETAL, V93, P1455, DOI 10.1136/adc.2007.121327; Brenner S, 2010, TOXICOL IN VITRO, V24, P2090, DOI 10.1016/j.tiv.2010.06.005; Carlson BA, 2011, MOL IMMUNOL, V49, P311, DOI 10.1016/j.molimm.2011.09.001; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chen HH, 2012, FREE RADICAL BIO MED, V52, P1054, DOI 10.1016/j.freeradbiomed.2011.12.012; Cho HY, 2012, ANTIOXID REDOX SIGN, V17, P1066, DOI 10.1089/ars.2011.4288; Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC; Copple IM, 2012, ADV PHARMACOL, V63, P43, DOI 10.1016/B978-0-12-398339-8.00002-1; Dasgupta C, 2009, AM J PHYSIOL-LUNG C, V296, pL1031, DOI 10.1152/ajplung.90392.2008; Davis Beckley K, 2013, Methods Mol Biol, V1031, P27, DOI 10.1007/978-1-62703-481-4_3; Diet A, 2007, J BIOL CHEM, V282, P36199, DOI 10.1074/jbc.M706420200; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Glorieux C, 2015, FREE RADICAL BIO MED, V87, P84, DOI 10.1016/j.freeradbiomed.2015.06.017; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Iliodromiti Z, 2013, J MATERN-FETAL NEO M, V26, P1696, DOI 10.3109/14767058.2013.798284; Johnson TJ, 2013, J PEDIATR-US, V162, P243, DOI 10.1016/j.jpeds.2012.07.013; Keller RL, 2012, AVERYS DIS NEWBORN, P658; Kim H, 2010, J BIOL CHEM, V285, P34419, DOI 10.1074/jbc.M110.126839; Lee HJ, 2014, YONSEI MED J, V55, P99, DOI 10.3349/ymj.2014.55.1.99; Lee JW, 2014, MOL CELL BIOCHEM, V390, P143, DOI 10.1007/s11010-014-1965-y; Leoncini E, 2011, J FOOD SCI, V76, pH175, DOI 10.1111/j.1750-3841.2011.02311.x; Lim YT, 2012, MICROBIOL IMMUNOL, V56, P411, DOI 10.1111/j.1348-0421.2012.00453.x; Liu ZP, 2014, J LIPID RES, V55, P201, DOI 10.1194/jlr.M040394; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manzanero S, 2012, METHODS MOL BIOL, V844, P177, DOI 10.1007/978-1-61779-527-5_12; McGrath-Morrow S, 2009, AM J PHYSIOL-LUNG C, V296, pL565, DOI 10.1152/ajplung.90487.2008; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Poggi C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/721043; Reddy NRR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129422; Reddy NM, 2009, J IMMUNOL, V182, P7264, DOI 10.4049/jimmunol.0804248; Ricote M, 1999, J LEUKOCYTE BIOL, V66, P733, DOI 10.1002/jlb.66.5.733; Ricote M, 2004, ARTERIOSCL THROM VAS, V24, P230, DOI 10.1161/01.ATV.0000103951.67680.B1; SANDSTROM BER, 1987, BIOCHIM BIOPHYS ACTA, V929, P148, DOI 10.1016/0167-4889(87)90170-4; Schneider Monika, 2013, Methods Mol Biol, V1031, P37, DOI 10.1007/978-1-62703-481-4_4; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Takeda K, 2009, ANAT REC, V292, P1045, DOI 10.1002/ar.20921; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Wilson-Costello D, 2009, PEDIATRICS, V123, pe430, DOI 10.1542/peds.2008-1928; Zhang X., 2008, CURR PROTOC IMMUNOL; Zhang Xia, 2009, V531, P123, DOI 10.1007/978-1-59745-396-7_9	47	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184469	10.1371/journal.pone.0184469	http://dx.doi.org/10.1371/journal.pone.0184469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886148	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100131
J	Nsubuga, F; Ampaire, I; Kasasa, S; Luzze, H; Kisakye, A				Nsubuga, Fred; Ampaire, Immaculate; Kasasa, Simon; Luzze, Henry; Kisakye, Annet			Positive predictive value and effectiveness of measles case-based surveillance in Uganda, 2012-2015	PLOS ONE			English	Article							DISEASES; RUBELLA	Introduction Disease surveillance is a critical component in the control and elimination of vaccine preventable diseases. The Uganda National Expanded Program on Immunization strives to have a sensitive surveillance system within the Integrated Disease Surveillance and Response (IDSR) framework. We analyzed measles surveillance data to determine the effectiveness of the measles case-based surveillance system and estimate its positive predictive value in order to inform policy and practice. Methods An IDSR alert was defined as >= 1 suspected measles case reported by a district in a week, through the electronic Health Management Information System. We defined an alert in the measles case-based surveillance system (CBS) as >= 1 suspected measles case with a blood sample collected for confirmation during the corresponding week in a particular district. Effectiveness of CBS was defined as having >= 80% of IDSR alerts with a blood sample collected for laboratory confirmation. Positive predictive value was defined as the proportion of measles case-patients who also had a positive measles serological result (IgM +). We reviewed case-based surveillance data with laboratory confirmation and measles surveillance data from the electronic Health Management Information System from 2012-2015. Results A total of 6,974 suspected measles case-persons were investigated by the measles case-based surveillance between 2012 and 2015. Of these, 943 (14%) were measles specific IgM positive. The median age of measles case-persons between 2013 and 2015 was 4.0 years. Between 2013 and 2015, 72% of the IDSR alerts reported in the electronic Health Management Information System, had blood samples collected for laboratory confirmation. This was however less than the WHO recommended standard of >= 80%. The PPV of CBS between 2013 and 2015 was 8.6%. Conclusion In conclusion, the effectiveness of measles case-based surveillance was sub-optimal, while the PPV showed that true measles cases have significantly reduced in Uganda. We recommended strengthening of case-based surveillance to ensure that all suspected measles cases have blood samples collected for laboratory confirmation to improve detection and ensure elimination by 2020.	[Nsubuga, Fred; Ampaire, Immaculate; Luzze, Henry] Minist Hlth, Uganda Natl Expanded Program Immunizat, Kampala, Uganda; [Kasasa, Simon] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Kisakye, Annet] WHO, Country Off, Kampala, Uganda	Makerere University; World Health Organization	Nsubuga, F (corresponding author), Minist Hlth, Uganda Natl Expanded Program Immunizat, Kampala, Uganda.	fred.nsubuga@musph.ac.ug		Nsubuga, Fred/0000-0002-0264-7014	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Durrheim DN, 2014, VACCINE, V32, P6880, DOI 10.1016/j.vaccine.2014.10.061; Filia A, 2006, KOREA, V1, P4; Guris D, 2004, J INFECT DIS, V189, pS177, DOI 10.1086/374606; GURIS D, 2001, MODULE BEST PRACTICE; Hutchins SS, 2004, J INFECT DIS, V189, pS153, DOI 10.1086/379652; Kiberu VM, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-40; Lukwago L, 2013, HLTH POLICY PLAN; Mbabazi WB, 2009, HEALTH POLICY PLANN, V24, P261, DOI 10.1093/heapol/czp008; Ministry of Health-Uganda, 2010, UG EPI MULT PLAN; Nsubuga P, 2010, GLOB PUBLIC HEALTH, V5, P364, DOI 10.1080/17441690903334943; Nsubuga P, 2006, PUBLIC HLTH SURVEILL, V2nd; Regional Office for Africa, 2020, OP STAT COVID 19 PRE; Romaguera R. A., 2000, PRINCIPLES PRACTICE, P176; Rota PA, 2009, CURR TOP MICROBIOL, V330, P129; Spika JS, 2003, J INFECT DIS, V187, pS191, DOI 10.1086/368336; Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-17; THACKER SB, 1983, JAMA-J AM MED ASSOC, V249, P1181; Uganda Ministry of Health, 2010, HLTH MAN INF SYST; VOGT RL, 1983, AM J PUBLIC HEALTH, V73, P795, DOI 10.2105/AJPH.73.7.795; WHO, 1999, GUID EP PREP RESP ME; WHO [Regional Office for Africa], GUID MEASL SURV; World Health Organization, 2012, WORLD HLTH STAT; World Health Organization, AFRO MEASL SURV GUID; World Health Organization, STRENGTH NAT SURV SY	24	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184549	10.1371/journal.pone.0184549	http://dx.doi.org/10.1371/journal.pone.0184549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886171	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100153
J	Singh, R; De Sarkar, N; Sarkar, S; Roy, R; Chattopadhyay, E; Ray, A; Biswas, NK; Maitra, A; Roy, B				Singh, Richa; De Sarkar, Navonil; Sarkar, Sumanta; Roy, Roshni; Chattopadhyay, Esita; Ray, Anindita; Biswas, Nidhan K.; Maitra, Arindam; Roy, Bidyut			Analysis of the whole transcriptome from gingivo-buccal squamous cell carcinoma reveals deregulated immune landscape and suggests targets for immunotherapy	PLOS ONE			English	Article							CANCER; EXPRESSION; THERAPY	Background Gingivo-buccal squamous cell carcinoma (GBSCC) is one of the most common oral cavity cancers in India with less than 50% patients surviving past 5 years. Here, we report a whole transcriptome profile on a batch of GBSCC tumours with diverse tobacco usage habits. The study provides an entire landscape of altered expression with an emphasis on searching for targets with therapeutic potential. Methods Whole transcriptomes of 12 GBSCC tumours and adjacent normal tissues were sequenced and analysed to explore differential expression of genes. Expression changes were further compared with those in TCGA head and neck cohort (n = 263) data base and validated in an independent set of 10GBSCC samples. Results Differentially expressed genes (n = 2176) were used to cluster the patients based on their tobacco habits, resulting in 3 subgroups. Immune response was observed to be significantly aberrant, along with cell adhesion and lipid metabolism processes. Different modes of immune evasion were seen across 12 tumours with up-regulation or consistent expression of CD47, unlike other immune evasion genes such as PDL1, FUT4, CTLA4 and BTLA which were downregulated in a few samples. Variation in infiltrating immune cell signatures across tumours also indicates heterogeneity in immune evasion strategies. A few actionable genes such as ITGA4, TGFB1 and PTGS1/COX1 were over expressed in most samples. Conclusion This study found expression deregulation of key immune evasion genes, such as CD47 and PDL1, and reasserts their potential as effective immunotherapeutic targets for GBSCC, which requires further clinical studies. Present findings reiterate the idea of using transcriptome profiling to guide precision therapeutic strategies.	[Singh, Richa; De Sarkar, Navonil; Roy, Roshni; Chattopadhyay, Esita; Ray, Anindita; Roy, Bidyut] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Sarkar, Sumanta; Biswas, Nidhan K.; Maitra, Arindam] Natl Inst Biomed Genom, Kalyani, W Bengal, India; [De Sarkar, Navonil] Fred Hutchinson Canc Res Ctr, HB Div, 1124 Columbia St, Seattle, WA 98104 USA; [Roy, Roshni] Baylor Scott & White Hlth, CGR, Dallas, TX USA	Indian Statistical Institute; Indian Statistical Institute Kolkata; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); Fred Hutchinson Cancer Center; Baylor Health Care System	Roy, B (corresponding author), Indian Stat Inst, Human Genet Unit, Kolkata, India.	broy@isical.ac.in	biswas, Nidhan Kumar K/A-4383-2009	biswas, Nidhan Kumar K/0000-0001-7960-3290; Roy, Bidyut/0000-0003-4117-5838; Ray, Anindita/0000-0003-4824-8913				Biswas NK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6835; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chen LP, 2015, J CLIN INVEST, V125, P3384, DOI 10.1172/JCI80011; Chen YX, 2013, BIOINFORMATICS, V29, P266, DOI 10.1093/bioinformatics/bts665; Chocolatewala NM, 2009, J CANCER RES THER, V5, P71, DOI 10.4103/0973-1482.52788; Conway C, 2015, ONCOTARGET, V6, P40186, DOI 10.18632/oncotarget.5529; Cuzick J, 2012, BRIT J CANCER, V106, P1095, DOI 10.1038/bjc.2012.39; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; De Sarkar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104839; Espinoza DO, 2010, FASEB J, V24, P1003, DOI 10.1096/fj.09-133728; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hinrichs CS, 2014, IMMUNOL REV, V257, P56, DOI 10.1111/imr.12132; Hurwitz AA, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0062-4; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Jadhav KB, 2013, N AM J MED SCI, V5, P671, DOI 10.4103/1947-2714.123239; Jiang Jing-ting, 2007, Journal of Zhejiang University-Science B, V8, P398, DOI 10.1631/jzus.2007.B0398; Jiang JT, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-4; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Liu Q, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1183850; Maitra A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3873; Mittal D, 2014, CURR OPIN IMMUNOL, V27, P16, DOI 10.1016/j.coi.2014.01.004; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nicorici D, 2014, BIORXIV; Norwood S, 2010, AM J TRANSL RES, V2, P447; Pickering CR, 2013, CANCER DISCOV, V3, P770, DOI 10.1158/2159-8290.CD-12-0537; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sun J, 2010, SIGNAL TRANSDUCT, DOI [10.1155/2010/985132, DOI 10.1155/2010/985132]; Takenaka K, 2005, CANCER EPIDEM BIOMAR, V14, P1972, DOI 10.1158/1055-9965.EPI-05-0060; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Van Roosbroeck K., 2016, CLIN CANC RES; Vargas-Ferreira Fabiana, 2012, Braz. Dent. J., V23, P586, DOI 10.1590/S0103-64402012000500020; Wagner AH, 2016, NUCLEIC ACIDS RES, V44; Wan YJ, 2014, CELL SIGNAL, V26, P2202, DOI 10.1016/j.cellsig.2014.05.015; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	38	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183606	10.1371/journal.pone.0183606	http://dx.doi.org/10.1371/journal.pone.0183606			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886030	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100031
J	Jensen, EA				Jensen, Eric Allen			Putting the methodological brakes on claims to measure national happiness through Twitter: Methodological limitations in social media analytics	PLOS ONE			English	Article								With the rapid global proliferation of social media, there has been growing interest in using this existing source of easily accessible 'big data' to develop social science knowledge. However, amidst the big data gold rush, it is important that long-established principles of good social research are not ignored. This article critically evaluates Mitchell et al.' s (2013) study, 'The Geography of Happiness: Connecting Twitter Sentiment and Expression, Demographics, and Objective Characteristics of Place', demonstrating the importance of attending to key methodological issues associated with secondary data analysis.	[Jensen, Eric Allen] Univ Warwick, Dept Sociol, Coventry, W Midlands, England	University of Warwick	Jensen, EA (corresponding author), Univ Warwick, Dept Sociol, Coventry, W Midlands, England.	e.jensen@warwick.ac.uk		Jensen, Eric/0000-0002-8332-4507				Agren P, 1999, P IRIS 20 SOC INF; Boellstorff T, 2008, COMING OF AGE IN SECOND LIFE: AN ANTHROPOLOGIST EXPLORES THE VIRTUALLY HUMAN, P1; Boyd D, 2012, INFORM COMMUN SOC, V15, P662, DOI 10.1080/1369118X.2012.678878; Graham M, 2014, PROF GEOGR, V66, P568, DOI 10.1080/00330124.2014.907699; Jensen E. A., 2016, DOING REAL RES PRACT; Liu B., 2015, SENTIMENT ANAL MINIG; Miller Daniel, 2001, INTERNET ETHNOGRAPHI; Mitchell J, 2010, COGNITIVE SCI, V34, P1388, DOI 10.1111/j.1551-6709.2010.01106.x; Mitchell L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064417; Navigli R, 2009, ACM COMPUT SURV, V41, DOI 10.1145/1459352.1459355; Perrin A, 2015, SOCIAL MEDIA USAGE 2; Ribeiro FN, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0085-1; Rosenquist J., 2021, P INT AAAI C WEB SOC, V5, P554; Sloan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142209; Sloan L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115545; Smith BK, 2016, PUBLIC UNDERST SCI, V25, P154, DOI 10.1177/0963662515623248	16	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0180080	10.1371/journal.pone.0180080	http://dx.doi.org/10.1371/journal.pone.0180080			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880882	gold, Green Published, Green Submitted			2022-12-27	WOS:000409467200002
J	Phillips, BL; Gautam, US; Bucsan, AN; Foreman, TW; Golden, NA; Niu, T; Kaushal, D; Mehra, S				Phillips, Bonnie L.; Gautam, Uma S.; Bucsan, Allison N.; Foreman, Taylor W.; Golden, Nadia A.; Niu, Tianhua; Kaushal, Deepak; Mehra, Smriti			LAG-3 potentiates the survival of Mycobacterium tuberculosis in host phagocytes by modulating mitochondrial signaling in an in-vitro granuloma model	PLOS ONE			English	Article							T-CELLS; IMMUNE-RESPONSE; RHESUS MACAQUES; GENE-EXPRESSION; DENDRITIC CELLS; INNATE IMMUNITY; IFN-GAMMA; INFECTION; MACROPHAGES; ACTIVATION	CD4(+) T-cell mediated Th1 immune responses are critical for immunity to TB. The immunomodulatory protein, lymphocyte activation gene-3 (LAG-3) decreases Th1-type immune responses in T-cells. LAG-3 expression is significantly induced in the lungs of macaques with active TB and correlates with increased bacterial burden. Overproduction of LAG-3 can greatly diminish responses and could lead to uncontrolled Mtb replication. To assess the effect of LAG-3 on the progression of Mtb infection, we developed a co-culture system wherein blood-derived macrophages are infected with Mtb and supplemented with macaque blood or lung derived CD4(+) T-cells. Silencing LAG-3 signaling in macaque lung CD4(+) T-cells enhanced killing of Mtb in co-cultures, accompanied by reduced mitochondrial electron transport and increased IFN-gamma expression. Thus, LAG-3 may modulate adaptive immunity to Mtb infection by interfering with the mitochondrial apoptosis pathway. Better understanding this pathway could allow us to circumvent immune features that promote disease.	[Phillips, Bonnie L.; Gautam, Uma S.; Bucsan, Allison N.; Foreman, Taylor W.; Golden, Nadia A.; Kaushal, Deepak; Mehra, Smriti] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA; [Phillips, Bonnie L.; Bucsan, Allison N.; Foreman, Taylor W.; Kaushal, Deepak] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Niu, Tianhua] Tulane Univ, Sch Publ Hlth, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA; [Mehra, Smriti] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA; [Phillips, Bonnie L.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC USA	Tulane University; Tulane University; Tulane University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Kaushal, D; Mehra, S (corresponding author), Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.; Kaushal, D (corresponding author), Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA.; Mehra, S (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.	dkaushal@tulane.edu; smehra@lsu.edu	Uma S Gautam, MSc/H-3474-2019; GAUTAM, UMA/AAI-1531-2021	Uma S Gautam, MSc/0000-0003-0326-6325; Bucsan, Allison N./0000-0002-0568-1701	NIH grants [P20GM110760, R01A1111943, R01HL106790, R01A1089323, P51OD011104, C06A1058609]; Louisiana State University CoBRE; Tulane National Primate Research Center Office; Louisiana Vaccine Center from the Tulane Office; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana State University CoBRE; Tulane National Primate Research Center Office; Louisiana Vaccine Center from the Tulane Office; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH grants P20GM110760, R01A1111943, R01HL106790, R01A1089323, P51OD011104, and C06A1058609, awards from the Louisiana State University CoBRE, the Tulane National Primate Research Center Office of the Director, and Pilot Projects Program, Louisiana Vaccine Center and a Bridge Fund from the Tulane Office of Vice President for Research. The funders had no role in design or interpretation.	Adekambi T, 2015, J CLIN INVEST, V125, P1827, DOI 10.1172/JCI77990; Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Andreae S, 2002, J IMMUNOL, V168, P3874, DOI 10.4049/jimmunol.168.8.3874; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Boros D L, 1978, Prog Allergy, V24, P183, DOI 10.1159/000314417; Cai YH, 2014, J IMMUNOL, V192, P2821, DOI 10.4049/jimmunol.1302269; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Castano D, 2014, TUBERCULOSIS, V94, P207, DOI 10.1016/j.tube.2014.01.001; Darrah PA, 2014, J IMMUNOL; Dutta Noton K, 2014, Trials Vaccinol, V3, P47, DOI 10.1016/j.trivac.2014.02.001; Dutta NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028958; Dutta NK, 2010, J INFECT DIS, V201, P1743, DOI 10.1086/652497; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Fenhalls G, 2002, IMMUNOLOGY, V105, P325, DOI 10.1046/j.1365-2567.2002.01378.x; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FLORY CM, 1992, J LEUKOCYTE BIOL, V51, P225, DOI 10.1002/jlb.51.3.225; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Foreman TW, 2016, P NATL ACAD SCI US; Gautam US, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095220; Gautam US, 2014, AM J RESP CELL MOL B; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Goldberg MV, 2011, CURR TOP MICROBIOL, V344, P269, DOI 10.1007/82_2010_114; Gong JH, 1996, INFECT IMMUN, V64, P913, DOI 10.1128/IAI.64.3.913-918.1996; Guirado E, 2015, MBIO, V6, DOI 10.1128/mBio.02537-14; Hemon P, 2011, J IMMUNOL, V186, P5173, DOI 10.4049/jimmunol.1002050; Hudock TA, 2017, AM J RESP CELL MOL B; Kapoor N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053657; Kaushal D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9533; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Lin P. L., 2013, ANTIMICROB AGENTS CH; Luo QY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00240; Macon-Lemaitre L, 2005, IMMUNOLOGY, V115, P170, DOI 10.1111/j.1365-2567.2005.02145.x; Martinez AN, 2013, J INFECT DIS, V207, P1253, DOI 10.1093/infdis/jit037; Mehra S, 2015, AM J RESP CRIT CARE; Mehra S, 2013, J INFECT DIS, V207, P1115, DOI 10.1093/infdis/jis778; Mehra S, 2012, J INFECT DIS, V205, P1203, DOI 10.1093/infdis/jis102; Mehra S, 2011, J MED PRIMATOL, V40, P233, DOI 10.1111/j.1600-0684.2011.00485.x; Mehra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012266; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; ORME IM, 1992, J IMMUNOL, V148, P189; Pai RK, 2003, J IMMUNOL, V171, P175, DOI 10.4049/jimmunol.171.1.175; Phillips BL, 2015, AM J PATHOL, V185, P820, DOI 10.1016/j.ajpath.2014.11.003; Poirier N, 2011, CLIN EXP IMMUNOL, V164, P265, DOI 10.1111/j.1365-2249.2011.04329.x; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Randolph GJ, 2008, CURR OPIN IMMUNOL, V20, P52, DOI 10.1016/j.coi.2007.10.010; Raviglione MC, 2007, B WORLD HEALTH ORGAN, V85, P327, DOI 10.2471/BLT.06.038513; Redford PS, 2011, MUCOSAL IMMUNOL, V4, P261, DOI 10.1038/mi.2011.7; Rojas RE, 1999, INFECT IMMUN, V67, P6461; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Russell DG, 2013, CURR OPIN MICROBIOL, V16, P78, DOI 10.1016/j.mib.2012.11.007; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Srivastava S, 2013, J IMMUNOL, V191, P1016, DOI 10.4049/jimmunol.1301236; Tian XL, 2015, J IMMUNOL, V194, P3873, DOI 10.4049/jimmunol.1402176; Triebel F, 2003, TRENDS IMMUNOL, V24, P619, DOI 10.1016/j.it.2003.10.001; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185	63	9	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0180413	10.1371/journal.pone.0180413	http://dx.doi.org/10.1371/journal.pone.0180413			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880895	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200003
J	Chromikova, V; Zaragoza, MA; Krammer, F				Chromikova, Veronika; Zaragoza, Maria A.; Krammer, Florian			Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody	PLOS ONE			English	Article							INFLUENZA; CYTOTOXICITY	Because of the broad neutralization and in vivo protection across influenza A and influenza B virus strains, monoclonal antibody CR9114 is widely used in influenza virus research as a positive control in many experiments. To produce amounts sufficient for the demand requires regular transient transfections, resulting in varying yield as well as differing batch to batch quality. Here, we report the development of a serum-free CHO DG44 cell line, stably producing a CR9114-like antibody with a potential to become a useful influenza virus research tool.	[Chromikova, Veronika; Zaragoza, Maria A.; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Zaragoza, Maria A.] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	florian.krammer@mssm.edu	Krammer, Florian/H-3237-2019	Krammer, Florian/0000-0003-4121-776X	NIAID [U19 AI109946]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI109946] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIAID grant U19 AI109946.; We would like to thank Dr. Yiannis Ioannou for kindly providing us with the CHO DG44 cells, Dr. Patrick Wilson for providing the vectors containing the CR9114 sequences and Paul Bunduc for his technical assistance during the screening and selection process of recombinant serum-free cell line. Funding was provided by NIAID grant U19 AI109946.	Ana-Sosa-Batiz F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154461; Chromikova V, 2015, CYTOTECHNOLOGY, V67, P343, DOI 10.1007/s10616-014-9693-4; Chusainow J, 2009, BIOTECHNOL BIOENG, V102, P1182, DOI 10.1002/bit.22158; Cox F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00399; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Dunand CJH, 2016, CELL HOST MICROBE, V19, P800, DOI 10.1016/j.chom.2016.05.014; Dunand CJH, 2015, J CLIN INVEST, V125, P1255, DOI 10.1172/JCI74374; He WQ, 2016, P NATL ACAD SCI USA, V113, P11931, DOI 10.1073/pnas.1609316113; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Lattenmayer C, 2007, J BIOTECHNOL, V128, P716, DOI 10.1016/j.jbiotec.2006.12.016; Lee J, 2016, NAT MED, V22, P1023, DOI 10.1038/nm.4145; Leon PE, 2016, P NATL ACAD SCI USA, V113, pE5944, DOI 10.1073/pnas.1613225113; Margine I, 2013, JOVE-J VIS EXP, DOI 10.3791/51112; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Tan GS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005578; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; URLAUB G, 1983, CELL, V33, P405, DOI 10.1016/0092-8674(83)90422-1; Vanderven HA, 2017, CURR OPIN VIROL, V22, P89, DOI 10.1016/j.coviro.2016.12.002; Wurm FM, 2011, NAT BIOTECHNOL, V29, P718, DOI 10.1038/nbt.1943	22	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183315	10.1371/journal.pone.0183315	http://dx.doi.org/10.1371/journal.pone.0183315			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910287	Green Submitted, gold, Green Published			2022-12-27	WOS:000410859200008
J	Jeon, JP; Lee, SU; Kim, SE; Kang, SH; Yang, JS; Choi, HJ; Cho, YJ; Ban, SP; Byoun, HS; Kim, YS				Jeon, Jin Pyeong; Lee, Si Un; Kim, Sung-Eun; Kang, Suk Hyung; Yang, Jin Seo; Choi, Hyuk Jai; Cho, Yong Jun; Ban, Seung Pil; Byoun, Hyoung Soo; Kim, Young Soo			Correlation of optic nerve sheath diameter with directly measured intracranial pressure in Korean adults using bedside ultrasonography	PLOS ONE			English	Article							SONOGRAPHIC MEASUREMENT; HYPERTENSION; ULTRASOUND; DIAGNOSIS	Objectives The correlation of optic nerve sheath diameter (ONSD) as seen on ultrasonography (US) and directly measured intracranial pressure (ICP) has been well described. Nevertheless, differences in ethnicity and type of ICP monitor used are obstacles to the interpretation. Therefore, we investigated the direct correlation between ONSD and ventricular ICP and defined an optimal cut-off point for identifying increased ICP (IICP) in Korean adults with brain lesions. Methods This prospective study included patients who required an external ventricular drainage (EVD) catheter for ICP control. IICP was defined as an opening pressure over 20 mmHg. ONSD was measured using a 13 MHz US probe before the procedure. Linear regression analysis and receiver operator characteristic (ROC) curve were used to assess the association between ONSD and ICP. Optimal cut-off value for identifying IICP was defined. Results A total of 62 patients who underwent ONSD measurement with simultaneous EVD catheter placement were enrolled in this study. Thirty-two patients (51.6%) were found to have IICP. ONSD in patients with IICP (5.80 +/- 0.45 mm) was significantly higher than in those without IICP (5.30 +/- 0.61 mm) (P < 0.01). The IICP group showed more significant linear correlation with ONSD (r = 0.57, P < 0.01) compared to the non-IICP group (r = 0.42, P = 0.02). ONSD > 5.6 mm disclosed a sensitivity of 93.75% and a specificity of 86.67% for identifying IICP. Conclusion ONSD as seen on bedside US correlated well with directly measured ICP in Korean adults with brain lesions. The optimal cut-off point of ONSD for detecting IICP was 5.6 mm.	[Jeon, Jin Pyeong; Kang, Suk Hyung; Yang, Jin Seo; Choi, Hyuk Jai; Cho, Yong Jun] Hallym Univ, Coll Med, Dept Neurosurg, Chunchon, South Korea; [Jeon, Jin Pyeong] Hallym Univ, Coll Med, New Frontier Res Inst, Chunchon, South Korea; [Lee, Si Un; Ban, Seung Pil; Byoun, Hyoung Soo] Seoul Natl Univ, Bundang Hosp, Dept Neurosurg, Seongnam, South Korea; [Kim, Sung-Eun] Seoul Emergency Operat Ctr, Dept Emergency Med, Seoul, South Korea; [Kim, Young Soo] Vet Hlth Serv Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea	Hallym University; Hallym University; Seoul National University (SNU); Veterans Health Service Medical Center	Kang, SH (corresponding author), Hallym Univ, Coll Med, Dept Neurosurg, Chunchon, South Korea.	nscharisma@daum.net	Kang, Sukhyung/R-6333-2019; Choi, Hyukjai/GSE-1138-2022	Kang, Sukhyung/0000-0002-1130-9754	Hallym University [HURF-2015-52]; National Research Foundation of Korea - Ministry of Science, Information and Communication Technologies and Future Planning of the Korea Government [2017M3A9E8033223]	Hallym University; National Research Foundation of Korea - Ministry of Science, Information and Communication Technologies and Future Planning of the Korea Government	This study was supported by Hallym University Research Fund (HURF-2015-52) and National Research Foundation of Korea grant funded by the Ministry of Science, Information and Communication Technologies and Future Planning of the Korea Government (No. 2017M3A9E8033223).	Amini A, 2013, AM J EMERG MED, V31, P236, DOI 10.1016/j.ajem.2012.06.025; Bauerle J, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-187; Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Blaivas M, 2003, ACAD EMERG MED, V10, P376, DOI 10.1111/j.1553-2712.2003.tb01352.x; Bundgaard H, 1998, ACTA ANAESTH SCAND, V42, P7; Chen H, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0361-x; Cold GE B H, 1998, ICP ANAESTHESIA SEVO, V71, P3; Frumin E, 2014, WEST J EMERG MED, V15, P217, DOI 10.5811/westjem.2013.9.16191; Geeraerts T, 2008, INTENS CARE MED, V34, P2062, DOI 10.1007/s00134-008-1149-x; Geeraerts T, 2007, INTENS CARE MED, V33, P1704, DOI 10.1007/s00134-007-0797-6; Girisgin AS, 2007, EMERG MED J, V24, P251, DOI 10.1136/emj.2006.040931; Goeres P, 2016, J CRIT CARE, V31, P168, DOI 10.1016/j.jcrc.2015.10.009; Helmke K, 1996, PEDIATR RADIOL, V26, P706, DOI 10.1007/BF01383384; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Ko SB, 2013, J STROKE, V15, P99, DOI 10.5853/jos.2013.15.2.99; Komut E, 2016, AM J EMERG MED, V34, P963, DOI 10.1016/j.ajem.2016.02.012; Kristiansson H N E, 2013, J NEUROSURG ANESTHES, V25, P14; Launey Y, 2014, J NEUROTRAUM, V31, P984, DOI 10.1089/neu.2012.2829; LEE SH, 2016, MEDICINE, V95, DOI DOI 10.1097/MD; Lenfeldt N K L, 2007, NEUROLOGY, V68, P4; Li ZM, 2016, NEUROSURG QUART, V26, P5; Maissan IM D P, 2015, J NEUROSURG, V123, P5; Maude RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081013; Moretti R, 2009, NEUROCRIT CARE, V11, P406, DOI 10.1007/s12028-009-9250-8; Moretti R, 2009, J NEUROSURG ANESTH, V21, P16, DOI 10.1097/ANA.0b013e318185996a; Newman WD, 2002, BRIT J OPHTHALMOL, V86, P1109, DOI 10.1136/bjo.86.10.1109; Philip Barlow FRCS, 1985, J NEUROSURG, V63, P5; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Rosenberg JB S A, 2011, NEUROCRIT CARE, V15, P10; Sekhon MS, 2014, INTENS CARE MED, V40, P1267, DOI 10.1007/s00134-014-3392-7; Soldatos T, 2008, CRIT CARE, V12, DOI 10.1186/cc6897; Tayal VS, 2007, ANN EMERG MED, V49, P508, DOI 10.1016/j.annemergmed.2006.06.040; Vender J, 2011, J CLIN MONIT COMPUT, V25, P231, DOI 10.1007/s10877-011-9300-6; Wang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132638; Wang LJ, 2016, ULTRASOUND MED BIOL, V42, P683, DOI 10.1016/j.ultrasmedbio.2015.11.020; Warden KF A A, 2011, J NEURO-OPHTHALMOL, V31, P4	37	40	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183170	10.1371/journal.pone.0183170	http://dx.doi.org/10.1371/journal.pone.0183170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902893	gold, Green Published, Green Submitted			2022-12-27	WOS:000410669200010
J	Lim, SH; Mburu, G; Bourne, A; Pang, J; Wickersham, JA; Wei, CKT; Yee, IA; Wang, BY; Cassolato, M; Azwa, I				Lim, Sin How; Mburu, Gitau; Bourne, Adam; Pang, Joselyn; Wickersham, Jeffrey A.; Wei, Clayton Koh Thuan; Yee, Ilias Adam; Wang, Bangyuan; Cassolato, Matteo; Azwa, Iskandar			Willingness to use pre-exposure prophylaxis for HIV prevention among men who have sex with men in Malaysia: Findings from an online survey	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; SEXUALLY-TRANSMITTED HIV; ASIA-PACIFIC REGION; TRANSGENDER WOMEN; HIGH-RISK; CONDOM USE; YOUNG MEN; PREP; ACCEPTABILITY; MSM	Objective We examined willingness to use pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men (MSM) in Malaysia. Methods An online survey of 990 MSM was conducted between March and April 2016. Eligibility criteria included being biological male, Malaysian citizen, 18 years of age or above, identifying as MSM, and being HIV negative or unknown status. Participants' demographics, sexual and drug use behaviors, attitudes towards PrEP, and preferences regarding future access to PrEP were collected. Bivariate analysis and logistic regression were performed to determine factors associated with willingness to use PrEP. Results Fewer than half of participants (44%) knew about PrEP before completing the survey. Overall, 39% of the sample were willing to take PrEP. Multivariate logistic regression indicated that Malay men (AOR: 1.73, 95% CI: 1.12, 2.70), having 2 or more male anal sex partners in the past 6 months (AOR: 1.98, 95% CI: 1.29, 3.05), previous knowledge of PrEP (AOR: 1.40, 95% CI: 1.06, 1.86), lack of confidence in practising safer sex (AOR: 1.36, 95% CI: 1.02, 1.81), and having ever paid for sex with a male partner (AOR: 1.39, 95% CI: 1.01, 1.91) were independently associated with greater willingness to use PrEP, while men who identified as heterosexual were less willing to use PrEP (AOR, 0.36, 95% CI: 0.13, 0.97). Majority of participants preferred to access PrEP at affordable cost below 100 Malaysian Ringgit (USD25) per month from community based organisations followed by private or government hospitals. Conclusions Overall, MSM in Malaysia reported a relatively low level of willingness to use PrEP, although willingness was higher among those previously aware of PrEP. There is a need to provide PrEP at affordable cost, increase demand and awareness of PrEP, and to provide access to this preventative medication via diverse, integrated and tailored sexual health services.	[Lim, Sin How; Wickersham, Jeffrey A.] Univ Malaya, Fac Med, CERiA, Kuala Lumpur, Malaysia; [Mburu, Gitau; Wang, Bangyuan; Cassolato, Matteo] Univ Lancaster, Div Hlth Res, Lancaster, England; [Bourne, Adam] La Trobe Univ, Australian Res Ctr Sex Hlth & Soc, Melbourne, Vic, Australia; [Bourne, Adam] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Sigma Res, London, England; [Pang, Joselyn] Australian Federat AIDS Org, Int Programs, Bangkok, Thailand; [Wickersham, Jeffrey A.] Yale Sch Med, Dept Internal Med, Sect Infect Dis, AIDS Program, New Haven, CT USA; [Wei, Clayton Koh Thuan; Yee, Ilias Adam] Malaysian AIDS Council, Kuala Lumpur, Malaysia; [Azwa, Iskandar] Univ Malaya, Fac Med, Infect Dis Unit, Kuala Lumpur, Malaysia	Universiti Malaya; Lancaster University; La Trobe University; University of London; London School of Hygiene & Tropical Medicine; Yale University; Universiti Malaya	Lim, SH (corresponding author), Univ Malaya, Fac Med, CERiA, Kuala Lumpur, Malaysia.	howie.ceria@gmail.com	Lim, Sin How/AAC-8004-2020; Azwa, Iskandar/N-9186-2017	Azwa, Iskandar/0000-0003-1977-6709; Mburu, Gitau/0000-0002-5812-0529	International HIV/AIDS Alliance; University of Malaya [HIRGA E000001-20001]; National Institute on Drug Abuse [KO1 DA038529]; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA038529] Funding Source: NIH RePORTER	International HIV/AIDS Alliance; University of Malaya(Universiti Malaya); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by funding from International HIV/AIDS Alliance through its Innovation Fund. Some authors (GM, BW, MC) were employed by the funder during the conduct of this research; however, the views expressed in this paper are those of the authors and not necessarily those of the funder. This work was additionally funded by University of Malaya grant HIRGA E000001-20001 to Dr. Lim Sin How, Dr. Iskandar Azwa, and the National Institute on Drug Abuse grant KO1 DA038529 to Dr. Jeffrey A Wickersham.	Aghaizu A, 2013, SEX TRANSM INFECT, V89, P207, DOI 10.1136/sextrans-2012-050648; Al-Tayyib AA, 2014, AIDS BEHAV, V18, pS340, DOI 10.1007/s10461-013-0553-6; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Ayala George, 2013, J Sex Transm Dis, V2013, P953123, DOI 10.1155/2013/953123; Baral SD, 2015, LANCET, V385, P260, DOI 10.1016/S0140-6736(14)60801-1; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Beyrer C, 2011, 3 M TECHN ADV GROUP; Bil JP, 2015, AIDS, V29, P955, DOI 10.1097/QAD.0000000000000639; Bourne A, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21899; Brooks RA, 2015, INT J STD AIDS, V26, P1040, DOI 10.1177/0956462415570159; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Chakrapani V, 2015, AIDS PATIENT CARE ST, V29, P569, DOI 10.1089/apc.2015.0143; Ding YY, 2016, BIOSCI TRENDS, V10, P113, DOI 10.5582/bst.2016.01035; Earnshaw VA, 2016, AIDS BEHAV, V20, P98, DOI 10.1007/s10461-015-1168-x; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Ferrer L, 2016, AIDS BEHAV, V20, P1423, DOI 10.1007/s10461-016-1379-9; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Frankis J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151385; Frankis JS, 2016, SEX TRANSM INFECT, V92, P279, DOI 10.1136/sextrans-2015-052101; Gersh J. K., 2014, Journal of AIDS and Clinical Research, V5, P335; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Gredig D, 2016, AIDS CARE, V28, P44, DOI 10.1080/09540121.2016.1146212; Hoagland B, 2017, AIDS BEHAV, V21, P1278, DOI 10.1007/s10461-016-1516-5; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Holt M, 2013, AIDS BEHAV, V17, P2156, DOI 10.1007/s10461-012-0313-z; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; Hoots BE, 2016, CLIN INFECT DIS, V63, P672, DOI 10.1093/cid/ciw367; Hosek SG, 2013, JAIDS-J ACQ IMM DEF, V62, P447, DOI 10.1097/QAI.0b013e3182801081; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Ismail M N, 2002, Obes Rev, V3, P203, DOI 10.1046/j.1467-789X.2002.00074.x; Jackson T, 2012, AIDS BEHAV, V16, P1853, DOI 10.1007/s10461-012-0188-z; Kanter J, 2011, INT J STD AIDS, V22, P30, DOI 10.1258/ijsa.2010.010277; Karris MY, 2014, CLIN INFECT DIS, V58, P704, DOI 10.1093/cid/cit796; Karuga RN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151716; Kennedy C, 2014, WHOHIV20149; Kesler MA, 2016, AIDS CARE, V28, P1378, DOI 10.1080/09540121.2016.1178703; Ko NY, 2016, AIDS EDUC PREV, V28, P128, DOI 10.1521/aeap.2016.28.2.128; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Krishnaswamy S, 2009, ASIA-PAC J PUBLIC HE, V21, P442, DOI 10.1177/1010539509345862; Lebouche B, 2016, HIV MED, V17, P152, DOI 10.1111/hiv.12286; Leonardi M, 2011, INT J STD AIDS, V22, P738, DOI 10.1258/ijsa.2011.011057; Lim SH, 2015, DRUG ALCOHOL DEPEN, V151, P31, DOI 10.1016/j.drugalcdep.2015.02.040; Lim SH, 2013, SEX TRANSM INFECT, V89, P642, DOI 10.1136/sextrans-2012-050995; Lorente N, 2012, AIDS CARE, V24, P468, DOI 10.1080/09540121.2011.626394; Mansergh G, 2010, JAIDS-J ACQ IMM DEF, V55, pE14, DOI 10.1097/QAI.0b013e3181f27616; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Ministry of Health Malaysia, 2015, NAT STRAT PLAN END A; Mustanski B, 2013, AIDS BEHAV, V17, P2999, DOI 10.1007/s10461-013-0507-z; Newman PA, 2012, PREV SCI, V13, P483, DOI 10.1007/s11121-012-0275-4; Ngadiman S, 2016, GLOBAL AIDS RESPONSE; Oldenburg C, 2016, SEX HLTH; Oldenburg CE, 2014, AIDS PATIENT CARE ST, V28, P109, DOI 10.1089/apc.2013.0372; Peinado Jesus, 2013, J Int Assoc Provid AIDS Care, V12, P278, DOI 10.1177/1545109712473650; Peng P, 2017, AIDS BEHAV; Pitpitan EV, 2016, AIDS BEHAV, V20, P431, DOI 10.1007/s10461-015-1172-1; Poynten IM, 2010, HIV MED, V11, P282, DOI 10.1111/j.1468-1293.2009.00777.x; Rampal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046365; Rocha LM, 2014, J INT AIDS SOC, V17, P150, DOI 10.7448/IAS.17.4.19734; Rosenthal E, 2014, AIDS CARE, V26, P176, DOI 10.1080/09540121.2013.803014; Rucinski KB, 2013, AIDS BEHAV, V17, P2180, DOI 10.1007/s10461-013-0443-y; Saberi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050061; Sineath R Craig, 2013, J Int Assoc Provid AIDS Care, V12, P227, DOI 10.1177/2325957413488184; Stoove A M, 2015, HIV PREEXPOSURE PROP; Tavitian-Exley I, 2015, ADDICTION, V110, P572, DOI 10.1111/add.12846; Waclawski Eugene, 2012, Occup Med (Lond), V62, P477, DOI 10.1093/occmed/kqs075; Wheelock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054288; White D, 2014, AM J MENS HEALTH, V8, P98, DOI 10.1177/1557988313489133; Whiteside YO, 2011, AIDS PATIENT CARE ST, V25, P365, DOI 10.1089/apc.2010.0224; WHO, 2012, GUID PREEXPOSURE OR; World Health Organization, 2015, WHOHIV201548; Yang DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059020, 10.1371/journal.pone.0054495, 10.1371/journal.pone.0062329]; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7; Young I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064038; Zablotska I, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.7.21119; Zhang Y, 2013, AIDS PATIENT CARE ST, V27, P137, DOI 10.1089/apc.2012.0412; Zhou F, 2012, PLOS ONE, V7	77	23	25	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0182838	10.1371/journal.pone.0182838	http://dx.doi.org/10.1371/journal.pone.0182838			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902857	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000410669200006
J	Wijayaratna, KP; Dixit, VV; Denant-Boemont, L; Waller, ST				Wijayaratna, Kasun P.; Dixit, Vinayak V.; Denant-Boemont, Laurent; Waller, S. Travis			An experimental study of the Online Information Paradox: Does en-route information improve road network performance?	PLOS ONE			English	Article							REAL-TIME INFORMATION; PRE-TRIP INFORMATION; DEPENDENT NETWORKS; CHOICE DECISIONS; DYNAMIC NETWORK; RISK ATTITUDES; SYSTEMS; CONGESTION; BEHAVIOR; MODELS	This study investigates the empirical presence of a theoretical transportation paradox, defined as the "Online Information Paradox" (OIP). The paradox suggests that, for certain road networks, the provision of online information deteriorate travel conditions for all users of that network relative to the situation where no online information is provided to users. The analytical presence of the paradox was derived for a specific network structure by using two equilibrium models, the first being the Expected User Equilibrium (EUE) solution (no information scenario) and the other being the User Equilibrium with Recourse (UER) solution (with information scenario). An incentivised computerised route choice game was designed using the concepts of experimental economics and administered in a controlled laboratory environment to investigate the physical presence of the paradox. Aggregate statistics of path flows and Total System Travel Costs (TSTC) were used to compare the experimental results with the theoretical findings. A total of 12 groups of 12 participants completed the experiment and the OIP and the occurrence of the OIP being significant was observed in 11 of the 12 cases. Though information increased travel costs for users on average, it reduced the volatility of travel costs experienced in the no information scenario indicating that information can achieve a more reliable system. Further replications of similar experiments and more importantly field based identification of the phenomena will force transport professionals to be aware of the emergence of the paradox. In addition, studies such as this emphasise the need for the adoption of adaptive traffic assignment techniques to appropriately model the acquisition of information on a road network.	[Wijayaratna, Kasun P.; Dixit, Vinayak V.; Waller, S. Travis] Univ New South Wales, Sch Civil & Environm Engn, Res Ctr Integrated Transport Innovat, Sydney, NSW, Australia; [Denant-Boemont, Laurent] Univ Rennes 1, Dept Econ, Ctr Res Econ & Management CREM CNRS, Rennes, France	University of New South Wales Sydney; Universite de Rennes	Wijayaratna, KP (corresponding author), Univ New South Wales, Sch Civil & Environm Engn, Res Ctr Integrated Transport Innovat, Sydney, NSW, Australia.	k.wijayaratna@unsw.edu.au	Waller, Steven T/N-3009-2017; Wijayaratna, Kasun/AAC-8070-2022; aubertin, rebeckah/O-9624-2015	Wijayaratna, Kasun/0000-0002-4604-7256; Dixit, Vinayak/0000-0001-7643-409X; Waller, Travis/0000-0002-2939-2090; Denant-Boemont, Laurent/0000-0001-8783-1250; aubertin, rebeckah/0000-0002-0558-7571	Australian Research Council [DP150103299]	Australian Research Council(Australian Research Council)	This work was supported by DP150103299: Investigating travel choice behaviour: a new approach using interactive experiments with driving simulators; URL: https://researchdata.ands.org.au/discovery-projects-grant-id-dp150103299/618084; funded by Australian Research Council. The funder had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Arbis D, 2016, ACCIDENT ANAL PREV, V94, P135, DOI 10.1016/j.aap.2016.05.027; ARNOTT R, 1991, TRANSPORT RES A-POL, V25, P309, DOI 10.1016/0191-2607(91)90146-H; Ben-Elia E., 2015, TRANSPORT REV, P1; BENAKIVA M, 1991, TRANSPORT RES A-POL, V25, P251, DOI 10.1016/0191-2607(91)90142-D; Braess D, 2005, TRANSPORT SCI, V39, P446, DOI 10.1287/trsc.1050.0127; Chorus C.G., 2006, EUR J TRANSP INFRAST; Daganzo CF, 2011, TRANSPORT RES B-METH, V45, P782, DOI 10.1016/j.trb.2011.02.001; Daganzo CF, 2011, TRANSPORT RES B-METH, V45, P278, DOI 10.1016/j.trb.2010.06.006; Dixit V., 2015, UNDERSTANDING TRANSP; Dixit VV, 2015, TRANSPORT RES A-POL, V80, P15, DOI 10.1016/j.tra.2015.07.002; Dixit VV, 2014, TRANSPORT RES C-EMER, V48, P301, DOI 10.1016/j.trc.2014.09.002; EMMERINK RHM, 1995, TRANSPORTATION, V22, P21, DOI 10.1007/BF01151617; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Gabuthy Y, 2006, REV NETWORK EC, V5; GALIZIO M, 1979, J APPL PSYCHOL, V64, P311, DOI 10.1037/0021-9010.64.3.311; Gao S, 2006, TRANSPORT RES B-METH, V40, P93, DOI 10.1016/j.trb.2005.02.001; Gao S, 2012, IEEE T INTELL TRANSP, V13, P1298, DOI 10.1109/TITS.2012.2187197; Hall RW, 1996, TRANSPORT RES C-EMER, V4, P289, DOI 10.1016/S0968-090X(97)82902-6; Henn V, 2006, EUR J OPER RES, V175, P1526, DOI 10.1016/j.ejor.2005.02.026; Kim S, 2005, IEEE T INTELL TRANSP, V6, P178, DOI 10.1109/TITS.2005.848362; Knight FH, 1924, Q J ECON, V38, P582, DOI 10.2307/1884592; Knorr F, 2014, TRANSPORT RES F-TRAF, V27, P44, DOI 10.1016/j.trf.2014.09.003; Koutspoulos H. N., 1994, TRANSPORT RES C-EMER, V2C, P91, DOI DOI 10.1016/0968-090X(94)90002-7; Lindsey R, 2014, TRANSPORT RES B-METH, V67, P187, DOI 10.1016/j.trb.2014.05.006; Lu X, 2012, TRANSPORTATION RES B; Lu X, 2014, MATH POPUL STUD, V21, P205, DOI 10.1080/08898480.2013.836418; Mahmassani HS, 2013, PROCD SOC BEHV, V80, P79, DOI 10.1016/j.sbspro.2013.05.007; MAHMASSANI HS, 1991, TRANSPORT RES A-POL, V25, P293, DOI 10.1016/0191-2607(91)90145-G; Meinhold G., 2009, WORKING PAPER; Mogridge MJH, 1987, INT J TRANSPORT EC, V14; Morgan J, 2009, GAME ECON BEHAV, V66, P348, DOI 10.1016/j.geb.2008.04.012; Papinski D, 2009, TRANSPORT RES F-TRAF, V12, P347, DOI 10.1016/j.trf.2009.04.001; Pigou A., 1932, EC WELFARE; Rapoport A, 2009, GAME ECON BEHAV, V65, P538, DOI 10.1016/j.geb.2008.02.007; Rapoport A, 2008, SPRINGER OPTIM APPL, V21, P309; Rapoport A, 2006, J ECON PSYCHOL, V27, P648, DOI 10.1016/j.joep.2006.06.001; Rapoport A, 2014, TRANSPORT RES B-METH, V68, P154, DOI 10.1016/j.trb.2014.06.007; Rey D, 2016, TRANSPORT POLICY, V46, P46, DOI 10.1016/j.tranpol.2015.11.010; Saberi M, 2014, EURO J TRANSP LOGIST, V3, P289, DOI 10.1007/s13676-013-0040-2; Schneider K., 2004, ALL ODDS NASH EQUILI; Selten R, 2007, GAME ECON BEHAV, V58, P394, DOI 10.1016/j.geb.2006.03.012; Selten R, 2004, HUMAN BEHAVIOUR AND TRAFFIC NETWORKS, P1; Simon H. A., 1982, MODELS BOUNDED RATIO; Simon HA, 1955, Q J ECON, V69, P99, DOI 10.2307/1884852; Uang ST, 2003, TRANSPORT RES C-EMER, V11, P423, DOI 10.1016/S0968-090X(03)00003-2; Unnikrishnan A, 2009, NETW SPAT ECON, V9, P575, DOI 10.1007/s11067-009-9114-y; Wardrop JG, 1952, P I CIVIL ENG, P325, DOI [10.1680/ipeds.1952.11362, DOI 10.1680/IPEDS.1952.11259]; Wijayaratna K, 2013, 18 INT C HONG KONG S; Wijayaratna KP, 2016, J CHOICE MODEL, V20, P16, DOI 10.1016/j.jocm.2016.09.004	49	19	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184191	10.1371/journal.pone.0184191	http://dx.doi.org/10.1371/journal.pone.0184191			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902854	Green Submitted, Green Published, gold			2022-12-27	WOS:000410669200029
J	Belair, DG; Wolf, CJ; Wood, C; Ren, HZ; Grindstaff, R; Padgett, W; Swank, A; MacMillan, D; Fisher, A; Winnik, W; Abbott, BD				Belair, David G.; Wolf, Cynthia J.; Wood, Carmen; Ren, Hongzu; Grindstaff, Rachel; Padgett, William; Swank, Adam; MacMillan, Denise; Fisher, Anna; Winnik, Witold; Abbott, Barbara D.			Engineering human cell spheroids to model embryonic tissue fusion in vitro	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GROWTH-FACTOR RECEPTOR; OSTEOGENIC DIFFERENTIATION; CLEFT-PALATE; STROMAL CELLS; EXPRESSION; BONE; MECHANISMS; GENE; PALATOGENESIS	Epithelial-mesenchymal interactions drive embryonic fusion events during development, and perturbations of these interactions can result in birth defects. Cleft palate and neural tube defects can result from genetic defects or environmental exposures during development, yet very little is known about the effect of chemical exposures on fusion events during human development because of a lack of relevant and robust human in vitro assays of developmental fusion behavior. Given the etiology and prevalence of cleft palate and the relatively simple architecture and composition of the embryonic palate, we sought to develop a three-dimensional culture system that mimics the embryonic palate and could be used to study fusion behavior in vitro using human cells. We engineered size-controlled human Wharton's Jelly stromal cell (HWJSC) spheroids and established that 7 days of culture in osteogenesis differentiation medium was sufficient to promote an osteogenic phenotype consistent with embryonic palatal mesenchyme. HWJSC spheroids supported the attachment of human epidermal keratinocyte progenitor cells (HPEKp) on the outer spheroid surface likely through deposition of collagens I and IV, fibronectin, and laminin by mesenchymal spheroids. HWJSC spheroids coated in HPEKp cells exhibited fusion behavior in culture, as indicated by the removal of epithelial cells from the seams between spheroids, that was dependent on epidermal growth factor signaling and fibroblast growth factor signaling in agreement with palate fusion literature. The method described here may broadly apply to the generation of three-dimensional epithelial-mesenchymal co-cultures to study developmental fusion events in a format that is amenable to predictive toxicology applications.	[Belair, David G.; Wolf, Cynthia J.; Wood, Carmen; Abbott, Barbara D.] US EPA, Tox Assessment Div, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA; [Ren, Hongzu; Grindstaff, Rachel; Padgett, William; Swank, Adam; MacMillan, Denise; Fisher, Anna; Winnik, Witold] US EPA, Res Cores Unit, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA	United States Environmental Protection Agency; United States Environmental Protection Agency	Abbott, BD (corresponding author), US EPA, Tox Assessment Div, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.	abbott.barbara@epa.gov	Belair, David/AAT-8237-2020	Belair, David/0000-0003-2145-3829; Abbott, Barbara/0000-0001-8996-5842	US Environmental Protection Agency	US Environmental Protection Agency(United States Environmental Protection Agency)	The information in this document has been funded wholly by the US Environmental Protection Agency. It has been subjected to review by the National Health and Environmental Effects Research Laboratory and approved for publication. Approval does not signify that the contents reflect the views of the Agency, nor does mention of trade names or commercial products constitute endorsement or recommendation for use.	Abbott BD, 2010, BIRTH DEFECTS RES B, V89, P266, DOI 10.1002/bdrb.20252; Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181; Baraniak PR, 2012, CELL TISSUE RES, V347, P701, DOI 10.1007/s00441-011-1215-5; Belair DG, 2017, TOXICOLOGY, V382, P93, DOI 10.1016/j.tox.2017.03.007; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Contador D, 2015, EXP BIOL MED, V240, P1235, DOI 10.1177/1535370214566565; Czajka CA, 2014, ANN BIOMED ENG, V42, P1049, DOI 10.1007/s10439-014-0986-8; Dahlmann J, 2013, BIOMATERIALS, V34, P2463, DOI 10.1016/j.biomaterials.2012.12.024; De la Fuente A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010496; Dean DM, 2007, FASEB J, V21, P4005, DOI 10.1096/fj.07-8710com; Dean DM, 2008, TISSUE ENG PT A, V14, P1989, DOI 10.1089/ten.tea.2007.0320; Deisenroth C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114133; Doherty KR, 2013, TOXICOL APPL PHARM, V272, P245, DOI 10.1016/j.taap.2013.04.027; Dudas M, 2004, DEV BIOL, V266, P96, DOI 10.1016/j.ydbio.2003.10.007; Dudas M, 2006, DEV BIOL, V296, P298, DOI 10.1016/j.ydbio.2006.05.030; Ebert R, 2015, STEM CELL RES, V15, P231, DOI 10.1016/j.scr.2015.06.008; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Feng J, 2008, FASEB J, V22; Ge Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162522; Ge Y, 2011, PROTEOMICS, V11, P2406, DOI 10.1002/pmic.201000741; Ghali O, 2015, BMC CELL BIOL, V16, DOI 10.1186/s12860-015-0056-6; Gittenberger-de Groot AC, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.05.002; Granchi D, 2010, TISSUE ENG PART C-ME, V16, P511, DOI [10.1089/ten.tec.2009.0405, 10.1089/ten.TEC.2009.0405]; Hakelien AM, 2014, STEM CELLS, V32, P2780, DOI 10.1002/stem.1759; He X, 2017, EXP CELL RES; Hemming S, 2016, STEM CELLS DEV, V25, P909, DOI 10.1089/scd.2015.0384; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Hu LH, 2015, J CELL PHYSIOL, V230, P1212, DOI 10.1002/jcp.24856; Iwata J, 2011, ORAL DIS, V17, P733, DOI 10.1111/j.1601-0825.2011.01806.x; Jaager K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038833; Jakab K, 2004, P NATL ACAD SCI USA, V101, P2864, DOI 10.1073/pnas.0400164101; Jakab K, 2010, BIOFABRICATION, V2, DOI 10.1088/1758-5082/2/2/022001; Kelm JM, 2006, TISSUE ENG, V12, P2151, DOI 10.1089/ten.2006.12.2151; Kitase Y, 2013, INT J DEV BIOL, V57, P55, DOI 10.1387/ijdb.120117yk; Knudsen T.B., 2017, CHEM RES TOXICOL; Lane J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00258; Langenbach F, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt328; Levi B, 2011, PLAST RECONSTR SURG, V127, P1182, DOI 10.1097/PRS.0b013e3182043a07; Li Y, 2011, J BONE MINER RES, V26, P2656, DOI 10.1002/jbmr.480; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Lobo SE, 2015, CELL TISSUE RES, V361, P477, DOI 10.1007/s00441-015-2116-9; Marga Francoise, 2007, Birth Defects Research, V81, P320, DOI 10.1002/bdrc.20109; Mastroiacovo P, 2011, CLEFT PALATE-CRAN J, V48, P66, DOI 10.1597/09-217; Meng L, 2009, J DENT RES, V88, P22, DOI 10.1177/0022034508327868; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Nakanishi Y, 2015, MOL CANCER THER, V14, P704, DOI 10.1158/1535-7163.MCT-14-0927-T; Nakanishi Y, 2014, MOL CANCER THER, V13, P2547, DOI 10.1158/1535-7163.MCT-14-0248; Nelson ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025847; Nicolaidou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039871; Onizuka S, 2016, J CELL BIOCHEM, V117, P2423, DOI 10.1002/jcb.25634; Perez-Pomares JM, 2006, BIOESSAYS, V28, P809, DOI 10.1002/bies.20442; Piek E, 2010, BONE, V46, P613, DOI 10.1016/j.bone.2009.10.024; Ray HJ, 2012, DEVELOPMENT, V139, P1701, DOI 10.1242/dev.068338; Rice R, 2004, J CLIN INVEST, V113, P1692, DOI 10.1172/JCI200420384; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Safadi FF, 2009, BONE PATHOLOGY, SECOND EDITION, P1, DOI 10.1007/978-1-59745-347-9_1; Safadi FF, 2003, J CELL PHYSIOL, V196, P51, DOI 10.1002/jcp.10319; Santos JM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0082-5; Saugspier M, 2010, STEM CELLS DEV, V19, P707, DOI [10.1089/scd.2010.0027, 10.1089/scd.2009.0027]; Schulze J, 2011, J BONE MINER RES, V26, P704, DOI 10.1002/jbmr.269; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Shum LC, 2016, STEM CELLS DEV, V25, P114, DOI 10.1089/scd.2015.0193; STEINBERG MS, 1962, SCIENCE, V137, P762, DOI 10.1126/science.137.3532.762; Taya Y, 1999, DEVELOPMENT, V126, P3869; Vater C, 2011, ACTA BIOMATER, V7, P463, DOI 10.1016/j.actbio.2010.07.037; Viale-Bouroncle S, 2015, BIOCHEM BIOPH RES CO, V457, P314, DOI 10.1016/j.bbrc.2014.12.107; Wang C, 2013, J BIOL CHEM, V288, P22174, DOI 10.1074/jbc.M113.463620; Wang JJ, 2009, J ZHEJIANG UNIV-SC B, V10, P355, DOI 10.1631/jzus.B0820252; Yamamoto T, 2003, DEV BIOL, V260, P512, DOI 10.1016/S0012-1606(03)00275-6; Yen CM, 2010, BIOMATERIALS, V31, P4341, DOI 10.1016/j.biomaterials.2010.02.014; Zeitouni S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-75	72	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184155	10.1371/journal.pone.0184155	http://dx.doi.org/10.1371/journal.pone.0184155			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898253	Green Published, Green Submitted, gold			2022-12-27	WOS:000410449500015
J	Hsiao, CY; Chiu, HY; Wang, TS; Tsai, TF				Hsiao, Chuan-Yu; Chiu, Hsien-Yi; Wang, Ting-Shun; Tsai, Tsen-Fang			Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; NECROSIS-FACTOR BLOCKERS; INTERFERON-GAMMA ASSAY; TO-SEVERE PSORIASIS; RHEUMATOID-ARTHRITIS; MYCOBACTERIUM-TUBERCULOSIS; ISONIAZID CHEMOPROPHYLAXIS; ACTIVE TUBERCULOSIS; THERAPY; AGENTS	Background There is increasing concern about the risk of latent tuberculosis infection (LTBI) reactivation during the use of biologics for psoriasis. Although ustekinumab had been documented with low risk of tuberculosis, the long-term follow-up of LTBI as determined by QuantiFERON-TB Gold (QFT-G) testing in patients treated with ustekinumab is limited. Objectives This study aims to use serial QFT-G testing as a screening method for detecting LTBI in patients with psoriasis from an intermediate tuberculosis burden country. Methods This retrospective review investigated 134 psoriatic patients in whom ustekinumab was prescribed for at least one year between 2010 and 2016 in National Taiwan University Hospital. All patients underwent annular QFT-G testing during ustekinumab therapy. Results Among the 134 enrolled patients, baseline LTBI rate was 13.4% (18/134). Indeterminate QFT-G result was noted in 5.2% (7/134) of patients and 71.4% (5/7) of them turn to be QFT-G negative during the next testing. 81.3% (109/134) of patients had a negative QFT-G at baseline and the seroconversion rate was 7.3% (8/109) in the serial QFT-G. All the patients in the conversion group were referred to a pulmonologist for evaluation and 81.5% (22/27) of them underwent chemoprophylactic therapy while on ustekinumab. No active TB infection was noted during further follow-up with or without chemoprophylaxis. Conclusions This study revealed that psoriatic patients receiving long-term ustekinumab therapy had a low QFT-G conversion rate (7.3%). The clinical significance of QFT-G conversion remains controversial and needs larger scale trials to investigate.	[Hsiao, Chuan-Yu; Chiu, Hsien-Yi; Wang, Ting-Shun; Tsai, Tsen-Fang] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan; [Hsiao, Chuan-Yu; Chiu, Hsien-Yi; Wang, Ting-Shun; Tsai, Tsen-Fang] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Dermatol, Hsinchu, Taiwan; [Wang, Ting-Shun] Natl Taiwan Univ Hosp, Dept Dermatol, Yun Lin Branch, Touliu, Yunlin, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Tsai, TF (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, Taipei, Taiwan.; Tsai, TF (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.	tftsai@yahoo.com		TSAI, TSEN-FANG/0000-0002-1498-1474; Chiu, Hsien-Yi/0000-0002-0493-9707				Ahn CS, 2015, J AM ACAD DERMATOL, V73, P420, DOI 10.1016/j.jaad.2015.06.004; Bartalesi F, 2013, J INFECTION, V66, P346, DOI 10.1016/j.jinf.2012.10.017; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Chen DY, 2008, ARTHRIT RHEUM-ARTHR, V59, P800, DOI 10.1002/art.23705; Chen DY, 2012, ANN RHEUM DIS, V71, P231, DOI 10.1136/annrheumdis-2011-200489; Chen YJ, 2013, J AM ACAD DERMATOL, V69, P25, DOI 10.1016/j.jaad.2012.12.966; Cheng CY, 2015, DERMATOL SIN, V33, P124, DOI 10.1016/j.dsi.2014.12.005; Chiu HY, 2011, BRIT J DERMATOL, V164, P553, DOI 10.1111/j.1365-2133.2010.10137.x; de Leon DP, 2008, J RHEUMATOL, V35, P776; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Errichetti E, 2014, EUR J DERMATOL, V24, P508, DOI 10.1684/ejd.2014.2386; Feng CG, 2005, J IMMUNOL, V174, P4185, DOI 10.4049/jimmunol.174.7.4185; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Garcovich S, 2012, J EUR ACAD DERMATOL, V26, P1572, DOI 10.1111/j.1468-3083.2011.04220.x; Gisondi P, 2014, BRIT J DERMATOL, V171, P884, DOI 10.1111/bjd.13130; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Hatzara C, 2015, ANN RHEUM DIS, V74, P1848, DOI 10.1136/annrheumdis-2014-205376; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kim KH, 2011, KOREAN J LAB MED, V31, P271, DOI 10.3343/kjlm.2011.31.4.271; Lein AD, 1999, CLIN DIAGN LAB IMMUN, V6, P606, DOI 10.1128/CDLI.6.4.606-609.1999; Mancuso JD, 2013, AM J RESP CRIT CARE, V187, P122, DOI 10.1164/rccm.201211-2033ED; Matulis G, 2008, ANN RHEUM DIS, V67, P84, DOI 10.1136/ard.2007.070789; Mohan AK, 2004, CLIN INFECT DIS, V39, P295, DOI 10.1086/421494; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Powell RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020061; Pratt A, 2007, RHEUMATOLOGY, V46, P1035, DOI 10.1093/rheumatology/kem064; Reddy M, 2010, J DERMATOL, V37, P413, DOI 10.1111/j.1346-8138.2010.00802.x; Saraceno R, 2014, EXPERT OPIN BIOL TH, V14, P151, DOI 10.1517/14712598.2014.860441; Sauzullo I, 2013, BRIT J DERMATOL, V169, P1133, DOI 10.1111/bjd.12544; Scrivo R, 2013, J RHEUMATOL, V40, P157, DOI 10.3899/jrheum.120688; Sivamani RK, 2013, CLIN REV ALLERG IMMU, V44, P121, DOI 10.1007/s12016-012-8301-7; Tsai TF, 2013, BRIT J DERMATOL, V168, P444, DOI 10.1111/j.1365-2133.2012.11162.x; Tsai TF, 2012, BRIT J DERMATOL, V167, P1145, DOI 10.1111/j.1365-2133.2012.11142.x; Tsai TF, 2011, J DERMATOL SCI, V63, P154, DOI 10.1016/j.jdermsci.2011.05.005	34	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184178	10.1371/journal.pone.0184178	http://dx.doi.org/10.1371/journal.pone.0184178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886099	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100076
J	Pawluski, J; Jego, P; Henry, S; Bruchet, A; Palme, R; Coste, C; Hausberger, M				Pawluski, Jodi; Jego, Patrick; Henry, Severine; Bruchet, Anaelle; Palme, Rupert; Coste, Caroline; Hausberger, Martine			Low plasma cortisol and fecal cortisol metabolite measures as indicators of compromised welfare in domestic horses (Equus caballus)	PLOS ONE			English	Article							PITUITARY-ADRENOCORTICAL AXIS; RANDOMIZED CLINICAL-TRIAL; ANIMAL-WELFARE; MANAGEMENT FACTORS; SOCIAL-ISOLATION; CHRONIC STRESS; NOISE STRESS; POOR WELFARE; RISK-FACTORS; BACK-PAIN	The hypothalamic-pituitary-adrenal (HPA) axis response to chronic stress is far from straight forward, particularly with regards to animal welfare. There are reports of no effect as well as both decreases and increases in cortisol after chronic stressors. Therefore, the first aim of the present study was to determine how measures of compromised welfare, such as chronic pain and haematological anomalies, related to cortisol levels in domestic horses (Equus caballus). Domestic horses are an informative model to investigate the impact of chronic stress (due to environment, pain, work, housing conditions...) on the HPA axis. The second aim was to determine whether levels of fecal cortisol metabolites (FCM) may be used as an indicator of welfare measures. The present study used fifty-nine horses (44 geldings and 15 mares), from three riding centres in Brittany, France. The primary findings show that horses whose welfare was clearly compromised (as indicated by an unusual ears backward position, presence of vertebral problems or haematological anomalies, e.g. anaemia) also had lower levels of both FCM and plasma cortisol. This work extends our previous findings showing that withdrawn postures, indicators of depressive-like behavior in horses, are associated with lower plasma cortisol levels. We also found that evening plasma cortisol levels positively correlated with FCM levels in horses. Future research aims to determine the extent to which factors of influence on welfare, such as living conditions (e.g. single stalls versus group housing in pasture or paddocks), early life factors, and human interaction, act as mediators of cortisol levels in horses.	[Pawluski, Jodi] Univ Rennes 1, Irset, INSERM, U1085, Rennes, France; [Jego, Patrick; Henry, Severine; Bruchet, Anaelle; Coste, Caroline] Univ Rennes 1, Stn Biol Paimpont, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci, Vienna, Austria; [Hausberger, Martine] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; University of Veterinary Medicine Vienna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Pawluski, J (corresponding author), Univ Rennes 1, Irset, INSERM, U1085, Rennes, France.; Hausberger, M (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	j.pawluski@gmail.com; martine.hausberger@univ-rennes1.fr	Palme, Rupert/A-3499-2008; Pawluski, Jodi L/K-5801-2015	Palme, Rupert/0000-0001-9466-3662; Pawluski, Jodi L/0000-0002-8240-8178	Caisse Centrale de la Mutualite Agricole, University of Rennes 1; Le Centre national de la recherche scientifique (CNRS)	Caisse Centrale de la Mutualite Agricole, University of Rennes 1; Le Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the Caisse Centrale de la Mutualite Agricole, University of Rennes 1 and the Le Centre national de la recherche scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the directors and staff of the riding centers for their help with data collection;C. Fureix, L. Dupont and C. Lavertue at the University of Rennes 1 and E Klobetz-Rassam at the University of Veterinary Medicine, Vienna, who aided with sample collection and analyses. This work was funded by the Caisse Centrale de la Mutualite Agricole, University of Rennes 1 and the Le Centre national de la recherche scientifique (CNRS).	Ashley FH, 2005, EQUINE VET J, P37; Bae YJ, 2015, BEST PRACT RES CL EN, V29, P761, DOI 10.1016/j.beem.2015.09.001; BARNETT JL, 1992, APPL ANIM BEHAV SCI, V34, P207, DOI 10.1016/S0168-1591(05)80116-9; Benhajali H, 2009, ANIMAL, V3, P1308, DOI 10.1017/S1751731109004820; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; Blokhuis HJ, 2003, ANIM WELFARE, V12, P445; BOTTOMS GD, 1972, AM J VET RES, V33, P785; Brauner S, 2009, WHY TREATING ANIMALS; BROOM DM, 1991, J ANIM SCI, V69, P4167, DOI 10.2527/1991.69104167x; Burn CC, 2010, VET J, V186, P385, DOI 10.1016/j.tvjl.2009.09.016; Casamassima D, 2001, SMALL RUMINANT RES, V41, P151, DOI 10.1016/S0921-4488(01)00201-2; Cauvin E, 1997, IN PRACTICE, V19, P522; Cooper J, 2002, ANIMAL WEL, V1, P99; Cyr NE, 2007, GEN COMP ENDOCR, V151, P82, DOI 10.1016/j.ygcen.2006.12.003; DAWKINS MS, 1990, BEHAV BRAIN SCI, V13, P1, DOI 10.1017/S0140525X00077104; deJonge FH, 1996, PHYSIOL BEHAV, V60, P389, DOI 10.1016/0031-9384(96)00013-3; Dickens MJ, 2013, GEN COMP ENDOCR, V191, P177, DOI 10.1016/j.ygcen.2013.06.014; Fisher AD, 1997, ANIM SCI, V64, P53, DOI 10.1017/S135772980001554X; Fonseca BPA, 2006, J EQUINE VET SCI, V26, P507, DOI 10.1016/j.jevs.2006.09.007; Fraser D, 1993, FOOD ANIMAL WELL-BEING, P37; Fureix C, 2015, APPL ANIM BEHAV SCI, V171, P8, DOI 10.1016/j.applanim.2015.08.036; Fureix C, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-3; Fureix C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039280; Fureix C, 2011, NATURWISSENSCHAFTEN, V98, P583, DOI 10.1007/s00114-011-0803-2; Fureix C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012434; Gillis C, 1999, VET CLIN N AM-EQUINE, V15, P97; Goodwin D, 2002, ANIMAL WEL, V1, P1; Harris PA, 2007, VET J, V173, P252, DOI 10.1016/j.tvjl.2005.12.009; Hausberger A, 2002, APPL ANIM BEHAV SCI, V76, P339, DOI 10.1016/S0168-1591(02)00016-3; Hausberger M, 2007, APPL ANIM BEHAV SCI, V107, P299, DOI 10.1016/j.applanim.2006.10.003; Hausberger M, 2016, APPL ANIM BEHAV SCI, V175, P41, DOI 10.1016/j.applanim.2015.09.005; Hausberger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014659; Hausberger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007625; Henry S, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-016-1429-1; HOFFSIS GF, 1970, AM J VET RES, V31, P1379; Houpt K, 2001, ANIM WELFARE, V10, P257; IRVINE CHG, 1994, DOMEST ANIM ENDOCRIN, V11, P227, DOI 10.1016/0739-7240(94)90030-2; JAMES VHT, 1970, J ENDOCRINOL, V48, P319, DOI 10.1677/joe.0.0480319; Jeffcoat LB, 1999, VET J, V158, P113, DOI 10.1053/tvjl.1998.0334; Jensen KH, 1996, PHYSIOL BEHAV, V59, P741, DOI 10.1016/0031-9384(95)02159-0; JOHNSON AL, 1986, J ANIM SCI, V63, P169, DOI 10.2527/jas1986.631169x; Juster RP, 2011, PSYCHONEUROENDOCRINO, V36, P797, DOI 10.1016/j.psyneuen.2010.11.001; Kanitz E, 2005, LIVEST PROD SCI, V94, P213, DOI 10.1016/j.livprodsci.2004.12.002; KIRKALDYWILLIS WH, 1985, CAN FAM PHYSICIAN, V31, P535; KIRKPATRICK JF, 1977, COMP BIOCHEM PHYS A, V57, P179, DOI 10.1016/0300-9629(77)90370-X; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Korte SM, 2007, PHYSIOL BEHAV, V92, P422, DOI 10.1016/j.physbeh.2006.10.018; LADEWIG J, 1989, HORM BEHAV, V23, P344, DOI 10.1016/0018-506X(89)90048-2; Landman MAAM, 2004, VET REC, V155, P165, DOI 10.1136/vr.155.6.165; Lebelt D, 1996, PFERDEHEILKUNDE, V12, P411; Lesimple C, 2016, APPL ANIMAL BEHAV SC; Lesimple C., 2016, ANIM BEHAV COGN, V3, P159, DOI [10.12966/abc.05.08.2016, DOI 10.12966/ABC.05.08.2016]; Lesimple C, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-209; Lesimple C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044604; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; LEY SJ, 1991, VET REC, V129, P45, DOI 10.1136/vr.129.3.45; Mateo JM, 2008, NEUROBIOL LEARN MEM, V89, P582, DOI 10.1016/j.nlm.2007.11.002; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McGreevy P, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P196; MCGREEVY PD, 1995, EQUINE VET J, V27, P86, DOI 10.1111/j.2042-3306.1995.tb03041.x; Merl S, 2000, J EQUINE VET SCI, V20, P586, DOI 10.1016/S0737-0806(00)70267-X; MEUNIERSALAUN MC, 1987, J ANIM SCI, V64, P1371, DOI 10.2527/jas1987.6451371x; Michaud K, 2008, STRESS, V11, P177, DOI 10.1080/10253890701727874; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Mills DS, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P212; Mormede P, 2007, PHYSIOL BEHAV, V92, P317, DOI 10.1016/j.physbeh.2006.12.003; Mostl E, 1999, J VET MED A, V46, P621, DOI 10.1046/j.1439-0442.1999.00256.x; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; Muhtz C, 2013, PAIN MED, V14, P498, DOI 10.1111/j.1526-4637.2012.01514.x; Munksgaard L, 1996, J ANIM SCI, V74, P769; Nicol CJ, 2002, VET REC, V151, P658, DOI 10.1136/vr.151.22.658; Nogueira GP, 1997, BRAZ J MED BIOL RES, V30, P1237, DOI 10.1590/S0100-879X1997001000016; Normando S, 2011, APPL ANIM BEHAV SCI, V133, P186, DOI 10.1016/j.applanim.2011.06.012; Otten W, 2004, ANIM SCI, V78, P271, DOI 10.1017/S1357729800054060; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Palme R, 2012, ANIM WELFARE, V21, P331, DOI 10.7120/09627286.21.3.331; Palme R, 1996, ANIM REPROD SCI, V43, P43, DOI 10.1016/0378-4320(95)01458-6; Parker M, 2008, BEHAV BRAIN RES, V191, P137, DOI 10.1016/j.bbr.2008.03.009; PEARCE GP, 1993, APPL ANIM BEHAV SCI, V36, P11, DOI 10.1016/0168-1591(93)90095-7; Pell SM, 1999, APPL ANIM BEHAV SCI, V64, P81, DOI 10.1016/S0168-1591(99)00029-5; Pruessner JC, 1999, PSYCHOSOM MED, V61, P197, DOI 10.1097/00006842-199903000-00012; Reefmann N, 2009, APPL ANIM BEHAV SCI, V118, P199, DOI 10.1016/j.applanim.2009.02.013; Rochais C, 2016, BEHAV PROCESS, V124, P93, DOI 10.1016/j.beproc.2015.12.010; Rochais C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20117; RUSHEN J, 1991, APPL ANIM BEHAV SCI, V28, P381, DOI 10.1016/0168-1591(91)90170-3; Sankey C, 2010, ANIM COGN, V13, P753, DOI 10.1007/s10071-010-0326-9; Selye H, 1956, J BONE JOINT SURG; Shearar KA, 2005, J MANIP PHYSIOL THER, V28, P493, DOI 10.1016/j.jmpt.2005.07.006; SIITERI PK, 1982, RECENT PROG HORM RES, V38, P457; Sullivan KA, 2008, EQUINE VET J, V40, P14, DOI 10.2746/042516407X240456; van Reenen CG, 2000, VET MICROBIOL, V75, P135, DOI 10.1016/S0378-1135(00)00211-X; Veissier I, 1997, J ANIM SCI, V75, P356; Visser EK, 2014, J ANIM SCI, V92, P844, DOI 10.2527/jas.2013-6692; Visser EK, 2008, APPL ANIM BEHAV SCI, V114, P521, DOI 10.1016/j.applanim.2008.03.003; VON BORELL E, 1995, APPL ANIM BEHAV SCI, V44, P219, DOI 10.1016/0168-1591(95)00615-Y; Waring G.H., 2003, HORSE BEHAV, V2; Wood TG, 2001, J MANIP PHYSIOL THER, V24, P260, DOI 10.1067/mmt.2001.114365; [No title captured]	100	47	47	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182257	10.1371/journal.pone.0182257	http://dx.doi.org/10.1371/journal.pone.0182257			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886020	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100005
J	Rahman, MS; Thomas, P				Rahman, Md Saydur; Thomas, Peter			Molecular and biochemical responses of hypoxia exposure in Atlantic croaker collected from hypoxic regions in the northern Gulf of Mexico	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; INDUCED GENE-EXPRESSION; ENVIRONMENTAL HYPOXIA; RAINBOW-TROUT; UP-REGULATION; OXIDATIVE STRESS; NITRIC-OXIDE; HIF-1-ALPHA; FISH; HIF-2-ALPHA	A major impact of global climate change has been the marked increase worldwide in the incidence of coastal hypoxia (dissolved oxygen, DO<2.0 mgl(-1)). However, the extent of hypoxia exposure to motile animals such as fish collected from hypoxic waters as well as their molecular and physiological responses to environmental hypoxia exposure are largely unknown. A suite of potential hypoxia exposure biomarkers was evaluated in Atlantic croaker collected from hypoxic and normoxic regions in the northern Gulf of Mexico (nGOM), and in croaker after laboratory exposure to hypoxia (DO: 1.7 mg l(-1)). Expression of hypoxia-inducible factor-a, hif-alpha; neuronal nitric oxide synthase, nNOS; and insulin-like growth factor binding protein, igfbp mRNAs and protein carbonyl (PC, an oxidative stress indicator) content were elevated several-fold in brain and liver tissues of croaker collected from nGOM hypoxic sites. All of these molecular and biochemical biomarkers were also upregulated -3-10-fold in croaker brain and liver tissues within 1-2 days of hypoxia exposure in controlled laboratory experiments. These results suggest that hif-as, nNOS and igfbp-1 transcripts and PC contents are useful biomarkers of environmental hypoxia exposure and some of its physiological effects, making them important components for improved assessments of long-term impacts of environmental hypoxia on fish populations.	[Rahman, Md Saydur] Univ Texas Rio Grande Valley, Sch Earth Environm & Marine Sci, Brownsville, TX 78520 USA; [Rahman, Md Saydur; Thomas, Peter] Univ Texas Austin, Marine Sci Inst, Port Aransas, TX 78373 USA	University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Austin	Rahman, MS (corresponding author), Univ Texas Rio Grande Valley, Sch Earth Environm & Marine Sci, Brownsville, TX 78520 USA.; Rahman, MS (corresponding author), Univ Texas Austin, Marine Sci Inst, Port Aransas, TX 78373 USA.	md.rahman@utrgv.edu	Rahman, Mohammad Sohelur/AAJ-7376-2020; Thomas, Peter/U-9908-2019; Rahman, Mohammad Saifur/GZM-5483-2022	Rahman, Mohammad Sohelur/0000-0002-4489-2202; Thomas, Peter/0000-0001-6656-4907; Rahman, Mohammad Saifur/0000-0002-9887-4456	NOAA Coastal Ocean Program Gulf of Mexico GOMEX grant [NA06NOS4780131, NA09NOS4780179]; National Science Foundation [IOS-1119242]	NOAA Coastal Ocean Program Gulf of Mexico GOMEX grant; National Science Foundation(National Science Foundation (NSF))	This research work was supported by grants from the NOAA Coastal Ocean Program Gulf of Mexico GOMEX grant nos. NA06NOS4780131 and NA09NOS4780179 (to P.T.), and the National Science Foundation to P.T. and M.S.R. (grant no. IOS-1119242).; This research work was supported by grants from the NOAA Coastal Ocean Program Gulf of Mexico GOMEX grant nos. NA06NOS4780131 and NA09NOS4780179 (to P.T.), and the National Science Foundation to P.T. and M.S.R. (grant no. IOS-1119242). The help of the crew of the RV Pelican, Louisiana Universities Marine Consortium; Dr. John A. Mohan, Department of Marine Sciences, Texas A&M University, Galveston; and Susan Lawson, University of Texas Marine Science Institute, Port Aransas, are gratefully acknowledged. We greatly appreciate the academic editor and three anonymous reviewers for their valuable comments and suggestions on the manuscript.	Abbaraju NV, 2012, FISH PHYSIOL BIOCHEM, V38, P615, DOI 10.1007/s10695-011-9542-8; Baptista RB, 2016, FISH PHYSIOL BIOCHEM, V42, P1307, DOI 10.1007/s10695-016-0219-1; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Catron T, 2001, BIOCHEM BIOPH RES CO, V282, P602, DOI 10.1006/bbrc.2001.4613; CHELLAPPA S, 1995, J FISH BIOL, V47, P775, DOI 10.1111/j.1095-8649.1995.tb06002.x; Conley DJ, 2009, SCIENCE, V323, P1014, DOI 10.1126/science.1167755; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Duan CM, 2010, GEN COMP ENDOCR, V167, P344, DOI 10.1016/j.ygcen.2010.04.009; DUNN JF, 1987, CAN J ZOOL, V65, P1144, DOI 10.1139/z87-179; Froehlich HE, 2015, COMP BIOCHEM PHYS A, V189, P58, DOI 10.1016/j.cbpa.2015.07.016; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; Hochachka P.W., 2002, BIOCH ADAPTATION MEC, P1; Kajimura S, 2007, J FISH BIOL, V71, P309, DOI 10.1111/j.1095-8649.2007.01606.x; Kodama K, 2012, MAR POLLUT BULL, V64, P1339, DOI 10.1016/j.marpolbul.2012.05.002; Kodama K, 2012, BIOL LETTERS, V8, P278, DOI 10.1098/rsbl.2011.0887; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McNatt RA, 2004, J EXP MAR BIOL ECOL, V311, P147, DOI 10.1016/j.jembe.2004.05.006; McNeill B, 2006, J EXP BIOL, V209, P4214, DOI 10.1242/jeb.02519; Nikinmaa M, 2005, AM J PHYSIOL-REG I, V288, pR1079, DOI 10.1152/ajpregu.00626.2004; Pialoux V, 2009, FREE RADICAL BIO MED, V46, P321, DOI 10.1016/j.freeradbiomed.2008.10.047; Rabalais NN, 2007, ESTUAR COAST, V30, P753, DOI 10.1007/BF02841332; Rabalais NN, 2010, BIOGEOSCIENCES, V7, P585, DOI 10.5194/bg-7-585-2010; Rahman MS, 2007, GENE, V396, P273, DOI 10.1016/j.gene.2007.03.009; Rahman MS, 2015, COMP BIOCHEM PHYS A, V185, P91, DOI 10.1016/j.cbpa.2015.03.013; Rahman MS, 2013, GEN COMP ENDOCR, V192, P71, DOI 10.1016/j.ygcen.2013.03.001; Rahman MS, 2011, AM J PHYSIOL-ENDOC M, V301, pE637, DOI 10.1152/ajpendo.00168.2011; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Richards JG, 2011, J EXP BIOL, V214, P191, DOI 10.1242/jeb.047951; Rodrigo MC, 2002, J PHARMACOL TOXICOL, V47, P87, DOI 10.1016/S1056-8719(02)00218-6; Ryckman LYC, 2010, THESIS, P1; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Thomas P, 2012, P ROY SOC B-BIOL SCI, V279, P28, DOI 10.1098/rspb.2011.0529; Thomas P, 2009, J EXP MAR BIOL ECOL, V381, pS38, DOI 10.1016/j.jembe.2009.07.008; WRIGHT PA, 1989, J EXP BIOL, V147, P169; Wu RSS, 2003, ENVIRON SCI TECHNOL, V37, P1137, DOI 10.1021/es0258327; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9; Yu RMK, 2008, AQUAT TOXICOL, V90, P235, DOI 10.1016/j.aquatox.2008.09.004	39	11	11	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184341	10.1371/journal.pone.0184341	http://dx.doi.org/10.1371/journal.pone.0184341			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886098	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100100
J	Andersen, JH; Jaeger, P; Sonne, TL; Dahl, JB; Mathiesen, O; Grevstad, U				Andersen, Jakob Hessel; Jaeger, Pia; Sonne, Tobias Laier; Dahl, Jorgen Berg; Mathiesen, Ole; Grevstad, Ulrik			Clonidine used as a perineural adjuvant to ropivacaine, does not prolong the duration of sensory block when controlling for systemic effects: A paired, blinded, randomized trial in healthy volunteers	PLOS ONE			English	Article							BRACHIAL-PLEXUS BLOCK; PERIPHERAL-NERVE BLOCKS; POSTOPERATIVE ANALGESIA; ADDING CLONIDINE; AXILLARY; ANESTHESIA; METAANALYSIS; DEXAMETHASONE; 0.75-PERCENT; MEPIVACAINE	Background Clonidine used as an adjuvant to ropivacaine have been shown to prolong the duration of peripheral nerve blocks. The mechanism of action remains unclear. We hypothesized, that clonidine used as an adjuvant to ropivacaine extends the duration of an adductor canal block (ACB) by a peripheral mechanism, compared to ropivacaine alone when controlling for systemic effects. Methods We conducted a paired, blinded, randomized trial in healthy volunteers. Participants received bilateral ACBs containing 20 ml ropivacaine 0.5% + 1 ml clonidine 150 mu g/ml in one leg and 20 ml ropivacaine 0.5% + 1 ml saline in the other leg. The primary outcome measure was duration of sensory block assessed by temperature sensation (alcohol swab). Secondary outcome measures were duration of sensory block assessed by: pinprick, maximum pain during tonic heat stimulation, warmth detection threshold and heat pain detection threshold. Results We enrolled 21 volunteers and all completed the trial. There was no difference in duration of sensory block assessed with an alcohol swab: Mean duration in the leg receiving ropivacaine + clonidine was 19.4h (SD 2.7) compared to 19.3h (SD 2.4) in the leg receiving ropivacaine + placebo with a mean difference of 0.1h (95% CI: -1.0 to 1.3), P = 0.83. No differences in block duration were detected when assessed by: Pinprick, mean difference 0.0 h (95% CI: -1.3 to 1.3), maximum pain during tonic heat stimulation, mean difference 0.7 h (95% CI: -2.1 to 0.8), warmth detection threshold, mean difference -0.1 h (95% CI: -1.8 to 1.6) or heat pain detection threshold, mean difference -0.2 h (95% CI: -1.7 to 1.4). Conclusions Administering clonidine perineurally as an adjuvant to ropivacaine in an ACB did not prolong the duration of sensory block in a setup controlling for systemic effects of clonidine.	[Andersen, Jakob Hessel; Sonne, Tobias Laier; Mathiesen, Ole] Zealand Univ Hosp, Dept Anaesthesiol, Koge, Denmark; [Jaeger, Pia] Rigshosp, Dept Anaesthesiol, Ctr Head & Orthoped, Copenhagen East, Denmark; [Dahl, Jorgen Berg] Bispebjerg Hosp, Dept Anaesthesiol, Copenhagen NV, Denmark; [Grevstad, Ulrik] Gentofte Univ Hosp, Dept Anaesthesiol, Hellerup, Denmark	Rigshospitalet; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Herlev & Gentofte Hospital	Andersen, JH (corresponding author), Zealand Univ Hosp, Dept Anaesthesiol, Koge, Denmark.	Hessel@dadlnet.dk		Mathiesen, Ole/0000-0003-4544-0619; Andersen, Jakob/0000-0003-1402-8162	Regions Zealand Research Foundation; department of Anesthesiology Zealand University Hospital, Koge, Denmark	Regions Zealand Research Foundation; department of Anesthesiology Zealand University Hospital, Koge, Denmark	This work was supported by Regions Zealand Research Foundation and funding from department of Anesthesiology Zealand University Hospital, Koge, Denmark.	Abdallah FW, 2013, ANESTH ANALG, V117, P271, DOI 10.1213/ANE.0b013e318290c566; Albrecht E, 2015, ANAESTHESIA, V70, P71, DOI 10.1111/anae.12823; Ali QE, 2014, INDIAN J ANAESTH, V58, P709, DOI 10.4103/0019-5049.147150; Allegri M, 2010, EUR J PAIN S, V4, P219; Antonucci S, 2001, Minerva Anestesiol, V67, P23; Beaussier M, 2005, ANESTH ANALG, V101, P1659, DOI 10.1213/01.ANE.0000184046.64631.50; Bhatia R, 2014, SINGAP MED J, V55, P229; Capdevila X, 2008, CURR OPIN ANESTHESIO, V21, P619, DOI 10.1097/ACO.0b013e32830c66c2; Casati A, 2000, ANESTH ANALG, V91, P388, DOI 10.1097/00000539-200008000-00029; Casati A, 2001, Minerva Anestesiol, V67, P407; Culebras X, 2001, ANESTH ANALG, V92, P199; Dalle C, 2001, MUSCLE NERVE, V24, P254, DOI 10.1002/1097-4598(200102)24:2<254::AID-MUS110>3.0.CO;2-#; Danelli G, 2006, J CLIN ANESTH, V18, P585, DOI 10.1016/j.jclinane.2006.03.016; Eisenach JC, 1996, ANESTHESIOLOGY, V85, P655, DOI 10.1097/00000542-199609000-00026; El Saied AH, 2000, CAN J ANAESTH, V47, P962, DOI 10.1007/BF03024866; Erlacher W, 2000, ACTA ANAESTH SCAND, V44, P53, DOI 10.1034/j.1399-6576.2000.440110.x; Erlacher W, 2001, CAN J ANAESTH, V48, P522, DOI 10.1007/BF03016825; Esteves S, 2002, Rev Esp Anestesiol Reanim, V49, P302; GAUMANN D, 1992, ANESTH ANALG, V75, P69; Helayel Pablo Escovedo, 2005, Rev. Bras. Anestesiol., V55, P483, DOI 10.1590/S0034-70942005000500002; Ilfeld BM, 2011, ANESTH ANALG, V113, P904, DOI 10.1213/ANE.0b013e3182285e01; Jaeger P, 2016, BRIT J ANAESTH, V117, P635, DOI 10.1093/bja/aew318; Jenstrup MT, 2012, ACTA ANAESTH SCAND, V56, P357, DOI 10.1111/j.1399-6576.2011.02621.x; Liu SS, 2005, ANESTH ANALG, V101, P1634, DOI 10.1213/01.ANE.0000180829.70036.4F; Mannion S, 2005, ANESTH ANALG, V100, P873, DOI 10.1213/01.ANE.0000143950.13939.7A; Marian AA, 2015, REGION ANESTH PAIN M, V40, P623, DOI 10.1097/AAP.0000000000000277; McClure JH, 1996, BRIT J ANAESTH, V76, P300, DOI 10.1093/bja/76.2.300; Patil Kalyani Nilesh, 2015, J Anaesthesiol Clin Pharmacol, V31, P365, DOI 10.4103/0970-9185.161674; Popping DM, 2009, ANESTHESIOLOGY, V111, P406, DOI 10.1097/ALN.0b013e3181aae897; Pratap JN, 2007, ANESTH ANALG, V104, P982, DOI 10.1213/01.ane.0000257949.46444.a8; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Sia S, 1999, ANESTH ANALG, V88, P1109, DOI 10.1097/00000539-199905000-00027; SINGELYN FJ, 1992, REGION ANESTH, V17, P148; Trifa M, 2012, PEDIATR ANESTH, V22, P425, DOI 10.1111/j.1460-9592.2012.03809.x; YaDeau JT, 2008, ANESTH ANALG, V106, P1916, DOI 10.1213/ane.0b013e318172fe44	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0181351	10.1371/journal.pone.0181351	http://dx.doi.org/10.1371/journal.pone.0181351			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880902	Green Submitted, Green Published, gold			2022-12-27	WOS:000409467200004
J	Kwiecien, JM; Bassey-Archibong, BI; Dabrowski, W; Rayner, LG; Lucas, AR; Daniel, JM				Kwiecien, Jacek M.; Bassey-Archibong, Blessing I.; Dabrowski, Wojciech; Rayner, Lyndsay G.; Lucas, Alexandra R.; Daniel, Juliet M.			Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PORTAL-VEIN INVASION; HEPATOCELLULAR-CARCINOMA; MATRIX METALLOPROTEINASES; PROMOTES; MIGRATION; GROWTH; INTRAVASATION; PROGRESSION; PHENOTYPE	The metastatic activity of breast carcinomas results from complex genetic changes in epithelial tumor cells and accounts for 90% of deaths in affected patients. Although the invasion of the local lymphatic vessels and veins by malignant breast tumor cells and their subsequent metastasis to the lung, has been recognized, the mechanisms behind the metastatic activity of breast tumor cells to other distal organs and the pathogenesis of metastatic cancer are not well understood. In this study, we utilized derivatives of the well-established and highly metastatic triple negative breast cancer (TNBC) cell line MDA-MB-231 (MDA-231) to study breast tumor metastasis in a mouse model. These MDA-231 derivatives had depleted expression of Kaiso, a POZ-ZF transcription factor that is highly expressed in malignant, triple negative breast cancers. We previously reported that Kaiso depletion attenuates the metastasis of xenografted MDA-231 cells. Herein, we describe the pathological features of the metastatic activity of parental (Kaiso(positive)) versus Kaiso(depleted) MDA-231 cells. Both Kaiso(positive) and Kaiso(depleted) MDA-231 cells metastasized from the original tumor in the mammary fat pad to the lung. However, while Kaiso(positive) cells formed large masses in the lung parenchyma, invaded large pulmonary blood vessels and formed secondary metastases and large tumors in the distal organs, Kaiso(depleted) cells metastasized only to the lung where they formed small metastatic lesions. Importantly, intravascular invasion and secondary metastases in distal organs were not observed in mice xenografted with Kaiso(depleted) cells. It thus appears that the lung may constitute a barrier for less invasive breast tumors such as the Kaiso(depleted) TNBC cells; this barrier may limit tumor growth and prevents Kaiso(depleted) TNBC cells from invading the pulmonary blood vessels and forming secondary metastases in distal organs.	[Kwiecien, Jacek M.] McMaster Univ, Dept Pathol & Mol Med, HSC 1U22D, Hamilton, ON, Canada; [Kwiecien, Jacek M.] Med Univ Lublin, Dept Clin Pathomorphol, Lublin, Poland; [Bassey-Archibong, Blessing I.; Rayner, Lyndsay G.; Daniel, Juliet M.] McMaster Univ, Dept Biol, LSB 331, Hamilton, ON, Canada; [Dabrowski, Wojciech] Med Univ Lublin, Dept Anaesthesia & Intens Therapy, Lublin, Poland; [Lucas, Alexandra R.] Arizona State Univ, Biodesign Inst, Tempe, AZ USA	McMaster University; Medical University of Lublin; McMaster University; Medical University of Lublin; Arizona State University; Arizona State University-Tempe	Kwiecien, JM (corresponding author), McMaster Univ, Dept Pathol & Mol Med, HSC 1U22D, Hamilton, ON, Canada.; Kwiecien, JM (corresponding author), Med Univ Lublin, Dept Clin Pathomorphol, Lublin, Poland.	kwiecien@mcmaster.ca	Dabrowski, Wojciech/AAN-8425-2020	Dabrowski, Wojciech/0000-0003-0449-2375	NSERC Discovery Grant [RGPIN6442-15 - JMD]; Canadian Breast Cancer Foundation - JMD; Schlumberger Faculty for the Future Fellowship BIB-A	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Breast Cancer Foundation - JMD; Schlumberger Faculty for the Future Fellowship BIB-A	This work was supported NSERC Discovery Grant # RGPIN6442-15 - JMD; Canadian Breast Cancer Foundation - JMD and the Schlumberger Faculty for the Future Fellowship BIB-A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Saleh S, 2011, INT J ONCOL, V38, P1197, DOI 10.3892/ijo.2011.942; Al-Jarrah Q, 2014, INT J SURG CASE REP, V5, P551, DOI 10.1016/j.ijscr.2014.06.005; Armstrong AJ, 2011, MOL CANCER RES, V9, P997, DOI 10.1158/1541-7786.MCR-10-0490; Asrani K, 2013, MOL CANCER RES, V11, P393, DOI 10.1158/1541-7786.MCR-12-0542; Baker EA, 2002, J CLIN PATHOL-MOL PA, V55, P300; Bassey-Archibong BI, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.17; Bassey-Archibong BI, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.92; Bouris P, 2015, MATRIX BIOL, V43, P42, DOI 10.1016/j.matbio.2015.02.008; Cao YW, 2015, KAOHSIUNG J MED SCI, V31, P70, DOI 10.1016/j.kjms.2014.11.008; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; CHUNG JW, 1995, AM J ROENTGENOL, V165, P315, DOI 10.2214/ajr.165.2.7618547; Condeelis J, 2005, ANNU REV CELL DEV BI, V21, P695, DOI 10.1146/annurev.cellbio.21.122303.120306; Daniel JM, 2001, HYBRIDOMA, V20, P159, DOI 10.1089/027245701750293484; Dasgupta S, 2009, ONCOGENE, V28, P2860, DOI 10.1038/onc.2009.145; Di Modugno F, 2006, CLIN CANCER RES, V12, P1470, DOI 10.1158/1078-0432.CCR-05-2027; Ding Z, 2014, ONCOGENE, V33, P2065, DOI 10.1038/onc.2013.166; Donaldson NS, 2010, EXP CELL RES, V316, P1692, DOI 10.1016/j.yexcr.2010.03.011; Fei F, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0277-8; Folkins AK, 2010, MODERN PATHOL, V23, P1073, DOI 10.1038/modpathol.2010.91; Gertler F, 2011, TRENDS CELL BIOL, V21, P81, DOI 10.1016/j.tcb.2010.10.001; Gialeli C, 2011, FEBS J, V278, P16, DOI 10.1111/j.1742-4658.2010.07919.x; Han ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039520; Hsu HH, 2012, J CELL PHYSIOL, V227, P3648, DOI 10.1002/jcp.24072; Hsu HH, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-61; Jezierska A, 2009, MED SCI MONITOR, V15; Jin H, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3694; Jones J, 2016, CANCER LETT, V380, P513, DOI 10.1016/j.canlet.2016.06.025; Jones J, 2014, CLIN EXP METASTAS, V31, P497, DOI 10.1007/s10585-014-9644-7; KANEKO T, 1995, ANN SURG, V222, P711, DOI 10.1097/00000658-199512000-00004; Koshikawa N, 2000, J CELL BIOL, V148, P615, DOI 10.1083/jcb.148.3.615; Kukko HM, 2010, MODERN PATHOL, V23, P1151, DOI 10.1038/modpathol.2010.100; Lee IJ, 2009, J VASC INTERV RADIOL, V20, P22, DOI 10.1016/j.jvir.2008.09.030; Leung HW, 2015, BBA-MOL CELL RES, V1853, P1827, DOI 10.1016/j.bbamcr.2015.04.020; Li F, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0180-8; Maynadier M, 2013, INT J ONCOL, V43, P1683, DOI 10.3892/ijo.2013.2095; Mehner C, 2014, ONCOTARGET, V5, P2736, DOI 10.18632/oncotarget.1932; Mete O, 2011, MODERN PATHOL, V24, P1545, DOI 10.1038/modpathol.2011.119; Murakami E, 2016, ACTA HISTOCHEM CYTOC, V49, P131, DOI 10.1267/ahc.16020; NAKASHIMA T, 1983, CANCER, V51, P863, DOI 10.1002/1097-0142(19830301)51:5<863::AID-CNCR2820510520>3.0.CO;2-D; Patsialou A, 2013, INTRAVITAL, V2, P1; Perentes JY, 2011, CANCER RES, V71, P4527, DOI 10.1158/0008-5472.CAN-10-4376; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Pierre CC, 2015, BBA-MOL BASIS DIS, V1852, P1846, DOI 10.1016/j.bbadis.2015.06.011; Pignatelli J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005329; Puzovic V, 2014, NEOPLASMA, V61, P439, DOI 10.4149/neo_2014_054; Quaglia A, 2005, ARCH PATHOL LAB MED, V129, P639; Rabi ZA, 2015, CANCER BIOMARK, V15, P45; Rhodes LV, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.27; Rizwani W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100888; Robinson BD, 2009, CLIN CANCER RES, V15, P2433, DOI 10.1158/1078-0432.CCR-08-2179; Roussos ET, 2011, CLIN EXP METASTAS, V28, P515, DOI 10.1007/s10585-011-9388-6; Su P, 2014, INT J CLIN EXP PATHO, V7, P3008; Sugino T, 2008, CLIN EXP METASTAS, V25, P835, DOI 10.1007/s10585-008-9199-6; Thaiparambil JT, 2011, INT J CANCER, V129, P2744, DOI 10.1002/ijc.25938; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vermeulen JF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037864; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vucemilo Tiha, 2014, Coll Antropol, V38, P135; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2002, CANCER RES, V62, P6278; Wyckoff JB, 2007, CANCER RES, V67, P2649, DOI 10.1158/0008-5472.CAN-06-1823; Xu Y, 2016, ONCOGENE; Yang E, 2016, ONCOGENE, V35, P1529, DOI 10.1038/onc.2015.217	63	6	6	10	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183883	10.1371/journal.pone.0183883	http://dx.doi.org/10.1371/journal.pone.0183883			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880889	gold, Green Published, Green Submitted			2022-12-27	WOS:000409467200026
J	Manuwald, U; Heinke, P; Salzsieder, E; Hegewald, J; Schoffer, O; Kugler, J; Kapellen, TM; Kiess, W; Rothe, U				Manuwald, Ulf; Heinke, Peter; Salzsieder, Eckhard; Hegewald, Janice; Schoffer, Olaf; Kugler, Joachim; Kapellen, Thomas M.; Kiess, Wieland; Rothe, Ulrike			Incidence trends of type 1 diabetes before and after the reunification in children up to 14 years of age in Saxony, Eastern Germany	PLOS ONE			English	Article							BIRTH-WEIGHT; CHILDHOOD; TIME; RISK; POPULATION; GENOTYPES; MELLITUS; REGISTRY; EUROPE; RATES	Aims The aim of this study was to analyze the incidence rates of type 1 diabetes in Saxony before and after the German reunification. Methods The study examined two registries: one until 1990 and one since 1999. Only patients under 15 years of age with type 1 diabetes and living in Saxony were included in the study. Standardized incidence rates were described based on direct age standardization procedures using the Standard European Population for each calendar year between the observation periods 1982-1989 and 1999-2014. Age was grouped into three classes: 0-4, 5-9 and 10-14 years of age. Incidence data were presented as age-standardized incidence rates per 100,000 person-years (PY) with 95% confidence intervals [CI]. Joinpoint regression was used for trend analyses and Poisson regression was used to adjust for the effects of age and sex on the incidence. Results A total number of 2,092 incident cases of type 1 diabetes (1,109 males; 983 females) were included. The age-standardized incidence rates of type 1 diabetes per 100,000 PY was 7.9 [95% CI 6.8; 8.9] in the period from 1982-1989 and 20.1 [95% CI 14.0; 26.1] in the period from 1999-2014. The yearly increase in incidence over the entire time period (1982-2014) was 4.3% according to the average annual percent change (AAPC) method, and estimated to be 4.4% [95% CI 4.0; 4.8%] using a Poisson regression model adjusting for sex and age group. Conclusion In this study, a significantly increasing incidence of type 1 diabetes was observed after reunification. In future studies it would be interesting to follow up on the question of which environmental and lifestyle factors could be causing the increasing type 1 diabetes incidence.	[Manuwald, Ulf; Kugler, Joachim; Rothe, Ulrike] Tech Univ Dresden, Hlth Sci, Publ Hlth, Fac Med Carl Gustav Carus, Dresden, Germany; [Heinke, Peter; Salzsieder, Eckhard] Inst Diabet Gerhardt Katsch Karlsburg, Karlsburg, Germany; [Hegewald, Janice] Tech Univ Dresden, Inst & Policlin Occupat & Social Med, Fac Med Carl Gustav Carus, Dresden, Germany; [Schoffer, Olaf] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Ctr Evidence Based Healthcare, Dresden, Germany; [Kapellen, Thomas M.; Kiess, Wieland] Univ Leipzig, Dept Women & Child Hlth, Ctr Pediat Res, Hosp Children & Adolescents, Leipzig, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Leipzig University	Manuwald, U (corresponding author), Tech Univ Dresden, Hlth Sci, Publ Hlth, Fac Med Carl Gustav Carus, Dresden, Germany.	Ulf.Manuwald@tu-dresden.de	Schoffer, Olaf/R-1841-2016	Schoffer, Olaf/0000-0001-6922-7148; Hegewald, Janice/0000-0003-3388-161X; Prof. Rothe, Ulrike/0000-0001-9779-7260	German Research Foundation; Open Access Publication Funds of the TU Dresden	German Research Foundation(German Research Foundation (DFG)); Open Access Publication Funds of the TU Dresden	We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the TU Dresden.	Bache I, 1999, DIABETES CARE, V22, P1063, DOI 10.2337/diacare.22.7.1063; Barat P, 2008, DIABETES METAB, V34, P601, DOI 10.1016/j.diabet.2008.06.002; Bendas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132716; Bodin J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/208947; Breslow N E, 1987, IARC Sci Publ, P1; Cardwell CR, 2012, DIABETES CARE, V35, P2215, DOI 10.2337/dc12-0438; Cardwell CR, 2005, DIABETIC MED, V22, P200, DOI 10.1111/j.1464-5491.2005.01369.x; Ehehalt S, 2012, EXP CLIN ENDOCR DIAB, V120, P441, DOI 10.1055/s-0032-1309045; Ehehalt S, 2010, DIABETES CARE, V33, P338, DOI 10.2337/dc09-1503; Galler A, 2010, HORM RES PAEDIAT, V74, P285, DOI 10.1159/000303141; GREEN A, 1992, LANCET, V339, P905, DOI 10.1016/0140-6736(92)90938-Y; Green A, 2000, LANCET, V355, P873; Green A, 2001, DIABETOLOGIA S3, V44, P3; Gulden E, 2015, CLIN IMMUNOL, V159, P143, DOI 10.1016/j.clim.2015.05.013; Hathout EH, 2006, PEDIATR DIABETES, V7, P81, DOI 10.1111/j.1399-543X.2006.00150.x; Hermann R, 2003, DIABETOLOGIA, V46, P420, DOI 10.1007/s00125-003-1045-4; Kaindl M, 2014, U WIEN, P18; Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Kramer U, 2010, CLIN EXP ALLERGY, V40, P289, DOI 10.1111/j.1365-2222.2009.03435.x; Kukko M, 2004, DIABETES CARE, V27, P676, DOI 10.2337/diacare.27.3.676; Lehmann I, 2002, ALLERGY, V57, P129, DOI 10.1046/j.0105-4538.2002.00001.x; MICHAELIS D, 1993, DIABETES METAB, V19, P110; Michaelis D, 1993, DIABETES STOFFWECH H, V2, P245; Mohr SB, 2008, DIABETOLOGIA, V51, P1391, DOI 10.1007/s00125-008-1061-5; Patterson CC, 2012, DIABETOLOGIA, V55, P2142, DOI 10.1007/s00125-012-2571-8; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Potzsch O, 2012, GEBURTEN DEUTSCHLAND, P11; Schober E, 2008, EUR J PEDIATR, V167, P293, DOI 10.1007/s00431-007-0480-5; Soltesz G, 2007, PEDIATR DIABETES, V8, P6, DOI 10.1111/j.1399-5448.2007.00280.x; Stene LC, 2001, BMJ-BRIT MED J, V322, P889, DOI 10.1136/bmj.322.7291.889	30	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183665	10.1371/journal.pone.0183665	http://dx.doi.org/10.1371/journal.pone.0183665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880877	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200022
J	Hernandez-Lopez, R; Chavez-Gonzalez, A; Torres-Barrera, P; Moreno-Lorenzana, D; Lopez-DiazGuerrero, N; Santiago-German, D; Isordia-Salas, I; Smadja, D; Yoder, MC; Majluf-Cruz, A; Alvarado-Moreno, JA				Hernandez-Lopez, Rubicel; Chavez-Gonzalez, Antonieta; Torres-Barrera, Patricia; Moreno-Lorenzana, Dafne; Lopez-DiazGuerrero, Norma; Santiago-German, David; Isordia-Salas, Irma; Smadja, David; Yoder, Mervin C.; Majluf-Cruz, Abraham; Antonio Alvarado-Moreno, J.			Reduced proliferation of endothelial colonyforming cells in unprovoked venous thromboembolic disease as a consequence of endothelial dysfunction	PLOS ONE			English	Article							COLONY-FORMING CELLS; CORONARY-ARTERY-DISEASE; PROGENITOR CELLS; OXIDATIVE STRESS; THERAPEUTIC OPPORTUNITIES; ACCELERATED SENESCENCE; PREMATURE SENESCENCE; ANGIOGENESIS; MECHANISMS; EXPRESSION	Background Venous thromboembolic disease (VTD) is a public health problem. We recently reported that endothelial colony-forming cells (ECFCs) derived from endothelial cells (EC) (ECFCECs) from patients with VTD have a dysfunctional state. For this study, we proposed that a dysfunctional status of these cells generates a reduction of its proliferative ability, which is also associated with senescence and reactive oxygen species (ROS). Methods and results Human mononuclear cells (MNCs) were obtained from peripheral blood from 40 healthy human volunteers (controls) and 50 patients with VTD matched by age (20-50 years) and sex to obtain ECFCs. We assayed their proliferative ability with plasma of patients and controls and supernatants of cultures from ECFC-ECs, senescence-associated beta-galactosidase (SA-beta-gal), ROS, and expression of ephrin-B2/ Eph-B4 receptor. Compared with cells from controls, cells from VTD patients showed an 8-fold increase of ECFCs that emerged 1 week earlier, reduced proliferation at long term (39%) and, in passages 4 and 10, a highly senescent rate (30 +/- 1.05% vs. 91.3 +/- 15.07%, respectively) with an increase of ROS and impaired expression of ephrin-B2/Eph-4 genes. Proliferation potential of cells from VTD patients was reduced in endothelial medium [ 1.4 +/- 0.22 doubling population (DP)], control plasma (1.18 +/- 0.31 DP), or plasma from VTD patients (1.65 +/- 0.27 DP). Conclusions As compared with controls, ECFC-ECs from individuals with VTD have higher oxidative stress, proliferation stress, cellular senescence, and low proliferative potential. These findings suggest that patients with a history of VTD are ECFC-ECs dysfunctional that could be associated to permanent risk for new thrombotic events.	[Hernandez-Lopez, Rubicel; Isordia-Salas, Irma; Majluf-Cruz, Abraham; Antonio Alvarado-Moreno, J.] Inst Mexicano Seguro Social, Unidad Invest Med Trombosis Hemostasia & Aterogen, Mexico City, DF, Mexico; [Hernandez-Lopez, Rubicel; Lopez-DiazGuerrero, Norma] Univ Autonoma Metropolitana, Posgrad Biol Expt, Mexico City, DF, Mexico; [Chavez-Gonzalez, Antonieta; Torres-Barrera, Patricia; Moreno-Lorenzana, Dafne] Inst Mexicano Seguro Social, Unidad Invest Med Enfermedades Oncol, Mexico City, DF, Mexico; [Santiago-German, David] Inst Mexicano Seguro Social, Serv Urgencias, Mexico City, DF, Mexico; [Smadja, David] Paris Descartes Univ, INSERM, Fac Pharm Paris, UMR S 1140, Paris, France; [Smadja, David] Hop Europeen Georges Pompidou, AP HP, Hematol Dept, Paris, France; [Yoder, Mervin C.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Instituto Mexicano del Seguro Social; Universidad Autonoma Metropolitana - Mexico; Instituto Mexicano del Seguro Social; Instituto Mexicano del Seguro Social; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Indiana University System; Indiana University Bloomington	Alvarado-Moreno, JA (corresponding author), Inst Mexicano Seguro Social, Unidad Invest Med Trombosis Hemostasia & Aterogen, Mexico City, DF, Mexico.	alvarado_m01@yahoo.com.mx	Stefanadis, Christodoulos/ABH-2232-2020; HERNANDEZ, RUBICEL/AAF-3705-2020; Smadja, David/M-3872-2017	Stefanadis, Christodoulos/0000-0001-5974-6454; Yoder, Mervin/0000-0003-4354-7631; Hernandez-Lopez, Jose Rubicel/0000-0002-1281-5528; Smadja, David/0000-0001-7731-9202; Santiago German, David/0000-0002-6145-970X; LOPEZ DIAZ GUERRERO, NORMA EDITH/0000-0001-7470-9360; Moreno Lorenzana, Dafne Linda/0000-0003-3029-4241	Instituto Mexicano del Seguro Social (IMSS, Mexico) [FIS/IMSS/PROT/G15/1428]; Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico) [SALUD-2016-273432]; Experimental Biology Department, Autonomous University of Mexico, Iztapalapa; CONACYT, Mexico [237229]; IMSS [98376215]	Instituto Mexicano del Seguro Social (IMSS, Mexico); Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Experimental Biology Department, Autonomous University of Mexico, Iztapalapa; CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); IMSS	This study was partially supported by the grants FIS/IMSS/PROT/G15/1428 from the Instituto Mexicano del Seguro Social (IMSS, Mexico) and the grant SALUD-2016-273432 from the Consejo Nacional de Ciencia y Tecnologia (CONACYT, Mexico), provided funding for the study (JAA-M). RH-L received a grant from the Experimental Biology Department, Autonomous University of Mexico, Iztapalapa. CONACYT, Mexico: 237229 and IMSS: 98376215. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou I, 2006, ATHEROSCLEROSIS, V189, P247, DOI 10.1016/j.atherosclerosis.2006.06.021; Alvarado-Moreno JA, 2016, THROMB RES, V137, P157, DOI 10.1016/j.thromres.2015.11.005; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Baker CD, 2013, AM J PHYSIOL-LUNG C, V305, pL73, DOI 10.1152/ajplung.00400.2012; Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770; Brito R, 2015, EXP CLIN ENDOCR DIAB, V123, P325, DOI 10.1055/s-0035-1548765; Case J, 2008, ANTIOXID REDOX SIGN, V10, P1895, DOI 10.1089/ars.2008.2118; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1575, DOI 10.1152/ajpheart.00364.2005; Dernbach E, 2004, BLOOD, V104, P3591, DOI 10.1182/blood-2003-12-4103; Dutta D, 2012, CIRC RES, V110, P1125, DOI 10.1161/CIRCRESAHA.111.246108; Erber R, 2006, EMBO J, V25, P628, DOI 10.1038/sj.emboj.7600949; Gamberucci A, 1998, BIOCHEM J, V331, P623, DOI 10.1042/bj3310623; Gerber HP, 1998, J BIOL CHEM, V273, P13313, DOI 10.1074/jbc.273.21.13313; He TR, 2004, ARTERIOSCL THROM VAS, V24, P2021, DOI 10.1161/01.ATV.0000142810.27849.8f; Huang L, 2007, CELL TRANSPLANT, V16, P887, DOI 10.3727/096368907783338181; Hulsmans M, 2012, CURR ATHEROSCLER REP, V14, P264, DOI 10.1007/s11883-012-0237-0; Ingram DA, 2007, STEM CELLS, V25, P297, DOI 10.1634/stemcells.2006-0340; Jung EJ, 2011, BIOCHEM BIOPH RES CO, V404, P841, DOI 10.1016/j.bbrc.2010.12.072; Kim H, 2015, CYTOTHERAPY, V17, P579, DOI 10.1016/j.jcyt.2014.12.003; Kim KA, 2014, BIOL PHARM BULL, V37, P1248, DOI 10.1248/bpb.b14-00172; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Kushner EJ, 2009, CLIN CHEM LAB MED, V47, P47, DOI 10.1515/CCLM.2009.016; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Li WD, 2015, VASCUL PHARM; Li YF, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0130-8; Ligi I, 2014, J MATERN-FETAL NEO M, V27, P233, DOI 10.3109/14767058.2013.807237; Liu L, 2009, ATHEROSCLEROSIS, V202, P405, DOI 10.1016/j.atherosclerosis.2008.05.024; Liu Yan-rong, 2005, Zhejiang Da Xue Xue Bao Yi Xue Ban, V34, P163; Mena HA, J THROMBOSIS HAEMOST, V14, P397; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Meneveau N, 2011, BASIC RES CARDIOL, V106, P1397, DOI 10.1007/s00395-011-0220-x; Mikhed Y, 2015, INT J MOL SCI, V16, P15918, DOI 10.3390/ijms160715918; Muto A, 2011, J EXP MED, V208, P561, DOI 10.1084/jem.20101854; Patel RS, 2015, CIRC RES, V116, P289, DOI 10.1161/CIRCRESAHA.116.304187; Pedram A, 1998, J BIOL CHEM, V273, P26722, DOI 10.1074/jbc.273.41.26722; Peng J, 2015, J CARDIOVASC PHARM, V65, P80, DOI 10.1097/FJC.0000000000000166; Raskob GE, 2014, J THROMB HAEMOST, V12, P1580, DOI 10.1111/jth.12698; Rosti V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015277; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Schatteman GC, 2000, J CLIN INVEST, V106, P571, DOI 10.1172/JCI9087; Sipos PI, 2013, J CLIN ENDOCR METAB, V98, P4953, DOI 10.1210/jc.2013-2580; Sultan SA, 2015, J CELL PHYSIOL, V230, P2695, DOI 10.1002/jcp.24993; Tilling L, 2009, BRIT J CLIN PHARMACO, V68, P484, DOI 10.1111/j.1365-2125.2009.03486.x; Urao N, 2013, FREE RADICAL BIO MED, V54, P26, DOI 10.1016/j.freeradbiomed.2012.10.532; van Ierssel SH, 2015, J NEUROSCI RES, V93, P866, DOI 10.1002/jnr.23566; Vassallo PF, 2014, BLOOD, V123, P2116, DOI 10.1182/blood-2013-02-484956; Vemparala K, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-104; Yao EH, 2006, CURR PHARM BIOTECHNO, V7, P101, DOI 10.2174/138920106776597685; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Zhang YM, 2009, FASEB J, V23, P1358, DOI 10.1096/fj.08-110296	50	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183827	10.1371/journal.pone.0183827	http://dx.doi.org/10.1371/journal.pone.0183827			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910333	Green Submitted, Green Published, gold			2022-12-27	WOS:000410859200019
J	Zhang, SX; Kolominsky-Rabas, PL				Zhang, Shixuan; Kolominsky-Rabas, Peter L.			How TAVI registries report clinical outcomes-A systematic review of endpoints based on VARC-2 definitions	PLOS ONE			English	Review							AORTIC-VALVE IMPLANTATION; VALVULAR HEART-DISEASE; FOLLOW-UP; TRANSCATHETER; REPLACEMENT; STENOSIS; METAANALYSIS; MORTALITY; REGURGITATION; MANAGEMENT	Introduction Transcatheter aortic valve implantation (TAVI) has been demonstrated to be an alternative treatment for severe aortic stenosis in patients considered as high surgical risk. Since its first human implantation by Cribier et al., TAVI has been shown to increase survival rate and quality of life for high surgical risks patients. The objective of this study is to provide an overview of TAVI registries and the reporting clinical outcomes based on the VARC-2 definitions. In addition, the comparability and adherence of VARC-2 reporting within the identified TAVI registries was reviewed. Materials and methods A systematic review of TAVI registries reporting VARC-2 definitions has been performed in line with PRISMA guidelines in PubMed, ScienceDirect, Scopus databases and EMBASE. Based on VARC-2, patients' characteristics and procedure characteristics, 30-day clinical outcomes, 1-year mortality and composited endpoints were extracted from each registry's publications. Results This review identified 466 studies that were potentially relevant, and 20 TAVI registries reported VARC-2 definitions involved in our present review. Of all 20 registries, an overall sample size of 12,583 patients was involved. The 30-day all-cause mortality ranged from 0 to 12.7%. From 20 registries, 14 registries reported the cardiovascular mortality at 30 days. 9 registries reported myocardial infarction ( MI) rate based on VARC-2 definitions, and 7 registries reported peri-procedural MI rate (<72h). In our review, most of registries presented MI rates ranging from 0.5% to 2%. The majority of registries have reported complications such as bleeding, vascular complications and new pacemaker implantation. Conclusion Since the introduction of VARC definitions from 2011, VARC and VARC-2 definitions are still not systematically used by all TAVI studies. These endpoint definitions warrant a concise and systemic analysis of outcome measures. Reporting TAVI-outcome uniformly makes study result comparison feasible. This definitely will increase patient safety, additionally to provide sufficient evidence to support decision makers like regulatory bodies, HTA agencies, payers.	[Zhang, Shixuan; Kolominsky-Rabas, Peter L.] Friedrich Alexander Univ Erlangen Nurnberg, Interdisciplinary Ctr Hlth Technol Assessment HTA, Erlangen, Bavaria, Germany; [Kolominsky-Rabas, Peter L.] Natl Leading Edge Cluster Med Technol Med Valley, Erlangen, Bavaria, Germany	University of Erlangen Nuremberg	Zhang, SX (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Interdisciplinary Ctr Hlth Technol Assessment HTA, Erlangen, Bavaria, Germany.	Shixuan.Zhang@uk-erlangen.de		Kolominsky-Rabas, Peter/0000-0002-7168-058X	German Federal Ministry of Education and Research (BMBF), as part of National Leading-Edge Cluster Medical Technologies 'Medical Valley EMN.'	German Federal Ministry of Education and Research (BMBF), as part of National Leading-Edge Cluster Medical Technologies 'Medical Valley EMN.'	The research is supported by the German Federal Ministry of Education and Research (BMBF), as part of the National Leading-Edge Cluster Medical Technologies 'Medical Valley EMN.'r The research is supported by the German Federal Ministry of Education and Research (BMBF), as part of the National Leading-Edge Cluster Medical Technologies 'Medical Valley EMN'.	Abdel-Wahab M, 2014, HEART, V100, P1250, DOI 10.1136/heartjnl-2013-305385; Gomez AMA, 2013, REV ESP CARDIOL, V66, P85, DOI 10.1016/j.rec.2012.10.020; Binder RK, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.115.002653; Borz B, 2014, INT J CARDIOL, V173, P436, DOI 10.1016/j.ijcard.2014.03.011; Chieffo A, 2016, JACC-CARDIOVASC INTE, V9, P1589, DOI 10.1016/j.jcin.2016.05.015; Chieffo A, 2015, CATHETER CARDIO INTE, V86, P875, DOI 10.1002/ccd.25975; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Czarny MJ, 2014, CLIN MED INSIGHTS-CA, V8, P15, DOI 10.4137/CMC.S15716; De Backer O, 2016, INT J CARDIOL, V219, P92, DOI 10.1016/j.ijcard.2016.05.072; De Brito FS, 2016, CATHETERIZATION CARD, V85, pE153; de Brito Junior FS, 2011, REV BRASILEIRA CARDI, V19; Genereux P, 2012, J AM COLL CARDIOL, V59, P2317, DOI 10.1016/j.jacc.2012.02.022; Indraratna P, 2016, INT J CARDIOL, V224, P382, DOI 10.1016/j.ijcard.2016.09.018; Inohara T, 2016, CATHETER CARDIO INTE, V87, P963, DOI 10.1002/ccd.26266; IQTIG, 2015, QUAL 2015; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kappetein AP, 2013, J THORAC CARDIOV SUR, V145, P6, DOI 10.1016/j.jtcvs.2012.09.002; Kim LK, 2015, AM J CARDIOL, V116, P1910, DOI 10.1016/j.amjcard.2015.09.040; Kodali S, 2016, EUROPEAN HEART J; Landes U, 2016, CLIN CARDIOL; Lefevre T, 2016, JACC-CARDIOVASC INTE, V9, P68, DOI 10.1016/j.jcin.2015.09.027; Lefevre T, 2011, EUR HEART J, V32, P148, DOI 10.1093/eurheartj/ehq427; Leon MB, 2011, EUR HEART J, V32, P205, DOI 10.1093/eurheartj/ehq406; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Manning WJ, 2013, JAMA-J AM MED ASSOC, V310, P1490, DOI 10.1001/jama.2013.279194; Margulis AV, 2014, CLIN EPIDEMIOL, V6, P359, DOI 10.2147/CLEP.S66677; Martinez GJ, 2014, INTERN MED J, V44, P876, DOI 10.1111/imj.12514; Martinez-Selles M, 2016, EUROINTERVENTION, V11, P1180, DOI 10.4244/EIJY15M02_05; Muralidharan A, 2016, AM J CARDIOL, V118, P1031, DOI 10.1016/j.amjcard.2016.07.011; Mylotte D, 2013, J AM COLL CARDIOL, V62, P210, DOI 10.1016/j.jacc.2013.03.074; Nishimura RA, 2014, J AM COLL CARDIOL, V63, P2438, DOI 10.1016/j.jacc.2014.02.537; Panchal HB, 2014, AM J CARDIOL, V114, P1882, DOI 10.1016/j.amjcard.2014.09.029; Petronio AS, 2016, EUROINTERVENTION, V12, P381, DOI 10.4244/EIJY15M03_05; Reinohl J, 2015, NEW ENGL J MED, V373, P2438, DOI 10.1056/NEJMoa1500893; Ribeiro HB, 2015, J AM COLL CARDIOL, V66, P2075, DOI 10.1016/j.jacc.2015.08.881; Salinas P, 2016, REV ESP CARDIOL, V69, P37, DOI 10.1016/j.rec.2015.03.017; Salizzoni S, 2016, EUR J CARDIOTHORAC S; Schymik G, 2015, CATHETER CARDIO INTE, V86, P738, DOI 10.1002/ccd.25866; Schymik G, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.113.000761; Siemieniuk RA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5130; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tarantini G, 2013, INT J CARDIOL, V168, P5001, DOI 10.1016/j.ijcard.2013.07.123; Thomas M, 2010, CIRCULATION, V122, P62, DOI 10.1161/CIRCULATIONAHA.109.907402; Van Mieghem NM, 2016, EUROINTERVENTION, V11, pE1305, DOI 10.4244/EIJV11I10A253; Walters DL, 2014, INT J CARDIOL, V170, P406, DOI 10.1016/j.ijcard.2013.11.027; Walther T, 2012, ANN CARDIOTHORAC SUR, V1, P216, DOI 10.3978/j.issn.2225-319X.2012.07.10; Walther T, 2011, EUR J CARDIO-THORAC, V39, P532, DOI 10.1016/j.ejcts.2010.06.002; Webb JG, 2007, CIRCULATION, V116, P755, DOI 10.1161/CIRCULATIONAHA.107.698258; Yoon SH, 2016, JACC-CARDIOVASC INTE, V9, P926, DOI 10.1016/j.jcin.2016.01.047	50	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0180815	10.1371/journal.pone.0180815	http://dx.doi.org/10.1371/journal.pone.0180815			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910289	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200002
J	Aihara, T; Ogawa, T; Shimokawa, T; Yamashita, O				Aihara, Takatsugu; Ogawa, Takeshi; Shimokawa, Takeaki; Yamashita, Okito			Anodal transcranial direct current stimulation of the right anterior temporal lobe did not significantly affect verbal insight	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; PREFRONTAL CORTEX; RIGHT-HEMISPHERE; PERFORMANCE; ACTIVATION; TASK; TDCS	Humans often utilize past experience to solve difficult problems. However, if past experience is insufficient to solve a problem, solvers may reach an impasse. Insight can be valuable for breaking an impasse, enabling the reinterpretation or re-representation of a problem. Previous studies using between-subjects designs have revealed a causal relationship between the anterior temporal lobes (ATLs) and non-verbal insight, by enhancing the right ATL while inhibiting the left ATL using transcranial direct current stimulation (tDCS). In addition, neuro-imaging studies have reported a correlation between right ATL activity and verbal insight. Based on these findings, we hypothesized that the right ATL is causally related to both nonverbal and verbal insight. To test this hypothesis, we conducted an experiment with 66 subjects using a within-subjects design, which typically has greater statistical power than a between-subjects design. Subjects participated in tDCS experiments across 2 days, in which they solved both non-verbal and verbal insight problems under active or sham stimulation conditions. To dissociate the effects of right ATL stimulation from those of left ATL stimulation, we used two montage types; anodal tDCS of the right ATL together with cathodal tDCS of the left ATL (stimulating both ATLs) and anodal tDCS of the right ATL with cathodal tDCS of the left cheek (stimulating only the right ATL). The montage used was counterbalanced across subjects. Statistical analyses revealed that, regardless of the montage type, there were no significant differences between the active and sham conditions for either verbal or non-verbal insight, although the finding for non-verbal insight was inconclusive because of a lack of statistical power. These results failed to support previous findings suggesting that the right ATL is the central locus of insight.	[Aihara, Takatsugu; Shimokawa, Takeaki; Yamashita, Okito] Adv Telecommun Res Inst Int ATR, Neural Informat Anal Labs, Kyoto, Japan; [Ogawa, Takeshi] Adv Telecommun Res Inst Int ATR, Cognit Mech Labs, Kyoto, Japan	Advanced Telecommunications Research Institute International; Advanced Telecommunications Research Institute International	Aihara, T (corresponding author), Adv Telecommun Res Inst Int ATR, Neural Informat Anal Labs, Kyoto, Japan.	aihara@atr.jp	Yamashita, Okito/ABW-9839-2022	Yamashita, Okito/0000-0002-6039-3657	ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology, Japan [24700617]	ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). Takatsugu Aihara was supported by KAKENHI (24700617) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, JAPANESE J PSYCHOL; Arsalidou M, 2011, NEUROIMAGE, V54, P2382, DOI 10.1016/j.neuroimage.2010.10.009; Bowden EM, 1998, PSYCHOL SCI, V9, P435, DOI 10.1111/1467-9280.00082; Bowden EM, 2005, TRENDS COGN SCI, V9, P322, DOI 10.1016/j.tics.2005.05.012; Bowden EM, 2003, BEHAV RES METH INS C, V35, P634, DOI 10.3758/BF03195543; Bowden EM, 2003, PSYCHON B REV, V10, P730, DOI 10.3758/BF03196539; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cerruti C, 2009, J COGNITIVE NEUROSCI, V21, P1980, DOI 10.1162/jocn.2008.21143; Chi RP, 2012, NEUROSCI LETT, V515, P121, DOI 10.1016/j.neulet.2012.03.012; Chi RP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016655; Chu Y, 2011, J PROBL SOLVING, V3, P119, DOI 10.7771/1932-6246.1094; Gobel SM, 2006, CORTEX, V42, P774, DOI 10.1016/S0010-9452(08)70416-7; Goel V, 2015, J PROBL SOLVING, V8, P23, DOI 10.7771/1932-6246.1172; GRAFMAN J, 1982, CORTEX, V18, P37, DOI 10.1016/S0010-9452(82)80017-8; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; Jones Kevin T, 2012, Front Psychiatry, V3, P81, DOI 10.3389/fpsyt.2012.00081; Jung YJ, 2013, BIOMED ENG LETT, V3, P39, DOI 10.1007/s13534-013-0087-x; Jung-Beeman M, 2004, PLOS BIOL, V4; Kasahara K, 2013, NEUROSCI LETT, V545, P86, DOI 10.1016/j.neulet.2013.04.022; Kawahito J., 2011, HIROSHIMA PSYCHOL RE, P225, DOI [DOI 10.15027/32396, 10.15027/32396, DOI 10.15027/32396(INJAPANESEWITHENGLISHABSTRACT)]; Kim JH, 2014, NEUROSCI LETT, V564, P6, DOI 10.1016/j.neulet.2014.01.054; Knoblich G, 1999, J EXP PSYCHOL LEARN, V25, P1534, DOI 10.1037/0278-7393.25.6.1534; Kounios J, 2008, NEUROPSYCHOLOGIA, V46, P281, DOI 10.1016/j.neuropsychologia.2007.07.013; Kounios J, 2014, ANNU REV PSYCHOL, V65, P71, DOI 10.1146/annurev-psych-010213-115154; Li LM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00181; Mayer E, 1999, BRAIN, V122, P1107, DOI 10.1093/brain/122.6.1107; Metuki N, 2012, BRAIN STIMUL, V5, P110, DOI 10.1016/j.brs.2012.03.002; Miniussi C., 2012, TRANSCRANIAL BRAIN S; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Ollinger M, 2008, EXP PSYCHOL, V55, P269, DOI 10.1027/1618-3169.55.4.269; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Subramaniam K, 2009, J COGNITIVE NEUROSCI, V21, P415, DOI 10.1162/jocn.2009.21057; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zmigrod S, 2015, CREATIVITY RES J, V27, P353, DOI 10.1080/10400419.2015.1087280	37	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184749	10.1371/journal.pone.0184749	http://dx.doi.org/10.1371/journal.pone.0184749			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902872	gold, Green Published, Green Submitted			2022-12-27	WOS:000410669200061
J	Chang, J; Xia, YF; Wasserloos, K; Deng, MH; Blose, KJ; Vorp, DA; Turnquist, HR; Billiar, TR; Pitt, BA; Zhang, MZ; Zhang, LM				Chang, Jing; Xia, Yuefeng; Wasserloos, Karla; Deng, Meihong; Blose, Kory J.; Vorp, David A.; Turnquist, Heth R.; Billiar, Timothy R.; Pitt, Bruce A.; Zhang, Ma-Zhong; Zhang, Li-Ming			Cyclic stretch induced IL-33 production through HMGB1/TLR-4 signaling pathway in murine respiratory epithelial cells	PLOS ONE			English	Article							INDUCED LUNG INJURY; MECHANICAL STRETCH; CYSTIC-FIBROSIS; DUAL-FUNCTION; IN-VIVO; EXPRESSION; LIPOPOLYSACCHARIDE; INFLAMMATION; HMGB1; MICE	Interleukin 33 (IL-33), an inflammatory and mechanically responsive cytokine, is an important component of a TLR4-dependent innate immune process in mucosal epithelium. Although TLR4 also plays a role in sensing biomechanical stretch, a pathway of stretch-induced TLR4-dependent IL-33 biosynthesis has not been revealed. In the current study, we show that short term (6 h) cyclic stretch (CS) of cultured murine respiratory epithelial cells (MLE-12) increased intracellular IL-33 expression in a TLR4 dependent fashion. There was no detectable IL-33 in conditioned media in this interval. CS, however, increased release of the notable alarmin, HMGB1, and a neutralizing antibody (2G7) to HMGB1 completely abolished the CS mediated increase in IL-33. rHMGB1 increased IL-33 synthesis and this was partially abrogated by silencing TLR4 suggesting additional receptors for HMGB1 are involved in its regulation of IL-33. Collectively, these data reveal a HMGB1/TLR4/IL-33 pathway in the response of respiratory epithelium to mechanical stretch.	[Chang, Jing; Zhang, Ma-Zhong] Shanghai Jiao Tong Univ, Dept Anesthesiol, Shanghai Childrens Med Ctr, Sch Med, Shanghai, Peoples R China; [Chang, Jing; Wasserloos, Karla; Pitt, Bruce A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15261 USA; [Chang, Jing; Zhang, Li-Ming] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA; [Xia, Yuefeng] Cent S Univ, Hunan Canc Hosp, Dept Anesthesiol, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Deng, Meihong; Vorp, David A.; Turnquist, Heth R.; Billiar, Timothy R.] Univ Pittsburgh, Sch Med, Dept Surg, Pittsburgh, PA USA; [Blose, Kory J.; Vorp, David A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA USA; [Vorp, David A.] Univ Pittsburgh, Dept Cardiothorac Surg, Pittsburgh, PA USA	Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, MZ (corresponding author), Shanghai Jiao Tong Univ, Dept Anesthesiol, Shanghai Childrens Med Ctr, Sch Med, Shanghai, Peoples R China.; Zhang, LM (corresponding author), Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15261 USA.	zmzscmc@shsmu.edu.cn; ZhangL1@anes.upmc.edu	Turnquist, Heth R/L-2319-2016	Turnquist, Heth R/0000-0002-4173-4014; Pitt, Bruce/0000-0003-0099-6648	NIH [R01 -GM -108639, R01-GM-50441]; Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines Foundation of China [2015ZB0106]; Shanghai Pudong New District Science and Technology Development Innovation Foundation of China [PKJ 2013-Y61]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122489, T32HL076124] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines Foundation of China; Shanghai Pudong New District Science and Technology Development Innovation Foundation of China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This publication was made possible by the following grants: NIH grants R01 -GM -108639 (LMZ) and R01-GM-50441(TRB); Shanghai Municipal Commission of Health and Family Planning, Key Developing Disciplines Foundation of China [2015ZB0106] (MZZ); Shanghai Pudong New District Science and Technology Development Innovation Foundation of China [PKJ 2013-Y61] (MZZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker MN, 2000, J BIOL CHEM, V275, P29731, DOI 10.1074/jbc.M000184200; Bertheloot D, 2017, CELL MOL IMMUNOL, V14, P43, DOI 10.1038/cmi.2016.34; Cayrol C, 2009, P NATL ACAD SCI USA, V106, P9021, DOI 10.1073/pnas.0812690106; Chang Jing, 2016, Transl Perioper Pain Med, V1, P24; Diamond G, 1996, P NATL ACAD SCI USA, V93, P5156, DOI 10.1073/pnas.93.10.5156; Ding N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074633; Entezari M, 2012, MOL MED, V18, P477, DOI 10.2119/molmed.2012.00024; FEARNS C, 1995, J EXP MED, V181, P857, DOI 10.1084/jem.181.3.857; Fu J, 2016, INT IMMUNOPHARMACOL, V38, P267, DOI 10.1016/j.intimp.2016.06.010; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Gutschow MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053222; Ha TZ, 2005, CARDIOVASC RES, V68, P224, DOI 10.1016/j.cardiores.2005.05.025; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; Hu GC, 2010, CRIT CARE MED, V38, P194, DOI 10.1097/CCM.0b013e3181bc7c17; John AE, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad5568; John G, 2011, EXP LUNG RES, V37, P319, DOI 10.3109/01902148.2011.569968; Kakkar R, 2012, J BIOL CHEM, V287, P6941, DOI 10.1074/jbc.M111.298703; Kim DE, 2012, BIOCHEM BIOPH RES CO, V421, P436, DOI 10.1016/j.bbrc.2012.03.131; Kuhn H, 2014, RESPIROLOGY, V19, P67, DOI 10.1111/resp.12149; Li HH, 2012, AM J RESP CELL MOL, V47, P528, DOI 10.1165/rcmb.2012-0127OC; Li HH, 2010, ANESTHESIOLOGY, V113, P619, DOI 10.1097/ALN.0b013e3181e89ab2; Li J., 2016, STEM CELLS INT, V2016, P6, DOI DOI 10.1016/J.ENGGE0.2016.03.006; Lin SH, 2016, CLIN IMMUNOLOGY; Lundback P, 2016, HEPATOLOGY, V64, P1699, DOI 10.1002/hep.28736; Luzina IG, 2013, AM J RESP CELL MOL, V49, P999, DOI 10.1165/rcmb.2013-0093OC; Martinez-Gonzalez I, 2013, AM J RESP CELL MOL, V49, P552, DOI 10.1165/rcmb.2012-0406OC; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Moussion C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003331; Paris G, 2014, INT FORUM ALLERGY RH, V4, P15, DOI 10.1002/alr.21237; Qin SX, 2006, J EXP MED, V203, P1637, DOI 10.1084/jem.20052203; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sebag SC, 2013, J BIOL CHEM, V288, P7875, DOI 10.1074/jbc.M112.403220; Shyu KG, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-15; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Tao AB, 2015, BBA-MOL BASIS DIS, V1852, P2075, DOI 10.1016/j.bbadis.2015.07.015; Tao WW, 2015, INT IMMUNOPHARMACOL, V27, P138, DOI 10.1016/j.intimp.2015.05.005; Tjota MY, 2013, J CLIN INVEST, V123, P2287, DOI 10.1172/JCI63802; Ullah MA, 2014, J ALLERGY CLIN IMMUN, V134, P440, DOI 10.1016/j.jaci.2013.12.1035; Vande Geest Jonathan P, 2004, J Biomech, V37, P1923, DOI 10.1016/j.jbiomech.2004.02.022; Vaneker M, 2008, ANESTHESIOLOGY, V109, P465, DOI 10.1097/ALN.0b013e318182aef1; Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010; Wu JB, 2013, J IMMUNOL, V190, P3590, DOI 10.4049/jimmunol.1200860; Wu XJ, 2013, MOL CELL BIOCHEM, V380, P249, DOI 10.1007/s11010-013-1680-0; Xia J, 2015, AM J PHYSIOL-LUNG C, V308, pL619, DOI 10.1152/ajplung.00305.2014; Xu J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002365; Xu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108914; Yang SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121391	48	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184770	10.1371/journal.pone.0184770	http://dx.doi.org/10.1371/journal.pone.0184770			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898270	Green Submitted, Green Published, gold			2022-12-27	WOS:000410449500049
J	Morais, ER; Oliveira, KC; de Paula, RG; Ornelas, AMM; Moreira, EBC; Badoco, FR; Magalhaes, LG; Verjovski-Almeida, S; Rodrigues, V				Morais, Enyara R.; Oliveira, Katia C.; de Paula, Renato G.; Ornelas, Alice M. M.; Moreira, Erika B. C.; Badoco, Fernanda Rafacho; Magalhaes, Lizandra G.; Verjovski-Almeida, Sergio; Rodrigues, Vanderlei			Effects of proteasome inhibitor MG-132 on the parasite Schistosoma mansoni	PLOS ONE			English	Article							20S PROTEASOME; TRANSCRIPTOME ANALYSIS; REGULATORY PARTICLE; MICROARRAY; PATHWAY; GENE; APOPTOSIS; IDENTIFICATION; PROTEOLYSIS; CURCUMIN	Proteasome is a proteolytic complex responsible for intracellular protein turnover in eukaryotes, archaea and in some actinobacteria species. Previous work has demonstrated that in Schistosoma mansoni parasites, the proteasome inhibitor MG-132 affects parasite development. However, the molecular targets affected by MG-132 in S. mansoni are not entirely known. Here, we used expression microarrays to measure the genome-wide changes in gene expression of S. mansoni adult worms exposed in vitro to MG-132, followed by in silico functional analyses of the affected genes using Ingenuity Pathway Analysis (IPA). Scanning electron microscopy was used to document changes in the parasites' tegument. We identified 1,919 genes with a statistically significant (q-value <= 0.025) differential expression in parasites treated for 24 h with MG-132, when compared with control. Of these, a total of 1,130 genes were up-regulated and 790 genes were down-regulated. A functional gene interaction network comprised of MG-132 and its target genes, known from the literature to be affected by the compound in humans, was identified here as affected by MG-132. While MG-132 activated the expression of the 26S proteasome genes, it also decreased the expression of 19S chaperones assembly, 20S proteasome maturation, ubiquitin-like NEDD8 and its partner cullin-3 ubiquitin ligase genes. Interestingly, genes that encode proteins related to potassium ion binding, integral membrane component, ATPase and potassium channel activities were significantly down-regulated, whereas genes encoding proteins related to actin binding and microtubule motor activity were significantly up-regulated. MG132 caused important changes in the worm tegument; peeling, outbreaks and swelling in the tegument tubercles could be observed, which is consistent with interference on the ionic homeostasis in S. mansoni. Finally, we showed the down-regulation of Bax pro-apoptotic gene, as well as up-regulation of two apoptosis inhibitor genes, IAP1 and BRE1, and in contrast, down-regulation of Apaf-1 apoptotic activator, thus suggesting that apoptosis is deregulated in S. mansoni exposed to MG-132. A considerable insight has been gained concerning the potential of MG-132 as a gene expression modulator, and overall the data suggest that the proteasome might be an important molecular target for the design of new drugs against schistosomiasis.	[Morais, Enyara R.; de Paula, Renato G.; Ornelas, Alice M. M.; Moreira, Erika B. C.; Rodrigues, Vanderlei] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil; [Oliveira, Katia C.; Verjovski-Almeida, Sergio] Univ Sao Paulo, Dept Bioquim, Inst Quim, Sao Paulo, SP, Brazil; [Oliveira, Katia C.] Adolfo Lutz Inst, Ctr Parasitol & Micol, Nucleo Enteroparasitas, Sao Paulo, SP, Brazil; [Badoco, Fernanda Rafacho; Magalhaes, Lizandra G.] Univ Franca, Nucleo Pesquisa Ciencias Exatas & Tecnol, Grp Pesquisa Prod Nat, Franca, SP, Brazil; [Verjovski-Almeida, Sergio] Inst Butantan, Lab Expressao Genica Eucariotos, Sao Paulo, SP, Brazil; [Morais, Enyara R.] Univ Fed Uberlandia, Inst Genet Bioquim, Campus Patos de Minas, Patos De Minas, MG, Brazil; [Oliveira, Katia C.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Microbiol Imunol & Parasitol, Discipline Parasitol, Sao Paulo, SP, Brazil; [Ornelas, Alice M. M.] Univ Fed Rio de Janeiro, Inst Biol, Ctr Ciencias & Saude, Rio De Janeiro, RJ, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Adolfo Lutz; Universidad de Franca; Instituto Butantan; Universidade Federal de Uberlandia; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do Rio de Janeiro	Morais, ER (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil.; Morais, ER (corresponding author), Univ Fed Uberlandia, Inst Genet Bioquim, Campus Patos de Minas, Patos De Minas, MG, Brazil.	ermorais@ufu.br	Oliveira, K C/B-9079-2012; DE PAULA, RENATO GRACIANO/T-8688-2019; Verjovski-Almeida, Sergio/E-4082-2012; Ornelas, Alice M M/K-1548-2018; RAFACHO BADOCO, FERNANDA/GOV-7103-2022; De Paula, Renato Graciano/Q-2222-2016; Badoco, Fernanda/GYD-8954-2022; Magalhães, Lizandra/B-9702-2014	Oliveira, K C/0000-0002-8535-0901; DE PAULA, RENATO GRACIANO/0000-0002-6712-437X; Verjovski-Almeida, Sergio/0000-0002-6356-2401; Ornelas, Alice M M/0000-0003-4131-4850; RAFACHO BADOCO, FERNANDA/0000-0001-9055-4143; De Paula, Renato Graciano/0000-0002-6712-437X; Badoco, Fernanda/0000-0001-9055-4143; Magalhães, Lizandra/0000-0003-2959-6752; Morais, Enyara/0000-0001-5193-889X				Almeida GT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004086; Anderson L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004334; Bergquist R, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0286-2; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Botros S, 2003, ANTIMICROB AGENTS CH, V47, P3853, DOI 10.1128/AAC.47.12.3853-3858.2003; Burri L, 2000, P NATL ACAD SCI USA, V97, P10348, DOI 10.1073/pnas.190268597; Caffrey CR, 2015, FUTURE MED CHEM, V7, P675, DOI [10.4155/FMC.15.27, 10.4155/fmc.15.27]; Cai PF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1947-x; Cai PF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004684; Charlesworth A, 2004, J BIOL CHEM, V279, P17650, DOI 10.1074/jbc.M313837200; Dai Y, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2036-5; de Diego JL, 2001, BIOCHEMISTRY-US, V40, P1053, DOI 10.1021/bi001659k; de Paula R, 2015, PARASITOL RES, V114, P1747, DOI 10.1007/s00436-015-4360-z; de Paula RG, 2014, PARASITOL RES, V113, P2887, DOI 10.1007/s00436-014-3950-5; DeMarco R, 2006, MOL BIOCHEM PARASIT, V150, P123, DOI 10.1016/j.molbiopara.2006.07.002; DEVERAUX Q, 1995, J BIOL CHEM, V270, P29660; Fitzpatrick JM, 2005, MOL BIOCHEM PARASIT, V141, P1, DOI 10.1016/j.molbiopara.2005.01.007; Gaczynska Maria, 2005, V301, P3; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Goldberg AL, 2012, J CELL BIOL, V199, P583, DOI 10.1083/jcb.201210077; Greenberg RM, 2014, CURR CLIN MICROBIOL, V1, P51, DOI 10.1007/s40588-014-0007-6; Griffin Thomas A., 2000, Molecular Cell Biology Research Communications, V3, P212, DOI 10.1006/mcbr.2000.0213; Groll M, 2004, BBA-MOL CELL RES, V1695, P33, DOI 10.1016/j.bbamcr.2004.09.025; Guerra-Sa R, 2005, EXP PARASITOL, V109, P228, DOI 10.1016/j.exppara.2005.01.002; Guo N, 2013, ASIA-PAC J CLIN ONCO, V9, P6, DOI 10.1111/j.1743-7563.2012.01535.x; Hoffmann KF, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-8-research0041; Kasinathan RS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001425; Kasinathan RS, 2010, MOL BIOCHEM PARASIT, V173, P25, DOI 10.1016/j.molbiopara.2010.05.003; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Khare S, 2016, NATURE, V537, P229, DOI 10.1038/nature19339; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lee EF, 2011, P NATL ACAD SCI USA, V108, P6999, DOI 10.1073/pnas.1100652108; Leutner S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002532; Li H, 2016, NATURE, V530, P233, DOI 10.1038/nature16936; Li H, 2014, J AM CHEM SOC, V136, P13562, DOI 10.1021/ja507692y; Magalhaes LG, 2009, PARASITOL RES, V104, P1197, DOI 10.1007/s00436-008-1311-y; Makioka A, 2002, PARASITOL RES, V88, P454, DOI 10.1007/s00436-002-0601-z; Mathieson W, 2011, MOL BIOCHEM PARASIT, V175, P118, DOI 10.1016/j.molbiopara.2010.10.005; Morais ER, 2013, MOL BIOCHEM PARASIT, V187, P91, DOI 10.1016/j.molbiopara.2012.11.006; Nath SR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00078; Nehybova T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040729; Nkemgu-Njinkeng J, 2002, ANTIMICROB AGENTS CH, V46, P2038, DOI 10.1128/AAC.46.6.2038-2040.2002; Oliveira KC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000556; Park Ji Eun, 2017, PLoS One, V12, pe0173247, DOI 10.1371/journal.pone.0173247; Peng JB, 2010, PARASITOL RES, V106, P967, DOI 10.1007/s00436-010-1752-y; Pereira RV, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0957-4; Picard MAL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004930; Prasad R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073530; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ramos PC, 1998, CELL, V92, P489, DOI 10.1016/S0092-8674(00)80942-3; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Robertson CD, 1999, MOL BIOCHEM PARASIT, V103, P49, DOI 10.1016/S0166-6851(99)00110-3; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rojo JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171677; Rosenberg SH, 2011, P NATL ACAD SCI USA, V108, P6695, DOI 10.1073/pnas.1104151108; Santiago EDF, 2014, ANTIMICROB AGENTS CH, V58, P352, DOI 10.1128/AAC.01900-13; Savulescu AF, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.006890; Shaw MK, 2000, PARASITOLOGY, V121, P35, DOI 10.1017/S0031182099006071; Siddiqui AA, 2017, TRENDS PARASITOL, V33, P194, DOI 10.1016/j.pt.2016.10.010; Sidor-Kaczmarek J, 2017, CELL BIOL TOXICOL; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; Tebeje BM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1799-4; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Vale N, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02582-16, 10.1128/aac.02582-16]; Verjovski-Almeida S, 2004, TRENDS PARASITOL, V20, P304, DOI 10.1016/j.pt.2004.04.012; Verjovski-Almeida S, 2003, NAT GENET, V35, P148, DOI 10.1038/ng1237; Verjovski-Almeida S, 2007, EXP PARASITOL, V117, P236, DOI 10.1016/j.exppara.2007.04.005; Vermeire JJ, 2006, MOL BIOCHEM PARASIT, V147, P39, DOI 10.1016/j.molbiopara.2006.01.006; Waisberg M, 2008, EXP PARASITOL, V120, P357, DOI 10.1016/j.exppara.2008.09.005; Waisberg M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-181; Walter D, 2010, J CELL SCI, V123, P1931, DOI 10.1242/jcs.065938; WHO, 2017, SCHIST MED CTR FACT; WHO, 2016, SCHIST MED CTR FACT; Wilck N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040781; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Zanotto A, 2012, INVEST NEW DRUG, V30, P2252, DOI 10.1007/s10637-012-9804-z	79	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184192	10.1371/journal.pone.0184192	http://dx.doi.org/10.1371/journal.pone.0184192			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898250	Green Published, gold, Green Submitted			2022-12-27	WOS:000410449500017
J	Jung, J; Kim, S; Cho, H; Nam, K				Jung, JeYoung; Kim, Sunmi; Cho, Hyesuk; Nam, Kichun			Structural and functional correlates for language efficiency in auditory word processing	PLOS ONE			English	Article							VENTROLATERAL THALAMIC-STIMULATION; MILD COGNITIVE IMPAIRMENT; MIDDLE TEMPORAL GYRUS; SPEECH-PERCEPTION; TASK-PERFORMANCE; SEMANTIC SYSTEM; READING-ABILITY; WORKING-MEMORY; CORTICAL AREAS; VISUAL-CORTEX	This study aims to provide convergent understanding of the neural basis of auditory word processing efficiency using a multimodal imaging. We investigated the structural and functional correlates of word processing efficiency in healthy individuals. We acquired two structural imaging (T1-weighted imaging and diffusion tensor imaging) and functional magnetic resonance imaging (fMRI) during auditory word processing (phonological and semantic tasks). Our results showed that better phonological performance was predicted by the greater thalamus activity. In contrary, better semantic performance was associated with the less activation in the left posterior middle temporal gyrus (pMTG), supporting the neural efficiency hypothesis that better task performance requires less brain activation. Furthermore, our network analysis revealed the semantic network including the left anterior temporal lobe (ATL), dorsolateral prefrontal cortex (DLPFC) and pMTG was correlated with the semantic efficiency. Especially, this network acted as a neural efficient manner during auditory word processing. Structurally, DLPFC and cingulum contributed to the word processing efficiency. Also, the parietal cortex showed a significate association with the word processing efficiency. Our results demonstrated that two features of word processing efficiency, phonology and semantics, can be supported in different brain regions and, importantly, the way serving it in each region was different according to the feature of word processing. Our findings suggest that word processing efficiency can be achieved by in collaboration of multiple brain regions involved in language and general cognitive function structurally and functionally.	[Jung, JeYoung] Univ Manchester, Sch Biol Sci, Div Neurosci & Expt Psychol, Neurosci & Aphasia Res Unit, Manchester, Lancs, England; [Kim, Sunmi; Cho, Hyesuk; Nam, Kichun] Korea Univ, Wisdom Sci Ctr, Seoul, South Korea; [Nam, Kichun] Korea Univ, Dept Psychol, Seoul, South Korea	University of Manchester; Korea University; Korea University	Jung, J (corresponding author), Univ Manchester, Sch Biol Sci, Div Neurosci & Expt Psychol, Neurosci & Aphasia Res Unit, Manchester, Lancs, England.; Nam, K (corresponding author), Korea Univ, Wisdom Sci Ctr, Seoul, South Korea.; Nam, K (corresponding author), Korea Univ, Dept Psychol, Seoul, South Korea.	jeyoung.jung@manchester.ac.uk; kichun@korea.ac.kr		Jung, JeYoung/0000-0003-3739-7331	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016R1A2B4007876]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2016R1A2B4007876). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, HUMAN NEUROANATOMY T; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Bartlett EL, 2013, BRAIN LANG, V126, P29, DOI 10.1016/j.bandl.2013.03.003; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Baumeister J, 2008, EUR J APPL PHYSIOL, V104, P625, DOI 10.1007/s00421-008-0811-x; Beaulieu C, 2005, NEUROIMAGE, V25, P1266, DOI 10.1016/j.neuroimage.2004.12.053; Bhatnagar SC, 2005, BRAIN LANG, V92, P1, DOI 10.1016/j.bandl.2004.05.002; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Booth JR, 2003, HUM BRAIN MAPP, V19, P155, DOI 10.1002/hbm.10111; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Chee M, 2001, NEUROIMAGE, V13, pS516; Crittenden BM, 2014, CEREB CORTEX, V24, P532, DOI 10.1093/cercor/bhs333; De Schotten MT, 2012, LEARNING READ IMPROV; Delano-Wood L, 2012, J ALZHEIMERS DIS, V29, P589, DOI 10.3233/JAD-2012-102103; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Dronkers NF, 2004, COGNITION, V92, P145, DOI 10.1016/j.cognition.2003.11.002; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Faw B, 2003, CONSCIOUS COGN, V12, P83, DOI 10.1016/S1053-8100(02)00030-2; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Geschwind N., 1974, DISCONNEXION SYNDROM; Grogan A, 2012, NEUROPSYCHOLOGIA, V50, P1347, DOI 10.1016/j.neuropsychologia.2012.02.019; HAIER RJ, 1992, INTELLIGENCE, V16, P415, DOI 10.1016/0160-2896(92)90018-M; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hoffman P, 2012, APHASIOLOGY, V26, P1119, DOI 10.1080/02687038.2011.608838; Howell D. C., 2010, FUNDAMENTAL STAT BEH; Johnson MD, 2000, BRAIN COGNITION, V42, P218, DOI 10.1006/brcg.1999.1101; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kang YJ, 2015, LAB PHONOL, V6, P469, DOI 10.1515/lp-2015-0014; Kantarci K, 2011, NEUROLOGY, V77, P26, DOI 10.1212/WNL.0b013e31822313dc; Kim S, 1993, KOREAN PRONUNCIATION; Klingberg T, 2000, NEURON, V25, P493, DOI 10.1016/S0896-6273(00)80911-3; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee CC, 2013, BRAIN LANG, V126, P22, DOI 10.1016/j.bandl.2012.05.004; Lee H, 2007, J NEUROSCI, V27, P1184, DOI 10.1523/JNEUROSCI.4442-06.2007; Lim SJ, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00230; Maguire EA, 2004, NEUROIMAGE, V22, P171, DOI 10.1016/j.neuroimage.2003.12.036; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mechelli A, 2004, NATURE, V431, P757, DOI 10.1038/431757a; Metzler-Baddeley C, 2012, J NEUROSCI, V32, P17612, DOI 10.1523/JNEUROSCI.3299-12.2012; MOORE O, 1991, SRA-J SOC RES ADMIN, V23, P45; Mori S., 2005, AM SOC NEURORADIOLOG; Neubauer AC, 2009, NEUROSCI BIOBEHAV R, V33, P1004, DOI 10.1016/j.neubiorev.2009.04.001; Noonan KA, 2013, J COGN NEUROSCI; OJEMANN GA, 1975, BRAIN LANG, V2, P101, DOI 10.1016/S0093-934X(75)80057-5; OJEMANN GA, 1971, BRAIN, V94, P225, DOI 10.1093/brain/94.2.225; OJEMANN GA, 1985, APPL NEUROPHYSIOL, V48, P212; Penfield W., 1959, SPEECH BRAIN MECH; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; PETERSEN SE, 1990, SCIENCE, V249, P1041, DOI 10.1126/science.2396097; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Richardson FM, 2011, J NEUROSCI, V31, P8239, DOI 10.1523/JNEUROSCI.6519-10.2011; ROUILLER EM, 1991, EXP BRAIN RES, V86, P483, DOI 10.1007/BF00230523; Schwartz MF, 2009, BRAIN, V132, P3411, DOI 10.1093/brain/awp284; Seghier ML, 2013, NEUROSCIENTIST, V19, P43, DOI 10.1177/1073858412440596; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Steinbrink C, 2008, NEUROPSYCHOLOGIA, V46, P3170, DOI 10.1016/j.neuropsychologia.2008.07.015; Timmann D, 2009, NEUROSCIENCE, V162, P836, DOI 10.1016/j.neuroscience.2009.01.040; Townsend J. T., 1983, STOCHASTIC MODELING; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; Van Ettinger-Veenstra H, 2012, BRAIN LANG, V120, P395, DOI 10.1016/j.bandl.2011.10.002; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Vanderhasselt MA, 2009, PSYCHON B REV, V16, P609, DOI 10.3758/PBR.16.3.609; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Visser M, 2011, J COGNITIVE NEUROSCI, V23, P3121, DOI 10.1162/jocn_a_00007; Visser M, 2012, J COGNITIVE NEUROSCI, V24, P1766, DOI 10.1162/jocn_a_00244; Weber B, 2006, EPILEPSIA, V47, P880, DOI 10.1111/j.1528-1167.2006.00515.x; Wei T, 2012, J NEUROSCI, V32, P481, DOI 10.1523/JNEUROSCI.1953-11.2012; Wernicke C., 1874, APHASISCHE SYMPTOMEN; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Y-K Kim-Renaud, 1994, THEORETICAL ISSUES K	78	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184232	10.1371/journal.pone.0184232	http://dx.doi.org/10.1371/journal.pone.0184232			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG4OS	28892503	gold, Green Published, Green Submitted			2022-12-27	WOS:000410243200011
J	Baek, IJ; Moss, DS; Lustig, AJ				Baek, In-Joon; Moss, Daniel S.; Lustig, Arthur J.			The mre11 A470 alleles influence the hereditability and the segregation of telosomes in Saccharomyces cerevisiae	PLOS ONE			English	Article							TELOMERE LENGTH; GENE-EXPRESSION; DNA-BINDING; YEAST; RAP1; ELONGATION; HETEROCHROMATIN; MAINTENANCE; REPLICATION; MECHANISM	Telomeres, the nucleoprotein complexes at the termini of linear chromosomes, are essential for the processes of end replication, end protection, and chromatin segregation. The Mre11 complex is involved in multiple cellular roles in DNA repair and structure in the regulation and function of telomere size homeostasis. In this study, we characterize yeast telomere chromatin structure, phenotypic heritability, and chromatin segregation in both wild-type [ MRE11] and A470 motif alleles. MRE11 strains confer a telomere size of 300 base pairs of G+T irregular simple sequence repeats. This DNA and a portion of subtelomeric DNA is embedded in a telosome: a MNase-resistant non-nucleosomal particle. Chromatin immuno-precipitation shows a three to four-fold lower occupancy of Mre11A470T proteins than wildtype proteins in telosomes. Telosomes containing the Mre11A470T protein confer a greater resistance to MNase digestion than wild-type telosomes. The integration of a wild-type MRE11 allele into an ectopic locus in the genome of an mre11A470T mutant and the introduction of an mre11A470T allele at an ectopic site in a wild-type strain lead to unexpectedly differing results. In each case, the replicated sister chromatids inherit telosomes containing only the protein encoded by the genomic mre11 locus, even in the presence of protein encoded by the opposing ectopic allele. We hypothesize that the telosome segregates by a conservative mechanism. These data support a mechanism for the linkage between sister chromatid replication and maintenance of either identical mutant or identical wild-type telosomes after replication of sister chromatids. These data suggest the presence of an active mechanism for chromatin segregation in yeast.	[Baek, In-Joon; Moss, Daniel S.; Lustig, Arthur J.] Tulane Univ, Med Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70118 USA	Tulane University	Lustig, AJ (corresponding author), Tulane Univ, Med Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70118 USA.	alustig@tulane.edu		Moss, Daniel/0000-0001-7639-7276	NIH [R01GM069943]; School of Medicine of Tulane University; Tulane University Dean of Research Office; Louisiana Consortium for Cancer Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); School of Medicine of Tulane University; Tulane University Dean of Research Office; Louisiana Consortium for Cancer Research	This project was funded by NIH (www.nih.gov) R01GM069943 to AJL and by funds from the School of Medicine of Tulane University, Tulane University Dean of Research Office, and the Louisiana Consortium for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Anbalagan S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002024; Antoniacci LM, 2006, CURR BIOL, V16, P902, DOI 10.1016/j.cub.2006.03.060; Ballew BJ, 2013, AGING CELL, V12, P719, DOI 10.1111/acel.12099; Blackburn EH, 1995, TELOMERES, Vx; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Cabianca DS, 2016, NUCLEUS-PHILA, V7, P301, DOI 10.1080/19491034.2016.1187354; Cassani C, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002387; COLLINS K, 1993, GENE DEV, V7, P1364, DOI 10.1101/gad.7.7b.1364; Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Gao HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088633; Ghosal G, 2006, BIOCHEM BIOPH RES CO, V343, P1, DOI 10.1016/j.bbrc.2006.02.148; Hecht A, CELL; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Hirano Y, 2009, MOL CELL, V33, P312, DOI 10.1016/j.molcel.2008.12.027; Hirashima K, 2015, NUCLEIC ACIDS RES, V43, P2022, DOI 10.1093/nar/gkv063; Houreld NN, 2017, PHOTOMED LASER SURG, V35, P69, DOI 10.1089/pho.2016.4220; Iglesias N, 2011, EMBO REP, V12, P587, DOI 10.1038/embor.2011.73; Joseph IS, 2010, GENETICS, V185, P761, DOI 10.1534/genetics.110.117598; Kitada T, 2012, GENE DEV, V26, P2443, DOI 10.1101/gad.201095.112; Konig P, 1996, CELL, V85, P125, DOI 10.1016/S0092-8674(00)81088-0; KURTZ S, 1991, GENE DEV, V5, P616, DOI 10.1101/gad.5.4.616; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; Lansdorp PM, 2012, ANN NY ACAD SCI, V1266, P1, DOI 10.1111/j.1749-6632.2012.06505.x; LEFFAK IM, 1984, NATURE, V307, P82, DOI 10.1038/307082a0; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Liaw H, 2006, MOL CELL BIOL, V26, P7616, DOI 10.1128/MCB.01082-06; LOUIS EJ, 1990, GENETICS, V124, P533; LOUIS EJ, 1992, GENETICS, V131, P559; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Martina M, 2012, MOL CELL BIOL, V32, P1604, DOI 10.1128/MCB.06547-11; Mechin Valerie, 2007, V355, P1; Nakatani Y, 2006, E SCHERING RES FDN W, V57, P89; Pardo B, 2005, EMBO J, V24, P3117, DOI 10.1038/sj.emboj.7600778; Price CM, 2010, CELL CYCLE, V9, P3157, DOI 10.4161/cc.9.16.12547; Ray A, 1999, MOL CELL BIOL, V19, P31; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Ribeyre C, 2012, NAT STRUCT MOL BIOL, V19, P307, DOI 10.1038/nsmb.2225; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Sarthy J, 2009, EMBO J, V28, P3390, DOI 10.1038/emboj.2009.275; Schoeftner S, 2010, SEMIN CELL DEV BIOL, V21, P186, DOI 10.1016/j.semcdb.2009.09.015; Schoeftner S, 2009, EMBO J, V28, P2323, DOI 10.1038/emboj.2009.197; Seifert FU, 2016, EMBO J, V35, P759, DOI 10.15252/embj.201592934; Shi T, 2013, CELL, V153, P1340, DOI 10.1016/j.cell.2013.05.007; SIKORSKI RS, 1989, GENETICS, V122, P19; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Sridhar A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004691; Stewart JA, 2012, EMBO J, V31, P3537, DOI 10.1038/emboj.2012.215; Suzuki K, 2011, RADIAT PROT DOSIM, V143, P279, DOI 10.1093/rpd/ncq533; Toogun OA, 2008, MOL CELL BIOL, V28, P457, DOI 10.1128/MCB.01417-07; Torres-Ramos CA, 2002, MOL CELL BIOL, V22, P2419, DOI 10.1128/MCB.22.7.2419-2426.2002; Treco DA, 2001, CURR PROTOC MOL BIOL; Tseng SF, 2009, NUCLEIC ACIDS RES, V37, P3602, DOI 10.1093/nar/gkp235; Vannier JB, 2012, CELL, V149, P795, DOI 10.1016/j.cell.2012.03.030; WRIGHT JH, 1995, NUCLEIC ACIDS RES, V23, P1454, DOI 10.1093/nar/23.9.1454; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197; Yang CW, 2017, NUCLEIC ACIDS RES, V45, P8314, DOI 10.1093/nar/gkx503; Zaman Z, 2002, CURR BIOL, V12, P930, DOI 10.1016/S0960-9822(02)00865-5	61	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183549	10.1371/journal.pone.0183549	http://dx.doi.org/10.1371/journal.pone.0183549			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886051	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100029
J	Chiang, GPK; Chen, ZG; Chan, MCW; Lee, SHM; Kwok, AK; Yeung, ACM; Nelson, EAS; Hon, KL; Leung, TF; Chan, PKS				Chiang, Grace P. K.; Chen, Zigui; Chan, Martin C. W.; Lee, Simon H. M.; Kwok, Angela K.; Yeung, Apple C. M.; Nelson, E. Anthony S.; Hon, Kam Lun; Leung, Ting Fan; Chan, Paul K. S.			Clinical features and seasonality of parechovirus infection in an Asian subtropical city, Hong Kong	PLOS ONE			English	Article							HOSPITALIZED CHILDREN; ACUTE GASTROENTERITIS; YOUNG-CHILDREN; STOOL SAMPLES; ENTEROVIRUS; EPIDEMIOLOGY; PREVALENCE; GENOTYPES; INFANTS; CHINA	Background The epidemiology of human parechovirus (HPeV) in Asia remains obscure. We elucidated the prevalence, seasonality, type distribution and clinical presentation of HPeV among children in Hong Kong. Methods A 24-month prospective study to detect HPeV in children <= 36 months hospitalized for acute viral illnesses. Results 2.3% of the 3911 children examined had HPeV infection, with most (87.5%) concentrated in September-January (autumn-winter). 81.3% were HPeV1 and 12.5% were HPeV4, while HPeV3 was rare (2.5%). HPeV was a probable cause of the disease in 47.7% (42/88), mostly self-limiting including acute gastroenteritis, upper respiratory tract infection and maculopapular rash. A neonate developed severe sepsis-like illness with HPeV3 as the only pathogen detected. A high proportion (60.0%) of children coinfected with HPeV and other respiratory virus(es) had acute bronchiolitis or pneumonia. Six children with HPeV coinfections developed convulsion / pallid attack. Most rash illnesses exhibited a generalized maculopapular pattern involving the trunk and limbs, and were more likely associated with HPeV4 compared to other syndrome groups (36.4% vs. 3.1%, p = 0.011). Conclusions In Hong Kong, HPeV exhibits a clear seasonality (autumn-winter) and was found in a small proportion (2.3%) of young children (<= 36 months) admitted with features of acute viral illnesses. The clinical presentation ranged from mild gastroenteritis, upper respiratory tract infection and febrile rash to convulsion and severe sepsis-like illness. HPeV3, which is reported to associate with more severe disease in neonates, is rare in Hong Kong. HPeV coinfection might associate with convulsion and aggravate other respiratory tract infections.	[Chiang, Grace P. K.; Lee, Simon H. M.; Nelson, E. Anthony S.; Hon, Kam Lun; Leung, Ting Fan] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Paediat, Fac Med, Shatin, Hong Kong, Peoples R China; [Chen, Zigui; Chan, Martin C. W.; Kwok, Angela K.; Yeung, Apple C. M.; Chan, Paul K. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Fac Med, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Chan, PKS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Fac Med, Shatin, Hong Kong, Peoples R China.	paulkschan@cuhk.edu.hk	Chan, Martin/B-3588-2009; Chan, Paul KS/J-9360-2013; Nelson, E Anthony S/ABF-4238-2020; LEUNG, Ting Fan/E-7728-2013; Chen, Zigui/E-8490-2017	Chan, Martin/0000-0002-1568-1596; Chan, Paul KS/0000-0002-6360-4608; Nelson, E Anthony S/0000-0002-2521-3403; LEUNG, Ting Fan/0000-0002-6469-1926; Chen, Zigui/0000-0002-8577-1298	Health and Medical Research Fund (HMRF) - Food and Health Bureau, Hong Kong Special Administrative Region [13120362]	Health and Medical Research Fund (HMRF) - Food and Health Bureau, Hong Kong Special Administrative Region	This research was supported by the Health and Medical Research Fund (HMRF, http://rfs1.fhb.gov.hk/english/welcome/welcome.html) granted by Food and Health Bureau, Hong Kong Special Administrative Region [project no. 13120362]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boivin G, 2005, EMERG INFECT DIS, V11, P103, DOI 10.3201/eid1101.040606; Cabrerizo M, 2016, J MED VIROL IN PRESS; Chen HF, 2014, ARCH VIROL, V159, P971, DOI 10.1007/s00705-013-1915-0; Cordey S, 2015, J CLIN VIROL, V68, P69, DOI 10.1016/j.jcv.2015.05.003; de Crom SCM, 2016, EUR J PEDIATR, V175, P1023, DOI 10.1007/s00431-016-2725-7; de Crom SCM, 2016, J CLIN VIROL, V77, P15, DOI 10.1016/j.jcv.2016.01.014; Drexler JF, 2009, EMERG INFECT DIS, V15, P310, DOI 10.3201/eid1502.081028; Esposito S, 2014, J CLIN VIROL, V60, P84, DOI 10.1016/j.jcv.2014.03.003; Han TH, 2011, ARCH VIROL, V156, P1471, DOI 10.1007/s00705-011-0995-y; Harvala H, 2011, J MED VIROL, V83, P889, DOI 10.1002/jmv.22023; Harvala H, 2010, CURR OPIN INFECT DIS, V23, P224, DOI 10.1097/QCO.0b013e32833890ca; Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0; Joki-Korpela P, 1998, CLIN INFECT DIS, V27, P129, DOI 10.1086/514615; Khamrin P, 2011, J VIROL METHODS, V173, P390, DOI 10.1016/j.jviromet.2011.02.012; Locatelli G, 2000, J CLIN MICROBIOL, V38, P4042, DOI 10.1128/JCM.38.11.4042-4048.2000; Loi C, 2016, ARCH DIS CH IN PRESS; Nirei J, 2016, PEDIATR INT, V58, P400, DOI 10.1111/ped.12869; Nix WA, 2008, J CLIN MICROBIOL, V46, P2519, DOI 10.1128/JCM.00277-08; Pham NTK, 2010, J CLIN MICROBIOL, V48, P115, DOI 10.1128/JCM.01015-09; Renaud C, 2015, INFECT DIS CLIN N AM, V29, P415, DOI 10.1016/j.idc.2015.05.005; Schuffenecker I, 2012, J CLIN VIROL, V54, P337, DOI 10.1016/j.jcv.2012.04.016; Shoji K, 2014, PEDIATR DERMATOL, V31, P258, DOI 10.1111/j.1525-1470.2012.01819.x; Shoji K, 2013, PEDIATR INFECT DIS J, V32, P233, DOI 10.1097/INF.0b013e31827b1fd0; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanway G, 2000, REV MED VIROL, V10, P57, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;57::AID-RMV266&gt;3.0.CO;2-H; Tang JW, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.34.30326; Tauriainen S, 2007, J MED VIROL, V79, P457, DOI 10.1002/jmv.20831; van der Sanden S, 2008, J CLIN MICROBIOL, V46, P2884, DOI 10.1128/JCM.00168-08; Verboon-Maciolek MA, 2008, ANN NEUROL, V64, P266, DOI 10.1002/ana.21445; Verboon-Maciolek MA, 2008, PEDIATR INFECT DIS J, V27, P241, DOI 10.1097/INF.0b013e31815c1b07; Wildenbeest JG, 2013, PEDIATRICS, V132, pE243, DOI 10.1542/peds.2012-1136; Yamamoto SP, 2015, J MED MICROBIOL, V64, P1415, DOI 10.1099/jmm.0.000167; Yip CCY, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-182; Zhong HQ, 2011, J MED VIROL, V83, P1428, DOI 10.1002/jmv.22114	34	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184533	10.1371/journal.pone.0184533	http://dx.doi.org/10.1371/journal.pone.0184533			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886185	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100150
J	Huber, D; Henriksson, R; Jakobsson, S; Mooe, T				Huber, Daniel; Henriksson, Robin; Jakobsson, Stina; Mooe, Thomas			Nurse-led telephone-based follow-up of secondary prevention after acute coronary syndrome: One-year results from the randomized controlled NAILED-ACS trial	PLOS ONE			English	Article							HEART-DISEASE; THERAPEUTIC INERTIA; RISK; IMPLEMENTATION; INTERVENTION; ADHERENCE; PEOPLE	Background Secondary prevention after acute coronary syndrome (ACS) could reduce morbidity and mortality, but guideline targets are seldom reached. We hypothesized that nurse-led telephone- based intervention would increase adherence. Methods The NAILED ACS trial is a prospective, controlled, randomized trial. Patients admitted for ACS at Ostersund hospital, Sweden, were randomized to usual follow-up by a general practitioner or a nurse-led intervention. The intervention comprised telephone follow-up after 1 month and then yearly with lifestyle counselling and titration of medications until reaching target values for LDL-C (< 2.5 mmol/L) and blood pressure (BP; < 140/90 mmHg) or set targets were deemed unachievable. This is a 12-month exploratory analysis of the intervention. Results A total of 768 patients (396 intervention, 372 control) completed the 12-month follow-up. After titration at the 1-month follow-up, mean LDL-C was 0.38 mmol/L (95% CI 0.28 to 0.48, p< 0.05), mean systolic BP 7 mmHg (95% CI 4.5 to 9.2, p< 0.05), and mean diastolic BP 4 mmHg (95% CI 2.4 to 4.1, p< 0.05) lower in the intervention group. Target values for LDL-C and systolic BP were met by 94.1% and 91.9% of intervention patients and 68.4% and 65.6% of controls (p< 0.05). At 12 months, mean LDL was 0.3 mmol/L (95% CI 0.1 to 0.4, p < 0.05), systolic BP 1.5 mmHg (95% CI -1.0 to 4.1, p = 0.24), and mean diastolic BP 2.1 mmHg (95% CI 0.6 to 3.6, p < 0.05) lower in the intervention group. Target values for LDL-C and systolic BP were met in 77.7% and 68.9% of intervention patients and 63.2% and 63.7% of controls (p< 0.05 and p = 0.125). Conclusion Nurse-led telephone-based secondary prevention was significantly more efficient at improving LDL-C and diastolic BP levels than usual care. The effect of the intervention declined between 1 and 12 months. Further evaluation of the persistence to the intervention is needed.	[Huber, Daniel; Henriksson, Robin; Jakobsson, Stina; Mooe, Thomas] Umea Univ, Dept Publ Hlth & Clin Med, Unit Res Educ & Dev Ostersund, Umea, Sweden	Umea University	Huber, D (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Unit Res Educ & Dev Ostersund, Umea, Sweden.	daniel.huber@regionjh.se		Huber, Daniel/0000-0002-4938-3191; Henriksson, Robin/0000-0001-9571-5946; Huber, Daniel/0000-0002-9817-5436	Unit of Research, Education and Development, Ostersund Hospital, Region Jamtland Harjedalen	Unit of Research, Education and Development, Ostersund Hospital, Region Jamtland Harjedalen	The study and all authors were funded by the Unit of Research, Education and Development, Ostersund Hospital, Region Jamtland Harjedalen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Chen HY, 2015, HEART LUNG, V44, P299, DOI 10.1016/j.hrtlng.2015.02.004; Huber D, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1203-x; Jakobsson S, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0252-0; Jorstad HT, 2013, HEART, V99, P1421, DOI 10.1136/heartjnl-2013-303989; Kotb A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096581; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Mooe T, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.3466; Neubeck L, 2009, EUR J CARDIOV PREV R, V16, P281, DOI 10.1097/HJR.0b013e32832a4e7a; Nieuwlaat R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub4; Okonofua EC, 2006, HYPERTENSION, V47, P345, DOI 10.1161/01.HYP.0000200702.76436.4b; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Perk J, 2015, EUROINTERVENTION, V10, DOI 10.4244/EIJV10I11A223; Piepoli MF, 2016, ATHEROSCLEROSIS, V252, P207, DOI [10.1177/2047487316653709, 10.1016/j.atherosclerosis.2016.05.037]; Redon J, 2010, J HYPERTENS, V28, P1770, DOI 10.1097/HJH.0b013e32833b4953; Smith SC, 2012, EUR HEART J, V33, P2910, DOI 10.1093/eurheartj/ehs313; Snaterse M, 2016, HEART, V102, P50, DOI 10.1136/heartjnl-2015-308050; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397	21	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183963	10.1371/journal.pone.0183963	http://dx.doi.org/10.1371/journal.pone.0183963			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886083	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100048
J	Masia, M; Padilla, S; Moreno, S; Barber, X; Iribarren, JA; del Romero, J; Gomez-Sirvent, JL; Rivero, M; Vidal, F; Campins, AA; Gutierrez, F				Masia, Mar; Padilla, Sergio; Moreno, Santiago; Barber, Xavier; Iribarren, Jose A.; del Romero, Jorge; Gomez-Sirvent, Juan L.; Rivero, Maria; Vidal, Francesc; Campins, Antonio A.; Gutierrez, Felix		Cohorte Red Invest Sida CoRIS	Prediction of long-term outcomes of HIV-infected patients developing non-AIDS events using a multistate approach	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; COMPETING RISKS; DISEASE PROGRESSION; GENERAL-POPULATION; COHORT; MODELS; AGE; MORBIDITY; DEATH	Objetives Outcomes of people living with HIV (PLWH) developing non-AIDS events (NAEs) remain poorly defined. We aimed to classify NAEs according to severity, and to describe clinical outcomes and prognostic factors after NAE occurrence using data from CoRIS, a large Spanish HIV cohort from 2004 to 2013. Design Prospective multicenter cohort study. Methods Using a multistate approach we estimated 3 transition probabilities: from alive and NAE-free to alive and NAE-experienced ("NAE development"); from alive and NAE-experienced to death ("Death after NAE");and from alive and NAE-free to death ("Death without NAE"). We analyzed the effect of different covariates, including demographic, immunologic and virologic data, on death or NAE development, based on estimates of hazard ratios (HR). We focused on the transition "Death after NAE". Results 8,789 PLWH were followed-up until death, cohort censoring or loss to follow-up. 792 first incident NAEs occurred in 9.01% PLWH (incidence rate 28.76; 95% confidence interval [CI], 26.80-30.84, per 1000 patient-years). 112 (14.14%) NAE-experienced PLWH and 240 (2.73%) NAE-free PLWH died. Adjusted HR for the transition "Death after NAE" was 12.1 (95% CI, 4.90-29.89). There was a graded increase in the adjusted HRs for mortality according to NAE severity category: HR (95% CI), 4.02 (2.45-6.57) for intermediate-severity; and 9.85 (5.45-17.81) for serious NAEs compared to low-severity NAEs. Male sex (HR 2.04; 95% CI, 1.11-3.84), age> 50 years (1.78, 1.08-2.94), hepatitis C-coinfection (2.52, 1.38-4.61), lower CD4 cell count at cohort entry (HR 2.49; 95% CI 1.20-5.14 for CD4 cell count below 200 and HR 2.16; 95% CI 1.01-4.66 for CD4 cell count between 200-350, both compared to CD4 cell count higher than 500) and concomitant CD4< 200 cells/mL (2.22, 1.42-3.44) were associated with death after NAE. CD4 count and HIV-1 RNA at engagement, previous AIDS and hepatitis C-coinfection predicted mortality in NAE-free persons. Conclusion NAEs, including low-severity events, increase prominently the risk for mortality in PLWH. Prognostic factors differ between NAE-experienced and NAE-free persons. These findings should be taken into account in the clinical management of PLWH developing NAEs and may permit more targeted prevention efforts.	[Masia, Mar; Padilla, Sergio; Gutierrez, Felix] Univ Miguel Hernandez, Hosp Gen Elche, Infect Dis Unit, Alicante, Spain; [Moreno, Santiago] IRYCIS, Hosp Ramo & Cajal, Infect Dis Serv, Madrid, Spain; [Barber, Xavier] Univ Miguel Hernandez, Ctr Invest Operat, Stat, Alicante, Spain; [Iribarren, Jose A.] Hosp Univ Donostia, San Sebastian, Spain; [del Romero, Jorge] Ctr Sanitario Sandoval, Madrid, Spain; [Gomez-Sirvent, Juan L.] Hosp Univ Canarias, Santa Cruz De Tenerife, Spain; [Rivero, Maria] Hosp Navarra, Pamplona, Spain; [Vidal, Francesc] Hosp Univ Joan XIII, Tarragona, Spain; [Campins, Antonio A.] Hosp Univ Son Espases, Palma De Mallorca, Spain; [Cohorte Red Invest Sida CoRIS] Inst Salud Carlos III, Madrid, Spain	Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche; Universidad de la Laguna; Servicio Navarro de Salud - Osasunbidea; Hospital Universitari Son Espases; Instituto de Salud Carlos III	Gutierrez, F (corresponding author), Univ Miguel Hernandez, Hosp Gen Elche, Infect Dis Unit, Alicante, Spain.	gutierrez_fel@gva.es	Soriano, Vicente/O-5730-2018; Blanco, Jose-Ramon/L-6768-2018; Iribarren, José/AAK-5528-2021; Fernández-González, Marta/U-7492-2017; Padilla, Sergio/U-7682-2017; Rodero, Félix Gutiérrez/Q-7880-2018; Moreno, Santiago/T-2653-2017; Oteo, Jose A./AAB-3134-2020; Barber, Xavier/A-6204-2009; Chueca, Natalia/T-9734-2019; gonzalez, cristina/U-2024-2019; Pulido, Federico/B-8417-2009; Masia, Mar/U-7510-2017; Asensi Alvarez, Victor/AAH-2171-2020; Montero, Marta/H-7555-2017; Arribas, Jose/A-1595-2015; Hernando, Asuncion/M-7916-2014; Blanco Garcia, Francisco J/C-3192-2014	Soriano, Vicente/0000-0002-4624-5199; Blanco, Jose-Ramon/0000-0002-4268-0150; Fernández-González, Marta/0000-0001-9949-8504; Rodero, Félix Gutiérrez/0000-0002-9485-6867; Moreno, Santiago/0000-0002-2843-1094; Oteo, Jose A./0000-0001-7080-6542; Barber, Xavier/0000-0003-3079-5855; Chueca, Natalia/0000-0002-3420-3290; gonzalez, cristina/0000-0002-6924-990X; Pulido, Federico/0000-0002-7414-8812; Rubio Garcia, Rafael/0000-0001-8132-4303; Barreiro, Pablo/0000-0002-3819-5371; Vidal, Francesc/0000-0002-6692-6186; Calabuig, Eva/0000-0002-0177-0037; PELAZAS GONZALEZ, RICARDO/0000-0002-1565-4520; Padilla, Sergio/0000-0002-8420-7310; Casado, Jose Luis/0000-0002-7639-8591; Masia, Mar/0000-0001-9878-2458; Asensi Alvarez, Victor/0000-0003-4211-456X; /0000-0001-7808-5479; De Los Santos Gil, Ignacio/0000-0001-7073-5211; Montero, Marta/0000-0002-3432-5394; Nogueras, Maria-Mercedes/0000-0001-5925-1929; Arribas, Jose/0000-0002-7410-9450; PENARANDA VERA, MARIA/0000-0001-6290-3457; Hernando, Asuncion/0000-0002-1901-1119; Navarro Ruiz, Andres/0000-0001-7009-280X; Gijon, Paloma/0000-0002-5011-1927; Blanco Garcia, Francisco J/0000-0001-9821-7635	Plan Nacional R + D + I [RD12/0017/0023, RD 16/0025/0038]; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); FIS [PI08/893, PI13/02256, PI16/01740]; FISABIO [UGP-14-197]; Contrato de Intensificacion de la Actividad Investigadora [INT 14/00207]; Contrato Predoctotal FISABIO [UGP-15-152]; Contrato Rio Hortega [CM15/00187]	Plan Nacional R + D + I; ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER); FIS(Instituto de Salud Carlos III); FISABIO; Contrato de Intensificacion de la Actividad Investigadora; Contrato Predoctotal FISABIO; Contrato Rio Hortega	This work was supported by the RD12/0017/0023 and RD 16/0025/0038 projects as part of the Plan Nacional R + D + I and cofinanced by ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER), FIS (PI08/893), FIS (PI13/02256), FIS (PI16/01740), FISABIO UGP-14-197, Contrato de Intensificacion de la Actividad Investigadora INT 14/00207, Contrato Predoctotal FISABIO 2015 (UGP-15-152) and Contrato Rio Hortega (CM15/00187).	Achenbach CJ, 2011, AIDS, V25, P691, DOI 10.1097/QAD.0b013e3283437f77; Achhra AC, 2010, AIDS, V24, P1877, DOI 10.1097/QAD.0b013e32833b1b26; Alioum A, 1998, EPIDEMIOLOGY, V9, P605, DOI 10.1097/00001648-199811000-00007; Andersen PK, 2002, STAT METHODS MED RES, V11, P203, DOI 10.1191/0962280202sm281ra; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Wreede LC, 2011, J STAT SOFTW, V38, P1; Furuya-Kanamori L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078403; Gill J, 2010, CLIN INFECT DIS, V50, P1387, DOI 10.1086/652283; Guaraldi G, 2011, CLIN INFECT DIS, V53, P1120, DOI 10.1093/cid/cir627; Guihenneuc-Jouyaux C, 2000, BIOMETRICS, V56, P733, DOI 10.1111/j.0006-341X.2000.00733.x; Hasse B, 2011, CLIN INFECT DIS, V53, P1130, DOI 10.1093/cid/cir626; Helleberg M, 2014, AIDS, V28, P1499, DOI 10.1097/QAD.0000000000000283; Hernando V, 2012, AIDS, V26, P1829, DOI 10.1097/QAD.0b013e328352ada4; Hessamfar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102671; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hsu DC, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-29; Kohli R, 2006, CLIN INFECT DIS, V43, P90, DOI 10.1086/504871; Lapadula G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124741; Lifson AR, 2010, HIV CLIN TRIALS, V11, P205, DOI 10.1310/hct1104-205; Lucero C, 2013, AIDS RES HUM RETROV, V29, P1161, DOI [10.1089/aid.2012.0367, 10.1089/AID.2012.0367]; Masia M, 2013, AIDS, V27, P181, DOI 10.1097/QAD.0b013e32835a1156; Meira-Machado L, 2009, STAT METHODS MED RES, V18, P195, DOI 10.1177/0962280208092301; Miller CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095061; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Paula AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094636; Petoumenos K, 2014, HIV MED, V15, P595, DOI 10.1111/hiv.12162; Pineda JA, 2007, HEPATOLOGY, V46, P622, DOI 10.1002/hep.21757; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Sobrino-Vegas P, 2011, ENFERM INFEC MICR CL, V29, P645, DOI 10.1016/j.eimc.2011.06.002; Sommen C, 2009, STAT MED, V28, P1554, DOI 10.1002/sim.3570	33	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184329	10.1371/journal.pone.0184329	http://dx.doi.org/10.1371/journal.pone.0184329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886092	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100097
J	Michalicova, P; Mravec, F; Pekar, M				Michalicova, Petra; Mravec, Filip; Pekar, Miloslav			Fluorescence study of freeze-drying as a method for support the interactions between hyaluronan and hydrophobic species	PLOS ONE			English	Article							ANTITUMOR-ACTIVITY; AQUEOUS-SOLUTIONS; DELIVERY-SYSTEMS; IR SPECTROMETRY; DRUG-DELIVERY; ACID; WATER; SECONDARY; CD44; CONFORMATIONS	A freeze-drying method enabling solubilization of hydrophobic species in aqueous solutions of native hyaluronan is described. The method is based on opening the access to supposed hydrophobic patches on hyaluronan by disturbing its massive hydration shell. Hydrophobic and/or polarity-sensitive fluorescence probes were used as hydrophobic models or indicators of interactions with hydrophobic patches. Fluorescence parameters specific to individual probes confirmed the efficiency of the freeze-drying method. This work is the first step in developing biocompatible and biodegradable carriers for hydrophobic drugs with targeted distribution of the active compound from native, chemically non-modified hyaluronan.	[Pekar, Miloslav] Brno Univ Technol, Fac Chem, Inst Phys & Appl Chem, Brno, Czech Republic; Brno Univ Technol, Fac Chem, Mat Res Ctr, Brno, Czech Republic	Brno University of Technology; Brno University of Technology	Pekar, M (corresponding author), Brno Univ Technol, Fac Chem, Inst Phys & Appl Chem, Brno, Czech Republic.	pekar@fch.vut.cz	Mravec, Filip/G-7170-2015	Mravec, Filip/0000-0001-6114-4751; Pekar, Miloslav/0000-0002-3878-0917	Materials Research Centre at FCH BUT-Sustainability and Development [L01211, LO1211]; National Programme for Sustainability I (Ministry of Education, Youth and Sports, Czech Republic)	Materials Research Centre at FCH BUT-Sustainability and Development; National Programme for Sustainability I (Ministry of Education, Youth and Sports, Czech Republic)	This work was supported by the Materials Research Centre at FCH BUT-Sustainability and Development, L01211, with financial support from National Programme for Sustainability I (Ministry of Education, Youth and Sports, Czech Republic) (http://www.msmt.cz/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Materials Research Centre at FCH BUT-Sustainability and Development, LO1211, with financial support from National Programme for Sustainability I (Ministry of Education, Youth and Sports, Czech Republic).	Abdelwahed W, 2006, ADV DRUG DELIVERY RE, V58, P76; Adhikary R, 2009, J PHYS CHEM B, V113, P11999, DOI 10.1021/jp905139n; Almond A, 2003, GLYCOBIOLOGY, V13, P255, DOI 10.1093/glycob/cwg031; BETTELHEIM FA, 1992, CURR EYE RES, V11, P411, DOI 10.3109/02713689209001794; Brown T., 2008, CURRENT PHARM BIOTEC, V9, P421; Cowman MK, 2005, BIOPHYS J, V88, P590, DOI 10.1529/biophysj.104.049361; Creuzet C, 2006, POLYMER, V47, P2706, DOI 10.1016/j.polymer.2006.02.052; Franks F, 1998, EUR J PHARM BIOPHARM, V45, P221, DOI 10.1016/S0939-6411(98)00004-6; Garcia-Abuin A, 2011, CARBOHYD POLYM, V85, P500, DOI 10.1016/j.carbpol.2011.02.028; Girish KS, 2007, LIFE SCI, V80, P1921, DOI 10.1016/j.lfs.2007.02.037; Hatakeyama H, 1998, THERMOCHIM ACTA, V308, P3, DOI 10.1016/S0040-6031(97)00325-0; Haxaire K, 2003, BIOPOLYMERS, V72, P149, DOI 10.1002/bip.10342; HEATLEY F, 1988, BIOCHEM J, V254, P489, DOI 10.1042/bj2540489; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Jin Yu-Jin, 2010, Journal of Pharmaceutical Investigation, V40, P33, DOI 10.4333/KPS.2010.40.S.033; Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X; Lapcik L, 1998, CHEM REV, V98, P2663, DOI 10.1021/cr941199z; Lasagna M, 1996, BIOCHEMISTRY-US, V35, P973, DOI 10.1021/bi951983t; Lee H, 2008, BIOCONJUGATE CHEM, V19, P1319, DOI 10.1021/bc8000485; LIAPIS AI, 1994, SEPAR TECHNOL, V4, P144, DOI 10.1016/0956-9618(94)80017-0; Lu KW, 2013, EXP LUNG RES, V39, P191, DOI 10.3109/01902148.2013.791893; Marechal Y, 2003, BIOPOLYMERS, V72, P162, DOI 10.1002/bip.10343; Ni N, 2001, INT J PHARM, V226, P39, DOI 10.1016/S0378-5173(01)00757-8; Ossipov DA, 2010, EXPERT OPIN DRUG DEL, V7, P681, DOI 10.1517/17425241003730399; Oyarzun-Ampuero FA, 2013, EUR J PHARM SCI, V49, P483, DOI 10.1016/j.ejps.2013.05.008; Peer D, 2004, NEOPLASIA, V6, P343, DOI 10.1593/neo.03460; Petrak K, 2005, DRUG DISCOV TODAY, V10, P1667, DOI 10.1016/S1359-6446(05)03698-6; Philippova OE, 2001, BIOMACROMOLECULES, V2, P483, DOI 10.1021/bm005649a; Prusova A, 2013, CARBOHYD POLYM, V95, P515, DOI 10.1016/j.carbpol.2013.03.031; Sanchez FG, 1996, J LUMIN, V69, P179, DOI 10.1016/S0022-2313(96)00116-0; SCOTT JE, 1992, EUR J BIOCHEM, V209, P675, DOI 10.1111/j.1432-1033.1992.tb17335.x; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Bicudo RCS, 2012, J NANOSCI NANOTECHNO, V12, P2849, DOI 10.1166/jnn.2012.5814; Spagnoli C, 2005, CARBOHYD RES, V340, P929, DOI 10.1016/j.carres.2005.01.024; Teagarden DL, 2002, EUR J PHARM SCI, V15, P115, DOI 10.1016/S0928-0987(01)00221-4; THALBERG K, 1989, J PHYS CHEM-US, V93, P1478, DOI 10.1021/j100341a058; Tokita Y, 1997, POLYM DEGRAD STABIL, V55, P159, DOI 10.1016/S0141-3910(96)00128-0; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Tsinontides SC, 2004, INT J PHARM, V280, P1, DOI 10.1016/j.ijpharm.2004.04.018; Valeur B, 2001, MOL FLUORESCENCE PRI, V2nd; Vandamme E., 2002, BIOPOLYMERS POLYSACC; Wang W, 2012, CHINESE J CHEM ENG, V20, P551, DOI 10.1016/S1004-9541(11)60218-8; WEDLOCK DJ, 1983, INT J BIOL MACROMOL, V5, P186, DOI 10.1016/0141-8130(83)90036-3; Wittaya-Areekul S, 1998, J PHARM SCI, V87, P491, DOI 10.1021/js9702832	44	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184558	10.1371/journal.pone.0184558	http://dx.doi.org/10.1371/journal.pone.0184558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886150	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100154
J	Moura, RA; Quaresma, C; Vieira, AR; Goncalves, MJ; Polido-Pereira, J; Romao, VC; Martins, N; Canhao, H; Fonseca, JE				Moura, Rita A.; Quaresma, Claudia; Vieira, Ana R.; Goncalves, Maria J.; Polido-Pereira, Joaquim; Romao, Vasco C.; Martins, Nadia; Canhao, Helena; Fonseca, Joao E.			B-cell phenotype and IgD-CD27-memory B cells are affected by TNF-inhibitors and tocilizumab treatment in rheumatoid arthritis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; FAS-MEDIATED APOPTOSIS; REGULATORY T-CELLS; PERIPHERAL-BLOOD; FACTOR-ALPHA; CHEMOATTRACTANT CXCL13; DISEASE PATIENTS; SYNOVIAL-FLUID; FACTOR THERAPY; SOLUBLE CD23	Background The use of TNF-inhibitors and/or the IL-6 receptor antagonist, tocilizumab, in rheumatoid arthritis (RA) have pleiotropic effects that also involve circulating B-cells. The main goal of this study was to assess the effect of TNF-inhibitors and tocilizumab on B-cell phenotype and gene expression in RA. Methods Blood samples were collected from untreated early RA (ERA) patients, established RA patients under methotrexate treatment, established RA patients before and after treatment with TNF-inhibitors and tocilizumab, and healthy donors. B-cell subpopulations were characterized by flow cytometry and B-cell gene expression was analyzed by real-time PCR on isolated B-cells. Serum levels of BAFF, CXCL13 and sCD23 were determined by ELISA. Results The frequency of total CD19+ B cells in circulation was similar between controls and all RA groups, irrespective of treatment, but double negative (DN) IgD-CD27-memory B cells were significantly increased in ERA and established RA when compared to controls. Treatment with TNF-inhibitors and tocilizumab restored the frequency of IgD-CD27-B-cells to normal levels, but did not affect other B cell subpopulations. TACI, CD95, CD5, HLA-DR and TLR9 expression on B-cells significantly increased after treatment with either TNF-inhibitors and/or tocilizumab, but no significant changes were observed in BAFF-R, BCMA, CD69, CD86, CXCR5, CD23, CD38 and IgM expression on B-cells when comparing baseline with post-treatment follow-ups. Alterations in B-cell gene expression of BAFF-R, TACI, TLR9, Fc gamma RIIB, BCL-2, BLIMP-1 and beta 2M were found in ERA and established RA patients, but no significant differences were observed after TNF-inhibitors and tocilizumab treatment when comparing baseline and follow-ups. Serum levels of CXCL13, sCD23 and BAFF were not significantly affected by treatment with TNF-inhibitors and tocilizumab. Conclusions In RA patients, the use of TNF-inhibitors and/or tocilizumab treatment affects B-cell phenotype and IgD-CD27-memory B cells in circulation, but not B-cell gene expression levels.	[Moura, Rita A.; Quaresma, Claudia; Vieira, Ana R.; Goncalves, Maria J.; Polido-Pereira, Joaquim; Romao, Vasco C.; Canhao, Helena; Fonseca, Joao E.] Univ Lisbon, Fac Med, Inst Med Mol, Rheumatol Res Unit, Lisbon, Portugal; [Goncalves, Maria J.; Polido-Pereira, Joaquim; Romao, Vasco C.; Martins, Nadia; Canhao, Helena; Fonseca, Joao E.] Hosp Santa Maria, Lisbon Acad Med Ctr, Ctr Hosp Lisboa Norte, EPE,Rheumatol Dept, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria	Moura, RA (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Rheumatol Res Unit, Lisbon, Portugal.	ritaaguiarmoura@gmail.com	Romão, Vasco C/O-8224-2014; Canhao, Helena/C-9611-2018; Polido-Pereira, Joaquim/AAV-7464-2020; Moura, Rita A./AAI-5024-2020	Romão, Vasco C/0000-0002-5603-9436; Canhao, Helena/0000-0003-1894-4870; Moura, Rita A./0000-0002-9685-6924; Polido Pereira, Joaquim/0000-0002-7188-8516	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [SFRH/6PD/81936/2011]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	RAM was funded by Fundacao para a Ciencia e a Tecnologia (FCT, www.fct.pt) (SFRH/6PD/81936/2011), Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alivernini S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12970; Angelin-Duclos C, 2000, J IMMUNOL, V165, P5462, DOI 10.4049/jimmunol.165.10.5462; Anolik JH, 2008, J IMMUNOL, V180, P688, DOI 10.4049/jimmunol.180.2.688; Berkowska MA, 2014, J ALLERGY CLIN IMMUN, V134, P688, DOI 10.1016/j.jaci.2014.03.036; BOUSSIOTIS VA, 1994, P NATL ACAD SCI USA, V91, P7007, DOI 10.1073/pnas.91.15.7007; Bugatti S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3742; Bulati M, 2015, J ALZHEIMERS DIS, V44, P1241, DOI 10.3233/JAD-142412; Cambridge G, 2014, J AUTOIMMUN, V50, P67, DOI 10.1016/j.jaut.2013.12.002; Canete JD, 2009, ANN RHEUM DIS, V68, P751, DOI 10.1136/ard.2008.089284; Canhao H, 2012, RHEUMATOLOGY, V51, P2020, DOI 10.1093/rheumatology/kes184; Cantaert T, 2012, ARTHRITIS RHEUM-US, V64, P1859, DOI 10.1002/art.34364; Carbone G, 2013, INT J BIOL SCI, V9, P279, DOI 10.7150/ijbs.5996; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Castigli E, 2007, J ALLERGY CLIN IMMUN, V120, P885, DOI 10.1016/j.jaci.2007.06.012; Catalan D, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2985; CHOMARAT P, 1993, ARTHRITIS RHEUM-US, V36, P234, DOI 10.1002/art.1780360215; Claes N, 2016, J IMMUNOL, V197, P4576, DOI 10.4049/jimmunol.1502448; Colonna-Romano G, 2009, MECH AGEING DEV, V130, P681, DOI 10.1016/j.mad.2009.08.003; Conigliaro P, 2014, CLIN EXP IMMUNOL, V177, P234, DOI 10.1111/cei.12335; Di Sabatino A, 2008, INFLAMM BOWEL DIS, V14, P591, DOI 10.1002/ibd.20374; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Engelmann R, 2015, RHEUMATOLOGY, V54, P545, DOI 10.1093/rheumatology/keu351; Fecteau JF, 2006, J IMMUNOL, V177, P3728, DOI 10.4049/jimmunol.177.6.3728; Fekete A, 2007, J AUTOIMMUN, V29, P154, DOI 10.1016/j.jaut.2007.07.002; Gottenberg JE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2773; Hong S, 2015, LIFE SCI, V122, P37, DOI 10.1016/j.lfs.2014.12.008; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Jones JD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4552; Jourdan M, 2014, LEUKEMIA, V28, P1647, DOI 10.1038/leu.2014.61; Kamphuis LS, 2013, AM J RESP CRIT CARE, V187, P406, DOI 10.1164/rccm.201206-1024OC; Kanbe K, 2011, CLIN RHEUMATOL, V30, P1407, DOI 10.1007/s10067-011-1833-z; Kanswal S, 2008, J IMMUNOL, V181, P976, DOI 10.4049/jimmunol.181.2.976; Karampetsou MP, 2011, CLIN IMMUNOL, V140, P8, DOI 10.1016/j.clim.2011.01.012; Kikuchi J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0526-4; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kobayashi S, 2013, ARTHRITIS RHEUM-US, V65, P3063, DOI 10.1002/art.38173; Li Z, 2015, INFLAMM BOWEL DIS, V21, P2787, DOI 10.1097/MIB.0000000000000554; Loza E, 1999, RHEUMATOLOGY, V38, P325, DOI 10.1093/rheumatology/38.4.325; Magnusson SE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2206; Mahmood Z, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0580-y; Manzo A, 2008, ARTHRITIS RHEUM, V58, P3377, DOI 10.1002/art.23966; Michelutti A, 2011, MOL MED, V17, P901, DOI 10.2119/molmed.2011.00034; Moura RA, 2013, J RHEUMATOL, V40, P1293, DOI 10.3899/jrheum.121110; Moura RA, 2012, CLIN REV ALLERG IMMU, V43, P281, DOI 10.1007/s12016-012-8318-y; Moura RA, 2011, RHEUMATOLOGY, V50, P278, DOI 10.1093/rheumatology/keq338; Moura RA, 2010, RHEUMATOLOGY, V49, P1082, DOI 10.1093/rheumatology/keq029; Nakayamada S., 2017, RHEUMATOLOGY; Ng LG, 2004, J IMMUNOL, V173, P807, DOI 10.4049/jimmunol.173.2.807; Parker A, 2007, J RHEUMATOL, V34, P1817; Rapetti L, 2015, ANN RHEUM DIS, V74, P294, DOI 10.1136/annrheumdis-2013-204049; Roll P, 2012, SCAND J RHEUMATOL, V41, P180, DOI 10.3109/03009742.2011.645056; Roll P, 2011, ARTHRITIS RHEUM-US, V63, P1255, DOI 10.1002/art.30242; Romao VC, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/279890; Sakurai D, 2007, EUR J IMMUNOL, V37, P110, DOI 10.1002/eji.200636623; Salinas GF, 2013, ANN RHEUM DIS, V72, P1037, DOI 10.1136/annrheumdis-2011-201270; Schmutz C, 2005, ARTHRITIS RES THER, V7, pR217, DOI 10.1186/ar1475; Smeets TJM, 2003, ARTHRITIS RHEUM-US, V48, P2155, DOI 10.1002/art.11098; Snir A, 2011, CLIN EXP RHEUMATOL, V29, P697; Souto-Carneiro MM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2718; Takagi R, 2008, J IMMUNOL, V181, P186, DOI 10.4049/jimmunol.181.1.186; Timmermans WMC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160103; Uson J, 1997, J RHEUMATOL, V24, P2069; van der Houwen TB, 2017, RHEUMATOLOGY, V56, P134, DOI 10.1093/rheumatology/kew366; Vasquez C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139718; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859; Wu YCB, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00081; Yang J, 2015, INT J RHEUMATIC DIS	69	42	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182927	10.1371/journal.pone.0182927	http://dx.doi.org/10.1371/journal.pone.0182927			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886017	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100012
J	Sanches, PR; Correa, TD; Ferrari-Marinho, T; Naves, PVF; Ladeia-Frota, C; Caboclo, LO				Sanches, Paula Rodrigues; Correa, Thiago Domingos; Ferrari-Marinho, Taissa; Ferreira Naves, Pedro Vicente; Ladeia-Frota, Carol; Caboclo, Luis Otavio			Outcomes of patients with altered level of consciousness and abnormal electroencephalogram: A retrospective cohort study	PLOS ONE			English	Article							NONCONVULSIVE STATUS EPILEPTICUS; PERIODIC EEG PATTERNS; CRITICALLY-ILL; SEIZURES; TERMINOLOGY; GUIDELINE; PRESSURE; ETIOLOGY	Introduction Nonconvulsive seizures (NCS) are frequent in hospitalized patients and may further aggravate injury in the already damaged brain, potentially worsening outcomes in encephalopathic patients. Therefore, both early seizure recognition and treatment have been advocated to prevent further neurological damage. Objective Evaluate the main EEG patterns seen in patients with impaired consciousness and address the effect of treatment with antiepileptic drugs (AEDs), continuous intravenous anesthetic drugs (IVADs), or the combination of both, on outcomes. Methods This was a single center retrospective cohort study conducted in a private, tertiary care hospital. Consecutive adult patients with altered consciousness submitted to a routine EEG between January 2008 and February 2011 were included in this study. Based on EEG pattern, patients were assigned to one of three groups: Group Interictal Patterns (IP; EEG showing only interictal epileptiform discharges or triphasic waves), Group Rhythmic and Periodic Patterns (RPP; at least one EEG with rhythmic or periodic patterns), and Group Ictal (Ictal; at least one EEG showing ictal pattern). Groups were compared in terms of administered antiepileptic treatment and frequency of unfavorable outcomes (modified Rankin scale >= 3 and in-hospital mortality). Results Two hundred and six patients (475 EEGs) were included in this analysis. Interictal pattern was observed in 35.4% (73/206) of patients, RPP in 53.4% (110/206) and ictal in 11.2% (23/206) of patients. Treatment with AEDs, IVADs or a combination of both was administered in half of the patients. While all Ictal group patients received treatment (AEDs or IVADs), only 24/73 (32.9%) IP group patients and 55/108 (50.9%) RPP group patients were treated (p<0.001). Hospital length of stay (LOS) and frequency of unfavorable outcomes did not differ among the groups. In-hospital mortality was higher in IVADs treated RPP patients compared to AEDs treated RPP patients [11/19 (57.9%) vs. 11/36 (30.6%) patients, respectively, p = 0.049]. Hospital LOS, in-hospital mortality and frequency of unfavorable outcomes did not differ between Ictal patients treated exclusively with AEDs or IVADs. Conclusion In patients with acute altered consciousness and abnormal routine EEG, antiepileptic treatment did not improve outcomes regardless of the presence of periodic, rhythmic or ictal EEG patterns.	[Sanches, Paula Rodrigues; Correa, Thiago Domingos] Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, Brazil; [Ferrari-Marinho, Taissa; Ferreira Naves, Pedro Vicente; Ladeia-Frota, Carol; Caboclo, Luis Otavio] Hosp Israelita Albert Einstein, Dept Clin Neurophysiol, Sao Paulo, Brazil	Hospital Israelita Albert Einstein; Hospital Israelita Albert Einstein	Correa, TD (corresponding author), Hosp Israelita Albert Einstein, Intens Care Unit, Sao Paulo, Brazil.	thiago.correa@einstein.br	Sanches, Paula/N-5040-2014	Sanches, Paula/0000-0001-9329-9010; Domingos Correa, Thiago/0000-0001-9546-3910				Beniczky S, 2013, EPILEPSIA, V54, P28, DOI 10.1111/epi.12270; BLECK TP, 1993, CRIT CARE MED, V21, P98, DOI 10.1097/00003246-199301000-00019; BRENNER RP, 1990, J CLIN NEUROPHYSIOL, V7, P249, DOI 10.1097/00004691-199004000-00007; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; GROEGER JS, 1992, CRIT CARE MED, V20, P846, DOI 10.1097/00003246-199206000-00024; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI [10.1097/WNP.0000000000000806, 10.1097/WNP.0b013e3182784729]; Idro R, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-57; Kanich W, 2002, AM J EMERG MED, V20, P613, DOI 10.1053/ajem.2002.35464; Kaplan PW, 2002, EPILEPSY BEHAV, V3, P122, DOI 10.1006/ebeh.2002.0336; Kaplan PW, 2000, NEUROPHYSIOL CLIN, V30, P377, DOI 10.1016/S0987-7053(00)00238-0; Koren JP, 2016, CLIN NEUROPHYSIOL, V127, P1176, DOI 10.1016/j.clinph.2015.09.135; Litt B, 1998, EPILEPSIA, V39, P1194, DOI 10.1111/j.1528-1157.1998.tb01311.x; Meierkord H, 2010, EUR J NEUROL, V17, P348, DOI 10.1111/j.1468-1331.2009.02917.x; Noachtar S, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P21; Rossetti AO, 2014, INTENS CARE MED, V40, P1359, DOI 10.1007/s00134-014-3363-z; Rossetti AO, 2006, J NEUROL NEUROSUR PS, V77, P611, DOI 10.1136/jnnp.2005.080887; Sinha SR, 2016, J CLIN NEUROPHYSIOL, V33, P303, DOI 10.1097/WNP.0000000000000308; Sokic DV, 2009, SEIZURE-EUR J EPILEP, V18, P215, DOI 10.1016/j.seizure.2008.10.002; Solomon T, 2002, BRAIN, V125, P1084, DOI 10.1093/brain/awf116; Sutter R, 2014, NEUROLOGY, V82, P656, DOI 10.1212/WNL.0000000000000009; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Trinka E, 2015, EPILEPSY BEHAV, V49, P203, DOI 10.1016/j.yebeh.2015.05.005; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Young GB, 1996, NEUROLOGY, V47, P83	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184050	10.1371/journal.pone.0184050	http://dx.doi.org/10.1371/journal.pone.0184050			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886073	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100058
J	Bailey, RC; Adera, F; Mackesy-Amiti, ME; Adipo, T; Nordstrom, SK; Mehta, SD; Jaoko, W; Langi, FLFG; Obiero, W; Obat, E; Otieno, FO; Young, MR				Bailey, Robert C.; Adera, Fredrick; Mackesy-Amiti, Mary Ellen; Adipo, Timothy; Nordstrom, Sherry K.; Mehta, Supriya D.; Jaoko, Walter; Langi, F. L. Fredrik G.; Obiero, Walter; Obat, Edmon; Otieno, Fredrick O.; Young, Marisa R.			Prospective comparison of two models of integrating early infant male circumcision with maternal child health services in Kenya: The Mtoto Msafi Mbili Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; HIV PREVENTION; HUMAN-PAPILLOMAVIRUS; ACCUCIRC DEVICE; WESTERN KENYA; MOGEN CLAMP; SCALING-UP; YOUNG MEN; ACCEPTABILITY; AMPUTATION	As countries scale up adult voluntary medical male circumcision (VMMC) for HIV prevention, they are looking ahead to long term sustainable strategies, including introduction of early infant male circumcision (EIMC). To address the lack of evidence regarding introduction of EIMC services in sub-Saharan African settings, we conducted a simultaneous, prospective comparison of two models of EIMC service delivery in Homa Bay County, Kenya. In one division a standard delivery package (SDP) was introduced and included health facility- based provision of EIMC services with community engagement for client referral versus in a different division a standard package plus (SDPplus) that included community-delivered EIMC services. Babies 1-60 days old were eligible for EIMC. A representative sample of mothers and fathers of baby boys at 16 health facilities was surveyed. We examined differences between mothers and fathers in the SDP and SDPplus divisions and identified factors associated with EIMC uptake. We report adjusted prevalence ratios (aPR). Of 1660 mothers interviewed, 1501 (89%) gave approval to contact the father, and 1259 fathers (84%) were interviewed. The proportion of babies circumcised was slightly greater in the SDPplus division than the SDP division (27.3% vs 23.7%), but the difference was not significant (p = 0.08). In adjusted analyses, however, the prevalence of babies being circumcised was greater in the SDPplus division (aPR = 1.23, 95% CI: 1.04-1.45) and the factors associated with a baby being circumcised were the mother having received information about EIMC (during pregnancy, aPR = 4.81, 95% CI: 2.21-3.42), having discussed circumcision with the father if married or cohabiting (aPR = 5.39, 95% CI: 3.31-8.80) or being single (aPR = 5.67, 95% CI: 3.31-9.69), perceiving herself to be living with HIV (aPR = 1.39, 95% CI: 1.15-1.67), or having a post-secondary education (aPR = 1.33, 95% CI: 1.04-1.69), and the father being Muslim (aPR = 1.85, 95% CI: 1.29-2.65) or circumcised (aPR = 1.34, 95% CI: 1.13-1.59). The median age of 2117 babies circumcised was 8 days (IQR: 1-36), and the median weight was 3.6 kg (IQR: 3.2-4.4). There were 6 moderate adverse events (AEs) (0.28%); 5 severe AEs (0.24%), all involving an injury to the glans penis, requiring hospitalization and corrective surgery; and one death probably related to the procedure. There were no AEs among the 365 procedures performed outside health facilities. Information and education campaigns must reach members of the general population, especially men and fathers, who are influential to the EIMC decision. Serious AEs using the Mogen clamp are rare, but do occur and require efficient, reliable emergency back-up. Our results can assist countries considering scale-up of EIMC services for HIV prevention as their adult VMMC programs mature.	[Bailey, Robert C.; Mackesy-Amiti, Mary Ellen; Mehta, Supriya D.; Langi, F. L. Fredrik G.] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA; [Adera, Fredrick; Adipo, Timothy; Obat, Edmon; Otieno, Fredrick O.] Nyanza Reprod Hlth Soc, Kisumu, Kenya; [Nordstrom, Sherry K.] Advocate Christ Med Ctr, Advocate Med Grp, Oak Lawn, IL USA; [Obiero, Walter] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Obiero, Walter] Univ Illinois, Sch Publ Hlth, Div Hlth Policy & Adm, Chicago, IL USA; [Young, Marisa R.] Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30322 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Nairobi; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Emory University	Bailey, RC (corresponding author), Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL 60607 USA.	rcbailey@uic.edu	Jaoko, Walter/AAN-5048-2020; Mackesy-Amiti, Mary E/B-7208-2008; Langi, Fima Lanra Fredrik G/GPT-0204-2022; Young, Marisa/GXH-4437-2022; Langi, Fima Lanra Fredrik G./GPT-0090-2022	Mackesy-Amiti, Mary E/0000-0002-7238-5240; Langi, Fima Lanra Fredrik G./0000-0002-2730-8836; Otieno, Fredrick Odhiambo/0000-0003-0823-412X; Jaoko, Walter/0000-0002-7134-6581	Division of AIDS, National Institute of Allergy and Infectious Disease, National institutes of Health [U01AI099953]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI099953, R01AI108371] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Disease, National institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by grant U01AI099953 to RCB from the Division of AIDS, National Institute of Allergy and Infectious Disease, National institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis MC, 2004, OBSTET GYNECOL SURV, V59, P379, DOI 10.1097/00006254-200405000-00026; Amuri M, 2016, GLOB HEALTH-SCI PRAC, V4, pS29, DOI 10.9745/GHSP-D-15-00210; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Bailey RC, PLOS ONE, V12; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Davey DLJ, 2016, AIDS, V30, P1847, DOI 10.1097/QAD.0000000000001121; Fitzgerald L, 2016, GLOB HEALTH-SCI PRAC, V4, pS76, DOI 10.9745/GHSP-D-15-00186; Government of Kenya Ministry of Health, 2014, NAT AIDS STD CONTR P; Government of Kenya Ministry of Health, NAT AIDS STI CONTR P; Government of Kenya Ministry of Health, 2013, POL PROP PRES IN FRE; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; HIV/AIDS World Health Organization and Joined United Nations Programme on, 2007, MAL CIRC GLOB TRENDS; Kenya National Bureau of Statistics (KNBS), 2009, KEN DEM HLTH SURV 20; Kikaya V, 2016, GLOB HEALTH-SCI PRAC, V4, pS87, DOI 10.9745/GHSP-D-15-00231; Luo CW, 2016, GLOB HEALTH-SCI PRAC, V4, pS1, DOI 10.9745/GHSP-D-16-00106; Mangenah C, 2015, JAIDS-J ACQ IMM DEF, V69, P560, DOI 10.1097/QAI.0000000000000699; Mavhu W, 2016, GLOB HEALTH-SCI PRAC, V4, pS42, DOI 10.9745/GHSP-D-15-00199; Mavhu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032475; Ministry of Health, KEN HLTH INF SYST DH; Morris Brian J, 2017, World J Clin Pediatr, V6, P89, DOI 10.5409/wjcp.v6.i1.89; Morris BJ, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-20; National AIDS Control Council, 2014, KEN RESP PROGR REP 2; Njeuhmeli E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159167; Njeuhmeli E, 2016, GLOB HEALTH-SCI PRAC, V4, pS9, DOI 10.9745/GHSP-D-16-00159; Obiero W, IS EARLY INFANT MALE; Patel HI, 2001, J PEDIATR SURG, V36, P235, DOI 10.1053/jpsu.2001.20062; Plank RM, 2010, AIDS BEHAV, V14, P1198, DOI 10.1007/s10461-009-9632-0; Sherman J, 1996, J UROLOGY, V156, P842, DOI 10.1016/S0022-5347(01)65836-1; Sint TT, 2016, GLOB HEALTH-SCI PRAC, V4, pS3, DOI 10.9745/GHSP-D-15-00229; Stata Corp, 2013, STATA STAT SOFTW REL; Strimling BS, 1996, PEDIATRICS, V97, P906; Waters E, 2013, AIDS BEHAV, V17, P2114, DOI 10.1007/s10461-012-0297-8; Weiss HA, 2000, AIDS, V14, P2361, DOI 10.1097/00002030-200010200-00018; WISWELL TE, 1993, CLIN PEDIATR, V32, P130, DOI 10.1177/000992289303200301; World Health Organization; Johns Hopkins Program for International Education in Gynecology and Obstetrics, 2010, MAN EARL INF MAL CIR; Young MR, 2016, AIDS BEHAV, V20, P2545, DOI 10.1007/s10461-016-1288-y; Young MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047395; Young MR, 2012, PEDIATRICS, V130, pE175, DOI 10.1542/peds.2011-2290	41	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184170	10.1371/journal.pone.0184170	http://dx.doi.org/10.1371/journal.pone.0184170			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880904	Green Submitted, gold, Green Published			2022-12-27	WOS:000409467200038
J	Chen, Y; Li, XX; Chi, XJ; Wang, S; Ma, YM; Chen, JL				Chen, Ye; Li, Xinxin; Chi, Xiaojuan; Wang, Song; Ma, Yanmei; Chen, Jilong			Comprehensive analysis of the codon usage patterns in the envelope glycoprotein E2 gene of the classical swine fever virus	PLOS ONE			English	Article							TRANSLATIONAL SELECTION; MUTATION PRESSURE; EPIDEMIOLOGY; EVOLUTION; BIAS; INFECTION; VIRULENCE; HOST	The classical swine fever virus (CSFV), circulating worldwide, is a highly contagious virus. Since the emergence of CSFV, it has caused great economic loss in swine industry. The envelope glycoprotein E2 gene of the CSFV is an immunoprotective antigen that induces the immune system to produce neutralizing antibodies. Therefore, it is essential to study the codon usage of the E2 gene of the CSFV. In this study, 140 coding sequences of the E2 gene were analyzed. The value of effective number of codons (ENC) showed low codon usage bias in the E2 gene. Our study showed that codon usage could be described mainly by mutation pressure ENC plot analysis combined with principal component analysis (PCA) and translational selection-correlation analysis between the general average hydropathicity (Gravy) and aromaticity (Aroma), and nucleotides at the third position of codons (A3s, T3s, G3s, C3s and GC3s). Furthermore, the neutrality analysis, which explained the relationship between GC12s and GC3s, revealed that natural selection had a key role compared with mutational bias during the evolution of the E2 gene. These results lay a foundation for further research on the molecular evolution of CSFV.	[Chen, Ye; Li, Xinxin; Chi, Xiaojuan; Wang, Song; Ma, Yanmei; Chen, Jilong] Fujian Agr & Forestry Univ, Coll Anim Sci, Key Lab Fujian Taiwan Anim Pathogen Biol, Fuzhou, Fujian, Peoples R China; [Chen, Jilong] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Fujian Agriculture & Forestry University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Ma, YM; Chen, JL (corresponding author), Fujian Agr & Forestry Univ, Coll Anim Sci, Key Lab Fujian Taiwan Anim Pathogen Biol, Fuzhou, Fujian, Peoples R China.; Chen, JL (corresponding author), Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China.	89mym@163.com; chenjl@im.ac.cn	Chen, Ji-Long/AAJ-2134-2021	Chen, Ji-Long/0000-0002-4274-0563	Natural Science Foundation of China [U1405216, U1305212, 31402217]; Key National Basic Research Program (973) of China [2015CB910502]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key National Basic Research Program (973) of China(National Basic Research Program of China)	This work was supported by Natural Science Foundation of China (U1405216) to XC, National Key National Basic Research Program (973) of China (2015CB910502), and Natural Science Foundation of China (U1305212, 31402217) to JLC and XC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Belalov IS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056642; Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106; Butt AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090905; Chen R, 2007, DNA SEQUENCE, V18, P269, DOI 10.1080/10425170601136564; Chen Y, 2014, INFECT GENET EVOL, V28, P95, DOI 10.1016/j.meegid.2014.09.004; Choori P, 2015, VET WORLD, V8, P541, DOI 10.14202/vetworld.2015.541-544; Comeron JM, 1998, J MOL EVOL, V47, P268, DOI 10.1007/PL00006384; Edwards S, 2000, VET MICROBIOL, V73, P103, DOI 10.1016/S0378-1135(00)00138-3; Gupta SK, 2001, GENE, V273, P63, DOI 10.1016/S0378-1119(01)00576-5; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Hulst MM, 1997, J GEN VIROL, V78, P2779, DOI 10.1099/0022-1317-78-11-2779; Jenkins GM, 2003, VIRUS RES, V92, P1, DOI 10.1016/S0168-1702(02)00309-X; Ji W, 2014, INFECT GENET EVOL, V25, P69, DOI 10.1016/j.meegid.2014.04.008; Kumar N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154376; Li GR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3935-8; Lindenbach B.D., 2007, FLAVIVIRIDAE VIRUSES; Lindenbach BD, 2007, FLAVIVIRUS VIRUSES T; Liu WQ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-325; Liu XD, 2010, ARCH VIROL, V155, P685, DOI 10.1007/s00705-010-0631-2; Lowings P, 1996, J GEN VIROL, V77, P1311, DOI 10.1099/0022-1317-77-6-1311; Lu G, 2013, VIRUS GENES, V47, P250, DOI 10.1007/s11262-013-0935-x; MARIN A, 1989, NUCLEIC ACIDS RES, V17, P6181; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Meyers G, 1996, ADV VIRUS RES, V47, P53, DOI 10.1016/S0065-3527(08)60734-4; Moennig V, 2003, VET J, V165, P11, DOI 10.1016/S1090-0233(02)00112-0; Nasrullah I, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0456-4; Naveen K, 2016, PLOS ONE, V11; Pan CH, 2005, ARCH VIROL, V150, P1101, DOI 10.1007/s00705-004-0485-6; Parmley JL, 2007, DO SYNONYMOUS MUTATI; Peixoto L, 2003, GENE, V320, P109, DOI 10.1016/S0378-1119(03)00815-1; Risatti GR, 2005, VIROLOGY, V343, P116, DOI 10.1016/j.virol.2005.08.015; Risatti GR, 2005, J VIROL, V79, P3787, DOI 10.1128/JVI.79.6.3787-3796.2005; Romero H, 2003, GENE, V317, P141, DOI 10.1016/S0378-1119(03)00701-7; SHARP PM, 1986, J MOL EVOL, V24, P28, DOI 10.1007/BF02099948; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; Simon G, 2013, VET MICROBIOL, V166, P631, DOI 10.1016/j.vetmic.2013.06.032; Su S, 2017, TRENDS MICROBIOLOGY; Su S, 2016, TRENDS MICROBIOL, V24, P490, DOI 10.1016/j.tim.2016.03.003; Su S, 2015, J VIROL, V89, P8671, DOI 10.1128/JVI.01034-15; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z; Tautz N, 1997, J VIROL, V71, P5415, DOI 10.1128/JVI.71.7.5415-5422.1997; THIEL HJ, 1991, J VIROL, V65, P4705, DOI 10.1128/JVI.65.9.4705-4712.1991; Wong EHM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-253; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhao S, 2008, BIOSYSTEMS, V92, P207, DOI 10.1016/j.biosystems.2008.01.006; Zhao YC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3021-7; Zhou H, 2015, INFECT GENET EVOL, V35, P27, DOI 10.1016/j.meegid.2015.07.024; Zhou JH, 2013, INFECT GENET EVOL, V14, P105, DOI 10.1016/j.meegid.2012.09.020; Zhou JH, 2010, VET RES COMMUN, V34, P393, DOI 10.1007/s11259-010-9359-4; Zhou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092828	51	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183646	10.1371/journal.pone.0183646	http://dx.doi.org/10.1371/journal.pone.0183646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880881	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200021
J	Ready, D; Yagiz, K; Amin, P; Yildiz, Y; Funari, V; Bozdag, S; Cinar, B				Ready, Damien; Yagiz, Kader; Amin, Pooneh; Yildiz, Yuksel; Funari, Vincent; Bozdag, Serdar; Cinar, Bekir			Mapping the STK4/Hippo signaling network in prostate cancer cell	PLOS ONE			English	Article							ANDROGEN RECEPTOR; INCREASED SURVIVAL; TUMOR-SUPPRESSOR; HIPPO PATHWAY; HISTONE H2B; KINASE MST1; PHOSPHORYLATION; YAP1; ENZALUTAMIDE; ABIRATERONE	Dysregulation of MST1/STK4, a key kinase component of the Hippo-YAP pathway, is linked to the etiology of many cancers with poor prognosis. However, how STK4 restricts the emergence of aggressive cancer remains elusive. Here, we investigated the effects of STK4, primarily localized in the cytoplasm, lipid raft, and nucleus, on cell growth and gene expression in aggressive prostate cancer. We demonstrated that lipid raft and nuclear STK4 had superior suppressive effects on cell growth in vitro and in vivo compared with cytoplasmic STK4. Using RNA sequencing and bioinformatics analysis, we identified several differentially expressed (DE) genes that responded to ectopic STK4 in all three subcellular compartments. We noted that the number of DE genes observed in lipid raft and nuclear STK4 cells were much greater than cytoplasmic STK4. Our functional annotation clustering showed that these DE genes were commonly associated with oncogenic pathways such as AR, PI3K/AKT, BMP/SMAD, GPCR, WNT, and RAS as well as unique pathways such as JAK/STAT, which emerged only in nuclear STK4 cells. These findings indicate that MST1/STK4/Hippo signaling restricts aggressive tumor cell growth by intersecting with multiple molecular pathways, suggesting that targeting of the STK4/Hippo pathway may have important therapeutic implications for cancer.	[Ready, Damien; Bozdag, Serdar] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA; [Yagiz, Kader] Cedars Sinai Med Ctr, Dept Med, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Amin, Pooneh; Cinar, Bekir] Clark Atlanta Univ, Dept Biol Sci, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA; [Yildiz, Yuksel] Adnan Menderes Univ, Dept Physiol, Aydin, Turkey; [Funari, Vincent] Cedars Sinai Med Ctr, Dept Med, Los Angeles, CA 90048 USA; [Funari, Vincent] Cedars Sinai Med Ctr, Div Genet, Los Angeles, CA 90048 USA; [Cinar, Bekir] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA	Marquette University; Cedars Sinai Medical Center; Clark Atlanta University; Adnan Menderes University; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Emory University	Bozdag, S (corresponding author), Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA.; Cinar, B (corresponding author), Clark Atlanta Univ, Dept Biol Sci, Ctr Canc Res & Therapeut Dev, Atlanta, GA 30314 USA.; Cinar, B (corresponding author), Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA.	serdar.bozdag@marquette.edu; bcinar@cau.edu	CİNAR, BEKIR MURAT/AAL-4474-2021	CİNAR, BEKIR MURAT/0000-0002-7906-5039; Cinar, Bekir/0000-0003-4028-7600	NIH/National Center for Advancing Translational Science [UL1TR000124]; NIH/National Institute on Minority Health and Health Disparities and Research Centers in Minority Institution Program [5G12MD007590]; National Institute on Minority Health and Health Disparities [G12MD007590] Funding Source: NIH RePORTER	NIH/National Center for Advancing Translational Science; NIH/National Institute on Minority Health and Health Disparities and Research Centers in Minority Institution Program; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported in part by the NIH/National Center for Advancing Translational Science (grant #UL1TR000124), and the NIH/National Institute on Minority Health and Health Disparities and Research Centers in Minority Institution Program (grant #5G12MD007590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2015, NUCL ACIDS RES, V43, pD204; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; Barry ER, 2013, CURR OPIN CELL BIOL, V25, P247, DOI 10.1016/j.ceb.2012.12.006; Beer TM, 2014, NEW ENGL J MED, V371, P1755, DOI 10.1056/NEJMc1410239; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cinar B, 2004, BIOCHEM J, V379, P421, DOI 10.1042/BJ20031661; Cinar B, 2007, EMBO J, V26, P4523, DOI 10.1038/sj.emboj.7601872; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; Cinar B, 2011, CANCER RES, V71, P4303, DOI 10.1158/0008-5472.CAN-10-4532; Collak FK, 2012, J BIOL CHEM, V287, P23698, DOI 10.1074/jbc.M112.358713; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Freeman MR, 2005, TRENDS ENDOCRIN MET, V16, P273, DOI 10.1016/j.tem.2005.06.002; Gomez M, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-22; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Imajo M, 2015, NAT CELL BIOL, V17, P7, DOI 10.1038/ncb3084; Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim W, 2016, BMB REP; Kuser-Abali G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9126; Kuser-Abali G, 2014, EPIGENETICS-US, V9, P634, DOI 10.4161/epi.27957; Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McNeal AS, 2015, CANCER DISCOV, V5, P1072, DOI 10.1158/2159-8290.CD-15-0196; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Nguyen LT, 2015, CANCER CELL, V27, P797, DOI 10.1016/j.ccell.2015.05.005; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Pritchard CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5988; Rawat SJ, 2016, CURR BIOL, V26, P1556, DOI 10.1016/j.cub.2016.04.027; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Saito A, 2015, AM J PHYSIOL-LUNG C, V309, pL756, DOI 10.1152/ajplung.00238.2015; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Serrano I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3976; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Yuan ZQ, 2010, J BIOL CHEM, V285, P3815, DOI 10.1074/jbc.M109.059675; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang K, 2015, BIOCHEMISTRY-US, V54, P6555, DOI 10.1021/acs.biochem.5b01014; Zhao B, 2009, CANCER CELL, V16, P363, DOI 10.1016/j.ccr.2009.10.008; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026; Zhuang LY, 2002, CANCER RES, V62, P2227	60	17	17	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184590	10.1371/journal.pone.0184590	http://dx.doi.org/10.1371/journal.pone.0184590			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880957	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200080
J	Wang, P; Wang, HN; Liu, Q; Tian, X; Shi, YX; Zhang, XC				Wang, Pei; Wang, Huinan; Liu, Qing; Tian, Xia; Shi, Yanxi; Zhang, Xiaocun			QTL mapping of selenium content using a RIL population in wheat	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOTYPIC VARIATION; BIOFORTIFICATION; REGIONS	Selenium (Se) is an essential trace element that plays various roles in human health. Understanding the genetic control of Se content and quantitative trait loci (QTL) mapping provide a basis for Se biofortification of wheat to enhance grain Se content. In the present study, a set of recombinant inbred lines (RILs) derived from two Chinese winter wheat varieties (Tainong18 and Linmai6) was used to detect QTLs for Se content in hydroponic and field trials. In total, 16 QTLs for six Se content-related traits were detected on eight chromosomes, 1B, 2B, 4B, 5A, 5B, 5D, 6A, and 7D. Of these, seven QTLs were detected at the seedling stage and nine at the adult stage. The contribution of each QTL to Se content ranged from 7.37% to 20.22%. QSsece-7D. 2, located between marker loci D-3033829 and D-1668160, had the highest contribution (20.22%). This study helps in understanding the genetic basis for Se contents and will provide a basis for gene mapping of Se content in wheat.	[Wang, Pei; Zhang, Xiaocun] Shandong Agr Univ, Coll Food Sci & Engn, Tai An, Shandong, Peoples R China; [Wang, Huinan] Shandong Agr Univ, Coll Agron, Shandong Key Lab Crop Biol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Liu, Qing; Tian, Xia; Shi, Yanxi] Qingdao Agr Univ, Coll Resources & Environm, Qingdao, Shandong, Peoples R China	Shandong Agricultural University; Shandong Agricultural University; Qingdao Agricultural University	Zhang, XC (corresponding author), Shandong Agr Univ, Coll Food Sci & Engn, Tai An, Shandong, Peoples R China.	xczhang@sdau.edu.cn	Zhang, Xiaocun/G-9783-2018	Zhang, Xiaocun/0000-0001-7179-2891	Ministry of Agriculture Public Welfare Special Fund of China [20130316]; Agriculture Research System of Shandong Province, China; Postdoctoral Fund of Shandong Agricultural University [76432]; Youth Innovation Fund of Shandong Agricultural University [24023]	Ministry of Agriculture Public Welfare Special Fund of China; Agriculture Research System of Shandong Province, China; Postdoctoral Fund of Shandong Agricultural University; Youth Innovation Fund of Shandong Agricultural University	This study was supported by the Ministry of Agriculture Public Welfare Special Fund of China (20130316); Agriculture Research System of Shandong Province, China; Postdoctoral Fund of Shandong Agricultural University (76432) and Youth Innovation Fund of Shandong Agricultural University (24023).	[Anonymous], 2000, SCI TOTAL ENVIRON, V249, P347; Ates D., 2016, PLOS ONE, V11; Beladel B, 2013, APPL RADIAT ISOTOPES, V71, P7, DOI 10.1016/j.apradiso.2012.09.009; Blazina T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5717; CHURCHILL GA, 1994, GENETICS, V138, P963; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Eiche E, 2015, SCI TOTAL ENVIRON, V505, P952, DOI 10.1016/j.scitotenv.2014.10.080; Genc Y, 2005, J TRACE ELEM MED BIO, V18, P319, DOI 10.1016/j.jtemb.2005.02.005; Golubkina NA, 1999, J TRACE ELEM MED BIO, V13, P15, DOI 10.1016/S0946-672X(99)80018-2; Guerrero B, 2014, PLANT PHYSIOL BIOCH, V83, P300, DOI 10.1016/j.plaphy.2014.08.009; Haug Anna, 2007, Microbial Ecology in Health and Disease, V19, P209, DOI 10.1080/08910600701698986; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; Lyons GH, 2005, J TRACE ELEM MED BIO, V19, P75, DOI 10.1016/j.jtemb.2005.04.005; Poblaciones MJ, 2014, FOOD CHEM, V146, P378, DOI 10.1016/j.foodchem.2013.09.070; Pu ZE, 2014, J INTEGR AGR, V13, P2322, DOI 10.1016/S2095-3119(13)60640-1; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Rayman MP, 2000, LANCET, V356, P233, DOI 10.1016/S0140-6736(00)02490-9; Roman M, 2014, METALLOMICS, V6, P25, DOI 10.1039/c3mt00185g; Souza GA, 2014, PLANT SCI, V224, P27, DOI 10.1016/j.plantsci.2014.03.022; Wang S, 2007, WINDOWS QTL CARTOGRA, V2, P5; WHO, 1996, TRAC EL HUM NUTR HLT; Zhang G, 2014, CONSTRUCTION HIGH DE; [张现伟 Zhang Xianwei], 2010, [植物遗传资源学报, Journal of Plant Genetic Resources], V11, P445; Zhao F, 2007, COMP BIOCHEM PHYS A, V146, pS246, DOI 10.1016/j.cbpa.2007.01.571; Zhao FJ, 2009, J CEREAL SCI, V49, P290, DOI 10.1016/j.jcs.2008.11.007	27	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184351	10.1371/journal.pone.0184351	http://dx.doi.org/10.1371/journal.pone.0184351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880898	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200055
J	Pati, S; Swain, S; Metsemakers, J; Knottnerus, JA; van den Akker, M				Pati, Sanghamitra; Swain, Subhashisa; Metsemakers, Job; Knottnerus, J. Andre; van den Akker, Marjan			Pattern and severity of multimorbidity among patients attending primary care settings in Odisha, India	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PEPTIC-ULCER DISEASE; HEALTH-CARE; POPULATION; OSTEOARTHRITIS; COMORBIDITIES; EPIDEMIOLOGY; ARTHROPLASTY; HYPERTENSION; PREVALENCE	Multimorbidity is increasingly the primary concern of healthcare systems globally with substantial implications for patient outcomes and resource cost. A critical knowledge gap exists as to the magnitude of multimorbidity in primary care practice in low and middle income countries with available information limited to prevalence. In India, primary care forms the bulk of the health care delivery being provided through both public (community health center) and private general practice setting. We undertook a study to identify multimorbidity patterns and relate these patterns to severity among primary care attendees in Odisha state of India. A total of 1649 patients attending 40 primary care facilities were interviewed using a structured multimorbidity assessment questionnaire. Multimorbidity patterns (dyad and triad) were identified for 21 chronic conditions, functional limitation was assessed as a proxy measure of severity and the mean severity score for each pattern, was determined after adjusting for age. The leading dyads in younger age group i.e. 18-29 years were acid peptic disease with arthritis/chronic back ache/tuberculosis/chronic lung disease, while older age groups had more frequent combinations of hypertension + arthritis/chronic lung disease/vision difficulty, and arthritis + chronic back ache. The triad of acid peptic disease + arthritis + chronic backache was common in men in all age groups. Tuberculosis and lung diseases were associated with significantly higher age-adjusted mean severity score (poorer functional ability). Among men, arthritis, chronic backache, chronic lung disease and vision impairment were observed to have highest severity) whereas women reported higher severity for combinations of hypertension, chronic back ache and arthritis. Given the paucity of studies on multimorbidity patterns in low and middle income countries, future studies should seek to assess the reproducibility of our findings in other populations and settings. Another task is the potential implications of different multimorbidity clusters for designing care protocols, as currently the protocols are disease specific, hardly taking comorbidity into account.	[Pati, Sanghamitra; Swain, Subhashisa] Indian Inst Publ Hlth, Publ Hlth Fdn India, Bhubaneswar, Odisha, India; [Metsemakers, Job; Knottnerus, J. Andre; van den Akker, Marjan] Maastricht Univ, Sch Caphri, Dept Family Med, Maastricht, Netherlands; [van den Akker, Marjan] Katholieke Univ Leuven, Dept Gen Practice, Leuven, Belgium; [Pati, Sanghamitra] FW Govt India, Minist Hlth & FW, Dept Hlth Res, Reg Med Res Ctr,Indian Council Med Res, Bhubaneswar, Orissa, India	Public Health Foundation of India; Maastricht University; Maastricht University Medical Centre (MUMC); KU Leuven; Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre (RMRC), Bhubaneswar	Pati, S (corresponding author), Indian Inst Publ Hlth, Publ Hlth Fdn India, Bhubaneswar, Odisha, India.; Pati, S (corresponding author), FW Govt India, Minist Hlth & FW, Dept Hlth Res, Reg Med Res Ctr,Indian Council Med Res, Bhubaneswar, Orissa, India.	drsanghamitra12@gmail.com	Knottnerus, Johannes A/A-3829-2009	van den Akker, Marjan/0000-0002-1022-8637; Pati, Sanghamitra/0000-0002-7717-5592; Swain, Subhashisa/0000-0001-9207-1065	Wellcome Trust; consortium of UK universities	Wellcome Trust(Wellcome TrustEuropean Commission); consortium of UK universities	This work was supported by a Wellcome Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India and a consortium of UK universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Wellcome Trust Capacity Strengthening Strategic Award to the Public Health Foundation of India and a consortium of UK universities. The authors are grateful to all the study participants, field investigators and participating physicians, Department of Health and Family Welfare, Government of Odisha and Indian Medical Association, Odisha branch for their valuable support with data collection. Authors would also like to thank all the staff of Indian Institute of Public Health, Bhubaneswar (IIPHB) for day to day support, as the Principal Investigator (PI) was working as Additional Professor at IIPHB-PHFI when the research was done.	Agborsangaya CB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-201; Anjum Qudsia, 2006, JPMA Journal of the Pakistan Medical Association, V56, P13; Arokiasamy P, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015571640; Arroll B, 2010, ANN FAM MED, V8, P348, DOI 10.1370/afm.1139; Banjare P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097832; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bayliss Elizabeth A, 2005, Health Qual Life Outcomes, V3, P51; Bhojani U, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-306; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Brilleman SL, 2013, FAM PRACT, V30, P172, DOI 10.1093/fampra/cms060; Christiansen SC, 2016, J ALLER CL IMM-PRACT, V4, P76, DOI 10.1016/j.jaip.2015.07.009; Dutta AK, 2012, INDIAN J GASTROENTER, V31, P111, DOI 10.1007/s12664-012-0201-5; Everhart JS, 2013, CLIN ORTHOP RELAT R, V471, P3112, DOI 10.1007/s11999-013-2923-9; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; France EF, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636146; Garin N, 2016, J GERONTOL A-BIOL, V71, P205, DOI 10.1093/gerona/glv128; Gore Mugdha, 2011, J Med Econ, V14, P497, DOI 10.3111/13696998.2011.594347; Government of Odisha, 2001, DISTR WIS SOIOEC IND; Gupta M, 2005, INDIAN J PHARM, V37, P404; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Jackson CA, 2015, AGE AGEING; John PDS, 2014, CAN FAM PHYSICIAN, V60, P272; Khanam MA, 2011, J HEALTH POPUL NUTR, P29; KHUROO MS, 1989, GUT, V30, P930, DOI 10.1136/gut.30.7.930; Kowal P, 2012, INT J EPIDEMIOL, V41, P1639, DOI 10.1093/ije/dys210; Kumar A., 2015, ECON POLIT WEEKLY, V50, P46; Kumari R, 2008, INDIAN J PHARMACOL, V40, P243, DOI 10.4103/0253-7613.45148; Lee JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127199; LOFDAHL CG, 1989, J CARDIOVASC PHARM, V14, pS40; Lofdahl CG, 1989, J CARDIOVASC PHARM, V14, pS59; Nimako BA, 2013, GLOB HLTH, V9; Nunes BP, 2016, INT J PUBLIC HLTH; Pati S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6582487; Pati S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007235; PIPER JM, 1991, ANN INTERN MED, V114, P735, DOI 10.7326/0003-4819-114-9-735; Poongothai S, 2009, J Assoc Physicians India, V57, P147; Prados-Torres A, 2014, J CLIN EPIDEMIOL, V67, P254, DOI 10.1016/j.jclinepi.2013.09.021; Prior JA, 2014, RHEUMATOLOGY, V53, P1794, DOI 10.1093/rheumatology/keu175; Purty AJ, 2006, TURK J MED SCI, V36; Qian JH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004536; Ranstad K, 2014, SCAND J PRIM HEALTH, V32, P99, DOI 10.3109/02813432.2014.929819; Rodriguez LAG, 1998, ARCH INTERN MED, V158, P33, DOI 10.1001/archinte.158.1.33; Singh JA, 2009, CLIN RHEUMATOL, V28, P1025, DOI 10.1007/s10067-009-1201-4; Smith SM, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-6; SOWERS JR, 1988, MED CLIN N AM, V72, P1399, DOI 10.1016/S0025-7125(16)30714-3; Srivastava RK, 2011, INDIAN J COMMUNITY M, V36, pS7, DOI [DOI 10.4103/0970-0218.94703.PUBMED, DOI 10.4103/0970-0218.94703]; Steinman MA, 2012, J AM GERIATR SOC, V60, P1872, DOI 10.1111/j.1532-5415.2012.04158.x; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Wallace JL, 2000, BEST PRACT RES CLIN	51	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183966	10.1371/journal.pone.0183966	http://dx.doi.org/10.1371/journal.pone.0183966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910309	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200025
J	Kobayashi, M; Iwase, T; Yamamoto, K; Ra, E; Murotani, K; Terasaki, H				Kobayashi, Misato; Iwase, Takeshi; Yamamoto, Kentaro; Ra, Eimei; Murotani, Kenta; Terasaki, Hiroko			Perioperative factors that are significantly correlated with final visual acuity in eyes after successful rhegmatogenous retinal detachment surgery	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MACULAR DETACHMENT; PRIMARY VITRECTOMY; SCLERAL BUCKLE; REPAIR; REATTACHMENT; RECOVERY; DURATION; HEIGHT	Purpose To determine the perioperative factors that are significantly correlated with the final visual acuity following reattachment of a macula-off rhegmatogenous retinal detachment (RRD) by vitrectomy. Methods Twenty-nine eyes of 29 patients with a successfully reattached RRD by vitrectomy were retrospectively analyzed. Spectral-domain optical coherence tomographic images of the macular regions were used to measure the thicknesses of the retinal layers and the integrity of the microstructures of the photoreceptors at 2 weeks, 1, 2, 3, 6, 9, and 12 months following the vitrectomy. The best-corrected visual acuities (BCVA) were evaluated at the same times. Results The improvement of the BCVA from the preoperative BCVA to that at postoperative Week 2 (-0.67 +/- 0.69 logMAR units) was the largest change between adjacent observation periods for the entire study duration. It was significantly greater than the improvement between Week 2 and Month 12 (-0.32 +/- 0.22 logMAR units; P<0.001). The thickness of the ellipsoid zone (EZ)-retinal pigment epithelium (RPE) increased significantly with time (P<0.001). The final BCVA was significantly correlated with the BCVA at Week 2 (r = 0.61, P<0.001), the EZ-RPE thickness at Week 2 (r = -0.40, P = 0.035), the integrity of the external limiting membrane (ELM) (r = -0.61, P = 0.003), and an intact EZ (r = -0.66, P = 0.001) at Week 2. Multiple stepwise regression analyses of the final BCVA showed that the BCVA at Week 2 (P = 0.017) and the integrity of the EZ at Week 2 (P = 0.006) were independent predictors of the final BCVA. Conclusions The significantly better BCVA and presence of an intact EZ at 2 weeks following vitrectomy and their significant correlations with the BCVA at Month 12 indicate that these perioperative values can be used to predict the BCVA at Month 12 after a reattachment of macula-off RRD following vitrectomy.	[Kobayashi, Misato; Iwase, Takeshi; Yamamoto, Kentaro; Ra, Eimei; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi, Japan; [Murotani, Kenta] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan	Nagoya University; Nagoya University	Iwase, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi, Japan.	tiwase@med.nagoya-u.ac.jp						Campo RV, 1999, OPHTHALMOLOGY, V106, P1811, DOI 10.1016/S0161-6420(99)90353-6; D'Amico DJ, 2008, NEW ENGL J MED, V359, P2346, DOI 10.1056/NEJMcp0804591; dell'Omo R, 2015, INVEST OPHTH VIS SCI, V56, P1040, DOI 10.1167/iovs.14-15633; Diederen RMH, 2007, OPHTHALMOLOGY, V114, P705, DOI 10.1016/j.ophtha.2006.09.004; Gharbiya M, 2012, RETINA-J RET VIT DIS, V32, P43, DOI 10.1097/IAE.0b013e3182180114; Goto T, 2013, ACTA OPHTHALMOL, V91, P552, DOI 10.1111/j.1755-3768.2012.02455.x; GRIZZARD WS, 1994, GRAEF ARCH CLIN EXP, V232, P1, DOI 10.1007/BF00176431; Hasegawa T, 2014, RETINA-J RET VIT DIS, V34, P1848, DOI 10.1097/IAE.0000000000000160; Hassan TS, 2002, OPHTHALMOLOGY, V109, P146, DOI 10.1016/S0161-6420(01)00886-7; Itoh Y, 2012, AM J OPHTHALMOL, V153, P111, DOI 10.1016/j.ajo.2011.05.039; Jackson TL, 2003, INVEST OPHTH VIS SCI, V44, P4026, DOI 10.1167/iovs.02-1264; Kobayashi M, 2016, INVEST OPHTH VIS SCI, V57, P889, DOI 10.1167/iovs.15-18403; Lewis GP, 2002, INVEST OPHTH VIS SCI, V43, P2412; MACHEMER R, 1991, AM J OPHTHALMOL, V112, P159, DOI 10.1016/S0002-9394(14)76695-4; Mervin K, 1999, AM J OPHTHALMOL, V128, P155, DOI 10.1016/S0002-9394(99)00104-X; Mowatt L, 2010, EYE, V24, P323, DOI 10.1038/eye.2009.74; Oshima Y, 2000, JPN J OPHTHALMOL, V44, P538, DOI 10.1016/S0021-5155(00)00205-7; Ross W, 2005, OPHTHALMOLOGY, V112, P1213, DOI 10.1016/j.ophtha.2005.01.040; SABATES NR, 1989, AM J OPHTHALMOL, V108, P22, DOI 10.1016/S0002-9394(14)73255-6; Sakai T, 2003, INVEST OPHTH VIS SCI, V44, P416, DOI 10.1167/iovs.02-0633; Schocket LS, 2006, OPHTHALMOLOGY, V113, P666, DOI 10.1016/j.ophtha.2006.01.003; SHARMA T, 1994, RETINA-J RET VIT DIS, V14, P338, DOI 10.1097/00006982-199414040-00008; Smith AJ, 2008, OPHTHALMOLOGY, V115, P1923, DOI 10.1016/j.ophtha.2008.05.025; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P1571, DOI 10.1167/iovs.07-0838; Staurenghi G, 2014, OPHTHALMOLOGY, V121, P1572, DOI 10.1016/j.ophtha.2014.02.023; Tan HS, 2013, BRIT J OPHTHALMOL, V97, P80, DOI 10.1136/bjophthalmol-2012-302140; TANI P, 1981, AM J OPHTHALMOL, V92, P611, DOI 10.1016/S0002-9394(14)74651-3; Terauchi G, 2015, BR J OPHTHALMOL; Wakabayashi T, 2009, OPHTHALMOLOGY, V116, P519, DOI 10.1016/j.ophtha.2008.10.001	29	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184783	10.1371/journal.pone.0184783	http://dx.doi.org/10.1371/journal.pone.0184783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902881	Green Submitted, gold, Green Published			2022-12-27	WOS:000410669200066
J	Soghigian, J; Livdahl, T				Soghigian, John; Livdahl, Todd			Differential response to mosquito host sex and parasite dosage suggest mixed dispersal strategies in the parasite Ascogregarina taiwanensis	PLOS ONE			English	Article							AEDES-ALBOPICTUS DIPTERA; APICOMPLEXA LECUDINIDAE; LIFE-CYCLE; ULTRASTRUCTURE; TRANSMISSION; INFECTIONS; CULICIDAE; EVOLUTION; AEGYPTI	Mixed dispersal strategies are a form of bet hedging in which a species or population utilizes different dispersal strategies dependent upon biotic or abiotic conditions. Here we provide an example of a mixed dispersal strategy in the Aedes albopictus / Ascogregarina taiwanensis host/parasite system, wherein upon host emergence, the gregarine parasite is either carried with an adult mosquito leaving the larval habitat, or released back into the larval habitat. We show that the parasite invests a larger proportion of its dispersing (oocyst) life stage into adult female mosquitoes as opposed to adult male mosquitoes at low parasite exposure levels. However, as the exposure level of parasite increases, so does the parasite investment in adult males, whereas there is no change in the proportion of oocysts in the adult female, regardless of dose. Thus, A. taiwanensis is utilizing several dispersal strategies, depending upon host sex and intraspecific density. Furthermore, we demonstrate that this parasite reduces body size, increases time to emergence in females, and leads to a reduction in estimates of per capita growth rate of the host.	[Soghigian, John; Livdahl, Todd] Clark Univ, Dept Biol, Worcester, MA 01610 USA; [Soghigian, John] Connecticut Agr Expt Stn, Dept Environm Sci, New Haven, CT 06504 USA	Clark University; Connecticut Agricultural Experiment Station	Livdahl, T (corresponding author), Clark Univ, Dept Biol, Worcester, MA 01610 USA.	tlivdahl@clarku.edu			NIH [1R15A1092577]; NSF [1311535]; Biology Department of Clark University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI092577] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Biology Department of Clark University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was partially funded by NIH grant 1R15A1092577, NSF grant #1311535, and the Biology Department of Clark University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Rohani, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P138; Aliabadi Brianna W., 2002, Biological Invasions, V4, P283, DOI 10.1023/A:1020933705556; ANDREADIS TG, 1979, J PROTOZOOL, V26, P444, DOI 10.1111/j.1550-7408.1979.tb04651.x; Andreadis TG, 2012, J INVERTEBR PATHOL, V109, P59, DOI 10.1016/j.jip.2011.09.011; Barker CM, 2003, J MED ENTOMOL, V40, P403, DOI 10.1603/0022-2585-40.4.403; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beier JC, 1985, GREGARINE PARASITES; Bodenmann P, 2006, LANCET, V368, P258, DOI 10.1016/S0140-6736(06)69046-6; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Chen WJ, 1999, PARASITOL TODAY, V15, P153, DOI 10.1016/S0169-4758(99)01418-0; Chen WJ, 1997, J EUKARYOT MICROBIOL, V44, P326, DOI 10.1111/j.1550-7408.1997.tb05674.x; Chen WJ, 1997, J EUKARYOT MICROBIOL, V44, P101, DOI 10.1111/j.1550-7408.1997.tb05945.x; Chen WJ, 1996, J MED ENTOMOL, V33, P212, DOI 10.1093/jmedent/33.2.212; Comiskey NM, 1999, J MED ENTOMOL, V36, P55, DOI 10.1093/jmedent/36.1.55; DENNO RF, 1991, AM NAT, V138, P1513, DOI 10.1086/285298; Denno RF, 2012, PLANTHOPPERS THEIR E; Erthal JA, 2012, J MED ENTOMOL, V49, P1109, DOI 10.1603/ME12018; Fellous S, 2009, J EVOLUTION BIOL, V22, P582, DOI 10.1111/j.1420-9101.2008.01665.x; Fox J., 2018, R COMPANION APPL REG, VThird; Friedenberg NA, 2003, ECOL LETT, V6, P953, DOI 10.1046/j.1461-0248.2003.00524.x; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; JARVINEN O, 1976, HEREDITAS, V84, P61; Kaplan L, 2010, BIOL INVASIONS; LANDIN J, 1977, OIKOS, V29, P156, DOI 10.2307/3543307; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; LIVDAHL TP, 1984, J ANIM ECOL, V53, P573, DOI 10.2307/4535; Lounibos LP, 2002, J VECTOR ECOL, V27, P86; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Mitchell A, 2016, FUNCT ECOL, V30, P733, DOI 10.1111/1365-2435.12535; MUNSTERMANN LE, 1990, J AM MOSQUITO CONTR, V6, P235; MURAJI M, 1988, RES POPUL ECOL, V30, P315, DOI 10.1007/BF02513252; Navarro DJ, 2015, LEARNING STAT R TUTO; O'Neal PA, 2013, J ANIM ECOL, V82, P256, DOI 10.1111/j.1365-2656.2012.02017.x; Passos R. A, 2008, J INVERTEBR PATHOL, V97, P230, DOI DOI 10.1016/J.JIP; R Core Team, 2016, R FDN STAT COMP; Reyes-Villanueva F, 2003, J INVERTEBR PATHOL, V84, P47, DOI 10.1016/S0022-2011(03)00119-8; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Roychoudhury S, 2006, J AM MOSQUITO CONTR, V22, P29, DOI 10.2987/8756-971X(2006)22[29:NFOTDP]2.0.CO;2; Sheridan LAD, 2000, OIKOS, V88, P327, DOI 10.1034/j.1600-0706.2000.880211.x; Soghigian J, 2017, ECOL EVOL, V7, P1453, DOI 10.1002/ece3.2748; Stonedahl GM, 1982, GERRIDAE WATER STRID; Travis JMJ, 1999, P ROY SOC B-BIOL SCI, V266, P1837, DOI 10.1098/rspb.1999.0854; Tseng M, 2004, P ROY SOC B-BIOL SCI, V271, pS186, DOI 10.1098/rsbl.2003.0139; Tseng M., 2017, J MED ENTOMOL; Tseng M, 2007, J AM MOSQUITO CONTR, V23, P30, DOI 10.2987/8756-971X(2007)23[30:APAPBA]2.0.CO;2; Vepsalainen K., 1978, P218; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	47	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184573	10.1371/journal.pone.0184573	http://dx.doi.org/10.1371/journal.pone.0184573			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902912	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200047
J	Toral-Granda, MV; Causton, CE; Jager, H; Trueman, M; Izurieta, JC; Araujo, E; Cruz, M; Zander, KK; Izurieta, A; Garnett, ST				Toral-Granda, M. Veronica; Causton, Charlotte E.; Jager, Heinke; Trueman, Mandy; Carlos Izurieta, Juan; Araujo, Eddy; Cruz, Marilyn; Zander, Kerstin K.; Izurieta, Arturo; Garnett, Stephen T.			Alien species pathways to the Galapagos Islands, Ecuador	PLOS ONE			English	Article							SANTA-CRUZ; CONSERVATION; TOURISM; THREATS; ACCUMULATION; ERADICATION; DISPERSAL; INVASIONS; DISEASES; IMPACTS	Alien species, one of the biggest threats to natural ecosystems worldwide, are of particular concern for oceanic archipelagos such as Gala A pagos. To enable more effective management of alien species, we reviewed, collated and analysed all available records of alien species for Gala A pagos. We also assembled a comprehensive dataset on pathways to and among the Gala A pagos Islands, including tourist and resident numbers, tourist vessels, their itineraries and visitation sites, aircraft capacity and occupancy, air and sea cargo and biosecurity interceptions. So far, 1,579 alien terrestrial and marine species have been introduced to Gala A pagos by humans. Of these, 1,476 have become established. Almost half of these were intentional introductions, mostly of plants. Most unintentional introductions arrived on plants and plant associated material, followed by transport vehicles, and commodities (in particular fruit and vegetables). The number, frequency and geographic origin of pathways for the arrival and dispersal of alien species to and within Gala A pagos have increased over time, tracking closely the increase in human population (residents and tourists) on the islands. Intentional introductions of alien species should decline as biosecurity is strengthened but there is a danger that unintentional introductions will increase further as tourism on Gala A pagos expands. This unique world heritage site will only retain its biodiversity values if the pathways for invasion are managed effectively.	[Toral-Granda, M. Veronica; Trueman, Mandy; Izurieta, Arturo; Garnett, Stephen T.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Casuarina, NT, Australia; [Causton, Charlotte E.; Jager, Heinke; Izurieta, Arturo] Charles Darwin Fdn, Puerto Ayora, Galapagos Islan, Ecuador; [Carlos Izurieta, Juan] Minist Turismo Ecuador, Observ Turismo Galapagos, Puerto Ayora, Galapagos Islan, Ecuador; [Araujo, Eddy] Direcc Parque Nacl Galapagos, Puerto Ayora, Galapagos Islan, Ecuador; [Cruz, Marilyn] Agencia Bioseguridad Galapagos, Puerto Ayora, Galapagos Islan, Ecuador; [Zander, Kerstin K.] Charles Darwin Univ, Northern Inst, Casuarina, NT, Australia	Charles Darwin University; Charles Darwin University	Toral-Granda, MV (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Casuarina, NT, Australia.	veronica.toral-granda@cdu.edu.au	Jäger, Heinke/ABH-5731-2020; Zander, Kerstin/M-2888-2013	Jäger, Heinke/0000-0001-9065-4048; Zander, Kerstin/0000-0002-2237-1801; Toral-Granda, M. Veronica/0000-0002-0324-1833	International Postgraduate Research Scholarship (IPRS); Australian Postgraduate Award (APA) scholarship; Galapagos Conservancy	International Postgraduate Research Scholarship (IPRS)(Australian Government); Australian Postgraduate Award (APA) scholarship(Australian Government); Galapagos Conservancy	MVTG is supported by an International Postgraduate Research Scholarship (IPRS) and an Australian Postgraduate Award (APA) scholarship to Charles Darwin University. CEC and HJ are supported by the Galapagos Conservancy https//www.galapagos.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MT, JCI, EA, MC, KKZ, Al, STG received no specific funding for this work.; This project was supported by an Australian Research Training Program scholarship to the Charles Darwin University and by the Galapagos Conservancy. We greatly appreciate the assistance and cooperation of the Ecuadorian Ministry of Environment through the Directorate of the Galapagos National Park and the Galapagos Biosecurity Agency; the Ministry of Tourism through the Tourism Monitoring System (Observatorio de Turismo de Galapagos), the Ecuadorian Civil Aviation Directorate and the Charles Darwin Foundation who kindly provided the databases underpinning this study. Special thanks to Hanno Seebens and Franz Essl who provided useful insights and comments to the manuscript; and to Inti Keith, Gustavo Jimenez, Diana Flores, Henri Herrera, Patricia Jaramillo, Brad Sinclair, Leon Baert, Brand Phillips, Alan Tye, Anne Guezou, Patricia Parker, Sharon Deem, Ingrid Jaramillo, Ginger Lozano, Sandra Gamboa, Danny Rueda, Galo Quezada, Christian Sevilla, Jorge Ramirez, Edgar Navas, Fanny Soto, Rocio Arias, Victor Carrion, Manuel Mejia, Monica Ramos, Marcelo Montesdeoca, Erika Guerrero, Nancy Duran, Alex Fonseca, Marco Echeverria, Duglas Acuria, Rafael Conde, Rommel Iturbide, Ronal Azuero, Viviana Duque, Alberto Velez and all of the ABG personnel for their invaluable help with species identification, data collection, input or suggestions. Thanks to personnel at DGNP for support in collections. Ian Leiper designed Fig 1. Tom Poulsom and Mark Gardener provided key ideas that prompted further discussion. This publication is contribution number 2144 of the Charles Darwin Foundation for the Galapagos Islands.	Amador E., 1996, PLAN MANEJO PARQUE N; [Anonymous], 2015, WORKSH DEV ACT PLAN; [Anonymous], [No title captured]; Atkinson R., 2012, ROLE SCI CONSERVATIO, P183; Baine M, 2007, OCEAN COAST MANAGE, V50, P148, DOI 10.1016/j.ocecoaman.2006.04.001; Bataille A, 2009, P ROY SOC B-BIOL SCI, V276, P3769, DOI 10.1098/rspb.2009.0998; Bataille A, 2009, P NATL ACAD SCI USA, V106, P10230, DOI 10.1073/pnas.0901308106; Benitez-Capistros F, 2014, ECOL INDIC, V38, P113, DOI 10.1016/j.ecolind.2013.10.019; Buddenhagen C. E., 2006, Pacific Conservation Biology, V12, P272; Bungartz F, 2009, C DARWING FDN GALAPA; Campbell ML, 2015, MANAG BIOL INVASION, V6, P227, DOI 10.3391/mbi.2015.6.3.01; Caujape-Castells J, 2010, PERSPECT PLANT ECOL, V12, P107, DOI 10.1016/j.ppees.2009.10.001; Causton C. E., 2000, NOT GALAPAGOS, V61, P10; Causton CE, 2004, BIOL CONTROL, V29, P315, DOI 10.1016/j.biocontrol.2003.07.002; Causton CE, 2006, ANN ENTOMOL SOC AM, V99, P121, DOI 10.1603/0013-8746(2006)099[0121:AITAIF]2.0.CO;2; Causton CE, LATEST RECORDS INTRO; Causton CE, 2008, GALAPAGOS REPORT 200, P142; Causton CE, 2007, GALAPAGOS REPORT 200, P55; Chown SL, 2012, P NATL ACAD SCI USA, V109, P4938, DOI 10.1073/pnas.1119787109; Convention on Biological Diversity, 2014, PATHW INTR INV SPEC; Cruz D, 2008, GALAPAGOS REPORT 200, P48; Deem SL, 2012, ANIM CONSERV, V15, P73, DOI 10.1111/j.1469-1795.2011.00489.x; Deem SL, 2012, J WILDLIFE DIS, V48, P39, DOI 10.7589/0090-3558-48.1.39; Deem SL, 2008, GALAPAGOS REPORT 200, P125; DEGROOT RS, 1983, BIOL CONSERV, V26, P291, DOI 10.1016/0006-3207(83)90093-9; Epler B, 2007, TOURISM EC POPULATIO; Essl F, 2015, BIOSCIENCE, V65, P769, DOI 10.1093/biosci/biv082; Gardener MR, 2011, GLOB ENVIRON STUD, P73, DOI 10.1007/978-4-431-53989-6_6; Gilbert B, 2013, P NATL ACAD SCI USA, V110, P1744, DOI 10.1073/pnas.1212375110; Global Invasive Species Database, 2017, GLOBAL INVASIVE SPEC; Gonzalez JA, 2008, ECOL SOC, V13; Grenier C., 2012, ROLE SCI CONSERVATIO, P256; Guezou A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010276; Haralambopoulos N, 1996, ANN TOURISM RES, V23, P503, DOI 10.1016/0160-7383(95)00075-5; Hulme PE, 2008, J APPL ECOL, V45, P403, DOI 10.1111/j.1365-2664.2007.01442.x; [INEC Censos INdEy], 2016, PRINC RES CENS POBL, P22; IUCN, 2000, GUIDELINES PREVENTIO; Jeschke JM, 2014, CONSERV BIOL, V28, P1188, DOI 10.1111/cobi.12299; Keith Inti, 2016, Pacific Conservation Biology, V22, P377, DOI 10.1071/PC15020; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; Kueffer C, 2010, PERSPECT PLANT ECOL, V12, P145, DOI 10.1016/j.ppees.2009.06.002; Larrea I., 2011, CLIMATE CHANGE VULNE; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Leadley P. W., 2014, TECHNICAL SERIES, V78; Leishman MR, 2015, DIVERS DISTRIB, V21, P848, DOI 10.1111/ddi.12338; Levy JK, 2008, J VET INTERN MED, V22, P60, DOI 10.1111/j.1939-1676.2007.0034.x; Liebhold Andrew M., 2006, American Entomologist, V52, P48; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Lundh J. P., 2006, Galapagos Research, V64, P12; Ma MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128479; Machuca-Mestanza J., 2004, CRONOLOGIA HIST GALA; McGeoch MA, 2016, BIOL INVASIONS, V18, P299, DOI 10.1007/s10530-015-1013-1; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Orellana D, 2016, INT ARCH PHOTOGRAMME; Parque Nacional Galapagos, 2014, PLAN MAN AR PROT GAL; Peck Stewart B., 1998, American Entomologist, V44, P218; Phillips RB, 2012, BIOL CONSERV, V147, P264, DOI 10.1016/j.biocon.2012.01.013; Pickering C, 2010, J SUSTAIN TOUR, V18, P239, DOI 10.1080/09669580903406613; Ramirez J, 2015, INFORME GALAPAGOS 20, P118; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Rosero O, 2015, OPTIMIZACION FLOTA E; Seebens H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14435; Segura Ronquillo SC, 2016, REV EMPRESARIAL ICE, V10, P56; SENPLADES, 2010, GAL AG BUEN VIV PROP, P1; Sharma Gyan P., 2010, S. Afr. j. sci., V106, P1; Snell HM, 1996, J BIOGEOGR, V23, P619, DOI 10.1111/j.1365-2699.1996.tb00022.x; Taylor J.E., 2006, ECOTOURISM EC GROWTH; Trueman M, 2010, BIOL INVASIONS, V12, P3949, DOI 10.1007/s10530-010-9822-8; Tye A, 2006, BIOL INVASIONS, V8, P201, DOI 10.1007/s10530-004-3574-2; Tye A., 2008, GALAPAGOS REPORT 200, P153; TYE A, 2002, BIODIVERSITY VISION, P12; UNESCO-IUCN. Gala A pagos Islands, 2007, GAL ISL EC REACT MON; van Kleunen M, 2015, NATURE, V525, P100, DOI 10.1038/nature14910; Mejia CV, 2015, ECOL ECON, V117, P1, DOI 10.1016/j.ecolecon.2015.05.014; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wikelski M, 2004, ECOL SOC, V9; World Tourism Organization, 2015, UNWTO ANN REP 2014; Zapata CE, 2008, GALAPAGOS REPORT 200, P60; Zapata-Erazo F, 2010, INFORME GALAPAGOS 20, P19	79	48	52	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184379	10.1371/journal.pone.0184379	http://dx.doi.org/10.1371/journal.pone.0184379			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902860	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200034
J	Vange, P; Bruland, T; Doseth, B; Fossmark, R; Sousa, MML; Beisvag, V; Sordal, O; Qvigstad, G; Waldum, HL; Sandvik, AK; Bakke, I				Vange, Pal; Bruland, Torunn; Doseth, Berit; Fossmark, Reidar; Sousa, Mirta M. L.; Beisvag, Vidar; Sordal, Oystein; Qvigstad, Gunnar; Waldum, Helge L.; Sandvik, Arne K.; Bakke, Ingunn			The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival	PLOS ONE			English	Article							POLYPEPTIDE-EXPRESSING METAPLASIA; BETA-SUBUNIT-DEFICIENT; PARIETAL-CELLS; PROGNOSTIC-SIGNIFICANCE; INTESTINAL METAPLASIA; ADENOCARCINOMA CELLS; HELICOBACTER-PYLORI; MONGOLIAN GERBILS; EPITHELIAL-CELLS; GENE-EXPRESSION	The cytoprotective protein clusterin is often dysregulated during tumorigenesis, and in the stomach, upregulation of clusterin marks emergence of the oxyntic atrophy (loss of acid-producing parietal cells)-associated spasmolytic polypeptide-expressing metaplasia (SPEM). The hormone gastrin is important for normal function and maturation of the gastric oxyntic mucosa and hypergastrinemia might be involved in gastric carcinogenesis. Gastrin induces expression of clusterin in adenocarcinoma cells. In the present study, we examined the expression patterns and gastrin-mediated regulation of clusterin in gastric tissue from: humans; rats treated with proton pump (H+/K+-ATPase) inhibitors and/or a gastrin receptor (CCK2R) antagonist; H+/K+-ATPase beta-subunit knockout (H/K-beta KO) mice; and Mongolian gerbils infected with Helicobacter pylori and given a CCK2R antagonist. Biological function of secretory clusterin was studied in human gastric cancer cells. Clusterin was highly expressed in neuroendocrine cells in normal oxyntic mucosa of humans and rodents. In response to hypergastrinemia, expression of clusterin increased significantly and its localization shifted to basal groups of proliferative cells in the mucous neck cell-chief cell lineage in all animal models. That shift was partially inhibited by antagonizing the CCK2R in rats and gerbils. The oxyntic mucosa of H/K-beta KO mice contained areas with clusterin-positive mucous cells resembling SPEM. In gastric adenocarcinomas, clusterin mRNA expression was higher in diffuse tumors containing signet ring cells compared with diffuse tumors without signet ring cells, and clusterin seemed to be secreted by tumor cells. In gastric cancer cell lines, gastrin increased secretion of clusterin, and both gastrin and secretory clusterin promoted survival after starvation-and chemotherapy-induced stress. Overall, our results indicate that clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and stimulates gastric cancer cell survival.	[Vange, Pal; Bruland, Torunn; Doseth, Berit; Fossmark, Reidar; Sousa, Mirta M. L.; Beisvag, Vidar; Sordal, Oystein; Qvigstad, Gunnar; Waldum, Helge L.; Sandvik, Arne K.; Bakke, Ingunn] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, NTNU, Trondheim, Norway; [Bruland, Torunn; Doseth, Berit; Bakke, Ingunn] St Olavs Univ Hosp, Med Clin, Trondheim, Norway; [Fossmark, Reidar; Sordal, Oystein; Qvigstad, Gunnar; Waldum, Helge L.; Sandvik, Arne K.] St Olavs Univ Hosp, Dept Gastroenterol & Hepatol, Trondheim, Norway; [Sandvik, Arne K.] NTNU, Ctr Mol Inflammat Res CEMIR, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Bakke, I (corresponding author), Norwegian Univ Sci & Technol, Dept Clin & Mol Med, NTNU, Trondheim, Norway.	ingunn.bakke@ntnu.no	Bluland, Torunn/AAT-5730-2021; Fossmark, Reidar/AAP-6442-2021; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022	Fossmark, Reidar/0000-0002-5365-9357; Bakke, Ingunn/0000-0003-0356-6184; Bruland, Torunn/0000-0002-1568-2476; Waldum, Helge/0000-0002-3137-0843	Liaison Committee; Faculty of Medicine and Health Sciences at NTNU; Cancer Fund at St. Olav's University Hospital, Trondheim, Norway; Familien Blix fond til fremme av medisinskforskning; Central Norway Regional Health Authority	Liaison Committee; Faculty of Medicine and Health Sciences at NTNU; Cancer Fund at St. Olav's University Hospital, Trondheim, Norway; Familien Blix fond til fremme av medisinskforskning; Central Norway Regional Health Authority	This work was supported by The Liaison Committee between the Central Norway Regional Health Authority and NTNU, Norwegian University of Science and Technology (https://innisida.ntnu. no/wiki/-/wiki/Norsk/Felles+forskningsutvalg+og +Felles+utdanningsutvalg+for+St.+Olavs+Hospital +og+Fakultet+for+medisin+og+helse), The Faculty of Medicine and Health Sciences at NTNU (http:// www.ntnu.edu/mh), The Cancer Fund at St. Olav's University Hospital, Trondheim, Norway (https:// stolav.no/en) and "Familien Blix fond til fremme av medisinskforskning". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Wahida Afroz, Anne Kristensen and Bjorn Munkvold for skillful technical assistance. We owe special gratitude to the medical students Kari Thune Uglane, Eline Buran Wesche and Magnus Grinna Normann for performing their Master theses in Medicine on topics related to this paper. Uglane and Normann contributed to in vitro experiments and Wesche to the examination of clusterin expression in oxyntic mucosa of H+/K+-ATPase beta-subunit knockout mice. We thank Dr. Steve Warrington for language editing the manuscript. We thank the animal unit Comparative Medicine Core facility (CMC), NTNU for assistance with animal models. The imaging analyses were performed in collaboration with Dr. Bjornar Sporsheim at Cellular & Molecular Imaging Core Facility (CMIC), NTNU. Proteomic analyses were performed in collaboration with Proteomics and Metabolomics Core Facility (PRO-MEC), NTNU and The Proteomics Unit at the University of Bergen (PROBE). The microarray and bioinformatics analysis were provided in collaboration with Arnar Flatberg and the Genomics Core Facility (GCF), NTNU. All core facilities (CMC, CMIC, PROMEC and GCF) at NTNU are funded by the Faculty of Medicine and Health Sciences at NTNU and the Central Norway Regional Health Authority.	Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; Alnasser HA, 2016, AM J PHYSIOL-RENAL, V310, pF160, DOI 10.1152/ajprenal.00304.2015; Andersen CL, 2007, MOL CELL PROTEOMICS, V6, P1039, DOI 10.1074/mcp.M600261-MCP200; Bakkelund KE, 2010, SCAND J GASTROENTERO, V45, P1042, DOI 10.3109/00365521.2010.490952; Bhandari S, 2016, BIOCHEM BIOPH RES CO, V475, P119, DOI 10.1016/j.bbrc.2016.05.052; Bi J, 2010, NEOPLASMA, V57, P191, DOI 10.4149/neo_2010_03_191; Bringeland EA, 2014, BRIT J SURG, V101, P1712, DOI 10.1002/bjs.9650; Burclaff J, 2017, GASTROENTEROLOGY, V152, P762, DOI 10.1053/j.gastro.2016.12.001; Burkitt MD, 2009, WORLD J GASTROENTERO, V15, P1, DOI 10.3748/wjg.15.1; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Choi E, 2014, GUT, V63, P1711, DOI 10.1136/gutjnl-2013-305964; CORREA P, 1975, LANCET, V2, P58; Correa P, 2012, J DIGEST DIS, V13, P2, DOI 10.1111/j.1751-2980.2011.00550.x; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Dimaline R, 2014, J PHYSIOL-LONDON, V592, P2951, DOI 10.1113/jphysiol.2014.272435; Fjeldbo CS, 2012, AM J PHYSIOL-GASTR L, V302, pG21, DOI 10.1152/ajpgi.00197.2011; Forster S, 2011, MODERN PATHOL, V24, P1390, DOI 10.1038/modpathol.2011.99; Fossmark R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/975479; Franic TV, 2005, J PATHOL, V207, P43, DOI 10.1002/path.1811; Franic TV, 2001, AM J PHYSIOL-GASTR L, V281, pG1502, DOI 10.1152/ajpgi.2001.281.6.G1502; Goldenring JR, 2011, EXP CELL RES, V317, P2759, DOI 10.1016/j.yexcr.2011.08.017; Goldenring JR, 2010, GASTROENTEROLOGY, V138, P2207, DOI 10.1053/j.gastro.2010.04.023; Gutacker C, 1999, BIOCHEM J, V339, P759, DOI 10.1042/0264-6021:3390759; Hayakawa Y, 2016, CURR OPIN PHARMACOL, V31, P31, DOI 10.1016/j.coph.2016.08.013; Hayakawa Y, 2015, GUT, V64, P544, DOI 10.1136/gutjnl-2014-307190; Henderson-Jackson EB, 2013, PANCREAS, V42, P967, DOI 10.1097/MPA.0b013e318293734b; Howlett M, 2009, GASTROENTEROLOGY, V136, P967, DOI 10.1053/j.gastro.2008.12.003; Humphries JM, 2014, BBA-PROTEINS PROTEOM, V1844, P1051, DOI 10.1016/j.bbapap.2014.01.018; Karam SM, 2003, STEM CELLS, V21, P322, DOI 10.1634/stemcells.21-3-322; KIM JP, 1994, SURG ONCOL, V3, P221, DOI 10.1016/0960-7404(94)90037-X; KLEVELAND PM, 1985, SCAND J GASTROENTERO, V20, P569, DOI 10.3109/00365528509089698; Lenferink AEG, 2010, ONCOGENE, V29, P831, DOI 10.1038/onc.2009.399; Lennerz JKM, 2010, AM J PATHOL, V177, P1514, DOI 10.2353/ajpath.2010.100328; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu WT, 2012, CLIN CHIM ACTA, V413, P1098, DOI 10.1016/j.cca.2012.03.003; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Mourra N, 2014, HISTOPATHOLOGY, V65, P642, DOI 10.1111/his.12450; Nam KT, 2010, GASTROENTEROLOGY, V139, P2028, DOI 10.1053/j.gastro.2010.09.005; Nomura S, 2005, AM J PHYSIOL-GASTR L, V288, pG362, DOI 10.1152/ajpgi.00160.2004; Norsett KG, 2011, AM J PHYSIOL-GASTR L, V301, pG446, DOI 10.1152/ajpgi.00527.2010; Nozaki K, 2008, GASTROENTEROLOGY, V134, P511, DOI 10.1053/j.gastro.2007.11.058; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Penno MAS, 2012, J PROTEOMICS, V77, P40, DOI 10.1016/j.jprot.2012.07.002; Rao SV, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3055-5; Rizzi F, 2010, ENDOCR-RELAT CANCER, V17, pR1, DOI 10.1677/ERC-09-0140; Rohne Philipp, 2016, BioMolecular Concepts, V7, P1, DOI 10.1515/bmc-2015-0026; Scarff KL, 1999, GASTROENTEROLOGY, V117, P605, DOI 10.1016/S0016-5085(99)70453-1; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seishima R, 2015, CANCER PREV RES, V8, P492, DOI 10.1158/1940-6207.CAPR-15-0025-T; Selvik LKM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-429; SOLCIA E, 1988, DIGESTION, V41, P185, DOI 10.1159/000199786; Sordal O, 2013, HELICOBACTER, V18, P397, DOI 10.1111/hel.12066; Taghavi S, 2012, J CLIN ONCOL, V30, P3493, DOI 10.1200/JCO.2012.42.6635; Takaishi S, 2005, GASTROENTEROLOGY, V128, P1965, DOI 10.1053/j.gastro.2005.03.027; Takaishi S, 2009, AM J PATHOL, V175, P365, DOI 10.2353/ajpath.2009.081165; Trougakos IP, 2013, GERONTOLOGY, V59, P514, DOI 10.1159/000351207; Trougakos IP, 2009, CLIN CANCER RES, V15, P48, DOI 10.1158/1078-0432.CCR-08-1805; Vange P, 2015, J PATHOL, V237, P447, DOI 10.1002/path.4591; Waldum HL, 2009, SCAND J GASTROENTERO, V44, P390, DOI 10.1080/00365520802624219; Watson SA, 2006, NAT REV CANCER, V6, P936, DOI 10.1038/nrc2014; Weis VG, 2014, AM J PHYSIOL-GASTR L, V307, pG777, DOI 10.1152/ajpgi.00169.2014; Weis VG, 2013, GUT, V62, P1270, DOI 10.1136/gutjnl-2012-302401; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yamaguchi H, 2002, DIGEST DIS SCI, V47, P573, DOI 10.1023/A:1017920220149; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yoo MW, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201600332; Yoshizawa N, 2007, LAB INVEST, V87, P1265, DOI 10.1038/labinvest.3700682; Zhang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6775; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291; Zhang M, 2010, J GASTROINTEST SURG, V14, P601, DOI 10.1007/s11605-009-1127-9; Zhang Y, 2017, HUM PATHOL, V63, P128, DOI 10.1016/j.humpath.2017.02.016; Zoubeidi A, 2012, INT J BIOCHEM CELL B, V44, P1646, DOI 10.1016/j.biocel.2012.04.010	72	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184514	10.1371/journal.pone.0184514	http://dx.doi.org/10.1371/journal.pone.0184514			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902909	gold, Green Submitted, Green Published			2022-12-27	WOS:000410669200042
J	Zhu, HB; Lemos, H; Bhatt, B; Islam, BN; Singh, A; Gurav, A; Huang, L; Browning, DD; Mellor, A; Fulzele, S; Singh, N				Zhu, Huabin; Lemos, Henrique; Bhatt, Brinda; Islam, Bianca N.; Singh, Abhijit; Gurav, Ashish; Huang, Lei; Browning, Darren D.; Mellor, Andrew; Fulzele, Sadanand; Singh, Nagendra			Carbidopa, a drug in use for management of Parkinson disease inhibits T cell activation and autoimmunity	PLOS ONE			English	Article								Carbidopa is a drug that blocks conversion of levodopa to dopamine outside of central nervous system (CNS) and thus inhibits unwanted side effects of levodopa on organs located outside of CNS during management of Parkinson's Disease (PD). PD is associated with increased expression of inflammatory genes in peripheral and central nervous system (CNS), infiltration of immune cells into brain, and increased numbers of activated/memory T cells. Animal models of PD have shown a critical role of T cells in inducing pathology in CNS. However, the effect of carbidopa on T cell responses in vivo is unknown. In this report, we show that carbidopa strongly inhibited T cell activation in vitro and in vivo. Accordingly, carbidopa mitigated myelin oligodendrocyte glycoprotein peptide fragment 35-55 (MOG35-55) induced experimental autoimmune encephalitis (EAE) and collagen induced arthritis in animal models. The data presented here suggest that in addition to blocking peripheral conversion of levodopa, carbidopa may inhibit T cell responses in PD individuals and implicate a potential therapeutic use of carbidopa in suppression of T cell mediated pathologies.	[Zhu, Huabin; Bhatt, Brinda; Islam, Bianca N.; Browning, Darren D.; Singh, Nagendra] Augusta Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Lemos, Henrique; Huang, Lei; Mellor, Andrew] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Singh, Abhijit] Augusta Univ, Dept Emergency Med, Med Coll Georgia, Augusta, GA USA; [Gurav, Ashish] Univ Penn, Sch Dent Med, Philadelphia, PA 19104 USA; [Fulzele, Sadanand] Augusta Univ, Dept Orthoped Surg, Med Coll Georgia, Augusta, GA USA	University System of Georgia; Augusta University; Newcastle University - UK; University System of Georgia; Augusta University; University of Pennsylvania; University System of Georgia; Augusta University	Singh, N (corresponding author), Augusta Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.	nasingh@augusta.edu	de Paula Lemos, Henrique/AAI-2698-2020	de Paula Lemos, Henrique/0000-0002-0539-3283; Browning, Darren/0000-0003-0497-7620; Zhu, Huabin/0000-0002-4557-795X	National Institutes of Health [R01DK103576]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health grant R01DK103576 to NS.	Baisakhi Saha ACM, 2001, NEUROIMMUNOMODULAT, V9, P11; Baisakhi Saha ACM, 2001, INT IMMUNOPHARMACOL, V1, P12; Barnes JGaNM, 2003, TRENDS IMMUNOL, V24, P6; Biswarup Basu CS, 2010, J BIOL CHEM, V285, P7; Christine S., 2016, AUTOIMMUNITY, V49, P14; Fahn S, 2008, MOVEMENT DISORD, V23, pS497, DOI 10.1002/mds.22028; FISZER U, 1994, ACTA NEUROL SCAND, V90, P160; George T., 2013, J PARKINSON DIS, V3, P12; Greengard LBaP, 2014, FRONT NEUROANAT, V8, P16; Henrique Lemos LH, 2014, J IMMUNOL, V192, P8; Ioanna Kokkinou EN, 2008, BLOOD CELL MOL DIS, V42, P7; Joans Bergquist AT, 1994, P NATL ACAD SCI USA, V91, P5; Jonathan Kipnis MC, 2004, J NEUROSCI, V2004, P11; Julie Rowin MT, 2012, MUSCLE NERVE, V46, P5; Kazuhisa Nakano TH, 2009, INT IMMUNOLOGY, V21, P10; Lars Brichta PG, 2013, TRENDS NEUROSCI, V36, P12; Lesch RMsaK-P, 1998, ROLE SEROTONIN IMMUN, V12, P23; Levite M., 2008, CURRENT OPINION PHAR, V8, P12; Lindstrom aJS, 1983, ENDOCRINOLOGY, V112, P6; LOVENBERG W, 1962, J BIOL CHEM, V237, P89; Marco Cosentino AMF, 2007, BLOOD, V109, P11; Matilde Leon-Ponte GPAaPJOC, 2007, BLOOD, V109, P9; Michal J., 2005, TNF J NEUROIMMUNOLOG, V169, P11; Musso SB, 1996, J CLIN ENDOCR METAB, V81, P5; Palash Bhattacharya IB, 2015, J INTERFERON CYTOKIN, V35, P15; Palash Bhattacharya MT, 2015, CYTOKINE, V75, P11; Peta J., 2006, BLOOD, V107, P9; Przedborski WDaS, 2003, NEURON, V39, P21; Regina Katzenschlager AJL, 2002, J NEUROL S2, V249, P7; Saunders JAH, 2012, J NEUROIMMUNE PHARM, V7, P927, DOI 10.1007/s11481-012-9402-z; Scott CL, 2011, TRENDS IMMUNOL, V32, P412, DOI 10.1016/j.it.2011.06.003; Shukkur M., 2014, J CELL MOL MED, V18, P7; Shukkur M., 2012, PLOS ONE, V7, P6; Shukkur M., 2013, CNS NEUROSCIENCE THE, V19, P8; Shukkur M, 2014, BRAIN BEHAV IMMUN, V42, P5; Stanley Fahn DO, 2004, NEW ENGL J MED, V351, P11; William R., 1986, CLIN EXPT PHARM PHYS, V13, P7; Yoshiko Watanabe TN, 2006, J IMMUNOL, V176, P10	38	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0183484	10.1371/journal.pone.0183484	http://dx.doi.org/10.1371/journal.pone.0183484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898256	Green Submitted, Green Published, gold			2022-12-27	WOS:000410449500006
J	Galle, R; Urak, I; Nikolett, GS; Hartel, T				Galle, Robert; Urak, Istvan; Nikolett, Galle-Szpisjak; Hartel, Tibor			Sparse trees and shrubs confers a high biodiversity to pastures: Case study on spiders from Transylvania	PLOS ONE			English	Article							WOOD-PASTURES; CONSERVATION VALUE; CARABID BEETLES; INDIVIDUAL-TREE; DIVERSITY; ARANEAE; COMMUNITIES; MANAGEMENT; SCARABAEIDAE; GEOTRUPIDAE	The integration of food production and biodiversity conservation represents a key challenge for sustainability. Several studies suggest that even small structural elements in the landscape can make a substantial contribution to the overall biodiversity value of the agricultural landscapes. Pastures can have high biodiversity potential. However, their intensive and monofunctional use typically erodes its natural capital, including biodiversity. Here we address the ecological value of fine scale structural elements represented by sparsely scattered trees and shrubs for the spider communities in a moderately intensively grazed pasture in Transylvania, Eastern Europe. The pasture was grazed with sheep, cattle and buffalo (ca 1 Livestock Unit ha(-1)) and no chemical fertilizers were applied. Sampling sites covered the open pasture as well as the existing fine-scale heterogeneity created by scattered trees and shrub. 40 sampling locations each being represented by three 1 m(2) quadrats were situated in a stratified design while assuring spatial independency of sampling locations. We identified 140 species of spiders, out of which 18 were red listed and four were new for the Romanian fauna. Spider species assemblages of open pasture, scattered trees, trees and shrubs and the forest edge were statistically distinct. Our study shows that sparsely scattered mature woody vegetation and shrubs substantially increases the ecological value of managed pastures. The structural complexity provided by scattered trees and shrubs makes possible the co-occurrence of high spider diversity with a moderately high intensity grazing possible in this wood-pasture. Our results are in line with recent empirical research showing that sparse trees and shrubs increases the biodiversity potential of pastures managed for commodity production.	[Galle, Robert; Nikolett, Galle-Szpisjak] Univ Szeged, Dept Ecol, Szeged, Hungary; [Urak, Istvan; Hartel, Tibor] Sapientia Hungarian Univ Transylvania, Dept Environm Sci, Ecosyst Serv Lab, Cluj Napoca, Romania; [Hartel, Tibor] Babes Bolyai Univ, Fac Biol, Dept Taxon & Ecol, Cluj Napoca, Romania	Szeged University; Sapientia Hungarian University of Transylvania; Babes Bolyai University from Cluj	Galle, R (corresponding author), Univ Szeged, Dept Ecol, Szeged, Hungary.	galle.robert@gmail.com	Tibor, Hartel/B-3440-2012; Urak, Istvan/AAE-3600-2019; Gallé, Róbert/L-9921-2018	Gallé, Róbert/0000-0002-5516-8623; Urak, Istvan/0000-0003-2130-5068	European Community's Seventh Framework Programme [613520]	European Community's Seventh Framework Programme(European Commission)	This work received support from European Community's Seventh Framework Programme under Grant Agreement No. 613520 (Project AGFORWARD, 2014-present), https://ec.europa.eu/research/fp7/index_en.cfm.r TH received funding from the European Community's Seventh Framework Programme under Grant Agreement No. 613520 (Project AGFORWARD, 2014-present).	Beaufoy G, 2015, BOOKL PROD WOOD PAST; Bergmeier E, 2010, BIODIVERS CONSERV, V19, P2995, DOI 10.1007/s10531-010-9872-3; Bonn A, RIVER RES APPL, P43; Cardoso Pedro, 2011, PLoS One, V6, pe21710, DOI 10.1371/journal.pone.0021710; Cattin MF, 2003, BIOL CONSERV, V113, P179, DOI 10.1016/S0006-3207(02)00297-5; Clarke K. R., 2001, CHANGES MARINE COMMU; Entling W, 2007, GLOBAL ECOL BIOGEOGR, V16, P440, DOI 10.1111/j.1466-8238.2006.00305.x; Falk S., 2014, EUROPEAN WOOD PASTUR, P132; Fischer J, 2014, CONSERV LETT, V7, P149, DOI 10.1111/conl.12084; Freese A, 2006, ANIM CONSERV, V9, P388, DOI 10.1111/j.1469-1795.2006.00045.x; Frick H, 2007, ANN ZOOL FENN, V44, P43; GALANTE E, 1995, ENVIRON ENTOMOL, V24, P1063, DOI 10.1093/ee/24.5.1063; GALANTE E, 1991, ENVIRON ENTOMOL, V20, P90, DOI 10.1093/ee/20.1.90; Galle R, 2009, COMMUNITY ECOL, V10, P146, DOI 10.1556/ComEc.10.2009.2.2; Galle R, 2015, BIOLOGIA, V70, P104, DOI 10.1515/biolog-2015-0011; Garcia-Tejero S, 2016, AGR ECOSYST ENVIRON, V233, P192, DOI 10.1016/j.agee.2016.09.004; Halada L, 2011, BIODIVERS CONSERV, V20, P2365, DOI 10.1007/s10531-011-9989-z; Hartel T., 2014, EUROPEAN WOOD PASTUR; Hartel T, 2015, EUROPE'S CHANGING WOODS AND FORESTS FROM WILDWOOD TO MANAGED LANDSCAPES, P61, DOI 10.1079/9781780643373.0061; Hartel T, 2014, BASIC APPL ECOL, V15, P385, DOI 10.1016/j.baae.2014.06.007; Heisler GM, 2003, AGR FOREST METEOROL, V120, P113, DOI 10.1016/j.agrformet.2003.08.024; Hothorn T., 2016, SIMULTANEOUS INFEREN; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Hsieh YL, 2011, BIODIVERS CONSERV, V20, P2953, DOI 10.1007/s10531-011-0158-1; Jakobsson S, 2017, J APPL ECOL; Kiebacher T, 2017, AGR ECOSYST ENVIRON, V239, P293, DOI 10.1016/j.agee.2017.01.034; Kosulic O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148585; Kosulic O, 2014, ECOL ENG, V68, P133, DOI 10.1016/j.ecoleng.2014.03.030; Lambeets K, 2008, BIODIVERS CONSERV, V17, P3133, DOI 10.1007/s10531-007-9313-0; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Lindenmayer DB, 2017, BIOL REV, V92, P1434, DOI 10.1111/brv.12290; Lindenmayer DB, 2017, BIOL CONSERV; Lindsay EA, 2009, FOREST ECOL MANAG, V258, P178, DOI 10.1016/j.foreco.2009.04.005; llerer O K, 2014, WOOD PASTURE MANAGEM, P219; Manning AD, 2006, BIOL CONSERV, V132, P311, DOI 10.1016/j.biocon.2006.04.023; Matveinen-Huju K, 2006, FOREST ECOL MANAG, V230, P119, DOI 10.1016/j.foreco.2006.04.025; Mcelhinny C, 2010, AUSTRAL ECOL, V35, P87, DOI 10.1111/j.1442-9993.2009.02016.x; Moreno G, 2016, AGROFOREST SYST, V90, P87, DOI 10.1007/s10457-015-9817-7; Moscaliuc LA, 2014, RED LIST SPIDERS ARA, P118; Muff P, 2009, INSECT CONSERV DIVER, V2, P36, DOI 10.1111/j.1752-4598.2008.00037.x; Muff Patrick, 2007, Arachnologische Mitteilungen, P16; Nemet E, 2016, COMMUNITY ECOL, V17, P79, DOI 10.1556/168.2016.17.1.10; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Oroszi S., 2004, FOREST MANAGEMENT TR, V63, P1; Paltto H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024675; Plieninger T, 2015, BIOL CONSERV, V190, P70, DOI 10.1016/j.biocon.2015.05.014; Ranius T, 2000, J INSECT CONSERV, V4, P23, DOI 10.1023/A:1009682722905; Reyes-Lopez J, 2003, ACTA OECOL, V24, P195, DOI 10.1016/S1146-609X(03)00086-9; Rezac M, 2015, BIOLOGIA, V70, P645, DOI 10.1515/biolog-2015-0079; Rossetti I, 2015, AGR ECOSYST ENVIRON, V202, P203, DOI 10.1016/j.agee.2015.01.008; Ruzicka V, 2002, CATALOGUE SPIDERS CZ; Savannas Mistry J., 2000, PROGR PHYS GEOGRAPHY, V24, P601; Sebek P, 2016, FOREST ECOL MANAG, V380, P172, DOI 10.1016/j.foreco.2016.08.052; Seibold S, 2016, J APPL ECOL, V53, P934, DOI 10.1111/1365-2664.12607; Taboada A, 2006, FOREST ECOL MANAG, V237, P436, DOI 10.1016/j.foreco.2006.09.077; Taboada A, 2006, ENTOMOL FENNICA, V17, P284; Torres-Vila LM, 2017, B ENTOMOL RES; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x	58	16	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183465	10.1371/journal.pone.0183465	http://dx.doi.org/10.1371/journal.pone.0183465			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886058	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100024
J	Gui, B; Hsieh, CL; Kantoff, PW; Kibel, AS; Jia, L				Gui, Bin; Hsieh, Chen-Lin; Kantoff, Philip W.; Kibel, Adam S.; Jia, Li			Androgen receptor-mediated downregulation of microRNA-221 and-222 in castration-resistant prostate cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; PROFILE ANALYSIS; BREAST-CANCER; CELL-LINES; MIR-221; EXPRESSION; PROGRESSION; CARCINOMA; PROLIFERATION; TRANSCRIPTION	MicroRNAs (miRNAs) play important roles in cancer formation and progression by suppressing the production of key functional proteins at the post-transcriptional level in a sequence-specific manner. While differential expression of miRNAs is widely observed in cancers including prostate cancer (PCa), how these miRNAs are transcriptionally regulated is largely unknown. MiRNA-221 and miRNA-222 (miR-221/-222) are well-established oncogenes and overexpressed in breast, liver, pancreas, and lung cancer, but their expression and biological functions in PCa remain controversial. Both up and down regulation have been observed in patient samples. Specifically, studies have demonstrated miR-221/-222 function as oncogenes, and promote PCa cell proliferation and the development of castration-resistant prostate cancer (CRPC). However, the expression level of miR-221/-222 is downregulated in several miRNA expression profiling studies. In this study, we demonstrate miR-221/-222 are androgen receptor (AR)-repressed genes and reside in a long primary transcript (pri-miRNA). Derepression of miR-221/-222 after androgen deprivation therapy (ADT) may enhance PCa cell proliferation potential through promoting G1/S phase transition. This function is likely transient but important in the development of CRPC. Downregulation of miR-221/-222 subsequently occurs once AR activity is restored through AR overexpression in CRPC. Our findings shed light on the complexity of transcriptional regulation of miRNAs in PCa and suggest context-dependent targeting of oncogenic miRNAs.	[Gui, Bin; Kibel, Adam S.; Jia, Li] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Div Urol, Boston, MA 02115 USA; [Hsieh, Chen-Lin] Harvard Med Sch, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA USA; [Kantoff, Philip W.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Jia, L (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Div Urol, Boston, MA 02115 USA.	ljia@bwh.harvard.edu		Kantoff, Philip/0000-0001-7275-0597	Anthony DiNovi Fund; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Anthony DiNovi Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Anthony DiNovi Fund.; This work was supported by Anthony DiNovi Fund. We thank Gerhard Coetzee, Peter Jones, Jeffrey Friedman, Dali Zheng, Zongtai Qi, Kathryn Jacobs, and Kaidi Wang for advice and technical assistance.	Agaoglu FY, 2011, TUMOR BIOL, V32, P583, DOI 10.1007/s13277-011-0154-9; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Bouvy-Liivrand M, 2017, NUCL ACIDS RES; Cai CM, 2011, CANCER CELL, V20, P457, DOI 10.1016/j.ccr.2011.09.001; Chen Y, 2011, CANCER PREV RES, V4, P76, DOI 10.1158/1940-6207.CAPR-10-0167; Coarfa C, 2015, ONCOGENE; Corey E, 2003, PROSTATE, V55, P239, DOI 10.1002/pros.10198; Decker KF, 2012, NUCLEIC ACIDS RES, V40, P10765, DOI 10.1093/nar/gks888; Di Leva G, 2010, JNCI-J NATL CANCER I, V102, P706, DOI 10.1093/jnci/djq102; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Fornari F, 2008, ONCOGENE, V27, P5651, DOI 10.1038/onc.2008.178; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; Galardi S, 2011, NUCLEIC ACIDS RES, V39, P3892, DOI 10.1093/nar/gkr006; Garofalo M, 2012, CURR MOL MED, V12, P27, DOI 10.2174/156652412798376170; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Goto Y, 2015, BRIT J CANCER, V113, P1055, DOI 10.1038/bjc.2015.300; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He HSHS, 2010, NAT GENET, V42, P343, DOI 10.1038/ng.545; Hinske LCG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-533; Jia L, 2006, MOL CELL BIOL, V26, P7331, DOI 10.1128/MCB.00581-06; Kawaguchi T, 2013, BRIT J CANCER, V108, P361, DOI 10.1038/bjc.2012.546; Kim J, 2003, NUCLEIC ACIDS RES, V31, P6741, DOI 10.1093/nar/gkg909; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kneitz B, 2014, CANCER RES, V74, P2591, DOI 10.1158/0008-5472.CAN-13-1606; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Shen J, 2012, PROSTATE, V72, P1469, DOI 10.1002/pros.22499; Song CJ, 2015, PROSTATE, V75, P500, DOI 10.1002/pros.22936; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Sun T, 2014, ONCOGENE, V33, P2790, DOI 10.1038/onc.2013.230; Sun T, 2012, PROSTATE, V72, P1093; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; THALMANN GN, 1994, CANCER RES, V54, P2577; Tilki D, 2016, EUR UROL FOCUS, V2, P499, DOI 10.1016/j.euf.2016.11.013; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Wang L, 2009, CANCER RES, V69, P9490, DOI 10.1158/0008-5472.CAN-09-2183; Zheng D, 2016, ONCOGENE, V35, P4807, DOI 10.1038/onc.2016.13; Zheng DL, 2013, MOL CANCER RES, V11, P482, DOI 10.1158/1541-7786.MCR-12-0520	43	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184166	10.1371/journal.pone.0184166	http://dx.doi.org/10.1371/journal.pone.0184166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886115	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100074
J	Liang, J; Shaulov, Y; Savage-Dunn, C; Boissinot, S; Hoque, T				Liang, Jun; Shaulov, Yakov; Savage-Dunn, Cathy; Boissinot, Stephane; Hoque, Tasmia			Chloride intracellular channel proteins respond to heat stress in Caenorhabditis elegans	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION SIGNAL; CRYSTAL-STRUCTURE; ION-CHANNEL; CLIC4; DROSOPHILA; CANCER; FAMILY; TRANSLOCATION; MORPHOGEN; HEDGEHOG	Chloride intracellular channel proteins (CLICs) are multi-functional proteins that are expressed in various cell types and differ in their subcellular location. Two CLIC homologs, EXL-1 (excretory canal abnormal like-1) and EXC-4 (excretory canal abnormal-4), are encoded in the Caenorhabditis elegans genome, providing an excellent model to study the functional diversification of CLIC proteins. EXC-4 functions in excretory canal formation during normal animal development. However, to date, the physiological function of EXL-1 remains largely unknown. In this study, we demonstrate that EXL-1 responds specifically to heat stress and translocates from the cytoplasm to the nucleus in intestinal cells and body wall muscle cells under heat shock. In contrast, we do not observe EXC-4 nuclear translocation under heat shock. Full protein sequence analysis shows that EXL-1 bears a non-classic nuclear localization signal (NLS) that EXC-4 is lacking. All mammalian CLIC members have a nuclear localization signal, with the exception of CLIC3. Our phylogenetic analysis of the CLIC gene families across various animal species demonstrates that the duplication of CLICs in protostomes and deuterostomes occurred independently and that the NLS was subsequently lost in amniotes and nematodes, suggesting convergent evolution. We also observe that EXL-1 nuclear translocation occurs in a timely ordered manner in the intestine, from posterior to anterior regions. Finally, we find that exl-1 loss of function mutants are more susceptible to heat stress than wild-type animals, demonstrating functional relevance of the nuclear translocation. This research provides the first link between CLICs and environmental heat stress. We propose that C. elegans CLICs evolved to achieve different physiological functions through subcellular localization change and spatial separation in response to external or internal signals.	[Liang, Jun; Hoque, Tasmia] CUNY, Dept Sci, Borough Manhattan Community Coll, New York, NY 10021 USA; [Shaulov, Yakov; Savage-Dunn, Cathy] CUNY, Dept Biol, Queens Coll, Flushing, NY USA; [Savage-Dunn, Cathy] Grad Ctr, Biol PhD Program, New York, NY USA; [Savage-Dunn, Cathy] Grad Ctr, Biochem PhD Program, New York, NY USA; [Boissinot, Stephane] New York Univ Abu Dhabi, Saadiyat Isl campus, Abu Dhabi, U Arab Emirates	City University of New York (CUNY) System; City University of New York (CUNY) System; Queens College NY (CUNY)	Liang, J (corresponding author), CUNY, Dept Sci, Borough Manhattan Community Coll, New York, NY 10021 USA.	Jliang@bmcc.cuny.edu		Boissinot, Stephane/0000-0002-8760-1284; Savage-Dunn, Cathy/0000-0002-3457-0509	National Institute of Health, National Institute on Aging [1 R03AG048578-01]; City University of New York (CUNY) [CIRG 1817]; PSC-CUNY [66184-00 44, 67248-00 45]; NIH Office of Research Infrastructure Program [P40OD010440]; NATIONAL INSTITUTE ON AGING [R03AG048578] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institute of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); City University of New York (CUNY); PSC-CUNY; NIH Office of Research Infrastructure Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by: National Institute of Health, National Institute on Aging, award number: 1 R03AG048578-01 to JL, https:// www.nia.nin gov/, The City University of New York (CUNY), award number: CIRG 1817 to C.S.D. and J.L., http://www2.cuny.edu/research; PSC-CUNY, award number: 66184-00 44 and 67248-00 45 to J.L., https://www.rfcuny.org/rfwebsite/research/.; C. elegans strains were obtained from the Caenorhabditis Genetics Center, which is supported by the NIH Office of Research Infrastructure Program (P40OD010440). We thank Dr. Iva Greenwald for providing gamma radiation resource for strain integration at Columbia University; we thank Dr. Mara Schvarzstein for providing DAPI staining protocol. We also thank undergraduate students Aijo De Castro and Moufoutahotou Mohamadou from BMCC to help with some experiments.	Aggarwal A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/476357; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Andersen EF, 2014, AM J MED GENET A, V164, P1795, DOI 10.1002/ajmg.a.36524; Ashley RH, 2003, MOL MEMBR BIOL, V20, P1, DOI 10.1080/09687680210042746; Bamps S, 2009, MECH AGEING DEV, V130, P762, DOI 10.1016/j.mad.2009.10.001; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Berry KL, 2006, J MOL BIOL, V359, P1316, DOI 10.1016/j.jmb.2006.04.046; Berry KL, 2003, SCIENCE, V302, P2134, DOI 10.1126/science.1087667; Bhandari P, 2012, GENES BRAIN BEHAV, V11, P387, DOI 10.1111/j.1601-183X.2012.00765.x; BRENNER S, 1974, GENETICS, V77, P71; Coburn C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001613; Dozynkiewicz MA, 2012, DEV CELL, V22, P131, DOI 10.1016/j.devcel.2011.11.008; Dulhunty A, 2001, J BIOL CHEM, V276, P3319, DOI 10.1074/jbc.M007874200; Fernandez-Salas E, 1999, J BIOL CHEM, V274, P36488, DOI 10.1074/jbc.274.51.36488; Foehr ML, 2006, DEVELOPMENT, V133, P2887, DOI 10.1242/dev.02476; He GA, 2011, EUR J IMMUNOL, V41, P1221, DOI 10.1002/eji.201041266; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Iwasa H, 2013, EXP CELL RES, V319, P931, DOI 10.1016/j.yexcr.2013.01.020; Knowles LM, 2013, MOL CANCER RES, V11, P194, DOI 10.1158/1541-7786.MCR-12-0300; Landis JN, 2010, DEV DYNAM, V239, P1405, DOI 10.1002/dvdy.22244; Lapierre LR, 2012, TRENDS ENDOCRIN MET, V23, P637, DOI 10.1016/j.tem.2012.07.007; Liang J, 2013, JOVE-J VIS EXP, DOI 10.3791/4373; Littler DR, 2010, PROTEINS, V78, P1594, DOI 10.1002/prot.22675; Macpherson IR, 2014, J CELL SCI, V127, P3893, DOI 10.1242/jcs.135947; Malik M, 2010, J BIOL CHEM, V285, P23818, DOI 10.1074/jbc.M109.091611; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mi W, 2008, PROTEINS, V71, P509, DOI 10.1002/prot.21922; Molina-Navarro MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079792; Murthi P, 2012, PLACENTA, V33, P741, DOI 10.1016/j.placenta.2012.06.011; Mynott AV, 2011, FEBS J, V278, P1662, DOI 10.1111/j.1742-4658.2011.08086.x; Nadeau SI, 2007, ADV EXP MED BIOL, V594, P100; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Panowski SH, 2009, TRENDS ENDOCRIN MET, V20, P259, DOI 10.1016/j.tem.2009.03.006; Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030; Shiio Y, 2006, J BIOL CHEM, V281, P2750, DOI 10.1074/jbc.M509349200; Shukla A, 2009, NAT CELL BIOL, V11, P777, DOI 10.1038/ncb1885; Singh H, 2007, MOL MEMBR BIOL, V24, P41, DOI 10.1080/09687860600927907; Strigini M, 1997, DEVELOPMENT, V124, P4697; Suh KS, 2012, CARCINOGENESIS, V33, P986, DOI 10.1093/carcin/bgs115; Suh KS, 2004, J BIOL CHEM, V279, P4632, DOI 10.1074/jbc.M311632200; Suh KS, 2007, MOL CARCINOGEN, V46, P599, DOI 10.1002/mc.20324; Suh KS, 2007, J CELL SCI, V120, P2631, DOI 10.1242/jcs.002741; Suh KS, 2007, CLIN CANCER RES, V13, P121, DOI 10.1158/1078-0432.CCR-06-1562; Takano K, 2012, HUM MOL GENET, V21, P4497, DOI 10.1093/hmg/dds292; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Ulmasov B, 2009, AM J PATHOL, V174, P1084, DOI 10.2353/ajpath.2009.080625; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Vervoort M, 2000, BIOESSAYS, V22, P460, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;460::AID-BIES8&gt;3.0.CO;2-G; Wirthmueller L, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00149; Zhong JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039378; Zou J, 2011, PLANT CELL REP, V30, P2155, DOI 10.1007/s00299-011-1122-y	52	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184308	10.1371/journal.pone.0184308	http://dx.doi.org/10.1371/journal.pone.0184308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886120	gold, Green Published			2022-12-27	WOS:000410001100095
J	Mathes, RW; Lall, R; Levin-Rector, A; Sell, J; Paladini, M; Konty, KJ; Olson, D; Weiss, D				Mathes, Robert W.; Lall, Ramona; Levin-Rector, Alison; Sell, Jessica; Paladini, Marc; Konty, Kevin J.; Olson, Don; Weiss, Don			Evaluating and implementing temporal, spatial, and spatio-temporal methods for outbreak detection in a local syndromic surveillance system	PLOS ONE			English	Article							NEW-YORK-CITY; DETECTION ALGORITHMS; CRITICAL-LOOK; BIOSURVEILLANCE; DISEASE; EARS	The New York City Department of Health and Mental Hygiene has operated an emergency department syndromic surveillance system since 2001, using temporal and spatial scan statistics run on a daily basis for cluster detection. Since the system was originally implemented, a number of new methods have been proposed for use in cluster detection. We evaluated six temporal and four spatial/spatio-temporal detection methods using syndromic surveillance data spiked with simulated injections. The algorithms were compared on several metrics, including sensitivity, specificity, positive predictive value, coherence, and timeliness. We also evaluated each method's implementation, programming time, run time, and the ease of use. Among the temporal methods, at a set specificity of 95%, a Holt-Winters exponential smoother performed the best, detecting 19% of the simulated injects across all shapes and sizes, followed by an autoregressive moving average model (16%), a generalized linear model (15%), a modified version of the Early Aberration Reporting System's C2 algorithm (13%), a temporal scan statistic (11%), and a cumulative sum control chart (< 2%). Of the spatial/spatio-temporal methods we tested, a spatial scan statistic detected 3% of all injects, a Bayes regression found 2%, and a generalized linear mixed model and a space-time permutation scan statistic detected none at a specificity of 95%. Positive predictive value was low (< 7%) for all methods. Overall, the detection methods we tested did not perform well in identifying the temporal and spatial clusters of cases in the inject dataset. The spatial scan statistic, our current method for spatial cluster detection, performed slightly better than the other tested methods across different inject magnitudes and types. Furthermore, we found the scan statistics, as applied in the SaTScan software package, to be the easiest to program and implement for daily data analysis.	[Mathes, Robert W.; Lall, Ramona; Levin-Rector, Alison; Sell, Jessica; Paladini, Marc; Konty, Kevin J.; Olson, Don; Weiss, Don] New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA	New York City Department of Health & Mental Hygiene	Mathes, RW (corresponding author), New York City Dept Hlth & Mental Hyg, New York, NY 10013 USA.	rmathes@health.nyc.gov	Levin-Rector, Alison/AAA-6756-2020	Olson, Donald/0000-0002-5980-229X	Alfred P. Sloan Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	The funder of this project is the Alfred P. Sloan Foundation (http://www.sloan.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SATSCAN V9 3 SOFTWAR; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Bregman B, 2012, PUBLIC HEALTH REP, V127, P195, DOI 10.1177/003335491212700208; Burkom HS, 2007, STAT MED, V26, P4202, DOI 10.1002/sim.2835; Corberan-Vallet A, 2011, STAT MED, V30, P3095, DOI 10.1002/sim.4340; Correa TR, 2015, STAT MED, V34, P1081, DOI 10.1002/sim.6400; Fricker RD, 2008, STAT MED, V27, P3407, DOI 10.1002/sim.3197; Fricker RD, 2011, STAT MED, V30, P403, DOI 10.1002/sim.3880; Griffin BA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-483; Groenewold MR, 2007, PUBLIC HEALTH REP, V122, P521, DOI 10.1177/003335490712200414; Hadler JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011677; Hagen K.S., 2011, STAT POLITICS POLICY, V2; Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646; Heffernan Richard, 2004, MMWR Suppl, V53, P23; Hutwagner L, 2005, EMERG INFECT DIS, V11, P314, DOI 10.3201/eid1102.040587; Hutwagner L, 2003, J URBAN HEALTH, V80, pI89; Ito K, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0057-0; Jones JH, 2008, STANF SPRING WORKSH; Kleinman K, 2004, AM J EPIDEMIOL, V159, P217, DOI 10.1093/aje/kwh029; Kotzen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130468; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2015, STAT MED, V34, P1094, DOI 10.1002/sim.6430; Lawson AB, 2005, SPATIAL AND SYNDROMIC SURVEILLANCE FOR PUBLIC HEALTH, P1, DOI 10.1002/0470092505; Murphy SP, 2008, J AM MED INFORM ASSN, V15, P77, DOI 10.1197/jamia.M2587; Neill DB, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-20; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Reis Ben Y, 2003, BMC Med Inform Decis Mak, V3, P2, DOI 10.1186/1472-6947-3-2; Seil K, 2016, DISASTER MED PUBLIC, P1; Tokars JI, 2009, EMERG INFECT DIS, V15, P533, DOI 10.3201/eid1504.080616; Unkel S, 2012, J ROYAL STAT SOC A, V175, P1; Watkins RE, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-37; Westheimer E, 2012, PLOS CURR, V4	34	16	17	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184419	10.1371/journal.pone.0184419	http://dx.doi.org/10.1371/journal.pone.0184419			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886112	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100115
J	Tan, SH; Nusse, R				Tan, Si Hui; Nusse, Roel			In vivo lineage tracing reveals Axin2-expressing, long-lived cortical thymic epithelial progenitors in the postnatal thymus	PLOS ONE			English	Article							MEDULLARY EPITHELIUM; BETA-CATENIN; ADULT THYMUS; CELLS; DIFFERENTIATION; IDENTIFICATION; ORGANOGENESIS; TRANSCRIPTION; POPULATION	In the thymus, cortical and medullary thymic epithelial cells (TECs) are instrumental for generating a repertoire of functional T cells. Hence, there has been much interest in the ontogeny of TECs. While medullary TEC (mTEC) and bipotent progenitors have been identified, the existence of a cortical TEC (cTEC) progenitor remains ambiguous. In this study, we used lineage tracing based on a target gene of the Wnt pathway, Axin2. We found that Axin2 initially labels cells in both the cortical and medullary compartments. Using Axin2CreERT2 mice to track the fate of labelled cells, we identified long-lived cortical TEC progenitors that give rise to expanding clones and contribute to homeostasis in postnatal thymus. In contrast, no clonal expansion was found in the medullary or in the K5K8-double positive compartments. The identification of cTEC progenitors and their regulation by Wnt signaling have important implications for our understanding of thymus physiology during homeostasis and TEC-related disorders.	[Tan, Si Hui] Stanford Univ, Sch Med, Program Canc Biol, Stanford, CA USA; [Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Sch Med, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Nusse, R (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA.	rnusse@stanford.edu		Tan, Si Hui/0000-0002-0809-0085	National Science Scholarship from A*STAR, Singapore	National Science Scholarship from A*STAR, Singapore	S.T. was supported by a National Science Scholarship from A*STAR, Singapore.	Balciunaite G, 2002, NATURE; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001; Bredenkamp N, 2014, NAT CELL BIOL, V16, P902, DOI 10.1038/ncb3023; Bredenkamp N, 2014, DEVELOPMENT, V141, P1627, DOI 10.1242/dev.103614; Brunk F, 2015, J IMMUNOLOGY; Ge Q, 2013, DEV COMP IMMUNOL, V39, P85, DOI 10.1016/j.dci.2012.01.002; Gill J, 2002, NAT IMMUNOL, V3, P635, DOI 10.1038/ni812; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Hamazaki Y, 2015, EUR J IMMUNOL, V45, P2985, DOI 10.1002/eji.201545844; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Liang CC, 2013, IMMUNOL CELL BIOL, V91, P511, DOI 10.1038/icb.2013.34; Lustig B, 2002, CELLULAR BIOL; Mayer CE, 2016, EUR J IMMUNOL, V46, P846, DOI 10.1002/eji.201545995; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ohigashi I, 2015, CELL REP, V13, P1432, DOI 10.1016/j.celrep.2015.10.012; Onder L, 2015, EUR J IMMUNOL, V45, P2218, DOI 10.1002/eji.201545677; Pongracz J, 2003, EUR J IMMUNOL, V33, P1949, DOI 10.1002/eji.200323564; Rodewald HR, 2008, ANNU REV IMMUNOL, V26, P355, DOI 10.1146/annurev.immunol.26.021607.090408; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; Staal FJT, 2003, CURR OPIN IMMUNOL, V15, P204, DOI 10.1016/S0952-7915(03)00003-7; Sun L, 2014, BIOMED RES INT, V2014; Takahama Y., 2006, NAT REV IMMUNOL; Ulyanchenko S, 2016, CELL REP, V14, P2819, DOI 10.1016/j.celrep.2016.02.080; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Wong K, 2014, CELL REP, V8, P1198, DOI 10.1016/j.celrep.2014.07.029; Zuklys S, 2009, J IMMUNOL, V182, P2997, DOI 10.4049/jimmunol.0713723	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184582	10.1371/journal.pone.0184582	http://dx.doi.org/10.1371/journal.pone.0184582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886197	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100162
J	Alberts, CC; Saranholi, BH; Frei, F; Galetti, PM				Alberts, Carlos C.; Saranholi, Bruno H.; Frei, Fernando; Galetti, Pedro M., Jr.			Comparing hair-morphology and molecular methods to identify fecal samples from Neotropical felids	PLOS ONE			English	Article							OCELOTS LEOPARDUS-PARDALIS; PUMAS PUMA-CONCOLOR; JAGUARS PANTHERA-ONCA; GUARD-HAIRS; SPECIES IDENTIFICATION; BRAZILIAN FELIDS; POPULATION-SIZE; DNA; HYBRIDIZATION; CARNIVORES	To avoid certain problems encountered with more-traditional and invasive methods in behavioral-ecology studies of mammalian predators, such as felids, molecular approaches have been employed to identify feces found in the field. However, this method requires a complete molecular biology laboratory, and usually also requires very fresh fecal samples to avoid DNA degradation. Both conditions are normally absent in the field. To address these difficulties, identification based on morphological characters (length, color, banding, scales and medullar patterns) of hairs found in feces could be employed as an alternative. In this study we constructed a morphological identification key for guard hairs of eight Neotropical felids (jaguar, oncilla, Geoffroy's cat, margay, ocelot, Pampas cat, puma and jaguarundi) and compared its efficiency to that of a molecular identification method, using the ATP6 region as a marker. For this molecular approach, we simulated some field conditions by postponing sample-conservation procedures. A blind test of the identification key obtained a nearly 70% overall success rate, which we considered equivalent to or better than the results of some molecular methods (probably due to DNA degradation) found in other studies. The jaguar, puma and jaguarundi could be unequivocally discriminated from any other Neotropical felid. On a scale ranging from inadequate to excellent, the key proved poor only for the margay, with only 30% of its hairs successfully identified using this key; and have intermediate success rates for the remaining species, the oncilla, Geoffroy's cat, ocelot and Pampas cat, were intermediate. Complementary information about the known distributions of felid populations may be necessary to substantially improve the results obtained with the key. Our own molecular results were even better, since all blind-tested samples were correctly identified. Part of these identifications were made from samples kept in suboptimal conditions, with some samples remaining outdoors for up to seven days, simulating conditions in the field. It appears that both methods can be used, depending on the available laboratory facilities and on the expected results.	[Alberts, Carlos C.] Univ Estadual Paulista, Fac Ciencias & Letras Assis, LEvEtho Lab Evolut & Ethol, Assis, SP, Brazil; [Saranholi, Bruno H.; Galetti, Pedro M., Jr.] Univ Fed Sao Carlos, Dept Genet & Evolucao, LabBMC Lab Biodiversidade Mol & Conservacao, Sao Carlos, SP, Brazil; [Frei, Fernando] Univ Estadual Paulista, Fac Ciencias & Letras Assis, LEA, Assis, SP, Brazil	Universidade Estadual Paulista; Universidade Federal de Sao Carlos; Universidade Estadual Paulista	Alberts, CC (corresponding author), Univ Estadual Paulista, Fac Ciencias & Letras Assis, LEvEtho Lab Evolut & Ethol, Assis, SP, Brazil.	calberts@assis.unesp.br	SARANHOLI, BRUNO HENRIQUE/AAK-2395-2020; Alberts, Carlos C/K-6883-2012; Galetti, Pedro M/ABC-1005-2020	SARANHOLI, BRUNO HENRIQUE/0000-0002-8221-3557; Alberts, Carlos C/0000-0001-6656-2207; Galetti, Pedro M/0000-0001-5916-6126	 [Fpaesp 04/08187-3];  [Fapesp 2013/24453-4];  [CNPq 308385/2014-4]	; ; 	The morphological aspects of this study were supported by a grant (Fpaesp 04/08187-3) while the molecular features of it were supported by two grants (Fapesp 2013/24453-4 and CNPq 308385/2014-4). The funders had no role in study design, data collection and analysis, or decision to publish this work.	Alberts CC, 2010, GENET MOL RES, V9, P2429, DOI 10.4238/vol9-4gmr1027; BUSCH M, 1986, Physis Seccion C los Continentes y los Organismos Terrestres, V44, P113; Chakraborty R, 1999, MAMMALIA, V63, P93, DOI 10.1515/mamm.1999.63.1.93; Chakraborty R, 1996, MAMMALIA, V60, P473; Chapron G, 2008, J APPL ECOL, V45, P1667, DOI 10.1111/j.1365-2664.2008.01538.x; Chaves PB, 2012, MOL ECOL RESOUR, V12, P18, DOI 10.1111/j.1755-0998.2011.03056.x; Chernova OF, 2003, BIOL BULL+, V30, P53, DOI 10.1023/A:1022067527584; Davison A, 2002, J ZOOL, V257, P141, DOI 10.1017/S0952836902000730; De Barba M, 2014, CONSERV GENET RESOUR, V6, P821, DOI 10.1007/s12686-014-0257-x; de Oliveira TG, 2014, J MAMM EVOL, V21, P427, DOI 10.1007/s10914-013-9251-4; FAGEN RM, 1978, CARNIVORE, V1, P72; Farrell LE, 2000, MOL ECOL, V9, P1583, DOI 10.1046/j.1365-294x.2000.01037.x; Felix G. A., 2014, Archivos de Zootecnia, V63, P107; Galvez N, 2013, ORYX, V47, P251, DOI 10.1017/S0030605312000099; Harmsen BJ, 2009, J MAMMAL, V90, P612, DOI 10.1644/08-MAMM-A-140R.1; Harrison RL, 2002, WILDLIFE SOC B, V30, P412; HILTON H, 1978, AM MIDL NAT, V100, P223, DOI 10.2307/2424793; Ingberman Bianca, 2006, Arquivos do Museu Nacional Rio de Janeiro, V64, P61; Japyassu HF, 2006, BEHAV RES METHODS, V38, P549, DOI 10.3758/BF03193884; Johnson WE, 1999, MOL ECOL, V8, pS79, DOI 10.1046/j.1365-294X.1999.00796.x; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; KEOGH HJ, 1983, S AFR J WILDL RES, V13, P89; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kohn MH, 1997, TRENDS ECOL EVOL, V12, P223, DOI 10.1016/S0169-5347(97)01050-1; Leyhausen P., 1963, Zeitschrift fuer Tierpsychologie, V20, P627; Lonsinger RC, 2015, MOL ECOL RESOUR, V15, P831, DOI 10.1111/1755-0998.12356; Luca J.R., 2005, MONOGRAPH; Malange J, 2013, BEHAVIOUR, V150, P1295, DOI 10.1163/1568539X-00003096; Martin Paula Sanches, 2009, Biota Neotropica, V9, P233; Martins IA, 2005, THESIS; Miotto RA, 2014, ORYX, V48, P250, DOI 10.1017/S0030605312000841; Miotto RA, 2007, BIOTROPICA, V39, P647, DOI 10.1111/j.1744-7429.2007.00315.x; Moreno RS, 2006, J MAMMAL, V87, P808, DOI 10.1644/05-MAMM-A-360R2.1; Murphy MA, 2002, CONSERV GENET, V3, P435, DOI 10.1023/A:1020503330767; Nagy-Reis MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168441; Oliveira T., 1995, NEOTROPICAL CATS ECO; PERRIN MR, 1980, S AFR J WILDL RES, V10, P1; Quadros J, 1998, J ZOOL, V244, P331, DOI 10.1111/j.1469-7998.1998.tb00037.x; Quadros J, 2006, REV BRAS ZOOL, V23, P279, DOI 10.1590/S0101-81752006000100023; Ramon-Laca A, 2015, WILDLIFE BIOL, V21, P195, DOI 10.2981/wlb.00096; Rinaldi AR, 2015, ZOOLOGIA-CURITIBA, V32, P77, DOI 10.1590/S1984-46702015000100012; Rodgers TW, 2015, MAMM BIOL, V80, P380, DOI 10.1016/j.mambio.2015.05.004; Rodgers TW, 2014, TROP CONSERV SCI, V7, P690, DOI 10.1177/194008291400700408; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; STAINS HOWARD J., 1958, JOUR WILDLIFE MANAGEMENT, V22, P95, DOI 10.2307/3797306; Tende T, 2014, CURR ZOOL, V60, P351, DOI 10.1093/czoolo/60.3.351; Vanstreels RET, 2010, BIOTA NEOTROP, V10, P333, DOI 10.1590/S1676-06032010000100029; THOMPSON ID, 1987, CAN FIELD NAT, V101, P614; Trigo TC, 2008, MOL ECOL, V17, P4317, DOI 10.1111/j.1365-294X.2008.03919.x; Trigo TC, 2013, CURR BIOL, V23, P2528, DOI 10.1016/j.cub.2013.10.046; Villalba M. Lilian, 2012, Endangered Species Research, V16, P85, DOI 10.3354/esr00389; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; WALLIS RL, 1993, CAN J ZOOL, V71, P587, DOI 10.1139/z93-080; Wang E, 2002, STUD NEOTROP FAUNA E, V37, P207, DOI 10.1076/snfe.37.3.207.8564; Woodruff SP, 2015, MOL ECOL RESOUR, V15, P843, DOI 10.1111/1755-0998.12362; Wultsch C., 2016, PLOS ONE, V11; Wultsch C, 2015, WILDLIFE SOC B, V39, P403, DOI 10.1002/wsb.540; Wultsch C, 2014, MOL ECOL RESOUR, V14, P1171, DOI 10.1111/1755-0998.12266; Zhang B.-W., 2006, BIOCH GENET, V44, P494, DOI DOI 10.1007/S10528-006-9050-1	62	9	9	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184073	10.1371/journal.pone.0184073	http://dx.doi.org/10.1371/journal.pone.0184073			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880947	gold, Green Published, Green Submitted			2022-12-27	WOS:000409467200033
J	Stenbaek, DS; Dam, VH; Fisher, PM; Hansen, N; Hjordt, LV; Frokjaer, VG				Stenbaek, Dea Siggaard; Dam, Vibeke Hoyrup; Fisher, Patrick MacDonald; Hansen, Nanna; Hjordt, Liv Vadskjaer; Frokjaer, Vibe Gedsoe			No evidence for a role of the serotonin 4 receptor in five-factor personality traits: A positron emission tomography brain study	PLOS ONE			English	Article							IN-VIVO; POLYMORPHISM 5-HTTLPR; 5-HT1A RECEPTORS; HEALTHY-SUBJECTS; TRANSPORTER AVAILABILITY; MAJOR DEPRESSION; BINDING; PET; ANXIETY; METAANALYSIS	Serotonin (5-HT) brain architecture appears to be implicated in normal personality traits as supported by genetic associations and studies using molecular brain imaging. However, so far, no studies have addressed potential contributions to variation in normal personality traits from in vivo serotonin 4 receptor (5-HT4R) brain availability, which has recently become possible to image with Positron Emission Tomography (PET). This is particularly relevant since availability of 5-HT4R has been shown to adapt to synaptic levels of 5-HT and thus offers information about serotonergic tone in the healthy brain. In 69 healthy participants (18 females), the associations between personality traits assessed with the five-factor NEO Personality Inventory-Revised (NEO PI-R) and regional cerebral 5-HT4R binding in neocortex, amygdala, hippocampus, and anterior cingulate cortex (ACC) were investigated using linear regression models. The associations between each of the five personality traits and a latent variable construct of global 5-HT4R levels were also evaluated using latent variable structural equation models. We found no significant associations between the five NEO personality traits and regional 5-HT4R binding (all p-values >.17) or the latent construct of global 5-HT4R levels (all p-values >.37). Our findings indicate that NEO personality traits and 5-HT4R are not related in healthy participants. Under the assumption that global 5-HT4R levels index 5-HT tone, our data also suggest that 5-HT tone per se is not directly implicated in normal personality traits.	[Stenbaek, Dea Siggaard; Dam, Vibeke Hoyrup; Fisher, Patrick MacDonald; Hansen, Nanna; Hjordt, Liv Vadskjaer; Frokjaer, Vibe Gedsoe] Copenhagen Univ Hosp, Rigshosp, Neurosci Ctr, Neurobiol Res Unit, Copenhagen, Denmark; [Stenbaek, Dea Siggaard; Dam, Vibeke Hoyrup; Fisher, Patrick MacDonald; Hjordt, Liv Vadskjaer; Frokjaer, Vibe Gedsoe] Copenhagen Univ Hosp, Rigshosp, Ctr Integrated Mol Brain Imaging, Copenhagen, Denmark; [Stenbaek, Dea Siggaard; Dam, Vibeke Hoyrup; Fisher, Patrick MacDonald; Hjordt, Liv Vadskjaer; Frokjaer, Vibe Gedsoe] Copenhagen Univ Hosp, Rigshosp, Ctr Expt Med Neuropharmacol, Copenhagen, Denmark; [Hjordt, Liv Vadskjaer] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen	Stenbaek, DS (corresponding author), Copenhagen Univ Hosp, Rigshosp, Neurosci Ctr, Neurobiol Res Unit, Copenhagen, Denmark.; Stenbaek, DS (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Integrated Mol Brain Imaging, Copenhagen, Denmark.; Stenbaek, DS (corresponding author), Copenhagen Univ Hosp, Rigshosp, Ctr Expt Med Neuropharmacol, Copenhagen, Denmark.	dea@nru.dk	Fisher, Patrick MacDonald/V-8158-2017; Frøkjær, Vibe Gedsø/N-8955-2019	Fisher, Patrick MacDonald/0000-0002-8115-0611; Frøkjær, Vibe Gedsø/0000-0002-9321-2365; Stenbaek, Dea/0000-0002-5439-4637	Danish Council for Independent Research [271-07-0651]; Lundbeck Foundation [R90-A7722]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Lundbeck Foundation(Lundbeckfonden)	The database study was supported by The Danish Council for Independent Research (grant number 271-07-0651, http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research) and The Lundbeck Foundation (grant number R90-A7722, http://www.lundbeckfonden.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Borg J, 2003, AM J PSYCHIAT, V160, P1965, DOI 10.1176/appi.ajp.160.11.1965; Carver CS, 2006, PSYCHIAT RES, V144, P1, DOI 10.1016/j.psychres.2006.03.013; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Costa J. P. T., 2005, PERSONALITY ADULTHOO; da Cunha-Bang S, 2016, SOC COGN AFFECT NEUR, V11, P548, DOI 10.1093/scan/nsv140; Deyoung CG, 2010, PERSONALITY NEUROSCI, P1165; Domino G., 2006, PSYCHOL TESTING INTR, V2nd ed; Elliott R, 2002, ARCH GEN PSYCHIAT, V59, P597, DOI 10.1001/archpsyc.59.7.597; Fisher PM, 2015, HUM BRAIN MAPP, V36, P313, DOI 10.1002/hbm.22630; Fisher PM, 2015, NEUROPSYCHOPHARMACOL, V40, P1510, DOI 10.1038/npp.2014.339; Frokjaer VG, 2008, BIOL PSYCHIAT, V63, P569, DOI 10.1016/j.biopsych.2007.07.009; Frokjaer VG, 2010, NEUROPSYCHOPHARMACOL, V35, P1129, DOI 10.1038/npp.2009.218; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Geldenhuys WJ, 2011, CNS DRUGS, V25, P765, DOI 10.2165/11590190-000000000-00000; Gerretsen P, 2010, SOC NEUROSCI-UK, V5, P375, DOI 10.1080/17470911003589309; Haahr ME, 2014, MOL PSYCHIATR, V19, P427, DOI 10.1038/mp.2013.147; Haahr ME, 2012, HUMAN BRAIN MAPPING; Hirvonen J, 2015, PSYCHIAT RES-NEUROIM, V234, P1, DOI 10.1016/j.pscychresns.2015.04.007; Holst KK, 2013, COMPUTATION STAT, V28, P1385, DOI 10.1007/s00180-012-0344-y; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jans LAW, 2007, MOL PSYCHIATR, V12, P522, DOI 10.1038/sj.mp.4001920; Jones SE, 2011, J CRIM JUST, V39, P329, DOI 10.1016/j.jcrimjus.2011.03.004; Kalbitzer J, 2009, NEUROIMAGE, V45, P280, DOI 10.1016/j.neuroimage.2008.12.001; Karlsson H, 2011, MOL PSYCHIATR, V16, P282, DOI 10.1038/mp.2009.126; Kendler KS, 2010, PSYCHOL MED, V40, P801, DOI 10.1017/S0033291709991140; Kim JH, 2015, BRAIN RES, V1629, P63, DOI 10.1016/j.brainres.2015.10.006; Knudsen GM, 2016, NEUROIMAGE, V124, P1213, DOI 10.1016/j.neuroimage.2015.04.025; Kotov R, 2010, PSYCHOL BULL, V136, P768, DOI 10.1037/a0020327; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lehto K, 2015, PROG NEURO-PSYCHOPH, V57, P31, DOI 10.1016/j.pnpbp.2014.10.005; Licht CL, 2009, J NEUROCHEM, V109, P1363, DOI 10.1111/j.1471-4159.2009.06050.x; Lo MT, 2017, NAT GENET, V49, P152, DOI 10.1038/ng.3736; Madsen K, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu034; Madsen K, 2011, J CEREBR BLOOD F MET, V31, P1475, DOI 10.1038/jcbfm.2011.11; Madsen MK, 2016, SOC COGN AFFECT NEUR, V11, P140, DOI 10.1093/scan/nsv098; Malouff JM, 2005, J PSYCHOPATHOL BEHAV, V27, P101, DOI 10.1007/s10862-005-5384-y; Marner L, 2010, NEUROIMAGE, V50, P855, DOI 10.1016/j.neuroimage.2010.01.054; Marner L, 2009, J NUCL MED, V50, P900, DOI 10.2967/jnumed.108.058552; Middeldorp CM, 2007, BEHAV GENET, V37, P294, DOI 10.1007/s10519-006-9139-7; Moresco FM, 2002, NEUROIMAGE, V17, P1470, DOI 10.1006/nimg.2002.1239; Muller PC, 2010, HDB BEHAV NEUROBIOLO; Munafo MR, 2009, AM J MED GENET B, V150B, P271, DOI 10.1002/ajmg.b.30808; Nielsen K, 2006, SYNAPSE, V59, P270, DOI 10.1002/syn.20240; Olesen OV, 2009, NUCL SCI S NSS MIC; Pinborg LH, 2008, NEUROIMAGE, V40, P1175, DOI 10.1016/j.neuroimage.2007.09.019; Plieger T, 2014, INT J NEUROPSYCHOPH, V17, P851, DOI 10.1017/S1461145713001776; Rabiner EA, 2002, NEUROIMAGE, V15, P620, DOI 10.1006/nimg.2001.0984; Reimold M, 2008, MOL PSYCHIATR, V13, P606, DOI 10.1038/sj.mp.4002149; Selvaraj S, 2014, NEUROSCI BIOBEHAV R, V45, P233, DOI 10.1016/j.neubiorev.2014.06.005; Sen S, 2004, AM J MED GENET B, V127B, P85, DOI 10.1002/ajmg.b.20158; Skovdahl H. H., 2011, NEO PI R MANUAL KLIN; Soloff PH, 2010, PSYCHIAT RES-NEUROIM, V181, P77, DOI 10.1016/j.pscychresns.2009.08.007; Stenbaek DS, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.674; Svarer C, 2005, NEUROIMAGE, V24, P969, DOI 10.1016/j.neuroimage.2004.10.017; Takano A, 2007, BIOL PSYCHIAT, V62, P588, DOI 10.1016/j.biopsych.2006.11.007; Tauscher J, 2001, AM J PSYCHIAT, V158, P1326, DOI 10.1176/appi.ajp.158.8.1326; Tuominen L, 2013, PSYCHOL MED, V43, P881, DOI 10.1017/S003329171200164X; Vidal R, 2009, J NEUROCHEM, V110, P1120, DOI 10.1111/j.1471-4159.2009.06210.x	59	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184403	10.1371/journal.pone.0184403	http://dx.doi.org/10.1371/journal.pone.0184403			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880910	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200066
J	Gomez-Moreno, AZ; Pineda-Tenor, D; Jimenez-Sousa, MA; Sanchez-Ruano, JJ; Artaza-Varasa, T; Saura-Montalban, J; Ryan, P; Resino, S				Zaida Gomez-Moreno, Ana; Pineda-Tenor, Daniel; Angeles Jimenez-Sousa, Maria; Jose Sanchez-Ruano, Juan; Artaza-Varasa, Tomas; Saura-Montalban, Jose; Ryan, Pablo; Resino, Salvador			Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: A retrospective study	PLOS ONE			English	Article							VENOUS-PRESSURE GRADIENT; TRANSIENT ELASTOGRAPHY FIBROSCAN; HEPATOCELLULAR-CARCINOMA; PORTAL-HYPERTENSION; CLINICAL-PRACTICE; INITIAL TREATMENT; CIRRHOSIS; INTERFERON-ALPHA-2B; COMPLICATIONS; RIBAVIRIN	The management of patients with chronic hepatitis C (CHC) depends on their clinical stage. Thus, noninvasive early recognition of patients with CHC at high risk for developing liver-related events (LREs) is important because it ensures optimal preventative management strategies may be employed that can affect the course of CHC disease. Our aim was to determine whether liver stiffness measurement (LSM) in hepatitis C virus (HCV)-infected patients is associated with a risk of LREs, particularly in cirrhotic patients. We carried out a retrospective study on 343 HCV-infected patients stratified according to cirrhosis (LSM<12.5 kPa vs. LSM >= 12.5 kPa), and the cirrhotic patient group (LSM >= 12.5 kPa) was divided according to risk of esophageal varices (LSM < 25 kPa vs. LSM >= 25 kPa). For all patients, each incremental unit in the natural logarithm (Ln) of LSM was associated with 14.76 times higher risk of developing LREs (p<0.001). Patients with cirrhosis (LSM >= 12.5 kPa) had a higher risk of LREs than patients without cirrhosis (LSM<12.5 kPa) [ adjusted hazard ratio (aHR) = 30.97; p<0.001]. When only cirrhotic patients were analyzed (n = 60), each incremental unit in the Ln of LSM was associated with 10.56 times higher risk of developing LREs (p = 0.010). Patients with LSM >= 25 kPa had a greater risk for LRE development compared to those with LSM<25 kPa (aHR = 3.65; p = 0.045). The AUROC for predicting the onset of LREs was 0.876 in all patients and 0.729 in cirrhotic patients. In conclusion, LSM was associated with an increased risk of developing LREs in HCV-infected patients, even within the group of cirrhotic patients.	[Zaida Gomez-Moreno, Ana; Jose Sanchez-Ruano, Juan; Artaza-Varasa, Tomas] Hosp Virgen Salud, Serv Digest, Toledo, Spain; [Pineda-Tenor, Daniel] Hosp Univ Fuenlabrada, Serv Lab Clin, Madrid, Spain; [Angeles Jimenez-Sousa, Maria; Resino, Salvador] Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Infecc Viral & Inmunidad, Majadahonda, Spain; [Saura-Montalban, Jose] Complejo Hosp Toledo, Serv Lab Clin, Toledo, Spain; [Ryan, Pablo] Hosp Univ Infanta Leonor, Serv Med Interna, Madrid, Spain	Complejo Hospitalario de Toledo; Hospital Universitario Fuenlabrada; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Complejo Hospitalario de Toledo; Hospital Universitario Infanta Leonor	Resino, S (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Infecc Viral & Inmunidad, Majadahonda, Spain.	sresino@isciii.es	Resino, Salvador/B-2430-2008; Jiménez-Sousa, Maria A./I-8725-2012; RYAN, PABLO/GRF-3462-2022; Ryan, Pablo/AAM-1924-2021	Resino, Salvador/0000-0001-8783-0450; Jiménez-Sousa, Maria A./0000-0002-1945-6169; RYAN, PABLO/0000-0002-4212-7419; Ryan, Pablo/0000-0002-4212-7419; Pineda-Tenor, Daniel/0000-0001-6343-5384	Instituto de Salud Carlos III [PI14CIII/00011, CD13/00013]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work has been supported by grants given by Instituto de Salud Carlos III [grant numbers PI14CIII/00011 and CD13/00013]	Asrani SK, 2013, GASTROENTEROLOGY, V145, P375, DOI 10.1053/j.gastro.2013.04.005; Calvaruso V, 2012, LIVER INT, V32, P2, DOI 10.1111/j.1478-3231.2011.02703.x; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2009, J HEPATOL, V50, P59, DOI 10.1016/j.jhep.2008.08.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Castera L, 2015, DIGEST DIS, V33, P498, DOI 10.1159/000374097; Castera L, 2012, J HEPATOL, V56, P696, DOI 10.1016/j.jhep.2011.07.005; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; European Association for the Study of the Liver, 2014, Journal of Hepatology, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Foucher J, 2006, GUT, V55, P403, DOI 10.1136/gut.2005.069153; Garcia-Tsao G, 2017, HEPATOLOGY, V65, P310, DOI 10.1002/hep.28906; Janjua NZ, 2017, J HEPATOL, V66, P504, DOI 10.1016/j.jhep.2016.10.028; Kim JH, 2015, LIVER INT, V35, P1103, DOI 10.1111/liv.12628; Klibansky DA, 2012, J VIRAL HEPATITIS, V19, pE184, DOI 10.1111/j.1365-2893.2011.01493.x; Lee HW, 2016, GUT LIVER, V10, P429, DOI 10.5009/gnl15021; Mallet V, 2008, ANN INTERN MED, V149, P399, DOI 10.7326/0003-4819-149-6-200809160-00006; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; O'Shea RS, 2010, HEPATOLOGY, V51, P307, DOI 10.1002/hep.23258; Pang JXQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095776; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Perez-Latorre L, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw212; Perez-Latorre L, 2014, CLIN INFECT DIS, V58, P713, DOI 10.1093/cid/cit768; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Poynard T, 2013, J HEPATOL, V59, P675, DOI 10.1016/j.jhep.2013.05.015; Pritchett S, 2011, J Viral Hepat, V18, pe75, DOI 10.1111/j.1365-2893.2010.01375.x; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Ripoll C, 2007, GASTROENTEROLOGY, V133, P481, DOI 10.1053/j.gastro.2007.05.024; Ripoll C, 2009, J HEPATOL, V50, P923, DOI 10.1016/j.jhep.2009.01.014; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sanyal AJ, 2008, GASTROENTEROLOGY, V134, P1715, DOI 10.1053/j.gastro.2008.03.007; Serfaty L, 2016, LIVER INT, V36, P67, DOI 10.1111/liv.13016; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shi KQ, 2013, LIVER INT, V33, P62, DOI 10.1111/liv.12003; Shiffman ML, 2014, ANN HEPATOL, V13, P340, DOI 10.1016/S1665-2681(19)30840-3; Singh S, 2013, CLIN GASTROENTEROL H, V11, P1573, DOI 10.1016/j.cgh.2013.07.034; Sultanik P, 2016, ALIMENT PHARM THER; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; van der Meer AJ, 2017, J HEPATOL, V66, P485, DOI 10.1016/j.jhep.2016.10.017; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Fernandez-Montero JV, 2013, AIDS, V27, P1129, DOI 10.1097/QAD.0b013e32835e063f; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; Zipprich A, 2012, LIVER INT, V32, P1407, DOI 10.1111/j.1478-3231.2012.02830.x	44	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184404	10.1371/journal.pone.0184404	http://dx.doi.org/10.1371/journal.pone.0184404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880930	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200067
J	Bai, SH; Darby, I; Nevenimo, T; Hannet, G; Hannet, D; Poienou, M; Grant, E; Brooks, P; Walton, D; Randall, B; Wallace, HM				Bai, Shahla Hosseini; Darby, Ian; Nevenimo, Tio; Hannet, Godfrey; Hannet, Dalsie; Poienou, Matthew; Grant, Elektra; Brooks, Peter; Walton, David; Randall, Bruce; Wallace, Helen M.			Effects of roasting on kernel peroxide value, free fatty acid, fatty acid composition and crude protein content	PLOS ONE			English	Article							NUTS; TEMPERATURE; ALMONDS; OIL; HAZELNUTS; NUTRIENT; PROFILE; IMPACT; SOIL; RAW	Roasting nuts may alter their chemical composition leading to changes in their health benefits. However, the presence of testa may alleviate the negative effects of thermal treatments. Hence, this study aimed to explore the effects of roasting on kernel chemical quality and colour development of Canarium indicum and examine to what extent testa would protect kernels against damage from roasting. Roasting decreased peroxide value but increased free fatty acid, probably due to increased cell destruction and lack of enzyme inactivation, respectively. Protein content of kernels significantly decreased after roasting compared to raw kernels. However, testa-on kernels contained significantly higher protein content compared to testa-off kernels. Whilst colour development and mottling were observed in temperatures beyond 120 degrees C, roasting did not alter fatty acid compositions of kernels. The mild roasting and presence of testa in kernels can be used to enhance health benefits of kernels.	[Bai, Shahla Hosseini; Darby, Ian; Grant, Elektra; Brooks, Peter; Walton, David; Randall, Bruce; Wallace, Helen M.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol, Maroochydore, Qld, Australia; [Nevenimo, Tio; Hannet, Godfrey; Hannet, Dalsie; Poienou, Matthew] Isl Reg Ctr Keravat, Natl Agr Res Inst, Kokopo, East New Britai, Papua N Guinea	University of the Sunshine Coast	Bai, SH (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Genecol, Maroochydore, Qld, Australia.	shossein@usc.edu.au	Bai, Shahla/H-6757-2013; Wallace, Helen/AAB-3162-2019	Bai, Shahla/0000-0001-8646-6423; Wallace, Helen/0000-0002-8801-4401; Brooks, Peter/0000-0003-4915-4986; Darby, Ian/0000-0002-6173-2083	Australian Centre for International Agricultural Research [FST/2014/099]	Australian Centre for International Agricultural Research	Financial support was provided by the Australian Centre for International Agricultural Research (project FST/2014/099).; The authors would like to thank the National Agriculture Research Institute and Papua New Guinea Government for allowing this research and access to the experimental sites especially National Agriculture Research Institute (NARI) in Kerevat, New East Britain. The authors would like to thank NARI staff who contributed in sample collection, processing and analysis. Financial support was provided by the Australian Centre for International Agricultural Research (project FST/2014/099).	Alamprese C, 2009, J FOOD ENG, V95, P272, DOI 10.1016/j.jfoodeng.2009.05.001; Alasalvar C, 2006, J AGR FOOD CHEM, V54, P10177, DOI 10.1021/jf061702w; Alasalvar C, 2010, INT J FOOD SCI NUTR, V61, P630, DOI 10.3109/09637481003691820; Alasalvar C, 2010, J AGR FOOD CHEM, V58, P8674, DOI 10.1021/jf101039f; Amaral JS, 2006, J AGR FOOD CHEM, V54, P1315, DOI 10.1021/jf052287v; AOAC. AOAC official method 940.28, 2003, FATT AC FREE CRUD RE; AOAC (Association of Official Analytical Chemists), 1999, OFFICIAL METHODS ANA, V16; AYATSE JO, 1983, FOOD CHEM, V12, P135, DOI 10.1016/0308-8146(83)90024-9; Bai SH, 2017, AGR ECOSYST ENVIRON, V246, P134, DOI 10.1016/j.agee.2017.06.003; Bai SH, 2015, ENVIRON SCI POLLUT R, V22, P3803, DOI 10.1007/s11356-014-3649-2; Buransompob A, 2003, J FOOD PROCESS PRES, V27, P445, DOI 10.1111/j.1745-4549.2003.tb00529.x; Chew LY, 2011, J FOOD COMPOS ANAL, V24, P670, DOI 10.1016/j.jfca.2011.01.006; Chukwumah Y, 2007, J AGR FOOD CHEM, V55, P9266, DOI 10.1021/jf071877l; Ciemniewska-Zytkiewicz H, 2015, FOOD ANAL METHOD, V8, P2465, DOI 10.1007/s12161-015-0133-7; Crews C, 2005, J AGR FOOD CHEM, V53, P4843, DOI 10.1021/jf047836w; Das I, 2014, J STORED PROD RES, V59, P152, DOI 10.1016/j.jspr.2014.07.005; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Granvogl M, 2006, J AGR FOOD CHEM, V54, P5933, DOI 10.1021/jf061150h; Griel AE, 2006, BRIT J NUTR, V96, pS68, DOI 10.1017/BJN20061866; Hamilton K, 2010, NUTR DIET, V67, P182, DOI 10.1111/j.1747-0080.2010.01453.x; Hannah L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072590; Johns T., 2006, Unasylva (English ed.), V57, P34; KEME T, 1983, REV CHOC CONFECT BAK, V8, P24; Kita A., 2007, POL J FOOD NUTR SCI, V57, P89; Kodad O, 2008, J AGR FOOD CHEM, V56, P4096, DOI 10.1021/jf8001679; Labuza T. P., 1971, CRC Critic. Rev. Fd Technol., V2, P355, DOI 10.1080/10408397109527127; Leakey R, 2008, AGROFOREST SYST, V73, P77, DOI 10.1007/s10457-007-9103-4; Li XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159061; Liaotrakoon W, 2016, INT FOOD RES J, V23, P986; Lin JT, 2016, FOOD CHEM, V190, P520, DOI 10.1016/j.foodchem.2015.06.004; Locatelli M, 2015, J AGR FOOD CHEM, V63, P7294, DOI 10.1021/acs.jafc.5b03201; Metwalli S, 1983, J AGR RES TANTA U; Nevenimo T, 2007, AGROFOREST SYST, V69, P117, DOI 10.1007/s10457-006-9024-7; Ozdemir M, 2001, FOOD CHEM, V73, P185, DOI 10.1016/S0308-8146(00)00260-0; Randall BW, 2016, ACTA HORTIC, V1109, P169, DOI 10.17660/ActaHortic.2016.1109.28; Rengel A., 2015, Natural Science, V7, P535, DOI 10.4236/ns.2015.712054; Rogel-Castillo C, 2015, J AGR FOOD CHEM, V63, P8234, DOI 10.1021/acs.jafc.5b03121; Ros E, 2010, NUTRIENTS, V2, P652, DOI 10.3390/nu2070652; Saklar S, 2003, FOOD RES INT, V36, P19, DOI 10.1016/S0963-9969(02)00103-5; Saklar S, 2001, INT J FOOD SCI TECH, V36, P271, DOI 10.1046/j.1365-2621.2001.00457.x; Schlormann W, 2015, FOOD CHEM, V180, P77, DOI 10.1016/j.foodchem.2015.02.017; Severini C, 2000, J AGR FOOD CHEM, V48, P4635, DOI 10.1021/jf0000575; Seyhan F, 2002, J FOOD ENG, V52, P387, DOI 10.1016/S0260-8774(01)00130-3; Tan CP, 2001, J AM OIL CHEM SOC, V78, P1227, DOI 10.1007/s11745-001-0418-5; Thomson L.A., 2006, TRADITIONAL TREES PA, P209; Wallace H, 2016, ACTA HORTIC, V1128, P145, DOI 10.17660/ActaHortic.2016.1128.20; Walton DA, 2016, ACTA HORTIC, V1109, P43, DOI 10.17660/ActaHortic.2016.1109.7; Walton DA, 2016, ACTA HORTIC, V1109, P17, DOI 10.17660/ActaHortic.2016.1109.3; Walton DA, 2017, HORTICULTURAE, V3, DOI 10.3390/horticulturae3010024; Walton DA, 2010, J SCI FOOD AGR, V90, P2163, DOI 10.1002/jsfa.4063; Weeks A, 2005, MOL PHYLOGENET EVOL, V35, P85, DOI 10.1016/j.ympev.2004.12.021	51	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184279	10.1371/journal.pone.0184279	http://dx.doi.org/10.1371/journal.pone.0184279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902859	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200030
J	Meng, Z; Klinngam, W; Edman, MC; Hamm-Alvarez, SF				Meng, Zhen; Klinngam, Wannita; Edman, Maria C.; Hamm-Alvarez, Sarah F.			Interferon-gamma-treatment in vitro elicits some of the changes in cathepsin S and antigen presentation characteristic of lacrimal glands and corneas from the NOD mouse model of Sjogren's Syndrome	PLOS ONE			English	Article							MHC CLASS-II; NONOBESE DIABETIC MICE; REGULATORY FACTOR-I; DRY-EYE DISEASE; SALIVARY-GLAND; EPITHELIAL-CELLS; HLA-DR; PROINFLAMMATORY CYTOKINES; DENDRITIC CELLS; EXPRESSION	Inflammation and impaired secretion by lacrimal and salivary glands are hallmarks of the autoimmune disease, Sjogren's Syndrome. These changes in the lacrimal gland promote dryness and inflammation of the ocular surface, causing pain, irritation and corneal damage. The changes that initiate and sustain autoimmune inflammation in the lacrimal gland are not well-established. Here we demonstrate that interferon-gamma (IFN-gamma) is significantly elevated in lacrimal gland and tears of the male NOD mouse, a model of autoimmune dacryoadenitis which exhibits many ocular characteristics of Sjogren's Syndrome, by 12 weeks of age early in lacrimal gland inflammation. Working either with primary cultured lacrimal gland acinar cells from BALB/c mice and/or rabbits, in vitro IFN-gamma treatment for 48 hr decreased expression of Rab3D concurrent with increased expression of cathepsin S. Although total cellular cathepsin S activity was not commensurately increased, IFN-gamma treated lacrimal gland acinar cells showed a significant increase in carbachol-stimulated secretion of cathepsin S similar to the lacrimal gland in disease. In vitro IFN-gamma treatment did not increase the expression of most components of major histocompatibility complex (MHC) class II-mediated antigen presentation although antigen presentation was slightly but significantly stimulated in primary cultured lacrimal gland acinar cells. However, exposure of cultured human corneal epithelial cells to IFN-gamma more robustly increased expression and activity of cathepsin S in parallel with increased expression and function of MHC class II-mediated antigen presentation. We propose that early elevations in IFN-gamma contribute to specific features of ocular disease pathology in Sjogren's Syndrome.	[Meng, Zhen; Klinngam, Wannita; Hamm-Alvarez, Sarah F.] Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA; [Edman, Maria C.; Hamm-Alvarez, Sarah F.] Univ Southern Calif, Dept Ophthalmol, USC Roski Eye Inst, Los Angeles, CA 90089 USA; [Edman, Maria C.; Hamm-Alvarez, Sarah F.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	Hamm-Alvarez, SF (corresponding author), Univ Southern Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA.; Hamm-Alvarez, SF (corresponding author), Univ Southern Calif, Dept Ophthalmol, USC Roski Eye Inst, Los Angeles, CA 90089 USA.; Hamm-Alvarez, SF (corresponding author), Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90033 USA.	shalvar@usc.edu	EDMAN, MARIA C./K-6624-2019	EDMAN, MARIA C./0000-0001-7399-4358; Hamm-Alvarez, Sarah/0000-0001-8195-5703	National Institutes of Health [R01 EY011386]; esearch to Prevent Blindness (RPB), New York, NY [10022]; NIH [R01 EY011386]; Cell & Tissue Imaging Core at the Research Center for Liver Disease, University of Southern California [P30 DK048522]; NATIONAL EYE INSTITUTE [R01EY011386, R01EY026635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); esearch to Prevent Blindness (RPB), New York, NY; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cell & Tissue Imaging Core at the Research Center for Liver Disease, University of Southern California; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health R01 EY011386 to SHA and by an unrestricted departmental grant from Research to Prevent Blindness (RPB), New York, NY 10022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH R01 EY011386 to SHA and by an unrestricted departmental grant from Research to Prevent Blindness (RPB), New York, NY 10022. We thank Francie Yarber for primary rabbit LGAC preparations. We acknowledge the support of the Cell & Tissue Imaging Core at the Research Center for Liver Disease, University of Southern California (P30 DK048522) for their laser capture microscopy services.	ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Bahamondes V, 2011, ARTHRITIS RHEUM-US, V63, P3126, DOI 10.1002/art.30500; Beers C, 2003, J EXP MED, V197, P169, DOI 10.1084/jem.20020978; Cha S, 2004, SCAND J IMMUNOL, V60, P552, DOI 10.1111/j.0300-9475.2004.01508.x; DAIBATA M, 1994, MOL IMMUNOL, V31, P255, DOI 10.1016/0161-5890(94)90122-8; Delaleu N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3313; Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775; ELASRAR AMA, 1989, BRIT J OPHTHALMOL, V73, P587, DOI 10.1136/bjo.73.8.587; Evans E, 2008, AM J PHYSIOL-CELL PH, V294, pC662, DOI 10.1152/ajpcell.00623.2006; FOX RI, 1994, J IMMUNOL, V152, P5532; FOX RI, 1986, ARTHRITIS RHEUM, V29, P1105, DOI 10.1002/art.1780290908; FRANCO A, 1987, CLIN EXP RHEUMATOL, V5, P199; Gierow JP, 1996, AM J PHYSIOL-CELL PH, V271, pC1685, DOI 10.1152/ajpcell.1996.271.5.C1685; Giroux M, 2003, J IMMUNOL, V171, P4187, DOI 10.4049/jimmunol.171.8.4187; Gottenberg JE, 2006, P NATL ACAD SCI USA, V103, P2770, DOI 10.1073/pnas.0510837103; Hamano H, 1996, PATHOBIOLOGY, V64, P255, DOI 10.1159/000164056; Hamm-Alvarez SF, 2014, ARTHRITIS RHEUMATOL, V66, P1872, DOI 10.1002/art.38633; Hunger RE, 1998, J CLIN INVEST, V101, P1300, DOI 10.1172/JCI1230; Jackson DC, 2016, INVEST OPHTH VIS SCI, V57, P4824, DOI 10.1167/iovs.16-19757; Kambayashi T, 2014, NAT REV IMMUNOL, V14, P719, DOI 10.1038/nri3754; Kamoi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043688; Kang EH, 2011, CLIN EXP RHEUMATOL, V29, P970; Lavoie TN, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/549107; Li XD, 2010, INVEST OPHTH VIS SCI, V51, P5019, DOI 10.1167/iovs.09-4523; Massingale ML, 2009, CORNEA, V28, P1023, DOI 10.1097/ICO.0b013e3181a16578; Maubach G, 2007, BBA-MOL CELL RES, V1773, P219, DOI 10.1016/j.bbamcr.2006.11.005; Mavragani CP, 2014, ANNU REV PATHOL-MECH, V9, P273, DOI 10.1146/annurev-pathol-012513-104728; Meng Z, 2016, AM J PHYSIOL-CELL PH; MIRCHEFF AK, 1991, INVEST OPHTH VIS SCI, V32, P2302; Mulder DJ, 2011, AM J PATHOL, V178, P744, DOI 10.1016/j.ajpath.2010.10.027; Nakagawa TY, 1999, IMMUNITY, V10, P207, DOI 10.1016/S1074-7613(00)80021-7; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; REYES VE, 1991, J IMMUNOL, V146, P3877; Riese RJ, 2001, IMMUNITY, V15, P909, DOI 10.1016/S1074-7613(01)00247-3; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Roescher N, 2012, ORAL DIS, V18, P96, DOI 10.1111/j.1601-0825.2011.01852.x; Roescher N, 2009, ORAL DIS, V15, P519, DOI 10.1111/j.1601-0825.2009.01582.x; Saegusa K, 2002, J CLIN INVEST, V110, P361, DOI 10.1172/JCI200214682; Schenke-Layland K, 2010, EXP EYE RES, V90, P223, DOI 10.1016/j.exer.2009.10.008; Shen L, 2012, CLIN IMMUNOL, V145, P251, DOI 10.1016/j.clim.2012.09.013; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Solomon A, 2001, INVEST OPHTH VIS SCI, V42, P2283; Tripathi T, 2014, INVEST OPHTH VIS SCI, V55, P3912, DOI 10.1167/iovs.14-14486; van Woerkom JM, 2005, ANN RHEUM DIS, V64, P1474, DOI 10.1136/ard.2004.031781; van's Gravesande KS, 2002, J IMMUNOL, V168, P4488, DOI 10.4049/jimmunol.168.9.4488; Wu AJ, 1997, J CELL PHYSIOL, V173, P110, DOI 10.1002/(SICI)1097-4652(199710)173:1<110::AID-JCP13>3.0.CO;2-M; Wu KJ, 2009, EXP EYE RES, V89, P319, DOI 10.1016/j.exer.2009.03.020; Yamano S, 1999, CLIN IMMUNOL, V92, P265, DOI 10.1006/clim.1999.4759; Youinou P, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3348; Zhao PS, 2014, J BIOL CHEM, V289, P27215, DOI 10.1074/jbc.M114.599712; Zoukhri D, 2002, INVEST OPHTH VIS SCI, V43, P1429; Zywalewska-Gorna Nella, 2007, Klin Oczna, V109, P435	52	19	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184781	10.1371/journal.pone.0184781	http://dx.doi.org/10.1371/journal.pone.0184781			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902875	gold, Green Published, Green Submitted			2022-12-27	WOS:000410669200065
J	Tyack, Z; Kimble, R; McPhail, S; Plaza, A; Simons, M				Tyack, Zephanie; Kimble, Roy; McPhail, Steven; Plaza, Anita; Simons, Megan			Psychometric properties of the Brisbane Burn Scar Impact Profile in adults with burn scars	PLOS ONE			English	Article							QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; HEALTH-STATUS; HYPERTROPHIC SCAR; VALIDATION; CHILDREN; QUESTIONNAIRE; INSTRUMENTS; RELIABILITY; SCALES	Objective The aim of the study was to determine the longitudinal validity, reproducibility, responsiveness and interpretability of the adult version of the Brisbane Burn Scar Impact Profile, a patient-report measure of health-related quality of life. Methods A prospective longitudinal cohort study of patients with or at risk of burn scarring was conducted at three assessment points (at baseline around the time of wound healing, one to two weeks post-baseline and 1-month post-baseline). Participants attending a major metropolitan adult burn centre at baseline were recruited. Participants completed the Brisbane Burn Scar Impact Profile and the 36-item Short Form Health Survey and Patient Observer Scar Assessment Scale. Intraclass Correlation Coefficients (ICCs), smallest detectable change, percentage of those who improved, stayed the same or worsened and Area under the Receiver Operating Characteristic Curve (AUC) were used to test the aim. Results Data were included for 118 participants at baseline, 68 participants at one to two weeks and 57 participants at 1-month post-baseline. All groups of items had acceptable reproducibility, except for the overall impact of burn scars (ICC = 0.69), the impact of sensations which was not expected to be stable (ICC = 0.63), mobility and daily activities (ICC = 0.63, 0.67 respectively). The responsiveness of six out of seven groups of items able to be tested against external criterion was supported (AUC = 0.72-0.75). Hypothesised correlations of changes in the Brisbane Burn Scar Impact Profile items with changes in criterion measures generally supported longitudinal validity (e.g., nine out of thirteen hypotheses using the SF-36 as an external criterion were supported). Internal consistency estimates, item-total and inter-item correlations indicated there was likely redundancy of some groups of items, particularly in the relationships and social interaction, appearance and emotional reactions items (Chronbach's alpha range = 0.94-0.95). Conclusion Support was found for the reproducibility, longitudinal validity, responsiveness and interpretability of most groups of Brisbane Burn Scar Impact Profile items and some individual items in the test population. Potential redundancy of items should be investigated further.	[Tyack, Zephanie; Kimble, Roy; Simons, Megan] Univ Queensland, Ctr Childrens Burns & Trauma Res, Childrens Hlth Res Ctr, South Brisbane, Qld, Australia; [Tyack, Zephanie; McPhail, Steven] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia; [Tyack, Zephanie; McPhail, Steven] Queensland Univ Technol, Sch Publ Hlth & Social Work, Kelvin Grove, Qld, Australia; [McPhail, Steven] Metro South Hlth, Ctr Functioning & Hlth Res, Buranda, Australia; [Plaza, Anita] Royal Brisbane & Womens Hosp, Herston, Qld, Australia; [Simons, Megan] Lady Cilento Childrens Hosp, Dept Occupat Therapy, South Brisbane, Qld, Australia	University of Queensland; Queensland University of Technology (QUT); Queensland University of Technology (QUT); Royal Brisbane & Women's Hospital	Tyack, Z (corresponding author), Univ Queensland, Ctr Childrens Burns & Trauma Res, Childrens Hlth Res Ctr, South Brisbane, Qld, Australia.; Tyack, Z (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia.; Tyack, Z (corresponding author), Queensland Univ Technol, Sch Publ Hlth & Social Work, Kelvin Grove, Qld, Australia.	z.tyack@uq.edu.au	tyack, zephanie/A-7810-2015; Simons, Megan A/D-4961-2018; Tyack, Zephanie/Z-4135-2019	tyack, zephanie/0000-0003-3376-5731; Simons, Megan A/0000-0002-8993-5202; Tyack, Zephanie/0000-0003-3376-5731; McPhail, Steven/0000-0002-1463-662X	Queensland Children's Medical Research Institute; Queensland Health, Health Practitioner Research Scheme; Queensland Children's Medical Research Institute, Central Queensland Hospital and Health Service; Australian Catholic University	Queensland Children's Medical Research Institute; Queensland Health, Health Practitioner Research Scheme; Queensland Children's Medical Research Institute, Central Queensland Hospital and Health Service; Australian Catholic University	Queensland Children's Medical Research Institute provided funding to support the use of consumables and time for the lead investigator to collect the data. Central Queensland Hospital and Health Service provided staff support for the lead investigator to oversee the project. The Queensland Health, Health Practitioner Research Scheme 2012-2013 provided funding for a research assistant to assist to collect the data. The Australian Catholic University provided staff support for the lead investigator to collect data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the patients with burns scarring who participated in the study. The authors also wish to acknowledge support by the Queensland Children's Medical Research Institute, Central Queensland Hospital and Health Service, the Queensland Health, Health Practitioner Research Scheme 2012-2013, and the Australian Catholic University. We sincerely thank Professor Jenny Ziviani and Dr Leila Cuttle for providing input into the study design and assisting in obtaining funding for the study.	Ahn CS, 2012, BURNS, V38, P967, DOI 10.1016/j.burns.2012.05.016; BLADES B, 1982, J TRAUMA, V22, P872, DOI 10.1097/00005373-198210000-00012; BLALOCK SJ, 1994, J TRAUMA, V36, P508, DOI 10.1097/00005373-199404000-00009; Bock O, 2006, ARCH DERMATOL RES, V297, P433, DOI 10.1007/s00403-006-0651-7; BRIGGS SR, 1986, J PERS, V54, P106, DOI 10.1111/j.1467-6494.1986.tb00391.x; Brown BC, 2010, PLAST RECONSTR SURG, V125, P1439, DOI 10.1097/PRS.0b013e3181d4fd89; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Durani P, 2009, PLAST RECONSTR SURG, V123, P1481, DOI 10.1097/PRS.0b013e3181a205de; Edgar D, 2010, BURNS, V36, P1013, DOI 10.1016/j.burns.2010.03.001; Gangemi EN, 2008, ARCH FACIAL PLAST S, V10, P93, DOI 10.1001/archfaci.10.2.93; Giraudeau B, 2001, STAT MED, V20, P3205, DOI 10.1002/sim.935; Griffiths C, 2017, J BURN CARE RES, V38, pE521, DOI 10.1097/BCR.0000000000000474; Lawrence JW, 2012, J BURN CARE RES, V33, P136, DOI 10.1097/BCR.0b013e3182374452; Mirastschijski U, 2015, Ann Burns Fire Disasters, V28, P215; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; Mundy LR, 2016, AESTHET PLAST SURG, V40, P792, DOI 10.1007/s00266-016-0642-9; MUNSTER AM, 1987, J TRAUMA, V27, P425, DOI 10.1097/00005373-198704000-00015; Nedelec B, 2008, J BURN CARE RES, V29, P489, DOI 10.1097/BCR.0b013e3181710869; Nitescu C, 2012, ROM J MORPHOL EMBRYO, V53, P577; QFAB Bioinformatics, 2015, ANZMTG STAT DEC TREE; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Ryan CM, 2013, J BURN CARE RES, V34, pE121, DOI 10.1097/BCR.0b013e31827e7ecf; Schouten HJ, 2012, BURNS, V38, P19, DOI 10.1016/j.burns.2011.06.003; Simons M, 2016, BURNS, V42, P620, DOI 10.1016/j.burns.2015.11.012; Streiner D. L., 2015, HLTH MEASUREMENT SCA, V5<feminine, DOI [10.1093/med/9780199685219.001.0001, DOI 10.1093/MED/9780199685219.001.0001, 10.1093/MED/9780199685219.001.0001]; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Tyack Z, 2015, BURNS, V41, P1405, DOI 10.1016/j.burns.2015.05.021; Tyack Z, 2012, BURNS, V38, P6, DOI 10.1016/j.burns.2011.09.021; van der Veer WM, 2009, BURNS, V35, P15, DOI 10.1016/j.burns.2008.06.020; van der Wal MBA, 2012, WOUND REPAIR REGEN, V20, P676, DOI 10.1111/j.1524-475X.2012.00820.x; van der Wal MBA, 2012, QUAL LIFE RES, V21, P13, DOI 10.1007/s11136-011-9924-5; van Loey NE, 2012, J TRAUMA ACUTE CARE, V72, P513, DOI 10.1097/TA.0b013e3182199072; Ward R S, 1989, J Burn Care Rehabil, V10, P536, DOI 10.1097/00004630-198911000-00015; Ware J., 1993, SF 36 HLTH SURVEY MA	34	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184452	10.1371/journal.pone.0184452	http://dx.doi.org/10.1371/journal.pone.0184452			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902874	Green Submitted, Green Published, gold			2022-12-27	WOS:000410669200038
J	Dirnbock, T; Djukic, I; Kitzler, B; Kobler, J; Mol-Dijkstra, JP; Posch, M; Reinds, GJ; Schlutow, A; Starlinger, F; Wamelink, WGW				Dirnboeck, Thomas; Djukic, Ika; Kitzler, Barbara; Kobler, Johannes; Mol-Dijkstra, Janet P.; Posch, Max; Reinds, Gert Jan; Schlutow, Angela; Starlinger, Franz; Wamelink, Wieger G. W.			Climate and air pollution impacts on habitat suitability of Austrian forest ecosystems	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; NITROGEN DEPOSITION; ATMOSPHERIC DEPOSITION; SOIL ACIDIFICATION; GLOBAL ASSESSMENT; FLOOR VEGETATION; PLANT DIVERSITY; SEA-SALT; TERRESTRIAL; SENSITIVITY	Climate change and excess deposition of airborne nitrogen (N) are among the main stressors to floristic biodiversity. One particular concern is the deterioration of valuable habitats such as those protected under the European Habitat Directive. In future, climate-driven shifts (and losses) in the species potential distribution, but also N driven nutrient enrichment may threaten these habitats. We applied a dynamic geochemical soil model (VSD+) together with a novel niche-based plant response model (PROPS) to 5 forest habitat types (18 forest sites) protected under the EU Directive in Austria. We assessed how future climate change and N deposition might affect habitat suitability, defined as the capacity of a site to host its typical plant species. Our evaluation indicates that climate change will be the main driver of a decrease in habitat suitability in the future in Austria. The expected climate change will increase the occurrence of thermophilic plant species while decreasing cold-tolerant species. In addition to these direct impacts, climate change scenarios caused an increase of the occurrence probability of oligotrophic species due to a higher N immobilisation in woody biomass leading to soil N depletion. As a consequence, climate change did offset eutrophication from N deposition, even when no further reduction in N emissions was assumed. Our results show that climate change may have positive side-effects in forest habitats when multiple drivers of change are considered.	[Dirnboeck, Thomas; Djukic, Ika; Kobler, Johannes] Environm Agcy Austria, Dept Ecosyst Res & Environm Informat Management, Spittelauer Lande 5, Vienna, Austria; [Kitzler, Barbara; Starlinger, Franz] Austrian Res Ctr Forests BFW, Vienna, Austria; [Mol-Dijkstra, Janet P.; Reinds, Gert Jan; Wamelink, Wieger G. W.] Alterra, Wageningen, Netherlands; [Posch, Max] RIVM, Coordinat Ctr Effects, Bilthoven, Netherlands; [Schlutow, Angela] OEKO DATA Ecosyst Anal & Environm Data Management, Strausberg, Germany	Wageningen University & Research; Netherlands National Institute for Public Health & the Environment	Dirnbock, T (corresponding author), Environm Agcy Austria, Dept Ecosyst Res & Environm Informat Management, Spittelauer Lande 5, Vienna, Austria.	thomas.dirnboeck@umweltbundesamt.at	Kitzler, Barbara/ACM-1987-2022; Kobler, Johannes/E-7042-2012; Forests, ICP/F-7626-2019; Kitzler, Barbara/HGF-0438-2022; Djukic, Ika/N-6684-2018	Djukic, Ika/0000-0002-5144-9321; Dirnbock, Thomas/0000-0002-8294-0690; Kitzler, Barbara/0000-0002-1617-9186; Kobler, Johannes/0000-0003-0052-4245	Austrian Climate Research Program [ACRP5 - CCN-Adapt - KR12AC5K01308]; Austrian Federal Ministry of Agriculture, Forestry	Austrian Climate Research Program; Austrian Federal Ministry of Agriculture, Forestry	The study was funded by the Austrian Climate Research Program (ACRP5 - CCN-Adapt - KR12AC5K01308) and by the Austrian Federal Ministry of Agriculture, Forestry. We are grateful to the data providers of the UNECE-CLRTAP International Cooperative Programmes ICP Forests and ICP Integrated Monitoring.	Adriaenssens S, 2013, BIOGEOCHEMISTRY, V116, P215, DOI 10.1007/s10533-013-9846-0; Aherne J, 2012, BIOGEOCHEMISTRY, V107, P471, DOI 10.1007/s10533-010-9569-4; Akselsson C, 2013, SCI TOTAL ENVIRON, V444, P271, DOI 10.1016/j.scitotenv.2012.11.106; [Anonymous], 2007, AR4WG1 IPCC; [Anonymous], 2014, CH2014IMPACTS; [Anonymous], 2014, MODELLING MAPPING IM; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Belyazid S, 2011, ENVIRON POLLUT, V159, P789, DOI 10.1016/j.envpol.2010.11.005; Bleeker A, 2011, ENVIRON POLLUT, V159, P2280, DOI 10.1016/j.envpol.2010.10.036; Bobbink R, 2010, ECOL APPL, V20, P30, DOI 10.1890/08-1140.1; Bonten LTC, 2016, ENVIRON MODELL SOFTW, V79, P75, DOI 10.1016/j.envsoft.2016.01.009; Butler SM, 2012, OECOLOGIA, V168, P819, DOI 10.1007/s00442-011-2133-7; Butterbach-Bahl K., 2011, EUROPEAN NITROGEN AS, P99, DOI 10.1017/CBO9780511976988.009; Coleman K., 2005, MODEL DESCRIPTION US; Cools N, 2014, FOREST ECOL MANAG, V311, P3, DOI 10.1016/j.foreco.2013.06.047; Cools N, 2011, IFOREST, P4; De Vries W, 2010, ECOL APPL, V20, P60, DOI 10.1890/08-1019.1; de Vries W, 2011, ENVIRON POLLUT, V159, P2289, DOI 10.1016/j.envpol.2010.11.023; Delbaere B., 2009, BIOSCORE TOOL ASSESS; Dirnbock T, 2014, GLOBAL CHANGE BIOL, V20, P429, DOI 10.1111/gcb.12440; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; European Commission DG Environment, 2013, EUR28 EUR COMM DG EN; Gaudio N, 2015, ECOL MODEL, V306, P24, DOI 10.1016/j.ecolmodel.2014.10.002; Gilliam FS, 2006, J ECOL, V94, P1176, DOI 10.1111/j.1365-2745.2006.01155.x; Guisan A, 2011, J BIOGEOGR, V38, P1433, DOI 10.1111/j.1365-2699.2011.02550.x; Hulber K, 2008, APPL VEG SCI, V11, P395, DOI 10.3170/2008-7-18489; Jandl R., 2012, Applied and Environmental Soil Science, V2012, P632602; Jonard M, 2015, GLOBAL CHANGE BIOL, V21, P418, DOI 10.1111/gcb.12657; Jost G, 2011, WATER AIR SOIL POLL, V218, P633, DOI 10.1007/s11270-010-0674-8; Kirk GJD, 2010, GLOBAL CHANGE BIOL, V16, P3111, DOI 10.1111/j.1365-2486.2009.02135.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lexer MJ, 2002, FOREST ECOL MANAG, V162, P53, DOI 10.1016/S0378-1127(02)00050-6; Loibl W., 2011, RECLIP CENTURY 1 MOD; Maes SL, 2014, PLANT ECOL, V215, P899, DOI 10.1007/s11258-014-0341-z; Marschall J., HILTSTATELN FORSTEIN; Matzner E, 2004, ECOL STU AN, V172, P339; McDonnell TC, 2014, ENVIRON POLLUT, V187, P55, DOI 10.1016/j.envpol.2013.12.021; Meunier CL, 2016, GLOBAL CHANGE BIOL, V22, P164, DOI 10.1111/gcb.12967; Millenium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL; Mulder C, 2015, BIOGEOSCIENCES, V12, P4113, DOI 10.5194/bg-12-4113-2015; Mutsch, 2013, PROJEKT BIOSOIL EURO; Neumann M, 2001, FOREST CONDITION MON; OECD, 2015, CLIMATE CHANGE RISKS, DOI [10.1787/9789264238787-en, DOI 10.1787/9789264238787-EN]; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Penuelas J, 2013, GLOBAL CHANGE BIOL, V19, P2303, DOI 10.1111/gcb.12143; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Porter EM, 2013, BIOGEOCHEMISTRY, V114, P93, DOI 10.1007/s10533-012-9803-3; Posch M., 2014, MODELLING MAPPING IM, P41; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Reinds GJ, 2008, GEODERMA, V146, P475, DOI 10.1016/j.geoderma.2008.06.022; Reinecke J, 2014, J VEG SCI, V25, P113, DOI 10.1111/jvs.12069; Rizzetto S, 2016, ENVIRON POLLUT, V213, P1016, DOI 10.1016/j.envpol.2015.12.048; Rowe EC, 2016, BIOL CONSERVATION; Rowe EC, 2015, ENVIRON POLLUT SER, V25, P297, DOI 10.1007/978-94-017-9508-1_11; Rowe EC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161085; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Schlutow A, 2015, ENVIRON POLLUT SER, V25, P381, DOI 10.1007/978-94-017-9508-1_14; Schopp W, 2003, HYDROL EARTH SYST SC, V7, P436, DOI 10.5194/hess-7-436-2003; Simpson D, 2012, ATMOS CHEM PHYS, V12, P7825, DOI 10.5194/acp-12-7825-2012; Stockle CO, 1999, CLIMGEN MANUAL; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; Team RC, 2015, R LANG ENV STAT COMP; Templer PH, 2012, ECOLOGY, V93, P1816, DOI 10.1890/11-1146.1; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tuxen R., 1956, ANGEW PFLANZENSOZIOL, V13, P5; UNECE, 1999, 1999 GOTH PROT AB AC; Vanhellemont M, 2014, PLANT ECOL EVOL, V147, P22, DOI 10.5091/plecevo.2014.921; Vet R, 2014, ATMOS ENVIRON, V93, P3, DOI 10.1016/j.atmosenv.2013.10.060; Wamelink GWW, 2009, FOREST ECOL MANAG, V258, P1774, DOI 10.1016/j.foreco.2008.10.024; Wohlgemuth T, 2015, ANN FOREST SCI, V72, DOI 10.1007/s13595-015-0474-9; Zechmeister HG, 2007, ENVIRON POLLUT, V147, P696, DOI 10.1016/j.envpol.2006.09.008; Zechmeister-Boltenstern S, 2015, ECOL MONOGR, V85, P133, DOI 10.1890/14-0777.1	74	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184194	10.1371/journal.pone.0184194	http://dx.doi.org/10.1371/journal.pone.0184194			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898262	gold, Green Published, Green Submitted			2022-12-27	WOS:000410449500018
J	Wu, MY; Chen, TT; Chen, YC; Tarng, DC; Wu, YC; Lin, HH; Tu, YK				Wu, Mei-Yi; Chen, Tzu-Ting; Chen, Ying-Chun; Tarng, Der-Cherng; Wu, Yun-Chun; Lin, Hsien-Ho; Tu, Yu-Kang			Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; VASOPRESSIN ANTAGONIST; SYSTOLIC DYSFUNCTION; DOUBLE-BLIND; SHORT-TERM; RENAL DYSFUNCTION; MULTICENTER; INCONSISTENCY; FUROSEMIDE	Aims Several studies reported treatment benefits of tolvaptan in patients with congestive heart failure (CHF). However, the optimal dosage remains unclear. We aimed to compare different dosage of tolvaptan to determine the optimal dosage in terms of the efficacy and safety. Methods We searched MEDLINE, PubMed, EMBASE, Cochrane CENTRAL and ClinicalTrials.gov through Aug 31, 2016. Randomized controlled trials (RCTs) comparing tolvaptan of different dosages or to placebo in patients with CHF were included. We used network meta-analysis to look for the optimal dosage in terms of effectiveness and safety. Urine output, body weight change and change in serum sodium were the main outcomes of efficacy. Adverse effects were the secondary outcomes. Quality was assessed by Cochrane risk-of-bias tool. Results Twelve RCTs reporting 14 articles with 5793 patients (mean age, 65.7 +/- 11.9 years; 73.7% man) were included. Compared with placebo, the tolvaptan 30 mg had similar effects to tolvaptan 45-90 mg in terms of urine output (mean difference [MD] 2.03 liter; 95% confidence interval [CI] 1.3 to 2.71), body weight change (MD -1.12 kg; 95% CI -1.37 to -0.88) and change in serum sodium (MD 3.06 meq/L; 95% CI 2.43 to 3.68). Compared with placebo, tolvaptan of different dosage showed a non-significant higher risk of adverse effects. Conclusions These findings suggest that tolvaptan 30 mg and 45 mg may be the optimum dosage for CHF patients, because of its ability to provide favourable clinical results without greater adverse effects. However, tolvaptan is not beneficial for reducing all-cause mortality in CHF patients.	[Wu, Mei-Yi] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Nephrol, New Taipei, Taiwan; [Wu, Mei-Yi] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, New Taipei, Taiwan; [Wu, Mei-Yi; Chen, Tzu-Ting; Wu, Yun-Chun; Lin, Hsien-Ho; Tu, Yu-Kang] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Chen, Ying-Chun] Taipei Med Univ, Shuang Ho Hosp, Dept Pharm, New Taipei, Taiwan; [Tarng, Der-Cherng] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Tarng, Der-Cherng] Taipei Vet Gen Hosp, Div Nephrol, Dept Med, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; National Taiwan University; Taipei Medical University; Shuang Ho Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Tu, YK (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei, Taiwan.	yukangtu@ntu.edu.tw	chen, ying/HHS-8254-2022	LIN, HSIEN-HO/0000-0002-7481-6016; Tu, Yu-Kang/0000-0002-2461-474X; Wu, Mei-Yi/0000-0002-5777-2752; Wu, Yun-Chun/0000-0002-8038-0925	Ministry of Science and Technology in Taiwan [MOST103-2314-B-002-032-MY3]	Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	Yun-Chun Wu and Yu-Kang Tu were partly funded by a grant from the Ministry of Science and Technology in Taiwan (grant no. MOST103-2314-B-002-032-MY3).	Alskaf E, 2016, J CARDIOVASC PHARM, V68, P196, DOI 10.1097/FJC.0000000000000405; Aperis G, 2011, REV RECENT CLIN TRIA, V6, P177, DOI 10.2174/157488711795177895; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias S, 2013, MED DECIS MAKING, V33, P641, DOI 10.1177/0272989X12455847; Freda BJ, 2011, AM J KIDNEY DIS, V58, P1005, DOI 10.1053/j.ajkd.2011.07.023; Gheorghiade M, 2004, JAMA-J AM MED ASSOC, V291, P1963, DOI 10.1001/jama.291.16.1963; Gheorghiade M, 2003, CIRCULATION, V107, P2690, DOI 10.1161/01.CIR.0000070422.41439.04; Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Inomata Takayuki, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS57, DOI 10.1007/s10557-011-6349-x; Izumi Y, 2014, J PHARMACOL SCI, V124, P1, DOI 10.1254/jphs.13R13CP; Jujo K, 2016, ESC HEART FAIL, V3, P177, DOI 10.1002/ehf2.12088; Klein L, 2005, CIRCULATION, V111, P2454, DOI 10.1161/01.CIR.0000165065.82609.3D; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Majure DT, 2011, CURR TREAT OPT CARD, V13, P570, DOI DOI 10.1007/S11936-011-0149-2; Matsue Y, 2016, INT J CARDIOL, V221, P188, DOI 10.1016/j.ijcard.2016.07.063; Matsue Y, 2016, J CARD FAIL, V22, P423, DOI 10.1016/j.cardfail.2016.02.007; Matsuzaki Masunori, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS19, DOI 10.1007/s10557-011-6303-y; Matsuzaki Masunori, 2011, Cardiovasc Drugs Ther, V25 Suppl 1, pS33, DOI 10.1007/s10557-011-6304-x; Michael Felker G, 2010, Congest Heart Fail, V16 Suppl 1, pS68, DOI 10.1111/j.1751-7133.2010.00172.x; Nistor I, 2015, INT UROL NEPHROL, V47, P335, DOI 10.1007/s11255-014-0855-2; Ponikowski P., 2016, EUROPEAN HEART J, V2015; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shanmugam Elangovan, 2016, Indian Heart J, V68 Suppl 1, pS15, DOI 10.1016/j.ihj.2015.07.006; Udelson JE, 2008, J AM COLL CARDIOL, V52, P1540, DOI 10.1016/j.jacc.2008.08.013; Udelson JE, 2007, J AM COLL CARDIOL, V49, P2151, DOI 10.1016/j.jacc.2007.01.091; Udelson JE, 2011, J CARD FAIL, V17, P973, DOI 10.1016/j.cardfail.2011.08.005; Xiong B, 2015, HEART FAIL REV, V20, P633, DOI 10.1007/s10741-015-9503-x; Yancy CW, 2016, CIRCULATION, V134, pE282, DOI 10.1161/CIR.0000000000000435; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yang CJ, 2015, INT J CLIN EXP MED, V8, P22117	33	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184380	10.1371/journal.pone.0184380	http://dx.doi.org/10.1371/journal.pone.0184380			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898297	Green Submitted, Green Published, gold			2022-12-27	WOS:000410449500024
J	del Pozo-Cruz, B; Manas, A; Martin-Garcia, M; Marin-Puyalto, J; Garcia-Garcia, FJ; Rodriguez-Manas, L; Guadalupe-Grau, A; Ara, I				del Pozo-Cruz, Borja; Manas, Asier; Martin-Garcia, Maria; Marin-Puyalto, Jorge; Garcia-Garcia, Francisco J.; Rodriguez-Manas, Leocadio; Guadalupe-Grau, Amelia; Ara, Ignacio			Frailty is associated with objectively assessed sedentary behaviour patterns in older adults: Evidence from the Toledo Study for Healthy Aging (TSHA)	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PHYSICAL PERFORMANCE; SITTING TIME; MORTALITY; PREVALENCE; PREDICTION; DISABILITY	Objective The aim of this study was to examine the association of sedentary behaviour patterns with frailty in older people. Setting Clinical setting. Design Cross-sectional, observational study. Participants and measurements A triaxial accelerometer was used in a subsample from the Toledo Study for Healthy Aging (519 participants, 67-97 years) to assess several sedentary behaviour patterns including sedentary time per day, the number and duration (min) of breaks in sedentary time per day, and the proportion of the day spent in sedentary bouts of 10 minutes or more. Frailty was assessed using the Frailty Trait Scale (FTS). Regression analysis was used to ascertain the associations between sedentary behaviour patterns and frailty. Results Sedentary time per day and the proportion of the day spent in sedentary bouts of 10 minutes or more, were positively associated with frailty in the study sample. Conversely, the time spent in breaks in sedentary time was negatively associated with frailty. Conclusion In summary, breaking up sedentary time and time spent in sedentary behaviour are associated with frailty in older people.	[del Pozo-Cruz, Borja] Univ Auckland, Dept Exercise Sci, Auckland, New Zealand; [Manas, Asier; Martin-Garcia, Maria; Ara, Ignacio] Univ Castilla La Mancha, GENUD Toledo Res Grp, Toledo, Spain; [Manas, Asier; Martin-Garcia, Maria; Garcia-Garcia, Francisco J.; Rodriguez-Manas, Leocadio; Ara, Ignacio] CIBER Frailty & Hlth Aging CIBERFES, Madrid, Spain; [Marin-Puyalto, Jorge] Univ Zaragoza, Fac Hlth & Sport Sci, GENUD Res Grp, Huesca, Spain; [Garcia-Garcia, Francisco J.; Guadalupe-Grau, Amelia] Hosp Virgen del Valle, Dept Geriatr, Toledo, Spain; [Rodriguez-Manas, Leocadio] Hosp Univ Getafe, Dept Geriatr, Getafe, Spain; [Guadalupe-Grau, Amelia] Tech Univ Madrid, Dept Hlth & Human Performance, ImFINE Res Grp, Madrid, Spain	University of Auckland; Universidad de Castilla-La Mancha; CIBER - Centro de Investigacion Biomedica en Red; CIBERFES; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Zaragoza; Complejo Hospitalario de Toledo; Hospital Universitario de Getafe; Universidad Politecnica de Madrid	del Pozo-Cruz, B (corresponding author), Univ Auckland, Dept Exercise Sci, Auckland, New Zealand.	b.delpozocruz@auckland.ac.nz	Marín-Puyalto, Jorge/ABE-9479-2020; Guadalupe-Grau, Amelia/H-4961-2016; Garcia-Garcia, Francisco Jose/R-9258-2017; Bote, Asier Mañas/S-8856-2017	Marín-Puyalto, Jorge/0000-0002-1042-542X; Guadalupe-Grau, Amelia/0000-0003-2573-4572; Garcia-Garcia, Francisco Jose/0000-0003-3690-6069; Bote, Asier Mañas/0000-0002-1683-1365; Rodriguez-Manas, Leocadio/0000-0002-6551-1333; Ara Royo, Ignacio/0000-0002-2854-6684; , Borja/0000-0003-3944-2212; del Pozo Cruz, Borja/0000-0002-9728-1317	Instituto de Salud Carlos III (Ministerio de Economia, Industria y Competitividad), Spain [RD12/0043/0026, RD12/0040/0020, RD12/0040/0001, CB16/10/00456, CB16/10/00477, CB16/10/00464, PI15/01305, PI10/01532]; FP7-Health Innovation program, European Union and Biomedical Research Networking Center on Frailty and Healthy Aging (CIBERFES) [FP7-305483-2]; FEDER funds from the European Union	Instituto de Salud Carlos III (Ministerio de Economia, Industria y Competitividad), Spain; FP7-Health Innovation program, European Union and Biomedical Research Networking Center on Frailty and Healthy Aging (CIBERFES); FEDER funds from the European Union(European Commission)	This work was supported by grants RD12/0043/0026, RD12/0040/0020, RD12/0040/0001 CB16/10/00456, CB16/10/00477, CB16/10/00464, PI15/01305 and PI10/01532, from the Instituto de Salud Carlos III (Ministerio de Economia, Industria y Competitividad), Spain, by Grant FP7-305483-2 from the FP7-Health-2012 Innovation program, European Union and Biomedical Research Networking Center on Frailty and Healthy Aging (CIBERFES) and FEDER funds from the European Union.	Aguilar-Farias N, 2014, J SCI MED SPORT, V17, P293, DOI 10.1016/j.jsams.2013.07.002; Blair SN, 2012, SCAND J MED SCI SPOR, V22, pE24, DOI 10.1111/j.1600-0838.2012.01462.x; Blodgett J, 2015, MATURITAS, V80, P187, DOI 10.1016/j.maturitas.2014.11.010; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Cawthon PM, 2007, J AM GERIATR SOC, V55, P1216, DOI 10.1111/j.1532-5415.2007.01259.x; Chastin SFM, 2015, OBESITY, V23, P1800, DOI 10.1002/oby.21180; Colley Rachel, 2010, Health Rep, V21, P63; Daniels R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-278; DASC R, 2016, J SPORTS MED PHYS FI; Ensrud KE, 2009, J AM GERIATR SOC, V57, P492, DOI 10.1111/j.1532-5415.2009.02137.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford ES, 2012, INT J EPIDEMIOL, V41, P1338, DOI 10.1093/ije/dys078; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Garcia-Garcia FJ, 2011, J NUTR HEALTH AGING, V15, P852, DOI 10.1007/s12603-011-0075-8; Gomez-Cabello A, 2012, MATURITAS, V73, P337, DOI 10.1016/j.maturitas.2012.09.001; Guadalupe-Grau A, 2015, AGE AGEING, V44, P790, DOI 10.1093/ageing/afv080; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Jefferis Barbara J, 2015, Br J Sports Med, V49, P1591, DOI 10.1136/bjsports-2014-093514; Garcia-Garcia FJ, 2014, J AM MED DIR ASSOC, V15, DOI 10.1016/j.jamda.2014.01.004; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; Manas A, 2017, EUR J SPORT SCI, V17, P940, DOI 10.1080/17461391.2017.1327983; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Sardinha LB, 2015, EXP GERONTOL, V72, P278, DOI 10.1016/j.exger.2015.10.010; Sardinha LB, 2015, J GERONTOL A-BIOL, V70, P119, DOI 10.1093/gerona/glu193; Sirven N, 2017, EUR J HEALTH ECON, V18, P243, DOI 10.1007/s10198-016-0772-7; Stamatakis E, 2011, BRIT J HOSP MED, V72, P192, DOI 10.12968/hmed.2011.72.4.192; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Walston J, 2006, J AM GERIATR SOC, V54, P991, DOI 10.1111/j.1532-5415.2006.00745.x; WHO guidelines approved by the guidelines review committee, 2010, GLOB REC PHYS ACT HL	31	53	53	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0183911	10.1371/journal.pone.0183911	http://dx.doi.org/10.1371/journal.pone.0183911			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG4OS	28892505	Green Published, gold, Green Submitted			2022-12-27	WOS:000410243200006
J	Canesin, G; Evans-Axelsson, S; Hellsten, R; Krzyzanowska, A; Prasad, CP; Bjartell, A; Andersson, T				Canesin, Giacomo; Evans-Axelsson, Susan; Hellsten, Rebecka; Krzyzanowska, Agnieszka; Prasad, Chandra P.; Bjartell, Anders; Andersson, Tommy			Treatment with the WNT5A-mimicking peptide Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model	PLOS ONE			English	Article							PROTEIN EXPRESSION; WNT-5A PROTEIN; MIGRATION; INVASION; PROLIFERATION; PROGRESSION; AGGRESSIVENESS; ACTIVATION; MECHANISMS; RESISTANCE	Prostate cancer patients with high WNT5A expression in their tumors have been shown to have more favorable prognosis than those with low WNT5A expression. This suggests that reconstitution of Wnt5a in low WNT5A-expressing tumors might be an attractive therapeutic approach. To explore this idea, we have in the present study used Foxy-5, a WNT5A mimicking peptide, to investigate its impact on primary tumor and metastasis in vivo and on prostate cancer cell viability, apoptosis and invasion in vitro. We used an in vivo orthotopic xenograft mouse model with metastatic luciferase-labeled WNT5A-low DU145 cells and metastatic luciferase-labeled WNT5A-high PC3prostate cancer cells. We provide here the first evidence that Foxy-5 significantly inhibits the initial metastatic dissemination of tumor cells to regional and distal lymph nodes by 90% and 75%, respectively. Importantly, this effect was seen only with the WNT5A-low DU145 cells and not with the WNT5A-high PC3 cells. The inhibiting effect in the DU145-based model occurred despite the fact that no effects were observed on primary tumor growth, apoptosis or proliferation. These findings are consistent with and supported by the in vitro data, where Foxy-5 specifically targets invasion without affecting apoptosis or viability of WNT5A-low prostate cancer cells. To conclude, our data indicate that the WNT5A-mimicking peptide Foxy-5, which has been recently used in a phase 1 clinical trial, is an attractive candidate for complimentary anti-metastatic treatment of prostate cancer patients with tumors exhibiting absent or low WNT5A expression.	[Canesin, Giacomo; Prasad, Chandra P.; Andersson, Tommy] Lund Univ, Skane Univ Hosp Malmo, Clin Res Ctr, Dept Translat Med,Div Cell & Expt Pathol, Malmo, Sweden; [Canesin, Giacomo; Evans-Axelsson, Susan; Hellsten, Rebecka; Krzyzanowska, Agnieszka; Bjartell, Anders] Lund Univ, Skane Univ Hosp Malmo, Dept Translat Med, Div Urol Canc, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital	Andersson, T (corresponding author), Lund Univ, Skane Univ Hosp Malmo, Clin Res Ctr, Dept Translat Med,Div Cell & Expt Pathol, Malmo, Sweden.	tommy.andersson@med.lu.se	Canesin, Giacomo/H-4541-2019; Prasad, Chandra Prakash/B-6404-2015	Canesin, Giacomo/0000-0002-3318-4550; Evans Axelsson, Susan/0000-0002-4240-0550; Andersson, Tommy/0000-0003-4032-5769; Prasad, Chandra Prakash/0000-0002-4911-7483	Swedish Cancer Foundation [140643, 140274]; Swedish Research Council [B0434701, D0484201]; BioCare program at Lund University; Skane University Hospital Research Foundation; Gunnar Nilsson's Cancer Foundation; Governmental Funding of Clinical Research within the National Health Services (ALF); Royal Physiographic Society	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); BioCare program at Lund University; Skane University Hospital Research Foundation; Gunnar Nilsson's Cancer Foundation; Governmental Funding of Clinical Research within the National Health Services (ALF); Royal Physiographic Society	This work was supported by the Swedish Cancer Foundation (https://www.cancerfonden.se/) to TA (140643) and to AB (140274), the Swedish Research Council (http://www.vr.se/) to TA (B0434701) and to AB (D0484201), the BioCare program at Lund University (https//www.biocare.nu/) to TA, the Skane University Hospital Research Foundation, the Gunnar Nilsson's Cancer Foundation (http://www.cancerstiftelsen.com/) and Governmental Funding of Clinical Research within the National Health Services (ALF) all to TA and AB, and the Royal Physiographic Society (http://www.fysiografen.se/sv/) to GC. The funding sources had no role in the study design, data collection and analysis, the decision to publish, or in the preparation of the manuscript.	Asem MS, 2016, CANCERS, V8, DOI 10.3390/cancers8090079; Bennett LL, 2014, ANN PHARMACOTHER, V48, P530, DOI 10.1177/1060028013518899; Blanc E, 2005, ONCOGENE, V24, P1277, DOI 10.1038/sj.onc.1208255; Canesin G., 2014, ONCOGENE; Canesin G, 2015, EUR UROL; Chen C, 2015, PROSTATE, V75, P883, DOI 10.1002/pros.22971; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Doctor SM, 2014, CANCER-AM CANCER SOC, V120, P833, DOI 10.1002/cncr.28494; Endo M, 2015, INT REV CEL MOL BIO, V314, P117, DOI 10.1016/bs.ircmb.2014.10.003; Ganguly SS, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00364; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Hellsten R, 2008, PROSTATE, V68, P269, DOI 10.1002/pros.20699; Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871; Jansson M, 2001, J CELL SCI, V114, P2043; Jantscheff P, 2009, PROSTATE, V69, P1151, DOI 10.1002/pros.20964; Jiang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058329; Jonsson M, 2002, CANCER RES, V62, P409; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Khaja ASS, 2012, CANCER MED-US, V1, P96, DOI 10.1002/cam4.5; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Linnskog R, 2014, MOL ONCOL, V8, P1365, DOI 10.1016/j.molonc.2014.05.008; Liss Michael A., 2010, Cancer Genomics & Proteomics, V7, P245; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Ma F, 2016, J CLIN INVEST, V126, P1745, DOI 10.1172/JCI78815; Martin SK, 2014, AM J CLIN EXP UROL, V2, P15; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Miyamoto DT, 2015, SCIENCE, V349, P1351, DOI 10.1126/science.aab0917; Mouraviev Vladimir, 2014, Rev Urol, V16, P122; Nandana S, 2014, AM J CLIN EXP UROL, V2, P92; Nouri M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00370; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Peng XH, 2015, ONCOL REP, V34, P1565, DOI 10.3892/or.2015.4098; Prasad CP, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0421-0; Prasad CP, 2013, MOL ONCOL, V7, P870, DOI 10.1016/j.molonc.2013.04.005; Quintela ML, 2015, CANC TREAT REV; Reel B, 2015, J CANCER, V6, P1020, DOI 10.7150/jca.12733; Ren W, 2016, BIOCHEM BIOPH RES CO, V469, P633, DOI 10.1016/j.bbrc.2015.12.054; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Safholm A, 2008, CLIN CANCER RES, V14, P6556, DOI 10.1158/1078-0432.CCR-08-0711; Sandsmark E, 2016, ONCOTARGET; Schulte G, 2010, PHARMACOL REV, V62, P632, DOI 10.1124/pr.110.002931; Sepulveda L, 2015, CASE REP UROL, V2015; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sridhar SS, 2014, EUR UROL, V65, P289, DOI 10.1016/j.eururo.2013.08.008; Syed Khaja Azharuddin Sajid, 2011, PLoS One, V6, pe26539, DOI 10.1371/journal.pone.0026539; Thiele S, 2015, J BONE MINER RES, V30, P488, DOI 10.1002/jbmr.2362; Thiele S, 2011, J CELL BIOCHEM, V112, P1593, DOI 10.1002/jcb.23070; Tseng JC, 2016, ONCOTARGET, V7, P38010, DOI 10.18632/oncotarget.9380; van Dodewaard-de Jong JM, 2015, CLIN GENITOURIN CANC; Wu J, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0650-6; Yamamoto H, 2010, ONCOGENE, V29, P2036, DOI 10.1038/onc.2009.496; Zhang CY, 2016, MOL NUTR FOOD RES, V60, P1427, DOI 10.1002/mnfr.201500918; Zhou Y, 2015, J MOL ENDOCRINOL, V54, pR15, DOI 10.1530/JME-14-0203; Zobniw CM, 2014, RES REP UROL, V6, P97, DOI 10.2147/RRU.S29003	58	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184418	10.1371/journal.pone.0184418	http://dx.doi.org/10.1371/journal.pone.0184418			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886116	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100114
J	Casula, E; Asuni, GP; Sogos, V; Fadda, S; Delogu, F; Cincotti, A				Casula, Elisa; Asuni, Gino P.; Sogos, Valeria; Fadda, Sarah; Delogu, Francesco; Cincotti, Alberto			Osmotic behaviour of human mesenchymal stem cells: Implications for cryopreservation	PLOS ONE			English	Article							UMBILICAL-CORD BLOOD; BONE-MARROW; MEMBRANE-PERMEABILITY; STEM/PROGENITOR CELLS; DIMETHYL-SULFOXIDE; VOLUME REGULATION; INACTIVE VOLUME; ADIPOSE-TISSUE; PARAMETERS; GLYCEROL	Aimed at providing a contribution to the optimization of cryopreservation processes, the present work focuses on the osmotic behavior of human mesenchymal stem cells (hMSCs). Once isolated from the umbilical cord blood (UCB) of three different donors, hMSCs were characterized in terms of size distribution and their osmotic properties suitably evaluated through the exposure to hypertonic and isotonic aqueous solutions at three different temperatures. More specifically, inactive cell volume and cell permeability to water and di-methyl sulfoxide (DMSO) were measured, being cell size determined using impedance measurements under both equilibrium and dynamic conditions. Experimental findings indicate that positive cell volume excursions are limited by the apparent increase of inactive volume, which occurs during both the shrink-swell process following DMSO addition and the subsequent restoration of isotonic conditions in the presence of hypertonic solutions of impermeant or permeant solutes. Based on this evidence, hMSCs must be regarded as imperfect osmometers, and their osmotic behavior described within a scenario no longer compatible with the simple two-parameter model usually utilized in the literature. In this respect, the activation of mechano-sensitive ion-channels seemingly represents a reasonable hypothesis for rationalizing the observed osmotic behavior of hMSCs from UCB.	[Casula, Elisa; Delogu, Francesco; Cincotti, Alberto] Univ Cagliari, Dipartimento Ingn Meccan Chim & Mat, Cagliari, Italy; [Asuni, Gino P.; Cincotti, Alberto] Univ Cagliari, Ctr Interdipartimentale Ingn & Sci Ambiental, Cagliari, Italy; [Sogos, Valeria] Cittadella Univ, Univ Cagliari, Dipartimento Sci Biomed, Monserrato, Italy; [Fadda, Sarah] Imperial Coll London, Dept Chem Engn, Ctr Proc Syst Engn, London, England	University of Cagliari; University of Cagliari; University of Cagliari; Imperial College London	Cincotti, A (corresponding author), Univ Cagliari, Dipartimento Ingn Meccan Chim & Mat, Cagliari, Italy.; Cincotti, A (corresponding author), Univ Cagliari, Ctr Interdipartimentale Ingn & Sci Ambiental, Cagliari, Italy.	alberto.cincotti@dimcm.unica.it	Sogos, Valeria/B-5471-2012	Sogos, Valeria/0000-0002-4021-1043; Delogu, Francesco/0000-0003-2520-9057; Casula, Elisa/0000-0002-2813-329X; Fadda, Sarah/0000-0002-5919-1409; CINCOTTI, ALBERTO/0000-0001-8121-9415	Regione Autonoma della Sardegna (RAS) [L.7/2007 RAS, CUP F71J12000900002]; Alberto Cincotti	Regione Autonoma della Sardegna (RAS)(Russian Academy of SciencesRegione Sardegna); Alberto Cincotti	The Regione Autonoma della Sardegna (RAS) is gratefully acknowledged for funding this research (Progetto L.7/2007 RAS, Bando 2012, CUP F71J12000900002), Alberto Cincotti, https://www.regione.sardegna.it. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker JP, 1999, CRYO-LETT, V20, P315; Barnard JG, 2012, J PHARM SCI-US, V101, P140, DOI 10.1002/jps.22732; Bieback K, 2004, STEM CELLS, V22, P625, DOI 10.1634/stemcells.22-4-625; Bryan AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029866; Campagnoli C, 2001, BLOOD, V98, P2396, DOI 10.1182/blood.V98.8.2396; Carvalho KAT, 2008, TRANSPL P, V40, P839, DOI 10.1016/j.transproceed.2008.03.004; Casula E, 2015, CHEM ENGINEER TRANS, V43, P265, DOI 10.3303/CET1543045; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Fadda S, 2011, CRYOBIOLOGY, V62, P218, DOI 10.1016/j.cryobiol.2011.03.006; Fadda S, 2011, AICHE J, V57, P1075, DOI 10.1002/aic.12320; Fadda S, 2010, AICHE J, V56, P2173, DOI 10.1002/aic.12137; Fernandez JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057268; Gang EJ, 2004, STEM CELLS, V22, P617, DOI 10.1634/stemcells.22-4-617; GROVES MR, 1980, IEEE T BIO-MED ENG, V27, P364, DOI 10.1109/TBME.1980.326649; HEMPLING HG, 1984, CRYOBIOLOGY, V21, P133, DOI 10.1016/0011-2240(84)90204-9; Higgins AZ, 2008, CRYOBIOLOGY, V57, P223, DOI 10.1016/j.cryobiol.2008.09.001; Higgins AZ, 2010, CRYOBIOLOGY, V60, P117, DOI 10.1016/j.cryobiol.2009.10.002; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Hunt CJ, 2003, CRYOBIOLOGY, V46, P61, DOI 10.1016/S0011-2240(02)00180-3; Jiang HY, 2013, BIOPHYS J, V105, P609, DOI 10.1016/j.bpj.2013.06.021; Karlsson J.O., 2000, PRINCIPLES TISSUE EN, P293, DOI [10.1007/11749219, DOI 10.1016/B978-012436630-5/50028-3]; Kashuba CM, 2014, CRYOBIOLOGY, V68, P166, DOI 10.1016/j.cryobiol.2013.12.007; Katkov II, 2008, CRYOBIOLOGY, V57, P142, DOI 10.1016/j.cryobiol.2008.07.009; Katkov II, 2011, CRYOBIOLOGY, V62, P232, DOI 10.1016/j.cryobiol.2011.02.006; KEDEM O, 1958, BIOCHIM BIOPHYS ACTA, V27, P229, DOI 10.1016/0006-3002(58)90330-5; Kleinhans FW, 1998, CRYOBIOLOGY, V37, P271, DOI 10.1006/cryo.1998.2135; Lee MW, 2004, BIOCHEM BIOPH RES CO, V320, P273, DOI 10.1016/j.bbrc.2004.04.206; Mazur P, 2004, LIFE IN THE FROZEN STATE, P3, DOI 10.1201/9780203647073.ch1; Mukherjee IN, 2007, CRYOBIOLOGY, V55, P10, DOI 10.1016/j.cryobiol.2007.04.002; Parekkadan B, 2007, TISSUE ENG, V13, P2465, DOI 10.1089/ten.2007.0054; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poignard C, 2011, EUR BIOPHYS J BIOPHY, V40, P235, DOI 10.1007/s00249-010-0641-8; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Tarasov AI, 2004, CRYOBIOLOGY, V48, P333, DOI 10.1016/j.cryobiol.2004.02.010; Vian AM, 2014, CRYOBIOLOGY, V68, P35, DOI 10.1016/j.cryobiol.2013.11.004; Wang HY, 2011, CRYOLETTERS, V32, P81; Wang X, 2010, CRYOBIOLOGY, V61, P58, DOI 10.1016/j.cryobiol.2010.05.001; Wexler SA, 2003, BRIT J HAEMATOL, V121, P368, DOI 10.1046/j.1365-2141.2003.04284.x; Xu YQ, 2014, ARCH BIOCHEM BIOPHYS, V550, P67, DOI 10.1016/j.abb.2014.04.010; Zhang X, 2011, J CELL BIOCHEM, V112, P1206, DOI 10.1002/jcb.23042; Zhurova M, 2014, CRYOBIOLOGY, V68, P379, DOI 10.1016/j.cryobiol.2014.04.002; ZIMMERMANN U, 1974, BIOPHYS J, V14, P881, DOI 10.1016/S0006-3495(74)85956-4; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	44	16	16	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184180	10.1371/journal.pone.0184180	http://dx.doi.org/10.1371/journal.pone.0184180			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886069	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100077
J	Cavas-Martinez, F; Bataille, L; Fernandez-Pacheco, DG; Canavate, FJF; Alio, JL				Cavas-Martinez, Francisco; Bataille, Laurent; Fernandez-Pacheco, Daniel G.; Canavate, Francisco J. F.; Alio, Jorge L.			A new approach to keratoconus detection based on corneal morphogeometric analysis	PLOS ONE			English	Article							SUBCLINICAL KERATOCONUS; SCHEIMPFLUG PHOTOGRAPHY; ANTERIOR; SUSPECT; SHAPE; ABERRATIONS; TOMOGRAPHY; PARAMETERS; TOPOGRAPHY; PACHYMETRY	Purpose To characterize corneal structural changes in keratoconus using a new morphogeometric approach and to evaluate its potential diagnostic ability. Methods Comparative study including 464 eyes of 464 patients (age, 16 and 72 years) divided into two groups: control group (143 healthy eyes) and keratoconus group (321 keratoconus eyes). Topographic information (Sirius, CSO, Italy) was processed with SolidWorks v2012 and a solid model representing the geometry of each cornea was generated. The following parameters were defined: anterior (Aant) and posterior (Apost) corneal surface areas, area of the cornea within the sagittal plane passing through the Z axis and the apex (Aapexant, Aapexpost) and minimum thickness points (Amctant, Amctpost) of the anterior and posterior corneal surfaces, and average distance from the Z axis to the apex (Dapexant, Dapexpost) and minimum thickness points (Dmctant, Dmctpost) of both corneal surfaces. Results Significant differences among control and keratoconus group were found in Aapexant, Aapexpost, Amctant, Amctpost, Dapexant, Dapexpost ( all p< 0.001), Apost ( p = 0.014), and Dmctpost (p = 0.035). Significant correlations in keratoconus group were found between Aant and Apost (r = 0.836), Amctant and Amctpost (r = 0.983), and Dmctant and Dmctpost (r = 0.954, all p< 0.001). A logistic regression analysis revealed that the detection of keratoconus grade I (Amsler Krumeich) was related to Apost, Atot, Aapexant, Amctant, Amctpost, Dapexpost, Dmctant and Dmctpost (Hosmer- Lemeshow: p> 0.05, R 2 Nagelkerke: 0.926). The overall percentage of cases correctly classified by the model was 97.30%. Conclusions Our morphogeometric approach based on the analysis of the cornea as a solid is useful for the characterization and detection of keratoconus.	[Cavas-Martinez, Francisco; Bataille, Laurent; Fernandez-Pacheco, Daniel G.; Canavate, Francisco J. F.] Tech Univ Cartagena, Dept Graph Express, Cartagena, Spain; [Bataille, Laurent] Vissum Corp Alicante, Res & Dev Dept, Alicante, Spain; [Bataille, Laurent; Alio, Jorge L.] Vissum Corp Alicante, Keratoconus Unit, Alicante, Spain; [Alio, Jorge L.] Univ Miguel Hernandez, Div Ophthalmol, Alicante, Spain; [Alio, Jorge L.] Vissum Corp Alicante, Dept Refract Surg, Alicante, Spain	Universidad Politecnica de Cartagena; VISSUM; VISSUM; Universidad Miguel Hernandez de Elche; VISSUM	Cavas-Martinez, F (corresponding author), Tech Univ Cartagena, Dept Graph Express, Cartagena, Spain.	francisco.cavas@upct.es	Bataille, laurent/AAU-4164-2021; Cavas-Martínez, Francisco/L-3143-2014; Fernández-Pacheco, Daniel G./K-9725-2015	Bataille, laurent/0000-0003-4882-6859; Cavas-Martínez, Francisco/0000-0002-8391-0688; Fernández-Pacheco, Daniel G./0000-0002-1504-8475	Carlos III Health Institute-General Subdirection of Networks and Cooperative Investigation Centers (R&D&I National Plan) [RD12/0034/0007, RD16/0008/0012]; European Regional Development Fund (FEDER)	Carlos III Health Institute-General Subdirection of Networks and Cooperative Investigation Centers (R&D&I National Plan); European Regional Development Fund (FEDER)(European Commission)	This publication has been carried out in the framework of the Thematic Network for Co-Operative Research in Health (RETICS) reference number RD12/0034/0007 and RD16/0008/0012, financed by the Carlos III Health Institute-General Subdirection of Networks and Cooperative Investigation Centers (R&D&I National Plan 2008-2011) and the European Regional Development Fund (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Ameerh MA, 2014, INT J OPHTHALMOL-CHI, V7, P714, DOI 10.3980/j.issn.2222-3959.2014.04.24; Alio JL, 2011, J CATARACT REFR SURG, V37, P552, DOI 10.1016/j.jcrs.2010.10.046; Arbelaez MC, 2012, OPHTHALMOLOGY, V119, P2231, DOI 10.1016/j.ophtha.2012.06.005; Auffarth GU, 2000, J CATARACT REFR SURG, V26, P222, DOI 10.1016/S0886-3350(99)00355-7; Cavas-Martinez F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110249; de Sanctis U, 2008, OPHTHALMOLOGY, V115, P1534, DOI 10.1016/j.ophtha.2008.02.020; Gordon-Shaag A, 2012, OPTOMETRY VISION SCI, V89, P411, DOI 10.1097/OPX.0b013e318249d727; Jafarinasab Mohammad Reza, 2015, J Ophthalmic Vis Res, V10, P10, DOI 10.4103/2008-322X.156085; Jonuscheit S, 2015, OPHTHAL PHYSL OPT, V35, P45, DOI 10.1111/opo.12179; Kocamis SI, 2016, SEMIN OPHTHALMOL, V31, P203, DOI 10.3109/08820538.2014.914234; Kozobolis V, 2012, EUR J OPHTHALMOL, V22, P920, DOI 10.5301/ejo.5000184; Mahmoud AM, 2013, AM J OPHTHALMOL, V156, P1102, DOI 10.1016/j.ajo.2013.07.018; Montalban R, 2013, CORNEA, V32, P916, DOI 10.1097/ICO.0b013e3182904950; Montalban R, 2013, GRAEF ARCH CLIN EXP, V251, P1547, DOI 10.1007/s00417-013-2261-3; Montalban R, 2013, J CATARACT REFR SURG, V39, P211, DOI 10.1016/j.jcrs.2012.10.033; Pinero DP, 2012, J CATARACT REFR SURG, V38, P2167, DOI 10.1016/j.jcrs.2012.10.022; Pinero DP, 2010, J CATARACT REFR SURG, V36, P814, DOI 10.1016/j.jcrs.2009.11.012; Prakash G, 2012, EYE, V26, P650, DOI 10.1038/eye.2011.365; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Ramos-Lopez D, 2013, OPTOMETRY VISION SCI, V90, P335, DOI 10.1097/OPX.0b013e3182843f2a; Vazquez PRR, 2014, AM J OPHTHALMOL, V158, P32, DOI 10.1016/j.ajo.2014.03.018; Saad A., 2012, INT J KERATOCONUS EC, V1, P100, DOI [DOI 10.5005/JP-J0UR-NALS-10025-1019, 10.5005/jp-journals-10025-1019, DOI 10.5005/JP-JOURNALS-10025-1019]; Steinberg J, 2015, ACTA OPHTHALMOL, V93, pe199, DOI 10.1111/aos.12590; Tomidokoro A, 2000, OPHTHALMOLOGY, V107, P1328, DOI 10.1016/S0161-6420(00)00159-7; Touboul D, 2011, J CATARACT REFR SURG, V37, P2144, DOI 10.1016/j.jcrs.2011.06.029; Ucakhan OO, 2011, J CATARACT REFR SURG, V37, P1116, DOI 10.1016/j.jcrs.2010.12.049; Wahba SS, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/6392472	27	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184569	10.1371/journal.pone.0184569	http://dx.doi.org/10.1371/journal.pone.0184569			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886157	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100158
J	Davidov, DM; Davis, SM; Zhu, MT; Afifi, TO; Kimber, M; Goldstein, AL; Pitre, N; Gurka, KK; Stocks, C				Davidov, Danielle M.; Davis, Stephen M.; Zhu, Motao; Afifi, Tracie O.; Kimber, Melissa; Goldstein, Abby L.; Pitre, Nicole; Gurka, Kelly K.; Stocks, Carol			Intimate partner violence-related hospitalizations in Appalachia and the non-Appalachian United States	PLOS ONE			English	Article							PHYSICAL HEALTH CONSEQUENCES; EMERGENCY-DEPARTMENTS; DOMESTIC VIOLENCE; SUBSTANCE-ABUSE; NATIONAL-SURVEY; RISK-FACTORS; OF-LIFE; PREVALENCE; WOMEN; CARE	The highly rural region of Appalachia faces considerable socioeconomic disadvantage and health disparities that are recognized risk factors for intimate partner violence (IPV). The objective of this study was to estimate the rate of IPV-related hospitalizations in Appalachia and the non-Appalachian United States for 2007-2011 and compare hospitalizations in each region by clinical and sociodemographic factors. Data on IPV-related hospitalizations were extracted from the State Inpatient Databases, which are part of the Healthcare Cost and Utilization Project. Hospitalization day, year, in-hospital mortality, length of stay, average and total hospital charges, sex, age, payer, urban-rural location, income, diagnoses and procedures were compared between Appalachian and non-Appalachian counties. Poisson regression models were constructed to test differences in the rate of IPV-related hospitalizations between both regions. From 2007-2011, there were 7,385 hospitalizations related to IPV, with one-third (2,645) occurring in Appalachia. After adjusting for age and rurality, Appalachian counties had a 22% higher hospitalization rate than non-Appalachian counties (ARR = 1.22, 95% CI: 1.14-1.31). Appalachian residents may be at increased risk for IPV and associated conditions. Exploring disparities in healthcare utilization and costs associated with IPV in Appalachia is critical for the development of programs to effectively target the needs of this population.	[Davidov, Danielle M.; Davis, Stephen M.] West Virginia Univ, Dept Emergency Med & Social & Behav Sci, Morgantown, WV 26506 USA; [Davidov, Danielle M.] West Virginia Univ, Dept Social & Behav Sci, Morgantown, WV 26506 USA; [Zhu, Motao; Gurka, Kelly K.] West Virginia Univ, Dept Epidemiol, Morgantown, WV USA; [Afifi, Tracie O.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB, Canada; [Afifi, Tracie O.] Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada; [Kimber, Melissa] McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON, Canada; [Goldstein, Abby L.] Univ Toronto, Dept Appl Psychol & Human Dev, OISE, Toronto, ON, Canada; [Pitre, Nicole] Univ Alberta, Fac Nursing, Edmonton, AB, Canada; [Stocks, Carol] Agcy Healthcare Res & Qual, Rockville, MD USA; [Zhu, Motao] Nationwide Childrens Hosp, Ctr Injury Res & Policy, Res Inst, Columbus, OH USA; [Zhu, Motao] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Gurka, Kelly K.] Univ Florida, Dept Epidemiol, Gainesville, FL USA	West Virginia University; West Virginia University; West Virginia University; University of Manitoba; University of Manitoba; McMaster University; University of Toronto; University of Alberta; Agency for Healthcare Research & Quality; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University; State University System of Florida; University of Florida	Davidov, DM (corresponding author), West Virginia Univ, Dept Emergency Med & Social & Behav Sci, Morgantown, WV 26506 USA.; Davidov, DM (corresponding author), West Virginia Univ, Dept Social & Behav Sci, Morgantown, WV 26506 USA.	ddavidov@hsc.wvu.edu; carol.stocks@ahrq.hhs.gov	Kimber, Melissa/ABH-5900-2020; Gurka, Kelly K./M-2004-2014	Kimber, Melissa/0000-0002-1255-8947; Gurka, Kelly K./0000-0003-2779-3234; afifi, tracie/0000-0002-3745-9785; zhu, motao/0000-0001-5639-4801; Davidov, Danielle/0000-0002-6754-6724	Canadian Institutes of Health Research Institute of Gender and Health; Institute of Neurosciences Mental Health and Addictions [RDG99326]; National Institute Of General Medical Sciences of the National Institutes of Health [U54GM104942]; National Institute on Minority Health and Health Disparities; Research Manitoba Establishment Award; Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	Canadian Institutes of Health Research Institute of Gender and Health(Canadian Institutes of Health Research (CIHR)); Institute of Neurosciences Mental Health and Addictions; National Institute Of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Research Manitoba Establishment Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Canadian Institutes of Health Research Institute of Gender and Health and Institute of Neurosciences Mental Health and Addictions to the PreVAiL Preventing Violence Across the Lifespan Research Network) (Centre for Research Development in Gender, Mental Health and Violence across the Lifespan, grant #RDG99326). DD is supported by a grant from the National Institute Of General Medical Sciences of the National Institutes of Health under Award Number U54GM104942 and a Loan Repayment Program Grant from the National Institute on Minority Health and Health Disparities. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services. TA is supported by a Research Manitoba Establishment Award and a Canadian Institutes of Health Research New Investigator Award. MK is supported by a Women's Health Scholar Post Doctoral Fellowship Award from the Ontario Ministry of Health and Long-Term Care.	ABBOTT J, 1995, JAMA-J AM MED ASSOC, V273, P1763, DOI 10.1001/jama.273.22.1763; Afifi TO, 2009, J INTERPERS VIOLENCE, V24, P1398, DOI 10.1177/0886260508322192; [Anonymous], 2016, DEF PAT CTR MED HOM; [Anonymous], APP REG DAT OV 2010; [Anonymous], 2017, REP HLTH SYST IMPR; [Anonymous], 2015, HCUP CLIN CLASS SOFT; [Anonymous], 2016, HCUP DAT; Appalachian Regional Commission, AB ARC; Bailey BA, 2010, INT J WOMENS HEALTH, V2, P183, DOI 10.2147/ijwh.s8632; Behringer B., 2006, PREV CHRONIC DIS, V3, P1; Bennett L, 2008, VAWNET, V16, P2009; Bonomi AE, 2006, AM J PREV MED, V30, P458, DOI 10.1016/j.amepre.2006.01.015; Bonomi AE, 2009, HEALTH SERV RES, V44, P1052, DOI 10.1111/j.1475-6773.2009.00955.x; Breiding MJ, 2008, AM J PREV MED, V34, P112, DOI 10.1016/j.amepre.2007.10.001; Breiding MJ, 2009, J RURAL HEALTH, V25, P240, DOI 10.1111/j.1748-0361.2009.00225.x; Breiding MatthewJ., 2015, INTIMATE PARTNER VIO; Btoush R, 2008, J EMERG NURS, V34, P419, DOI 10.1016/j.jen.2007.10.015; Btoush R, 2009, WOMEN HEALTH ISS, V19, P253, DOI 10.1016/j.whi.2009.03.004; Bushy A, 1998, J Am Med Womens Assoc (1972), V53, P53; Campbell J, 2002, ARCH INTERN MED, V162, P1157, DOI 10.1001/archinte.162.10.1157; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P527; Coker AL, 2000, ARCH FAM MED, V9, P451, DOI 10.1001/archfami.9.5.451; Coker AL, 2004, PAEDIATR PERINAT EP, V18, P260, DOI 10.1111/j.1365-3016.2004.00569.x; Coker AL, 2000, AM J PUBLIC HEALTH, V90, P553, DOI 10.2105/AJPH.90.4.553; Dunn LL, 2004, JOGNN, V33, P54, DOI 10.1177/0884217503261080; Edwards KM, 2015, TRAUMA VIOLENCE ABUS, V16, P359, DOI 10.1177/1524838014557289; Edwards KM, 2014, AM J COMMUN PSYCHOL, V53, P198, DOI 10.1007/s10464-014-9633-7; El-Bassel N, 2003, WOMEN HEALTH ISS, V13, P16, DOI 10.1016/S1049-3867(02)00142-1; El-Bassel N, 2005, AM J PUBLIC HEALTH, V95, P465, DOI 10.2105/AJPH.2003.023200; Gallup-Black A, 2005, HOMICIDE STUD, V9, P149, DOI 10.1177/1088767904274158; Gold M, 2008, J PUBLIC HEALTH MAN, pS36, DOI 10.1097/01.PHH.0000338385.82436.44; Halverson JA, 2002, ETHNIC DIS, V12, pS3; Halverson JA, 2004, ANAL DISPARITIES HLT; Healthcare Cost and Utilization Project (HCUP), 2016, AGENCY HEALTHCARE RE; Hendryx M, 2008, J RURAL HEALTH, V24, P179, DOI 10.1111/j.1748-0361.2008.00155.x; Hink AB, 2015, J TRAUMA ACUTE CARE, V79, P709, DOI 10.1097/TA.0000000000000856; Kelly U, 2010, WEST J EMERG MED, V11, P247; Kernic MA, 2000, AM J PUBLIC HEALTH, V90, P1416, DOI 10.2105/AJPH.90.9.1416; Koss M P, 1992, Arch Fam Med, V1, P53, DOI 10.1001/archfami.1.1.53; Kothari CL, 2015, ADV EMERG MED, V22; Kothari RU, 2014, J TRAUMA ACUTE CARE, V77, P129, DOI 10.1097/TA.0000000000000269; Kramer A, 2004, WOMEN HEALTH ISS, V14, P19, DOI 10.1016/j.whi.2003.12.002; Lane NM, 2012, HLTH CARE COSTS ACCE; LAST JM, 1963, LANCET, V2, P28; Lipsky S, 2004, MATERN CHILD HLTH J, V8, P55, DOI 10.1023/B:MACI.0000025727.68281.aa; Logan TK, 2003, J FAM VIOLENCE, V18, P83, DOI 10.1023/A:1022837114205; Malcoe LH, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-20; Mixer SJ, 2014, J HOSP PALLIAT NURS, V16, P526, DOI 10.1097/NJH.0000000000000114; Morenoff JD, 1997, SOC FORCES, V76, P31, DOI 10.2307/2580317; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Peek-Asa C, 2011, J WOMENS HEALTH, V20, P1743, DOI 10.1089/jwh.2011.2891; Plichta SB, 2007, TRAUMA VIOLENCE ABUS, V8, P226, DOI 10.1177/1524838007301220; Roberts GL, 1996, ANN EMERG MED, V27, P747, DOI 10.1016/S0196-0644(96)70194-4; Rudman WJ, 2000, WOMEN HEALTH, V30, P1, DOI 10.1300/J013v30n04_01; Schafer SD, 2008, PUBLIC HEALTH REP, V123, P628, DOI 10.1177/003335490812300513; Seiling S, 2003, CONSUMER INTERESTS A, V49; Shannon Lisa, 2006, Violence Vict, V21, P167, DOI 10.1891/088667006780644226; Smith SG, 2017, NATL INTIMATE PARTNE; Thomson G.E., 2006, EXAMINING HLTH DISPA; U.S. Census Bureau, 2016, POP HOUS UN EST; Wallis AB, 2010, HEALTH CARE WOMEN IN, V31, P113, DOI 10.1080/07399330903042815; Zhang Z A Infante M Meit N English M Dunn and K H Bowers, 2008, ANAL MENTAL HLTH SUB; Zhu MT, 2013, ANN EPIDEMIOL, V23, P377, DOI 10.1016/j.annepidem.2013.04.001	65	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184222	10.1371/journal.pone.0184222	http://dx.doi.org/10.1371/journal.pone.0184222			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886119	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100084
J	Festa, S; Coppotelli, BM; Madueno, L; Loviso, CL; Macchi, M; Tauil, RMN; Valacco, MP; Morelli, IS				Festa, Sabrina; Marina Coppotelli, Bibiana; Madueno, Laura; Lorena Loviso, Claudia; Macchi, Marianela; Neme Tauil, Ricardo Martin; Pia Valacco, Maria; Susana Morelli, Irma			Assigning ecological roles to the populations belonging to a phenanthrene-degrading bacterial consortium using omic approaches	PLOS ONE			English	Article							RING-HYDROXYLATING OXYGENASES; CONTAMINATED SOIL; BIODEGRADATION; BURKHOLDERIA; BIOAUGMENTATION; DEGRADATION; STRAIN; SPHINGOMONAS; ENUMERATION; REMEDIATION	The present study describes the behavior of a natural phenanthrene-degrading consortium (CON), a synthetic consortium (constructed with isolated strains from CON) and an isolated strain form CON (Sphingobium sp. AM) in phenanthrene cultures to understand the interactions among the microorganisms present in the natural consortium during phenanthrene degradation as a sole carbon and energy source in liquid cultures. In the contaminant degradation assay, the defined consortium not only achieved a major phenanthrene degradation percentage (> 95%) but also showed a more efficient elimination of the intermediate metabolite. The opposite behavior occurred in the CON culture where the lowest phenanthrene degradation and the highest HNA accumulation were observed, which suggests the presence of positive and also negative interaction in CON. To consider the uncultured bacteria present in CON, a metagenomic library was constructed with total CON DNA. One of the resulting scaffolds (S1P3) was affiliated with the Betaproteobacteria class and resulted in a significant similarity with a genome fragment from Burkholderia sp. HB1 chromosome 1. A complete gene cluster, which is related to one of the lower pathways (meta-cleavage of catechol) involved in PAH degradation (ORF 31-43), mobile genetic elements and associated proteins, was found. These results suggest the presence of at least one other microorganism in CON besides Sphingobium sp. AM, which is capable of degrading PAH through the meta-cleavage pathway. Burkholderiales order was further found, along with Sphingomonadales order, by a metaproteomic approach, which indicated that both orders were metabolically active in CON. Our results show the presence of negative interactions between bacterial populations found in a natural consortium selected by enrichment techniques; moreover, the synthetic syntrophic processing chain with only one microorganism with the capability of degrading phenanthrene was more efficient in contaminant and intermediate metabolite degradation than a generalist strain (Sphingobium sp. AM).	[Festa, Sabrina; Marina Coppotelli, Bibiana; Madueno, Laura; Macchi, Marianela; Susana Morelli, Irma] UNLP, CINDEFI, Ctr Invest Desarrollo Fermentac Ind, La Plata, Buenos Aires, Argentina; [Festa, Sabrina; Marina Coppotelli, Bibiana; Madueno, Laura; Macchi, Marianela; Susana Morelli, Irma] Consejo Nacl Invest Cient & Tecn, CCT La Plata, La Plata, Buenos Aires, Argentina; [Lorena Loviso, Claudia] Consejo Nacl Invest Cient & Tecn, CENPAT, Ctr Nacl Patagon, Puerto Madryn, Chubut, Argentina; [Neme Tauil, Ricardo Martin; Pia Valacco, Maria] UBA, CONICET, IQUIBICEN, Fac Ciencias Exactas & Nat,Ctr Estudios Quim & Bi, Buenos Aires, DF, Argentina; [Susana Morelli, Irma] Comis Invest Cient Prov Buenos Aires, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Comision de Investigaciones Cientificas	Festa, S (corresponding author), UNLP, CINDEFI, Ctr Invest Desarrollo Fermentac Ind, La Plata, Buenos Aires, Argentina.; Festa, S (corresponding author), Consejo Nacl Invest Cient & Tecn, CCT La Plata, La Plata, Buenos Aires, Argentina.	sabrinafesta@yahoo.com.ar		Macchi, Marianela/0000-0002-7339-3795; Coppotelli, Bibiana/0000-0003-3439-5170	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT2013-0103]; CONICET; FYPF; CIC	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FYPF; CIC	This research was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT2013-0103) http://www.agencia.mincyt.gob.ar/ CONICET, FYPF and CIC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Atllas R, 1998, MICROBIAL ECOLOGY FU; Benndorf D, 2007, ISME J, V1, P224, DOI 10.1038/ismej.2007.39; Celiker H, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.54; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chakraborty J, 2014, ENV MICROBIOL REP, V6, P519, DOI 10.1111/1758-2229.12182; Chakraborty R, 2012, CURR OPIN BIOTECH, V23, P483, DOI 10.1016/j.copbio.2012.01.015; Chauhan A, 2010, BIODEGRADATION, V21, P861, DOI 10.1007/s10532-010-9361-0; Chen Y., 2010, 2010 AS PAC POW EN E, P1, DOI 10.1109/APPEEC.2010.5448560; Chistoserdova L, 2014, MICROB BIOTECHNOL, V7, P1, DOI 10.1111/1751-7915.12077; Coenye T, 2007, BURKHOLDERIA MOLECUL; De Roy K, 2014, ENVIRON MICROBIOL, V16, P1472, DOI 10.1111/1462-2920.12343; Desai C, 2010, BIORESOURCE TECHNOL, V101, P1558, DOI 10.1016/j.biortech.2009.10.080; El Amrani A, 2015, ENVIRON SCI TECHNOL, V49, P11281, DOI 10.1021/acs.est.5b01740; Entcheva P, 2001, APPL ENVIRON MICROB, V67, P89, DOI 10.1128/AEM.67.1.89-99.2001; Escalante AE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00143; Festa S, 2016, APPL SOIL ECOL, V98, P8, DOI 10.1016/j.apsoil.2015.08.025; Festa S, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw125; Festa S, 2013, INT BIODETER BIODEGR, V85, P42, DOI 10.1016/j.ibiod.2013.06.006; Fuentes MS, 2014, BIOREMEDIATION IN LATIN AMERICA: CURRENT RESEARCH AND PERSPECTIVES, P267, DOI 10.1007/978-3-319-05738-5_17; Fuentes MS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/392573; Ghevariya CM, 2011, METHODOLOGY BIORESOU, V102; Gieg LM, 2014, CURR OPIN BIOTECH, V27, P21, DOI 10.1016/j.copbio.2013.09.002; Goldschmidt F, 2016, ROLE METABOLIC INTER; Huang X, 2008, MAR POLLUT BULL, V57, P538, DOI 10.1016/j.marpolbul.2007.12.013; Izmalkova T Yu, 2013, Genetika, V49, P703; Janbandhu A, 2011, J HAZARD MATER, V187, P333, DOI 10.1016/j.jhazmat.2011.01.034; Jiang HL, 2007, APPL MICROBIOL BIOT, V75, P1191, DOI 10.1007/s00253-007-0917-9; Joshi VV, 2015, BIOREMEDIAT J, V19, P160, DOI 10.1080/10889868.2014.995369; Kang H, 2003, CAN J MICROBIOL, V49, P139, DOI 10.1139/W03-009; Khara P, 2014, FEBS OPEN BIO, V4, P290, DOI 10.1016/j.fob.2014.03.001; Khomenkov V G, 2005, Prikl Biokhim Mikrobiol, V41, P298; Kim SJ, 2009, CURR OPIN MICROBIOL, V12, P301, DOI 10.1016/j.mib.2009.03.006; Kunze M, 2009, MICROBIOL-SGM, V155, P4069, DOI 10.1099/mic.0.032110-0; Laurie AD, 1999, J BACTERIOL, V181, P531, DOI 10.1128/JB.181.2.531-540.1999; Liu DM, 2015, MICROB BIOTECHNOL, V8, P950, DOI 10.1111/1751-7915.12290; Martinez P, 2007, ARCH MICROBIOL, V188, P289, DOI 10.1007/s00203-007-0247-4; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; NELSON MJK, 1987, APPL ENVIRON MICROB, V53, P949, DOI 10.1128/AEM.53.5.949-954.1987; Ohtsubo Y, 2015, AM SOC MICROBIOLOGY, V3; Palleja A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-335; Patil KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038581; Perez-Pantoja D, 2012, ENVIRON MICROBIOL, V14, P1091, DOI 10.1111/j.1462-2920.2011.02613.x; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Ren HJ, 2012, CHEM RES CHINESE U, V28, P666; Salles JF, 2002, APPL ENVIRON MICROB, V68, P1595, DOI 10.1128/AEM.68.4.1595-1603.2002; Schneider T, 2010, PROTEOMICS, V10, P785, DOI 10.1002/pmic.200900450; Seo JS, 2007, BIODEGRADATION, V18, P123, DOI 10.1007/s10532-006-9048-8; Sharma P, 2008, INDIAN J MICROBIOL, V48, P173, DOI 10.1007/s12088-008-0031-4; Stump SM, 2016, J THEOR BIOL, V404, P348, DOI 10.1016/j.jtbi.2016.06.019; Suenaga H, 2009, ISME J, V3, P1335, DOI 10.1038/ismej.2009.76; Tao XQ, 2007, PROCESS BIOCHEM, V42, P401, DOI 10.1016/j.procbio.2006.09.018; Tauler M, 2016, APPL MICROBIOL BIOT, V100, P3321, DOI 10.1007/s00253-015-7195-8; Tiwari JN, 2010, WORLD J MICROB BIOT, V26, P1727, DOI 10.1007/s11274-010-0350-6; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Vinas M, 2005, APPL ENVIRON MICROB, V71, P7008, DOI 10.1128/AEM.71.11.7008-7018.2005; Waigi MG, 2015, INT BIODETER BIODEGR, V104, P333, DOI 10.1016/j.ibiod.2015.06.008; Wang C, 2016, INT J FUTUR GENER CO, V9, P1, DOI 10.14257/ijfgcn.2016.9.3.01; Wang J, 2007, PETROL SCI, V4, P68, DOI 10.1007/s12182-007-0012-y; Williams MA, 2010, SOIL BIOL BIOCHEM, V42, P1148, DOI 10.1016/j.soilbio.2010.03.021; Wongwilaiwalin S, 2013, APPL MICROBIOL BIOT, V97, P8941, DOI 10.1007/s00253-013-4699-y; Wrenn BA, 1996, CAN J MICROBIOL, V42, P252, DOI 10.1139/m96-037	61	20	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184505	10.1371/journal.pone.0184505	http://dx.doi.org/10.1371/journal.pone.0184505			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886166	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100141
J	Must, K; Hytonen, MK; Orro, T; Lohi, H; Jokelainen, P				Must, Kart; Hytonen, Marjo K.; Orro, Toomas; Lohi, Hannes; Jokelainen, Pikka			Toxoplasma gondii seroprevalence varies by cat breed	PLOS ONE			English	Article							FELINE INFECTIOUS PERITONITIS; FATAL TOXOPLASMOSIS; OTOCOLOBUS-MANUL; PREVALENCE; FINLAND; DISEASE; SERIES; HOST	Toxoplasma gondii is a widespread zoonotic parasite that is relevant for veterinary and public health. The domestic cat, the definitive host species with the largest worldwide population, has become evolutionarily and epidemiologically the most important host of T. gondii. The outcome of T. gondii infection is influenced by congenital and acquired host characteristics. We detected differences in T. gondii seroprevalence by cat breed in our previous studies. The aims of this study were to estimate T. gondii seroprevalence in selected domestic cat breeds, and to evaluate whether being of a certain breed is associated with T. gondii seropositivity, when the age and lifestyle of the cat are taken into account. The studied breeds were the Birman, British Shorthair, Burmese, Korat, Norwegian Forest Cat, Ocicat, Persian, and Siamese. Plasma samples were analyzed for the presence of immunoglobulin G antibodies against T. gondii with a commercial direct agglutination test at dilution 1: 40. The samples were accompanied by owner-completed questionnaires that provided background data on the cats. Overall, 41.12% of the 1121 cats tested seropositive, and the seroprevalence increased with age. The Burmese had the lowest seroprevalence (18.82%) and the Persian had the highest (60.00%). According to the final multivariable logistic regression model, the odds to test seropositive were four to seven times higher in Birmans, Ocicats, Norwegian Forest Cats, and Persians when compared with the Burmese, while older age and receiving raw meat were also risk factors for T. gondii seropositivity. This study showed that T. gondii seroprevalence varies by cat breed and identified being of certain breeds, older age, and receiving raw meat as risk factors for seropositivity.	[Must, Kart; Orro, Toomas; Jokelainen, Pikka] Estonian Univ Life Sci, Inst Vet Med & Anim Sci, Tartu, Estonia; [Hytonen, Marjo K.; Lohi, Hannes] Univ Helsinki, Res Programs Unit, Mol Neurol, Helsinki, Finland; [Hytonen, Marjo K.; Lohi, Hannes] Folkhalsan Inst Genet, Helsinki, Finland; [Hytonen, Marjo K.; Lohi, Hannes; Jokelainen, Pikka] Univ Helsinki, Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Jokelainen, Pikka] Statens Serum Inst, Copenhagen, Denmark	Estonian University of Life Sciences; University of Helsinki; University of Helsinki; Statens Serum Institut	Must, K (corresponding author), Estonian Univ Life Sci, Inst Vet Med & Anim Sci, Tartu, Estonia.	k2rtmust@gmail.com	Jokelainen, Pikka/U-7238-2019; Lohi, Hannes/F-4596-2011; Orro, Toomas/I-3727-2018	Jokelainen, Pikka/0000-0002-3035-5094; Lohi, Hannes/0000-0003-1087-5532; Orro, Toomas/0000-0002-4895-8029; Hytonen, Marjo/0000-0003-1976-5874; Must, Kart/0000-0001-9174-9591	Finnish Cat Association; Estonian University of Life Sciences [M14143VLVP]; Base Financing of Estonian University of Life Sciences [8P160014VLVP]	Finnish Cat Association; Estonian University of Life Sciences; Base Financing of Estonian University of Life Sciences	The study was supported by the Finnish Cat Association, by project funding M14143VLVP from the Strategic Development Fund of the Estonian University of Life Sciences, and by project funding 8P160014VLVP from Base Financing of Estonian University of Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahman S, 2007, MED MYCOL, V45, P449, DOI 10.1080/13693780701377170; Alvarado-Esquivel C, 2015, EUR J MICROBIOL IMMU, V5, P112, DOI [10.1556/EUJMI-D-15-00004, 10.1556/EuJMI-D-15-00004]; Basso W, 2005, PARASITOLOGY, V130, P293, DOI 10.1017/S0031182004006584; Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Cavailles P, 2006, P NATL ACAD SCI USA, V103, P744, DOI 10.1073/pnas.0506643103; Cornelissen JBWJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104740; Dean AG, OPENEPI OPEN SOURCE; Dubey JP., 2022, TOXOPLASMOSIS ANIMAL, V3rd, P1; Gazzinelli RT, 2014, CELL HOST MICROBE, V15, P132, DOI 10.1016/j.chom.2014.01.004; Golovko L, 2013, VIRUS RES, V175, P58, DOI 10.1016/j.virusres.2013.04.006; Gustafsson K, 1997, J COMP PATHOL, V117, P361, DOI 10.1016/S0021-9975(97)80083-7; Jokelainen P, 2013, J WILDLIFE DIS, V49, P527, DOI 10.7589/2011-12-352; Jokelainen P, 2012, J VET DIAGN INVEST, V24, P1115, DOI 10.1177/1040638712461787; Jokelainen P, 2012, J WILDLIFE DIS, V48, P454, DOI 10.7589/0090-3558-48.2.454; Jokelainen P, 2011, J WILDLIFE DIS, V47, P154, DOI 10.7589/0090-3558-47.1.154; Jokelainen P, 2010, VET PARASITOL, V171, P331, DOI 10.1016/j.vetpar.2010.04.008; Ketz-Riley CJ, 2003, J ZOO WILDLIFE MED, V34, P239, DOI 10.1638/01-112; Maubon D, 2008, TRENDS PARASITOL, V24, P299, DOI 10.1016/j.pt.2008.03.012; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morley EK, 2005, PARASITOLOGY, V131, P181, DOI 10.1017/S0031182005007614; Must K, 2015, VECTOR-BORNE ZOONOT, V15, P597, DOI 10.1089/vbz.2015.1809; Pas A, 2008, J ZOO WILDLIFE MED, V39, P362, DOI 10.1638/2007-0149.1; Pesteanu-Somogyi LD, 2006, J FELINE MED SURG, V8, P1, DOI 10.1016/j.jfms.2005.04.003; Rochet E, 2015, INFECT IMMUN, V83, P2109, DOI 10.1128/IAI.02985-14; Sergent W, 2005, INFECT IMMUN, V73, P6990, DOI 10.1128/IAI.73.10.6990-6997.2005; Sneidere A, 2017, VECTOR BORNE ZOONOTI; Spycher A, 2011, J VET DIAGN INVEST, V23, P104, DOI 10.1177/104063871102300117; Subauste CS, 2011, OCUL IMMUNOL INFLAMM, V19, P297, DOI 10.3109/09273948.2010.605198; Yap GS, 2006, MICROBES INFECT, V8, P1174, DOI 10.1016/j.micinf.2005.10.031	29	21	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184659	10.1371/journal.pone.0184659	http://dx.doi.org/10.1371/journal.pone.0184659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886182	gold, Green Submitted, Green Published			2022-12-27	WOS:000410001100175
J	Vaesen, K; Katzav, J				Vaesen, Krist; Katzav, Joel			How much would each researcher receive if competitive government research funding were distributed equally among researchers?	PLOS ONE			English	Article							GRANT APPLICATIONS; SYSTEM; VALIDITY; SCIENCE; TIME	Scientists are increasingly dissatisfied with funding systems that rely on peer assessment and, accordingly, have suggested several proposals for reform. One of these proposals is to distribute available funds equally among all qualified researchers, with no interference from peer review. Despite its numerous benefits, such egalitarian sharing faces the objection, among others, that it would lead to an unacceptable dilution of resources. The aim of the present paper is to assess this particular objection. We estimate (for the Netherlands, the U. S. and the U. K.) how much researchers would receive were they to get an equal share of the government budgets that are currently allocated through competitive peer assessment. For the Netherlands, we furthermore estimate what researchers would receive were we to differentiate between researchers working in low-cost, intermediate-cost and high-cost disciplines. Given these estimates, we then determine what researchers could afford in terms of PhD students, Postdocs, travel and equipment. According to our results, researchers could, on average, maintain current PhD student and Postdoc employment levels, and still have at their disposal a moderate (the U. K.) to considerable (the Netherlands, U. S.) budget for travel and equipment. This suggests that the worry that egalitarian sharing leads to unacceptable dilution of resources is unjustified. Indeed, our results strongly suggest that there is room for far more egalitarian distribution of funds than happens in the highly competitive funding schemes so prevalent today.	[Vaesen, Krist] Eindhoven Univ Technol, Sch Innovat Sci, Eindhoven, Netherlands; [Vaesen, Krist] Leiden Univ, Fac Archaeol, Human Origins Grp, Leiden, Netherlands; [Katzav, Joel] Univ Queensland, Sch Hist & Philosoph Inquiry, St Lucia, Qld, Australia	Eindhoven University of Technology; Leiden University; Leiden University - Excl LUMC; University of Queensland	Vaesen, K (corresponding author), Eindhoven Univ Technol, Sch Innovat Sci, Eindhoven, Netherlands.; Vaesen, K (corresponding author), Leiden Univ, Fac Archaeol, Human Origins Grp, Leiden, Netherlands.	k.vaesen@tue.nl		Vaesen, Krist/0000-0002-7496-7463	Netherlands Organisation for Scientific Research (NWO) [276-20-021]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	KV received support from the Netherlands Organisation for Scientific Research (NWO), grant number 276-20-021. See: ham://www.nwo.ni/en/research-and-results/researchprojects/I/98/11799.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, PHD STUDENT SALARIES; Association of Universities in the Netherlands, 2016, PROM; Association of Universities in the Netherlands, 2016, PHD STUD; Association of Universities in the Netherlands, 2015, PERS 2014; Association of Universities in the Netherlands. Bekostiging Universiteiten, 2016, BEK U; Benda WGG, 2011, INT J FORECASTING, V27, P166, DOI 10.1016/j.ijforecast.2010.03.003; Bollen J, 2014, EMBO REP, V15, P131, DOI 10.1002/embr.201338068; Bornmann L, 2010, J INFORMETR, V4, P211, DOI 10.1016/j.joi.2009.10.004; Cheng BLM, 2014, LATEST PHD GRADUATE; Fang FC, 2016, MBIO, V7, DOI 10.1128/mBio.00422-16; Fortin JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065263; Germain RN, 2015, CELL, V161, P1485, DOI 10.1016/j.cell.2015.05.052; Gordon R, 2009, ACCOUNT RES, V16, P13, DOI 10.1080/08989620802689821; Gov. uk, 2016, EMPL INC MAN; Gov. uk, 2016, INC TAX RAT PERS ALL; Herbert DL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004462; Herbert DL, 2013, NATURE, V495, P314, DOI 10.1038/495314d; Higher Education Funding Council for England, 2016, STAFF EMPL HEFCE FUN; Higher Education Funding Council for England, QUAL REL RES FUND DA; Higher Education Statistics Agency, 2014, STAFF HIGH ED PROV U; Ioannidis JPA, 2011, NATURE, V477, P529, DOI 10.1038/477529a; Johnson VE, 2008, P NATL ACAD SCI USA, V105, P11076, DOI 10.1073/pnas.0804538105; Langfeldt L, 2001, SOC STUD SCI, V31, P820, DOI 10.1177/030631201031006002; Ledford H, 2016, NATURE, V533, P450, DOI 10.1038/nature.2016.19949; Marsh HW, 2008, AM PSYCHOL, V63, P160, DOI 10.1037/0003-066X.63.3.160; Mietchen D, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002027; National Center for Education Statistics, 2011, FALL 2011 STUD FIN A; National Science Board, 2013, 208 NAT HIGHW TRAFF; National Science Foundation, 2012, HIGH ED RES DEV SYRV; National Science Foundation, 2012, HIGH ED RES DEV SURV; National Science Foundation, 2013, FY 2012 AG FIN REP; National Science Foundation, 2015, REP NAT SCI BOARD NA; National Science Foundation, 2012, FY 2011 AG FIN REP; National Science Foundation, 2012, GRAD STUD POSTD SCI; Netherlands Organisation for Scientific Research, 2015, JAARVERSLAG 2014; Netherlands Organisation for Scientific Research, 2013, SAL TAB TOP GRANTS; Neufeld J, 2016, RES EVALUAT, V25, P50, DOI 10.1093/reseval/rvv029; Pollart SM, 2015, ACAD MED, V90, P355, DOI 10.1097/ACM.0000000000000470; Research Councils UK, 2006, REP RES COUNC UK EFF; ROY R, 1985, SCI TECHNOL HUM VAL, P73; Royal Society, 2015, BREXIT IMPACT UK EU; Tax Foundation, 2016, AX BRACK; The Royal Society, 2017, NEWT INT FELL; UK Department for Business Innovation & Skills, 2010, ALL SCI RES FUND; Universities UK, 2015, HIGH ED FACTS FIG 20; Vennekens A, 2016, TOTALE INVESTERINGEN; Wessely S, 1998, LANCET, V352, P301, DOI 10.1016/S0140-6736(97)11129-1; Wilsdon J., 2015, METRIC TIDE LIT REV	48	25	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183967	10.1371/journal.pone.0183967	http://dx.doi.org/10.1371/journal.pone.0183967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886054	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100049
J	Wan, X; Liu, YY; Zhao, YY; Sun, XQ; Fan, DX; Guo, L				Wan, Xing; Liu, Yuanyuan; Zhao, Yuyan; Sun, Xiaoqi; Fan, Dongxiao; Guo, Lei			Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1 alpha-dependent and -independent mechanism	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; PERIPHERAL-TISSUES; SIGNALING PATHWAY; GASTRIC-CANCER; RECEPTOR; HYPOXIA; EXPRESSION; APOPTOSIS; GROWTH; PROTEIN	Orexins are hypothalamic neuropeptides that regulate feeding, reward, wakefulness and energy homeostasis. The present study sought to characterize the involvement of orexin A in glucose metabolism in HepG2 human hepatocellular carcinoma cells, and investigated the role of hypoxia-inducible factor-1 alpha (HIF-1 alpha) in the response. HepG2 cells were exposed to different concentrations of orexin A (10(-9) to 10(-7) M) in vitro, without or with the orexin receptor 1 (OX1R) inhibitor (SB334867), HIF-1 alpha inhibitor (YC-1) or a combination of both inhibitors. Subsequently, OX1R, HIF-1 alpha expression and localization, glucose uptake, glucose transporter 1 (GLUT1) expression and ATP content were measured. We further investigated the intracellular fate of glucose by measuring the gene expression of pyruvate dehydrogenase kinase 1 (PDK1), lactate dehydrogenase (LDHA) and pyruvate dehydrogenase B (PDHB), as well as metabolite levels including lactate generation and mitochondrial pyruvate dehydrogenase (PDH) activity. The activity of phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway was also assessed. Our results showed that the expression of OX1R was predominantly located in the nucleus in HepG2 cells. Orexin A oxygen-independently promoted the mRNA and protein expression of HIF-1 alpha as well as its nuclear accumulation in HepG2 cells and the elevated HIF-1 alpha protein was associated, at least partly, with the activation of the PI3K/Akt/mTOR pathway. Orexin A stimulated GLUT1 expression, glucose uptake as well as ATP generation in HepG2 cells via OX1R acting through the HIF-1 alpha pathway. Moreover, orexin A inhibited LDHA, PDK1 expression and lactate production, stimulated PDHB expression and PDH enzyme activity independent of HIF-1 alpha. Our results indicated that orexin signaling facilitated the glucose flux into mitochondrial oxidative metabolism rather than glycolysis in HepG2 cells. These findings provide new insight into the regulation of glucose metabolism by orexin A in hepatocellular carcinoma cells.	[Wan, Xing] China Med Univ, Affiliated Hosp 1, Dept Med Oncol, Shenyang, Liaoning, Peoples R China; [Liu, Yuanyuan; Zhao, Yuyan; Sun, Xiaoqi] China Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shenyang, Liaoning, Peoples R China; [Fan, Dongxiao; Guo, Lei] China Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University	Zhao, YY (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Endocrinol, Shenyang, Liaoning, Peoples R China.; Guo, L (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Shenyang, Liaoning, Peoples R China.	g572@sina.com; guolei@cmu.edu.cn	liu, yuanyuan/GWZ-5838-2022		National Natural Science Foundation of China [81071460, 81271996]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant numbers 81071460, 81271996).r We are thankful to China medical university affiliated hospital laboratory center for kindly providing equipments needed. We thank Ms. Liang Zhang for excellent technical assistance. This work was supported by the National Natural Science Foundation of China (grant numbers 81071460 and 81271996).	Agani F, 2013, CURR CANCER DRUG TAR, V13, P245, DOI 10.2174/1568009611313030003; Alexandre D, 2014, EUR J CANCER, V50, P2126, DOI 10.1016/j.ejca.2014.05.008; Amann T, 2009, AM J PATHOL, V174, P1544, DOI 10.2353/ajpath.2009.080596; Bieganska K, 2012, J MOL NEUROSCI, V48, P706, DOI 10.1007/s12031-012-9799-0; Butterick TA, 2013, REV ENDOCR METAB DIS, V14, P357, DOI 10.1007/s11154-013-9259-3; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Feng Y, 2014, NEUROSCI LETT, V579, P35, DOI 10.1016/j.neulet.2014.07.014; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Han XQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100380; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ju SJ, 2014, INT J MOL MED, V34, P153, DOI 10.3892/ijmm.2014.1769; Kaelin WG, 2005, BIOCHEM BIOPH RES CO, V338, P627, DOI 10.1016/j.bbrc.2005.08.165; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karteris E, 2003, J PHARMACOL SCI, V93, P126, DOI 10.1254/jphs.93.126; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kishida M, 2012, ONCOL LETT, V3, P525, DOI 10.3892/ol.2011.528; Kodadek T, 2010, MOL BIOSYST, V6, P1366, DOI 10.1039/c003468a; Lee BL, 2008, CARCINOGENESIS, V29, P44, DOI 10.1093/carcin/bgm232; Leonard CS, 2014, BRIT J PHARMACOL, V171, P294, DOI 10.1111/bph.12296; Li JC, 2014, BRIT J PHARMACOL, V171, P332, DOI 10.1111/bph.12415; Liu YY, 2015, INT J MOL MED, V35, P539, DOI 10.3892/ijmm.2014.2038; Nakabayashi M, 2003, MOL CELL ENDOCRINOL, V205, P43, DOI 10.1016/S0303-7207(03)00206-5; Obre E, 2015, INT J BIOCHEM CELL B, V59, P167, DOI 10.1016/j.biocel.2014.12.008; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Prabhu A, 2014, CANCER RES, V74, P787, DOI 10.1158/0008-5472.CAN-13-1423; Rouet-Benzineb P, 2004, J BIOL CHEM, V279, P45875, DOI 10.1074/jbc.M404136200; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schuld A, 2000, LANCET, V355, P1274, DOI 10.1016/S0140-6736(05)74704-8; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Shen Y, 2013, J STEROID BIOCHEM, V138, P376, DOI 10.1016/j.jsbmb.2013.07.005; Shiuchi T, 2009, CELL METAB, V10, P466, DOI 10.1016/j.cmet.2009.09.013; Sikder D, 2007, GENE DEV, V21, P2995, DOI 10.1101/gad.1584307; Skrzypski M, 2011, DIABETOLOGIA, V54, P1841, DOI 10.1007/s00125-011-2152-2; Sokolowska P, 2014, J MOL NEUROSCI, V52, P48, DOI 10.1007/s12031-013-0165-7; Spinazzi R, 2005, J CLIN ENDOCR METAB, V90, P3544, DOI 10.1210/jc.2004-2385; Takanaga H, 2008, BBA-BIOMEMBRANES, V1778, P1091, DOI 10.1016/j.bbamem.2007.11.015; Tsuneki H, 2008, DIABETOLOGIA, V51, P657, DOI 10.1007/s00125-008-0929-8; Tsuneki H, 2015, DIABETES, V64, P459, DOI 10.2337/db14-0695; Voisin T, 2006, ENDOCRINOLOGY, V147, P4977, DOI 10.1210/en.2006-0201; Voisin T, 2011, CANCER RES, V71, P3341, DOI 10.1158/0008-5472.CAN-10-3473; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xu TR, 2013, CELL SIGNAL, V25, P2413, DOI 10.1016/j.cellsig.2013.07.025; Yuan LB, 2011, ANESTHESIOLOGY, V114, P340, DOI 10.1097/ALN.0b013e318206ff6f; Zhang Y, 2013, CANCER BIOL THER, V14, P81, DOI 10.4161/cbt.22958	50	14	16	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184213	10.1371/journal.pone.0184213	http://dx.doi.org/10.1371/journal.pone.0184213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886081	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100083
J	Song, SQ; Lin, FL; Zhu, PY; Wu, CY; Zhao, SL; Han, Q; Li, XM				Song, Shiqing; Lin, Faliang; Zhu, Pengyan; Wu, Changyan; Zhao, Shuling; Han, Qiao; Li, Xiaomei			Extract of Spatholobus suberctus Dunn ameliorates ischemia-induced injury by targeting miR-494	PLOS ONE			English	Article							PROTECTS PC12 CELLS; STROKE; APOPTOSIS; PROLIFERATION; INHIBITION; EXPRESSION; CANCER; SOX8; DIFFERENTIATION; PI3K/AKT/MTOR	Cerebral stroke is a leading cause of death and permanent disability. The current therapeutic outcome of ischemic stroke (>85% of all strokes) is very poor, thus novel therapeutic drug is urgently needed. In vitro cell model of ischemia was established by oxygen-glucose deprivation (OGD) and in vivo animal model of ischemia was established by middle cerebral artery occlusion (MCAO). The effects of Spatholobus suberctus Dunn extract (SSCE) on OGD-induced cell injury, MCAO-induced neural injury and miR-494 level were all evaluated. The possible target genes were virtually screened utilizing bioinformatics and verified by luciferase assay. Subsequently, the effects of abnormally expressed miR-494 on OGD-induced cell injury and target gene expression were determined. Additionally, whether SSCE affected target gene expression through modulation of miR-494 was studied. Finally, the effects of aberrantly expressed Sox8 on OGD-induced injury and signaling pathways were estimated. SSCE reduced OGD-induced cell injury and ameliorated MCAO-induced neuronal injury, along with down-regulation of miR-494. Then, OGD-induced cell injury was increased by miR-494 overexpression but decreased by miR-494 silence. Sox8 was a target gene of miR-494, and SSCE could up-regulate Sox8 expression via down-regulating miR-494. Afterwards, OGD-induced cell injury was proved to be increased by Sox8 inhibition but reduced by Sox8 overexpression. Finally, OGD-induced inhibition of PI3K/AKT/mTOR and MAPK pathways was further inhibited by Sox8 silence but activated by Sox8 overexpression. SSCE ameliorates ischemia-induced injury both in vitro and in vivo by miR-494-mediated modulation of Sox8, involving activations of PI3K/AKT/mTOR and MAPK pathways.	[Song, Shiqing; Lin, Faliang; Zhao, Shuling] Qingdao Univ, Med Coll, Yantai Yuhuangding Hosp, Yantai, Shandong, Peoples R China; [Zhu, Pengyan; Wu, Changyan] Yantai Hosp Tradit Chinese Med, Yantai, Shandong, Peoples R China; [Han, Qiao] Yantai Blood Ctr, Yantai, Shandong, Peoples R China; [Li, Xiaomei] Zunyi Med Coll, Affiliated Hosp, Zunyi, Guizhou, Peoples R China	Qingdao University; Zunyi Medical University	Li, XM (corresponding author), Zunyi Med Coll, Affiliated Hosp, Zunyi, Guizhou, Peoples R China.	lixiaomei0419@126.com						Castillo SD, 2012, EXPERT OPIN THER TAR, V16, P903, DOI 10.1517/14728222.2012.709239; Cocho D, 2005, NEUROLOGY, V64, P719, DOI 10.1212/01.WNL.0000152041.20486.2F; Dong HM, 2012, MOL BIOL REP, V39, P6495, DOI 10.1007/s11033-012-1477-3; Duan HF, 2015, TUMOR BIOL, V36, P6679, DOI 10.1007/s13277-015-3356-8; Feigin VL, 2007, STROKE, V38, P1734, DOI 10.1161/STROKEAHA.107.487132; Gibson CL, 2013, J CEREBR BLOOD F MET, V33, P1355, DOI 10.1038/jcbfm.2013.102; Grise EM, 2012, CURR OPIN CRIT CARE, V18, P132, DOI 10.1097/MCC.0b013e3283513279; He J-T, 2012, MOLECULES, V17, DOI DOI 10.3390/M0LECULES17010315; Herlofsen SR, 2014, STEM CELLS, V32, P1629, DOI 10.1002/stem.1642; Honardoost MA, 2015, GENE, V572, P153, DOI 10.1016/j.gene.2015.08.043; Hsiao PC, 2014, TUMOR BIOL, V35, P11903, DOI 10.1007/s13277-014-2457-0; Iwawaki Y, 2015, J BIOSCI BIOENG, V120, P456, DOI 10.1016/j.jbiosc.2015.02.006; Jeon YJ, 2013, ARTERIOSCL THROM VAS, V33, P420, DOI 10.1161/ATVBAHA.112.300251; Jiang GL, 2014, CELL MOL NEUROBIOL, V34, P591, DOI 10.1007/s10571-014-0043-z; Kawakami Z, 2011, J ETHNOPHARMACOL, V134, P74, DOI 10.1016/j.jep.2010.11.063; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; Kim SW, 2012, NEUROBIOL DIS, V46, P147, DOI 10.1016/j.nbd.2011.12.056; Lee HK, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep42891; Liu Y, 2015, GENE THER, V22, P729, DOI 10.1038/gt.2015.39; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Manfredi GI, 2015, ENDOCRINE, V48, P363, DOI 10.1007/s12020-014-0380-1; Paeme S, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-86; Pan ST, 2015, DRUG DES DEV THER, V9, P1601, DOI 10.2147/DDDT.S76057; Sun LN, 2013, INT J BIOL SCI, V9, P811, DOI 10.7150/ijbs.6734; Sun Y, 2013, CNS NEUROSCI THER, V19, P813, DOI 10.1111/cns.12142; Toyama T, 2014, NAT PROD COMMUN, V9, P1755; Toyama T, 2012, ARCH ORAL BIOL, V57, P1529, DOI 10.1016/j.archoralbio.2012.05.011; Ueda H, 2009, PHARMACOL THERAPEUT, V123, P323, DOI 10.1016/j.pharmthera.2009.05.007; Wang RK, 2015, NEUROCHEM RES, V40, P1945, DOI 10.1007/s11064-015-1690-2; Wang YM, 2012, STROKE, V43, P2444, DOI 10.1161/STROKEAHA.112.658997; Welten SMJ, 2014, CIRC RES, V115, P696, DOI 10.1161/CIRCRESAHA.114.304747; Wezel A, 2015, ANN SURG, V262, P841, DOI 10.1097/SLA.0000000000001466; Xie C, 2014, INT J CLIN EXP PATHO, V7, P6534; Xu Jian-Ya, 2010, Zhong Yao Cai, V33, P1595; Xu YR, 2017, SEMIN CELL DEV BIOL, V63, P23, DOI 10.1016/j.semcdb.2016.07.028; Zhang SQ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0918-3; Zhang Y, 2015, J PHARMACEUT BIOMED, V102, P110, DOI 10.1016/j.jpba.2014.09.006	38	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184348	10.1371/journal.pone.0184348	http://dx.doi.org/10.1371/journal.pone.0184348			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880896	Green Published, gold			2022-12-27	WOS:000409467200053
J	Kim, DJ; Norden, PR; Salvador, J; Barry, DM; Bowers, SLK; Cleaver, O; Davis, GE				Kim, Dae Joong; Norden, Pieter R.; Salvador, Jocelynda; Barry, David M.; Bowers, Stephanie L. K.; Cleaver, Ondine; Davis, George E.			Src- and Fyn-dependent apical membrane trafficking events control endothelial lumen formation during vascular tube morphogenesis	PLOS ONE			English	Article							3-DIMENSIONAL EXTRACELLULAR MATRICES; BLOOD-VESSEL FORMATION; IN-VITRO; CAPILLARY LUMEN; COLLAGEN MATRIX; CELL POLARITY; MURAL CELLS; TUBULOGENESIS; ANGIOGENESIS; REQUIRES	Here we examine the question of how endothelial cells (ECs) develop their apical membrane surface domain during lumen and tube formation. We demonstrate marked apical membrane targeting of activated Src kinases to this apical domain during early and late stages of this process. Immunostaining for phosphotyrosine or phospho-Src reveals apical membrane staining in intracellular vacuoles initially. This is then followed by vacuole to vacuole fusion events to generate an apical luminal membrane, which is similarly decorated with activated phospho-Src kinases. Functional blockade of Src kinases completely blocks EC lumen and tube formation, whether this occurs during vasculogenic tube assembly or angiogenic sprouting events. Multiple Src kinases participate in this apical membrane formation process and siRNA suppression of Src, Fyn and Yes, but not Lyn, blocks EC lumen formation. We also demonstrate strong apical targeting of Src-GFP and Fyn-GFP fusion proteins and increasing their expression enhances lumen formation. Finally, we show that Src- and Fyn-associated vacuoles track and fuse along a subapically polarized microtubule cytoskeleton, which is highly acetylated. These vacuoles generate the apical luminal membrane in a stereotypically polarized, perinuclear position. Overall, our study identifies a critical role for Src kinases in creating and decorating the EC apical membrane surface during early and late stages of lumen and tube formation, a central event in the molecular control of vascular morphogenesis.	[Kim, Dae Joong; Norden, Pieter R.; Salvador, Jocelynda; Bowers, Stephanie L. K.; Davis, George E.] Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Barry, David M.; Cleaver, Ondine] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX USA	University of Missouri System; University of Missouri Columbia; University of Texas System; University of Texas Southwestern Medical Center Dallas	Davis, GE (corresponding author), Univ Missouri, Sch Med, Dept Med Pharmacol & Physiol, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.	davisgeo@health.missouri.edu		Salvador, Jocelynda/0000-0002-5992-9135; Norden, Pieter/0000-0002-5960-5245	National Heart, Lung and Blood Institute [HL126518, HL128584]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136139, R01HL128584] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung and Blood Institute (HL126518) "GTPases as molecular gatekeepers of cytoskeletal and cellular polarization during endothelial tubulogenesis"; and National Heart, Lung and Blood Institute (HL128584) "Novel growth factor and signaling requirements for human capillary tube assembly.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Barry DM, 2016, CIRC RES, V119, P810, DOI 10.1161/CIRCRESAHA.116.309094; Barry DM, 2015, DEVELOPMENT, V142, P3058, DOI 10.1242/dev.125260; Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9; Bayless KJ, 2002, J CELL SCI, V115, P1123; Bowers SLK, 2016, ADV PHARMACOL, V77, P241, DOI 10.1016/bs.apha.2016.04.005; Bryant DM, 2014, DEV CELL, V31, P171, DOI 10.1016/j.devcel.2014.08.027; Bryant DM, 2010, NAT CELL BIOL, V12, P1035, DOI 10.1038/ncb2106; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Davis George E., 2007, Birth Defects Research, V81, P270, DOI 10.1002/bdrc.20107; Davis GE, 2015, CELL POLARITY 1: BIOLOGICAL ROLE AND BASIC MECHANISMS, P205, DOI 10.1007/978-3-319-14463-4_9; Davis GE, 2015, CONNECT TISSUE RES, V56, P392, DOI 10.3109/03008207.2015.1066781; Davis GE, 2014, DEV CELL, V31, P140, DOI 10.1016/j.devcel.2014.10.011; Davis GE, 2013, METHODS MOL BIOL, V1066, P17, DOI 10.1007/978-1-62703-604-7_2; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; Hoang MV, 2010, MICROVASC RES; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923; Kim DJ, 2013, BLOOD, V121, P3521, DOI 10.1182/blood-2012-11-470179; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Koh W, 2008, J CELL SCI, V121, P989, DOI 10.1242/jcs.020693; Koh W, 2009, J CELL SCI, V122, P1812, DOI 10.1242/jcs.045799; Koo Y, 2016, ANGIOGENESIS, V19, P173, DOI 10.1007/s10456-016-9498-5; Lampugnani MG, 2010, J CELL SCI, V123, P1073, DOI 10.1242/jcs.059329; Lanahan A, 2013, DEV CELL, V25, P156, DOI 10.1016/j.devcel.2013.03.019; Lilly B, 2009, PHYSIOL GENOMICS, V36, P69, DOI 10.1152/physiolgenomics.90318.2008; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; MarieCardine A, 1995, EUR J IMMUNOL, V25, P3290, DOI 10.1002/eji.1830251214; Nakatsu MN, 2008, METHOD ENZYMOL, V443, P65, DOI 10.1016/S0076-6879(08)02004-1; Norden PR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147758; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rocha SF, 2014, CIRC RES, V115, P581, DOI 10.1161/CIRCRESAHA.115.304718; Sacharidou A, 2010, BLOOD, V115, P5259, DOI 10.1182/blood-2009-11-252692; Salazar R, 1999, EXP CELL RES, V249, P22, DOI 10.1006/excr.1999.4460; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Smith AO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085147; Strasser GA, 2010, BLOOD, V115, P5102, DOI 10.1182/blood-2009-07-230284; Stratman AN, 2017, DEVELOPMENT, V144, P115, DOI 10.1242/dev.143131; Stratman AN, 2012, MICROSC MICROANAL, V18, P68, DOI 10.1017/S1431927611012402; Stratman AN, 2011, BLOOD, V117, P3709, DOI 10.1182/blood-2010-11-316752; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Stratman AN, 2009, BLOOD, V114, P237, DOI 10.1182/blood-2008-12-196451; Tian YM, 2009, MECH DEVELOP, V126, P710, DOI 10.1016/j.mod.2009.05.002; Wang Y, 2010, DEVELOPMENT, V137, P3119, DOI 10.1242/dev.048785; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Xu K, 2011, SEMIN CELL DEV BIOL, V22, P993, DOI 10.1016/j.semcdb.2011.05.001; Xu K, 2011, DEV CELL, V20, P526, DOI 10.1016/j.devcel.2011.02.010; Yu JXA, 2015, DEVELOPMENT, V142, P2951, DOI 10.1242/dev.123174; Zheng XJ, 2012, DEV CELL, V23, P342, DOI 10.1016/j.devcel.2012.06.004; Zovein AC, 2010, DEV CELL, V18, P39, DOI 10.1016/j.devcel.2009.12.006	52	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184461	10.1371/journal.pone.0184461	http://dx.doi.org/10.1371/journal.pone.0184461			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910325	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200048
J	Mangan, AM; Pejchar, L; Werner, SJ				Mangan, Anna M.; Pejchar, Liba; Werner, Scott J.			Bird use of organic apple orchards: Frugivory, pest control and implications for production	PLOS ONE			English	Article							SERVICES; DAMAGE; DIVERSITY; SIZE	As the largest terrestrial biomes, crop and pasturelands can have very large positive or negative impacts on biodiversity and human well-being. Understanding how animals use and impact agroecosystems is important for making informed decisions that achieve conservation and production outcomes. Yet, few studies examine the tradeoffs associated with wildlife in agricultural systems. We examined bird use of organic apple orchards as well as how birds influence fruit production positively through control of an economically important insect pest (codling moth (Cydia pomonella)) and negatively through fruit damage. We conducted transect surveys, observed bird frugivory and assessed bird and insect damage with an exclosure experiment in small organic farms in western Colorado. We found that organic apple orchards in this region provide habitat for a large number of both human-adapted and human-sensitive species and that the species in orchards were relatively similar to adjacent hedgerow habitats. Habitat use did not vary as a function of orchard characteristics, and apple damage by both birds and C. pomonella was consistent within and across apple blocks that varied in size. A small subset of bird species was observed foraging on apples yet the effect of birds as agents of fruit damage appeared rather minor and birds did not reduce C. pomonella damage. Our results demonstrate that organic apple orchards have the potential to provide habitat for diverse bird communities, including species typically sensitive to human activities, with little apparent effect on production.	[Mangan, Anna M.; Werner, Scott J.] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80521 USA; [Mangan, Anna M.; Pejchar, Liba] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	United States Department of Agriculture (USDA); Colorado State University	Mangan, AM (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80521 USA.; Mangan, AM (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.	anna.mangan@aphis.usda.gov		Pejchar, Liba/0000-0002-9253-9884	National Wildlife Research Center; United States Department of Agriculture; Wildlife Services; Arkion(R) Life Sciences; Colorado State University Center for Collaborative Conservation; Colorado Field Ornithologists; Animal and Plant Health Inspection Service	National Wildlife Research Center(United States Department of Agriculture (USDA)); United States Department of Agriculture(United States Department of Agriculture (USDA)); Wildlife Services; Arkion(R) Life Sciences; Colorado State University Center for Collaborative Conservation; Colorado Field Ornithologists; Animal and Plant Health Inspection Service	This project was funded in part by the National Wildlife Research Center, a unit within the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services (https://www.aphis.usda.gov/aphis/ourfocus/wildlifedamage/programs/nwm) and by Arkion (R) Life Sciences (http://www.arkionls.com/). The Colorado State University Center for Collaborative Conservation (www.collaborativeconservaton.org/ccc-fellows-program-overview) and the Colorado Field Ornithologists (http://cobirds.org/CFO/Grants/) also contributed small grants to AM M to support this research. Corporate collaborations do not imply endorsement by the United States Department of Agriculture. Co-authors at the National Wildlife Research Center and Colorado State University had input on the study design, data collection, analysis, writing and submission of this paper.	Agnello A, 1996, CORNELL COOPERATIVE; Altieri MA, 1999, AGR ECOSYST ENVIRON, V74, P19, DOI 10.1016/S0167-8809(99)00028-6; Anderson A, 2013, CROP PROT, V52, P103, DOI 10.1016/j.cropro.2013.05.019; Anderson D. R., 2008, MODEL BASED INFERENC; Bailey L, 2005, GEOLOGICAL SURVEY, P2327; BAILEY PT, 1979, AUST J EXP AGR, V19, P247, DOI 10.1071/EA9790247; Baumgartner JA, 1999, BIRD ARTHROPOD PREDA; Belfrage K, 2005, AMBIO, V34, P582, DOI 10.1639/0044-7447(2005)034[0582:TEOFSA]2.0.CO;2; Bouvier JC, 2011, ENVIRON TOXICOL CHEM, V30, P212, DOI 10.1002/etc.377; Buckland S.T., 2001, pi; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; BURNHAM KP, 1980, WILDLIFE MONOGR, P7; Caprile JL, 2011, PEST NOTES CODLING M; Cranshaw WS, 2013, CODLING MOTH CONTROL; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Doherty PF, 2012, J ORNITHOL, V152, pS317, DOI 10.1007/s10336-010-0598-5; ESRI, 2014, ARCGIS 10 3 DESKTOP; Farr CM, 2017, ECOL APPL; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Garfinkel M, 2015, AGR ECOSYST ENVIRON, V211, P24, DOI 10.1016/j.agee.2015.04.023; Henderson J., 1913, PRACTICAL VALUE BIRD; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Iknayan KJ, 2014, TRENDS ECOL EVOL, V29, P97, DOI 10.1016/j.tree.2013.10.012; Irvin E, 2013, J WILDLIFE MANAGE, V77, P1564, DOI 10.1002/jwmg.609; Jedlicka JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027347; Karp DS, 2014, ECOLOGY, V95, P1065, DOI 10.1890/13-1012.1; Klonsky K., 2014, SAMPLE COSTS PRODUCE; Kross SM, 2016, AGR ECOSYST ENVIRON, V225, P140, DOI 10.1016/j.agee.2016.03.043; Kross SM, 2012, CONSERV BIOL, V26, P142, DOI 10.1111/j.1523-1739.2011.01756.x; Laake JL, 2013, 7600 Sand Point Way NE, Patent No. 98115; Lindell Catherine A., 2012, Human-Wildlife Interactions, V6, P283; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; Mazerolle M. J., 2016, PACKAGE AICCMODAVG; Mols CMM, 2002, J APPL ECOL, V39, P888, DOI 10.1046/j.1365-2664.2002.00761.x; Naccari C, 2009, ENVIRON INT, V35, P594, DOI 10.1016/j.envint.2008.11.002; Peisley RK, 2016, PEERJ, V4, DOI 10.7717/peerj.2179; PEISLEY RK, 2015, SPRINGER SCI REV, V3, P113, DOI DOI 10.1007/S40362-015-0035-5; Pimentel David, 2005, Environment Development and Sustainability, V7, P229, DOI 10.1007/s10668-005-7314-2; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; R-Core-Team, 2015, LANG ENV STAT COMP; Reese GC, 2013, METHODS ECOL EVOL, V4, P891, DOI 10.1111/2041-210X.12070; Rodriguez EN, 1995, INTEGRATED STRATEGY; Rosenberg KV, 2014, STATE BIRDS; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Simpson R, 2013, CARTOGRAPHERS COLORA; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tracey J., 2007, MANAGING BIRD DAMAGE; Tracey JP, 2010, CROP PROT, V29, P435, DOI 10.1016/j.cropro.2009.10.008; USDA, 2012, 2012 CENS AGR COL ST; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	54	13	14	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183405	10.1371/journal.pone.0183405	http://dx.doi.org/10.1371/journal.pone.0183405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910290	Green Published, gold			2022-12-27	WOS:000410859200010
J	Agostini, VO; Ritter, MD; Macedo, AJ; Muxagata, E; Erthal, F				Agostini, Vanessa Ochi; Ritter, Matias do Nascimento; Macedo, Alexandre Jose; Muxagata, Erik; Erthal, Fernando			What determines sclerobiont colonization on marine mollusk shells?	PLOS ONE			English	Article							MICRO-TEXTURED SURFACES; INVERTEBRATE LARVAE; MYTILUS-GALLOPROVINCIALIS; FLOW-CYTOMETRY; TEMPORAL RESOLUTION; DEATH ASSEMBLAGES; BIOFILM FORMATION; SETTLEMENT; ATTACHMENT; TOPOGRAPHY	Empty mollusk shells may act as colonization surfaces for sclerobionts depending on the physical, chemical, and biological attributes of the shells. However, the main factors that can affect the establishment of an organism on hard substrates and the colonization patterns on modern and time-averaged shells remain unclear. Using experimental and field approaches, we compared sclerobiont (i.e., bacteria and invertebrate) colonization patterns on the exposed shells (internal and external sides) of three bivalve species (Anadara brasiliana, Mactra isabelleana, and Amarilladesma mactroides) with different external shell textures. In addition, we evaluated the influence of the host characteristics (mode of life, body size, color alteration, external and internal ornamentation and mineralogy) of sclerobionts on dead mollusk shells (bivalve and gastropod) collected from the Southern Brazilian coast. Finally, we compared field observations with experiments to evaluate how the biological signs of the present-day invertebrate settlements are preserved in molluscan death assemblages (incipient fossil record) in a subtropical shallow coastal setting. The results enhance our understanding of sclerobiont colonization over modern and paleoecology perspectives. The data suggest that sclerobiont settlement is enhanced by (i) high(er) biofilm bacteria density, which is more attracted to surfaces with high ornamentation; (ii) heterogeneous internal and external shell surface; (iii) shallow infaunal or attached epifaunal life modes; (iv) colorful or post-mortem oxidized shell surfaces; (v) shell size (<50 mm(2) or >1,351 mm(2)); and (vi) calcitic mineralogy. Although the biofilm bacteria density, shell size, and texture are considered the most important factors, the effects of other covarying attributes should also be considered. We observed a similar pattern of sclerobiont colonization frequency over modern and paleoecology perspectives, with an increase of invertebrates occurring on textured bivalve shells. This study demonstrates how bacterial biofilms may influence sclerobiont colonization on biological hosts (mollusks), and shows how ecological relationships in marine organisms may be relevant for interpreting the fossil record of sclerobionts.	[Agostini, Vanessa Ochi; Muxagata, Erik] Univ Fed Rio Grande FURG, Inst Oceanog, Lab Zooplancton, Rio Grande, RS, Brazil; [Agostini, Vanessa Ochi] Univ Fed Rio Grande FURG, Inst Oceanog, Programa Posgrad Oceanog Biol, Rio Grande, RS, Brazil; [Ritter, Matias do Nascimento] Univ Fed Rio Grande do Sul, Inst Geociencias, Programa Posgrad Geociencias, Porto Alegre, RS, Brazil; [Macedo, Alexandre Jose] Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, RS, Brazil; [Macedo, Alexandre Jose] Univ Fed Rio Grande do Sul, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Erthal, Fernando] Univ Fed Rio Grande do Sul, Inst Geociencias, Dept Paleontol & Estratig, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande; Universidade Federal do Rio Grande; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Ritter, MD (corresponding author), Univ Fed Rio Grande do Sul, Inst Geociencias, Programa Posgrad Geociencias, Porto Alegre, RS, Brazil.	mnritter@gmail.com	Agostini, Vanessa VOA/L-2497-2018; Erthal, Fernando/C-5941-2013; Muxagata, Erik/M-6563-2015; Macedo, Alexandre J/C-5178-2013; do Nascimento Ritter, Matias/A-1500-2013	Agostini, Vanessa VOA/0000-0002-8325-254X; Erthal, Fernando/0000-0001-8036-192X; Muxagata, Erik/0000-0002-4210-5252; Macedo, Alexandre J/0000-0002-8951-4029; do Nascimento Ritter, Matias/0000-0001-8150-4443	FAPERGS [1982-2551/13-7]; CNPq [141217/2014-6, 140568/2014-0]; International Ocean Discovery Program [CAPES 0195/2016-02-BEX]	FAPERGS(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); International Ocean Discovery Program	This study was partially supported by the FAPERGS (1982-2551/13-7). Additional funds were covered by the CNPq (141217/2014-6 to VOA and 140568/2014-0 to MNR), and by the International Ocean Discovery Program (CAPES 0195/2016-02-BEX to MNR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini Vanessa Ochi, 2016, Marine Biodiversity Records, V9, P84, DOI 10.1186/s41200-016-0061-2; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2006, ATLANTICA; Azevedo FBB, 2006, BRAZ ARCH BIOL TECHN, V49, P263, DOI 10.1590/S1516-89132006000300012; Bao WY, 2007, MAR BIOL, V150, P565, DOI 10.1007/s00227-006-0383-4; Barclay KM, 2013, PALAEOGEOGR PALAEOCL, V383, P79, DOI 10.1016/j.palaeo.2013.05.007; Behrensmeyer AK, 2005, PALEOBIOLOGY, V31, P607, DOI 10.1666/0094-8373(2005)031[0607:ATMDST]2.0.CO;2; Ben Abdallah L. Gargouri, 2012, Transitional Waters Bulletin, V6, P20; Berntsson KM, 2000, BIOFOULING, V16, P245, DOI 10.1080/08927010009378449; Berntsson KM, 2000, J EXP MAR BIOL ECOL, V251, P59, DOI 10.1016/S0022-0981(00)00210-0; Bers AV, 2004, BIOFOULING, V20, P43, DOI 10.1080/08927010410001655533; Best MMR, 2008, PALAIOS, V23, P796, DOI 10.2110/palo.2005.p05-076r; Bouvier T, 2001, CYTOMETRY, V44, P188, DOI 10.1002/1097-0320(20010701)44:3<188::AID-CYTO1111>3.0.CO;2-C; Brett CE, 2011, PALAEOGEOGR PALAEOCL, V312, P278, DOI 10.1016/j.palaeo.2011.05.019; Bromley RG, 2006, PALAEOGEOGR PALAEOCL, V232, P429, DOI 10.1016/j.palaeo.2005.07.007; Buckup L, 1999, CRUSTACEOS RIO GRAND; 고수근, 2011, Fisheries and Aquatic Sciences, V14, P339; Bush AM, 2011, ANNU REV EARTH PL SC, V39, P241, DOI 10.1146/annurev-earth-040809-152556; CACERESMARTINEZ J, 1994, MAR ECOL PROG SER, V112, P107, DOI 10.3354/meps112107; Callender WR, 2002, PALAIOS, V17, P50, DOI 10.1669/0883-1351(2002)017<0050:TTAAFS>2.0.CO;2; Carl C, 2012, BIOFOULING, V28, P175, DOI 10.1080/08927014.2012.662676; CHIA FS, 1979, J MORPHOL, V160, P275, DOI 10.1002/jmor.1051600303; Correa ICS, 1978, AN 30 C BRAS GEOL RE, V2, P851; Dobretsov S, 2006, J EXP MAR BIOL ECOL, V333, P263, DOI 10.1016/j.jembe.2006.01.019; Dobretsov S, 2013, BIOFOULING, V29, P423, DOI 10.1080/08927014.2013.776042; Dreanno C, 2007, J EXP MAR BIOL ECOL, V351, P276, DOI 10.1016/j.jembe.2007.07.003; Faimali M, 2004, J EXP MAR BIOL ECOL, V306, P37, DOI 10.1016/j.jembe.2003.12.019; Feng GP, 2015, NPJ BIOFILMS MICROBI, V1, DOI 10.1038/npjbiofilms.2015.22; Ferguson N, 2013, ECOLOGY, V94, P126, DOI 10.1890/12-0795.1; Freckelton ML, 2017, SCI REP-UK, V7, DOI 10.1038/srep42557; Glasby TM, 2000, J EXP MAR BIOL ECOL, V248, P177, DOI 10.1016/S0022-0981(00)00169-6; Gollner S, 2006, CAH BIOL MAR, V47, P397; Hadfield MG, 2011, ANNU REV MAR SCI, V3, P453, DOI 10.1146/annurev-marine-120709-142753; Harper EM, 2003, PALAEOGEOGR PALAEOCL, V210, P185, DOI 10.1016/S0031-0182(03)00624-2; HELDAL M, 1994, J MICROBIOL METH, V20, P255; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; Hills JM, 1998, BIOFOULING, V12, P57, DOI 10.1080/08927019809378346; Hsu LC, 2013, APPL ENVIRON MICROB, V79, P2703, DOI 10.1128/AEM.03436-12; Jenkins SR, 2003, HYDROBIOLOGIA, V503, P143, DOI 10.1023/B:HYDR.0000008496.68710.22; Johnson William S., 2012, P1; Jurgens K, 1999, APPL ENVIRON MICROB, V65, P1241; Kelley PH, 2003, PREDATOR PREY INTERA, P113; Keough MJ, 1998, J EXP MAR BIOL ECOL, V231, P1, DOI 10.1016/S0022-0981(98)00073-2; Khandeparker L, 2011, MAR ECOL-EVOL PERSP, V32, P509, DOI 10.1111/j.1439-0485.2011.00439.x; Kidwell SM, 2013, PALAEONTOLOGY, V56, P487, DOI 10.1111/pala.12042; Klompmaker AA, 2017, SCIENCE, V356, P1178, DOI 10.1126/science.aam7468; Kowalewski Michal, 2002, Paleontological Society Papers, V8, P3; Kowalewski Michal, 2003, Topics in Geobiology, V21, P1; Lescinsky HL, 2002, PALAIOS, V17, P171, DOI 10.1669/0883-1351(2002)017<0171:MSEABR>2.0.CO;2; Liow LH, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0981; Lopes R.P., 2012, SOC BRASILEIRA PALEO, V2, P179; Madin JS, 2006, SCIENCE, V312, P897, DOI 10.1126/science.1123591; Marshall DJ, 2003, MAR ECOL PROG SER, V255, P145, DOI 10.3354/meps255145; Martin-Rodriguez AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123652; Mieszkin S, 2013, BIOFOULING, V29, P1097, DOI 10.1080/08927014.2013.828712; Mikkelsen PM, 2008, SEASHELLS SO FLORIDA; MONTEFORTE M, 1994, HYDROBIOLOGIA, V291, P21, DOI 10.1007/BF00024236; Norland S., 1993, HDB METHODS AQUATIC; Olszewski TD, 2004, PALAIOS, V19, P39, DOI 10.1669/0883-1351(2004)019<0039:MTIOTD>2.0.CO;2; Petrone L, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2014.0047; Picot J, 2012, CYTOTECHNOLOGY, V64, P109, DOI 10.1007/s10616-011-9415-0; Rios E.C., 2009, COMPENDIUM BRAZILIAN; Ritter MD, 2017, PALAIOS, V32, P572, DOI 10.2110/palo.2017.003; Rodland DL, 2006, J GEOL, V114, P313, DOI 10.1086/501221; Rodland DL, 2014, PALAIOS, V29, P170, DOI 10.2110/palo.2013.033; Rodland DL, 2004, PALAIOS, V19, P381, DOI 10.1669/0883-1351(2004)019<0381:COALWE>2.0.CO;2; Santos A, 2008, GEOBIOS-LYON, V41, P43, DOI 10.1016/j.geobios.2007.01.009; Sarmento VC, 2012, J MAR BIOL ASSOC UK, V92, P1117, DOI 10.1017/S0025315411001718; Scardino AJ, 2008, BIOFOULING, V24, P45, DOI 10.1080/08927010701784391; Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717; Stanley S.M., 1970, MEM GEOL SOC AM, V125, P1, DOI DOI 10.1130/MEM125-P1; STANLEY STEVEN M., 1968, J PALEONTOL, V42, P214; Sun J, 2003, J PLANKTON RES, V25, P1331, DOI 10.1093/plankt/fbg096; SVANE I, 1995, J EXP MAR BIOL ECOL, V187, P51, DOI 10.1016/0022-0981(94)00171-9; Tait K, 2013, MOL ECOL, V22, P2588, DOI 10.1111/mec.12273; Tamburri MN, 2008, J SHELLFISH RES, V27, P601, DOI 10.2983/0730-8000(2008)27[601:SOCALE]2.0.CO;2; Taylor PD, 2016, PALAEONTOLOGY, V59, P481, DOI 10.1111/pala.12239; Taylor PD, 2003, EARTH-SCI REV, V62, P1, DOI 10.1016/S0012-8252(02)00131-9; Taylor PD, 2002, PALAIOS, V17, P522, DOI 10.1669/0883-1351(2002)017<0522:ANTFMO>2.0.CO;2; Tsuchiya M, 2002, HELGOLAND MAR RES, V56, P31, DOI 10.1007/s10152-001-0099-2; Unabia CRC, 1999, MAR BIOL, V133, P55, DOI 10.1007/s002270050442; VERMEIJ G J, 1977, Paleobiology, V3, P245; Visscher JP, 1928, BIOL BULL-US, V54, P336, DOI 10.2307/1537021; Vladkova T., 2008, SURFACE MODIFICATION, P135, DOI [10.1007/978-3-540-69796-1_7, DOI 10.1007/978-3-540-69796-1_7]; Walker S, 2012, GLOBAL BIODIVERSITY, P129, DOI DOI 10.1007/978-90-481-3428-1_; Walker SE, 1995, LETHAIA, V28, P371, DOI 10.1111/j.1502-3931.1995.tb01829.x; Whalan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117675; Whitehead KA, 2006, COLLOID SURFACE B, V51, P44, DOI 10.1016/j.colsurfb.2006.05.003; YULE AB, 1984, J MAR BIOL ASSOC UK, V64, P429, DOI 10.1017/S0025315400030101; ZARITSKY A, 1975, J THEOR BIOL, V54, P243, DOI 10.1016/S0022-5193(75)80129-9	90	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184745	10.1371/journal.pone.0184745	http://dx.doi.org/10.1371/journal.pone.0184745			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902894	Green Published, gold			2022-12-27	WOS:000410669200059
J	Hughes, K; Fosgate, GT; Budke, CM; Ward, MP; Kerry, R; Ingram, B				Hughes, Kristen; Fosgate, Geoffrey T.; Budke, Christine M.; Ward, Michael P.; Kerry, Ruth; Ingram, Ben			Modeling the spatial distribution of African buffalo (Syncerus caffer) in the Kruger National Park, South Africa	PLOS ONE			English	Article							MOUTH-DISEASE; AUTOREGRESSIVE MODELS; BOVINE TUBERCULOSIS; GROUP-SIZE; SELECTION; WILDLIFE; PATTERNS; HABITAT; LIVESTOCK; BOUNDARY	The population density of wildlife reservoirs contributes to disease transmission risk for domestic animals. The objective of this study was to model the African buffalo distribution of the Kruger National Park. A secondary objective was to collect field data to evaluate models and determine environmental predictors of buffalo detection. Spatial distribution models were created using buffalo census information and archived data from previous research. Field data were collected during the dry (August 2012) and wet (January 2013) seasons using a random walk design. The fit of the prediction models were assessed descriptively and formally by calculating the root mean square error (rMSE) of deviations from field observations. Logistic regression was used to estimate the effects of environmental variables on the detection of buffalo herds and linear regression was used to identify predictors of larger herd sizes. A zero-inflated Poisson model produced distributions that were most consistent with expected buffalo behavior. Field data confirmed that environmental factors including season (P = 0.008), vegetation type (P = 0.002), and vegetation density (P = 0.010) were significant predictors of buffalo detection. Bachelor herds were more likely to be detected in dense vegetation (P = 0.005) and during the wet season (P = 0.022) compared to the larger mixed-sex herds. Static distribution models for African buffalo can produce biologically reasonable results but environmental factors have significant effects and therefore could be used to improve model performance. Accurate distribution models are critical for the evaluation of disease risk and to model disease transmission.	[Hughes, Kristen; Fosgate, Geoffrey T.] Univ Pretoria, Dept Prod Anim Studies, Onderstepoort, South Africa; [Budke, Christine M.] Texas A&M Univ, Vet Integrat Biosci, College Stn, TX USA; [Ward, Michael P.] Univ Sydney, Fac Vet Sci, Camden, NSW, Australia; [Kerry, Ruth] Brigham Young Univ, Dept Geog, Provo, UT 84602 USA; [Ingram, Ben] Univ Talca, Fac Ingn, Curico, Chile	University of Pretoria; Texas A&M University System; Texas A&M University College Station; University of Sydney; Brigham Young University; Universidad de Talca	Fosgate, GT (corresponding author), Univ Pretoria, Dept Prod Anim Studies, Onderstepoort, South Africa.	geoffrey.fosgate@up.ac.za	Ward, Michael Patrick/W-1897-2019; Ward, Michael Patrick/GRX-1851-2022; Ward, Michael/C-5758-2009; Fosgate, Geoffrey T/N-8700-2014; Ingram, Ben/P-5777-2017	Ward, Michael Patrick/0000-0002-9921-4986; Ward, Michael/0000-0002-9921-4986; Fosgate, Geoffrey T/0000-0002-9432-0042; Ingram, Ben/0000-0003-4557-4342; Kerry, Ruth/0000-0001-9174-0167	Research Development Programme at the University of Pretoria [A0T384]; National Research Foundation [76734]	Research Development Programme at the University of Pretoria; National Research Foundation	This work was funded by the Research Development Programme (Project No. A0T384) at the University of Pretoria and Incentive Funding for Rated Researchers from the National Research Foundation (Project No. 76734). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayebazibwe C, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-54; Bar-David S, 2009, ECOLOGY, V90, P2467, DOI 10.1890/08-1532.1; Bastos ADS, 2003, J GEN VIROL, V84, P1595, DOI 10.1099/vir.0.18859-0; Bauer JJ, 2014, SOCIOL METHOD RES, V43, P519, DOI 10.1177/0049124114521150; Bonabeau E, 1999, P NATL ACAD SCI USA, V96, P4472, DOI 10.1073/pnas.96.8.4472; Brahmbhatt DP, 2012, PREV VET MED, V103, P16, DOI 10.1016/j.prevetmed.2011.08.003; Bucini G., 2010, ECOSYSTEM FUNCTION S, P219, DOI DOI 10.1201/B10275; Cross PC, 2004, ANN ZOOL FENN, V41, P879; FUNSTON PJ, 1994, AFR J ECOL, V32, P100, DOI 10.1111/j.1365-2028.1994.tb00562.x; Gertenbach WPD, 1984, KOEDOE, V26, P9; Highfield L, 2008, VET RES, V39, DOI 10.1051/vetres:2007055; Jori F, 2011, PREV VET MED, V100, P210, DOI 10.1016/j.prevetmed.2011.03.015; Jori F, 2009, REV SCI TECH OIE, V28, P917, DOI 10.20506/rst.28.3.1932; Kerry R, 2013, INT J GEOGR INF SCI, V27, P47, DOI 10.1080/13658816.2012.663917; Kerry R, 2010, GEOGR ANAL, V42, P53, DOI 10.1111/j.1538-4632.2010.00782.x; Korte LM, 2008, J ZOOL, V275, P229, DOI 10.1111/j.1469-7998.2008.00430.x; Lanzas C, 2015, PREV VET MED, V118, P207, DOI 10.1016/j.prevetmed.2014.09.012; Lee D, 2011, SPAT SPATIO-TEMPORAL, V2, P79, DOI 10.1016/j.sste.2011.03.001; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Macandza VA, 2004, S AFR J WILDL RES, V34, P113; McDowell A, 2003, STATA J, V3, P178, DOI 10.1177/1536867X0300300207; Michel AL, 2012, ONDERSTEPOORT J VET, V79, DOI 10.4102/ojvr.v79i2.453; Mloszewski M.J., 1983, pi; Monestiez P, 2006, ECOL MODEL, V193, P615, DOI 10.1016/j.ecolmodel.2005.08.042; Neelon B, 2013, J R STAT SOC A STAT, V176, P389, DOI 10.1111/j.1467-985X.2012.01039.x; Owen-Smith N, 2012, WILDLIFE RES, V39, P452, DOI 10.1071/WR12062; Palmer MV, 2013, TRANSBOUND EMERG DIS, V60, P1, DOI 10.1111/tbed.12115; Pearson K., 1905, NATURE, V72, P1; Premashthira Sith, 2011, Animal Health Research Reviews, V12, P225, DOI 10.1017/S146625231100017X; Redfern JV, 2003, ECOLOGY, V84, P2092, DOI 10.1890/01-0625; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; Seydack Armin H., 2012, Koedoe, V54, P1; Smit IPJ, 2011, ECOGRAPHY, V34, P67, DOI 10.1111/j.1600-0587.2010.06029.x; Tekleghiorghis T, 2016, TRANSBOUND EMERG DIS, V63, P136, DOI 10.1111/tbed.12248; Thomson GR, 2003, VIRUS RES, V91, P145, DOI 10.1016/S0168-1702(02)00263-0; van Schalkwyk OL, 2016, TRANSBOUND EMERG DIS, V63, P333, DOI 10.1111/tbed.12280; Ward MP, 2015, AUST VET J, V93, P4, DOI 10.1111/avj.12278; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1	40	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0182903	10.1371/journal.pone.0182903	http://dx.doi.org/10.1371/journal.pone.0182903			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902858	gold, Green Published			2022-12-27	WOS:000410669200008
J	Shetty, R; Sharma, A; Pahuja, N; Chevour, P; Padmajan, N; Dhamodaran, K; Jayadev, C; Nuijts, RMMA; Ghosh, A; Nallathambi, J				Shetty, Rohit; Sharma, Anupam; Pahuja, Natasha; Chevour, Priyanka; Padmajan, Neeraja; Dhamodaran, Kamesh; Jayadev, Chaitra; Nuijts, Rudy M. M. A.; Ghosh, Arkasubhra; Nallathambi, Jeyabalan			Oxidative stress induces dysregulated autophagy in corneal epithelium of keratoconus patients	PLOS ONE			English	Article							GENE-EXPRESSION; REACTIVE OXYGEN; GUIDELINES; APOPTOSIS; ASSAYS; DAMAGE	Oxidative stress is one of the key factors that contributes to the pathogenesis of keratoconus (KC). Macroautophagy is a vital cellular mechanism that is activated in response to oxidative stress. The aim of this study was to understand the role of the autophagic lysosomal pathway in the oxidative damage of KC corneal epithelium and the human corneal epithelial cell line (HCE). The corneal epithelium was collected from 78 KC patients undergoing corneal cross-linking or topography guided photorefractive keratectomy. We performed microarray, qPCR and western blot analysis for the expression of autophagy markers on this epithelium from patients with different clinical grades of KC. A differential expression pattern of autophagy related markers was observed in the diseased corneal cone-specific epithelium compared to matched peripheral epithelium from KC patients with increasing clinical severity. Human corneal epithelial cells exposed to oxidative stress were analyzed for the expression of key proteins associated with KC pathogenesis and the autophagic pathway. Oxidative stress led to an increase in reactive oxygen species and an imbalanced expression of autophagy markers in the HCE cells. Further, reduced levels of Akt/p70S6 Kinase, which is a known target of the mTOR pathway was observed in HCE cells under oxidative stress as well as in KC epithelium. Our results suggest that an altered expression of proteins suggestive of defective autophagy and is a consequence of oxidative damage. This could play a possible role in the pathogenesis of KC.	[Shetty, Rohit; Pahuja, Natasha; Jayadev, Chaitra] Narayana Hlth City, Narayana Nethralaya Eye Hosp, Dept Cornea & Refract Surg, Bangalore, Karnataka, India; [Sharma, Anupam; Chevour, Priyanka; Padmajan, Neeraja; Dhamodaran, Kamesh; Ghosh, Arkasubhra; Nallathambi, Jeyabalan] Narayana Nethralaya Fdn, GROW Res Lab, Bangalore, Karnataka, India; [Nuijts, Rudy M. M. A.] Maastricht Univ, Med Ctr, Maastricht, Netherlands	Maastricht University	Ghosh, A; Nallathambi, J (corresponding author), Narayana Nethralaya Fdn, GROW Res Lab, Bangalore, Karnataka, India.	arkasubhra@narayananethralaya.com; drnallathambi@narayananethralaya.com		Ghosh, Arkasubhra/0000-0002-6570-5891	Department of Science and Technology (DST)-SERB, New Delhi, India [SBNS/LS-68/2013]; Department of Atomic Energy (DAE), Board of Research in Nuclear Sciences (BRNS), Mumbai, India [37(1)/14/11/2016]; Narayana Nethralaya Foundation, Bangalore, India	Department of Science and Technology (DST)-SERB, New Delhi, India(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); Department of Atomic Energy (DAE), Board of Research in Nuclear Sciences (BRNS), Mumbai, India; Narayana Nethralaya Foundation, Bangalore, India	This study was supported by Department of Science and Technology (DST)-SERB (SBNS/LS-68/2013), New Delhi, India; Department of Atomic Energy (DAE), Board of Research in Nuclear Sciences (BRNS), (37(1)/14/11/2016) Mumbai, India; Narayana Nethralaya Foundation, Bangalore, India.	Arnal E, 2011, INVEST OPHTH VIS SCI, V52, P8592, DOI 10.1167/iovs.11-7732; Atilano SR, 2005, INVEST OPHTH VIS SCI, V46, P1256, DOI 10.1167/iovs.04-1395; Behndig A, 2001, INVEST OPHTH VIS SCI, V42, P2293; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blasiak J, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/768026; Buddi R, 2002, J HISTOCHEM CYTOCHEM, V50, P341, DOI 10.1177/002215540205000306; Cejkova J, 2012, HISTOL HISTOPATHOL, V27, P1029, DOI 10.14670/HH-27.1029; Cejkova J, 2010, HISTOL HISTOPATHOL, V25, P1403, DOI 10.14670/HH-25.1403; Choi SI, 2014, BIOCHEM BIOPH RES CO, V450, P1505, DOI 10.1016/j.bbrc.2014.07.035; Choi SI, 2012, AUTOPHAGY, V8, P1782, DOI 10.4161/auto.22067; Chwa M, 2008, INVEST OPHTH VIS SCI, V49, P4361, DOI 10.1167/iovs.08-1969; Chwa M, 2006, INVEST OPHTH VIS SCI, V47, P1902, DOI 10.1167/iovs.05-0828; Dabir SS, 2014, INDIAN J OPHTHALMOL, V62, P66, DOI 10.4103/0301-4738.126186; Fass E, 2006, J BIOL CHEM, V281, P36303, DOI 10.1074/jbc.M607031200; Gordon-Shaag A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/795738; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Iqbal O, 2013, CORNEA, V32, P702, DOI 10.1097/ICO.0b013e318282987a; Kaarniranta K, 2009, AGEING RES REV, V8, P128, DOI 10.1016/j.arr.2009.01.001; Karamichos D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04608; Kenney M. Cristina, 2000, CLAO Journal, V26, P10; Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Krumeich JH, 1998, J CATARACT REFR SURG, V24, P456, DOI 10.1016/S0886-3350(98)80284-8; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liton PB, 2008, INVEST OPHTH VIS SCI, V49, P3961, DOI 10.1167/iovs.08-1915; Marino G, 2011, CURR OPIN CELL BIOL, V23, P198, DOI 10.1016/j.ceb.2010.10.001; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Moore MN, 2008, AUTOPHAGY, V4, P254, DOI 10.4161/auto.5528; Nishtala K, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0051-9; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Oh S, 2008, CELL STRESS CHAPERON, V13, P447, DOI 10.1007/s12192-008-0041-5; Olivan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134830; Onodera J, 2005, J BIOL CHEM, V280, P31582, DOI 10.1074/jbc.M506736200; Pahuja N, 2016, INVEST OPHTH VIS SCI, V57, P5372, DOI 10.1167/iovs.16-19677; Porter K, 2013, AUTOPHAGY, V9, P581, DOI 10.4161/auto.23568; Pulliero A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098106; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Shetty R, 2015, INVEST OPHTH VIS SCI, V56, P738, DOI 10.1167/iovs.14-14831; Shetty R, 2015, MOL VIS, V21, P12; Shoham A, 2008, FREE RADICAL BIO MED, V45, P1047, DOI 10.1016/j.freeradbiomed.2008.07.021; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sugar J, 2012, CORNEA, V31, P716, DOI 10.1097/ICO.0b013e31823f8c72; Sykakis E, 2012, PATHOLOGY, V44, P234, DOI 10.1097/PAT.0b013e3283511b42; Trocoli A, 2014, CELL DEATH DIFFER, V21, P1852, DOI 10.1038/cdd.2014.102; Wenk J, 2001, CURR PROBL DERMATOL, V29, P83; Winkler BS, 1999, MOL VIS, V5; You J, 2015, J OPHTHALMOLOGY, V2015; Zhou LL, 1998, INVEST OPHTH VIS SCI, V39, P1117	54	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184628	10.1371/journal.pone.0184628	http://dx.doi.org/10.1371/journal.pone.0184628			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902914	Green Submitted, Green Published, gold			2022-12-27	WOS:000410669200051
J	Ding, SJ; Zhu, LB; Tian, YH; Zhu, TH; Huang, XF; Zhang, XM				Ding, Shaojie; Zhu, Libo; Tian, Yonghong; Zhu, Tianhong; Huang, Xiufeng; Zhang, Xinmei			P2X3 receptor involvement in endometriosis pain via ERK signaling pathway	PLOS ONE			English	Article							INCREASED MICROVASCULAR DENSITY; PERITONEAL ENDOMETRIOSIS; NERVE-FIBERS; EXPRESSION; WOMEN; HYPERALGESIA; INNERVATION; NOCICEPTORS; ACTIVATION; DISCOVERY	The purinergic receptor P2X ligand-gated ion channel 3 (P2X3) is crucially involved in peripheral nociceptive processes of somatic and visceral pain. Endometriosis pain is considered as a kind of inflammatory and neuropathic pain. However, whether P2X3 is involved in endometriosis pain has not been reported up to date. Here, we aimed to determine whether P2X3 expression in endometriotic lesions is involved in endometriosis pain, which is regulated by inflammatory mediators through extracellular regulated protein kinases (ERK) signalling pathway. We found that P2X3 expressions in endometriosis endometrium and endometriotic lesions were both significantly higher as compared with control endometrium (P< 0.05), and both positively correlated with pain (P< 0.05). The expression levels of phosphorylated -ERK (p-ERK), phosphorylated-cAMP-response element binding protein (p-CREB), and P2X3 in endometriotic stromal cells (ESCs) were all significantly increased in comparison to the initial levels after treated with interleukin (IL)-1 beta (P< 0.05) or adenosine triphosphate (ATP) (P< 0.05), respectively, and did not increase after the ESCs were pre-treated with ERK1/ 2 inhibitor. Additionally, P2X3 and calcitonin gene related peptide (CGRP) were co-expressed in endometriotic lesions. These obtained results suggest that P2X3 might be involved in endometriosis pain signal transduction via ERK signal pathway.	[Ding, Shaojie; Zhu, Libo; Tian, Yonghong; Zhu, Tianhong; Huang, Xiufeng; Zhang, Xinmei] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Zhang, XM (corresponding author), Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China.	zxm20130729@163.com		zhang, xinmei/0000-0001-7122-6435	National Nature Science Foundation of China [81270672, 81471433, 81471495, 81671429]; Zhejiang Key Medical Sciences (Minimally Invasive Gynecology)	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Key Medical Sciences (Minimally Invasive Gynecology)	We appreciate the financial support of the National Nature Science Foundation of China (Grant Nos. 81270672, 81471433, 81471495 and 81671429), and Zhejiang Key Medical Sciences (Minimally Invasive Gynecology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold J, 2012, BRAIN BEHAV IMMUN, V26, P132, DOI 10.1016/j.bbi.2011.08.004; Birt JA, 2013, REPROD SCI, V20, P514, DOI 10.1177/1933719113477479; Burnstock G, 2014, EXP PHYSIOL, V99, P16, DOI 10.1113/expphysiol.2013.071951; Burnstock G, 2013, EUR J PHARMACOL, V716, P24, DOI 10.1016/j.ejphar.2013.01.078; Cantin LD, 2012, BIOORG MED CHEM LETT, V22, P2565, DOI 10.1016/j.bmcl.2012.01.124; Chaban Victor, 2013, Curr Trends Neurol, V7, P51; Cho T, 2012, NEUROREPORT, V23, P530, DOI 10.1097/WNR.0b013e328353fabc; Cook SP, 2002, PAIN, V95, P41, DOI 10.1016/S0304-3959(01)00372-4; de Arellano MLB, 2013, EUR J PAIN, V17, P1425, DOI 10.1002/j.1532-2149.2013.00323.x; Edelmayer RM, 2014, BIOCHEM PHARMACOL, V87, P390, DOI 10.1016/j.bcp.2013.11.019; Fabbretti E, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00236; Greaves E, 2015, AM J PATHOL, V185, P2286, DOI 10.1016/j.ajpath.2015.04.012; Greaves E, 2014, J CLIN ENDOCR METAB, V99, pE1738, DOI 10.1210/jc.2014-2282; Huang XF, 2012, EUR J OBSTET GYN R B, V165, P104, DOI 10.1016/j.ejogrb.2012.06.034; Joseph EK, 2013, J NEUROSCI, V33, P2849, DOI 10.1523/JNEUROSCI.3229-12.2013; Kajitani T, 2013, ENDOCR J, V60, P1155; Kobayashi H, 2014, ARCH GYNECOL OBSTET, V289, P13, DOI 10.1007/s00404-013-3049-8; Lin CL, 2013, PURINERG SIGNAL, V9, P249, DOI 10.1007/s11302-012-9347-y; Liu JG, 2012, REPROD SCI, V19, P1110, DOI 10.1177/1933719112443876; Mansfield KJ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/182862; McAllister SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031758; McKinnon BD, 2016, HUM REPROD UPDATE, V22, P382, DOI 10.1093/humupd/dmv060; McKinnon BD, 2015, TRENDS ENDOCRIN MET, V26, P1, DOI 10.1016/j.tem.2014.10.003; Mo G, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-47; Nie J, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.11.035; Nirgianakis K, 2013, EUR J OBSTET GYN R B, V170, P550, DOI 10.1016/j.ejogrb.2013.08.010; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Prado FC, 2013, NEUROPHARMACOLOGY, V67, P252, DOI 10.1016/j.neuropharm.2012.11.011; Sales KJ, 2003, REPRODUCTION, V126, P559, DOI 10.1530/rep.0.1260559; Schiavuzzo JG, 2015, NEUROSCIENCE, V285, P24, DOI 10.1016/j.neuroscience.2014.11.020; Sikora J, 2012, AM J REPROD IMMUNOL, V68, P138, DOI 10.1111/j.1600-0897.2012.01147.x; Song Nan, 2012, Zhonghua Fu Chan Ke Za Zhi, V47, P333; STRATHY JH, 1982, FERTIL STERIL, V38, P667; Vilotti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081138; Wang GY, 2009, HUM REPROD, V24, P827, DOI 10.1093/humrep/den464; Wickiewicz D, 2013, ARCH GYNECOL OBSTET, V288, P805, DOI 10.1007/s00404-013-2828-6; Wu JJ, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0828-3; Xu GY, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-60; Yasuda M, 2012, NEUROSCI LETT, V528, P67, DOI 10.1016/j.neulet.2012.08.067; Zhang XM, 2010, FERTIL STERIL, V94, P730, DOI 10.1016/j.fertnstert.2009.03.026; Zhang XM, 2010, FERTIL STERIL, V93, P2362, DOI 10.1016/j.fertnstert.2008.12.142; Zhang XM, 2010, HUM REPROD, V25, P392, DOI 10.1093/humrep/dep427; Zhang XM, 2009, FERTIL STERIL, V92, P1799, DOI 10.1016/j.fertnstert.2009.05.016; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; Zhou WD, 2010, HUM REPROD, V25, P3110, DOI 10.1093/humrep/deq287	45	30	31	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184647	10.1371/journal.pone.0184647	http://dx.doi.org/10.1371/journal.pone.0184647			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898282	Green Submitted, gold, Green Published			2022-12-27	WOS:000410449500038
J	Elderman, M; Sovran, B; Hugenholtz, F; Graversen, K; Huijskes, M; Houtsma, E; Belzer, C; Boekschoten, M; de Vos, P; Dekker, J; Wells, J; Faas, M				Elderman, Marlies; Sovran, Bruno; Hugenholtz, Floor; Graversen, Katrine; Huijskes, Myrte; Houtsma, Eva; Belzer, Clara; Boekschoten, Mark; de Vos, Paul; Dekker, Jan; Wells, Jerry; Faas, Marijke			The effect of age on the intestinal mucus thickness, microbiota composition and immunity in relation to sex in mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GUT-MICROBIOTA; GASTROINTESTINAL-TRACT; BARRIER; CELLS; HOMEOSTASIS; SYSTEM; PATHOGENESIS; ANTIGENS; COLITIS	A mucus layer covers and protects the intestinal epithelial cells from direct contact with microbes. This mucus layer not only prevents inflammation but also plays an essential role in microbiota colonization, indicating the complex interplay between mucus composition-microbiota and intestinal health. However, it is unknown whether the mucus layer is influenced by age or sex and whether this contributes to reported differences in intestinal diseases in males and females or with ageing. Therefore, in this study we investigated the effect of age on mucus thickness, intestinal microbiota composition and immune composition in relation to sex. The ageing induced shrinkage of the colonic mucus layer was associated with bacterial penetration and direct contact of bacteria with the epithelium in both sexes. Additionally, several genes involved in the biosynthesis of mucus were downregulated in old mice, especially in males, and this was accompanied by a decrease in abundances of various Lactobacillus species and unclassified Clostridiales type IV and XIV and increase in abundance of the potential pathobiont Bacteroides vulgatus. The changes in mucus and microbiota in old mice were associated with enhanced activation of the immune system as illustrated by a higher percentage of effector T cells in old mice. Our data contribute to a better understanding of the interplay between mucus-microbiota-and immune responses and ultimately may lead to more tailored design of strategies to modulate mucus production in targeted groups.	[Elderman, Marlies; Sovran, Bruno; Hugenholtz, Floor; Belzer, Clara; Boekschoten, Mark; de Vos, Paul; Dekker, Jan; Wells, Jerry] Top Inst Food & Nutr, Wageningen, Netherlands; [Elderman, Marlies; Houtsma, Eva; de Vos, Paul; Faas, Marijke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, Groningen, Netherlands; [Sovran, Bruno; Graversen, Katrine; Huijskes, Myrte; Dekker, Jan; Wells, Jerry] Wageningen Univ, Host Microbe Interact Grp, Wageningen, Netherlands; [Hugenholtz, Floor; Belzer, Clara] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [Boekschoten, Mark] Wageningen Univ, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Faas, Marijke] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Groningen, Netherlands	Top Institute Food & Nutrition; University of Groningen; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; University of Groningen	Elderman, M (corresponding author), Top Inst Food & Nutr, Wageningen, Netherlands.; Elderman, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, Groningen, Netherlands.	m.e.elderman@umcg.nl	de Vos, Paul/A-3170-2013; Belzer, Clara/P-6500-2018; Boekschoten, Mark/AAS-4597-2021	Belzer, Clara/0000-0001-6922-836X; Boekschoten, Mark/0000-0002-2139-0795; de vos, paul/0000-0001-9618-2408; Graversen, Katrine Baekby/0000-0002-9965-5845; Elderman, Marlies/0000-0002-4661-9808	Top Institute Food and Nutrition, Wageningen, The Netherlands;  [GH002]	Top Institute Food and Nutrition, Wageningen, The Netherlands(Netherlands Government); 	This work was supported by a project from the Top Institute Food and Nutrition, Wageningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The grant (GH002) was given to P.dV.	Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Birchenough GMH, 2015, MUCOSAL IMMUNOL, V8, P712, DOI 10.1038/mi.2015.32; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brinton RD, 2012, ENDOCRINOLOGY, V153, P3571, DOI 10.1210/en.2012-1340; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Butto LF, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00555; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036095; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Ha CY, 2014, NAT REV GASTRO HEPAT, V11, P128, DOI 10.1038/nrgastro.2013.241; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Johansson MEV, 2014, INFLAMM BOWEL DIS, V20, P2124, DOI 10.1097/MIB.0000000000000117; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Lahti L, 2011, IEEE ACM T COMPUT BI, V217, P225; Lee SH, 2015, INTEST RES, V13, P11, DOI 10.5217/ir.2015.13.1.11; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Lim MA, 2014, EXP GERONTOL, V49, P55, DOI 10.1016/j.exger.2013.10.006; Liu ZJ, 2009, WORLD J GASTROENTERO, V15, P5784, DOI 10.3748/wjg.15.5784; Man AL, 2014, CELL IMMUNOL, V289, P112, DOI 10.1016/j.cellimm.2014.04.001; Michielan A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/628157; Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Ouyang XS, 2011, CELL IMMUNOL, V266, P208, DOI 10.1016/j.cellimm.2010.10.007; Parekh PJ, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.16; Pigrau M, 2016, NEUROGASTROENT MOTIL, V28, P463, DOI 10.1111/nmo.12717; Prakash S, 2011, BIOL-TARGETS THER, V5, P71, DOI 10.2147/BTT.S19099; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Rokhsefat S, 2016, DIG DIS SCI; RUSELERVANEMBDEN JGH, 1989, FEMS MICROBIOL LETT, V58, P37, DOI 10.1111/j.1574-6968.1989.tb03014.x; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Shiba T, 2003, MICROBIOL IMMUNOL, V47, P371, DOI 10.1111/j.1348-0421.2003.tb03368.x; Sovran B, 2016, INFLAMM BOWEL DIS, V22, P826, DOI 10.1097/MIB.0000000000000688; Sovran B, 2015, INFLAMM BOWEL DIS, V21, P531, DOI 10.1097/MIB.0000000000000319; Strugala V, 2003, P NUTR SOC, V62, P237, DOI 10.1079/PNS2002205; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Varum FJO, 2012, J PHARM PHARMACOL, V64, P218, DOI 10.1111/j.2042-7158.2011.01399.x; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; YAMABAYASHI S, 1987, HISTOCHEM J, V19, P565, DOI 10.1007/BF01687364; Yan Jun, 2010, Immun Ageing, V7, P4, DOI 10.1186/1742-4933-7-4; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04	51	61	61	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184274	10.1371/journal.pone.0184274	http://dx.doi.org/10.1371/journal.pone.0184274			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898292	Green Published, gold			2022-12-27	WOS:000410449500020
J	Telles, FJ; Corcobado, G; Trillo, A; Rodriguez-Girones, MA				Jane Telles, Francismeire; Corcobado, Guadalupe; Trillo, Alejandro; Rodriguez-Girones, Miguel A.			Multimodal cues provide redundant information for bumblebees when the stimulus is visually salient, but facilitate red target detection in a naturalistic background	PLOS ONE			English	Article							AFFECTS COLOR PREFERENCE; BOMBUS-TERRESTRIS; DECISION-MAKING; FLORAL SCENT; FORAGING SPEED; RECEPTOR NOISE; FLOWER SIZE; BEES; DISCRIMINATION; HONEYBEES	Our understanding of how floral visitors integrate visual and olfactory cues when seeking food, and how background complexity affects flower detection is limited. Here, we aimed to understand the use of visual and olfactory information for bumblebees (Bombus terrestris terrestris L.) when seeking flowers in a visually complex background. To explore this issue, we first evaluated the effect of flower colour (red and blue), size (8, 16 and 32 mm), scent (presence or absence) and the amount of training on the foraging strategy of bumblebees (accuracy, search time and flight behaviour), considering the visual complexity of our background, to later explore whether experienced bumblebees, previously trained in the presence of scent, can recall and make use of odour information when foraging in the presence of novel visual stimuli carrying a familiar scent. Of all the variables analysed, flower colour had the strongest effect on the foraging strategy. Bumblebees searching for blue flowers were more accurate, flew faster, followed more direct paths between flowers and needed less time to find them, than bumblebees searching for red flowers. In turn, training and the presence of odour helped bees to find inconspicuous (red) flowers. When bees foraged on red flowers, search time increased with flower size; but search time was independent of flower size when bees foraged on blue flowers. Previous experience with floral scent enhances the capacity of detection of a novel colour carrying a familiar scent, probably by elemental association influencing attention.	[Jane Telles, Francismeire; Rodriguez-Girones, Miguel A.] CSIC, EEZA, Dept Funct & Evolutionary Ecol, Almeria, Spain; [Corcobado, Guadalupe] Masaryk Univ, Dept Bot & Zool, Brno, Czech Republic; [Trillo, Alejandro] Donana Biol Stn, Dept Integrat Ecol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Masaryk University Brno; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Telles, FJ (corresponding author), CSIC, EEZA, Dept Funct & Evolutionary Ecol, Almeria, Spain.	meirecuesta@gmail.com	Rodriguez-Girones, Miguel A/H-1859-2015; Telles, Francismeire J/O-2856-2017	Rodriguez-Girones, Miguel A/0000-0002-5619-9819; Telles, Francismeire J/0000-0001-8507-6546; Trillo, Alejandro/0000-0002-6944-0923	Spanish Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional - FEDER [CGL2015-71396-P]; Spanish National Research Council (CSIC); European Social Fund [JAE: JAEPre033]; Spanish Ministerio de Ciencia e InnovaciOn/Fondo Europeo de Desarrollo Regional FEDER [CGL2015-71396-P]	Spanish Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional - FEDER; Spanish National Research Council (CSIC); European Social Fund(European Social Fund (ESF)); Spanish Ministerio de Ciencia e InnovaciOn/Fondo Europeo de Desarrollo Regional FEDER	This work was supported by the Spanish Ministerio de Ciencia e Innovacion/Fondo Europeo de Desarrollo Regional - FEDER (grant number CGL2015-71396-P to M.A.R.G.) and a PhD studentship to F.J.T. from the Spanish National Research Council (CSIC), co-funded by the European Social Fund (grant number JAE: JAEPre033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Shikhar Mann for the initial code of bee flight analysis and Andreas Kampgen for the development of the BeeTracker program and assistance during video analyses. This work was supported by the Spanish Ministerio de Ciencia e InnovaciOn/Fondo Europeo de Desarrollo Regional FEDER (grant number CGL2015-71396-P to M.A.R.G.) and a PhD studentship to F.J.T. from the Spanish National Research Council (CSIC), co-funded by the European Social Fund (grant number JAE: JAEPre033).	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 2006, INT J COMP PSYCHOL; BACKHAUS W, 1991, VISION RES, V31, P1381, DOI 10.1016/0042-6989(91)90059-E; Ballantyne G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043869; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bergamo PJ, 2016, FUNCT ECOL, V30, P710, DOI 10.1111/1365-2435.12537; Bukovac Z, 2016, EVOLUTIONARY ECOLOGY, P1; Byers KJRP, 2014, J EXP BIOL, V217, P614, DOI 10.1242/jeb.092213; Carlsson MA, 2006, BIOLOGY OF FLORAL SCENT, P243; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P169, DOI 10.1080/07929978.1997.10676682; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L, 2007, ARTHROPOD-PLANT INTE, V1, P37, DOI 10.1007/s11829-007-9001-8; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Cronk Q, 2008, J EXP BOT, V59, P715, DOI 10.1093/jxb/ern009; DAFNI A, 1990, ISRAEL J BOT, V39, P81; De Ibarra NH, 2000, J EXP BIOL, V203, P3289; Dobson Heidi E.M., 1999, Plant Species Biology, V14, P153, DOI 10.1046/j.1442-1984.1999.00020.x; Dotterl S, 2010, CAN J ZOOL, V88, P668, DOI 10.1139/Z10-031; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Dyer AG, 2004, J COMP PHYSIOL A, V190, P759, DOI 10.1007/s00359-004-0547-y; Farre-Armengol G, 2013, PERSPECT PLANT ECOL, V15, P56, DOI 10.1016/j.ppees.2012.12.002; Forrest J, 2009, NATURWISSENSCHAFTEN, V96, P921, DOI 10.1007/s00114-009-0549-2; Galizia CG, 2005, BEHAV ECOL, V16, P159, DOI 10.1093/beheco/arh147; Garbuzov M, 2014, FUNCT ECOL, V28, P364, DOI 10.1111/1365-2435.12178; Gegear RJ, 2005, ANIM BEHAV, V69, P939, DOI 10.1016/j.anbehav.2004.06.029; Gegear RJ, 2017, ECOLOGY, V98, P489, DOI 10.1002/ecy.1661; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; Giurfa M, 1998, J COMP PHYSIOL A, V183, P101, DOI 10.1007/s003590050238; Goodale E, 2014, NATURWISSENSCHAFTEN, V101, P523, DOI 10.1007/s00114-014-1188-9; Goulson D, 2007, BEHAV ECOL SOCIOBIOL, V61, P1523, DOI 10.1007/s00265-007-0384-4; Goyret J, 2009, P ROY SOC B-BIOL SCI, V276, P2739, DOI 10.1098/rspb.2009.0456; Junker RR, 2015, J INDIAN I SCI, V95, P43; Katzenberger TD, 2013, BEHAV ECOL SOCIOBIOL, V67, P1587, DOI 10.1007/s00265-013-1570-1; Knauer AC, 2015, ECOL LETT, V18, P135, DOI 10.1111/ele.12386; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; Kunze J, 2001, BEHAV ECOL, V12, P447, DOI 10.1093/beheco/12.4.447; LEHRER M, 1995, PHILOS T R SOC B, V347, P123, DOI 10.1098/rstb.1995.0017; Leonard A.S., 2011, EVOLUTION PLANT POLL, P261, DOI DOI 10.1016/J.ANBEHAV.2012.01.007; Leonard AS, 2014, J COMP PHYSIOL A, V200, P463, DOI 10.1007/s00359-014-0904-4; Lunau K, 2006, NATURWISSENSCHAFTEN, V93, P325, DOI 10.1007/s00114-006-0105-2; LUNAU K, 1991, ETHOLOGY, V88, P203, DOI 10.1111/j.1439-0310.1991.tb00275.x; LUNAU K, 1992, CAN J ZOOL, V70, P2139, DOI 10.1139/z92-288; Lunau K, 2011, J EXP BIOL, V214, P1607, DOI 10.1242/jeb.052688; Martinez-Harms J, 2010, J EXP BIOL, V213, P564, DOI 10.1242/jeb.037622; Ne'eman Gidi, 2017, Journal of Pollination Ecology, V20, P1, DOI 10.26786/1920-7603(2017)one; Nouvian M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10247; Odell E, 1999, AM MIDL NAT, V142, P257, DOI 10.1674/0003-0031(1999)142[0257:BFRTVI]2.0.CO;2; Orban LL, 2014, INSECT SOC, V61, P325, DOI 10.1007/s00040-014-0366-2; Parachnowitsch AL, 2012, NEW PHYTOL, V195, P667, DOI 10.1111/j.1469-8137.2012.04188.x; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; R Core Team, 2021, R LANGUAGE ENV STAT; Raguso Robert A., 1999, Plant Species Biology, V14, P95, DOI 10.1046/j.1442-1984.1999.00014.x; Reisenman CE, 2008, ARTHROPOD-PLANT INTE, V2, P137, DOI 10.1007/s11829-008-9041-8; Rivest SA, 2017, EVOL ECOL, V31, P435, DOI 10.1007/s10682-017-9893-4; Rodriguez-Girones MA, 2004, PLOS BIOL, V2, P1515, DOI 10.1371/journal.pbio.0020350; Rodriguez-Girones MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071551; Rohde K, 2013, J COMP PHYSIOL A, V199, P197, DOI 10.1007/s00359-012-0783-5; Sanchez D, 2011, INSECT SOC, V58, P575, DOI 10.1007/s00040-011-0181-y; Skorupski P, 2007, J COMP PHYSIOL A, V193, P485, DOI 10.1007/s00359-006-0206-6; Spaethe J, 2001, P NATL ACAD SCI USA, V98, P3898, DOI 10.1073/pnas.071053098; Telles FJ, 2015, SCI NAT-HEIDELBERG, V102, DOI 10.1007/s00114-014-1256-1; Vereecken NJ, 2009, ANN BOT-LONDON, V104, P1077, DOI 10.1093/aob/mcp208; Vorobyev M, 1998, P ROY SOC B-BIOL SCI, V265, P351, DOI 10.1098/rspb.1998.0302; Vorobyev M, 2001, VISION RES, V41, P639, DOI 10.1016/S0042-6989(00)00288-1; Wright GA, 2013, SCIENCE, V339, P1202, DOI 10.1126/science.1228806; Wright GA, 2009, FUNCT ECOL, V23, P841, DOI 10.1111/j.1365-2435.2009.01627.x; Zuur Alain F., 2009, P1	71	15	17	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184760	10.1371/journal.pone.0184760	http://dx.doi.org/10.1371/journal.pone.0184760			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898287	gold, Green Published, Green Submitted			2022-12-27	WOS:000410449500047
J	Ereskovsky, AV; Richter, DJ; Lavrov, DV; Schippers, KJ; Nichols, SA				Ereskovsky, Alexander V.; Richter, Daniel J.; Lavrov, Dennis V.; Schippers, Klaske J.; Nichols, Scott A.			Transcriptome sequencing and delimitation of sympatric Oscarella species (O. carmela and O. pearsei sp nov) from California, USA	PLOS ONE			English	Article							PORIFERA; DEMOSPONGIAE; SPONGES; PLAKINIDAE; EVOLUTION; LOBULARIS; ACCURATE; ORIGIN; GENES; GENUS	The homoscleromorph sponge Oscarella carmela, first described from central California, USA is shown to represent two superficially similar but both morphologically and phylogenetically distinct species that are co-distributed. We here describe a new species as Oscarella pearsei, sp. nov. and re-describe Oscarella carmela; the original description was based upon material from both species. Further, we correct the identification of published genomic/transcriptomic resources that were originally attributed to O. carmela, and present new Illumina-sequenced transcriptome assemblies for each of these species, and the mitochondrial genome sequence for O. pearsei sp. nov. Using SSU and LSU ribosomal DNA and the mitochondrial genome, we report the phylogenetic relationships of these species relative to other Oscarella species, and find strong support for the placement of O. pearsei sp. nov. in a distinct clade within genus Oscarella defined by the presence of spherulous cells that contain paracrystalline inclusions; O. carmela lacks this cell type. Oscarella pearsei sp. nov and O. carmela can be tentatively distinguished based upon gross morphological differences such as color, surface texture and extent of mucus production, but can be more reliably identified using mitochondrial and nuclear barcode sequencing, ultrastructural characteristics of cells in the mesohyl, and the morphology of the follicle epithelium which surrounds the developing embryo in reproductively active individuals.	[Ereskovsky, Alexander V.] Avignon Univ, Aix Marseille Univ, Inst Mediterraneen Biodivers & Ecol Marine & Cont, CNRS,IRD,Stn Marine Endoume, Marseille, France; [Ereskovsky, Alexander V.] St Petersburg State Univ, Fac Biol, Dept Embryol, 7-9 Univ Skaya Emb, St Petersburg, Russia; [Richter, Daniel J.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Richter, Daniel J.] UPMC Univ Paris 06, Sorbonne Univ, Adaptat & Divers Milieu Marin, UMR 7144,CNRS,Equipe EPE,Stn Biol Roscoff, Roscoff, France; [Lavrov, Dennis V.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA USA; [Schippers, Klaske J.; Nichols, Scott A.] Univ Denver, Dept Biol Sci, SGM 203, Denver, CO 80208 USA	Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Saint Petersburg State University; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Iowa State University; University of Denver	Nichols, SA (corresponding author), Univ Denver, Dept Biol Sci, SGM 203, Denver, CO 80208 USA.	scott.nichols@du.edu	Ereskovsky, Alexander/B-3136-2013; Lavrov, Dennis/V-3699-2019; Ereskovsky, Alexander/W-1504-2019	Ereskovsky, Alexander/0000-0003-1079-7204; Lavrov, Dennis/0000-0002-2745-1704; Richter, Daniel/0000-0002-9238-5571; Nichols, Scott/0000-0002-4765-754X; Schippers, Klaske/0000-0002-1605-3372				Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bergquist PR, 2004, NEW ZEAL J MAR FRESH, V38, P51, DOI 10.1080/00288330.2004.9517217; Boury-Esnault N, 2013, INTEGR COMP BIOL, V53, P416, DOI 10.1093/icb/ict042; BOURYESNAULT N, 1995, OPHELIA, V43, P25, DOI 10.1080/00785326.1995.10430575; BOURYESNAULT N, 1992, J NAT HIST, V26, P271, DOI 10.1080/00222939200770131; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Chombard C, 1998, SYST BIOL, V47, P351, DOI 10.1080/106351598260761; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Ereskovsky AV, 2006, ZOOTAXA, P37, DOI 10.11646/zootaxa.1376.1.2; Ereskovsky AV, 2009, CAH BIOL MAR, V50, P369; Ereskovsky AV, 2009, BIOESSAYS, V31, P89, DOI 10.1002/bies.080058; Gazave E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063976; Gazave E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014290; Gloeckner V, 2013, MAR BIOL, V160, P781, DOI 10.1007/s00227-012-2133-0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hemmrich G, 2008, BIOESSAYS, V30, P1010, DOI 10.1002/bies.20813; Katoh K, 2011, J R SOC INTERFACE, V8, P305, DOI 10.1098/rsif.2010.0419; Lartillot N, 2013, SYST BIOL, V62, P611, DOI 10.1093/sysbio/syt022; Lavrov DV, 2008, MOL PHYLOGENET EVOL, V49, P111, DOI 10.1016/j.ympev.2008.05.014; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Muricy G, 1996, CAN J ZOOL, V74, P881, DOI 10.1139/z96-102; Muricy Guilherme, 2004, Proceedings of the California Academy of Sciences, V55, P598; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nichols SA, 2012, P NATL ACAD SCI USA, V109, P13046, DOI 10.1073/pnas.1120685109; Pearson W R, 1994, Methods Mol Biol, V25, P365; Pena JF, 2016, EVODEVO, V7, DOI 10.1186/s13227-016-0050-x; Perez T, 2011, MAR ECOL-EVOL PERSP, V32, P174, DOI 10.1111/j.1439-0485.2011.00435.x; Pett W, 2013, INTEGR COMP BIOL, V53, P495, DOI 10.1093/icb/ict079; Sambrook Joseph, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot3944; van Soest RWM, WORLD PORIFERA DATAB; Voigt O, 2016, ORG DIVERS EVOL, V16, P53, DOI 10.1007/s13127-015-0247-1; Wang XJ, 2007, MOL BIOL EVOL, V24, P363, DOI 10.1093/molbev/msl167; Yang XA, 2010, BIOINFORMATICS, V26, P2526, DOI 10.1093/bioinformatics/btq468	38	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0183002	10.1371/journal.pone.0183002	http://dx.doi.org/10.1371/journal.pone.0183002			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892487	Green Published, Green Submitted, gold			2022-12-27	WOS:000410243200003
J	Winters, N; Langer, L; Geniets, A				Winters, Niall; Langer, Laurenz; Geniets, Anne			Physical, psychological, sexual, and systemic abuse of children with disabilities in East Africa: Mapping the evidence	PLOS ONE			English	Article							RISK-FACTORS; MALTREATMENT; EXPERIENCES; EDUCATION; EPILEPSY; ADOLESCENTS; ATTITUDES; BELIEFS; CARERS; RWANDA	Children with disabilities (CWDs) are at a higher risk of being maltreated than are typical children. The evidence base on the abuse of children with disabilities living in low- and middle-income countries is extremely limited but the problem is particularly acute in East Africa. We don't know the types of evidence that exist on this topic. This problem is compounded by the fact that key indicators of disability, such as reliable prevalence rates, are not available currently. This paper addresses this serious problem by mapping the existing evidence-base to document the coverage, patterns, and gaps in existing research on the abuse of children with disabilities in East Africa. An evidence map, following systematic review guidelines, was conducted and included a systematic search, transparent and structured data extraction, and critical appraisal. Health and social science databases (Medline, EMBASE, PsychInfo, Taylor&Francis, Web of Science, and SAGE) were systematically searched for relevant studies. A substantive grey literature search was also conducted. All empirical research on the abuse of CWDs in East Africa was eligible for inclusion: Data on abuse was systematically extracted and the research evidence, following critical appraisal, mapped according to the type of abuse and disability condition, highlighting gaps and patterns in the evidence-base. 6005 studies were identified and screened, of which 177 received a full-text assessment. Of these, 41 studies matched the inclusion criteria. By mapping the available data and reports and systematically assessing their trustworthiness and relevance, we highlight significant gaps in the available evidence base. Clear patterns emerge that show a major data gap and lack of research on sexual abuse of children with disabilities and an identifiable lack of methodological quality in many relevant studies. These make the development of a concerted and targeted research effort to tackle the abuse of children with disabilities in East Africa extremely difficult. This needs to be addressed urgently if the abuse of children with disabilities is to be prioritised by the global health community.	[Winters, Niall; Geniets, Anne] Univ Oxford, Dept Educ, Oxford, England; [Langer, Laurenz] Univ Johannesburg, Africa Ctr Evidence, Johannesburg, South Africa	University of Oxford; University of Johannesburg	Winters, N (corresponding author), Univ Oxford, Dept Educ, Oxford, England.	niall.winters@education.ox.ac.uk		Winters, Niall/0000-0001-8597-2914	University of Oxford [143/052]	University of Oxford	This work was supported by the John Fell Fund, University of Oxford, Grant number: 143/052, URL: https://www.admin.ox.aca.uk/pras/jff/. NW and AG received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACPF, 2011, CHILDR DISUG HIDD RE; ACPF, 2014, AFT REP CHILDR DIS; ACPF, 2010, BREAK SIL VIOL CHILD; ACPF, 2011, CHILDR DIS ETH HIDD; Adinkrah M, 2011, CHILD ABUSE NEGLECT, V35, P741, DOI 10.1016/j.chiabu.2011.05.011; Advantage Africa, 2015, ASSESSMENT SOCIAL CU; Aldersey HM, 2012, AFRICAN J DISABILITY, V1, P1; Ambikile Joel Semel, 2012, Child Adolesc Psychiatry Ment Health, V6, P16, DOI 10.1186/1753-2000-6-16; Amuyunzu M, 1998, MED ANTHROPOL Q, V12, P490, DOI 10.1525/maq.1998.12.4.490; Bannink F, 2015, INT J DISABIL DEV ED, V62, P182, DOI 10.1080/1034912X.2014.998174; Bayat M, 2015, J INTELL DISABIL RES, V59, P1, DOI 10.1111/jir.12118; Black DA, 2001, AGGRESS VIOLENT BEH, V6, P121, DOI 10.1016/S1359-1789(00)00021-5; Black DA, 2001, AGGRESS VIOLENT BEH, V6, P203, DOI 10.1016/S1359-1789(00)00023-9; Black DA, 2001, AGGRESS VIOLENT BEH, V6, P189, DOI 10.1016/S1359-1789(00)00022-7; Boersma M, 2013, DISABIL CBR INCLUSIV, V24, P112, DOI [10.5463/DCID.v24i3.261, DOI 10.5463/DCID.V24I3.261]; Brown J, 1998, CHILD ABUSE NEGLECT, V22, P1065, DOI 10.1016/S0145-2134(98)00087-8; Bryceson DF, 2010, J MOD AFR STUD, V48, P353, DOI 10.1017/S0022278X10000303; Buchmann K, 2015, EPILEPSY BEHAV, V42, P71, DOI 10.1016/j.yebeh.2014.10.027; Collings S, 1993, SOC WORK, V29, P301; Devries KM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1017; El Sharkawy G, 2006, EPILEPSY BEHAV, V8, P201, DOI 10.1016/j.yebeh.2005.09.011; Gona JK, 2011, CHILD CARE HLTH DEV, V37, P175, DOI 10.1111/j.1365-2214.2010.01124.x; Gona JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132729; Gough D., 2017, INTRO SYSTEMATIC REV; Gough D, 2007, RES PAP EDUC, V22, P213, DOI [10.1080/02671520701296189, DOI 10.1080/02671520701296189]; Hanass-Hancock J, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-34; Handicap International, 2010, RES FIND KNOWL ATT P; Hartley S, 2005, CHILD CARE HLTH DEV, V31, P167, DOI 10.1111/j.1365-2214.2004.00464.x; Ingstad B, 2007, SEE ME NOT FORGET ME; Ingstad B, 1995, DISABILITY CULTURE; Karangwa E, 2007, INT J INCLUSIVE EDUC, V11, P607, DOI DOI 10.1080/13603110600790340; Karangwa E, 2010, INT J DISABIL DEV ED, V57, P267, DOI 10.1080/1034912X.2010.501183; Kim JY, 2013, LANCET, V382, P1060, DOI 10.1016/S0140-6736(13)61047-8; Kisanji J., 1995, INNOVATIONS DEV COUN, P51; Lachman P, 1996, CHILD ABUSE NEGLECT, V20, P543, DOI 10.1016/0145-2134(96)00042-7; Lalor K, 2004, CHILD ABUSE NEGLECT, V28, P833, DOI 10.1016/j.chiabu.2003.11.022; Lalor K, 2004, CHILD ABUSE NEGLECT, V28, P439, DOI 10.1016/j.chiabu.2003.07.005; Langer L, 2015, S AFR REV SOCIOL, V46, P66, DOI 10.1080/21528586.2014.989665; Linkov I, 2009, SCI TOTAL ENVIRON, V407, P5199, DOI 10.1016/j.scitotenv.2009.05.004; Marshall J., 1997, INT J DISABIL DEV ED, V44, P341, DOI DOI 10.1080/0156655970440405; McKinnon MC, 2015, NATURE, V528, P185, DOI 10.1038/528185a; McNally A, 2013, AFR J DISABIL, V2, DOI 10.4102/ajod.v2i1.21; Meinck F, 2015, TRAUMA VIOLENCE ABUS, V16, P81, DOI 10.1177/1524838014523336; Meinck F, 2015, CHILD ABUSE REV, V24, P182, DOI 10.1002/car.2283; Miles S, 2012, THIRD WORLD Q, V32, P1515; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mukuria G, 2006, PREV SCH FAIL, V50, P49, DOI 10.3200/PSFL.50.2.49-54; Mulindwa IN, 2003, STUDY REPRODUCTIVE H; Mushi D, 2012, EPILEPSY BEHAV, V23, P224, DOI 10.1016/j.yebeh.2011.12.003; Mutamba B, 2013, AFR HEALTH SCI, V13, P986, DOI 10.4314/ahs.v13i4.18; Mutua K, 2001, INT J DISABIL DEV ED, V48, P179, DOI DOI 10.1080/10349120120053658; Nakamanya S, 2015, DISABIL REHABIL, V37, P1470, DOI 10.3109/09638288.2014.972582; RWIZA HT, 1993, EPILEPSIA, V34, P1017, DOI 10.1111/j.1528-1157.1993.tb02127.x; Save the Children, 2011, OUT SHAD SEX VIOL CH; Sebera F, 2015, EPILEPSY BEHAV, V46, P126, DOI 10.1016/j.yebeh.2015.03.028; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Snilstveit B., 2013, 6725 WORLD BANK IND, P6725, DOI DOI 10.1596/1813-9450-6725; Stewart R, 2014, J DEV EFFECT, V6, P58, DOI 10.1080/19439342.2013.877060; Stith SM, 2009, AGGRESS VIOLENT BEH, V14, P13, DOI 10.1016/j.avb.2006.03.006; Stone-MacDonald A, 2012, INT J DISABIL DEV ED, V59, P393, DOI 10.1080/1034912X.2012.723947; Stopler L., 2007, HIDDEN SHAME VIOLENC; Sullivan PM, 2000, CHILD ABUSE NEGLECT, V24, P1257, DOI 10.1016/S0145-2134(00)00190-3; Under the same sun, CHILDR ALB AFR MURD; United Nations, 2018, UN NEWS; Warf BC, 2011, J NEUROSURG-PEDIATR, V7, P127, DOI 10.3171/2010.11.PEDS10428; WHITE R, 1987, AM J ORTHOPSYCHIAT, V57, P93, DOI 10.1111/j.1939-0025.1987.tb03513.x; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2022, ENS HLTH SEC AFR REG; Winkler A, 2010, AFRICAN J TRADITIONA, V7; World Health Organization, 1999, WHOHSCPVI991; Yousafzai AK, 2005, DISABIL REHABIL, V27, P1357, DOI 10.1080/09638280500164297	71	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184541	10.1371/journal.pone.0184541	http://dx.doi.org/10.1371/journal.pone.0184541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG4OS	28892508	Green Published, Green Submitted, gold			2022-12-27	WOS:000410243200017
J	Abdala-Roberts, L; Pratt, R; Pratt, JD; Mooney, KA				Abdala-Roberts, Luis; Pratt, Riley; Pratt, Jessica D.; Mooney, Kailen A.			Traits underlying community consequences of plant intra-specific diversity	PLOS ONE			English	Article							ARTHROPOD COMMUNITY; SEX; HERBIVORE; PERFORMANCE; MYCORRHIZAL; RESPONSES; DENSITY; SCALE; ANTS	A plant's performance and interactions with other trophic levels are recorgnized to be contingent upon plant diversity and underlying associational dynamics, but far less is known about the plant traits driving such phenomena. We manipulated diversity in plant traits using pairs of plant and a substitutive design to elucidate the mechanisms underlying diversity effects operating at a fine spatial scale. Specifically, we measured the effects of diversity in sex (sexual monocultures vs. male and female genotypes together) and growth rate (growth rate monocultures vs. fast-and slow-growing genotypes together) on growth of the shrub Baccharis salicifolia and on above-and belowground consumers associated with this plant. We compared effects on associate abundance (# associates per plant) vs. density (# associates per kg plant biomass) to elucidate the mechanisms underlying diversity effects; effects on abundance but not density suggest diversity effects are mediated by resource abundance (i.e. plant biomass) alone, whereas effects on density suggest diversity effects are mediated by plant-based heterogeneity or quality. Sexual diversity increased root growth but reduced the density (but not abundance) of the dietary generalist aphid Aphis gossypii and its associated aphid-tending ants, suggesting sex mixtures were of lower quality to this herbivore (e.g. via reduced plant quality), and that this effect indirectly influenced ants. Sexual diversity had no effect on the abundance or density of parasitoids attacking A. gossypii, the dietary specialist aphid Uroleucon macolai, or mycorrhizae. In contrast, growth rate diversity did not influence plant growth or any associates except for the dietary specialist aphid U. macolai, which increased in both abundance and density at high diversity, suggesting growth rate mixtures were of higher quality to this herbivore. These results highlight that plant associational and diversity effects on consumers are contingent upon the source of plant trait variation, and that the nature of such dynamics may vary both within and among trophic levels.	[Abdala-Roberts, Luis] Univ Autonoma Yucatan, Dept Ecol Trop, Campus Ciencias Biol & Agropecuarias, Merida, Yucatan, Mexico; [Pratt, Riley; Pratt, Jessica D.; Mooney, Kailen A.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Pratt, Riley] Irvine Ranch Conservancy, Irvine, CA USA	Universidad Autonoma de Yucatan; University of California System; University of California Irvine	Mooney, KA (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	mooneyk@uci.edu			NSF [DEB-1354734, DEB-1120794]; CONACyT repatriation grant [250934]; National Science Foundation [DEB-1354734, DEB-1120794]	NSF(National Science Foundation (NSF)); CONACyT repatriation grant; National Science Foundation(National Science Foundation (NSF))	This work was funded by NSF awards DEB-1354734 and DEB-1120794 to KAM, and LAR was supported by CONACyT repatriation grant 250934.; Victoria Hanna, Hong Chen, Annie Vo, Laura Ashmore, Wen-chi Ho and Rose Chang assisted in the field and lab. The San Joaquin Marsh Reserve of the University of California Natural Reserve System, and the UC-Irvine Greenhouse and Arboretum provided logistical support. National Science Foundation grants DEB-1354734 and DEB-1120794 to KAM	Abdala-Roberts L, 2016, ECOLOGY, V97, P743, DOI 10.1890/15-0444.1; Abdala-Roberts L, 2015, OIKOS, V124, P1527, DOI 10.1111/oik.02033; Abdala-Roberts L, 2014, ECOLOGY, V95, P2879, DOI 10.1890/13-2029.1; Abdala-Roberts L, 2013, OIKOS, V122, P1157, DOI 10.1111/j.1600-0706.2012.00159.x; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; Agren J., 1999, GENDER SEXUAL DIMORP, P217, DOI DOI 10.1007/978-3-662-03908-3_8; Ashman TL, 2005, AM J BOT, V92, P891, DOI 10.3732/ajb.92.5.891; Barbosa P, 2009, ANNU REV ECOL EVOL S, V40, P1, DOI 10.1146/annurev.ecolsys.110308.120242; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; Bommarco R, 2003, OIKOS, V102, P440, DOI 10.1034/j.1600-0579.2003.12578.x; Castagneyrol B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044247; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cook-Patton SC, 2011, ECOLOGY, V92, P915, DOI 10.1890/10-0999.1; Cornelissen T, 2005, OIKOS, V111, P488, DOI 10.1111/j.1600-0706.2005.14075.x; Crawford KM, 2013, ECOLOGY, V94, P1025, DOI 10.1890/12-1468.1; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Delph LF, 1999, GENDER SEXUAL DIMORP, P149, DOI DOI 10.1007/978-3-662-03908-3_6; Fichtner A, 2017, ECOL LETT, V20, P892, DOI 10.1111/ele.12786; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; Geber MA, 1999, GENDER SEXUAL DIMORP; Hajek P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00415; Halpern SL, 2014, ECOL ENTOMOL, V39, P217, DOI 10.1111/een.12088; Hamback PA, 2014, ECOLOGY, V95, P1370, DOI 10.1890/13-0793.1; Hughes AR, 2014, J ECOL, V102, P651, DOI 10.1111/1365-2745.12244; Johnson MTJ, 2006, ECOL LETT, V9, P24, DOI 10.1111/j.1461-0248.2005.00833.x; Kim TN, 2015, ECOLOGY, V96, P1431, DOI 10.1890/14-1097.1; Koricheva J, 2000, OECOLOGIA, V125, P271, DOI 10.1007/s004420000450; Kos M, 2015, ECOLOGY, V96, P164, DOI 10.1890/14-0563.1; LLOYD DG, 1977, BOT REV, V43, P177, DOI 10.1007/BF02860717; McArt SH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0639; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Mooney K.A., 2012, TRAIT MEDIATED INDIR, P107; Mooney KA, 2012, ARTHROPOD-PLANT INTE, V6, P553, DOI 10.1007/s11829-012-9204-5; Mooney KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034403; Moreira X, 2016, CURR OPIN INSECT SCI, V14, P1, DOI 10.1016/j.cois.2015.10.003; Moreira X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105438; Moreira X, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0133; Moritz KK, 2016, ECOL EVOL, V6, P1154, DOI 10.1002/ece3.1923; Petry WK, 2013, ECOLOGY, V94, P2055, DOI 10.1890/12-2170.1; Plath M, 2012, OECOLOGIA, V169, P477, DOI 10.1007/s00442-011-2215-6; PRICE PW, 1991, OIKOS, V62, P244, DOI 10.2307/3545270; Renner SS, 2014, AM J BOT, V101, P1588, DOI 10.3732/ajb.1400196; SAS Institute Inc, 2008, SAS VERS 9 2; SILANDER JA, 1985, OECOLOGIA, V66, P256, DOI 10.1007/BF00379863; Tack AJM, 2012, OIKOS, V121, P481, DOI 10.1111/j.1600-0706.2011.19926.x; Tilman D, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P21; Underwood N, 2014, Q REV BIOL, V89, P1, DOI 10.1086/674991; Varga S, 2010, ECOLOGY, V91, P2583, DOI 10.1890/09-1383.1; Vega-Frutis R, 2013, PLANT BIOLOGY, V15, P558, DOI 10.1111/j.1438-8677.2012.00673.x	49	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183493	10.1371/journal.pone.0183493	http://dx.doi.org/10.1371/journal.pone.0183493			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886028	gold, Green Published			2022-12-27	WOS:000410001100026
J	Chang, HH; Moro, A; Takakura, K; Su, HY; Mo, A; Nakanishi, M; Waldron, RT; French, SW; Dawson, DW; Hines, OJ; Li, G; Go, VLW; Sinnett-Smith, J; Pandol, SJ; Lugea, A; Gukovskaya, AS; Duff, MO; Rosenberg, DW; Rozengurt, E; Eibl, G				Chang, Hui-Hua; Moro, Aune; Takakura, Kazuki; Su, Hsin-Yuan; Mo, Allen; Nakanishi, Masako; Waldron, Richard T.; French, Samuel W.; Dawson, David W.; Hines, O. Joe; Li, Gang; Go, Vay Liang W.; Sinnett-Smith, James; Pandol, Stephen J.; Lugea, Aurelia; Gukovskaya, Anna S.; Duff, Michael O.; Rosenberg, Daniel W.; Rozengurt, Enrique; Eibl, Guido			Incidence of pancreatic cancer is dramatically increased by a high fat, high calorie diet in KrasG12D mice	PLOS ONE			English	Article							BODY-MASS INDEX; KRAS(G12D) MOUSE MODEL; INTRAEPITHELIAL NEOPLASIA; DUCTAL ADENOCARCINOMA; TUMOR-GROWTH; AUTOPHAGY; PROGRESSION; OBESITY; CELLS; RISK	Epidemiologic data has linked obesity to a higher risk of pancreatic cancer, but the underlying mechanisms are poorly understood. To allow for detailed mechanistic studies in a relevant model mimicking diet-induced obesity and pancreatic cancer, a high-fat, high-calorie diet (HFCD) was given to P48(+/Cre); LSL-KRAS(G12D) (KC) mice carrying a pancreas-specific oncogenic Kras mutation. The mice were randomly allocated to a HFCD or control diet (CD). Cohorts were sacrificed at 3, 6, and 9 months and tissues were harvested for further analysis. Compared to CD-fed mice, HFCD-fed animals gained significantly more weight. Importantly, the cancer incidence was remarkably increased in HFCD-fed KC mice, particularly in male KC mice. In addition, KC mice fed the HFCD showed more extensive inflammation and fibrosis, and more advanced PanIN lesions in the pancreas, compared to agematched CD-fed animals. Interestingly, we found that the HFCD reduced autophagic flux in PanIN lesions in KC mice. Further, exome sequencing of isolated murine PanIN lesions identified numerous genetic variants unique to the HFCD. These data underscore the role of sustained inflammation and dysregulated autophagy in diet-induced pancreatic cancer development and suggest that diet-induced genetic alterations may contribute to this process. Our findings provide a better understanding of the mechanisms underlying the obesity-cancer link in males and females, and will facilitate the development of interventions targeting obesity-associated pancreatic cancer.	[Chang, Hui-Hua; Moro, Aune; Hines, O. Joe; Eibl, Guido] UCLA, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA; [Takakura, Kazuki; Waldron, Richard T.; Go, Vay Liang W.; Sinnett-Smith, James; Pandol, Stephen J.; Lugea, Aurelia; Gukovskaya, Anna S.; Rozengurt, Enrique] UCLA, David Geffen Sch Med, Div Digest Dis, Dept Med, Los Angeles, CA 90095 USA; [Takakura, Kazuki; Waldron, Richard T.; Sinnett-Smith, James; Pandol, Stephen J.; Lugea, Aurelia; Gukovskaya, Anna S.; Rozengurt, Enrique] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Su, Hsin-Yuan; Waldron, Richard T.; Pandol, Stephen J.; Lugea, Aurelia] Cedars Sinai Med Ctr, Dept Med, Pancreat Res Grp, Los Angeles, CA 90048 USA; [Mo, Allen; Nakanishi, Masako; Rosenberg, Daniel W.] UCONN Hlth, Ctr Mol Oncol, Farmington, CT USA; [French, Samuel W.] Harbor UCLA Med Ctr, Dept Pathol, Torrance, CA 90509 USA; [French, Samuel W.] Univ Southern Calif, Southern Calif Res Ctr ALPD & Cirrhosis, Dept Pathol, Keck Sch Med, Los Angeles, CA USA; [Dawson, David W.] UCLA, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Li, Gang] UCLA, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90024 USA; [Duff, Michael O.] UCONN Hlth, Dept Genet & Genome Sci, Farmington, CT USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Eibl, G (corresponding author), UCLA, David Geffen Sch Med, Dept Surg, Los Angeles, CA 90095 USA.	GEibl@mednet.ucla.edu	Waldron, Richard Taliesin/ABF-2773-2020	Waldron, Richard Taliesin/0000-0003-3151-6002; Gukovskaya, Anna/0000-0003-3737-5335	National Institute of Health [P01 CM63200, R01 AA019954]; NIDDK [P30DK41301]; Hirshberg Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE [P50CA211015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019954] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Hirshberg Foundation for Pancreatic Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was funded by the National Institute of Health (P01 CM63200 to GE and R01 AA019954 to AL), the NIDDK-supported CURE: Digestive Diseases Research Core Center Grant (P30DK41301 to ER), and the Hirshberg Foundation for Pancreatic Cancer Research (http://pancreatic.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajan M, 2012, J GASTROEN HEPATOL, V27, P10, DOI 10.1111/j.1440-1746.2011.07008.x; Albini A, 2016, CLIN CANCER RES, V22, P4322, DOI 10.1158/1078-0432.CCR-16-0695; Apte MV, 2013, GASTROENTEROLOGY, V144, P1210, DOI 10.1053/j.gastro.2012.11.037; Arslan AA, 2010, ARCH INTERN MED, V170, P791, DOI 10.1001/archinternmed.2010.63; Aune D, 2012, ANN ONCOL, V23, P843, DOI 10.1093/annonc/mdr398; Bracci PM, 2012, MOL CARCINOGEN, V51, P53, DOI 10.1002/mc.20778; Dawson DW, 2013, CANCER PREV RES, V6, P1064, DOI 10.1158/1940-6207.CAPR-13-0065; Donohoe CL, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-12; Fujii S, 2008, CANCER SCI, V99, P1813, DOI 10.1111/j.1349-7006.2008.00893.x; Fukuda A, 2011, CANCER CELL, V19, P441, DOI 10.1016/j.ccr.2011.03.002; Funahashi H, 2007, CANCER RES, V67, P7068, DOI 10.1158/0008-5472.CAN-07-0970; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gukovsky I, 2013, GASTROENTEROLOGY, V144, P1199, DOI 10.1053/j.gastro.2013.02.007; Hertzer KM, 2015, PANCREAS; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hruban RH, 2007, MODERN PATHOL, V20, pS61, DOI 10.1038/modpathol.3800685; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Jiang PD, 2014, CELL RES, V24, P69, DOI 10.1038/cr.2013.161; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kensler TW, 2016, CANCER PREV RES, V9, P2, DOI 10.1158/1940-6207.CAPR-15-0406; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khandekar MJ, 2011, NAT REV CANCER, V11, P886, DOI 10.1038/nrc3174; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Kuusisto E, 2008, NEUROPATH APPL NEURO, V34, P169, DOI 10.1111/j.1365-2990.2007.00884.x; Laklai H, 2016, NAT MED, V22, P497, DOI 10.1038/nm.4082; Langhe RP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10909; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Li DH, 2009, JAMA-J AM MED ASSOC, V301, P2553, DOI 10.1001/jama.2009.886; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Lowenfels AB, 2005, J CELL BIOCHEM, V95, P649, DOI 10.1002/jcb.20461; Luo J, 2008, BRIT J CANCER, V99, P527, DOI 10.1038/sj.bjc.6604487; McAndrews KM, 2015, ACS CHEM BIOL, V10, P1932, DOI 10.1021/acschembio.5b00353; Meyskens Jr F. L., 2016, J NATL CANC I, V108; Mohamed A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00070; Nezis IP, 2012, ANTIOXID REDOX SIGN, V17, P786, DOI 10.1089/ars.2011.4394; Okumura T, 2017, ONCOTARGET, V8, P18280, DOI 10.18632/oncotarget.15430; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Rozengurt E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00357; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; United States, 2014, CANCER RES, V74, P2913; Vongsuvanh R, 2013, CANCER LETT, V330, P1, DOI 10.1016/j.canlet.2012.11.038; Waghray M, 2013, CURR OPIN GASTROEN, V29, P537, DOI 10.1097/MOG.0b013e328363affe; Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362; Yang SH, 2011, AUTOPHAGY, V7, P912, DOI 10.4161/auto.7.8.15762; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111	48	71	71	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184455	10.1371/journal.pone.0184455	http://dx.doi.org/10.1371/journal.pone.0184455			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886117	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100125
J	Martinez-Alvarez, A; Pons, F; de Diego-Balaguer, R				Martinez-Alvarez, Anna; Pons, Ferran; de Diego-Balaguer, Ruth			Endogenous temporal attention in the absence of stimulus-driven cues emerges in the second year of life	PLOS ONE			English	Article							HUMAN BRAIN; INFANTS; TIME; SENSITIVITY; EXPECTATIONS; SYSTEM	Anticipating both where and when an object will appear is a critical ability for adaptation. Research in the temporal domain in adults indicate that dissociable mechanisms relate to endogenous attention driven by the properties of the stimulus themselves (e.g. rhythmic, sequential, or trajectory cues) and driven by symbolic cues. In infancy, we know that the capacity to endogenously orient attention progressively develops through infancy. However, the above-mentioned distinction has not yet been explored since previous studies involved stimulus-driven cues. The current study tested 12- and 15-month-olds in an adaptation of the anticipatory eye movement procedure to determine whether infants were able to anticipate a specific location and temporal interval predicted only by symbolic pre-cues. In the absence of stimulus-driven cues, results show that only 15-month-olds could show anticipatory behavior based on the temporal information provided by the symbolic cues. Distinguishing stimulus-driven expectations from those driven by symbolic cues allowed dissecting more clearly the developmental progression of temporal endogenous attention.	[Martinez-Alvarez, Anna; Pons, Ferran; de Diego-Balaguer, Ruth] Univ Barcelona, Dept Cognit Dev & Educ Psychol, Barcelona, Spain; [Martinez-Alvarez, Anna; de Diego-Balaguer, Ruth] Bellvitge Biomed Res Inst IDIBELL, Cognit & Brain Plast Unit, Barcelona, Spain; [Pons, Ferran; de Diego-Balaguer, Ruth] Univ Barcelona, Inst Neurosci, Barcelona, Spain; [Pons, Ferran] Inst Recerca St Joan de Deu, Barcelona, Spain; [de Diego-Balaguer, Ruth] ICREA, Barcelona, Spain	University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; ICREA	Martinez-Alvarez, A (corresponding author), Univ Barcelona, Dept Cognit Dev & Educ Psychol, Barcelona, Spain.; Martinez-Alvarez, A (corresponding author), Bellvitge Biomed Res Inst IDIBELL, Cognit & Brain Plast Unit, Barcelona, Spain.	a.martinez.alvarez@ub.edu	Martinez-Alvarez, Anna/AAS-7567-2020; Pons, Ferran/A-1156-2013; de Diego-Balaguer, Ruth/V-2131-2017	Martinez-Alvarez, Anna/0000-0001-5551-8171; Pons, Ferran/0000-0001-5919-8590; de Diego-Balaguer, Ruth/0000-0002-2357-5195	European Commission [ERC-StG-313841]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This research has been supported by the European Commission (ERC-StG-313841, TuningLang) to RDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank the infants and their families who participated in the study and Helena Moline for her assistance scheduling and testing infants in the APAL Lab. We would like to thank also David Cucurell and Estela Camara for technical support in data analysis and Barbara Albareda-Castellot for giving us access to the initial stimuli. We are deeply thankful to David Lewkowicz and Clement Francois for their very helpful comments to earlier versions of the manuscript. This research has been supported by the European Commission (ERC-StG-313841, TuningLang) to RDB.	Addyman C, 2010, ANIM COGN; Adler SA, 2008, J COGN DEV, V9, P1, DOI 10.1080/15248370701836568; Albareda-Castellot B, 2011, DEVELOPMENTAL SCI, V14, P395, DOI 10.1111/j.1467-7687.2010.00989.x; Astheimer L, 2014, DEV COGN NEUROS-NETH, V7, P1, DOI 10.1016/j.dcn.2013.10.005; Bares M, 2007, EXP BRAIN RES, V180, P355, DOI 10.1007/s00221-007-0857-8; Beudel M, 2008, NEUROREPORT, V19, P1055, DOI 10.1097/WNR.0b013e328303b7b9; Capizzi M, 2015, COGNITION, V134, P39, DOI 10.1016/j.cognition.2014.09.002; Capizzi M, 2012, COGNITION, V123, P293, DOI 10.1016/j.cognition.2012.02.005; Colombo J, 2002, CURR DIR PSYCHOL SCI, V11, P196, DOI 10.1111/1467-8721.00199; Colombo J, 2001, ANNU REV PSYCHOL, V52, P337, DOI 10.1146/annurev.psych.52.1.337; Colombo J, 2006, EMERGENCE BASIS ENDO, P283; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Correa A, 2006, BRAIN RES, V1076, P116, DOI 10.1016/j.brainres.2005.11.074; Correa A, 2014, NEUROPSYCHOLOGIA, V65, P131, DOI 10.1016/j.neuropsychologia.2014.10.023; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 1998, J NEUROSCI, V18, P7426; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Courage ML, 2008, ATTENTION, P106; de Diego-Balaguer R, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00044; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; Gomez R, 2005, INFANCY, V7, P183, DOI 10.1207/s15327078in0702_4; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; HAITH MM, 1988, CHILD DEV, V59, P467, DOI 10.2307/1130325; Johnson KA, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01417; Johnson KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123625; Johnson SP, 2003, CHILD DEV, V74, P94, DOI 10.1111/1467-8624.00523; Jonides J., 1981, VOLUNTARY VERSUS AUT; JUSCZYK PW, 1994, J MEM LANG, V33, P630, DOI 10.1006/jmla.1994.1030; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Lewkowicz DJ, 2012, P NATL ACAD SCI USA, V109, P1431, DOI 10.1073/pnas.1114783109; Los S.A., 2010, ATTENTION TIME, P289, DOI [10.1093/acprof:oso/9780199563456.003.0021, DOI 10.1093/ACPROF:OSO/9780199563456.001.0001]; McMurray B, 2004, INFANCY, V6, P203, DOI 10.1207/s15327078in0602_4; Mento G, 2015, DEV TRAJECTORIES INT, P1; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Nazzi T, 2000, J MEM LANG, V43, P1, DOI 10.1006/jmla.2000.2698; Nobre AC, 2010, ATTENTION TIME; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pons F, 2015, BILINGUALISM MODULAT; Rohenkohl G, 2014, J VISION, V14, DOI 10.1167/14.4.8; Rohenkohl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014620; Ruff Holly A., 1996, ATTENTION EARLY DEV; Sanabria D, 2011, J EXP PSYCHOL HUMAN, V37, P236, DOI 10.1037/a0019956; Santelmann LM, 1998, COGNITION, V69, P105, DOI 10.1016/S0010-0277(98)00060-2; Soderstrom M, 2002, PROC ANN BUCLD, P643; Steinborn MB, 2008, ACTA PSYCHOL, V129, P297, DOI 10.1016/j.actpsy.2008.08.005; ter Schure S, 2014, INFANCY, V19, P476, DOI 10.1111/infa.12057; Vallesi A., 2010, ATTENTION TIME, P303, DOI [DOI 10.1093/ACPROF:OSO/9780199563456.003.0022, 10.1093/acprof:oso/9780199563456.003.0022]; Vallesi A, 2013, COGNITION, V127, P22, DOI 10.1016/j.cognition.2012.11.011	49	9	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184698	10.1371/journal.pone.0184698	http://dx.doi.org/10.1371/journal.pone.0184698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886169	gold, Green Submitted, Green Published			2022-12-27	WOS:000410001100179
J	Needell, JC; Ir, D; Robertson, CE; Kroehl, ME; Frank, DN; Zipris, D				Needell, James C.; Ir, Diana; Robertson, Charles E.; Kroehl, Miranda E.; Frank, Daniel N.; Zipris, Danny			Maternal treatment with short-chain fatty acids modulates the intestinal microbiota and immunity and ameliorates type 1 diabetes in the offspring	PLOS ONE			English	Article							GUT MICROBIOTA; INFLAMMATORY RESPONSES; INNATE IMMUNITY; KILHAM RAT; VIRUS; METABOLITES; INTERFACE; DISEASE; CELLS	We recently hypothesized that the intestinal microbiota and the innate immune system play key roles in the mechanism of Kilham Rat Virus-induced type 1 diabetes in the LEW1. WR1 rat. We used this animal model to test the hypothesis that maternal therapy with short-chain fatty acids can modulate the intestinal microbiota and reverse virus-induced proinflammatory responses and type 1 diabetes in rat offspring. We observed that administration of short-chain fatty acids to rat breeders via drinking water prior to pregnancy and further treatment of the offspring with short-chain fatty acids after weaning led to disease amelioration. In contrast, rats that were administered short-chain fatty acids beginning at weaning were not protected from type 1 diabetes. Short-chain fatty acid therapy exerted a profound effect on the intestinal microbiome in the offspring reflected by a reduction and an increase in the abundances of Firmicutes and Bacteroidetes taxa, respectively, on day 5 post-infection, and reversed virus-induced alterations in certain bacterial taxa. Principal component analysis and permutation multivariate analysis of variance tests further revealed that short-chain fatty acids induce a distinct intestinal microbiota compared with uninfected animals or rats that receive the virus only. Short-chain fatty acids downregulated Kilham Rat Virus-induced proinflammatory responses in the intestine. Finally, short-chain fatty acids altered the B and T cell compartments in Peyer's patches. These data demonstrate that short-chain fatty acids can reshape the intestinal microbiota and prevent virus-induced islet autoimmunity and may therefore represent a useful therapeutic strategy for disease prevention.	[Needell, James C.; Zipris, Danny] Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; [Ir, Diana; Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO USA; [Robertson, Charles E.; Frank, Daniel N.] Univ Colorado, Microbiome Res Consortium MiRC, Aurora, CO USA; [Kroehl, Miranda E.] Colorado Sch Publ Hlth, Dept Biostat & Informat, Aurora, CO USA; [Kroehl, Miranda E.] Univ Colorado Denver, Aurora, CO USA; [Zipris, Danny] Innate Biotechnol LLC, Denver, CO 80231 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Zipris, D (corresponding author), Univ Colorado Denver, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA.; Zipris, D (corresponding author), Innate Biotechnol LLC, Denver, CO 80231 USA.	zdanny@innatebiotechnologies.com		ROBERTSON, CHARLES/0000-0002-4136-4121	NIH/NCATS Colorado CCTSI [UL1 TR001082]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	NIH/NCATS Colorado CCTSI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH/NCATS Colorado CCTSI Grant Number UL1 TR001082. Contents are the authors' sole responsibility and do not necessarily represent official NIH views.	Alkanani AK, 2015, DIABETES, V64, P3510, DOI 10.2337/db14-1847; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Culina S, 2012, DIABETES METAB, V38, P379, DOI 10.1016/j.diabet.2012.05.005; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; de Goffau MC, 2014, DIABETOLOGIA, V57, P1569, DOI 10.1007/s00125-014-3274-0; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Frank DN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-362; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; GUBERSKI DL, 1991, SCIENCE, V254, P1010, DOI 10.1126/science.1658938; Hara N, 2013, J MOL MED, P1; Hara N, 2014, INNATE IMMUN-LONDON, V20, P574, DOI 10.1177/1753425913502242; Hara N, 2012, J IMMUNOL, V189, P3805, DOI 10.4049/jimmunol.1201257; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Huang CB, 2011, ARCH ORAL BIOL, V56, P650, DOI 10.1016/j.archoralbio.2011.01.011; Keeney KM, 2014, ANNU REV MICROBIOL, V68, P217, DOI 10.1146/annurev-micro-091313-103456; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Londono P, 2010, CLIN IMMUNOL, V135, P401, DOI 10.1016/j.clim.2010.01.007; Marino E, 2017, NAT IMMUNOL, V18, P552, DOI 10.1038/ni.3713; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Myles IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087181; Myles IA, 2013, J IMMUNOL, V191, P3200, DOI 10.4049/jimmunol.1301057; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Thaiss CA, 2014, CURR OPIN IMMUNOL, V26, P41, DOI 10.1016/j.coi.2013.10.016; Toivonen RK, 2014, DIABETOLOGIA, V57, P2183, DOI 10.1007/s00125-014-3325-6; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wolter TR, 2009, CLIN IMMUNOL, V132, P103, DOI 10.1016/j.clim.2009.02.007; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Zhou YN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6381; Zipris D, 2003, J IMMUNOL, V170, P3592, DOI 10.4049/jimmunol.170.7.3592; Zipris D, 2007, J IMMUNOL, V178, P693, DOI 10.4049/jimmunol.178.2.693	53	33	38	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183786	10.1371/journal.pone.0183786	http://dx.doi.org/10.1371/journal.pone.0183786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886045	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100039
J	Swathy, B; Banerjee, M				Swathy, Babu; Banerjee, Moinak			Haloperidol induces pharmacoepigenetic response by modulating miRNA expression, global DNA methylation and expression profiles of methylation maintenance genes and genes involved in neurotransmission in neuronal cells	PLOS ONE			English	Article							ANTIPSYCHOTIC-DRUG TREATMENT; LIPID-METABOLISM; SCHIZOPHRENIA; RECEPTOR; ASSOCIATION; OLANZAPINE; BRAIN	Introduction Haloperidol has been extensively used in various psychiatric conditions. It has also been reported to induce severe side effects. We aimed to evaluate whether haloperidol can influence host methylome, and if so what are the possible mechanisms for it in neuronal cells. Impact on host methylome and miRNAs can have wide spread alterations in gene expression, which might possibly help in understanding how haloperidol may impact treatment response or induce side effects. Methods SK-N-SH, a neuroblasoma cell line was treated with haloperidol at 10 mu m concentration for 24 hours and global DNA methylation was evaluated. Methylation at global level is maintained by methylation maintenance machinery and certain miRNAs. Therefore, the expression of methylation maintenance genes and their putative miRNA expression profiles were assessed. These global methylation alterations could result in gene expression changes. Therefore genes expressions for neurotransmitter receptors, regulators, ion channels and transporters were determined. Subsequently, we were also keen to identify a strong candidate miRNA based on biological and in-silico approach which can reflect on the pharmacoepigenetic trait of haloperidol and can also target the altered neuroscience panel of genes used in the study. Results Haloperidol induced increase in global DNA methylation which was found to be associated with corresponding increase in expression of various epigenetic modifiers that include DNMT1, DNMT3A, DNMT3B and MBD2. The expression of miR-29b that is known to putatively regulate the global methylation by modulating the expression of epigenetic modifiers was observed to be down regulated by haloperidol. In addition to miR-29b, miR-22 was also found to be downregulated by haloperidol treatment. Both these miRNA are known to putatively target several genes associated with various epigenetic modifiers, pharmacogenes and neurotransmission. Interestingly some of these putative target genes involved in neurotransmission were observed to be upregulated while CHRM2 gene expression was down regulated. Conclusions Haloperidol can influence methylation traits thereby inducing a pharmacoepigenomic response, which seems to be regulated by DNMTs and their putative miRNA expression. Increased methylation seems to influence CHRM2 gene expression while microRNA could influence neurotransmission, pharmacogene expression and methylation events. Altered expression of various therapeutically relevant genes and miRNA expression, could account for their role in therapeutic response or side effects.	[Swathy, Babu; Banerjee, Moinak] Rajiv Gandhi Ctr Biotechnol, Human Mol Genet Lab, Trivandrum, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Banerjee, M (corresponding author), Rajiv Gandhi Ctr Biotechnol, Human Mol Genet Lab, Trivandrum, Kerala, India.	moinak_ban@hotmail.com	Banerjee, Moinak/X-4471-2018	Banerjee, Moinak/0000-0002-0842-0398	Dept. of Biotechnology, Government of India	Dept. of Biotechnology, Government of India	SB and MB acknowledges Dept. of Biotechnology, Government of India for providing research fellowship to SB and intramural support to MB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SB and MB acknowledges Dept. of Biotechnology, Government of India for providing research fellowship to SB and intramural support to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Feher LZ, 2005, NEUROCHEM INT, V47, P271, DOI 10.1016/j.neuint.2005.04.020; Ferno J, 2005, PHARMACOGENOMICS J, V5, P298, DOI 10.1038/sj.tpj.6500323; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Inoue A, 1998, MOL BRAIN RES, V55, P285, DOI 10.1016/S0169-328X(98)00009-6; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Kornhuber J, 1999, AM J PSYCHIAT, V156, P885, DOI 10.1176/ajp.156.6.885; Li JH, 2004, J NEUROCHEM, V90, P1117, DOI 10.1111/j.1471-4159.2004.02569.x; MACGIBBON GA, 1994, MOL BRAIN RES, V23, P21, DOI 10.1016/0169-328X(94)90207-0; Melas PA, 2012, FASEB J, V26, P2712, DOI 10.1096/fj.11-202069; Melka Melkaye G, 2013, J Mol Psychiatry, V1, P19, DOI 10.1186/2049-9256-1-19; Melka MG, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-1; Minet-Ringuet J, 2007, MOL PSYCHIATR, V12, P562, DOI 10.1038/sj.mp.4001948; Miyauchi M, 2016, NEUROPSYCHOBIOLOGY, V74, P60, DOI 10.1159/000452770; Narayan S, 2007, J NEUROSCI RES, V85, P757, DOI 10.1002/jnr.21161; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Santarelli DM, 2013, PSYCHOPHARMACOLOGY, V227, P67, DOI 10.1007/s00213-012-2939-y; Scarr E, 2009, MOL PSYCHIATR, V14, P1017, DOI 10.1038/mp.2008.28; Shi WT, 2012, J PSYCHIATR RES, V46, P198, DOI 10.1016/j.jpsychires.2011.09.010; Shimabukuro M, 2006, BEHAV BRAIN FUNCT, V2, P1, DOI DOI 10.1186/1744-9081-2-1; Swathy B, 2017, EPIGENOMICS-UK, V9, P721, DOI 10.2217/epi-2016-0106; Thomas EA, 2003, MOL PSYCHIATR, V8, P983, DOI 10.1038/sj.mp.4001425	21	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184209	10.1371/journal.pone.0184209	http://dx.doi.org/10.1371/journal.pone.0184209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886082	Green Published, gold			2022-12-27	WOS:000410001100081
J	Andersen, K; Fjerstad, M; Basnett, I; Neupane, S; Acre, V; Sharma, SK; Jackson, E				Andersen, Kathryn; Fjerstad, Mary; Basnett, Indira; Neupane, Shailes; Acre, Valerie; Sharma, Sharad Kumar; Jackson, Emily			Determination of medical abortion eligibility by women and community health volunteers in Nepal: A toolkit evaluation	PLOS ONE			English	Article							REDUCTION STRATEGY; MISOPROSTOL; PREGNANCY	Objective To determine if pregnant, literate women and female community health volunteers (FCHVs) in Nepal can accurately determine a woman's eligibility for medical abortion (MA) using a toolkit, compared to comprehensive abortion care (CAC) trained providers. Study design We conducted a prospective diagnostic accuracy study in which women presenting for first trimester abortion, and FCHVs, independently assessed each woman's eligibility for MA using a modified gestational dating wheel to determine gestational age and a nine-point checklist of MA contraindications or cautions. Ability to determine MA eligibility was compared to experienced CAC-providers using Nepali standard of care. Results Both women (n = 3131) and FCHVs (n = 165) accurately interpreted the wheel 96% of the time, and the eligibility checklist 72% and 95% of the time, respectively. Of the 649 women who reported potential contraindications or cautions on the checklist, 88% misidentified as eligible. Positive predictive value (PPV) of women's assessment of eligibility based on gestational age was 93% (95% CI 92, 94) compared to CAC-providers' (n = 47); PPV of the medical contraindications checklist and overall (90% [95% CI 88, 91] and 93% [95% CI 92, 94] respectively) must be interpreted with caution given women's difficulty using the checklist. PPV of FCHVs' determinations were 93% (95% CI 92, 94), 90% (95% CI 89,91), and 93% (95% CI 91, 94) respectively. Conclusion Although a promising strategy to assist women and FCHVs to assess MA eligibility, further refinement of the eligibility tools, particularly the checklist, is needed before their widespread use.	[Andersen, Kathryn; Acre, Valerie] Ipas, Chapel Hill, NC 27516 USA; [Fjerstad, Mary] WomanCare Global, 8910 Univ Ctr Lane, San Diego, CA USA; [Neupane, Shailes] Valley Res Grp VaRG, Lalitpur, Nepal		Andersen, K (corresponding author), Ipas, Chapel Hill, NC 27516 USA.	andersenk@ipas.org						Andersen K, 2013, GLOB HEALTH-SCI PRAC, V1, P372, DOI 10.9745/GHSP-D-12-00026; Ashok PW, 1998, HUM REPROD, V13, P2962, DOI 10.1093/humrep/13.10.2962; Barnard S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011242.pub2; Bhandari A, 2011, BJOG-INT J OBSTET GY, V118, P26, DOI 10.1111/j.1471-0528.2011.03109.x; Briozzo L, 2006, INT J GYNECOL OBSTET, V95, P221, DOI 10.1016/j.ijgo.2006.07.013; Collumbien M, 2012, SOCIAL SCI METHODS R; Dean G, 2012, CONTRACEPTION, V85, P144, DOI 10.1016/j.contraception.2011.05.016; Olavarrieta CD, 2015, B WORLD HEALTH ORGAN, V93, P249, DOI 10.2471/BLT.14.143990; Gouk EV, 1999, BRIT J OBSTET GYNAEC, V106, P535, DOI 10.1111/j.1471-0528.1999.tb08320.x; Hyman A, 2013, CONTRACEPTION, V87, P128, DOI 10.1016/j.contraception.2012.10.020; Johnston HB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146305; K C N P, 2011, Kathmandu Univ Med J (KUMJ), V9, P260; McDonald J.A., 2003, REPROD HLTH EPIDEMIO; Puri M, 2014, REPROD HLTH MATTER S, P1; Raymond EG, 2015, CONTRACEPTION, V92, P190, DOI 10.1016/j.contraception.2015.06.020; Rocca CH, 2013, BJOG-INT J OBSTET GY, V120, P1075, DOI 10.1111/1471-0528.12242; Samandari G, 2012, REPROD HLTH, V9, P1742; Sherris J, 2005, INT J GYNECOL OBSTET, V88, P76, DOI 10.1016/j.ijgo.2004.09.006; Suvedi B. K., 2009, NEPAL MATERNAL MORTA; Tang OS, 2003, HUM REPROD, V18, P2315, DOI 10.1093/humrep/deg475; TEMPLETON A, 1990, BRIT J OBSTET GYNAEC, V97, P480; VANLOOK PFA, 1993, BRIT MED J, V307, P532; Winikoff B, 2012, OBSTET GYNECOL, V120, P1070, DOI [10.1097/AOG.0b013e31826c315f, http://10.1097/AOG.0b013e31826c315f]; World Health Organization, 2015, HLTH WORK ROL PROV S; World Health Organization, 2013, UNS AB GLOB REG EST; World Health Organization (WHO), 2012, TRENDS MAT MORT 1990; Zamberlin N, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-34	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0178248	10.1371/journal.pone.0178248	http://dx.doi.org/10.1371/journal.pone.0178248			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880926	gold, Green Published, Green Submitted			2022-12-27	WOS:000409467200001
J	Gaisberger, H; Kindt, R; Loo, J; Schmidt, M; Bognounou, F; Da, SS; Diallo, OB; Ganaba, S; Gnoumou, A; Lompo, D; Lykke, AM; Mbayngone, E; Nacoulma, BMI; Ouedraogo, M; Ouedraogo, O; Parkouda, C; Porembski, S; Savadogo, P; Thiombiano, A; Zerbo, G; Vinceti, B				Gaisberger, Hannes; Kindt, Roeland; Loo, Judy; Schmidt, Marco; Bognounou, Fidele; Da, Sie Sylvestre; Diallo, Ousmane Boukary; Ganaba, Souleymane; Gnoumou, Assan; Lompo, Djingdia; Lykke, Anne Mette; Mbayngone, Elisee; Nacoulma, Blandine Marie Ivette; Ouedraogo, Moussa; Ouedraogo, Oumarou; Parkouda, Charles; Porembski, Stefan; Savadogo, Patrice; Thiombiano, Adjima; Zerbo, Guibien; Vinceti, Barbara			Spatially explicit multi-threat assessment of food tree species in Burkina Faso: A fine-scale approach	PLOS ONE			English	Article							WEST-AFRICA; LAND-USE; CLIMATE; CONSERVATION; BIODIVERSITY; VEGETATION; CONSENSUS; EXAMPLE; IMPACT; FRUITS	Over the last decades agroforestry parklands in Burkina Faso have come under increasing demographic as well as climatic pressures, which are threatening indigenous tree species that contribute substantially to income generation and nutrition in rural households. Analyzing the threats as well as the species vulnerability to them is fundamental for priority setting in conservation planning. Guided by literature and local experts we selected 16 important food tree species (Acacia macrostachya, Acacia senegal, Adansonia digitata, Annona senegalensis, Balanites aegyptiaca, Bombax costatum, Boscia senegalensis, Detarium microcarpum, Lannea microcarpa, Parkia biglobosa, Sclerocarya birrea, Strychnos spinosa, Tamarindus indica, Vitellaria paradoxa, Ximenia americana, Ziziphus mauritiana) and six key threats to them (overexploitation, overgrazing, fire, cotton production, mining and climate change). We developed a species-specific and spatially explicit approach combining freely accessible datasets, species distribution models (SDMs), climate models and expert survey results to predict, at fine scale, where these threats are likely to have the greatest impact. We find that all species face serious threats throughout much of their distribution in Burkina Faso and that climate change is predicted to be the most prevalent threat in the long term, whereas overexploitation and cotton production are the most important short-term threats. Tree populations growing in areas designated as 'highly threatened' due to climate change should be used as seed sources for ex situ conservation and planting in areas where future climate is predicting suitable habitats. Assisted regeneration is suggested for populations in areas where suitable habitat under future climate conditions coincides with high threat levels due to short-term threats. In the case of Vitellaria paradoxa, we suggest collecting seed along the northern margins of its distribution and considering assisted regeneration in the central part where the current threat level is high due to overexploitation. In the same way, population-specific recommendations can be derived from the individual and combined threat maps of the other 15 food tree species. The approach can be easily transferred to other countries and can be used to analyze general and species specific threats at finer and more local as well as at broader (continental) scales in order to plan more selective and efficient conservation actions in time. The concept can be applied anywhere as long as appropriate spatial data are available as well as knowledgeable experts.	[Gaisberger, Hannes; Loo, Judy; Vinceti, Barbara] Biovers Int, Via Tre Denari 472-A, Rome, Italy; [Kindt, Roeland] World Agroforestry Ctr ICRAF, Nairobi, Kenya; [Schmidt, Marco] Senckenberg Biodivers & Climate Res Ctr, Data & Modelling Ctr, Senckenberganlage 25, Frankfurt, Germany; [Bognounou, Fidele] Univ Quebec, 2600 Blvd Laurier, Ville De Quebec, PQ, Canada; [Da, Sie Sylvestre] West African Sci Serv Ctr Climate Change & Adapte, Blvd Mouammar Kadhafi, Ouagadougou, Burkina Faso; [Diallo, Ousmane Boukary; Ganaba, Souleymane] INERA CNRST, Environm & Agr Res Inst, Ouagadougou, Burkina Faso; [Gnoumou, Assan] Univ Aube Nouvelle, Ouagadougou, Burkina Faso; [Lompo, Djingdia; Ouedraogo, Moussa; Zerbo, Guibien] CNSF, Natl Forest Seed Ctr, Ouagadougou, Burkina Faso; [Lykke, Anne Mette] Aarhus Univ, Vejlsovej 25, Silkeborg, Denmark; [Mbayngone, Elisee] Univ NDjamena, Ave Mobutu, Ndjamena, Chad; [Nacoulma, Blandine Marie Ivette; Ouedraogo, Oumarou; Thiombiano, Adjima] Univ Ouagadougou, Lab Bot & Plant Ecol, Ouagadougou, Burkina Faso; [Parkouda, Charles] DTA, IRSAT CNRST, Dept Food Technol, Ouagadougou, Burkina Faso; [Porembski, Stefan] Univ Rostock, Rostock, Germany; [Savadogo, Patrice] World Agroforestry Ctr, Niamey, Niger; [Savadogo, Patrice] Int Crop Res Inst Semiarid Trop ICRAF ICRISAT, Niamey, Niger	Alliance; Bioversity International; CGIAR; World Agroforestry (ICRAF); Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Quebec; Aarhus University; University of Rostock; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Gaisberger, H (corresponding author), Biovers Int, Via Tre Denari 472-A, Rome, Italy.	h.gaisberger@cgiar.org	Bognounou, Fidèle/E-5190-2013; ZERBO, Guibien Cléophas/N-2002-2013; Savadogo, Patrice/AAJ-1116-2020; Lykke, Anne Mette/N-7051-2019; Schmidt, Marco/C-3821-2009; Nacoulma, Blandine Marie Ivette/AAJ-3125-2020; Kindt, Roeland/AAV-3346-2020	Bognounou, Fidèle/0000-0003-2809-6078; Lykke, Anne Mette/0000-0002-4337-8607; Schmidt, Marco/0000-0001-6087-6117; Kindt, Roeland/0000-0002-7672-0712; Gaisberger, Hannes/0000-0002-6023-1236	Austria Development Agency [12610]; CGIAR Research Program on Forests, Trees and Agroforestry; CGIAR Research Program on Forests, Trees and Agroforestry (FTA)	Austria Development Agency; CGIAR Research Program on Forests, Trees and Agroforestry(CGIAR); CGIAR Research Program on Forests, Trees and Agroforestry (FTA)(CGIAR)	This work was supported by Austria Development Agency, Grant 12610, http://www. entwicklung.at/en/, to BV; and CGIAR Research Program on Forests, Trees and Agroforestry, http://foreststreesagroforestry.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Finally, we would like to thank all donors who supported this research through their contributions to the CGIAR Research Program on Forests, Trees and Agroforestry (FTA).	Binam JN, 2015, ENVIRON ECON POLICY, V17, P543, DOI 10.1007/s10018-015-0107-4; Bioversity International, SAFOREN W AFR MAD FO; Boffa J. M., 1999, AGROFORESTRY PARKLAN; Cadima X, 2014, J NAT CONSERV, V22, P113, DOI 10.1016/j.jnc.2013.09.007; DGAT, 2010, 1 MIN EC FIN, P456; Dressler S, 2014, TAXON, V63, P1159, DOI [10.12705/635.26, DOI 10.12705/635.26]; Faye M. D., 2011, Forests, Trees and Livelihoods, V20, P113; Fischer C, 2011, FOREST ECOL MANAG, V262, P1532, DOI 10.1016/j.foreco.2011.07.001; Gonzalez P, 2012, J ARID ENVIRON, V78, P55, DOI 10.1016/j.jaridenv.2011.11.001; Henry S, 2004, POPUL ENVIRON, V25, P423, DOI 10.1023/B:POEN.0000036928.17696.e8; Heubes J, 2012, MODELLING IMPACT FUT; Heubes J, 2013, J ARID ENVIRON, V96, P48, DOI 10.1016/j.jaridenv.2013.04.008; Higgins J, 2010, ECOREGIONAL ASSESSME; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; ICRAF, AGR DAT; ICRAF, 2006, 799 ICRAF IFAD WORLD; IMF (International Monetary Fund), 2014, 14230 IMF; IUCN-CMP (International Union for the Conservation of Nature-Conservation Measures Partnership), 2007, WORKING PAPER; Jamnadass RH, 2011, INT FOREST REV, V13, P338, DOI 10.1505/146554811798293836; Jarvis A, 2010, J NAT CONSERV, V18, P180, DOI 10.1016/j.jnc.2009.08.003; Kindt R., 2015, BIODIVERSITYR PACKAG; Kindt R, 2008, BIODIVERS CONSERV, V17, P1883, DOI 10.1007/s10531-008-9326-3; Lamien N, 1995, USE COMMERCIALIZATIO; Lee J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126252; Maranz S, 2004, ECON BOT, V58, P588, DOI 10.1663/0013-0001(2004)058[0588:NVAIPF]2.0.CO;2; Maranz S, 2009, J BIOGEOGR, V36, P1181, DOI 10.1111/j.1365-2699.2008.02081.x; McPherson M., 2008, J CONSERV PLANN, V4, P60; Metcalf SJ, 2013, BIOL CONSERV, V162, P1, DOI 10.1016/j.biocon.2013.03.005; NASA's Earth Observing System Data and Information System (EOSDIS), 2012, FIR INF RES MAN SYST; Ofori DA, 2014, CURR OPIN ENV SUST, V6, P123, DOI 10.1016/j.cosust.2013.11.016; Pare A L., 2001, NEGOTIATING RIGHTS A; Pica-Ciamarra U., 2007, Land Reform, Land Settlement and Cooperatives, P19; Platts PJ, 2015, AFR J ECOL, V53, P103, DOI 10.1111/aje.12180; Powell B, 2015, FOOD SECUR, V7, P535, DOI 10.1007/s12571-015-0466-5; Ranjitkar S, 2016, ENVIRON MODELL SOFTW, V75, P263, DOI 10.1016/j.envsoft.2015.10.027; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; ROMNEY AK, 1986, AM ANTHROPOL, V88, P313, DOI 10.1525/aa.1986.88.2.02a00020; Ryan CM, 2011, ECOL APPL, V21, P48, DOI 10.1890/09-1489.1; SAFORGEN Food Tree Species Working Group, 2000, PRIOR FOOD TREE SPEC; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Schmidt Marco, 2012, Biodiversity Ecol, V4, P105, DOI 10.7809/b-e.00065; Some A L, 2013, IFPRI RES MONOGRAPH, P79; Stadlmayr B, 2013, J SCI FOOD AGR, V93, P2627, DOI 10.1002/jsfa.6196; Swenson NG, 2010, ECOLOGY, V91, P2234, DOI 10.1890/09-1743.1; Teklehaimanot Z, 2004, AGROFOREST SYST, V61-2, P207, DOI 10.1023/B:AGFO.0000029000.22293.d1; Terrible PB, 1975, ATLAS HAUTE VOLTA AR; TNC, 2007, CONS ACT PLANN HDB D; TNC (The Nature Conservancy), 2003, SUCCESS; UNDP, 2020, HUM DEV DAT 1990 201; USDA (United States Department of Agriculture), 2015, 2015 W AFR COTT PROD; USGS, 2011, MIN RES DAT SYST MRD; van Breugel P, 2016, ECOSYSTEMS, V19, P369, DOI 10.1007/s10021-015-9938-x; van Zonneveld M, 2014, APPL VEG SCI, V17, P528, DOI 10.1111/avsc.12081; Vieilledent G, 2013, BIOL CONSERV, V166, P11, DOI 10.1016/j.biocon.2013.06.007; Vinceti B, 2013, SUSTAINABILITY-BASEL, V5, P4797, DOI 10.3390/su5114797; Wezel A., 2006, Environment Development and Sustainability, V8, P553, DOI 10.1007/s10668-006-9055-2; World Database on Protected Areas (WDPA), 2010, WDPA IS JOINT PROD U; Zizka A, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/1746-4269-11-9	58	36	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184457	10.1371/journal.pone.0184457	http://dx.doi.org/10.1371/journal.pone.0184457			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880962	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000409467200072
J	Mastrangeli, R; Satwekar, A; Cutillo, F; Ciampolillo, C; Palinsky, W; Longobardi, S				Mastrangeli, Renato; Satwekar, Abhijeet; Cutillo, Francesca; Ciampolillo, Cinzia; Palinsky, Wolf; Longobardi, Salvatore			In-vivo biological activity and glycosylation analysis of a biosimilar recombinant human follicle-stimulating hormone product (Bemfola) compared with its reference medicinal product (GONAL-f)	PLOS ONE			English	Article							GLYCOPROTEIN HORMONES; GLYCOPEPTIDE ANALYSIS; OVARIAN STIMULATION; BETA-SUBUNIT; HUMAN FSH; GONADOTROPINS; MASS; HETEROGENEITY; CONSISTENCY; PROFILES	Recombinant human follicle-stimulating hormone (r-hFSH) is widely used in fertility treatment. Although biosimilar versions of r-hFSH (follitropin alfa) are currently on the market, given their structural complexity and manufacturing process, it is important to thoroughly evaluate them in comparison with the reference product. This evaluation should focus on how they differ (e.g., active component molecular characteristics, impurities and potency), as this could be associated with clinical outcome. This study compared the site-specific glycosylation profile and batch-to-batch variability of the in-vivo bioactivity of Bemfola, a biosimilar follitropin alfa, with its reference medicinal product GONAL-f. The focus of this analysis was the site-specific glycosylation at asparagine (Asn) 52 of the a-subunit of FSH, owing to the pivotal role of Asn52 glycosylation in FSH receptor (FSHR) activation/signalling. Overall, Bemfola had bulkier glycan structures and greater sialylation than GONAL-f. The nominal specific activity for both Bemfola and GONAL-f is 13,636 IU/mg. Taking into account both the determined potency and the nominal amount the average specific activity of Bemfola was 14,522 IU/mg (105.6% of the nominal value), which was greater than the average specific activity observed for GONAL-f (13,159 IU/mg; 97.3% of the nominal value; p = 0.0048), although this was within the range stated in the product label. A higher batch-to-batch variability was also observed for Bemfola versus GONAL-f (coefficient of variation: 8.3% vs 5.8%). A different glycan profile was observed at Asn52 in Bemfola compared with GONAL-f (a lower proportion of bi-antennary structures [similar to 53% vs similar to 77%], and a higher proportion of tri-antennary [similar to 41% vs similar to 23%] and tetra-antennary structures [similar to 5% vs < 1%]). These differences in the Asn52 glycan profile might potentially lead to differences in FSHR activation. This, together with the greater bioactivity and higher batch-to-batch variability of Bemfola, could partly explain the reported differences in clinical outcomes. The clinical relevance of the differences observed between GONAL-f and Bemfola should be further investigated.	[Mastrangeli, Renato] Merck Serono SpA, Biotech Dev Programme, Rome, Italy; [Mastrangeli, Renato; Satwekar, Abhijeet; Cutillo, Francesca; Ciampolillo, Cinzia; Palinsky, Wolf; Longobardi, Salvatore] Merck KGaA, Darmstadt, Germany; [Satwekar, Abhijeet; Cutillo, Francesca] Merck Serono SpA, Pharamceut & Analyt Dev Biotech Prod, Rome, Italy; [Ciampolillo, Cinzia] Merck RBM SpA, Analyt BQC, Turin, Italy; [Palinsky, Wolf] Merck Biopharma, Biotech Dev Programme, Aubonne, Switzerland; [Longobardi, Salvatore] Merck Serono SpA, Global Med Affairs Fertil, Rome, Italy	Merck KGaA; EMD Serono Inc.; Merck KGaA; Merck KGaA; EMD Serono Inc.; Merck KGaA; EMD Serono Inc.	Mastrangeli, R (corresponding author), Merck Serono SpA, Biotech Dev Programme, Rome, Italy.; Mastrangeli, R (corresponding author), Merck KGaA, Darmstadt, Germany.	renato.mastrangeli@merckgroup.com		Satwekar, Abhijeet/0000-0002-2355-9849; Mastrangeli, Renato/0000-0002-0294-8773	Merck KGaA, Darmstadt, Germany	Merck KGaA, Darmstadt, Germany(Merck & Company)	This study was funded by Merck KGaA, Darmstadt, Germany. The funder provided support in the form of salaries for AS, CC, FC, RM, WP and SL. AS, CC, FC, RM, WP and SL had additional roles in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The specific roles of the authors are listed in the 'author contributions' section. Medical writing assistance was provided by Steven Goodrick of inScience Communications, UK, funded by Merck KGaA, Darmstadt, Germany. All authors participated in the manuscript development and revision and the decision to publish the paper. The primary author (RM) is responsible for the manuscript content and approval to submit the manuscript.; The authors would like to thank Xuliang Jiang (EMD Serono), Sonia Senatore, Marco Berardi, Angelo Palmese, Mara Rossi, Carlo Emanuele Giartosio, Horst Bierau and Monica Lispi (Merck Serono S.p.A) and Thomas D'Hooghe (Merck KGaA. Darmstadt, Germany) for their support and comments. We would also like to thank the anonymous reviewers for their helpful comments. Writing support was provided by Steven Goodrick of inScience Communications, funded by Merck KGaA, Darmstadt, Germany.	Andersen CY, 2004, REPROD BIOMED ONLINE, V9, P231, DOI 10.1016/S1472-6483(10)62135-9; Anobile CJ, 1998, MOL HUM REPROD, V4, P631, DOI 10.1093/molehr/4.7.631; [Anonymous], EUROPEAN PHARMACOPOE; Bassett R, 2005, REPROD BIOMED ONLINE, V10, P169, DOI 10.1016/S1472-6483(10)60937-6; BISHOP LA, 1995, ENDOCRINOLOGY, V136, P2635, DOI 10.1210/en.136.6.2635; Bousfield GR, 2008, BIOCHEMISTRY-US, V47, P1708, DOI 10.1021/bi701764w; Bousfield GR, 2007, MOL CELL ENDOCRINOL, V260, P40, DOI 10.1016/j.mce.2006.02.017; Bousfield GR, 2011, REV ENDOCR METAB DIS, V12, P289, DOI 10.1007/s11154-011-9191-3; Dalpathado DS, 2006, BIOCHEMISTRY-US, V45, P8665, DOI 10.1021/bi060435k; Davis John S, 2014, J Glycomics Lipidomics, V4, pe117; Daya Salim, 2004, Treat Endocrinol, V3, P161, DOI 10.2165/00024677-200403030-00004; Desaire H, 2013, MOL CELL PROTEOMICS, V12, P893, DOI 10.1074/mcp.R112.026567; Emperaire J., 2015, REV PHYSL; Emperaire J., 2011, MED THERAPEUTIQUE ME, V13, P49; European Medicines Agency, 2014, BEMF; European Medicines Agency, 2013, OV; European Medicines Agency, 2015, EUR PUBL ASS REP; Gervais A, 2003, GLYCOBIOLOGY, V13, P179, DOI 10.1093/glycob/cwg020; Gilar M, 2011, ANAL BIOCHEM, V417, P80, DOI 10.1016/j.ab.2011.05.028; Grass J, 2011, ANAL BIOANAL CHEM, V400, P2427, DOI 10.1007/s00216-011-4923-5; Hugues JN, 2005, REPROD BIOMED ONLINE, V10, P11; Jiang XL, 2014, J BIOL CHEM, V289, P14273, DOI 10.1074/jbc.M114.549592; Jiang XL, 2014, MOL CELL ENDOCRINOL, V382, P424, DOI 10.1016/j.mce.2013.08.021; LAMBERT A, 1995, HUM REPROD, V10, P1928, DOI 10.1093/oxfordjournals.humrep.a136208; Landomiel F, 2014, MOL CELL ENDOCRINOL, V382, P452, DOI 10.1016/j.mce.2013.09.035; Orvieto R, 2016, REPROD BIOL ENDOCRIN, V14, DOI 10.1186/s12958-016-0167-8; Rettenbacher M, 2015, REPROD BIOMED ONLINE, V30, P504, DOI 10.1016/j.rbmo.2015.01.005; Reusch D, 2015, MABS-AUSTIN, V7, P732, DOI 10.1080/19420862.2015.1045173; SAIRAM MR, 1985, SCIENCE, V229, P65, DOI 10.1126/science.2990039; Sam T., 2013, PHARM BIOTECHNOLOGY, P277; Ulloa-Aguirre A, 2003, BIOL REPROD, V69, P379, DOI 10.1095/biolreprod.103.016915; Ulloa-Aguirre A, 2001, HUM REPROD, V16, P599, DOI 10.1093/humrep/16.4.599; Ulloa-Aguirre A, 1999, ENDOCRINE, V11, P205, DOI 10.1385/ENDO:11:3:205; Visvanathan M, 2010, BCB 10 P 1 ACM INT C; Vitt UA, 2001, BIOL REPROD, V65, P1542, DOI 10.1095/biolreprod65.5.1542; Walton WJ, 2001, J CLIN ENDOCR METAB, V86, P3675, DOI 10.1210/jcem.86.8.7712; Wide L, 2013, UPSALA J MED SCI, V118, P153, DOI 10.3109/03009734.2013.782081; Wolzt M, 2016, EUR J DRUG METAB PH, V41, P259, DOI 10.1007/s13318-015-0257-6; Yding Andersen C, 2002, Reprod Biomed Online, V5, P232; Zuccotti M, 2011, HUM REPROD UPDATE, V17, P525, DOI 10.1093/humupd/dmr009	40	30	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184139	10.1371/journal.pone.0184139	http://dx.doi.org/10.1371/journal.pone.0184139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880909	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200035
J	Poznanski, RR; Cacha, LA; Ali, J; Rizvi, ZH; Yupapin, P; Salleh, SH; Bandyopadhyay, A				Poznanski, R. R.; Cacha, L. A.; Ali, J.; Rizvi, Z. H.; Yupapin, P.; Salleh, S. H.; Bandyopadhyay, A.			Induced mitochondrial membrane potential for modeling solitonic conduction of electrotonic signals	PLOS ONE			English	Article							ELECTRIC-FIELDS; SYNAPTIC-TRANSMISSION; CABLE EQUATION; CAPACITANCE; PROPAGATION; DENDRITES; DIFFUSION; ELECTRODIFFUSION; SYSTEM	A cable model that includes polarization-induced capacitive current is derived for modeling the solitonic conduction of electrotonic potentials in neuronal branchlets with microstructure containing endoplasmic membranes. A solution of the nonlinear cable equation modified for fissured intracellular medium with a source term representing charge 'soakage' is used to show how intracellular capacitive effects of bound electrical charges within mitochondrial membranes can influence electrotonic signals expressed as solitary waves. The elastic collision resulting from a head-on collision of two solitary waves results in localized and non-dispersing electrical solitons created by the nonlinearity of the source term. It has been shown that solitons in neurons with mitochondrial membrane and quasi-electrostatic interactions of charges held by the microstructure (i.e., charge 'soakage') have a slower velocity of propagation compared with solitons in neurons with microstructure, but without endoplasmic membranes. When the equilibrium potential is a small deviation from rest, the nonohmic conductance acts as a leaky channel and the solitons are small compared when the equilibrium potential is large and the outer mitochondrial membrane acts as an amplifier, boosting the amplitude of the endogenously generated solitons. These findings demonstrate a functional role of quasi-electrostatic interactions of bound electrical charges held by microstructure for sustaining solitons with robust self-regulation in their amplitude through changes in the mitochondrial membrane equilibrium potential. The implication of our results indicate that a phenomenological description of ionic current can be successfully modeled with displacement current in Maxwell's equations as a conduction process involving quasi-electrostatic interactions without the inclusion of diffusive current. This is the first study in which solitonic conduction of electrotonic potentials are generated by polarization-induced capacitive current in microstructure and nonohmic mitochondrial membrane current.	[Poznanski, R. R.] Univ Teknol Malaysia, Fac Biosci & Med Engn, Johor Baharu 81310, Malaysia; [Cacha, L. A.; Ali, J.; Rizvi, Z. H.] Univ Teknol Malaysia, Ibnu Sina ISIR, Ctr Laser, Johor Baharu 81310, Malaysia; [Yupapin, P.] Ton Duc Thang Univ, CORG, Dist 7, Ho Chi Minh City, Vietnam; [Yupapin, P.] Ton Duc Thang Univ, Fac Elect & Elect Engn, Dist 7, Ho Chi Minh City, Vietnam; [Salleh, S. H.] Univ Teknol Malaysia, Ctr Biomed Engn, Johor Baharu 81310, Johor, Malaysia; [Bandyopadhyay, A.] Natl Inst Mat Sci, Res Ctr Adv Measurement & Characterizat, Tsukuba, Ibaraki 3050047, Japan	Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; Ton Duc Thang University; Ton Duc Thang University; Universiti Teknologi Malaysia; National Institute for Materials Science	Poznanski, RR (corresponding author), Univ Teknol Malaysia, Fac Biosci & Med Engn, Johor Baharu 81310, Malaysia.	poznanski@biomedical.utm.my	Bandyopadhyay, Anirban/ABF-1728-2020	Bandyopadhyay, Anirban/0000-0002-8823-4914	UTM Postdoctoral Research Fellowship	UTM Postdoctoral Research Fellowship	L.A. Cacha was supported by UTM Postdoctoral Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research assistance provided by Yaseen M.S. Al-Wesabi in preparation of the manuscript for production is much appreciated. L.A. Cacha was supported by UTM Postdoctoral Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIZAWA Y, 1975, PROG THEOR PHYS, V53, P305, DOI 10.1143/PTP.53.305; ALVAREZ O, 1978, BIOPHYS J, V21, P1, DOI 10.1016/S0006-3495(78)85505-2; Bedard C, 2016, GEN CABLE MODELS NEU, P1; Bressloff PC, 2009, PHYS REV E, V79; Christov CI, 1996, PHYS REV E, V54, P3621, DOI 10.1103/PhysRevE.54.3621; Drazin PG., 1996, SOLITONS INTRO; DUBOIS DM, 1974, P NATL ACAD SCI USA, V71, P2858, DOI 10.1073/pnas.71.7.2858; El Hady A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7697; FERNANDEZ JM, 1983, J GEN PHYSIOL, V82, P331, DOI 10.1085/jgp.82.3.331; FITZHUGH R, 1961, BIOPHYS J, V1, P445, DOI 10.1016/S0006-3495(61)86902-6; FRANKENHAEUSER B, 1964, J PHYSIOL-LONDON, V171, P302, DOI 10.1113/jphysiol.1964.sp007378; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; GARDNERMEDWIN AR, 1983, J PHYSIOL-LONDON, V335, P393, DOI 10.1113/jphysiol.1983.sp014541; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; Ghosh S, 1999, J THEOR BIOL, V200, P299, DOI 10.1006/jtbi.1999.0993; Gonzalez-Perez A, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031047; Halnes G, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003386; Heimburg T, 2012, BIOPHYS J, V103, P918, DOI 10.1016/j.bpj.2012.07.010; Henry BI, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.128103; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holcman D, 2015, NAT REV NEUROSCI, V16, P685, DOI 10.1038/nrn4022; Howell B, 2015, J NEURAL ENG, V13; Huxley A., 1959, J PHYSL, V148, p80P; Jack J.J.B., 1975, ELECT CURRENT FLOW E; Jonas EA, 1999, SCIENCE, V286, P1347, DOI 10.1126/science.286.5443.1347; Kasevich RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023412; Langlands TAM, 2009, J MATH BIOL, V59, P761, DOI 10.1007/s00285-009-0251-1; Lazarevich IA, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062718; Leonetti M, 1999, EUROPHYS LETT, V46, P107, DOI 10.1209/epl/i1999-00568-7; Leonetti M, 1998, EUR PHYS J B, V2, P325, DOI 10.1007/s100510050256; Lindsay KA, 2004, PROG BIOPHYS MOL BIO, V85, P71, DOI 10.1016/j.pbiomolbio.2003.08.001; Maex R, 2017, J INTEGR NEUROSCI, V16, P73, DOI 10.3233/JIN-170008; Major G, 2013, ANNU REV NEUROSCI, V36, P1, DOI 10.1146/annurev-neuro-062111-150343; MCILROY D K, 1970, Mathematical Biosciences, V7, P313, DOI 10.1016/0025-5564(70)90131-8; Meier SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122401; Mori Y, 2009, COMM APP MATH COM SC, V4, P85, DOI 10.2140/camcos.2009.4.85; Poznanski RR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01849-3; Poznanski RR, 2012, J INTEGR NEUROSCI, V11, P417, DOI 10.1142/S0219635212500264; Poznanski Roman R., 2004, Journal of Integrative Neuroscience, V3, P267, DOI 10.1142/S0219635204000439; Poznanski RR, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.021902; QIAN N, 1989, BIOL CYBERN, V62, P1, DOI 10.1007/BF00217656; Qiu C, 2015, J NEUROSCI, V35, P15800, DOI 10.1523/JNEUROSCI.1045-15.2015; Radman T, 2007, J NEUROSCI, V27, P3030, DOI 10.1523/JNEUROSCI.0095-07.2007; Rall W., COMPR PHYSIOL; Richardson G, 2009, MATH MED BIOL, V26, P201, DOI 10.1093/imammb/dqn027; Ricketts D.S., 2011, ELECT SOLITONS THEOR; RINZEL J, 1973, BIOPHYS J, V13, P1313, DOI 10.1016/S0006-3495(73)86065-5; Scott A., 1977, NEUROPHYSICS; SCOTT AC, 1973, P IEEE, V61, P1443, DOI 10.1109/PROC.1973.9296; Shemer I, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000036; Stuart GJ, 2015, NAT NEUROSCI, V18, P1713, DOI 10.1038/nn.4157; Thompson CJ, 1999, CHAOS SOLITON FRACT, V10, P1825, DOI 10.1016/S0960-0779(98)00131-3; Tuckwell H.C., 1988, INTRO THEORETICAL NE, DOI [10.1017/CBO9780511623202, DOI 10.1017/CBO9780511623202]; Tuszynski JA, 2003, INTRO MOL BIOPHYSICS; Wazwaz AM, 2009, NONLINEAR PHYS SCI, P1, DOI 10.1007/978-3-642-00251-9; Zhang MM, 2014, J NEUROSCI, V34, P1409, DOI 10.1523/JNEUROSCI.3877-13.2014	56	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183677	10.1371/journal.pone.0183677	http://dx.doi.org/10.1371/journal.pone.0183677			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880876	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200023
J	Tian, H; Wang, H; Hui, XL; Wang, ZH; Drijber, RA; Liu, JS				Tian, Hui; Wang, Hui; Hui, Xiaoli; Wang, Zhaohui; Drijber, Rhae A.; Liu, Jinshan			Changes in soil microbial communities after 10 years of winter wheat cultivation versus fallow in an organic-poor soil in the Loess Plateau of China	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; NITROGEN-FERTILIZER; MANAGEMENT REGIMES; NORTHEAST CHINA; BIOMASS-C; CARBON; CONSERVATION; PRODUCTIVITY; FUMIGATION; EXTRACTION	Agricultural management methods, such as cultivation or fallowing, have led to significant changes in soil fertility and hence, crop yield. Such changes may have stemmed from changes in soil microbial communities and associated biogeochemical processes. This phenomenon is particularly true in organic-poor soil in the Loess Plateau of China. In this study, we examined three existing soil management regimes as part of a 10-year field experiment and evaluated their effects on fungal and bacterial community structures by performing high-throughput 454 pyrosequencing. These management regimes were (i) fertilized winter wheat (Triticum aestivum L.) (FW), (ii) continuous natural fallow with weeds but without crop grown (NF), and (iii) continuous bare fallow without weeds or crop grown (BF). After 10 years, soil organic carbon (SOC), microbial biomass carbon (MBC), and available potassium (K) concentrations were highest in NF. Soil N behaved differently, with BF obtaining the highest nitrate nitrogen (N). Meanwhile, slight differences in total N (TN) were observed among FW, NF, and BF. Available phosphorus (P) was highest and available K was lowest in FW. Microbial communities were dominated by Ascomycota (59.1% of fungal sequences), and Acidobacteria, Actinobacteria, Bacteroidetes, Firmicutes, and Proteobacteria (75.7% of bacterial sequences) in FW, NF and BF at the phylum level. Soil management regimes did not affect the fungal and bacterial richness and diversity but significantly modified their community compositions. Compared with FW, the abundances of Ascomycota (fungi phylum) and Alternaria, Gibberella, and Emericella (fungi genus) were increased by NF, whereas the values of Chaetomium, Humicola, and Cryptococcus (fungi genus) were decreased by BF. The abundances of Verrucomicrobia (bacteria phylum), and Steroidobacter (bacteria genus) were increased by NF, and Bacteroides (bacteria genus) was increased by BF. Canonical correspondence analysis showed that SOC, available P, and TN might be the key factors in community formation. Therefore, the decadal absence of plants (BF) affected soil fertility by increased available K and nitrate N, whileas natural fallow (NF) affected soil fertility by increased SOC, available K, and MBC, and they all changed fungal and bacterial community compositions.	[Tian, Hui; Wang, Hui; Hui, Xiaoli; Wang, Zhaohui; Liu, Jinshan] Northwest A&F Univ, Coll Nat Resources & Environm, Key Lab Plant Nutr & Agroenvironm Northwest China, Minist Agr, Yangling, Shaanxi, Peoples R China; [Drijber, Rhae A.] Univ Nebraska, Dept Agron & Hort, Lincoln, NE USA	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; University of Nebraska System; University of Nebraska Lincoln	Liu, JS (corresponding author), Northwest A&F Univ, Coll Nat Resources & Environm, Key Lab Plant Nutr & Agroenvironm Northwest China, Minist Agr, Yangling, Shaanxi, Peoples R China.	jsliu@nwsuaf.edu.cn	LIU, JS/AFQ-6791-2022	Liu, J.S./0000-0001-9268-2595	National Natural Science Foundation of China [41501308, 41201238]; Chinese National Key Basic Research Special Funds [2015BAD23B04]; Chinese Special Fund for Agro-scientific Research in the Public Interest [201303104, 201503124]; Research Fund for the Doctoral Program of Higher Education of China [20120204120012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Key Basic Research Special Funds(National Basic Research Program of China); Chinese Special Fund for Agro-scientific Research in the Public Interest; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This research was supported jointly by grants from the National Natural Science Foundation of China (41501308, 41201238), Chinese National Key Basic Research Special Funds (2015BAD23B04), and Chinese Special Fund for Agro-scientific Research in the Public Interest (201303104, 201503124), Research Fund for the Doctoral Program of Higher Education of China (20120204120012).; This research was supported jointly by grants from the National Natural Science Foundation of China (41501308, 41201238), Chinese National Key Basic Research Special Funds (2015BAD23B04), and Chinese Special Fund for Agro-scientific Research in the Public Interest (201303104, 201503124), Research Fund for the Doctoral Program of Higher Education of China (20120204120012).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez R, 2005, SOIL USE MANAGE, V21, P38, DOI 10.1079/SUM2005291; [Anonymous], 1982, CHEM MICROBIOLOGY PR; Bao SD, 2000, PHYS CH EM ANAL SOIL; Barre P, 2010, BIOGEOSCIENCES, V7, P3839, DOI 10.5194/bg-7-3839-2010; Batlle-Aguilar J, 2011, AGRON SUSTAIN DEV, V31, P251, DOI 10.1051/agro/2010007; Bremner JM, 1982, AGRONOMY, P595, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C31; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P831, DOI 10.1016/0038-0717(85)90143-9; CABRERA ML, 1993, SOIL SCI SOC AM J, V57, P1007, DOI 10.2136/sssaj1993.03615995005700040021x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cederlund H, 2014, APPL SOIL ECOL, V84, P62, DOI 10.1016/j.apsoil.2014.06.003; Cooperative Research Group on Chinese Soil Taxonomy, 2001, CHINESE SOIL TAXONOM; Dang YaAi, 2007, Plant Nutrition and Fertilizer Science, V13, P1020; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diekow J, 2005, PLANT SOIL, V268, P319, DOI 10.1007/s11104-004-0330-4; Dong WY, 2014, APPL SOIL ECOL, V84, P140, DOI 10.1016/j.apsoil.2014.06.007; Drijber RA, 2000, SOIL BIOL BIOCHEM, V32, P1419, DOI 10.1016/S0038-0717(00)00060-2; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; [樊军 Fan Jun], 2003, [水土保持研究, Research of Soil and Water Conservation], V10, P85; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gomez-Montano L, 2013, SOIL BIOL BIOCHEM, V65, P50, DOI 10.1016/j.soilbio.2013.04.005; Gong ZiTong, 1999, Pedosphere, V9, P193; Guenet B, 2011, APPL SOIL ECOL, V51, P87, DOI 10.1016/j.apsoil.2011.07.006; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kong AYY, 2010, SOIL BIOL BIOCHEM, V42, P1523, DOI 10.1016/j.soilbio.2010.05.021; Krey T, 2013, EUR J SOIL BIOL, V55, P124, DOI 10.1016/j.ejsobi.2012.12.007; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; Li H, 2011, PLANT SOIL, V349, P157, DOI 10.1007/s11104-011-0909-5; Liu GB, 1999, AMBIO, V28, P663; Liu JS, 2016, SOIL SCI PLANT NUTR, V62, P263, DOI 10.1080/00380768.2016.1179559; Liu JJ, 2014, SOIL BIOL BIOCHEM, V70, P113, DOI 10.1016/j.soilbio.2013.12.014; Liu ZP, 2011, AGR ECOSYST ENVIRON, V142, P184, DOI 10.1016/j.agee.2011.05.002; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Mello A, 2011, MYCOLOGIA, V103, P1184, DOI 10.3852/11-027; Nelson D., 1983, PUBLICATION AM SOC A, P539, DOI 10.2134/agronmonogr9.2.2-d.c29; Oksanen J, 2013, MULTIVARIATE ANAL EC; OLSEN STERLING R., 1957, SOIL SCI SOC AMER PROC, V21, P144; Pan Y, 2014, FEMS MICROBIOL ECOL, V90, P195, DOI 10.1111/1574-6941.12384; Polyanskaya LM, 2012, EURASIAN SOIL SCI+, V45, P710, DOI 10.1134/S1064229312030088; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shi P, 2015, ARCH AGRON SOIL SCI, V61, P1303, DOI 10.1080/03650340.2014.996136; Tardy V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130672; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; Unger PW., 2008, J CROP PROD, V2, P1, DOI [10.1300/J144v02n02_01, DOI 10.1300/J144V02N02_01]; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang QK, 2014, SOIL BIOL BIOCHEM, V72, P145, DOI 10.1016/j.soilbio.2014.01.020; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Xun WB, 2016, ENVIRON MICROBIOL, V18, P1907, DOI 10.1111/1462-2920.13098; Yang XY, 2012, GEODERMA, V177, P49, DOI 10.1016/j.geoderma.2012.01.033; Zhang HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092733; Zhou J, 2016, SOIL BIOL BIOCHEM, V95, P135, DOI 10.1016/j.soilbio.2015.12.012; Zhou ZC, 2006, ECOL MODEL, V198, P263, DOI 10.1016/j.ecolmodel.2006.04.019; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	59	11	12	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184223	10.1371/journal.pone.0184223	http://dx.doi.org/10.1371/journal.pone.0184223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880897	Green Submitted, Green Published, gold			2022-12-27	WOS:000409467200042
J	Zhang, LW; Zeng, YB; Fang, Y				Zhang, Liangwen; Zeng, Yanbing; Fang, Ya			The effect of health status and living arrangements on long term care models among older Chinese: A cross-sectional study	PLOS ONE			English	Article							TRENDS; ADULTS; PEOPLE	Background Currently, there are many studies focusing on the influencing factors of the elderly people's living arrangements or health status, but little is known about the relationship between living arrangements or health status and long-term care models for the old-age, especially the joint effects. Objective We aimed to assess the effects of health status and living arrangements on long-term care models (LTCM) among the elderly of Xiamen, China, especially their cumulative joint effects. Methods A total of 14,373 participants aged >= 60 years by multistage sampling in Xiamen of China were enrolled. Multinomial logistic regression was used to estimate the Odds ratios (ORs) regressing LTCM on health status and living arrangements using the Anderson model as theoretical framework. Results Totally, 14,292 valid questionnaires were obtained, of which 86.37% selected home care. With the increase of disability degree, older people are more likely to choose institutional care, compared to living alone (ORs = 1.75, 2.06, 4.00, 4.01 for the "relatively independent', "mild disability', "moderate disability', and "total disability', respectively, in comparison with "completely independent'). The elderly living with children and other family members preferred to choose home care. (ORs = 0.50, 0.39, 0.40, and 0.43 for the "living with children', "living with spouse', "living with children and spouse', and "living with others', respectively, in comparison with "alone'). Additionally, residence, number of children, education level, and feelings of loneliness were the determinants of the choice of social pension. Conclusion A multitude of older people are trended to choose home care in Xiamen of China. There was an interaction and joint effect between the degree of disability and the living arrangements on LTCM. Therefore, policymakers should pay close attention to care for those living alone, childless, and disabled elders to meet their care needs, especially in home care. In addition, the social construction of facilities for elders in rural areas should be strengthened.	[Zhang, Liangwen; Zeng, Yanbing; Fang, Ya] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Fujian, Peoples R China; [Zhang, Liangwen; Zeng, Yanbing; Fang, Ya] Xiamen Univ, Sch Publ Hlth, Key Lab Hlth Technol Assessment, Fujian Prov Univ, Xiamen, Fujian, Peoples R China	Xiamen University; Fuzhou University; Xiamen University	Fang, Y (corresponding author), Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Xiamen, Fujian, Peoples R China.; Fang, Y (corresponding author), Xiamen Univ, Sch Publ Hlth, Key Lab Hlth Technol Assessment, Fujian Prov Univ, Xiamen, Fujian, Peoples R China.	Fangya@xmu.edu.cn			Center for Health Economics and Policy at the School of Public Health, Xiamen University; Youth Project of National Natural Science Fund [71403229]; project of National Natural Science Fund [81573257]; project of Natural Science Fund of Fujian Province [2017J01133]	Center for Health Economics and Policy at the School of Public Health, Xiamen University; Youth Project of National Natural Science Fund; project of National Natural Science Fund; project of Natural Science Fund of Fujian Province	This study was supported by The Center for Health Economics and Policy at the School of Public Health, Xiamen University, the Youth Project of National Natural Science Fund (No. 71403229), the project of National Natural Science Fund (No. 81573257), and the project of Natural Science Fund of Fujian Province (No. 2017J01133). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2007, LTCM, V25, P86; [Anonymous], 2000, J POPULAT, V3, P30; Bei Z, 2012, RES PROGR LONG TERM; Chen SY, 2009, AGEING INT, V34, P172, DOI 10.1007/s12126-009-9043-6; Chen W, 2015, ASSESSMENT DISABILIT; China NBoSoPsRo, 2015, NAT EC SOC DEV STAT; Chou YC, 2015, EUR J AGEING, V12, P95, DOI 10.1007/s10433-014-0322-z; ChuWHD Song G, 2008, CHINESE HLTH ENTERPR, V23, P836; Arias-Merino ED, 2012, ARCH GERONTOL GERIAT, V54, pE271, DOI 10.1016/j.archger.2012.02.010; Feng W., 2007, POPULATION CHINA BEG, P177; Gaymu J, 2008, EUR J AGEING, V5, P5, DOI 10.1007/s10433-008-0072-x; Gaymu J, 2006, EUR J POPUL, V22, P241, DOI 10.1007/s10680-006-9004-7; Jing Wang MW, 2008, CHINESE GEN PRACTICE; Kim HJ, 2015, J DEV PHYS DISABIL, V27, P307, DOI 10.1007/s10882-014-9418-9; Kuo T T-GFM, 2001, RES AGING; Lefevre T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115064; Li LW, 2009, SOC SCI MED, V68, P220, DOI 10.1016/j.socscimed.2008.10.013; Long S FX, 2007, NANJING SOCIAL SCI, P98; Lu L ZG, 2014, HLTH RELATED QUALITY; Ouellette-Kuntz H, 2015, INT REV RES DEV DISA, V48, P151, DOI 10.1016/bs.irrdd.2015.03.004; Peng X SS, 2010, PLOS ONE, V5, P121; Sereny M, 2011, RES AGING, V33, P172, DOI 10.1177/0164027510392387; [苏丽惠 SU Li-hui], 2010, [广东医学, Guangdong Medical Journal], V31, P633; Wang H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067140, 10.1371/journal.pone.0053879, 10.1371/journal.pone.0057030, 10.1371/journal.pone.0062841]; Woo J, 2002, INT J EPIDEMIOL, V31, P772, DOI 10.1093/ije/31.4.772; Yang M., 2012, CHINESE NURSING RES, V26, P37; Zhang WP, 2009, INT C POWER ELECT DR, P159; Zhao P, 2010, JPN J CLIN ONCOL, V40, P281, DOI 10.1093/jjco/hyp187; Zheng H CSL, 2011, SHANGHAI ARCH PSYCHI, V23, P79	29	22	24	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0182219	10.1371/journal.pone.0182219	http://dx.doi.org/10.1371/journal.pone.0182219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880887	gold, Green Published, Green Submitted			2022-12-27	WOS:000409467200006
J	Huang, XB; Mu, XH; Wan, QL; He, XM; Wu, GS; Luo, HR				Huang, Xiao-Bing; Mu, Xiao-Hui; Wan, Qin-Li; He, Xiao-Ming; Wu, Gui-Sheng; Luo, Huai-Rong			Aspirin increases metabolism through germline signalling to extend the lifespan of Caenorhabditis elegans	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; STEM-CELLS; C. ELEGANS; REPRODUCTIVE-SYSTEM; SODIUM-SALICYLATE; FAT-METABOLISM; KAPPA-B; LONGEVITY; ACID; DISEASE	Aspirin is a prototypic cyclooxygenase inhibitor with a variety of beneficial effects on human health. It prevents age-related diseases and delays the aging process. Previous research has shown that aspirin might act through a dietary restriction-like mechanism to extend lifespan. To explore the mechanism of action of aspirin on aging, we determined the wholegenome expression profile of Caenorhabditis elegans treated with aspirin. Transcriptome analysis revealed the RNA levels of genes involved in metabolism were primarily increased. Reproduction has been reported to be associated with metabolism. We found that aspirin did not extend the lifespan or improve the heat stress resistance of germline mutants of glp1. Furthermore, Oil Red O staining showed that aspirin treatment decreased lipid deposition and increased expression of lipid hydrolysis and fatty acid beta-oxidation-related genes. The effect of germline ablation on lifespan was mainly mediated by DAF-12 and DAF-16. Next, we performed genetic analysis with a series of worm mutants and found that aspirin did not further extend the lifespans of daf-12 and daf-16 single mutants, glp-1; daf-12 and glp-1; daf16 double mutants, or glp-1; daf-12; daf-16 triple mutants. The results suggest that aspirin increase metabolism and regulate germline signalling to activate downstream DAF-12 and DAF-16 to extend lifespan.	[Huang, Xiao-Bing; Wan, Qin-Li; He, Xiao-Ming; Wu, Gui-Sheng; Luo, Huai-Rong] Southwest Med Univ, Sch Pharm, Dept Pharmacol, Key Lab Aging & Regenerat Med, Luzhou, Sichuan, Peoples R China; [Mu, Xiao-Hui; Luo, Huai-Rong] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China; [Mu, Xiao-Hui; Luo, Huai-Rong] Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Nat Med Chem, Kunming, Yunnan, Peoples R China; [Mu, Xiao-Hui] Univ Chinese Acad Sci, Beijing, Peoples R China	Southwest Medical University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Luo, HR (corresponding author), Southwest Med Univ, Sch Pharm, Dept Pharmacol, Key Lab Aging & Regenerat Med, Luzhou, Sichuan, Peoples R China.; Luo, HR (corresponding author), Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Kunming, Yunnan, Peoples R China.; Luo, HR (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Yunnan Key Lab Nat Med Chem, Kunming, Yunnan, Peoples R China.	lhr@swmu.edu.cn	Luo, Huai-Rong/ABE-7525-2021	Luo, Huai-Rong/0000-0001-8912-6694; wan, qinli/0000-0003-2864-912X	National Natural Science Foundation of China [81370453, 81671405]; Natural Science Foundation of Yunnan Province [2015FB172]; Science and Technology Cooperation Project of Luzhou and Southwest Medical University [2016LZXNYD-Z05]; National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province); Science and Technology Cooperation Project of Luzhou and Southwest Medical University; National Institutes of Health (NIH) Office of Research Infrastructure Programs	This work was supported by the National Natural Science Foundation of China (81370453 and 81671405), the Natural Science Foundation of Yunnan Province (2015FB172), and the Science and Technology Cooperation Project of Luzhou and Southwest Medical University (2016LZXNYD-Z05).; We thank the Caenorhabditis Genetics Center (CGC), which is funded by the National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD010440), for providing some of the Caenorhabditis elegans strains used in this work.	AD2000 Collaborative Grp, 2008, LANCET NEUROL, V7, P41, DOI 10.1016/S1474-4422(07)70293-4; Ai GQ, 2016, MOL MED REP, V14, P1726, DOI 10.3892/mmr.2016.5449; Amrit FRG, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005788; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Antebi A, 2013, EXP GERONTOL, V48, P596, DOI 10.1016/j.exger.2012.09.009; Arantes-Oliveira N, 2002, SCIENCE, V295, P502, DOI 10.1126/science.1065768; Ayyadevara S, 2017, ANTIOXID REDOX SIGNA; Ayyadevara S, 2013, ANTIOXID REDOX SIGN, V18, P481, DOI 10.1089/ars.2011.4151; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Bode-Boger SM, 2005, BIOCHEM BIOPH RES CO, V334, P1226, DOI 10.1016/j.bbrc.2005.07.014; Chakraborty K, 2003, PLATELETS, V14, P421, DOI 10.1080/095371032000158763; Choi HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143447; Dachineni R, 2016, MOL CANCER RES, V14, P241, DOI 10.1158/1541-7786.MCR-15-0360; Danilov A, 2015, ONCOTARGET, V6, P19428, DOI 10.18632/oncotarget.5118; Finamore F, 2015, J PROTEOMICS, V114, P125, DOI 10.1016/j.jprot.2014.11.005; Gallo Marco, 2010, Journal of Biology (London), V9, P7, DOI 10.1186/jbiol215; Ghazi A, 2013, GENESIS, V51, P1, DOI 10.1002/dvg.22345; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Kaser-Pebernard S, 2014, STEM CELL REP, V2, P547, DOI 10.1016/j.stemcr.2014.02.007; Kamble P, 2013, EUR J PHARMACOL, V699, P55, DOI 10.1016/j.ejphar.2012.11.051; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Lucanic M, 2013, AGEING RES REV, V12, P445, DOI 10.1016/j.arr.2012.06.006; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; McCormick M, 2012, AGING CELL, V11, P192, DOI 10.1111/j.1474-9726.2011.00768.x; McNellis RJ, 2016, AM FAM PHYSICIAN, V94, P661; Medeiros R, 2013, AM J PATHOL, V182, P1780, DOI 10.1016/j.ajpath.2013.01.051; Mitchell JA, 1997, MOL PHARMACOL, V51, P907, DOI 10.1124/mol.51.6.907; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Pathare PP, 2012, PLOS GENET, V8, P333, DOI 10.1371/journal.pgen.1002645; Qin Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8107; Shirakawa K, 2016, ELIFE, V5, DOI 10.7554/eLife.11156; Smith BK, 2016, DIABETES, V65, P3352, DOI 10.2337/db16-0564; Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x; Tatar Marc, 2002, Sci Aging Knowledge Environ, V2002, ppe2, DOI 10.1126/sageke.2002.3.pe2; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wan QL, 2013, EXP GERONTOL, V48, P499, DOI 10.1016/j.exger.2013.02.020; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wang Z, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005027; Wilson MA, 2006, AGING CELL, V5, P59, DOI 10.1111/j.1474-9726.2006.00192.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012810; Zheng SQ, 2017, J GERONTOL A-BIOL, V72, P464, DOI 10.1093/gerona/glw105; Zheng SQ, 2014, AGE, V36, DOI 10.1007/s11357-014-9719-z	49	18	19	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184027	10.1371/journal.pone.0184027	http://dx.doi.org/10.1371/journal.pone.0184027			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910305	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200027
J	Kirk, IK; Weinhold, N; Brunak, S; Belling, K				Kirk, Isa Kristina; Weinhold, Nils; Brunak, Soren; Belling, Kirstine			The impact of the protein interactome on the syntenic structure of mammalian genomes	PLOS ONE			English	Article							GENE; IDENTIFICATION; MOUSE; DRAFT; MAP	Conserved synteny denotes evolutionary preserved gene order across species. It is not well understood to which degree functional relationships between genes are preserved in syntenic blocks. Here we investigate whether protein-coding genes conserved in mammalian syntenic blocks encode gene products that serve the common functional purpose of interacting at protein level, i.e. connectivity. High connectivity among protein-protein interactions (PPIs) was only moderately associated with conserved synteny on a genome-wide scale. However, we observed a smaller subset of 3.6% of all syntenic blocks with high-confidence PPIs that had significantly higher connectivity than expected by random. Additionally, syntenic blocks with high-confidence PPIs contained significantly more chromatin loops than the remaining blocks, indicating functional preservation among these syntenic blocks. Conserved synteny is typically defined by sequence similarity. In this study, we also examined whether a functional relationship, here PPI connectivity, can identify syntenic blocks independently of orthology. While orthology-based syntenic blocks with high-confident PPIs and the connectivity-based syntenic blocks largely overlapped, the connectivity-based approach identified additional syntenic blocks that were not found by conventional sequence-based methods alone. Additionally, the connectivity-based approach enabled identification of potential orthologous genes between species. Our analyses demonstrate that subsets of syntenic blocks are associated with highly connected proteins, and that PPI connectivity can be used to detect conserved synteny even if sequence conservation drifts beyond what orthology algorithms normally can identify.	[Kirk, Isa Kristina; Brunak, Soren; Belling, Kirstine] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Prot Res, Copenhagen, Denmark; [Weinhold, Nils] Mem Sloan Kettering Canc Ctr, Computat Biol Program, 1275 York Ave, New York, NY 10021 USA	Novo Nordisk Foundation; University of Copenhagen; Memorial Sloan Kettering Cancer Center	Belling, K (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn, Ctr Prot Res, Copenhagen, Denmark.	kirstine.belling@cpr.ku.dk	Belling, Kirstine/AAJ-6569-2021	Belling, Kirstine/0000-0001-5664-1948	SyBoSS (EU) [242129]; Novo Nordisk Foundation [NNF14CC0001]; Novo Nordisk Foundation Center for Protein Research [PI S�ren Brunak] Funding Source: researchfish	SyBoSS (EU); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Foundation Center for Protein Research	This work was supported by FP7 grant SyBoSS (EU 7th Framework G.A. No 242129) (SB received the funding), and the Novo Nordisk Foundation (grant agreement NNF14CC0001) (SB received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge funding from the FP7 grant SyBoSS (EU 7th Framework G.A. No 242129) as well as the Novo Nordisk Foundation (grant agreement NNF14CC0001).	Anthon C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-459; Bellott DW, 2014, NATURE, V508, P494, DOI 10.1038/nature13206; Bourque G, 2004, GENOME RES, V14, P507, DOI 10.1101/gr.1975204; Courcelle E, 2008, NUCLEIC ACIDS RES, V36, pD485, DOI 10.1093/nar/gkm805; Lopez MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010654; Dogini DB, 2014, GENET MOL BIOL, V37, P285, DOI 10.1590/S1415-47572014000200014; Donthu Ravikiran, 2009, BMC Res Notes, V2, P148, DOI 10.1186/1756-0500-2-148; Dutkowski J, 2007, BIOINFORMATICS, V23, pI149, DOI 10.1093/bioinformatics/btm194; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Larkin DM, 2009, GENOME RES, V19, P770, DOI 10.1101/gr.086546.108; Li TB, 2017, NAT METHODS, V14, P61, DOI 10.1038/nmeth.4083; Malewski Tadeusz, 2006, Animal Science Papers and Reports, V24, P39; Ouedraogo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050653; Pereira-Leal JB, 2005, GENOME RES, V15, P552, DOI 10.1101/gr.3102105; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ruiz-Herrera A, 2012, HEREDITY, V108, P28, DOI 10.1038/hdy.2011.102; Ruiz-Herrera A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r115; Sanchez C, 1999, NUCLEIC ACIDS RES, V27, P89, DOI 10.1093/nar/27.1.89; Sankoff D, 1996, DISCRETE APPL MATH, V71, P247, DOI 10.1016/S0166-218X(96)00067-4; Sinha AU, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-82; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Winterbach W, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-90; YODER FE, 1974, AM J HUM GENET, V26, P535; Yuan ZD, 2013, INT J MOL SCI, V14, P20820, DOI 10.3390/ijms141020820; Zheng XH, 2005, BIOINFORMATICS, V21, P703, DOI 10.1093/bioinformatics/bti045	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0179112	10.1371/journal.pone.0179112	http://dx.doi.org/10.1371/journal.pone.0179112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910296	gold, Green Published, Green Submitted			2022-12-27	WOS:000410859200001
J	Kleineidam, CJ; Heeb, EL; Neupert, S				Kleineidam, Christoph Johannes; Heeb, Eva Linda; Neupert, Stefanie			Social interactions promote adaptive resource defense in ants	PLOS ONE			English	Article							INTRASPECIFIC COMPETITION; NESTMATE-RECOGNITION; TERRITORIAL MARKING; CAMPONOTUS-FELLAH; CATAGLYPHIS-NIGER; FORMICA-POLYCTENA; HARVESTER ANTS; ANTENNAL LOBE; WOOD-ANT; HYMENOPTERA	Social insects vigorously defend their nests against con-and heterospecific competitors. Collective defense is also seen at highly profitable food sources. Aggressive responses are elicited or promoted by several means of communication, e.g. alarm pheromones and other chemical markings. In this study, we demonstrate that the social environment and interactions among colony members (nestmates) modulates the propensity to engage in aggressive behavior and therefore plays an important role in allocating workers to a defense task. We kept Formica rufa workers in groups or isolated for different time spans and then tested their aggressiveness in one-on-one encounters with other ants. In groups of more than 20 workers that are freely interacting, individuals are aggressive in one-on-one encounters with non-nestmates, whereas aggressiveness of isolated workers decreases with increasing isolation time. We conclude that ants foraging collectively and interacting frequently, e.g. along foraging trails and at profitable food sources, remain in a social context and thereby maintain high aggressiveness against potential competitors. Our results suggest that the nestmate recognition system can be utilized at remote sites for an adaptive and flexible tuning of the response against competitors.	[Kleineidam, Christoph Johannes; Heeb, Eva Linda; Neupert, Stefanie] Univ Konstanz, Dept Biol, Behav Neurobiol, Constance, Germany	University of Konstanz	Kleineidam, CJ (corresponding author), Univ Konstanz, Dept Biol, Behav Neurobiol, Constance, Germany.	Christoph.Kleineidam@uni-konstanz.de	Kleineidam, Christoph J/A-6529-2009	Kleineidam, Christoph J/0000-0003-0671-1455	EUROPEAN COMMISSION Research Executive Agency Marie Curie Actions - International Research Staff Exchange Scheme [319015]; DAAD, PPPAustralien-Kleineidam [57219808]; IMPRS Organismal Biology, University of Konstanz [M.R8.A.ORNI0001 J]	EUROPEAN COMMISSION Research Executive Agency Marie Curie Actions - International Research Staff Exchange Scheme; DAAD, PPPAustralien-Kleineidam; IMPRS Organismal Biology, University of Konstanz	Funded by EUROPEAN COMMISSION Research Executive Agency Marie Curie Actions - International Research Staff Exchange Scheme Project No: 319015. http://ec.europa.eu/research/ maricurieactions/funded-projects/international-research-staff-exchange-scheme_en to CJK and SN. DAAD, PPPAustralien2015-Kleineidam. https://www.daad.de/de/ to CJK and SN Projekt 57219808. IMPRS Organismal Biology, University of Konstanz. http://www.orn.mpg.de/2453/Short_ portrait to SN. Projekt M.R8.A.ORNI0001 J. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS ES, 1990, ANIM BEHAV, V39, P321, DOI 10.1016/S0003-3472(05)80877-2; ALLOWAY TM, 1979, ANIM BEHAV, V27, P202, DOI 10.1016/0003-3472(79)90140-4; [Anonymous], 2017, R LANG ENV STAT COMP, V55, P275; Batchelor TP, 2010, ANIM BEHAV, V80, P443, DOI 10.1016/j.anbehav.2010.05.030; BECKERS R, 1992, INSECT SOC, V39, P59, DOI 10.1007/BF01240531; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Blum MS, 1996, ANNU REV ENTOMOL, V41, P353, DOI 10.1146/annurev.en.41.010196.002033; Bos N, 2013, J EXP BIOL, V216, P3314, DOI 10.1242/jeb.087007; Boulay R, 2004, INSECT SOC, V51, P55, DOI 10.1007/s00040-003-0706-0; Boulay R, 2007, ANIM BEHAV, V74, P985, DOI 10.1016/j.anbehav.2007.02.013; Boulay R, 2010, ECOLOGY, V91, P3312, DOI 10.1890/09-1520.1; Brandstaetter AS, 2008, NATURWISSENSCHAFTEN, V95, P601, DOI 10.1007/s00114-008-0360-5; Brandstaetter AS, 2011, J NEUROPHYSIOL, V106, P2437, DOI 10.1152/jn.01106.2010; Brandstaetter AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021383; Buczkowski G, 2005, ANIM BEHAV, V69, P741, DOI 10.1016/j.anbehav.2004.06.027; Cammaerts MC, 2000, J INSECT BEHAV, V13, P679, DOI 10.1023/A:1007891910530; Cammaerts MC, 2004, BEHAV PROCESS, V67, P417, DOI 10.1016/j.beproc.2004.07.002; CROZIER RH, 1979, BEHAV ECOL SOCIOBIOL, V4, P217, DOI 10.1007/BF00297645; d'Ettorre P, 2010, ANT ECOLOGY, P194; Davidson JD, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00115; Esponda F, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2838; Fournier D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156440; Frizzi F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137919; Gelman A., 2007, DATA ANAL USING REGR; Gordon DM, 1996, NATURE, V380, P121, DOI 10.1038/380121a0; Greene MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052219; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; Guerrieri FJ, 2008, J EXP BIOL, V211, P1109, DOI 10.1242/jeb.008508; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; HOLLDOBLER B, 1980, SCIENCE, V210, P732, DOI 10.1126/science.210.4471.732; Holldobler B., 1990, pi; HORSTMANN K, 1983, Z NATURFORSCH C, V38, P508; JUTSUM AR, 1979, ANIM BEHAV, V27, P833, DOI 10.1016/0003-3472(79)90020-4; JUTSUM AR, 1979, ANIM BEHAV, V27, P839, DOI 10.1016/0003-3472(79)90021-6; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; Kleineidam C, 2001, NATURWISSENSCHAFTEN, V88, P301, DOI 10.1007/s001140100235; Knaden M, 2004, SCIENCE, V305, P60, DOI 10.1126/science.1097165; Knaden M, 2003, J INSECT BEHAV, V16, P717, DOI 10.1023/B:JOIR.0000007706.38674.73; Kuebler LS, 2010, J COMP NEUROL, V518, P352, DOI 10.1002/cne.22217; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Langen TA, 2000, BEHAV ECOL SOCIOBIOL, V48, P285, DOI 10.1007/s002650000223; LeBoeuf AC, 2014, CURR OPIN INSECT SCI, V5, P16, DOI 10.1016/j.cois.2014.09.010; Lenoir A, 2001, PHYSIOL ENTOMOL, V26, P275, DOI 10.1046/j.0307-6962.2001.00244.x; Leonhardt SD, 2007, J COMP PHYSIOL A, V193, P993, DOI 10.1007/s00359-007-0252-8; LOFQVIST J, 1976, J INSECT PHYSIOL, V22, P1331, DOI 10.1016/0022-1910(76)90155-4; LUMSDEN CJ, 1983, J THEOR BIOL, V100, P81, DOI 10.1016/0022-5193(83)90093-0; MAYADE S, 1993, BEHAV PROCESS, V30, P131, DOI 10.1016/0376-6357(93)90003-A; Newey PS, 2010, BEHAV ECOL, V21, P381, DOI 10.1093/beheco/arp201; Nowbahari E, 2007, LEARN BEHAV, V35, P87, DOI 10.3758/BF03193043; ROEDER T, 1994, COMP BIOCHEM PHYS C, V107, P1, DOI 10.1016/1367-8280(94)90003-5; Sakata H, 2001, ECOL RES, V16, P395, DOI 10.1046/j.1440-1703.2001.00404.x; SKINNER GJ, 1980, J ANIM ECOL, V49, P381, DOI 10.2307/4253; Stevenson PA, 2005, J NEUROSCI, V25, P1431, DOI 10.1523/JNEUROSCI.4258-04.2005; Szczuka A, 2013, ACTA NEUROBIOL EXP, V73, P495; Tanner CJ, 2008, ANIM BEHAV, V76, P1335, DOI 10.1016/j.anbehav.2008.04.022; Tanner CJ, 2006, P ROY SOC B-BIOL SCI, V273, P2737, DOI 10.1098/rspb.2006.3626; Tanner CJ, 2009, ANIM BEHAV, V77, P297, DOI 10.1016/j.anbehav.2008.10.016; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Vander Meer Robert K., 1998, P79; VANDERMEER RK, 1989, J CHEM ECOL, V15, P2115, DOI 10.1007/BF01207442; Wagner D, 1998, J CHEM ECOL, V24, P2021, DOI 10.1023/A:1020781508889; Weidenmuller A, 2004, BEHAV ECOL, V15, P120, DOI 10.1093/beheco/arg101; Wenseleers T, 2002, J INSECT BEHAV, V15, P85, DOI 10.1023/A:1014484229639; WILSON EO, 1980, BEHAV ECOL SOCIOBIOL, V7, P143, DOI 10.1007/BF00299520; WILSON EO, 1953, Q REV BIOL, V28, P136, DOI 10.1086/399512	66	7	7	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183872	10.1371/journal.pone.0183872	http://dx.doi.org/10.1371/journal.pone.0183872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910322	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200021
J	Singh, V; Ahmed, S; Dreyfuss, ML; Kiran, U; Chaudhery, DN; Srivastava, VK; Ahuja, RC; Baqui, AH; Darmstadt, GL; Santosham, M; West, KP				Singh, Veena; Ahmed, Saifuddin; Dreyfuss, Michele L.; Kiran, Usha; Chaudhery, Deepika N.; Srivastava, Vinod K.; Ahuja, Ramesh C.; Baqui, Abdullah H.; Darmstadt, Gary L.; Santosham, Mathuram; West, Keith P., Jr.			Non-governmental organization facilitation of a community-based nutrition and health program: Effect on program exposure and associated infant feeding practices in rural India	PLOS ONE			English	Article							EDUCATIONAL INTERVENTION; CHILD UNDERNUTRITION; YOUNG-CHILDREN; DULAR PROGRAM; GROWTH	Background Integrated nutrition and health programs seek to reduce undernutrition by educating child caregivers about infant feeding and care. Data on the quality of program implementation and consequent effects on infant feeding practices are limited. This study evaluated the effectiveness of enhancing a nutrition and health program on breastfeeding and complementary-feeding practices in rural India. Methods Utilizing a quasi-experimental design, one of the implementing districts of a Cooperative for Assistance and Relief Everywhere (CARE) nutrition and health program was randomly selected for enhanced services and compared with a district receiving the Government of India's standard nutrition and health package alone. A cohort of 942 mother-child dyads was longitudinally followed from birth to 18 months. In both districts, the evaluation focused on responses to services delivered by community-based nutrition and health care providers [anganwadi workers (AWWs) and auxiliary nurse midwives (ANMs)]. Findings The CARE enhanced program district showed an improvement in program coverage indicators (e.g., contacts, advice) through outreach visits by both AWWs (28.8-59.8% vs. 0.7-12.4%; all p<0.05) and ANMs (8.6-46.2% vs. 6.1-44.2%; <0.05 for ages >= 6 months). A significantly higher percentage of child caregivers reported being contacted by the AWWs in the CARE program district (20.5-45.6% vs. 0.3-21.6%; p<0.05 for all ages except at 6months). No differences in ANM household contacts were reported. Overall, coverage remained low in both areas. Less than a quarter of women received any infant feeding advice in the intervention district. Earlier and exclusive breastfeeding improved with increasing number or quality of visits by either level of health care provider (OR: 2.04-3.08, p = <0.001), after adjusting for potentially confounding factors. Socio-demographic indicators were the major determinants of exclusive breastfeeding up to 6 month and age-appropriate complementary-feeding practices thereafter in the program-enhanced but not comparison district. Interpretation An enhanced nutrition and health intervention package improved program exposure and associated breastfeeding but not complementary-feeding practices, compared to standard government package.	[Singh, Veena; West, Keith P., Jr.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Human Nutr, Baltimore, MD 21205 USA; [Ahmed, Saifuddin; Dreyfuss, Michele L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat & Family Hlth, Baltimore, MD USA; [Kiran, Usha; Chaudhery, Deepika N.] CARE India, New Delhi, India; [Srivastava, Vinod K.; Ahuja, Ramesh C.] King George Med Univ, Lucknow, Uttar Pradesh, India; [Baqui, Abdullah H.; Darmstadt, Gary L.; Santosham, Mathuram] Johns Hopkins Bloomberg Sch Publ Hlth, Hlth Syst Div, Dept Int Hlth, Baltimore, MD USA; [Kiran, Usha] Bill & Melinda Gates Fdn, Global Hlth Program, New Delhi, India; [Chaudhery, Deepika N.] World Bank, Hlth Nutr & Populat Global Practice, New Delhi, India; [Srivastava, Vinod K.] Hind Inst Med Sci, Sitapur, Uttar Pradesh, India; [Darmstadt, Gary L.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; King George's Medical University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; The World Bank; Stanford University	Singh, V (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Human Nutr, Baltimore, MD 21205 USA.	veena.singh@gmail.com	Darmstadt, Gary/AAU-7488-2020	Darmstadt, Gary/0000-0002-7522-5824; Singh, Veena/0000-0002-6296-3318	USAID, India Mission [HRN-A-00-96-90006-00]; Gates Grant GH [614]; Johns Hopkins University; United States Agency for International Development (USAID), India Mission [HRN-A-00-96-90006-00]	USAID, India Mission(United States Agency for International Development (USAID)); Gates Grant GH; Johns Hopkins University(Johns Hopkins University); United States Agency for International Development (USAID), India Mission(United States Agency for International Development (USAID))	The study was funded by USAID, India Mission, through Global Research Activity Award #HRN-A-00-96-90006-00 to the Johns Hopkins Bloomberg School of Public Health, MD, USA. VS was supported during analysis and reporting through Gates Grant GH 614 and the George G. Graham Professorship Endowment at Johns Hopkins University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by the United States Agency for International Development (USAID), India Mission, through Global Research Activity Award # HRN-A-00-96-90006-00 to the Johns Hopkins Bloomberg School of Public Health, MD, USA. We thank Massee Bateman of USAID for his support, insight and guidance. We acknowledge the hard work and dedication of project staff of CARE-India and the Johns Hopkins University. VS was supported during analysis and reporting through Gates Grant GH 614 and the George G. Graham Professorship Endowment at Johns Hopkins University.	Avula R, 2011, J NUTR, V141, P680, DOI 10.3945/jn.109.116954; Bhandari N, 2005, HEALTH POLICY PLANN, V20, P328, DOI 10.1093/heapol/czi039; Bhandari N, 2004, J NUTR, V134, P2342; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bolam A, 1998, BRIT MED J, V316, P805, DOI 10.1136/bmj.316.7134.805; BROWN LV, 1992, AM J CLIN NUTR, V56, P994, DOI 10.1093/ajcn/56.6.994; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Census of India, 2009, WELC WEBS CENS IND; Dubowitz T, 2007, FOOD NUTR BULL, V28, P266, DOI 10.1177/156482650702800302; Gragnolati M., 2006, Economic and Political Weekly, V41, P1193; Heikens GT, 2008, LANCET, V371, P181, DOI 10.1016/S0140-6736(07)61691-2; Horton S., 2009, SCALING NUTR WHAT WI; Levinson FJ, 2007, FOOD NUTR BULL, V28, P259, DOI 10.1177/156482650702800301; Ministry of Women and Child Development, 2007, NAT REP WORLD FIT CH; Morrow AL, 1999, LANCET, V353, P1226, DOI 10.1016/S0140-6736(98)08037-4; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; Penny ME, 2005, LANCET, V365, P1863, DOI 10.1016/S0140-6736(05)66426-4; The Third National Family Health Survey (NFHS-3), 2005, INT I POPULATION SCI; WHO UNICEF and partners, 2010, IND ASS INF YOUNG 3	19	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183316	10.1371/journal.pone.0183316	http://dx.doi.org/10.1371/journal.pone.0183316			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910328	Green Submitted, gold, Green Published			2022-12-27	WOS:000410859200009
J	Bonnefond, H; Grimaud, G; Rumin, J; Bougaran, G; Talec, A; Gachelin, M; Boutoute, M; Pruvost, E; Bernard, O; Sciandra, A				Bonnefond, Hubert; Grimaud, Ghjuvan; Rumin, Judith; Bougaran, Gael; Talec, Amelie; Gachelin, Manon; Boutoute, Marc; Pruvost, Eric; Bernard, Olivier; Sciandra, Antoine			Continuous selection pressure to improve temperature acclimation of Tisochrysis lutea	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; EVOLUTIONARY ADAPTATION; LIPID PRODUCTION; GROWTH; MICROALGAE; PHYTOPLANKTON; LIGHT; PRODUCTIVITY; METABOLISM; BENEFITS	Temperature plays a key role in outdoor industrial cultivation of microalgae. Improving the thermal tolerance of microalgae to both daily and seasonal temperature fluctuations can thus contribute to increase their annual productivity. A long term selection experiment was carried out to increase the thermal niche (temperature range for which the growth is possible) of a neutral lipid overproducing strain of Tisochrysis lutea. The experimental protocol consisted to submit cells to daily variations of temperature for 7 months. The stress intensity, defined as the amplitude of daily temperature variations, was progressively increased along successive selection cycles. Only the amplitude of the temperature variations were increased, the daily average temperature was kept constant along the experiment. This protocol resulted in a thermal niche increase by 3 degrees C (+16.5%), with an enhancement by 9% of the maximal growth rate. The selection process also affected T. lutea physiology, with a feature generally observed for 'cold-temperature' type of adaptation. The amount of total and neutral lipids was significantly increased, and eventually productivity was increased by 34%. This seven month selection experiment, carried out in a highly dynamic environment, challenges some of the hypotheses classically advanced to explain the temperature response of microalgae.	[Bonnefond, Hubert; Talec, Amelie; Gachelin, Manon; Boutoute, Marc; Pruvost, Eric; Sciandra, Antoine] UPMC Univ Paris 06, Sorbonne Univ, CNRS, INSU,LOV, Villefranche Sur Mer, France; [Grimaud, Ghjuvan; Bernard, Olivier] INRIA, BIOCORE, Sophia Antipolis, France; [Rumin, Judith; Bougaran, Gael] PBA, IFREMER, Nantes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Inria; Ifremer	Bernard, O (corresponding author), INRIA, BIOCORE, Sophia Antipolis, France.	olivier.bernard@inria.fr	Bernard, Olivier/J-1133-2014; Grimaud, Ghjuvan/AAP-3177-2021; Sciandra, Antoine/D-7625-2012	Bernard, Olivier/0000-0003-2539-9014; Grimaud, Ghjuvan/0000-0003-2752-4755; Bougaran, Gael/0000-0002-3463-7590	ADEME; ANR Facteur [4 ANR-12-BIME-0004]	ADEME; ANR Facteur(French National Research Agency (ANR))	This work was supported by grant income pre-graduated pHd, ADEME (https://appelsaprojets.ademe.fr/aap/AAC%20Th%C3%A8ses2016-10); and ANR Facteur 4 ANR-12-BIME-0004 (http://wwz.ifremer.fr/facteur4/Presentation).r H. Bonnefond acknowledges the support of an ADEME grant. The experiments were carried out in the framework of the ANR Facteur 4 ANR-12-BIME-0004. The authors gratefully acknowledge P. Chang for improvement of the English and T. Blasco for total carbon measurements.	Bechet Q, 2013, BIOTECHNOL ADV, V31, P1648, DOI 10.1016/j.biotechadv.2013.08.014; BENNETT AF, 1992, EVOLUTION, V46, P16, DOI 10.1111/j.1558-5646.1992.tb01981.x; BENNETT AF, 1993, EVOLUTION, V47, P1, DOI 10.1111/j.1558-5646.1993.tb01194.x; Bernard O., 2016, ODIN; Bernard O, 2012, BIORESOURCE TECHNOL, V123, P520, DOI 10.1016/j.biortech.2012.07.022; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bougaran G, 2012, BIOTECHNOL BIOENG, V109, P2737, DOI 10.1002/bit.24560; Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003; Carrier G, 2014, PLOS ONE, V9; Chevin LM, 2011, BIOL LETTERS, V7, P210, DOI 10.1098/rsbl.2010.0580; Converti A, 2009, CHEM ENG PROCESS, V48, P1146, DOI 10.1016/j.cep.2009.03.006; Costas E, 2014, OCEANOGR OPEN ACCESS, V2; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Devos N, 1998, J PHYCOL, V34, P655, DOI 10.1046/j.1529-8817.1998.340655.x; Huertas IE, 2011, P ROY SOC B-BIOL SCI, V278, P3534, DOI 10.1098/rspb.2011.0160; Eppley RW, 1972, FISH B, P70; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; GEIDER RJ, 1987, NEW PHYTOL, V106, P1, DOI 10.1111/j.1469-8137.1987.tb04788.x; Gigova L, 2012, J PHYCOL, V48, P85, DOI 10.1111/j.1529-8817.2011.01088.x; Grimaud GM, 2015, IFAC PAPERSONLINE, V48, P228, DOI 10.1016/j.ifacol.2015.05.059; Guillard R., 1975, CULT MAR INVERTEBR A, V1975; Guschina IA, 2006, PROG LIPID RES, V45, P160, DOI 10.1016/j.plipres.2006.01.001; HANSEN SR, 1980, SCIENCE, V207, P1491; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; HUEY RB, 1976, Q REV BIOL, V51, P363, DOI 10.1086/409470; Knies JL, 2009, AM NAT, V173, P419, DOI 10.1086/597224; Kobayashi Y, 2014, GENOME BIOL EVOL, V6, P2731, DOI 10.1093/gbe/evu216; Lacour T, 2012, J PHYCOL, V48, P647, DOI 10.1111/j.1529-8817.2012.01154.x; LEVINS RICHARD, 1968; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Luria SE, 1943, GENETICS, V28, P491; Marchetti J, 2012, AQUACULTURE, V326, P106, DOI 10.1016/j.aquaculture.2011.11.020; Masci P, 2008, IFAC P VOLUMES IFAC, DOI [10.3182/20080706-5-KR-1001.3265, DOI 10.3182/20080706-5-KR-1001.3265]; MORRISON WR, 1964, J LIPID RES, V5, P600; MORTAINBERTRAND A, 1988, MAR BIOL, V100, P135, DOI 10.1007/BF00392963; Padfield D, 2016, ECOL LETT, V19, P133, DOI 10.1111/ele.12545; Ras M, 2013, REV ENVIRON SCI BIO, V12, P153, DOI 10.1007/s11157-013-9310-6; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; Renaud SM, 2002, AQUACULTURE, V211, P195, DOI 10.1016/S0044-8486(01)00875-4; Renaud SM, 1995, J APPL, P595; Roleda MY, 2013, BIORESOURCE TECHNOL, V129, P439, DOI 10.1016/j.biortech.2012.11.043; Siddiqui KS, 2013, ANNU REV EARTH PL SC, V41, P87, DOI 10.1146/annurev-earth-040610-133514; SRIHARAN S, 1991, APPL BIOCHEM BIOTECH, V28-9, P317, DOI 10.1007/BF02922611; THOMPSON PA, 1992, J PHYCOL, V28, P481, DOI 10.1111/j.0022-3646.1992.00481.x; Urban MC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3085; Vitova A M, 2015, BIOTECHNOL ADV; Xu Y, 2003, J BACTERIOL, V185, P5519, DOI 10.1128/JB.185.18.5519-5526.2003	47	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183547	10.1371/journal.pone.0183547	http://dx.doi.org/10.1371/journal.pone.0183547			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902878	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200013
J	Moremi, N; Clause, H; Vogel, U; Mshana, SE				Moremi, Nyambura; Clause, Heike; Vogel, Ulrich; Mshana, Stephen E.			Faecal carriage of CTX-M extended-spectrum beta-lactamase-producing Enterobacteriaceae among street children dwelling in Mwanza city, Tanzania	PLOS ONE			English	Article							ESCHERICHIA-COLI; KLEBSIELLA-PNEUMONIAE; EPIDEMIOLOGY; RESISTANCE; EMERGENCE; BLA(CTX-M-15); COMMUNITY; HUMANS; ST131	Background Data on ESBL carriage of healthy people including children are scarce especially in developing countries. We analyzed the prevalence and genotypes of ESBL-producing Enterobacteriaceae (EPE) in Tanzanian street children with rare contact to healthcare facilities but significant interactions with the environment, animals and other people. Methodology/Principle findings Between April and July 2015, stool samples of 107 street children, who live in urban Mwanza were analyzed for EPE. Intestinal carriage of EPE was found in 34 (31.8%, 95% CI; 22.7-40.3) children. Of the 36 isolates from 34 children, 30 (83.3%) were Escherichia coli (E. coli) and six Klebsiella pneumoniae (K. pneumoniae). Out of 36 isolates, 36 (100%), 35 (97%), 25 (69%) and 16 (44%) were resistant to tetracycline, trimethoprim-sulfamethoxazole, ciprofloxacin and gentamicin, respectively. Beta-lactamase genes and the multilocus sequence types of E. coli and K. pneumoniae were characterized. ESBL gene blaCTX-M-15 was detected in 75% (27/36) of ESBL isolates. Sequence types (STs) 131, 10, 448 and 617 were the most prevalent in E. coli. Use of local herbs (OR: 3.5, 95% CI: 1.51-8.08, P = 0.003) and spending day and night on streets (OR: 3.6, 95% CI: 1.44-8.97, P = 0.005) were independent predictors of ESBL carriage. Conclusions/Significance We observed a high prevalence of blaCTX-M-15 in EPE collected from street children in Tanzania. Detection of E. coli STs 131, 10, 38 and 648, which have been observed worldwide in animals and people, highlights the need for multidisciplinary approaches to understand the epidemiology and drivers of antimicrobial resistance in low-income countries.	[Moremi, Nyambura; Mshana, Stephen E.] Catholic Univ Hlth & Allied SciencesBugando, Dept Microbiol & Immunol, Mwanza, Tanzania; [Moremi, Nyambura; Clause, Heike; Vogel, Ulrich] Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany	University of Wurzburg	Moremi, N (corresponding author), Catholic Univ Hlth & Allied SciencesBugando, Dept Microbiol & Immunol, Mwanza, Tanzania.; Moremi, N (corresponding author), Univ Wurzburg, Inst Hyg & Microbiol, Wurzburg, Germany.	nyambura.moremi@stud-mail.uni-wuerzburg.de	Mshana, Stephen/AAE-1900-2022	Moremi, Nyambura/0000-0002-5303-1156				Aibinu I, 2012, CLIN MICROBIOL INFEC, V18, pE49, DOI 10.1111/j.1469-0691.2011.03730.x; Andriatahina T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-204; Beyene Y, 1997, E AFR MED J, V74, P85; Bonnedahl J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005958; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Centres for Disease Control and prevention (US), 2013, ANTIBIOTIC RESISTANC; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; EUCAST The European Committee on Antimicrobial Susceptibility Testing, 2021, BREAKP TABL INT MICS; Feikin Daniel R, 2010, Int J Epidemiol, V39, P450, DOI 10.1093/ije/dyp374; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hernandez J, 2010, ENV MICROBIOL REP, V2, P329, DOI 10.1111/j.1758-2229.2010.00142.x; Isendahl J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051981; Karanika S, 2016, CLIN INFECT DIS, V63, P310, DOI 10.1093/cid/ciw283; Kayange N, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-39; Koneman E., 2006, KONEMANS COLOR ATLAS, V6; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Menke E M, 1997, Issues Compr Pediatr Nurs, V20, P153; Moremi N, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01862; Moremi Nyambura, 2014, BMC Res Notes, V7, P211, DOI 10.1186/1756-0500-7-211; Mshana SE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1527-x; Murray TS, 2015, CURR OPIN PEDIATR, V27, P124, DOI 10.1097/MOP.0000000000000182; Naseer U, 2010, CLIN MICROBIOL INFEC, V16, P171, DOI 10.1111/j.1469-0691.2009.02861.x; Oteo J, 2009, J ANTIMICROB CHEMOTH, V64, P524, DOI 10.1093/jac/dkp211; Pagani L, 2003, J CLIN MICROBIOL, V41, P4264, DOI 10.1128/JCM.41.9.4264-4269.2003; Pena C, 2001, J HOSP INFECT, V47, P53, DOI 10.1053/jhin.2000.0862; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Reddy P, 2007, CLIN INFECT DIS, V45, P846, DOI 10.1086/521260; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Seni J, 2016, FRONT MICROBIOL, V11, P7; Shi HQ, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0063-7; Tellevik MG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168024; Veldman K, 2014, INT J FOOD MICROBIOL, V177, P72, DOI 10.1016/j.ijfoodmicro.2014.02.014; Verraes C, 2013, INT J ENV RES PUB HE, V10, P2643, DOI 10.3390/ijerph10072643; Wellington EMH, 2013, LANCET INFECT DIS, V13, P155, DOI 10.1016/S1473-3099(12)70317-1; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13	39	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184592	10.1371/journal.pone.0184592	http://dx.doi.org/10.1371/journal.pone.0184592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898269	Green Submitted, Green Published, gold			2022-12-27	WOS:000410449500035
J	Zhao, J; Mysona, BA; Wang, J; Gonsalvez, GB; Smith, SB; Bollinger, KE				Zhao, Jing; Mysona, Barbara A.; Wang, Jing; Gonsalvez, Graydon B.; Smith, Sylvia B.; Bollinger, Kathryn E.			Sigma 1 receptor regulates ERK activation and promotes survival of optic nerve head astrocytes	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OXIDATIVE STRESS; GLIAL-CELLS; AUTORADIOGRAPHIC LOCALIZATION; LIGAND (+)-PENTAZOCINE; THERAPEUTIC TARGETS; NEURONAL DEATH; PROTEIN-KINASE; UP-REGULATION; IN-VITRO	The sigma 1 receptor (S1R) is a unique transmembrane protein that has been shown to regulate neuronal differentiation and cellular survival. It is expressed within several cell types throughout the nervous system and visceral organs, including neurons and glia within the eye. S1R ligands are therapeutic targets for diseases ranging from neurodegenerative conditions to neoplastic disorders. However, effects of S1R activation and inhibition within glia cells are not well characterized. Within the eye, the astrocytes at the optic nerve head are crucial to the health and survival of the neurons that send visual information to the brain. In this study, we used the S1R-specific agonist, (+)-pentazocine, to evaluate S1R activation within optic nerve head-derived astrocytes (ONHAs). Treatment of ONHAs with (+)-pentazocine attenuated the level and duration of stress-induced ERK phosphorylation following oxidative stress exposure and promoted survival of ONHAs. These effects were specific to S1R activation because they were not observed in ONHAs that were depleted of S1R using siRNA-mediated knockdown. Collectively, our results suggest that S1R activation suppresses ERK1/2 phosphorylation and protects ONHAs from oxidative stress-induced death.	[Zhao, Jing; Mysona, Barbara A.; Wang, Jing; Smith, Sylvia B.; Bollinger, Kathryn E.] James & Jean Culver Vis Discovery Inst, Augusta, GA 30912 USA; [Zhao, Jing; Mysona, Barbara A.; Smith, Sylvia B.; Bollinger, Kathryn E.] Augusta Univ, Med Coll Georgia, Dept Ophthalmol, Augusta, GA 30912 USA; [Zhao, Jing; Mysona, Barbara A.; Wang, Jing; Gonsalvez, Graydon B.; Smith, Sylvia B.; Bollinger, Kathryn E.] Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Bollinger, KE (corresponding author), James & Jean Culver Vis Discovery Inst, Augusta, GA 30912 USA.; Bollinger, KE (corresponding author), Augusta Univ, Med Coll Georgia, Dept Ophthalmol, Augusta, GA 30912 USA.; Bollinger, KE (corresponding author), Augusta Univ, Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA USA.	kbollinger@augusta.edu		Wang, Jing/0000-0003-2891-670X; Mysona, Barbara/0000-0002-7632-5755	National Institutes of Health [5K08EY021758-03, R01 EY014560]; American Glaucoma Society Young Clinician Scientist Award; NATIONAL EYE INSTITUTE [R01EY028103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Glaucoma Society Young Clinician Scientist Award; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by National Institutes of Health Grants 5K08EY021758-03 and R01 EY014560, https://www.nih.gov/, and American Glaucoma Society Young Clinician Scientist Award http://americanglaucomasociety.net/(KEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmo CT, 2006, CURR NEUROVASC RES, V3, P89, DOI 10.2174/156720206776875849; Alonso G, 2000, NEUROSCIENCE, V97, P155, DOI 10.1016/S0306-4522(00)00014-2; Beckel JM, 2014, GLIA, V62, P1486, DOI 10.1002/glia.22695; Behensky AA, 2013, J PHARMACOL EXP THER, V347, P458, DOI 10.1124/jpet.113.208348; Bhat NR, 1999, J NEUROCHEM, V72, P112, DOI 10.1046/j.1471-4159.1999.0720112.x; Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001; Canals S, 2003, MOL CELL NEUROSCI, V24, P1012, DOI 10.1016/j.mcn.2003.08.004; Cobos EJ, 2008, CURR NEUROPHARMACOL, V6, P344, DOI 10.2174/157015908787386113; Das D, 2016, BIOCHEM BIOPH RES CO, V470, P319, DOI 10.1016/j.bbrc.2016.01.055; DECOSTA BR, 1989, FEBS LETT, V251, P53, DOI 10.1016/0014-5793(89)81427-9; Do W, 2013, BIOCHEM BIOPH RES CO, V439, P215, DOI 10.1016/j.bbrc.2013.08.057; Dun Y, 2007, INVEST OPHTH VIS SCI, V48, P4785, DOI 10.1167/iovs.07-0343; Francardo V, 2014, NEURAL REGEN RES, V9, P1882, DOI 10.4103/1673-5374.145351; Francardo V, 2014, BRAIN, V137, P1998, DOI 10.1093/brain/awu107; Ha YJ, 2011, INVEST OPHTH VIS SCI, V52, P7749, DOI 10.1167/iovs.11-8169; Happy M, 2015, BIOCHEM BIOPH RES CO, V456, P683, DOI 10.1016/j.bbrc.2014.12.029; Hayashi T, 2000, J PHARMACOL EXP THER, V293, P788; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; Jiang GL, 2006, INVEST OPHTH VIS SCI, V47, P5576, DOI 10.1167/iovs.06-0608; Kim FJ, 2012, BIOCHEM BIOPH RES CO, V426, P177, DOI 10.1016/j.bbrc.2012.08.052; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Kume T, 2002, EUR J PHARMACOL, V455, P91, DOI 10.1016/S0014-2999(02)02582-7; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Langa F, 2003, EUR J NEUROSCI, V18, P2188, DOI 10.1046/j.1460-9568.2003.02950.x; Luo Y, 2006, J BIOL CHEM, V281, P16436, DOI 10.1074/jbc.M512430200; Malik M, 2015, BRIT J PHARMACOL, V172, P2519, DOI 10.1111/bph.13076; Mandal A, 2010, INVEST OPHTH VIS SCI, V51, P3129, DOI 10.1167/iovs.09-4614; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; Martin PM, 2004, MOL BRAIN RES, V123, P66, DOI 10.1016/j.molbrainres.2003.12.019; Maurice T, 2009, PHARMACOL THERAPEUT, V124, P195, DOI 10.1016/j.pharmthera.2009.07.001; Mavlyutov TA, 2016, NEUROSCIENCE, V331, P148, DOI 10.1016/j.neuroscience.2016.06.030; Mavlyutov TA, 2011, MOL VIS, V17, P1034; Moon JY, 2014, BRIT J PHARMACOL, V171, P5881, DOI 10.1111/bph.12893; Moriguchi S, 2011, J NEUROCHEM, V117, P879, DOI 10.1111/j.1471-4159.2011.07256.x; Mueller BH, 2014, EXP EYE RES, V128, P156, DOI 10.1016/j.exer.2014.10.007; Mueller BH, 2013, EXP EYE RES, V107, P21, DOI 10.1016/j.exer.2012.11.002; Newman EA, 1998, J NEUROSCI, V18, P4022; Nguyen L, 2014, EUR J PHARMACOL, V743, P42, DOI 10.1016/j.ejphar.2014.09.022; Ola MS, 2001, MOL BRAIN RES, V95, P86; Ouyang YB, 2007, J NEUROSCI, V27, P4253, DOI 10.1523/JNEUROSCI.0211-07.2007; Rosenberger J, 2001, J NEUROCHEM, V79, P35, DOI 10.1046/j.1471-4159.2001.00520.x; Schneider M, 2016, EXP EYE RES, V142, P49, DOI 10.1016/j.exer.2015.08.014; Smith SB, 2008, INVEST OPHTH VIS SCI, V49, P4154, DOI 10.1167/iovs.08-1824; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Su TP, 2016, TRENDS PHARMACOL SCI, V37, P262, DOI 10.1016/j.tips.2016.01.003; Subramaniam S, 2010, FEBS J, V277, P22, DOI 10.1111/j.1742-4658.2009.07367.x; Tan F, 2010, NEUROPHARMACOLOGY, V59, P416, DOI 10.1016/j.neuropharm.2010.05.014; Tehrani S, 2014, INVEST OPHTH VIS SCI, V55, DOI 10.1167/iovs.14-14969; Tuerxun T, 2010, NEUROSCI LETT, V469, P303, DOI 10.1016/j.neulet.2009.12.013; van Waarde A, 2015, BBA-BIOMEMBRANES, V1848, P2703, DOI 10.1016/j.bbamem.2014.08.022; Vargas JLC, 2016, NEURAL REGEN RES, V11, P424, DOI 10.4103/1673-5374.179053; Wang J, 2016, P NATL ACAD SCI USA, V113, pE3764, DOI 10.1073/pnas.1521749113; Wang J, 2015, FREE RADICAL BIO MED, V86, P25, DOI 10.1016/j.freeradbiomed.2015.04.009; Wang LX, 2005, INVEST OPHTH VIS SCI, V46, P1403, DOI 10.1167/iovs.04-1209; Whitlock BB, 1996, J NEUROIMMUNOL, V67, P83; Williams PA, 2017, EXPT EYE RES; WOLFE SA, 1989, ENDOCRINOLOGY, V124, P1160, DOI 10.1210/endo-124-3-1160; Wortzel Inbal, 2011, Genes Cancer, V2, P195, DOI 10.1177/1947601911407328; Zhang Y, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0250-7; Zhao J, 2016, INVEST OPHTH VIS SCI, V57, P453, DOI 10.1167/iovs.15-18565; Zhao J, 2014, INVEST OPHTH VIS SCI, V55, P3375, DOI 10.1167/iovs.13-12823	62	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184421	10.1371/journal.pone.0184421	http://dx.doi.org/10.1371/journal.pone.0184421			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898265	Green Submitted, gold, Green Published			2022-12-27	WOS:000410449500027
J	Chowdhury, MM; Makris, GC; Tarkin, JM; Joshi, FR; Hayes, PD; Rudd, JHF; Coughlin, PA				Chowdhury, Mohammed M.; Makris, Gregory C.; Tarkin, Jason M.; Joshi, Francis R.; Hayes, Paul D.; Rudd, James. H. F.; Coughlin, Patrick A.			Lower limb arterial calcification (LLAC) scores in patients with symptomatic peripheral arterial disease are associated with increased cardiac mortality and morbidity	PLOS ONE			English	Article							THORACIC AORTA CALCIFICATION; ALL-CAUSE MORTALITY; COMPUTED-TOMOGRAPHY; CORONARY-ARTERY; VASCULAR CALCIFICATION; MEDICAL THERAPY; SCORING METHOD; RISK; CALCIUM; ATHEROSCLEROSIS	Aims The association of coronary arterial calcification with cardiovascular morbidity and mortality is well-recognized. Lower limb arterial calcification (LLAC) is common in PAD but its impact on subsequent health is poorly described. We aimed to determine the association between a LLAC score and subsequent cardiovascular events in patients with symptomatic peripheral arterial disease (PAD). Methods LLAC scoring, and the established Bollinger score, were derived from a database of unenhanced CT scans, from patients presenting with symptomatic PAD. We determined the association between these scores outcomes. The primary outcome was combined cardiac mortality and morbidity (CM/M) with a secondary outcome of all-cause mortality. Results 220 patients (66% male; median age 69 years) were included with follow-up for a median 46 [IQR 31-64] months. Median total LLAC scores were higher in those patients suffering a primary outcome (6831 vs. 1652; p = 0.012). Diabetes mellitus (p = 0.039), ischaemic heart disease (p = 0.028), chronic kidney disease (p = 0.026) and all-cause mortality (p = 0.012) were more common in patients in the highest quartile of LLAC scores. The area under the curve of the receiver operator curve for the LLAC score was greater (0.929: 95% CI [0.884- 0.974]) than for the Bollinger score (0.824: 95% CI [0.758-0.890]) for the primary outcome. A LLAC score >= 4400 had the best diagnostic accuracy to determine the outcome measure. Conclusion This is the largest study to investigate links between lower limb arterial calcification and cardiovascular events in symptomatic PAD. We describe a straightforward, reproducible, CT-derived measure of calcification-the LLAC score.	[Chowdhury, Mohammed M.; Hayes, Paul D.; Coughlin, Patrick A.] Cambridge Univ Hosp Trust, Div Vasc & Endovasc Surg, Addenbrookes Hosp, Cambridge, England; [Makris, Gregory C.] Oxford Univ Hosp Trust, Div Vasc & Intervent Radiol, John Radcliffe Hosp, Oxford, England; [Tarkin, Jason M.; Rudd, James. H. F.] Cambridge Univ Hosp Trust, Div Cardiovasc Med, Addenbrookes Hosp, Cambridge, England; [Joshi, Francis R.] Rigshosp, Heart Ctr, Copenhagen, Denmark	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Rigshospitalet; University of Copenhagen	Chowdhury, MM (corresponding author), Cambridge Univ Hosp Trust, Div Vasc & Endovasc Surg, Addenbrookes Hosp, Cambridge, England.	mmc59@cam.ac.uk	Makris, Gregory/AAR-4430-2021	Tarkin, Jason/0000-0002-9132-120X; Coughlin, Patrick/0000-0003-1342-1114; Chowdhury, Mohammed M./0000-0003-0384-7197; Rudd, James/0000-0003-2243-3117	Royal College of Surgeons of England Fellowship Programme; British Heart Foundation Research Fellowship [FS/16/29/31957]; Wellcome Trust Research Training Fellowship [104492/Z/14/Z]; NIHR Cambridge Biomedical Research Centre; British Heart Foundation; HEFCE; Wellcome Trust; EPSRC [EP/N014588/1] Funding Source: UKRI; British Heart Foundation [FS/16/29/31957, PG/09/083/27667, FS/12/29/29463] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/N014588/1] Funding Source: researchfish	Royal College of Surgeons of England Fellowship Programme; British Heart Foundation Research Fellowship; Wellcome Trust Research Training Fellowship(Wellcome Trust); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); HEFCE(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); British Heart Foundation(British Heart Foundation); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	M.M.C. is supported by the Royal College of Surgeons of England Fellowship Programme and a British Heart Foundation Research Fellowship award FS/16/29/31957. J.M.T. is supported by a Wellcome Trust Research Training Fellowship (104492/Z/14/Z). J.H.F.R. is part supported by the NIHR Cambridge Biomedical Research Centre, the British Heart Foundation, HEFCE and the Wellcome Trust.; M.M.C is supported by the Royal College of Surgeons of England Fellowship Programme and a British Heart Foundation Research Fellowship award FS/16/29/31957.; J.M.T is supported by a Wellcome Trust Research Training Fellowship (104492/Z/14/Z).; J.H.F.R is part-supported by the NIHR Cambridge Biomedical Research Centre, the British Heart Foundation, HEFCE and the Wellcome Trust.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Aikawa E, 2007, CIRCULATION, V116, P2841, DOI 10.1161/CIRCULATIONAHA.107.732867; Akai T, 2014, INT ANGIOL, V33, P426; Allison MA, 2012, ARTERIOSCL THROM VAS, V32, P140, DOI 10.1161/ATVBAHA.111.235234; Bos D, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.115.003843; Bradbury AW, 2010, J VASC SURG, V51, p5S, DOI 10.1016/j.jvs.2010.01.073; Bradbury AW, 2010, J VASC SURG, V51, p32S, DOI 10.1016/j.jvs.2010.01.075; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Caruana MF, 2005, EUR J VASC ENDOVASC, V29, P443, DOI 10.1016/j.ejvs.2005.01.015; Cleven Arjen H G, 2005, Eur J Gen Pract, V11, P107; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Falk E, 2006, J AM COLL CARDIOL, V47, pC7, DOI 10.1016/j.jacc.2005.09.068; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Greenland P, 2007, J AM COLL CARDIOL, V49, P378, DOI 10.1016/j.jacc.2006.10.001; Huang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090201; Hussain MA, 2016, JAMA SURG, V151, P742, DOI 10.1001/jamasurg.2016.0415; Jacobs PC, 2010, ATHEROSCLEROSIS, V209, P455, DOI 10.1016/j.atherosclerosis.2009.09.031; Joshi FR, 2016, J AM COLL CARDIOL, V67, P69, DOI 10.1016/j.jacc.2015.10.050; Kim J, 2013, J NUCL CARDIOL, V20, P375, DOI 10.1007/s12350-013-9675-5; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Matsuo Y, 2012, ATHEROSCLEROSIS, V223, P365, DOI 10.1016/j.atherosclerosis.2012.05.023; New SEP, 2011, CIRC RES, V108, P1381, DOI 10.1161/CIRCRESAHA.110.234146; Ohtake T, 2011, J VASC SURG, V53, P676, DOI 10.1016/j.jvs.2010.09.070; Olin JW, 2016, J AM COLL CARDIOL, V67, P1339, DOI 10.1016/j.jacc.2015.12.049; Popovic B, 2009, AM J CARDIOL, V104, P1377, DOI 10.1016/j.amjcard.2009.07.001; Rumberger JA, 1997, J AM COLL CARDIOL, V29, P1542, DOI 10.1016/S0735-1097(97)00093-4; Sampson UKA, 2014, GLOB HEART, V9, P145, DOI 10.1016/j.gheart.2013.12.008; Santos RD, 2010, ATHEROSCLEROSIS, V209, P131, DOI 10.1016/j.atherosclerosis.2009.08.025; Shanahan CM, 2013, NAT REV NEPHROL, V9, P661, DOI 10.1038/nrneph.2013.176; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Singh DK, 2012, DIABETES RES CLIN PR, V97, P158, DOI 10.1016/j.diabres.2012.01.038; Vagnarelli F, 2016, ATHEROSCLEROSIS, V245, P43, DOI 10.1016/j.atherosclerosis.2015.11.014; van Gils MJ, 2013, ATHEROSCLEROSIS, V227, P95, DOI 10.1016/j.atherosclerosis.2012.12.017; Vengrenyuk Y, 2006, P NATL ACAD SCI USA, V103, P14678, DOI 10.1073/pnas.0606310103	34	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182952	10.1371/journal.pone.0182952	http://dx.doi.org/10.1371/journal.pone.0182952			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886041	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100013
J	Guzman, JM; Luckenbach, JA; Middleton, MA; Massee, KC; Jensen, C; Goetz, FW; Jasonowicz, AJ; Swanson, P				Guzman, Jose M.; Luckenbach, J. Adam; Middleton, Mollie A.; Massee, Kenneth C.; Jensen, Cortney; Goetz, Frederick W.; Jasonowicz, Andrew J.; Swanson, Penny			Reproductive life history of sablefish (Anoplopoma fimbria) from the US Washington coast	PLOS ONE			English	Article							COD GADUS-MORHUA; GONADAL-STEROIDS; DICENTRARCHUS-LABRAX; OOCYTE DEVELOPMENT; SERUM-LEVELS; SEA BASS; MATURITY; PLASMA; FISHES; CYCLE	Sablefish (Anoplopoma fimbria) is a marine groundfish that supports valuable fisheries in the North Pacific Ocean and holds promise for marine aquaculture. Limited information is available, however, about its reproductive biology. This study aimed to characterize the complete reproductive cycle, including seasonal changes in gonadal development (macroscopic and histological), plasma sex steroid levels (17 beta-estradiol -E2-, and 11-ketotestosterone -11KT-), gonadosomatic and hepatosomatic indices (GSI, and HSI), and condition factor (K) of female and male sablefish captured off the Washington coast. Adult fish (209 females, 159 males) were caught by longline monthly from August 2012 to August 2013. Early signs of recruitment of ovarian follicles into secondary growth, indicated by oocytes containing small yolk granules and cortical alveoli, were first observed in March. Oogenesis progressed during spring and summer, and fully vitellogenic follicles were first observed in July. Vitellogenic growth was correlated with increases in plasma E2, GSI, HSI and K. Perio-vulatory females, indicated by fully-grown oocytes with migrating germinal vesicles and hydrated oocytes, were found from November to February. At this stage, plasma E2 and GSI reached maximal levels. In males, proliferating cysts containing spermatocytes were first observed in April. Testicular development proceeded during spring and summer, a period during which all types of male germ cells were found. The first clusters of spermatozoa appeared in July, concomitant with a 5.2-fold increase in GSI. Spermiating males were observed from November to April; at this time, spermatids were absent or greatly reduced, and testis lobules were filled with spermatozoa. The highest levels of plasma 11KT were found in males at this stage. Postspawning ovaries and testes, and basal steroids levels were found in fish captured from February to April. These results suggest that sablefish in coastal Washington initiate their reproductive cycle in March/April and spawn primarily in January/February.	[Guzman, Jose M.; Luckenbach, J. Adam; Massee, Kenneth C.; Goetz, Frederick W.; Swanson, Penny] NOAA, Natl Marine Fisheries Serv, Northwest Fisheries Sci Ctr, Environm & Fisheries Sci Div, Seattle, WA 98112 USA; [Guzman, Jose M.; Middleton, Mollie A.; Jasonowicz, Andrew J.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Luckenbach, J. Adam; Swanson, Penny] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA; [Jensen, Cortney] Ocean Associates Inc, NOAA, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Washington; University of Washington Seattle; Washington State University; National Oceanic Atmospheric Admin (NOAA) - USA	Guzman, JM (corresponding author), NOAA, Natl Marine Fisheries Serv, Northwest Fisheries Sci Ctr, Environm & Fisheries Sci Div, Seattle, WA 98112 USA.; Guzman, JM (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	jmguzman@uw.edu	Middleton, Mollie/Z-2446-2019		National Oceanic and Atmospheric Administration Cooperation Research Program; National Oceanic and Atmospheric Administration Office of Aquaculture; National Academy of Sciences; NOAA Cooperative Research Program; NOAA Office of Aquaculture; NOAA through the National Academy of Sciences	National Oceanic and Atmospheric Administration Cooperation Research Program; National Oceanic and Atmospheric Administration Office of Aquaculture; National Academy of Sciences; NOAA Cooperative Research Program; NOAA Office of Aquaculture; NOAA through the National Academy of Sciences	This research was supported by funding from National Oceanic and Atmospheric Administration Cooperation Research Program and National Oceanic and Atmospheric Administration Office of Aquaculture to FWG and PS. JMG received a postdoctoral fellowship form The National Academy of Sciences. Ocean Associates Inc. provides professional consulting services to government organizations, UN agencies, academia, non-governmental organizations, and the private sector. In the current study NOAH contracted Ocean Associates Inc. to provide a qualified contractor to help in conducting the research project. The funder provided support in the form of salary for author CJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.; This research was supported by funding from the NOAA Cooperative Research Program and NOAA Office of Aquaculture. JMG received a National Research Council postdoctoral fellowship funded by NOAA through the National Academy of Sciences. Valuable assistance was provided by Eric Samuelson and the crew of the F/V Playboy Too in collecting sablefish by longline for the study and aging of otoliths was performed by Patrick MacDonald (Pacific States Marine Fisheries). The authors are grateful to Melissa Head and Cara Rodgveller for comments on an earlier draft of this manuscript.	Almeida FFL, 2008, BIOL REPROD, V78, P27, DOI 10.1095/biolreprod.107.063669; Begtashi I, 2004, AQUACULTURE, V241, P539, DOI 10.1016/j.aquaculture.2004.07.011; Bell F, 1945, ANOPLOPOMA FIMBRIA, P94; BOLGER T, 1989, J FISH BIOL, V34, P171, DOI 10.1111/j.1095-8649.1989.tb03300.x; BORG B, 1994, COMP BIOCHEM PHYS C, V109, P219, DOI 10.1016/0742-8413(94)00063-G; Brown-Peterson NJ, 2011, MAR COAST FISH, V3, P52, DOI 10.1080/19425120.2011.555724; CAILLIET GM, 1988, CALIF FISH GAME, V74, P132; Cavaco JEB, 1998, AM J PHYSIOL-REG I, V275, pR1793, DOI 10.1152/ajpregu.1998.275.6.R1793; Chilton DE, 1982, AGE DETERMINATION ME, P60; Dahle R, 2003, COMP BIOCHEM PHYS A, V136, P641, DOI 10.1016/S1095-6433(03)00215-0; FUJIWARA S, 1988, NIPPON SUISAN GAKK, V54, P1333; Gunnarsson A, 2006, J FISH BIOL, V68, P1158, DOI 10.1111/j.0022-1112.2006.00990.x; Guzman JM, 2008, GEN COMP ENDOCR, V156, P285, DOI 10.1016/j.ygcen.2008.02.002; Guzman JM, 2015, GEN COMP ENDOCR, V221, P101, DOI 10.1016/j.ygcen.2015.02.024; Guzman JM, 2013, GEN COMP ENDOCR, V193, P37, DOI 10.1016/j.ygcen.2013.07.007; Hanselman DH, 2011, STOCK ASSESSMENT FIS, P307; HARMIN SA, 1995, MAR BIOL, V121, P601, DOI 10.1007/BF00349295; Haukenes AH, 2008, N AM J AQUACULT, V70, P212, DOI 10.1577/A07-025.1; Head MA, 2014, FISH RES, V159, P56, DOI 10.1016/j.fishres.2014.05.007; HEYAMOTO HIROMU, 1965, COMMERCIAL FISH REV, V27, P1; Hiramatsu N, 2002, FISHERIES SCI, V68, P694, DOI 10.2331/fishsci.68.sup1_694; Hunter JR, 1989, CALIFORNIA COOPERATI, V30, P160; Jamieson B.G.M., 1991, FISH EVOLUTION SYSTE; JOHNSON LL, 1991, J EXP MAR BIOL ECOL, V152, P161, DOI 10.1016/0022-0981(91)90213-G; Junquera S, 2003, ICES J MAR SCI, V60, P767, DOI 10.1016/S1054-3139(03)00073-0; KIMURA DK, 1993, FISH B-NOAA, V91, P271; Kwon JY, 1999, J FISH BIOL, V54, P370, DOI 10.1006/jfbi.1998.0871; Leary S, 2013, AVMA GUIDELINES EUTH, P69; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Lowerre-Barbieri SK, 2011, MAR COAST FISH, V3, P71, DOI 10.1080/19425120.2011.556932; Luckenbach JA, 2017, AQUACULTURE, V479, P285, DOI 10.1016/j.aquaculture.2017.05.037; Luckenbach JA, 2016, FISH PHYSIOL BIOCHEM, V42, P233, DOI 10.1007/s10695-015-0132-z; MACEWICZ BJ, 1994, CAL COOP OCEAN FISH, V35, P160; MASON JC, 1983, CAN J FISH AQUAT SCI, V40, P2126, DOI 10.1139/f83-247; MATSUYAMA M, 1991, JPN J ICHTHYOL, V37, P381, DOI 10.1007/BF02905364; Miura T, 2002, ZOOL SCI, V19, P321, DOI 10.2108/zsj.19.321; Mori H, 2003, FISHERIES SCI, V69, P910, DOI 10.1046/j.1444-2906.2003.00707.x; Morita SH, 2012, ENVIRON BIOL FISH, V94, P505, DOI 10.1007/s10641-010-9613-1; MOSER HG, 1994, CAL COOP OCEAN FISH, V35, P144; National Marine Service, 2014, FISH EC US, V2016, P163; Orlov AM, 2005, ICES J MAR SCI, V62, P1016, DOI 10.1016/j.icesjms.2005.03.002; Parks N, 1987, NMFSFNWC124 NOAA; Pavlidis M, 2000, GEN COMP ENDOCR, V118, P14, DOI 10.1006/gcen.1999.7440; Phillips JP, 1954, PACIFIC MARINE FISHE, V3, P23; Polzonetti-Magni AM, 2004, INT REV CYTOL, V239, P1, DOI 10.1016/S0074-7696(04)39001-7; PRAT F, 1990, GEN COMP ENDOCR, V78, P361, DOI 10.1016/0016-6480(90)90026-I; Quagio-Grassiotto I, 2011, J MORPHOL, V272, P1290, DOI 10.1002/jmor.10981; R Development Core Team, 2016, R LANG ENV STAT COMP; Rideout RM, 2011, MAR COAST FISH, V3, P176, DOI 10.1080/19425120.2011.556943; Rideout RM, 2000, CAN J ZOOL, V78, P1017, DOI 10.1139/cjz-78-6-1017; Rodgveller CJ, 2016, FISH B-NOAA, V114, P89, DOI 10.7755/FB.114.1.8; Sablefish Maloney N., 2004, MAR FISH REV, V66, P1; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Trippel Edward A., 2003, Journal of Northwest Atlantic Fishery Science, V33, P81, DOI 10.2960/J.v33.a6; Tyler CR, 1996, REV FISH BIOL FISHER, V6, P287, DOI 10.1007/BF00122584; Weltzien FA, 2002, COMP BIOCHEM PHYS A, V132, P567, DOI 10.1016/S1095-6433(02)00092-2; WEST G, 1990, AUST J MAR FRESH RES, V41, P199, DOI 10.1071/MF9900199	57	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184413	10.1371/journal.pone.0184413	http://dx.doi.org/10.1371/journal.pone.0184413			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886138	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100112
J	Hoque, DME; Kumari, V; Hoque, M; Ruseckaite, R; Romero, L; Evans, SM				Hoque, Dewan Md Emdadul; Kumari, Varuni; Hoque, Masuma; Ruseckaite, Rasa; Romero, Lorena; Evans, Sue M.			Impact of clinical registries on quality of patient care and clinical outcomes: A systematic review	PLOS ONE			English	Review							ACUTE MYOCARDIAL-INFARCTION; NATIONAL REGISTRY; HEALTH-CARE; OF-CARE; STROKE REGISTRY; HEART-FAILURE; RHEUMATOID-ARTHRITIS; REPERFUSION THERAPY; DISEASE REGISTRIES; ISCHEMIC-STROKE	Background Clinical quality registries (CQRs) are playing an increasingly important role in improving health outcomes and reducing health care costs. CQRs are established with the purpose of monitoring quality of care, providing feedback, benchmarking performance, describing pattern of treatment, reducing variation and as a tool for conducting research. Objectives To synthesise the impact of clinical quality registries (CQRs) as an 'intervention' on (I) mortality/survival; (II) measures of outcome that reflect a process or outcome of health care; (III) health care utilisation; and (IV) healthcare-related costs. Methods The following electronic databases were searched: MEDLINE, EMBASE, CENTRAL, CINAHL and Google Scholar. In addition, a review of the grey literature and a reference check of citations and reference lists within articles was undertaken to identify relevant studies in English covering the period January 1980 to December 2016. The PRISMA-P methodology, checklist and standard search strategy using pre-defined inclusion and exclusion criteria and structured data extraction tools were used. Data on study design and methods, participant characteristics attributes of included registries and impact of the registry on outcome measures and/or processes of care were extracted. Results We identified 30102 abstracts from which 75 full text articles were assessed and finally 17 articles were selected for synthesis. Out of 17 studies, six focused on diabetes care, two on cardiac diseases, two on lung diseases and others on organ transplantations, rheumatoid arthritis, ulcer healing, surgical complications and kidney disease. The majority of studies were "before after" design (#11) followed by cohort design (#2), randomised controlled trial (#2), experimental non randomised study and one cross sectional comparison. The measures of impact of registries were multifarious and included change in processes of care, quality of care, treatment outcomes, adherence to guidelines and survival. Sixteen of 17 studies demonstrated positive findings in their outcomes after implementation of the registry. Conclusions Despite the large number of published articles using data derived from CQRs, few have rigorously evaluated the impact of the registry as an intervention on improving health outcomes. Those that have evaluated this impact have mostly found a positive impact on healthcare processes and outcomes.	[Hoque, Dewan Md Emdadul; Kumari, Varuni; Hoque, Masuma; Ruseckaite, Rasa; Evans, Sue M.] Monash Univ, Sch Publ Hlth & Prevent Med, Alfred Ctr, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Hoque, Dewan Md Emdadul] Int Ctr Diarrhoeal Dis Res, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Romero, Lorena] Alfred Ctr, Ian Potter Lib, Melbourne, Vic, Australia	Monash University; International Centre for Diarrhoeal Disease Research (ICDDR)	Hoque, DME (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Alfred Ctr, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.; Hoque, DME (corresponding author), Int Ctr Diarrhoeal Dis Res, Maternal & Child Hlth Div, Dhaka, Bangladesh.	emdad.hoque@monash.edu	Ruseckaite, Rasa/H-4060-2014; Hoque, Dewan Md. Emdadul/J-1999-2019; Hoque, Dewan/O-3606-2015	Hoque, Dewan Md. Emdadul/0000-0001-8219-9196; Hoque, Dewan/0000-0001-8219-9196; Evans, Sue/0000-0003-2962-8400; Ruseckaite, Rasa/0000-0002-9078-2696	MIPRS; MGS; Monash Partners Academic Health Science Centre; Monash [25762931]	MIPRS; MGS; Monash Partners Academic Health Science Centre; Monash	DEH has received MIPRS for tuition fees and MGS scholarship for living costs and Monash ID: 25762931 for PhD Programme. SE has received funding support from Monash Partners Academic Health Science Centre. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACSQHC, 2016, EC EV CLIN QUAL REG; Armstrong BK, 2007, MED J AUSTRALIA, V187, P485, DOI 10.5694/j.1326-5377.2007.tb01383.x; Asplund K, 2003, CEREBROVASC DIS, V15, P5, DOI 10.1159/000068203; Australian Commission on Safety and Quality in Health Care, 2012, LOG DES AUSTR CLIN Q; Autier P, 2011, LANCET, V377, P99, DOI 10.1016/S0140-6736(10)62347-1; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; Bhatt DL, 2010, JAMA-J AM MED ASSOC, V303, P2188, DOI 10.1001/jama.2010.743; Black N, 2004, BMJ-BRIT MED J, V328, P1478, DOI 10.1136/bmj.328.7454.1478; Bradley EH, 2004, JAMA-J AM MED ASSOC, V292, P1563, DOI 10.1001/jama.292.13.1563; Breckenridge K, 2015, NEPHROL DIAL TRANSPL, V30, P1605, DOI 10.1093/ndt/gfv209; Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Bufalino VJ, 2011, CIRCULATION, V123, P2167, DOI 10.1161/CIR.0b013e3182181529; Carlhed R, 2006, AM HEART J, V152, P1175, DOI 10.1016/j.ahj.2006.07.028; CfD Control Prevention, 2011, MMWR-MORBID MORTAL W, V60, P206; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Dall TM, 2009, POPUL HEALTH MANAG, V12, P103, DOI 10.1089/pop.2009.12203; Dokholyan RS, 2009, AM HEART J, V157, P971, DOI 10.1016/j.ahj.2009.03.023; Emilsson L, 2015, J INTERN MED, V277, P94, DOI 10.1111/joim.12303; Evans SM, 2011, MED J AUSTRALIA, V194, P360, DOI 10.5694/j.1326-5377.2011.tb03007.x; Ferguson TB, 2003, JAMA-J AM MED ASSOC, V290, P49, DOI 10.1001/jama.290.1.49; Fonarow GC, 2005, ARCH INTERN MED, V165, P1469, DOI 10.1001/archinte.165.13.1469; Fonarow GC, 2010, CIRCULATION, V122, P585, DOI 10.1161/CIRCULATIONAHA.109.934471; Franklin PD, 2014, J BONE JOINT SURG AM, V96A, P104, DOI 10.2106/JBJS.N.00328; French WJ, 2012, JAMA-J AM MED ASSOC, V308, P771, DOI 10.1001/jama.2012.9500; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; George Mary G., 2009, Morbidity and Mortality Weekly Report, V58, P1; Georgiou A, 2006, Aust Fam Physician, V35, P77; Geubbels ELPE, 2006, INT J QUAL HEALTH C, V18, P127, DOI 10.1093/intqhc/mzi103; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Gitt AK, 2010, EUROPEAN HEART J; Gliklich RE., 2014, REGISTRIES EVALUATIN, V3; Goldfracht M, 2011, INT J QUAL HEALTH C, V23, P674, DOI 10.1093/intqhc/mzr051; Grau AJ, 2010, STROKE, V41, P1495, DOI 10.1161/STROKEAHA.110.582239; Han W, 2015, J AM MED INFORM ASS; Harris MF, 2002, MED J AUSTRALIA, V177, P250, DOI 10.5694/j.1326-5377.2002.tb04757.x; Harrison JK, 2015, NEPHRON, V129, P209, DOI 10.1159/000371888; Hickey GL, 2013, EUROPEAN J CARDIOTHO; Hills NK, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-20; Hoekstra JW, 2002, ACAD EMERG MED, V9, P1146, DOI 10.1111/j.1553-2712.2002.tb01569.x; Hong Yuling, 2006, Crit Pathw Cardiol, V5, P179, DOI 10.1097/01.hpc.0000243588.00012.79; Hoque DME, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010654; Jakobsen E, 2013, J THORAC ONCOL, V8, P1238, DOI 10.1097/JTO.0b013e3182a4070f; Johnson SC, 2005, NEUROLOGY, V64, P654; Jonsson A, 2010, EUR J HEART FAIL, V12, P25, DOI 10.1093/eurjhf/hfp175; Kapral MK, 2004, STROKE, V35, P1756, DOI 10.1161/01.STR.0000130423.50191.9f; Khuri SF, 1998, ANN SURG, V228, P491, DOI 10.1097/00000658-199810000-00006; Koduri G, 2010, RHEUMATOLOGY, V49, P1483, DOI 10.1093/rheumatology/keq035; LaBresh KA, 2008, ARCH INTERN MED, V168, P411, DOI 10.1001/archinternmed.2007.101; Larsson S, 2012, HEALTH AFFAIR, V31, P220, DOI 10.1377/hlthaff.2011.0762; Lim TO, 2008, NEPHROLOGY, V13, P745, DOI 10.1111/j.1440-1797.2008.01044.x; Lorenzoni L, 2014, LANCET, V384, P83, DOI 10.1016/S0140-6736(14)60571-7; Lundstrom M, 2014, INT J HEALTH CARE Q, V27, P140, DOI 10.1108/IJHCQA-10-2012-0101; Lyu H, 2015, J HEALTHCARE QUAL; Madhok R, 2002, BAYLOR U MED CTR P; Mallinson EKL, 2010, GUT, V59, P1378, DOI 10.1136/gut.2010.212449; McClellan M. B., 2008, EVIDENCE BASED MED C; McNeil JJ, 2010, MED J AUSTRALIA, V192, P244, DOI 10.5694/j.1326-5377.2010.tb03499.x; Mehra S, 2015, THYROID, V25, P157, DOI 10.1089/thy.2014.0270; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1136/bmj.i4086, 10.1136/bmj.b2535, 10.1186/2046-4053-4-1]; Oien R F, 2006, J Wound Care, V15, P259; Oien RF, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003091; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Peterson ED, 2007, RES METHODS SPEED DE; Peterson ED, 2008, AM HEART J, V156, P1045, DOI 10.1016/j.ahj.2008.07.028; Pollard C, 2009, J RURAL HEALTH, V25, P77, DOI 10.1111/j.1748-0361.2009.00202.x; Popay J, 2006, PRODUCT ESRC METHODS, pb92, DOI DOI 10.13140/2.1.1018.4643; Registry ASC, 2014, ANN REPORT; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Roski J, 2003, PREV MED, V36, P291, DOI 10.1016/S0091-7435(02)00052-X; Salim A, 2010, J TRAUMA, V69, P451, DOI 10.1097/TA.0b013e3181e7847a; Schechter MS, 2014, BMJ QUAL SAF, V23, P9, DOI 10.1136/bmjqs-2013-002378; Schmittdiel J, 2005, J GEN INTERN MED, V20, P855, DOI 10.1111/j.1525-1497.2005.0171.x; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; Scottish Intercollegiate Guidelines Network for RCT, COH CAS CONTR STUD; Shah Nipa R, 2015, J Registry Manag, V42, P3; Sorensen HT, 1996, INT J RISK SAFETY ME, V10, P1; Spertus JA, 2006, AM HEART J, V151, P589, DOI 10.1016/j.ahj.2005.05.026; Sposato LA, 2008, STROKE, V39, P3036, DOI 10.1161/STROKEAHA.108.521062; Stroebel Robert J, 2002, Jt Comm J Qual Improv, V28, P441; Thomas KG, 2007, J GEN INTERN MED, V22, P1740, DOI 10.1007/s11606-007-0431-x; Tottenborg SS, 2013, CLIN RESPIR J, V7, P319, DOI 10.1111/crj.12009; van der Veer SN, 2010, INT J MED INFORM, V79, P305, DOI 10.1016/j.ijmedinf.2010.01.011; Young A, 2007, RHEUMATOLOGY, V46, P350, DOI 10.1093/rheumatology/kel253; Young A, 2010, RHEUMATOLOGY	84	96	97	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183667	10.1371/journal.pone.0183667	http://dx.doi.org/10.1371/journal.pone.0183667			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886607	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100032
J	Grell, AS; Frederiksen, SD; Edvinsson, L; Ansar, S				Grell, Anne-Sofie; Frederiksen, Simona Denise; Edvinsson, Lars; Ansar, Saema			Cerebrovascular gene expression in spontaneously hypertensive rats	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR; DENSITY-LIPOPROTEIN RECEPTOR-1; SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASE-2; EXTRACELLULAR-MATRIX; LECTIN-LIKE; MECHANICAL STRETCH; VASCULAR INJURY; PLASMA-LEVELS; APOPTOSIS	Hypertension is a hemodynamic disorder and one of the most important and well-established risk factors for vascular diseases such as stroke. Blood vessels exposed to chronic shear stress develop structural changes and remodeling of the vascular wall through many complex mechanisms. However, the molecular mechanisms involved are not fully understood. Hypertension-susceptible genes may provide a novel insight into potential molecular mechanisms of hypertension and secondary complications associated with hypertension. The aim of this exploratory study was to identify gene expression differences in the middle cerebral arteries between 12-week-old male spontaneously hypertensive rats and their normotensive Wistar-Kyoto rats using an Affymetrix whole-transcriptome expression profiling. Quantitative PCR and western blotting were used to verify genes of interest. 169 genes were differentially expressed in the middle cerebral arteries from hypertensive compared to normotensive rats. The gene expression of 72 genes was decreased and the gene expression of 97 genes was increased. The following genes with a fold difference >= 1.40 were verified by quantitative PCR; Postn, Olr1, Fas, Vldlr, Mmp2, Timp1, Serpine1, Mmp11, Cd34, Ptgs1 and Ptgs2. The gene expression of Postn, Olr1, Fas, Vldlr, Mmp2, Timp1 and Serpine1 and the protein expression of LOX1 (also known as OLR1) were significantly increased in the middle cerebral arteries from spontaneously hypertensive rats compared to Wistar-Kyoto rats. In conclusion, the identified genes in the middle cerebral arteries from spontaneously hypertensive rats could be possible mediators of the vascular changes and secondary complications associated with hypertension. This study supports the selection of key genes to investigate in the future research of hypertension-induced end-organ damage.	[Grell, Anne-Sofie; Frederiksen, Simona Denise; Edvinsson, Lars] Rigshosp Glostrup, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark; [Edvinsson, Lars; Ansar, Saema] Lund Univ, Div Expt Vasc Res, Dept Clin Sci, Lund, Sweden	Lund University	Grell, AS (corresponding author), Rigshosp Glostrup, Glostrup Res Inst, Dept Clin Expt Res, Glostrup, Denmark.	anne-sofie.grell@regionh.dk	Frederiksen, Simona Denise/AAN-2233-2020; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Frederiksen, Simona Denise/0000-0002-9207-0350; Edvinsson, Lars/0000-0002-1805-1346	Lundbeckfonden [R59-A5404]; Lundbeck Foundation [R59-2010-5404] Funding Source: researchfish	Lundbeckfonden(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work was supported by Lundbeckfonden (R59-A5404) to Lars Edvinsson. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Salam VB, 2010, CIRCULATION, V122, P2058, DOI 10.1161/CIRCULATIONAHA.110.972745; Anwar MA, 2012, J VASC RES, V49, P463, DOI 10.1159/000339151; ARGRAVES KM, 1995, J BIOL CHEM, V270, P26550, DOI 10.1074/jbc.270.44.26550; Au A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18224; Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954; Boyle J. J., 2005, Current Vascular Pharmacology, V3, P63, DOI 10.2174/1570161052773861; Briones AM, 2010, CURR OPIN NEPHROL HY, V19, P187, DOI 10.1097/MNH.0b013e328335eec9; Castro MA, 2008, ATHEROSCLEROSIS, V198, P320, DOI 10.1016/j.atherosclerosis.2007.10.011; Chase AJ, 2003, J VASC RES, V40, P329, DOI 10.1159/000072697; Chelladurai P, 2012, EUR RESPIR J, V40, P766, DOI 10.1183/09031936.00209911; Chelluboina B, 2014, MOL NEUROBIOL, V49, P50, DOI 10.1007/s12035-013-8486-7; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Denorme F, 2016, STROKE, V47, P2419, DOI 10.1161/STROKEAHA.116.014091; Derosa G, 2006, ENDOTHELIUM-J ENDOTH, V13, P227, DOI 10.1080/10623320600780942; Drake C, 2011, BRAIN BEHAV IMMUN, V25, P1113, DOI 10.1016/j.bbi.2011.02.008; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Furumoto T, 2004, AM J CARDIOL, V93, P997, DOI 10.1016/j.amjcard.2003.12.053; Gonzalez JM, 2008, CLIN SCI, V114, P651, DOI 10.1042/CS20070361; Hakuno D, 2010, J CLIN INVEST, V120, P2292, DOI 10.1172/JCI40973; Hamakawa Y, 2004, NEUROL RES, V26, P767, DOI 10.1179/016164104225016074; Hamet P, 1996, CAN J PHYSIOL PHARM, V74, P850, DOI 10.1139/cjpp-74-7-850; Iadecola C, 2008, CELL METAB, V7, P476, DOI 10.1016/j.cmet.2008.03.010; Imanishi T, 2002, CIRC J, V66, P1060, DOI 10.1253/circj.66.1060; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Kataoka H, 1999, CIRCULATION, V99, P3110, DOI 10.1161/01.CIR.99.24.3110; Li YX, 2015, NEUROIMAGE, V111, P329, DOI 10.1016/j.neuroimage.2015.02.053; Lindner V, 2005, ARTERIOSCL THROM VAS, V25, P77, DOI 10.1161/01.ATV.0000149141.81230.c6; Liu XX, 2015, INT J BIOCHEM CELL B, V62, P15, DOI 10.1016/j.biocel.2015.02.009; Marchesi C, 2012, J HYPERTENS, V30, P3, DOI 10.1097/HJH.0b013e32834d249a; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nagase M, 1997, BIOCHEM BIOPH RES CO, V237, P496, DOI 10.1006/bbrc.1997.7176; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Parasuraman S, 2012, J PHARMACOL PHARMACO, V3, P172, DOI 10.4103/0976-500X.95521; Planas AM, 2001, NEUROBIOL DIS, V8, P834, DOI 10.1006/nbdi.2001.0435; Pravenec M, 2010, CURR HYPERTENS REP, V12, P5, DOI 10.1007/s11906-009-0083-9; Renna NF, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/808353; Rizzoni D, 2000, J HYPERTENS, V18, P885, DOI 10.1097/00004872-200018070-00010; Rosenbaum DM, 2000, J NEUROSCI RES, V61, P686, DOI 10.1002/1097-4547(20000915)61:6<686::AID-JNR12>3.0.CO;2-7; Sharifi AM, 1998, AM J HYPERTENS, V11, P1108, DOI 10.1016/S0895-7061(98)00120-4; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Tacken PJ, 2002, ATHEROSCLEROSIS, V162, P103, DOI 10.1016/S0021-9150(01)00697-9; Thogersen AM, 1998, CIRCULATION, V98, P2241, DOI 10.1161/01.CIR.98.21.2241; Tsai KL, 2016, J VASC SURG, V63, P204, DOI 10.1016/j.jvs.2014.05.098; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Virdis A, 2014, MATURITAS, V78, P179, DOI 10.1016/j.maturitas.2014.04.012; Xu XL, 2014, CELL PHYSIOL BIOCHEM, V33, P88, DOI 10.1159/000356652; Zervoudaki A, 2003, J HUM HYPERTENS, V17, P119, DOI 10.1038/sj.jhh.1001518; Zicha J, 1999, PHYSIOL REV, V79, P1227, DOI 10.1152/physrev.1999.79.4.1227	51	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184233	10.1371/journal.pone.0184233	http://dx.doi.org/10.1371/journal.pone.0184233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880918	gold, Green Published, Green Submitted			2022-12-27	WOS:000409467200043
J	Wortinger, LA; Oie, MG; Endestad, T; Wyller, VB				Wortinger, Laura Anne; Oie, Merete Glenne; Endestad, Tor; Wyller, Vegard Bruun			Altered right anterior insular connectivity and loss of associated functions in adolescent chronic fatigue syndrome	PLOS ONE			English	Article							NEUROCOGNITIVE BRAIN NETWORKS; COGNITIVE DYSFUNCTION; PREFRONTAL CORTEX; CLINICAL SYMPTOMS; ACTIVITY MONITOR; AEROBIC FITNESS; PAIN PERCEPTION; RELIABILITY; INTEROCEPTION; MECHANISMS	Impairments in cognition, pain intolerance, and physical inactivity characterize adolescent chronic fatigue syndrome (CFS), yet little is known about its neurobiology. The right dorsal anterior insular (dAI) connectivity of the salience network provides a motivational context to stimuli. In this study, we examined regional functional connectivity (FC) patterns of the right dAI in adolescent CFS patients and healthy participants. Eighteen adolescent patients with CFS and 18 aged-matched healthy adolescent control participants underwent resting-state functional magnetic resonance imaging. The right dAI region of interest was examined in a seed-to-voxel resting-state FC analysis using SPM and CONN toolbox. Relative to healthy adolescents, CFS patients demonstrated reduced FC of the right dAI to the right posterior parietal cortex (PPC) node of the central executive network. The decreased FC of the right dAI-PPC might indicate impaired cognitive control development in adolescent CFS. Immature FC of the right dAI-PPC in patients also lacked associations with three known functional domains: cognition, pain and physical activity, which were observed in the healthy group. These results suggest a distinct biological signature of adolescent CFS and might represent a fundamental role of the dAI in motivated behavior.	[Wortinger, Laura Anne; Wyller, Vegard Bruun] Akershus Univ Hosp, Dept Paediat & Adolescent Hlth, Nordbyhagen, Norway; [Wortinger, Laura Anne; Oie, Merete Glenne; Endestad, Tor] Univ Oslo, Dept Psychol, Oslo, Norway; [Oie, Merete Glenne] Innlandet Hosp Trust, Res Dept, Lillehammer, Norway	University of Oslo; University of Oslo; Innlandet Hospital Trust	Wortinger, LA (corresponding author), Akershus Univ Hosp, Dept Paediat & Adolescent Hlth, Nordbyhagen, Norway.; Wortinger, LA (corresponding author), Univ Oslo, Dept Psychol, Oslo, Norway.	l.a.w.bakke@medisin.uio.no		Wortinger, Laura/0000-0003-2721-3172; Endestad, Tor/0000-0002-4403-6887	Norwegian Research Council [228874]; South-Eastern Norway Regional Health Authority; University of Oslo (VBW)	Norwegian Research Council(Research Council of NorwayEuropean Commission); South-Eastern Norway Regional Health Authority; University of Oslo (VBW)	Norwegian Research Council, http://www.forskningsradet.no/en (VBW, grant number 228874); South-Eastern Norway Regional Health Authority, https://www.helse-sorost.no/south-eastern-norway-regional-health-authority (VBW); and the University of Oslo, http://www.uio.no/english/ (VBW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PROG BRAIN RES; [Anonymous], 2004, EV BAS GUID MAN CFS; Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Apkarian AV, 2008, CURR OPIN NEUROBIOL, V18, P464, DOI 10.1016/j.conb.2008.09.012; Baliki MN, 2009, J NEUROPHYSIOL, V101, P875, DOI 10.1152/jn.91100.2008; Baliki MN, 2015, NEURON, V87, P474, DOI 10.1016/j.neuron.2015.06.005; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Barnden LR, 2016, NEUROIMAGE-CLIN, V11, P530, DOI 10.1016/j.nicl.2016.03.017; Barnden LR, 2015, NMR BIOMED, V28, P404, DOI 10.1002/nbm.3261; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Boissoneault J, 2016, CLIN PHYSL FUNCT IMA; Boissoneault J, 2016, MAGN RESON IMAGING, V34, P603, DOI 10.1016/j.mri.2015.12.008; Botvinick M, 2015, ANNU REV PSYCHOL, V66, P83, DOI 10.1146/annurev-psych-010814-015044; Brurberg KG, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003973; Burkey AR, 1999, J NEUROSCI, V19, P4169; Castell BD, 2011, CLIN PSYCHOL-SCI PR, V18, P311, DOI 10.1111/j.1468-2850.2011.01262.x; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chai XQJ, 2012, NEUROIMAGE, V59, P1420, DOI 10.1016/j.neuroimage.2011.08.048; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; CHANGEUX JP, 1976, NATURE, V264, P705, DOI 10.1038/264705a0; Chechik G, 1998, NEURAL COMPUT, V10, P1759, DOI 10.1162/089976698300017124; Collin SM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008830; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Crawley EM, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000252; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2004, P NATL ACAD SCI USA, V101, P6333, DOI 10.1073/pnas.0401510101; Crossley NA, 2014, BRAIN, V137, P2382, DOI 10.1093/brain/awu132; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; Dahlgren G, 2010, GAIT POSTURE, V32, P386, DOI 10.1016/j.gaitpost.2010.06.022; Dowd KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047633; Erickson KI, 2015, CURR OPIN BEHAV SCI, V4, P27, DOI 10.1016/j.cobeha.2015.01.005; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Garralda ME, 2005, J CHILD PSYCHOL PSYC, V46, P1143, DOI 10.1111/j.1469-7610.2005.01424.x; Gay CW, 2015, BRAIN CONNECT; GOLDMANRAKIC PS, 1987, CHILD DEV, V58, P601, DOI 10.2307/1130201; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Gordon BA, 2010, CLIN REHABIL, V24, P1072, DOI 10.1177/0269215510371429; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Inst Med, 2015, BEYOND MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME: REDEFINING AN ILLNESS, P1; Jolles DD, 2011, CEREB CORTEX, V21, P385, DOI 10.1093/cercor/bhq104; Kawatani J, 2011, BRAIN DEV-JPN, V33, P832, DOI 10.1016/j.braindev.2010.12.009; Khan NA, 2014, PEDIATR EXERC SCI, V26, P138, DOI 10.1123/pes.2013-0125; Kurniawan IT, 2013, J NEUROSCI, V33, P6160, DOI 10.1523/JNEUROSCI.4777-12.2013; Lamm C, 2010, J COGNITIVE NEUROSCI, V22, P362, DOI 10.1162/jocn.2009.21186; Liu X, 2016, NEUROGASTROENT MOTIL, V28, P43, DOI 10.1111/nmo.12695; Lou HC, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.484; Mackenzie C, 2013, PAEDIAT CHILD HLTH, V23, P35, DOI DOI 10.1016/J.PAED.2012.10.001; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mansour AR, 2013, PAIN, V154, P2160, DOI 10.1016/j.pain.2013.06.044; McGrath CL, 2013, JAMA PSYCHIAT, V70, P821, DOI 10.1001/jamapsychiatry.2013.143; Menon V., 2015, BRAIN MAPPING ENCY R, V2, P597, DOI DOI 10.1016/B978-0-12-397025-1.00052-X; Menon V, 2011, TRENDS COGN SCI, V15, P483, DOI 10.1016/j.tics.2011.08.003; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Miller AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098156; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mizuno K, 2016, NEUROIMAGE-CLIN, V12, P600, DOI 10.1016/j.nicl.2016.09.016; Mizuno K, 2015, NEUROIMAGE-CLIN, V9, P355, DOI 10.1016/j.nicl.2015.09.001; Napadow V, 2010, ARTHRITIS RHEUM-US, V62, P2545, DOI 10.1002/art.27497; National Institute for Health and Clinical Excellence N, 2007, CHRON FAT SYNDR MYAL, P7; Nie HL, 2005, J PAIN, V6, P348, DOI 10.1016/j.jpain.2005.01.352; Nijhof SL, 2014, PSYCHONEUROENDOCRINO, V42, P199, DOI 10.1016/j.psyneuen.2014.01.017; Nijhof SL, 2012, LANCET, V379, P1412, DOI 10.1016/S0140-6736(12)60025-7; Nijhof SL, 2011, PEDIATRICS, V127, pE1169, DOI 10.1542/peds.2010-1147; Nijs J, 2012, EUR J CLIN INVEST, V42, P203, DOI 10.1111/j.1365-2362.2011.02575.x; Nisenbaum R, 2004, J PSYCHOSOM RES, V56, P171, DOI 10.1016/S0022-3999(03)00039-4; Ohara PT, 2003, J NEUROCYTOL, V32, P131, DOI 10.1023/B:NEUR.0000005598.09647.7f; Padmala S, 2011, J COGNITIVE NEUROSCI, V23, P3419, DOI 10.1162/jocn_a_00011; Pani L, 2000, MOL PSYCHIATR, V5, P14, DOI 10.1038/sj.mp.4000589; Pannekoek JN, 2014, J CHILD PSYCHOL PSYC, V55, P1317, DOI 10.1111/jcpp.12266; Papadopoulos AS, 2012, NAT REV ENDOCRINOL, V8, P22, DOI 10.1038/nrendo.2011.153; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stam CJ, 2014, NAT REV NEUROSCI, V15, P683, DOI 10.1038/nrn3801; Sulheim D, 2015, ARCH DIS CHILD, V100, P838, DOI 10.1136/archdischild-2014-306764; Sulheim D, 2014, JAMA PEDIATR, V168, P351, DOI 10.1001/jamapediatrics.2013.4647; Sullivan PF, 2005, PSYCHOL MED, V35, P1337, DOI 10.1017/S0033291705005210; Sund AM, 2001, EUR CHILD ADOLES PSY, V10, P222, DOI 10.1007/s007870170011; Supekar K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002374; Tanaka M, 2013, REV NEUROSCIENCE, V24, P617, DOI 10.1515/revneuro-2013-0035; Tanaka M, 2008, PSYCHOL REP, V103, P682, DOI 10.2466/PR0.103.3.682-690; Uddin LQ, 2011, J NEUROSCI, V31, P18578, DOI 10.1523/JNEUROSCI.4465-11.2011; Voss MW, 2011, NEUROSCIENCE, V199, P166, DOI 10.1016/j.neuroscience.2011.10.009; Voss M.W., 1985, J APPL PHYSIOL, V111, P1505, DOI DOI 10.1152/JAPPLPHYSI0L.00210.2011; Wechsler D., 2004, WISC 4 WECHSLER INTE, DOI 10.1037/t15174-000; Wechsler D., 2007, NORWEGIAN MANUAL SUP; Weng Y, 2016, BRAIN IMAGING BEHAV; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wiebking C, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00082; Winger A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005920; Wortinger LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159351; Wyller VB, 2013, BIOPSYCHOSOC MED, V7, DOI 10.1186/1751-0759-7-5; Wyller VB, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-10; Wyller VB, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0873-1; Wyller VB, 2011, EUR J APPL PHYSIOL, V111, P497, DOI 10.1007/s00421-010-1670-9; Zaki J, 2012, NEUROIMAGE, V62, P493, DOI 10.1016/j.neuroimage.2012.05.012; Zeineh MM, 2015, RADIOLOGY, V274, P517, DOI 10.1148/radiol.14141079	104	6	6	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184325	10.1371/journal.pone.0184325	http://dx.doi.org/10.1371/journal.pone.0184325			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880891	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000409467200050
J	Berghout, MA; Fabbricotti, IN; Buljac-Samardzic, M; Hilders, CGJM				Berghout, Mathilde A.; Fabbricotti, Isabelle N.; Buljac-Samardzic, Martina; Hilders, Carina G. J. M.			Medical leaders or masters? - A systematic review of medical leadership in hospital settings	PLOS ONE			English	Review							HEALTH-CARE; PROFESSIONAL IDENTITY; PHYSICIAN-LEADERS; MANAGEMENT; DOCTORS; COMPETENCES; EXECUTIVES; DIRECTORS; WORK; NEED	Medical leadership is increasingly considered as crucial for improving the quality of care and the sustainability of healthcare. However, conceptual clarity is lacking in the literature and in practice. Therefore, a systematic review of the scientific literature was conducted to reveal the different conceptualizations of medical leadership in terms of definitions, roles and activities, and personal-and context-specific features. Eight databases were systematically searched for eligible studies, including empirical studies published in peer-reviewed journals that included physicians carrying out a manager or leadership role in a hospital setting. Finally, 34 articles were included and their findings were synthesized and analyzed narratively. Medical leadership is conceptualized in literature either as physicians with formal managerial roles or physicians who act as informal 'leaders' in daily practices. In both forms, medical leaders must carry out general management and leadership activities and acts to balance between management and medicine, because these physicians must accomplish both organizational and medical staff objectives. To perform effectively, credibility among medical peers appeared to be the most important factor, followed by a scattered list of fields of knowledge, skills and attitudes. Competing logics, role ambiguity and a lack of time and support were perceived as barriers. However, the extent to which physicians must master all elicited features, remains ambiguous. Furthermore, the extent to which medical leadership entails a shift or a reallocation of tasks that are at the core of medical professional work remains unclear. Future studies should implement stronger research designs in which more theory is used to study the effect of medical leadership on professional work, medical staff governance, and subsequently, the quality and efficiency of care.	[Berghout, Mathilde A.; Fabbricotti, Isabelle N.; Buljac-Samardzic, Martina; Hilders, Carina G. J. M.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands	Erasmus University Rotterdam	Berghout, MA (corresponding author), Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands.	berghout@eshpm.eur.nl						Andersson T, 2015, LEADERSH HEALTH SERV, V28, P83, DOI 10.1108/LHS-04-2014-0032; Baker GR, 2011, PUBLIC MONEY MANAGE, V31, P355, DOI 10.1080/09540962.2011.598349; Barrable W, 1988, J Health Adm Educ, V6, P23; BETSON C, 1989, HOSP HEALTH SERV ADM, V34, P353; Blumenthal DM, 2012, ACAD MED, V87, P513, DOI 10.1097/ACM.0b013e31824a0c47; Buchanan D, 1997, J Manag Med, V11, P132, DOI 10.1108/02689239710177774; Chreim S, 2013, LEADERSHIP-LONDON, V9, P201, DOI 10.1177/1742715012468781; Dawson S., 1995, BRIT J MANAGE, V6, P169; Dedman GL, 2011, INT J CLIN LEADERSHI, V17, P61; Dine C Jessica, 2011, J Grad Med Educ, V3, P31, DOI 10.4300/JGME-D-10-00017.1; Doolin B, 2002, ORGAN STUD, V23, P369, DOI 10.1177/0170840602233003; Dwyer AJ, 2010, AUST HEALTH REV, V34, P506, DOI 10.1071/AH09750; Edmonstone J, 2009, INT J HEALTH PLAN M, V24, P290, DOI 10.1002/hpm.959; Evetts J, 2009, COMP SOCIOL, V8, P247, DOI 10.1163/156913309X421655; Frank JR, CANMEDS 2005 PHYS CO; Freidson E., 1994, PROFESSIONALISM REBO; Freidson E., 2001, PROFESSIONALISM 3 LO; Glouberman S, 2001, HEALTH CARE MANAGE R, V26, P56, DOI 10.1097/00004010-200101000-00006; Hallier J., 2005, EMPL RELAT, V27, P47; Ham C, 2011, J ROY SOC MED, V104, P113, DOI 10.1258/jrsm.2011.110042; Hoff TJ, 2000, SOC SCI MED, V50, P1433, DOI 10.1016/S0277-9536(99)00410-4; Holmboe Eric S, 2003, Jt Comm J Qual Saf, V29, P289; Hopkins MM, 2015, J MANAG DEV, V34, P566, DOI 10.1108/JMD-02-2014-0021; HUNTER DJ, 1992, SOC SCI MED, V35, P557, DOI 10.1016/0277-9536(92)90349-U; Kindig D A, 1989, J Health Adm Educ, V7, P33; Kippist Louise, 2009, J Health Organ Manag, V23, P642; Kuhlmann E, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1393-7; Leggat Sandra G, 2013, J Health Organ Manag, V27, P312; Leigh S, 1997, Health Manpow Manage, V23, P44, DOI 10.1108/09552069710166643; Llewellyn S, 2001, ORGAN STUD, V22, P593, DOI 10.1177/0170840601224003; McGivern G, 2015, PUBLIC ADMIN, V93, P412, DOI 10.1111/padm.12119; Meier N, 2015, J HEALTH ORGAN MANAG, V29, P1115, DOI 10.1108/JHOM-01-2014-0009; Mo Tone Opdahl, 2008, J Health Organ Manag, V22, P400, DOI 10.1108/14777260810893980; Murdoch-Eaton D, 2012, MED EDUC, V46, P120, DOI 10.1111/j.1365-2923.2011.04065.x; NHS Institute for Innovation and Improvement and Academy of Medical Royal Colleges, 2010, MED LEAD COMP FRAM E; Noordegraaf M., 2015, PUBLIC MANAG REV, V18, P1, DOI [DOI 10.1080/01916122.2014.988383, 10.1080/14719037.2015.1066416, DOI 10.1080/14719037.2015.1066416]; Northouse P. G., 2013, LEADERSHIP THEORY PR; Ong Bie Nio, 1998, BRIT J MANAGE, V9, P199, DOI DOI 10.1111/1467-8551.00084; Palmer R, 2009, INT J CLIN LEADERSHI, V16, P131; Pepermans R, 2001, INT J HEALTH PLAN M, V16, P281, DOI 10.1002/hpm.639; Platform Medisch Leiderschap, 2015, RAAMW MED LEID, V1, P16; Porter ME, 2007, JAMA-J AM MED ASSOC, V297, P1103, DOI 10.1001/jama.297.10.1103; Quinn JF, 2016, J HEALTH ORGAN MANAG, V30, P711, DOI 10.1108/JHOM-05-2015-0079; Robinson M, 2013, J SURG EDUC, V70, P606, DOI 10.1016/j.jsurg.2013.04.013; Rodgers M., 2006, GUIDANCE CONDUCT NAR, DOI DOI 10.13140/2.1.1018.4643; Rotar AM, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1396-4; Spehar I, 2015, J HEALTH ORGAN MANAG, V29, P353, DOI 10.1108/JHOM-03-2013-0047; Spurgeon P, 2015, LEADERSH HEALTH SERV, V28, P173, DOI 10.1108/LHS-03-2014-0029; Spyridonidis D, 2015, PUBLIC ADMIN, V93, P395, DOI 10.1111/padm.12114; Stoller JK, 2009, J GEN INTERN MED, V24, P876, DOI 10.1007/s11606-009-1007-8; Sutherland N., 2016, LEADERSHIP, V0, P1; Taylor CA, 2008, J GEN INTERN MED, V23, P748, DOI 10.1007/s11606-008-0565-5; Thomas A.B, 2005, CONTROVERSIES MANAGE; Thorne M L, 1997, J Manag Med, V11, P168; Thorne Marie L, 2002, Health Serv Manage Res, V15, P14, DOI 10.1258/0951484021912798; Thorne ML, 1997, HLTH SERVICES MANAGE, V10, P105; Vinot D, 2014, INT J PUBLIC SECT MA, V27, P406, DOI 10.1108/IJPSM-06-2012-0067; Warren OJ, 2011, POSTGRAD MED J, V87, P27, DOI 10.1136/pgmj.2009.093807; Willcocks S., 1995, J MANAGEMENT MED, V11, P181; Williams S J, 2001, J Health Adm Educ, V19, P195; Williams SJ, 1996, HEALTH CARE MANAGE R, V21, P29, DOI 10.1097/00004010-199605000-00005; Witman Y, 2011, ORGANIZATION, V18, P477, DOI 10.1177/1350508410380762	62	43	43	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184522	10.1371/journal.pone.0184522	http://dx.doi.org/10.1371/journal.pone.0184522			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910335	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200055
J	Bouvier, M; Durrieu, S; Gosselin, F; Herpigny, B				Bouvier, Marc; Durrieu, Sylvie; Gosselin, Frederic; Herpigny, Basile			Use of airborne lidar data to improve plant species richness and diversity monitoring in lowland and mountain forests	PLOS ONE			English	Article							ASSESSING BIODIVERSITY; UNDERSTORY VEGETATION; LAYER VEGETATION; STATISTICAL TEST; SOIL ACIDITY; MODELS; MANAGEMENT; STAND; AREA; METAANALYSIS	We explored the potential of airborne laser scanner (ALS) data to improve Bayesian models linking biodiversity indicators of the understory vegetation to environmental factors. Biodiversity was studied at plot level and models were built to investigate species abundance for the most abundant plants found on each study site, and for ecological group richness based on light preference. The usual abiotic explanatory factors related to climate, topography and soil properties were used in the models. ALS data, available for two contrasting study sites, were used to provide biotic factors related to forest structure, which was assumed to be a key driver of understory biodiversity. Several ALS variables were found to have significant effects on biodiversity indicators. However, the responses of biodiversity indicators to forest structure variables, as revealed by the Bayesian model outputs, were shown to be dependent on the abiotic environmental conditions characterizing the study areas. Lower responses were observed on the lowland site than on the mountainous site. In the latter, shade-tolerant and heliophilous species richness was impacted by vegetation structure indicators linked to light penetration through the canopy. However, to reveal the full effects of forest structure on biodiversity indicators, forest structure would need to be measured over much wider areas than the plot we assessed. It seems obvious that the forest structure surrounding the field plots can impact biodiversity indicators measured at plot level. Various scales were found to be relevant depending on: the biodiversity indicators that were modelled, and the ALS variable. Finally, our results underline the utility of lidar data in abundance and richness models to characterize forest structure with variables that are difficult to measure in the field, either due to their nature or to the size of the area they relate to.	[Bouvier, Marc; Durrieu, Sylvie] Irstea, UMR TETIS, 500 Rue Jean Francois Breton, Montpellier, France; [Bouvier, Marc] Info Geo Drones, Pepiniere Entreprises Versailles Grand Parc, Versailles, France; [Gosselin, Frederic; Herpigny, Basile] Irstea, UR EFNO, Domaine Barres, Nogent Sur Vernisson, France	AgroParisTech; INRAE; INRAE	Bouvier, M (corresponding author), Irstea, UMR TETIS, 500 Rue Jean Francois Breton, Montpellier, France.	marc.bouvier@gmx.com	; Durrieu, Sylvie/G-5601-2017	Bouvier, Marc/0000-0002-1565-9524; Gosselin, Frederic/0000-0003-3737-106X; Durrieu, Sylvie/0000-0001-6145-9614	French National Research Agency (ANR)	French National Research Agency (ANR)(French National Research Agency (ANR))	This research was supported by the French National Research Agency (ANR) Grant within the Framework of the BIOLID project (INDECO 2012) through the Carnot facility.; The authors thank the Agence nationale pour la gestion des dechets radioactifs (Andra) for providing the ALS dataset for the lowland site. We also thank the Institut National de l'Information Geographique et Forestiere (IGN), the Institut des sciences et industries du vivant et de l'environnement (AgroParisTech), and the Institut National de la Recherche Agronomique (INRA) for providing field inventories. This study would not have been possible without the availability of ALS data on the Mountain site from the FORESEE project (ANR- 2010-BIOE-008), supported by the French National Research Agency (ANR).	Al Bassatneh Marwan Cheikh, 2007, Ecologia Mediterranea, V33, P29; Allen RG, 1997, J HYDROL ENG, V2, P56, DOI 10.1061/(ASCE)1084-0699(1997)2:2(56); Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Axelsson P., 2000, INT ARCH PHOTOGRAMME, V33, P111; Baragatti M, 2013, STAT COMPUT, V23, P323, DOI 10.1007/s11222-012-9313-0; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Barbier S, 2009, FOREST ECOL MANAG, V258, pS176, DOI 10.1016/j.foreco.2009.09.004; Bontemps JD, 2014, FORESTRY, V87, P109, DOI 10.1093/forestry/cpt034; Bouvier M, 2015, REMOTE SENS ENVIRON, V156, P322, DOI 10.1016/j.rse.2014.10.004; Bradbury RB, 2005, IBIS, V147, P443, DOI 10.1111/j.1474-919x.2005.00438.x; Braun-blanquet J., 1932, PLANT SOCIOLOGY STUD, VFirst; Brosofske KD, 2001, FOREST ECOL MANAG, V146, P75, DOI 10.1016/S0378-1127(00)00447-3; Brunet J, 1996, FOREST ECOL MANAG, V88, P259, DOI 10.1016/S0378-1127(96)03845-5; Camp RJ, 2008, ECOLOGY, V89, P1469, DOI 10.1890/07-0462.1; Carey AB, 1991, SPRING BIRD COMMUNIT; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Coops NC, 2016, ECOL INDIC, V67, P346, DOI 10.1016/j.ecolind.2016.02.057; Dale M.R.T., 1999, SPATIAL PATTERN ANAL; Dixon PM, 2005, ECOLOGY, V86, P1751, DOI 10.1890/04-1343; Dubayah R, 2000, LAND SURFACE CHARACT, P25; Duguid MC, 2013, FOREST ECOL MANAG, V303, P81, DOI 10.1016/j.foreco.2013.04.009; Durrieu S, REMOTE SENS IN PRESS, V2; Ellenberg H., 1992, SCRIPTA GEOBOTANICA, V18, P1; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Gegout JC, 2005, J VEG SCI, V16, P257, DOI 10.1111/j.1654-1103.2005.tb02363.x; Gelman A., 2004, BAYESIAN DATA ANAL, V2; Getzin S, 2012, METHODS ECOL EVOL, V3, P397, DOI 10.1111/j.2041-210X.2011.00158.x; Gobakken T, 2009, CAN J FOREST RES, V39, P1036, DOI 10.1139/X09-025; Gorgens EB, 2015, ANN FOREST SCI, V72, P489, DOI 10.1007/s13595-015-0457-x; Gregory PC, 2011, MON NOT R ASTRON SOC, V410, P94, DOI 10.1111/j.1365-2966.2010.17428.x; Harrell FE, 2001, REGRESSION MODELING; Herpigny B, 2015, ECOL INFORM, V26, P18, DOI 10.1016/j.ecoinf.2014.12.002; Hopkinson C, 2009, REMOTE SENS ENVIRON, V113, P275, DOI 10.1016/j.rse.2008.09.012; Joly D, 2010, CYBERGEO, DOI 10.4000/cybergeo.23155; Julve P., 1998, INDEX BOTANIQUE ECOL; Lahde E, 1999, FOREST ECOL MANAG, V115, P213, DOI 10.1016/S0378-1127(98)00400-9; Lesak AA, 2011, REMOTE SENS ENVIRON, V115, P2823, DOI 10.1016/j.rse.2011.01.025; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Lexerod NL, 2006, FOREST ECOL MANAG, V222, P17, DOI 10.1016/j.foreco.2005.10.046; Lim K, 2003, CAN J REMOTE SENS, V29, P658, DOI 10.5589/m03-025; Lopatin J, 2014, GEOSCIENCE REMOTE SE, P1; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Magnusson M, 2007, FOREST SCI, V53, P619; MAJOR J, 1951, ECOLOGY, V32, P392, DOI 10.2307/1931718; MARTENS SN, 1993, FOREST ECOL MANAG, V61, P91, DOI 10.1016/0378-1127(93)90192-P; Muller J, 2014, FOREST ECOL MANAG, V312, P129, DOI 10.1016/j.foreco.2013.10.014; Muller J, 2009, J APPL ECOL, V46, P897, DOI 10.1111/j.1365-2664.2009.01677.x; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Richardson S, 2002, J ROY STAT SOC A STA, V165, P549, DOI 10.1111/1467-985X.00252; Roberts GO, 2007, J APPL PROBAB, V44, P458, DOI 10.1239/jap/1183667414; Simonson WD, 2012, CONSERV BIOL, V26, P840, DOI 10.1111/j.1523-1739.2012.01869.x; Spies TA, 1998, NORTHWEST SCI, V72, P34; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; TYLER G, 1989, FOREST ECOL MANAG, V28, P101, DOI 10.1016/0378-1127(89)90063-7; Vega C, 2016, REMOTE SENS ENVIRON, V175, P32, DOI 10.1016/j.rse.2015.12.039; Verrelst J, 2009, INT J APPL EARTH OBS, V11, P83, DOI 10.1016/j.jag.2008.09.001; Vrugt JA, 2009, INT J NONLIN SCI NUM, V10, P273, DOI 10.1515/IJNSNS.2009.10.3.273; Wei LP, 2015, FOREST ECOL MANAG, V338, P20, DOI 10.1016/j.foreco.2014.11.018; Wilkinson DJ, 2007, BRIEF BIOINFORM, V8, P109, DOI 10.1093/bib/bbm007; Wulder M, 1998, PROG PHYS GEOG, V22, P449, DOI 10.1177/030913339802200402; Zellweger F, 2014, BIODIVERS CONSERV, V23, P289, DOI 10.1007/s10531-013-0600-7; Zellweger F, 2013, FOREST ECOL MANAG, V307, P303, DOI [10.1016/j.foreco.2013.07.023, 10.1016/j.]; Zenner EK, 2008, FOREST ECOL MANAG, V256, P1785, DOI 10.1016/j.foreco.2008.05.030; Zilliox C, 2014, FOREST ECOL MANAG, V321, P105, DOI 10.1016/j.foreco.2013.07.049	64	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184524	10.1371/journal.pone.0184524	http://dx.doi.org/10.1371/journal.pone.0184524			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902920	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200043
J	Gupte, AN; Wong, ML; Msandiwa, R; Barnes, GL; Golub, J; Chaisson, RE; Hoffmann, CJ; Martinson, NA				Gupte, Akshay N.; Wong, Michelle L.; Msandiwa, Reginah; Barnes, Grace L.; Golub, Jonathan; Chaisson, Richard E.; Hoffmann, Christopher J.; Martinson, Neil A.			Factors associated with pulmonary impairment in HIV-infected South African adults	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CHRONIC RESPIRATORY-DISEASE; ANTIRETROVIRAL THERAPY ERA; TREATMENT START TRIAL; AIR-FLOW OBSTRUCTION; LUNG-FUNCTION; RISK-FACTORS; GENERAL-POPULATION; TUBERCULOSIS; COPD	Background HIV-infected individuals have increased risk of developing obstructive lung disease (OLD). Studies from developed countries report high viral load, low CD4 counts, and anti-retroviral therapy (ART) to be associated with OLD; but these findings may not be generalizable to populations in resource-limited settings. Methods We conducted a prospective cohort study of lung function in 730 HIV-infected black South African adults. Pre-bronchodilator spirometry was performed at enrollment and repeated annually for three years. Logistic regression models were used to identify factors associated with OLD, defined as FEV1/FVC < 0.70, at enrollment. Excess annual declines in FEV1 and FVC were modelled as the product-term of follow-up time and exposures using random effects regression. Results Median (IQR) age at enrollment was 36 (32-41) years, 85% were female and 30% ever-smoked with a median (IQR) exposure of 3 (1-6) pack-years. Median (IQR) CD4 count and viral load at enrollment were 372 (261-518) cells/mm(3) and 2655 (91-13,548) copies/mL respectively. Overall, 25% were receiving ART at enrollment, 16% of whom reported at least 6 months of ART receipt. OLD was found in 35 (5%) at enrollment. Increasing age (aOR = 2.08 per 10-years [95% CI 1.22-3.57], p = 0.007), current smoking (aOR = 3.55 [95% CI 1.20-10.53], p = 0.02), and CRP (aOR = 1.01 per unit-increase [95% CI 1.00-1.03], p = 0.04) were significantly associated with OLD at enrollment; while increasing CD4 count (aOR = 1.02 per-100 cells/mm(3) [95% CI 0.85-1.22], p = 0.82), viral load (aOR = 0.67 per log-increase [95% CI 0.43-1.10], p = 0.12) and receipt of ART (aOR = 0.57 [95% CI 0.18-1.75], p = 0.32) were not. The median (IQR) follow-up time was 18 (12-24) months. Participants with a history of tuberculosis (TB) had a 35 mL (95% CI 2-68, p = 0.03) and 57 mL (95% CI 19-96, p = 0.003) per year excess loss of FEV1 and FVC respectively. Conclusion Prevalent OLD was associated with older age, current smoking and higher CRP levels, but not CD4 counts and ART, in HIV-infected South African adults. Better understanding of the long-term effects of TB, smoking and inflammation on lung function in HIV-infected populations is urgently needed.	[Gupte, Akshay N.; Golub, Jonathan; Chaisson, Richard E.; Hoffmann, Christopher J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Gupte, Akshay N.] Johns Hopkins Univ, Sch Med, CCGHE, Baltimore, MD 21205 USA; [Wong, Michelle L.] Univ Witwatersrand, Chris Hani Baragwanath Acad Hosp, Johannesburg, South Africa; [Wong, Michelle L.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Msandiwa, Reginah; Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit PHRU, MRC Soweto Matlosana Collaborating Ctr HIV AIDS &, Johannesburg, South Africa; [Barnes, Grace L.; Golub, Jonathan; Chaisson, Richard E.; Hoffmann, Christopher J.; Martinson, Neil A.] Johns Hopkins Univ, Sch Med, Ctr TB Res, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; Johns Hopkins University	Gupte, AN (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.; Gupte, AN (corresponding author), Johns Hopkins Univ, Sch Med, CCGHE, Baltimore, MD 21205 USA.	agupte1@jhmi.edu			National Institutes of Health [R01HL090312, P30A1094189]; Ujala Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ujala Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Participant recruitment and followup was funded by the National Institutes of Health grants R01HL090312 and P30A1094189. AG received salary support from the Ujala Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti A, 2008, COPD, V5, P133, DOI 10.1080/15412550801941349; Ahmadi-Abhari S, 2014, AM J EPIDEMIOL, V179, P48, DOI 10.1093/aje/kwt208; Akkara SA, 2013, INT J TUBERC LUNG D, V17, P810, DOI 10.5588/ijtld.12.0317; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Banu Rekha V V, 2009, Indian J Tuberc, V56, P132; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; BURROWS B, 1987, NEW ENGL J MED, V317, P1309, DOI 10.1056/NEJM198711193172103; Byrne AL, 2015, INT J INFECT DIS, V32, P138, DOI 10.1016/j.ijid.2014.12.016; Celli BR, 2003, EUR RESPIR J, V22, P268, DOI 10.1183/09031936.03.00075102; Chung KP, 2011, CLINICS, V66, P549, DOI 10.1590/S1807-59322011000400005; Cosio MG, 2009, NEW ENGL J MED, V360, P2445, DOI 10.1056/NEJMra0804752; Cribbs SK, 2016, SEMIN RESP CRIT CARE, V37, P157, DOI 10.1055/s-0036-1572554; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Diaz PT, 2000, ANN INTERN MED, V132, P369, DOI 10.7326/0003-4819-132-5-200003070-00006; Drummond MB, 2012, THORAX, V67, P309, DOI 10.1136/thoraxjnl-2011-200702; Drummond MB, 2013, AIDS, V27, P1303, DOI 10.1097/QAD.0b013e32835e395d; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Georgia, 2012, GLOBAL AIDS RESPONSE; Gershon AS, 2011, LANCET, V378, P991, DOI 10.1016/S0140-6736(11)60990-2; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Golub JE, 2009, AIDS, V23, P631, DOI 10.1097/QAD.0b013e328327964f; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Harries AD, 2016, INT J TUBERC LUNG D, V20, P1010, DOI 10.5588/ijtld.16.0277; Hnizdo E, 2000, THORAX, V55, P32, DOI 10.1136/thorax.55.1.32; Hooper R, 2012, EUR RESPIR J, V39, P1343, DOI 10.1183/09031936.00002711; Ko Y, 2015, INT J TUBERC LUNG D, V19, P589, DOI 10.5588/ijtld.14.0454; Kunisaki KM, 2015, HIV MED, V16, P119, DOI 10.1111/hiv.12240; Kunisaki KM, 2016, LANCET RESP MED, V4, P980, DOI 10.1016/S2213-2600(16)30319-8; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Madeddu G, 2013, INFECTION, V41, P347, DOI 10.1007/s15010-012-0330-x; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Menezes AMB, 2007, EUR RESPIR J, V30, P1180, DOI 10.1183/09031936.00083507; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MOKOETLE KE, 1994, THORAX, V49, P340, DOI 10.1136/thx.49.4.340; Morris Alison, 2011, Proc Am Thorac Soc, V8, P320, DOI 10.1513/pats.201006-045WR; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Nakamura H, 2014, J INFECT CHEMOTHER, V20, P361, DOI 10.1016/j.jiac.2014.02.001; Ngahane BHM, 2016, RESP MED, V114, P67, DOI 10.1016/j.rmed.2016.03.007; Osman RK, 2016, PUBLIC HEALTH ACTION, V6, P199, DOI 10.5588/pha.16.0030; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pefura-Yone EW, 2015, RESP MED, V109, P247, DOI 10.1016/j.rmed.2014.12.003; Pelkonen M, 2001, THORAX, V56, P703, DOI 10.1136/thorax.56.9.703; Radovic M, 2016, INT J CHRONIC OBSTR, V11, P1307, DOI 10.2147/COPD.S106875; Rasmussen F, 2009, EUR RESPIR J, V33, P382, DOI 10.1183/09031936.00040708; Rennard SI, 2006, LANCET, V367, P1216, DOI 10.1016/S0140-6736(06)68516-4; Rennard Stephen I, 2008, Proc Am Thorac Soc, V5, P878, DOI 10.1513/pats.200804-035QC; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Saetta M, 1998, AM J RESP CRIT CARE, V157, P822, DOI 10.1164/ajrccm.157.3.9709027; Samperiz G, 2014, HIV MED, V15, P321, DOI 10.1111/hiv.12117; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Twigg HL, 1999, AM J RESP CRIT CARE, V159, P1439, DOI 10.1164/ajrccm.159.5.9808031; UNAIDS, 2016, GLOB AIDS UPD; van Durme YMTA, 2009, AM J RESP CRIT CARE, V179, P375, DOI 10.1164/rccm.200810-1540OC; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Wallis RS, 2015, NAT REV IMMUNOL, V15, P255, DOI 10.1038/nri3813; Zumla A, 2015, J INTERN MED, V277, P373, DOI 10.1111/joim.12256	62	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184530	10.1371/journal.pone.0184530	http://dx.doi.org/10.1371/journal.pone.0184530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902919	gold, Green Published, Green Submitted			2022-12-27	WOS:000410669200044
J	Zanolli, C; Hourset, M; Esclassan, R; Mollereau, C				Zanolli, Clement; Hourset, Mathilde; Esclassan, Remi; Mollereau, Catherine			Neanderthal and Denisova tooth protein variants in present-day humans	PLOS ONE			English	Article							ENAMEL-DENTIN JUNCTION; AMELOGENESIS IMPERFECTA; STRUCTURAL ORGANIZATION; EVOLUTIONARY ANALYSIS; PLEISTOCENE SITE; GENOME SEQUENCE; THICKNESS; MOLAR; GENE; AMELOBLASTIN	Environment parameters, diet and genetic factors interact to shape tooth morphostructure. In the human lineage, archaic and modern hominins show differences in dental traits, including enamel thickness, but variability also exists among living populations. Several polymorphisms, in particular in the non-collagenous extracellular matrix proteins of the tooth hard tissues, like enamelin, are involved in dental structure variation and defects and may be associated with dental disorders or susceptibility to caries. To gain insights into the relationships between tooth protein polymorphisms and dental structural morphology and defects, we searched for non-synonymous polymorphisms in tooth proteins from Neanderthal and Denisova hominins. The objective was to identify archaic-specific missense variants that may explain the dental morphostructural variability between extinct and modern humans, and to explore their putative impact on present-day dental phenotypes. Thirteen non-collagenous extracellular matrix proteins specific to hard dental tissues have been selected, searched in the publicly available sequence databases of Neanderthal and Denisova individuals and compared with modern human genome data. A total of 16 non-synonymous polymorphisms were identified in 6 proteins (ameloblastin, amelotin, cementum protein 1, dentin matrix acidic phosphoprotein 1, enamelin and matrix Gla protein). Most of them are encoded by dentin and enamel genes located on chromosome 4, previously reported to show signs of archaic introgression within Africa. Among the variants shared with modern humans, two are ancestral (common with apes) and one is the derived enamelin major variant, T648I (rs7671281), associated with a thinner enamel and specific to the Homo lineage. All the others are specific to Neanderthals and Denisova, and are found at a very low frequency in modern Africans or East and South Asians, suggesting that they may be related to particular dental traits or disease susceptibility in these populations. This modern regional distribution of archaic dental polymorphisms may reflect persistence of archaic variants in some populations and may contribute in part to the geographic dental variations described in modern humans.	[Zanolli, Clement; Hourset, Mathilde; Esclassan, Remi; Mollereau, Catherine] Univ Toulouse, CNRS, UMR5288, Lab Anthropol Mol & Imagerie Synth AMIS, Toulouse, France; [Hourset, Mathilde; Esclassan, Remi] Univ Toulouse, Fac Chirurg Dentaire, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse	Zanolli, C; Mollereau, C (corresponding author), Univ Toulouse, CNRS, UMR5288, Lab Anthropol Mol & Imagerie Synth AMIS, Toulouse, France.	clement.zanolli@gmail.com; catherine.mollereau-manaute@ipbs.fr	Esclassan, Remi/K-5651-2019; esclassan, remi/ACX-5520-2022	Esclassan, Remi/0000-0002-6605-9967; Mollereau, Catherine/0000-0003-1543-5624; Zanolli, Clement/0000-0002-5617-1613	CNRS; IFRO; CNRS (PEPS)	CNRS(Centre National de la Recherche Scientifique (CNRS)); IFRO; CNRS (PEPS)(Centre National de la Recherche Scientifique (CNRS))	The authors received funding from the CNRS and IFRO.	Al-Hashimi N, 2009, J MOL EVOL, V69, P635, DOI 10.1007/s00239-009-9302-x; Alliot-Licht B, 2015, CR BIOL, V338, P48, DOI 10.1016/j.crvi.2014.10.001; Arnaud J, 2017, AM J PHYS ANTHROPOL, V162, P370, DOI 10.1002/ajpa.23111; Arzate H, 2015, PERIODONTOL 2000, V67, P211, DOI 10.1111/prd.12062; Bailey SE, 2013, ANTHR PERSPECTIVES T, P222, DOI DOI 10.1017/CBO9780511984464.010; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; Bei M, 2009, CURR OPIN GENET DEV, V19, P504, DOI 10.1016/j.gde.2009.09.002; Castellano S, 2014, P NATL ACAD SCI USA, V111, P6666, DOI 10.1073/pnas.1405138111; Castiblanco GA, 2015, EUR J ORAL SCI, V123, P390, DOI 10.1111/eos.12214; Chan HC, 2010, J DENT RES, V89, P695, DOI 10.1177/0022034510365662; Chaussain C, 2014, J DENT RES, V93, P360, DOI 10.1177/0022034514522060; Daubert DM, 2016, INT J ORAL SCI, V8, P93, DOI 10.1038/ijos.2016.1; Delsuc F, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0431-0; Dogan GE, 2016, ARCH ORAL BIOL, V70, P125, DOI 10.1016/j.archoralbio.2016.06.014; Feeney RNM, 2010, ANTHROPOL SCI, V118, P191, DOI 10.1537/ase.091006; Gadhia K, 2012, BRIT DENT J, V212, P377, DOI 10.1038/sj.bdj.2012.314; Gao B, 2007, J UROLOGY, V177, P2361, DOI 10.1016/j.juro.2007.01.118; Gasse B, 2012, J DENT RES, V91, P1085, DOI 10.1177/0022034512460551; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Guy F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138802; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Hanihara T, 2008, AM J PHYS ANTHROPOL, V136, P169, DOI 10.1002/ajpa.20792; Harjunmaa E, 2014, NATURE, V512, P44, DOI 10.1038/nature13613; Harris EF, 2001, AM J PHYS ANTHROPOL, V115, P223, DOI 10.1002/ajpa.1077; Hart TC, 2003, J MED GENET, V40, P900, DOI 10.1136/jmg.40.12.900; Herrero J, 2016, DATABASE; Horvath JE, 2014, J HUM EVOL, V73, P75, DOI 10.1016/j.jhevol.2014.01.005; Hsieh P, 2016, GENOME RES, V26, P291, DOI 10.1101/gr.196634.115; Jagr M, 2014, PHYSIOL RES, V63, pS141, DOI 10.33549/physiolres.932702; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Kato A, 2014, AM J PHYS ANTHROPOL, V155, P447, DOI 10.1002/ajpa.22593; Kelley JL, 2008, GENETICS, V178, P1595, DOI 10.1534/genetics.107.077123; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kimura R, 2009, AM J HUM GENET, V85, P528, DOI 10.1016/j.ajhg.2009.09.006; Lopez-Valenzuela M, 2012, MOL BIOL EVOL, V29, P1797, DOI 10.1093/molbev/mss023; Lu XL, 2012, GENE, V511, P127, DOI 10.1016/j.gene.2012.09.112; Lu YF, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a008581; Macchiarelli R, 2006, NATURE, V444, P748, DOI 10.1038/nature05314; Macchiarelli R, 2009, GEODIVERSITAS, V31, P851, DOI 10.5252/g2009n4a851; Marcus JH, 2016, BIOINFORMATICS; Martin RMG, 2017, J HUM EVOL, V103, P20, DOI 10.1016/j.jhevol.2016.12.004; de Pinillos MM, 2014, CR PALEVOL, V13, P205, DOI 10.1016/j.crpv.2013.10.008; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; McKnight DA, 2008, HUM MUTAT, V29, P1392, DOI 10.1002/humu.20783; Meyer M, 2016, NATURE, V531, P504, DOI 10.1038/nature17405; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Nielsen R, 2017, NATURE, V541, P302, DOI 10.1038/nature21347; Olejniczak AJ, 2008, BIOL LETTERS, V4, P406, DOI 10.1098/rsbl.2008.0223; Olejniczak AJ, 2008, J HUM EVOL, V55, P12, DOI 10.1016/j.jhevol.2007.11.004; Opal S, 2015, AUST DENT J, V60, P2, DOI 10.1111/adj.12262; Paabo S, 2014, CELL, V157, P216, DOI 10.1016/j.cell.2013.12.036; Pampush JD, 2013, J HUM EVOL, V64, P216, DOI 10.1016/j.jhevol.2013.01.009; Pan L, 2016, J HUM EVOL, V96, P82, DOI 10.1016/j.jhevol.2016.05.003; Park JH, 2012, J HUM GENET, V57, P508, DOI 10.1038/jhg.2012.60; Poulter JA, 2014, HUM MOL GENET, V23, P5317, DOI 10.1093/hmg/ddu247; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; Sankararaman S, 2016, CURR BIOL, V26, P1241, DOI 10.1016/j.cub.2016.03.037; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Sawyer S, 2015, P NATL ACAD SCI USA, V112, P15696, DOI 10.1073/pnas.1519905112; Scott RG, 1997, ANTHR MODERN HUMAN T, P1; Seow WK, 2014, AUST DENT J, V59, P143, DOI 10.1111/adj.12104; Silvent J, 2013, J MOL EVOL, V76, P59, DOI 10.1007/s00239-013-9539-2; Skinner MM, 2008, J HUM EVOL, V54, P173, DOI 10.1016/j.jhevol.2007.09.012; Skinner MM, 2015, J HUM EVOL, V85, P35, DOI 10.1016/j.jhevol.2015.03.012; Smith CE, 2009, EUR J ORAL SCI, V117, P485, DOI 10.1111/j.1600-0722.2009.00666.x; Smith CEL, 2016, HUM MOL GENET, V25, P3578, DOI 10.1093/hmg/ddw203; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Smith TM, 2010, P NATL ACAD SCI USA, V107, P20923, DOI 10.1073/pnas.1010906107; Suryadeva S, 2015, J CLIN DIAGN RES, V9, pZE9, DOI 10.7860/JCDR/2015/11067.5606; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Wright JT, 2009, CELLS TISSUES ORGANS, V189, P224, DOI 10.1159/000151378; Yoshizaki K, 2013, ORTHOD WAVES, V72, P1, DOI 10.1016/j.odw.2013.01.040; Zanolli C, 2017, AM J PHYS ANTHROPOL, V162, P533, DOI 10.1002/ajpa.23135; Zanolli C, 2015, AM J PHYS ANTHROPOL, V156, P148, DOI 10.1002/ajpa.22611; Zanolli C, 2014, J HUM EVOL, V74, P96, DOI 10.1016/j.jhevol.2014.04.005; Zanolli C, 2013, CR PALEVOL, V12, P293, DOI 10.1016/j.crpv.2013.06.004; Zilberman U, 2004, J HUM EVOL, V46, P647, DOI 10.1016/j.jhevol.2004.02.005	80	13	13	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183802	10.1371/journal.pone.0183802	http://dx.doi.org/10.1371/journal.pone.0183802			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902892	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200017
J	Sharma-Poudyal, D; Schlatter, D; Yin, CT; Hulbert, S; Paulitz, T				Sharma-Poudyal, Dipak; Schlatter, Daniel; Yin, Chuntao; Hulbert, Scot; Paulitz, Timothy			Long-term no-till: A major driver of fungal communities in dryland wheat cropping systems	PLOS ONE			English	Article							CONSERVATION TILLAGE; PACIFIC-NORTHWEST; CROWN ROT; MICROBIAL BIOMASS; UNITED-STATES; SOIL-EROSION; COVER CROP; MANAGEMENT; DIVERSITY; CHINA	In the dryland Pacific Northwest wheat cropping systems, no-till is becoming more prevalent as a way to reduce soil erosion and fuel inputs. Tillage can have a profound effect on microbial communities and soilborne fungal pathogens, such as Rhizoctonia. We compared the fungal communities in long-term no-till (NT) plots adjacent to conventionally tilled (CT) plots, over three years at two locations in Washington state and one location in Idaho, US. We used pyrosequencing of the fungal ITS gene and identified 422 OTUs after rarefication. Fungal richness was higher in NT compared to CT, in two of the locations. Humicola nigrescens, Cryptococcus terreus, Cadophora spp. Hydnodontaceae spp., and Exophiala spp. were more abundant in NT, while species of Glarea, Coniochaetales, Mycosphaerella tassiana, Cryptococcus bhutanensis, Chaetomium perlucidum, and Ulocladium chartarum were more abundant in CT in most locations. Other abundant groups that did not show any trends were Fusarium, Mortierella, Penicillium, Aspergillus, and Macroventuria. Plant pathogens such as Rhizoctonia (Ceratobasidiaceae) were not abundant enough to see tillage differences, but Microdochium bolleyi, a weak root pathogen, was more abundant in NT. Our results suggest that NT fungi are better adapted at utilizing intact, decaying roots as a food source and may exist as root endophytes. CT fungi can utilize mature plant residues that are turned into the soil with tillage as pioneer colonizers, and then produce large numbers of conidia. But a larger proportion of the fungal community is not affected by tillage and may be niche generalists.	[Sharma-Poudyal, Dipak] Oregon Dept Agr, Salem, OR USA; [Schlatter, Daniel; Paulitz, Timothy] USDA ARS, Wheat Hlth, Genet & Qual Res Unit, Pullman, WA 99164 USA; [Yin, Chuntao; Hulbert, Scot; Paulitz, Timothy] Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University	Paulitz, T (corresponding author), USDA ARS, Wheat Hlth, Genet & Qual Res Unit, Pullman, WA 99164 USA.; Paulitz, T (corresponding author), Washington State Univ, Dept Plant Pathol, Pullman, WA 99164 USA.	timothy.paulitz@ars.usda.gov		Paulitz, Timothy/0000-0002-8885-3803	USDA-ARS; REACCH (Regional Approaches to Climate Change Pacific Northwest Agriculture) from USDA National Institute for Food and Agriculture [2011-68002-30191]; USDA-ARS Postdoctoral Research Associate Program	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); REACCH (Regional Approaches to Climate Change Pacific Northwest Agriculture) from USDA National Institute for Food and Agriculture; USDA-ARS Postdoctoral Research Associate Program	This study was supported by USDA-ARS base funding to corresponding author's CRIS; and REACCH (Regional Approaches to Climate Change Pacific Northwest Agriculture) award #2011-68002-30191 from USDA National Institute for Food and Agriculture. Support for the second author was from USDA-ARS Postdoctoral Research Associate Program.	Agusti-Brisach C, 2013, PLANT SOIL, V364, P5, DOI 10.1007/s11104-012-1333-1; Alberton O, 2010, PLANT SOIL, V328, P459, DOI 10.1007/s11104-009-0125-8; Aveskamp MM, 2010, STUD MYCOL, P1, DOI 10.3114/sim.2010.65.01; Bills GF, 1999, MYCOL RES, V103, P179, DOI 10.1017/S095375629800687X; Botha A, 2011, SOIL BIOL BIOCHEM, V43, P1, DOI 10.1016/j.soilbio.2010.10.001; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Cannon PF, 2007, FUNGAL FAMILIES WORL; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cummings JA, 2015, PLANT DIS, V99, P1284, DOI 10.1094/PDIS-10-14-1002-PDN; Degrune F, 2016, AGR ECOSYST ENVIRON, V224, P12, DOI 10.1016/j.agee.2016.03.017; Derpsch Rolf, 2010, International Journal of Agricultural and Biological Engineering, V3, P1, DOI 10.3965/j.issn.1934-6344.2010.01.001-025; Detheridge AP, 2016, AGR ECOSYST ENVIRON, V228, P49, DOI 10.1016/j.agee.2016.04.022; Eichorst SA, 2012, APPL ENVIRON MICROB, V78, P2316, DOI 10.1128/AEM.07313-11; Fernandez MR, 2007, CAN J PLANT SCI, V87, P953, DOI 10.4141/CJPS07005; Fernandez MR, 2009, CAN J PLANT SCI, V89, P549, DOI 10.4141/CJPS08091; Gonzalez-Chavez MDA, 2010, SOIL TILL RES, V106, P285, DOI 10.1016/j.still.2009.11.008; Govaerts B, 2008, APPL SOIL ECOL, V38, P197, DOI 10.1016/j.apsoil.2007.10.009; Helgason BL, 2010, SOIL BIOL BIOCHEM, V42, P2192, DOI 10.1016/j.soilbio.2010.08.015; Hosseini-Nasabnia Z, 2016, CAN J PLANT PATHOL, V38, P325, DOI 10.1080/07060661.2016.1228697; Huggins DR, 2008, SCI AM; Jangid K, 2011, SOIL BIOL BIOCHEM, V43, P2184, DOI 10.1016/j.soilbio.2011.06.022; Jiang X, 2011, APPL SOIL ECOL, V48, P168, DOI 10.1016/j.apsoil.2011.03.009; Johnson-Maynard JL, 2007, SOIL TILL RES, V94, P338, DOI 10.1016/j.still.2006.08.011; Kendrick B, 2011, GENERA HYPHOMYCETES; Khastini RO, 2014, EUR J PLANT PATHOL, V139, P333, DOI 10.1007/s10658-014-0389-6; KNUDSEN IMB, 1995, PLANT PATHOL, V44, P467, DOI 10.1111/j.1365-3059.1995.tb01669.x; Kwon-Chung KJ, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019760; Lal R, 2007, SOIL TILL RES, V93, P1, DOI 10.1016/j.still.2006.11.004; LeBlanc N, 2017, MYCOLOGIA, V109, P128, DOI 10.1080/00275514.2017.1281697; Lynch MDJ, 2006, APPL ENVIRON MICROB, V72, P7050, DOI 10.1128/AEM.00826-06; Mbuthia LW, 2015, SOIL BIOL BIOCHEM, V89, P24, DOI 10.1016/j.soilbio.2015.06.016; Montgomery DR, 2007, P NATL ACAD SCI USA, V104, P13268, DOI 10.1073/pnas.0611508104; Murugan R, 2014, BIOL FERT SOILS, V50, P487, DOI 10.1007/s00374-013-0871-x; Nallanchakravarthula S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111455; Paulitz TC, 2002, CAN J PLANT PATHOL, V24, P416; Penton CR, 2014, PLOS ONE, V9, P1, DOI DOI 10.1038/NMETH.F.303; Poll C, 2010, MICROB ECOL, V59, P130, DOI 10.1007/s00248-009-9541-9; Poole GJ, 2013, PHYTOPATHOLOGY, V103, P1130, DOI 10.1094/PHYTO-07-12-0181-R; Ritz K., 2004, Mycologist, V18, P52, DOI 10.1017/S0269915X04002010; Sale V, 2015, SOIL BIOL BIOCHEM, V84, P38, DOI 10.1016/j.soilbio.2015.02.005; Schillinger WF, 2014, PLANT DIS, V98, P389, DOI 10.1094/PDIS-04-13-0420-RE; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schroeder KL, 2006, PLANT DIS, V90, P1247, DOI 10.1094/PD-90-1247; Schroeder KL, 2004, DISSERTATION; Smiley RW, 2005, PLANT DIS, V89, P595, DOI 10.1094/PD-89-0595; Taheri AE, 2015, FUNGAL ECOL, V15, P73, DOI 10.1016/j.funeco.2015.03.005; Team RC, 2016, R LANG ENV STAT COMP; Tiscornia S, 2009, CRYPTOGAMIE MYCOL, V30, P363; Turrini A, 2016, BIOL FERT SOILS, V52, P643, DOI 10.1007/s00374-016-1106-8; United States Department of Agriculture, 2012, 2012 CENS AGR HIGHL; Uri ND, 1999, J SUSTAIN AGR, V14, P63, DOI 10.1300/J064v14n02_07; Vishniac HS, 2006, MICROB ECOL, V52, P90, DOI 10.1007/s00248-006-9066-4; Wang ZT, 2016, APPL SOIL ECOL, V101, P132, DOI 10.1016/j.apsoil.2016.02.002; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wortmann CS, 2008, AGRON J, V100, P1681, DOI 10.2134/agronj2007.0317; Yarwood SA, 2010, MICROB ECOL, V60, P606, DOI 10.1007/s00248-010-9675-9; Yin CT, 2017, PHYTOBIOMES J, V1, P83, DOI 10.1094/PBIOMES-09-16-0008-R; Yin CT, 2013, APPL ENVIRON MICROB, V79, P7428, DOI 10.1128/AEM.01610-13; Young IM, 2000, SOIL TILL RES, V53, P201, DOI 10.1016/S0167-1987(99)00106-3; Yurkov AM, 2012, FUNGAL ECOL, V5, P24, DOI 10.1016/j.funeco.2011.07.004; Zhang SX, 2015, SOIL TILL RES, V149, P46, DOI 10.1016/j.still.2015.01.001; Zhang XX, 2015, PLANT DIS, V99, P1610, DOI 10.1094/PDIS-04-14-0422-RE	62	37	39	7	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184611	10.1371/journal.pone.0184611	http://dx.doi.org/10.1371/journal.pone.0184611			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898288	Green Submitted, Green Published, gold			2022-12-27	WOS:000410449500037
J	Ajorloo, F; Vaezi, M; Saadat, A; Safaee, SR; Gharib, B; Ghanei, M; Siadat, SD; Vaziri, F; Fateh, A; Pazhouhandeh, M; Vaziri, B; Moazemi, R; Mahboudi, F; Jamnani, FR				Ajorloo, Faezeh; Vaezi, Mohammad; Saadat, Alireza; Safaee, Seyed Reza; Gharib, Behrouz; Ghanei, Mostafa; Siadat, Seyed Davar; Vaziri, Farzam; Fateh, Abolfazl; Pazhouhandeh, Mehrdad; Vaziri, Behrouz; Moazemi, Reza; Mahboudi, Fereidoun; Jamnani, Fatemeh Rahimi			A systems medicine approach for finding target proteins affecting treatment outcomes in patients with non-Hodgkin lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMA; TOPOISOMERASE-II-ALPHA; CHOP-LIKE CHEMOTHERAPY; SIGNALING PATHWAYS; MAST-CELLS; PERIPHERAL NEUROPATHY; NEGATIVE REGULATOR; SOMATIC MUTATIONS; MYELOID-LEUKEMIA; TUMOR-SUPPRESSOR	Autoantibody profiling with a systems medicine approach can help identify critical dysregulated signaling pathways (SPs) in cancers. In this way, immunoglobulins G (IgG) purified from the serum samples of 92 healthy controls, 10 pre-treated (PR) non-Hodgkin lymphoma (NHL) patients, and 20 NHL patients who underwent chemotherapy (PS) were screened with a phage-displayed random peptide library. Protein-protein interaction networks of the PR and PS groups were analyzed and visualized by Gephi. The results indicated AXIN2, SENP2, TOP2A, FZD6, NLK, HDAC2, HDAC1, and EHMT2, in addition to CAMK2A, PLCG1, PLCG2, GRM5, GRIN2B, GRIN2D, CACNA2D3, and SPTAN1 as hubs in 11 and 7 modules of PR and PS networks, respectively. PR-and PS-specific hubs were evaluated in the Kyoto Encyclopedia of Genes and Genomes (KEGG) and Reactome databases. The PR-specific hubs were involved in Wnt SP, signaling by Notch1 in cancer, telomere maintenance, and transcriptional misregulation. In contrast, glutamate receptor SP, Fc receptor-related pathways, growth factors-related SPs, and Wnt SP were statistically significant enriched pathways, based on the pathway analysis of PS hubs. The results revealed that the most PR-specific proteins were associated with events involved in tumor development, while chemotherapy in the PS group was associated with side effects of drugs and/or cancer recurrence. As the findings demonstrated, PR-and PS-specific proteins in this study can be promising therapeutic targets in future studies.	[Ajorloo, Faezeh] Islamic Azad Univ, East Tehran Branch, Fac Sci, Dept Biol, Tehran, Iran; [Ajorloo, Faezeh; Ghanei, Mostafa; Siadat, Seyed Davar; Vaziri, Farzam; Fateh, Abolfazl; Pazhouhandeh, Mehrdad; Jamnani, Fatemeh Rahimi] Pasteur Inst Iran, Innovat Ctr, Human Antibody Lab, Tehran, Iran; [Vaezi, Mohammad] Univ Tehran Med Sci, Hematol Oncol & Stem Cell Transplantat Res Ctr, Tehran, Iran; [Saadat, Alireza] Baqiyatallah Univ Med Sci, Dept Hematol & Oncol, Tehran, Iran; [Safaee, Seyed Reza] Univ Tehran Med Sci, Hematol & Oncol Res Ctr, Imam Khomeini Hosp Complex, Tehran, Iran; [Gharib, Behrouz] Qom Univ Med Sci, Dept Internal Med Hematol & Oncol, Qom, Iran; [Ghanei, Mostafa] Baqiyatallah Univ Med Sci, Chem Injuries Res Ctr, Tehran, Iran; [Siadat, Seyed Davar; Vaziri, Farzam; Fateh, Abolfazl; Jamnani, Fatemeh Rahimi] Pasteur Inst Iran, Dept Mycobacteriol & Pulm Res, Microbiol Res Ctr, Tehran, Iran; [Vaziri, Behrouz; Moazemi, Reza; Mahboudi, Fereidoun] Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran	Islamic Azad University; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Tehran University of Medical Sciences; Baqiyatallah University of Medical Sciences (BMSU); Tehran University of Medical Sciences; Baqiyatallah University of Medical Sciences (BMSU); Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Jamnani, FR (corresponding author), Pasteur Inst Iran, Innovat Ctr, Human Antibody Lab, Tehran, Iran.; Jamnani, FR (corresponding author), Pasteur Inst Iran, Dept Mycobacteriol & Pulm Res, Microbiol Res Ctr, Tehran, Iran.	Rahimi@pasteur.ac.ir	Fateh, Abolfazl/K-9507-2017; Rahimi Jamnani, Fatemeh/F-2752-2015; saadat, Alireza Reza/AHE-0812-2022; Siadat, Seyed Davar/A-2204-2012; Vaziri, Farzam/K-9535-2017; rahimi, fatemeh/HCH-7193-2022; Vaziri, Behrouz/B-4619-2009; Ghanei, Mostafa/V-1975-2019; Pazhouhandeh, Mehrdad/ABE-3323-2021	Fateh, Abolfazl/0000-0002-2043-8523; Rahimi Jamnani, Fatemeh/0000-0001-7172-8435; saadat, Alireza Reza/0000-0003-4192-0391; Siadat, Seyed Davar/0000-0002-6892-5603; Vaziri, Farzam/0000-0001-7788-2548; Ghanei, Mostafa/0000-0001-9372-0928; 	Iran National Science Foundation [92002095]	Iran National Science Foundation(Iran National Science Foundation (INSF))	This work was supported by grants from the Iran National Science Foundation (grant number 92002095).	Abbas S, 2014, HAEMATOLOGICA, V99, P848, DOI 10.3324/haematol.2013.095604; Ansari-Pour N, 2016, J PROTEOME RES, V15, P1011, DOI 10.1021/acs.jproteome.5b01080; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Beckham TH, 2013, ADV CANCER RES, V117, P1, DOI 10.1016/B978-0-12-394274-6.00001-7; Bilici A, 2012, J BUON, V17, P502; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bonavida B, 2007, ONCOGENE, V26, P3629, DOI 10.1038/sj.onc.1210365; Bower JE, 2014, NAT REV CLIN ONCOL, V11, P597, DOI 10.1038/nrclinonc.2014.127; BRISTOW MR, 1980, J CARDIOVASC PHARM, V2, P487, DOI 10.1097/00005344-198009000-00002; Bruntz RC, 2014, PHARMACOL REV, V66, P1033, DOI 10.1124/pr.114.009217; Burger R, 2013, TRANSFUS MED HEMOTH, V40, P336, DOI 10.1159/000354194; Canta A, 2015, TOXICS, V3, P198, DOI 10.3390/toxics3020198; Chen T, 2015, ONCOGENE, V34, P4019, DOI 10.1038/onc.2014.332; Chung SS, 2010, MOL CELL BIOL, V30, P2135, DOI 10.1128/MCB.00852-09; Crisafulli C, 2015, PROG NEURO-PSYCHOPH, V59, P21, DOI 10.1016/j.pnpbp.2014.12.009; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; de Oliveira GP, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00216; de Sa Rodrigues LC, 2015, VET COMP ONCOLOGY; Debroas E, 2015, AIMS MOL SCI, V2, P175, DOI 10.3934/molsci.2015.2.175; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Ding J, 2013, CELL METAB, V18, P896, DOI 10.1016/j.cmet.2013.11.004; Diouf B, 2015, JAMA-J AM MED ASSOC, V313, P815, DOI 10.1001/jama.2015.0894; Dubielecka PM, 2005, BIOCHEM PHARMACOL, V69, P73, DOI 10.1016/j.bcp.2004.08.031; Elbaz Osama A-G HA, 2014, INT J CANC RES, V10, P96, DOI DOI 10.3923/IJCR.2014.96.105; Fatemi M, 2014, CANCER-AM CANCER SOC, V120, P172, DOI 10.1002/cncr.28316; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Fisher RI, 2003, LEUKEMIA, V17, P1948, DOI 10.1038/sj.leu.2403096; Friedberg JW, 2011, HEMATOL-AM SOC HEMAT, P498, DOI 10.1182/asheducation-2011.1.498; Gao YJ, 2013, BIOMED REP, V1, P47, DOI 10.3892/br.2012.9; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Golan T, 2004, J BIOL CHEM, V279, P14879, DOI 10.1074/jbc.M306421200; Grabarczyk P, 2007, ONCOGENE, V26, P3797, DOI 10.1038/sj.onc.1210152; Guo R, 2011, J CLIN ONCOL, V29, pE257, DOI 10.1200/JCO.2010.32.1802; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Gurrola-Diaz C, 2003, ONCOGENE, V22, P5636, DOI 10.1038/sj.onc.1206790; Haddad TC, 2006, THROMB RES, V118, P555, DOI 10.1016/j.thromres.2005.10.015; Hadjihannas MV, 2006, P NATL ACAD SCI USA, V103, P10747, DOI 10.1073/pnas.0604206103; Han CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067033; Han YQ, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00156; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Heo TH, 2016, ONCOTARGET, V7, P15460, DOI 10.18632/oncotarget.7102; Hinrichsen I, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-11; Hood FE, 2013, J CELL BIOL, V202, P463, DOI 10.1083/jcb.201211127; Huang X, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-22; Hussner J, 2012, MOL PHARMACOL, V81, P679, DOI 10.1124/mol.111.075994; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Jantas D, 2008, NEUROCHEM INT, V52, P864, DOI 10.1016/j.neuint.2007.10.003; Jantas D, 2009, NEUROTOX RES, V15, P24, DOI 10.1007/s12640-009-9002-8; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang BY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-61; Jiang M, 2011, CELL DEATH DIFFER, V18, P1005, DOI 10.1038/cdd.2010.168; Jiao X, 2012, GENE CHROMOSOME CANC, V51, P480, DOI 10.1002/gcc.21935; Jung KH, 2010, J CELL BIOCHEM, V110, P687, DOI 10.1002/jcb.22579; Kim BK, 2015, BMB REP, V48, P360, DOI 10.5483/BMBRep.2015.48.6.031; Kim JT, 2013, CARCINOGENESIS, V34, P953, DOI 10.1093/carcin/bgt018; Kolla V, 2014, CANCER RES, V74, P652, DOI 10.1158/0008-5472.CAN-13-3056; Kuribayashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080773; Lattanzio Rossano, 2013, Advances in Biological Regulation, V53, P309, DOI 10.1016/j.jbior.2013.07.006; Li FZ, 2005, WORLD J SURG, V29, P306, DOI 10.1007/s00268-004-7813-6; Li Y, 2013, INT J EMERG TECHNOL, V8, P10, DOI 10.3991/ijet.v8i5.2904; Lieu C, 2011, CLIN CANCER RES, V17, P6130, DOI 10.1158/1078-0432.CCR-11-0659; Liu PY, 2012, CARCINOGENESIS, V33, P1270, DOI 10.1093/carcin/bgs148; Liu XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067181; Loh KC, 2011, ANTI-CANCER AGENT ME, V11, P782; Lohri A, 1997, J CLIN PATHOL, V50, P22, DOI 10.1136/jcp.50.1.22; Ludwig L, 2009, CANCER LETT, V275, P194, DOI 10.1016/j.canlet.2008.10.010; Luddecke S, 2016, ONCOGENE, V35, P2398, DOI 10.1038/onc.2015.290; M Bastian, 2009, INT AAAI C WEBL SOC; Ma LW, 2013, J ORAL PATHOL MED, V42, P47, DOI 10.1111/j.1600-0714.2012.01179.x; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Maluf FC, 2002, CANCER, V94, P3219, DOI 10.1002/cncr.10595; Mazzoni SM, 2014, CANCER LETT, V355, P1, DOI 10.1016/j.canlet.2014.09.018; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Medina VA, 2010, BRIT J PHARMACOL, V161, P755, DOI 10.1111/j.1476-5381.2010.00961.x; Mehrotra AKR, 2015, INT J IMMUNOTHER CAN, V1; Minard-Colin V, 2015, J CLIN ONCOL, V33, P2963, DOI 10.1200/JCO.2014.59.5827; Monaco S, 2015, CELL SIGNAL, V27, P204, DOI 10.1016/j.cellsig.2014.11.007; Montaigne D, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/951539; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Morgan MA, 2015, GENE DEV, V29, P238, DOI 10.1101/gad.255182.114; Morton Lindsay M., 2014, Journal of the National Cancer Institute Monographs, P130, DOI 10.1093/jncimonographs/lgu013; Munoz O, 2004, LEUKEMIA, V18, P2015, DOI 10.1038/sj.leu.2403485; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Novellasdemunt L, 2015, AM J PHYSIOL-CELL PH, V309, pC511, DOI 10.1152/ajpcell.00117.2015; Octavia Y, 2012, J MOL CELL CARDIOL, V52, P1213, DOI 10.1016/j.yjmcc.2012.03.006; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Palmieri C, 2012, BRIT J CANCER, V107, P375, DOI 10.1038/bjc.2012.231; Park SB, 2013, CA-CANCER J CLIN, V63, P419, DOI 10.3322/caac.21204; Pastor-Anglada M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00013; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Pentheroudakis G, 2010, LEUKEMIA LYMPHOMA, V51, P1260, DOI 10.3109/10428194.2010.483749; Pfreundschuh M, 2011, LANCET ONCOL, V12, P1013, DOI 10.1016/S1470-2045(11)70235-2; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Pon JR, 2016, BLOOD, V127, P181, DOI 10.1182/blood-2015-07-658401; Prickett TD, 2012, CLIN CANCER RES, V18, P4240, DOI 10.1158/1078-0432.CCR-11-1217; Ribeiro FM, 2010, CNS NEUROL DISORD-DR, V9, P574; Robinson WH, 2015, NAT REV RHEUMATOL, V11, P171, DOI 10.1038/nrrheum.2014.220; Ryan JL, 2007, ONCOLOGIST, V12, P22, DOI 10.1634/theoncologist.12-S1-22; Sandhu V, 2016, MOL ONCOL, V10, P303, DOI 10.1016/j.molonc.2015.10.011; Schmidt M, 2009, BRIT J HAEMATOL, V144, P796, DOI 10.1111/j.1365-2141.2008.07503.x; Shankar SR, 2013, EPIGENETICS-US, V8, P16, DOI 10.4161/epi.23331; Shankland KR, 2012, LANCET, V380, P848, DOI 10.1016/S0140-6736(12)60605-9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao YT, 2016, TOXICOLOGY, V347, P29, DOI 10.1016/j.tox.2016.03.001; Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x; Stanislaus A, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-30; Steelman LS, 2008, LEUKEMIA, V22, P686, DOI 10.1038/leu.2008.26; Stubgen JP, 2015, J CLIN NEUROL, V11, P283, DOI 10.3988/jcn.2015.11.3.283; Svejda B, 2013, CANCER SCI, V104, P844, DOI 10.1111/cas.12174; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tai D, 2015, ONCOLOGIST, V20, P1189, DOI 10.1634/theoncologist.2015-0057; Tamura H, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-220; Tang LD, 2010, EUR J CANCER, V46, P170, DOI 10.1016/j.ejca.2009.10.003; Teh Jessica, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P211; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Teke HU, 2014, J BUON, V19, P191; Theoharides TC, 2015, NEW ENGL J MED, V373, P1885, DOI 10.1056/NEJMc1510021; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Thier S, 2012, NEUROLOGY, V79, P243, DOI 10.1212/WNL.0b013e31825fdeed; Tiash S., 2015, J CANC METASTASIS TR, V1, P190, DOI [DOI 10.4103/2394-4722.163151, 10.4103/2394-4722.163151]; Turton NJ, 2001, ONCOGENE, V20, P1300, DOI 10.1038/sj.onc.1204235; Valkenburg Kenneth C, 2011, Cancers (Basel), V3, P2050, DOI 10.3390/cancers3022050; Vaque JP, 2014, BLOOD, V123, P2034, DOI 10.1182/blood-2013-05-504308; Ververis K, 2013, BIOL-TARGETS THER, V7, P47, DOI 10.2147/BTT.S29965; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Wallace KB, 2003, PHARMACOL TOXICOL, V93, P105, DOI 10.1034/j.1600-0773.2003.930301.x; Wang J, 2014, MOLECULES, V19, P1912, DOI 10.3390/molecules19021912; Wang XJ, 2005, NEW ENGL J MED, V353, P1224, DOI 10.1056/NEJMoa051931; Wang YY, 2015, ONCOTARGET, V6, P11725, DOI 10.18632/oncotarget.3955; Widmaier M, 2012, J CELL SCI, V125, P1839, DOI 10.1242/jcs.093864; Willard SS, 2013, INT J BIOL SCI, V9, P728, DOI 10.7150/ijbs.6475; Wu X, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3182; Xie HJ, 2016, ONCOTARGET, V7, P1341, DOI 10.18632/oncotarget.6372; Xu YW, 2014, AM J GASTROENTEROL, V109, P36, DOI 10.1038/ajg.2013.384; Xueling GE, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-33; Yamaguchi F, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-468; Yang JS, 2015, COMPOS SCI TECHNOL, V115, P9, DOI 10.1016/j.compscitech.2015.04.015; Yashiro M, 2010, INT J CANCER, V126, P1004, DOI 10.1002/ijc.24763; Younes A, 2014, LANCET ONCOL, V15, P1019, DOI 10.1016/S1470-2045(14)70311-0; Zaenker P, 2016, AUTOIMMUN REV, V15, P477, DOI 10.1016/j.autrev.2016.01.017; Zelenetz AD, 2003, ANN ONCOL, V14, P5, DOI 10.1093/annonc/mdg702; Zhang J, 2015, ONCOTARGET, V6, P2917, DOI 10.18632/oncotarget.2784; Zhang QY, 2014, GASTROENTEROLOGY, V146, P461, DOI 10.1053/j.gastro.2013.10.011; Zhang YH, 2013, TUMOR BIOL, V34, P3147, DOI 10.1007/s13277-013-0883-z; Zhao R, 2012, LUNG CANCER, V76, P324, DOI 10.1016/j.lungcan.2011.11.019; Zhao YJ, 2015, ONCOLOGIST, V20, P660, DOI 10.1634/theoncologist.2014-0465; Zou HY, 2015, GENET MOL RES, V14, P16546, DOI 10.4238/2015.December.11.1	148	9	9	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0183969	10.1371/journal.pone.0183969	http://dx.doi.org/10.1371/journal.pone.0183969			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892521	Green Published, gold, Green Submitted			2022-12-27	WOS:000410243200007
J	McLoughlin, I; Zhang, HM; Xie, ZP; Song, Y; Xiao, W; Phan, H				McLoughlin, Ian; Zhang, Haomin; Xie, Zhipeng; Song, Yan; Xiao, Wei; Phan, Huy			Continuous robust sound event classification using time-frequency features and deep learning	PLOS ONE			English	Article							AUDIO CLASSIFICATION; IMAGE FEATURE	The automatic detection and recognition of sound events by computers is a requirement for a number of emerging sensing and human computer interaction technologies. Recent advances in this field have been achieved by machine learning classifiers working in conjunction with time-frequency feature representations. This combination has achieved excellent accuracy for classification of discrete sounds. The ability to recognise sounds under real-world noisy conditions, called robust sound event classification, is an especially challenging task that has attracted recent research attention. Another aspect of real-word conditions is the classification of continuous, occluded or overlapping sounds, rather than classification of short isolated sound recordings. This paper addresses the classification of noise-corrupted, occluded, overlapped, continuous sound recordings. It first proposes a standard evaluation task for such sounds based upon a common existing method for evaluating isolated sound classification. It then benchmarks several high performing isolated sound classifiers to operate with continuous sound data by incorporating an energy-based event detection front end. Results are reported for each tested system using the new task, to provide the first analysis of their performance for continuous sound event detection. In addition it proposes and evaluates a novel Bayesian-inspired front end for the segmentation and detection of continuous sound recordings prior to classification.	[McLoughlin, Ian] Univ Kent, Sch Comp, Medway, Kent, England; [McLoughlin, Ian; Zhang, Haomin; Xie, Zhipeng; Song, Yan] Univ Sci & Technol China, Natl Engn Lab Speech & Language Informat Proc, Hefei, Anhui, Peoples R China; [Xiao, Wei] Huawei Technol Duesseldorf GmbH, European Res Ctr, Munich, Germany; [Phan, Huy] Univ Lubeck, Inst Signal Proc, Lubeck, Germany	University of Kent; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Huawei Technologies; University of Lubeck	McLoughlin, I (corresponding author), Univ Kent, Sch Comp, Medway, Kent, England.; McLoughlin, I (corresponding author), Univ Sci & Technol China, Natl Engn Lab Speech & Language Informat Proc, Hefei, Anhui, Peoples R China.	ivm@kent.ac.uk	McLoughlin, Ian/AAS-9081-2020	McLoughlin, Ian/0000-0001-7111-2008	Huawei Innovation Research Program under Machine Hearing and Perception Project [YB2012120147]; Huawei Technologies	Huawei Innovation Research Program under Machine Hearing and Perception Project(Huawei Technologies); Huawei Technologies(Huawei Technologies)	This work was supported by the Huawei Innovation Research Program under Machine Hearing and Perception Project Contract No. YB2012120147. Huawei Technologies provided support in the form of salaries for author WX, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This work was supported by the Huawei Innovation Research Program under Machine Hearing and Perception Project Contract No. YB2012120147.	Abdel-Hamid O, 2012, INT CONF ACOUST SPEE, P4277, DOI 10.1109/ICASSP.2012.6288864; Ajmera J, 2003, ASRU'03: 2003 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING ASRU '03, P411, DOI 10.1109/ASRU.2003.1318476; [Anonymous], EUROSPEECH; Bouvrie J., 2006, NEURAL NETS; Cai R, 2006, IEEE T AUDIO SPEECH, V14, P1026, DOI 10.1109/TSA.2005.857575; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chechik G., 2008, P 1 ACM INT C MULT I, P105, DOI DOI 10.1145/1460096.1460115; Chen IF, 2010, 11TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2010 (INTERSPEECH 2010), VOLS 3 AND 4, P2298; Chen LH, 2014, IEEE-ACM T AUDIO SPE, V22, P1859, DOI 10.1109/TASLP.2014.2353991; Dennis J, 2013, PATTERN RECOGN LETT, V34, P1085, DOI 10.1016/j.patrec.2013.02.015; Dennis J.W., 2014, SOUND EVENT RECOGNIT; Dennis J, 2013, IEEE T AUDIO SPEECH, V21, P367, DOI 10.1109/TASL.2012.2226160; Dennis J, 2011, IEEE SIGNAL PROC LET, V18, P130, DOI 10.1109/LSP.2010.2100380; Guo GD, 2003, IEEE T NEURAL NETWOR, V14, P209, DOI 10.1109/TNN.2002.806626; Heittola T, 2011, WORKSH MACH LIST MUL, P36; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Phan H, 2016, IEEE-ACM T AUDIO SPE, V24, P807, DOI 10.1109/TASLP.2016.2530401; Phan H, 2015, IEEE-ACM T AUDIO SPE, V23, P20, DOI 10.1109/TASLP.2014.2367814; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lecun Y., 1995, HDB BRAIN THEORY NEU, DOI DOI 10.1109/IJCNN.2004.1381049; Lin CC, 2005, IEEE T SPEECH AUDI P, V13, P644, DOI 10.1109/TSA.2005.851880; Lyon RF, 2013, US Patent, Patent No. [8,463,719, 8463719]; Lyon RF, 2010, IEEE SIGNAL PROC MAG, V27, P131, DOI 10.1109/MSP.2010.937498; McLoughlin I., 2017, CONTINUOUS ROBUST SO; McLoughlin I, 2015, IEEE-ACM T AUDIO SPE, V23, P540, DOI 10.1109/TASLP.2015.2389618; Palm R. B., 2012, PREDICTION CANDIDATE; Phan H, 2014, 15 ANN C INT SPEECH, P1; Sainath TN, 2013, INT CONF ACOUST SPEE, P8614, DOI 10.1109/ICASSP.2013.6639347; Walters TC, 2011, AUDITORY BASED PROCE; Xu YY, 2018, CLIMATIC CHANGE, V146, P393, DOI 10.1007/s10584-015-1565-1; Zhang HM, 2015, INT CONF ACOUST SPEE, P559, DOI 10.1109/ICASSP.2015.7178031	31	18	18	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0182309	10.1371/journal.pone.0182309	http://dx.doi.org/10.1371/journal.pone.0182309			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892478	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000410243200001
J	Baguma, R; Penn-Nicholson, A; Smit, E; Erasmus, M; Day, J; Makhethe, L; de Kock, M; Hughes, EJ; van Rooyen, M; Pienaar, B; Stone, L; Hanekom, W; Brennan, MJ; Wallis, RS; Hatherill, M; Scriba, TJ				Baguma, Richard; Penn-Nicholson, Adam; Smit, Erica; Erasmus, Mzwandile; Day, Jonathan; Makhethe, Lebohang; de Kock, Marwou; Hughes, E. Jane; van Rooyen, Michele; Pienaar, Bernadette; Stone, Lynnett; Hanekom, Willem; Brennan, Michael J.; Wallis, Robert S.; Hatherill, Mark; Scriba, Thomas J.			Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population	PLOS ONE			English	Article							CD4 T-CELLS; IN-VITRO; IFN-GAMMA; INTERFERON-GAMMA; INTRACELLULAR GROWTH; BCG VACCINATION; INFECTION; PROTECTION; RESPONSES; BOVIS	The determinants of immunological protection against Mycobacterium tuberculosis (M. tb) infection in humans are not known. Mycobacterial growth inhibition assays have potential utility as in vitro surrogates of in vivo immunological control of M. tb. We evaluated a whole blood growth inhibition assay in a setting with high burden of TB and aimed to identify immune responses that correlate with control of mycobacterial growth. We hypothesized that individuals with underlying M. tb infection will exhibit greater M. tb growth inhibition than uninfected individuals and that children aged 4 to 12 years, an age during which TB incidence is curiously low, will also exhibit greater M. tb growth inhibition than adolescents or adults. Neither M. tb infection status, age of the study participants, nor M. tb strain was associated with differential control of mycobacterial growth. Abundance and function of innate or T cell responses were also not associated with mycobacterial growth. Our data suggest that this assay does not provide a useful measure of age-associated differential host control of M. tb infection in a high TB burden setting. We propose that universally high levels of mycobacterial sensitization (through environmental non-tuberculous mycobacteria and/or universal BCG vaccination) in persons from high TB burden settings may impart broad inhibition of mycobacterial growth, irrespective of M. tb infection status. This sensitization may mask the augmentative effects of mycobacterial sensitization on M. tb growth inhibition that is typical in low burden settings.	[Baguma, Richard; Penn-Nicholson, Adam; Smit, Erica; Erasmus, Mzwandile; Day, Jonathan; Makhethe, Lebohang; de Kock, Marwou; Hughes, E. Jane; van Rooyen, Michele; Pienaar, Bernadette; Stone, Lynnett; Hanekom, Willem; Hatherill, Mark; Scriba, Thomas J.] Univ Cape Town, SATVI, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Baguma, Richard; Penn-Nicholson, Adam; Smit, Erica; Erasmus, Mzwandile; Day, Jonathan; Makhethe, Lebohang; de Kock, Marwou; Hughes, E. Jane; van Rooyen, Michele; Pienaar, Bernadette; Stone, Lynnett; Hanekom, Willem; Hatherill, Mark; Scriba, Thomas J.] Univ Cape Town, Dept Pathol, Div Immunol, Cape Town, South Africa; [Brennan, Michael J.] Aeras, Rockville, MD USA; [Wallis, Robert S.] Aurum Inst, Johannesburg, South Africa	University of Cape Town; University of Cape Town	Penn-Nicholson, A (corresponding author), Univ Cape Town, SATVI, Inst Infect Dis & Mol Med, Cape Town, South Africa.; Penn-Nicholson, A (corresponding author), Univ Cape Town, Dept Pathol, Div Immunol, Cape Town, South Africa.	adam.penn-nicholson@uct.ac.za	Scriba, Thomas/AAH-9413-2020; Scriba, Thomas/GPX-2573-2022; Wallis, Robert S./A-8018-2009	Scriba, Thomas/0000-0002-0641-1359; Baguma, Richard/0000-0002-5106-021X; Penn-Nicholson, Adam/0000-0002-1883-0059; Wallis, Robert S./0000-0001-6152-5183; Hanekom, Willem/0000-0003-3070-6154	European and Developing Countries Clinical Trials Partnership (EDCTP) [TA.2011.40200.010]; US FDA (FDA) [IU18FD004012-01]	European and Developing Countries Clinical Trials Partnership (EDCTP); US FDA (FDA)(United States Department of Health & Human Services)	An author of this publication (Scriba) received funding from the European and Developing Countries Clinical Trials Partnership (EDCTP) through a project entitled "Inflammatory determinants of risk of tuberculosis disease" (grant #TA.2011.40200.010). However, EDCTP cannot accept any responsibility for information or views expressed herein. This work was also supported by a grant from the US FDA (FDA grant #IU18FD004012-01, PI Brennan). Aeras provided support in the form of salaries for author MJB, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrews JR, 2015, AM J RESP CRIT CARE, V191, P584, DOI 10.1164/rccm.201409-1704OC; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Blaser N, 2016, EPIDEMICS-NETH, V14, P54, DOI 10.1016/j.epidem.2015.10.001; Boom WH, 1999, MICROBES INFECT, V1, P187, DOI 10.1016/S1286-4579(99)80033-1; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Carpenter E, 1997, IMMUNOL CELL BIOL, V75, P554, DOI 10.1038/icb.1997.86; Caruso AM, 1999, J IMMUNOL, V162, P5407; Chen TT, 2016, J INFECT DIS, V214, P300, DOI 10.1093/infdis/jiw141; CHENG SH, 1988, CLIN EXP IMMUNOL, V74, P20; Cheng T, 2017, PLOS PATHOG, V13; Cheon SH, 2002, CLIN DIAGN LAB IMMUN, V9, P901, DOI 10.1128/CDLI.9.4.901-907.2002; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Cowley SC, 2003, J IMMUNOL, V171, P4689, DOI 10.4049/jimmunol.171.9.4689; Denis M, 2004, CELL IMMUNOL, V232, P1, DOI 10.1016/j.cellimm.2005.01.003; Elias D, 2005, T ROY SOC TROP MED H, V99, P363, DOI 10.1016/j.trstmh.2004.08.006; Fine PEM, 1999, A DISCUSSION DOCUMEN, P1; Fletcher HA, 2013, CLIN VACCINE IMMUNOL, V20, P1683, DOI 10.1128/CVI.00427-13; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1992, P NATL ACAD SCI USA, V89, P12013, DOI 10.1073/pnas.89.24.12013; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Gopal R, 2012, EUR J IMMUNOL, V42, P364, DOI 10.1002/eji.201141569; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Hanekom WA, 2004, J IMMUNOL METHODS, V291, P185, DOI 10.1016/j.jim.2004.06.010; Hoft DF, 2002, J INFECT DIS, V186, P1448, DOI 10.1086/344359; Houben RMGJ, 2016, PLOS MED, V13; Jasenosky LD, 2015, IMMUNOL REV, V264, P74, DOI 10.1111/imr.12274; Kagina BM, 2015, J IMMUNOL METHODS, V417, P22, DOI 10.1016/j.jim.2014.12.003; Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC; Kampmann B, 2004, INFECT IMMUN, V72, P6401, DOI 10.1128/IAI.72.11.6401-6407.2004; Kampmann B, 2000, J INFECT DIS, V182, P895, DOI 10.1086/315766; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Lin PL, 2012, AIDS RES HUM RETROV, V28, P1693, DOI [10.1089/aid.2012.0028, 10.1089/AID.2012.0028]; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; Mahomed H, 2011, INT J TUBERC LUNG D, V15, P331; Manca C, 1999, J IMMUNOL, V162, P6740; Marais BJ, 2005, ANN TROP PAEDIATR, V25, P79, DOI 10.1179/146532805X45665; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Marsay L, 2013, TUBERCULOSIS, V93, P551, DOI 10.1016/j.tube.2013.04.007; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Parra M, 2009, CLIN VACCINE IMMUNOL, V16, P1025, DOI 10.1128/CVI.00067-09; Penn-Nicholson A, 2015, TUBERCULOSIS, V95, P350, DOI 10.1016/j.tube.2015.03.002; Philips JA, 2012, ANNU REV PATHOL-MECH, V7, P353, DOI 10.1146/annurev-pathol-011811-132458; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; SCHLESINGER LS, 1990, J IMMUNOL, V144, P2771; Scriba TJ, 2008, J IMMUNOL, V180, P1962, DOI 10.4049/jimmunol.180.3.1962; Silver RF, 1998, J IMMUNOL, V160, P2408; Subbian S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110016; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Tanner R, 2017, SCI REP-UK, V7, DOI 10.1038/srep43478; Tena GN, 2003, J INFECT DIS, V187, P1544, DOI 10.1086/374799; Via LE, 2015, ANTIMICROB AGENTS CH, V59, P4181, DOI 10.1128/AAC.00115-15; Via LE, 2012, ANTIMICROB AGENTS CH, V56, P4391, DOI 10.1128/AAC.00531-12; Wallis RS, 2001, J INFECT DIS, V183, P1300, DOI 10.1086/319679; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wood R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025098; Woodworth JS, 2014, J IMMUNOL, V192, P3247, DOI 10.4049/jimmunol.1300283; Worku S, 2003, INFECT IMMUN, V71, P1763, DOI 10.1128/IAI.71.4.1763-1773.2003; Worku S, 2000, CLIN INFECT DIS, V30, pS257, DOI 10.1086/313887; Yao SY, 2014, J IMMUNOL, V192, P2120, DOI 10.4049/jimmunol.1301373; Zelmer A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1751-4	68	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184563	10.1371/journal.pone.0184563	http://dx.doi.org/10.1371/journal.pone.0184563			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886145	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100155
J	Elattar, MA; Vink, LW; van Mourik, MS; Baan, J; van Bavel, ET; Planken, RN; Marquering, HA				Elattar, Mustafa A.; Vink, Leon W.; van Mourik, Martijn S.; Baan, Jan, Jr.; van Bavel, Ed T.; Planken, R. Nils; Marquering, Henk A.			Dynamics of the aortic annulus in 4D CT angiography for transcatheter aortic valve implantation patients	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; ROOT; CALCIFICATION; REPLACEMENT; DIAMETER; DIASTOLE; SYSTOLE; REGURGITATION; SEGMENTATION; DIMENSIONS	Background Transcatheter aortic valve implantation (TAVI) is a well-established treatment for patients with severe aortic valve stenosis. This procedure requires pre-operative planning by assessment of aortic dimensions on CT Angiography (CTA). It is well-known that the aortic root dimensions vary over the heart cycle. However, sizing is commonly performed at either mid-systole or end-diastole only, which has resulted in an inadequate understanding of its full dynamic behavior. Study goal We studied the variation in annulus measurements during the cardiac cycle and determined if this variation is dependent on the amount of calcification at the annulus. Methods We measured and compared aortic root annular dimensions and calcium volume in CTA acquisitions at 10 cardiac cycle phases in 51 aortic stenosis patients. Sub-group analysis was performed based on the volume of calcium by splitting the population into mildly and severely calcified valves subgroups. Results For most annulus measurements, the largest differences were found between 10% and 70 to 80% cardiac cycle phases. Mean difference (+/- standard deviation) in annular minimum diameter, maximum diameter, area, and aspect ratio between mid-systole and end-diastole phases were 1.0 +/- 0.29 mm (p = 0.065), 0.30 +/- 0.24 mm (p = 0.7), 24.1 +/- 7.6 mm(2) (p < 0.001), and 0.041 +/- 0.012 (p = 0.039) respectively. Calcium volume measurements varied strongly during the cardiac cycle. The dynamic annulus area was behaving differently between mildly and severely calcified subgroups (p = 0.02). Furthermore, patients with severe aortic calcification were associated with larger annulus diameters. Conclusion There is a significant variation of annulus area and calcium volume measurement during the cardiac cycle. In our measurements, only the dynamic variation of the annulus area is dependent on the severity of the aortic calcification. For TAVI candidates, the annulus area is significantly larger in mid-systole compared to end-diastole.	[Elattar, Mustafa A.; Vink, Leon W.; van Bavel, Ed T.; Marquering, Henk A.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Amsterdam, Netherlands; [van Mourik, Martijn S.; Baan, Jan, Jr.] Univ Amsterdam, Acad Med Ctr, Dept Heart Ctr, Amsterdam, Netherlands; [Planken, R. Nils; Marquering, Henk A.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Elattar, MA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Amsterdam, Netherlands.	Mustafa.elattar@gmail.com	Planken, RN/GMX-0438-2022	Elattar, Mustafa/0000-0001-7936-3522; Planken, R. Nils/0000-0003-3940-4670; Marquering, Henk/0000-0002-1414-6313; van Bavel, Ed/0000-0001-8654-986X	Dutch Technology Foundation STW [11630]; Netherlands Organization for Scientific Research (NWO); Ministry of Economic Affairs	Dutch Technology Foundation STW(Technologiestichting STW); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Ministry of Economic Affairs	This research is supported by the Dutch Technology Foundation STW under grant number of 11630, which is part of the Netherlands Organization for Scientific Research (NWO), and which is partly funded by the Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis or preparation of the manuscript. Approval for publishing the results is granted.	Bekeredjian R, 2015, J INVASIVE CARDIOL, V27, P172; Bell V, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.003039; Bertaso AG, 2012, INT J CARDIOVAS IMAG, V28, P2091, DOI 10.1007/s10554-012-0018-4; Blanke P, 2013, RADIOLOGY, V269, P650, DOI 10.1148/radiol.13120696; Buellesfeld L, 2014, EUROINTERVENTION, V10, P732, DOI 10.4244/EIJV10I6A126; Dagum P, 1999, CIRCULATION, V100, P54; de Heer LM, 2011, INT J CARDIOVAS IMAG, V27, P1195, DOI 10.1007/s10554-011-9838-x; de Vaan J, 2012, EUROINTERVENTION, V7, P1464, DOI 10.4244/EIJV7I12A228; Delgado V, 2011, ANN THORAC SURG, V91, P716, DOI 10.1016/j.athoracsur.2010.09.060; Elattar MA, 2014, MED BIOL ENG COMPUT, V52, P611, DOI 10.1007/s11517-014-1165-7; Eveborn GW, 2012, HEART, P396; Feldmann S., 2014, COREVALVE ASSESSING, P59; Geller G., 2012, AORTIC ANNULUS ANATO; Gnyaneshwar R, 2002, ANN THORAC SURG, V73, P1122, DOI 10.1016/S0003-4975(01)03588-3; Gurvitch R, 2011, JACC-CARDIOVASC INTE, V4, P1235, DOI 10.1016/j.jcin.2011.07.014; Halapas A, 2015, HELL J CARDIOL, V56, P9; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Jurencak T, 2015, EUR RADIOL, V25, P1975, DOI 10.1007/s00330-015-3607-5; Kaleschke Gerrit, 2010, EuroIntervention, V6 Suppl G, pG20, DOI 10.4244/; Kazui T, 2006, J HEART VALVE DIS, V15, P617; Khalique OK, 2014, CIRC-CARDIOVASC IMAG, V7, P155, DOI 10.1161/CIRCIMAGING.113.001153; Lansac E, 2002, EUR J CARDIO-THORAC, V22, P497, DOI 10.1016/S1010-7940(02)00405-0; Lu TLC, 2009, EUR RADIOL, V19, P664, DOI 10.1007/s00330-008-1182-8; McEniery CM, 2009, HYPERTENSION, V53, P524, DOI 10.1161/HYPERTENSIONAHA.108.126615; Messika-Zeitoun D, 2010, J AM COLL CARDIOL, V55, P186, DOI 10.1016/j.jacc.2009.06.063; Morgan-Hughes GJ, 2003, RADIOLOGY, V228, P583, DOI 10.1148/radiol.2282020873; Mylotte D, 2012, ANN CARDIOTHORAC SUR, V1, P206, DOI 10.3978/j.issn.2225-319X.2012.06.08; O'Rourke M, 2008, JACC-CARDIOVASC IMAG, V1, P749, DOI 10.1016/j.jcmg.2008.08.002; ROBERTS WC, 1971, AM J CARDIOL, V27, P497, DOI 10.1016/0002-9149(71)90412-7; Salaun E, 2016, INT J CARDIOL, V208, P28, DOI 10.1016/j.ijcard.2016.01.048; Salgado RA, 2014, RADIOGRAPHICS, V34, P1517, DOI 10.1148/rg.346130149; Shabestari AA, 2013, INT J CARDIOVAS IMAG, V29, P1391, DOI 10.1007/s10554-013-0217-7; Vahanian A, 2008, EUR HEART J, V29, P1463, DOI 10.1093/eurheartj/ehn183; Wiegerinck EMA, 2014, INT J CARDIOVAS IMAG, V30, P399, DOI 10.1007/s10554-013-0343-2; Yankah AC, 2001, EUR J CARDIO-THORAC, V20, P835, DOI 10.1016/S1010-7940(01)00885-5; Ye J, 2010, J THORAC CARDIOV SUR, V139, P1107, DOI 10.1016/j.jtcvs.2009.10.056; Zheng YF, 2012, IEEE T MED IMAGING, V31, P2307, DOI 10.1109/TMI.2012.2216541	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184133	10.1371/journal.pone.0184133	http://dx.doi.org/10.1371/journal.pone.0184133			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886071	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100070
J	Hruschka, DJ; Hadley, C; Hackman, J				Hruschka, Daniel J.; Hadley, Craig; Hackman, Joseph			Material wealth in 3D: Mapping multiple paths to prosperity in low- and middle-income countries	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; NATIVE AMAZONIANS; ASSET INDEXES; EAST-AFRICA; INEQUALITY; HOUSEHOLD; POVERTY; TRANSMISSION; HEALTH; POOR	Material wealth is a key factor shaping human development and well-being. Every year, hundreds of studies in social science and policy fields assess material wealth in low- and middle-income countries assuming that there is a single dimension by which households can move from poverty to prosperity. However, a one-dimensional model may miss important kinds of prosperity, particularly in countries where traditional subsistence-based livelihoods coexist with modern cash economies. Using multiple correspondence analysis to analyze representative household data from six countries-Nepal, Bangladesh, Ethiopia, Kenya, Tanzania and Guatemala-across three world regions, we identify a number of independent dimension of wealth, each with a clear link to locally relevant pathways to success in cash and agricultural economies. In all cases, the first dimension identified by this approach replicates standard one-dimensional estimates and captures success in cash economies. The novel dimensions we identify reflect success in different agricultural sectors and are independently associated with key benchmarks of food security and human growth, such as adult body mass index and child height. The multidimensional models of wealth we describe here provide new opportunities for examining the causes and consequences of wealth inequality that go beyond success in cash economies, for tracing the emergence of hybrid pathways to prosperity, and for assessing how these different pathways to economic success carry different health risks and social opportunities.	[Hruschka, Daniel J.; Hackman, Joseph] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Hadley, Craig] Emory Univ, Anthropol Dept, Atlanta, GA 30322 USA	Arizona State University; Arizona State University-Tempe; Emory University	Hruschka, DJ (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.	dhruschk@asu.edu			National Science Foundation grant - Programs in Cultural Anthropology, Social Psychology Program and Decision, Risk, and Management Sciences [BCS-1150813]; National Science Foundation grant - Programs in Cultural Anthropology and Methodology, Measurement and Statistics [BCS-1658766]; Virginia G Piper Charitable Trust	National Science Foundation grant - Programs in Cultural Anthropology, Social Psychology Program and Decision, Risk, and Management Sciences; National Science Foundation grant - Programs in Cultural Anthropology and Methodology, Measurement and Statistics; Virginia G Piper Charitable Trust	DJH acknowledges support from the National Science Foundation grant BCS-1150813, jointly funded by Programs in Cultural Anthropology, Social Psychology Program and Decision, Risk, and Management Sciences, and BCS-1658766, jointly funded by Programs in Cultural Anthropology and Methodology, Measurement and Statistics, and support from the Virginia G Piper Charitable Trust through an award to Mayo Clinic/ASU Obesity Solutions. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Bank W., 2016, GLOBAL MONITORING RE; Bingenheimer JB, 2007, INT FAM PLAN PERSPEC, V33, P83, DOI 10.1363/3308307; Blumenstock J, 2015, SCIENCE, V350, P1073, DOI 10.1126/science.aac4420; Bourdieu P., 1984, DISTINCTION SOCIAL C; Bowles S, 2010, CURR ANTHROPOL, V51, P7, DOI 10.1086/649206; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; BurnSilver S, 2016, NOMAD PEOPLES, V20, P8, DOI 10.3197/np.2016.200103; BurnSilver Shauna, 2016, AM ANTHR; Chakraborty NM, 2016, GLOB HEALTH-SCI PRAC, V4, P141, DOI 10.9745/GHSP-D-15-00384; Colleran H, 2015, FERTILITY DECLINE CH; Creanga AA, 2011, B WORLD HEALTH ORGAN, V89, P258, DOI 10.2471/BLT.10.083329; Crooks DL, 2007, AM J HUM BIOL, V19, P669, DOI 10.1002/ajhb.20668; Onis M, 2006, ACTA PAEDIATR, V95, P7, DOI 10.1080/08035320500495407; Douglas M., 2002, WORLD GOODS ANTHR CO; Ellis F, 1998, J DEV STUD, V35, P1, DOI 10.1080/00220389808422553; Estes RJ, 2017, INT HANDB QUALITY, P1, DOI 10.1007/978-3-319-39101-4; FERGUSON J, 1992, AM ANTHROPOL, V94, P55, DOI 10.1525/aa.1992.94.1.02a00040; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D, 2000, STRUCTURE SOCIAL DIS; Garenne M, 2003, J HEALTH POPUL NUTR, V21, P235; Gennaioli N, 2013, Q J ECON, V128, P105, DOI 10.1093/qje/qjs050; Gibson-Graham JK, 2008, PROG HUM GEOG, V32, P613, DOI 10.1177/0309132508090821; Godoy R, 2010, ANIM CONSERV, V13, P265, DOI 10.1111/j.1469-1795.2009.00330.x; Godoy R, 2005, ECON HUM BIOL, V3, P136, DOI 10.1016/j.ehb.2005.01.001; Green M, 2015, ECON ANTHROPOL, V2, P295, DOI 10.1002/sea2.12032; Greenacre M., 2006, MULTIPLE CORRES ANAL, DOI DOI 10.1201/9781420011319.CH1; Guedes GR, 2012, HUM ECOL, V40, P41, DOI 10.1007/s10745-011-9444-5; Gurven M, 2015, HUM ECOL, V43, P515, DOI 10.1007/s10745-015-9764-y; Guyer J. I., 1997, ENDOWMENTS ASSETS AN; Hadley C, 2011, SOC SCI MED, V73, P1534, DOI 10.1016/j.socscimed.2011.09.004; Harttgen K, 2013, REV INCOME WEALTH, V59, pS37, DOI 10.1111/roiw.12016; Headey D, 2015, WORLD DEV, V66, P749, DOI 10.1016/j.worlddev.2014.09.022; Headey DD, 2013, WORLD DEV, V42, P76, DOI 10.1016/j.worlddev.2012.07.002; Howe LD, 2012, INT J EPIDEMIOL; Hruschka D., 2017, FAT PLANET OBESITY C, P15; Hruschka D, 2016, OBESITY REV; Hruschka DJ, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0155; Hruschka DJ, 2015, B WORLD HEALTH ORGAN, V93, P483, DOI 10.2471/BLT.14.147082; Hruschka DJ, 2014, AM J PHYS ANTHROPOL, V153, P542, DOI 10.1002/ajpa.22452; Hruschka DJ, 2013, ECON HUM BIOL, V11, P337, DOI 10.1016/j.ehb.2012.01.001; Huisman J, 2009, WORLD DEV, V37, P179, DOI 10.1016/j.worlddev.2008.01.007; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Jerven M., 2013, POOR NUMBERS WE ARE; Kaiser BN, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22987; KAPLAN H, 1994, POPUL DEV REV, V20, P753, DOI 10.2307/2137661; Kasper C, 2015, CURR ANTHROPOL, V56, P701, DOI 10.1086/683024; Lawson DW, 2015, P NATL ACAD SCI USA, V112, P13827, DOI 10.1073/pnas.1507151112; Little PD, 2006, J DEV STUD, V42, P200, DOI 10.1080/00220380500405287; Little PD, 2008, DEV CHANGE, V39, P587, DOI 10.1111/j.1467-7660.2008.00497.x; Little PD, 2009, HUM ORGAN, V68, P154, DOI 10.17730/humo.68.2.n70t617197x4w778; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; Mulder MB, 2011, PHILOS T R SOC B, V366, P344, DOI 10.1098/rstb.2010.0231; Mulder MB, 2009, SCIENCE, V326, P682, DOI 10.1126/science.1178336; Murphy DJ, 2014, ECON ANTHROPOL, V1, P104, DOI 10.1111/sea2.12007; Nolin DA, 2012, EVOL HUM BEHAV, V33, P334, DOI 10.1016/j.evolhumbehav.2011.11.003; Ostby G, 2009, INT STUD QUART, V53, P301, DOI 10.1111/j.1468-2478.2009.00535.x; Pages J, 2016, MULTIPLE FACTOR ANAL; Pickett R. Wilkinson, 2010, SPIRIT LEVEL WHY EQU; Piketty T., 2014, CAPITAL 21 CENTURY; Pitchforth E, 2007, HEALTH POLICY PLANN, V22, P311, DOI 10.1093/heapol/czm022; Rutstein S.O., 2014, MAKING DEMOGRAPHIC H; Rutstein S. O., 2004, DHS WEALTH INDEX; Schilbach F, 2016, AM ECON REV, V106, P435, DOI 10.1257/aer.p20161101; Sen A.K., 1981, POVERTY FAMINES; Shenk MK, 2013, P NATL ACAD SCI USA, V110, P8045, DOI 10.1073/pnas.1217029110; Sheppard ZA, 2009, AM J HUM BIOL, V21, P48, DOI 10.1002/ajhb.20814; Smith EA, 2010, CURR ANTHROPOL, V51, P19, DOI 10.1086/648530; Traissac P, 2012, INT J EPIDEMIOL, V41, P1207, DOI 10.1093/ije/dys122; Undurraga EA, 2010, MED ANTHROPOL Q, V24, P522, DOI 10.1111/j.1548-1387.2010.01121.x; van Deurzen I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115109; Wilkie DS, 2005, CONSERV BIOL, V19, P268, DOI 10.1111/j.1523-1739.2005.00372.x; Zelner JL, 2012, AM J PUBLIC HEALTH, V102, P2233, DOI 10.2105/AJPH.2012.300795; Ziker JP, 2016, CURR ANTHROPOL, V57, P221, DOI 10.1086/685730	74	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184616	10.1371/journal.pone.0184616	http://dx.doi.org/10.1371/journal.pone.0184616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886176	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100168
J	Ishida, T; Yoshida, T; Shinohara, K; Cao, K; Nakahama, K; Morita, I; Ohno-Matsui, K				Ishida, Tomoka; Yoshida, Takeshi; Shinohara, Kosei; Cao, Kejia; Nakahama, Ken-ichi; Morita, Ikuo; Ohno-Matsui, Kyoko			Potential role of sirtuin 1 in Muller glial cells in mice choroidal neovascularization	PLOS ONE			English	Article							MACULAR DEGENERATION; EXPRESSION; RESVERATROL; VEGF; GROWTH; ACTIN	This study investigated the potential role of sirtuin 1 in Muller glial cells in choroidal neovascularization. In the in vitro study, primary Muller glial cells were cultured and treated with resveratrol, a sirtuin 1 activator. Glial fibrillary acidic protein expression and angiogenesis-related gene expression were examined using quantitative polymerase chain reaction and phagocytosis, as a marker of Muller glial cell function; in addition, a latex bead assay was used to analyze cell function. For the in vivo study, choroidal neovascularization was induced in C57BL/6 mice via laser photocoagulation, and resveratrol was administered intravitreally. Eyecup whole mounts were created to measure choroidal neovascularization volumes on day 7. Immunohistochemical analysis with anti-glial fibrillary acidic protein antibody was used to detect Muller glial cell activation in eyes with choroidal neovascularization on day 1, 3, 5, and 7 after laser surgery. Resveratrol significantly promoted glial fibrillary acidic protein, anti-angiogenic factor, pigment epithelium-derived factor, and thrombospondin-1 expression in the cells as well as the phagocytic activities. Treatment of the choroidal neovascularization model with resveratrol resulted in early activation of Muller glial cells near choroidal neovascularization sites. Resveratrol-activated cells but not the controls migrated to the top of choroidal neovascularization sites and into the lesions from day 3. Resveratrol reduced the choroidal neovascularization size relative to controls. In conclusion, sirtuin 1 activation in Muller glial cells suppressed the development of choroidal neovascularization, and therefore, might be a therapeutic option.	[Ishida, Tomoka; Yoshida, Takeshi; Shinohara, Kosei; Cao, Kejia; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol & Visual Sci, Tokyo, Japan; [Nakahama, Ken-ichi; Morita, Ikuo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cellular Physiol Chem, Tokyo, Japan; [Morita, Ikuo] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Nanomed DNP, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Yoshida, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol & Visual Sci, Tokyo, Japan.	takec.oph@tmd.ac.jp			Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder	Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder	The study was funded by a grant provided by the Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder to Takeshi Yoshida from Santen Pharmaceutical. The funding website is http://www.santensogyosya-kikin-jp. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruckbauer A, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-77; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cvetkova NP, 2016, CLIN OPHTHALMOL, V10, P1047, DOI 10.2147/OPTH.S101050; Gaustad JV, 2016, ONCOTARGET; Giani A, 2011, INVEST OPHTH VIS SCI, V52, P3880, DOI 10.1167/iovs.10-6266; Harada C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1190; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; HICKS D, 1990, EXP EYE RES, V51, P119, DOI 10.1016/0014-4835(90)90063-Z; Jablonski MM, 2001, GLIA, V35, P14, DOI 10.1002/glia.1066; Johnen S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/863845; Kanavi MR, 2014, MOLECULES, V19, P17578, DOI 10.3390/molecules191117578; Kitada M, 2016, AGING-US, V8, P2290, DOI 10.18632/aging.101068; Lassota N, 2008, ACTA OPHTHALMOL, V86, P495, DOI [10.1111/j.1600-0420.2007.01127.x, 10.1111/j.1755-3768.2008.01412.x]; Loov C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033090; Machalinska A, 2013, EXP EYE RES, V112, P68, DOI 10.1016/j.exer.2013.04.004; MADIGAN MC, 1994, RETINA-J RET VIT DIS, V14, P65, DOI 10.1097/00006982-199401000-00014; Motonishi S, 2015, J AM SOC NEPHROL, V26, P1939, DOI 10.1681/ASN.2014030289; Nagai N, 2014, SCI REP, V11, P29619; Nagai N, 2014, J NUTR BIOCHEM, V25, P1218, DOI 10.1016/j.jnutbio.2014.05.015; Nagineni CN, 2014, AGING DIS, V5, P88, DOI 10.14366/AD.2014.050088; Ohno-Matsui K, 2003, BIOCHEM BIOPH RES CO, V303, P962, DOI 10.1016/S0006-291X(03)00446-7; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Ryan SJ, 1994, SUBRETINAL NEOVASCUL, P1027; Said AMA, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0433-3; Saviano Sandro, 2016, Digit J Ophthalmol, V22, P46, DOI 10.5693/djo.01.2014.01.004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shao Y, 2016, DIABETES-METAB RES, V32, P534, DOI 10.1002/dmrr.2788; Sheu SJ, 2013, INVEST OPHTH VIS SCI, V54, P6426, DOI 10.1167/iovs.13-12024; Singh PK, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-33; Tong Y, 2013, INT J OPHTHALMOL, V9, P1028; Wang XL, 2016, BIOMED PHARMACOTHER, V83, P41, DOI 10.1016/j.biopha.2016.06.009; Weber ML, 2016, DEV OPHTHALMOL, V55, P167, DOI 10.1159/000431194; Xu J, 2012, ANGIOGENESIS, V15, P213, DOI 10.1007/s10456-012-9254-4; Yang SQ, 2016, DRUG DES DEV THER, V10, P1857, DOI 10.2147/DDDT.S97653; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080288; Yoshida T, 2005, J CLIN INVEST, V115, P2793, DOI 10.1172/JCI24635; Yuan YJ, 2016, MECH AGEING DEV, V155, P10, DOI 10.1016/j.mad.2016.02.003; Zhang HM, 2015, CYTOKINE, V76, P549, DOI 10.1016/j.cyto.2015.06.019	39	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183775	10.1371/journal.pone.0183775	http://dx.doi.org/10.1371/journal.pone.0183775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886036	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100036
J	Jiang, ML; Lv, MC; Deng, Z; Zhai, GL				Jiang, Mingliang; Lv, Mouchao; Deng, Zhong; Zhai, Guoliang			A wireless soil moisture sensor powered by solar energy	PLOS ONE			English	Article							WATER-CONTENT; DOMAIN REFLECTOMETRY; IRRIGATION; NETWORKS; FIELD; MANAGEMENT; RESISTANCE; CHINA; AREA	XIn a variety of agricultural activities, such as irrigation scheduling and nutrient management, soil water content is regarded as an essential parameter. Either power supply or long-distance cable is hardly available within field scale. For the necessity of monitoring soil water dynamics at field scale, this study presents a wireless soil moisture sensor based on the impedance transform of the frequency domain. The sensor system is powered by solar energy, and the data can be instantly transmitted by wireless communication. The sensor electrodes are embedded into the bottom of a supporting rod so that the sensor can measure soil water contents at different depths. An optimal design with time executing sequence is considered to reduce the energy consumption. The experimental results showed that the sensor is a promising tool for monitoring moisture in large-scale farmland using solar power and wireless communication.	[Jiang, Mingliang; Lv, Mouchao; Deng, Zhong; Zhai, Guoliang] Chinese Acad Agr Sci, Farmland Irrigat Res Inst, Xinxiang City, Henan, Peoples R China; [Jiang, Mingliang; Lv, Mouchao; Deng, Zhong; Zhai, Guoliang] Key Lab Water Saving Agr Henan Prov, Xinxiang City, Henan, Peoples R China; [Jiang, Mingliang; Lv, Mouchao; Deng, Zhong; Zhai, Guoliang] CAAS, Ctr Efficient Irrigat Engn & Technol Res, Xinxiang City, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Farmland Irrigation Research Institute, CAAS; Chinese Academy of Agricultural Sciences	Lv, MC (corresponding author), Chinese Acad Agr Sci, Farmland Irrigat Res Inst, Xinxiang City, Henan, Peoples R China.; Lv, MC (corresponding author), Key Lab Water Saving Agr Henan Prov, Xinxiang City, Henan, Peoples R China.; Lv, MC (corresponding author), CAAS, Ctr Efficient Irrigat Engn & Technol Res, Xinxiang City, Henan, Peoples R China.	13937381585@163.com			Central Public-interest Scientific Institution Basal Research Fund (Farmland Irrigation Research Institute, CMS) [FIRI2016-25]; Chinese Academy of Agricultural Sciences	Central Public-interest Scientific Institution Basal Research Fund (Farmland Irrigation Research Institute, CMS); Chinese Academy of Agricultural Sciences	This work was supported by Central Public-interest Scientific Institution Basal Research Fund (Farmland Irrigation Research Institute, CMS) (FIRI2016-25), http://www.firi.org.cn/; Science and Technology Innovation Project of The Chinese Academy of Agricultural Sciences, http://www.caas.net.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the financial supports of the Central Public-interest Scientific Institution Basal Research Fund (Farmland Irrigation Research Institute, CAAS) (FIRI2016-25) and Science and Technology Innovation Project of The Chinese Academy of Agricultural Sciences.	Akhtar F, 2015, RENEW SUST ENERG REV, V45, P769, DOI 10.1016/j.rser.2015.02.021; Al-Asadi RA, 2014, SOIL TILL RES, V135, P60, DOI 10.1016/j.still.2013.09.002; AUSTIN RS, 1979, SOIL SCI SOC AM J, V43, P808, DOI 10.2136/sssaj1979.03615995004300040039x; Avanzi F, 2014, ADV WATER RESOUR, V68, P32, DOI 10.1016/j.advwatres.2014.02.012; Baghdadi N, 2013, IEEE GEOSCI REMOTE S, V10, P731, DOI 10.1109/LGRS.2012.2220333; Gaskin GJ, 1996, J AGR ENG RES, V63, P153, DOI 10.1006/jaer.1996.0017; HERKELRATH WN, 1991, WATER RESOUR RES, V27, P857, DOI 10.1029/91WR00311; Huang J, 2016, AGR WATER MANAGE, V163, P285, DOI 10.1016/j.agwat.2015.09.003; Janik G., 2015, SCI WORLD J; Jaria F, 2013, T ASABE, V56, P155; Lehmann P, 2013, WATER RESOUR RES, V49, P7992, DOI 10.1002/2013WR014560; Ma Y, 2013, AGR WATER MANAGE, V127, P13, DOI 10.1016/j.agwat.2013.05.011; Mosuro GO, 2012, NEAR-SURFACE GEOPHYSICS AND ENVIRONMENT PROTECTION, P29; Naderi-Boldaji M, 2011, SENSOR ACTUAT A-PHYS, V171, P131, DOI 10.1016/j.sna.2011.07.021; Navarro-Hellin H, 2015, AGR WATER MANAGE, V151, P64, DOI 10.1016/j.agwat.2014.10.022; Oates MJ, 2017, AGR WATER MANAGE, V183, P41, DOI 10.1016/j.agwat.2016.12.002; Ojha T, 2015, COMPUT ELECTRON AGR, V118, P66, DOI 10.1016/j.compag.2015.08.011; Pakparvar M, 2016, SOIL RES, V54, P360, DOI 10.1071/SR15154; Rashid B, 2016, J NETW COMPUT APPL, V60, P192, DOI 10.1016/j.jnca.2015.09.008; Rehmani M H., 2016, ANAT REC, V112, P195; Robinson DA, 2008, VADOSE ZONE J, V7, P358, DOI 10.2136/vzj2007.0143; Sardini E, 2011, IEEE T INSTRUM MEAS, V60, P1838, DOI 10.1109/TIM.2010.2089090; Song LN, 2012, J APPL GEOPHYS, V83, P11, DOI 10.1016/j.jappgeo.2012.03.011; Tarange P. H., 2015, 2015 INT C CIRC POW, P1, DOI DOI 10.1109/ICCPCT.2015.7159327; Thompson RB, 2007, AGR WATER MANAGE, V92, P13, DOI 10.1016/j.agwat.2007.04.009; Toll D. G., 2014, DATA ACQUISITION CON; TOPP GC, 1980, WATER RESOUR RES, V16, P574, DOI 10.1029/WR016i003p00574; Vaz CMP, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0160; Vaz CMP, 2001, SOIL SCI SOC AM J, V65, P4, DOI 10.2136/sssaj2001.6514; Wang XB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129231; Whalley WR, 2007, EUR J SOIL SCI, V58, P18, DOI 10.1111/j.1365-2389.2006.00790.x; Zink A, 2011, SOIL TILL RES, V114, P127, DOI 10.1016/j.still.2011.04.004	32	4	5	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184125	10.1371/journal.pone.0184125	http://dx.doi.org/10.1371/journal.pone.0184125			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886067	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100068
J	Jin, J; Hu, KJ; Zhou, YZ; Li, WM				Jin, Jing; Hu, Kejia; Zhou, Yongzhao; Li, Weimin			Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis	PLOS ONE			English	Article							NEUTROPHIL-TO-LYMPHOCYTE; C-REACTIVE PROTEIN; SYSTEMIC INFLAMMATORY RESPONSE; PRETREATMENT NEUTROPHIL; SURVIVAL; RATIO; PLATELET; ASSOCIATION; PREDICTS; MARKERS	Objective To perform a meta-analysis of prospective and retrospective studies exploring the association of the modified Glasgow prognostic score (mGPS) with overall survival (OS) in patients with lung cancer. Methods Relevant studies were identified by searching the Cochrane Library, Web of Science, Embase and PubMed until April 16, 2017. We combined hazard ratios (HRs) and 95% confidence intervals (CIs) to assess the correlation between mGPS and OS in patients with lung cancer. Results Eleven studies involving 5817 participants from several countries were included in the meta-analysis. In a pooled analysis of all studies, elevated mGPS predicted poorer OS (HR = 1.77; 95% CI: 1.35-2.31; P<0.05). Subgroup analyses stratified by mGPS showed that mGPS of 1 or 2 and mGPS >= 1 were predictive of poorer OS and that the HR for mGPS of 2 (HR = 5.82; 95% CI: 1.85-18.22; P = 0.003) was significantly greater than that for mGPS of 1 (HR = 1.74; 95% CI: 1.24-2.45; P = 0.001) and mGPS >= 1 (HR = 1.42; 95% CI: 1.14-1.76; P = 0.002). Among patients undergoing surgery, elevated mGPS had a non-significant correlation with reduced OS (HR = 2.48; 95% CI: 0.90-6.85; P = 0.079), whereas the correlation was significant for patients receiving chemotherapy or other palliative treatment (HR = 1.74; 95% CI: 1.31-2.30; P<0.05). Conclusions Our findings indicate that mGPS may have prognostic value in lung cancer, as we detected a significant association between elevated mGPS and poorer OS. The association between mGPS and poorer OS was non-significant among patients undergoing surgery, which may be attributable to lower tumor load. However, further studies are warranted to draw firm conclusions.	[Jin, Jing; Zhou, Yongzhao; Li, Weimin] Sichuan Univ, West China Hosp, Dept Pulm & Crit Care, Chengdu, Sichuan, Peoples R China; [Hu, Kejia] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Li, WM (corresponding author), Sichuan Univ, West China Hosp, Dept Pulm & Crit Care, Chengdu, Sichuan, Peoples R China.	weimi003@yahoo.com	Hu, Kejia/AAR-8573-2021	Hu, Kejia/0000-0001-6680-8107	Technology Support Program of Science and Technology Department of Sichuan Province [2014SZ023]	Technology Support Program of Science and Technology Department of Sichuan Province	This work was supported by grants from Technology Support Program of Science and Technology Department of Sichuan Province (2014SZ023) and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Technology Support Program of Science and the Technology Department of Sichuan Province (2014SZ023).	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Alifano M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106914; Alifano M, 2011, J THORAC CARDIOV SUR, V142, P1161, DOI 10.1016/j.jtcvs.2011.07.021; Bambury RM, 2013, J NEURO-ONCOL, V114, P149, DOI 10.1007/s11060-013-1164-9; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chen H, 2016, PANMINERVA MED; Eggers H, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0705-6; Fan H, 2016, J CANCER RES CLIN, V142, P1285, DOI 10.1007/s00432-015-2113-0; Grose D, 2014, LUNG CANC INT, V2014; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hooper CE, 2015, BRIT J CANCER, V112, P1175, DOI 10.1038/bjc.2015.62; Kinoshita A, 2012, MED ONCOL, V29, P2800, DOI 10.1007/s12032-012-0220-1; Kishi T, 2015, INT J RADIAT ONCOL, V92, P619, DOI 10.1016/j.ijrobp.2015.02.018; Kos M, 2016, WIEN KLIN WOCHENSCHR, V128, P635, DOI 10.1007/s00508-015-0724-8; Lan H, 2016, ONCOTARGET; Leung EYL, 2012, J THORAC ONCOL, V7, P655, DOI 10.1097/JTO.0b013e318244ffe1; Liu ZQ, 2014, ASIAN J ANDROL, V16, P467, DOI 10.4103/1008-682X.123686; McMillan DC, 2013, CANCER TREAT REV, V39, P534, DOI 10.1016/j.ctrv.2012.08.003; Meek CL, 2010, CLIN NUTR, V29, P206, DOI 10.1016/j.clnu.2009.08.013; Morris-Stiff G, 2008, EJSO-EUR J SURG ONC, V34, P727, DOI 10.1016/j.ejso.2008.01.016; Nikolic I, 2016, CROAT MED J, V57, P287, DOI 10.3325/cmj.2016.57.287; O'Rourke K, 2001, APPLIED STATISTICS IN THE PHARMACEUTICAL INDUSTRY: WITH CASE STUDIES USING S-PLUS, P397; Oh BS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-78; Osugi J, 2016, J CANCER RES THER, V12, P945, DOI 10.4103/0973-1482.176168; Pinato DJ, 2014, BRIT J CANCER, V110, P1930, DOI 10.1038/bjc.2014.145; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Rinehart J, 2013, CANCER CHEMOTH PHARM, V71, P1375, DOI 10.1007/s00280-013-2111-3; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI 10.2217/FON.09.136; Sanchez-Salcedo P, 2016, LUNG CANCER, V97, P28, DOI 10.1016/j.lungcan.2016.04.010; Shao N, 2015, TUMOR BIOL, V36, P8465, DOI 10.1007/s13277-015-3611-z; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Simmons CP, 2015, LUNG CANCER, V88, P304, DOI 10.1016/j.lungcan.2015.03.020; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tomita M, 2012, ANTICANCER RES, V32, P3535; Wang X, 2016, ONCOTARGETS THER, V9, P5761, DOI 10.2147/OTT.S106296; Woo HD, 2015, CANCER CAUSE CONTROL, V26, P1661, DOI 10.1007/s10552-015-0663-8; Wu YX, 2016, INT IMMUNOPHARMACOL, V36, P94, DOI 10.1016/j.intimp.2016.04.006; Zhang XW, 2015, INT J CLIN EXP MED, V8, P15222; ZHAO XW, 2017, SCI REP-UK, V7, DOI DOI 10.1038/S41598-017-; Zhou T, 2015, TUMOR BIOL, V36, P337, DOI 10.1007/s13277-014-2623-4; Zhu LZ, 2016, ONCOTARGETS THER, V9, P4879, DOI 10.2147/OTT.S107279	42	37	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184412	10.1371/journal.pone.0184412	http://dx.doi.org/10.1371/journal.pone.0184412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886134	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100111
J	Liu, TT; Chen, MX; Song, Y; Li, HL; Lu, BZ				Liu, Tiantian; Chen, Minxin; Song, Yu; Li, Hongliang; Lu, Benzhuo			Quality improvement of surface triangular mesh using a modified Laplacian smoothing approach avoiding intersection	PLOS ONE			English	Article							GENERATION	We present a systematic procedure to improve the qualities of triangular molecular surface meshes and at the same time preserve the manifoldness. The procedure utilizes an algorithm to remove redundant points having three or four valences and another algorithm to smooth the mesh using a modified version of Laplacian method without causing intersecting triangles. This approach can be effectively applied to any manifold surface meshes with arbitrary complex geometry. In this paper, the tested meshes are biomolecular surface meshes exhibiting typically highly irregular geometry. The results show that the qualities of the surface meshes are greatly improved and the manifoldness of the surface meshes are preserved. Compared with the original meshes, these improved molecular surface meshes can be directly applied to boundary element simulations and generation of body-fitted volume meshes using Tetgen. The procedure has been incorporated into our triangular molecular surface mesh generator, TMSmesh 2.0. It can be also used as a standalone program and works together with any other surface triangular mesh generator to obtain qualified manifold mesh. The package is downloadable at https://doi.org/10.6084/m9. figshare. 5346169.v1 and can be run online at http://www.xyzgate.com.	[Liu, Tiantian; Chen, Minxin] Soochow Univ, Dept Math, Suzhou 215006, Peoples R China; [Liu, Tiantian; Lu, Benzhuo] Chinese Acad Sci, State Key Lab Sci & Engn Comp, Natl Ctr Math & Interdisciplinary Sci, Acad Math & Syst Sci, Beijing 100190, Peoples R China; [Song, Yu; Li, Hongliang] China Acad Engn Phys, Microsyst Terahertz Res Ctr, Chengdu, Sichuan, Peoples R China	Soochow University - China; Chinese Academy of Sciences; Academy of Mathematics & System Sciences, CAS; Chinese Academy of Engineering Physics	Chen, MX (corresponding author), Soochow Univ, Dept Math, Suzhou 215006, Peoples R China.; Lu, BZ (corresponding author), Chinese Acad Sci, State Key Lab Sci & Engn Comp, Natl Ctr Math & Interdisciplinary Sci, Acad Math & Syst Sci, Beijing 100190, Peoples R China.	chenminxin@suda.edu.cn; bzlu@lsec.cc.ac.cn	Song, Yu/E-7195-2011; Li, Hongliang/AAE-1641-2019	Song, Yu/0000-0002-9106-6333; 	Science Challenge Project [TZ2016003]; China NSF [NSFC 91530102, NSFC 21573274, NSFC 11301368, NSFC 11404300]; NSF of Jiangsu Province [BK20130278]	Science Challenge Project; China NSF(National Natural Science Foundation of China (NSFC)); NSF of Jiangsu Province	This work was funded by the Science Challenge Project (No. TZ2016003), China NSF (NSFC 91530102, NSFC 21573274, NSFC 11301368, NSFC 11404300) and NSF of Jiangsu Province (BK20130278).	Alliez P, 2002, ACM T GRAPHIC, V21, P347, DOI 10.1145/566570.566588; Alliez P, 2008, MATH VIS, P53, DOI 10.1007/978-3-540-33265-7_2; Attene M, 2003, GRAPH MODELS, V65, P260, DOI 10.1016/S1524-0703(03)00048-1; Bechet E, 2002, COMPUT AIDED DESIGN, V34, P1, DOI 10.1016/S0010-4485(00)00146-9; Ben-Chen M, 2008, COMPUT GRAPH FORUM, V27, P449, DOI 10.1111/j.1467-8659.2008.01142.x; Borouchaki H, 2000, INT J NUMER METH ENG, V49, P233; Chen MX, 2012, J MOL GRAPH MODEL, V38, P411, DOI 10.1016/j.jmgm.2012.09.006; Chen MX, 2011, J CHEM THEORY COMPUT, V7, P203, DOI 10.1021/ct100376g; Cignoni P, 2008, COMPUTING, P129, DOI DOI 10.2312/LOCALCHAPTEREVENTS/ITALCHAP/ITALIANCHAPCONF2008/129-136; Dassi F, CURVATURE ADAPTED AN, P19; Eck M., 1995, Computer Graphics Proceedings. SIGGRAPH 95, P173, DOI 10.1145/218380.218440; Fang QQ, 2009, I S BIOMED IMAGING, P1142, DOI 10.1109/ISBI.2009.5193259; Floater MS, 1997, COMPUT AIDED GEOM D, V14, P231, DOI 10.1016/S0167-8396(96)00031-3; Floater MS, 2003, COMPUT AIDED GEOM D, V20, P19, DOI 10.1016/S0167-8396(03)00002-5; Frey P, 2000, P 9 INT MESH ROUNDT, P123; Frey PJ, 1998, COMPUTING VISUALIZAT, V1, P13; HERRMANN LR, 1976, J ENG MECH DIV-ASCE, V102, P749; Hoppe H., 1996, Computer Graphics Proceedings. SIGGRAPH '96, P99, DOI 10.1145/237170.237216; Hormann K, 2000, CURVE SURFACE DESIGN; Ito Y, 2002, AIAA J, V40, P490, DOI 10.2514/2.1672; Laug P, 2003, INT J NUMER METH ENG, V58, P209, DOI 10.1002/nme.770; Levy B, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778856; Liu T, 2017, EFFICIENT QUALIFIED; Liu TT, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2654-9; Lu BZ, 2008, COMMUN COMPUT PHYS, V3, P973; Marchandise E, 2014, ENG COMPUT-GERMANY, V30, P383, DOI 10.1007/s00366-012-0309-3; Marcum DL, 2001, ENG COMPUT-GERMANY, V17, P211, DOI 10.1007/PL00013386; Rassineux A, 2000, INT J NUMER METH ENG, V49, P31, DOI 10.1002/1097-0207(20000910/20)49:1/2<31::AID-NME921>3.3.CO;2-Y; Sakalli I, 2014, J CHEM THEORY COMPUT, V10, P5095, DOI 10.1021/ct5005092; Sheffer A, 2005, ACM T GRAPHIC, V24, P311, DOI 10.1145/1061347.1061354; Si H, 2015, ACM T MATH SOFTWARE, V41, DOI 10.1145/2629697; Sorkine O, 2004, P 2004 EUR; Surazhsky V., 2003, P 12 INT MESH ROUNDT, P215; Tristano JR, 1998, P 7 INT MESH ROUNDT, P429; Tu B., 2014, Computational Science and Discovery, V7, DOI 10.1088/1749-4680/7/1/014002; Tutte W. T., 1963, P LOND MATH SOC, Vs3-s13, P743, DOI DOI 10.1112/PLMS/S3-13.1.743; Wang D, 2007, COMMUN NUMER METH EN, V23, P227, DOI 10.1002/cnm.894; Xie Y, 2017, J COMPUT CHEM, V38, P541, DOI 10.1002/jcc.24703; Zayer R, 2007, P ACM EG S GEOM PROC; Zhang B, 2015, COMPUT PHYS COMMUN, V190, P173, DOI 10.1016/j.cpc.2014.12.022; Zheng Y, 2001, ENG COMPUT-GERMANY, V17, P28, DOI 10.1007/s003660170021; Zigelman G, 2002, IEEE T VIS COMPUT GR, V8, P198, DOI 10.1109/2945.998671	43	18	18	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184206	10.1371/journal.pone.0184206	http://dx.doi.org/10.1371/journal.pone.0184206			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886110	gold, Green Submitted, Green Published			2022-12-27	WOS:000410001100080
J	Noh, JW; Kim, KB; Park, J; Hong, J; Kwon, YD				Noh, Jin-Won; Kim, Kyoung-Beom; Park, Jumin; Hong, Janghun; Kwon, Young Dae			Relationship between the number of family members and stress by gender: Cross-sectional analysis of the fifth Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; MULTIPLE ROLES; WOMEN; WORK; DEPRESSION	Background Due to gendered inequalities in the division of domestic work, women with paid employment and family caregiving responsibilities can feel extremely tired with general distress and depression. Therefore, the purpose of this study was to examine the association between the number of family members and stress level by gender among Korean adults using a nationally representative dataset. Methods We used a sample of 6,293 subjects aged 19 or older (3,629 female and 2,264 male) from the fifth Korea National Health and Nutrition Examination Survey. A multivariable logistic regression analysis with sociodemographic and health-related characteristics was conducted. Because there were gender differences, a stratified analysis was performed for each gender. Results Age, number of family members, education level, occupational status, depression, self-rated health status, and chronic diseases were found to have a significant association with stress level in the study subjects (p<0.05). The probability of perceiving stress increased among females from family with two members (OR 1.521), three family members (OR 1.893), or four or more family members without spouse (OR 2.035) compared to those who live alone. Conclusion We found that unmarried women are more likely to be stressed as the number of family members increases. Gender expectations giving women the main responsibility for domestic and care work may become a source of stress. Reconciliation of family and work remains women's responsibility in Korea. As family problems are recently becoming a big issue, our study shows the importance of considering gender difference in studies on stress according to family roles and functions.	[Noh, Jin-Won; Hong, Janghun] Eulji Univ, Dept Healthcare Management, Seongnam, South Korea; [Noh, Jin-Won] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Global Hlth Unit, Groningen, Netherlands; [Kim, Kyoung-Beom] Korea Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Park, Jumin] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Kwon, Young Dae] Catholic Univ Korea, Dept Humanities & Social Med, Coll Med, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea	Eulji University; University of Groningen; Korea University; Korea University Medicine (KU Medicine); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Catholic University of Korea; Catholic University of Korea	Kwon, YD (corresponding author), Catholic Univ Korea, Dept Humanities & Social Med, Coll Med, Seoul, South Korea.; Kwon, YD (corresponding author), Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea.	snukyd1@naver.com	Kwon, Young Dae/T-1591-2017; Huiting, Wang/AAC-3216-2019	Kwon, Young Dae/0000-0002-8781-6832; Huiting, Wang/0000-0003-1898-3407; Noh, Jin-Won/0000-0001-5172-4023				APOSTAL RA, 1993, J CAREER DEV, V20, P121, DOI 10.1177/089484539302000203; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Cho Su-Jin, 2008, J Prev Med Public Health, V41, P355, DOI 10.3961/jpmph.2008.41.5.355; Chung JH, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.94; COOMBS RH, 1991, FAM RELAT, V40, P97, DOI 10.2307/585665; Danzer SC, 2012, EXP NEUROL, V233, P22, DOI 10.1016/j.expneurol.2011.05.023; Durand M, 2015, REV INCOME WEALTH, V61, P4, DOI 10.1111/roiw.12156; Edwards JR, 1999, ORGAN BEHAV HUM DEC, V77, P85, DOI 10.1006/obhd.1998.2813; Gallo LC, 2013, J BEHAV MED, V36, P379, DOI 10.1007/s10865-012-9432-2; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; HOFFMAN C, 1990, J PERS SOC PSYCHOL, V58, P197, DOI 10.1037/0022-3514.58.2.197; Honda A, 2015, SAF HEALTH WORK, V6, P114, DOI 10.1016/j.shaw.2014.12.004; International Labour Organization, 2014, WORLD WORK REP 2014; Kim GS, 2005, PUBLIC HEALTH NURS, V22, P389, DOI 10.1111/j.0737-1209.2005.220503.x; Kirby DD, 2004, PARENTING STRESS; Lahelma E, 2002, SOC SCI MED, V54, P727, DOI 10.1016/S0277-9536(01)00105-8; LAW SA, 1983, U PENN LAW REV, V131, P1249, DOI 10.2307/3311870; Lee KJ, 2004, SEX ROLES, V51, P469, DOI 10.1023/B:SERS.0000049235.60839.ef; Nolen-Hoeksema S, 2004, CLIN PSYCHOL REV, V24, P981, DOI 10.1016/j.cpr.2004.08.003; Quick H E, 1998, J Occup Health Psychol, V3, P44, DOI 10.1037/1076-8998.3.1.44; Schwartzberg N S, 1996, J Occup Health Psychol, V1, P211, DOI 10.1037/1076-8998.1.2.211; Scott SB, 2014, PSYCHOL AGING, V29, P577, DOI 10.1037/a0037282; Shelton BA, 1996, ANNU REV SOCIOL, V22, P299, DOI 10.1146/annurev.soc.22.1.299; Takeda Y, 2004, SOC SCI MED, V59, P69, DOI 10.1016/j.socscimed.2003.10.003; Vingilis ER, 2002, CAN J PUBLIC HEALTH, V93, P193, DOI 10.1007/BF03404999; Walters V, 2002, SOC SCI MED, V54, P677, DOI 10.1016/S0277-9536(01)00117-4	26	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184235	10.1371/journal.pone.0184235	http://dx.doi.org/10.1371/journal.pone.0184235			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886136	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100086
J	Poolsup, N; Suksomboon, N; Paw, NJ				Poolsup, Nalinee; Suksomboon, Naeti; Paw, Naw Juna			Effect of dragon fruit on glycemic control in prediabetes and type 2 diabetes: A systematic review and meta-analysis	PLOS ONE			English	Review							ANTIPROLIFERATIVE ACTIVITIES; HYLOCEREUS-POLYRHIZUS; WHITE PITAYAS; RED PITAYA; ANTIOXIDANT	Objective The purpose of this study was to systematically determine the effect of dragon fruit on glycemic control in prediabetes and type 2 diabetes. Methods Electronic databases including MEDLINE, CENTRAL, CINAHL, Scopus, ScienceDirect r, Proquest, Web of Science((R)), LILACS, NAPRALERT, SciFinder, Clinicalkey, Herbmed, NCCIH and Google Scholar were searched from their earliest inception up to March 2017 for relevant randomized controlled trials (RCTs) which compared dragon fruit with placebo or no treatment in prediabetes or type 2 diabetes. Clinicaltrials. gov, clinicaltrialresults. org, and ISRCTN registry were also searched. Personal contact with experts and historical search of related articles was undertaken. Outcome of interest were fasting plasma glucose (FPG) and 2 hours post-prandial glucose (2HPP). Study selection, data extraction and study quality assessment were performed independently by two investigators. Disagreements were resolved by a third reviewer. Treatment effect was estimated with mean difference (MD). Effect estimates were pooled using inverse-variance weighted method. Heterogeneity was assessed with the Q statistic and quantified with the I 2 statistic. DerSimonian and Laird random- effects model was used when the Q-statistic was significant at the level of 0.1, otherwise a fixed-effects model was used. Results Among 401 studies identified from literature search, 4 RCTs involving 36 prediabetes subjects and 109 type 2 diabetes patients were included in the analysis. In prediabetes, FPG reduction was significant with MD of -15.1 mg/dL (95% CI: -23.8 to -6.5 mg/dL, P-value = 0.0006). Meta-analysis in type 2 diabetes showed no effect of dragon fruit on FPG (MD -26.5 mg/dL, 95% CI: -72.6 mg/dL to 19.6 mg/dL) and in 2HPP (MD -30.5 mg/dL, 95% CI: -80.9 mg/dL to 19.9 mg/dL). Conclusion The available evidence in prediabetes is interesting. This will shed some light on diabetes prevention. The effect in T2DM was not significant. However, a trend towards greater blood glucose reduction with higher dose was observed.	[Poolsup, Nalinee] Silpakorn Univ, Fac Pharm, Dept Pharm, Nakhon Pathom, Thailand; [Suksomboon, Naeti; Paw, Naw Juna] Mahidol Univ, Fac Pharm, Dept Pharm, Bangkok, Thailand	Silpakorn University; Mahidol University	Suksomboon, N (corresponding author), Mahidol Univ, Fac Pharm, Dept Pharm, Bangkok, Thailand.	naeti.suk@mahidol.ac.th			Thailand Research Fund (TRF); Faculty of Pharmacy, Mahidol University, Thailand [IRG5780007]	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Faculty of Pharmacy, Mahidol University, Thailand	This research was supported by grants from Thailand Research Fund (TRF) and Faculty of Pharmacy, Mahidol University, Thailand (IRG5780007). The funding organisations played no role in the design, conduct, analysis or publication of this research.	Abd Hadi N., 2012, BORNEO SCI J, V31, P113; Akhiruddin MAB, 2013, THESIS; Akhlis M., 2015, THESIS; [Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001; Asyari IHN, 2009, THESIS; Budiatmaja AC, 2014, THESIS; Choo WeeSim, 2011, Advances in Applied Science Research, V2, P418; Egger M, 2017, BMJ-BRIT MED J, V315, P629; Firdayati F., 2015, THESIS MOH POLYTECHN; Hapsari AI, 2015, THESIS; Higgins JP, COCHRANE HDB SYSTEMA; Ismaviani ND, 2014, THESIS; Kim H, 2011, J FOOD SCI, V76, pC38, DOI 10.1111/j.1750-3841.2010.01908.x; Le Bellec Fabrice, 2006, Fruits, V61, P237, DOI 10.1051/fruits:2006021; Lim TK, 2012, EDIBLE MEDICINAL AND NON-MEDICINAL PLANTS: VOL 1, FRUITS, P1, DOI 10.1007/978-90-481-8661-7; Marcelia K., 2015, J NUTR COLL, V4, P79, DOI [10.14710/jnc.v4i1.8624, DOI 10.14710/JNC.V4I2.10056, DOI 10.14710/JNC.V4I1.8624]; Nitithan Suree, 2004, Journal of the Medical Association of Thailand, V87, P1444; Omidizadeh A, 2014, RSC ADV, V4, P62978, DOI 10.1039/c4ra10789f; Pablo P.G., 2015, THESIS; Pertiwi WA, 2014, J NUTR COLL, V3, P762; Prabhakar PK, 2008, CURR DIABETES REV, V4, P291, DOI 10.2174/157339908786241124; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Song HZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149670; Song HZ, 2016, J AGR FOOD CHEM, V64, P236, DOI 10.1021/acs.jafc.5b05177; Suh DH, 2014, J AGR FOOD CHEM, V62, P8764, DOI 10.1021/jf5020704; Swarup KRLA, 2010, PHARMACOGN RES, V2, P31, DOI 10.4103/0974-8490.60582; WHO, GLOB REP DIAB; Wiardani NK, 2014, J SKALA HUSADA, V11, P59; Wu LC, 2006, FOOD CHEM, V95, P319, DOI 10.1016/j.foodchem.2005.01.002; Yeh GY, 2003, DIABETES CARE, V26, P1277, DOI 10.2337/diacare.26.4.1277	30	16	17	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184577	10.1371/journal.pone.0184577	http://dx.doi.org/10.1371/journal.pone.0184577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886195	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100161
J	So, D; Knoppers, BM				So, Derek; Knoppers, Bartha M.			Ethics approval in applications for openaccess clinical trial data: An analysis of researcher statements to clinicalstudydatarequest. com	PLOS ONE			English	Article							INTERNATIONAL COMMITTEE	Although there are a number of online platforms for patient-level clinical trial data sharing from industry sponsors, they are not very harmonized regarding the role of local ethics approval in the research proposal review process. The first and largest of these platforms is ClinicalStudyDataRequest. com (CSDR), which includes over three thousand trials from thirteen sponsors including GlaxoSmithKline, Novartis, Roche, Sanofi, and Bayer. CSDR asks applicants to state whether they have received ethics approval for their research proposal, but in most cases does not require that they submit evidence of approval. However, the website does require that applicants without ethical approval state the reason it was not required. In order to examine the perspectives of researchers on this topic, we coded every response to that question received by CSDR between June 2014 and February 2017. Of 111 applicants who stated they were exempt from ethics approval, 63% mentioned de-identification, 57% mentioned the use of existing data, 33% referred to local or jurisdictional regulations, and 20% referred to the approvals obtained by the original study. We conclude by examining the experience of CSDR within the broader context of the access mechanisms and policies currently being used by other data sharing platforms, and discuss how our findings might be used to help clinical trial data providers design clear and informative access documents.	[So, Derek; Knoppers, Bartha M.] McGill Univ, Dept Human Genet, Ctr Genom & Policy, Montreal, PQ, Canada	McGill University	So, D (corresponding author), McGill Univ, Dept Human Genet, Ctr Genom & Policy, Montreal, PQ, Canada.	derek.so@mail.mcgill.ca			Canadian Institutes of Health Research, Doctoral Research Award [146265]; Pfizer	Canadian Institutes of Health Research, Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Pfizer(Pfizer)	This work was supported by Canadian Institutes of Health Research, Doctoral Research Award #146265 for Derek So; http://www.cihr-irsc. gc.ca/e/193.html. Bartha M. Knoppers is remunerated for her work on the Independent Review Panels of clinicalstudydatarequest.com and of Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbbVie, 2017, DAT INF SHAR QUAL RE; Almirall, 2017, CLIN TRIALS; Amgen, 2017, CLIN TRIAL DAT SHAR; [Anonymous], 2017, IT WORKS 2 SCREENS; [Anonymous], 2017, STUD SPONS 1 SCREEN; Bauchner H, 2016, JAMA-J AM MED ASSOC, V315, P1237, DOI 10.1001/jama.2016.2420; Bial, 2014, TRANSP; Bill & Melinda gates Foundation [internet], 1999, BILL MEL GAT FDN OP; Biogen, 2017, CLIN TRIAL TRANSP DA; Bloom T, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001797; Bristol-Myers Squibb, 2017, DAT SHAR REQ PROC; Bull S, 2015, J EMPIR RES HUM RES, V10, P225, DOI 10.1177/1556264615594767; Celgene, 2014, WELC CELG CLIN TRIAL; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Chiesi, 2017, CLIN TRIAL TRANSP ST; ClinialStudyDataRequest. com, METR 3 SCREENS; Clinical Trials at Novo Nordisk, 2013, CLIN TRIALS NOV NORD; ClinicalStudyDataRequest. com, 2015, CLIN DAT REQ FORM; ClinicalStudyDataRequest. com, 2015, DAT SHAR AGR; Committee on Strategies for Responsible Sharing of Clinical Trial Data, 2015, SHAR CLIN TRIAL DAT; Duke Clinical Research Institute [Internet], SOAR DAT 1 SCREEN; EFPIA, 2017, RESP DAT SHAR; Eichler HG, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001202; EMA, 2014, EUROPEAN MED AGENCY; EMD Serono, 2017, EMD SER COMM RESP CL; European Federation of Pharmaceutical Industries and Associations (EFPIA) and Pharmaceutical Research and Manufacturers of America (PhRMA), 2013, PRINC RESP CLIN TRIA; Global Alliance for Genomics & Health, 2016, GLOB ALL GEN HLTH DA; Global Alliance for Genomics & Health, GLOB ALL GEN HLTH ET; Godlee F, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7888; Gru E nenthal Group [Internet], 2017, DAT SHAR 1 SCREEN; Holdren JP, 2013, INCREAING ACCESS RES; International Society for Biological and Environmental Repositories, 2011, BE3ST PRACT REP COLL; Ipsen Group [Internet], 2014, SCI PUBL PUBL DISCL; Krumholz HM, 2014, JAMA-J AM MED ASSOC, V312, P1002, DOI 10.1001/jama.2014.9647; Leo Pharma, 2013, GET ACC AN PAT LEV D; Mello MM, 2013, NEW ENGL J MED, V369, P1651, DOI 10.1056/NEJMhle1309073; Menarini Group [Internet], 2015, DAT 1 SCREEN; Merck, 2009, POL PERSP 1 SCREEN; National Cancer Institute [Internet], WELC CANC DAT ACC SY; National Health Service, 2010, NRES GUID RES DAT AP; National Heart, AGR TEMPL; National Institutes of Health [Internet], 2012, NIH DAT SHAR POL IMP; OECD, 2009, OECD GUID HUM BIOB G; Otsuka Pharmaceutical Co, 2017, CLIN TRIAL DAT TRANS; Pfizer, 2002, WELC INT SYST PFIZ I; PharmaCM DT, 2017, ASTRAZENECA GROUP CO; Project Data Sphere, 2017, APPL FOR ACC; Servier, 2017, SERV CLIN TRIAL DAT; ShireTrials. com, 2016, ENH DAT SHAR RES; So D, 2013, PUBLIC HEALTH GENOM, V16, P322, DOI 10.1159/000355941; Strom BL, 2016, NEW ENGL J MED, V375, P1608, DOI 10.1056/NEJMp1610336; Sudlow R, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0171-x; Taichman DB, 2017, NEW ENGL J MED, V376, P2277, DOI 10.1056/NEJMe1705439; Taichman DB, 2016, ANN INTERN MED, V164, P505, DOI 10.7326/M15-2928; The Global Alliance for Genomics and Health (GA4GH), 2014, FRAM RESP SHAR GEN H; The Multi-Regional Clinical, 2017, BRIGH WOM HOSP DIV G; The PLoS Med Editors, 2016, PLOS MED, V13; The YODA Project [Internet], DAT REQ REV PROC 1 S; TrialScope, PHARMACM PLATF 2 SCR; Tudur Smith, 2015, GOOD PRACTICE PRINCI; US Food and Drug Administration, 2013, AV MASK DEID NONS SA; Valby H., 2015, CLIN TRIAL DAT SHAR; Vickers AJ, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2323; Viiv Healthcare, WHO WE AR; VISTA, 2012, VISTA INT STROKE TRI; Walport M, 2011, LANCET, V377, P537, DOI 10.1016/S0140-6736(10)62234-9; Westergren A., HOUS J INT L, V38, P3; World Health Organization [Internet], 2017, DEV GLOB NORMS SHAR	68	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184491	10.1371/journal.pone.0184491	http://dx.doi.org/10.1371/journal.pone.0184491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886178	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100138
J	Sonntag, R; Braun, S; Al-Salehi, L; Reinders, J; Mueller, U; Kretzer, JP				Sonntag, Robert; Braun, Steffen; Al-Salehi, Loay; Reinders, Joern; Mueller, Ulrike; Kretzer, J. Philippe			Three-dimensional friction measurement during hip simulation	PLOS ONE			English	Article							LOADING CONDITIONS; COBALT-CHROMIUM; HEAD SIZE; WEAR; METAL; LUBRICATION; JOINT; TAPER; ARTHROPLASTY; REPLACEMENTS	Objectives Wear of total hip replacements has been the focus of many studies. However, frictional effects, such as high loading on intramodular connections or the interface to the bone, as well as friction associated squeaking have recently increased interest about the amount of friction that is generated during daily activities. The aim of this study was thus to establish and validate a three-dimensional friction setup under standardized conditions. Materials and methods A standard hip simulator was modified to allow for high precision measurements of small frictional effects in the hip during three-dimensional hip articulation. The setup was verified by an ideal hydrostatic bearing and validated with a static-load physical pendulum and an extension-flexion rotation with a dynamic load profile. Additionally, a pendulum model was proposed for screening measurement of frictional effects based on the damping behavior of the angular oscillation without the need for any force/moment transducer. Finally, three-dimensional friction measurements have been realized for ceramic-on-polyethylene bearings of three different sizes (28, 36 and 40 mm). Results A precision of less than 0.2 Nm during three-dimensional friction measurements was reported, while increased frictional torque (resultant as well as taper torque) was measured for larger head diameters. These effects have been confirmed by simple pendulum tests and the theoretical model. A comparison with current literature about friction measurements is presented. Conclusions This investigation of friction is able to provide more information about a field that has been dominated by the reduction of wear. It should be considered in future pre-clinical testing protocols given by international organizations of standardization.	[Sonntag, Robert; Braun, Steffen; Al-Salehi, Loay; Reinders, Joern; Mueller, Ulrike; Kretzer, J. Philippe] Heidelberg Univ Hosp, Clin Orthoped & Trauma Surg, Lab Biomech & Implant Res, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Sonntag, R (corresponding author), Heidelberg Univ Hosp, Clin Orthoped & Trauma Surg, Lab Biomech & Implant Res, Heidelberg, Germany.	robert.sonntag@med.uni-heidelberg.de		Reinders, Jorn/0000-0002-8258-7735	Ministry of Art and Science of Baden-Wurttemberg, Germany	Ministry of Art and Science of Baden-Wurttemberg, Germany	The work was funded through the Ministry of Art and Science of Baden-Wurttemberg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajjar M, 2013, J BIOMED MATER RES B, V101B, P213, DOI 10.1002/jbm.b.32824; Bergmann G, 2001, J BIOMECH, V34, P859, DOI 10.1016/S0021-9290(01)00040-9; Bishop N, 2007, ANN M GERM BIOM SOC; Bishop NE, 2008, MED ENG PHYS, V30, P1057, DOI 10.1016/j.medengphy.2008.01.001; Bishop NE, 2012, FRICTION IN LAGER DI; Bishop NE, 2013, J ORTHOP RES, V31, P807, DOI 10.1002/jor.22255; Bowsher JG, 2001, WEAR, V250, P167, DOI 10.1016/S0043-1648(01)00619-6; Brockett C, 2007, J BIOMED MATER RES B, V81B, P508, DOI 10.1002/jbm.b.30691; CHARNLEY J, 1960, ANN RHEUM DIS, V19, P10, DOI 10.1136/ard.19.1.10; CHARNLEY J, 1960, BRIT MED J, V1, P821, DOI 10.1136/bmj.1.5176.821; Cooper HJ, 2012, J BONE JOINT SURG AM, V94A, P1655, DOI 10.2106/JBJS.K.01352; Damm P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120438; Damm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078373; DAVIDSON JA, 1988, J BIOMED MATER RES-A, V22, P69; Fabry C, 2013, MED ENG PHYS, V35, P131, DOI 10.1016/j.medengphy.2012.07.014; Flannery M, 2008, WEAR, V265, P1009, DOI 10.1016/j.wear.2008.02.023; Goetz D D, 1993, Iowa Orthop J, V13, P29; Haider H, 2016, P I MECH ENG H, V230, P373, DOI 10.1177/0954411916644476; Halim T, 2014, P I MECH ENG H, V228, P703, DOI 10.1177/0954411914538782; HALL RM, 1994, WEAR, V175, P159, DOI 10.1016/0043-1648(94)90179-1; Jones E. S., 1936, LANCET, V227, P1043, DOI DOI 10.1016/S0140-6736(01)37157-X; Kaddick C, 2015, AM SOC TEST MATER, V1591, P336, DOI 10.1520/STP159120140146; Kurtz SM, 2013, CLIN ORTHOP RELAT R, V471, P3270, DOI 10.1007/s11999-013-3096-2; Liao YS, 2003, BIOMATERIALS, V24, P3047, DOI 10.1061/S01429612(03)00148-0; Liu F, 2006, P I MECH ENG H, V220, P695, DOI 10.1243/09544119JEIM172; MA SM, 1983, J BONE JOINT SURG AM, V65, P366, DOI 10.2106/00004623-198365030-00012; McKellop H, 1999, J ORTHOP RES, V17, P157, DOI 10.1002/jor.1100170203; O'Kelly J, 1977, EVALUATION ARTIFICIA, P19; Panagiotidou A, 2015, BONE JOINT J, V97B, P463, DOI 10.1302/0301-620X.97B4.34800; Plate Johannes F, 2012, BMC Res Notes, V5, P553, DOI 10.1186/1756-0500-5-553; Rehmer A, 2012, CLIN BIOMECH, V27, P77, DOI 10.1016/j.clinbiomech.2011.08.002; Saikko V, 1992, Proc Inst Mech Eng H, V206, P201, DOI 10.1243/PIME_PROC_1992_206_292_02; Saikko V, 2016, P I MECH ENG H, V230, P366, DOI 10.1177/0954411915610602; Saikko V, 2009, J TRIBOL-T ASME, V131, DOI 10.1115/1.2991121; Schafer R, 1998, J MATER SCI-MATER M, V9, P687, DOI 10.1023/A:1008926213433; Singh SP, 2013, INDIAN J ORTHOP, V47, P443, DOI 10.4103/0019-5413.118198; Sonntag R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071622; Spinelli M, 2010, P I MECH ENG H, V224, P865, DOI 10.1243/09544119JEIM683; Stanton T E, 1923, ENGINEER, V29, P678; Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902; Unsworth A, 2016, P I MECH ENG H, V230, P359, DOI 10.1177/0954411916637382; WALKER PS, 1971, WEAR, V17, P285, DOI 10.1016/0043-1648(71)90032-9; Witt F, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01199	43	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184043	10.1371/journal.pone.0184043	http://dx.doi.org/10.1371/journal.pone.0184043			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886102	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100056
J	Thirion-Delalande, C; Gervais, F; Fisch, C; Cuine, J; Baron-Bodo, V; Moingeon, P; Mascarell, L				Thirion-Delalande, Catherine; Gervais, Frederic; Fisch, Cecile; Cuine, Jean; Baron-Bodo, Veronique; Moingeon, Philippe; Mascarell, Laurent			Comparative analysis of the oral mucosae from rodents and non-rodents: Application to the nonclinical evaluation of sublingual immunotherapy products	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; ALLERGEN IMMUNOTHERAPY; CLINICAL BENEFIT; MURINE MODEL; MOUSE MODEL; EFFICACY; TOLERANCE; ANTIGEN; TABLETS	Background A comparative characterization of the oral mucosa in various animals is needed to identify the best animal model(s) for nonclinical evaluation of sublingual immunotherapy products. With this aim, we studied the histological characteristics and immune cell infiltrates of oral mucosae from common animal species. Methods Three oral regions (i.e. ventral surface of the tongue, mouth floor and cheek) obtained from eight animal species, including rodents (i.e. mice, rats, hamsters, guinea pigs) and nonrodents (i.e. rabbits, dogs, minipigs and monkeys) were characterized by histology and immunohistology in comparison with a human tongue. Results Rodents exhibit a thin keratinized epithelium with low epithelial extensions, whereas nonrodents, most particularly minipigs and monkeys, display a non-keratinized epithelium with larger rete ridges, similarly to humans. Glycogen-rich cells in the superficial epithelial layers are observed in samples from both minipigs, monkeys and humans. Comparable immune subpopulations detected in the 3 oral regions from rodent and non-rodent species include MHC-II+ antigen presenting cells, mostly CD163(+) macrophages, located in the lamina propria (LP) and muscle tissue in the vicinity of resident CD3(+)CD4(+) T cells. Limited numbers of mast cells are also detected in the LP and muscle tissue from all species. Conclusion The oral mucosae of minipigs and monkeys are closest to that of humans, and the immune networks are quite similar between all rodents and non-rodents. Taking into account the ethical and logistical difficulties of performing research in the latter species, rodents and especially mice, should preferentially be used for pharmacodynamics/efficacy studies. Our data also support the use of minipigs to perform biodistribution and safety studies of sublingual immunotherapy products.	[Thirion-Delalande, Catherine; Gervais, Frederic] CiToxLAB, Evreux, France; [Fisch, Cecile; Cuine, Jean] Stallergenes Greer, Tech Dev Dept, Antony, France; [Baron-Bodo, Veronique; Moingeon, Philippe; Mascarell, Laurent] Stallergenes Greer, Res Dept, Antony, France	Stallergenes Greer; Stallergenes Greer	Mascarell, L (corresponding author), Stallergenes Greer, Res Dept, Antony, France.	lmascarell@stallergenes.com			Stallergenes Greer; CiToxLAB France	Stallergenes Greer; CiToxLAB France	This study was supported by Stallergenes Greer and CiToxLAB France which provided support in the form of salaries for authors [CF, JC, VB, PM and LM work for Stallergenes Greer CT and FG work for CiToxLAB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other specific funding was received for this work.	Akdis M, 2014, J ALLERGY CLIN IMMUN, V133, P621, DOI 10.1016/j.jaci.2013.12.1088; Allam JP, 2008, ALLERGY, V63, P720, DOI 10.1111/j.1398-9995.2007.01611.x; Allam JP, 2011, ALLERGY, V66, P532, DOI 10.1111/j.1398-9995.2010.02510.x; Allam JP, 2008, J ALLERGY CLIN IMMUN, V121, P368, DOI 10.1016/j.jaci.2007.09.045; Allam JP, 2014, CURR OPIN ALLERGY CL, V14, P564, DOI 10.1097/ACI.0000000000000118; Allam JP, 2010, J ALLERGY CLIN IMMUN, V126, P638, DOI 10.1016/j.jaci.2010.04.039; Allam JP, 2003, J ALLERGY CLIN IMMUN, V112, P141, DOI 10.1067/mai.2003.1607; [Anonymous], 2007, CLIN IMMUNOL, V120, P1338; Bagnasco M, 2005, INT ARCH ALLERGY IMM, V138, P197, DOI 10.1159/000088719; Bagnasco M, 2001, CLIN EXP ALLERGY, V31, P54, DOI 10.1046/j.1365-2222.2001.00999.x; Bode G, 2010, J PHARMACOL TOX MET, V62, P196, DOI 10.1016/j.vascn.2010.05.009; Bordas-Le Floch V, 2012, INT ARCH ALLERGY IMM, V158, P157, DOI 10.1159/000331143; Brimnes J, 2007, CLIN EXP ALLERGY, V37, P488, DOI 10.1111/j.1365-2222.2006.02624.x; Canonica GW, 2014, WORLD ALLERGY ORGAN, V7, DOI 10.1186/1939-4551-7-6; Dahl R, 2008, J ALLERGY CLIN IMMUN, V121, P512, DOI 10.1016/j.jaci.2007.10.039; Dahl R, 2006, J ALLERGY CLIN IMMUN, V118, P434, DOI 10.1016/j.jaci.2006.05.003; Didier A, 2011, J ALLERGY CLIN IMMUN, V128, P559, DOI 10.1016/j.jaci.2011.06.022; Gueguen C, 2016, J ALLERGY CLIN IMMUN, V137, P545, DOI 10.1016/j.jaci.2015.09.015; Helm RM, 2002, CURR OPIN ALLERGY CL, V2, P541, DOI 10.1097/00130832-200212000-00011; Helm RM, 2002, J ALLERGY CLIN IMMUN, V109, P136, DOI 10.1067/mai.2002.120551; Liu LL, 2013, INT ARCH ALLERGY IMM, V161, P205, DOI 10.1159/000346335; Marcucci F, 2007, ALLERGY, V62, P1475, DOI 10.1111/j.1398-9995.2007.01519.x; Mascarell L, 2015, ALLERGY, V70, P408, DOI 10.1111/all.12576; Mascarell L, 2011, MUCOSAL IMMUNOL, V4, P638, DOI 10.1038/mi.2011.28; Mascarell L, 2009, CLIN EXP ALLERGY, V39, P1910, DOI 10.1111/j.1365-2222.2009.03337.x; Mascarell L, 2008, J ALLERGY CLIN IMMUN, V122, P603, DOI 10.1016/j.jaci.2008.06.034; Moingeon P, 2013, J ALLER CL IMM-PRACT, V1, P228, DOI 10.1016/j.jaip.2013.03.013; Nagai Y, 2015, CLIN EXP ALLERGY, V45, P677, DOI 10.1111/cea.12329; Nolte H, 2016, J ALLERGY CLIN IMMUN, V138, P1631, DOI 10.1016/j.jaci.2016.06.044; Nolte H, 2015, J ALLERGY CLIN IMMUN, V135, P1494, DOI 10.1016/j.jaci.2014.12.1911; Okamoto Y, 2016, ALLERGY, V72, P435; Razafindratsita A, 2007, J ALLERGY CLIN IMMUN, V120, P278, DOI 10.1016/j.jaci.2007.04.009; Roux M, 2016, J ALLERGY CLIN IMMUN, V138, P451, DOI 10.1016/j.jaci.2016.03.039; Squier C A, 2001, J Natl Cancer Inst Monogr, P7; Svensson J, 2011, J IMMUNOL, V187, P3671, DOI 10.4049/jimmunol.1100130; Svensson-Arvelund J, 2015, J IMMUNOL, V194, P1534, DOI 10.4049/jimmunol.1401536; Tanaka Y, 2017, MUCOSAL IMMUNOL, V10, P79, DOI 10.1038/mi.2016.46; Tourdot S, 2011, CLIN EXP ALLERGY, V41, P1784, DOI 10.1111/j.1365-2222.2011.03865.x; Tourdot S, 2013, VACCINE, V31, P2628, DOI 10.1016/j.vaccine.2013.03.041; Virchow JC, 2016, JAMA-J AM MED ASSOC, V315, P1715, DOI 10.1001/jama.2016.3964; Wahn U, 2009, J ALLERGY CLIN IMMUN, V123, P160, DOI 10.1016/j.jaci.2008.10.009; Wu TF, 2013, CELLS TISSUES ORGANS, V197, P239, DOI 10.1159/000342926; Yu HQ, 2010, INT ARCH ALLERGY IMM, V152, P41, DOI 10.1159/000260082; Zhang CY, 2014, VACCINE, V32, P5669, DOI 10.1016/j.vaccine.2014.08.013	44	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183398	10.1371/journal.pone.0183398	http://dx.doi.org/10.1371/journal.pone.0183398			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886055	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100021
J	Davenport, KA; Hoover, CE; Bian, JF; Telling, GC; Mathiason, CK; Hoover, EA				Davenport, Kristen A.; Hoover, Clare E.; Bian, Jifeng; Telling, Glenn C.; Mathiason, Candace K.; Hoover, Edward A.			PrPC expression and prion seeding activity in the alimentary tract and lymphoid tissue of deer	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; WHITE-TAILED DEER; TIME RT-PCR; PROTEIN PRPC; MULE DEER; ODOCOILEUS-HEMIONUS; NERVOUS-SYSTEM; MOUSE SCRAPIE; SPONGIFORM ENCEPHALOPATHY; ORAL-TRANSMISSION	The agent responsible for prion diseases is a misfolded form of a normal protein (PrPC). The prion hypothesis stipulates that PrPC must be present for the disease to manifest. Cervid populations across the world are infected with chronic wasting disease, a horizontally-transmissible prion disease that is likely spread via oral exposure to infectious prions (PrPCWD). Though PrPCWD has been identified in many tissues, there has been little effort to characterize the overall PrPC expression in cervids and its relationship to PrPCWD accumulation. We used immunohistochemistry (IHC), western blot and enzyme-linked immunosorbent assay to describe PrPC expression in naive white-tailed deer. We used real-time, quaking-induced conversion (RT-QuIC) to detect prion seeding activity in CWD-infected deer. We assessed tissues comprising the alimentary tract, alimentary-associated lymphoid tissue and systemic lymphoid tissue from 5 naive deer. PrPC was expressed in all tissues, though expression was often very low compared to the level in the CNS. IHC identified specific cell types wherein PrPC expression is very high. To compare the distribution of PrPC to PrPCWD, we examined 5 deer with advanced CWD infection. Using RT-QuIC, we detected prion seeding activity in all 21 tissues. In 3 subclinical deer sacrificed 4 months post-inoculation, we detected PrPCWD consistently in alimentary-associated lymphoid tissue, irregularly in alimentary tract tissues, and not at all in the brain. Contrary to our hypothesis that PrPC levels dictate prion accumulation, PrPC expression was higher in the lower gastrointestinal tissues than in the alimentary-associated lymphoid system and was higher in salivary glands than in the oropharyngeal lymphoid tissue. These data suggest that PrPC expression is not the sole driver of prion accumulation and that alimentary tract tissues accumulate prions before centrifugal spread from the brain occurs.	[Davenport, Kristen A.; Hoover, Clare E.; Bian, Jifeng; Telling, Glenn C.; Mathiason, Candace K.; Hoover, Edward A.] Colorado State Univ, Microbiol Immunol & Pathol Dept, Prion Res Ctr, Ft Collins, CO 80523 USA	Colorado State University	Hoover, EA (corresponding author), Colorado State Univ, Microbiol Immunol & Pathol Dept, Prion Res Ctr, Ft Collins, CO 80523 USA.	edward.hoover@colostate.edu	Davenport, Kristen A/O-3327-2017; Telling, Glenn C/G-1217-2019; Bian, Jifeng/AAE-6262-2019	Telling, Glenn C/0000-0002-6294-1805; Bian, Jifeng/0000-0001-6838-9938; Davenport, Kristen/0000-0003-3496-2454	 [R01-NS-061902];  [HHSN2722010000091-TO-D-05];  [T32-OD0-10437];  [R01-NS-076894];  [R01-AI112956];  [F30-ORIP-118143]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061902] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010437, F30OD021442] Funding Source: NIH RePORTER	; ; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding wa s provided by R01-NS-061902 (EAH), HHSN2722010000091-TO-D-05 (EAH), T32-OD0-10437 (CEH), R01-NS-076894 (CKM), R01-AI112956 (CKM), and F30-ORIP-118143 (KAD); https//www.nih.gov/. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Andreoletti O, 2000, J GEN VIROL, V81, P3115, DOI 10.1099/0022-1317-81-12-3115; Angers RC, 2006, SCIENCE, V311, P1117, DOI 10.1126/science.1122864; Balachandran A, 2010, CAN VET J, V51, P169; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Bosque PJ, 2002, P NATL ACAD SCI USA, V99, P3812, DOI 10.1073/pnas.052707499; Brandner S, 1996, P NATL ACAD SCI USA, V93, P13148, DOI 10.1073/pnas.93.23.13148; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Cheng YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166187; Clouse MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117935; Davenport KA, 2015, J VIROLOGY; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Department for Environment FaRA Animal and Plant Health Agency, 2016, CERV SPONG ENC NORW; Donaldson DS, 2012, MUCOSAL IMMUNOL, V5, P216, DOI 10.1038/mi.2011.68; Ford MJ, 2002, NEUROSCIENCE, V113, P177, DOI 10.1016/S0306-4522(02)00155-0; Fournier JG, 1998, CELL TISSUE RES, V292, P77, DOI 10.1007/s004410051036; Fox KA, 2006, J GEN VIROL, V87, P3451, DOI 10.1099/vir.0.81999-0; GARCIACRESPO D, 2005, BMC VET RES, V1, P1; Glaysher BR, 2007, J IMMUNOL, V178, P3757, DOI 10.4049/jimmunol.178.6.3757; Haley NJ, 2015, ANNU REV ANIM BIOSCI, V3, P305, DOI 10.1146/annurev-animal-022114-111001; Haley NJ, 2011, J VIROL, V85, P6309, DOI 10.1128/JVI.00425-11; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007990; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Haley NJ, 2014, J CLIN MICROBIOLOGY; Heggebo R, 2002, J GEN VIROL, V83, P479, DOI 10.1099/0022-1317-83-2-479; Henderson DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074377; Henderson DM, 2015, J VIROLOGY; Henderson DM, 2014, J GEN VIROLOGY; Hoover CE, 2017, J VIROLOGY; HORIUCHI M, 1995, J GEN VIROL, V76, P2583, DOI 10.1099/0022-1317-76-10-2583; Jewell JE, 2006, J GEN VIROL, V87, P3443, DOI 10.1099/vir.0.81777-0; Kang HE, 2012, J BIOL CHEM, V287, P37219, DOI 10.1074/jbc.M112.395921; KIMBERLIN RH, 1983, J NEUROL SCI, V61, P315, DOI 10.1016/0022-510X(83)90165-X; KIMBERLIN RH, 1983, J GEN VIROL, V64, P713, DOI 10.1099/0022-1317-64-3-713; KIMBERLIN RH, 1988, J GEN VIROL, V69, P2953, DOI 10.1099/0022-1317-69-12-2953; KIMBERLIN RH, 1979, J COMP PATHOL, V89, P551, DOI 10.1016/0021-9975(79)90046-X; KIMBERLIN RH, 1989, VIRUS RES, V12, P213, DOI 10.1016/0168-1702(89)90040-3; KIMBERLIN RH, 1989, VIRUS RES, V12, P201, DOI 10.1016/0168-1702(89)90039-7; Kyd JM, 2008, VACCINE, V26, P6221, DOI 10.1016/j.vaccine.2008.09.061; Lemaire-Vieille C, 2000, P NATL ACAD SCI USA, V97, P5422, DOI 10.1073/pnas.080081197; Mabbott NA, 2006, NAT REV MICROBIOL, V4, P201, DOI 10.1038/nrmicro1346; Mathiason CK, 2010, J VIROL, V84, P5097, DOI 10.1128/JVI.02169-09; Michel B, 2012, SCI REP-UK, V2, DOI 10.1038/srep00440; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Miron N, 2012, CLIN EXP IMMUNOL, V167, P405, DOI 10.1111/j.1365-2249.2011.04523.x; Morel E, 2004, J BIOL CHEM, V279, P1499, DOI 10.1074/jbc.M308578200; Morel E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003000; Ning ZY, 2005, ANIM BIOTECHNOL, V16, P55, DOI 10.1081/ABIO-200053404; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Paltrinieri S, 2004, J HISTOCHEM CYTOCHEM, V52, P1639, DOI 10.1369/jhc.4A6441.2004; Peralta OA, 2009, PRION, V3, P161, DOI 10.4161/pri.3.3.9772; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Prinz M, 2003, AM J PATHOL, V162, P1103, DOI 10.1016/S0002-9440(10)63907-7; Race B, 2009, J VIROL, V83, P9608, DOI 10.1128/JVI.01127-09; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; Race R, 1998, J INFECT DIS, V178, P949, DOI 10.1086/515669; Sigurdson CJ, 1999, J GEN VIROL, V80, P2757, DOI 10.1099/0022-1317-80-10-2757; Sigurdson CJ, 2001, J GEN VIROL, V82, P2327, DOI 10.1099/0022-1317-82-10-2327; Spraker TR, 2002, VET PATHOL, V39, P546, DOI 10.1354/vp.39-5-546; Stewart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050623; Thomzig A, 2004, J CLIN INVEST, V113, P1465, DOI 10.1172/JCI200421083; Tichopad A, 2003, MOL CELL PROBE, V17, P5, DOI 10.1016/S0890-8508(02)00114-7; Urayama A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32338; van Keulen LJM, 2002, APMIS, V110, P23, DOI 10.1034/j.1600-0463.2002.100104.x; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89	66	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183927	10.1371/journal.pone.0183927	http://dx.doi.org/10.1371/journal.pone.0183927			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880938	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200028
J	Matsui, H; Sugie, A				Matsui, Hideaki; Sugie, Atsushi			An optimized method for counting dopaminergic neurons in zebrafish	PLOS ONE			English	Article							PARKINSONS-DISEASE; ANIMAL-MODELS; MEDAKA FISH; DANIO-RERIO; BRAIN; SYSTEM; DEGENERATION; DYSFUNCTION; INHIBITION; DEFICIENCY	In recent years, considerable effort has been devoted to the development of a fish model for Parkinson's disease (PD) to examine the pathological mechanisms of neurodegeneration. To effectively evaluate PD pathology, the ability to accurately and reliably count dopaminergic neurons is important. However, there is currently no such standardized method. Due to the relatively small number of dopaminergic neurons in fish, stereological estimation would not be suitable. In addition, serial sectioning requires proficiency to not lose any sections, and it permits double counting due to the large size of some of the dopaminergic neurons. In this study, we report an optimized protocol for staining dopaminergic neurons in zebrafish and provide a reliable counting method. Finally, using our optimized protocol, we confirmed that administration of 6-hydroxydopamine (a neurotoxin) or the deletion of the PINK1 gene (one of the causative genes of familiar PD) in zebrafish caused significant reduction in the number of dopaminergic and noradrenergic neurons. In summary, this method will serve as an important tool for the appropriate evaluation and establishment of fish PD models.	[Matsui, Hideaki; Sugie, Atsushi] Niigata Univ, Ctr Transdisciplinary Res, Dept Neurosci Dis, Niigatashi, Niigata, Japan; [Matsui, Hideaki; Sugie, Atsushi] Niigata Univ, Brain Res Inst, Niigatashi, Niigata, Japan	Niigata University; Niigata University	Matsui, H (corresponding author), Niigata Univ, Ctr Transdisciplinary Res, Dept Neurosci Dis, Niigatashi, Niigata, Japan.; Matsui, H (corresponding author), Niigata Univ, Brain Res Inst, Niigatashi, Niigata, Japan.	hide0729@bri.niigata-u.ac.jp		Matsui, Hideaki/0000-0003-4908-1035	Japan Intractable Diseases Research Foundation; GSK Japan Research Grant; Takeda Science Foundation Grant; JSPS KAKENHI [JP 17925674]	Japan Intractable Diseases Research Foundation; GSK Japan Research Grant; Takeda Science Foundation Grant; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Intractable Diseases Research Foundation (http:// www.nanbyou.jp), and GSK Japan Research Grant 2015 (http://jp.gsk.com/jp/research/ glaxosmithkine-research-grant/glaxosmithklineresearch-grant-2015/) and Takeda Science Foundation Grant, JSPS KAKENHI grant numbers JP 17925674. The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Behrouz B, 2007, NEUROSCIENCE, V147, P592, DOI 10.1016/j.neuroscience.2007.05.007; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Blin M, 2008, MOL CELL NEUROSCI, V39, P592, DOI 10.1016/j.mcn.2008.08.006; Busby ER, 2010, FISH PHYSIOL, V29, P173, DOI 10.1016/S1546-5098(10)02905-5; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Del Tredici K, 2013, J NEUROL NEUROSUR PS, V84, P774, DOI 10.1136/jnnp-2011-301817; Drobysheva D, 2008, J HISTOCHEM CYTOCHEM, V56, P1049, DOI 10.1369/jhc.2008.951137; Filippi A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-135; Filippi A, 2012, DEV BIOL, V369, P133, DOI 10.1016/j.ydbio.2012.06.010; Filippi A, 2010, J COMP NEUROL, V518, P423, DOI 10.1002/cne.22213; Flinn LJ, 2013, ANN NEUROL, V74, P837, DOI 10.1002/ana.23999; GUPTA M, 1986, NEUROSCI LETT, V70, P326, DOI 10.1016/0304-3940(86)90573-2; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jay M, 2015, CURR BIOL, V25, P435, DOI 10.1016/j.cub.2014.12.033; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; KAH O, 1984, NEUROSCI LETT, V48, P293, DOI 10.1016/0304-3940(84)90053-3; Kastenhuber E, 2010, J COMP NEUROL, V518, P439, DOI 10.1002/cne.22214; Keatinge M, 2015, HUM MOL GENET, V24, P6640, DOI 10.1093/hmg/ddv369; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lohr H, 2009, DEVELOPMENT, V136, P1007, DOI 10.1242/dev.033878; MacRae CA, 2015, NAT REV DRUG DISCOV, V14, P721, DOI 10.1038/nrd4627; Matsui H., NEUROSCIENC IN PRESS; Matsui H., DEV GROWTH IN PRESS; Matsui H, 2014, J PARKINSON DIS, V4, P301, DOI 10.3233/JPD-130289; Matsui H, 2013, HUM MOL GENET, V22, P2423, DOI 10.1093/hmg/ddt095; Matsui H, 2013, FEBS LETT, V587, P1316, DOI 10.1016/j.febslet.2013.02.046; Matsui Hideaki, 2012, Exp Neurobiol, V21, P94, DOI 10.5607/en.2012.21.3.94; Matsui H, 2010, J NEUROCHEM, V115, P1150, DOI 10.1111/j.1471-4159.2010.07012.x; Matsui H, 2010, J NEUROCHEM, V115, P178, DOI 10.1111/j.1471-4159.2010.06918.x; Matsui H, 2009, NEUROSCI RES, V65, P263, DOI 10.1016/j.neures.2009.07.010; MEEK J, 1993, J COMP NEUROL, V328, P145, DOI 10.1002/cne.903280111; Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3; Parkinsonism Fahn S., 1995, PARKINSONISM MERRITT, P713; Rink E, 2004, BRAIN RES, V1011, P206, DOI 10.1016/j.brainres.2004.03.027; Rink E, 2002, DEV BRAIN RES, V137, P89, DOI 10.1016/S0165-3806(02)00354-1; Ryu S, 2007, CURR BIOL, V17, P873, DOI 10.1016/j.cub.2007.04.003; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Sotiriou E, 2010, NEUROBIOL AGING, V31, P2103, DOI 10.1016/j.neurobiolaging.2008.11.010; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Uemura N, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005065; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704	46	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184363	10.1371/journal.pone.0184363	http://dx.doi.org/10.1371/journal.pone.0184363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880915	Green Submitted, gold, Green Published			2022-12-27	WOS:000409467200058
J	Romoren, M; Gjelstad, S; Lindbaek, M				Romoren, Maria; Gjelstad, Svein; Lindbaek, Morten			A structured training program for health workers in intravenous treatment with fluids and antibiotics in nursing homes: A modified stepped-wedge cluster-randomised trial to reduce hospital admissions	PLOS ONE			English	Article							MULTIFACETED INTERVENTION; ACQUIRED PNEUMONIA; RESIDENTS; OUTCOMES; GUIDELINES; INFECTION; MORTALITY; HAZARDS	Objectives Hospitalization is potentially detrimental to nursing home patients and resource demanding for the specialist health care. This study assessed if a brief training program in administrating intravenous fluids and antibiotics in nursing homes could reduce hospital transfers and ensure high quality care locally. Design A pragmatic and modified cluster randomized stepped-wedge trial with randomization on nursing home level. Participants 330 cases in 296 nursing home residents from 30 nursing homes were included. Cases were patients provided intravenous antibiotics or intravenous fluids, in nursing home or hospital. Primary outcome was localization of treatment, secondary outcomes were number of days treated, days of hospitalization among admitted patients, type of antibiotics used and 30-day mortality. Intervention The nursing homes sequentially received a one-day educational program for the health workers including theory and practical training in intravenous treatment of dehydration and infection, run by two skilled nurses. After completing the training program, the nursing homes had competence to provide intravenous treatment locally. Results The intervention had a highly significant effect on treatment in nursing homes (OR 8.35, 2.08 to 33.6; P<0.01, or RR 2.23, 1.48 to 2.56). The number treated in nursing homes was stable over time; the number treated in hospital gradually decreased (chi square for trend P< 0.001). Among patients receiving intravenous antibiotics in the nursing homes, 50 (46%) died within 30 days, compared to 30 (36%) treated in the hospital (P = 0.19). Among patients receiving intravenous fluids locally, 21 (19%) died within 30 days, compared to 2 (8%) in the hospital group (P = 0.34). Mortality was associated with reduced consciousness and elevated c-reactive protein. Conclusions A brief educational program delivered to nursing home personnel was feasible and effective in reducing acute hospital admissions from nursing homes for treatment of dehydration and infections.	[Romoren, Maria] Vestfold Hosp Trust, Dept Adm, Tonsberg, Norway; [Romoren, Maria; Gjelstad, Svein; Lindbaek, Morten] Univ Oslo, Dept Gen Practice, Inst Hlth & Soc, Oslo, Norway	University of Oslo	Romoren, M (corresponding author), Vestfold Hosp Trust, Dept Adm, Tonsberg, Norway.; Romoren, M (corresponding author), Univ Oslo, Dept Gen Practice, Inst Hlth & Soc, Oslo, Norway.	maria.romoren@medisin.uio.no			South-Eastern Norway Regional Health Authority; University of Oslo, Norway	South-Eastern Norway Regional Health Authority; University of Oslo, Norway	The 3iV project received funding grants from the South-Eastern Norway Regional Health Authority and the University of Oslo, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agotnes G, 2016, AGEING INT, V41, P3, DOI 10.1007/s12126-015-9232-4; [Anonymous], 2012, TIDSSKR LAEGEFOREN, DOI DOI 10.4045/TIDSSKR.12.0194; Boockvar KS, 2005, J AM GERIATR SOC, V53, P590, DOI 10.1111/j.1532-5415.2005.53205.x; Carpenter I, 2004, AGING CLIN EXP RES, V16, P259; Coque T M, 2008, Euro Surveill, V13; CREDITOR MC, 1993, ANN INTERN MED, V118, P219, DOI 10.7326/0003-4819-118-3-199302010-00011; Friedman SM, 2008, GERONTOLOGIST, V48, P537, DOI 10.1093/geront/48.4.537; Graverholt B, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-36; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Hutt E, 2011, J AM MED DIR ASSOC, V12, P499, DOI 10.1016/j.jamda.2010.03.011; Leontjevas R, 2013, LANCET, V381, P2255, DOI 10.1016/S0140-6736(13)60590-5; Loeb M, 2005, BRIT MED J, V331, P669, DOI 10.1136/bmj.38602.586343.55; Loeb M, 2006, JAMA-J AM MED ASSOC, V295, P2503, DOI 10.1001/jama.295.21.2503; Medical Research Council, 2006, DEV EVALUATING COMPL; Naughton BJ, 2001, J AM GERIATR SOC, V49, P1020, DOI 10.1046/j.1532-5415.2001.49203.x; Nielsen L, 2015, OPEN J MED MICROBIOL, V5, P28, DOI [10.4236/ojmm.2015.51005, DOI 10.4236/OJMM.2015.51005]; Norway Statistics, POPULATION; Norwegian Board of Health Supervision, 2003, PLEIE OMS KOMM TJEN; Norwegian Institute of Public Health, CAUS OF DEATH; Office of the Auditor General of Norway, 2016, RIKSR HELS ETT INNF; Onder G, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-5; Ouslander JG, 2010, J AM GERIATR SOC, V58, P627, DOI 10.1111/j.1532-5415.2010.02768.x; Selbaek G, 2007, INT J GERIATR PSYCH, V22, P843, DOI 10.1002/gps.1749; Steen Tore Walgaard, 2013, Tidsskr Nor Laegeforen, V133, P1819, DOI 10.4045/tidsskr.12.0935; Stern A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-83; The Norwegian Directorate of Health, 2016, NAT GUID ANT PRESCR; The Norwegian Directorate of Health, 2013, NAT GUID ANT PRESCR; Thiem U, 2009, AGE AGEING, V38, P693, DOI 10.1093/ageing/afp164; van der Steen JT, 2004, J AM GERIATR SOC, V52, P691, DOI 10.1111/j.1532-5415.2004.52204.x; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	30	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0182619	10.1371/journal.pone.0182619	http://dx.doi.org/10.1371/journal.pone.0182619			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880941	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200008
J	Santos, C; Nelson, CD; Zhebentyayeva, T; Machado, H; Gomes-Laranjo, J; Costa, RL				Santos, Carmen; Nelson, Charles Dana; Zhebentyayeva, Tetyana; Machado, Helena; Gomes-Laranjo, Jose; Costa, Rita Lourenco			First interspecific genetic linkage map for Castanea sativa x Castanea crenata revealed QTLs for resistance to Phytophthora cinnamomi	PLOS ONE			English	Article							EST-SSR MARKERS; PROTEIN; OVEREXPRESSION; ARABIDOPSIS; TRAITS; BLIGHT; PLANTS; CROSS	The Japanese chestnut (Castanea crenata) carries resistance to Phytophthora cinnamomi, the destructive and widespread oomycete causing ink disease. The European chestnut (Castanea sativa), carrying little to no disease resistance, is currently threatened by the presence of the oomycete pathogen in forests, orchards and nurseries. Determining the genetic basis of P. cinnamomi resistance, for further selection of molecular markers and candidate genes, is a prominent issue for implementation of marker assisted selection in the breeding programs for resistance. In this study, the first interspecific genetic linkage map of C. sativa x C. crenata allowed the detection of QTLs for P. cinnamomi resistance. The genetic map was constructed using two independent, control-cross mapping populations. Chestnut populations were genotyped using 452 microsatellite and single nucleotide polymorphism molecular markers derived from the available chestnut transcriptomes. The consensus genetic map spans 498,9 cM and contains 217 markers mapped with an average interval of 2.3 cM. For QTL analyses, the progression rate of P. cinnamomi lesions in excised shoots inoculated was used as the phenotypic metric. Using non-parametric and composite interval mapping approaches, two QTLs were identified for ink disease resistance, distributed in two linkage groups: E and K. The presence of QTLs located in linkage group E regarding P. cinnamomi resistance is consistent with a previous preliminary study developed in American x Chinese chestnut populations, suggesting the presence of common P. cinnamomi defense mechanisms across species. Results presented here extend the genomic resources of Castanea genus providing potential tools to assist the ongoing and future chestnut breeding programs.	[Santos, Carmen; Machado, Helena; Costa, Rita Lourenco] Inst Nacl Invest Agr & Vet, Lab Biol Mol, IP Ave Republ, Oeiras, Portugal; [Nelson, Charles Dana] US Forest Serv, Southern Inst Forest Genet, Southern Res Stn, USDA, Saucier, MS USA; [Nelson, Charles Dana] Univ Kentucky, Forest Hlth Res & Educ Ctr, Lexington, KY USA; [Zhebentyayeva, Tetyana] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Zhebentyayeva, Tetyana] Clemson Univ, Genom & Computat Biol Lab, Clemson, SC USA; [Gomes-Laranjo, Jose] Univ Tras Os Montes & Alto Douro, Ctr Invest & Tecnol Agroambientais & Biol, Vila Real, Portugal; [Costa, Rita Lourenco] Univ Lisboa Tapada Ajuda, Inst Super Agron, Ctr Estudos Florestais, Lisbon, Portugal; [Santos, Carmen] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier, Ave Republ, Oeiras, Portugal	United States Department of Agriculture (USDA); United States Forest Service; University of Kentucky; Clemson University; Clemson University; University of Tras-os-Montes & Alto Douro; Universidade de Lisboa; Universidade Nova de Lisboa	Costa, RL (corresponding author), Inst Nacl Invest Agr & Vet, Lab Biol Mol, IP Ave Republ, Oeiras, Portugal.; Costa, RL (corresponding author), Univ Lisboa Tapada Ajuda, Inst Super Agron, Ctr Estudos Florestais, Lisbon, Portugal.	rita.lcosta@iniav.pt	MACHADO, HELENA/GVS-1123-2022; Costa, Rita Lourenco/Q-4564-2019; Costa, Rita L/B-5190-2016	Costa, Rita Lourenco/0000-0001-9503-6126; Costa, Rita L/0000-0001-9503-6126; Santos, Carmen/0000-0003-3743-7591; Machado, Helena/0000-0002-1775-0962	Centro de Estudos Florestais (CEF); Fundacao para a Ciencia e Tecnologia I.P. (FCT), Portugal [UID/AGR/00239/2013]; Fundacao para a Ciencia e Tecnologia [PTDC/AGR-CFL/101707/2008];  [SFRH/BD/85140/2012]	Centro de Estudos Florestais (CEF); Fundacao para a Ciencia e Tecnologia I.P. (FCT), Portugal; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); 	Authors acknowledge the funding provided by Centro de Estudos Florestais (CEF), which is a research unit funded by Fundacao para a Ciencia e Tecnologia I.P. (FCT), Portugal (UID/AGR/00239/2013). We acknowledge Fundacao para a Ciencia e Tecnologia through the project PTDC/AGR-CFL/101707/2008 and the PhD grant SFRH/BD/85140/2012 and also Programa ProDere Medida 4.1 Ref 45967 Developing processes and Technologies aiming the production of ink disease resistant. chestnut rootstocks, compatible with national varieties certified with molecular markers and Programa ProDer, Medida 4.1 Ref 53593 Innovation in the production chain of chestnut: competitiveness and sustainability. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostakis SL, 2001, FOREST ECOL MANAG, V152, P225, DOI 10.1016/S0378-1127(00)00605-8; Baker AM, 2009, NUCLEIC ACIDS RES, V37, P5019, DOI 10.1093/nar/gkp515; Bodenes C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-153; Brondani RPV, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-20; Casasoli M, 2004, PLANT CELL ENVIRON, V27, P1088, DOI 10.1111/j.1365-3040.2004.01214.x; Casasoli M, 2001, THEOR APPL GENET, V102, P1190, DOI 10.1007/s00122-001-0553-1; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Coelho AC, 2011, NZ J FORESTRY SCI, P143; CRANDALL BS, 1945, PHYTOPATHOLOGY, V35, P162; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Durand J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-570; Fang GC, 2013, TREE GENET GENOMES, V9, P525, DOI 10.1007/s11295-012-0576-6; Hardham AR, 2005, MOL PLANT PATHOL, V6, P589, DOI 10.1111/J.1364-3703.2005.00308.X; Jacobs DF, 2013, NEW PHYTOL, V197, P378, DOI 10.1111/nph.12020; JANSEN RC, 1994, GENETICS, V136, P1447; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; Kosambi DD, 1944, AM MATH MON, P382, DOI [10.1080/00029890.1944.11999118, DOI 10.1007/978-81-322-3676-4_17, 10.1007/978-81-322-3676-4_17]; Kubisiak TL, 2013, TREE GENET GENOMES, V9, P557, DOI 10.1007/s11295-012-0579-3; Kubisiak TL, 1997, PHYTOPATHOLOGY, V87, P751, DOI 10.1094/PHYTO.1997.87.7.751; Lowe KM, 2006, THEOR APPL GENET, V112, P1582, DOI 10.1007/s00122-006-0264-8; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Santos C, 2015, PLANT PATHOL, V64, P901, DOI 10.1111/ppa.12313; Santos C, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00515; Santos C, 2015, SCI HORTIC-AMSTERDAM, V194, P181, DOI 10.1016/j.scienta.2015.07.043; Schlink K, 2010, FUNCT INTEGR GENOMIC, V10, P253, DOI 10.1007/s10142-009-0143-x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Serrazina S, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0829-7; Sisco P, 2005, P 3 INT CHESTN C ACT, V693; Staton M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1942-1; Varet A, 2003, PLANT PHYSIOL, V132, P2023, DOI 10.1104/pp.103.020438; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Zhang Q, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-537; Zhebentyayeva T, 2014, ACTA HORTIC, V1019, P263, DOI 10.17660/ActaHortic.2014.1019.40	34	28	29	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184381	10.1371/journal.pone.0184381	http://dx.doi.org/10.1371/journal.pone.0184381			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880954	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200062
J	Cui, JY; Liang, HW; Pan, XL; Li, D; Jiao, N; Liu, YH; Fu, J; He, XY; Sun, GX; Zhang, CL; Zhao, CH; Li, DH; Dai, EY; Zen, K; Zhang, FM; Zhang, CY; Chen, X; Ling, H				Cui, Jia-Yi; Liang, Hong-Wei; Pan, Xin-Ling; Li, Di; Jiao, Na; Liu, Yan-Hong; Fu, Jin; He, Xiao-Yu; Sun, Gao-Xiang; Zhang, Chun-Lei; Zhao, Chi-Hao; Li, Dong-Hai; Dai, En-Yu; Zen, Ke; Zhang, Feng-Min; Zhang, Chen-Yu; Chen, Xi; Ling, Hong			Characterization of a novel panel of plasma microRNAs that discriminates between Mycobacterium tuberculosis infection and healthy individuals	PLOS ONE			English	Article							CIRCULATING MICRORNAS; POTENTIAL BIOMARKERS; EXPRESSION; SERUM; IDENTIFICATION; DIAGNOSIS; MIR-320A; CANCER; ROLES	Cavities are important in clinical diagnosis of pulmonary tuberculosis (TB) infected by Mycobacterium tuberculosis. Although microRNAs (miRNAs) play a vital role in the regulation of inflammation, the relation between plasma miRNA and pulmonary tuberculosis with cavity remains unknown. In this study, plasma samples were derived from 89 cavitary pulmonary tuberculosis (CP-TB) patients, 89 non-cavitary pulmonary tuberculosis (NCP-TB) patients and 95 healthy controls. Groups were matched for age and gender. In the screening phase, Illumina high-throughput sequencing technology was employed to analyze miRNA profiles in plasma samples pooled from CP-TB patients, NCP-TB patients and healthy controls. During the training and verification phases, quantitative RT-PCR (qRT-PCR) was conducted to verify the differential expression of selected miRNAs among groups. Illumina high-throughput sequencing identified 29 differentially expressed plasma miRNAs in TB patients when compared to healthy controls. Furthermore, qRT-PCR analysis validated miR-769-5p, miR-320a and miR-22-3p as miRNAs that were differently present between TB patients and healthy controls. ROC curve analysis revealed that the potential of these 3 miRNAs to distinguish TB patients from healthy controls was high, with the area under the ROC curve (AUC) ranged from 0.692 to 0.970. Moreover, miR-320a levels were decreased in drug-resistant TB patients than pan-susceptible TB patients (AUC = 0.882). In conclusion, we identified miR-769-5p, miR-320a and miR-22-3p as potential blood-based biomarkers for TB. In addition, miR-320a may represent a biomarker for drug-resistant TB.	[Cui, Jia-Yi; Pan, Xin-Ling; Li, Di; He, Xiao-Yu; Sun, Gao-Xiang; Dai, En-Yu; Zhang, Feng-Min; Ling, Hong] Harbin Med Univ, Dept Microbiol, Harbin, Heilongjiang, Peoples R China; [Cui, Jia-Yi; Pan, Xin-Ling; Li, Di; He, Xiao-Yu; Sun, Gao-Xiang; Dai, En-Yu; Zhang, Feng-Min; Ling, Hong] Heilongjiang Prov Key Lab Infect & Immun, Harbin, Heilongjiang, Peoples R China; [Cui, Jia-Yi; Pan, Xin-Ling; Li, Di; He, Xiao-Yu; Sun, Gao-Xiang; Dai, En-Yu; Zhang, Feng-Min; Ling, Hong] Key Lab Pathogen Biol, Harbin, Heilongjiang, Peoples R China; [Cui, Jia-Yi; Pan, Xin-Ling; Li, Di; He, Xiao-Yu; Sun, Gao-Xiang; Dai, En-Yu; Zhang, Feng-Min; Zhang, Chen-Yu; Ling, Hong] Harbin Med Univ, Wu Lien Teh Inst, Harbin, Heilongjiang, Peoples R China; [Liang, Hong-Wei; Zhao, Chi-Hao; Li, Dong-Hai; Zen, Ke; Zhang, Chen-Yu; Chen, Xi] Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Sch Life Sci,NJU Adv Inst Life Sci NAILS, Nanjing, Jiangsu, Peoples R China; [Jiao, Na; Zhang, Chun-Lei] Harbin Chest Hosp, Harbin, Heilongjiang, Peoples R China; [Liu, Yan-Hong] Harbin Med Univ, Affiliated Hosp 2, Dept Lab Med, Harbin, Heilongjiang, Peoples R China; [Fu, Jin] Harbin Med Univ, Affiliated Hosp 2, Dept Neurol, Harbin, Heilongjiang, Peoples R China; [Ling, Hong] Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University; Nanjing University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Ling, H (corresponding author), Harbin Med Univ, Dept Microbiol, Harbin, Heilongjiang, Peoples R China.; Ling, H (corresponding author), Heilongjiang Prov Key Lab Infect & Immun, Harbin, Heilongjiang, Peoples R China.; Ling, H (corresponding author), Key Lab Pathogen Biol, Harbin, Heilongjiang, Peoples R China.; Zhang, CY; Ling, H (corresponding author), Harbin Med Univ, Wu Lien Teh Inst, Harbin, Heilongjiang, Peoples R China.; Zhang, CY; Chen, X (corresponding author), Nanjing Univ, Jiangsu Engn Res Ctr MicroRNA Biol & Biotechnol, State Key Lab Pharmaceut Biotechnol, Sch Life Sci,NJU Adv Inst Life Sci NAILS, Nanjing, Jiangsu, Peoples R China.; Ling, H (corresponding author), Harbin Med Univ, Dept Parasitol, Harbin, Heilongjiang, Peoples R China.	cyzhang@nju.edu.cn; xichen@nju.edu.cn; lingh@ems.hrbmu.edu.cn		ling, hong/0000-0002-1886-1242				Abd-El-Fattah AA, 2013, CELL BIOCHEM BIOPHYS, V67, P875, DOI 10.1007/s12013-013-9575-y; Abdalla AE, 2016, INFECT GENET EVOL, V45, P378, DOI 10.1016/j.meegid.2016.09.023; Alipoor SD, 2016, EUR J PHARMACOL, V791, P395, DOI 10.1016/j.ejphar.2016.09.015; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Barry S, 2009, TUBERCULOSIS, V89, P48, DOI 10.1016/j.tube.2008.07.002; Barry SE, 2015, J CELL MOL MED, V19, P1606, DOI 10.1111/jcmm.12535; Bettencourt P, 2016, TUBERCULOSIS, V97, P1, DOI 10.1016/j.tube.2015.12.004; Busch A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010081; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079652; Cheng ZA, 2013, J CLIN IMMUNOL, V33, P567, DOI 10.1007/s10875-012-9834-5; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Dorhoi A, 2016, SEMIN IMMUNOPATHOL, V38, P153, DOI 10.1007/s00281-015-0531-3; Feng L., 2012, DRUG SUSCEPTIBILITY; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Gasparini P, 2015, P NATL ACAD SCI USA, V112, P14924, DOI 10.1073/pnas.1520329112; George GP, 2010, INDIAN J CLIN BIOCHE, V25, P4, DOI 10.1007/s12291-010-0008-z; Gidlof O, 2015, J VASC RES, V52, P71, DOI 10.1159/000431367; Guz M, 2014, DIS MARKERS, V2014, DOI 10.1155/2014/218169; Hennessey PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032307; Hong YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep24229; Ko JM, 2015, EUR J RADIOL, V84, P2339, DOI 10.1016/j.ejrad.2015.07.032; Lee JH, 2015, CANCER RES, V75, P1298, DOI 10.1158/0008-5472.CAN-14-2783; Li D, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1848-9; Li GB, 2014, INT J MOL SCI, V15, P15845, DOI 10.3390/ijms150915845; Liu FT, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-158; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo EC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05908; Perrin FMR, 2010, INT J TUBERC LUNG D, V14, P1596; Qi XM, 2014, FEBS LETT, V588, P3732, DOI 10.1016/j.febslet.2014.08.021; Qi YH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-384; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Schultz NA, 2012, WORLD J SURG, V36, P2699, DOI 10.1007/s00268-012-1705-y; Small Peter M, 2009, Kekkaku, V84, P721; Versluis D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11981; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Welsh KJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/307631; WHO, 2016, GLOB TUB REP WHO; Wu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092292; Wu J, 2012, HUM IMMUNOL, V73, P31, DOI 10.1016/j.humimm.2011.10.003; Xie H, 2014, J INVEST DERMATOL, V134, P507, DOI 10.1038/jid.2013.355; Yang CH, 2013, INT J CANCER, V132, P116, DOI 10.1002/ijc.27657; Zhang CX, 2015, INT J CLIN EXP PATHO, V8, P655; Zhang H, 2014, MATH PROBL ENG, V2014, DOI [10.1155/2014/183580, 10.1007/978-3-319-07200-5_1]; Zhang XY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078348, 10.1371/journal.pone.0082079]; Zheng DL, 2011, INT J CLIN EXP PATHO, V4, P575; Zheng ML, 2016, MICROB PATHOGENESIS, V100, P78, DOI 10.1016/j.micpath.2016.09.005; Zhou MY, 2016, MOL MED REP, V13, P4620, DOI 10.3892/mmr.2016.5097	48	38	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184113	10.1371/journal.pone.0184113	http://dx.doi.org/10.1371/journal.pone.0184113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910318	gold, Green Published, Green Submitted			2022-12-27	WOS:000410859200031
J	Roy, J; Wycislo, KL; Pondenis, H; Fan, TM; Das, A				Roy, Jahnabi; Wycislo, Kathryn L.; Pondenis, Holly; Fan, Timothy M.; Das, Aditi			Comparative proteomic investigation of metastatic and non-metastatic osteosarcoma cells of human and canine origin	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; BREAST-CANCER PROGRESSION; HLA CLASS-I; PROGNOSTIC-SIGNIFICANCE; PULMONARY METASTASIS; SIGNALING PATHWAYS; MELANOMA-CELLS; ANNEXIN-II; EXPRESSION; PROLIFERATION	Osteosarcoma is the most common bone cancer in dogs and people. In order to improve clinical outcomes, it is necessary to identify proteins that are differentially expressed by metastatic cells. Membrane bound proteins are responsible for multiple pro-metastatic functions. Therefore characterizing the differential expression of membranous proteins between metastatic and non-metastatic clonal variants will allow the discovery of druggable targets and consequently improve treatment methodology. The objective of this investigation was to systemically identify the membrane-associated proteomics of metastatic and non-metastatic variants of human and canine origin. Two clonal variants of divergent in vivo metastatic potential from human and canine origins were used. The plasma membranes were isolated and peptide fingerprinting was used to identify differentially expressed proteins. Selected proteins were further validated using western blotting, flow cytometry, confocal microscopy and immunohistochemistry. Over 500 proteins were identified for each cell line with nearly 40% of the proteins differentially regulated. Conserved between both species, metastatic variants demonstrated significant differences in expression of membrane proteins that are responsible for pro-metastatic functions. Additionally, CD147, CD44 and vimentin were validated using various biochemical techniques. Taken together, through a comparative proteomic approach we have identified several differentially expressed cell membrane proteins that will help in the development of future therapeutics.	[Roy, Jahnabi] Univ Illinois, Dept Chem, Urbana, IL USA; [Wycislo, Kathryn L.] Univ Illinois, Dept Pathobiol, Urbana, IL USA; [Pondenis, Holly; Fan, Timothy M.] Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA; [Das, Aditi] Univ Illinois, Neurosci Program, Div Nutr Sci,Dept Comparat Biosci, Dept Biochem,Beckman Inst Adv Sci, Urbana, IL 61801 USA; [Das, Aditi] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Fan, TM (corresponding author), Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA.; Das, A (corresponding author), Univ Illinois, Neurosci Program, Div Nutr Sci,Dept Comparat Biosci, Dept Biochem,Beckman Inst Adv Sci, Urbana, IL 61801 USA.; Das, A (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.	t-fan@illinois.edu; aditidas@illinois.edu	Wycislo, Kathryn L./AAN-3317-2021	Wycislo, Kathryn L./0000-0002-3074-6044; Fan, Timothy/0000-0003-2510-7050; Pondenis, Holly/0000-0003-1708-3570	Campus Research Board; Office of the Provost, University of Illinois at Urbana-Champaign	Campus Research Board; Office of the Provost, University of Illinois at Urbana-Champaign	This work was supported by Campus Research Board, and the Office of the Provost, University of Illinois at Urbana-Champaign.	Barroga EF, 1999, J VET MED SCI, V61, P361; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Corthay A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00197; DIXON WT, 1990, INT J CANCER, V45, P59, DOI 10.1002/ijc.2910450113; Domcke S, 2013, NAT COMMUN, P4; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Elenjord R, 2009, FEBS J, V276, P5275, DOI 10.1111/j.1742-4658.2009.07223.x; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Feral CC, 2005, P NATL ACAD SCI USA, V102, P355, DOI 10.1073/pnas.0404852102; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Goodsell D S, 1999, Oncologist, V4, P263; Hanash S, 2014, GENOME MED, V6, DOI 10.1186/gm529; Hua YQ, 2011, TUMOR BIOL, V32, P1013, DOI 10.1007/s13277-011-0203-4; Hughes DPM, 2009, EXPERT OPIN DRUG DEL, V6, P1311, DOI 10.1517/17425240903280422; Hutchings CJ, 2010, MABS-AUSTIN, V2, P594, DOI 10.4161/mabs.2.6.13420; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Inokuchi J, 2009, INT J CANCER, V124, P68, DOI 10.1002/ijc.23928; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kischel P, 2008, NEOPLASIA, V10, P1014, DOI 10.1593/neo.08570; Koshi H, 2015, PATHOL INT, V65, P460, DOI 10.1111/pin.12323; Lahat G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010105; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leth-Larsen R, 2010, MOL CELL PROTEOMICS, V9, P1369, DOI 10.1074/mcp.R900006-MCP200; Li Y, 2009, HISTOPATHOLOGY, V54, P677, DOI 10.1111/j.1365-2559.2009.03280.x; Liu XJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-74; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; Lu Q, 2013, ONCOL LETT, V5, P201, DOI 10.3892/ol.2012.981; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Mikami S, 2014, INT J CANC; Mohammad HS, 2008, INT J ONCOL, V33, P1157, DOI 10.3892/ijo_00000105; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Pinheiro C, 2009, DIS MARKERS, V26, P97, DOI [10.3233/DMA-2009-0596, 10.1155/2009/169678]; Poschke I, 2011, CANCER IMMUNOL IMMUN, V60, P1161, DOI 10.1007/s00262-011-1012-8; PosthumaDeBoer J, 2013, BRIT J CANCER, V109, P2142, DOI 10.1038/bjc.2013.578; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Roy J, 2015, BIOCHEMISTRY-US, V54, P6299, DOI 10.1021/acs.biochem.5b00954; Sanz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085110; Shapiro P, 2002, CRIT REV CL LAB SCI, V39, P285, DOI 10.1080/10408360290795538; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Sillanpaa S, 2003, CLIN CANCER RES, V9, P5318; Singh A, 2015, EUR J PHARMACOL, V763, P178, DOI 10.1016/j.ejphar.2015.05.011; Su J, 2009, CANCER LETT, V273, P140, DOI 10.1016/j.canlet.2008.07.034; Tsukahara T, 2006, CANCER SCI, V97, P1374, DOI 10.1111/j.1349-7006.2006.00317.x; Vihinen P, 1996, CELL GROWTH DIFFER, V7, P439; VISHWANATHA JK, 1993, CARCINOGENESIS, V14, P2575, DOI 10.1093/carcin/14.12.2575; Wang LP, 2010, NEOPLASMA, V57, P253, DOI 10.4149/neo_2010_03_253; Werbeck JL, 2014, VET PATHOL, V51, P868, DOI 10.1177/0300985813505116; Xu J, 2007, HEPATOLOGY, V45, P269, DOI 10.1002/hep.21465; Zeestraten ECM, 2014, BRIT J CANCER, V110, P459, DOI 10.1038/bjc.2013.696; Zhang ZY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-206	54	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183930	10.1371/journal.pone.0183930	http://dx.doi.org/10.1371/journal.pone.0183930			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910304	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200023
J	Blanco-Guillot, F; Delgado-Sanchez, G; Mongua-Rodriguez, N; Cruz-Hervert, P; Ferreyra-Reyes, L; Ferreira-Guerrero, E; Yanes-Lane, M; Montero-Campos, R; Bobadilla-del-Valle, M; Torres-Gonzalez, P; Ponce-de-Leon, A; Sifuentes-Osornio, J; Garcia-Garcia, L				Blanco-Guillot, Francles; Delgado-Sanchez, Guadalupe; Mongua-Rodriguez, Norma; Cruz-Hervert, Pablo; Ferreyra-Reyes, Leticia; Ferreira-Guerrero, Elizabeth; Yanes-Lane, Mercedes; Montero-Campos, Rogelio; Bobadilla-del-Valle, Miriam; Torres-Gonzalez, Pedro; Ponce-de-Leon, Alfredo; Sifuentes-Osornio, Jose; Garcia-Garcia, Lourdes			Molecular clustering of patients with diabetes and pulmonary tuberculosis: A systematic review and meta-analysis	PLOS ONE			English	Review							NEW-YORK-CITY; MYCOBACTERIUM-TUBERCULOSIS; RISK-FACTORS; 1ST INSIGHT; TRANSMISSION PATTERNS; HIGH PREVALENCE; EPIDEMIOLOGY; HIV; DIVERSITY; MELLITUS	Introduction Many studies have explored the relationship between diabetes mellitus (DM) and tuberculosis (TB) demonstrating increased risk of TB among patients with DM and poor prognosis of patients suffering from the association of DM/TB. Owing to a paucity of studies addressing this question, it remains unclear whether patients with DM and TB are more likely than TB patients without DM to be grouped into molecular clusters defined according to the genotype of the infecting Mycobacterium tuberculosis bacillus. That is, whether there is convincing molecular epidemiological evidence for TB transmission among DM patients. Objective: We performed a systematic review and meta-analysis to quantitatively evaluate the propensity for patients with DM and pulmonary TB (PTB) to cluster according to the genotype of the infecting M. tuberculosis bacillus. Materials and methods We conducted a systematic search in MEDLINE and LILACS from 1990 to June, 2016 with the following combinations of key words "tuberculosis AND transmission" OR "tuberculosis diabetes mellitus" OR "Mycobacterium tuberculosis molecular epidemiology" OR "RFLPIS6110" OR "Spoligotyping" OR "MIRU-VNTR". Studies were included if they met the following criteria: (i) studies based on populations from defined geographical areas; (ii) use of genotyping by IS6110-restriction fragment length polymorphism (RFLP) analysis and spoligotyping or mycobacterial interspersed repetitive unit-variable number of tandem repeats (MIRU-VNTR) or other amplification methods to identify molecular clustering; (iii) genotyping and analysis of 50 or more cases of PTB; (iv) study duration of 11 months or more; (v) identification of quantitative risk factors for molecular clustering including DM; (vi) > 60% coverage of the study population; and (vii) patients with PTB confirmed bacteriologically. The exclusion criteria were: (i) Extrapulmonary TB; (ii) TB caused by nontuberculous mycobacteria; (iii) patients with PTB and HIV; (iv) pediatric PTB patients; (v) TB in closed environments (e.g. prisons, elderly homes, etc.); (vi) diabetes insipidus and (vii) outbreak reports. Hartung-Knapp-Sidik-Jonkman method was used to estimate the odds ratio (OR) of the association between DM with molecular clustering of cases with TB. In order to evaluate the degree of heterogeneity a statistical Q test was done. The publication bias was examined with Begg and Egger tests. Review Manager 5.3.5 CMA v. 3 and Biostat and Software package R were used. Results Selection criteria were met by six articles which included 4076 patients with PTB of which 13% had DM. Twenty seven percent of the cases were clustered. The majority of cases (48%) were reported in a study in China with 31% clustering. The highest incidence of TB occurred in two studies from China. The global OR for molecular clustering was 0.84 (IC 95% 0.40-1.72). The heterogeneity between studies was moderate (I-2 = 55%, p = 0.05), although there was no publication bias (Beggs test p = 0.353 and Eggers p = 0.429). Conclusion There were very few studies meeting our selection criteria. The wide confidence interval indicates that there is not enough evidence to draw conclusions about the association. Clustering of patients with DM in TB transmission chains should be investigated in areas where both diseases are prevalent and focus on specific contexts.	[Blanco-Guillot, Francles] Inst Nacl Salud Publ, Ctr Invest Enfermedad Infecciosas, Doctorado Ciencias Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Delgado-Sanchez, Guadalupe; Mongua-Rodriguez, Norma; Cruz-Hervert, Pablo; Ferreyra-Reyes, Leticia; Ferreira-Guerrero, Elizabeth; Yanes-Lane, Mercedes; Montero-Campos, Rogelio; Garcia-Garcia, Lourdes] Inst Nacl Salud Publ, Ctr Invest Enfermedad Infecciosas, Cuernavaca, Morelos, Mexico; [Mongua-Rodriguez, Norma] Univ Nacl Autonoma Mexico, Fac Med, Maestria Ciencias Med Enfasis Epidemiol, Distrito Federal, Mexico; [Yanes-Lane, Mercedes] Univ Autonoma San Luis Potosi, Fac Med, San Luis Potosi, San Luis Potosi, Mexico; [Bobadilla-del-Valle, Miriam; Torres-Gonzalez, Pedro; Ponce-de-Leon, Alfredo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Lab Microbiol, Mexico City, DF, Mexico; [Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Direcc Med, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; Universidad Autonoma de San Luis Potosi; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Garcia-Garcia, L (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedad Infecciosas, Cuernavaca, Morelos, Mexico.	garcigarml@gmail.com	García, Maria de Lourdes/I-2724-2019; Bobadilla-del-Valle, Miriam/AAD-6418-2020; Cruz-Hervert, Luis Pablo/AEI-4595-2022	García, Maria de Lourdes/0000-0001-5262-1157; Cruz-Hervert, Luis Pablo/0000-0002-6094-958X; Sifuentes-Osornio, Jose/0000-0001-9584-1360; Torres-Gonzalez, Pedro/0000-0002-2944-2721; BOBADILLA-DEL VALLE, MIRIAM/0000-0003-1184-827X; Blanco-Guillot, Francles/0000-0001-8149-1347; Ponce-de-Leon, Alfredo/0000-0003-2640-2916	Consejo Nacional de Ciencia y Tecnologia [360456, PDC-PN-2015-01-1557, PDCPN2014-01-247582, S0008- FONSEC SSA/IMSS/ISSSTE -2015-1 261599]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	FBG received a doctoral scholarship from the Consejo Nacional de Ciencia y Tecnologia, http://www.conacyt.gob.mx (360456). The study was partially funded by the Consejo Nacional de Ciencia y Tecnologia, http://www.conacyt.gob.mx (PDC-PN-2015-01-1557 (to Dr. EFG), PDCPN2014-01-247582 (to Dr. LGG) and S0008- FONSEC SSA/IMSS/ISSSTE -2015-1 261599 to Dr. GDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Attiyah RJ, 2009, CLIN EXP IMMUNOL, V158, P64, DOI 10.1111/j.1365-2249.2009.04000.x; Alavi SM, 2014, JUNDISHAPUR J MICROB, V7; Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bock NN, 2007, J INFECT DIS, V196, pS108, DOI 10.1086/518661; Borgdorff MW, 2013, CLIN MICROBIOL INFEC, V19, P889, DOI 10.1111/1469-0691.12253; Borgdorff MW, 2001, AM J EPIDEMIOL, V154, P934, DOI 10.1093/aje/154.10.934; Borrell S, 2010, CLIN MICROBIOL INFEC, V16, P568, DOI 10.1111/j.1469-0691.2009.02886.x; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Chang JT, 2011, J FORMOS MED ASSOC, V110, P372, DOI 10.1016/S0929-6646(11)60055-7; Chen KS, 2016, INT J TUBERC LUNG D, V20, P57, DOI 10.5588/ijtld.15.0215; Chiang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121698; Coker R, 2006, BRIT MED J, V332, P85, DOI 10.1136/bmj.38684.687940.80; Davey J, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-160; Dawson P, 2016, AM J PUBLIC HEALTH, V106, P563, DOI 10.2105/AJPH.2015.302910; de Beer JL, 2013, J CLIN MICROBIOL, V51, P1193, DOI 10.1128/JCM.03061-12; Dekhil N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153983; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Devi KR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145860; Diab HM, 2016, TUBERCULOSIS, V96, P13, DOI 10.1016/j.tube.2015.11.002; Dobler CC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000666; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Jimenez-Corona ME, 2013, THORAX, V68, P214, DOI 10.1136/thoraxjnl-2012-201756; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; Garcia-Garcia MD, 2000, INT J TUBERC LUNG D, V4, P12; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; Gomez DI, 2013, TUBERCULOSIS, V93, P192, DOI 10.1016/j.tube.2012.10.003; Diaz AG, 2015, TROP MED INT HEALTH, V20, P1534, DOI 10.1111/tmi.12569; Gonzalez Y, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-19; Gurjav U, 2016, INFECT GENET EVOL, V40, P346, DOI 10.1016/j.meegid.2015.07.014; Harries AD, 2011, INT J TUBERC LUNG D, V15, P1436, DOI 10.5588/ijtld.11.0503; Harris TG, 2013, AM J INFECT CONTROL, V41, P155, DOI 10.1016/j.ajic.2012.02.015; Heldal E, 2003, EUR RESPIR J, V22, P637, DOI 10.1183/09031936.03.00019103; Hernandez-Garduno E, 2002, CAN MED ASSOC J, V167, P349; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hong MS, 2017, EUROPEAN J CLIN MICR; Houben RMGJ, 2011, INT J TUBERC LUNG D, V15, P24; Hoza AS, 2016, TUBERCULOSIS, V98, P116, DOI 10.1016/j.tube.2016.02.002; Hu Y, 2016, TUBERCULOSIS, V97, P18, DOI 10.1016/j.tube.2015.11.007; Huang CC, 2014, CLIN INFECT DIS, V58, P765, DOI 10.1093/cid/cit948; Inigo J, 2007, J CLIN MICROBIOL, V45, P63, DOI 10.1128/JCM.01644-06; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Jagielski T, 2015, EUR J CLIN MICROBIOL, V34, P41, DOI 10.1007/s10096-014-2202-z; JAGIELSKI T, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/645802; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kanamori H, 2016, INT J TUBERC LUNG D, V20, P505, DOI 10.5588/ijtld.15.0607; Kik SV, 2008, AM J RESP CRIT CARE, V178, P96, DOI 10.1164/rccm.200708-1256OC; Kozinska M, 2016, POL ARCH MED WEWN, V126, P32; Kumar NP, 2013, J INFECT DIS, V208, P739, DOI 10.1093/infdis/jit241; Leung CC, 2008, AM J EPIDEMIOL, V167, P1486, DOI 10.1093/aje/kwn075; Li YA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1441-2; Lieberman TD, 2016, NAT MED, V22, P1470, DOI 10.1038/nm.4205; Lonnroth K, 2014, LANCET DIABETES ENDO, V2, P730, DOI 10.1016/S2213-8587(14)70109-3; Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Middelkoop K, 2015, J INFECT DIS, V211, P53, DOI 10.1093/infdis/jiu403; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morcillo N., 2007, Rev. argent. microbiol., V39, P145; Murase Y, 2010, EMERG INFECT DIS, V16, P948, DOI 10.3201/eid1606.091844; Nava-Aguilera E, 2009, INT J TUBERC LUNG D, V13, P17; Nogueira CL, 2016, TUBERCULOSIS, V97, P57, DOI 10.1016/j.tube.2015.12.005; Oni T, 2013, LANCET RESP MED, V1, P356, DOI 10.1016/S2213-2600(13)70116-4; Outhred AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150550; Penuelas-Urquides K, 2014, MEM I OSWALDO CRUZ, V109, P814, DOI 10.1590/0074-0276130550; Perez A, 2006, AM J TROP MED HYG, V74, P604, DOI 10.4269/ajtmh.2006.74.604; Perez-Lago L, 2016, J CLIN MICROBIOL, V54, P779, DOI 10.1128/JCM.02851-15; Pigott T, 2012, ADV METAANALYSIS; Ponce-De-Leon A, 2004, DIABETES CARE, V27, P1584, DOI 10.2337/diacare.27.7.1584; Reis-Santos B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062604; Restrepo BI, 2008, CLIN INFECT DIS, V47, P634, DOI 10.1086/590565; Restrepo BI, 2014, DIABETES RES CLIN PR, V106, P191, DOI 10.1016/j.diabres.2014.06.011; Restrepo BI, 2013, TUBERCULOSIS, V93, pS10, DOI 10.1016/S1472-9792(13)70004-0; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Ruslami R, 2010, TROP MED INT HEALTH, V15, P1289, DOI 10.1111/j.1365-3156.2010.02625.x; Shabbeer A, 2012, INFECT GENET EVOL, V12, P767, DOI 10.1016/j.meegid.2011.08.019; Shariff NM, 2015, INT J MYCOBACT, V4, P323, DOI 10.1016/j.ijmyco.2015.09.003; Singla R, 2006, INT J TUBERC LUNG D, V10, P74; Small Peter M., 1994, P569; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Stavrum R, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-309; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Surikova OV, 2005, EUR J EPIDEMIOL, V20, P963, DOI 10.1007/s10654-005-3636-5; Suwanpimolkul G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114442; Talarico S, 2011, TUBERCULOSIS, V91, P244, DOI 10.1016/j.tube.2011.01.007; Tian PW, 2014, EUR REV MED PHARMACO, V18, P1482; Tsukaguchi Katsuhiko, 2002, Kekkaku, V77, P409; Valentine JC, 2010, J EDUC BEHAV STAT, V35, P215, DOI 10.3102/1076998609346961; Vallerskog T, 2010, J IMMUNOL, V184, P6275, DOI 10.4049/jimmunol.1000304; van Soolingen D, 1999, J INFECT DIS, V180, P726, DOI 10.1086/314930; Varma-Basil M, 2011, MEM I OSWALDO CRUZ, V106, P524, DOI 10.1590/S0074-02762011000500002; Vynnycky E, 2001, EPIDEMIOL INFECT, V126, P43, DOI 10.1017/S095026880100499X; Wang C.-H., 1999, Tubercle and Lung Disease, V79, P235, DOI 10.1054/tuld.1998.0167; Wang QM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100949, 10.1371/journal.pone.0110209]; Yang CG, 2015, CLIN INFECT DIS, V61, P219, DOI 10.1093/cid/civ255; Yates TA, 2016, LANCET INFECT DIS, V16, P227, DOI 10.1016/S1473-3099(15)00499-5; Yuen CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153728; Zetola NM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010046	98	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184675	10.1371/journal.pone.0184675	http://dx.doi.org/10.1371/journal.pone.0184675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902922	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200052
J	Johansson, F; Halvarsson, P; Mikolajewski, DJ; Hoglund, J				Johansson, Frank; Halvarsson, Peter; Mikolajewski, Dirk J.; Hoeglund, Jacob			Phylogeography and larval spine length of the dragonfly Leucorhinia dubia in Europe	PLOS ONE			English	Article							LEUCORRHINIA-DUBIA; MORPHOLOGICAL DEFENSE; PREDATION; TRAIT; FISH; STICKLEBACKS; MANIPULATION; EVOLUTION; ODONATA; SHAPE	Presence or absence of predators selects for different kind of morphologies. Hence, we expect variation in traits that protect against predators to vary over geographical areas where predators vary in past and present abundance. Abdominal larval spines in dragonfly larvae provide protection against fish predators. We studied geographical variation in larval spine length of the dragonfly Leucorrhinia dubia across Western Europe using a phylogenetic approach. Larvae were raised in a common garden laboratory experiment in the absence of fish predators. Results show that larvae from northern Europe (Sweden and Finland) had significantly longer larval spines compared to larvae from western and central Europe. A phylogeny based on SNP data suggests that short larval spines is the ancestral stage in the localities sampled in this study, and that long spines have evolved in the Fenno-Scandian clade. The role of predators in shaping the morphological differences among the sampled localities is discussed.	[Johansson, Frank; Halvarsson, Peter; Hoeglund, Jacob] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Mikolajewski, Dirk J.] Free Univ Berlin, Inst Biol, Berlin, Germany	Uppsala University; Free University of Berlin	Johansson, F (corresponding author), Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden.	frank.johansson@ebc.uu.se	Halvarsson, Peter/GWC-2612-2022	Halvarsson, Peter/0000-0002-6940-5634; Johansson, Frank/0000-0002-2302-2603	Swedish Research Council; Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) [SNIC b2015095]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX)	This work was supported by The Swedish Research Council and the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under Project SNIC b2015095 to Dr. Frank Johansson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram PA, 2000, AM NAT, V156, pS45, DOI 10.1086/303415; [Anonymous], 2014, TRACER V1 6; Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; BENKE AC, 1970, ECOLOGY, V51, P328, DOI 10.2307/1933673; Bouckaert R. R., 2014, DENSITREE 2 SEEING T; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Boudot J. -P., 2015, ATLAS EUROPEAN DRAGO; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; Bryant D, 2012, MOL BIOL EVOL, V29, P1917, DOI 10.1093/molbev/mss086; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; COOPER SM, 1986, OECOLOGIA, V68, P446, DOI 10.1007/BF01036753; Damm S, 2012, ORG DIVERS EVOL, V12, P267, DOI 10.1007/s13127-012-0079-1; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; EDMUNDS M, 1974, DEFENCE ANIMALS; Ge DY, 2011, P ROY SOC B-BIOL SCI, V278, P2133, DOI 10.1098/rspb.2010.1500; HAVEL JE, 1984, LIMNOL OCEANOGR, V29, P487, DOI 10.4319/lo.1984.29.3.0487; Hovmoller R, 2004, MOL PHYLOGENET EVOL, V30, P653, DOI 10.1016/S1055-7903(03)00226-4; JOHANSSON F, 1994, OECOLOGIA, V100, P74, DOI 10.1007/BF00317132; Johansson F, 2017, BIOL J LINN SOC, V121, P294, DOI 10.1093/biolinnean/blw033; Johansson F, 2003, J FRESHWATER ECOL, V18, P415, DOI 10.1080/02705060.2003.9663977; Johansson F, 2002, CAN J ZOOL, V80, P199, DOI 10.1139/Z01-225; Johansson F, 2002, CAN J ZOOL, V80, P944, DOI 10.1139/Z02-073; Johansson Frank, 2008, P127; Kishida O, 2007, ECOLOGY, V88, P1948, DOI 10.1890/07-0132.1; Kognitz S., 1998, LIBELLEN IN BAYERN; Large SI, 2013, OECOLOGIA, V171, P961, DOI 10.1007/s00442-012-2450-5; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Mastretta-Yanes A, 2015, MOL ECOL RESOUR, V15, P28, DOI 10.1111/1755-0998.12291; McCauley SJ, 2007, OIKOS, V116, P121, DOI 10.1111/j.2006.0030-1299.15105.x; Mikolajewski DJ, 2010, EVOLUTION, V64, P3327, DOI 10.1111/j.1558-5646.2010.01078.x; Mikolajewski DJ, 2006, EVOLUTION, V60, P1306; Mikolajewski DJ, 2004, EVOL ECOL RES, V6, P619; Mikolajewski DJ, 2004, BEHAV ECOL, V15, P614, DOI 10.1093/beheco/arh061; PAJUNEN V. ILMARI, 1962, ANN ZOOL SOC ZOOL BOT FENNICAE VANAMO", V24, P1; Parchman TL, 2012, MOL ECOL, V21, P2991, DOI 10.1111/j.1365-294X.2012.05513.x; Paxton RJ, 1996, MOL ECOL, V5, P511, DOI 10.1111/j.1365-294X.1996.tb00343.x; Petrin Z, 2010, EVOL ECOL, V24, P1003, DOI 10.1007/s10682-010-9361-x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Trussell GC, 2000, P NATL ACAD SCI USA, V97, P2123, DOI 10.1073/pnas.040423397; Vamosi SM, 2005, CAN J ZOOL, V83, P894, DOI 10.1139/Z05-063; Vamosi SM, 2002, P ROY SOC B-BIOL SCI, V269, P923, DOI 10.1098/rspb.2001.1946; Walker JA, 1997, BIOL J LINN SOC, V61, P3, DOI 10.1111/j.1095-8312.1997.tb01777.x; Walker JA, 2000, J ZOOL, V252, P293; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Wildermuth H, 2005, LIBELLEN SCHWEIZ; Wittwer T, 2010, INSECT CONSERV DIVER, V3, P124, DOI 10.1111/j.1752-4598.2010.00083.x	47	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184596	10.1371/journal.pone.0184596	http://dx.doi.org/10.1371/journal.pone.0184596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902918	Green Submitted, gold, Green Published			2022-12-27	WOS:000410669200048
J	Park, J; Cho, SY; Cho, MC; Jeong, H; Son, H				Park, Juhyun; Cho, Sung Yong; Cho, Min Chul; Jeong, Hyeon; Son, Hwancheol			5-year long-term efficacy of 120-W GreenLight photoselective vaporization of the prostate for benign prostate hyperplasia	PLOS ONE			English	Article							HOLMIUM LASER ENUCLEATION; TRANSURETHRAL RESECTION; FOLLOW-UP; OUTCOMES; COMPLICATIONS; EXPERIENCE; MANAGEMENT; MORBIDITY; MORTALITY; TURP	Purpose To investigate 5-year long-term postoperative efficacy in benign prostate hyperplasia (BPH) following 120-W GreenLight high-performance system photoselective vaporization of the prostate (HPS-PVP) Methods This was a retrospective study of surgical outcomes in 159 men who underwent HPS-PVP and were followed over 60 months postoperatively. Definitions of treatment success were established based on the following three variables: international prostate symptom scores (IPSS), maximum flow rates (Q(max)), and quality of life scores QoL). Logistic regression analyses were performed to determine predictors of the postoperative success. Results Postoperative IPSS/QoL, Q(max) and post-voided residual urine volume were significantly improved after HPS-PVP. Postoperative Prostate specific antigen and prostate volume were also well reduced and sustained for 5 years. The postoperative success rate was assessed as 82.1%, 80.8% and 76.1% for each 1-, 3-, and 5-year. Thirty-eight (23.9%) patients had immediate postoperative complications, which were managed successfully with nonsurgical methods. None required transfusions, two (1.2%) patients required endoscopic reoperation for postoperative voiding difficulty due to bladder neck contracture or urethral stricture, and five (3.1%) required HPS-PVP reoperation. Presence of diabetes, voiding symptom subscore, QoL, maximal cystometric capacity, and bladder outlet obstructive index were valuable preoperative parameters for predicting postoperative success. Conclusions HPS-PVP is an effective, long-term treatment option for BPH, with sustained efficacy of 76.1% at 5-year follow up. Several preoperative parameters could help to predict the durable surgical improvements.	[Park, Juhyun; Cho, Sung Yong; Cho, Min Chul; Jeong, Hyeon; Son, Hwancheol] Seoul Natl Univ, Dept Urol, Coll Med, SMG SNU Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital	Son, H (corresponding author), Seoul Natl Univ, Dept Urol, Coll Med, SMG SNU Boramae Med Ctr, Seoul, South Korea.	volley@snu.ac.kr	CHO, MIN CHUL/R-7835-2019		MOTIE/KEIT, Republic of Korea [10067258]	MOTIE/KEIT, Republic of Korea	This research was supported by the Materials and Components Technology Development Program of MOTIE/KEIT, Republic of Korea (10067258, Development of a holmium/thulium laser resonator for treatment of prostatic hyperplasia). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Materials and Components Technology Development Program of MOTIE/KEIT, Republic of Korea (10067258, Development of a holmium/thulium laser resonator for treatment of prostatic hyperplasia).	Cho SY, 2012, UROLOGY, V80, P396, DOI 10.1016/j.urology.2012.01.063; Cornu JN, 2016, UROL CLIN N AM, V43, P377, DOI 10.1016/j.ucl.2016.04.006; Guo SW, 2015, LASER MED SCI, V30, P1147, DOI 10.1007/s10103-015-1721-x; Hai MA, 2009, UROLOGY, V73, P807, DOI 10.1016/j.urology.2008.08.502; Homma Y, 1996, Int J Urol, V3, P267, DOI 10.1111/j.1442-2042.1996.tb00532.x; Hueber PA, 2012, CAN J UROL, V19, P6450; Kollmorgen TA, 1996, UROLOGY, V48, P217, DOI 10.1016/S0090-4295(96)00157-4; Malek RS, 2005, J UROLOGY, V174, P1344, DOI 10.1097/01.ju.0000173913.41401.67; Nair SM, 2016, CURR UROL REP, V17, DOI 10.1007/s11934-016-0603-5; Nitti Victor W, 2005, Rev Urol, V7 Suppl 6, pS14; Pereira-Correia JA, 2012, BJU INT, V110, P1184, DOI 10.1111/j.1464-410X.2011.10878.x; Rassweiler J, 2006, EUR UROL, V50, P969, DOI 10.1016/j.eururo.2005.12.042; Reich O, 2008, J UROLOGY, V180, P246, DOI 10.1016/j.juro.2008.03.058; Rieken M, 2014, NAT REV UROL, V11, P142, DOI 10.1038/nrurol.2014.23; Rieken M, 2010, WORLD J UROL, V28, P53, DOI 10.1007/s00345-009-0504-z; Ryoo HS, 2015, INT NEUROUROL J, V19, P278, DOI 10.5213/inj.2015.19.4.278; Sancha FG, 2015, WORLD J UROL, V33, P539, DOI 10.1007/s00345-014-1339-9; Seki N, 2008, J ENDOUROL, V22, P1731, DOI 10.1089/end.2007.0368; Son H, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.06.034; Son H, 2010, KOREAN J UROL, V51, P737, DOI 10.4111/kju.2010.51.11.737; TOPPERCER A, 1979, UROLOGY, V14, P204, DOI 10.1016/0090-4295(79)90164-X; Unnikrishnan R, 2017, CLEV CLIN J MED, V84, P53, DOI 10.3949/ccjm.84a.16008; Welch G, 2002, UROLOGY, V59, P245, DOI 10.1016/S0090-4295(01)01506-0; Wendt-Nordahl G, 2007, J ENDOUROL, V21, P1081, DOI 10.1089/end.2006.0370; Yamada Y, 2016, J ENDOUROLOGY; Yeo JK, 2016, INVESTIG CLIN UROL, V57, P30, DOI 10.4111/icu.2016.57.1.30	26	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184442	10.1371/journal.pone.0184442	http://dx.doi.org/10.1371/journal.pone.0184442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902866	Green Submitted, gold, Green Published			2022-12-27	WOS:000410669200037
J	Shimada, T; Nagata, N; Okahara, K; Joya, A; Hayashida, T; Oka, S; Sakurai, T; Akiyama, J; Uemura, N; Gatanaga, H				Shimada, Takayuki; Nagata, Naoyoshi; Okahara, Koki; Joya, Akane; Hayashida, Tsunefusa; Oka, Shinichi; Sakurai, Toshiyuki; Akiyama, Junichi; Uemura, Naomi; Gatanaga, Hiroyuki			PCR detection of human herpesviruses in colonic mucosa of individuals with inflammatory bowel disease: Comparison with individuals with immunocompetency and HIV infection	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; ULCERATIVE-COLITIS; CYTOMEGALOVIRUS-INFECTION; IMMUNE-RESPONSE; CROHNS-DISEASE; CMV INFECTION; DNA; PREVALENCE; DIAGNOSIS; PATHOGEN	Background Detection of human herpesviruses (HHVs) other than cytomegalovirus (CMV) in colonic mucosa of individuals with inflammatory bowel disease (IBD) remains unknown. This study identified eight HHVs in the colonic mucosa of individuals with IBD and compared the results with immunocompetent and human immunodeficiency virus (HIV)-infected individuals. Methods A total of 89 individuals who had colorectal ulcer on colonoscopy were enrolled: 26 with immunocompetency (n = 26), 41 with IBD, and 22 with HIV infection. We examined the colonic ulcers for the presence of eight HHVs-herpes simplex virus (HSV)-1/2, varicella zoster virus (VZV), CMV, Epstein-Barr virus (EBV), HHV-6, HHV-7, and HHV-8-using mucosal PCR. Results The IBD group had positivity rates of 0%, 0%, 0%, 53.7%, 24.4%, 39%, 39%, and 0% for HSV-1, HSV-2, VZV, EBV, CMV, HHV-6, HHV-7, and HHV-8, respectively. The positivity rates of EBV and CMV in colonic mucosa increased significantly in the order of the immunocompetent, IBD, and HIV groups (EBV: 23.1%, 53.7%, 72.7%, P for trend = 0.0005; CMV, 7.7%, 24.4%, 54.5%, P for trend = 0.0003, respectively), but no increase was found in the other HHVs. Median mucosal EBV DNA values in the immunocompetent, IBD, and HIV groups were 0, 76, and 287 copies/mu g DNA, respectively (P for trend = 0.002). Corresponding median mucosal CMV DNA values were 0, 0, and 17 copies/mu g DNA ( P for trend = 0.0001). There was no significant difference in the positivity rates of the eight HHVs between ulcerative colitis and Crohn's disease. Conclusion The HHVs of EBV, CMV, HHV-6, and HHV-7, but not of HSV-1, HSV-2, VZV, or HHV-8, were identified in the colonic mucosa of IBD individuals. EBV and CMV in colonic mucosa was correlated with host immune status in increasing order of immunocompetent, IBD, and HIV-infected individuals.	[Shimada, Takayuki; Nagata, Naoyoshi; Okahara, Koki; Sakurai, Toshiyuki; Akiyama, Junichi] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Joya, Akane; Hayashida, Tsunefusa; Oka, Shinichi; Gatanaga, Hiroyuki] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan.	nnagata_ncgm@yahoo.co.jp			National Center for Global Health and Medicine [26A-201, 29-2001]	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This study was funded by a Grant-in-Aid for Research from the National Center for Global Health and Medicine (26A-201 and 29-2001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Beuselinck K, 2005, J CLIN MICROBIOL, V43, P5541, DOI 10.1128/JCM.43.11.5541-5546.2005; Ciccocioppo R, 2015, WORLD J GASTROENTERO, V21, P1915, DOI 10.3748/wjg.v21.i6.1915; Cottone M, 2001, AM J GASTROENTEROL, V96, P773, DOI 10.1111/j.1572-0241.2001.03620.x; Gilden DH, 2007, NAT CLIN PRACT NEURO, V3, P82, DOI 10.1038/ncpneuro0401; Lavagna A, 2006, DIGEST LIVER DIS, V38, P887, DOI 10.1016/j.dld.2006.07.011; Lawlor G, 2010, INFLAMM BOWEL DIS, V16, P1620, DOI 10.1002/ibd.21275; Leveque N, 2010, J MED VIROL, V82, P1694, DOI 10.1002/jmv.21877; Machida U, 2000, J CLIN MICROBIOL, V38, P2536, DOI 10.1128/JCM.38.7.2536-2542.2000; Matsuoka K, 2007, AM J GASTROENTEROL, V102, P331, DOI 10.1111/j.1572-0241.2006.00989.x; McCurdy JD, 2015, CLIN GASTROENTEROL H, V13, P131, DOI 10.1016/j.cgh.2014.05.026; Miller CS, 2005, J CLIN MICROBIOL, V43, P2173, DOI 10.1128/JCM.43.5.2173-2180.2005; MYREN J, 1984, SCAND J GASTROENTERO, V19, P1; Nahar S, 2015, WORLD J GASTROENTERO, V21, P12667, DOI 10.3748/wjg.v21.i44.12667; Nakase H, 2010, DIGEST DIS SCI, V55, P1498, DOI 10.1007/s10620-010-1162-0; Nikolaus S, 2007, GASTROENTEROLOGY, V133, P1670, DOI 10.1053/j.gastro.2007.09.001; Nissen LHC, 2015, J CROHNS COLITIS, V9, P398, DOI 10.1093/ecco-jcc/jjv040; Ormeci AC, 2016, EUR REV MED PHARMACO, V20, P858; Rahier JF, 2014, J CROHNS COLITIS, V8, P443, DOI 10.1016/j.crohns.2013.12.013; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Sipponen T, 2011, SCAND J GASTROENTERO, V46, P1324, DOI 10.3109/00365521.2011.605466; Tanaka T, 2009, BIOMED RES-TOKYO, V30, P279, DOI 10.2220/biomedres.30.279; WAKEFIELD AJ, 1992, J MED VIROL, V38, P183, DOI 10.1002/jmv.1890380306; Weir JP, 1998, VIRUS GENES, V16, P85, DOI 10.1023/A:1007905910939; Xu XR, 2014, WORLD J GASTROENTERO, V20, P3255, DOI 10.3748/wjg.v20.i12.3255; Yanai H, 1999, AM J GASTROENTEROL, V94, P1582, DOI 10.1111/j.1572-0241.1999.01148.x; Zhuravskaya T, 1997, BLOOD, V90, P2482, DOI 10.1182/blood.V90.6.2482.2482_2482_2491	27	16	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184699	10.1371/journal.pone.0184699	http://dx.doi.org/10.1371/journal.pone.0184699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902907	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200055
J	Worm, M; Kirschbaum, F; von der Emde, G				Worm, Martin; Kirschbaum, Frank; von der Emde, Gerhard			Social interactions between live and artificial weakly electric fish: Electrocommunication and locomotor behavior of Mormyrus rume proboscirostris towards a mobile dummy fish	PLOS ONE			English	Article							GNATHONEMUS-PETERSII MORMYRIDAE; POLLIMYRUS-ISIDORI CUVIER; ORGAN DISCHARGE PATTERNS; AGONISTIC BEHAVIOR; VALENCIENNES MORMYRIDAE; ELECTRORECEPTOR ORGANS; SPECIES RECOGNITION; SIGNALING BEHAVIOR; ECHO RESPONSE; LATERAL LINE	Mormyrid weakly electric fish produce short, pulse-type electric organ discharges for actively probing their environment and to communicate with conspecifics. Animals emit sequences of pulse-trains that vary in overall frequency and temporal patterning and can lead to time-locked interactions with the discharge activity of other individuals. Both active electrolocation and electrocommunication are additionally accompanied by stereotypical locomotor patterns. However, the concrete roles of electrical and locomotor patterns during social interactions in mormyrids are not well understood. Here we used a mobile fish dummy that was emitting different types of electrical playback sequences to study following behavior and interaction patterns (electrical and locomotor) between individuals of weakly electric fish. We confronted single individuals of Mormyrus rume proboscirostris with a mobile dummy fish designed to attract fish from a shelter and recruit them into an open area by emitting electrical playbacks of natural discharge sequences. We found that fish were reliably recruited by the mobile dummy if it emitted electrical signals and followed it largely independently of the presented playback patterns. While following the dummy, fish interacted with it spatially by displaying stereotypical motor patterns, as well as electrically, e.g. through discharge regularizations and by synchronizing their own discharge activity to the playback. However, the overall emission frequencies of the dummy were not adopted by the following fish. Instead, social signals based on different temporal patterns were emitted depending on the type of playback. In particular, double pulses were displayed in response to electrical signaling of the dummy and their expression was positively correlated with an animals' rank in the dominance hierarchy. Based on additional analysis of swimming trajectories and stereotypical locomotor behavior patterns, we conclude that the reception and emission of electrical communication signals play a crucial role in mediating social interactions in mormyrid weakly electric fish.	[Worm, Martin; von der Emde, Gerhard] Univ Bonn, Inst Zool, Dept Neuroethol Sensory Ecol, Bonn, Germany; [Kirschbaum, Frank] Humboldt Univ, Fac Life Sci, Biol & Ecol Fishes, Berlin, Germany	University of Bonn; Humboldt University of Berlin	Worm, M (corresponding author), Univ Bonn, Inst Zool, Dept Neuroethol Sensory Ecol, Bonn, Germany.	mworm@uni-bonn.de			Deutsche Forschungsgemeinschaft; Graduiertenkolleg Bionik [GR1572]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduiertenkolleg Bionik	This study was funded by the Deutsche Forschungsgemeinschaft (wwv.dfg.de), Graduiertenkolleg Bionik (GR1572) to MW and GvdE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaid N, 2013, BEHAV PROCESS, V100, P9, DOI 10.1016/j.beproc.2013.07.010; Abaid N, 2012, BEHAV BRAIN RES, V233, P545, DOI 10.1016/j.bbr.2012.05.047; Altringham JD, 2003, SENSORY ECOLOGY COMM; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Arnegard ME, 2005, P ROY SOC B-BIOL SCI, V272, P1305, DOI 10.1098/rspb.2005.3101; Baier B, 2007, BEHAVIOUR, V144, P115, DOI 10.1163/156853907779947409; Baker CA, 2013, J EXP BIOL, V216, P2365, DOI 10.1242/jeb.082289; BASS AH, 1983, SCIENCE, V220, P971, DOI 10.1126/science.6844924; BAUER R, 1972, EXPERIENTIA, V28, P669, DOI 10.1007/BF01944968; BAUER R, 1974, BEHAVIOUR, V50, P306, DOI 10.1163/156853974X00507; BELL CC, 1989, J COMP NEUROL, V286, P391, DOI 10.1002/cne.902860309; BELL CC, 1989, J NEUROSCI, V9, P1029; BELL CC, 1974, J COMP PHYSIOL, V92, P201, DOI 10.1007/BF00694506; Bennett M.V.L., 1971, P493; Bohn Kirsten M., 2015, Journal of the Acoustical Society of America, V137, P2249, DOI 10.1121/1.4920204; Bradbury J. W., 2011, PRINCIPLES ANIMAL CO; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Butail S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076123; Carlson BA, 2004, ANIM BEHAV, V68, P867, DOI 10.1016/j.anbehav.2003.10.031; Carlson BA, 2004, J EXP BIOL, V207, P1073, DOI 10.1242/jeb.00851; Carlson BA, 2002, J PHYSIOLOGY-PARIS, V96, P405, DOI 10.1016/S0928-4257(03)00019-6; Carlson BA, 2000, HORM BEHAV, V38, P177, DOI 10.1006/hbeh.2000.1613; Carlson BA, 2016, J EXP BIOL, V219, P31, DOI 10.1242/jeb.127720; CHASE ID, 1994, ANIM BEHAV, V48, P393, DOI 10.1006/anbe.1994.1253; Ciali S, 1997, J FISH BIOL, V50, P1074, DOI 10.1006/jfbi.1996.0372; CROCKETT DP, 1986, J COMP PSYCHOL, V100, P3, DOI 10.1037/0735-7036.100.1.3; DERBIN C, 1968, J ULTRA MOL STRUCT R, V22, P469, DOI 10.1016/S0022-5320(68)90035-X; Donati E, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/6/066009; ENQUIST M, 1983, J THEOR BIOL, V102, P387, DOI 10.1016/0022-5193(83)90376-4; Faria JJ, 2010, BEHAV ECOL SOCIOBIOL, V64, P1211, DOI 10.1007/s00265-010-0988-y; Feulner PGD, 2009, BIOL LETTERS, V5, P225, DOI 10.1098/rsbl.2008.0566; Gebhardt K, 2012, J FISH BIOL, V81, P2235, DOI 10.1111/j.1095-8649.2012.03448.x; Gebhardt K., 2012, THESIS; Gebhardt K, 2012, BEHAVIOUR, V149, P623, DOI 10.1163/156853912X649911; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Hanika S, 2005, BEHAVIOUR, V142, P145, DOI 10.1163/1568539053627677; HARDER W, 1968, Z VERGL PHYSIOL, V59, P272; HEILIGENBERG W, 1976, J COMP PHYSIOL, V109, P357, DOI 10.1007/BF00663615; Hofmann V, 2013, J EXP BIOL, V216, P2487, DOI 10.1242/jeb.082420; Hollmann M, 2008, J ZOOL, V276, P149, DOI 10.1111/j.1469-7998.2008.00465.x; HOPKINS CD, 1981, SCIENCE, V212, P85, DOI 10.1126/science.7209524; HOPKINS CD, 1981, AM ZOOL, V21, P211; HOPKINS CD, 1974, AM SCI, V62, P426; HOPKINS CD, 1988, ANNU REV NEUROSCI, V11, P497, DOI 10.1146/annurev.ne.11.030188.002433; Jones G, 2011, J COMP PHYSIOL A, V197, P447, DOI 10.1007/s00359-010-0565-x; Kareklas K, 2016, FRONT ZOOL, V13, DOI 10.1186/s12983-016-0154-0; Khait V, 2009, J FISH BIOL, V75, P490, DOI 10.1111/j.1095-8649.2009.02250.x; Knornschild M, 2012, P ROY SOC B-BIOL SCI, V279, P4827, DOI 10.1098/rspb.2012.1995; Kopman V, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0540; KRAMER B, 1978, BEHAV ECOL SOCIOBIOL, V4, P61, DOI 10.1007/BF00302561; KRAMER B, 1979, BEHAV ECOL SOCIOBIOL, V6, P67, DOI 10.1007/BF00293246; KRAMER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P45, DOI 10.1007/BF00299952; KRAMER B, 1976, BEHAV ECOL SOCIOBIOL, V1, P425, DOI 10.1007/BF00299402; KRAMER B, 1974, J COMP PHYSIOL, V93, P203, DOI 10.1007/BF00607000; KRAMER B, 1994, ANIM BEHAV, V48, P435, DOI 10.1006/anbe.1994.1257; Kreysing M, 2012, SCIENCE, V336, P1700, DOI 10.1126/science.1218072; Landgraf Tim, 2014, Biomimetic and Biohybrid Systems. Third International Conference, Living Machines 2014. Proceedings. LNCS: 8608, P178; Landgraf T, 2016, BIOINSPIR BIOMIM, V11, DOI 10.1088/1748-3190/11/1/015001; LUCKER H, 1981, BEHAV ECOL SOCIOBIOL, V9, P103, DOI 10.1007/BF00293581; Machnik P, 2011, J ETHOL, V29, P131, DOI 10.1007/s10164-010-0235-z; Marras S, 2012, J R SOC INTERFACE, V9, P1856, DOI 10.1098/rsif.2012.0084; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; MCGREGOR PK, 1992, NATO ADV SCI I A-LIF, V228, P1; MOLLER P, 1980, TRENDS NEUROSCI, V3, P105, DOI 10.1016/0166-2236(80)90041-7; MOLLER P, 1976, SCIENCE, V193, P697, DOI 10.1126/science.948747; MOLLER P, 1989, ETHOLOGY, V82, P177; MOLLER P, 1973, ANIM BEHAV, V21, P501, DOI 10.1016/S0003-3472(73)80010-7; MOLLER P, 1982, ANIM BEHAV, V30, P641, DOI 10.1016/S0003-3472(82)80134-6; MOLLER P, 1970, ANIM BEHAV, V18, P768, DOI 10.1016/0003-3472(70)90026-6; Moller P, 1995, ELECT FISHES HIST BE, P17; Orlov AA, 2009, DOKLADY BIOL SCI; Phamduy P, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/3/036021; PITCHER T, 1979, ANIM BEHAV, V27, P126, DOI 10.1016/0003-3472(79)90133-7; Pohlmann K, 2001, P NATL ACAD SCI USA, V98, P7371, DOI 10.1073/pnas.121026298; Polverino G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077589; Riehl, 1995, FORTPFLANZUNGSBIOLOG, P81; Ruberto T, 2017, J EXP ANAL BEHAV, V107, P279, DOI 10.1002/jeab.247; Ruberto T, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160505; RUSSELL CJ, 1974, J COMP PHYSIOL, V92, P181, DOI 10.1007/BF00694505; SCHLUGER JH, 1987, J EXP BIOL, V130, P359; Schuster S, 2001, J EXP BIOL, V204, P1401; SMITH JM, 1988, PHILOS T ROY SOC B, V319, P557, DOI 10.1098/rstb.1988.0065; SZABO T, 1965, J MORPHOL, V117, P229, DOI 10.1002/jmor.1051170208; Terleph TA, 2004, J FISH BIOL, V64, P1373, DOI 10.1111/j.0022-1112.2004.00401.x; TEYSSEDRE C, 1986, BEHAV PROCESS, V12, P77, DOI 10.1016/0376-6357(86)90073-2; Tinbergen N., 1948, Wilson Bulletin, V60, P6; TOERRING MJ, 1979, BEHAV ECOL SOCIOBIOL, V4, P369, DOI 10.1007/BF00303243; Tyack PL, 2000, CETACEAN SOCIETIES, P270; von der Emde G, 2007, J EXP BIOL, V210, P3082, DOI 10.1242/jeb.005694; von der Emde G, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00026; von der Emde G, 2008, J PHYSIOL-PARIS, V102, P279, DOI 10.1016/j.jphysparis.2008.10.017; VONDEREMDE G, 1992, ETHOLOGY, V92, P177; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105; Ward AJW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032411; Witzany G., 2013, BIOCOMMUNICATION ANI; Worm Martin, 2014, Biomimetic and Biohybrid Systems. Third International Conference, Living Machines 2014. Proceedings. LNCS: 8608, P446	97	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184622	10.1371/journal.pone.0184622	http://dx.doi.org/10.1371/journal.pone.0184622			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902915	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200050
J	Al-Barrak, L; Kanjo, E; Younis, EMG				Al-barrak, Lulwah; Kanjo, Eiman; Younis, Eman M. G.			NeuroPlace: Categorizing urban places according to mental states	PLOS ONE			English	Article							DIRECTED ATTENTION; BRAIN; SYSTEMS; STRESS; EEG	Urban spaces have a great impact on how people's emotion and behaviour. There are number of factors that impact our brain responses to a space. This paper presents a novel urban place recommendation approach, that is based on modelling in-situ EEG data. The research investigations leverages on newly affordable Electroencephalogram (EEG) headsets, which has the capability to sense mental states such as meditation and attention levels. These emerging devices have been utilized in understanding how human brains are affected by the surrounding built environments and natural spaces. In this paper, mobile EEG headsets have been used to detect mental states at different types of urban places. By analysing and modelling brain activity data, we were able to classify three different places according to the mental state signature of the users, and create an association map to guide and recommend people to therapeutic places that lessen brain fatigue and increase mental rejuvenation. Our mental states classifier has achieved accuracy of (%90.8). NeuroPlace breaks new ground not only as a mobile ubiquitous brain monitoring system for urban computing, but also as a system that can advise urban planners on the impact of specific urban planning policies and structures. We present and discuss the challenges in making our initial prototype more practical, robust, and reliable as part of our on-going research. In addition, we present some enabling applications using the proposed architecture.	[Al-barrak, Lulwah] Univ Bristol, Comp Dept, Bristol, Avon, England; [Kanjo, Eiman; Younis, Eman M. G.] Nottingham Trent Univ, Dept Comp & Technol, Nottingham, England; [Younis, Eman M. G.] Menia Univ, Fac Comp & Informat, Al Minya, Egypt	University of Bristol; Nottingham Trent University; Egyptian Knowledge Bank (EKB); Minia University	Kanjo, E (corresponding author), Nottingham Trent Univ, Dept Comp & Technol, Nottingham, England.	eiman.kanjo@ntu.ac.uk	Kanjo, Eiman/AAX-4677-2020	Kanjo, Eiman/0000-0002-1720-0661; Younis, Eman Mamdoh Gmal Eldeen/0000-0003-2778-4231	King Saud University	King Saud University(King Saud University)	This work was supported by King Saud University.	Al-Barrak L., 2013, P 4 AUG HUM INT C, P186; Al-Dowaihi D., 2013, AL DOW COMP MED APPL; Al-Husain L., 2013, SENSE SPACE MAPPING, P1321; Alajmi N., 2013, 5 INT WORKSH AFF INT; Alajmi N, 2013, INT CONF AFFECT, P745, DOI 10.1109/ACII.2013.138; Anderson TW., 2003, INTRO MULTIVARIATE S, V3; [Anonymous], 2009, EMOTIV SYSTEMS; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Campbell A. T., 2010, P 2 ACM SIGCOMM WORK; Carletta J., 1996, COMPUTATIONAL LINGUI, V22, P149; Carrico L., 2012, P 3 AUG HUM INT C ME; Chamberlain A, 2014, PERS UBIQUIT COMPUT, V18, P1775, DOI 10.1007/s00779-013-0756-x; Consolvo S., 2008, P SIGCHI C HUM FACT; Cresswell T., 2004, PLACE INTRO; Debener S, 2012, PSYCHOPHYSIOLOGY, V49, P1617, DOI 10.1111/j.1469-8986.2012.01471.x; Dodds S., 2011, PLOS ONE, V6; FERRI FJ, 1994, MACH INTELL PATT REC, V16, P403; Girden E, 1991, REPEATED MEASURES QU; Golbeck J., 2011, INT C PRIV SEC RISK; Hama Y, 2001, JPN PSYCHOL RES, V43, P218, DOI 10.1111/1468-5884.00179; Healey JA, 2005, IEEE T INTELL TRANSP, V6, P156, DOI 10.1109/TITS.2005.848368; Jain A, 1997, IEEE T PATTERN ANAL, V19, P153, DOI 10.1109/34.574797; Kanjo E, 2018, INFORM FUSION, V40, P18, DOI 10.1016/j.inffus.2017.05.005; Kanjo E, 2015, PERS UBIQUIT COMPUT, V19, P1197, DOI 10.1007/s00779-015-0842-3; Kanjo E, 2010, MOBILE NETW APPL, V15, P562, DOI 10.1007/s11036-009-0217-y; Kanjo E, 2009, IEEE PERVAS COMPUT, V8, P50, DOI 10.1109/MPRV.2009.79; KAPLAN S, 1995, J ENVIRON PSYCHOL, V15, P169, DOI 10.1016/0272-4944(95)90001-2; Kaplan S, 2010, PERSPECT PSYCHOL SCI, V5, P43, DOI 10.1177/1745691609356784; Kohlleppel T, 2002, HORTTECHNOLOGY, V12, P489, DOI 10.21273/HORTTECH.12.3.489; Lansdall-Welfare T., 2012, P 21 INT C COMP WWW; Lathia N., 2013, IEEE PERVASIVE COMPU, V2013; Lisetti CL, 2004, EURASIP J APPL SIG P, V2004, P1672, DOI 10.1155/S1110865704406192; Mawass N. El, 2013, SUPERMARKET STRESS M, P1043; Michael S., 2004, P WAMES; Miller RGJ, 1991, SIMULTANEOUS STAT IN; Mostow J, 2011, ARTIFICIAL INTELLIGE; Muller KR, 2008, J NEUROSCI METH, V167, P82, DOI 10.1016/j.jneumeth.2007.09.022; Oralhan Z, 2016, IETE J RES, V62, P795, DOI 10.1080/03772063.2016.1176543; Patel S, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-21; Purver M., 2012, P EACL AV FRANC; Reddy S, 2010, ACM T SENSOR NETWORK, V6, DOI 10.1145/1689239.1689243; Relph E., 1976, PLACE PLACELESSNESS; RICHARD A. J., 2002, APPL MULTIVARIATE ST; Rish I., 2001, IJCAI 2001 WORKSH EM; Rosenbaum MS, 2009, J SERV MANAGE, V20, P173, DOI 10.1108/09564230910952762; Seigneur J-M, 2011, P 2 AUGM HUM INT C; Seo HS, 2008, J AGR FOOD CHEM, V56, P4665, DOI 10.1021/jf8001137; Stansfeld SA, 2003, BRIT MED BULL, V68, P243, DOI 10.1093/bmb/ldg033; Su L, 2013, MIND GARDEN BRAIN BO; Thrift N., 2003, KEY CONCEPTS GEOGRAP, P95; ULRICH RS, 1991, J ENVIRON PSYCHOL, V11, P201, DOI 10.1016/S0272-4944(05)80184-7; Wang Q, 2010, CYB CW 2010 INT C; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wright F, 2010, EMOTIONAL INSTANT ME; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Yazdani N., 2010, P 24 BCS INT SPEC GR; Zappi P., 2012, P 11 ACM IEEE C INF, P16	57	18	18	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0183890	10.1371/journal.pone.0183890	http://dx.doi.org/10.1371/journal.pone.0183890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG6AR	28898244	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000410449500008
J	Fukada, I; Ito, Y; Kobayashi, K; Shibayama, T; Takahashi, S; Horii, R; Akiyama, F; Iwase, T; Ohno, S				Fukada, Ippei; Ito, Yoshinori; Kobayashi, Kokoro; Shibayama, Tomoko; Takahashi, Shunji; Horii, Rie; Akiyama, Futoshi; Iwase, Takuji; Ohno, Shinji			The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel	PLOS ONE			English	Article							RANDOMIZED PHASE-III; TAXANES; TAXOL; PHARMACOKINETICS; ASSOCIATION; TRIAL; RISK	Background Paclitaxel plays a central role in chemotherapy for breast cancer. Peripheral neuropathy, a well-known toxicity with paclitaxel, may be of interest in predicting the efficacy of paclitaxel therapy for patients with metastatic breast cancer. We performed a retrospective analysis assessing whether the early occurrence of peripheral neuropathy (EPN) was a predictive marker for better efficacy in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel. Patients and methods Between January 2000 and August 2008, we examined the records of 168 patients with metastatic breast cancer treated with paclitaxel in our hospital. EPN was defined as a symptom of Grade 2 or more during first three months of treatment. The overall response rate (ORR) and time to treatment failure (TTF) in each group were analyzed retrospectively. Results Of 168 patients with metastatic breast cancer who were treated with paclitaxel, EPN was documented in 101 patients (60.1%). The clinical benefit rate (CR, PR, and SD >= 6 months) was 72.3% in the EPN group and 49.3% in the non-EPN group (p = 0.002). The TTF of the EPN group (median 11.2 months, 95% CI: 9.5-12.9) was significantly longer than that of the non-EPN group (5.7 months, 95% CI: 4.6-6.8) (p<0.001). Multivariate analysis demonstrated that EPN (p<0.001), dose intensity of less than 70% (p<0.001), and the history of microtubule agents (p = 0.001) were the significant favorable prognostic factors for TTF. Conclusion The early onset of peripheral neuropathy might be a robust predictor for TTF in patients with metastatic breast cancer treated with paclitaxel.	[Fukada, Ippei; Ito, Yoshinori; Kobayashi, Kokoro; Shibayama, Tomoko] Japanese Fdn Canc Res, Breast Oncol Ctr, Canc Inst Hosp, Dept Breast Med Oncol, Tokyo, Japan; [Takahashi, Shunji] Japanese Fdn Canc Res, Dept Med Oncol, Canc Inst Hosp, Tokyo, Japan; [Horii, Rie] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Pathol, Tokyo, Japan; [Akiyama, Futoshi] Japanese Fdn Canc Res, Canc Inst, Dept Pathol, Tokyo, Japan; [Iwase, Takuji] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Dept Breast Surg Oncol, Tokyo, Japan; [Ohno, Shinji] Japanese Fdn Canc Res, Canc Inst Hosp, Breast Oncol Ctr, Tokyo, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research	Fukada, I (corresponding author), Japanese Fdn Canc Res, Breast Oncol Ctr, Canc Inst Hosp, Dept Breast Med Oncol, Tokyo, Japan.	ippei.fukada@jfcror.jp						Argyriou AA, 2008, CRIT REV ONCOL HEMAT, V66, P218, DOI 10.1016/j.critrevonc.2008.01.008; Fukada I, 2016, ONCOL LETT, V12, P663, DOI 10.3892/ol.2016.4627; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Grisold W, 2012, NEURO-ONCOLOGY, V14, P45, DOI 10.1093/neuonc/nos203; HARRIS JW, 1994, CANCER RES, V54, P4026; Hershman DL, 2016, J CLIN ONCOL, V34, P3014, DOI 10.1200/JCO.2015.66.2346; Hertz DL, 2013, ANN ONCOL, V24, P1472, DOI 10.1093/annonc/mdt018; Hertz DL, 2012, BREAST CANCER RES TR, V134, P401, DOI 10.1007/s10549-012-2054-0; Jones SE, 2005, J CLIN ONCOL, V23, P5542, DOI 10.1200/JCO.2005.02.027; Kumar G, 1995, CANCER CHEMOTH PHARM, V36, P129; LaPointe NE, 2013, NEUROTOXICOLOGY, V37, P231, DOI 10.1016/j.neuro.2013.05.008; Mielke S, 2005, ANTICANCER RES, V25, P4423; Mielke S, 2005, CLIN CANCER RES, V11, P4843, DOI 10.1158/1078-0432.CCR-05-0298; Peters CM, 2007, EXP NEUROL, V203, P42, DOI 10.1016/j.expneurol.2006.07.022; RAHMAN A, 1994, CANCER RES, V54, P5543; Rivera E, 2015, CANCER CHEMOTH PHARM, V75, P659, DOI 10.1007/s00280-014-2607-5; Schneider BP, 2015, CLIN CANCER RES, V21, P5082, DOI 10.1158/1078-0432.CCR-15-0586; Schneider BP, 2012, J CLIN ONCOL, V30, P3051, DOI 10.1200/JCO.2011.39.8446; Seidman AD, 2008, J CLIN ONCOL, V26, P1642, DOI 10.1200/JCO.2007.11.6699; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA	20	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184322	10.1371/journal.pone.0184322	http://dx.doi.org/10.1371/journal.pone.0184322			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898275	Green Published, Green Submitted, gold			2022-12-27	WOS:000410449500022
J	Hart, G; Gaoue, OG; de la Torre, L; Navarrete, H; Muriel, P; Macia, MJ; Balslev, H; Leon-Yanez, S; Jorgensen, P; Duffy, DC				Hart, G.; Gaoue, Orou G.; de la Torre, Lucia; Navarrete, Hugo; Muriel, Priscilla; Macia, Manuel J.; Balslev, Henrik; Leon-Yanez, Susana; Jorgensen, Peter; Duffy, David Cameron			Availability, diversification and versatility explain human selection of introduced plants in Ecuadorian traditional medicine	PLOS ONE			English	Article							ETHNOBOTANICAL SURVEY; PATTERNS; WEEDS	Globally, a majority of people use plants as a primary source of healthcare and introduced plants are increasingly discussed as medicine. Protecting this resource for human health depends upon understanding which plants are used and how use patterns will change over time. The increasing use of introduced plants in local pharmacopoeia has been explained by their greater abundance or accessibility (availability hypothesis), their ability to cure medical conditions that are not treated by native plants (diversification hypothesis), or as a result of the introduced plants' having many different simultaneous roles (versatility hypothesis). In order to describe the role of introduced plants in Ecuador, and to test these three hypotheses, we asked if introduced plants are over-represented in the Ecuadorian pharmacopoeia, and if their use as medicine is best explained by the introduced plants' greater availability, different therapeutic applications, or greater number of use categories. Drawing on 44,585 plant-use entries, and the checklist of >17,000 species found in Ecuador, we used multi-model inference to test if more introduced plants are used as medicines in Ecuador than expected by chance, and examine the support for each of the three hypotheses above. We find nuanced support for all hypotheses. More introduced plants are utilized than would be expected by chance, which can be explained by geographic distribution, their strong association with cultivation, diversification (except with regard to introduced diseases), and therapeutic versatility, but not versatility of use categories. Introduced plants make a disproportionately high contribution to plant medicine in Ecuador. The strong association of cultivation with introduced medicinal plant use highlights the importance of the maintenance of human-mediated environments such as homegardens and agroforests for the provisioning of healthcare services.	[Hart, G.; Gaoue, Orou G.; Duffy, David Cameron] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA; [Gaoue, Orou G.] Univ Johannesburg, Dept Geog Environm Management & Energy Studies, APK Campus, Johannesburg, South Africa; [de la Torre, Lucia] Pontificia Univ Catolica Ecuador, Herbario QCA, Quito, Ecuador; [Navarrete, Hugo; Muriel, Priscilla; Leon-Yanez, Susana] Pontificia Univ Catolica Ecuador, Escuela Biol, Quito, Ecuador; [Macia, Manuel J.] Univ Autonoma Madrid, Dept Biol, Area Bot, Madrid, Spain; [Balslev, Henrik] Aarhus Univ, Inst Biosci, Aarhus, Denmark; [Jorgensen, Peter] Missouri Bot Garden, St Louis, MO USA; [Duffy, David Cameron] Univ Hawaii Manoa, Pacific Cooperat Studies Unit, Honolulu, HI 96822 USA; [Gaoue, Orou G.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	University of Hawaii System; University of Hawaii Manoa; University of Johannesburg; Pontificia Universidad Catolica del Ecuador; Pontificia Universidad Catolica del Ecuador; Autonomous University of Madrid; Aarhus University; Missouri Botanical Gardens; University of Hawaii System; University of Hawaii Manoa; University of Tennessee System; University of Tennessee Knoxville	Hart, G (corresponding author), Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA.	gmhart@hawaii.edu	Muriel, Priscilla/V-2760-2019; Gaoue, Orou G./B-4932-2011; Navarrete, Hugo/CAJ-3461-2022; Balslev, Hendrik/AAE-4071-2020; Macia, Manuel J/H-4631-2012	Muriel, Priscilla/0000-0002-7874-8057; Gaoue, Orou G./0000-0002-0946-2741; Macia, Manuel J/0000-0002-4676-612X; Navarrete, Hugo/0000-0002-5262-9754				Alchon S.A., 1991, NATIVE SOC DIS COLON; Alencar NL, 2014, REV BRAS FARMACOGN, V24, P506, DOI 10.1016/j.bjp.2014.09.003; Alencar NL, 2010, ECON BOT, V64, P68, DOI 10.1007/s12231-009-9104-5; Bennett BC, 2000, ECON BOT, V54, P90, DOI 10.1007/BF02866603; Bennett BC, 2008, J ETHNOPHARMACOL, V116, P422, DOI 10.1016/j.jep.2007.12.006; Bjora CS, 2015, J ETHNOBIOL ETHNOMED, V11, DOI 10.1186/s13002-015-0060-0; Bletter N, 2010, PLANTS ADOPTION WHY, P1; Bussmann R, 2015, MED PLANTS THEIR ECO; Bussmann RW, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-47; Cadena-Gonzalez AL, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-23; Cook F. E. M., 1995, Economic botany data collection standard.; Cook Noble David, 1998, BORN DIE DIS NEW WOR; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; da Silva TC, 2014, ETHNOBIOL CONSERV, V3, DOI 10.15451/ec2014-6-3.4-1-12; de Albuquerque UP, 2006, J ETHNOBIOL ETHNOMED, V2, DOI 10.1186/1746-4269-2-30; de Almeida CFCBR, 2005, J ARID ENVIRON, V62, P127, DOI 10.1016/j.jaridenv.2004.09.020; de la Torre L, 2012, ECOL SOC, V17, DOI 10.5751/ES-04582-170115; de Medeiros PM, 2013, J ETHNOPHARMACOL, V150, P729, DOI 10.1016/j.jep.2013.09.026; dos Santos LL, 2014, ECON BOT, V68, P283, DOI 10.1007/s12231-014-9281-8; Elton C. S., 1958, ECOLOGY INVASIONS AN; Eyssartier C, 2008, J ETHNOBIOL ETHNOMED, V4, DOI 10.1186/1746-4269-4-25; FEENY D, 1990, HUM ECOL, V18, P1, DOI 10.1007/BF00889070; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Fenn Elizabeth, 2001, POX AM GREAT SMALLPO; Gavin MC, 2009, J APPL ECOL, V46, P1275, DOI 10.1111/j.1365-2664.2009.01713.x; Giovannini P, 2015, J ETHNOPHARMACOL, V164, P78, DOI 10.1016/j.jep.2015.01.038; Gruca M, 2014, J ETHNOPHARMACOL, V155, P1388, DOI 10.1016/j.jep.2014.06.047; Hofmann A., 1979, PLANTS GODS THEIR SA; Jorgensen P., 2018, CATALOGUE VASCULAR P; Jorgensen PM, 2004, CLIM CHANG BIODIVERS, P192; Kirkham WS, 2005, UNDERSTANDING MERREM; Kunwar RM, 2015, J ETHNOPHARMACOL, V163, P210, DOI 10.1016/j.jep.2015.01.035; Kunwar RM, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/792789; Lewu FB, 2009, AFR J BIOTECHNOL, V8, P929; Lukes J, 2007, P NATL ACAD SCI USA, V104, P9375, DOI 10.1073/pnas.0703678104; Macia MJ, 2005, J ETHNOPHARMACOL, V97, P337, DOI 10.1016/j.jep.2004.11.022; McClatchey WC, 2009, PHARMACOL THERAPEUT, V123, P239, DOI 10.1016/j.pharmthera.2009.04.002; MOERMAN DE, 1979, J ETHNOPHARMACOL, V1, P111, DOI 10.1016/0378-8741(79)90002-3; Moerman DE, 1996, J ETHNOPHARMACOL, V52, P1, DOI 10.1016/0378-8741(96)01393-1; Muniz de Medeiros P., 2015, EVOLUTIONARY ETHNOBI, P163; Neill D, 2012, REV AMAZONICA CIENCI, V1, P70; Palmer CT, 2004, ECON BOT, V58, pS280, DOI 10.1663/0013-0001(2004)58[S280:TIORIP]2.0.CO;2; Pfeiffer JM, 2008, ENVIRON CONSERV, V35, P281, DOI 10.1017/S0376892908005146; PRANCE G T, 1987, Conservation Biology, V1, P296, DOI 10.1111/j.1523-1739.1987.tb00050.x; Prance G. T., 1998, Plants for food and medicine. Proceedings of the joint conference of the Society for Economic Botany and the International Society for Ethnopharmacology, London, UK, 1-6 July 1996., P185; R Core Team, 2013, R LANG ENV STAT COMP; Robinson M.M., 2011, WORLD MED SITUATION, P27; Soldati GT, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/648469; Stepp JR, 2004, J ETHNOPHARMACOL, V92, P163, DOI 10.1016/j.jep.2004.03.002; Stepp JR, 2001, J ETHNOPHARMACOL, V75, P19, DOI 10.1016/S0378-8741(00)00385-8; Turner N., 2014, ANCIENT PATHWAYS ANC, V74; V de la Torre L., 2008, ENCICLOPEDIA PLANTAS; Vitousek PM, 1997, NEW ZEAL J ECOL, V21, P1; Voeks RA, 2004, ANN ASSOC AM GEOGR, V94, P868; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Yessoufou K, 2015, MOL ECOL RESOUR, V15, P405, DOI 10.1111/1755-0998.12310; Zimdahl R. L., 1999, FUNDAMENTALS WEED SC	57	26	28	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184369	10.1371/journal.pone.0184369	http://dx.doi.org/10.1371/journal.pone.0184369			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886104	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100103
J	Kong, M; Kim, SM; Ham, DI				Kong, Mingui; Kim, Sung Min; Ham, Don-Il			Comparison of clinical features and 3-month treatment response among three different choroidal thickness groups in polypoidal choroidal vasculopathy	PLOS ONE			English	Article							INDOCYANINE GREEN VIDEOANGIOGRAPHY; CENTRAL SEROUS CHORIORETINOPATHY; PHOTODYNAMIC THERAPY; MACULAR DEGENERATION; INTRAVITREAL BEVACIZUMAB; RANIBIZUMAB THERAPY	Eyes with polypoidal choroidal vasculopathy (PCV) were recently reported to have various choroidal thickness, and choroidal thickness might be associated with visual outcome in the treatment of many retinal disorders. The range of subfoveal choroidal thickness (SFCT), clinical features, and 3-month treatment response among three groups having different range of SFCT were investigated in PCV eyes. In 78 treatment-naive eyes with PCV, SFCT was measured using optical coherence tomography. Eyes were classified into thin, medium, and thick groups, using mean and one standard deviation of SFCT. Clinical features and imaging findings were compared among the three groups. Some eyes were treated with three consecutive monthly injection of anti-vascular endothelial growth factor (VEGF) as an initial treatment. They were also classified into three thickness groups, and the short-term post-treatment improvement in visual acuity and central retinal thickness were compared among groups. The mean SFCT was 271.9 +/- 135.6 mu m. Twelve, 53, and 13 eyes were classified into thin (<136.3 mu m), medium (136.3-407.5 mu m), and thick (>407.5 mu m) groups, respectively. The thin group showed older age, lower visual acuity, and a higher prevalence of fundus tessellation than the other two groups (P<0.05). In multiple linear regression analyses, baseline BCVA was correlated with baseline SFCT. Forty-six eyes completed three consecutive anti-VEGF treatments. The thin group showed no visual improvement after treatment (P = 0.141), unlike the other two groups showing visual improvement (P<0.05). Eyes with PCV have a broad range of SFCT, and PCV eyes with a thin choroid manifest worse visual function than eyes with a medium or thick choroid.	[Kong, Mingui] Hangil Eye Hosp, Incheon, South Korea; [Kong, Mingui] Catholic Kwandong Univ, Coll Med, Dept Ophthalmol, Incheon, South Korea; [Kim, Sung Min; Ham, Don-Il] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Catholic Kwandong University; Sungkyunkwan University (SKKU); Samsung Medical Center	Ham, DI (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	oculus@naver.com						Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Balaratnasingam C, 2015, RETINA; Byon IS, 2014, OSLI RETINA, V45, P534, DOI 10.3928/23258160-20141118-08; Cho HJ, 2012, EYE, V26, P426, DOI 10.1038/eye.2011.324; Cho M, 2009, AM J OPHTHALMOL, V148, P70, DOI 10.1016/j.ajo.2009.02.012; Chung SE, 2011, OPHTHALMOLOGY, V118, P840, DOI 10.1016/j.ophtha.2010.09.012; Ding XY, 2011, INVEST OPHTH VIS SCI, V52, P9555, DOI 10.1167/iovs.11-8076; Gomi F, 2008, BRIT J OPHTHALMOL, V92, P70, DOI 10.1136/bjo.2007.122283; GUYER DR, 1994, ARCH OPHTHALMOL-CHIC, V112, P1057, DOI 10.1001/archopht.1994.01090200063023; Hikichi T, 2014, BRIT J OPHTHALMOL, V98, P1201, DOI 10.1136/bjophthalmol-2013-304555; Honda S, 2014, OPHTHALMOLOGICA, V232, P92, DOI 10.1159/000360308; Ikuno Y, 2010, INVEST OPHTH VIS SCI, V51, P2173, DOI 10.1167/iovs.09-4383; Jirarattanasopa P, 2012, INVEST OPHTH VIS SCI, V53, P3663, DOI 10.1167/iovs.12-9619; Kim JH, 2013, EYE, V27, P809, DOI 10.1038/eye.2013.78; Koizumi H, 2011, GRAEF ARCH CLIN EXP, V249, P1123, DOI 10.1007/s00417-011-1620-1; Lai TYY, 2008, BRIT J OPHTHALMOL, V92, P661, DOI 10.1136/bjo.2007.135103; Manjunath V, 2010, AM J OPHTHALMOL, V150, P325, DOI 10.1016/j.ajo.2010.04.018; Maruko I, 2013, AM J OPHTHALMOL, V156, P548, DOI 10.1016/j.ajo.2013.03.041; Nishide T, 2013, GRAEF ARCH CLIN EXP, V251, P2415, DOI 10.1007/s00417-013-2419-z; Ouyang YL, 2011, INVEST OPHTH VIS SCI, V52, P7019, DOI 10.1167/iovs.11-8046; Rayess N, 2015, AM J OPHTHALMOL, V159, P85, DOI 10.1016/j.ajo.2014.09.033; Sakurada Y, 2016, RETINA; Shin J.Y., 2015, ACTA OPHTHALMOL; SPAIDE RF, 1995, RETINA-J RET VIT DIS, V15, P100, DOI 10.1097/00006982-199515020-00003; Spaide RF, 2009, AM J OPHTHALMOL, V147, P801, DOI 10.1016/j.ajo.2008.12.010; Stangos AN, 2010, AM J OPHTHALMOL, V150, P666, DOI 10.1016/j.ajo.2010.05.035; Tateiwa H, 2002, GRAEF ARCH CLIN EXP, V240, P354, DOI 10.1007/s00417-002-0459-x; Uyama M, 2002, AM J OPHTHALMOL, V133, P639, DOI 10.1016/S0002-9394(02)01404-6; Yan YN, 2015, OPHTHALMOLOGY; Yang LH, 2013, RETINA-J RET VIT DIS, V33, P1584, DOI 10.1097/IAE.0b013e318285cbb3; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001	31	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184058	10.1371/journal.pone.0184058	http://dx.doi.org/10.1371/journal.pone.0184058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886052	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100060
J	Riley, SN				Riley, Sean N.			Investigating the multivariate nature of NHL player performance with structural equation modeling	PLOS ONE			English	Article							ICE HOCKEY; ROBUSTNESS; ANALYTICS	Hockey is a complex and multifaceted game, yet many of the statistical tools used to evaluate performance are univariate. To garner a better understanding of hockey's multifaceted nature, two structural equation models (SEMs) assessing the interrelations between offense, defense, and possession were built from three seasons of NHL data. Overall, it was found that the concepts of offense, defense, and possession are best understood via a small constellation of measured variables, and that offense mediates the relationship between possession and defense such that higher levels of offense leads to poorer defensive performance. These findings are discussed within the context of ranking player performance.	[Riley, Sean N.] Carleton Univ, Inst Cognit Sci, Ottawa, ON, Canada	Carleton University	Riley, SN (corresponding author), Carleton Univ, Inst Cognit Sci, Ottawa, ON, Canada.	sean.n.d.riley@gmail.com		Riley, Sean N/0000-0001-7253-4309				[Anonymous], THESIS; Baughman AK, 2015, IEEE COMPUT INTELL M, V10, P62, DOI 10.1109/MCI.2015.2437551; Beneventano P., 2012, INT J BUSINESS HUMAN, V2, P67; BOLLEN K, 1991, PSYCHOL BULL, V110, P305, DOI 10.1037/0033-2909.110.2.305; Chan TC, 2012, MIT SLOAN SPORTS AN; Chan TCY, 2012, INTERFACES, V42, P131, DOI 10.1287/inte.1110.0612; Costa G. B., 2007, UNDERSTANDING SABERM; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; Diamantopoulos A., 2000, INTRO LISREL GUIDE U; DiStefano C., 2009, PRACT ASSESS RES EVA, V14, P1, DOI DOI 10.10/1531-7714; Franks A., 2015, MIT SLOAN SPORTS AN; Fry MJ, 2012, INTERFACES, V42, P105, DOI 10.1287/inte.1120.0633; Gao SY, 2008, TRANSP RES RECORD, P116, DOI 10.3141/2082-14; Goldfarb D., 2014, ARXIV14097635; Gramacy RB, 2013, J QUANT ANAL SPORTS, V9, P97, DOI 10.1515/jqas-2012-0001; Hair J., 2010, MULTIVARIATE DATA AN, V7; HENLY SJ, 1993, BRIT J MATH STAT PSY, V46, P313, DOI 10.1111/j.2044-8317.1993.tb01019.x; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; lacobucci D., 2009, J CONSUM PSYCHOL, V19, P673, DOI DOI 10.1016/JJCPS.2009.09.002; Lewis Michael, 2004, MONEYBALL ART WINNIN; Lock D, 2014, J QUANT ANAL SPORTS, V10, P197, DOI 10.1515/jqas-2013-0100; Macdonald B., 2012, P 2012 SLOAN SPORTS; McDonald RP, 2002, PSYCHOL METHODS, V7, P64, DOI 10.1037//1082-989X.7.1.64; MUTHEN B, 1985, BRIT J MATH STAT PSY, V38, P171, DOI 10.1111/j.2044-8317.1985.tb00832.x; Nachtigall C., 2003, METHODS PSYCHOL RES, V8, P1, DOI DOI 10.1080/10705511.2021.1935263; Pileggi H, 2012, IEEE T VIS COMPUT GR, V18, P2819, DOI 10.1109/TVCG.2012.263; Reinartz W, 2009, INT J RES MARK, V26, P332, DOI 10.1016/j.ijresmar.2009.08.001; Roith J, 2014, INT J SPORTS SCI, V4, P84; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Schuckers Michael, 2013, MIT SLOAN SPORTS AN; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Stensland HK, 2014, ACM T MULTIM COMPUT, V10, DOI 10.1145/2541011; Thomas AC, 2013, ANN APPL STAT, V7, P1497, DOI 10.1214/13-AOAS646; Tulsky E, 2013, MIT SLOAN SPORTS AN; Weston R, 2006, COUNS PSYCHOL, V34, P719, DOI 10.1177/0011000006286345	35	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184346	10.1371/journal.pone.0184346	http://dx.doi.org/10.1371/journal.pone.0184346			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886094	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100101
J	Zheng, ZQ; Sze, CW; Keng, CT; Al-Haddawi, M; Liu, M; Tan, SY; Kwek, HL; Her, ZS; Chan, XY; Barnwal, B; Loh, E; Chang, KTE; Tan, TC; Tan, YJ; Chen, QF				Zheng, Zhiqiang; Sze, Ching Wooen; Keng, Choong Tat; Al-Haddawi, Muthafar; Liu, Min; Tan, Sue Yee; Kwek, Hwee Ling; Her, Zhisheng; Chan, Xue Ying; Barnwal, Bhaskar; Loh, Eva; Chang, Kenneth Tou En; Tan, Thiam Chye; Tan, Yee-Joo; Chen, Qingfeng			Hepatitis C virus mediated chronic inflammation and tumorigenesis in the humanised immune system and liver mouse model	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; HCV-RELATED CIRRHOSIS; CD8(+) T-CELLS; HEPATOCELLULAR-CARCINOMA; INTERFERON-ALPHA; VIRAL-HEPATITIS; SERUM; RECURRENCE; INFECTION; EXPANSION	Hepatitis C is a liver disease caused by infection of the Hepatitis C virus (HCV). Many individuals infected by the virus are unable to resolve the viral infection and develop chronic hepatitis, which can lead to formation of liver cirrhosis and cancer. To understand better how initial HCV infections progress to chronic liver diseases, we characterised the long term pathogenic effects of HCV infections with the use of a humanised mouse model (HIL mice) we have previously established. Although HCV RNA could be detected in infected mice up to 9 weeks post infection, HCV infected mice developed increased incidences of liver fibrosis, granulomatous inflammation and tumour formation in the form of hepatocellular adenomas or hepatocellular carcinomas by 28 weeks post infection compared to uninfected mice. We also demonstrated that chronic liver inflammation in HCV infected mice was mediated by the human immune system, particularly by monocytes/macrophages and T cells which exhibited exhaustion phenotypes. In conclusion, HIL mice can recapitulate some of the clinical symptoms such as chronic inflammation, immune cell exhaustion and tumorigenesis seen in HCV patients. Our findings also suggest that persistence of HCV-associated liver disease appear to require initial infections of HCV and immune responses but not long term HCV viraemia.	[Zheng, Zhiqiang; Keng, Choong Tat; Al-Haddawi, Muthafar; Liu, Min; Tan, Sue Yee; Kwek, Hwee Ling; Her, Zhisheng; Chan, Xue Ying; Barnwal, Bhaskar; Tan, Yee-Joo; Chen, Qingfeng] Inst Mol & Cell Biol, Singapore, Singapore; [Sze, Ching Wooen; Tan, Yee-Joo; Chen, Qingfeng] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Loh, Eva; Chang, Kenneth Tou En] KK Womens & Childrens Hosp, Dept Pathol & Lab Med, Singapore, Singapore; [Chang, Kenneth Tou En; Tan, Thiam Chye] Duke NUS Grad Med Sch, Singapore, Singapore; [Tan, Thiam Chye] KK Womens & Childrens Hosp, Dept Obstet & Gynaecol, Singapore, Singapore; [Chen, Qingfeng] Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; KK Women's & Children's Hospital; National University of Singapore; KK Women's & Children's Hospital; Guangzhou Medical University	Tan, YJ; Chen, QF (corresponding author), Inst Mol & Cell Biol, Singapore, Singapore.; Tan, YJ; Chen, QF (corresponding author), Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.; Chen, QF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	yee_joo_tan@nuhs.edu.sg; qchen@imcb.a-star.edu.sg	Sze, Ching Wooen/AAV-4777-2020	Zheng, Zhiqiang/0000-0003-1028-3246; KENG, CHOONG TAT/0000-0003-2898-5924; Tan, Yee-Joo/0000-0002-2278-4497; Sze, Ching Wooen/0000-0003-0913-7567	Joint Council Office Development Programme [1334k00082]; Agency for Science, Technology and Research (A*STAR), Singapore; National Research Foundation Fellowship Singapore [NRF-NRFF2017-03]; Advanced Molecular Pathology Laboratory (Institute of Molecular and Cell Biology, Singapore); IMCB FACS core (Institute of Molecular and Cell Biology, Singapore)	Joint Council Office Development Programme; Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); National Research Foundation Fellowship Singapore(National Research Foundation, Singapore); Advanced Molecular Pathology Laboratory (Institute of Molecular and Cell Biology, Singapore); IMCB FACS core (Institute of Molecular and Cell Biology, Singapore)	"This study was supported by Joint Council Office Development Programme 1334k00082, the Agency for Science, Technology and Research (A*STAR), Singapore. Qingfeng Chen is also supported by National Research Foundation Fellowship Singapore NRF-NRFF2017-03. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. C. M. Rice (Rockefeller University, USA) for providing the Huh7.5 cell line, Dr. H. Hotta (Kobe University, Japan) for the J6/JFH1-P47 HCV virus, the Advanced Molecular Pathology Laboratory (Institute of Molecular and Cell Biology, Singapore) for the histology support, Dr. V. C. K. Yu (National University of Singapore, Singapore) for CpGODN induced mouse liver tumour samples and the IMCB FACS core (Institute of Molecular and Cell Biology, Singapore) for flow cytometry support.	Accapezzato D, 2004, J CLIN INVEST, V113, P963, DOI [10.1172/JCI200420415, 10.1172/JCI200420515]; Afdhal NH, 2004, NATURAL HIST HEPATIT; Ara A Kardashian, 2015, Gastroenterol Hepatol (N Y), V11, P458; Averhoff FM, 2012, CLIN INFECT DIS, V55, pS10, DOI 10.1093/cid/cis361; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Benvegnu LB, 1997, HEPATOLOGY, V25, P211, DOI 10.1002/hep.510250138; Bertoletti A, 1997, GASTROENTEROLOGY, V112, P193, DOI 10.1016/S0016-5085(97)70235-X; Bioulac-Sage P, 2007, HEPATOLOGY, V46, P740, DOI 10.1002/hep.21743; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Boettler T, 2005, J VIROL, V79, P7860, DOI 10.1128/JVI.79.12.7860-7867.2005; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Bungyoku Y, 2009, J GEN VIROL, V90, P1681, DOI 10.1099/vir.0.010983-0; Chen QF, 2013, STEM CELLS, V31, P1160, DOI 10.1002/stem.1359; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Chuang EM, 2004, TRENDS BIOTECHNOL, V22, P517, DOI 10.1016/j.tibtech.2004.08.011; Coash M, 2012, J FORMOS MED ASSOC, V111, P3, DOI 10.1016/j.jfma.2011.11.023; Conti F, 2016, J HEPATOL, V65, P727, DOI 10.1016/j.jhep.2016.06.015; Coverdale SA, 2004, AM J GASTROENTEROL, V99, P636, DOI 10.1111/j.1572-0241.2004.04085.x; Dolganiuc A, 2006, J IMMUNOL, V177, P6758, DOI 10.4049/jimmunol.177.10.6758; Dorner M, 2011, NATURE, V474, P208, DOI 10.1038/nature10168; Dustin LB, 2014, J LEUKOCYTE BIOL, V96, P535, DOI 10.1189/jlb.4RI0214-126R; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Gotte M, 2016, NAT REV GASTRO HEPAT, V13, P338, DOI 10.1038/nrgastro.2016.60; HAGIWARA H, 1993, GASTROENTEROLOGY, V104, P877, DOI 10.1016/0016-5085(93)91025-D; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Isidro RA, 2016, AM J PHYSIOL-GASTR L, V311, pG59, DOI 10.1152/ajpgi.00123.2016; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Joseph NM, 2014, MODERN PATHOL, V27, P62, DOI 10.1038/modpathol.2013.114; Keng CT, 2015, GUT; Kosaka K, 2013, BIOCHEM BIOPH RES CO, V441, P230, DOI 10.1016/j.bbrc.2013.10.040; Llovet JM, 2016, NATURE REVIEWS GASTR; McGuinness PH, 2000, GUT, V46, P260, DOI 10.1136/gut.46.2.260; Mercer DF, 2001, NAT MED, V7, P927, DOI 10.1038/90968; Mohd-Ismail NK, 2009, J VIROL, V83, P9993, DOI 10.1128/JVI.00509-09; NAITO M, 1994, HEPATOLOGY, V19, P871, DOI 10.1002/hep.1840190411; Ogawa E, 2013, J HEPATOL, V58, P495, DOI 10.1016/j.jhep.2012.10.017; Ozaras R, 2004, J CLIN GASTROENTEROL, V38, P449, DOI 10.1097/00004836-200405000-00011; Panasiuk A, 2004, WORLD J GASTROENTERO, V10, P3639, DOI 10.3748/wjg.v10.i24.3639; Pearlman BL, 2011, CLIN INFECT DIS, V52, P889, DOI 10.1093/cid/cir076; Pol S., 2016, J HEPATOLOGY; Poordad F, 2012, J VIRAL HEPATITIS, V19, P449, DOI 10.1111/j.1365-2893.2012.01617.x; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Revie D, 2014, WORLD J GASTROENTERO, V20, P2777, DOI 10.3748/wjg.v20.i11.2777; Sempoux C., 2013, INT J HEPATOLOGY, V2013; Shoukry NH, 2003, J EXP MED, V197, P1645, DOI 10.1084/jem.20030239; Shrivastava S, 2013, J VIROL, V87, P12284, DOI 10.1128/JVI.01962-13; Smith-Palmer J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0748-8; Tassopoulos NC, 1999, J HEPATOL, V31, P193, DOI 10.1016/S0168-8278(99)80400-0; TONG MJ, 1995, NEW ENGL J MED, V332, P1463, DOI 10.1056/NEJM199506013322202; van Aalten SM, 2011, J HEPATOL, V55, P120, DOI 10.1016/j.jhep.2010.10.030; Washburn ML, 2011, GASTROENTEROLOGY, V140, P1334, DOI 10.1053/j.gastro.2011.01.001; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x	59	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184127	10.1371/journal.pone.0184127	http://dx.doi.org/10.1371/journal.pone.0184127			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886065	gold, Green Submitted, Green Published			2022-12-27	WOS:000410001100069
J	Foulis, SA; Jones, SL; van Emmerik, RE; Kent, JA				Foulis, Stephen A.; Jones, Stephanie L.; van Emmerik, Richard E.; Kent, Jane A.			Post-fatigue recovery of power, postural control and physical function in older women	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; AGE; FORCE; STRENGTH; VELOCITY; ADULTS; PERFORMANCE; BALANCE; HEALTH; YOUNG	Low muscle power, particularly at high velocities, has been linked to poor physical function in older adults. Any loss in muscle power following fatiguing exercise or daily activities could impact physical function and postural control until power has fully recovered. To test the overall hypothesis that a common task such as walking can result in prolonged power loss and decreased physical function and balance, 17 healthy older (66-81 years) women completed a 32-min walking test (32MWT) designed to induce neuromuscular fatigue, followed by 60min of recovery (60R). Fatigue and recovery of knee extensor muscle power (3 velocities) were quantified by dynamometry. Function was quantified by chair rise time and postural control by measures of center of pressure (COP) range (mm) and velocity (mm.s(-1)) during quiet stance. Power declined at all velocities by 8-13% 2min following the 32MWT (p <= 0.02) and remained depressed by 8-26% at 60R (p <= 0.04). Postural control decreased following the 32MWT, indicated by increased COP range in the anterior-posterior (AP, p< 0.01) direction and a trend in the medial-lateral (ML) direction (p = 0.09), and returned to baseline by 60R (p >= 0.10). COP velocity was unchanged immediately following the 32MWT, but at 60R was lower in ML (p = 0.03) and tended to be reduced in AP (p = 0.07). Changes in high-velocity power (270 degrees.s(-1)) were associated with altered postural control (p = 0.02) and chair rise performance (p <= 0.03). These results provide evidence of long-duration neuromuscular changes following fatigue in healthy older women that may place them at increased risk for functional deficits during everyday mobility tasks.	[Foulis, Stephen A.; Jones, Stephanie L.; van Emmerik, Richard E.; Kent, Jane A.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Kent, JA (corresponding author), Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA.	jkent@kin.umass.edu	Foulis, Stephen/AAS-3574-2020	Foulis, Stephen/0000-0002-8437-5058; Jones, Stephanie/0000-0001-9954-3803				Allman BL, 2002, MUSCLE NERVE, V25, P785, DOI 10.1002/mus.10116; Allman BL, 2001, MUSCLE NERVE, V24, P1156, DOI 10.1002/mus.1127; BASSEY EJ, 1992, CLIN SCI, V82, P321, DOI 10.1042/cs0820321; Bauer C, 2008, ARCH PHYS MED REHAB, V89, P1977, DOI 10.1016/j.apmr.2008.02.033; Bean JF, 2002, J AM GERIATR SOC, V50, P461; Borg G, 1998, BORGS PERCEIVED EXER; Boyer KA, 2012, GAIT POSTURE, V36, P149, DOI 10.1016/j.gaitpost.2012.02.007; Buchner DM, 1996, AGE AGEING, V25, P386, DOI 10.1093/ageing/25.5.386; Callahan DM, 2011, J APPL PHYSIOL, V111, P1345, DOI 10.1152/japplphysiol.00367.2011; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cuoco A, 2004, J GERONTOL A-BIOL, V59, P1200, DOI 10.1093/gerona/59.11.1200; DAY BL, 1993, J PHYSIOL-LONDON, V469, P479, DOI 10.1113/jphysiol.1993.sp019824; Du Pasquier RA, 2003, NEUROPHYSIOL CLIN, V33, P213, DOI 10.1016/j.neucli.2003.09.001; EDWARDS RHT, 1977, J PHYSIOL-LONDON, V272, P769, DOI 10.1113/jphysiol.1977.sp012072; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hashiba M, 1998, JPN J PHYSIOL, V48, P499, DOI 10.2170/jjphysiol.48.499; Helbostad JL, 2007, J GERONTOL A-BIOL, V62, P1010, DOI 10.1093/gerona/62.9.1010; Hiemstra LA, 2001, J ORTHOP SPORT PHYS, V31, P598, DOI 10.2519/jospt.2001.31.10.598; Hortobagyi T, 2003, J GERONTOL A-BIOL, V58, P453; Ikezoe T, 2012, GERIATR GERONTOL INT, V12, P86, DOI 10.1111/j.1447-0594.2011.00735.x; JEVSEVAR DS, 1993, PHYS THER, V73, P229, DOI 10.1093/ptj/73.4.229; Kent-Braun JA, 1999, J APPL PHYSIOL, V87, P22, DOI 10.1152/jappl.1999.87.1.22; Kent-Braun JA, 2014, MUSCLE NERVE, V49, P209, DOI 10.1002/mus.23903; Kent-Braun JA, 2009, EXERC SPORT SCI REV, V37, P3, DOI 10.1097/JES.0b013e318190ea2e; Klein CS, 2001, J APPL PHYSIOL, V91, P1341, DOI 10.1152/jappl.2001.91.3.1341; Lanza IR, 2003, J APPL PHYSIOL, V95, P2361, DOI 10.1152/japplphysiol.00724.2002; Lion A, 2010, J ELECTROMYOGR KINES, V20, P1196, DOI 10.1016/j.jelekin.2010.07.016; Loram ID, 2002, J PHYSIOL-LONDON, V540, P1111, DOI 10.1113/jphysiol.2001.013077; LORD SR, 1994, AGE AGEING, V23, P452, DOI 10.1093/ageing/23.6.452; Menz HB, 2005, J GERONTOL A-BIOL, V60, P1546, DOI 10.1093/gerona/60.12.1546; Moore JB, 2005, PERCEPT MOTOR SKILL, V100, P725, DOI 10.2466/PMS.100.3.725-733; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; Nardone A, 1998, ARCH PHYS MED REHAB, V79, P920, DOI 10.1016/S0003-9993(98)90088-0; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Petrella JK, 2005, J APPL PHYSIOL, V98, P211, DOI 10.1152/japplphysiol.00294.2004; Power GA, 2010, J APPL PHYSIOL, V109, P669, DOI 10.1152/japplphysiol.01254.2009; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Simonsick EM, 2001, J GERONTOL A-BIOL, V56, pM644, DOI 10.1093/gerona/56.10.M644; Tevald MA, 2014, AGE, V36, DOI 10.1007/s11357-014-9713-5; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Van Emmerik REA, 2010, GAIT POSTURE, V32, P608, DOI 10.1016/j.gaitpost.2010.09.002; Weir JP, 1998, EUR J APPL PHYSIOL O, V78, P555, DOI 10.1007/s004210050460; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211	45	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183483	10.1371/journal.pone.0183483	http://dx.doi.org/10.1371/journal.pone.0183483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG0PY	28880935	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200019
J	Goel, A; Shivaprasad, C; Kolly, A; Sarathi, HAV; Atluri, S				Goel, Amit; Shivaprasad, Channabasappa; Kolly, Anish; Sarathi, Vijaya H. A.; Atluri, Sridevi			Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy	PLOS ONE			English	Article							SMALL FIBER NEUROPATHY; PERIPHERAL NEUROPATHY; RISK-FACTORS; FOOT ULCERATION; SUDOMOTOR FUNCTION; NERVE-CONDUCTION; PREVALENCE; DIAGNOSIS; POLYNEUROPATHY; ASSOCIATION	The early diagnosis of diabetic peripheral neuropathy (DPN) is challenging. Sudomotor dysfunction is one of the earliest detectable abnormalities in DPN. The present study aimed to determine the diagnostic performance of the electrochemical skin conductance (ESC) test in detecting early DPN, compared with the vibration perception threshold (VPT) test and diabetic neuropathy symptom (DNS) score, using the modified neuropathy disability score (NDS) as the reference standard. Five hundred and twenty-three patients with type 2 diabetes underwent an NDS-based clinical assessment for neuropathy. Participants were classified into the DPN and non-DPN groups based on the NDS (>= 6). Both groups were evaluated further using the DNS, and VPT and ESC testing. A receiver-operator characteristic (ROC) curve analysis was performed to compare the efficacy of ESC measurements with those of DNS and VPT testing in detecting DPN. The DPN group (n = 110, 21%) had significantly higher HbA1c levels and longer diabetes durations compared with the non-DPN group (n = 413). The sensitivity of feet ESC < 60 mu S, VPT testing, and DNS in detecting DPN were 85%, 72%, and 52%, respectively. The specificity of feet ESC, VPT, and DNS in detecting DPN were 85%, 90% and 60% respectively. The areas under the curves of the ROC plots for feet ESC, VPT testing, and DNS were 0.88, 0.84, and 0.6, respectively. A significant inverse linear relationship was noted between VPT and feet ESC (r = -0.45, p = <0.0001). The odds ratios for having DPN, based on the mean feet ESC testing < 60 mu S, VPT testing > 15 V, and DNS >= 1, were 16.4, 10.9 and 1.8, respectively. ESC measurement is an objective and sensitive technique for the early detection of DPN. Feet ESC measurement was superior to VPT testing for identifying patients with early DPN.	[Goel, Amit; Shivaprasad, Channabasappa; Kolly, Anish; Sarathi, Vijaya H. A.; Atluri, Sridevi] Vydehi Inst Med Sci & Res Ctr, Dept Endocrinol, Bangalore, Karnataka, India		Shivaprasad, C (corresponding author), Vydehi Inst Med Sci & Res Ctr, Dept Endocrinol, Bangalore, Karnataka, India.	shvprsd.c@gmail.com	Sarathi, Vijaya/ABC-2232-2020	Sarathi, Vijaya/0000-0002-0243-0448; Shivaprasad, Channabasappa/0000-0003-2847-1747				Abbott CA, 2002, DIABETIC MED, V19, P377, DOI 10.1046/j.1464-5491.2002.00698.x; Abbott CA, 2011, DIABETES CARE, V34, P2220, DOI 10.2337/dc11-1108; An JY, 2008, INTERNAL MED, V47, P1395, DOI 10.2169/internalmedicine.47.0901; Apelqvist J, 2008, DIABETES-METAB RES, V24, pS181, DOI 10.1002/dmrr.848; Bansal D, 2014, J DIABETES INVEST, V5, P714, DOI 10.1111/jdi.12223; BOULTON AJM, 1986, DIABETIC MED, V3, P335, DOI 10.1111/j.1464-5491.1986.tb00775.x; Boulton AJM, 2005, LANCET, V366, P1719, DOI 10.1016/S0140-6736(05)67698-2; Boulton AJM, 2005, DIABETES CARE, V28, P956, DOI 10.2337/diacare.28.4.956; Boulton AJM, 2004, DIABETES CARE, V27, P1458, DOI 10.2337/diacare.27.6.1458; Boulton AJM, 2005, CLIN DIABETES, V23, P9, DOI DOI 10.2337/DIACLIN.23.1.9; Bourron O, 2014, J CLIN ENDOCR METAB, V99, P4250, DOI 10.1210/jc.2014-1047; Cabezas-Cerrato J, 1998, DIABETOLOGIA, V41, P1263, DOI 10.1007/s001250051063; Calvet JH, 2013, EXP CLIN ENDOCR DIAB, V121, P80, DOI 10.1055/s-0032-1323777; Casellini CM, 2013, DIABETES TECHNOL THE, V15, P948, DOI 10.1089/dia.2013.0129; DYCK PJ, 1991, NEUROLOGY, V41, P799, DOI 10.1212/WNL.41.6.799; England JD, 2005, NEUROLOGY, V64, P199, DOI 10.1212/01.WNL.0000149522.32823.EA; Eranki VG, 2013, DIABETES RES CLIN PR, V101, pE11, DOI 10.1016/j.diabres.2013.07.003; Gill HK, 2014, J POSTGRAD MED, V60, P270, DOI 10.4103/0022-3859.138750; Gilman S, 2002, J NEUROL NEUROSUR PS, V73, P473, DOI 10.1136/jnnp.73.5.473; Gin H, 2011, DIABETES METAB, V37, P527, DOI 10.1016/j.diabet.2011.05.003; GUY RJC, 1985, DIABETOLOGIA, V28, P131; He TY, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8289740; Hebert HL, 2017, PAIN, V158, P560, DOI 10.1097/j.pain.0000000000000785; Hu GT, 2017, DIABETES RES CLIN PR, V131, P42, DOI 10.1016/j.diabres.2017.06.017; Jayaprakash P, 2011, INDIAN J MED RES, V133, P645; Jin HY, 2015, J DIABETES INVEST, V6, P18, DOI 10.1111/jdi.12236; Kasznicki J, 2014, ARCH MED SCI, V10, P345, DOI 10.5114/aoms.2014.42588; KUMAR S, 1994, DIABETIC MED, V11, P480, DOI 10.1111/j.1464-5491.1994.tb00310.x; Mao F, 2017, J DIABETES INVEST, V8, P363, DOI 10.1111/jdi.12575; Martin CL, 2010, DIABETES CARE, V33, P2635, DOI 10.2337/dc10-0616; Mayaudon H, 2010, DIABETES METAB, V36, P450, DOI 10.1016/j.diabet.2010.05.004; Meijer JWG, 2003, DIABETES CARE, V26, P697, DOI 10.2337/diacare.26.3.697; Meijer JWG, 2002, DIABETIC MED, V19, P962, DOI 10.1046/j.1464-5491.2002.00819.x; Miranda-Palma B, 2005, DIABETES RES CLIN PR, V70, P8, DOI 10.1016/j.diabres.2005.02.013; Morkrid K, 2010, INT J DIABETES DEV C, V30, P11, DOI 10.4103/0973-3930.60004; Mythili A, 2010, INT J DIABETES DEV C, V30, P43, DOI 10.4103/0973-3930.60007; PARTANEN J, 1995, NEW ENGL J MED, V333, P89, DOI 10.1056/NEJM199507133330203; Pham H, 2000, DIABETES CARE, V23, P606, DOI 10.2337/diacare.23.5.606; Pop-Busui R, 2017, DIABETES CARE, V40, P136, DOI 10.2337/dc16-2042; Pradeepa R, 2008, DIABETIC MED, V25, P407, DOI 10.1111/j.1464-5491.2008.02397.x; Said G, 2007, NAT CLIN PRACT NEURO, V3, P331, DOI 10.1038/ncpneuro0504; Selvarajah D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138224; Shehab DK, 2012, QJM-INT J MED, V105, P315, DOI 10.1093/qjmed/hcr212; Sheshah E, 2016, J DIABETES METAB DIS, V15, DOI 10.1186/s40200-016-0252-8; Vinik AI, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00094; Weintrob N, 2007, J DIABETES COMPLICAT, V21, P13, DOI 10.1016/j.jdiacomp.2005.11.002; Won JC, 2016, ENDOCRINOL METAB, V31, P230, DOI 10.3803/EnM.2016.31.2.230; Wu SC, 2007, VASC HEALTH RISK MAN, V3, P65; Yajnik Chittaranjan S, 2012, ISRN Endocrinol, V2012, P103714, DOI 10.5402/2012/103714; Yang ZY, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009948.pub2; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697	51	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183973	10.1371/journal.pone.0183973	http://dx.doi.org/10.1371/journal.pone.0183973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880907	gold, Green Submitted, Green Published			2022-12-27	WOS:000409467200029
J	Patoine, A; Husseini, A; Kasaai, B; Gaumond, MH; Moffatt, P				Patoine, Alexa; Husseini, Abdallah; Kasaai, Bahar; Gaumond, Marie-Helene; Moffatt, Pierre			The osteogenic cell surface marker BRIL/IFITM5 is dispensable for bone development and homeostasis in mice	PLOS ONE			English	Article							IMPERFECTA TYPE-V; OSTEOBLAST DIFFERENTIATION; FAMILY PROTEINS; DISTINCT ROLES; GENE; EXPRESSION; INFECTION; MUTATION; BRIL; VISUALIZATION	BRIL (bone-restricted IFITM-like), is a short transmembrane protein expressed almost exclusively in osteoblasts. Although much is known about its bone-restricted gene expression pattern and protein biochemical and topological features, little information is available for BRIL physiological function. Two autosomal dominant forms of osteogenesis imperfecta (OI) are caused by distinct, but recurrent mutations in the BRIL gene. Yet, the underlying mechanisms by which those mutations lead to OI are still poorly understood. A previous report indicated that BRIL knockout (KO) mice had bone deformities, shortened long bones, and reproductive problems. Here we generated and systematically analyzed the skeletal phenotype of a new global Bril KO/LacZ knockin mouse model. KO mice reproduced and thrived normally up to 12 month of age. The skeletal phenotype of KO and WT littermates was assessed at embryonic (E13.5 to E18.5) and postnatal (2 days, 3 weeks, 3 months and 8 months) time-points. Embryos from E13.5 through to E18.5 showed significant X-Gal staining in all skeletal elements without any apparent patterning anomalies. Although bone deformities were never observed at any postnatal ages, minor and transient differences were noted in terms of bone length and static uCT parameters, but not systematically across all ages and genders. These changes, however, were not accompanied by significant alteration in bone material properties as assessed by a 3-point bending test. In addition, no changes were detected in circulating serum markers of bone turnover (P1NP, CTX-I, and osteocalcin). Gene expression monitoring also revealed no major impact of the loss of BRIL. Further, when mice were challenged with a surgically-induced fracture in tibia, bones repaired equally well in the KO mice as compared to WT. Finally, we showed that BRIL C-terminus is not a bona fide binding site for calcium. In conclusion, our in depth analysis suggest that skeletal patterning, bone mass accrual and remodeling in mice proceeded independent of BRIL.	[Patoine, Alexa; Husseini, Abdallah; Kasaai, Bahar; Gaumond, Marie-Helene; Moffatt, Pierre] Shriners Hosp Children Canada, Montreal, PQ, Canada; [Moffatt, Pierre] McGill Univ, Dept Human Genet, Montreal, PQ, Canada	McGill University	Moffatt, P (corresponding author), Shriners Hosp Children Canada, Montreal, PQ, Canada.; Moffatt, P (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	pmoffatt@shriners.mcgill.ca		Moffatt, Pierre/0000-0002-5793-1944	Canadian Institutes of Health Research [137102]; Shriners of North America [8022]; RSBO-FRQS	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Shriners of North America; RSBO-FRQS	PM received funding from the Canadian Institutes of Health Research (137102), and the Shriners of North America (8022). AP received a scholarship from the RSBO-FRQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; Baird JW, 2001, J BIOL CHEM, V276, P9189, DOI 10.1074/jbc.M008354200; Bassano I, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3801-8; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Chen WQ, 2015, TRENDS MICROBIOL, V23, P35, DOI 10.1016/j.tim.2014.09.005; Chen WQ, 2014, P NATL ACAD SCI USA, V111, P6040, DOI 10.1073/pnas.1318859111; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Cho TJ, 2012, AM J HUM GENET, V91, P343, DOI 10.1016/j.ajhg.2012.06.005; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Denessiouk K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109287; Farber CR, 2014, J BONE MINER RES; Fedde KN, 1999, J BONE MINER RES, V14, P2015, DOI 10.1359/jbmr.1999.14.12.2015; Forlino A, 2016, LANCET, V387, P1657, DOI 10.1016/S0140-6736(15)00728-X; Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16; Hanagata N, 2007, J BIOMED MATER RES A, V83A, P362, DOI 10.1002/jbm.a.31240; Hanagata N, 2011, BIOCHEM BIOPH RES CO, V409, P378, DOI 10.1016/j.bbrc.2011.04.136; Hanagata N, 2011, J BONE MINER METAB, V29, P279, DOI 10.1007/s00774-010-0221-0; Hickford D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-155; Hoyer-Kuhn H, 2013, J BONE MINER RES; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Karsenty G, 2012, NATURE, V481, P314, DOI 10.1038/nature10763; Kasaai B, 2013, J BIOL CHEM, V288, P13278, DOI 10.1074/jbc.M113.457010; Kawaguchi J, 2002, BIOTECHNIQUES, V32, P66, DOI 10.2144/02321st02; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; Lietman CD, 2015, J BONE MINER RES, V30, P498, DOI 10.1002/jbmr.2363; Loughna Siobhan, 2007, V411, P1; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Manigrasso MB, 2004, J ORTHOP TRAUMA, V18, P687, DOI 10.1097/00005131-200411000-00006; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Millan JL, 2016, CALCIFIED TISSUE INT, V98, P398, DOI 10.1007/s00223-015-0079-1; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Patoine A, 2014, J BONE MINER RES, V29, P2004, DOI 10.1002/jbmr.2243; Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024; Plotkin LI, 2015, CELL MOL LIFE SCI, V72, P2853, DOI 10.1007/s00018-015-1963-6; Poddar S, 2016, J VIROL, V90, P8780, DOI 10.1128/JVI.00655-16; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Semler O, 2012, AM J HUM GENET, V91, P349, DOI 10.1016/j.ajhg.2012.06.011; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Tanaka SS, 2005, DEV CELL, V9, P745, DOI 10.1016/j.devcel.2005.10.010; Tsukamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075831; Wee YS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123218	48	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184568	10.1371/journal.pone.0184568	http://dx.doi.org/10.1371/journal.pone.0184568			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880886	Green Submitted, Green Published, gold			2022-12-27	WOS:000409467200077
J	Power, JD; Plitt, M; Kundu, P; Bandettini, PA; Martin, A				Power, Jonathan D.; Plitt, Mark; Kundu, Prantik; Bandettini, Peter A.; Martin, Alex			Temporal interpolation alters motion in fMRI scans: Magnitudes and consequences for artifact detection	PLOS ONE			English	Article							RESTING-STATE FMRI; FUNCTIONAL CONNECTIVITY MRI; SURFACE-BASED ANALYSIS; HEAD MOTION; CEREBRAL-CORTEX; HUMAN BRAIN; SYSTEM; RECONSTRUCTION; ORGANIZATION; IMPACT	Head motion can be estimated at any point of fMRI image processing. Processing steps involving temporal interpolation (e.g., slice time correction or outlier replacement) often precede motion estimation in the literature. From first principles it can be anticipated that temporal interpolation will alter head motion in a scan. Here we demonstrate this effect and its consequences in five large fMRI datasets. Estimated head motion was reduced by 10-50% or more following temporal interpolation, and reductions were often visible to the naked eye. Such reductions make the data seem to be of improved quality. Such reductions also degrade the sensitivity of analyses aimed at detecting motion-related artifact and can cause a dataset with artifact to falsely appear artifact-free. These reduced motion estimates will be particularly problematic for studies needing estimates of motion in time, such as studies of dynamics. Based on these findings, it is sensible to obtain motion estimates prior to any image processing (regardless of subsequent processing steps and the actual timing of motion correction procedures, which need not be changed). We also find that outlier replacement procedures change signals almost entirely during times of motion and therefore have notable similarities to motion-targeting censoring strategies (which withhold or replace signals entirely during times of motion).	[Power, Jonathan D.; Plitt, Mark; Bandettini, Peter A.; Martin, Alex] NIMH, NIH, Bethesda, MD 20892 USA; [Kundu, Prantik] Mt Sinai Hosp, Dept Radiol, New York, NY 10029 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Icahn School of Medicine at Mount Sinai	Power, JD (corresponding author), NIMH, NIH, Bethesda, MD 20892 USA.	jdp9009@nyp.org	Jovicich, Jorge/D-2293-2010; martin, alex/B-6176-2009	Plitt, Mark/0000-0002-7154-6292; Power, Jonathan/0000-0002-6922-100X	Intramural Research Program, National Institute of Mental Health/NIH [ZIAMH002920, NCT01031407]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002920, ZIAMH002783] Funding Source: NIH RePORTER	Intramural Research Program, National Institute of Mental Health/NIH; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Intramural Research Program, National Institute of Mental Health/NIH (ZIAMH002920; NCT01031407). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Kevin Tran, David Godlove, and the NIH Helix/Biowulf staff for their computing support. We thank Steve Petersen and Brad Schlaggar for releasing the WU scans for public use and Becky Coalson for preparing these data for release. We thank Pablo Schklowsky for advice and help in movie creation. We thank our Reviewers for comments that strengthened the manuscript. This work was supported by the Intramural Research Program, National Institute of Mental Health/NIH (ZIAMH002920; NCT01031407).	Beall EB, 2014, NEUROIMAGE, V101, P21, DOI 10.1016/j.neuroimage.2014.06.038; Burgess GC, 2016, BRAIN CONNECT, V6, P669, DOI 10.1089/brain.2016.0435; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Gotts SJ, 2012, BRAIN, V135, P2711, DOI 10.1093/brain/aws160; Holmes AJ, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.31; Jo HJ, 2013, J APPL MATH, DOI 10.1155/2013/935154; Kundu P, 2013, P NATL ACAD SCI USA, V110, P16187, DOI 10.1073/pnas.1301725110; Laumann T. O., 2016, CEREB CORTEX; Laumann TO, 2015, NEURON, V87, P657, DOI 10.1016/j.neuron.2015.06.037; Maclaren J, 2013, MAGN RESON MED, V69, P621, DOI 10.1002/mrm.24314; Muschelli J, 2014, NEUROIMAGE, V96, P22, DOI 10.1016/j.neuroimage.2014.03.028; Oakes TR, 2005, NEUROIMAGE, V28, P529, DOI 10.1016/j.neuroimage.2005.05.058; Patel AX, 2014, NEUROIMAGE, V95, P287, DOI 10.1016/j.neuroimage.2014.03.012; PONCELET BP, 1992, RADIOLOGY, V185, P645, DOI 10.1148/radiology.185.3.1438740; Power JD, 2017, NEUROIMAGE, V154, P150, DOI 10.1016/j.neuroimage.2016.08.009; Power JD, 2017, NEUROIMAGE, V146, P609, DOI 10.1016/j.neuroimage.2016.09.038; Power JD, 2015, NEUROIMAGE, V105, P536, DOI 10.1016/j.neuroimage.2014.10.044; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Segonne F, 2005, LECT NOTES COMPUT SC, V3565, P393; Sladky R, 2011, NEUROIMAGE, V58, P588, DOI 10.1016/j.neuroimage.2011.06.078; Smyser CD, 2010, CEREB CORTEX, V20, P2852, DOI 10.1093/cercor/bhq035; Tremblay M, 2005, MAGN RESON MED, V53, P141, DOI 10.1002/mrm.20319; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yuan Zhou J C, 2016, BIORXIV; Zaitsev M, 2006, NEUROIMAGE, V31, P1038, DOI 10.1016/j.neuroimage.2006.01.039; Zeng LL, 2014, P NATL ACAD SCI USA, V111, P6058, DOI 10.1073/pnas.1317424111	36	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0182939	10.1371/journal.pone.0182939	http://dx.doi.org/10.1371/journal.pone.0182939			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880888	Green Submitted, Green Published, gold			2022-12-27	WOS:000409467200011
J	Hoffmann, S; Devleesschauwer, B; Aspinall, W; Cooke, R; Corrigan, T; Havelaar, A; Angulo, F; Gibb, H; Kirk, M; Lake, R; Speybroeck, N; Torgerson, P; Hald, T				Hoffmann, Sandra; Devleesschauwer, Brecht; Aspinall, Willy; Cooke, Roger; Corrigan, Tim; Havelaar, Arie; Angulo, Frederick; Gibb, Herman; Kirk, Martyn; Lake, Robin; Speybroeck, Niko; Torgerson, Paul; Hald, Tine			Attribution of global foodborne disease to specific foods: Findings from a World Health Organization structured expert elicitation	PLOS ONE			English	Article							UNITED-STATES; ENTERIC PATHOGENS; OUTBREAK DATA; ILLNESSES; TRANSMISSION; SALMONELLOSIS; PROPORTION; JUDGMENT; BURDEN; MODEL	Background Recently the World Health Organization, Foodborne Disease Burden Epidemiology Reference Group (FERG) estimated that 31 foodborne diseases (FBDs) resulted in over 600 million illnesses and 420,000 deaths worldwide in 2010. Knowing the relative role importance of different foods as exposure routes for key hazards is critical to preventing illness. This study reports the findings of a structured expert elicitation providing globally comparable food source attribution estimates for 11 major FBDs in each of 14 world subregions. Methods and findings We used Cooke's Classical Model to elicit and aggregate judgments of 73 international experts. Judgments were elicited from each expert individually and aggregated using both equal and performance weights. Performance weighted results are reported as they increased the informativeness of estimates, while retaining accuracy. We report measures of central tendency and uncertainty bounds on food source attribution estimate. For some pathogens we see relatively consistent food source attribution estimates across subregions of the world; for others there is substantial regional variation. For example, for non-typhoidal salmonellosis, pork was of minor importance compared to eggs and poultry meat in the American and African subregions, whereas in the European and Western Pacific subregions the importance of these three food sources were quite similar. Our regional results broadly agree with estimates from earlier European and North American food source attribution research. As in prior food source attribution research, we find relatively wide uncertainty bounds around our median estimates. Conclusions We present the first worldwide estimates of the proportion of specific foodborne diseases attributable to specific food exposure routes. While we find substantial uncertainty around central tendency estimates, we believe these estimates provide the best currently available basis on which to link FBDs and specific foods in many parts of the world, providing guidance for policy actions to control FBDs.	[Hoffmann, Sandra] USDA, Econ Res Serv, Washington, DC 20250 USA; [Devleesschauwer, Brecht] Sci Inst Publ Hlth WIV ISP, Dept Publ Hlth & Surveillance, Brussels, Belgium; [Aspinall, Willy] Aspinall & Associates, Tisbury, England; [Aspinall, Willy] Univ Bristol, Bristol, Avon, England; [Cooke, Roger] Resources Future Inc, Washington, DC USA; [Cooke, Roger] Delft Univ Technol, Delft, Netherlands; [Corrigan, Tim] WHO, Geneva, Switzerland; [Havelaar, Arie] Univ Florida, Gainesville, FL USA; [Havelaar, Arie] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Havelaar, Arie] Univ Utrecht, Utrecht, Netherlands; [Angulo, Frederick] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Gibb, Herman] Gibb Epidemiol Consulting LLC, Arlington, VA USA; [Kirk, Martyn] Australian Natl Univ, Canberra, ACT, Australia; [Lake, Robin] Inst Environm Sci & Res, Christchurch, New Zealand; [Speybroeck, Niko] Catholic Univ Louvain, Brussels, Belgium; [Torgerson, Paul] Univ Zurich, Zurich, Switzerland; [Hald, Tine] Tech Univ Denmark, Lyngby, Denmark	United States Department of Agriculture (USDA); University of Bristol; Resources for the Future; Delft University of Technology; World Health Organization; State University System of Florida; University of Florida; Netherlands National Institute for Public Health & the Environment; Utrecht University; Centers for Disease Control & Prevention - USA; Australian National University; Institute of Environmental Science & Research (ESR) - New Zealand; Universite Catholique Louvain; University of Zurich; Technical University of Denmark	Hoffmann, S (corresponding author), USDA, Econ Res Serv, Washington, DC 20250 USA.	shoffmann@ers.usda.gov	Torgerson, Paul R/M-4447-2013; Hald, Tine/B-5477-2016; Devleesschauwer, Brecht/G-9895-2018	Torgerson, Paul R/0000-0003-4277-9983; Hald, Tine/0000-0002-1115-9792; Devleesschauwer, Brecht/0000-0002-2867-6892; Speybroeck, Niko/0000-0003-3322-3502; Hoffmann, Sandra/0000-0003-2537-8731; Kirk, Martyn/0000-0001-5432-5984	Aspinall & Associates and Gibb Epidemio logy Consulting LLC; Natural Environment Research Council [NE/J017450/1] Funding Source: researchfish; NERC [NE/J017450/1] Funding Source: UKRI	Aspinall & Associates and Gibb Epidemio logy Consulting LLC; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was commissioned and paid for by the World Health Organization (WHO). Aspinall & Associates and Gibb Epidemio logy Consulting LLC provided support in the form of salaries for authors [WA, HJG], but did not have any additiona l role in the study design, data collection and analysis , decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributio ns' section.	[Anonymous], 2011, J SOCIO-ECON, DOI DOI 10.1016/J.SOCEC.2010.10.008; Aspinall W., 2013, RISK UNCERTAINTY ASS, P64, DOI DOI 10.1017/CBO9781139047562.005; Aspinall WP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149817; Atkinson R., 2003, SAGE ENCY SOCIAL SCI; Bamber JL, 2016, CLIMATIC CHANGE, P1; Batz MB, 2005, EMERG INFECT DIS, V11, P993, DOI 10.3201/eid1107.040634; Batz MB, 2012, J FOOD PROTECT, V75, P1278, DOI 10.4315/0362-028X.JFP-11-418; Bunn D. W., 1975, OPERATIONAL RES Q, P449; Burgman M., 2015, TRUSTING JUDGEMENTS; Butler AJ, 2015, FOODBORNE PATHOG DIS, V12, P335, DOI 10.1089/fpd.2014.1856; Cooke R. M., 1991, EXPERTS UNCERTAINTY; Cooke RM, 2008, RELIAB ENG SYST SAFE, V93, P657, DOI 10.1016/j.ress.2007.03.005; Davidson VJ, 2011, FOODBORNE PATHOG DIS, V8, P983, DOI 10.1089/fpd.2010.0786; De Knegt LV, 2015, EPIDEMIOL INFECT, V143, P1175, DOI 10.1017/S0950268814001903; De Waal CS, 2002, OUTBREAK ALERT, P57; Devleesschauwer B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142498; Ebel ED, 2016, EMERG INFECT DIS, V22, P1193, DOI 10.3201/eid2207.150833; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Flandoli F, 2011, RELIAB ENG SYST SAFE, V96, P1292, DOI 10.1016/j.ress.2011.05.012; Hald T, 2016, RISK ANAL, V36, P191, DOI 10.1111/risa.12385; Hald T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145839; Havelaar AH, 2008, FOODBORNE PATHOG DIS, V5, P649, DOI 10.1089/fpd.2008.0115; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hoffmann S, 2007, J FOOD PROTECT, V70, P1220, DOI 10.4315/0362-028X-70.5.1220; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Painter JA, 2009, FOODBORNE PATHOG DIS, V6, P1259, DOI 10.1089/fpd.2009.0350; Pires SM, 2013, FOODBORNE PATHOG DIS, V10, P206, DOI 10.1089/fpd.2012.1134; Pires SM, 2010, FOODBORNE PATHOG DIS, V7, P1351, DOI 10.1089/fpd.2010.0564; Pires SM, 2009, FOODBORNE PATHOG MAY, P6; Ravel A, 2010, FOODBORNE PATHOG DIS, V7, P1463, DOI 10.1089/fpd.2010.0582; Scallan E, 2011, EMERG INFECT DIS, V17; Shokouhi M, 2015, SIGIR 2015: PROCEEDINGS OF THE 38TH INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P963, DOI 10.1145/2766462.2767841; Tversky Amos., 1975, UTILITY PROBABILITY, P141, DOI [10.1007/978-94-010-1834-0_8, DOI 10.1017/CBO9780511809477.002, DOI 10.1007/978-94-010-1834-0_8]; Tyshenko M.G., 2012, INT J RISK ASSESS MA, V16, P48, DOI [10.1504/ijram.2012.047552, DOI 10.1504/IJRAM.2012.047552, 10.1504/IJRAM.2012.047552.]; Vally H, 2016, EPIDEMIOL INFECT, V144, P897, DOI 10.1017/S0950268815002435; Van der Fels-Klerx HJ, 2005, RISK ANAL, V25, P109, DOI 10.1111/j.0272-4332.2005.00571.x; WHO, 2017, CXCAC174018 WHO 5; World Health Organization, 2006, FOOD SAF RISK AN GUI; World Health Organization, WHO EST GLOB BURD FO	39	82	84	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183641	10.1371/journal.pone.0183641	http://dx.doi.org/10.1371/journal.pone.0183641			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910293	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000410859200013
J	Malpress, V; Bestley, S; Corney, S; Welsford, D; Labrousse, S; Sumner, M; Hindell, M				Malpress, Veda; Bestley, Sophie; Corney, Stuart; Welsford, Dirk; Labrousse, Sara; Sumner, Michael; Hindell, Mark			Bio-physical characterisation of polynyas as a key foraging habitat for juvenile male southern elephant seals (Mirounga leonina) in Prydz Bay, East Antarctica	PLOS ONE			English	Article							PHYTOPLANKTON DYNAMICS; ICE FORMATION; CIRCULATION; WATER; BEHAVIOR; OCEANOGRAPHY; TEMPERATURE; PREDATOR; SHELF; RATES	Antarctic coastal polynyas are persistent open water areas in the sea ice zone, and regions of high biological productivity thought to be important foraging habitat for marine predators. This study quantified southern elephant seal(Mirounga leonina) habitat use within and around the polynyas of the Prydz Bay region (63 degrees E E - 88 E degrees E) in East Antarctica, and examined the bio-physical characteristics structuring polynyas as foraging habitat. Output from a climatological regional ocean model was used to provide context for in situ temperature-salinity vertical profiles collected by tagged elephant seals and to characterise the physical properties structuring polynyas. Biological properties were explored using remotely-sensed surface chlorophyll (Chl-a) and, qualitatively, historical fish assemblage data. Spatially gridded residence time of seals was examined in relation to habitat characteristics using generalized additive mixed models. The results showed clear polynya usage during early autumn and increasingly concentrated usage during early winter. Bathymetry, Chl-a, surface net heat flux (representing polynya location), and bottom temperature were identified as significant bio-physical predictors of the spatio-temporal habitat usage. The findings from this study confirm that the most important marine habitats for juvenile male southern elephant seals within Prydz Bay region are polynyas. A hypothesis exists regarding the seasonal evolution of primary productivity, coupling from surface to subsurface productivity and supporting elevated rates of secondary production in the upper water column during summer-autumn. An advancement to this hypothesis is proposed here, whereby this bio-physical coupling is likely to extend throughout the water column as it becomes fully convected during autumn-winter, to also promote pelagic-benthic linkages important for benthic foraging within polynyas.	[Malpress, Veda; Bestley, Sophie; Labrousse, Sara; Hindell, Mark] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Malpress, Veda; Bestley, Sophie; Corney, Stuart; Sumner, Michael; Hindell, Mark] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Bestley, Sophie; Welsford, Dirk; Sumner, Michael] Australian Antarctic Div, Dept Environm, Kingston, Tas, Australia; [Labrousse, Sara] UPMC Univ, Sorbonne Univ, Paris 06, LOCEAN IPSL,UMR CNRS IRD MNHN 7159, Paris, France	University of Tasmania; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Australian Antarctic Division; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Malpress, V (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.; Malpress, V (corresponding author), Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia.	vedam@utas.edu.au	Bestley, Sophie/AAN-2483-2021	Bestley, Sophie/0000-0001-9342-669X; Welsford, Dirk/0000-0001-5379-5052; Sumner, Michael/0000-0002-2471-7511; Hindell, Mark/0000-0002-7823-7185; Labrousse, Sara/0000-0002-8099-3254	Australian Government's Co-operative Research Centre's Program through Antarctic Climate and Ecosystems Cooperative Research Centre; Australia Research Council [FS110200057]	Australian Government's Co-operative Research Centre's Program through Antarctic Climate and Ecosystems Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australia Research Council(Australian Research Council)	This work was supported by the Australian Government's Co-operative Research Centre's Program through the Antarctic Climate and Ecosystems Cooperative Research Centre. S. Bestley was supported by an Australia Research Council Super Science Fellowship FS110200057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2016, RAADTOOLS TOOLS SYNO; Arrigo KR, 2015, J GEOPHYS RES-OCEANS, V120, P5545, DOI 10.1002/2015JC010888; Arrigo KR, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001739; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Bailleul F, 2007, DEEP-SEA RES PT II, V54, P343, DOI 10.1016/j.dsr2.2006.11.005; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; Bestley S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2262; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Boehme L, 2009, OCEAN SCI, V5, P685, DOI 10.5194/os-5-685-2009; Brauner N, 1998, AICHE J, V44, P603, DOI 10.1002/aic.690440311; Broyer CD, 2014, BIOGEOGRAPHIC ATLAS; Brzezinski A, 2009, J GEODYN, V48, P235, DOI 10.1016/j.jog.2009.09.021; Chapman EW, 2004, DEEP-SEA RES PT II, V51, P2261, DOI 10.1016/j.dsr2.2004.07.005; Charrassin JB, 2008, P NATL ACAD SCI USA, V105, P11634, DOI 10.1073/pnas.0800790105; Claireaux G, 2006, J EXP BIOL, V209, P3420, DOI 10.1242/jeb.02346; Cottin M, 2012, MAR BIOL, V159, P1843, DOI 10.1007/s00227-012-1974-x; Cougnon EA, 2016, THESIS; Dinniman MS, 2011, DEEP-SEA RES PT II, V58, P1508, DOI 10.1016/j.dsr2.2010.11.013; Dinniman MS, 2004, DEEP-SEA RES PT II, V51, P2003, DOI 10.1016/j.dsr2.2004.07.030; Dragon AC, 2012, MAR ECOL PROG SER, V447, P243, DOI 10.3354/meps09498; Erdmann ES, 2011, DEEP-SEA RES PT II, V58, P1710, DOI 10.1016/j.dsr2.2010.10.054; Field IC, 2012, MAR MAMMAL SCI, V28, pE325, DOI 10.1111/j.1748-7692.2011.00519.x; Field IC, 2002, VET REC, V151, P235, DOI 10.1136/vr.151.8.235; Friedlaender AS, 2011, DEEP-SEA RES PT II, V58, P1729, DOI 10.1016/j.dsr2.2010.11.018; Friedlaender AS, 2006, WHALE DISTRIBUTION R; Galton-Fenzi BK, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008214; Gill PC, 1997, POLAR BIOL, V17, P401, DOI 10.1007/s003000050134; Grebmeier JM, 2007, ELSEV OCEANOGR SERIE, V74, P363, DOI 10.1016/S0422-9894(06)74011-9; Herraiz-Borreguero L, 2015, J GEOPHYS RES-OCEANS, V120, P3098, DOI 10.1002/2015JC010697; Hibberd T, 2016, THESIS; HINDELL MA, 1988, J MAMMAL, V69, P81, DOI 10.2307/1381750; HINDELL MA, 1991, AUST J ZOOL, V39, P595, DOI 10.1071/ZO9910595; Hindell MA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1213; Johnson GC, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004477; Johnson R, 2013, J GEOPHYS RES-OCEANS, V118, P3694, DOI 10.1002/jgrc.20270; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Karnovsky N, 2007, ELSEV OCEANOGR SERIE, V74, P391, DOI 10.1016/S0422-9894(06)74012-0; Kavanaugh MT, 2015, EFFECT CONTIMENTAL S; Labrousse S, 2015, PROG OCEANOGR, V137, P52, DOI 10.1016/j.pocean.2015.05.023; Lehodey P, 1998, FISH OCEANOGR, V7, P317, DOI 10.1046/j.1365-2419.1998.00063.x; Liu G, 2009, ICES J MAR SCI, V66, P420, DOI 10.1093/icesjms/fsn219; Marshall J, 2012, NAT GEOSCI, V5, P171, DOI [10.1038/ngeo1391, 10.1038/NGEO1391]; Maxwell SM, 2012, MAR MAMMAL SCI, V28, pE333, DOI 10.1111/j.1748-7692.2011.00527.x; McMahon CR, 2008, J EXP MAR BIOL ECOL, V360, P71, DOI 10.1016/j.jembe.2008.03.012; McMahon CR, 2000, VET REC, V146, P251, DOI 10.1136/vr.146.9.251; Melbourne-Thomas J, 2015, DEEP-SEA RES PT II, V114, P64, DOI 10.1016/j.dsr2.2013.02.017; Menemenlis D., 2008, MERCAT OCEAN Q NEWSL, V31(October), P13; Ohshima KI, 2013, NAT GEOSCI, V6, P235, DOI 10.1038/NGEO1738; Orsi AH, 1999, PROG OCEANOGR, V43, P55, DOI 10.1016/S0079-6611(99)00004-X; Patterson TA, 2010, ECOLOGY, P91; Photopoulou T, 2015, ANIMAL BIOTELEMETRY, V3, P1; Pinheiro J., 2006, MIXED EFFECTS MODELS; Pinheiro J, R PACKAGE VERSION; Raymond B, 2015, ECOGRAPHY, V38, P121, DOI 10.1111/ecog.01021; Rey F, 2014, PLOS ONE, V9; Ribic CA, 2011, DEEP-SEA RES PT II, V58, P1695, DOI 10.1016/j.dsr2.2009.09.017; Roquet F, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.28; Roquet F, 2013, GEOPHYS RES LETT, V40, P6176, DOI 10.1002/2013GL058304; Saba GK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5318; Schofield O, 2013, OCEANOGRAPHY, V26, P204, DOI 10.5670/oceanog.2013.63; Shchepetkin AF, 2009, J COMPUT PHYS, V228, P8985, DOI 10.1016/j.jcp.2009.09.002; Stabeno PJ, 1998, J MAR RES, V56, P239, DOI 10.1357/002224098321836172; Sumner MD, 2015, TRIP TOOLS ANAL ANIM, P1; Tamura T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032903; Thums M, 2011, ECOLOGY, V92, P1258, DOI 10.1890/09-1299.1; Vaz RAN, 1996, DEEP-SEA RES PT I, V43, P603, DOI 10.1016/0967-0637(96)00028-3; Wakefield ED, 2009, MAR ECOL PROG SER, V391, P165, DOI 10.3354/meps08203; Williams D., 1999, AURORA AUSTRALIS VOY; Williams GD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12577; Williams GD, 2011, OCEAN SCI, V7, P185, DOI 10.5194/os-7-185-2011; Williams GD, 2003, DEEP-SEA RES PT II, V50, P1373, DOI 10.1016/S0967-0645(03)00074-2; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	76	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184536	10.1371/journal.pone.0184536	http://dx.doi.org/10.1371/journal.pone.0184536			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902905	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000410669200046
J	Gursky, VV; Kozlov, KN; Kulakovskiy, IV; Zubair, A; Marjoram, P; Lawrie, DS; Nuzhdin, SV; Samsonova, MG				Gursky, Vitaly V.; Kozlov, Konstantin N.; Kulakovskiy, Ivan V.; Zubair, Asif; Marjoram, Paul; Lawrie, David S.; Nuzhdin, Sergey V.; Samsonova, Maria G.			Translating natural genetic variation to gene expression in a computational model of the Drosophila gap gene regulatory network	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; NONCODING DNA; CELLULAR RESOLUTION; REFERENCE PANEL; MELANOGASTER; EVOLUTION; SELECTION; SEGMENTATION; ENHANCERS; SEQUENCE	Annotating the genotype-phenotype relationship, and developing a proper quantitative description of the relationship, requires understanding the impact of natural genomic variation on gene expression. We apply a sequence-level model of gap gene expression in the early development of Drosophila to analyze single nucleotide polymorphisms (SNPs) in a panel of natural sequenced D. melanogaster lines. Using a thermodynamic modeling framework, we provide both analytical and computational descriptions of how single-nucleotide variants affect gene expression. The analysis reveals that the sequence variants increase (decrease) gene expression if located within binding sites of repressors (activators). We show that the sign of SNP influence (activation or repression) may change in time and space and elucidate the origin of this change in specific examples. The thermodynamic modeling approach predicts non-local and non-linear effects arising from SNPs, and combinations of SNPs, in individual fly genotypes. Simulation of individual fly genotypes using our model reveals that this non-linearity reduces to almost additive inputs from multiple SNPs. Further, we see signatures of the action of purifying selection in the gap gene regulatory regions. To infer the specific targets of purifying selection, we analyze the patterns of polymorphism in the data at two phenotypic levels: the strengths of binding and expression. We find that combinations of SNPs show evidence of being under selective pressure, while individual SNPs do not. The model predicts that SNPs appear to accumulate in the genotypes of the natural population in a way biased towards small increases in activating action on the expression pattern. Taken together, these results provide a systems-level view of how genetic variation translates to the level of gene regulatory networks via combinatorial SNP effects.	[Gursky, Vitaly V.] Ioffe Inst, Theoret Dept, St Petersburg, Russia; [Gursky, Vitaly V.; Kozlov, Konstantin N.; Samsonova, Maria G.] Peter Great St Petersburg Polytech Univ, Syst Biol & Bioinformat Lab, St Petersburg, Russia; [Kulakovskiy, Ivan V.] Engelhardt Inst Mol Biol, Moscow, Russia; [Kulakovskiy, Ivan V.] Vavilov Inst Gen Genet, Moscow, Russia; [Kulakovskiy, Ivan V.] Skolkovo Inst Sci & Technol, Ctr Data Intens Biomed & Biotechnol, Moscow, Russia; [Zubair, Asif; Marjoram, Paul; Lawrie, David S.; Nuzhdin, Sergey V.] Univ Southern Calif, Mol & Computat Biol, Los Angeles, CA USA	Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute; Peter the Great St. Petersburg Polytechnic University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Russian Academy of Sciences; Vavilov Institute of General Genetics; Skolkovo Institute of Science & Technology; University of Southern California	Gursky, VV (corresponding author), Ioffe Inst, Theoret Dept, St Petersburg, Russia.; Gursky, VV (corresponding author), Peter Great St Petersburg Polytech Univ, Syst Biol & Bioinformat Lab, St Petersburg, Russia.	gursky@math.ioffe.ru	Zubair, Asif/X-3860-2019; Kozlov, Konstantin/N-6748-2013; Kulakovskiy, Ivan/A-1462-2014; Gursky, Vitaly V/A-9187-2014	Zubair, Asif/0000-0002-0958-700X; Kozlov, Konstantin/0000-0001-6765-236X; Kulakovskiy, Ivan/0000-0002-6554-8128; Gursky, Vitaly V/0000-0003-4094-1983; Lawrie, David/0000-0002-6782-9986	Russian Foundation for Basic Research [16-01-00648-a, 17-04-01665-a]; National Institute of Health [1U01GM103804]; Dynasty Foundation Fellowship	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dynasty Foundation Fellowship	VVG was supported by the Russian Foundation for Basic Research (http://www.rfbr.ru), grant number 16-01-00648-a; KNK and MGS were supported by the Russian Foundation for Basic Research (http://www.rfbr.ru), grant number 17-04-01665-a; AZ, VVG, SVN, and PM were supported by the National Institute of Health (https://www.nih.gov), grant number 1U01GM103804; IVK was supported by the Dynasty Foundation Fellowship (http://www.dynastyfdn.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Arbiza L, 2013, NAT GENET, V45, P723, DOI 10.1038/ng.2658; Bothma JP, 2015, ELIFE, V4, DOI 10.7554/eLife.07956; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Campo D, 2013, MOL ECOL, V22, P5084, DOI 10.1111/mec.12468; Clemente F, 2012, J EVOLUTION BIOL, V25, P1975, DOI 10.1111/j.1420-9101.2012.02580.x; Crombach A, 2016, MOL BIOL EVOL, V33, P1293, DOI 10.1093/molbev/msw013; Dresch JM, 2013, BBA-GENE REGUL MECH, V1829, P946, DOI 10.1016/j.bbagrm.2013.04.011; Drosophila 12 Genomes Consortium, 2007, NATURE, V450, P203; Duque T, 2014, MOL BIOL EVOL, V31, P184, DOI 10.1093/molbev/mst170; Gallo SM, 2011, NUCLEIC ACIDS RES, V39, pD118, DOI 10.1093/nar/gkq999; Gjuvsland AB, 2013, J PHYSIOL-LONDON, V591, P2055, DOI 10.1113/jphysiol.2012.248864; Gusev A, 2016, NAT GENET, V48, P245, DOI 10.1038/ng.3506; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906; Harrison MM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002266; He BZ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002053; He X, 2012, MOL BIOL EVOL, V29, P1059, DOI 10.1093/molbev/msr277; He X, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000935; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Hoermann A, 2016, DEV BIOL, V411, P325, DOI 10.1016/j.ydbio.2016.01.005; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Jaeger J, 2004, GENETICS, V167, P1721, DOI 10.1534/genetics.104.027334; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jaeger J, 2012, CURR OPIN GENET DEV, V22, P533, DOI 10.1016/j.gde.2012.10.005; Jaeger J, 2011, CELL MOL LIFE SCI, V68, P243, DOI 10.1007/s00018-010-0536-y; Jaeger J, 2009, MOL BIOSYST, V5, P1549, DOI 10.1039/b904722k; Jiang P, 2015, DEV BIOL, V405, P173, DOI 10.1016/j.ydbio.2015.06.019; Kazemian M, 2014, GENOME BIOL EVOL, V6, P2301, DOI 10.1093/gbe/evu184; Kazemian M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000456; Kim AR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003243; Kozlov K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S12-S6; Kulakovskiy I. V., 2009, Biophysics, V54, P667, DOI 10.1134/S0006350909060013; Kulakovskiy IV, 2009, BIOINFORMATICS, V25, P2318, DOI 10.1093/bioinformatics/btp434; Kwasnieski JC, 2012, P NATL ACAD SCI USA, V109, P19498, DOI 10.1073/pnas.1210678109; Lawrie DS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003527; Li XY, 2014, ELIFE, V3, DOI 10.7554/eLife.03737; Li XY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r34; Little SC, 2013, CELL, V154, P789, DOI 10.1016/j.cell.2013.07.025; Lyman RF, 1996, GENETICS, V143, P277; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marjoram P, 2014, HEREDITY, V112, P79, DOI 10.1038/hdy.2013.52; Martinez C, 2014, MOL BIOL EVOL, V31, P903, DOI 10.1093/molbev/msu042; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Miles CM, 2011, EVOLUTION, V65, P33, DOI 10.1111/j.1558-5646.2010.01088.x; Mustonen V, 2008, P NATL ACAD SCI USA, V105, P12376, DOI 10.1073/pnas.0805909105; Palsson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091924; Papatsenko D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021145; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Pisarev A, 2009, NUCLEIC ACIDS RES, V37, pD560, DOI 10.1093/nar/gkn717; Reinitz John, 2003, ComPlexUs, V1, P54, DOI 10.1159/000070462; Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868; Rockman MV, 2002, MOL BIOL EVOL, V19, P1991, DOI 10.1093/oxfordjournals.molbev.a004023; Samee MAH, 2015, CELL SYST, V1, P396, DOI 10.1016/j.cels.2015.12.002; Samee MA, 2013, METHODS, V62, P79, DOI 10.1016/j.ymeth.2013.03.005; Schroeder MD, 2004, PLOS BIOL, V2, P1396, DOI 10.1371/journal.pbio.0020271; Schulz KN, 2015, GENOME RES, V25, P1715, DOI 10.1101/gr.192682.115; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sharon E, 2014, GENOME RES, V24, P1698, DOI 10.1101/gr.168773.113; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; Singh ND, 2009, MOL BIOL EVOL, V26, P1591, DOI 10.1093/molbev/msp071; Staller MV, 2015, P NATL ACAD SCI USA, V112, P785, DOI 10.1073/pnas.1413877112; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Surkova S, 2008, DEV BIOL, V313, P844, DOI 10.1016/j.ydbio.2007.10.037; Wotton KR, 2015, ELIFE, V4, DOI 10.7554/eLife.04785; Zabet NR, 2012, MOL BIOSYST, V8, P2815, DOI 10.1039/c2mb25201e; Zhen Y, 2012, METHODS MOL BIOL, V856, P141, DOI 10.1007/978-1-61779-585-5_6	68	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184657	10.1371/journal.pone.0184657	http://dx.doi.org/10.1371/journal.pone.0184657			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898266	Green Submitted, gold, Green Published			2022-12-27	WOS:000410449500040
J	Lin, HTV; Massam-Wu, T; Lin, CP; Wang, YJA; Shen, YC; Lu, WJ; Hsu, PH; Chen, YH; Borges-Walmsley, MI; Walmsley, AR				Lin, Hong-Ting Victor; Massam-Wu, Teresa; Lin, Chen-Ping; Wang, Yen-Jen Anna; Shen, Yu-Chi; Lu, Wen-Jung; Hsu, Pang-Hung; Chen, Yu-Hou; Borges-Walmsley, Maria Ines; Walmsley, Adrian Robert			The Vibrio cholerae var regulon encodes a metallo-beta-lactamase and an antibiotic efflux pump, which are regulated by VarR, a LysRtype transcription factor	PLOS ONE			English	Article							MEMBRANE-FUSION PROTEIN; MULTIDRUG EFFLUX; PSEUDOMONAS-AERUGINOSA; CITROBACTER-FREUNDII; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; MACAB-TOLC; MEXAB-OPRM; MACROLIDE TRANSPORTER; CARBAPENEM RESISTANCE	The genome sequence of V. cholerae O1 Biovar Eltor strain N16961 has revealed a putative antibiotic resistance (var) regulon that is predicted to encode a transcriptional activator (VarR), which is divergently transcribed relative to the putative resistance genes for both a metallo-beta-lactamase (VarG) and an antibiotic efflux-pump (VarABCDEF). We sought to test whether these genes could confer antibiotic resistance and are organised as a regulon under the control of VarR. VarG was overexpressed and purified and shown to have beta-lactamase activity against penicillins, cephalosporins and carbapenems, having the highest activity against meropenem. The expression of VarABCDEF in the Escherichia coli (Delta acrAB) strain KAM3 conferred resistance to a range of drugs, but most significant resistance was to the macrolide spiramycin. A gel-shift analysis was used to determine if VarR bound to the promoter regions of the resistance genes. Consistent with the regulation of these resistance genes, VarR binds to three distinct intergenic regions, varRG, varGA and varBC located upstream and adjacent to varG, varA and varC, respectively. VarR can act as a repressor at the varRG promoter region; whilst this repression was relieved upon addition of beta-lactams, these did not dissociate the VarR/varRG-DNA complex, indicating that the derepression of varR by beta-lactams is indirect. Considering that the genomic arrangement of VarR-VarG is strikingly similar to that of AmpR-AmpC system, it is possible that V. cholerae has evolved a system for resistance to the newer beta-lactams that would prove more beneficial to the bacterium in light of current selective pressures.	[Lin, Hong-Ting Victor; Lin, Chen-Ping; Wang, Yen-Jen Anna; Shen, Yu-Chi; Lu, Wen-Jung] Natl Taiwan Ocean Univ, Dept Food Sci, Keelung, Taiwan; [Lin, Hong-Ting Victor] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung, Taiwan; [Massam-Wu, Teresa; Borges-Walmsley, Maria Ines; Walmsley, Adrian Robert] Univ Durham, Dept Biosci, Durham, England; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan; [Chen, Yu-Hou] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Borges-Walmsley, Maria Ines; Walmsley, Adrian Robert] Univ Fed Sao Paulo, UNIFESP, Dept Bioquim, Sao Paulo, Brazil	National Taiwan Ocean University; National Taiwan Ocean University; Durham University; National Taiwan Ocean University; Academia Sinica - Taiwan; Universidade Federal de Sao Paulo (UNIFESP)	Walmsley, AR (corresponding author), Univ Durham, Dept Biosci, Durham, England.; Walmsley, AR (corresponding author), Univ Fed Sao Paulo, UNIFESP, Dept Bioquim, Sao Paulo, Brazil.	a.r.walmsley@dur.ac.uk	Hsu, Pang-Hung/C-5587-2018	Hsu, Pang-Hung/0000-0001-6873-6434; Walmsley, Adrian Robert/0000-0002-5136-0511; Massam-Wu, Teresa/0000-0002-4364-8734	Ministry of Science and Technology (Taiwan) [100-2313-B-019-001-MY2]; Wellcome Trust (UK) [084821/Z/08/Z]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, Taiwan); Wellcome Trust (UK)(Wellcome Trust)	This work was supported by a grant from the Ministry of Science and Technology (Taiwan, R. O.C., 100-2313-B-019-001-MY2) and a grant from the Wellcome Trust (UK, 084821/Z/08/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2012, B WORLD HEALTH ORGAN, V90, P209, DOI 10.2471/BLT.11.093427; Bagge N, 2002, ANTIMICROB AGENTS CH, V46, P3406, DOI 10.1128/AAC.46.11.3406-3411.2002; BARTOWSKY E, 1993, MOL MICROBIOL, V10, P555, DOI 10.1111/j.1365-2958.1993.tb00927.x; Begum Anowara, 2005, Microbiol Immunol, V49, P949; Bina JE, 2006, ARCH MICROBIOL, V186, P171, DOI 10.1007/s00203-006-0133-5; Bina XR, 2008, INFECT IMMUN, V76, P3595, DOI 10.1128/IAI.01620-07; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Cerda-Maira FA, 2008, J BACTERIOL, V190, P7441, DOI 10.1128/JB.00584-08; Chahboune A, 2005, ANTIMICROB AGENTS CH, V49, P1145, DOI 10.1128/AAC.49.3.1145-1149.2005; Chen SS, 2013, INT J ANTIMICROB AG, V41, P188, DOI 10.1016/j.ijantimicag.2012.10.008; Cheng QM, 2002, J BACTERIOL, V184, P6434, DOI 10.1128/JB.184.23.6434-6436.2002; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; Choudhury D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133842; Chowdhury PR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00394; Colmer JA, 1998, MOL MICROBIOL, V27, P63, DOI 10.1046/j.1365-2958.1998.00657.x; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Crawford PA, 2004, PROTEIN EXPRES PURIF, V36, P272, DOI 10.1016/j.pep.2004.04.017; Dietz H, 1997, ANTIMICROB AGENTS CH, V41, P2113, DOI 10.1128/AAC.41.10.2113; Du DJ, 2014, NATURE, V509, P512, DOI 10.1038/nature13205; Fritsche TR, 2005, CLIN INFECT DIS, V41, pS276, DOI 10.1086/430790; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; HARDER KW, 1994, BIOCHEM J, V298, P395, DOI 10.1042/bj2980395; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Hohl M, 2014, P NATL ACAD SCI USA, V111, P11025, DOI 10.1073/pnas.1400485111; Huda MN, 2003, MICROBIOL IMMUNOL, V47, P419, DOI 10.1111/j.1348-0421.2003.tb03379.x; Huda MN, 2001, FEMS MICROBIOL LETT, V203, P235, DOI 10.1111/j.1574-6968.2001.tb10847.x; Huda N, 2003, ANTIMICROB AGENTS CH, V47, P2413, DOI 10.1128/AAC.47.8.2413-2417.2003; Jacobs C, 1997, CELL, V88, P823, DOI 10.1016/S0092-8674(00)81928-5; JACOBS C, 1995, MOL MICROBIOL, V15, P553, DOI 10.1111/j.1365-2958.1995.tb02268.x; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Janganan TK, 2011, J BIOL CHEM, V286, P26900, DOI 10.1074/jbc.M111.246595; JAURIN B, 1982, EMBO J, V1, P875, DOI 10.1002/j.1460-2075.1982.tb01263.x; Jean SS, 2015, FUTURE MICROBIOL, V10, P407, DOI [10.2217/FMB.14.135, 10.2217/fmb.14.135]; Juan C, 2005, ANTIMICROB AGENTS CH, V49, P4733, DOI 10.1128/AAC.49.11.4733-4738.2005; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kobayashi N, 2003, FEBS LETT, V546, P241, DOI 10.1016/S0014-5793(03)00579-9; Kobayashi N, 2001, J BACTERIOL, V183, P5639, DOI 10.1128/JB.183.19.5639-5644.2001; KORFMANN G, 1989, ANTIMICROB AGENTS CH, V33, P1946, DOI 10.1128/AAC.33.11.1946; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Langaee TY, 2000, ANTIMICROB AGENTS CH, V44, P583, DOI 10.1128/AAC.44.3.583-589.2000; Li W, 2014, J BIOL CHEM, V289, P12633, DOI 10.1074/jbc.M113.536136; Li XZ, 1998, ANTIMICROB AGENTS CH, V42, P399; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; LINDBERG F, 1987, J BACTERIOL, V169, P1923, DOI 10.1128/jb.169.5.1923-1928.1987; LINDBERG F, 1985, P NATL ACAD SCI USA, V82, P4620, DOI 10.1073/pnas.82.14.4620; LINDBERG F, 1987, J BACTERIOL, V169, P758, DOI 10.1128/jb.169.2.758-763.1987; LINDQUIST S, 1989, MOL MICROBIOL, V3, P1091, DOI 10.1111/j.1365-2958.1989.tb00259.x; LINDQUIST S, 1989, J BACTERIOL, V171, P3746, DOI 10.1128/jb.171.7.3746-3753.1989; Lodge JM, 1990, PSEUDOMONAS AERUGINO; Lu S, 2013, J BACTERIOL, V195, P4865, DOI 10.1128/JB.00756-13; Lu S, 2012, MOL MICROBIOL, V86, P1132, DOI 10.1111/mmi.12046; Lucas CE, 1997, J BACTERIOL, V179, P4123, DOI 10.1128/jb.179.13.4123-4128.1997; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Masuda N, 1999, ANTIMICROB AGENTS CH, V43, P400, DOI 10.1128/AAC.43.2.400; McKenna M, 2013, NATURE, V499, P394, DOI 10.1038/499394a; Meletis G, 2012, HIPPOKRATIA, V16, P303; Mima T, 2007, J BACTERIOL, V189, P7600, DOI 10.1128/JB.00850-07; Modali SD, 2011, MOL MICROBIOL, V81, P937, DOI 10.1111/j.1365-2958.2011.07744.x; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Nagakubo S, 2002, J BACTERIOL, V184, P4161, DOI 10.1128/JB.184.15.4161-4167.2002; Nakae T, 1999, ANTIMICROB AGENTS CH, V43, P1301, DOI 10.1128/AAC.43.5.1301; Odumosu O, 2010, TOXINS, V2, P1612, DOI 10.3390/toxins2071612; Okamoto K, 2002, ANTIMICROB AGENTS CH, V46, P2696, DOI 10.1128/AAC.46.8.2696-2699.2002; Padilla E, 2010, ANTIMICROB AGENTS CH, V54, P177, DOI 10.1128/AAC.00715-09; Pages JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004817; Paul-Soto R, 1999, J BIOL CHEM, V274, P13242, DOI 10.1074/jbc.274.19.13242; Quale J, 2006, ANTIMICROB AGENTS CH, V50, P1633, DOI 10.1128/AAC.50.5.1633-1641.2006; Rahman MM, 2007, MICROBIOL IMMUNOL, V51, P1061, DOI 10.1111/j.1348-0421.2007.tb04001.x; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Sack DA., 2001, WHOCDSCSRDRS20018; Shakil S, 2011, J CHEMOTHERAPY, V23, P263, DOI 10.1179/joc.2011.23.5.263; Srikumar R, 1997, J BACTERIOL, V179, P7875, DOI 10.1128/jb.179.24.7875-7881.1997; Sun JJ, 2014, BIOCHEM BIOPH RES CO, V453, P254, DOI 10.1016/j.bbrc.2014.05.090; Taylor DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038208; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Thomas PW, 2011, BIOCHEMISTRY-US, V50, P10102, DOI 10.1021/bi201449r; Thomson JM, 2005, CURR OPIN MICROBIOL, V8, P518, DOI 10.1016/j.mib.2005.08.014; Thomson JM, 2005, ANN NY ACAD SCI, V1277, P91; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Turlin E, 2014, MICROBIOLOGYOPEN, V3, P849, DOI 10.1002/mbo3.203; Tyski S., 2015, PLOS ONE, V10; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang ZG, 1999, CURR OPIN CHEM BIOL, V3, P614, DOI 10.1016/S1367-5931(99)00017-4; Woolley RC, 2005, J BACTERIOL, V187, P5500, DOI 10.1128/JB.187.15.5500-5503.2005; Xu DG, 2006, J BIOL CHEM, V281, P8740, DOI 10.1074/jbc.M512517200; Xu Y, 2012, BIOCHEMISTRY-US, V48, P5218; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Yu Edward W., 2013, MICROBIAL EFFLUX PUM; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048; Ziha-Zarifi I, 1999, ANTIMICROB AGENTS CH, V43, P287, DOI 10.1128/AAC.43.2.287	94	17	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184255	10.1371/journal.pone.0184255	http://dx.doi.org/10.1371/journal.pone.0184255			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898293	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000410449500019
J	Saldias, MP; Fernandez, C; Morgan, A; Diaz, C; Morales, D; Jana, F; Gomez, A; Silva, A; Briceno, F; Oyarzun, A; Maldonado, F; Cerda, O; Smith, PC; Caceres, M				Paz Saldias, Maria; Fernandez, Christian; Morgan, Alejandra; Diaz, Catalina; Morales, Diego; Jana, Fabian; Gomez, Alvaro; Silva, Alonso; Briceno, Fernanda; Oyarzun, Alejandro; Maldonado, Felipe; Cerda, Oscar; Smith, Patricio C.; Caceres, Monica			Aged blood factors decrease cellular responses associated with delayed gingival wound repair	PLOS ONE			English	Article							GROWTH-FACTORS; DNA-DAMAGE; DONOR AGE; SENESCENCE; ALPHA; CELLS; BETA; SERUM; VEGF	Aging is a gradual biological process characterized by a decrease in cell and organism functions. Gingival wound healing is one of the impaired processes found in old rats. Here, we studied the in vivo wound healing process using a gingival repair rat model and an in vitro model using human gingival fibroblast for cellular responses associated to wound healing. To do that, we evaluated cell proliferation of both epithelial and connective tissue cells in gingival wounds and found decreased of Ki67 nuclear staining in old rats when compared to their young counterparts. We next evaluated cellular responses of primary gingival fibroblast obtained from young subjects in the presence human blood serum of individuals of different ages. Eighteen to sixty five years old masculine donors were classified into 3 groups: "young" from 18 to 22 years old, "middle-aged" from 30 to 48 years old and "aged" over 50 years old. Cell proliferation, measured through immunofluorescence for Ki67 and flow cytometry for DNA content, was decreased when middle-aged and aged serum was added to gingival fibroblast compared to young serum. Myofibroblastic differentiation, measured through alpha-smooth muscle actin (alpha-SMA), was stimulated with young but not middle-aged or aged serum both the protein levels and incorporation of alpha-SMA into actin stress fibers. High levels of PDGF, VEGF, IL-6R were detected in blood serum from young subjects when compared to middle-aged and aged donors. In addition, the pro-inflammatory cytokines MCP-1 and TNF were increased in the serum of aged donors. In old rat wound there is an increased of staining for TNF compared to young wound. Moreover, healthy gingiva (non injury) shows less staining compared to a wound site, suggesting a role in wound healing. Moreover, serum from middle-aged and aged donors was able to stimulate cellular senescence in young cells as determined by the expression of senescence associated beta-galactosidase and histone H2A.X phosphorylated at Ser139. Moreover, we detected an increased frequency of gamma-H2A. X-positive cells in aged rat gingival tissues. The present study suggests that serum factors present in middle-aged and aged individuals may be responsible, at least in part, for the altered responses observed during wound healing in aging.	[Paz Saldias, Maria; Fernandez, Christian; Morgan, Alejandra; Diaz, Catalina; Morales, Diego; Gomez, Alvaro; Silva, Alonso; Briceno, Fernanda; Cerda, Oscar; Caceres, Monica] Univ Chile, Inst Biomed Sci, Program Mol & Cell Biol, Fac Med, Santiago, Chile; [Jana, Fabian] Univ Aysen, Coyhaique, Chile; [Oyarzun, Alejandro] Univ Finis Terrae, Fac Dent, Santiago, Chile; [Maldonado, Felipe] Univ Chile, Hosp Clin, Dept Anesthesia, Fac Med, Santiago, Chile; [Cerda, Oscar; Caceres, Monica] Millennium Nucleus Ion Channels Associated Dis Mi, Santiago, Chile; [Smith, Patricio C.] Pontificia Univ Catolica Chile, Sch Dent, Fac Med, Santiago, Chile	Universidad de Chile; Universidad Finis Terrae; Universidad de Chile; Pontificia Universidad Catolica de Chile	Caceres, M (corresponding author), Univ Chile, Inst Biomed Sci, Program Mol & Cell Biol, Fac Med, Santiago, Chile.; Caceres, M (corresponding author), Millennium Nucleus Ion Channels Associated Dis Mi, Santiago, Chile.	monicacaceres@med.uchile.cl	Jaña, Fabián/D-9364-2017; Cerda, Oscar/N-3895-2018; Smith, Patricio C/I-5897-2014	Jaña, Fabián/0000-0001-7786-4569; Cerda, Oscar/0000-0003-2873-5722; Smith, Patricio C/0000-0001-7314-621X; Morales, Diego/0000-0002-5834-3685; Maldonado, Felipe/0000-0002-2633-4717; Fernandez, Christian/0000-0001-8157-5997; Gomez, Alvaro/0000-0001-9618-1755	National Fund for Science and Technology (Fondecyt) Grant [11140064]; Universidad de Chile [UINICIA 44051]; Fondecyt Grant [1160518]	National Fund for Science and Technology (Fondecyt) Grant; Universidad de Chile; Fondecyt Grant(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by National Fund for Science and Technology (Fondecyt) Grant 11140064 (MC), UINICIA 44051 Grant from Universidad de Chile (MC) and Fondecyt Grant 1160518 (OC).; The present study was funded by a grant from the National Fund for Science and Technology (Fondecyt) Grant 11140064 (MC), Grant from Universidad de Chile UINICIA 44051 (MC) and Fondecyt Grant 1160518 (OC). The authors have stated explicitly that there are no conflicts of interest in connection with this article.	Arancibia R, 2013, J PERIODONTOL, V84, P683, DOI 10.1902/jop.2012.120225; Baht GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8131; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bayer ML, 2012, MECH AGEING DEV, V133, P246, DOI 10.1016/j.mad.2012.02.002; Belsky DW, 2015, P NATL ACAD SCI USA, V112, pE4104, DOI 10.1073/pnas.1506264112; Bryan BA, 2010, FASEB J, V24, P3186, DOI 10.1096/fj.09-145102; Caceres M, 2014, J DENT RES, V93, P691, DOI 10.1177/0022034514533126; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Cook DN, 1996, J LEUKOCYTE BIOL, V59, P61, DOI 10.1002/jlb.59.1.61; Czarkowska-Paczek B, 2006, J PHYSIOL PHARMACOL, V57, P189; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Di Paolo NC, 2016, NAT IMMUNOL, V17, P906, DOI 10.1038/ni.3503; Fontana L, 2014, NATURE, V511, P405, DOI 10.1038/511405a; Goldberg MT, 2007, J INVEST DERMATOL, V127, P2645, DOI 10.1038/sj.jid.5700890; Hakkinen L, 2000, PERIODONTOL 2000, V24, P127, DOI 10.1034/j.1600-0757.2000.2240107.x; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hubackova S, 2016, ONCOGENE, V35, P1236, DOI 10.1038/onc.2015.162; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Liu RK, 2006, AM J PATHOL, V168, P757, DOI 10.2353/ajpath.2006.050907; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Rozman P, 2007, ACTA DERMATOVEN ALP, V16, P156; Smith PC, 2006, J DENT RES, V85, P150, DOI 10.1177/154405910608500207; Takaishi K, 2000, J BIOCHEM-TOKYO, V127, P511, DOI 10.1093/oxfordjournals.jbchem.a022634; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Wang CF, 2009, AGING CELL, V8, P311, DOI 10.1111/j.1474-9726.2009.00481.x; Weibrich G, 2002, J CRANIO MAXILL SURG, V30, P97, DOI 10.1054/jcms.2002.0285; Zhang CY, 2015, J CELL BIOL, V209, P289, DOI 10.1083/jcb.201409032; Zhang FQ, 2015, J BIOL CHEM, V290, P8232, DOI 10.1074/jbc.M114.623074; Zhou F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-78	33	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184189	10.1371/journal.pone.0184189	http://dx.doi.org/10.1371/journal.pone.0184189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898261	Green Published, gold, Green Submitted			2022-12-27	WOS:000410449500016
J	Lee, YJ; Choi, SM; Lee, YJ; Cho, YJ; Yoon, HI; Lee, JH; Lee, CT; Park, JS				Lee, Ye Jin; Choi, Sun Mi; Lee, Yeon Joo; Cho, Young-Jae; Yoon, Ho Il; Lee, Jae-Ho; Lee, Choon-Taek; Park, Jong Sun			Clinical impact of depression and anxiety in patients with idiopathic pulmonary fibrosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; FUNCTIONAL STATUS; HOSPITAL ANXIETY; SYMPTOM BURDEN; DISEASE; MANAGEMENT; COMORBIDITY; DYSPNEA	Background Although depression and anxiety represent significant yet treatable comorbidities in patients with idiopathic pulmonary fibrosis (IPF), their impact on the clinical course and prognosis of IPF remain unclear. Purpose We investigated the prevalence and clinical significance of depression and anxiety in patients with IPF. Methods The present study included a prospective cohort comprising 112 Korean patients with IPF who had completed the Hospital Anxiety and Depression Scale (HADS) questionnaire. Results Symptoms of depression and anxiety were present in 25.9% and 21.4% of patients with IPF, respectively (HADS scores >= 8). No significant differences in demographic data, age, sex, smoking status, Modified Medical Research Council Dyspnea Scale (MMRC) scores, pulmonary function tests, or Gender-Age-Physiology Index for IPF were observed between patients with depression or anxiety and those without. However, in patients with anxiety, St. George's Respiratory Questionnaire (SGRQ) scores were significantly higher than those of patients without anxiety (40.5 versus 23.5; p = 0.003). The survival rate and total number of hospital admissions did not significantly differ between patients with depression/anxiety and those without. Conclusions Our findings indicate that depression and anxiety are relatively common in patients with IPF. Although no significant differences were noted with regard to survival rate and hospitalization, the present study suggests that depression and anxiety significantly influence quality of life in patients with IPF.	[Lee, Ye Jin; Choi, Sun Mi] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Div Pulm & Crit Care Med,Dept Internal Med, Seoul, South Korea; [Lee, Yeon Joo; Cho, Young-Jae; Yoon, Ho Il; Lee, Jae-Ho; Lee, Choon-Taek; Park, Jong Sun] Seoul Natl Univ, Bundang Hosp, Coll Med, Div Pulm & Crit Care Med,Dept Internal Med, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Park, JS (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Div Pulm & Crit Care Med,Dept Internal Med, Seongnam, South Korea.	jspark.im@gmail.com	Cho, Young-Jae/D-5528-2012	Cho, Young-Jae/0000-0001-6943-4462; Lee, Ye Jin/0000-0002-7290-0265	SNUBH Research Fund [11-2011-036]	SNUBH Research Fund	This study was supported by a grant (no. 11-2011-036) from the SNUBH Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar AA, 2013, CHRON RESP DIS, V10, P127, DOI 10.1177/1479972313493098; Amin A, 2014, AAMJ, V12; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bosley CM, 1996, EUR RESPIR J, V9, P2346, DOI 10.1183/09031936.96.09112346; Eisner MD, 2010, THORAX, V65, P229, DOI 10.1136/thx.2009.126201; Ferrell BR, 2006, PALLIATIVE NURSING, V19, P315; Glaspole IN, 2017, RESPIROLOGY, V22, P950, DOI 10.1111/resp.12989; Holland AE, 2014, RESPIROLOGY, V19, P1215, DOI 10.1111/resp.12360; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; JONES PW, 1992, AM REV RESPIR DIS, V145, P1321, DOI 10.1164/ajrccm/145.6.1321; King CS, 2017, LANCET RESP MED, V5, P72, DOI 10.1016/S2213-2600(16)30222-3; Kozu R, 2011, RESPIRATION, V81, P196, DOI 10.1159/000315475; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Lindell KO, 2010, HEART LUNG, V39, P304, DOI 10.1016/j.hrtlng.2009.08.005; MAHLER DA, 1988, CHEST, V93, P580, DOI 10.1378/chest.93.3.580; Ng TP, 2007, ARCH INTERN MED, V167, P60, DOI 10.1001/archinte.167.1.60; Oh SM, 1999, J KOREAN NEUROPSYCHI, V38, P289; Ozalevli S, 2010, MULTIDISCIP RESP MED, V5, P31, DOI 10.1186/2049-6958-5-1-31; Pink K, 2014, ADV RES, V2, P320; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ryerson CJ, 2012, RESPIROLOGY, V17, P525, DOI 10.1111/j.1440-1843.2011.02122.x; Ryerson CJ, 2011, CHEST, V139, P609, DOI 10.1378/chest.10-0608; Schneider C, 2010, CHEST, V137, P341, DOI 10.1378/chest.09-0614; Swigris JJ, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0124-1; Xu WN, 2008, AM J RESP CRIT CARE, V178, P913, DOI 10.1164/rccm.200804-619OC; Yohannes AM, 2010, INT J GERIATR PSYCH, V25, P1209, DOI 10.1002/gps.2463; Yohannes AM, 2014, EUR RESPIR REV, V23, P345, DOI 10.1183/09059180.00007813; Yun YH, 2007, J CLIN EPIDEMIOL, V60, P1164, DOI 10.1016/j.jclinepi.2006.12.014; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	31	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184300	10.1371/journal.pone.0184300	http://dx.doi.org/10.1371/journal.pone.0184300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892504	gold, Green Submitted, Green Published			2022-12-27	WOS:000410243200013
J	Van der Linden, N; Leys, C; Klein, O; Bouchat, P				Van der Linden, Nicolas; Leys, Christophe; Klein, Olivier; Bouchat, Pierre			Are attitudes toward peace and war the two sides of the same coin? Evidence to the contrary from a French validation of the Attitudes Toward Peace and War Scale	PLOS ONE			English	Article							SOCIAL-DOMINANCE ORIENTATION; ABBREVIATED FORM; GENDER-GAP; MILITARISM; CONFLICT; SUPPORT; EMPATHY; VALUES	Bizumic et al. (2013) have recently shown that attitudes towards peace and war reflect two distinct constructs rather than two poles of a single dimension. We present an attempt at validating the French version of their 16-item Attitudes toward Peace and War Scale (APWS) on five distinct (mainly Belgian) French-speaking samples (total N = 808). Confirmatory factor and criterion validity analyses confirmed that attitudes toward peace and war, although negatively related, are distinct in terms of their antecedents and consequences. On the one hand, antecedents of attitudes toward peace included egalitarian ideological beliefs and empathic concern for others, and consequences included intentions to engage in pro-peace behaviors. On the other hand, antecedents of attitudes toward war included national identification and authoritarian ideological beliefs, and consequences included intentions to engage in pro-war behaviors. Furthermore, both attitudes toward peace and war were, respectively, negatively and positively related to (a right-wing) political orientation. Unexpectedly however, attitudes toward war were positively related to nonegalitarian ideological beliefs and were not related to personal distress. Scores on the translated scale were unrelated to socially desirable responding. In terms of known-groups validity, men had, respectively, more and less positive attitudes toward war and peace than women. Finally, based on exploratory factor analyses, the inclusion of some items for the factorial structure of the measure is questioned and a shortened form of the measure is validated. Overall, these findings are in line with Bizumic et al. and suggest that attitudes toward peace and war also reflect two distinct constructs in a French-speaking population.	[Van der Linden, Nicolas; Klein, Olivier; Bouchat, Pierre] Univ Libre Bruxelles, Ctr Social & Cultural Psychol, Brussels, Belgium; [Leys, Christophe] Univ Libre Bruxelles, Serv Anal Donnees, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Van der Linden, N; Bouchat, P (corresponding author), Univ Libre Bruxelles, Ctr Social & Cultural Psychol, Brussels, Belgium.	nivdlind@ulb.ac.be; pierre.bouchat@ulb.ac.be	; Klein, Olivier/F-1954-2011	Van der Linden, Nicolas/0000-0002-1288-948X; Bouchat, Pierre/0000-0002-6639-6453; Klein, Olivier/0000-0003-2737-8049; Leys, Christophe/0000-0002-3832-3097				Altemeyer B., 1988, ENEMIES FREEDOM UNDE; Bizumic B, 2013, POLIT PSYCHOL, V34, P673, DOI 10.1111/pops.12032; Blumberg HH, 2017, J AGGRESS CONFL PEAC, V9, P13, DOI 10.1108/JACPR-05-2016-0231; Bouchat P, EUROPEAN J IN PRESS; Bougie E, 2006, UNPUB; Brislin R.W., 1986, FIELD METHODS CROSS, P137; Brooks DJ, 2011, PUBLIC OPIN QUART, V75, P270, DOI 10.1093/poq/nfr005; Carnagey NL, 2007, AGGRESSIVE BEHAV, V33, P118, DOI 10.1002/ab.20173; CONOVER PJ, 1981, AM J POLIT SCI, V25, P617, DOI 10.2307/2110756; Cortright D., 2008, PEACE HIST MOVEMENT; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Droba DD, 1931, J EDUC PSYCHOL, V22, P96, DOI 10.1037/h0072309; Duarte S., 2004, REV INT PSYCHOL SOCI, V17, P97; Dupuis EC, 2011, J PSYCHOL ARTS SCI, V3, P6; Eagly A. H., 1987, SEX DIFFERENCES SOCI, DOI [10.1037/0022-3514.65.5.1010, DOI 10.4324/]; ECKHARDT W, 1969, J PEACE RES, P123; ELLIOTT GC, 1980, J CONFLICT RESOLUT, V24, P27, DOI 10.1177/002200278002400102; Enders C. K., 2010, APPL MISSING DATA AN; FRANCIS LJ, 1992, PERS INDIV DIFFER, V13, P443, DOI 10.1016/0191-8869(92)90073-X; GALTUNG J, 1985, J PEACE RES, V22, P141, DOI 10.1177/002234338502200205; Gilet AL, 2013, CAN J BEHAV SCI, V45, P42, DOI 10.1037/a0030425; HESKIN K, 1994, J SOC PSYCHOL, V134, P317, DOI 10.1080/00224545.1994.9711736; HITTNER JB, 1995, EDUC PSYCHOL MEAS, V55, P777; Ho AK, 2015, J PERS SOC PSYCHOL, V109, P1003, DOI 10.1037/pspi0000033; Institute for Economics & Peace, 2016 GLOB PEAC IND 1; Iyer R., 2010, ANN SCI M INT SOC PO; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kline R.B., 2019, APPL QUANTITATIVE AN, P171; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Le Bussy O., 2015, BELGIQUE EST GUERRE; Lewis CA, 2002, EUR J PSYCHOL ASSESS, V18, P179, DOI 10.1027//1015-5759.18.2.179; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; MACCALLUM RC, 1992, PSYCHOL BULL, V111, P490, DOI 10.1037/0033-2909.111.3.490; Maoz I., 2012, ENCY PEACE PSYCHOL, DOI DOI 10.1002/9780470672532.WBEPP296; McCleary DF, 2009, PEACE CONFL, V15, P161, DOI 10.1080/10781910902837248; McShane BB, 2017, J CONSUM RES, V43, P1048, DOI 10.1093/jcr/ucw085; Meade AW, 2012, PSYCHOL METHODS, V17, P437, DOI 10.1037/a0028085; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Nunnaly JC, 1994, PSYCHOMETRIC THEORY; Paez D, 2008, J CROSS CULT PSYCHOL, V39, P373, DOI 10.1177/0022022108316638; Paulhus D.L., 2007, HDB RES METHODS PERS, V1, P224, DOI DOI 10.1017/CBO9780511996481; Piurko Y, 2011, POLIT PSYCHOL, V32, P537, DOI 10.1111/j.1467-9221.2011.00828.x; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Preacher KJ, 2013, MULTIVAR BEHAV RES, V48, P28, DOI 10.1080/00273171.2012.710386; Roccas S, 2006, J PERS SOC PSYCHOL, V91, P698, DOI 10.1037/0022-3514.91.4.698; Sanchez-Mazas M, 2003, PSYCHOL BELG, V43, P55; Sarrica M, 2004, J PEACE RES, V41, P549, DOI 10.1177/0022343304045976; Sarrica M, 2007, PEACE CONFL, V13, P251, DOI 10.1080/10781910701471298; Smith M. B., 2004, PEACE CONFLICT J PEA, V10, P335, DOI [DOI 10.1207/S15327949PAC1004_, 10.1207/s15327949pac1004_3]; StataCorp, 2015, STAT STAT SOFTW REL; Strachan H., 2012, WHY WE SHOULD CELEBR; Sutton RM, 2005, BRIT J CRIMINOL, V45, P212, DOI 10.1093/bjc/azh084; Swiatkowski W, 2017, INT REV SOC PSYCHOL, V30, P111, DOI 10.5334/irsp.66; Thorisdottir H, 2007, PUBLIC OPIN QUART, V71, P175, DOI 10.1093/poq/nfm008; TOGEBY L, 1994, J PEACE RES, V31, P375, DOI 10.1177/0022343394031004002; Vail KE, 2010, PEACE CONFL, V16, P29, DOI 10.1080/10781910903486813; Van der Linden N., 2012, ENCY PEACE PSYCHOL, P1053; Van der Linden N, 2011, PEACE CONFL, V17, P217, DOI 10.1080/10781919.2011.587176; Verstreken J, 2009, BETREFFENDE VLAAMSE; Wagner-Egger P, 2007, REV INT PSYCHOL SOC, V20, P31; Zimet J., 2011, COMMEMORER GRANDE GU	63	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184001	10.1371/journal.pone.0184001	http://dx.doi.org/10.1371/journal.pone.0184001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG4OS	28892500	Green Published, gold, Green Submitted			2022-12-27	WOS:000410243200008
J	Balaban, CL; Banchio, C; Ceccarelli, EA				Balaban, Cecilia L.; Banchio, Claudia; Ceccarelli, Eduardo A.			TAT-mediated transduction of bacterial redox proteins generates a cytoprotective effect on neuronal cells	PLOS ONE			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; ESCHERICHIA-COLI; PENETRATING PEPTIDES; OXIDATIVE STRESS; HEME OXYGENASE; FERREDOXIN-NADP(+) REDUCTASE; LEPTOSPIRA-INTERROGANS; REACTIVE OXYGEN; IRON; DELIVERY	Cell penetrating peptides, also known as protein transduction domains, have the capacity to ubiquitously cross cellular membranes carrying many different cargos with negligible cytotoxicity. As a result, they have emerged as a powerful tool for macromolecular deliverybased therapies. In this study, catalytically active bacterial Ferredoxin-NADP(+) reductase (LepFNR) and Heme oxygenase (LepHO) fused to the HIV TAT-derived protein transduction peptide (TAT) were efficiently transduced to neuroblastoma SHSY-5Y cells. Proteins entered the cells through an endocytic pathway showing a time/concentration dependent mechanism that was clearly modulated by the nature of the cargo protein. Since ferredoxin NADP(+) reductases and heme oxygenases have been implicated in mechanisms of oxidative stress defense, neuroblastoma cells simultaneously transduced with TAT-LepFNR and TAT-LepHO were challenged by H2O2 incubations to judge the cytoprotective power of these bacterial enzymes. Accumulation of reactive oxygen species was significantly reduced in these transduced neuronal cells. Moreover, measurements of metabolic viability, membrane integrity, and cell survival indicated that these cells showed a better tolerance to oxidative stress. Our results open the possibility for the application of transducible active redox proteins to overcome the damage elicited by oxidative stress in cells and tissues.	[Balaban, Cecilia L.; Banchio, Claudia; Ceccarelli, Eduardo A.] Univ Nacl Rosario Ocampo & Esmeralda, CONICET, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario IBR, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Ceccarelli, EA (corresponding author), Univ Nacl Rosario Ocampo & Esmeralda, CONICET, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario IBR, Rosario, Santa Fe, Argentina.	ceccarelli@ibr-conicet.gov.ar	Ceccarelli, Eduardo A./V-2600-2019; Ceccarelli, Eduardo A./M-8699-2014	Ceccarelli, Eduardo A./0000-0001-5776-3306; Ceccarelli, Eduardo A./0000-0001-5776-3306	ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina [PICT-2012-1841, PICT 2013-0820]; CONICET Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 0345]	ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, Argentina; CONICET Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from PICT-2012-1841 (To EAC) and PICT 2013-0820 (to CB), ANPCYT, Ministerio de Ciencia, Tecnologia e Innovacion Productiva, http://www.agencia.mincyt.gob.ar Argentina and grant PIP 0345 (to EAC) from CONICET Consejo Nacional de Investigaciones Cientificas y Tecnicas, http://www.conicet.gov.ar Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; Arakaki AK, 1997, FASEB J, V11, P133, DOI 10.1096/fasebj.11.2.9039955; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Belting Mattias, 2009, V480, P1, DOI 10.1007/978-1-59745-429-2_1; BOLES E, 1993, EUR J BIOCHEM, V217, P469, DOI 10.1111/j.1432-1033.1993.tb18266.x; Brumaghim JL, 2003, J BIOL CHEM, V278, P42495, DOI 10.1074/jbc.M306251200; Cunningham O, 2000, BIOCHEM J, V345, P393, DOI 10.1042/0264-6021:3450393; Dennery PA, 2014, ANTIOXID REDOX SIGN, V20, P1743, DOI 10.1089/ars.2013.5674; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; Fischer R, 2002, BBA-BIOMEMBRANES, V1564, P365, DOI 10.1016/S0005-2736(02)00471-6; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Frankenberg-Dinkel N, 2004, ANTIOXID REDOX SIGN, V6, P825, DOI 10.1089/ars.2004.6.825; Glogau R, 2012, J DRUGS DERMATOL, V11, P38; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Grochot-Przeczek A, 2012, CLIN SCI, V122, P93, DOI 10.1042/CS20110147; HILL JM, 1984, NEUROSCIENCE, V11, P595, DOI 10.1016/0306-4522(84)90046-0; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Khan AA, 2011, BBA-MOL CELL RES, V1813, P668, DOI 10.1016/j.bbamcr.2011.01.008; Koeppen AH, 1995, J NEUROL SCI, V134, P1, DOI 10.1016/0022-510X(95)00202-D; Krapp AR, 2011, MICROBIOL-SGM, V157, P957, DOI 10.1099/mic.0.039461-0; Krapp AR, 1997, EUR J BIOCHEM, V249, P556, DOI 10.1111/j.1432-1033.1997.00556.x; Krapp AR, 2002, J BACTERIOL, V184, P1474, DOI 10.1128/JB.184.5.1474-1480.2002; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Ma J, 2012, P NATL ACAD SCI USA, V109, P8417, DOI 10.1073/pnas.1120045109; MCDONAGH AF, 1990, CLIN PERINATOL, V17, P359, DOI 10.1016/S0095-5108(18)30572-4; Mediavilla MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013501; Nascimento AS, 2006, ACTA CRYSTALLOGR F, V62, P662, DOI 10.1107/S1744309106020136; Ollinger R, 2007, ANTIOXID REDOX SIGN, V9, P2175, DOI 10.1089/ars.2007.1807; Saliola M, 2012, EUKARYOT CELL, V11, P1503, DOI 10.1128/EC.00211-12; Silhol M, 2002, EUR J BIOCHEM, V269, P494, DOI 10.1046/j.0014-2956.2001.02671.x; Singh SP, 2016, AM J PHYSIOL-CELL PH, V310, pC1, DOI 10.1152/ajpcell.00229.2015; Soldano A, 2014, BBA-GEN SUBJECTS, V1840, P3208, DOI 10.1016/j.bbagen.2014.07.021; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; van den Berg A, 2011, CURR OPIN BIOTECH, V22, P888, DOI 10.1016/j.copbio.2011.03.008; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Walrant A, 2012, NANOMEDICINE-UK, V7, P133, DOI [10.2217/NNM.11.165, 10.2217/nnm.11.165]; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Woodmansee AN, 2002, J BIOL CHEM, V277, P34055, DOI 10.1074/jbc.M203977200; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537; Ziegler A, 2008, ADV DRUG DELIVER REV, V60, P580, DOI 10.1016/j.addr.2007.10.005; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	51	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184617	10.1371/journal.pone.0184617	http://dx.doi.org/10.1371/journal.pone.0184617			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886198	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100169
J	Clayton, W; Eaton, CJ; Dupont, PY; Gillanders, T; Cameron, N; Saikia, S; Scott, B				Clayton, William; Eaton, Carla Jane; Dupont, Pierre-Yves; Gillanders, Tim; Cameron, Nick; Saikia, Sanjay; Scott, Barry			Analysis of simple sequence repeat (SSR) structure and sequence within Epichloe endophyte genomes reveals impacts on gene structure and insights into ancestral hybridization events	PLOS ONE			English	Article							FUNGAL ENDOPHYTES; MICROSATELLITE MARKERS; PERENNIAL RYEGRASS; INTERACTIVE TREE; LOLIUM-PERENNE; ONLINE TOOL; TALL FESCUE; LIFE ITOL; GRASSES; EVOLUTION	Epichloe grass endophytes comprise a group of filamentous fungi of both sexual and asexual species. Known for the beneficial characteristics they endow upon their grass hosts, the identification of these endophyte species has been of great interest agronomically and scientifically. The use of simple sequence repeat loci and the variation in repeat elements has been used to rapidly identify endophyte species and strains, however, little is known of how the structure of repeat elements changes between species and strains, and where these repeat elements are located in the fungal genome. We report on an in-depth analysis of the structure and genomic location of the simple sequence repeat locus B10, commonly used for Epichloe endophyte species identification. The B10 repeat was found to be located within an exon of a putative bZIP transcription factor, suggesting possible impacts on polypeptide sequence and thus protein function. Analysis of this repeat in the asexual endophyte hybrid Epichloe E uncinata revealed that the structure of B10 alleles reflects the ancestral species that hybridized to give rise to this species. Understanding the structure and sequence of these simple sequence repeats provides a useful set of tools for readily distinguishing strains and for gaining insights into the ancestral species that have undergone hybridization events.	[Clayton, William; Eaton, Carla Jane; Dupont, Pierre-Yves; Saikia, Sanjay; Scott, Barry] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [Eaton, Carla Jane; Dupont, Pierre-Yves; Scott, Barry] Massey Univ, Bioprotect Res Ctr, Palmerston North, New Zealand; [Gillanders, Tim; Cameron, Nick] Cropmark Seeds Ltd, Darfield, New Zealand	Massey University; Massey University	Scott, B (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand.; Scott, B (corresponding author), Massey Univ, Bioprotect Res Ctr, Palmerston North, New Zealand.	d.b.scott@massey.ac.nz		Scott, Barry/0000-0002-2224-2946; Eaton, Carla/0000-0002-0633-1535; Dupont, Pierre-Yves/0000-0002-7384-5181	Cropmark Seeds Ltd.	Cropmark Seeds Ltd.	The funder (Cropmark Seeds Ltd.) provided support in the form of salaries for authors [TG NC], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BACON CW, 1995, J ANIM SCI, V73, P861; Bailey J, 2015, AUSTRALAS PLANT PATH, V44, P97, DOI 10.1007/s13313-014-0326-3; Barker GM, 2015, NEW ZEAL J AGR RES, V58, P35, DOI 10.1080/00288233.2014.978480; BYRD AD, 1990, CURR GENET, V18, P347, DOI 10.1007/BF00318216; Card SD, 2014, FEMS MICROBIOL ECOL, V88, P94, DOI 10.1111/1574-6941.12273; CHRISTENSEN MJ, 1993, MYCOL RES, V97, P1083, DOI 10.1016/S0953-7562(09)80509-1; Craven KD, 2001, SYDOWIA, V53, P44; de Jong EV, 2003, GENOME, V46, P277, DOI [10.1139/G03-001, 10.1139/g03-001]; de Llanos R, 2010, YEAST, V27, P549, DOI 10.1002/yea.1799; GALLAGHER RT, 1981, NEW ZEAL VET J, V29, P189, DOI 10.1080/00480169.1981.34843; GERBER HP, 1994, SCIENCE, V263, P808, DOI 10.1126/science.8303297; Groppe K, 1997, APPL ENVIRON MICROB, V63, P1543, DOI 10.1128/AEM.63.4.1543-1550.1997; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hancock JM, 2005, GENE, V345, P113, DOI 10.1016/j.gene.2004.11.023; Hancock JM, 1995, J MOL EVOL, V41, P1038; Hantula J, 1996, EUR J FOREST PATHOL, V26, P159; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Johnson L.J., 2013, FUNGAL DIVERS, V60, P171, DOI [10.1007/s13225-013-0239-4, DOI 10.1007/S13225-013-0239-4]; Karaoglu H, 2014, AUSTRALAS PLANT PATH, V43, P47, DOI 10.1007/s13313-013-0244-9; Karimi S, 2012, MYCOLOGIA, V104, P1281, DOI 10.3852/11-316; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katti MV, 2001, MOL BIOL EVOL, V18, P1161, DOI 10.1093/oxfordjournals.molbev.a003903; Kirkby KA, 2011, WEED RES, V51, P261, DOI 10.1111/j.1365-3180.2011.00846.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; LEUCHTMANN A, 1990, PHYTOPATHOLOGY, V80, P1133, DOI 10.1094/Phyto-80-1133; LEUCHTMANN A, 1993, MYCOLOGIA, V85, P157, DOI 10.2307/3760451; Levdansky Emma, 2008, Fungal Biology Reviews, V22, P85, DOI 10.1016/j.fbr.2008.08.001; Leyva-Madrigal KY, 2014, J MICROBIOL METH, V101, P18, DOI 10.1016/j.mimet.2014.03.011; Li W, 2014, CURR GENET, V60, P237, DOI 10.1007/s00294-014-0428-z; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Li YC, 2002, MOL ECOL, V11, P2453, DOI 10.1046/j.1365-294X.2002.01643.x; Mason-Gamer RJ, 2010, MOL PHYLOGENET EVOL, V54, P10, DOI 10.1016/j.ympev.2009.10.002; Moon CD, 1999, APPL ENVIRON MICROB, V65, P1268; Moon CD, 2004, MOL ECOL, V13, P1455, DOI 10.1111/j.1365-294X.2004.02138.x; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; ROWAN DD, 1986, J CHEM ECOL, V12, P647, DOI 10.1007/BF01012099; Sampaio P, 2009, ANTON LEEUW INT J G, V96, P395, DOI 10.1007/s10482-009-9352-5; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; Schardl CL, 2012, FUNGAL ECOL, V5, P331, DOI 10.1016/j.funeco.2011.04.005; SCHARDL CL, 1991, PLANT SYST EVOL, V178, P27, DOI 10.1007/BF00937980; SCHARDL CL, 1994, GENETICS, V136, P1307; Tanaka A, 2012, CURR OPIN PLANT BIOL, V15, P462, DOI 10.1016/j.pbi.2012.03.007; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Triplett JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038702; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Young CA, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00095	49	5	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183748	10.1371/journal.pone.0183748	http://dx.doi.org/10.1371/journal.pone.0183748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886068	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100034
J	Dam, AEH; van Boxtel, MPJ; Rozendaal, N; Verhey, FRJ; de Vugt, ME				Dam, Alieske E. H.; van Boxtel, Martin P. J.; Rozendaal, Nico; Verhey, Frans R. J.; de Vugt, Marjolein E.			Development and feasibility of Inlife: A pilot study of an online social support intervention for informal caregivers of people with dementia	PLOS ONE			English	Article							HEALTH; NETWORK; BURDEN; SCALE; LONELINESS; PROGRAM	Background Informal caregivers of individuals with dementia have an increased risk to face social isolation due to progression of the disease. Online social media interventions might offer a new opportunity to increase access to social support and enhance positive interactions and openness in dementia care networks. Objective This explorative pilot study describes (1) the development of an online social support intervention Inlife, and (2) the evaluation of the feasibility of this intervention and the measurements to assess its effectiveness. Methods The Medical Research Council (MRC) framework guided the development of the online social support intervention. This is a stepwise approach that integrates potential users' views with the development and validation of the program content. The program was developed by combining (1) individual caregiver interviews (n = 10), (2) focus group sessions with experts and web designers (n = 6), and (3) individual think-aloud tests (n = 2). Subsequently, a pilot study with informal caregivers was conducted (n = 25) to examine the program's feasibility and preliminary effectiveness. Online self-report measures were completed at baseline and at four follow-up time points. Results In total, 23 participants completed the newly developed Inlife intervention. Despite the high number of low-active users (17/23, 73%), Inlife had a good feasibility score of 7.1 (range: 1-10). The Calendar and Timeline were used most frequently and contributed to better care coordination and positive interactions. Conclusions Although the Inlife platform received a sufficient feasibility rating, the uptake was not optimal. Therefore, the Inlife platform was adapted to limit the number of low-active users and improve user friendliness. Recommendations for additional treatment adherence were provided. The development according to the MRC framework and the sufficient feasibility rating of Inlife formed the basis for a future effectiveness study.	[Dam, Alieske E. H.; van Boxtel, Martin P. J.; Rozendaal, Nico; Verhey, Frans R. J.; de Vugt, Marjolein E.] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Alzheimer Ctr Limburg, Maastricht, Netherlands	Maastricht University	de Vugt, ME (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, Alzheimer Ctr Limburg, Maastricht, Netherlands.	m.devugt@maastrichtuniversity.nl			ZonMw [70-73305-98-611]; Alzheimer Research Centre Limburg	ZonMw(Netherlands Organization for Health Research and Development); Alzheimer Research Centre Limburg	This study was supported by ZonMw (70-73305-98-611). There was no additional external funding received for this study. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the caregivers for their participation in this study and the Alzheimer Research Centre Limburg and ZonMw for the (financial) support of this study.	Aalbers T, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4468; Amieva H, 2010, PSYCHOSOM MED, V72, P905, DOI 10.1097/PSY.0b013e3181f5e121; Baum A., 1984, HDB PSYCHOL HLTH; Beeson RA, 2003, ARCH PSYCHIAT NURS, V17, P135, DOI 10.1016/S0883-9417(03)00057-8; Bennett GG, 2009, ANNU REV PUBL HEALTH, V30, P273, DOI 10.1146/annurev.publhealth.031308.100235; Blom MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116622; Blom MM, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-17; Boots LMM, 2014, INT J GERIATR PSYCH, V29, P331, DOI 10.1002/gps.4016; Boots LMM, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5142; Boots LMM, 2015, INT PSYCHOGERIATR, V27, P927, DOI 10.1017/S1041610214002804; BRENNAN PF, 1995, NURS RES, V44, P166; Bujnowska-Fedak MM, 2014, TELEMED E-HEALTH, V20, P696, DOI 10.1089/tmj.2013.0318; Cacioppo JT, 2009, J PERS SOC PSYCHOL, V97, P977, DOI 10.1037/a0016076; Carbonneau H, 2010, DEMENTIA, V9, P327, DOI DOI 10.1177/1471301210375316; Clement S, 2015, PSYCHOL MED, V45, P11, DOI 10.1017/S0033291714000129; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Dam AEH, 2017, INT PSYPCHOGERIATR I, V30, P1; Dam AEH, 2016, MATURITAS, V85, P117, DOI 10.1016/j.maturitas.2015.12.008; DAVIS FD, 1989, MIS QUART, V13, P319, DOI 10.2307/249008; De Jong Gierveld J., 1999, MANUAL LONELINESS SC; De Jong Gierveld J., 2016, CAMBRIDGE HDB PERSON, P1; de Vugt M, 2017, AGING MENT HEALTH, V21, P1, DOI 10.1080/13607863.2016.1262822; DROES RM, 1991, BEWEGING PSYCHOSOCIA; Glueckauf RL, 2004, TELEMED J E-HEALTH, V10, P223, DOI 10.1089/1530562041641354; IBM Corp, 2016, IBM SPSS STAT MAC; Jaspers MWM, 2009, INT J MED INFORM, V78, P340, DOI 10.1016/j.ijmedinf.2008.10.002; KEMPEN GIJM, 1995, SOC INDIC RES, V35, P303, DOI 10.1007/BF01079163; Kerkhof YJ, 2016, INT PSYCHOGERIATR, P1; Kim H., 2015, INTERACTIVE J MED RE, V4; Leinonen E, 2001, INT J GERIATR PSYCH, V16, P387, DOI 10.1002/gps.351; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Lund A. M., 2001, MEASURING USABILITY, V12; Meiland Franka, 2017, JMIR Rehabil Assist Technol, V4, pe1, DOI 10.2196/rehab.6376; MONAHAN DJ, 1995, SOC WORK, V40, P305; Pinquart M, 2007, J GERONTOL B-PSYCHOL, V62, pP126, DOI 10.1093/geronb/62.2.P126; Reijnders J, 2015, EDUC GERONTOL, V41, P613, DOI 10.1080/03601277.2015.1024554; Schaller S, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.4354; Schulz R, 2004, AM J GERIAT PSYCHIAT, V12, P240, DOI 10.1176/appi.ajgp.12.3.240; Sutherland J, 2011, SCRUM GUIDE DEFINITI; Vernooij-Dassen MJFJ, 1999, J AM GERIATR SOC, V47, P256, DOI 10.1111/j.1532-5415.1999.tb04588.x; Wills T. A., 2000, SOCIAL SUPPORT MEASU, P86, DOI DOI 10.1093/MED:PSYCH/9780195126709.003.0004; Wittenberg-Lyles E, 2014, HEALTH COMMUN, V29, P901, DOI 10.1080/10410236.2013.815111; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR; Wright KB, 2010, COMMUN MONOGR, V77, P500, DOI 10.1080/03637751.2010.502538; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	46	30	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183386	10.1371/journal.pone.0183386	http://dx.doi.org/10.1371/journal.pone.0183386			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886056	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100019
J	Deckers, K; Schievink, SHJ; Rodriquez, MMF; van Oostenbrugge, RJ; van Boxtel, MPJ; Verhey, FRJ; Kohler, S				Deckers, Kay; Schievink, Syenna H. J.; Rodriquez, Maria M. F.; van Oostenbrugge, Robert J.; van Boxtel, Martin P. J.; Verhey, Frans R. J.; Kohler, Sebastian			Coronary heart disease and risk for cognitive impairment or dementia: Systematic review and meta-analysis	PLOS ONE			English	Review							MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; CARDIOVASCULAR-DISEASE; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; INCIDENT DEMENTIA; PREVENTION; MIDLIFE; LIFE; DECLINE	Aims/Hypothesis Accumulating evidence suggests an association between coronary heart disease and risk for cognitive impairment or dementia, but no study has systematically reviewed this association. Therefore, we summarized the available evidence on the association between coronary heart disease and risk for cognitive impairment or dementia. Methods Medline, Embase, PsycINFO, and CINAHL were searched for all publications until 8th January 2016. Articles were included if they fulfilled the inclusion criteria: (1) myocardial infarction, angina pectoris or coronary heart disease (combination of both) as predictor variable; (2) cognition, cognitive impairment or dementia as outcome; (3) population-based study; (4) prospective (>= 1 year follow-up), cross-sectional or case-control study design; (5) >= 100 participants; and (6) aged >= 45 years. Reference lists of publications and secondary literature were hand-searched for possible missing articles. Two reviewers independently screened all abstracts and extracted information from potential relevant full-text articles using a standardized data collection form. Study quality was assessed with the Newcastle-Ottawa Scale. We pooled estimates from the most fully adjusted model using random-effects meta-analysis. Results We identified 6,132 abstracts, of which 24 studies were included. A meta-analysis of 10 prospective cohort studies showed that coronary heart disease was associated with increased risk of cognitive impairment or dementia (OR = 1.45, 95% CI = 1.21-1.74, p<0.001). Between-study heterogeneity was low (I-2 = 25.7%, 95% CI = 0-64, p = 0.207). Similar significant associations were found in separate meta-analyses of prospective cohort studies for the individual predictors (myocardial infarction, angina pectoris). In contrast, meta-analyses of cross-sectional and case-control studies were inconclusive. Conclusion/Interpretation This meta-analysis suggests that coronary heart disease is prospectively associated with increased odds of developing cognitive impairment or dementia. Given the projected worldwide increase in the number of people affected by coronary heart disease and dementia, insight into causal mechanisms or common pathways underlying the heart-brain connection is needed.	[Deckers, Kay; Schievink, Syenna H. J.; van Boxtel, Martin P. J.; Verhey, Frans R. J.; Kohler, Sebastian] Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Rodriquez, Maria M. F.] Complexo Univ Vigo, Hosp Alvaro Cunqueiro, Dept Psiquiatria, Vigo, Spain; [van Oostenbrugge, Robert J.] Maastricht Univ, Med Ctr, Dept Neurol, Cardiovasc Res Inst Maastricht, Maastricht, Netherlands	Maastricht University; Maastricht University	Deckers, K (corresponding author), Maastricht Univ, Alzheimer Ctr Limburg, Sch Mental Hlth & Neurosci, Maastricht, Netherlands.	kay.deckers@maastrichtuniversity.nl		Deckers, Kay/0000-0003-1339-2974				Arntzen KA, 2011, EUR J NEUROL, V18, P737, DOI 10.1111/j.1468-1331.2010.03263.x; ARONSON MK, 1990, NEUROLOGY, V40, P1102, DOI 10.1212/WNL.40.7.1102; Brayne C, 1998, DEMENT GERIATR COGN, V9, P175, DOI 10.1159/000017043; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; Bursi F, 2006, AM J EPIDEMIOL, V163, P135, DOI 10.1093/aje/kwj025; Chen RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024817; de la Torre Jack C, 2012, Cardiovasc Psychiatry Neurol, V2012, P367516, DOI 10.1155/2012/367516; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Deckers K, 2015, INT J GERIATR PSYCH, V30, P234, DOI 10.1002/gps.4245; Elwood PC, 2002, AGE AGEING, V31, P43, DOI 10.1093/ageing/31.1.43; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Gruhn N, 2001, STROKE, V32, P2530, DOI 10.1161/hs1101.098360; Haring B, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000369; Hayden KM, 2006, ALZ DIS ASSOC DIS, V20, P93, DOI 10.1097/01.wad.0000213814.43047.86; Heath CA, 2015, J NEUROL NEUROSUR PS, V86, P959, DOI 10.1136/jnnp-2014-309033; Hughes TF, 2010, AM J GERIAT PSYCHIAT, V18, P413, DOI 10.1097/JGP.0b013e3181c65250; Ikram MA, 2008, STROKE, V39, P1421, DOI 10.1161/STROKEAHA.107.501106; IntHout J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010247; Justin B Ng, 2013, Clin Epidemiol, V5, P135, DOI 10.2147/CLEP.S30621; Kalantarian S, 2013, ANN INTERN MED, V158, P338, DOI 10.7326/0003-4819-158-5-201303050-00007; Kalmijn S, 1996, STROKE, V27, P2230, DOI 10.1161/01.STR.27.12.2230; Kivipelto M, 2002, ANN INTERN MED, V137, P149, DOI 10.7326/0003-4819-137-3-200208060-00006; Kwok CS, 2011, NEUROLOGY, V76, P914, DOI 10.1212/WNL.0b013e31820f2e38; Lipnicki DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065841; Massaia M, 2001, ARCH GERONTOL GERIAT, P253; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Newman AB, 2005, J AM GERIATR SOC, V53, P1101, DOI 10.1111/j.1532-5415.2005.53360.x; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Petrovitch H, 1998, AM J CARDIOL, V81, P1017, DOI 10.1016/S0002-9149(98)00082-4; Plassman BL, 2010, ANN INTERN MED, V153, P182, DOI 10.7326/0003-4819-153-3-201008030-00258; Roberts RO, 2010, NEUROBIOL AGING, V31, P1894, DOI 10.1016/j.neurobiolaging.2008.10.018; Ross GW, 1999, NEUROLOGY, V53, P337, DOI 10.1212/WNL.53.2.337; Santangeli P, 2012, HEART RHYTHM, V9, P1761, DOI 10.1016/j.hrthm.2012.07.026; Singh-Manoux A, 2003, J AM GERIATR SOC, V51, P1445, DOI 10.1046/j.1532-5415.2003.51464.x; Singh-Manoux A, 2008, EUR HEART J, V29, P2100, DOI 10.1093/eurheartj/ehn298; SPARKS DL, 1990, NEUROBIOL AGING, V11, P601, DOI 10.1016/0197-4580(90)90024-T; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Takahashi PY, 2012, CLIN INTERV AGING, V7, P27, DOI 10.2147/CIA.S28143; van Lennep JER, 2002, CARDIOVASC RES, V53, P538, DOI 10.1016/S0008-6363(01)00388-1; van Oijen M, 2007, ANN NEUROL, V61, P403, DOI 10.1002/ana.21073; Verhaeghen P, 2003, HEALTH PSYCHOL, V22, P559, DOI 10.1037/0278-6133.22.6.559; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wells G, 2000, NEWCASTLE OTTAWA SCA; World Health Organization, 1992, INTERNATIONAL STATIS; World Health Organization, 2011, GLOBAL ATLAS CARDIOV	46	121	124	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184244	10.1371/journal.pone.0184244	http://dx.doi.org/10.1371/journal.pone.0184244			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886155	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100087
J	Delval, A; Defebvre, L; Tard, C				Delval, Arnaud; Defebvre, Luc; Tard, Celine			Freezing during tapping tasks in patients with advanced Parkinson's disease and freezing of gait	PLOS ONE			English	Article							REPETITIVE FINGER MOVEMENTS; QUALITY-OF-LIFE; MOTOR; VARIABILITY; DISORDER; FALLS	Introduction Parkinson's disease patients with freezing of gait also experience sudden motor blocks (freezing) during other repetitive motor tasks. We assessed the proportion of patients with advanced PD and freezing of gait who also displayed segmental "freezing" in tapping tasks. Methods Fifteen Parkinson's disease patients with freezing of gait were assessed. Freezing of gait was evaluated using a standardized gait trajectory with the usual triggers. Patients performed repetitive tapping movements (as described in the MDS-UPDRS task) with the hands or the feet in the presence or absence of a metronome set to 4 Hz. Movements were recorded with a video motion system. The primary endpoint was the occurrence of segmental freezing in these tapping tasks. The secondary endpoints were (i) the relationship between segmental episodic phenomena and FoG severity, and (ii) the reliability of the measurements. Results For the upper limbs, freezing was observed more frequently with a metronome (21% of trials) than without a metronome (5%). For the lower limbs, the incidence of freezing was higher than for the upper limbs, and was again observed more frequently in the presence of an auditory cue (47%) than in its absence (14%). Conclusion Although freezing of the lower limbs was easily assessed during an MDS-UPDRS task with a metronome, it was not correlated with the severity of freezing of gait (as evaluated during a standardized gait trajectory). Only this latter was a reliable measurement in patients with advanced Parkinson's disease.	[Delval, Arnaud; Defebvre, Luc; Tard, Celine] Univ Lille, INSERM, Degenerat & Vasc Cognit Disorders U1171, Lille, France; [Delval, Arnaud; Tard, Celine] Lille Univ, Med Ctr, Clin Neurophysiol Dept, Lille, France; [Delval, Arnaud; Defebvre, Luc; Tard, Celine] Univ Lille, LiCEND, Lille Ctr Excellence Neurodegenerat Dis, Lille, France; [Defebvre, Luc; Tard, Celine] Lille Univ, Med Ctr, Neurol & Movement Disorders Dept, Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille	Delval, A (corresponding author), Univ Lille, INSERM, Degenerat & Vasc Cognit Disorders U1171, Lille, France.; Delval, A (corresponding author), Lille Univ, Med Ctr, Clin Neurophysiol Dept, Lille, France.; Delval, A (corresponding author), Univ Lille, LiCEND, Lille Ctr Excellence Neurodegenerat Dis, Lille, France.	arnaud.delval@chru-lille.fr	Tard, Céline/GRR-8269-2022	Delval, Arnaud/0000-0003-0642-3541	Santelys	Santelys	Celine Tard received a grant from Santelys and has received various honoraria for lectures on neuromuscular disorders. Luc Defebvre served on several Scientific Advisory Boards for Abbvie and Zambon. He has received various honoraria from pharmaceutical companies for consultancy and lectures on Parkinsons disease at symposia. These companies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thanks Santelys for funding.	Abe K, 2003, BRAIN RES BULL, V61, P219, DOI 10.1016/S0361-9230(03)00119-9; Almeida QJ, 2002, MOVEMENT DISORD, V17, P30, DOI 10.1002/mds.10030; Barbe MT, 2014, J NEUROL, V261, P330, DOI 10.1007/s00415-013-7199-1; Bronte-Stewart HM, 2000, MOVEMENT DISORD, V15, P36, DOI 10.1002/1531-8257(200001)15:1<36::AID-MDS1008>3.0.CO;2-M; Delval A, 2016, MOVEMENT DISORD, V31, P1837, DOI 10.1002/mds.26762; GIBB WRG, 1988, POSTGRAD MED J, V64, P345, DOI 10.1136/pgmj.64.751.345; Giladi N, 2001, J NEURAL TRANSM, V108, P53, DOI 10.1007/s007020170096; Giladi N, 2009, MOVEMENT DISORD, V24, P655, DOI 10.1002/mds.21745; Gilat M, 2017, NEUROIMAGE, V152, P207, DOI 10.1016/j.neuroimage.2017.02.073; Gilat M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066718; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Heremans E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142874; Heremans E, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0350-7; Herman T, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0411-y; Iansek R, 2006, MOVEMENT DISORD, V21, P1419, DOI 10.1002/mds.20998; Jones CRG, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00081; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Latt MD, 2009, MOVEMENT DISORD, V24, P1280, DOI 10.1002/mds.22561; Lewis SJG, 2009, PARKINSONISM RELAT D, V15, P333, DOI 10.1016/j.parkreldis.2008.08.006; Martens KAE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106561; Matar E, 2013, PARKINSONISM RELAT D, V19, P937, DOI 10.1016/j.parkreldis.2013.06.002; Moore O, 2007, MOVEMENT DISORD, V22, P2192, DOI 10.1002/mds.21659; Moreau C, 2008, J NEURAL TRANSM, V115, P1431, DOI 10.1007/s00702-008-0099-3; Morris TR, 2012, PARKINSONISM RELAT D, V18, P572, DOI 10.1016/j.parkreldis.2012.03.001; Naismith SL, 2010, J CLIN NEUROSCI, V17, P984, DOI 10.1016/j.jocn.2009.12.006; Nantel J, 2011, GAIT POSTURE, V34, P329, DOI 10.1016/j.gaitpost.2011.05.020; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nieuwboer A, 2009, EUR J NEUROSCI, V29, P1422, DOI 10.1111/j.1460-9568.2009.06681.x; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Perez-Lloret S, 2014, JAMA NEUROL, V71, P884, DOI 10.1001/jamaneurol.2014.753; Shine JM, 2013, BRAIN, V136, P3671, DOI 10.1093/brain/awt272; Snijders AH, 2008, MOVEMENT DISORD, V23, pS468, DOI 10.1002/mds.22144; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Stegemoller EL, 2013, NEUROSCI LETT, V552, P135, DOI 10.1016/j.neulet.2013.07.056; Stegemoller EL, 2009, MOVEMENT DISORD, V24, P1162, DOI 10.1002/mds.22535; Tard C, 2015, J PARKINSON DIS, V5, P379, DOI 10.3233/JPD-140498; Vercruysse S, 2014, NEUROSCI BIOBEHAV R, V43, P213, DOI 10.1016/j.neubiorev.2014.04.010; Vercruysse S, 2012, NEUROREHAB NEURAL RE, V26, P636, DOI 10.1177/1545968311431964; Vercruysse S, 2012, MOVEMENT DISORD, V27, P254, DOI 10.1002/mds.24015; Williams AJ, 2013, PARKINSONS DIS-US, V2013, DOI 10.1155/2013/595378; Yahalom G, 2004, PARKINSONISM RELAT D, V10, P143, DOI 10.1016/j.parkreldis.2003.10.001; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Ziv I, 1999, ACTA NEUROL SCAND, V99, P106, DOI 10.1111/j.1600-0404.1999.tb00666.x	44	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0181973	10.1371/journal.pone.0181973	http://dx.doi.org/10.1371/journal.pone.0181973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886015	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100004
J	Pokorn, T; Radisek, S; Javornik, B; Stajner, N; Jakse, J				Pokorn, Tine; Radisek, Sebastjan; Javornik, Branka; Stajner, Natasa; Jakse, Jernej			Development of hop transcriptome to support research into host-viroid interactions	PLOS ONE			English	Article							SMALL RNAS; PHYTOHORMONE PATHWAYS; GLANDULAR TRICHOMES; GENE-EXPRESSION; HUMULUS-LUPULUS; ARABIDOPSIS; TARGETS; PLANTS; IDENTIFICATION; BIOSYNTHESIS	Viroids, the smallest known pathogens, unable to encode any proteins, can cause severe diseases in their host plants. One of the proposed mechanisms of their pathogenicity includes silencing the host's genes via viroid-derived small RNAs, which are products of the host's immune response to the viroid's double stranded RNA. Humulus lupulus (hop) plants are hosts to several viroids; two of them, HLVd and CBCVd, are interesting models for studying host-viroid interactions, due to the symptomless infection of the former and severe stunting disease caused by the latter. To study these interactions, we constructed a deep hop NGS transcriptome based on 35 Gb paired-end sequencing data assembled into over 74 Mb of contigs. These transcripts were used for in-silico prediction of target transcripts of vd-sRNA of the two aforementioned viroids, using two different software tools. Prediction models revealed that 1062 and 1387 hop transcripts share nucleotide similarities with HLVd-and CBCVd-derived small RNAs, respectively, so they could be silenced in an RNA interference process. Furthermore, we selected 17 transcripts from 4 groups of targets involved in the metabolism of plant hormones, small RNA biogenesis, transcripts with high complementarity with viroid-derived small RNAs and transcripts targeted by CBCVd-derived small RNAs with high cellular concentrations. Their expression was monitored by reverse transcription quantitative PCR performed using leaf, flower and cone samples. Additionally, the expression of 5 pathogenesis related genes was monitored. Expression analysis confirmed high expression levels of four pathogenesis related genes in leaves of HLVd and CBCVd infected hop plants. Expression fluctuations were observed for the majority of targets, with possible evidence of downregulation of GATA transcription factor by CBCVd- and of linoleate 13S-lipoxygenase by HLVd-derived small RNAs. These results provide a deep transcriptome of hop and the first insights into complex viroid-hop plant interactions.	[Pokorn, Tine; Javornik, Branka; Stajner, Natasa; Jakse, Jernej] Univ Ljubljana, Biotech Fac, Agron Dept, Ljubljana, Slovenia; [Radisek, Sebastjan] Slovenian Inst Hop Res & Brewing, Dept Plant Protect, Zhalec, Slovenia; [Pokorn, Tine] Univ Ljubljana, Biotech Fac, Dept Anim Sci, Domzale, Slovenia	University of Ljubljana; University of Ljubljana	Jakse, J (corresponding author), Univ Ljubljana, Biotech Fac, Agron Dept, Ljubljana, Slovenia.	jernej.jakse@bf.uni-lj.si		Jakse, Jernej/0000-0002-8907-1627	Slovenian Research Agency - ARRS [J4-4153, 1000-11-310098]; Administration of the Republic of Slovenia for Food Safety, Veterinary and Plant Protection [2321-12-210006]	Slovenian Research Agency - ARRS(Slovenian Research Agency - Slovenia); Administration of the Republic of Slovenia for Food Safety, Veterinary and Plant Protection	This work was supported by J4-4153, Slovenian Research Agency - ARRS, http://www.sicris.si/public/jqm/prj.aspx?lang=eng& P4-0077, Slovenian Research Agency - ARRS, http://www.sicris.si/public/jqm/prg.aspx?lang=eng& 1000-11-310098, Slovenian Research Agency - ARRS; 2321-12-210006, Administration of the Republic of Slovenia for Food Safety, Veterinary and Plant Protection.	ADAMS AN, 1992, ANN APPL BIOL, V121, P585, DOI 10.1111/j.1744-7348.1992.tb03468.x; Attoui H, 2011, 9 INT COMM TAX VIR; Avina-Padilla K, 2015, GENE, V564, P197, DOI 10.1016/j.gene.2015.03.076; BARBARA DJ, 1990, ANN APPL BIOL, V117, P359, DOI 10.1111/j.1744-7348.1990.tb04222.x; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Ben Abdallah H, 2016, METHODS MOL BIOL, V1363, P9, DOI 10.1007/978-1-4939-3115-6_2; Bernad L, 2006, MOL CELL PROBE, V20, P105, DOI 10.1016/j.mcp.2005.11.001; Bullock JM, 2016, THESIS; Busov VB, 2003, PLANT PHYSIOL, V132, P1283, DOI 10.1104/pp.103.020354; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen WH, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-320; Clark SM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-12; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cregeen S, 2015, PLANT MOL BIOL REP, V33, P689, DOI 10.1007/s11105-014-0767-4; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Denance A N, 2013, FRONT PLANT SCI, V4; Di Serio F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007539; DIENER TO, 1971, VIROLOGY, V45, P411, DOI 10.1016/0042-6822(71)90342-4; Dijkstra C, 2008, PLANT CELL REP, V27, P463, DOI 10.1007/s00299-007-0471-z; Eastwell KC, 2010, PLANT HLTH PROGR; Flores R, 2004, FEBS LETT, V567, P42, DOI 10.1016/j.febslet.2004.03.118; Fu N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057686; Hataya Tatsuji, 1992, Annals of the Phytopathological Society of Japan, V58, P677, DOI 10.3186/jjphytopath.58.677; Iorizzo M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-389; Iqbal N, 2013, PLANT PHYSIOL BIOCH, V73, P128, DOI 10.1016/j.plaphy.2013.09.011; Itaya A, 2002, MOL PLANT MICROBE IN, V15, P990, DOI 10.1094/MPMI.2002.15.10.990; Itaya A, 2001, MOL PLANT MICROBE IN, V14, P1332, DOI 10.1094/MPMI.2001.14.11.1332; Jakse J, 2015, PLANT PATHOL, V64, P831, DOI 10.1111/ppa.12325; Kappagantu M, 2017, PLANT DIS, V101, P607, DOI 10.1094/PDIS-06-16-0884-RE; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kodama Y, 2012, NUCLEIC ACIDS RES, V40, pD54, DOI 10.1093/nar/gkr854; Kumar D, 2014, PLANT SCI, V228, P127, DOI 10.1016/j.plantsci.2014.04.014; Lacombe S, 2010, PLANT J, V61, P371, DOI 10.1111/j.1365-313X.2009.04062.x; Laxalt AM, 2002, CURR OPIN PLANT BIOL, V5, P332, DOI 10.1016/S1369-5266(02)00268-6; Lei JK, 2014, BIOINFORMATICS, V30, P2837, DOI 10.1093/bioinformatics/btu380; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu R, 2004, P NATL ACAD SCI USA, V101, P15742, DOI 10.1073/pnas.0404940101; Lu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129010; Ma KW, 2016, PLANT MOL BIOL, V91, P713, DOI 10.1007/s11103-016-0452-0; Martinez de Alba AE, 2002, J VIROL, V76, P13094, DOI 10.1128/JVI.76.24.13094-13096.2002; Matousek J, 2003, PLANT SOIL ENVIRON, V49, P168, DOI 10.17221/4109-PSE; Minoia S, 2014, J VIROL, V88, P11933, DOI 10.1128/JVI.01404-14; Mishra AK, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3271-4; Mishra AK, 2015, CRIT REV PLANT SCI, V34, P553, DOI 10.1080/07352689.2015.1078614; Moreton J, 2016, FRONT GENET, V6, DOI 10.3389/fgene.2015.00361; Nagel J, 2008, PLANT CELL, V20, P186, DOI 10.1105/tpc.107.055178; Natsume S, 2015, PLANT CELL PHYSIOL, V56, P428, DOI 10.1093/pcp/pcu169; Navarro B, 2012, PLANT J, V70, P991, DOI 10.1111/j.1365-313X.2012.04940.x; Navarro B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007686; Owens RA, 2012, MOL PLANT MICROBE IN, V25, P582, DOI 10.1094/MPMI-09-11-0258; Papaefthimiou I, 2001, NUCLEIC ACIDS RES, V29, P2395, DOI 10.1093/nar/29.11.2395; Patzak J, 2001, BIOL PLANTARUM, V44, P579, DOI 10.1023/A:1013798821676; PUCHTA H, 1988, NUCLEIC ACIDS RES, V16, P4197, DOI 10.1093/nar/16.10.4197; Qu YT, 2015, INT J MOL SCI, V16, P9732, DOI 10.3390/ijms16059732; Radisek S, 2012, PLANT DIS, V96, P592, DOI 10.1094/PDIS-08-11-0640-PDN; Randles J. W., 2003, Viroids, P3; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Rigal A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00373; Rivas S, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00104; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Rodio ME, 2006, J GEN VIROL, V87, P231, DOI 10.1099/vir.0.81356-0; RODRIGO I, 1991, PLANT MOL BIOL, V16, P931, DOI 10.1007/BF00015088; Sano T, 2001, VIRUS GENES, V22, P53, DOI 10.1023/A:1008182302704; Sano Teruo, 2004, Journal of General Plant Pathology, V70, P181, DOI 10.1007/s10327-004-0105-z; SASAKI M, 1977, P JPN ACAD B-PHYS, V53, P103, DOI 10.2183/pjab.53.103; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Srivastava PK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-348; Stajner N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068228; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Stocks MB, 2012, BIOINFORMATICS, V28, P2059, DOI 10.1093/bioinformatics/bts311; Suzuki N, 2005, PLANT PHYSIOL, V139, P1313, DOI 10.1104/pp.105.070110; Tsuda K, 2004, PLANT CELL PHYSIOL, V45, P225, DOI 10.1093/pcp/pch017; Ui-Tei Kumiko, 2012, Frontiers in Genetics, V3, P101, DOI 10.3389/fgene.2012.00101; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang GD, 2008, PLANT PHYSIOL, V148, P1254, DOI 10.1104/pp.108.125187; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; Zhang C, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.01237, 10.3389/fmicb.2015.01108]; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90	80	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184528	10.1371/journal.pone.0184528	http://dx.doi.org/10.1371/journal.pone.0184528			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886174	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100148
J	Huang, QF; Trenson, S; Zhang, ZY; Yang, WY; Van Aelst, L; Nkuipou-Kenfack, E; Wei, FF; Mujaj, B; Thijs, L; Ciarka, A; Zoidakis, J; Droogne, W; Vlahou, A; Janssens, S; Vanhaecke, J; Van Cleemput, J; Staessen, JA				Huang, Qi-Fang; Trenson, Sander; Zhang, Zhen-Yu; Yang, Wen-Yi; Van Aelst, Lucas; Nkuipou-Kenfack, Esther; Wei, Fang-Fei; Mujaj, Blerim; Thijs, Lutgarde; Ciarka, Agnieszka; Zoidakis, Jerome; Droogne, Walter; Vlahou, Antonia; Janssens, Stefan; Vanhaecke, Johan; Van Cleemput, Johan; Staessen, Jan A.			Urinary Proteomics in Predicting Heart Transplantation Outcomes (uPROPHET)-Rationale and database description	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC DYSFUNCTION; INTERNATIONAL SOCIETY; WORKING FORMULATION; EUROPEAN-SOCIETY; EJECTION FRACTION; LISTING CRITERIA; DIAGNOSIS; STANDARDIZATION; NOMENCLATURE; REJECTION	Objectives Urinary Proteomics in Predicting Heart Transplantation Outcomes (uPROPHET; NCT03152422) aims: (i) to construct new multidimensional urinary proteomic (UP) classifiers that after heart transplantation (HTx) help in detecting graft vasculopathy, monitoring immune system activity and graft performance, and in adjusting immunosuppression; (ii) to sequence UP peptide fragments and to identify key proteins mediating HTx-related complications; (iii) to validate UP classifiers by demonstrating analogy between UP profiles and tissue proteomic signatures (TP) in diseased explanted hearts, to be compared with normal donor hearts; (iv) and to identify new drug targets. This article describes the uPROPHET database construction, follow-up strategies and baseline characteristics of the HTx patients. Methods HTx patients enrolled at the University Hospital Gasthuisberg (Leuven) collected mid-morning urine samples. Cardiac biopsies were obtained at HTx. UP and TP methods and the statistical work flow in pursuit of the research objectives are described in detail in the Data supplement. Results Of 352 participants in the UP study (24.4% women), 38.9%, 40.3%, 5.7% and 15.1% had ischemic, dilated, hypertrophic or other cardiomyopathy. The median interval between HTx and first UP assessment (baseline) was 7.8 years. At baseline, mean values were 56.5 years for age, 25.2 kg/m(2) for body mass index, 142.3/84.8 mm Hg and 124.2/79.8 mm Hg for office and 24-h ambulatory systolic/diastolic pressure, and 58.6 mL/min/1.73 m(2) for the estimated glomerular filtration rate. Of all patients, 37.2% and 6.5% had a history of mild (grade = 1B) or severe (grade >= 2) cellular rejection. Anti-body mediated rejection had occurred in 6.2% patients. The number of follow-up urine samples available for future analyses totals over 950. The TP study currently includes biopsies from 7 healthy donors and 15, 14, and 3 patients with ischemic, dilated, and hypertrophic cardiomyopathy. Conclusions uPROPHET constitutes a solid resources for UP and TP research in the field of HTx and has the ambition to lay the foundation for the clinical application of UP in risk stratification in HTx patients.	[Huang, Qi-Fang; Zhang, Zhen-Yu; Yang, Wen-Yi; Wei, Fang-Fei; Mujaj, Blerim; Thijs, Lutgarde; Staessen, Jan A.] Univ Leuven, KU Leuven, Studies Coordinating Ctr,Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Leuven, Belgium; [Huang, Qi-Fang] Shanghai Jiao Tong Univ, Sch Med, Ctr Epidemiol Studies & Clin Trials,Rujin Hosp, Shanghai Inst Hypertens,Shanghai Key Lab Hyperten, Shanghai, Peoples R China; [Huang, Qi-Fang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp,Shanghai Key Lab Hypertens, Shanghai Inst Hypertens,Ctr Vasc Evaluat, Shanghai, Peoples R China; [Trenson, Sander; Van Aelst, Lucas; Ciarka, Agnieszka; Droogne, Walter; Janssens, Stefan; Vanhaecke, Johan; Van Cleemput, Johan] Univ Hosp Leuven, Div Cardiol, Leuven, Belgium; [Nkuipou-Kenfack, Esther] Mosa Diagnost GmbH, Hannover, Germany; [Zoidakis, Jerome; Vlahou, Antonia] Acad Athens, Biomed Res Fdn, Biotechnol Div, Athens, Greece; [Staessen, Jan A.] Maastricht Univ, R&D Grp VitaK, Maastricht, Netherlands	KU Leuven; Shanghai Jiao Tong University; Shanghai Jiao Tong University; KU Leuven; University Hospital Leuven; Modular Open Systems Approach (MOSA) Solutions; Academy of Athens; Maastricht University	Staessen, JA (corresponding author), Univ Leuven, KU Leuven, Studies Coordinating Ctr,Dept Cardiovasc Sci, Res Unit Hypertens & Cardiovasc Epidemiol, Leuven, Belgium.; Staessen, JA (corresponding author), Maastricht Univ, R&D Grp VitaK, Maastricht, Netherlands.	jan.staessen@med.kuleuven.be	Zoidakis, Jerome/AAO-8236-2021; Staessen, Jan A/A-1065-2011; Zoidakis, Jerome/P-9599-2018; Mujaj, Blerim/AAE-4593-2020; Zhang, Zhenyu/GZL-8479-2022; Ciarka, Agnieszka/AAI-4490-2020; Mujaj, Blerim/AAQ-4715-2020; Yang, Wenyi/ABA-5526-2021; Van Aelst, Lucas/GNM-7867-2022	Zoidakis, Jerome/0000-0002-4557-3430; Staessen, Jan A/0000-0002-3026-1637; Zoidakis, Jerome/0000-0002-4557-3430; Mujaj, Blerim/0000-0001-5831-0800; Zhang, Zhenyu/0000-0002-3785-7417; Thijs, Lutgarde/0000-0002-8108-2356; Yang, Wen-Yi/0000-0003-1279-0866	European Union [HEALTH-F7-305507]; European Research Council (Advanced Researcher Grant) [2011-294713-EPLORE, 713601-uPROPHET]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0881.13]; EPLORE	European Union(European Commission); European Research Council (Advanced Researcher Grant)(European Research Council (ERC)); Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium(FWO); EPLORE	This work was supported by the European Union (HEALTH-F7-305507 HOMAGE, URL: http://www.homage-hf.eu/) and the European Research Council (Advanced Researcher Grant 2011-294713-EPLORE and Proof-of-Concept Grant 713601-uPROPHET; URL: http://cordis.europa.eu/project/rcn/104182_en.html and http://cordis.europa.eu/project/rcn/205861_en.html) and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13, URL: http://www.fwo.be/) currently support the Studies Coordinating Centre in Leuven. The EPLORE grant paid for the urinary proteomic measurements at Mosaiques Diagnostics AG (Hannover, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelini A, 2011, J HEART LUNG TRANSPL, V30, P1214, DOI 10.1016/j.healun.2011.05.011; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Argiles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062837; Berry GJ, 2013, J HEART LUNG TRANSPL, V32, P1147, DOI 10.1016/j.healun.2013.08.011; BILLINGHAM ME, 1990, J HEART TRANSPLANT, V9, P587; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Coon JJ, 2008, PROTEOM CLIN APPL, V2, P964, DOI 10.1002/prca.200800024; EHRSAM RE, 1983, CLIN SCI, V65, P653, DOI 10.1042/cs0650653; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Fliser D, 2007, J AM SOC NEPHROL, V18, P1057, DOI 10.1681/ASN.2006090956; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gu YM, 2014, NEPHROL DIAL TRANSPL, V29, P2260, DOI 10.1093/ndt/gfu234; Haddad H, 2009, CAN J CARDIOL, V25, P197, DOI 10.1016/S0828-282X(09)70061-3; Htun NM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172036; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Kaiser T, 2004, BLOOD, V104, P340, DOI 10.1182/blood-2004-02-0518; Kilic A, 2014, J THORAC DIS, V6, P1097, DOI 10.3978/j.issn.2072-1439.2014.03.23; Kim SC, 2014, TRANSPLANT REV-ORLAN, V28, P15, DOI 10.1016/j.trre.2013.10.004; Kloch-Badelek M, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-10; Kuznetsova T, 2012, EUR HEART J, V33, P2342, DOI 10.1093/eurheartj/ehs185; Kuznetsova T, 2009, CIRC-HEART FAIL, V2, P105, DOI 10.1161/CIRCHEARTFAILURE.108.822627; Latosinska A, 2017, ONCOTARGET; Latosinska A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25619; Latosinska A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137048; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mehra MR, 2006, J HEART LUNG TRANSPL, V25, P1024, DOI 10.1016/j.healun.2006.06.008; Mehra MR, 2016, J HEART LUNG TRANSPL, V35, P1, DOI 10.1016/j.healun.2015.10.023; Mehra MR, 2010, J HEART LUNG TRANSPL, V29, P717, DOI 10.1016/j.healun.2010.05.017; Mischak H, 2015, NAT REV NEPHROL, V11, P221, DOI 10.1038/nrneph.2014.247; Mischak H, 2010, PROTEOM CLIN APPL, V4, P464, DOI 10.1002/prca.200900189; Nkuipou-Kenfack E, 2017, PROTEOM CLIN APPL, P11; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Pham MX, 2010, NEW ENGL J MED, V362, P1890, DOI 10.1056/NEJMoa0912965; Pieper R, 2004, PROTEOMICS, V4, P1159, DOI 10.1002/pmic.200300661; Pontillo C, 2016, NEPHROL DIAL TRANSPL; Pontillo C, 2017, KIDNEY INT REP, V2, P1066, DOI 10.1016/j.ekir.2017.06.004; Rossing K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157167; Schanstra JP, 2015, J AM SOC NEPHROL, V26, P1999, DOI 10.1681/ASN.2014050423; Schaub S, 2004, KIDNEY INT, V65, P323, DOI 10.1111/j.1523-1755.2004.00352.x; Schlant RC, 1974, HEART, P79; Snedecor GW, 1980, STATISTICAL METHODS, P78; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Wolsk E, 2017, JACC-HEART FAIL, V5, P337, DOI 10.1016/j.jchf.2016.10.012; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776; Zhang ZY, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005432; Zhang ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167582; Zhang ZY, 2015, HYPERTENSION, V66, P52, DOI 10.1161/HYPERTENSIONAHA.115.05296; Zhang ZY, 2014, INT J CARDIOL, V176, P158, DOI 10.1016/j.ijcard.2014.07.014; Zhang ZY, 2017, KI REPORTS	53	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184443	10.1371/journal.pone.0184443	http://dx.doi.org/10.1371/journal.pone.0184443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880921	Green Published, gold, Green Submitted			2022-12-27	WOS:000409467200070
J	Karasov, TL; Barrett, L; Hershberg, R; Bergelson, J				Karasov, Talia L.; Barrett, Luke; Hershberg, Ruth; Bergelson, Joy			Similar levels of gene content variation observed for Pseudomonas syringae populations extracted from single and multiple host species	PLOS ONE			English	Article							MICROBIAL PAN-GENOME; ARABIDOPSIS-THALIANA; PATHOGEN METAPOPULATION; PV. PHASEOLICOLA; PLANT; VIRULENCE; DIVERSITY; SYSTEM; VIRIDIFLAVA; VARIABILITY	Bacterial strains of the same species collected from different hosts frequently exhibit differences in gene content. In the ubiquitous plant pathogen Pseudomonas syringae, more than 30% of genes encoded by each strain are not conserved among strains colonizing other host species. Although they are often implicated in host specificity, the role of this large fraction of the genome in host-specific adaptation is largely unexplored. Here, we sought to relate variation in gene content between strains infecting different species to variation that persists between strains on the same host. We fully sequenced a collection of P. syringae strains collected from wild Arabidopsis thaliana populations in the Midwestern United States. We then compared patterns of variation observed in gene content within these A. thaliana-isolated strains to previously published P. syringae sequence from strains collected on a diversity of crop species. We find that strains collected from the same host, A. thaliana, differ in gene content by 21%, 2/3 the level of gene content variation observed across strains collected from different hosts. Furthermore, the frequency with which specific genes are present among strains collected within the same host and among strains collected from different hosts is highly correlated. This implies that most gene content variation is maintained irrespective of host association. At the same time, we identify specific genes whose presence is important for P. syringae's ability to flourish within A. thaliana. Specifically, the A. thaliana strains uniquely share a genomic island encoding toxins active against plants and surrounding microbes, suggesting a role for microbe-microbe interactions in dictating the abundance within this host. Overall, our results demonstrate that while variation in the presence of specific genes can affect the success of a pathogen within its host, the majority of gene content variation is not strongly associated with patterns of host use.	[Karasov, Talia L.; Bergelson, Joy] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Karasov, Talia L.; Barrett, Luke; Bergelson, Joy] Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA; [Barrett, Luke] CSIRO Agr, Canberra, ACT 2601, Australia; [Hershberg, Ruth] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Dept Genet, Haifa, Israel	University of Chicago; University of Chicago; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Bergelson, J (corresponding author), Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA.; Bergelson, J (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.	jbergels@uchicago.edu	Barrett, Luke G/I-5711-2015	Barrett, Luke G/0000-0001-6530-0731; Karasov, Talia/0000-0002-3592-6597; Bergelson, Joy/0000-0001-7893-7387	Graduate Assistance in Areas of National Need (GAANN); NSF DDIG [1311515]; ERC FP7 CIG grant; Yigal Allon Fellowship; Robert J. Shillman Career Advancement Chair;  [NSF345 MCB 0603515]	Graduate Assistance in Areas of National Need (GAANN)(US Department of Education); NSF DDIG(National Science Foundation (NSF)); ERC FP7 CIG grant; Yigal Allon Fellowship; Robert J. Shillman Career Advancement Chair; 	Funded by NSF345 MCB 0603515 to JB. https://www.nsf.gov/. TLK was supported by a Graduate Assistance in Areas of National Need (GAANN) training grant and NSF DDIG 1311515. https://www.nsf.gov/. RH was supported by an ERC FP7 CIG grant (https://erc.europa.eu/), by a Yigal Allon Fellowship (http://www.utdallas.edu/similar to DJL101000/DavidLary/Awards/Entries/1998/10/1_Alon_Fellowships_for_Outstanding_Young_Researchers.html), and by the Robert J. Shillman Career Advancement Chair.	Almeida NF, 2010, PHYTOPATHOLOGY, V100, P208, DOI 10.1094/PHYTO-100-3-0208; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arbuckle J. L., 2006, AMOS VERSION 7 0 COM; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baltrus DA, 2016, MOL PLANT PATHOL; Baltrus DA, 2012, MOL PLANT MICROBE IN, V25, P877, DOI 10.1094/MPMI-08-11-0218; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Barrett LG, 2011, ECOL LETT, V14, P1149, DOI 10.1111/j.1461-0248.2011.01687.x; Bartoli C, 2014, ENVIRON MICROBIOL, V16, P2301, DOI 10.1111/1462-2920.12433; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Bolotin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep35168; Bolotin E, 2015, GENOME BIOL EVOL, V7, P2173, DOI 10.1093/gbe/evv135; Butler MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057464; Cai RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002130; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Clarke CR, 2010, MOL PLANT MICROBE IN, V23, P198, DOI 10.1094/MPMI-23-2-0198; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Feil H, 2005, P NATL ACAD SCI USA, V102, P11064, DOI 10.1073/pnas.0504930102; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Ferrante P, 2010, PLANT PATHOL, V59, P954, DOI 10.1111/j.1365-3059.2010.02304.x; Gao LP, 2009, NEW PHYTOL, V184, P485, DOI 10.1111/j.1469-8137.2009.02959.x; Godfrey SAC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002010; Guenzi E, 1998, J BIOL CHEM, V273, P32857, DOI 10.1074/jbc.273.49.32857; Haegeman B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-196; HASEGAWA M, 1991, J MOL EVOL, V32, P443, DOI 10.1007/BF02101285; Hirano SS, 2000, MICROBIOL MOL BIOL R, V64, P624, DOI 10.1128/MMBR.64.3.624-653.2000; Hockett KL, 2014, MOL PLANT MICROBE IN, V27, P923, DOI 10.1094/MPMI-11-13-0354-R; Horton MW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6320; Hwang MSH, 2005, APPL ENVIRON MICROB, V71, P5182, DOI 10.1128/AEM.71.9.5182-5191.2005; Jackson RW, 2000, MOL MICROBIOL, V38, P186, DOI 10.1046/j.1365-2958.2000.02133.x; Jakob K, 2002, MOL PLANT MICROBE IN, V15, P1195, DOI 10.1094/MPMI.2002.15.12.1195; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Karasov TL, 2014, CURR OPIN PLANT BIOL, V18, P24, DOI 10.1016/j.pbi.2013.12.003; Kislyuk AO, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-32; Kniskern JM, 2007, MOL PLANT MICROBE IN, V20, P1512, DOI 10.1094/MPMI-20-12-1512; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; McCann HC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003503; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Morris CE, 2010, MBIO, V1, DOI 10.1128/mBio.00107-10; Morris CE, 2008, ISME J, V2, P321, DOI 10.1038/ismej.2007.113; Nowell RW, 2014, GENOME BIOL EVOL, V6, P1514, DOI 10.1093/gbe/evu123; Nowell RW, 2016, MOL PLANT PATHOL; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Renick LJ, 2008, PLANT DIS, V92, P372, DOI 10.1094/PDIS-92-3-0372; Sarkar SF, 2008, APPL ENVIRON MICROB, V74, P1961, DOI 10.1128/AEM.02553-07; Sarkar SF, 2006, GENETICS, V174, P1041, DOI 10.1534/genetics.106.060996; SAVAGEAU MA, 1983, AM NAT, V122, P732, DOI 10.1086/284168; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thompson JR, 2005, SCIENCE, V307, P1311, DOI 10.1126/science.1106028; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Thrall PH, 2001, J ECOL, V89, P736, DOI 10.1046/j.0022-0477.2001.00597.x; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Tsiamis G, 2000, EMBO J, V19, P3204, DOI 10.1093/emboj/19.13.3204; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026; Yu XL, 2013, P NATL ACAD SCI USA, V110, pE425, DOI 10.1073/pnas.1221892110; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	60	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184195	10.1371/journal.pone.0184195	http://dx.doi.org/10.1371/journal.pone.0184195			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880925	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200039
J	Kaur, A; Pati, PK; Pati, AM; Nagpal, AK				Kaur, Amritpreet; Pati, Pratap Kumar; Pati, Aparna Maitra; Nagpal, Avinash Kaur			In-silico analysis of cis-acting regulatory elements of pathogenesis-related proteins of Arabidopsis thaliana and Oryza sativa	PLOS ONE			English	Article							ABSCISIC-ACID; G-BOX; TRANSCRIPTIONAL ACTIVATION; MOLECULAR CHARACTERIZATION; FUNCTIONAL-ANALYSIS; PROMOTER ELEMENTS; GENE-EXPRESSION; GCC-BOX; IDENTIFICATION; DEFENSE	Pathogenesis related (PR) proteins are low molecular weight family of proteins induced in plants under various biotic and abiotic stresses. They play an important role in plant-defense mechanism. PRs have wide range of functions, acting as hydrolases, peroxidases, chitinases, anti-fungal, protease inhibitors etc. In the present study, an attempt has been made to analyze promoter regions of PR1, PR2, PR5, PR9, PR10 and PR12 of Arabidopsis thaliana and Oryza sativa. Analysis of cis-element distribution revealed the functional multiplicity of PRs and provides insight into the gene regulation. CpG islands are observed only in rice PRs, which indicates that monocot genome contains more GC rich motifs than dicots. Tandem repeats were also observed in 5'UTR of PR genes. Thus, the present study provides an understanding of regulation of PR genes and their versatile roles in plants.	[Kaur, Amritpreet; Nagpal, Avinash Kaur] Guru Nanak Dev Univ, Dept Bot & Environm Sci, Amritsar, Punjab, India; [Pati, Pratap Kumar] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India; [Pati, Aparna Maitra] Inst Himalayan Bioresource Technol, CSIR, Planning Project Monitoring & Evaluat Cell, Palampur, Himachal Prades, India	Guru Nanak Dev University; Guru Nanak Dev University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Nagpal, AK (corresponding author), Guru Nanak Dev Univ, Dept Bot & Environm Sci, Amritsar, Punjab, India.; Pati, PK (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.; Pati, AM (corresponding author), Inst Himalayan Bioresource Technol, CSIR, Planning Project Monitoring & Evaluat Cell, Palampur, Himachal Prades, India.	pkpati@yahoo.com; aparna@ihbt.res.in; avnagpal@yahoo.co.in	Nagpal, Avinash Kaur/J-9048-2018; bot, amrit/AAU-1660-2021	pati, pratap/0000-0001-9017-7608; Kaur, Amritpreet/0000-0001-5598-1318; Nagpal, Avinash Kaur/0000-0002-8036-9646	university grant commission (UGC), New Delhi, India	university grant commission (UGC), New Delhi, India(University Grants Commission, India)	Amritpreet Kaur received funding from university grant commission (UGC), New Delhi, India.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; ARIAS JA, 1993, PLANT CELL, V5, P485, DOI 10.1105/tpc.5.4.485; Ashikawa I, 2001, PLANT J, V26, P617, DOI 10.1046/j.1365-313x.2001.01062.x; Barrera V, 2012, NUCLEIC ACIDS RES, V40, P11490, DOI 10.1093/nar/gks928; BELL GI, 1992, COMPUT CHEM, V16, P135, DOI 10.1016/0097-8485(92)80040-7; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Caliskan Mahmut, 2000, Turkish Journal of Biology, V24, P717; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Chakravarthy S, 2003, PLANT CELL, V15, P3033, DOI 10.1105/tpc.017574; Chan CS, 2001, PLANT MOL BIOL, V46, P131, DOI 10.1023/A:1010602031070; Che FS, 2002, PLANT SCI, V162, P449, DOI 10.1016/S0168-9452(01)00585-4; Chen WQ, 2002, PLANT CELL, V14, P559, DOI 10.1105/tpc.010410; Choi C, 2015, NEW PHYTOL, V208, P846, DOI 10.1111/nph.13516; Chow CN, 2015, NUCLEIC ACIDS RES; Christensen AB, 2002, MOL PLANT PATHOL, V3, P135, DOI 10.1046/j.1364-3703.2002.00105.x; Dafoe NJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-191; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25; Dolferus R, 2001, IUBMB LIFE, V51, P79, DOI 10.1080/15216540152122058; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Ezcurra I, 2000, PLANT J, V24, P57, DOI 10.1046/j.1365-313x.2000.00857.x; Ferguson Ann A, 2011, Mob Genet Elements, V1, P135; Rodrigues MGF, 2017, SCI AGR, V74, P285, DOI [10.1590/1678-992x-2016-0195, 10.1590/1678-992X-2016-0195]; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Graham MY, 2003, PHYSIOL MOL PLANT P, V63, P141, DOI 10.1016/j.pmpp.2003.11.002; Grant-Downton RT, 2006, ANN BOT-LONDON, V97, P11, DOI 10.1093/aob/mcj001; Grimmig B, 2003, PLANT MOL BIOL, V51, P599, DOI 10.1023/A:1022385104386; Hattori T, 2002, PLANT CELL PHYSIOL, V43, P136, DOI 10.1093/pcp/pcf014; Hegde Y. R., 2013, Agricultural Reviews, V34, P145; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Huda KMK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057803; Hudson ME, 2003, PLANT PHYSIOL, V133, P1605, DOI 10.1104/pp.103.030437; Ishige F, 1999, PLANT J, V18, P443, DOI 10.1046/j.1365-313X.1999.00456.x; Jain S., 2015, ADV PLANTS AGR RES, V2, DOI DOI 10.15406/APAR.2015.02.00077; Jiang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129932; Kaur G, 2016, COMPUT BIOL CHEM, V62, P104, DOI 10.1016/j.compbiolchem.2016.04.002; KIM SR, 1993, PLANT PHYSIOL, V103, P97, DOI 10.1104/pp.103.1.97; Kim SY, 2002, PLANT PHYSIOL, V130, P688, DOI 10.1104/pp.003566; Komarnytsky S, 2003, GENET ENG P, V25, P113; Krishnamurthy A, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25761; Kundu S, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-15; Lacerda AF, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00116; Le Gourrierec J, 1999, PLANT J, V18, P663, DOI 10.1046/j.1365-313x.1999.00482.x; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lim DHK, 2010, OBSTET GYNAECOL, V12, P37, DOI 10.1576/toag.12.1.037.27556; Liu FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep18947; Liu JL, 2015, INT J MOL SCI, V16, P12131, DOI 10.3390/ijms160612131; Liu JJ, 2006, PHYSIOL MOL PLANT P, V68, P3, DOI 10.1016/j.pmpp.2006.06.004; Lodhi N, 2008, BBA-GENE REGUL MECH, V1779, P634, DOI 10.1016/j.bbagrm.2008.07.010; LOGEMANN E, 1995, P NATL ACAD SCI USA, V92, P5905, DOI 10.1073/pnas.92.13.5905; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Maruyama K, 2012, DNA RES, V19, P37, DOI 10.1093/dnares/dsr040; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Mazumder M, 2013, PLANT PHYSIOL BIOCH, V70, P43, DOI 10.1016/j.plaphy.2013.04.025; Mehrotra Shweta, 2014, Genomics Proteomics & Bioinformatics, V12, P164, DOI 10.1016/j.gpb.2014.07.003; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; Mongkolsiriwatana C., 2009, Kasetsart Journal, Natural Sciences, V43, P164; Nejad ES, 2012, PLANT OMICS, V5, P553; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Patthy L, 2008, INTRONS PHASE COMP; Petrov V, 2012, GENE, V499, P52, DOI 10.1016/j.gene.2012.02.035; Pozo MJ, 2008, NEW PHYTOL, V180, P511, DOI 10.1111/j.1469-8137.2008.02578.x; Rambani A, 2015, PLANT PHYSIOL, V168, P1364, DOI 10.1104/pp.15.00826; Ranty B, 2006, PLANT SIGNAL BEHAV, V1, P96, DOI 10.4161/psb.1.3.2998; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rinerson CI, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2057-4; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Scherer NM, 2005, GENET MOL BIOL, V28, P645, DOI 10.1590/S1415-47572005000500001; Sharma P., 2012, APPL ENVIRON SOIL SC, V2012, P1, DOI [10.1155/2012/217037, DOI 10.1155/2012/650206]; Siberil Y, 2001, EUR J BIOCHEM, V268, P5655, DOI 10.1046/j.0014-2956.2001.02552.x; Singh R, 2013, TROP PLANT BIOL, V6, P85, DOI 10.1007/s12042-013-9123-3; Sudisha J, 2012, PROG BIOL CONTROL, V12, P379, DOI 10.1007/978-94-007-1933-0_17; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; VANLOON LC, 1970, VIROLOGY, V40, P199, DOI 10.1016/0042-6822(70)90395-8; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Vinson C, 2012, EPIGENOMICS-UK, V4, P655, DOI [10.2217/EPI.12.55, 10.2217/epi.12.55]; Vriens K, 2014, MOLECULES, V19, P12280, DOI 10.3390/molecules190812280; Wang PC, 2013, PLANT PHYSIOL, V161, P1392, DOI 10.1104/pp.112.210724; Wang PF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1204-7; Whalley HJ, 2013, NEW PHYTOL, V197, P690, DOI 10.1111/nph.12087; Whalley HJ, 2011, PLANT CELL, V23, P4079, DOI 10.1105/tpc.111.090480; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Yoshihara T, 1996, FEBS LETT, V383, P213, DOI 10.1016/0014-5793(96)00233-5; YU LM, 1993, PLANT J, V3, P805, DOI 10.1111/j.1365-313X.1993.00805.x; Zhang MS, 2010, J GENET GENOMICS, V37, P1, DOI 10.1016/S1673-8527(09)60020-5; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zuo YC, 2011, GENOMICS, V97, P112, DOI 10.1016/j.ygeno.2010.11.002	90	71	73	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184523	10.1371/journal.pone.0184523	http://dx.doi.org/10.1371/journal.pone.0184523			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910327	gold, Green Published, Green Submitted			2022-12-27	WOS:000410859200056
J	Zhang, QF; Cheng, QR; Li, HX; Dong, X; Tu, WJ				Zhang, Qinfen; Cheng, Qirui; Li, Hongxin; Dong, Xuan; Tu, Wenjuan			Evaluation of auditory perception development in neonates by quantitative electroencephalography and auditory eventrelated potentials	PLOS ONE			English	Article							EEG POWER; AGE; CHILDHOOD; CHILDREN; INFANTS	Objective The present study was performed to investigate neonatal auditory perception function by quantitative electroencephalography (QEEG) and auditory event-related potentials (aERPs) and identify the characteristics of auditory perception development in newborns. Methods Fifty-three normal full-term neonates were divided into three groups according their age in days. An auditory oddball paradigm was used. QEEG (resting state and task state) and aERPs were performed. EEG d power in the resting and task states and at different ages was respectively analyzed. The N2 area and latency of aERPs at different ages were also compared. Results The four main findings of this study are as follows. First, the increase in the EEG d power was significantly greater in the task than resting state in Group 3 at the Fz lead (t = -3.371, P = 0.004) and in Groups 2 and 3 at the Cz lead (Group 2: t = -3.149, P = 0.005; Group 3: t = -3.609, P = 0.002). Second, the d power gradually increased from 1 to 10 days of age (Group 1), peaked at 11 to 20 days (Group 2), and gradually decreased from 21 to 28 days (Group 3). The data in the Fz lead during the task state and in the Cz lead during the resting and task states were statistically significant (F = 5.875, P = 0.005; F = 5.523, P = 0.007; and F = 5.402, P = 0.008, respectively). Third, the N2 area significantly increased with age by presentation of target stimuli (F = 5.26, P = 0.01). The N2 area increased most significantly from 21 to 28 days (Group 3). Finally, the N2 latency significantly decreased with age (Fz lead: F = 4.66, P = 0.023; Cz lead: F = 7.18, P = 0.005). The N2 latency decreased most significantly from 11 to 20 days of age (Group 2). Conclusion Rapid cognitive development occurs during the neonatal period. In the first several days after birth, the EEG delta power and N2 area manifested the characteristic performance of identifying task information. QEEG and aERP measurement can be used as objective indices with which to evaluate auditory perception development in neonates.	[Zhang, Qinfen; Li, Hongxin; Dong, Xuan; Tu, Wenjuan] Changzhou Childrens Hosp, Changzhou, Jiangsu, Peoples R China; [Cheng, Qirui] Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China		Dong, X; Tu, WJ (corresponding author), Changzhou Childrens Hosp, Changzhou, Jiangsu, Peoples R China.	dx6868@hotmail.com; tuwenjuan2008@163.com	ZHANG, QINFEN/GVT-5473-2022	ZHANG, QINFEN/0000-0001-7329-284X	Natural Science Foundation of Jiangsu Province [BK20161194]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the Natural Science Foundation of Jiangsu Province (BK20161194 to QinfenZhang).	Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; Bell MA, 2007, DEV NEUROPSYCHOL, V31, P21, DOI 10.1207/s15326942dn3101_2; Chipaux M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079028; Cirelli C, 2015, BIOL PSYCHIAT, V77, P1071, DOI 10.1016/j.biopsych.2014.12.017; Clarke AR, 2001, CLIN NEUROPHYSIOL, V112, P806, DOI 10.1016/S1388-2457(01)00488-6; Cuevas K, 2011, INT J PSYCHOPHYSIOL, V80, P119, DOI 10.1016/j.ijpsycho.2011.02.009; Cunningham J, 2001, CLIN NEUROPHYSIOL, V112, P758, DOI 10.1016/S1388-2457(01)00465-5; Dong X, 2000, CHIN MED J, V80, P684; Guntekin B, 2015, INT J PSYCHOPHYSIOL, V2, P1, DOI DOI 10.1016/J.IJPSYCH0.2015.02.001; Holst M, 2005, CLIN NEUROPHYSIOL, V116, P1949, DOI 10.1016/j.clinph.2005.04.008; Hovel H, 2014, CLIN NEUROPHYSIOL, V125, P449, DOI 10.1016/j.clinph.2013.07.026; Kolb B, 2013, BRAIN PLASTICITY BEH, DOI 10.4324%2F9780203773765; Kushnerenko EV, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00595; Lamm C, 2006, NEUROPSYCHOLOGIA, V44, P2139, DOI 10.1016/j.neuropsychologia.2005.10.013; Leipala JA, 2011, EARLY HUM DEV, V87, P89, DOI 10.1016/j.earlhumdev.2010.11.009; Lippe S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.048.2009; Marshall PJ, 2002, CLIN NEUROPHYSIOL, V113, P1199, DOI 10.1016/S1388-2457(02)00163-3; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Niemarkt HJ, 2011, PEDIATR RES, V70, P529, DOI 10.1203/PDR.0b013e31822d748b; Otero GA, 2011, EARLY HUM DEV, V87, P691, DOI 10.1016/j.earlhumdev.2011.05.010; Patel Salil H, 2005, Int J Med Sci, V2, P147; Picton TW, 2007, DEV NEUROPSYCHOL, V31, P249, DOI 10.1080/87565640701228732; Sankupellay M, 2011, CLIN NEUROPHYSIOL, V122, P236, DOI 10.1016/j.clinph.2010.06.030; Sur Shravani, 2009, Ind Psychiatry J, V18, P70, DOI 10.4103/0972-6748.57865; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Wronka E, 2007, ACTA NEUROBIOL EXP, V67, P155; Wunderlich JL, 2006, HEARING RES, V212, P185, DOI 10.1016/j.heares.2005.11.010	27	4	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183728	10.1371/journal.pone.0183728	http://dx.doi.org/10.1371/journal.pone.0183728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910297	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200014
J	Erkenswick, GA; Watsa, M; Pacheco, MA; Escalante, AA; Parker, PG				Erkenswick, Gideon A.; Watsa, Mrinalini; Pacheco, M. Andreina; Escalante, Ananias A.; Parker, Patricia G.			Chronic Plasmodium brasilianum infections in wild Peruvian tamarins	PLOS ONE			English	Article							SIMIAN MALARIA; NATURAL INFECTION; PRIMATE MALARIAS; PARASITES; HUMANS; RESERVOIRS; MARMOSET; CITY	There is an increased interest in potential zoonotic malarias. To date, Plasmodium malariae that infects humans remains indistinguishable from Plasmodium brasilianum, which is widespread among New World primates. Distributed throughout tropical Central and South America, the Callitrichidae are small arboreal primates in which detection of natural Plasmodium infection has been extremely rare. Most prior screening efforts have been limited to small samples, the use of low-probability detection methods, or both. Rarely have screening efforts implemented a longitudinal sampling design. Through an annual mark-recapture program of two sympatric callitrichids, the emperor (Saguinus imperator) and saddleback (Saguinus fuscicollis) tamarins, whole blood samples were screened for Plasmodium by microscopy and nested PCR of the cytochrome b gene across four consecutive years (2012-2015). Following the first field season, approximately 50% of the samples collected each subsequent year were from recaptured individuals. In particular, out of 245 samples from 129 individuals, 11 samples from 6 individuals were positive for Plasmodium, and all but one of these infections was found in S. imperator. Importantly, the cytochrome b sequences were 100% identical to former isolates of P. malariae from humans and P. brasilianum from Saimiri sp. Chronic infections were detected as evidenced by repeated infections (7) from two individuals across the 4-year study period. Furthermore, 4 of the 5 infected emperor tamarins were part of a single group spanning the entire study period. Overall, the low prevalence reported here is consistent with previous findings. This study identifies two new natural hosts for P. brasilianum and provides evidence in support of chronic infections in wildlife populations. Given that callitrichids are often found in mixed-species associations with other primates and can be resilient to human-disturbed environments, they could contribute to the maintenance of P. malariae populations if future work provides entomological and epidemiological evidence indicating human zoonotic infections.	[Erkenswick, Gideon A.; Parker, Patricia G.] Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA; [Erkenswick, Gideon A.; Parker, Patricia G.] Univ Missouri, Whitney R Harris World Ecol Ctr, St Louis, MO 63121 USA; [Erkenswick, Gideon A.; Watsa, Mrinalini] Field Projects Int, St Louis, MO USA; [Watsa, Mrinalini] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Pacheco, M. Andreina; Escalante, Ananias A.] Temple Univ, Dept Biol, Igem, Philadelphia, PA 19122 USA; [Parker, Patricia G.] St Louis Zoo, WildCare Inst, St Louis, MO USA	University of Missouri System; University of Missouri Saint Louis; University of Missouri System; University of Missouri Saint Louis; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Erkenswick, GA (corresponding author), Univ Missouri, Dept Biol, 8001 Nat Bridge Rd, St Louis, MO 63121 USA.; Erkenswick, GA (corresponding author), Univ Missouri, Whitney R Harris World Ecol Ctr, St Louis, MO 63121 USA.; Erkenswick, GA (corresponding author), Field Projects Int, St Louis, MO USA.	gaet4b@umsl.edu	Watsa, Mrinalini Erkenswick/AAP-1864-2020	Watsa, Mrinalini Erkenswick/0000-0002-8130-8810; Escalante, Ananias/0000-0002-1532-3430; Erkenswick, Gideon/0000-0001-6040-1170; Pacheco, Maria Andreina/0000-0002-5682-7299	Field Projects International; American Society of Mammologists; Sigma Xi Society; University of Missouri Trans World Airlines Scholarship Program; Whitney R. Harris World Ecology Center; University of Missouri-St. Louis	Field Projects International; American Society of Mammologists; Sigma Xi Society; University of Missouri Trans World Airlines Scholarship Program; Whitney R. Harris World Ecology Center; University of Missouri-St. Louis	Funding for this work was provided by Field Projects International (www.fieldprojects.org), the American Society of Mammologists (www. mammalsociety.org), Sigma Xi Society (www. sigmaxi.org), The University of Missouri Trans World Airlines Scholarship Program, Whitney R. Harris World Ecology Center (www.umsl.edu/similar to hwec/), and The Des Lee Collaborative Vision at the University of Missouri-St. Louis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarenga DAM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1724-0; Araujo MS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-180; BAERG DC, 1971, J PARASITOL, V57, P8, DOI 10.2307/3277745; Brunette GW, CDC YELL BOOK 2018 H; Buckner JC, 2015, MOL PHYLOGENET EVOL, V82, P413, DOI 10.1016/j.ympev.2014.04.031; Collins WE, 2007, CLIN MICROBIOL REV, V20, P579, DOI 10.1128/CMR.00027-07; CORREDOR V, 1994, GENETICS, V136, P857; Cox FEG, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-5; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Soto-Calderon ID, 2016, AM J PRIMATOL, V78, P1272, DOI 10.1002/ajp.22581; de Arruda ME, 1985, MEM I O CRUZ, V80, P367, DOI DOI 10.1590/S0074-02761985000300015; DEANE LM, 1966, B WORLD HEALTH ORGAN, V35, P805; DEANE LM, 1992, MEM I OSWALDO CRUZ, V87, P1, DOI 10.1590/S0074-02761992000700001; Divis PCS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004888; Duval L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-157; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Fandeur T, 2000, PARASITOLOGY, V120, P11, DOI 10.1017/S0031182099005168; Fuentes-Ramirez A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170704; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GEIMAN GM, 1969, AM J TROP MED HYG, V18, P351, DOI 10.4269/ajtmh.1969.18.351; Gordo M, 2013, DEV PRIMATOL-PROG PR, P357, DOI 10.1007/978-1-4614-8839-2_23; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Hayakawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007412; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Kaiser M, 2010, EMERG INFECT DIS, V16, P1956, DOI 10.3201/eid1612.100424; Krief S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000765; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lalremruata A, 2015, EBIOMEDICINE, V2, P1186, DOI 10.1016/j.ebiom.2015.07.033; Leclerc MC, 2004, PARASITOLOGY, V129, P677, DOI 10.1017/S0031182004006146; Leite GC, 2011, APPL ANIM BEHAV SCI, V132, P187, DOI 10.1016/j.applanim.2011.03.013; Lima GFMC, 2016, BLOOD TRANSFUS, V1-9; LOURENCODEOLIVEIRA R, 1995, MEM I OSWALDO CRUZ, V90, P331, DOI 10.1590/S0074-02761995000300004; Matauschek C, 2011, AM J PHYS ANTHROPOL, V144, P564, DOI 10.1002/ajpa.21445; Mehlotra RK, 2000, AM J TROP MED HYG, V62, P225, DOI 10.4269/ajtmh.2000.62.225; Muehlenbein MP, 2015, MOL BIOL EVOL, V32, P422, DOI 10.1093/molbev/msu310; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; Nunn C, 2005, BEHAV ECOL SOCIOBIOL, V59, P30, DOI 10.1007/s00265-005-0005-z; Nunn CL, 2005, GLOBAL MAMMAL PARASI; Pacheco MA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-328; Figueiredo MAP, 2015, REV BRAS PARASITOL V, V24, P122, DOI 10.1590/S1984-29612015034; Potapov P, 2008, ECOL SOC, V13, DOI 10.5751/es-02670-130251; Prugnolle F, 2010, P NATL ACAD SCI USA, V107, P1458, DOI 10.1073/pnas.0914440107; Ramasamy R, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00123; Rehg JA, 2006, INT J PRIMATOL, V27, P1399, DOI 10.1007/s10764-006-9076-6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosin Cooper, 2013, Neotropical Primates, V20, P25; Salazar-Castanon VH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/913696; Scuracchio P, 2011, REV INST MED TROP SP, V53, P55, DOI 10.1590/S0036-46652011000100010; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Ta TH, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-68; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valkiunas G, 2008, J PARASITOL, V94, P1395, DOI 10.1645/GE-1570.1; Volney B, 2002, ACTA TROP, V82, P11, DOI 10.1016/S0001-706X(02)00036-0; Watsa Mrinalini, 2015, Neotropical Primates, V22, P59; Watsa M, 2012, INT J PRIMATOL, V33, P1477, DOI 10.1007/s10764-012-9632-1; World Health Organization, 2016, BURNS FACT SHEET, P1; Yusof R, 2016, EMERG INFECT DIS, V22, P1371, DOI 10.3201/eid2208.151885	58	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184504	10.1371/journal.pone.0184504	http://dx.doi.org/10.1371/journal.pone.0184504			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902879	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200040
J	Meyerhoff, HS; Gehrer, NA				Meyerhoff, Hauke S.; Gehrer, Nina A.			Visuo-perceptual capabilities predict sensitivity for coinciding auditory and visual transients in multi-element displays	PLOS ONE			English	Article							SPATIAL ATTENTION; INTEGRATION; SEARCH; INTELLIGENCE; CAPTURE; WINDOW; TIME; CUES; DISCRIMINATION; VENTRILOQUISM	In order to obtain a coherent representation of the outside world, auditory and visual information are integrated during human information processing. There is remarkable variance among observers in the capability to integrate auditory and visual information. Here, we propose that visuo-perceptual capabilities predict detection performance for audiovisually coinciding transients in multi-element displays due to severe capacity limitations in audiovisual integration. In the reported experiment, we employed an individual differences approach in order to investigate this hypothesis. Therefore, we measured performance in a useful-field-of-view task that captures detection performance for briefly presented stimuli across a large perceptual field. Furthermore, we measured sensitivity for visual direction changes that coincide with tones within the same participants. Our results show that individual differences in visuo-perceptual capabilities predicted sensitivity for the presence of audiovisually synchronous events among competing visual stimuli. To ensure that this correlation does not stem from superordinate factors, we also tested performance in an unrelated working memory task. Performance in this task was independent of sensitivity for the presence of audiovisually synchronous events. Our findings strengthen the proposed link between visuo-perceptual capabilities and audiovisual integration. The results also suggest that basic visuo-perceptual capabilities provide the basis for the subsequent integration of auditory and visual information.	[Meyerhoff, Hauke S.] Leibniz Inst Wissensmedien, Tubingen, Germany; [Gehrer, Nina A.] Univ Tubingen, Dept Psychol, Tubingen, Germany	Leibniz Institut fur Wissensmedien; Eberhard Karls University of Tubingen	Meyerhoff, HS (corresponding author), Leibniz Inst Wissensmedien, Tubingen, Germany.	h.meyerhoff@iwm-tuebingen.de		Meyerhoff, Hauke/0000-0003-1836-4737				BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Belopolsky AV, 2007, PSYCHON B REV, V14, P934, DOI 10.3758/BF03194124; Belopolsky AV, 2010, VISION RES, V50, P2543, DOI 10.1016/j.visres.2010.08.023; Bertelson P, 2003, INT J PSYCHOPHYSIOL, V50, P147, DOI 10.1016/S0167-8760(03)00130-2; Chen YC, 2010, COGNITION, V114, P389, DOI 10.1016/j.cognition.2009.10.012; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Frings C, 2005, PERS INDIV DIFFER, V39, P1181, DOI 10.1016/j.paid.2005.02.024; Fujisaki W, 2005, EXP BRAIN RES, V166, P455, DOI 10.1007/s00221-005-2385-8; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Lewald J, 2004, NEUROSCI LETT, V357, P119, DOI 10.1016/j.neulet.2003.12.045; Lordanescu L, 2008, PSYCHON B REV, V15, P548, DOI 10.3758/PBR.15.3.548; Luciano M, 2005, BIOL PSYCHOL, V70, P1, DOI 10.1016/j.biopsycho.2004.11.011; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Meyerhoff HS, 2016, MEM COGNITION, V44, P390, DOI 10.3758/s13421-015-0575-6; Ngo MK, 2010, ATTEN PERCEPT PSYCHO, V72, P1654, DOI 10.3758/APP.72.6.1654; Olivers CNL, 2017, CAPACITY DETECT SYNC, V42, P2115; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; PERROTT DR, 1990, PERCEPT PSYCHOPHYS, V48, P214, DOI 10.3758/BF03211521; Santangelo V, 2007, J EXP PSYCHOL HUMAN, V33, P1311, DOI 10.1037/0096-1523.33.6.1311; Santangelo V, 2006, EXP BRAIN RES, V173, P40, DOI 10.1007/s00221-006-0361-6; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Slutsky DA, 2001, NEUROREPORT, V12, P7, DOI 10.1097/00001756-200101220-00009; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; Spence C, 2010, ANN NY ACAD SCI, V1191, P182, DOI 10.1111/j.1749-6632.2010.05440.x; Staufenbiel SM, 2011, EXP BRAIN RES, V213, P457, DOI 10.1007/s00221-011-2797-6; Stevenson RA, 2012, J EXP PSYCHOL HUMAN, V38, P1517, DOI 10.1037/a0027339; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Teder-Salejarvi WA, 2005, J COGNITIVE NEUROSCI, V17, P1396, DOI 10.1162/0898929054985383; van den Brink RL, 2014, CEREB CORTEX, V24, P2169, DOI 10.1093/cercor/bht069; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2013, PSYCHOL SCI, V24, P345, DOI 10.1177/0956797612452865; Van der Burg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039137; Van der Burg E, 2011, NEUROIMAGE, V55, P1208, DOI 10.1016/j.neuroimage.2010.12.068; VERNON PA, 1993, PERS INDIV DIFFER, V14, P35, DOI 10.1016/0191-8869(93)90172-Y; Vroomen J, 2000, J EXP PSYCHOL HUMAN, V26, P1583, DOI 10.1037/0096-1523.26.5.1583; Zou H, 2012, J VISION, V12, DOI 10.1167/12.5.2	42	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183723	10.1371/journal.pone.0183723	http://dx.doi.org/10.1371/journal.pone.0183723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902903	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200016
J	Lu, SR; Qian, Y; Huang, XY; Yu, H; Yang, J; Han, RQ; Su, J; Du, WC; Zhou, JY; Dong, MH; Yu, XJ; van Duijnhoven, FJB; Kampman, E; Wu, M				Lu, Shurong; Qian, Yun; Huang, Xingyu; Yu, Hao; Yang, Jie; Han, Renqiang; Su, Jian; Du, Wencong; Zhou, Jinyi; Dong, Meihua; Yu, Xiaojin; van Duijnhoven, Franzel J. B.; Kampman, Ellen; Wu, Ming			The association of dietary pattern and breast cancer in Jiangsu, China: A population-based case-control study	PLOS ONE			English	Article							NUTRITIONAL EPIDEMIOLOGY; RISK; MORTALITY; WOMEN; TRANSITION; SHANGHAI; COHORT; TRENDS	This study aims to examine the association of breast cancer with dietary patterns among Chinese women. A population-based case-control study was conducted in Jiangsu, China. Newly diagnosed primary breast cancer patients were recruited as cases (n = 818). Controls (n = 935), selected from the general population, were frequency matched to cases. A validated food frequency questionnaire was used to assess dietary intake. Dietary patterns were identified by factor analysis and multivariable odds ratios (OR) and 95% confidence intervals (CI) were estimated. Four dietary patterns were identified: salty, vegetarian, sweet and traditional Chinese. The traditional Chinese pattern was found to be robustly associated with a lower risk of breast cancer among both pre- and post-menopausal women (4th vs. 1st quartile: OR for pre- and post-menopausal women was 0.47 and 0.68, respectively). Women with high factor scores of the sweet pattern also showed a decreased risk of breast cancer (4th vs. 1st quartile: OR for pre-and post-menopausal women was 0.47 and 0.68, respectively). No marked association was observed between a vegetarian pattern or a salty pattern and breast cancer. These findings indicate that dietary patterns of the traditional Chinese and the sweet may favorably associate with the risk of breast cancer among Chinese women.	[Lu, Shurong; Yu, Hao; Yang, Jie; Han, Renqiang; Su, Jian; Du, Wencong; Zhou, Jinyi; Wu, Ming] Jiangsu Prov Ctr Dis Control & Prevent, Dept Chron Dis Control, Nanjing, Jiangsu, Peoples R China; [Qian, Yun; Dong, Meihua] Wuxi Ctr Dis Control & Prevent, Dept Chron Dis Control, Wuxi, Jiangsu, Peoples R China; [Huang, Xingyu; Yu, Xiaojin; Wu, Ming] Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [van Duijnhoven, Franzel J. B.; Kampman, Ellen] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Jiangsu Provincial Center for Disease Control & Prevention; Southeast University - China; Wageningen University & Research	Wu, M (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Chron Dis Control, Nanjing, Jiangsu, Peoples R China.; Wu, M (corresponding author), Southeast Univ, Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China.; Kampman, E (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	ellen.kampman@wur.nl; jswuming@vip.sina.com	van Duijnhoven, Fränzel/GWC-0059-2022; Lu, Shurong/AAZ-3528-2020	Lu, Shurong/0000-0001-6730-4306	World Cancer Research Fund [WCRF 2011/RFA/473]	World Cancer Research Fund(World Cancer Research Fund International (WCRF))	This study was funded by World Cancer Research Fund, Grant number: WCRF 2011/RFA/473 (URL: http://www.wcrf.org/) to MW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agurs-Collins T, 2009, AM J CLIN NUTR, V90, P621, DOI 10.3945/ajcn.2009.27666; Albuquerque RCR, 2014, NUTR REV, V72, P1, DOI 10.1111/nure.12083; Bradshaw PT, 2009, CANCER CAUSE CONTROL, V20, P1509, DOI 10.1007/s10552-009-9343-x; Buck K, 2011, CANCER CAUSE CONTROL, V22, P273, DOI 10.1007/s10552-010-9695-2; Butler LM, 2010, AM J CLIN NUTR, V91, P1013, DOI 10.3945/ajcn.2009.28572; Chajes V, 2014, MATURITAS, V77, P7, DOI 10.1016/j.maturitas.2013.10.004; Chan SG, 2007, J NUTR, V137, P2451, DOI 10.1093/jn/137.11.2451; Cottet V, 2009, AM J EPIDEMIOL, V170, P1257, DOI 10.1093/aje/kwp257; Couto E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055374; Cui XH, 2007, CANCER EPIDEM BIOMAR, V16, P1443, DOI 10.1158/1055-9965.EPI-07-0059; Demetriou CA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-113; DeSantis CE, 2015, CANCER EPIDEM BIOMAR, V24, P1495, DOI 10.1158/1055-9965.EPI-15-0535; Edefonti V, 2009, NUTR REV, V67, P297, DOI 10.1111/j.1753-4887.2009.00203.x; Fung TT, 2005, INT J CANCER, V116, P116, DOI 10.1002/ijc.20999; Ge K, 2008, FOOD NUTR CHINA, P58; Ge K, 2011, ASIA PAC J CLIN NUTR, V20, P439; Ghoncheh Mahshid, 2016, Asian Pac J Cancer Prev, V17, P43; Hirose K, 2007, CANCER SCI, V98, P1431, DOI 10.1111/j.1349-7006.2007.00540.x; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Huang Z, 2016, ANN ONCOL, V27, P1129, DOI 10.1093/annonc/mdw069; Jia MM, 2015, J THORAC DIS, V7, P1221, DOI 10.3978/j.issn.2072-1439.2015.05.15; Kim MK, 2004, INT J CANCER, V110, P435, DOI 10.1002/ijc.20132; Kojima R, 2017, BREAST CANCER-TOKYO, V24, P152, DOI 10.1007/s12282-016-0689-0; Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262; Mannisto S, 2005, CANCER CAUSE CONTROL, V16, P725, DOI 10.1007/s10552-005-1763-7; Nkondjock A, 2005, CANCER LETT, V223, P85, DOI 10.1016/j.canlet.2004.11.034; Norat T CD, 2008, ASS FOOD NUTR PHYS A; Popkin BM, 2003, J NUTR, V133, p3898S, DOI 10.1093/jn/133.11.3898S; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Sant M, 2007, INT J CANCER, V121, P911, DOI 10.1002/ijc.22714; Schulz M, 2008, BRIT J NUTR, V100, P942, DOI 10.1017/S0007114508966149; SEELY S, 1983, MED HYPOTHESES, V11, P319, DOI 10.1016/0306-9877(83)90095-6; Varraso R, 2012, AM J CLIN NUTR, V96, P1079, DOI 10.3945/ajcn.112.038109; Yan L, 2014, CHINESE J HLTH ED, V30, P387; Yang L, 2005, CANCER EPIDEM BIOMAR, V14, P243; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Zhang CX, 2011, CANCER CAUSE CONTROL, V22, P115, DOI 10.1007/s10552-010-9681-8; Zhao WH, 2002, PUBLIC HEALTH NUTR, V5, P829, DOI 10.1079/PHN2002374	38	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184453	10.1371/journal.pone.0184453	http://dx.doi.org/10.1371/journal.pone.0184453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898273	Green Submitted, Green Published, gold			2022-12-27	WOS:000410449500028
J	Sesmilo, G; Resmini, E; Sambo, M; Blanco, C; Calvo, F; Pazos, F; Fernandez-Catalina, P; de Icaya, PM; Paramo, C; Fajardo, C; Marazuela, M; Alvarez-Escola, C; Diez, JJ; Perea, V				Sesmilo, Gemma; Resmini, Eugenia; Sambo, Marcel; Blanco, Concepcion; Calvo, Fernando; Pazos, Fernando; Fernandez-Catalina, Pablo; Martinez de Icaya, Purificacion; Paramo, Concepcion; Fajardo, Carmen; Marazuela, Monica; Alvarez-Escola, Cristina; Jose Diez, Juan; Perea, Veronica		ACROSAHS Study Grp	Prevalence of acromegaly in patients with symptoms of sleep apnea	PLOS ONE			English	Article							CLINICAL-PRACTICE; DIAGNOSIS; GH; EPIDEMIOLOGY; GUIDELINES; PARAMETERS; MORTALITY; FEATURES	Acromegaly is a rare disease with nonspecific symptoms with acral enlargement being almost universally present at diagnosis. The estimated prevalence is 40-125 cases/million but targeted universal screening studies have found a higher prevalence (about 10 fold). The aim of the ACROSAHS study was to investigate the prevalence of acromegaly and acromegaly comorbidities in patients with sleep apnea symptoms and acral enlargement. ACROSAHS was a Spanish prospective non-interventional epidemiological study in 13 Hospital sleep referral units. Facial and acral enlargement symptoms including: ring size and shoe size increase, tongue, lips and jaws enlargement, paresthesia or carpal tunnel syndrome and widening of tooth spaces, as well as other typical acromegaly comorbidities were recorded with a self-administered questionnaire of patients who attended a first visit for sleep apnea symptoms between 09/2013 and 07/2014. Serum insulin-like growth factor type 1 (IGF1) was measured in patients with >= 1 acral symptom to determine the prevalence of acromegaly. Of the 1557 patients enrolled, 1477 with complete data (72% male) were analyzed. 530 patients (36%) reported at least 1 acral enlargement symptom and were tested for IGF-1, 41 were above range, persisted in 7, and among those, 2 cases of acromegaly were diagnosed (prevalence of at least 1.35 cases/1000). Overall, 1019 patients (69%) had >= 2 acromegaly symptoms and should have been screened according to guidelines; moreover 373 patients (25%) had >= 1 symptom of acral enlargement plus >= 3 other acromegaly symptoms. In conclusion, in patients with sleep apnea symptoms and acral enlargement, we found an acromegaly prevalence of at least 1.35 cases per 1000 and a high prevalence of typical acromegaly symptoms. It is important that sleep specialists are aware of acromegaly symptoms to aid with acromegaly diagnosis.	[Sesmilo, Gemma; Perea, Veronica] Hosp Quiron Dexeus Clin Suerio Estivill, Serv Endocrinol, Barcelona, Spain; [Resmini, Eugenia] Univ Autonoma Barcelona, Hosp St Pau, IIB St Pau, Barcelona, Spain; [Resmini, Eugenia] Univ Autonoma Barcelona, Hosp St Pau, Ctr Invest Biomed Enfermedades Raras CIBER ER, Dept Med,Serv Endocrino,Unidad 747, Barcelona, Spain; [Sambo, Marcel] Hosp Univ Gregorio Maranon, Serv Endocrinol, Madrid, Spain; [Blanco, Concepcion] Hosp Univ Principe Asturias, Serv Endocrinol, Madrid, Spain; [Calvo, Fernando] Hosp Clin Univ Lozano Blesa, Serv Endocrinol, Zaragoza, Spain; [Pazos, Fernando] Hosp Univ Marques de Valdecilla, Serv Endocrinol, Santander, Spain; [Fernandez-Catalina, Pablo] Complexo Hosp Pontevedra, Serv Endocrinol, Pontevedra, Spain; [Martinez de Icaya, Purificacion] Hosp Univ Severo Ochoa, Serv Endocrinol, Madrid, Spain; [Paramo, Concepcion] Complexo Hosp Univ Vigo, Serv Endocrinol, Vigo, Spain; [Fajardo, Carmen] Hosp Univ Ribera, Serv Endocrinol, Alzira, Spain; [Marazuela, Monica] Hosp La Princesa, Serv Endocrinol, Madrid, Spain; [Alvarez-Escola, Cristina] Hosp Univ La Paz, Serv Endocrinol, Madrid, Spain; [Jose Diez, Juan] Hosp Univ Ramon & Cajal, Serv Endocrinol, Madrid, Spain; [Perea, Veronica] Hosp Univ Motua Terrassa, Serv Endocrinol, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; General University Gregorio Maranon Hospital; Prince of Asturias University Hospital; Lozano Blesa University Clinical Hospital; Hospital Universitario Marques de Valdecilla (HUMV); Complexo Hospitalario Universitario de Pontevedra; Severo Ochoa University Hospital; Complexo Hospitalario Universitario de Vigo; Hospital de La Princesa; Hospital Universitario La Paz; Hospital Universitario Ramon y Cajal; Hospital Universitario Mutua Terrassa	Sesmilo, G (corresponding author), Hosp Quiron Dexeus Clin Suerio Estivill, Serv Endocrinol, Barcelona, Spain.	gsesmilo@gmail.com	Diez, Juan J./W-1803-2017	Diez, Juan J./0000-0002-2017-0694; Fajardo-Montanana, Carmen/0000-0002-0784-0761; Sambo, Marcel/0000-0003-4487-6525; Perea, Veronica/0000-0001-8104-7326	Ipsen Pharma, S.A., Spain	Ipsen Pharma, S.A., Spain(Ipsen)	The study was investigator initiated and was partially sponsored by Ipsen Pharma, S.A., Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	ALEXANDER L, 1980, CLIN ENDOCRINOL, V12, P71, DOI 10.1111/j.1365-2265.1980.tb03135.x; Annamalai AK, 2013, J CLIN ENDOCR METAB, V98, P1040, DOI 10.1210/jc.2012-3072; Burton T, 2016, PITUITARY, V19, P262, DOI 10.1007/s11102-015-0701-2; Cannavo S, 2010, EUR J ENDOCRINOL, V163, P509, DOI 10.1530/EJE-10-0465; Castellani C, 2016, ENDOCRINE, V51, P308, DOI 10.1007/s12020-015-0659-x; Daud S, 2011, PITUITARY, V14, P414, DOI 10.1007/s11102-009-0205-z; Dimaraki EV, 2002, J CLIN ENDOCR METAB, V87, P3537, DOI 10.1210/jc.87.8.3537; EZZAT S, 1994, MEDICINE, V73, P233, DOI 10.1097/00005792-199409000-00001; Ezzat S, 2006, CLIN INVEST MED, V29, P29; Freda Pamela U, 2003, Pituitary, V6, P175, DOI 10.1023/B:PITU.0000023424.72021.e2; Freda PU, 2009, CLIN ENDOCRINOL, V71, P166, DOI 10.1111/j.1365-2265.2009.03556.x; Galerneau LM, 2016, EUR RESPIR J, V48, P1489, DOI 10.1183/13993003.01229-2016; Hernandez-Gordillo Daniel, 2012, Open Respir Med J, V6, P28, DOI 10.2174/1874306401206010028; Holdaway IM, 2004, J CLIN ENDOCR METAB, V89, P667, DOI 10.1210/jc.2003-031199; Katznelson L, 2014, J CLIN ENDOCR METAB, V99, P3933, DOI 10.1210/jc.2014-2700; Katznelson L, 2011, ENDOCR PRACT, V17, P1; Kuhn E, 2015, EUR J ENDOCRINOL, V173, P693, DOI 10.1530/EJE-15-0500; Melmed S, 2006, NEW ENGL J MED, V355, P2558, DOI 10.1056/NEJMra062453; Mestron A, 2004, EUR J ENDOCRINOL, V151, P439, DOI 10.1530/eje.0.1510439; Minuto FM, 2012, PITUITARY, V15, P215, DOI 10.1007/s11102-011-0313-4; Nachtigall L, 2008, J CLIN ENDOCR METAB, V93, P2035, DOI 10.1210/jc.2007-2149; Pleava Roxana, 2016, Pneumologia, V65, P14; Pokrajac A, 2007, CLIN ENDOCRINOL, V67, P65, DOI 10.1111/j.1365-2265.2007.02836.x; Reid TJ, 2010, CLIN ENDOCRINOL, V72, P203, DOI 10.1111/j.1365-2265.2009.03626.x; Rosario PW, 2014, ARQ BRAS ENDOCRINOL, V58, P807, DOI 10.1590/0004-2730000003314; Rosario PW, 2012, PITUITARY, V15, P179, DOI 10.1007/s11102-011-0302-7; Rosario PW, 2011, PITUITARY, V14, P217, DOI 10.1007/s11102-010-0281-0; Sanchez-Ortiga R, 2015, ENDOCRINOL NUTR, V62, P366, DOI 10.1016/j.endonu.2015.05.007; Schneider HJ, 2008, CLIN ENDOCRINOL, V69, P432, DOI 10.1111/j.1365-2265.2008.03221.x; Sesmilo M, 2013, ENDOCRINOL NUTR, V60, P470, DOI 10.1016/j.endonu.2012.09.010; Sesmilo G, 2013, PITUITARY, V16, P115, DOI 10.1007/s11102-012-0384-x; van Haute FRB, 2008, EUR J ENDOCRINOL, V158, P459, DOI 10.1530/EJE-07-0753	32	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0183539	10.1371/journal.pone.0183539	http://dx.doi.org/10.1371/journal.pone.0183539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898247	Green Published, Green Submitted, gold			2022-12-27	WOS:000410449500007
J	Xiao, WB; Nazario, G; Wu, HM; Zhang, HM; Cheng, F				Xiao, WenBo; Nazario, Gina; Wu, HuaMing; Zhang, HuaMing; Cheng, Feng			A neural network based computational model to predict the output power of different types of photovoltaic cells	PLOS ONE			English	Article							HIDDEN NEURONS; SYSTEM; NUMBER; MODULE	In this article, we introduced an artificial neural network (ANN) based computational model to predict the output power of three types of photovoltaic cells, mono-crystalline (mono-), multi-crystalline (multi-), and amorphous (amor-) crystalline. The prediction results are very close to the experimental data, and were also influenced by numbers of hidden neurons. The order of the solar generation power output influenced by the external conditions from smallest to biggest is: multi-, mono-, and amor-crystalline silicon cells. In addition, the dependences of power prediction on the number of hidden neurons were studied. For multi-and amorphous crystalline cell, three or four hidden layer units resulted in the high correlation coefficient and low MSEs. For mono-crystalline cell, the best results were achieved at the hidden layer unit of 8.	[Xiao, WenBo; Wu, HuaMing; Zhang, HuaMing] Nanchang Hangkong Univ, Jiangxi Engn Lab Optoelect Testing Technol, Nanchang, Jiangxi, Peoples R China; [Nazario, Gina; Cheng, Feng] Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33620 USA	Nanchang Hangkong University; State University System of Florida; University of South Florida	Xiao, WB (corresponding author), Nanchang Hangkong Univ, Jiangxi Engn Lab Optoelect Testing Technol, Nanchang, Jiangxi, Peoples R China.; Cheng, F (corresponding author), Univ S Florida, Dept Pharmaceut Sci, Coll Pharm, Tampa, FL 33620 USA.	xiaowenbo1570@163.com; fcheng1@health.usf.edu	Cheng, Feng/A-9760-2009	Cheng, Feng/0000-0003-3619-8090	Jiangxi Province Science Major Program [20143ACB21011]; Scientific Research Foundation of Jiangxi Provincial Department of Education [GJJ150729]	Jiangxi Province Science Major Program; Scientific Research Foundation of Jiangxi Provincial Department of Education	This work was in part supported Jiangxi Province Science Major Program for Youths under Grant No. 20143ACB21011, and the Scientific Research Foundation of Jiangxi Provincial Department of Education under Grant No. GJJ150729. The above grants can be found in our school's internal website. So, i can not provide the URLs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was in part supported Jiangxi Province Science Major Program for Youths under Grant No. 20143ACB21011, and the Scientific Research Foundation of Jiangxi Provincial Department of Education under Grant No. GJJ150729.	Fernandez-Jimenez LA, 2012, RENEW ENERG, V44, P311, DOI 10.1016/j.renene.2012.01.108; Bai JB, 2015, SOL ENERGY, V112, P41, DOI 10.1016/j.solener.2014.09.048; Camargo LS, 2001, NEURAL COMPUT, V13, P2673, DOI 10.1162/089976601317098484; Fadare DA, 2009, APPL ENERG, V86, P1410, DOI 10.1016/j.apenergy.2008.12.005; Fernandez EF, 2014, SOL ENERGY, V100, P148, DOI 10.1016/j.solener.2013.11.036; Gajowniczek K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174098; Ghoneim, 2011, ENERGY SCI TECHNOL, V2, P43; Hu XS, 2016, ENERGY, V111, P971, DOI 10.1016/j.energy.2016.06.037; HUANG SC, 1991, IEEE T NEURAL NETWOR, V2, P47, DOI 10.1109/72.80290; Ismail HM, 2012, APPL ENERG, V92, P769, DOI 10.1016/j.apenergy.2011.08.027; Jiang N, 2008, 2008 INTERNATIONAL SYMPOSIUM ON INTELLIGENT INFORMATION TECHNOLOGY APPLICATION, VOL I, PROCEEDINGS, P103, DOI 10.1109/IITA.2008.462; Kheirkhah A, 2013, COMPUT IND ENG, V64, P425, DOI 10.1016/j.cie.2012.09.017; KURKOVA V, 1992, NEURAL NETWORKS, V5, P501, DOI 10.1016/0893-6080(92)90012-8; Lei Z., 2014, IFAC P, V47, P3899, DOI DOI 10.3182/20140824-6-ZA-1003.00657; [李芬 Li Fen], 2011, [气候变化研究进展, Advances in Climate Change Research], V7, P136; Li XW, 2014, RENEW SUST ENERG REV, V37, P517, DOI 10.1016/j.rser.2014.05.056; Liu JT, 2015, PHYS CHEM CHEM PHYS, V17, P3303, DOI 10.1039/c4cp04717f; Mellit A, 2013, RENEW ENERG, V60, P71, DOI 10.1016/j.renene.2013.04.011; Mellit A, 2008, PROG ENERG COMBUST, V34, P574, DOI 10.1016/j.pecs.2008.01.001; Panchal G, 2011, INT J COMPUT THEORY, V3, P332, DOI DOI 10.7763/IJCTE.2011.V3.328; Singh GK, 2013, ENERGY, V53, P1, DOI 10.1016/j.energy.2013.02.057; Tsai HF, 2012, SOL ENERGY, V86, P654, DOI 10.1016/j.solener.2011.11.014; Wu XH, 2016, J POWER SOURCES, V333, P203, DOI 10.1016/j.jpowsour.2016.09.157; Xiao WB, 2011, MOD PHYS LETT B, V25, P679, DOI 10.1142/S0217984911025948; Yona A, 2007, IEEE POWER ENG SOC, P3659; Yuan HC, 2003, COMPUT ELECTRON AGR, V40, P57, DOI 10.1016/S0168-1699(03)00011-5; ztopal A., 2012, SOL ENERGY, V86, P725	27	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184561	10.1371/journal.pone.0184561	http://dx.doi.org/10.1371/journal.pone.0184561			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898271	Green Published, Green Submitted, gold			2022-12-27	WOS:000410449500034
J	Santos, RO; Rehage, JS; Adams, AJ; Black, BD; Osborne, J; Kroloff, EKN				Santos, Rolando O.; Rehage, Jennifer S.; Adams, Aaron J.; Black, Brooke D.; Osborne, Jason; Kroloff, Emily K. N.			Quantitative assessment of a data-limited recreational bonefish fishery using a time-series of fishing guides reports	PLOS ONE			English	Article							SEAGRASS DIE-OFF; FLORIDA BAY; ALBULA-VULPES; ECOLOGICAL THRESHOLDS; LENGTH LIMITS; CATCH; ABUNDANCE; CONNECTIVITY; BEHAVIOR; MORTALITY	Recreational fisheries can be prone to severe declines, yet these fisheries, particularly catch-and-release, are often data-limited, constraining our ability to conduct stock assessments. A combination of catch and effort indices derived from fisheries-dependent data (FDD) gathered from fishing logbooks could be a powerful approach to inform these data gaps. This study demonstrates the utility of using different catch metrics such as indices of abundance, species richness associated with reported catch, and the success rate of targeted trips, to assess historical shifts in the trajectory of the data-limited bonefish (Albula vulpes) fishery in Florida Bay, an economically-important recreational fishery within the Caribbean Basin. We used FDD from fishing guide reports submitted to Everglades National Park to determine temporal patterns in the bonefish population over the past 35 years. These reports indicated a decline in recreational catches in Florida Bay since the late 1980s, with an accelerated decline starting in the late 1990s-early 2000s. Analyses showed an overall 42% reduction in bonefish catches. Trends in the proportion of positive trips (i.e., the probability of catching success) followed the declining catch patterns, suggesting major population changes starting in 1999-2000. As bonefish catches declined, species richness in bonefish trips increased by 34%, suggesting a decrease in bonefish abundance and/or shift in fishing effort (e.g., giving-up time, changes in preferred species). Results provide additional resolution to a pattern of decline for bonefish in South Florida and highlight the value of reconstructing time-series for the development of hypotheses about the potential driving mechanisms of species decline. Further, the data-limited nature of most recreational fisheries, and the increase in a use of catch-and-release as a fisheries management strategy point to the need to develop further data integration tools to assess population trends and the sustainability of these fishery resources.	[Santos, Rolando O.; Rehage, Jennifer S.; Kroloff, Emily K. N.] Florida Int Univ, Earth & Environm Dept, Miami, FL 33199 USA; [Santos, Rolando O.; Rehage, Jennifer S.] Florida Int Univ, Southeast Environm Res Ctr, Miami, FL 33199 USA; [Adams, Aaron J.; Black, Brooke D.] Bonefish & Tarpon Trust, Coral Gables, FL USA; [Osborne, Jason] USNPS SFNRC, Everglades Natl Pk, Homestead, FL USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University	Santos, RO (corresponding author), Florida Int Univ, Earth & Environm Dept, Miami, FL 33199 USA.; Santos, RO (corresponding author), Florida Int Univ, Southeast Environm Res Ctr, Miami, FL 33199 USA.	rsantosc@fiu.edu		Santos, Rolando/0000-0002-3885-9406	Bonefish and Tarpon Trust; Comprehensive Everglades Restoration Plan (CERP); NSF [WSC-1204762]; FCE LTER [NSF DEB-1237517]; Division Of Environmental Biology [1237517] Funding Source: National Science Foundation	Bonefish and Tarpon Trust; Comprehensive Everglades Restoration Plan (CERP); NSF(National Science Foundation (NSF)); FCE LTER; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding was provided by Bonefish and Tarpon Trust and the RECOVER (REstoration COordination & VERification) program of the Comprehensive Everglades Restoration Plan (CERP). The project was developed with additional support from NSF WSC-1204762 and in collaboration with the FCE LTER program (NSF DEB-1237517).	Adams AJ, 2014, FISH FISH, V15, P280, DOI 10.1111/faf.12017; Adams Aaron J., 2012, Gulf and Caribbean Research, V24, P13; Allen MS, 2013, FISHERIES MANAG ECOL, V20, P247, DOI 10.1111/j.1365-2400.2012.00871.x; Andersen T, 2009, TRENDS ECOL EVOL, V24, P49, DOI 10.1016/j.tree.2008.07.014; [Anonymous], STRUCCHANGE R PACKAG; Arlinghaus R, 2013, FISHERIES MANAG ECOL, V20, P91, DOI 10.1111/fme.12027; Ault J.S, 2008, BIOL MANAGEMENT WORL; Beaudreau AH, 2014, ECOL APPL, V24, P244, DOI 10.1890/13-0817.1; Blaber SJM, 2013, ESTUAR COAST SHELF S, V135, P57, DOI 10.1016/j.ecss.2012.11.002; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boyer JN, 2009, ECOL INDIC, V9, pS56, DOI 10.1016/j.ecolind.2008.11.013; Britten GL, 2014, ECOL LETT, V17, P1518, DOI 10.1111/ele.12354; Brownscombe JW, 2013, J EXP MAR BIOL ECOL, V440, P207, DOI 10.1016/j.jembe.2012.12.004; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campbell RA, 2004, FISH RES, V70, P209, DOI 10.1016/j.fishres.2004.08.026; Carlson JK, 2007, BIOL CONSERV, V136, P195, DOI 10.1016/j.biocon.2006.11.013; Cass-Calay Shannon L., 2009, Endangered Species Research, V7, P183, DOI 10.3354/esr00139; Coggins LG, 2007, FISH FISH, V8, P196, DOI 10.1111/j.1467-2679.2007.00247.x; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Cooke SJ, 2013, FISHERIES MANAG ECOL, V20, P268, DOI 10.1111/j.1365-2400.2012.00867.x; Cooke SJ, 2004, BIOSCIENCE, V54, P857, DOI 10.1641/0006-3568(2004)054[0857:TRORFI]2.0.CO;2; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; Cooke SJ, 2004, BIOL CONSERV, V118, P599, DOI 10.1016/j.biocon.2003.10.009; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Crabtree RE, 1996, FISH B-NOAA, V94, P442; Crabtree RE, 1998, FISH B-NOAA, V96, P754; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Dallas LJ, 2010, J FISH BIOL, V77, P947, DOI 10.1111/j.1095-8649.2010.02738.x; Danylchuk SE, 2007, J EXP MAR BIOL ECOL, V346, P127, DOI 10.1016/j.jembe.2007.03.008; Development RC, 2010, R LANG ENV STAT COMP; Dorenbosch M, 2007, MAR ECOL PROG SER, V334, P103, DOI 10.3354/meps334103; Erisman BE, 2011, CAN J FISH AQUAT SCI, V68, P1705, DOI 10.1139/F2011-090; Fedler A, 2013, EC IMPACT FLORIDA KE; Fedler T., 2009, EC IMPACT HECREATION; Ficetola GF, 2009, ECOGRAPHY, V32, P1075, DOI 10.1111/j.1600-0587.2009.05571.x; Finn JT, 2010, ECOL MODEL, V293, P139; Fonteneau A, 2003, MAR FRESHWATER RES, V54, P383, DOI 10.1071/MF01268; Fourqurean JW, 1999, ESTUARIES, V22, P345, DOI 10.2307/1353203; Frezza PE, 2015, ENVIRON BIOL FISH, V98, P2187, DOI 10.1007/s10641-015-0442-0; Gillanders BM, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P503; Graham NAJ, 2014, CURR BIOL, V24, pR359, DOI 10.1016/j.cub.2014.03.069; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Hall MO, 2016, MAR ECOL PROG SER, V560, P243, DOI 10.3354/meps11923; Heck KL, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P537; Holstein DM, 2014, MAR ECOL PROG SER, V499, P1, DOI 10.3354/meps10647; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Hughes RM, 2015, FISHERIES SCI, V81, P1, DOI 10.1007/s12562-014-0815-x; Jensen OP, 2012, THEOR ECOL-NETH, V5, P3, DOI 10.1007/s12080-011-0146-9; Kough AS, 2013, PLOS ONE, P8; Kroloff E, 2016, ARE ALL BONEFISH USI; Larkin MF, 2010, FISHERIES MANAG ECOL, V17, P254, DOI 10.1111/j.1365-2400.2009.00718.x; Larkin MF, 2011, THESIS, P214; M?llmann C., 2012, ADV ECOL RES; Madden CJ, 2009, ECOL INDIC, V9, pS68, DOI 10.1016/j.ecolind.2009.02.004; Maunder MN, 2004, FISH RES, V70, P389, DOI 10.1016/j.fishres.2004.08.015; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Meynecke JO, 2008, BIOL CONSERV, V141, P981, DOI 10.1016/j.biocon.2008.01.018; Muehlstein L.K., 1992, Proceedings of the Gulf and Caribbean Fisheries Institute, V42, P55; Muller RG, 2013, CENTROPOMUS UNDECIMA, P161; Nagelkerken I, 2015, FISH FISH, V16, P362, DOI 10.1111/faf.12057; Olds AD, 2012, MAR ECOL PROG SER, V462, P191, DOI 10.3354/meps09849; ORTH RJ, 1984, ESTUARIES, V7, P339, DOI 10.2307/1351618; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Osborne J., 2006, YEAR 2005 ANN MARINE; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; Post JR, 2013, FISHERIES MANAG ECOL, V20, P99, DOI 10.1111/fme.12008; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Roughgarden J, 1996, P NATL ACAD SCI USA, V93, P5078, DOI 10.1073/pnas.93.10.5078; Rudnick DT, 2005, WETLANDS, V25, P870, DOI 10.1672/0277-5212(2005)025[0870:ACEMOF]2.0.CO;2; Santos RO, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1335; Schmidt T., 2002, YEAR 2001 ANN FISHER; Schroeder DM, 2002, CAL COOP OCEAN FISH, V43, P182; Sosin Mark, 2008, V9, P345; Stabenau E, 2012, SALINITY HYDROLOGY F; Sundelof A, 2015, POPUL ECOL, V57, P237, DOI 10.1007/s10144-014-0460-3; Tilmant JT, 1986, P 4 C RES NAT PARKS, P75; Venables WN, 2004, FISH RES, V70, P319, DOI 10.1016/j.fishres.2004.08.011; Winker H, 2014, FISH RES, V155, P149, DOI 10.1016/j.fishres.2014.02.016; Winker H, 2013, FISH RES, V139, P118, DOI 10.1016/j.fishres.2012.10.014; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zeileis A, 2003, COMPUT STAT DATA AN, V44, P109, DOI 10.1016/S0167-9473(03)00030-6; Zieman JC, 1999, ESTUARIES, V22, P460, DOI 10.2307/1353211; Zuur Alain F., 2009, P1	85	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184776	10.1371/journal.pone.0184776	http://dx.doi.org/10.1371/journal.pone.0184776			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892509	Green Submitted, Green Published, gold			2022-12-27	WOS:000410243200022
J	Beacham, TD; Withler, RE				Beacham, Terry D.; Withler, Ruth E.			Population structure of sea-type and lake-type sockeye salmon and kokanee in the Fraser River and Columbia River drainages	PLOS ONE			English	Article							CROSS-SPECIES AMPLIFICATION; LIFE-HISTORY EVOLUTION; ONCORHYNCHUS-NERKA; NONANADROMOUS MORPHS; GENETIC-STRUCTURE; BRITISH-COLUMBIA; PACIFIC SALMON; DIVERGENCE; MICROSATELLITES; CONSERVATION	Population structure of three ecotypes of Oncorhynchus nerka (sea-type Sockeye Salmon, lake-type Sockeye Salmon, and Kokanee) in the Fraser River and Columbia River drainages was examined with microsatellite variation, with the main focus as to whether Kokanee population structure within the Fraser River drainage suggested either a monophyletic or polyphyletic origin of the ecotype within the drainage. Variation at 14 microsatellite loci was surveyed for sea-type and lake-type Sockeye Salmon and Kokanee sampled from 121 populations in the two river drainages. An index of genetic differentiation, F-ST, over all populations and loci was 0.087, with individual locus values ranging from 0.031 to 0.172. Standardized to an ecotype sample size of 275 individuals, the least genetically diverse ecotype was sea-type Sockeye Salmon with 203 alleles, whereas Kokanee displayed the greatest number of alleles (260 alleles), with lake-type Sockeye Salmon intermediate (241 alleles). Kokanee populations from the Columbia River drainage (Okanagan Lake, Kootenay Lake), the South Thompson River (a major Fraser River tributary) drainage populations, and the mid-Fraser River populations all clustered together in a neighbor-joining analysis, indicative of a monophyletic origin of the Kokanee ecotype in these regions, likely reflecting the origin of salmon radiating from a refuge after the last glaciation period. However, upstream of the mid-Fraser River populations, there were closer relationships between the lake-type Sockeye Salmon ecotype and the Kokanee ecotype, indicative of the Kokanee ecotype evolving independently from the lake-type Sockeye Salmon ecotype in parallel radiation. Kokanee population structure within the entire Fraser River drainage suggested a polyphyletic origin of the ecotype within the drainage. Studies employing geographically restricted population sampling may not outline accurately the phylogenetic history of salmonid ecotypes.	[Beacham, Terry D.; Withler, Ruth E.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada	Fisheries & Oceans Canada	Beacham, TD (corresponding author), Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC, Canada.	Terry.Beacham@dfo-mpo.gc.ca			Fisheries and Oceans Canada; Province of British Columbia	Fisheries and Oceans Canada; Province of British Columbia	Funding was provided by Fisheries and Oceans Canada and the Province of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks MA, 1999, J HERED, V90, P281, DOI 10.1093/jhered/90.2.281; Beacham T.D., 1998, North Pacific Anadromous Fish Commission Bulletin, V1, P227; BEACHAM TD, 1985, ENVIRON BIOL FISH, V14, P97, DOI 10.1007/BF00000818; Beacham TD, 2006, T AM FISH SOC, V135, P174, DOI 10.1577/T05-149.1; Beacham TD, 2004, T AM FISH SOC, V133, P1117, DOI 10.1577/T04-001.1; Beacham TD, 2004, J FISH BIOL, V65, P389, DOI 10.1111/j.0022-1112.2004.00457.x; Beacham TD, 2014, N AM J FISH MANAGE, V34, P335, DOI 10.1080/02755947.2014.880761; Burgner R. L., 1991, PACIFIC SALMON LIFE, P1; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Dodson JJ, 2013, BIOL REV, V88, P602, DOI 10.1111/brv.12019; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Foote CJ, 1999, ENVIRON BIOL FISH, V54, P263, DOI 10.1023/A:1007548807233; Frazer KK, 2013, J EVOLUTION BIOL, V26, P2606, DOI 10.1111/jeb.12250; Godbout L, 2011, CAN J FISH AQUAT SCI, V68, P1590, DOI 10.1139/F2011-089; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gustafson RG, 1999, ECOL FRESHW FISH, V8, P181, DOI 10.1111/j.1600-0633.1999.tb00069.x; Larson WA, 2017, MOL ECOL, V26, P554, DOI 10.1111/mec.13933; Lemay MA, 2015, MOL ECOL, V24, P798, DOI 10.1111/mec.13066; Lewis PO, 2001, GENETIC DATA ANAL GD; McPhail J.D., 1986, P615; Morris DB, 1996, CAN J FISH AQUAT SCI, V53, P120, DOI 10.1139/cjfas-53-1-120; NELSON JS, 1968, J FISH RES BOARD CAN, V25, P409, DOI 10.1139/f68-032; Nelson RJ, 2003, N AM J FISH MANAGE, V23, P703, DOI 10.1577/M01-194; Nelson RJ, 1999, ANIM GENET, V30, P228, DOI 10.1046/j.1365-2052.1999.00404-4.x; Nichols KM, 2016, EVOL APPL, V9, P1285, DOI 10.1111/eva.12412; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; RYDER JM, 1990, CAN J EARTH SCI, V27, P1316, DOI 10.1139/e90-142; Scribner KT, 1996, CAN J FISH AQUAT SCI, V53, P833, DOI 10.1139/cjfas-53-4-833; Smith CT, 1998, MOL ECOL, V7, P1614; Taylor EB, 1996, EVOLUTION, V50, P401, DOI [10.2307/2410810, 10.1111/j.1558-5646.1996.tb04502.x]; Veale AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01890-2; Veale AJ, 2016, EVOL APPL, V9, P1301, DOI 10.1111/eva.12430; WAPLES RS, 1990, CAN J FISH AQUAT SCI, V47, P968, DOI 10.1139/f90-111; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Winans GA, 1996, T AM FISH SOC, V125, P645, DOI 10.1577/1548-8659(1996)125&lt;0645:AVONIT&gt;2.3.CO;2; Withler RE, 2000, CAN J FISH AQUAT SCI, V57, P1985, DOI 10.1139/cjfas-57-10-1985; Wood C.C., 1987, Canadian Special Publication of Fisheries and Aquatic Sciences, V96, P12; Wood CC, 1995, AM FISH S S, V17, P195; Wood CC, 1996, EVOLUTION, V50, P1265, DOI [10.1111/j.1558-5646.1996.tb02367.x, 10.2307/2410667]; Wood CC, 2008, EVOL APPL, V1, P207, DOI 10.1111/j.1752-4571.2008.00028.x	40	13	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183713	10.1371/journal.pone.0183713	http://dx.doi.org/10.1371/journal.pone.0183713			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886033	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100033
J	Bisele, M; Bencsik, M; Lewis, MGC; Barnett, CT				Bisele, Maria; Bencsik, Martin; Lewis, Martin G. C.; Barnett, Cleveland T.			Optimisation of a machine learning algorithm in human locomotion using principal component and discriminant function analyses	PLOS ONE			English	Article							GAIT WAVE-FORMS; FEATURE-EXTRACTION; MOVEMENT; CLASSIFICATION; KINEMATICS; BAREFOOT; COORDINATION; VARIABILITY; PATTERNS; FORCES	Assessment methods in human locomotion often involve the description of normalised graphical profiles and/or the extraction of discrete variables. Whilst useful, these approaches may not represent the full complexity of gait data. Multivariate statistical methods, such as Principal Component Analysis (PCA) and Discriminant Function Analysis (DFA), have been adopted since they have the potential to overcome these data handling issues. The aim of the current study was to develop and optimise a specific machine learning algorithm for processing human locomotion data. Twenty participants ran at a selfselected speed across a 15m runway in barefoot and shod conditions. Ground reaction forces (BW) and kinematics were measured at 1000 Hz and 100 Hz, respectively from which joint angles (degrees), joint moments (N. m. kg(-1)) and joint powers (W. kg(-1)) for the hip, knee and ankle joints were calculated in all three anatomical planes. Using PCA and DFA, power spectra of the kinematic and kinetic variables were used as a training database for the development of a machine learning algorithm. All possible combinations of 10 out of 20 participants were explored to find the iteration of individuals that would optimise the machine learning algorithm. The results showed that the algorithm was able to successfully predict whether a participant ran shod or barefoot in 93.5% of cases. To the authors' knowledge, this is the first study to optimise the development of a machine learning algorithm.	[Bisele, Maria; Bencsik, Martin; Lewis, Martin G. C.; Barnett, Cleveland T.] Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England	Nottingham Trent University	Barnett, CT (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Nottingham, England.	cleveland.barnett@ntu.ac.uk	Barnett, Cleveland/D-2884-2013	Barnett, Cleveland/0000-0001-6898-9095; Lewis, Martin G C/0000-0001-5918-3444	Nottingham Trent University	Nottingham Trent University	The authors would like to thank Nottingham Trent University for funding Maria Bisele's Ph.D studentship.	Alaqtash M, 2011, IEEE ENG MED BIO, P453, DOI 10.1109/IEMBS.2011.6090063; Ali S, 2010, IEEE T PATTERN ANAL, V32, P288, DOI 10.1109/TPAMI.2008.284; Ardestani MM, 2016, J BIOMECH, V49, P2023, DOI 10.1016/j.jbiomech.2016.04.040; Ardestani MM, 2016, GAIT POSTURE, V46, P118, DOI 10.1016/j.gaitpost.2016.02.005; Baker R, 2009, GAIT POSTURE, V30, P265, DOI 10.1016/j.gaitpost.2009.05.020; Barnett C, 2009, PROSTHET ORTHOT INT, V33, P135, DOI 10.1080/03093640902751762; Barton GJ, 2012, HUM MOVEMENT SCI, V31, P284, DOI 10.1016/j.humov.2010.06.003; Begg R, 2005, J BIOMECH, V38, P401, DOI 10.1016/j.jbiomech.2004.05.002; Braunstein B, 2010, J BIOMECH, V43, P2120, DOI 10.1016/j.jbiomech.2010.04.001; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Chan Herman, 2011, 2011 Seventh International Conference on Natural Computation (ICNC 2011), P588, DOI 10.1109/ICNC.2011.6022097; Chau T, 2001, GAIT POSTURE, V13, P49, DOI 10.1016/S0966-6362(00)00094-1; Chau T, 2001, GAIT POSTURE, V13, P102, DOI 10.1016/S0966-6362(00)00095-3; Cretual A, 2010, GAIT POSTURE, V32, P307, DOI 10.1016/j.gaitpost.2010.05.015; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; Deluzio KJ, 2007, GAIT POSTURE, V25, P86, DOI 10.1016/j.gaitpost.2006.01.007; Deluzio KJ, 1997, HUM MOVEMENT SCI, V16, P201, DOI 10.1016/S0167-9457(96)00051-6; Deluzio KJ, 1999, HUM MOVEMENT SCI, V18, P701, DOI 10.1016/S0167-9457(99)00030-5; Dillmann U, 2014, GAIT POSTURE, V39, P882, DOI 10.1016/j.gaitpost.2013.11.021; Divert C, 2005, INT J SPORTS MED, V26, P593, DOI 10.1055/s-2004-821327; Eskofier BM, 2013, COMPUT METHOD BIOMEC, V16, P435, DOI 10.1080/10255842.2011.624515; Federolf P, 2012, J BIOMECH, V45, P1127, DOI 10.1016/j.jbiomech.2012.02.008; Gao F, 2011, IEEE ENG MED BIO, P7340, DOI 10.1109/IEMBS.2011.6091712; Hamill J, 2012, KINESIOLOGY REV, V1, P17; Jeon HS, 2008, IEEE ENG MED BIO, P4672, DOI 10.1109/IEMBS.2008.4650255; Kerrigan DC, 2009, PM&R, V1, P1058, DOI 10.1016/j.pmrj.2009.09.011; Kirtley C, 2006, CLIN GAIT ANAL THEOR; Kobsar D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139923; Leardini A, 2011, CLIN BIOMECH, V26, P562, DOI 10.1016/j.clinbiomech.2011.01.015; LeMoyne R, 2015, IEEE ENG MED BIO, P202, DOI 10.1109/EMBC.2015.7318335; Lever J, 2016, NAT METHODS, V13, P703, DOI 10.1038/nmeth.3968; Levine D., 2012, WHITTLES GAIT ANAL; Lieberman DE, 2010, NATURE, V463, P531, DOI 10.1038/nature08723; Mouchnino L, 2006, GAIT POSTURE, V24, P4, DOI 10.1016/j.gaitpost.2005.07.007; Muniz AMS, 2010, INT J NEUROSCI, V120, P609, DOI 10.3109/00207454.2010.504904; Novacheck TF, 2010, ORTHOP CLIN N AM, V41, P469, DOI 10.1016/j.ocl.2010.07.001; Phinyomark A, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1013-z; Phinyomark A, 2015, HUM MOVEMENT SCI, V44, P91, DOI 10.1016/j.humov.2015.08.018; Reid SM, 2010, GAIT POSTURE, V31, P197, DOI 10.1016/j.gaitpost.2009.10.005; Robertson G, 2013, HUMAN KINETICS, V2E; Schutte LM, 2000, GAIT POSTURE, V11, P25, DOI 10.1016/S0966-6362(99)00047-8; Soares DP, 2016, PROSTHET ORTHOT INT, V40, P729, DOI 10.1177/0309364615612634; Sugavaneswaran L, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046004; von Tscharner V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065063; Williams DSB, 2012, INT J SPORTS PHYS TH, V7, P525; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Wu JN, 2007, HUM MOVEMENT SCI, V26, P393, DOI 10.1016/j.humov.2007.01.015	47	11	12	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183990	10.1371/journal.pone.0183990	http://dx.doi.org/10.1371/journal.pone.0183990			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886059	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000410001100051
J	Geng, PL; Tian, S; Yuan, ZM; Hu, XM				Geng, Peiling; Tian, Shen; Yuan, Zhiming; Hu, Xiaomin			Identification and genomic comparison of temperate bacteriophages derived from emetic Bacillus cereus	PLOS ONE			English	Article							TAIL FIBER GENES; PHAGE; SEQUENCE; THURINGIENSIS; DNA; ANTHRACIS; ALIGNMENT; WEIHENSTEPHANENSIS; PATHOGENICITY; VIRULENCE	Cereulide-producing Bacillus cereus isolates can cause serious emetic ( vomiting) syndrome and even acute lethality. As mobile genetic elements, the exploration of prophages derived from emetic B. cereus isolates will help in our understanding of the genetic diversity and evolution of these pathogens. In this study, five temperate phages derived from cereulide-producing B. cereus strains were induced, with four of them undergoing genomic sequencing. Sequencing revealed that they all belong to the Siphoviridae family, but presented in different forms in their hosts. PfNC7401 and PfIS075 have typical icosahedral heads, probably existing alone as phagemids in the host with self-replicating capability in the lysogenic state. PfEFR-4, PfEFR-5, and PfATCC7953 have elongated heads, with the genomes of the former two identified as linear dsDNA, which could be integrated into the host genome during the lysogenic state. Genomic comparison of the four phages with others also derived from emetic B. cereus isolates showed similar genome structures and core genes, thus displaying host spectrum specificity. In addition, phylogenic analysis based on the complete genome and conserved tail fiber proteins of 36 Bacillus species-derived phages confirmed that the phages derived from emetic B. cereus strains were highly similar. Furthermore, one endolysin LysPfEFR-4 was cloned and showed lytic activity against all tested emetic B. cereus strains and cross-lytic activity against some other pathogenic bacteria, implying a potential to control bacterial contamination in the food supply.	[Geng, Peiling; Tian, Shen; Yuan, Zhiming; Hu, Xiaomin] Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan, Hubei, Peoples R China; [Geng, Peiling] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yuan, ZM; Hu, XM (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Emerging Infect Dis, Key Lab Special Pathogens & Biosafety, Wuhan, Hubei, Peoples R China.	yzm@wh.iov.cn; huxm@wh.iov.cn	Hu, Xiaomin/GRY-1539-2022		National Natural Science Foundation of China (NFSC) [31170006, 31570007]; NFSC [31170006, 31570007]	National Natural Science Foundation of China (NFSC)(National Natural Science Foundation of China (NSFC)); NFSC(National Natural Science Foundation of China (NSFC))	The project was supported by a National Natural Science Foundation of China (NFSC) grant 31170006 (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A: All information mentioned above has been confirmed and the Financial Disclosure has been edited as "The project was supported by National Natural Science Foundation of China (NFSC) grants 31170006 and 31570007 (http://www.nsfc.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."; We would like to thank Pei Zhang from the Core Facility and Technical Support, Wuhan Institute of Virology, for help with producing TEM micrographs. This work was supported by an NFSC grants (31170006 and 31570007).	AGATA N, 1995, FEMS MICROBIOL LETT, V129, P17, DOI 10.1016/0378-1097(95)00119-P; Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Andrup L, 2008, PLASMID, V59, P139, DOI 10.1016/j.plasmid.2007.11.005; Arslan S, 2014, ANAEROBE, V25, P42, DOI 10.1016/j.anaerobe.2013.11.006; Becker SC, 2009, GENE, V443, P32, DOI 10.1016/j.gene.2009.04.023; Becker SC, 2009, FEMS MICROBIOL LETT, V294, P52, DOI 10.1111/j.1574-6968.2009.01541.x; Bednarczyk A, 2008, POSTEP MIKROBIOL, V47, P51; Beims H, 2015, APPL ENVIRON MICROB, V81, P5411, DOI 10.1128/AEM.00804-15; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boyd EF, 2012, ADV VIRUS RES, V82, P91, DOI 10.1016/B978-0-12-394621-8.00014-5; Casjens SR, 2005, J BACTERIOL, V187, P1091, DOI 10.1128/JB.187.3.1091-1104.2005; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Didelot X, 2009, SYST APPL MICROBIOL, V32, P81, DOI 10.1016/j.syapm.2009.01.001; Ehling-Schulz M, 2005, MICROBIOL-SGM, V151, P183, DOI 10.1099/mic.0.27607-0; Ferreira R, 2014, HELICOBACTER, V19, P92; Fico S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-259; Figueroa-Bossi N, 1999, MOL MICROBIOL, V33, P167, DOI 10.1046/j.1365-2958.1999.01461.x; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Geng PL, 2017, INT J FOOD MICROBIOL, V241, P291, DOI 10.1016/j.ijfoodmicro.2016.10.030; Gillis A, 2014, APPL ENVIRON MICROB, V80, P7620, DOI 10.1128/AEM.01869-14; Gillis A, 2014, VIRUSES-BASEL, V6, P2623, DOI 10.3390/v6072623; Guinebretiere MH, 2013, INT J SYST EVOL MICR, V63, P31, DOI 10.1099/ijs.0.030627-0; Haaber J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13333; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; Hoton FM, 2009, ENV MICROBIOL REP, V1, P177, DOI 10.1111/j.1758-2229.2009.00028.x; Kolsto AB, 2002, CURR TOP MICROBIOL, V264, P95; Kong M, 2012, J VIROL, V86, P6379, DOI 10.1128/JVI.00706-12; Koskella B, 2014, FEMS MICROBIOL REV, V38, P916, DOI 10.1111/1574-6976.12072; Kroten MA, 2010, POL J MICROBIOL, V59, P3, DOI 10.33073/pjm-2010-001; Kwon HJ, 2013, VET MICROBIOL, V162, P785, DOI 10.1016/j.vetmic.2012.10.005; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee YD, 2012, J MICROBIOL BIOTECHN, V22, P649, DOI 10.4014/jmb.1110.10065; Lee YD, 2010, FOOD SCI BIOTECHNOL, V19, P1643, DOI 10.1007/s10068-010-0232-6; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mahichi F, 2009, FEMS MICROBIOL LETT, V295, P211, DOI 10.1111/j.1574-6968.2009.01588.x; Mao JZ, 2013, FEMS MICROBIOL LETT, V342, P30, DOI 10.1111/1574-6968.12104; Mei XF, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-149; Popp D, 2010, J BIOL CHEM, V285, P10130, DOI 10.1074/jbc.M109.071613; Ramisse V, 1996, FEMS MICROBIOL LETT, V145, P9, DOI 10.1016/0378-1097(96)00358-8; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Ravin V, 2002, J BACTERIOL, V184, P2455, DOI 10.1128/JB.184.9.2455-2459.2002; Romero P, 2009, APPL ENVIRON MICROB, V75, P1642, DOI 10.1128/AEM.02155-08; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Smeesters PR, 2011, RES MICROBIOL, V162, P446, DOI 10.1016/j.resmic.2011.02.009; Sozhamannan S, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-34; Stockdale SR, 2013, J BIOL CHEM, V288, P5581, DOI 10.1074/jbc.M112.444901; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas JA, 2007, VIROLOGY, V368, P405, DOI 10.1016/j.virol.2007.06.043; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorsen L, 2006, APPL ENVIRON MICROB, V72, P5118, DOI 10.1128/AEM.00170-06; Touchon M, 2017, CURR OPIN MICROBIOL, V38, P66, DOI 10.1016/j.mib.2017.04.010; Tsourkas PK, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01120-15; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; Verheust C, 2003, MICROBIOL-SGM, V149, P2083, DOI 10.1099/mic.0.26307-0; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; XUE Q, 1995, VIROLOGY, V212, P128, DOI 10.1006/viro.1995.1461; Yu SL, 2000, J BACTERIOL, V182, P5962, DOI 10.1128/JB.182.21.5962-5968.2000; Yuan YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037557; Zafar N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-12; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	64	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184572	10.1371/journal.pone.0184572	http://dx.doi.org/10.1371/journal.pone.0184572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886124	Green Submitted, gold, Green Published			2022-12-27	WOS:000410001100160
J	Margulies, CM; Chaim, IA; Mazumder, A; Criscione, J; Samson, LD				Margulies, Carrie M.; Chaim, Isaac Alexander; Mazumder, Aprotim; Criscione, June; Samson, Leona D.			Alkylation induced cerebellar degeneration dependent on Aag and Parp1 does not occur via previously established cell death mechanisms	PLOS ONE			English	Article							BASE EXCISION-REPAIR; MITOCHONDRIAL PERMEABILITY TRANSITION; DNA-DAMAGE RESPONSE; POLY(ADP-RIBOSE) POLYMERASE-1; NAD(+) DEPLETION; PROGRAMMED NECROSIS; OXIDATIVE STRESS; GRANULE NEURONS; ABASIC SITES; ACTIVATION	Alkylating agents are ubiquitous in our internal and external environments, causing DNA damage that contributes to mutations and cell death that can result in aging, tissue degeneration and cancer. Repair of methylated DNA bases occurs primarily through the base excision repair (BER) pathway, a multi-enzyme pathway initiated by the alkyladenine DNA glycosylase (Aag, also known as Mpg). Previous work demonstrated that mice treated with the alkylating agent methyl methanesulfonate (MMS) undergo cerebellar degeneration in an Aag-dependent manner, whereby increased BER initiation by Aag causes increased tissue damage that is dependent on activation of poly (ADP-ribose) polymerase 1 (Parp1). Here, we dissect the molecular mechanism of cerebellar granule neuron (CGN) sensitivity to MMS using primary ex vivo neuronal cultures. We first established a high-throughput fluorescent imaging method to assess primary neuron sensitivity to treatment with DNA damaging agents. Next, we verified that the alkylation sensitivity of CGNs is an intrinsic phenotype that accurately recapitulates the in vivo dependency of alkylation-induced CGN cell death on Aag and Parp1 activity. Finally, we show that MMS-induced CGN toxicity is independent of all the cellular events that have previously been associated with Parp-mediated toxicity, including mitochondrial depolarization, AIF translocation, calcium fluxes, and NAD(+) consumption. We therefore believe that further investigation is needed to adequately describe all varieties of Parp-mediated cell death.	[Margulies, Carrie M.; Chaim, Isaac Alexander; Mazumder, Aprotim; Criscione, June; Samson, Leona D.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Margulies, Carrie M.; Chaim, Isaac Alexander; Mazumder, Aprotim; Criscione, June; Samson, Leona D.] MIT, Ctr Environm Hlth Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Samson, Leona D.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Samson, Leona D.] MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Samson, LD (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Samson, LD (corresponding author), MIT, Ctr Environm Hlth Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Samson, LD (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Samson, LD (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lsamson@mit.edu		/0000-0002-7112-1454; Mazumder, Aprotim/0000-0002-3443-3010	National Institutes of Health [R01-ES022872]; Ellison Medical Foundation Senior Scholar Award [AG-SS-3046-12]; National Institute of Environmental Health Sciences [P30-ES002109]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation Senior Scholar Award(Lawrence Ellison Foundation); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by National Institutes of Health (https://www.edu.gov/) R01-ES022872 and an Ellison Medical Foundation Senior Scholar Award (AG-SS-3046-12) (http:// ellisonfoundation.org/); LDS is an American Cancer Society Research Professor. Imaging core facilities at the Center for Environmental Health Sciences were supported by P30-ES002109 from the National Institute of Environmental Health Sciences (https://www.niehs.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Ahmad T, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.213; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Andrabi SA, 2014, P NATL ACAD SCI USA, V111, P10209, DOI 10.1073/pnas.1405158111; Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; Avkin S, 2002, P NATL ACAD SCI USA, V99, P3764, DOI 10.1073/pnas.062038699; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bentle MS, 2006, J BIOL CHEM, V281, P33684, DOI 10.1074/jbc.M603678200; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Blenn C, 2011, CELL MOL LIFE SCI, V68, P1455, DOI 10.1007/s00018-010-0533-1; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Brunyanszki A, 2014, MOL PHARMACOL, V86, P450, DOI 10.1124/mol.114.094318; Cabon L, 2012, CELL DEATH DIFFER, V19, P245, DOI 10.1038/cdd.2011.91; Calvo JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003413; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Dantzer F, 1999, BIOCHIMIE, V81, P69, DOI 10.1016/S0300-9084(99)80040-6; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Ensminger M, 2014, J CELL BIOL, V206, P29, DOI 10.1083/jcb.201312078; Fouquerel E, 2014, CELL REP, V8, P1819, DOI 10.1016/j.celrep.2014.08.036; Gray JJ, 2013, BRAIN RES, V1494, P28, DOI 10.1016/j.brainres.2012.12.001; Guo X, 2013, J CLIN INVEST, V123, P5371, DOI 10.1172/JCI70911; Heacock ML, 2010, DNA REPAIR, V9, P929, DOI 10.1016/j.dnarep.2010.05.007; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Horton JK, 2005, J BIOL CHEM, V280, P15773, DOI 10.1074/jbc.M413841200; Jelinic P, 2014, MOL CANCER THER, V13, P1645, DOI 10.1158/1535-7163.MCT-13-0906-T; Kageyama Y, 2012, J CELL BIOL, V197, P535, DOI 10.1083/jcb.201110034; Kedar PS, 2012, MOL CANCER RES, V10, P360, DOI 10.1158/1541-7786.MCR-11-0477; Kouzoukas DE, 2013, J NEUROCHEM, V124, P323, DOI 10.1111/jnc.12076; Lee HY, 2009, J VIS EXP; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Martire S, 2015, MECH AGEING DEV, V146, P53, DOI 10.1016/j.mad.2015.04.001; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Nagel ZD, 2014, P NATL ACAD SCI USA, V111, pE1823, DOI 10.1073/pnas.1401182111; Pages V, 2008, P NATL ACAD SCI USA, V105, P1170, DOI 10.1073/pnas.0711227105; Pankotai E, 2009, MITOCHONDRION, V9, P159, DOI 10.1016/j.mito.2009.01.013; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Prasad R, 2001, J BIOL CHEM, V276, P32411, DOI 10.1074/jbc.C100292200; Prasad R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124269; Prasad R, 2014, NUCLEIC ACIDS RES, V42, P6337, DOI 10.1093/nar/gku288; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; SCHAAPER RM, 1983, P NATL ACAD SCI-BIOL, V80, P487, DOI 10.1073/pnas.80.2.487; Sharma J, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-9; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Sobol RW, 2003, J BIOL CHEM, V278, P39951, DOI 10.1074/jbc.M306592200; Sosna J, 2014, CELL MOL LIFE SCI, V71, P331, DOI 10.1007/s00018-013-1381-6; Sousa FG, 2012, CARCINOGENESIS, V33, P1433, DOI 10.1093/carcin/bgs132; Strosznajder JB, 2012, MOL NEUROBIOL, V46, P78, DOI 10.1007/s12035-012-8258-9; Szczesny B, 2014, NUCLEIC ACIDS RES, V42, P13161, DOI 10.1093/nar/gku1089; van Wijk SJL, 2005, FREE RADICAL BIO MED, V39, P81, DOI 10.1016/j.freeadbiomed.2005.03.021; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Vandenabeele P, 2013, CELL DEATH DIFFER, V20, P185, DOI 10.1038/cdd.2012.151; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Wang YF, 2009, J NEUROCHEM, V110, P687, DOI 10.1111/j.1471-4159.2009.06167.x; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Weerasooriya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107915; Xu XS, 2010, BRAIN RES, V1343, P206, DOI 10.1016/j.brainres.2010.04.080; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Zhang FJ, 2012, TOXICOL SCI, V128, P103, DOI 10.1093/toxsci/kfs142	67	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184619	10.1371/journal.pone.0184619	http://dx.doi.org/10.1371/journal.pone.0184619			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886188	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100170
J	Poma, A; Colafarina, S; Aruffo, E; Zarivi, O; Bonfigli, A; Di Bucchianico, S; Di Carlo, P				Poma, Anna; Colafarina, Sabrina; Aruffo, Eleonora; Zarivi, Osvaldo; Bonfigli, Antonella; Di Bucchianico, Sebastiano; Di Carlo, Piero			Effects of ozone exposure on human epithelial adenocarcinoma and normal fibroblasts cells	PLOS ONE			English	Article							CYTOGENETIC DAMAGE; GENE-EXPRESSION; AIR-POLLUTION; INHALATION; MODEL; GENOTOXICITY; POPULATIONS; GROWTH	Previous studies show variable ozone cytotoxicity and genotoxicity in cell cultures, laboratory animals and humans directly exposed to tropospheric ozone. The aim of this study was therefore to investigate and compare the cyto and genotoxic effects of ozone using adenocarcinoma human alveolar basal epithelial cells A549 and normal human fibroblasts Hs27. A cell culture chamber with controlled atmosphere (a simulation reactor) was built to inject a flow of 120 ppb of ozone, which is two times the threshold value for the protection of human health, fixed by the EU legislation. Cell proliferation was evaluated by a luminescent cell viability assay while we assessed the genotoxic potential of ozone by the induction of micronuclei as well as evaluating DNA strand breaks by the induction of micronuclei evaluated by means of the cytokinesis-block micronucleus (CBMN) assay as well as evaluating DNA strand breaks by Alkaline Comet Assay (CA) or Comet Assay. A549 cells viability decreases significantly at 24 hours treatment with 120 ppb of O-3 while at 48 hours and 72 hours O-3 treated cells viability doesn't differ in respect to the control. However a significative decrease of A549 viability is shown at 72 hours vs. 48 hours in both treated and not-treated cells. The viability trend in the Hs27 cells did not show any significant changes in treated samples compared to the control in all conditions. The two genotoxicity biomarkers, the micronucleus and the comet tests, showed in both the cell types exposed to ozone, a significant increase in the number of micronuclei and in the tail DNA % in respect to the control even if at different times/cell type. Moreover, we found that O-3 provokes genotoxic effects more evident in A549 cancer cells than in normal fibroblasts Hs27 ones. We applied a cell growth simulation model referred to ozone treated or not cell lines to confirm that the ozone exposure causes a slackening in the cells replication.	[Poma, Anna; Colafarina, Sabrina; Zarivi, Osvaldo; Bonfigli, Antonella; Di Bucchianico, Sebastiano] Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy; [Aruffo, Eleonora; Di Carlo, Piero] Univ G dAnnunzio, Dept Psychol Hlth & Terr Sci, Chieti, Italy; [Aruffo, Eleonora; Di Carlo, Piero] Univ Aquila, Ctr Excellence CETEMPS, Laquila, Italy	University of L'Aquila; G d'Annunzio University of Chieti-Pescara; University of L'Aquila	Poma, A (corresponding author), Univ Aquila, Dept Life Hlth & Environm Sci, Laquila, Italy.	annamariagiuseppina.poma@univaq.it	Di Carlo, Piero/Q-4450-2016; Poma, Anna/AAH-5751-2019; Zarivi, Osvaldo/V-2939-2018; Zarivi, Osvaldo/AAB-2150-2022; Di+Bucchianico, Sebastiano/AHI-8150-2022; Zarivi, Osvaldo/ABG-8795-2021; Di Bucchianico, Sebastiano/AAX-7000-2020	Di Carlo, Piero/0000-0003-4971-4509; Zarivi, Osvaldo/0000-0002-8312-9955; Zarivi, Osvaldo/0000-0002-8312-9955; Di+Bucchianico, Sebastiano/0000-0002-6396-892X; ARUFFO, ELEONORA/0000-0002-9164-7293	DiSPuTer (Department of Psychological, Health and Territorial Sciences, University "G. d'Annunzio" of Chieti-Pescara, Italy); Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy	DiSPuTer (Department of Psychological, Health and Territorial Sciences, University "G. d'Annunzio" of Chieti-Pescara, Italy); Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy	The research funds of DiSPuTer (Department of Psychological, Health and Territorial Sciences, University "G. d'Annunzio" of Chieti-Pescara, Italy) have been supporting the work of EA and PDC and the research funds of Department of Life, Health and Environmental Sciences, University of L'Aquila, Italy have been supporting the work of AP, SC, AB and OZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton C, 2017, MATH BIOSCI ENG, V14, P581, DOI 10.3934/mbe.2017034; Chen C, 2006, MUTAGENESIS, V21, P131, DOI 10.1093/mutage/gel007; Chuang GC, 2009, AM J PHYSIOL-LUNG C, V297, pL209, DOI 10.1152/ajplung.00102.2009; De Boer RJ, 2006, B MATH BIOL, V68, P1011, DOI 10.1007/s11538-006-9094-8; Devlin RB, 2012, CIRCULATION, V126, P104, DOI 10.1161/CIRCULATIONAHA.112.094359; Di Carlo P, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007900; Di Carlo P, 2015, ATMOS POLLUT RES, V6, P29, DOI 10.5094/APR.2015.004; Enderling H, 2014, CURR PHARM DESIGN, V20, P4934; European Environment Agency, 2015, AIR QUALITY EUROPE 2, DOI [10.2800/62459, DOI 10.2800/62459]; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Ganesan S, 2017, COMMUN NONLINEAR SCI, V46, P135, DOI 10.1016/j.cnsns.2016.10.013; Grozdanovski T, 2009, APPL MATH LETT, V22, P1091, DOI 10.1016/j.aml.2008.10.002; HALLAM TG, 1983, J MATH BIOL, V18, P25, DOI 10.1007/BF00275908; Holland N, 2015, ENVIRON MOL MUTAGEN, V56, P378, DOI 10.1002/em.21921; Hoogervorst EM, 2003, CARCINOGENESIS, V24, P613, DOI 10.1093/carcin/24.3.613; Huen K, 2006, ENVIRON MOL MUTAGEN, V47, P236, DOI 10.1002/em.20193; Kurt OK, 2016, CURR OPIN PULM MED, V22, P138, DOI 10.1097/MCP.0000000000000248; Lakey PSJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep32916; Lee H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169209; Leroy P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127283; Meyer PS, 1999, TECHNOL FORECAST SOC, V61, P209, DOI 10.1016/S0040-1625(99)00022-0; Mudway I. S., 2000, Molecular Aspects of Medicine, V21, P1, DOI 10.1016/S0098-2997(00)00003-0; Nadadur SS, 2005, ENVIRON HEALTH PERSP, V113, P1717, DOI 10.1289/ehp.7413; OECD, 2010, OECD PUBLISHING, P1, DOI [10.1787/9789264095830-en, DOI 10.1787/9789264095830-EN]; OLIVE PL, 1991, CANCER RES, V51, P4671; Paffett ML, 2015, TOXICOL SCI, V146, P244, DOI 10.1093/toxsci/kfv093; Pearl R, 1927, Q REV BIOL, V2, P532, DOI 10.1086/394288; Poma A, 2014, MICROSCOPY ADV SCI R, P275; RAJINI P, 1995, TOXICOL APPL PHARM, V130, P32, DOI 10.1006/taap.1995.1005; Raza A, 2014, EUR HEART J, V35, P861, DOI 10.1093/eurheartj/eht489; Scassellati C, 2017, TOXICOL IN VITRO, V44, P100, DOI 10.1016/j.tiv.2017.06.021; Tang T, 2012, ENVIRON MOL MUTAGEN, V53, P125, DOI 10.1002/em.20695; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Vadasz P, 2005, INT J FOOD MICROBIOL, V102, P257, DOI 10.1016/j.ijfoodmicro.2004.12.018; VANDERWAL WAA, 1994, TOXICOL LETT, V72, P291, DOI 10.1016/0378-4274(94)90040-X; VICTORIN K, 1992, MUTAT RES, V277, P221, DOI 10.1016/0165-1110(92)90045-B; Wang J, 2017, J APPL TOXICOL, V37, P495, DOI 10.1002/jat.3385; Witschi H, 1999, TOXICOL SCI, V52, P162, DOI 10.1093/toxsci/52.2.162; Zavala J, 2016, INHAL TOXICOL, V28, P251, DOI 10.3109/08958378.2016.1157227; ZWIETERING MH, 1990, APPL ENVIRON MICROB, V56, P1875	40	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184519	10.1371/journal.pone.0184519	http://dx.doi.org/10.1371/journal.pone.0184519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886142	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100146
J	Zahedi, K; Barone, S; Destefano-Shields, C; Brooks, M; Murray-Stewart, T; Dunworth, M; Li, WM; Doherty, JR; Hall, MA; Smith, RD; Cleveland, JL; Casero, RA; Soleimani, M				Zahedi, Kamyar; Barone, Sharon; Destefano-Shields, Christina; Brooks, Marybeth; Murray-Stewart, Tracy; Dunworth, Matthew; Li, Weimin; Doherty, Joanne R.; Hall, Mark A.; Smith, Roger D.; Cleveland, John L.; Casero, Robert A., Jr.; Soleimani, Manoocher			Activation of endoplasmic reticulum stress response by enhanced polyamine catabolism is important in the mediation of cisplatininduced acute kidney injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; LYSOSOMAL MEMBRANE PERMEABILIZATION; DNA-DAMAGE RESPONSE; HYDROGEN-PEROXIDE; SPERMIDINE/SPERMINE N-1-ACETYLTRANSFERASE; ALDEHYDE LOAD; CELL-DEATH; REACTIVE ALDEHYDES; CEREBRAL-ISCHEMIA; SPERMINE OXIDASE	Cisplatin-induced nephrotoxicity limits its use in many cancer patients. The expression of enzymes involved in polyamine catabolism, spermidine/spermine N-1 - acetyltransferase (SSAT) and spermine oxidase (SMOX) increase in the kidneys of mice treated with cisplatin. We hypothesized that enhanced polyamine catabolism contributes to tissue damage in cisplatin acute kidney injury (AKI). Using gene knockout and chemical inhibitors, the role of polyamine catabolism in cisplatin AKI was examined. Deficiency of SSAT, SMOX or neutralization of the toxic products of polyamine degradation, H2O2 and aminopropanal, significantly diminished the severity of cisplatin AKI. In vitro studies demonstrated that the induction of SSAT and elevated polyamine catabolism in cells increases the phosphorylation of eukaryotic translation initiation factor 2 alpha(eIF2 alpha) and enhances the expression of binding immunoglobulin protein BiP/GRP78) and CCAAT-enhancer- binding protein homologous protein (CHOP/GADD153). The increased expression of these endoplasmic reticulum stress response (ERSR) markers was accompanied by the activation of caspase-3. These results suggest that enhanced polyamine degradation in cisplatin AKI may lead to tubular damage through the induction of ERSR and the consequent onset of apoptosis. In support of the above, we show that the ablation of the SSAT or SMOX gene, as well as the neutralization of polyamine catabolism products modulate the onset of ERSR (e.g. lower BiP and CHOP) and apoptosis (e.g. reduced activated caspase-3). These studies indicate that enhanced polyamine catabolism and its toxic products are important mediators of ERSR and critical to the pathogenesis of cisplatin AKI.	[Zahedi, Kamyar; Barone, Sharon; Soleimani, Manoocher] Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45220 USA; [Zahedi, Kamyar; Barone, Sharon; Brooks, Marybeth; Soleimani, Manoocher] Univ Cincinnati, Coll Med, Ctr Genet Transport, Cincinnati, OH 45220 USA; [Zahedi, Kamyar; Barone, Sharon; Soleimani, Manoocher] Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA; [Destefano-Shields, Christina; Murray-Stewart, Tracy; Dunworth, Matthew; Casero, Robert A., Jr.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Li, Weimin] H Lee Moffitt Canc Ctr & Res Inst, Dept Tumor Biol, Tampa, FL USA; [Li, Weimin; Doherty, Joanne R.; Hall, Mark A.; Cleveland, John L.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Smith, Roger D.; Cleveland, John L.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; Johns Hopkins University; Johns Hopkins Medicine; H Lee Moffitt Cancer Center & Research Institute; Scripps Research Institute; University System of Ohio; University of Cincinnati	Zahedi, K; Soleimani, M (corresponding author), Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45220 USA.; Zahedi, K; Soleimani, M (corresponding author), Univ Cincinnati, Coll Med, Ctr Genet Transport, Cincinnati, OH 45220 USA.; Zahedi, K; Soleimani, M (corresponding author), Vet Affairs Med Ctr, Res Serv, Cincinnati, OH 45267 USA.	zahedika@ucmail.uc.edu; soleimm@ucmail.uc.edu	Stewart, Tracy Murray/B-6137-2017; 黎, 伟/GXM-4040-2022; soleimani, m/U-6889-2017; Doherty, Joanne/AAU-3288-2020; Zahedi, Kamyar/AAQ-3428-2021	Stewart, Tracy Murray/0000-0001-8679-6414; soleimani, m/0000-0002-3446-8870; Casero, Robert/0000-0001-5653-3306; Dunworth, Matthew/0000-0002-8852-169X; Doherty, Joanne/0000-0003-2705-5194; DeStefano Shields, Christina/0000-0003-4714-3423	National Institutes of Health [CA100603, CA-204345]; Maryland Cigarette Restitution Fund; Veterans Administration [5 I01 BX001000-06]; Center for Genetics of Transport and Epithelial Biology; NATIONAL CANCER INSTITUTE [R01CA204345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Cigarette Restitution Fund; Veterans Administration(US Department of Veterans Affairs); Center for Genetics of Transport and Epithelial Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health Grant CA100603 (JLC); National Institutes of Health Grant CA-204345 (RAC); Maryland Cigarette Restitution Fund (RAC); Veterans Administration 5 I01 BX001000-06 (MS); Center for Genetics of Transport and Epithelial Biology (MS) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbouti A, 2001, FREE RADICAL BIO MED, V31, P490, DOI 10.1016/S0891-5849(01)00608-6; Barone S, 2005, AM J PHYSIOL-CELL PH, V289, pC826, DOI 10.1152/ajpcell.00629.2004; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; BRUNK UT, 1995, FREE RADICAL BIO MED, V19, P813, DOI 10.1016/0891-5849(95)02001-Q; BRUNK UT, 1995, REDOX REP, V1, P267, DOI 10.1080/13510002.1995.11746997; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Chaturvedi R, 2015, ONCOGENE, V34, P3429, DOI 10.1038/onc.2014.273; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Driessens N, 2009, ENDOCR-RELAT CANCER, V16, P845, DOI 10.1677/ERC-09-0020; Golab F, 2009, KIDNEY INT, V75, P783, DOI 10.1038/ki.2008.683; Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108; Groenendyk J, 2010, CIRC RES, V107, P1185, DOI 10.1161/CIRCRESAHA.110.227033; HASAN R, 1995, FEBS LETT, V368, P27, DOI 10.1016/0014-5793(95)00591-V; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Ivanova S, 2002, P NATL ACAD SCI USA, V99, P5579, DOI 10.1073/pnas.082609299; Ivanova S, 1998, J EXP MED, V188, P327, DOI 10.1084/jem.188.2.327; JANNE J, 1991, ANN MED, V23, P241, DOI 10.3109/07853899109148056; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; Landau G, 2010, J BIOL CHEM, V285, P12474, DOI 10.1074/jbc.M110.106419; Li SY, 2009, J MOL CELL CARDIOL, V47, P247, DOI 10.1016/j.yjmcc.2009.03.017; Liu H, 2005, J AM SOC NEPHROL, V16, P1985, DOI 10.1681/ASN.2004090768; Mandal A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25795; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Mohammad MK, 2012, TOXICOL APPL PHARM, V265, P73, DOI 10.1016/j.taap.2012.09.021; Murray-Stewart T, 2016, ONCOGENE, V35, P5480, DOI 10.1038/onc.2016.91; Niiranen K, 2002, J BIOL CHEM, V277, P25323, DOI 10.1074/jbc.M203599200; Ozkok A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/967826; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Pallepati P, 2011, BBA-MOL CELL RES, V1813, P1987, DOI 10.1016/j.bbamcr.2011.07.021; Rider JE, 2007, AMINO ACIDS, V33, P231, DOI 10.1007/s00726-007-0513-4; Sun ZL, 2008, AM J PHYSIOL-RENAL, V294, pF491, DOI 10.1152/ajprenal.00263.2007; Tanel A, 2014, BBA-MOL CELL RES, V1843, P827, DOI 10.1016/j.bbamcr.2013.12.012; Wang ZH, 2004, J AM SOC NEPHROL, V15, P1844, DOI 10.1097/01.ASN.0000131525.77636.D5; Wood PL, 2007, BRAIN RES, V1145, P150, DOI 10.1016/j.brainres.2006.10.004; Wood PL, 2006, BRAIN RES, V1095, P190, DOI 10.1016/j.brainres.2006.04.038; Wood PL, 2006, BRAIN RES, V1122, P184, DOI 10.1016/j.brainres.2006.09.003; Zahedi K, 2003, AM J PHYSIOL-RENAL, V284, pF1046, DOI 10.1152/ajprenal.00318.2002; Zahedi K, 2007, AM J PHYSIOL-CELL PH, V292, pC1204, DOI 10.1152/ajpcell.00451.2006; Zahedi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110161; Zahedi K, 2012, AM J PHYSIOL-GASTR L, V303, pG546, DOI 10.1152/ajpgi.00431.2011; Zahedi K, 2010, AM J PHYSIOL-CELL PH, V299, pC164, DOI 10.1152/ajpcell.00512.2009; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zahedi K, 2009, AM J PHYSIOL-GASTR L, V296, pG899, DOI 10.1152/ajpgi.90507.2008; Zhu SY, 2015, ARCH TOXICOL, V89, P2197, DOI 10.1007/s00204-015-1633-3	48	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184570	10.1371/journal.pone.0184570	http://dx.doi.org/10.1371/journal.pone.0184570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886181	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100159
J	Gallay, PA; Chatterji, U; Kirchhoff, A; Gandarilla, A; Gunawardana, M; Pyles, RB; Marzinke, MA; Moss, JA; Baum, MM				Gallay, Philippe A.; Chatterji, Udayan; Kirchhoff, Aaron; Gandarilla, Angel; Gunawardana, Manjula; Pyles, Richard B.; Marzinke, Mark A.; Moss, John A.; Baum, Marc M.			Prevention of vaginal and rectal HIV transmission by antiretroviral combinations in humanized mice	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; HUMAN-IMMUNODEFICIENCY-VIRUS; PREEXPOSURE PROPHYLAXIS; MUCOSAL TRANSMISSION; EXPERIMENTAL-DESIGN; PARTIAL PROTECTION; INTRAVAGINAL RING; AFRICAN WOMEN; ANIMAL-MODEL; BLT MICE	With more than 7,000 new HIV infections daily worldwide, there is an urgent need for non-vaccine biomedical prevention (nBP) strategies that are safe, effective, and acceptable. Clinical trials have demonstrated that pre-exposure prophylaxis (PrEP) with antiretrovirals (ARVs) can be effective at preventing HIV infection. In contrast, other trials using the same ARVs failed to show consistent efficacy. Topical (vaginal and rectal) dosing is a promising regimen for HIV PrEP as it leads to low systematic drug exposure. A series of titration studies were carried out in bone marrow/liver/thymus (BLT) mice aimed at determining the adequate drug concentrations applied vaginally or rectally that offer protection against rectal or vaginal HIV challenge. The dose-response relationship of these agents was measured and showed that topical tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) can offer 100% protection against rectal or vaginal HIV challenges. From the challenge data, EC50 values of 4.6 mu M for TDF and 0.6 mu M for FTC for HIV vaginal administration and 6.1 mu M TDF and 0.18 mu M for FTC for rectal administration were obtained. These findings suggest that the BLT mouse model is highly suitable for studying the dose-response relationship in single and combination ARV studies of vaginal or rectal HIV exposure. Application of this sensitive HIV infection model to more complex binary and ternary ARV combinations, particularly where agents have different mechanisms of action, should allow selection of optimal ARV combinations to be advanced into pre-clinical and clinical development as nBP products.	[Gallay, Philippe A.; Chatterji, Udayan; Kirchhoff, Aaron; Gandarilla, Angel] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Gunawardana, Manjula; Moss, John A.; Baum, Marc M.] Oak Crest Inst Sci, Dept Chem, Monrovia, CA USA; [Pyles, Richard B.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Marzinke, Mark A.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Marzinke, Mark A.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA	Scripps Research Institute; University of Texas System; University of Texas Medical Branch Galveston; Johns Hopkins University; Johns Hopkins University	Gallay, PA (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	gallay@scripps.edu		Baum, Marc/0000-0003-1558-5649; Moss, John/0000-0001-8091-3245	National Institute of Allergy And Infectious Diseases of the National Institutes of Health [U19AI113048]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125365, U19AI113048] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under award number U19AI113048.; We thank Dr. I. Chen for providing the JR-CSF plasmid via the AIDS Research and Reagent Program. We thank Karen J. Clingerman for assistance with the surgeries. We thank Perrin Larton from Advanced Bioscience Resources from providing us with fetal tissues. We greatly thank Cheryl Stoddart, Jose Rivera and Bruce Torbett for helpful discussion and advice for the initial establishment of the humanized BLT mouse model at The Scripps Research Institute. Research reported in this publication was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health under Award Number U19AI113048. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This is publication no. 29525 from the Department of Immunology & Microbiology, The Scripps Research Institute, La Jolla, CA.	[Anonymous], TRUV PROD MON; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baeten JM, 2013, CURR HIV-AIDS REP, V10, P142, DOI 10.1007/s11904-013-0157-9; Baum MM, 2015, INT J PHARMACEUT, V495, P579, DOI 10.1016/j.ijpharm.2015.09.028; Chateau ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060024; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Chou TC, 2005, COMPUSYN DRUG COMBIN; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cohen MS, 2010, CLIN INFECT DIS, V50, pS85, DOI 10.1086/651478; Cutler B, 2008, LANCET INFECT DIS, V8, P685, DOI 10.1016/S1473-3099(08)70254-8; Delany-Moretlwe S, 2014, AIDS RES HUM RETROV, V30, pA281, DOI 10.1089/aid.2014.5637.abstract; Denton PW, 2012, TRENDS MICROBIOL, V20, P268, DOI 10.1016/j.tim.2012.03.007; Denton PW, 2011, J VIROL, V85, P7582, DOI 10.1128/JVI.00537-11; Denton PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008829; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Derdelinckx I, 2006, PLOS MED, V3, P1999, DOI 10.1371/journal.pmed.0030454; Deruaz M, 2013, J INFECT DIS, V208, pS131, DOI 10.1093/infdis/jit318; Grant RM, 2005, SCIENCE, V309, P2170, DOI 10.1126/science.1116204; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gupta K, 2006, PLOS MED, V3, P181, DOI 10.1371/journal.pmed.0030079; Hendrix CW, 2016, AIDS RES HUM RETROV, V32, P32, DOI [10.1089/aid.2015.0182, 10.1089/AID.2015.0182]; Hendrix CW, 2013, CELL, V155, P515, DOI 10.1016/j.cell.2013.09.030; Hendrix CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055013; Jilek BL, 2012, NAT MED, V18, P446, DOI 10.1038/nm.2649; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Karpel ME, 2015, CURR OPIN VIROL, V13, P75, DOI 10.1016/j.coviro.2015.05.002; Kovarova M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005075; Lan P, 2006, BLOOD, V108, P487, DOI 10.1182/blood-2005-11-4388; Landovitz Raphael J, 2007, Top HIV Med, V15, P99; Liu AY, 2006, JAMA-J AM MED ASSOC, V296, P863, DOI 10.1001/jama.296.7.863; Marcus JL, 2016, JAIDS-J ACQ IMM DEF, V73, P540, DOI 10.1097/QAI.0000000000001129; Marrazzo JM, 2015, OBSTET GYNECOL SURV, V70, P444, DOI 10.1097/01.ogx.0000466878.37011.6f; Mascolini Mark, 2009, J Int AIDS Soc, V12 Suppl 1, pS4, DOI 10.1186/1758-2652-12-S1-S4; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; McGowan I, 2010, CURR OPIN INFECT DIS, V23, P26, DOI 10.1097/QCO.0b013e328334fe70; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mesquita PMM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-113; Mesquita PMM, 2012, J ANTIMICROB CHEMOTH, V67, P1730, DOI 10.1093/jac/dks097; MILLER CJ, 1989, J VIROL, V63, P4277, DOI 10.1128/JVI.63.10.4277-4284.1989; Molina JM, 2015, NEW ENGL J MED, V373, P2237, DOI 10.1056/NEJMoa1506273; Nischang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038853; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Pauza CD, 1998, AIDS RES HUM RETROV, V14, pS83; Paxton LA, 2007, LANCET, V370, P89, DOI 10.1016/S0140-6736(07)61053-8; Shen L, 2008, NAT MED, V14, P762, DOI 10.1038/nm1777; Srinivasan P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157061; Stoddart CA, 2011, VIROLOGY, V417, P154, DOI 10.1016/j.virol.2011.05.013; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Turpin JA, 2011, DRUG DELIV TRANSL RE, V1, P194, DOI 10.1007/s13346-011-0034-2; Ursell LK, 2014, ANTIVIR RES, V102, P87, DOI 10.1016/j.antiviral.2013.12.004; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten Ariane, 2014, J Int AIDS Soc, V17, P19146, DOI 10.7448/IAS.17.3.19146; Veazey RS, 2008, CURR OPIN HIV AIDS, V3, P567, DOI 10.1097/COH.0b013e32830891bb; Veazey RS, 2005, NAT MED, V11, P1293, DOI 10.1038/nm1321; Wahl A, 2014, J IMMUNOL METHODS, V410, P28, DOI 10.1016/j.jim.2014.06.009; Wege AK, 2008, CURR TOP MICROBIOL, V324, P149; WHO-UNAIDS, 2010, REP GLOB AIDS EP; Williams R, 2008, J NEUROVIROL, V14, P292, DOI 10.1080/13550280802074539; Youle M, 2003, AIDS, V17, P937, DOI 10.1097/00002030-200304110-00027	65	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184303	10.1371/journal.pone.0184303	http://dx.doi.org/10.1371/journal.pone.0184303			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880948	gold, Green Published, Green Submitted			2022-12-27	WOS:000409467200048
J	Epstein, N; Fischer, MR				Epstein, Nurith; Fischer, Martin R.			Academic career intentions in the life sciences: Can research self-efficacy beliefs explain low numbers of aspiring physician and female scientists?	PLOS ONE			English	Article							GENDER-DIFFERENCES; MEDICINE; WOMEN; PRODUCTIVITY; PREDICTORS; AUTHORSHIP; STUDENTS; IMPACT; WORK	A lack of physician scientists as well as a high female dropout rate from academic medicine and basic life sciences is a concern in many countries. The current study analyzes academic career intentions within a sample of recent doctoral graduates from medicine and basic life sciences (N = 1109), focusing on research self-efficacy beliefs as explanatory variable of gender and disciplinary differences. To ensure that differences in research self-efficacy could not be attributed solely to objective scientific performance, we controlled for number of publications and dissertation grade. The results of multivariate analyses pointed to a strong and significant association between research self-efficacy and academic career intentions (beta = 0.49, p<0.001). The lower academic career intentions of medical doctoral graduates were no longer significant when controlling for research self-efficacy. Within the field of medicine, female doctoral graduates expressed lower research self-efficacy beliefs and academic career intentions. When controlling for research self-efficacy, the correlation between gender and academic career intention was no longer significant. In contrast, no gender differences were found within the basic life sciences with respect to neither academic career intentions nor research self-efficacy.	[Epstein, Nurith; Fischer, Martin R.] Klinikum Univ Munchen, Inst Didakt & Ausbildungsforsch Med, Munich, Germany	University of Munich	Epstein, N (corresponding author), Klinikum Univ Munchen, Inst Didakt & Ausbildungsforsch Med, Munich, Germany.	Nurith.Epstein@med.uni-muenchen.de			Federal Ministry for Education and Research, Germany (Bundesministerium fur Bildung und Forschung)	Federal Ministry for Education and Research, Germany (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	The study was conducted within the E-Prom project which was funded by the Federal Ministry for Education and Research, Germany (Bundesministerium fur Bildung und Forschung, https://www.bmbf.de/de/forschung-zum-wissenschaftlichen-nachwuchs-571.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele AE., 2006, KARRIEREVERLAUFE BER, P35; Abele AE, 2009, J VOCAT BEHAV, V74, P53, DOI 10.1016/j.jvb.2008.10.005; Abele-Brehm AE, 2004, Z ARB ORGAN, V48, P4, DOI 10.1026/0932-4089.48.1.4; Althaber A, 2011, KARRIERE KIND WISSEN; [Anonymous], 2011, STAT STAT SOFTW REL; Bakken LL, 2003, ACAD MED, V78, P1281, DOI 10.1097/00001888-200312000-00018; Bakken LL, 2010, ADV HEALTH SCI EDUC, V15, P167, DOI 10.1007/s10459-009-9190-2; Bandura A, 2001, CHILD DEV, V72, P187, DOI 10.1111/1467-8624.00273; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Baum C, 2009, BUNDESGESUNDHEITSBLA, V52, P856, DOI 10.1007/s00103-009-0903-8; Beisiegel U, 2009, BUNDESGESUNDHEITSBLA, V52, P850, DOI 10.1007/s00103-009-0904-7; Berning E., 2006, PROMOVIEREN U TEN BA; Berweger S, 2005, Z PADAGOG PSYCHOL, V19, P145, DOI 10.1024/1010-0652.19.3.145; Berweger S., 2008, THESIS; Bieschke KJ, 1996, J CAREER ASSESSMENT, V4, P59, DOI 10.1177/106907279600400104; Bornemann L, 2002, BEITRAGE HOCHSCHULFO, V24, P52; Briedis K, 2014, LAUFBAHNENTSCHEIDUNG; Brodesser D, 2015, GESIS PAPERS, P21; Buddeberg-Fischer B, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-70; Ceci SJ, 2009, PSYCHOL BULL, V135, P218, DOI 10.1037/a0014412; Collins JP, 2002, BIOSCIENCE, V52, P75, DOI 10.1641/0006-3568(2002)052[0075:MYLIIT]2.0.CO;2; Dalhoff J., 2005, DER CHIRURG BDC, V12, pM390; Destatis, 2015, WIESBADEN STAT BUNDE; Destatis, 2014, WIESBADEN STAT BUNDE; Deutsche Forschungsgemeinschaft (DFG), 2010, EMPF SEN KLIN FORSCH; Epstein N, 2016, BEITR HOCHSCHULFORSC, P162; Estrada M, 2011, J EDUC PSYCHOL, V103, P206, DOI 10.1037/a0020743; Festinger L., 1962, THEORY COGNITIVE DIS; Fitzenberger B, 2014, GER ECON REV, V15, P287, DOI 10.1111/geer.12010; Fox MF, 2005, SOC STUD SCI, V35, P131, DOI 10.1177/0306312705046630; Fuchs S, 2001, MINERVA, V39, P175, DOI 10.1023/A:1010380510013; Gensch K, 2006, ENTWICKLUNG ARZTLICH; Gerst T, 2012, DTSCH ARZTEBL, V109, P37; Gibbs KD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114736; Gordon R, 2012, ACCOUNT RES, V19, P89, DOI 10.1080/08989621.2012.660076; Gore PA, 2006, J CAREER ASSESSMENT, V14, P92, DOI 10.1177/1069072705281367; Hakimi M, 2010, GEFASSCHIRURGIE, V15, P589, DOI 10.1007/s00772-009-0772-3; Hamel MB, 2006, NEW ENGL J MED, V355, P310, DOI 10.1056/NEJMe068143; Hanika MMS, 2015, THESIS; Hauss K., 2015, INT J DEV RES, V6, P122, DOI [DOI 10.1108/IJRD-07-2014-0015, 10.1108/IJRD-07-2014-0015]; Hemmings B, 2009, ISS EDUC RES, V19, P243; Hornbostel S., 2012, IF WORKING PAPER, V12, P7; Huang CJ, 2013, EUR J PSYCHOL EDUC, V28, P663, DOI 10.1007/s10212-012-0134-5; Ills of the system. Reform is long overdue for Germany's archaic medical-education system which puts undue pressure on students and contaminates the scientific literature, 2015, NATURE, V527, P7; Jagsi R, 2006, NEW ENGL J MED, V355, P281, DOI 10.1056/NEJMsa053910; Jaksztat S, 2010, WISSENSCHAFTLICHEN; Jostl G, 2012, Z PSYCHOL, V220, P109, DOI 10.1027/2151-2604/a000102; Klock G., 2010, BIOL UNSERER Z, V40, P375; Kostoff RN, 2002, BIOSCIENCE, V52, P937, DOI 10.1641/0006-3568(2002)052[0937:OS]2.0.CO;2; Kyvik S, 2013, HIGH EDUC, V65, P525, DOI 10.1007/s10734-012-9561-0; Lind I, 2007, SCHWEIZERISCHE Z BIL, V29, P249; Loos S, 2014, SYSTEMATISCHE SITUAT; Loos S, 2014, FORSCHUNG INNOVATION; Musselin C, 2005, HIGH EDUC, V49, P135, DOI 10.1007/s10734-004-2918-2; Neugebauer KM, 2006, PLOS BIOL, V4, P494, DOI 10.1371/journal.pbio.0040097; Nonnemaker L, 2000, NEW ENGL J MED, V342, P399, DOI 10.1056/NEJM200002103420606; O'Brien KM, 1998, M AM PSYCHOL ASS C; Pajares F, 1996, REV EDUC RES, V66, P543, DOI 10.2307/1170653; Pfeiffer M, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0712-3; PHILLIPS JC, 1994, COUNS PSYCHOL, V22, P628, DOI 10.1177/0011000094224008; Plasa TN, 2014, BIOL UNSERER Z, V44, P364; Plumper T, 2007, POLIT VIERTELJAHR, V48, P97, DOI 10.1007/s11615-007-0008-7; Reimann S, 2014, Z FAMILIENFORSCHUNG, V26; Rosenberg LE, 1999, J CLIN INVEST, V103, P1621, DOI 10.1172/JCI7304; Rosta J, 2007, DTSCH ARZTEBL, V104, P2417; RUBECK RF, 1995, ACAD MED, V70, P318, DOI 10.1097/00001888-199504000-00016; Schunk D.H., 1984, ANN M AM ED RES ASS; SCHUNK DH, 1986, J EDUC RES, V79, P238, DOI 10.1080/00220671.1986.10885684; Sidhu R, 2009, J ROY SOC MED, V102, P337, DOI 10.1258/jrsm.2009.080378; Spiegel H, 2007, DTSCH AERZTEBL, V104, pA3385; Spies K, 1999, Z SOZIALPSYCHOL, V30, P229, DOI 10.1024//0044-3514.30.4.229; Stajkovic AD, 1998, PSYCHOL BULL, V124, P240, DOI 10.1037/0033-2909.124.2.240; Stallmach A., 2011, DTSCH ARZTEBL, V108, P380; Streiner DL, 2005, CAN J PSYCHIAT, V50, P115, DOI 10.1177/070674370505000207; Susanne Falk, 2007, BEITR HOCHSCHULFORSC, V29, P34; Symonds MRE, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000127; Tolli AP, 2008, J APPL PSYCHOL, V93, P692, DOI 10.1037/0021-9010.93.3.692; van Arensbergen P, 2012, SCIENTOMETRICS, V93, P857, DOI 10.1007/s11192-012-0712-y; Villablanca AC, 2011, J WOMENS HEALTH, V20, P1485, DOI 10.1089/jwh.2011.2737; Wissenschaftsrat, 2014, EMPF WEIT MED DEUTSC; Zemlo TR, 2000, FASEB J, V14, P221, DOI 10.1096/fasebj.14.2.221; ZIMMERMAN BJ, 1992, AM EDUC RES J, V29, P663, DOI 10.3102/00028312029003663	83	15	16	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184543	10.1371/journal.pone.0184543	http://dx.doi.org/10.1371/journal.pone.0184543			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910334	gold, Green Submitted, Green Published			2022-12-27	WOS:000410859200059
J	Bowler, D; Bohning-Gaese, K				Bowler, Diana; Boehning-Gaese, Katrin			Improving the community-temperature index as a climate change indicator	PLOS ONE			English	Article							BIRD POPULATIONS; HABITAT; FISH; IMPACTS	Climate change indicators are tools to assess, visualize and communicate the impacts of climate change on species and communities. Indicators that can be applied to different taxa are particularly useful because they allow comparative analysis to identify which kinds of species are being more affected. A general prediction, supported by empirical data, is that the abundance of warm-adapted species should increase over time, relative to the cool-adapted ones within communities, under increasing ambient temperatures. The community temperature index (CTI) is a community weighted mean of species' temperature preferences and has been used as an indicator to summarize this temporal shift. The CTI has the advantages of being a simple and generalizable indicator; however, a core problem is that temporal trends in the CTI may not only reflect changes in temperature. This is because species' temperature preferences often covary with other species attributes, and these other attributes may affect species response to other environmental drivers. Here, we propose a novel model-based approach that separates the effects of temperature preference from the effects of other species attributes on species' abundances and subsequently on the CTI. Using long-term population data of breeding birds in Denmark and demersal marine fish in the southeastern North Sea, we find differences in CTI trends with the original approach and our model-based approach, which may affect interpretation of climate change impacts. We suggest that our method can be used to test the robustness of CTI trends to the possible effects of other drivers of change, apart from climate change.	[Bowler, Diana; Boehning-Gaese, Katrin] Senckenberg Biodivers & Climate Res Ctr, Frankfurt, Germany; [Boehning-Gaese, Katrin] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Frankfurt, Germany	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt	Bowler, D (corresponding author), Senckenberg Biodivers & Climate Res Ctr, Frankfurt, Germany.	diana.e.bowler@gmail.com	Böhning-Gaese, Katrin/W-2601-2019	Böhning-Gaese, Katrin/0000-0003-0477-5586; Bowler, Diana/0000-0002-7775-1668	German Research Foundation DFG [B0 1221/23-1]	German Research Foundation DFG(German Research Foundation (DFG))	Funded by German Research Foundation DFG: Grant no. BO 1221/23-1). The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnagaud JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032819; BirdLifeInternational NatureServe, 2012, BIRD SPEC DISTR MAPS; Clavero M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018581; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Daan N, 2005, ICES J MAR SCI, V62, P177, DOI 10.1016/j.icesjms.2004.08.020; De Frenne P, 2013, P NATL ACAD SCI USA, V110, P18561, DOI 10.1073/pnas.1311190110; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Devictor V, 2008, GLOBAL ECOL BIOGEOGR, V17, P252, DOI 10.1111/j.1466-8238.2007.00364.x; Devictor V, 2012, NAT CLIM CHANGE, V2, P638, DOI 10.1038/nclimate1668; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Doxa A, 2010, J APPL ECOL, V47, P1348, DOI 10.1111/j.1365-2664.2010.01869.x; Duque A, 2015, P NATL ACAD SCI USA, V112, P10744, DOI 10.1073/pnas.1506570112; Duru M, 2010, ANN BOT-LONDON, V106, P823, DOI 10.1093/aob/mcq178; Eskildsen Anne, 2013, DANSK ORNITOLOGISK FORENINGS TIDSSKRIFT, V107, P191; Filz KJ, 2013, EUR J ENTOMOL, V110, P633, DOI 10.14411/eje.2013.086; Fisher JAD, 2010, ECOLOGY, V91, P2499, DOI 10.1890/09-1914.1; Frishkoff LO, 2016, ECOL LETT, V19, P1081, DOI 10.1111/ele.12645; Froese R, FISHBASE; Godet L, 2011, BIOL LETTERS, V7, P714, DOI 10.1098/rsbl.2011.0152; Haylock M, 2008, J GEOPHYS RES-ATMOS, V1984-2012, P113; Heldbjerg Henning, 2005, Dansk Ornitologisk Forenings Tidsskrift, V99, P182; ICES, 2012, 1IBTS8 ICES SISP; Jiguet F, 2010, GLOBAL CHANGE BIOL, V16, P497, DOI 10.1111/j.1365-2486.2009.01963.x; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Kaschner K., 2013, AQUAMAPS ENV DATASET; Larsen JL, 2011, ECOL INDIC, V11, P1459, DOI 10.1016/j.ecolind.2011.03.023; Lemoine N, 2007, CONSERV BIOL, V21, P495, DOI 10.1111/j.1523-1739.2006.00633.x; Lindstrom A, 2013, ECOGRAPHY, V36, P313, DOI 10.1111/j.1600-0587.2012.07799.x; Muus B.J., 1999, SEA FISH; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Philippart CJM, 1998, ICES J MAR SCI, V55, P342, DOI 10.1006/jmsc.1997.0321; Prince K, 2015, GLOBAL CHANGE BIOL, V21, P572, DOI 10.1111/gcb.12740; Ricotta C, 2011, OECOLOGIA, V167, P181, DOI 10.1007/s00442-011-1965-5; Roth T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082490; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Stefanescu C, 2011, J INSECT CONSERV, V15, P83, DOI 10.1007/s10841-010-9325-z; Stephens PA, 2016, SCIENCE, V352, P84, DOI 10.1126/science.aac4858; Tayleur CM, 2016, DIVERS DISTRIB, V22, P468, DOI 10.1111/ddi.12412; Van Swaay C.A.M., 2012, VLINDERSTICHTING DUT; Virkkala R, 2014, GLOBAL CHANGE BIOL, V20, P2995, DOI [10.1111/gcb.12573, 10.1111/gcb.1]; Zografou K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087245	44	22	22	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184275	10.1371/journal.pone.0184275	http://dx.doi.org/10.1371/journal.pone.0184275			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898285	Green Published, Green Submitted, gold			2022-12-27	WOS:000410449500021
J	Gimenez, J; Marcalo, A; Ramirez, F; Verborgh, P; Gauffier, P; Esteban, R; Nicolau, L; Gonzalez-Ortegon, E; Baldo, F; Vilas, C; Vingada, J; Forero, MG; de Stephanis, R				Gimenez, Joan; Marcalo, Ana; Ramirez, Francisco; Verborgh, Philippe; Gauffier, Pauline; Esteban, Ruth; Nicolau, Lidia; Gonzalez-Ortegon, Enrique; Baldo, Francisco; Vilas, Cesar; Vingada, Jose; Forero, Manuela G.; de Stephanis, Renaud			Diet of bottlenose dolphins (Tursiops truncatus) from the Gulf of Cadiz: Insights from stomach content and stable isotope analyses	PLOS ONE			English	Article							GRAPHICAL ANALYSIS; MEDITERRANEAN SEA; FEEDING STRATEGY; FISHING IMPACTS; MARINE MAMMALS; WESTERN SPAIN; MIXING MODELS; ECOLOGY; WATERS; ECOSYSTEM	The ecological role of species can vary among populations depending on local and regional differences in diet. This is particularly true for top predators such as the bottlenose dolphin (Tursiops truncatus), which exhibits a highly varied diet throughout its distribution range. Local dietary assessments are therefore critical to fully understand the role of this species within marine ecosystems, as well as its interaction with important ecosystem services such as fisheries. Here, we combined stomach content analyses (SCA) and stable isotope analyses (SIA) to describe bottlenose dolphins diet in the Gulf of Cadiz (North Atlantic Ocean). Prey items identified using SCA included European conger (Conger conger) and European hake (Merluccius merluccius) as the most important ingested prey. However, mass-balance isotopic mixing model (MixSIAR), using delta(13) C and delta(15) N, indicated that the assimilated diet consisted mainly on Sparidae species (e.g. seabream, Diplodus annularis and D. bellottii, rubberlip grunt, Plectorhinchus mediterraneus, and common pandora, Pagellus erythrinus) and a mixture of other species including European hake, mackerels (Scomber colias, S. japonicus and S. scombrus), European conger, red bandfish (Cepola macrophthalma) and European pilchard (Sardina pilchardus). These contrasting results highlight differences in the temporal and taxonomic resolution of each approach, but also point to potential differences between ingested (SCA) and assimilated (SIA) diets. Both approaches provide different insights, e.g. determination of consumed fish biomass for the management of fish stocks (SCA) or identification of important assimilated prey species to the consumer (SIA).	[Gimenez, Joan; Forero, Manuela G.] EBD CSIC, Dept Biol Conservac, Seville, Spain; [Marcalo, Ana; Nicolau, Lidia; Vingada, Jose] Univ Aveiro, Ctr Environm & Marine Studies CESAM, Campus Univ Santiago, Aveiro, Portugal; [Marcalo, Ana; Nicolau, Lidia; Vingada, Jose] Univ Minho, Dept Biol, CBMA, SPVS, Campus Gualtar, Braga, Portugal; [Ramirez, Francisco] Univ Barcelona, Dept Biol Evolut Ecol & Ciencies Ambientals, Barcelona, Spain; [Verborgh, Philippe; Gauffier, Pauline; Esteban, Ruth; de Stephanis, Renaud] Conservat Informat & Res Cetaceans CIRCE, Cadiz, Spain; [Gonzalez-Ortegon, Enrique] Consejo Super Invest Cient ICMAN CSIC, Inst Ciencias Marinas Andalucia, Campus Univ Rio San Pedro, Cadiz, Spain; [Baldo, Francisco] Ctr Oceanog Cadiz, IEO, Cadiz, Spain; [Vilas, Cesar] Consejeria Agr Pesca & Desarrollo Local, Junta Andalucia, FAPA Ctr El Toruno, Inst Invest & Formac Agr & Pesquera, Cadiz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade de Aveiro; Universidade do Minho; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN)	Gimenez, J (corresponding author), EBD CSIC, Dept Biol Conservac, Seville, Spain.	gimenez.verdugo@gmail.com	Esteban, Ruth/Q-8492-2018; Gimenez, Joan/C-6107-2015; Marçalo, Ana/ABI-5648-2020; Gauffier, Pauline/W-8148-2019; de Stephanis, Renaud/AAA-5682-2019; Baldó, Francisco/B-1477-2016; Gauffier, Pauline/M-3952-2014; Vilas, Cesar/A-4162-2011; Ortegón, Enrique González/L-7292-2014; Ramírez, Francisco/I-3553-2014; Nicolau, Lídia/AAG-5009-2021; Vingada, Jose/K-1404-2015	Esteban, Ruth/0000-0002-8674-6940; Gimenez, Joan/0000-0001-9207-4792; Marçalo, Ana/0000-0002-0485-341X; Gauffier, Pauline/0000-0003-2984-6993; Baldó, Francisco/0000-0003-4220-4207; Gauffier, Pauline/0000-0003-2984-6993; Vilas, Cesar/0000-0002-6229-8880; Ortegón, Enrique González/0000-0002-0282-499X; Ramírez, Francisco/0000-0001-9670-486X; de Stephanis, Renaud/0000-0003-2522-7933; Vingada, Jose/0000-0003-1940-1683	Fundacion Loro Parque, CEPSA (Compania Espanola de Petroleos S.A.) [CGL2011-25543]; SafeSea EEA-Grants; European Commission's Life Programme [MarPro NAT/PT/00038]; Spanish Ministry of Economy and Competitiveness through the Severo Ochoa Programme for Centres of Excellence in R +D+1 [SEV-2012-0262]; Portuguese Foundation for Science and Technology [SFRH/BPD/64889/2009, SFRH/BD/51416/2011]; Consejeria de Economia, Innovacion y Ciencia - Junta de Andalucia [ECOBOGUE-P11RNM7467]	Fundacion Loro Parque, CEPSA (Compania Espanola de Petroleos S.A.); SafeSea EEA-Grants; European Commission's Life Programme; Spanish Ministry of Economy and Competitiveness through the Severo Ochoa Programme for Centres of Excellence in R +D+1; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Consejeria de Economia, Innovacion y Ciencia - Junta de Andalucia(Junta de Andalucia)	The study was funded by Fundacion Loro Parque, CEPSA (Compania Espanola de Petroleos S.A.), EcoCet Project [CGL2011-25543], SafeSea EEA-Grants and European Commission's Life Programme [MarPro NAT/PT/00038]. J.G. and R.dS. were funded by the Spanish Ministry of Economy and Competitiveness through the Severo Ochoa Programme for Centres of Excellence in R +D+1 [SEV-2012-0262]. A.M. and L.N. were partly supported by the Portuguese Foundation for Science and Technology [SFRH/BPD/64889/2009 and SFRH/BD/51416/2011]. Project ECOBOGUE-P11RNM7467 was funded by "Consejeria de Economia, Innovacion y Ciencia - Junta de Andalucia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundsen PA, 1996, J FISH BIOL, V48, P607, DOI 10.1111/j.1095-8649.1996.tb01455.x; Torres MA, 2013, ECOL MODEL, V265, P26, DOI 10.1016/j.ecolmodel.2013.05.019; [Anonymous], 2007, J MAR BIOL ASSOC UK, V87, P213; Barros Nelio B., 2000, Aquatic Mammals, V26, P2; Santos MB, 2014, DEEP-SEA RES PT II, V106, P232, DOI 10.1016/j.dsr2.2013.09.040; Santos MB, 2013, MAR ECOL PROG SER, V481, P249, DOI 10.3354/meps10233; Blanco C, 2001, J MAR BIOL ASSOC UK, V81, P1053, DOI 10.1017/S0025315401005057; Bowen WD, 2013, MAR MAMMAL SCI, V29, P719, DOI 10.1111/j.1748-7692.2012.00604.x; Canty A., 2011, R PACKAGE VERSION, V1, P3; Chiaradia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092665; Clarke M.R, 1986, HDB IDENTIFICATION C; Coll M, 2014, FISH RES, V154, P179, DOI 10.1016/j.fishres.2014.01.013; Coll M, 2007, J MARINE SYST, V67, P119, DOI 10.1016/j.jmarsys.2006.10.002; COSTELLO MJ, 1990, J FISH BIOL, V36, P261, DOI 10.1111/j.1095-8649.1990.tb05601.x; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; Dunshea G, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1036; Fernandez R, 2011, MAR BIOL, V158, P1043, DOI 10.1007/s00227-011-1629-3; Gannon DP, 2004, MAR MAMMAL SCI, V20, P527, DOI 10.1111/j.1748-7692.2004.tb01177.x; Gimenez J, 2011, Vet Rec, V168, p101b, DOI 10.1136/vr.c5284; Gimenez J, 2016, J FISH BIOL; Gimenez J, 2016, J EXP MAR BIOL ECOL, V475, P54, DOI 10.1016/j.jembe.2015.11.001; Gladilina E. V., 2014, Vestnik Zoologii, V48, P83, DOI 10.2478/vzoo-2014-0009; Harkonen T.J., 1986, GUIDE OTOLITHS BONY, P256; Hernandez-Milian G., 2014, TROPHIC ROLE SMALL C; Hernandez-Milian G, 2015, AQUAT MAMM, V41, P226, DOI 10.1578/AM.41.2.2015.226; HYNES HBN, 1950, J ANIM ECOL, V19, P36, DOI 10.2307/1570; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; Jansen OE, 2013, MAR MAMMAL SCI, V29, pE295, DOI 10.1111/j.1748-7692.2012.00621.x; Kiszka JJ, 2014, MAR BIOL, V161, P953, DOI 10.1007/s00227-014-2395-9; Libralato S, 2006, ECOL MODEL, V195, P153, DOI 10.1016/j.ecolmodel.2005.11.029; Lopez N, 2016, ESTUAR COAST SHELF S, V175, P15, DOI 10.1016/j.ecss.2016.03.007; Louis M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1558; Di Beneditto APM, 2011, MAR BIOL, V158, P2209, DOI 10.1007/s00227-011-1726-3; Mann Janet, 2003, P236, DOI 10.1017/CBO9780511584022.010; McIntosh RR, 2006, WILDLIFE RES, V33, P661, DOI 10.1071/WR06025; Mendez-Fernandez P, 2012, J EXP MAR BIOL ECOL, V413, P150, DOI 10.1016/j.jembe.2011.12.007; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; PIERCE GJ, 1991, OCEANOGR MAR BIOL, V29, P409; Pinkas L., 1970, SCRIPPS I OCEANOGR, V152, P1; Querouil S, 2013, MAR BIOL, V160, P1325, DOI 10.1007/s00227-013-2184-x; Ramirez F, 2015, MAR ECOL PROG SER, V527, P221, DOI 10.3354/meps11282; Ramos R, 2009, MAR ECOL PROG SER, V377, P289, DOI 10.3354/meps07792; Santos MB, 2007, J MAR BIOL ASSOC UK, V87, P231, DOI 10.1017/S0025315407055233; Santos MB, 2015, HYDROBIOLOGIA, V750, P13, DOI 10.1007/s10750-014-2164-2; Santos MB, 2001, J MAR BIOL ASSOC UK, V81, P873, DOI 10.1017/S0025315401004714; Silva L, 2002, FISH RES, V59, P117, DOI 10.1016/S0165-7836(01)00420-9; Silva MA, 1999, J MAR BIOL ASSOC UK, V79, P531, DOI 10.1017/S0025315498000654; Smith JA, 2013, METHODS ECOL EVOL, V4, P612, DOI 10.1111/2041-210X.12048; Smith SC, 2000, MAR MAMMAL SCI, V16, P315, DOI 10.1111/j.1748-7692.2000.tb00927.x; Sobrino I, 1994, DESCRIPCION PESQUERI, V151; Spitz J, 2006, ESTUAR COAST SHELF S, V70, P259, DOI 10.1016/j.ecss.2006.04.020; Spitz J, 2010, J EXP MAR BIOL ECOL, V390, P73, DOI 10.1016/j.jembe.2010.05.010; Stock B.C., 2013, MIXSIAR GUI USER MAN; Tollit DJ, 2009, ECOL APPL, V19, P889, DOI 10.1890/07-1701.1; Tuset VM, 2008, SCI MAR, V72, P7, DOI 10.3989/scimar.2008.72s1199; Vander Zanden MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116182; Vespe M, 2016, J MAPS; Votier SC, 2003, POLAR BIOL, V26, P20, DOI 10.1007/s00300-002-0446-z; Walker JL, 1999, MAR MAMMAL SCI, V15, P335, DOI 10.1111/j.1748-7692.1999.tb00805.x; Watt J., 1997, ICES COOPERATIVE RES	63	32	32	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184673	10.1371/journal.pone.0184673	http://dx.doi.org/10.1371/journal.pone.0184673			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898268	Green Submitted, Green Published, gold			2022-12-27	WOS:000410449500042
J	Hoevenaar-Blom, MP; Guillemont, J; Ngandu, T; Beishuizen, CRL; Coley, N; van Charante, EPM; Andrieu, S; Kivipelto, M; Soininen, H; Brayne, C; Meiller, Y; Richard, E				Hoevenaar-Blom, Marieke P.; Guillemont, Juliette; Ngandu, Tiia; Beishuizen, Cathrien R. L.; Coley, Nicola; van Charante, Eric P. Moll; Andrieu, Sandrine; Kivipelto, Miia; Soininen, Hilkka; Brayne, Carol; Meiller, Yannick; Richard, Edo			Improving data sharing in research with context-free encoded missing data	PLOS ONE			English	Article							CLINICAL-TRIALS	Lack of attention to missing data in research may result in biased results, loss of power and reduced generalizability. Registering reasons for missing values at the time of data collection, or-in the case of sharing existing data-before making data available to other teams, can save time and efforts, improve scientific value and help to prevent erroneous assumptions and biased results. To ensure that encoding of missing data is sufficient to understand the reason why data are missing, it should ideally be context-free. Therefore, 11 context-free codes of missing data were carefully designed based on three completed randomized controlled clinical trials and tested in a new randomized controlled clinical trial by an international team consisting of clinical researchers and epidemiologists with extended experience in designing and conducting trials and an Information System expert. These codes can be divided into missing due to participant and/or participation characteristics (n = 6), missing by design (n = 4), and due to a procedural error (n = 1). Broad implementation of context-free missing data encoding may enhance the possibilities of data sharing and pooling, thus allowing more powerful analyses using existing data.	[Hoevenaar-Blom, Marieke P.; Beishuizen, Cathrien R. L.; Richard, Edo] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Guillemont, Juliette] Univ Toulouse, INSERM, Toulouse, France; [Ngandu, Tiia; Kivipelto, Miia] Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki, Finland; [Coley, Nicola; Andrieu, Sandrine] Toulouse Univ Hosp, Dept Epidemiol & Publ Hlth, Toulouse, France; [Coley, Nicola; Andrieu, Sandrine] Univ Toulouse, INSERM, UMR1027, Toulouse, France; [van Charante, Eric P. Moll] Univ Amsterdam, Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Kivipelto, Miia; Soininen, Hilkka] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Kivipelto, Miia] Stockholm Univ, Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Kivipelto, Miia] Karolinska Inst, Ctr Alzheimer Res, Stockholm, Sweden; [Soininen, Hilkka] Kuopio Univ Hosp, Neurol, Neuroctr, Kuopio, Finland; [Brayne, Carol] Univ Cambridge, Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Meiller, Yannick] ESCP Europe, Dept Informat & Operat Management, Paris, France; [Richard, Edo] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Finland National Institute for Health & Welfare; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; University of Amsterdam; Academic Medical Center Amsterdam; University of Eastern Finland; Karolinska Institutet; Stockholm University; Karolinska Institutet; Kuopio University Hospital; University of Eastern Finland; University of Cambridge; heSam Universite; ESCP Business School; Radboud University Nijmegen	Hoevenaar-Blom, MP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands.	m.p.hoevenaarblom@amc.uva.nl	van Charante, Eric Moll/L-4856-2019; Richard, Edo/AAT-7173-2020; Coley, Nicola L/E-7048-2016; Brayne, Carol/AAA-4285-2020; Hoevenaar-Blom, Maria/AGI-1087-2022; Richard, Edo/N-8460-2016; ANDRIEU, Sandrine/G-1343-2018; Kivipelto, Miia/AAS-3557-2021	van Charante, Eric Moll/0000-0002-1489-5218; Richard, Edo/0000-0002-7250-3390; Coley, Nicola L/0000-0002-1671-824X; Brayne, Carol/0000-0001-5307-663X; Richard, Edo/0000-0002-7250-3390; ANDRIEU, Sandrine/0000-0002-1142-770X; Ngandu, Tiia/0000-0002-3698-2021; Guillemont, Juliette/0000-0002-8608-6751	European Unions Seventh Framework Program (FP7) [305374]; MIND-AD; Academy of Finland [291803]; VTR; Kuopio University Hospital [5772815]; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	European Unions Seventh Framework Program (FP7); MIND-AD; Academy of Finland(Academy of Finland); VTR; Kuopio University Hospital; National Institute for Health Research(National Institute for Health Research (NIHR))	HATICE (www.hatice.eu) is a collaborative project co-funded by the European Unions Seventh Framework Program (FP7, 2007-2013), under grant agreement No 305374. The research leading to these results has also been funded by the Multimodal preventive trials for Alzheimer's Disease: towards multinational strategies-programme: MIND-AD, Academy of Finland (291803) and VTR, Kuopio University Hospital (5772815). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CDISC, CLIN DAT ACQ STAND H; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Little RJA, 1999, J RHEUMATOL, V26, P1654; Little RJ, 2012, NEW ENGL J MED, V367, P1355, DOI 10.1056/NEJMsr1203730; Meiller Y, 2016, 22 AM C INF SYST SAN; National Research Council Panel on Handling Missing Data in Clinical Trials, 2010, PREV TREATM MISS DAT; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Richard E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010806; van Charante EPM, 2016, LANCET, V388, P797, DOI 10.1016/S0140-6736(16)30950-3; Vellas B, 2014, J Prev Alzheimers Dis, V1, P13	10	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0182362	10.1371/journal.pone.0182362	http://dx.doi.org/10.1371/journal.pone.0182362			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898245	Green Published, gold			2022-12-27	WOS:000410449500002
J	Peters, CH; Yu, A; Zhu, WD; Silva, JR; Ruben, PC				Peters, Colin H.; Yu, Alec; Zhu, Wandi; Silva, Jonathan R.; Ruben, Peter C.			Depolarization of the conductance-voltage relationship in the Na(V)1.5 mutant, E1784K, is due to altered fast inactivation	PLOS ONE			English	Article							LONG-QT SYNDROME; GATED SODIUM-CHANNELS; DESCRIBE SLOW INACTIVATION; ST-SEGMENT ELEVATION; NA+-CHANNEL; BRUGADA-SYNDROME; SCN5A MUTATIONS; MOLECULAR-MECHANISM; CALCIUM REGULATION; MAXIMAL EXERCISE	E1784K is the most common mixed long QT syndrome/Brugada syndrome mutant in the cardiac voltage-gated sodium channel Na(V)1.5. E1784K shifts the midpoint of the channel conductance-voltage relationship to more depolarized membrane potentials and accelerates the rate of channel fast inactivation. The depolarizing shift in the midpoint of the conductance curve in E1784K is exacerbated by low extracellular pH. We tested whether the E1784K mutant shifts the channel conductance curve to more depolarized membrane potentials by affecting the channel voltage-sensors. We measured ionic currents and gating currents at pH 7.4 and pH 6.0 in Xenopus laevis oocytes. Contrary to our expectation, the movement of gating charges is shifted to more hyperpolarized membrane potentials by E1784K. Voltage-clamp fluorimetry experiments show that this gating charge shift is due to the movement of the DIVS4 voltage-sensor being shifted to more hyperpolarized membrane potentials. Using a model and experiments on fast inactivation-deficient channels, we show that changes to the rate and voltage-dependence of fast inactivation are sufficient to shift the conductance curve in E1784K. Our results localize the effects of E1784K to DIVS4, and provide novel insight into the role of the DIV-VSD in regulating the voltage-dependencies of activation and fast inactivation.	[Peters, Colin H.; Yu, Alec; Ruben, Peter C.] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [Zhu, Wandi; Silva, Jonathan R.] Washington Univ, Dept Biomed Engn, St Louis, MO USA	Simon Fraser University; Washington University (WUSTL)	Ruben, PC (corresponding author), Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada.	pruben@sfu.ca	Zhu, Wandi/AAD-2096-2020	Silva, Jonathan/0000-0002-3696-3955; Zhu, Wandi/0000-0003-0927-5687	Natural Sciences and Engineering Research Council of Canada Graduate Doctoral Scholarship [GXS0117]; American Heart Association [15PRE25080073]; Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award [394530]; Natural Sciences and Engineering Research Council of Canada grant [31611509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136553] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada Graduate Doctoral Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC)); American Heart Association(American Heart Association); Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	CHP was supported by a Natural Sciences and Engineering Research Council of Canada Graduate Doctoral Scholarship (GXS0117). AY was supported by a Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award (394530). WZ was supported by an American Heart Association fellowship (15PRE25080073). The JRS lab was supported by an American Heart Association grant (16GRNT31200025). The PCR lab was supported by a Natural Sciences and Engineering Research Council of Canada grant (31611509). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelsayed M., 2015, J PHYSL; Allam S, 2001, ANAESTHESIA, V56, P385, DOI 10.1046/j.1365-2044.2001.01976-24.x; Amin AS, 2009, CIRC-ARRHYTHMIA ELEC, V2, P531, DOI 10.1161/CIRCEP.109.862441; Armstrong CM, 2006, P NATL ACAD SCI USA, V103, P17991, DOI 10.1073/pnas.0607603103; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Baranchuk A, 2012, ANN NONINVAS ELECTRO, V17, P299, DOI 10.1111/j.1542-474X.2012.00525.x; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bezzina C, 1999, CIRC RES, V85, P1206; Capes DL, 2013, J GEN PHYSIOL, V142, P101, DOI 10.1085/jgp.201310998; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; Chanda B, 2004, J GEN PHYSIOL, V123, P217, DOI 10.1085/jgp.200308971; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Cheng JD, 2011, PHYSIOL GENOMICS, V43, P461, DOI 10.1152/physiolgenomics.00198.2010; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; COBBE SM, 1980, J MOL CELL CARDIOL, V12, P745, DOI 10.1016/0022-2828(80)90077-2; Crotti L, 2012, J AM COLL CARDIOL, V60, P1410, DOI 10.1016/j.jacc.2012.04.037; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; Garcia-Borbolla M, 2007, REV ESP CARDIOL, V60, P993, DOI 10.1157/13109656; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; Gurkiewicz M, 2011, J NEUROPHYSIOL, V105, P1546, DOI 10.1152/jn.00703.2010; HERMANSEN L, 1972, J APPL PHYSIOL, V32, P304, DOI 10.1152/jappl.1972.32.3.304; Hick JL, 1999, ACAD EMERG MED, V6, P239, DOI 10.1111/j.1553-2712.1999.tb00164.x; Hsu EJ, 2017, J GEN PHYSL; Hu D., 2012, CIRCULATION, V126; Jones DK, 2013, BIOPHYS J, V105, P101, DOI 10.1016/j.bpj.2013.04.022; Jones DK, 2011, BIOPHYS J, V101, P2147, DOI 10.1016/j.bpj.2011.08.056; Jones DK, 2013, J BIOL CHEM, V288, P4782, DOI 10.1074/jbc.M112.434266; Labro AJ, 2012, J GEN PHYSIOL, V140, P481, DOI 10.1085/jgp.201210817; Lupoglazoff JM, 2001, CIRC RES, V89, pE16, DOI 10.1161/hh1401.095087; Makita N, 2002, CIRCULATION, V106, P1269, DOI 10.1161/01.CIR.0000027139.42087.B6; Makita N, 2008, J CLIN INVEST, V118, P2219, DOI [10.1172/JCl34057, 10.1172/JCI34057]; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Meregalli PG, 2005, CARDIOVASC RES, V67, P367, DOI 10.1016/j.cardiores.2005.03.005; Mizusawa Y, 2012, CIRC-ARRHYTHMIA ELEC, V5, P606, DOI 10.1161/CIRCEP.111.964577; Nekouzadeh A, 2008, BIOPHYS J, V95, P3510, DOI 10.1529/biophysj.108.136721; Ortega-Carnicer J, 2001, J ELECTROCARDIOL, V34, P345, DOI 10.1054/jelc.2001.26318; OSNES JB, 1972, J APPL PHYSIOL, V32, P59, DOI 10.1152/jappl.1972.32.1.59; Peters CH, 2016, PROG BIOPHYS MOL BIO, V120, P77, DOI 10.1016/j.pbiomolbio.2015.12.009; Potet F, 2015, CIRC-ARRHYTHMIA ELEC, V8, P933, DOI 10.1161/CIRCEP.115.002760; Priori SG, 2000, CIRCULATION, V102, P2509, DOI 10.1161/01.CIR.102.20.2509; Ruan YF, 2007, CIRCULATION, V116, P1137, DOI 10.1161/CIRCULATIONAHA.107.707877; Ruan YF, 2010, CIRC RES, V106, P1374, DOI 10.1161/CIRCRESAHA.110.218891; Ruan YF, 2008, CIRC-ARRHYTHMIA ELEC, V1, P290, DOI 10.1161/CIRCEP.108.795617; Rudokas MW, 2014, JOVE-J VIS EXP, DOI 10.3791/51040; Sarhan MF, 2012, P NATL ACAD SCI USA, V109, P3558, DOI 10.1073/pnas.1114748109; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; SCHAUF CL, 1976, BIOPHYS J, V16, P771, DOI 10.1016/S0006-3495(76)85727-X; Schwartz PJ, 2012, CIRC-ARRHYTHMIA ELEC, V5, P868, DOI 10.1161/CIRCEP.111.962019; Sheets MF, 2003, J GEN PHYSIOL, V121, P163, DOI 10.1085/jgp.20028651; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; Shimizu W, 1999, J ELECTROCARDIOL, V32, P177, DOI 10.1016/S0022-0736(99)90077-8; Silva JR, 2013, J GEN PHYSIOL, V141, P309, DOI 10.1085/jgp.201210909; Silva JR, 2013, J GEN PHYSIOL, V141, P323, DOI 10.1085/jgp.201210910; Skinner JR, 2005, ARCH DIS CHILD, V90, P528, DOI 10.1136/adc.2004.058115; Stefani E, 1998, METHOD ENZYMOL, V293, P300; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; Tan PS, 2012, J GEN PHYSIOL, V140, P293, DOI 10.1085/jgp.201110761; Van Petegem F, 2012, BIOPHYS J, V103, P2243, DOI 10.1016/j.bpj.2012.10.020; Varga Z, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1228, DOI 10.1161/CIRCEP.115.003155; VASSILEV P, 1989, P NATL ACAD SCI USA, V86, P8147, DOI 10.1073/pnas.86.20.8147; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Vilin YY, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00109; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; Wang DW, 1996, P NATL ACAD SCI USA, V93, P13200, DOI 10.1073/pnas.93.23.13200; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang SM, 1997, J PHYSIOL-LONDON, V502, P45, DOI 10.1111/j.1469-7793.1997.045bl.x; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wijeyeratne YD, 2014, EUROPACE, V16, piii7; Wilde AAM, 2010, J MOL CELL CARDIOL, V49, P543, DOI 10.1016/j.yjmcc.2010.07.012; Yan GX, 1999, CIRCULATION, V100, P1660, DOI 10.1161/01.CIR.100.15.1660; YAN GX, 1992, CIRC RES, V71, P460, DOI 10.1161/01.RES.71.2.460; Zhang ZH, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/408012; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254	76	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184605	10.1371/journal.pone.0184605	http://dx.doi.org/10.1371/journal.pone.0184605			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898267	gold, Green Submitted, Green Published			2022-12-27	WOS:000410449500036
J	Jenkins, TP; Rathnayaka, Y; Perera, PK; Peachey, LE; Nolan, MJ; Krause, L; Rajakaruna, RS; Cantacessi, C				Jenkins, Timothy P.; Rathnayaka, Yasara; Perera, Piyumali K.; Peachey, Laura E.; Nolan, Matthew J.; Krause, Lutz; Rajakaruna, Rupika S.; Cantacessi, Cinzia			Infections by human gastrointestinal helminths are associated with changes in faecal microbiota diversity and composition	PLOS ONE			English	Article							EXPERIMENTAL HOOKWORM INFECTION; SOIL-TRANSMITTED HELMINTHS; GLUTEN CHALLENGES; GUT MICROBIOTA; COLONIZATION; TRANSMISSION; RESISTANCE; IMPACT	Investigations of the impact that patent infections by soil-transmitted gastrointestinal nematode parasites exert on the composition of the host gut commensal flora are attracting growing interest by the scientific community. However, information collected to date varies across experiments, and further studies are needed to identify consistent relationships between parasites and commensal microbial species. Here, we explore the qualitative and quantitative differences between the microbial community profiles of cohorts of human volunteers from Sri Lanka with patent infection by one or more parasitic nematode species (H +), as well as that of uninfected subjects (H-) and of volunteers who had been subjected to regular prophylactic anthelmintic treatment (Ht). High-throughput sequencing of the bacterial 16S rRNA gene, followed by bioinformatics and biostatistical analyses of sequence data revealed no significant differences in alpha diversity (Shannon) and richness between groups (P = 0.65, P = 0.13 respectively); however, beta diversity was significantly increased in H+ and Ht when individually compared to H-volunteers (P = 0.04). Among others, bacteria of the families Verrucomicrobiaceae and Enterobacteriaceae showed a trend towards increased abundance in H+, whereas the Leuconostocaceae and Bacteroidaceae showed a relative increase in H-and Ht respectively. Our findings add valuable knowledge to the vast, and yet little explored, research field of parasite - microbiota interactions and will provide a basis for the elucidation of the role such interactions play in pathogenic and immune-modulatory properties of parasitic nematodes in both human and animal hosts.	[Jenkins, Timothy P.; Peachey, Laura E.; Cantacessi, Cinzia] Univ Cambridge, Dept Vet Med, Cambridge, England; [Rathnayaka, Yasara; Perera, Piyumali K.; Rajakaruna, Rupika S.] Univ Peradeniya, Dept Zool, Peradeniya, Sri Lanka; [Nolan, Matthew J.] Univ London, Royal Vet Coll, N Mymms, England; [Krause, Lutz] Univ Queensland, Diamantina Inst, Translat Res Inst, Woolloongabba, Qld, Australia	University of Cambridge; University of Peradeniya; University of London; University of London Royal Veterinary College; University of Queensland	Cantacessi, C (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	cc779@cam.ac.uk	Jenkins, Timothy P./B-4714-2019; Jenkins, Tim/V-7689-2019; Krause, Lutz/G-6283-2013; Cantacessi, Cinzia/B-7356-2014	Jenkins, Timothy P./0000-0003-2979-5663; Jenkins, Tim/0000-0003-2979-5663; Perera, Piyumali/0000-0003-2441-9028; Krause, Lutz/0000-0003-3806-0845; Cantacessi, Cinzia/0000-0001-6863-2950	University of Peradeniya [URG/2016/88/S]; Wellcome Trust; Isaac Newton Trust; University of Cambridge; Biotechnology and Biological Sciences Research Council; BBSRC [1643688] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1643688] Funding Source: researchfish	University of Peradeniya; Wellcome Trust(Wellcome Trust); Isaac Newton Trust; University of Cambridge(University of Cambridge); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants by University of Peradeniya, grant no. URG/2016/88/S to RSR and PKP; the Wellcome Trust/ Isaac Newton Trust/ University of Cambridge to CC; a Postgraduate Award by the Biotechnology and Biological Sciences Research Council to TPJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albonico M, 2004, INT J PARASITOL, V34, P1205, DOI 10.1016/j.ijpara.2004.08.001; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; Brooker SJ, 2015, LANCET INFECT DIS, V15, P941, DOI 10.1016/S1473-3099(15)70042-3; Brown EM, 2013, NAT IMMUNOL, V14, P660, DOI 10.1038/ni.2611; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Campbell SJ, 2016, TRENDS PARASITOL, V32, P97, DOI 10.1016/j.pt.2015.10.006; Cantacessi C, 2014, J INFECT DIS, V210, P1431, DOI 10.1093/infdis/jiu256; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cooper P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076573; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Frank W, 1987, PARASITOLOGIE TRANSP; Gems D, 1996, P NATL ACAD SCI USA, V93, P1665, DOI 10.1073/pnas.93.4.1665; Giacomin P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36797; Giacomin P, 2016, TRENDS PARASITOL, V32, P664, DOI 10.1016/j.pt.2016.05.006; Giacomin P, 2015, SCI REP-UK, V5, DOI 10.1038/srep13797; Glendinning L, 2014, PARASITOLOGY, V141, P1255, DOI 10.1017/S0031182014000699; Gunawardena K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001341; Hausen MA, 2011, PARASITOL INT, V60, P54, DOI 10.1016/j.parint.2010.10.003; Holm JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125495; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ismail MM, 2003, CONTROLLING DISEASE DUE TO HELMINTH INFECTIONS, P127; Jayawardena R, 2013, PUBLIC HEALTH NUTR, V16, P653, DOI 10.1017/S1368980012003011; Jeffery IB, 2012, GUT MICROBES, V3, P572, DOI 10.4161/gmic.21772; Kekkonen RA, 2008, WORLD J GASTROENTERO, V14, P1192, DOI 10.3748/wjg.14.1192; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002880; Li RW, 2016, SCI REP-UK, V6, DOI 10.1038/srep20606; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McKenney EA, 2015, GUT MICROBES, V6, P182, DOI 10.1080/19490976.2015.1047128; Murray CJL, 2013, LANCET, V381, P628; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Pearson MS, 2012, J ALLERGY CLIN IMMUN, V130, P13, DOI 10.1016/j.jaci.2012.05.029; Perera P, 2013, JNSF, V41; Ramanan D, 2016, SCIENCE, V352, P608, DOI 10.1126/science.aaf3229; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Reynolds LA, 2014, GUT MICROBES, V5, P522, DOI 10.4161/gmic.32155; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sepehri S, 2007, INFLAMM BOWEL DIS, V13, P675, DOI 10.1002/ibd.20101; Swidsinski A, 2011, GUT, V60, P34, DOI 10.1136/gut.2009.191320; Theodoropoulos G, 2001, TRENDS PARASITOL, V17, P130, DOI 10.1016/S1471-4922(00)01775-X; Truscott JE, 2016, ADV PARASIT, V94, P133, DOI 10.1016/bs.apar.2016.08.002; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; WHO, 2012, ACC WORK OV GLOB IMP, P13; Wolff MJ, 2012, TRENDS PARASITOL, V28, P187, DOI 10.1016/j.pt.2012.02.008; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yoo JY, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030173; Zaiss MM, 2015, IMMUNITY, V43, P998, DOI 10.1016/j.immuni.2015.09.012; Zakrzewski M, 2017, BIOINFORMATICS, V33, P782, DOI 10.1093/bioinformatics/btw725; Zempleni J, 2005, ANNU REV NUTR, V25, P175, DOI 10.1146/annurev.nutr.25.121304.131724	52	57	59	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184719	10.1371/journal.pone.0184719	http://dx.doi.org/10.1371/journal.pone.0184719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892494	Green Published, gold, Green Accepted			2022-12-27	WOS:000410243200021
J	Davies, J; Li, SQ; Tong, SY; Baird, RW; Beaman, M; Higgins, G; Cowie, BC; Condon, JR; Davis, JS				Davies, Jane; Li, Shu Qin; Tong, Steven Y.; Baird, Rob W.; Beaman, Miles; Higgins, Geoff; Cowie, Benjamin C.; Condon, John R.; Davis, Joshua S.			Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population	PLOS ONE			English	Article							NORTHERN-TERRITORY; HEPATOCELLULAR-CARCINOMA; VIRUS; VACCINATION; AUSTRALIA; GENOTYPES; EPIDEMIOLOGY; PROTECTION; PROGRAM; PEOPLE	Background Indigenous populations globally are disproportionately affected by chronic hepatitis B virus (HBV) infection however contemporary sero-prevalence data are often absent. In the Indigenous population of the Northern Territory (NT) of Australia the unique C4 sub-genotype of HBV universally circulates. There are no studies of the sero-prevalence, nor the impact of the vaccination program (which has a serotype mismatch compared to C4), at a population-wide level. Methods We examined all available HBV serology results obtained from the three main laboratories serving NT residents between 1991 and 2011. Data were linked with a NT government database to determine Indigenous status and the most recent test results for each individual were extracted as a cross-sectional database including 88,112 unique individuals. The primary aim was to obtain a contemporary estimate of HBsAg positivity for the NT by Indigenous status. Results Based on all tests from 2007-2011 (35,633 individuals), hepatitis B surface antigen (HBsAg) positivity was 3.40% (95% CI 3.19-3.61), being higher in Indigenous (6.08% [5.65%-6.53%]) than non-Indigenous (1.56%[1.38%-1.76%]) Australians, p<0.0001. Birth cohort analysis showed HBsAg positivity fell over time for Indigenous people, with this decrease commencing prior to universal infant vaccination (which commenced in 1990), with an ongoing but slower rate of decline since 1990, (0.23% decrease per year versus 0.17%). Conclusions HBsAg positivity is high in the NT, particularly in the Indigenous population. HBsAg positivity has fallen over time but a substantial part of this decrease is due to factors other than the universal vaccination program.	[Davies, Jane; Tong, Steven Y.; Condon, John R.; Davis, Joshua S.] Menzies Sch Hlth Res, Dept Global & Trop Hlth, Darwin, NT, Australia; [Davies, Jane] Royal Darwin Hosp, Infect Dis Dept, Darwin, NT, Australia; [Li, Shu Qin; Condon, John R.] Northern Terr Dept Hlth, Hlth Gains Planning Branch, Darwin, NT, Australia; [Tong, Steven Y.] Univ Melbourne, Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Tong, Steven Y.; Cowie, Benjamin C.] Royal Melbourne Hosp, Victorian Infect Dis Serv, Melbourne, Vic, Australia; [Baird, Rob W.] Royal Darwin Hosp, Terr Pathol, Darwin, NT, Australia; [Beaman, Miles] Western Diagnost Pathol, Myaree, WA, Australia; [Beaman, Miles] Univ Western Australia, Perth, WA, Australia; [Beaman, Miles] Univ Notre Dame Australia, Fremantle, WA, Australia; [Higgins, Geoff] SA Pathol, Adelaide, SA, Australia; [Cowie, Benjamin C.] Doherty Inst, WHO Collaborating Ctr Viral Hepatitis, Melbourne, Vic, Australia; [Davis, Joshua S.] John Hunter Hosp, New Lambton Hts, NSW, Australia	Charles Darwin University; Menzies School of Health Research; University of Melbourne; Royal Melbourne Hospital; University of Western Australia; University of Notre Dame Australia; SA Pathology; John Hunter Hospital	Davies, J (corresponding author), Menzies Sch Hlth Res, Dept Global & Trop Hlth, Darwin, NT, Australia.; Davies, J (corresponding author), Royal Darwin Hosp, Infect Dis Dept, Darwin, NT, Australia.	Jane.davies@menzies.edu.au	Condon, John R/N-2281-2013; Davies, Jane/AAD-8109-2019; Tong, Steven/N-2353-2013; Cowie, Benjamin/HFZ-9941-2022; Davis, Joshua/N-2288-2013	Condon, John R/0000-0003-4952-0990; Davies, Jane/0000-0002-3843-837X; Tong, Steven/0000-0002-1368-8356; Cowie, Benjamin/0000-0002-7087-5895; Davis, Joshua/0000-0001-9864-5699; baird, robert/0000-0003-2006-5277	Australian National Health & Medical Research Council; Sidney Myer Fund	Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sidney Myer Fund	JD, JSD and SYT received salary support from the Australian National Health & Medical Research Council and JD also received salary support from the Sidney Myer Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Western Diagnostic Pathology provided support in the form of salary for MB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions section. There was no other specific funding for this project.	[Anonymous], 2011, CENS POP HOUS; Aratchige PE, 2012, N TERRITORY DIS CONT, V19, P1; Australian Bureau of Statistics, 2013, 3412 0 MIGR; Australian Institute of Health and Welfare, 2011, AIHW IND HLTH CHECK; Chen CJ, 2011, J GASTROEN HEPATOL, V26, P628, DOI 10.1111/j.1440-1746.2011.06695.x; Cowie B., 2015, HEPATITIS B MAPPING; Davies J, 2013, J GASTROEN HEPATOL, V28, P1234, DOI 10.1111/jgh.12177; Dent E, 2010, COMMUN DIS INTELL, V34, P435; Elkin A P, 1993, ABORIGINAL MEN HIGH; Farrell T, 2016, M UNMET NEED ROAD AL; GARDNER ID, 1992, MED J AUSTRALIA, V156, P638, DOI 10.5694/j.1326-5377.1992.tb121461.x; Gidding HF, 2007, VACCINE, V25, P8637, DOI 10.1016/j.vaccine.2007.07.046; Graham S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-403; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Linden A, 2015, STATA J, V15, P480, DOI 10.1177/1536867X1501500208; Littlejohn M, 2014, J MED VIROL, V86, P695, DOI 10.1002/jmv.23888; Liu B, 2012, VACCINE, V30, P7309, DOI 10.1016/j.vaccine.2012.09.033; Livingston SE, 2007, J INFECT DIS, V195, P5, DOI 10.1086/509894; McMahon BJ, 2001, ANN INTERN MED, V135, P759, DOI 10.7326/0003-4819-135-9-200111060-00006; McMahon BJ, 2009, J INFECT DIS, V200, P1390, DOI 10.1086/606119; Morrison J, 1967, Med J Aust, V1, P125; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Parker C, 2014, MED J AUSTRALIA, V201, P470, DOI 10.5694/mja13.11117; Peto TJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-7; Rossi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044611; Schultz R, 2008, AUST NZ J PUBL HEAL, V32, P575, DOI 10.1111/j.1753-6405.2008.00313.x; Tew K., 2008, VALIDATION PATIENT D; Trudgen R, 2000, WHY WARRIORS LAY DIE; van der Sande MAB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000753; Wood N, 2005, COMMUN DIS INTELL, V29, P289	31	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184082	10.1371/journal.pone.0184082	http://dx.doi.org/10.1371/journal.pone.0184082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886050	Green Published, gold			2022-12-27	WOS:000410001100064
J	Delius, J; Frank, O; Hofmann, T				Delius, Judith; Frank, Oliver; Hofmann, Thomas			Label-free quantitative H-1 NMR spectroscopy to study low-affinity ligand-protein interactions in solution: A contribution to the mechanism of polyphenol-mediated astringency	PLOS ONE			English	Article							SENSORY-GUIDED DECOMPOSITION; PROLINE-RICH PROTEIN; BLACK TEA INFUSIONS; SALIVARY PROTEINS; GREEN TEA; RED WINE; SUBMAXILLARY MUCINS; CONDENSED TANNINS; NMR; PRECIPITATION	Nuclear magnetic resonance (NMR) spectroscopy is well-established in assessing the binding affinity between low molecular weight ligands and proteins. However, conventional NMR-based binding assays are often limited to small proteins of high purity and may require elaborate isotopic labeling of one of the potential binding partners. As protein-polyphenol complexation is assumed to be a key event in polyphenol-mediated oral astringency, here we introduce a label-free, ligand-focused H-1 NMR titration assay to estimate binding affinities and characterize soluble complex formation between proteins and low molecular weight polyphenols. The method makes use of the effects of NMR line broadening due to protein- ligand interactions and quantitation of the non-bound ligand at varying protein concentrations by quantitative H-1 NMR spectroscopy (qHNMR) using electronic reference to access in vivo concentration (ERETIC 2). This technique is applied to assess the interaction kinetics of selected astringent tasting polyphenols and purified mucin, a major lubricating glycoprotein of human saliva, as well as human whole saliva. The protein affinity values (BC50) obtained are subsequently correlated with the intrinsic mouth-puckering, astringent oral sensation imparted by these compounds. The quantitative NMR method is further exploited to study the effect of carboxymethyl cellulose, a candidate-anti-astringent xi protein binding antagonist, on the polyphenol-protein interaction. Consequently, the NMR approach presented here proves to be a versatile tool to study the interactions between proteins and lowaffinity ligands in solution and may find promising applications in the discovery of bioactives.	[Delius, Judith; Frank, Oliver; Hofmann, Thomas] Tech Univ Munich, Chair Food Chem & Mol Sensory Sci, Lise Meitner Str 34, Freising Weihenstephan, Germany	Technical University of Munich	Hofmann, T (corresponding author), Tech Univ Munich, Chair Food Chem & Mol Sensory Sci, Lise Meitner Str 34, Freising Weihenstephan, Germany.	thomas.hofmann@tum.de	Frank, Oliver/AAO-9888-2021	Frank, Oliver/0000-0003-0437-5005				Bartolome B, 2000, J FOOD SCI, V65, P617, DOI 10.1111/j.1365-2621.2000.tb16060.x; Baxter NJ, 1997, BIOCHEMISTRY-US, V36, P5566, DOI 10.1021/bi9700328; BETTELHEIM FA, 1965, ARCH BIOCHEM BIOPHYS, V109, P259, DOI 10.1016/0003-9861(65)90360-7; Biegler M., 2016, BIOTRIBOLOGY, V6, P12, DOI [10.1016/j.biotri.2016.03.002, DOI 10.1016/J.BIOTRI.2016.03.002]; Brannan GD, 2001, J SENS STUD, V16, P261, DOI 10.1111/j.1745-459X.2001.tb00300.x; Brock A, 2008, CHEMOSENS PERCEPT, V1, P268, DOI 10.1007/s12078-008-9028-y; Cala O, 2010, FASEB J, V24, P4281, DOI 10.1096/fj.10-158741; Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z; Charlton AJ, 2002, J AM CHEM SOC, V124, P9899, DOI 10.1021/ja0126374; Davis AL, 1996, MAGN RESON CHEM, V34, P887, DOI 10.1002/(SICI)1097-458X(199611)34:11<887::AID-OMR995>3.0.CO;2-U; de Freitas V, 2003, FOOD CHEM, V81, P503, DOI 10.1016/S0308-8146(02)00479-X; de Freitas V, 2012, CURR ORG CHEM, V16, P724, DOI 10.2174/138527212799958002; Delius J, 2017, J AGR FOOD CHEM, V65, P2147, DOI 10.1021/acs.jafc.7b00436; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Frank O, 2014, J AGR FOOD CHEM, V62, P2506, DOI 10.1021/jf405529b; Georgiades P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105302; Giordani E, 2011, FOOD RES INT, V44, P1752, DOI 10.1016/j.foodres.2011.01.036; Goncalves R, 2011, FOOD CHEM, V125, P665, DOI 10.1016/j.foodchem.2010.09.061; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Hara K, 2012, EUR J ORAL SCI, V120, P132, DOI 10.1111/j.1600-0722.2012.00947.x; Henze A., 2009, THESIS; Horne J, 2002, CHEM SENSES, V27, P653, DOI 10.1093/chemse/27.7.653; Hufnagel JC, 2008, J AGR FOOD CHEM, V56, P1376, DOI 10.1021/jf073031n; Jobstl E, 2004, BIOMACROMOLECULES, V5, P942, DOI 10.1021/bm0345110; Kallithraka S, 2001, J SCI FOOD AGR, V81, P261, DOI 10.1002/1097-0010(20010115)81:2<261::AID-JSFA804>3.0.CO;2-T; Kallithraka S, 1998, J SENS STUD, V13, P29, DOI 10.1111/j.1745-459X.1998.tb00073.x; Monteleone E, 2004, FOOD QUAL PREFER, V15, P761, DOI 10.1016/j.foodqual.2004.06.002; MURRAY NJ, 1994, EUR J BIOCHEM, V219, P923, DOI 10.1111/j.1432-1033.1994.tb18574.x; OLSSON H, 1991, SCAND J DENT RES, V99, P316; Pascal C, 2009, BIOPOLYMERS, V91, P745, DOI 10.1002/bip.21221; Peleg H, 1999, FOOD QUAL PREFER, V10, P343, DOI 10.1016/S0950-3293(99)00009-9; Poncet-Legrand C, 2006, FOOD HYDROCOLLOID, V20, P687, DOI 10.1016/j.foodhyd.2005.06.009; RAMIREZMARTINEZ JR, 1977, J FOOD SCI, V42, P1201, DOI 10.1111/j.1365-2621.1977.tb14459.x; Rayment SA, 2000, J DENT RES, V79, P1765; Rinaldi A, 2012, FOOD CHEM, V135, P2498, DOI 10.1016/j.foodchem.2012.07.031; Sarni-Manchado P, 1999, J AGR FOOD CHEM, V47, P42, DOI 10.1021/jf9805146; Scharbert S, 2004, J AGR FOOD CHEM, V52, P3498, DOI 10.1021/jf049802u; Scharbert S, 2004, EUR FOOD RES TECHNOL, V218, P442, DOI 10.1007/s00217-004-0888-3; Schwarz B, 2008, EUR FOOD RES TECHNOL, V227, P1693, DOI 10.1007/s00217-008-0895-x; Schwarz B, 2007, J AGR FOOD CHEM, V55, P1394, DOI 10.1021/jf0629078; Sharp KA, 2016, P NATL ACAD SCI USA, V113, P1684, DOI 10.1073/pnas.1600098113; Soares S, 2012, J AGR FOOD CHEM, V60, P3966, DOI 10.1021/jf3002747; Soares SI, 2009, J AGR FOOD CHEM, V57, P4352, DOI 10.1021/jf900302r; Stark T, 2005, J AGR FOOD CHEM, V53, P5407, DOI 10.1021/jf050457y; Sun XL, 2009, PROTEOM CLIN APPL, V3, P810, DOI 10.1002/prca.200800242; TETTAMANTI G, 1968, ARCH BIOCHEM BIOPHYS, V124, P41, DOI 10.1016/0003-9861(68)90301-9; Thornton DJ, 1999, GLYCOBIOLOGY, V9, P293, DOI 10.1093/glycob/9.3.293; Troszynska A, 2010, FOOD QUAL PREFER, V21, P463, DOI 10.1016/j.foodqual.2009.12.005; Wider G, 2006, J AM CHEM SOC, V128, P2571, DOI 10.1021/ja055336t; Williamson MP, 2006, J ALLERGY CLIN IMMUN, V118, P1369, DOI 10.1016/j.jaci.2006.08.016; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wollmann N, 2013, J AGR FOOD CHEM, V61, P2045, DOI 10.1021/jf3052576	52	14	15	6	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184487	10.1371/journal.pone.0184487	http://dx.doi.org/10.1371/journal.pone.0184487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886151	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100136
J	Duan, F; Watanabe, K; Yoshimura, Y; Kikuchi, M; Minabe, Y; Aihara, K				Duan, Fang; Watanabe, Katsumi; Yoshimura, Yuko; Kikuchi, Mitsuru; Minabe, Yoshio; Aihara, Kazuyuki			Detection of atypical network development patterns in children with autism spectrum disorder using magnetoencephalography	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; BRAIN NETWORKS; SMALL-WORLD; SYNCHRONIZATION LIKELIHOOD; FRONTAL-CORTEX; EEG; PHASE; MEG; DYNAMICS; RESPONSIVENESS	Autism spectrum disorder (ASD) is a developmental disorder that involves developmental delays. It has been hypothesized that aberrant neural connectivity in ASD may cause atypical brain network development. Brain graphs not only describe the differences in brain networks between clinical and control groups, but also provide information about network development within each group. In the present study, graph indices of brain networks were estimated in children with ASD and in typically developing (TD) children using magnetoencephalography performed while the children viewed a cartoon video. We examined brain graphs from a developmental point of view, and compared the networks between children with ASD and TD children. Network development patterns (NDPs) were assessed by examining the association between the graph indices and the raw scores on the achievement scale or the age of the children. The ASD and TD groups exhibited different NDPs at both network and nodal levels. In the left frontal areas, the nodal degree and efficiency of the ASD group were negatively correlated with the achievement scores. Reduced network connections were observed in the temporal and posterior areas of TD children. These results suggested that the atypical network developmental trajectory in children with ASD is associated with the development score rather than age.	[Duan, Fang; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Watanabe, Katsumi] Univ Tokyo, Res Ctr Adv Sci & Technol, Tokyo, Japan; [Watanabe, Katsumi] Waseda Univ, Dept Intermedia Art & Sci, Tokyo, Japan; [Yoshimura, Yuko; Kikuchi, Mitsuru; Minabe, Yoshio] Kanazawa Univ, Grad Sch Med Sci, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan	University of Tokyo; University of Tokyo; Waseda University; Kanazawa University	Duan, F (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	duan@sat.t.u-tokyo.ac.jp		Watanabe, Katsumi/0000-0003-1282-9994	Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Japan Science and Technology Agency KAKENHI [15H05707]; Center of Innovation Program	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Science and Technology Agency KAKENHI; Center of Innovation Program	This work was partially supported by Core Research for Evolutional Science and Technology and the Center of Innovation Program, the Japan Science and Technology Agency. This work was also supported by Japan Science and Technology Agency KAKENHI grant number 15H05707. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam Y, 2010, NEUROIMAGE, V52, P336, DOI 10.1016/j.neuroimage.2010.04.010; Ahmadlou M, 2012, J NEUROSCI METH, V211, P203, DOI 10.1016/j.jneumeth.2012.08.020; Alexander-Bloch AF, 2013, CEREB CORTEX, V23, P127, DOI 10.1093/cercor/bhr388; Alfonso V.C., 2013, ESSENTIALS CROSS BAT; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ansari-Asl K, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031916; Baker AEZ, 2008, J AUTISM DEV DISORD, V38, P867, DOI 10.1007/s10803-007-0459-0; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Bastos AM, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00175; Boersma M, 2013, BRAIN CONNECT, V3, P41, DOI 10.1089/brain.2012.0127; Bollobas B., 1998, MODERN GRAPH THEORY; Bullmore ET, 2012, NAT REV NEUROSCI, V13, P336, DOI 10.1038/nrn3214; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carper RA, 2005, BIOL PSYCHIAT, V57, P126, DOI 10.1016/j.biopsych.2004.11.005; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Douw L, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00174; Duan F, 2014, BRAIN COGNITION, V86, P10, DOI 10.1016/j.bandc.2014.01.011; Ecker C, 2015, LANCET NEUROL, V14, P1121, DOI 10.1016/S1474-4422(15)00050-2; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hilton CL, 2010, J AUTISM DEV DISORD, V40, P633, DOI 10.1007/s10803-009-0905-2; Kana RK, 2006, BRAIN, V129, P2484, DOI 10.1093/brain/awl164; Kaufman N.L., 1983, K ABC KAUFMAN ASSESS; Kikuchi M, 2016, PSYCHIAT CLIN NEUROS, V70, P74, DOI 10.1111/pcn.12338; Kikuchi M, 2013, NEUROIMAGE-CLIN, V2, P394, DOI 10.1016/j.nicl.2013.03.003; Kikuchi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01139; Kikuchi M, 2011, J NEUROSCI, V31, P14984, DOI 10.1523/JNEUROSCI.2785-11.2011; Lazar AS, 2010, CLIN NEUROPHYSIOL, V121, P1844, DOI 10.1016/j.clinph.2010.03.054; Lee PS, 2009, CEREB CORTEX, V19, P1787, DOI 10.1093/cercor/bhn209; Lizier JT, 2011, J COMPUT NEUROSCI, V30, P85, DOI 10.1007/s10827-010-0271-2; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Matlis S, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0355-8; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Myers SM, 2007, PEDIATRICS, V120, P1162, DOI 10.1542/peds.2007-2362; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Orekhova EV, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-40; Osterhage H, 2007, INT J NEURAL SYST, V17, P139, DOI 10.1142/S0129065707001019; Pedersen M, 2015, NEUROIMAGE-CLIN, V8, P536, DOI 10.1016/j.nicl.2015.05.009; Richards JE, 2010, DEV REV, V30, P203, DOI 10.1016/j.dr.2010.03.005; Schwartz S, 2017, PEDIATR NEUROL, V67, P7, DOI 10.1016/j.pediatrneurol.2016.10.018; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Thatcher RW, 2008, HUM BRAIN MAPP, V29, P1400, DOI 10.1002/hbm.20474; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tsiaras V, 2011, COMPUT BIOL MED, V41, P1166, DOI 10.1016/j.compbiomed.2011.04.004; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Velazquez JLP, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00037; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Wang H, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00307; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wing L, 2002, J CHILD PSYCHOL PSYC, V43, P307, DOI 10.1111/1469-7610.00023; Xue SW, 2013, BRAIN COGNITION, V81, P24, DOI 10.1016/j.bandc.2012.09.004; Yan Z, 2011, NEUROSCI LETT, V499, P199, DOI 10.1016/j.neulet.2011.05.061; Zamoscik V, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00079	64	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184422	10.1371/journal.pone.0184422	http://dx.doi.org/10.1371/journal.pone.0184422			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886147	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100116
J	Niu, SF; Niu, L; Yang, XY; Wang, CF; Jia, XD				Niu, Shufen; Niu, Ling; Yang, Xiyan; Wang, Caifen; Jia, Xiangdong			Heterogeneous hybrid signcryption for multi-message and multi-receiver	PLOS ONE			English	Article							ID-BASED SIGNCRYPTION; SENSOR NETWORKS; EFFICIENT SIGNCRYPTION; PRIVACY; SECURITY; SCHEMES; SYSTEMS	To achieve secure communication in heterogeneous cryptography systems, we present a heterogeneous hybrid signcryption scheme. The proposed scheme allows a sender in an identity-based cryptography system to send multi-message to multi-receiver in a certificate-less cryptography system with different master keys. At the same time, all users are mapped to a distinct pseudo-identity for conditional identity privacy preservation. A trusted authority could trace the real identity when necessary. Compared with existing schemes, the proposed scheme is more practical for actual applications. In addition, the proposed scheme has indistinguishability against adaptive chosen ciphertext attacks and existential unforge-ability against adaptive chosen message attacks under the random oracle model.	[Niu, Shufen; Niu, Ling; Yang, Xiyan; Wang, Caifen; Jia, Xiangdong] Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou, Gansu, Peoples R China	Northwest Normal University - China	Niu, SF (corresponding author), Northwest Normal Univ, Coll Comp Sci & Engn, Lanzhou, Gansu, Peoples R China.	sfniu76@nwnu.edu.cn			National Natural Science Foundation of China [61562077, 61462077, 61662071, 61662069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China under grant 61562077, 61462077, 61662071, 61662069.	Cramer R, 2003, SIAM J COMPUT, V33, P167, DOI 10.1137/S0097539702403773; Dent AW, 2005, LECT NOTES COMPUT SC, V3650, P203, DOI 10.1007/11556992_15; Dent AW, 2005, LECT NOTES COMPUT SC, V3574, P253; Horng SJ, 2015, INFORM SCIENCES, V317, P48, DOI 10.1016/j.ins.2015.04.033; Huang Q, 2011, COMPUT J, V54, P525, DOI 10.1093/comjnl/bxq095; Li FG, 2016, COMPUT COMMUN, V89-90, P154, DOI 10.1016/j.comcom.2016.03.007; Li FG, 2016, WIRELESS PERS COMMUN, V89, P1391, DOI 10.1007/s11277-016-3327-4; Li F, 2013, IEEE SYST J, V7, P420, DOI 10.1109/JSYST.2012.2221897; Li FG, 2009, 2009 INTERNATIONAL CONFERENCE ON AVAILABILITY, RELIABILITY, AND SECURITY (ARES), VOLS 1 AND 2, P534, DOI 10.1109/ARES.2009.44; Li FG, 2009, LECT NOTES COMPUT SC, V5487, P289, DOI 10.1007/978-3-642-01440-6_23; Li FG, 2009, LECT NOTES COMPUT SC, V5451, P112; Li L, 2015, APPL MATH COMPUT, V252, P397, DOI 10.1016/j.amc.2014.11.107; Li MT, 2017, J MATH ANAL APPL, V446, P1292, DOI 10.1016/j.jmaa.2016.09.043; Li YH, 2016, SECUR COMMUN NETW, V9, P4574, DOI 10.1002/sec.1650; Pointcheval D, 2000, J CRYPTOL, V13, P361, DOI 10.1007/s001450010003; Smart NP, 2005, LECT NOTES COMPUT SC, V3352, P208; Sun GQ, 2016, NONLINEAR DYNAM, V85, P1, DOI 10.1007/s11071-016-2671-y; Sun YX, 2011, CHINESE J ELECTRON, V20, P317; Sun YX, 2010, SCI CHINA INFORM SCI, V53, P557, DOI 10.1007/s11432-010-0061-5; Tan CH, 2008, ARES 2008: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON AVAILABILITY, SECURITY AND RELIABILITY, P1275, DOI 10.1109/ARES.2008.112; Tonguz O, 2007, 2007 MOBILE NETWORKING FOR VEHICULAR ENVIRONMENTS, P7, DOI 10.1109/MOVE.2007.4300825; Wang Caifen, 2016, Computer Engineering, V42, P150, DOI 10.3969/j.issn.1000-3428.2016.01.027; [俞惠芳 Yu Huifang], 2015, [计算机学报, Chinese Journal of Computers], V38, P804; [张玉磊 Zhang Yulei], 2016, [电子学报, Acta Electronica Sinica], V44, P2432; Zheng YL, 1997, LECT NOTES COMPUT SC, V1294, P165	25	14	14	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184407	10.1371/journal.pone.0184407	http://dx.doi.org/10.1371/journal.pone.0184407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886125	gold, Green Submitted, Green Published			2022-12-27	WOS:000410001100108
J	Pelusi, C; Giagulli, VA; Baccini, M; Fanelli, F; Mezzullo, M; Fazzini, A; Bianchi, N; Carbone, MD; De Pergola, G; Mastroroberto, M; Labate, AMM; Pasquali, R				Pelusi, Carla; Giagulli, Vito Angelo; Baccini, Margherita; Fanelli, Flaminia; Mezzullo, Marco; Fazzini, Alessia; Bianchi, Nicola; Carbone, Matteo Domenico; De Pergola, Giovanni; Mastroroberto, Marianna; Labate, Antonio Maria Morselli; Pasquali, Renato			Clomiphene citrate effect in obese men with low serum testosterone treated with metformin due to dysmetabolic disorders: A randomized, double-blind, placebo-controlled study	PLOS ONE			English	Article							HYPOGONADOTROPIC HYPOGONADISM; BIOAVAILABLE TESTOSTERONE; INSULIN-RESISTANCE; WEIGHT-LOSS; ESTROGEN; THERAPY; INFERTILITY; EFFICACY; GLUCOSE; TRIAL	Context Low testosterone (T) levels are often found in obese men with impaired glucose tolerance (IGT) and overt type 2 diabetes (T2DM); however, the mechanisms underlying this condition and its correct therapy are still under debate. Objective To evaluate the effectiveness of clomiphene citrate (CC) in increasing endogenous T levels in obese men with low serum T and with IGT or T2DM treated with metformin (MET). Design Cross-over, randomized, double-blind, placebo-controlled study. Methods 24 obese men, aged 47.3 +/- 6.3 (range 35-55 years), with low T level (<= 3 ng/mL) and naive diagnosis of IGT or T2DM were included. Subjects were randomized to CC 25 mg/day or placebo (Plac) with MET 2 g/day for 3 months. After a 6-week wash-out period, subjects were moved to the alternative arm for additional 3 months. Clinical evaluation and blood exams performed prior to and at the end of treatment. Results Of 24 randomized, 21 were evaluable, classified as IGT (n = 11) or T2DM (n = 10). Compared to baseline levels, T levels increased significantly after 3 months of CC treatment (3.03 +/- 0.80 to 5.99 +/- 1.67 ng/mL P<0.001) but not after the Plac treatment (2.87 +/- 0.78 to 3.09 +/- 0.84 ng/mL P<0.001 between the treatments). T changes were similar in IGT and T2DM subjects. Gonadotropins as well raised significantly after CC treatment (LH 3.83 +/- 1.45 to 8.53 +/- 6.40 mU/mL; FSH 4.84 +/- 1.67 to 10.15 +/- 5.08 mU/mL P<0.001 respectively), whereas no changes for LH (3.51 +/- 1.59 to 3.63 +/- 1.39 mU/mL) but a smooth increased for FSH (4.61 +/- 2.49 to 5.39 +/- 2.65 mU/mL; P = 0.004) were shown after Plac treatment (LH P = 0.001 and FSH P = 0.002 between treatments). Furthermore, fasting glucose (106.8 +/- 23.2 to 101.1 +/- 25.7 mg/dL; P = 0.004), insulin (19.3 +/- 12.1 to 15.6 +/- 10.1 mu U/mL; P = 0.010) and HOMA-IR (4.94 +/- 2.89 to 3.69 +/- 2.12; P = 0.001) decreased significantly during the CC treatment period, whereas no significant changes were observed in any of these parameters in the Plac treatment. Conclusions A low dose of CC therapy was able to significantly increase serum T levels in all participants with mild modifications of clinical and metabolic parameters.	[Pelusi, Carla; Baccini, Margherita; Fanelli, Flaminia; Mezzullo, Marco; Fazzini, Alessia; Bianchi, Nicola; Mastroroberto, Marianna; Labate, Antonio Maria Morselli; Pasquali, Renato] Univ Bologna, S Orsola Malpighi Hosp, Div Endocrinol, Alma Mater Studiorum, Bologna, Italy; [Pelusi, Carla; Baccini, Margherita; Fanelli, Flaminia; Mezzullo, Marco; Fazzini, Alessia; Bianchi, Nicola; Mastroroberto, Marianna; Labate, Antonio Maria Morselli; Pasquali, Renato] Univ Bologna, S Orsola Malpighi Hosp, Ctr Appl Biomed Res, Dept Med & Surg Sci,Alma Mater Studiorum, Bologna, Italy; [Giagulli, Vito Angelo] Conversano Hosp, Outpatients Clin Endocrinol & Metab Dis, Bari, Italy; [Carbone, Matteo Domenico] Inst Clin & Hormonal Res, Foggia, Italy; [De Pergola, Giovanni] Univ Bari, Nutr Outpatient Clin, Clin Oncol Unit, Bari, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Universita degli Studi di Bari Aldo Moro	Pasquali, R (corresponding author), Univ Bologna, S Orsola Malpighi Hosp, Div Endocrinol, Alma Mater Studiorum, Bologna, Italy.; Pasquali, R (corresponding author), Univ Bologna, S Orsola Malpighi Hosp, Ctr Appl Biomed Res, Dept Med & Surg Sci,Alma Mater Studiorum, Bologna, Italy.	renato.pasquali@unibo.it			Italian Research Project of Relevant Interest	Italian Research Project of Relevant Interest	This study was funded by Italian Research Project of Relevant Interest (PRIM 2010-2011).	Alves MG, 2014, BRIT J PHARMACOL, V171, P1033, DOI 10.1111/bph.12522; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Brand JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100409; Casulari LA, 2010, MINERVA ENDOCRINOL, V35, P145; Chua ME, 2013, ANDROLOGY-US, V1, P749, DOI 10.1111/j.2047-2927.2013.00107.x; Corona G, 2016, EUR J ENDOCRINOL, V174, pR99, DOI 10.1530/EJE-15-0262; Corona G, 2013, EUR J ENDOCRINOL, V168, P829, DOI 10.1530/EJE-12-0955; Crabbe P, 2007, J CLIN ENDOCR METAB, V92, P3604, DOI 10.1210/jc.2007-0117; Dandona P, 2011, J CLIN ENDOCR METAB, V96, P2643, DOI 10.1210/jc.2010-2724; Dhindsa S, 2011, DIABETES CARE, V34, P1854, DOI 10.2337/dc11-0208; Dhindsa S, 2010, DIABETES CARE, V33, P1186, DOI 10.2337/dc09-1649; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Elbers JMH, 1997, J CLIN ENDOCR METAB, V82, P3267, DOI 10.1210/jc.82.10.3267; Fanelli F, 2016, 18TH EUROPEAN CONGRE; Fanelli F, 2013, J CLIN ENDOCR METAB, V98, P3058, DOI 10.1210/jc.2013-1381; Fanelli F, 2011, STEROIDS, V76, P244, DOI 10.1016/j.steroids.2010.11.005; Feldman HA, 2002, J CLIN ENDOCR METAB, V87, P589, DOI 10.1210/jc.87.2.589; Ferreira C, 2015, CURR PHARM DESIGN, V21, P3621, DOI 10.2174/1381612821666150710150041; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Giagulli VA, 2011, INT J ANDROL, V34, P236, DOI 10.1111/j.1365-2605.2010.01081.x; GIAGULLI VA, 1994, J CLIN ENDOCR METAB, V79, P997, DOI 10.1210/jc.79.4.997; Gianatti EJ, 2014, DIABETES CARE, V37, P2098, DOI 10.2337/dc13-2845; Goldstein SR, 2000, HUM REPROD UPDATE, V6, P212, DOI 10.1093/humupd/6.3.212; Grossmann M, 2008, J CLIN ENDOCR METAB, V93, P1834, DOI 10.1210/jc.2007-2177; GUAY AT, 1995, J CLIN ENDOCR METAB, V80, P3546, DOI 10.1210/jc.80.12.3546; Helo S, 2015, J SEX MED, V12, P1761, DOI 10.1111/jsm.12944; Kapoor D, 2007, DIABETES CARE, V30, P911, DOI 10.2337/dc06-1426; Katz DJ, 2012, BJU INT, V110, P573, DOI 10.1111/j.1464-410X.2011.10702.x; MACDONALD PC, 1979, J CLIN ENDOCR METAB, V49, P905, DOI 10.1210/jcem-49-6-905; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Morelli A, 2014, MOL CELL ENDOCRINOL, V382, P107, DOI 10.1016/j.mce.2013.09.017; Moskovic DJ, 2012, BJU INT, V110, P1524, DOI 10.1111/j.1464-410X.2012.10968.x; Nasrolahi O, 2013, IRAN J REPROD MED, V11, P1013; Niskanen L, 2004, DIABETES OBES METAB, V6, P208, DOI 10.1111/j.1462-8902.2004.00335.x; Patel DP, 2015, INT J IMPOT RES, V27, P221, DOI 10.1038/ijir.2015.21; Samavat J, 2014, EUR J ENDOCRINOL, V171, P555, DOI 10.1530/EJE-14-0596; Stanworth RD, 2014, EUR J ENDOCRINOL, V170, P193, DOI 10.1530/EJE-13-0703; Tartarin P, 2012, HUM REPROD, V27, P3304, DOI 10.1093/humrep/des264; Taylor F, 2010, J SEX MED, V7, P269, DOI 10.1111/j.1743-6109.2009.01454.x; TENOVER JS, 1987, J CLIN ENDOCR METAB, V65, P1118, DOI 10.1210/jcem-65-6-1118; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; VOIGT W, 1970, J BIOL CHEM, V245, P5594; Wang C, 2008, EUR J ENDOCRINOL, V159, P507, DOI 10.1530/EJE-08-0601	45	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183369	10.1371/journal.pone.0183369	http://dx.doi.org/10.1371/journal.pone.0183369			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886024	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100017
J	Raymond, SL; Lopez, MC; Baker, HV; Larson, SD; Efron, PA; Sweeney, TE; Khatri, P; Moldawer, LL; Wynn, JL				Raymond, Steven L.; Lopez, Maria Cecilia; Baker, Henry V.; Larson, Shawn D.; Efron, Philip A.; Sweeney, Timothy E.; Khatri, Purvesh; Moldawer, Lyle L.; Wynn, James L.			Unique transcriptomic response to sepsis is observed among patients of different age groups	PLOS ONE			English	Article							PRETERM INFANTS; IN-VIVO; CHEMOTAXIS; EPIDEMIOLOGY; NEUTROPHILS; MORTALITY; ADHERENCE; IMMUNITY; NETWORK; TIME	Sepsis is a major cause of morbidity and mortality, especially at the extremes of age. To understand the human age-specific transcriptomic response to sepsis, a multi-cohort, pooled analysis was conducted on adults, children, infants, and neonates with and without sepsis. Nine public whole-blood gene expression datasets (636 patients) were employed. Age impacted the transcriptomic host response to sepsis. Gene expression from septic neonates and adults was more dissimilar whereas infants and children were more similar. Neonates showed reductions in inflammatory recognition and signaling pathways compared to all other age groups. Likewise, adults demonstrated decreased pathogen sensing, inflammation, and myeloid cell function, as compared to children. This may help to explain the increased incidence of sepsis-related organ failure and death in adults. The number of dys-regulated genes in septic patients was proportional to age and significantly differed among septic adults, children, infants, and neonates. Overall, children manifested a greater transcriptomic intensity to sepsis as compared to the other age groups. The transcriptomic magnitude for adults and neonates was dramatically reduced as compared to children and infants. These findings suggest that the transcriptomic response to sepsis is age-dependent, and diagnostic and therapeutic efforts to identify and treat sepsis will have to consider age as an important variable.	[Raymond, Steven L.; Larson, Shawn D.; Efron, Philip A.; Moldawer, Lyle L.] Univ Florida, Coll Med, Dept Surg, Gainesville, FL USA; [Lopez, Maria Cecilia; Baker, Henry V.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Sweeney, Timothy E.; Khatri, Purvesh] Stanford Univ, Dept Med, Div Biomed Informat Res, Sch Med, Stanford, CA 94305 USA; [Khatri, Purvesh] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Wynn, James L.] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA; [Wynn, James L.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Stanford University; Stanford University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wynn, JL (corresponding author), Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA.; Wynn, JL (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	james.wynn@peds.ufl.edu	Larson, Shawn D/AFD-9859-2022; Lopez, Maria/HHC-3659-2022	Larson, Shawn D/0000-0002-8564-0140; Khatri, Purvesh/0000-0002-4143-4708; Wynn, James/0000-0001-7052-4836; Moldawer, Lyle/0000-0002-9041-9838; Sweeney, Timothy/0000-0002-3596-1093	Bill and Melinda Gates Foundation; National Institute of General Medical Sciences [K08 GM106143, R01 GM097531, R01 GM040586, R01 GM113945, P50 GM111152]; National Institute of Allergy and Infectious Diseases [1U19AI109662, U19AI057229, U541117925]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI117925, U19AI057229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097531, P50GM111152, K08GM106143, R01GM113945, R01GM040586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the Bill and Melinda Gates Foundation, the National Institute of General Medical Sciences (K08 GM106143, R01 GM097531, R01 GM040586, R01 GM113945, and P50 GM111152), and the National Institute of Allergy and Infectious Diseases (1U19AI109662, U19AI057229, and U541117925). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson SJ, 2016, MOL MED, P22; Barton L, 1999, PEDIATRICS, V103, P446, DOI 10.1542/peds.103.2.446; BEKTAS S, 1990, ACTA PAEDIATR SCAND, V79, P1031, DOI 10.1111/j.1651-2227.1990.tb11379.x; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Cohen-Wolkowiez M, 2009, PEDIATR INFECT DIS J, V28, P1052, DOI 10.1097/INF.0b013e3181acf6bd; Cuenca AG, 2013, CRIT CARE MED, V41, P1175, DOI 10.1097/CCM.0b013e318277131c; Gentile LF, 2014, J IMMUNOL, V192, P3156, DOI 10.4049/jimmunol.1301726; Girard TD, 2005, CLIN INFECT DIS, V40, P719, DOI 10.1086/427876; Hall Margaret Jean, 2011, NCHS Data Brief, P1; Hu N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099671; Jones CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114509; Kermorvant-Duchemin E, 2008, PEDIATR CRIT CARE ME, V9, P186, DOI 10.1097/PCC.0b013e31816689a8; KRAUSE PJ, 1986, PEDIATR RES, V20, P296, DOI 10.1203/00006450-198604000-00004; Mahajan P, 2016, JAMA-J AM MED ASSOC, V316, P846, DOI 10.1001/jama.2016.9207; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Nacionales DC, 2014, J IMMUNOL, V192, P612, DOI 10.4049/jimmunol.1302109; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Ramchandran R, 2008, AM J PHYSIOL-LUNG C, V295, pL363, DOI 10.1152/ajplung.90241.2008; Simon R, 2008, CURR OPIN BIOTECH, V19, P26, DOI 10.1016/j.copbio.2007.10.008; Simon R, 2009, BEST PRACT RES CL HA, V22, P271, DOI 10.1016/j.beha.2009.07.001; Smith CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5649; Stevenson EK, 2014, CRIT CARE MED, V42, P625, DOI 10.1097/CCM.0000000000000026; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Sweeney TE, 2017, CRIT CARE MED, V45, P934, DOI 10.1097/CCM.0000000000002402; Sweeney TE, 2017, CRIT CARE MED, V45, P1, DOI 10.1097/CCM.0000000000002021; Sweeney TE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7165; Sweeney TE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5993; Tang BMP, 2008, CRIT CARE MED, V36, P1125, DOI 10.1097/CCM.0b013e3181692c0b; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Watson RS, 2003, AM J RESP CRIT CARE, V167, P695, DOI 10.1164/rccm.200207-682OC; Wynn JL, 2007, SHOCK, V28, P675, DOI 10.1097/shk.0b013e3180556d09; Wynn JL, 2015, MOL MED, V21, P496, DOI 10.2119/molmed.2015.00064; Wynn JL, 2014, PEDIATR CRIT CARE ME, V15, P523, DOI 10.1097/PCC.0000000000000157; Wynn JL, 2011, MOL MED, V17, P1146, DOI 10.2119/molmed.2011.00169	34	24	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184159	10.1371/journal.pone.0184159	http://dx.doi.org/10.1371/journal.pone.0184159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886074	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100071
J	Roodt, D; Lohaus, R; Sterck, L; Swanepoel, RL; Van de Peer, Y; Mizrachi, E				Roodt, Danielle; Lohaus, Rolf; Sterck, Lieven; Swanepoel, Riaan L.; Van de Peer, Yves; Mizrachi, Eshchar			Evidence for an ancient whole genome duplication in the cycad lineage	PLOS ONE			English	Article							EXTANT GYMNOSPERMS; SEED PLANT; MOLECULAR EVOLUTION; DIVERGENCE TIMES; ORIGIN; DIVERSIFICATION; POLYPLOIDY; PHYLOGENY; EPHEDRA; GENES	Contrary to the many whole genome duplication events recorded for angiosperms (flowering plants), whole genome duplications in gymnosperms (non-flowering seed plants) seem to be much rarer. Although ancient whole genome duplications have been reported for most gymnosperm lineages as well, some are still contested and need to be confirmed. For instance, data for ginkgo, but particularly cycads have remained inconclusive so far, likely due to the quality of the data available and flaws in the analysis. We extracted and sequenced RNA from both the cycad Encephalartos natalensis and Ginkgo biloba. This was followed by transcriptome assembly, after which these data were used to build paralog age distributions. Based on these distributions, we identified remnants of an ancient whole genome duplication in both cycads and ginkgo. The most parsimonious explanation would be that this whole genome duplication event was shared between both species and had occurred prior to their divergence, about 300 million years ago.	[Roodt, Danielle; Swanepoel, Riaan L.; Mizrachi, Eshchar] Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst, Private Bag X20, Pretoria, South Africa; [Roodt, Danielle; Swanepoel, Riaan L.; Van de Peer, Yves; Mizrachi, Eshchar] Univ Pretoria, Ctr Bioinformat & Computat Biol, Genom Res Inst, Private Bag X20, Pretoria, South Africa; [Lohaus, Rolf; Sterck, Lieven; Van de Peer, Yves] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Lohaus, Rolf; Sterck, Lieven; Van de Peer, Yves] VIB Ctr Plant Syst Biol, Ghent, Belgium; [Lohaus, Rolf; Sterck, Lieven; Van de Peer, Yves] Univ Ghent, Bioinformat Inst Ghent, Ghent, Belgium	University of Pretoria; University of Pretoria; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Mizrachi, E (corresponding author), Univ Pretoria, Dept Genet, Forestry & Agr Biotechnol Inst, Private Bag X20, Pretoria, South Africa.; Mizrachi, E (corresponding author), Univ Pretoria, Ctr Bioinformat & Computat Biol, Genom Res Inst, Private Bag X20, Pretoria, South Africa.	eshchar.mizrachi@fabi.up.ac.za	Van de Peer, Yves/AAE-7666-2019; Mizrachi, Eshchar/N-3179-2014; Sterck, Lieven/A-9439-2016; Van de Peer, Yves/D-4388-2009	Van de Peer, Yves/0000-0003-4327-3730; Sterck, Lieven/0000-0001-7116-4000; Van de Peer, Yves/0000-0003-4327-3730; Roodt, Danielle/0000-0001-7839-7704; Mizrachi, Eshchar/0000-0002-3126-9593	UP Research Development Programme (RDP); Genomics Research Institute (GRI); Ghent University [01MR0310W]; European Union Seventh Framework Programme (FP7) under European Research Council Advanced Grant [322739 - DOUBLEUP, 322739 -DOUBLEUP]	UP Research Development Programme (RDP); Genomics Research Institute (GRI); Ghent University(Ghent University); European Union Seventh Framework Programme (FP7) under European Research Council Advanced Grant(European Research Council (ERC))	The authors acknowledge the UP Research Development Programme (RDP), the Genomics Research Institute (GRI), Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks' Project (no. 01MR0310W) of Ghent University, and funding from the European Union Seventh Framework Programme (FP7/2007-2013) under European Research Council Advanced Grant Agreement 322739 - DOUBLEUP for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Jason Samson, Philip Rousseau and the Manie van der Schijff Botanical Gardens of the University of Pretoria for plant material and assisting with sampling. EM acknowledges the UP Research Development Programme (RDP) and the Genomics Research Institute (GRI) for support. YVdP acknowledges the Multidisciplinary Research Partnership 'Bioinformatics: from nucleotides to networks' Project (no. 01MR0310W) of Ghent University, and funding from the European Union Seventh Framework Programme (FP7/2007-2013) under European Research Council Advanced Grant Agreement 322739 -DOUBLEUP.	Arrigo N, 2012, CURR OPIN PLANT BIOL, V15, P140, DOI 10.1016/j.pbi.2012.03.010; Bowe LM, 2000, P NATL ACAD SCI USA, V97, P4092, DOI 10.1073/pnas.97.8.4092; Brenner ED, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r78; Burleigh JG, 2012, J BOT, V2012; Calonje M., 2013, WORLD LIST CYCADS; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chaw SM, 2000, P NATL ACAD SCI USA, V97, P4086, DOI 10.1073/pnas.97.8.4086; Chaw SM, 1997, MOL BIOL EVOL, V14, P56, DOI 10.1093/oxfordjournals.molbev.a025702; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Condamine FL, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0347-8; Crisp MD, 2011, NEW PHYTOL, V192, P997, DOI 10.1111/j.1469-8137.2011.03862.x; Cui LY, 2006, GENOME RES, V16, P738, DOI 10.1101/gr.4825606; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; De La Torre AR, 2017, MOL BIOL EVOL, V34, P1363, DOI 10.1093/molbev/msx069; de la Torre-Barcena JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005764; Doyle JA, 1996, INT J PLANT SCI, V157, pS3, DOI 10.1086/297401; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Gilbert D., 2013, EVIDENTIALGENE MRNA, P1, DOI [10.7490/f1000research.1112594.1, DOI 10.7490/F1000RESEARCH.1112594.1]; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Guan R, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0154-1; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Huang JL, 2005, MOL PHYLOGENET EVOL, V35, P48, DOI 10.1016/j.ympev.2004.12.020; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jones, 2002, CYCADS WORLD ANCIENT; KHOSHOO TN, 1959, EVOLUTION, V13, P24, DOI 10.2307/2405943; Lee EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002411; Li Z, 2017, GENOME BIOL EVOL, V9, P1130, DOI 10.1093/gbe/evx070; Li Z, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501084; Madlung A, 2013, HEREDITY, V110, P99, DOI 10.1038/hdy.2012.79; Magallon S, 2002, AM J BOT, V89, P1991, DOI 10.3732/ajb.89.12.1991; Magallon SA, 2005, EVOLUTION, V59, P1653, DOI 10.1554/04-565.1; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Mayrose I, 2015, NEW PHYTOL, V206, P27, DOI 10.1111/nph.13192; Mayrose I, 2011, SCIENCE, V333, P1257, DOI 10.1126/science.1207205; Nagalingum NS, 2011, SCIENCE, V334, P796, DOI 10.1126/science.1209926; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Ruprecht C, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603195; Rydin C, 2004, P NATL ACAD SCI USA, V101, P16571, DOI 10.1073/pnas.0407588101; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schneider H, 2004, NATURE, V428, P553, DOI 10.1038/nature02361; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Solds DE, 2008, ANN NY ACAD SCI, V1133, P3, DOI 10.1196/annals.1438.005; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; Taylor TN, 2009, PALEOBOTANY: THE BIOLOGY AND EVOLUTION OF FOSSIL PLANTS, 2ND EDITION, P1; VandePeer Y, 2017, NAT REV GENET; Vanneste K, 2015, PLANT CELL, V27, P1567, DOI 10.1105/tpc.15.00157; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Vanneste K, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0353; Vanneste K, 2013, MOL BIOL EVOL, V30, P177, DOI 10.1093/molbev/mss214; Wickett NJ, 2014, P NATL ACAD SCI USA, V111, pE4859, DOI 10.1073/pnas.1323926111; Wu CS, 2013, GENOME BIOL EVOL, V5, P243, DOI 10.1093/gbe/evt001; Wu H, 2016, MOL ECOL, V25, P1192, DOI 10.1111/mec.13538; Xi ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080870; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	56	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184454	10.1371/journal.pone.0184454	http://dx.doi.org/10.1371/journal.pone.0184454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886111	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100124
J	Sarkar, A; Stoneking, M; Nandineni, MR				Sarkar, Anujit; Stoneking, Mark; Nandineni, Madhusudan R.			Unraveling the human salivary microbiome diversity in Indian populations	PLOS ONE			English	Article							BACTERIAL; COMMUNITIES; SEQUENCES	The importance of studying the salivary microbiome has been highlighted for its connection to health and disease and as a potential tool for supplementing human genetic diversity studies. While the salivary microbiome has been studied in various world populations, Indian populations have not been examined. We therefore analyzed microbiome diversity in saliva samples from 92 volunteers from eight different sampling locations in India by amplifying and sequencing variable regions (V1 and V2) of the bacterial 16S rRNA gene. The results showed immense bacterial richness in Indian populations; we identified 165 bacterial genera and 785 unique Operational Taxonomic Units (OTUs), with substantial sharing among the populations. There were small, but significant correlations in the abundance of bacterial genera in sampling locations from the same geographic region. Most of the core OTUs detected were also observed previously in other populations, but Solobacterium spp., Lachnoanaerobaculum spp. and Alloprevotella spp. were observed to be a component of the saliva microbiome unique to Indian populations. Importantly, nine bacterial genera were observed that were not listed in the Human Oral Microbiome Database (HOMD). These results highlight the importance of analyzing underrepresented populations like those of India.	[Sarkar, Anujit; Nandineni, Madhusudan R.] Ctr DNA Fingerprinting & Diagnost CDFD, Lab Genom & Profiling Applicat, Hyderabad, Telangana, India; [Sarkar, Anujit] Manipal Univ, Grad Studies, Manipal, India; [Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Nandineni, Madhusudan R.] Ctr DNA Fingerprinting & Diagnost CDFD, Lab DNA Fingerprinting Serv, Hyderabad, Telangana, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE); Max Planck Society; Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Nandineni, MR (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Lab Genom & Profiling Applicat, Hyderabad, Telangana, India.; Stoneking, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany.; Nandineni, MR (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Lab DNA Fingerprinting Serv, Hyderabad, Telangana, India.	stoneking@eva.mpg.de; nandineni@cdfd.org.in	Sarkar, Anujit/AAY-7250-2021	Sarkar, Anujit/0000-0003-3170-2542; Nandineni, Madhusudan Reddy/0000-0002-8933-4503	Department of Science and Technology, Government of India [IGSTC/MPG/PG (MR)/2011]; Max Planck Society [M.PG.A.EVAN0002]; University Grants Commission, India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Max Planck Society(Max Planck Society); University Grants Commission, India(University Grants Commission, India)	This research was funded as part of the Max Planck Partner Group Programme to MRN from the Department of Science and Technology (http://www.dst.gov.in), Government of India (project No. IGSTC/MPG/PG (MR)/2011) and the Max Planck Society (https://www.mpg.de/en) (project No. M.PG.A.EVAN0002). A.S. was the recipient of Junior and Senior Research Fellowships of the University Grants Commission, India towards the pursuit of a Ph.D. degree of the Manipal University, Karnataka, India.	Acharya A., 2017, ORAL DIS; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85; Belstrom D, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.23609; Cameron SJS, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv091; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, P326; David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89; De Filippis F, 2014, PLOS ONE, P9; Dehingia M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18563; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; Foxman B, 2016, ANN EPIDEMIOL, V26, P348, DOI 10.1016/j.annepidem.2016.03.006; Ghosh TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095547; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Hedberg ME, 2012, INT J SYST EVOL MICR, V62, P2685, DOI 10.1099/ijs.0.033613-0; Henne K, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0190-3; Horz HP, 2012, ENV MICROBIOL REP, V4, P390, DOI 10.1111/j.1758-2229.2012.00340.x; Hu S, 2007, EXPERT REV PROTEOMIC, V4, P531, DOI 10.1586/14789450.4.4.531; Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kazor CE, 2003, J CLIN MICROBIOL, V41, P558, DOI 10.1128/JCM.41.2.558-563.2003; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Lazarevic V., 2011, J INTEGR OMICS, V1, P28, DOI [DOI 10.5584/JI0MICS.V1I1.43, 10.5584/jiomics.v1i1.43, DOI 10.5584/JIOMICS.V1I1.43]; Li J, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0316-1; Li K, 2013, PLOS ONE, P8; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Meyer M, 2010, COLD SPRING HARB PRO, P5; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; Sato Y, 2015, PLOS ONE, V10, P1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013; Shetty SA, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-24; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Stahringer SS, 2012, GENOME RES, V22, P2146, DOI 10.1101/gr.140608.112; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Wang K, 2016, SCI REP-UK, V6, DOI 10.1038/srep22943; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yang B, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0992-y; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	51	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184515	10.1371/journal.pone.0184515	http://dx.doi.org/10.1371/journal.pone.0184515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886168	Green Published, Green Submitted, gold			2022-12-27	WOS:000410001100144
J	Storme, M; Semionov, A; Assayag, D; Lefson, M; Kitty, D; Dannenbaum, D; Torrie, J; Lejeune, P; Robinson, E; Khan, FA				Storme, Matthieu; Semionov, Alexandre; Assayag, Deborah; Lefson, Michael; Kitty, Darlene; Dannenbaum, David; Torrie, Jill; Lejeune, Pierre; Robinson, Elizabeth; Khan, Faiz Ahmad			Estimating the incidence of interstitial lung diseases in the Cree of Eeyou Istchee, northern Quebec	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; PREVALENCE; DIAGNOSIS; SURVIVAL; EPIDEMIOLOGY; PNEUMONIA; UPDATE	Background Little is known about the epidemiology of interstitial lung disease (ILD) amongst Canada's Indigenous populations. Clinicians working in Eeyou Istchee (the Cree territory of the James Bay region of Quebec, population 17, 956) suspected that ILD was more common in this area. We sought to identify all prevalent and incident cases of ILD in Eeyou Istchee between 2006 and 2013, to describe characteristics of affected patients, distribution of subtypes, and estimate disease incidence. Methods Potential ILD cases amongst Eeyou Istchee residents were identified by searching hospitalization databases and lists of patients on long term home oxygen in the region's nine communities, and surveying physicians and nurses. Clinical, radiological and pathological data were reviewed. Potential cases were classified as 'Definite ILD' if an open lung biopsy demonstrated ILD or, in the absence of histopathologic confirmation, if their thoracic CT imaging was deemed consistent with ILD by a panel of two respirologists and a chest radiologist. Potential cases for whom CT images could not be retrieved for our review were not eligible for classification as Definite ILD, unless they had undergone open lung biopsy. The Definite ILD group was further categorized by subtype of ILD. For usual interstitial pneumonia and non-specific interstitial pneumonitis patterns, we assumed cases were idiopathic in the absence of documentation of connective tissue disease or occupational exposures in the medical chart. For Definite ILD and the most common subtype, we calculated the average annual incidence rates, age-standardized to the province of Quebec, for 2006 to 2013, using a gamma distribution to calculate 95% confidence intervals. Results Of 167 potential cases, 52 were categorized as Definite ILD: 14 on the basis of histopathology and 38 on the basis of CT imaging alone. Six patients had a prior history of connective tissue disease. Information on occupation was recorded in the charts of 18/52 (35%) cases, and missing in the remainder. We found the most common subtype was idiopathic pulmonary fibrosis (27/52, 52%), followed by idiopathic non-specific interstitial pneumonia (13/52, 25%), and secondary usual interstitial pneumonia associated with connective tissue diseases (5/52, 10%). The age-standardized annual incidence between 2006-2013 was 80 per 100,000 person-years observed (PYO) for ILD, and 46 per 100,000 PYO for idiopathic pulmonary fibrosis. Interpretation The incidence of ILD and of idiopathic pulmonary fibrosis in Eeyou Istchee may be higher than rates reported in other populations; however, cautious interpretation is required due to the lack of histopathological confirmation in the majority of cases, and our reliance on chart review to exclude secondary causes. A prospective study of incident cases with standardized assessments to establish the types of ILD and to assess for potential causes could overcome some of the limitations of the present analysis. Studies evaluating ILD incidence and subtype distribution in other Indigenous populations would also be of interest.	[Storme, Matthieu; Khan, Faiz Ahmad] McGill Univ, Div Resp Med, Montreal, PQ, Canada; [Semionov, Alexandre] McGill Univ, Hlth Ctr, Radiol Dept, Montreal, PQ, Canada; [Assayag, Deborah] Jewish Gen Hosp, Pulm Div, Montreal, PQ, Canada; [Lefson, Michael; Kitty, Darlene; Dannenbaum, David; Robinson, Elizabeth] Cree Board Hlth & Social Serv James Bay, Dept Med, Montreal, PQ, Canada; [Dannenbaum, David; Torrie, Jill; Lejeune, Pierre; Robinson, Elizabeth] Cree Board Hlth & Social Serv James Bay, Dept Publ Hlth, Montreal, PQ, Canada; [Robinson, Elizabeth] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Khan, Faiz Ahmad] McGill Univ, Hlth Ctr, Montreal Chest Inst, Montreal, PQ, Canada; [Khan, Faiz Ahmad] McGill Univ, Hlth Ctr, Ctr Outcomes Res & Evaluat, Resp Epidemiol & Clin Res Unit,Res Inst, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Khan, FA (corresponding author), McGill Univ, Div Resp Med, Montreal, PQ, Canada.; Khan, FA (corresponding author), McGill Univ, Hlth Ctr, Montreal Chest Inst, Montreal, PQ, Canada.; Khan, FA (corresponding author), McGill Univ, Hlth Ctr, Ctr Outcomes Res & Evaluat, Resp Epidemiol & Clin Res Unit,Res Inst, Montreal, PQ, Canada.	faiz.ahmadkhan@mcgill.ca	Assayag, Deborah/ABE-4299-2021	Semionov, Alexandre/0000-0002-8255-3324	Cree Health Board; Fonds de Recherche Sante Quebec (FRQS)	Cree Health Board; Fonds de Recherche Sante Quebec (FRQS)	The study was funded by the Cree Health Board, members of whom are amongst the coauthors and contributed to study design, data collection and analysis, decision to publish, and preparation of the manuscript. FAK received salary support from the Fonds de Recherche Sante Quebec (FRQS); the FRQS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz ZA, 2004, THORAX, V59, P506, DOI 10.1136/thx.2003.020396; COULTAS DB, 1994, AM J RESP CRIT CARE, V150, P967, DOI 10.1164/ajrccm.150.4.7921471; de la Sante A et des Services Sociaux, 2015, SANT SERV SOC; Fay MP, 1997, STAT MED, V16, P791; Fernandez-Perez ER, 2010, CHEST, V137, P242, DOI [10.1378/chest.09-1002, 10.1378/chest.09-1871]; Garcia Christine Kim, 2011, Proc Am Thorac Soc, V8, P158, DOI 10.1513/pats.201008-056MS; Hodgson U, 2002, THORAX, V57, P338, DOI 10.1136/thorax.57.4.338; Hopkins RB, 2016, EUR RESPIR J, V48, P187, DOI 10.1183/13993003.01504-2015; Hunninghake GW, 2003, CHEST, V124, P1215, DOI 10.1378/chest.124.4.1215; Hunninghake GW, 2001, AM J RESP CRIT CARE, V164, P193, DOI 10.1164/ajrccm.164.2.2101090; Hutchinson J, 2015, EUR RESPIR J, V46, P795, DOI 10.1183/09031936.00185114; Hyldgaard C, 2014, RESP MED, V108, P793, DOI 10.1016/j.rmed.2013.09.002; Kaunisto J, 2013, BMC PULM MED, V13, DOI 10.1186/1471-2466-13-53; Martinez Fernando J, 2006, Proc Am Thorac Soc, V3, P81, DOI 10.1513/pats.200511-123JH; Ospina MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123204; Ospina MB, 2012, CAN RESPIR J, V19, P355, DOI 10.1155/2012/825107; Park JH, 2007, AM J RESP CRIT CARE, V175, P705, DOI 10.1164/rccm.200607-912OC; Public Health Agency of Canada, 2008, TUB CAN 2008; Raghu G, 2014, LANCET RESP MED, V2, P566, DOI 10.1016/S2213-2600(14)70101-8; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Saad N, 2013, THORAX, V68, P361, DOI 10.1136/thoraxjnl-2012-201823; Song JW, 2009, CHEST, V136, P23, DOI 10.1378/chest.08-2572; Statistics Canada, 2015, CAN COMM HLTH SURV 2; Strand MJ, 2014, CHEST, V146, P775, DOI 10.1378/chest.13-2388; Travis W.D., 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Yamauchi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166168	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184548	10.1371/journal.pone.0184548	http://dx.doi.org/10.1371/journal.pone.0184548			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886193	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100152
J	Tanner, EP; Papes, M; Elmore, RD; Fuhlendorf, SD; Davis, CA				Tanner, Evan P.; Papes, Monica; Elmore, R. Dwayne; Fuhlendorf, Samuel D.; Davis, Craig A.			Incorporating abundance information and guiding variable selection for climate-based ensemble forecasting of species' distributional shifts	PLOS ONE			English	Article							ECOLOGICAL-NICHE MODELS; COLINUS-VIRGINIANUS; EXTINCTION RISK; SCALED QUAIL; HABITAT USE; LAND-COVER; CONSERVATION; RANGE; PREDICTION; WEATHER	Ecological niche models (ENMs) have increasingly been used to estimate the potential effects of climate change on species' distributions worldwide. Recently, predictions of species abundance have also been obtained with such models, though knowledge about the climatic variables affecting species abundance is often lacking. To address this, we used a well-studied guild (temperate North American quail) and the Maxent modeling algorithm to compare model performance of three variable selection approaches: correlation/variable contribution (CVC), biological (i.e., variables known to affect species abundance), and random. We then applied the best approach to forecast potential distributions, under future climatic conditions, and analyze future potential distributions in light of available abundance data and presence-only occurrence data. To estimate species' distributional shifts we generated ensemble forecasts using four global circulation models, four representative concentration pathways, and two time periods (2050 and 2070). Furthermore, we present distributional shifts where 75%, 90%, and 100% of our ensemble models agreed. The CVC variable selection approach outperformed our biological approach for four of the six species. Model projections indicated species-specific effects of climate change on future distributions of temperate North American quail. The Gambel's quail (Callipepla gambelii) was the only species predicted to gain area in climatic suitability across all three scenarios of ensemble model agreement. Conversely, the scaled quail (Callipepla squamata) was the only species predicted to lose area in climatic suitability across all three scenarios of ensemble model agreement. Our models projected future loss of areas for the northern bobwhite (Colinus virginianus) and scaled quail in portions of their distributions which are currently areas of high abundance. Climatic variables that influence local abundance may not always scale up to influence species' distributions. Special attention should be given to selecting variables for ENMs, and tests of model performance should be used to validate the choice of variables.	[Tanner, Evan P.; Elmore, R. Dwayne; Fuhlendorf, Samuel D.; Davis, Craig A.] Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA; [Papes, Monica] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA	Oklahoma State University System; Oklahoma State University - Stillwater; University of Tennessee System; University of Tennessee Knoxville	Tanner, EP (corresponding author), Oklahoma State Univ, Dept Nat Resource Ecol & Management, Stillwater, OK 74078 USA.	evan.tannner@okstate.edu	Fuhlendorf, Samuel/A-2931-2011; Tanner, Evan/K-9325-2015	Fuhlendorf, Samuel/0000-0002-8726-9402; Tanner, Evan/0000-0003-0063-7004	Oklahoma Department of Wildlife Conservation [W-161-R]; National Science Foundation [OIA-1301789]; Office Of The Director [1301789] Funding Source: National Science Foundation	Oklahoma Department of Wildlife Conservation; National Science Foundation(National Science Foundation (NSF)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by Oklahoma Department of Wildlife Conservation; Grant W-161-R, https://www.wildlifedepartment.com/; National Science Foundation; Grant OIA-1301789, www.nsf.gov. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; [Anonymous], 1987, MAP PROJECTIONS WORK, DOI DOI 10.3133/PP1395; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Bahn V, 2013, OIKOS, V122, P321, DOI 10.1111/j.1600-0706.2012.00299.x; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Beever EA, 2011, GLOBAL CHANGE BIOL, V17, P2054, DOI 10.1111/j.1365-2486.2010.02389.x; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; BOTSFORD LW, 1988, J WILDLIFE MANAGE, V52, P469, DOI 10.2307/3801593; Brambilla M, 2012, J ANIM ECOL, V81, P781, DOI 10.1111/j.1365-2656.2012.01970.x; BRENNAN LA, 1987, CONDOR, V89, P66, DOI 10.2307/1368760; BRENNAN LA, 1991, WILDLIFE SOC B, V19, P544; Bridges AS, 2001, J WILDLIFE MANAGE, V65, P10, DOI 10.2307/3803270; BROWN DE, 1979, J WILDLIFE MANAGE, V43, P522, DOI 10.2307/3800365; Brown DE, 1989, ARIZONA GAME BIRDS P; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Bucklin DN, DIVERS DISTRIB; CAMPBELL H, 1968, J WILDLIFE MANAGE, V32, P641, DOI 10.2307/3798952; Campbell H., 1965, Journal of Wildlife Management, V29, P801, DOI 10.2307/3798556; Campbell H, 1973, WILDLIFE MONOGR, V34, P3; Caro TM, 2003, ANIM CONSERV, V6, P171, DOI 10.1017/S1367943003003214; Carroll JM, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00163.1; Church K. E., 1993, P NATL QUAIL S, V3, P44; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crosby AD, 2015, BIOL CONSERV, V186, P233, DOI 10.1016/j.biocon.2015.03.018; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Doherty PF, 2003, ANN ZOOL FENN, V40, P145; Domisch S, 2013, GLOBAL CHANGE BIOL, V19, P752, DOI 10.1111/gcb.12107; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elmore RD, 2017, WILDLIFE SOC B, V41, P183, DOI 10.1002/wsb.772; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fink D, 2010, ECOL APPL, V20, P2131, DOI 10.1890/09-1340.1; FRANCIS WJ, 1970, J WILDLIFE MANAGE, V34, P249, DOI 10.2307/3799009; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gifford ME, 2012, ECOGRAPHY, V35, P193, DOI 10.1111/j.1600-0587.2011.06866.x; Giuliano WM, 1993, P NATL QUAIL S, V3, P64; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2014, NAT CLIM CHANGE, V4, P175, DOI 10.1038/nclimate2157; GULLION GW, 1960, ECOLOGY, V41, P516; Gullion GW, 1954, P W ASS STATE GAME F, V32, P234; Guralnick R, 2007, GLOBAL ECOL BIOGEOGR, V16, P14, DOI [10.1111/j.1466-822X.2006.00260.x, 10.1111/j.1466-8238.2006.00260.x]; Guthery F. S., 2002, P NATL QUAIL S, V5, P99; Guthery FS, 2005, WILDLIFE MONOGR, P1; Guthery FS, 2001, J WILDLIFE MANAGE, V65, P850, DOI 10.2307/3803034; Guthery FS, 1997, J WILDLIFE MANAGE, V61, P291, DOI 10.2307/3802584; GUTIERREZ RJ, 1983, AUK, V100, P33, DOI 10.1093/auk/100.1.33; Gutierrez RJ, 1980, LIVING BIRD, V18, P71; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Heffelfinger JR, 1999, J WILDLIFE MANAGE, V63; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hochachka WM, 2012, TRENDS ECOL EVOL, V27, P130, DOI 10.1016/j.tree.2011.11.006; Hosner PA, 2015, J BIOGEOGR, V42, P1883, DOI 10.1111/jbi.12555; HOVICK TJ, 2014, ECOSPHERE, V5; Howard C, 2014, METHODS ECOL EVOL, V5, P506, DOI 10.1111/2041-210X.12184; Hungerford CR, 1960, THESIS; Hurlbert AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031662; Inger R, 2015, ECOL LETT, V18, P28, DOI 10.1111/ele.12387; Jimenez-Valverde A, 2011, GLOBAL ECOL BIOGEOGR, V20, P114, DOI 10.1111/j.1466-8238.2010.00574.x; Johnson Ned K., 1994, Studies in Avian Biology, V15, P27; Knowles LL, 2007, CURR BIOL, V17, P940, DOI 10.1016/j.cub.2007.04.033; Kramer-Schadt S, 2013, DIVERS DISTRIB, V19, P1366, DOI 10.1111/ddi.12096; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Legault A, 2013, BIOL CONSERV, V167, P149, DOI 10.1016/j.biocon.2013.07.041; Lehmann V. W., 1984, BOBWHITES RIO GRANDE; Leyva-Espinosa RI, 2000, THESIS; Li RQ, 2010, INTEGR ZOOL, V5, P154, DOI 10.1111/j.1749-4877.2010.00198.x; Link WA, 1998, ECOL APPL, V8, P258, DOI 10.1890/1051-0761(1998)008[0258:EPCFCD]2.0.CO;2; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lusk JJ, 2002, J WILDLIFE MANAGE, V66, P1040, DOI 10.2307/3802936; Lusk JJ, 2001, ECOL MODEL, V146, P3, DOI 10.1016/S0304-3800(01)00292-7; MacArthur R. H., 1972, GEOGRAPHICAL ECOLOGY; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Matala MM, 2013, GLOB CHANGE BIOL, V20; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Monahan WB, 2008, BIOL LETTERS, V4, P595, DOI 10.1098/rsbl.2008.0154; NatureServe, 2015, NATURESERVE EXPL ONL; O'Neill R.V., 1979, Statistical Ecology Series, V9, P59; Oberholser HC, 1974, BIRD LIFE TEXAS; Oliver TH, 2012, J APPL ECOL, V49, P581, DOI 10.1111/j.1365-2664.2012.02138.x; Palmer WE, 2011, RANG WID PLAN REC BO; Pardieck KL, 2014, N AM BREEDING BIRD S; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Perez RM, 2002, P NATL QUAIL S, V5, P106; Peterjohn B. G., 1994, BIRDING, V26, P386; Peterson AT, 2008, GLOBAL ECOL BIOGEOGR, V17, P135, DOI 10.1111/j.1466-8238.2007.00347.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pope M, 2002, THESIS; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pyron RA, 2015, BIOL REV, V90, P1248, DOI 10.1111/brv.12154; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; RAITT RJ, 1966, CONDOR, V68, P541, DOI 10.2307/1366263; Reyna KS, 2012, POULTRY SCI, V91, P41, DOI 10.3382/ps.2011-01676; Robbins C.S., 1986, BREEDING BIRD SURVEY; Rodder D, 2010, NATURWISSENSCHAFTEN, V97, P781, DOI 10.1007/s00114-010-0694-7; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Roseberry J.L., 1984, POPULATION ECOLOGY B; ROSENE W, 1969, BOBWHITE QUAIL ITS L; Sahlean TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091994; Sauer J. R., 2014, N AM BREEDING BIRD S, P3; Savage AE, 1974, T WE SECTION WILDLIE, V10, P84; Schemnitz SD, 1961, WILDLIFE MONOGR, V8, P3; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sohl TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112251; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Steen DA, 2015, J WILDLIFE MANAGE, V79, P872, DOI 10.1002/jwmg.897; Stoddard H.L., 1931, BOBWHITE QUAIL ITS H; STROMBERG MR, 1990, CONDOR, V92, P229, DOI 10.2307/1368404; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Sumner E. L., 1935, California Fish and Game, V21, P167; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; Tanner EP, 2017, GLOB CHANGE BIOL; Tanner EP, 2017, WILSON J ORNITHOL, V129, P354, DOI 10.1676/16-055.1; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; Thuiller W, 2014, ECOGRAPHY, V37, P1155, DOI 10.1111/ecog.00836; Van Couwenberghe R, 2013, ECOGRAPHY, V36, P665, DOI 10.1111/j.1600-0587.2012.07362.x; VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Varner J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104648; Venier LA, 1999, J BIOGEOGR, V26, P315, DOI 10.1046/j.1365-2699.1999.00273.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; WIENS JA, 1987, OIKOS, V48, P132, DOI 10.2307/3565849; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Wilson JW, 2013, BIOL CONSERV, V164, P170, DOI 10.1016/j.biocon.2013.04.021; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004; Zornes M, 2009, W QUAIL CONSERVATION, P1	145	10	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184316	10.1371/journal.pone.0184316	http://dx.doi.org/10.1371/journal.pone.0184316			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886075	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100096
J	Kang, HL; Nakae, A; Ito, H; Vitayaburananont, P; Minamoto, T; Ikeda, T; Osaka, M; Mashimo, T; Fujino, Y; Hagihira, S				Kang, Hongling; Nakae, Aya; Ito, Hiroshi; Vitayaburananont, Piyasak; Minamoto, Takehiro; Ikeda, Takashi; Osaka, Mariko; Mashimo, Takashi; Fujino, Yuji; Hagihira, Satoshi			Effects of sedation on subjective perception of pain intensity and autonomic nervous responses to pain: A preliminary study	PLOS ONE			English	Article							BISPECTRAL INDEX; GENERAL-ANESTHESIA; PERIPHERAL PERFUSION; CONSCIOUS SEDATION; HEALTHY-VOLUNTEERS; PROPOFOL; SYSTEM; VARIABILITY; NOCICEPTION; ALFENTANIL	Rather than relying solely on subjective pain evaluation using means such as the visual analogue scale (VAS), in clinical situations it is possible to observe evoked responses of the autonomic nervous system (ANS) as objective indicators. Few studies, however, have reported these relationships under finely controlled sedation. 16 healthy male participants were administrated in intravenous sedation with either propofol or midazolam randomly. We initially determined, using pharmacokinetic simulation, the effect-site concentration (Ce) of anaesthetic at loss of response to verbal command and eyelash reflex (Ce-LOR). Then subsequently adjusted Ce to 75%, 50%, and 25% of Ce-LOR to achieve deep, moderate, and light sedation. At awake control state and each sedation level, a noxious electrical stimulation was applied three times at the right forearm, an average pain intensity of the three stimuli was rated on a VAS (0 +/- 10). Changes in the peripheral perfusion index measured by oximetry were used as an indicator of ANS response. We analyzed the influence of sedation level on VAS and ANS responses compared to the awake control state. While ANS responses were similar in all conditions, VAS was statistically significantly lower in moderate (5.6 +/- 0.6, p < 0.005) or deep (5.3 +/- 0.6, p < 0.001) sedation than in the awake state (7.2 +/- 0.4). This study revealed that even when the ANS responds similarly to the same stimulation,subjective pain perception is attenuated by sedation. A cerebral mechanism other than that of the brainstem might determine subjective pain intensity.	[Kang, Hongling; Nakae, Aya; Ito, Hiroshi; Vitayaburananont, Piyasak; Mashimo, Takashi; Fujino, Yuji; Hagihira, Satoshi] Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care, Suita, Osaka, Japan; [Minamoto, Takehiro; Ikeda, Takashi; Osaka, Mariko] Osaka Univ, Grad Sch Human Sci, Suita, Osaka, Japan; [Nakae, Aya] Osaka Univ, Immunol Frontier Res Ctr, Brain Immune Interact, Suita, Osaka, Japan; [Ito, Hiroshi] NIHON KODEN Corp, Strateg Technol Operat, Technol Standardizat Dept, ECG Anal Sect 1, Tokyo, Japan; [Vitayaburananont, Piyasak] Navamindradhiraj Univ, Fac Med, Vajira Hosp, Dept Anesthesiol, Bangkok, Thailand; [Minamoto, Takehiro; Osaka, Mariko] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Suita, Osaka, Japan; [Ikeda, Takashi] Kanazawa Univ, Res Ctr Child Mental Dev, Kanazawa, Ishikawa, Japan; [Osaka, Mariko] Osaka Univ, Inst Acad Initiat, Suita, Osaka, Japan; [Mashimo, Takashi] Toyanaka Municipal Hosp, Toyonaka, Osaka, Japan; [Hagihira, Satoshi] Kansai Med Univ, Dept Anesthesiol, Hirakata, Osaka, Japan	Osaka University; Osaka University; National Institute of Information & Communications Technology (NICT) - Japan; Kanazawa University; Osaka University; Kansai Medical University	Hagihira, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Anesthesiol & Intens Care, Suita, Osaka, Japan.; Hagihira, S (corresponding author), Kansai Med Univ, Dept Anesthesiol, Hirakata, Osaka, Japan.	hagihirs@hirakata.kmu.ac.jp			Ministry of Education, Culture. Sports, Science and Technology, Japan [2340036, 23592287]; global COE program "Center of Human -friendly Robotics Based on Cognitive Neuroscience"	Ministry of Education, Culture. Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); global COE program "Center of Human -friendly Robotics Based on Cognitive Neuroscience"	This work was supported by Grants-in-Aid (JSPS #2340036: M.O. and JSPS #23592287: S.H.) from the Ministry of Education, Culture. Sports, Science and Technology, Japan. This work was partially supported by the global COE program "Center of Human -friendly Robotics Based on Cognitive Neuroscience." URL: https://www.jsps. got.jp/english/index.html.	Amico E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100012; Arbour Richard, 2003, AACN Clin Issues, V14, P185, DOI 10.1097/00044067-200305000-00009; Bandschapp O, 2010, ANESTHESIOLOGY, V113, P421, DOI 10.1097/ALN.0b013e3181e33ac8; Bob P, 2008, CONSCIOUS COGN, V17, P355, DOI 10.1016/j.concog.2007.12.001; Chen ACN, 2001, INT J PSYCHOPHYSIOL, V42, P147, DOI 10.1016/S0167-8760(01)00163-5; Dahaba AA, 2005, ANESTH ANALG, V101, P765, DOI 10.1213/01.ane.0000167269.62966.af; Ebert TJ, 2005, ANESTHESIOLOGY, V103, P20, DOI 10.1097/00000542-200507000-00007; Faymonville ME, 1997, PAIN, V73, P361, DOI 10.1016/S0304-3959(97)00122-X; Frolich MA, 2013, ANESTHESIOLOGY, V118, P611, DOI 10.1097/ALN.0b013e318281592d; Frolich MA, 2005, ANESTH ANALG, V100, P481, DOI 10.1213/01.ANE.0000142125.61206.7A; Ginosar Y, 2009, ACTA ANAESTH SCAND, V53, P1018, DOI 10.1111/j.1399-6576.2009.01968.x; Glass PS, 1997, ANESTHESIOLOGY, V86, P836, DOI 10.1097/00000542-199704000-00014; Gray JM, 1998, ANAESTHESIA, V53, P22, DOI 10.1111/j.1365-2044.1998.53s114.x; HAUGEN FP, 1968, ANESTHESIOLOGY, V29, P785, DOI 10.1097/00000542-196807000-00022; Hotbauer RK, 2004, ANESTHESIOLOGY, V100, P386, DOI 10.1097/00000542-200402000-00031; Irwin MG, 2002, ANAESTHESIA, V57, P242, DOI 10.1046/j.0003-2409.2001.02446.x; Jensen EW, 2014, ACTA ANAESTH SCAND, V58, P933, DOI 10.1111/aas.12359; Kiviniemi VJ, 2005, MAGN RESON IMAGING, V23, P531, DOI 10.1016/j.mri.2005.02.009; Lima A, 2005, INTENS CARE MED, V31, P1316, DOI 10.1007/s00134-005-2790-2; Lima AP, 2002, CRIT CARE MED, V30, P1210; Matsumura H, 2012, INT WOUND J, V9, P451, DOI 10.1111/j.1742-481X.2011.00911.x; Nakanishi O, 1997, ORAL SURG ORAL MED O, V84, P11, DOI 10.1016/S1079-2104(97)90286-9; Nasraway SA, 2002, CRIT CARE MED, V30, P1483, DOI 10.1097/00003246-200207000-00014; PetersenFelix S, 1996, BRIT J ANAESTH, V77, P165, DOI 10.1093/bja/77.2.165; Price DD, 2002, CONSCIOUS COGN, V11, P593, DOI 10.1016/S1053-8100(02)00018-1; Pryor KO, 2015, BRIT J ANAESTH, V115, P104, DOI 10.1093/bja/aev038; R Core Team, 2013, R LANG ENV STAT COMP; Robinson BJ, 1997, ANESTHESIOLOGY, V86, P64, DOI 10.1097/00000542-199701000-00010; Schlereth T, 2008, NEUROMOL MED, V10, P141, DOI 10.1007/s12017-007-8018-6; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Storm H, 2013, ACTA ANAESTH SCAND, V57, P89, DOI 10.1111/aas.12017; Swinhoe CF, 1998, ANAESTHESIA, V53, P61, DOI 10.1111/j.1365-2044.1998.53s104.x; von Dincklage F, 2012, ANAESTHESIA, V67, P899, DOI 10.1111/j.1365-2044.2012.07187.x; WILDERSMITH OHG, 1995, ANAESTHESIA, V50, P218, DOI 10.1111/j.1365-2044.1995.tb04560.x; Zacny JP, 1996, J CLIN ANESTH, V8, P469, DOI 10.1016/0952-8180(96)00126-2; ZBINDEN AM, 1994, ANESTHESIOLOGY, V80, P261, DOI 10.1097/00000542-199402000-00005	36	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183635	10.1371/journal.pone.0183635	http://dx.doi.org/10.1371/journal.pone.0183635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880899	Green Submitted, gold, Green Published			2022-12-27	WOS:000409467200020
J	Mindu, C; Lopez-Varela, E; Alonso-Menendez, Y; Mausse, Y; Augusto, OJ; Gondo, K; Munoz, J; Sacarlal, J; Garcia-Basteiro, AL; Alonso, PL; Munguambe, K				Mindu, Carolina; Lopez-Varela, Elisa; Alonso-Menendez, Yara; Mausse, Yolanda; Augusto, Orvalho Joaquim; Gondo, Kizito; Munoz, Jose; Sacarlal, Jahit; Garcia-Basteiro, Alberto L.; Alonso, Pedro L.; Munguambe, Khatia			Caretakers' perspectives of paediatric TB and implications for care-seeking behaviours in Southern Mozambique	PLOS ONE			English	Article							TUBERCULOSIS TREATMENT; TRADITIONAL HEALERS; PULMONARY TUBERCULOSIS; EXPERIENCES; ADHERENCE; CHILDREN; MANHICA	Background Tuberculosis (TB) remains an important public health concern, especially in poorly resourced settings. TB diagnosis is challenging, particularly for children, who are the most vulnerable to its' impacts. Lack of knowledge and awareness of the disease compromises prompt diagnosis and treatment compliance. Objective To gain insights regarding caretakers' knowledge of the aetiology and prevention of paediatric TB in southern Mozambique, to describe their care-seeking behaviours and to assess the acceptability of diagnostic procedures. Methods A total of 35 caretakers were interviewed, all of which had children with TB compatible symptoms. Eleven were caretakers of children diagnosed with TB at the health facility, 11 of children for whom TB was excluded as a diagnosis at the health facility and 13 of children with TB compatible symptoms identified in the community. The first two groups took part in a TB incidence study, while the third group did not. All underwent the same semi-structured interviews, the results of which were analysed and compared using content analysis. Results Even when confronted with signs suggestive of TB, most caretakers never suspected it or misinterpreted the signs, even among caretakers with TB and TB contacts. There was limited knowledge of TB, except among those undergoing treatment. The transgression of social norms was often presented as an explanation for TB in parallel to medically sound causes. The use of traditional care for prevention is widespread, but it varied for treatment purposes. TB diagnostic procedures were considered painful but were unanimously tolerated. Conclusions and significance Misconceptions of paediatric TB, associated complex care-seeking itineraries and negative feelings of the diagnostic procedures may result in delays, low adherence and lost to follow-up, which needs to be addressed by adequately framed health promotion approaches.	[Mindu, Carolina; Lopez-Varela, Elisa; Alonso-Menendez, Yara; Mausse, Yolanda; Augusto, Orvalho Joaquim; Gondo, Kizito; Munoz, Jose; Sacarlal, Jahit; Garcia-Basteiro, Alberto L.; Alonso, Pedro L.; Munguambe, Khatia] CISM, Cambeve, Maputo, Mozambique; [Lopez-Varela, Elisa; Munoz, Jose; Garcia-Basteiro, Alberto L.; Alonso, Pedro L.] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Global Hlth Inst, Barcelona, Spain; [Sacarlal, Jahit; Munguambe, Khatia] UEM, Fac Med, Maputo, Mozambique; [Garcia-Basteiro, Alberto L.] Acad Med Ctr, AIGHD, Amsterdam, Netherlands	Centro de Investigacao em Saude de Manhica; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; University of Amsterdam; Academic Medical Center Amsterdam	Lopez-Varela, E; Munguambe, K (corresponding author), CISM, Cambeve, Maputo, Mozambique.; Lopez-Varela, E (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Global Hlth Inst, Barcelona, Spain.; Munguambe, K (corresponding author), UEM, Fac Med, Maputo, Mozambique.	elisa.lopez@manhica.net; khatia.munguambe@manhica.net	varela, elisa lopez/ABE-4092-2020; Alonso, Pedro L/AAZ-3645-2020; Gutiérrez, José/GSJ-1846-2022; Gutierrez, Jose Muñoz/AAH-6954-2020; Gutiérrez, Jose Muñoz/X-5917-2018; Sacarlal, Jahit/R-3172-2016; Augusto, Orvalho/J-8767-2019	varela, elisa lopez/0000-0002-6725-5687; Alonso, Pedro L/0000-0003-3292-3443; Gutierrez, Jose Muñoz/0000-0002-0945-1735; Gutiérrez, Jose Muñoz/0000-0002-0945-1735; Sacarlal, Jahit/0000-0003-1059-217X; Augusto, Orvalho/0000-0002-0005-3968; Fernandez, Ivette/0000-0001-5179-0477; Alonso Menendez, Yara/0000-0003-0183-5061	Fundo Nacional de Investigacao, Ministry of Science and Technology, Mozambique [0073-INV/FNI]; Spanish Agency for International Cooperation and Development (AECID)	Fundo Nacional de Investigacao, Ministry of Science and Technology, Mozambique; Spanish Agency for International Cooperation and Development (AECID)	This work was supported by the Fundo Nacional de Investigacao, Ministry of Science and Technology, Mozambique (grant: 0073-INV/FNI). The CISM receives core funding from the Spanish Agency for International Cooperation and Development (AECID).	Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339; Barker RD, 2006, INT J TUBERC LUNG D, V10, P670; Bjerrum S, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-6; Boene H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086038; Brouwer JA, 1998, INT J TUBERC LUNG D, V2, P231; Chow F, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-67; Cremers AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119861; Deribew A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-400; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Eastwood SV, 2004, INT J TUBERC LUNG D, V8, P70; Franck C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-426; Garcia-Basteiro AL, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1534-y; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Graham SM, 2014, LANCET, V383, P1605, DOI 10.1016/S0140-6736(14)60420-7; Green EC, 2010, PURITY POLLUTION INV; Instituto Nacional de Estat A o stica (INE), 2010, 3 REC GER POP CAD SO; Jani Yagnavalkya B G D T N, 2015, INT J RES MED SCI, V3, P3572; Kaona FAD, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-68; Liefooghe R, 1997, TROP MED INT HEALTH, V2, P809, DOI 10.1046/j.1365-3156.1997.d01-380.x; Loapez-Varela E, 2015, EUR RESPIR J; Looez-Varela E, 2015, PEDIATR INFECT DIS J, V34, P686, DOI 10.1097/INF.0000000000000710; Makanjuola T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087166; Marais BJ, 2013, LANCET INFECT DIS, V13, P287, DOI 10.1016/S1473-3099(13)70031-8; Melaku S, 2013, TUBERC RES TREAT, V2013, DOI DOI 10.1155/2013/475605; Montgomery CM, 2010, SOC SCI MED, V70, P1648, DOI 10.1016/j.socscimed.2010.01.020; Munguambe K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-344; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Oeser CC, 2005, AM J TROP MED HYG, V73, P571, DOI 10.4269/ajtmh.2005.73.571; PAZSOLDAN VA, 2014, FRONT PUBLIC HEALTH, V2, P1; Perez-Velez CM, 2012, NEW ENGL J MED, V367, P348, DOI 10.1056/NEJMra1008049; Pool R, 2006, TROP MED INT HEALTH, V11, P1670, DOI 10.1111/j.1365-3156.2006.01725.x; Sacoor C, 2013, INT J EPIDEMIOL, V42, P1309, DOI 10.1093/ije/dyt148; Saifodine A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-559; Salaniponi FML, 2000, INT J TUBERC LUNG D, V4, P327; Stop TB Partnership, 2015, STOP TB PARTNERSHIP; da Silva TDV, 2014, REV ESC ENFERM USP, V48, P39, DOI 10.1590/S0080-623420140000800007; WHO, 2016, GLOB TUB REP; WHO/UNICEF, 2015, MOZ WHO UNICEF EST I; Wilkinson D, 1999, INT J TUBERC LUNG D, V3, P838; World Health Organization, 2014, WHOHTMTB2014082014; World Health Organization (WHO), 2014, WHO VACC PREV DIS MO; Yimer S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-454; Zhang SR, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-132	43	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0182213	10.1371/journal.pone.0182213	http://dx.doi.org/10.1371/journal.pone.0182213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910284	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200003
J	Ganczer, A; Balogh, M; Albert, L; Debertin, G; Kovacs-Oller, T; Volgyi, B				Ganczer, Alma; Balogh, Marton; Albert, Laszlo; Debertin, Gabor; Kovacs-Oller, Tamas; Volgyi, Bela			Transiency of retinal ganglion cell action potential responses determined by PSTH time constant	PLOS ONE			English	Article							MOUSE RETINA; BIPOLAR CELLS; PRIMATE RETINA; KAINATE; RECEPTORS; CHANNELS; PATHWAYS	Retinal ganglion cells (RGC) have been described to react to light stimuli either by producing short bursts of spikes or by maintaining a longer, continuous train of action potentials. Fast, quickly decaying responses are considered to be transient in nature and encode information about movement and direction, while cell responses that show a slow, drawn-out response fall into the sustained category and are thought to be responsible for carrying information related to color and contrast. Multiple approaches have been introduced thus far to measure and determine response transiency. In this study, we adopted and slightly modified a method described by Zeck and Masland to characterize RGC response transiency values and compare them to those obtained by alternative methods. As the first step, RGC spike responses were elicited by light stimulation and peristimulus time histograms (PSTHs) were generated. PSTHs then were used to calculate the time constant (PSTH tau approach). We show that this method is comparable to or more reliable than alternative approaches to describe the temporal characteristics of RGC light responses. In addition, we also show that PSTH tau-s are compatible with time constants measured on RGC and/or bipolar cell graded potentials; thus they are suitable for studying signaling through parallel retinal pathways.	[Ganczer, Alma; Balogh, Marton; Albert, Laszlo; Debertin, Gabor; Kovacs-Oller, Tamas; Volgyi, Bela] MTA PTE NAP B Retinal Elect Synapses Res Grp, Pecs, Hungary; [Ganczer, Alma; Balogh, Marton; Albert, Laszlo; Debertin, Gabor; Kovacs-Oller, Tamas; Volgyi, Bela] Univ Pecs, Dept Expt Zool & Neurobiol, Pecs, Hungary; [Ganczer, Alma; Balogh, Marton; Albert, Laszlo; Debertin, Gabor; Kovacs-Oller, Tamas; Volgyi, Bela] Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary	University of Pecs; University of Pecs	Volgyi, B (corresponding author), MTA PTE NAP B Retinal Elect Synapses Res Grp, Pecs, Hungary.; Volgyi, B (corresponding author), Univ Pecs, Dept Expt Zool & Neurobiol, Pecs, Hungary.; Volgyi, B (corresponding author), Univ Pecs, Janos Szentagothai Res Ctr, Pecs, Hungary.	volgyi01@gamma.ttk.pte.hu	Volgyi, Bela/A-9079-2013; Kovács-Öller, Tamás/B-5530-2012; Volgyi, Bela/B-1016-2011	Volgyi, Bela/0000-0001-7481-390X; Kovács-Öller, Tamás/0000-0002-3353-4485; 	OTKA [K105247]; Hungarian Brain Research Program [KTIA_NAP_13-2- 2015-0008]; European Union; State of Hungary - European Social Fund [TAMOP-4.2.4.A/211/1-2012-0001]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Brain Research Program; European Union(European Commission); State of Hungary - European Social Fund	Supported by OTKA K105247 to B.V. and by the Hungarian Brain Research Program (KTIA_NAP_13-2- 2015-0008) to B.V. This research was also supported by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP-4.2.4.A/211/1-2012-0001 National Excellence Program to B.V.	Anishchenko A, 2010, J NEUROPHYSIOL, V103, P1856, DOI 10.1152/jn.00896.2009; Borghuis BG, 2014, J NEUROSCI, V34, P6128, DOI 10.1523/JNEUROSCI.4941-13.2014; Brivanlou IH, 1998, NEURON, V20, P527, DOI 10.1016/S0896-6273(00)80992-7; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DeVries SH, 2006, NEURON, V50, P735, DOI 10.1016/j.neuron.2006.04.034; Erisir A, 1999, J NEUROPHYSIOL, V82, P2476, DOI 10.1152/jn.1999.82.5.2476; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Farrow K, 2011, J NEUROPHYSIOL, V105, P1516, DOI 10.1152/jn.00331.2010; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Greschner M, 2011, J PHYSIOL-LONDON, V589, P75, DOI 10.1113/jphysiol.2010.193888; Ichinose T, 2014, J NEUROSCI, V34, P8761, DOI 10.1523/JNEUROSCI.3965-13.2014; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Lindstrom SH, 2014, J PHYSIOL-LONDON, V592, P1457, DOI 10.1113/jphysiol.2013.265033; MASTRONARDE DN, 1983, J NEUROPHYSIOL, V49, P350, DOI 10.1152/jn.1983.49.2.350; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; PENN JS, 1984, VISION RES, V24, P1673, DOI 10.1016/0042-6989(84)90325-0; Petrusca D, 2007, J NEUROSCI, V27, P11019, DOI 10.1523/JNEUROSCI.2836-07.2007; Puthussery T, 2014, J NEUROSCI, V34, P7611, DOI 10.1523/JNEUROSCI.4855-13.2014; Volgyi B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069426; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Volgyi B, 2005, J COMP NEUROL, V492, P66, DOI 10.1002/cne.20700; Zeck GM, 2007, EUR J NEUROSCI, V26, P367, DOI 10.1111/j.1460-9568.2007.05670.x; Zhang Y, 2009, J NEUROSCI, V29, P9186, DOI 10.1523/JNEUROSCI.0184-09.2009	26	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0183436	10.1371/journal.pone.0183436	http://dx.doi.org/10.1371/journal.pone.0183436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898257	gold, Green Submitted, Green Published			2022-12-27	WOS:000410449500005
J	Amzal, B; Fu, S; Meng, J; Lister, J; Karcher, H				Amzal, Billy; Fu, Shuai; Meng, Jie; Lister, Johanna; Karcher, Helene			Cabozantinib versus everolimus, nivolumab, axitinib, sorafenib and best supportive care: A network meta-analysis of progression-free survival and overall survival in second line treatment of advanced renal cell carcinoma	PLOS ONE			English	Article							OPEN-LABEL; TRIAL; GUIDELINES; EFFICACY; THERAPY; MODEL	Background Relative effect of therapies indicated for the treatment of advanced renal cell carcinoma (aRCC) after failure of first line treatment is currently not known. The objective of the present study is to evaluate progression-free survival (PFS) and overall survival (OS) of cabozantinib compared to everolimus, nivolumab, axitinib, sorafenib, and best supportive care (BSC) in aRCC patients who progressed after previous VEGFR tyrosine-kinase inhibitor (TKI) treatment. Methodology & findings Systematic literature search identified 5 studies for inclusion in this analysis. The assessment of the proportional hazard (PH) assumption between the survival curves for different treatment arms in the identified studies showed that survival curves in two of the studies did not fulfil the PH assumption, making comparisons of constant hazard ratios (HRs) inappropriate. Consequently, a parametric survival network meta-analysis model was implemented with five families of functions being jointly fitted in a Bayesian framework to PFS, then OS, data on all treatments. The comparison relied on data digitized from the Kaplan-Meier curves of published studies, except for cabozantinib and its comparator everolimus where patient level data were available. This analysis applied a Bayesian fixed-effects network meta-analysis model to compare PFS and OS of cabozantinib versus its comparators. The log-normal fixed-effects model displayed the best fit of data for both PFS and OS, and showed that patients on cabozantinib had a higher probability of longer PFS and OS than patients exposed to comparators. The survival advantage of cabozantinib increased over time for OS. For PFS the survival advantage reached its maximum at the end of the first year's treatment and then decreased over time to zero. Conclusion With all five families of distributions, cabozantinib was superior to all its comparators with a higher probability of longer PFS and OS during the analyzed 3 years, except with the Gompertz model, where nivolumab was preferred after 24 months.	[Amzal, Billy; Fu, Shuai; Meng, Jie; Lister, Johanna; Karcher, Helene] Analyt LA SER, Decis Analyt & Value Access, London, England		Amzal, B (corresponding author), Analyt LA SER, Decis Analyt & Value Access, London, England.	b.amzal@analytica-laser.com			Ipsen Pharma SAS	Ipsen Pharma SAS(Ipsen)	This research was funded by Ipsen Pharma SAS. The funders decided on publication of this manuscript. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Caldwell DM, 2005, BMJ-BRIT MED J, V331, P897, DOI 10.1136/bmj.331.7521.897; Choueiri TK, 2015, NEW ENGL J MED, V373, P1814, DOI 10.1056/NEJMoa1510016; Choueiri TK, 2016, LANCET ONCOL; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; Cox C, 2007, STAT MED, V26, P4352, DOI 10.1002/sim.2836; Escudier B, 2014, ANN ONCOL, V25, P49, DOI 10.1093/annonc/mdu259; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2009, J CLIN ONCOL, V27, P3312, DOI 10.1200/JCO.2008.19.5511; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Guo J, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.e15591; Gupta K, 2008, CANCER TREAT REV, V34, P193, DOI 10.1016/j.ctrv.2007.12.001; Guyot P, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-9; Hoaglin DC, 2011, CONDUCTING INDIREC 2; Hollaender N., 2014, METHODS ESTIMATE SUR; Holland J M, 1975, CA Cancer J Clin, V25, P121, DOI 10.3322/canjclin.25.3.121; Hutson TE, 2014, J CLIN ONCOL, V32, P760, DOI 10.1200/JCO.2013.50.3961; Jonasch E, 2013, J CLIN ONCOL S1, V31; Korhonen P, 2012, J BIOPHARM STAT, V22, P1258, DOI 10.1080/10543406.2011.592233; Korhonen P, 2010, J CLIN ONCOL, V28; Ljungberg B, 2014, EUROPEAN ASS UROLOGY; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2015, LANCET ONCOL, V16, P1473, DOI 10.1016/S1470-2045(15)00290-9; Motzer RJ, 2014, J CLIN ONCOL, V32, P2766, DOI 10.1200/JCO.2013.54.6911; Motzer RJ, 2014, LANCET ONCOL, V15, P286, DOI 10.1016/S1470-2045(14)70030-0; Motzer RJ, 2013, J CLIN ONCOL, V31, P3791, DOI 10.1200/JCO.2012.47.4940; Motzer RJ, 2013, LANCET ONCOL, V14, P552, DOI 10.1016/S1470-2045(13)70093-7; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; National Comprehensive Cancer Network, 2017, NCCN CLIN PRACT GUID; National Institute for Health and Care Excellence, 2016, SINGL TECHN APPR NIV; National Institute for Health and Care Excellence, 2016, REN CELL CARC MET TR; Negrier S, 2010, MED ONCOL, V27, P899, DOI 10.1007/s12032-009-9303-z; Ouwens MJNM, 2010, RES SYNTH METHODS, V1, P258, DOI 10.1002/jrsm.25; Pal S, 2015, CLIN CANCER RES, V21, P3420, DOI 10.1158/1078-0432.CCR-14-3370; Powles T, 2014, J CLIN ONCOL S1, V32; Powles T, 2016, EUR UROL; Powles T, 2016, J CLIN ONCOL, V34, P1660, DOI 10.1200/JCO.2015.64.8808; Powles T, 2016, EUR UROL, V69, P450, DOI 10.1016/j.eururo.2015.08.035; Powles T, 2016, EUR UROL, V69, P4, DOI 10.1016/j.eururo.2015.10.017; Ratain MJ, 2006, J CLIN ONCOL, V24, P2505, DOI 10.1200/JCO.2005.03.6723; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Tannir NM, 2014, J CLIN ONCOL, V32; Wiecek W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155389; Zhou L, 2016, ONCOGENE, V35, P2687, DOI 10.1038/onc.2015.343; Znaor A, 2015, EUR UROL, V67, P519, DOI 10.1016/j.eururo.2014.10.002	48	40	40	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184423	10.1371/journal.pone.0184423	http://dx.doi.org/10.1371/journal.pone.0184423			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886175	Green Published, Green Accepted, gold			2022-12-27	WOS:000410001100117
J	Dudas, RB; Lovejoy, C; Cassidy, S; Allison, C; Smith, P; Baron-Cohen, S				Dudas, Robert B.; Lovejoy, Chris; Cassidy, Sarah; Allison, Carrie; Smith, Paula; Baron-Cohen, Simon			The overlap between autistic spectrum conditions and borderline personality disorder	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; SYSTEMATIZING QUOTIENT; EMPATHY QUOTIENT; ADULTS; WOMEN; AQ; IMPULSIVITY; PREVALENCE; FEMALES	Background Both people with autism spectrum conditions (ASC) and borderline personality disorder (BPD) are significantly challenged in terms of understanding and responding to emotions and in interpersonal functioning. Aims To compare ASC, BPD, and comorbid patients in terms of autistic traits, empathy, and systemizing. Methods 624 ASC, 23 BPD, and 16 comorbid (ASC+BPD) patients, and 2,081 neurotypical controls (NC) filled in the Autism Spectrum Quotient (AQ), the Empathy Quotient (EQ) and the Systemizing Quotient-Revised (SQ-R). Results On the AQ, the ASC group scored higher than the BPD group, who in turn scored higher than the comorbid group, who scored higher than controls. On the EQ, we found the comorbid and ASC groups scored lower than the BPD group, who were not different from controls. Finally, on the SQ-R, we found the ASC and BPD group both scored higher than controls. Conclusions Similar to ASC, BPD patients have elevated autistic traits and a strong drive to systemize, suggesting an overlap between BPD and ASC.	[Dudas, Robert B.; Lovejoy, Chris; Cassidy, Sarah; Allison, Carrie; Smith, Paula; Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Dudas, Robert B.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge City Older Peoples Mental Hlth Serv, Cambridge, England; [Cassidy, Sarah] Coventry Univ, Ctr Res Psychol Behav & Achievement, Coventry, W Midlands, England; [Baron-Cohen, Simon] Cambridgeshire & Peterborough NHS Fdn Trust, CLASS Clin, Cambridge, England	University of Cambridge; Coventry University	Dudas, RB (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England.; Dudas, RB (corresponding author), Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge City Older Peoples Mental Hlth Serv, Cambridge, England.	rbd21@cam.ac.uk	Dudas, Robert/Y-1497-2019; Cassidy, Sarah/K-8147-2015	Dudas, Robert/0000-0001-6151-2630; Cassidy, Sarah/0000-0003-1982-3034; Lovejoy, Christopher Andrew/0000-0003-0919-1264; Baron-Cohen, Simon/0000-0001-9217-2544	Autism Research Trust; MRC; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust; MRC [G0600977] Funding Source: UKRI; Medical Research Council [G0600977] Funding Source: researchfish	Autism Research Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors were supported by the Autism Research Trust and the MRC during the period of this work. The research was also supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East of England at Cambridgeshire and Peterborough NHS Foundation Trust. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th, DOI DOI 10.4324/9780203772287-23; Anckarsater H, 2006, AM J PSYCHIAT, V163, P1239, DOI 10.1176/appi.ajp.163.7.1239; Baer RA, 2012, CLIN PSYCHOL REV, V32, P359, DOI 10.1016/j.cpr.2012.03.002; Bargiela S, 2016, J AUTISM DEV DISORD, V46, P3281, DOI 10.1007/s10803-016-2872-8; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2014, PLOS ONE, V9; Baron-Cohen S, 2009, ANN NY ACAD SCI, V1156, P68, DOI 10.1111/j.1749-6632.2009.04467.x; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Cassidy S, 2014, AUTISM RES, V7, P112, DOI 10.1002/aur.1351; Dinsdale N, 2013, J PERS DISORD, V27, P172, DOI 10.1521/pedi.2013.27.2.172; Dougherty DM, 1999, PSYCHIAT RES, V85, P315, DOI 10.1016/S0165-1781(99)00011-6; Dowson J, 2004, COMPR PSYCHIAT, V45, P29, DOI 10.1016/j.comppsych.2003.09.013; Duerden EG, 2012, J AUTISM DEV DISORD, V42, P2460, DOI 10.1007/s10803-012-1497-9; Fertuck EA, 2009, PSYCHOL MED, V39, P1979, DOI 10.1017/S003329170900600X; Fitzgerald M, 2005, AUTISM, V9, P452; Flury JM, 2008, J RES PERS, V42, P312, DOI 10.1016/j.jrp.2007.05.008; Franzen N, 2011, PSYCHIAT RES, V187, P224, DOI 10.1016/j.psychres.2010.11.012; Frick C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041650; Goldenfeld N, 2005, CLIN NEUROPSYCHIATR, V2, P338; Grant BF, 2008, J CLIN PSYCHIAT, V69, P533, DOI 10.4088/JCP.v69n0404; Guttman HA, 2000, FAM PROCESS, V39, P345, DOI 10.1111/j.1545-5300.2000.39306.x; Harari H, 2010, PSYCHIAT RES, V175, P277, DOI 10.1016/j.psychres.2009.03.002; Hofvander B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-35; Hull L, 2016, PUTTING MY BEST NORM; Jeung H, 2014, PSYCHOPATHOLOGY, V47, P220, DOI 10.1159/000357191; KROHN A, 1974, INT J PSYCHOANAL PSY, V3, P142; LADISICH W, 1988, BRIT J MED PSYCHOL, V61, P155, DOI 10.1111/j.2044-8341.1988.tb02774.x; Lai MC, 2015, LANCET PSYCHIAT, V2, P1013, DOI 10.1016/S2215-0366(15)00277-1; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lawrence KA, 2010, J PERS DISORD, V24, P785, DOI 10.1521/pedi.2010.24.6.785; Lazarus SA, 2014, CLIN PSYCHOL REV, V34, P193, DOI 10.1016/j.cpr.2014.01.007; Lugnegard T, 2012, COMPR PSYCHIAT, V53, P333, DOI 10.1016/j.comppsych.2011.05.014; Nanchen K, 2016, Z PSYCHIATR PSYCH PS, V64, P247, DOI 10.1024/1661-4747/a000286; Pelletier G, 1998, J AM ACAD CHILD PSY, V37, P1128, DOI 10.1097/00004583-199811000-00005; Preissler S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00182; Rathus JH, 2002, SUICIDE LIFE-THREAT, V32, P146, DOI 10.1521/suli.32.2.146.24399; Rentrop M, 2008, PSYCHOPATHOLOGY, V41, P50, DOI 10.1159/000110626; Ruzich E, 2015, MOL AUTISM, V6, DOI [10.1186/s13229-015-0038-8, 10.1186/2040-2392-6-2]; Ryden G, 2008, CLIN NEUROPSYCHIATR, V5, P22; Scott LN, 2011, PERSONAL DISORD, V2, P98, DOI 10.1037/a0020011; Stoffers JM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005652.pub2; Strunz S, 2015, J AUTISM DEV DISORD, V45, P4026, DOI 10.1007/s10803-014-2183-x; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; WILLEY LH, 1999, PRETENDING NORMAL LI; Woodbury-Smith MR, 2005, J AUTISM DEV DISORD, V35, P331, DOI 10.1007/s10803-005-3300-7	47	40	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184447	10.1371/journal.pone.0184447	http://dx.doi.org/10.1371/journal.pone.0184447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886113	Green Submitted, gold, Green Published			2022-12-27	WOS:000410001100123
J	Guo, H; Wu, T; Lu, Q; Dong, J; Ren, YF; Nan, KJ; Lv, Y; Zhang, XF				Guo, Hui; Wu, Tao; Lu, Qiang; Dong, Jian; Ren, Yi-Fan; Nan, Ke-Jun; Lv, Yi; Zhang, Xu-Feng			Hepatocellular carcinoma in elderly: Clinical characteristics, treatments and outcomes compared with younger adults	PLOS ONE			English	Article							CANCER-PATIENTS; SURVIVAL; AGE; DIAGNOSIS; FEATURES; MANAGEMENT; PROGNOSIS; RESECTION; POORER; IMPACT	The number of elderly patients diagnosed with hepatocellular carcinoma (HCC) is expected to increase. The present study aims to evaluate the role of age on treatments and outcome of HCC patients. 1530 patients firstly diagnosed with HCC were retrospectively included and classified as older (>= 65 years, n = 318, 21%) and younger patients (<65 years, n = 1212, 79%). The two groups were compared with clinical characteristics, tumor burden, Barcelona Clinics Liver Cancer (BCLC) stage, treatments and long-term prognosis. Elderly patients were more HCV infected, had more diabetes, poorer performance status, and were less aggressively treated. The proportion of HCC within BCLC stage 0-A, B or C was similar between the two groups, but elderly patients were more presented with BCLC stage D. The overall survival of older patients was poorer compared to younger patients before and after propensity score matching. However, elderly patients were less often effectively treated with surgery and loco-regional therapies across different BCLC stages. After stratified by BCLC stages or treatments, older patients showed comparable long-term outcome to younger patients. Performance status, BCLC stages and effective treatments, rather than age, was independent factors determining prognosis in the whole cohort and only elderly patients by multivariate analysis. In conclusion, older could have comparable survival to younger patients within the same tumor stage or after similar treatments. Thus, equally active treatments should be encouraged to elderly patients.	[Guo, Hui; Lu, Qiang; Dong, Jian; Ren, Yi-Fan; Lv, Yi; Zhang, Xu-Feng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China; [Guo, Hui; Wu, Tao; Nan, Ke-Jun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Oncol, Xian, Shaanxi, Peoples R China; [Lu, Qiang; Dong, Jian; Ren, Yi-Fan; Lv, Yi; Zhang, Xu-Feng] Xi An Jiao Tong Univ, Inst Adv Surg Technol & Engn, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Zhang, XF (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China.; Zhang, XF (corresponding author), Xi An Jiao Tong Univ, Inst Adv Surg Technol & Engn, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China.	xfzhang125@xjtu.edu.cn	zhang, xian/GYA-0290-2022; zhang, xu/GRX-9733-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xu/GYE-3558-2022	LU, QIANG/0000-0002-8294-4966				ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Balducci L, 2000, Oncologist, V5, P224, DOI 10.1634/theoncologist.5-3-224; Bechis SK, 2011, J CLIN ONCOL, V29, P235, DOI 10.1200/JCO.2010.30.2075; Borzio M, 2017, LIVER INT; Chang PE, 2008, J GASTROENTEROL, V43, P881, DOI 10.1007/s00535-008-2238-x; Chang WT, 2012, SURGERY, V152, P809, DOI 10.1016/j.surg.2012.03.024; Cho SJ, 2007, J GASTROEN HEPATOL, V22, P1226, DOI 10.1111/j.1440-1746.2007.04914.x; Cho Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165722; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Haymart MR, 2009, ONCOLOGIST, V14, P216, DOI 10.1634/theoncologist.2008-0194; Jansen PLM, 2002, BEST PRACT RES CL GA, V16, P149, DOI 10.1053/bega.2002.0271; Jung YK, 2016, J GASTROEN HEPATOL, V31, P467, DOI 10.1111/jgh.13152; Lee SH, 2011, J AM GERIATR SOC, V59, P241, DOI 10.1111/j.1532-5415.2010.03273.x; Leff DR, 2007, AM SURGEON, V73, P42; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Miki D, 2008, J GASTROENTEROL, V43, P550, DOI 10.1007/s00535-008-2194-5; Mirici-Cappa F, 2010, GUT, V59, P387, DOI 10.1136/gut.2009.194217; Nishikawa H, 2013, J CANCER, V4, P635, DOI 10.7150/jca.7279; Oishi K, 2009, J GASTROINTEST SURG, V13, P695, DOI 10.1007/s11605-008-0758-6; Ozenne V, 2011, DIGEST LIVER DIS, V43, P1001, DOI 10.1016/j.dld.2011.06.019; Poon RTP, 1999, AM J GASTROENTEROL, V94, P2460; Repetto L, 2002, J CLIN ONCOL, V20, P494, DOI 10.1200/JCO.20.2.494; Su CW, 2012, ARCH SURG-CHICAGO, V147, P137, DOI 10.1001/archsurg.2011.288; Tas F, 2013, ONCOL LETT, V6, P1507, DOI 10.3892/ol.2013.1566; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Zhang WJ, 2015, ONCOTARGET, V6, P633, DOI 10.18632/oncotarget.2719; Zheng LZ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-300	29	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184160	10.1371/journal.pone.0184160	http://dx.doi.org/10.1371/journal.pone.0184160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886106	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100072
J	Kwon, YC; Kim, JJ; Yun, SW; Yu, JJ; Yoon, KL; Lee, KY; Kil, HR; Kim, GB; Han, MK; Song, MS; Lee, HD; Ha, KS; Sohn, S; Ebata, R; Hamada, H; Suzuki, H; Ito, K; Onouchi, Y; Hong, YM; Jang, GY; Lee, JK				Kwon, Young-Chang; Kim, Jae-Jung; Yun, Sin Weon; Yu, Jeong Jin; Yoon, Kyung Lim; Lee, Kyung-Yil; Kil, Hong-Ryang; Kim, Gi Beom; Han, Myung-Ki; Song, Min Seob; Lee, Hyoung Doo; Ha, Kee-Soo; Sohn, Sejung; Ebata, Ryota; Hamada, Hiromichi; Suzuki, Hiroyuki; Ito, Kaoru; Onouchi, Yoshihiro; Hong, Young Mi; Jang, Gi Young; Lee, Jong-Keuk		Korean Kawasaki Dis Genetics Conso	Male-specific association of the FCGR2A His167Arg polymorphism with Kawasaki disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FC-GAMMA-RIIA; IMMUNE-RESPONSES; SUSCEPTIBILITY LOCI; ATRIAL-FIBRILLATION; ULCERATIVE-COLITIS; SEMAPHORIN SEMA6A; RECEPTOR FAMILY; IGG SUBCLASSES; IDENTIFIES 3	Kawasaki disease (KD) is an acute systemic vasculitis that can potentially cause coronary artery aneurysms in some children. KD occurs approximately 1.5 times more frequently in males than in females. To identify sex-specific genetic variants that are involved in KD pathogenesis in children, we performed a sex-stratified genome-wide association study (GWAS), using the Illumina HumanOmni1-Quad BeadChip data (249 cases and 1,000 controls) and a replication study for the 34 sex-specific candidate SNPs in an independent sample set (671 cases and 3,553 controls). Male-specific associations were detected in three common variants: rs1801274 in FCGR2A [odds ratio (OR) = 1.40, P = 9.31 x 10(-5)], rs12516652 in SEMA6A (OR = 1.87, P = 3.12 x 10(-4)), and rs5771303 near IL17REL (OR = 1.57, P = 2.53 x 10(-5)). The male-specific association of FCGR2A, but not SEMA6A and IL17REL, was also replicated in a Japanese population (OR = 1.74, P = 1.04 x 10(-4) in males vs. OR = 1.22, P = 0.191 in females). In a meta-analysis with 1,461 cases and 5,302 controls, a very strong association of KD with the nonsynonymous SNP rs1801274 (p.His167Arg, previously assigned as p.His131Arg) in FCGR2A was confirmed in males (OR = 1.48, P = 1.43 x 10(-7)), but not in the females (OR = 1.17, P = 0.055). The present study demonstrates that p.His167Arg, a KD-associated FCGR2A variant, acts as a susceptibility gene in males only. Overall, the gender differences associated with FCGR2A in KD provide a new insight into KD susceptibility.	[Kwon, Young-Chang; Kim, Jae-Jung; Lee, Jong-Keuk] Univ Ulsan, Asan Inst Life Sci, Coll Med, Seoul, South Korea; [Yun, Sin Weon] Chung Ang Univ Hosp, Dept Pediat, Seoul, South Korea; [Yu, Jeong Jin] Univ Ulsan, Dept Pediat, Asan Med Ctr, Coll Med, Seoul, South Korea; [Yoon, Kyung Lim] Kyung Hee Univ Hosp Gangdong, Dept Pediat, Seoul, South Korea; [Lee, Kyung-Yil] Catholic Univ Korea, Dept Pediat, Daejeon St Marys Hosp, Daejeon, South Korea; [Kil, Hong-Ryang] Chungnam Natl Univ Hosp, Dept Pediat, Daejeon, South Korea; [Kim, Gi Beom] Seoul Natl Univ, Childrens Hosp, Dept Pediat, Seoul, South Korea; [Han, Myung-Ki] Univ Ulsan, Gangneung Asan Hosp, Dept Pediat, Kangnung, South Korea; [Song, Min Seob] Inje Univ, Dept Pediat, Haeundae Paik Hosp, Busan, South Korea; [Lee, Hyoung Doo] Pusan Natl Univ Hosp, Dept Pediat, Busan, South Korea; [Ha, Kee-Soo; Jang, Gi Young] Univ Korea Hosp, Dept Pediat, Seoul, South Korea; [Sohn, Sejung; Hong, Young Mi] Ewha Womans Univ Hosp, Dept Pediat, Seoul, South Korea; [Ebata, Ryota] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba, Japan; [Hamada, Hiromichi] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pediat, Yachiyo, Japan; [Suzuki, Hiroyuki] Wakayama Med Univ, Dept Pediat, Wakayama, Japan; [Ito, Kaoru; Onouchi, Yoshihiro] RIKEN Ctr Integrat Med Sci, Lab Cardiovasc Dis, Yokohama, Kanagawa, Japan; [Onouchi, Yoshihiro] Chiba Univ, Grad Sch Med, Dept Publ Hlth, Chiba, Japan	University of Ulsan; Chung Ang University; Chung Ang University Hospital; University of Ulsan; Asan Medical Center; Kyung Hee University; Kyung Hee University Hospital; Catholic University of Korea; Chungnam National University; Chungnam National University Hospital; Seoul National University (SNU); Seoul National University Hospital; University of Ulsan; Inje University; Pusan National University; Pusan National University Hospital; Korea University; Korea University Medicine (KU Medicine); Ewha Womans University; Chiba University; Tokyo Women's Medical University; Wakayama Medical University; RIKEN; Chiba University	Lee, JK (corresponding author), Univ Ulsan, Asan Inst Life Sci, Coll Med, Seoul, South Korea.	cookie_jklee@hotmail.com	Song, Min Seob/R-3075-2019; Ebata, Ryota/AAQ-5832-2021; Ito, Kaoru/AAZ-3440-2021	Ebata, Ryota/0000-0001-8471-1042; Ha, Kee Soo/0000-0001-6753-5411; BYEON, JUNGHYE/0000-0001-5479-2451; Lee, Kyung-Yil/0000-0001-6510-1580	Ministry of Health & Welfare of the Republic of Korea [HI15C1575]; Korea Center for Disease Control and Prevention [2014-ER7402-00]; Grants-in-Aid for Scientific Research [15K09696] Funding Source: KAKEN	Ministry of Health & Welfare of the Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea Center for Disease Control and Prevention; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from the Ministry of Health & Welfare of the Republic of Korea (HI15C1575) and a grant from the Korea Center for Disease Control and Prevention (2014-ER7402-00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; Becker KG, 2012, AUTISM RES, V5, P77, DOI 10.1002/aur.1227; Bernard F, 2012, GLIA, V60, P1590, DOI 10.1002/glia.22378; BREDIUS RGM, 1994, IMMUNOLOGY, V83, P624; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duan JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103329; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gautier G, 2006, AM J PATHOL, V168, P453, DOI 10.2353/ajpath.2006.050288; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; GREEN MS, 1992, INT J EPIDEMIOL, V21, P381, DOI 10.1093/ije/21.2.381; Ha S, 2016, J KOREAN MED SCI, V31, P1445, DOI 10.3346/jkms.2016.31.9.1445; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holman RC, 2010, PEDIATR INFECT DIS J, V29, P483, DOI 10.1097/INF.0b013e3181cf8705; Huang WC, 2009, PEDIATRICS, V123, pe401, DOI 10.1542/peds.2008-2187; Khor CC, 2011, NAT GENET, V43, P1241, DOI 10.1038/ng.981; Kim JJ, 2012, PEDIATR CARDIOL, V33, P513, DOI 10.1007/s00246-011-0143-1; Kim JJ, 2011, HUM GENET, V129, P487, DOI 10.1007/s00439-010-0937-x; Kissick HT, 2014, P NATL ACAD SCI USA, V111, P9887, DOI 10.1073/pnas.1402468111; Klein SL, 2012, BIOESSAYS, V34, P1050, DOI 10.1002/bies.201200099; Kuo HC, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/564625; Kuo HC, 2015, ARTHRITIS RHEUMATOL, V67, P828, DOI 10.1002/art.38976; Lee YC, 2012, NAT GENET, V44, P522, DOI 10.1038/ng.2227; Lloyd-Jones DM, 2004, CIRCULATION, V110, P1042, DOI 10.1161/01.CIR.0000140263.20897.42; Lubitz SA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006284; MANTEL N, 1959, J NATL CANCER I, V22, P719; Maxwell KF, 1999, NAT STRUCT BIOL, V6, P437; Meleine M, 2014, WORLD J GASTROENTERO, V20, P6725, DOI 10.3748/wjg.v20.i22.6725; Moon K.W., 2015, R STAT GRAPHS MED PA; Nakamura Y, 2012, J EPIDEMIOL, V22, P216, DOI 10.2188/jea.JE20110126; Nasr A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-110; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; PARREN PWHI, 1992, J CLIN INVEST, V90, P1537, DOI 10.1172/JCI116022; Potiron VA, 2009, CANCER LETT, V273, P1, DOI 10.1016/j.canlet.2008.05.032; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiao JL, 2015, IMMUNOL REV, V268, P241, DOI 10.1111/imr.12370; Reynolds JM, 2012, J IMMUNOL, V189, P4226, DOI 10.4049/jimmunol.1103014; SALMON JE, 1992, J CLIN INVEST, V89, P1274, DOI 10.1172/JCI115712; Sasaki MM, 2016, INFLAMM BOWEL DIS, V22, P20, DOI 10.1097/MIB.0000000000000610; Singh S, 2015, ARCH DIS CHILD, V100, P1084, DOI 10.1136/archdischild-2014-307536; Smith GD, 1997, BMJ-BRIT MED J, V315, P1610, DOI 10.1136/bmj.315.7122.1610; Voysey M, 2016, VACCINE, V34, P1657, DOI 10.1016/j.vaccine.2016.02.036; Wu BJ, 2011, IMMUNOGENETICS, V63, P835, DOI 10.1007/s00251-011-0554-4; Xie G, 2013, ARTHRITIS RHEUM-US, V65, P2457, DOI 10.1002/art.38036	51	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184248	10.1371/journal.pone.0184248	http://dx.doi.org/10.1371/journal.pone.0184248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886140	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100088
J	Mekonnen, Z; Amuamuta, A; Mulu, W; Yimer, M; Zenebe, Y; Adem, Y; Abera, B; Gebeyehu, W; Gebregziabher, Y				Mekonnen, Zewdie; Amuamuta, Asmare; Mulu, Wondemagegn; Yimer, Mulat; Zenebe, Yohannes; Adem, Yesuf; Abera, Bayeh; Gebeyehu, Wondemu; Gebregziabher, Yakob			Clinical chemistry reference intervals of healthy adult populations in Gojjam Zones of Amhara National Regional State, Northwest Ethiopia	PLOS ONE			English	Article								Background Reference interval is crucial for disease screening, diagnosis, monitoring, progression and treatment efficacy. Due to lack of locally derived reference values for the parameters, clinicians use reference intervals derived from western population. But, studies conducted in different African countries have indicated differences between locally and western derived reference values. Different studies also indicated considerable variation in clinical chemistry reference intervals by several variables such as age, sex, geographical location, environment, lifestyle and genetic variation. Objective This study aimed to determine the reference intervals of common clinical chemistry parameters of the community of Gojjam Zones, Northwest Ethiopia. Method Population based cross-sectional study was conducted from November 2015 to December 2016 in healthy adult populations of Gojjam zone. Data such as, medical history, physical examination and socio-demographic data were collected. In addition, laboratory investigations were undertaken to screen the population. Clinical chemistry parameters were measured using Mindray BS 200 clinical chemistry autoanalyzer as per the manufacturer's instructions. Descriptive statistics was used to calculate mean, median and 95 th percentiles. Independent sample T-test and one way ANOVA were used to see association between variables. Results After careful screening of a total of 799 apparently healthy adults who were consented for this study, complete data from 446 (224 females and 222 males) were included for the analysis. The mean age of both the study participants was 28.8 years. Males had high (P<0.05) mean and 2.5th-97.5th percentile ranges of ALT, AST, ALP, creatinine and direct bilirubin. The reference intervals of amylase, LDH, total protein and total bilirubin were not significantly different between the two sex groups (P>0.05). Mean, median, 95% percentile values of AST, ALP, amylase, LDH, creatinine, total protein, total bilirubin, and direct bilirubin across all age groups of participants were similar (P>0.05). But, there was a significant difference in the value of ALT (P<0.05). The reference intervals of ALT, total protein and creatinine were significantly (P<0.05) high in people having monthly income >1500 ETB compared to those with low monthly income. Significant (P<0.05) higher values of the ALT, ALP and total protein were observed in people living in high land compared to low land residences. Conclusion The study showed that some of the common clinical chemistry parameters reference intervals of healthy adults in Gojjam zones were higher than the reference intervals generated from developed countries. Therefore, strict adherence to the reference values generated in developed countries could lead to inappropriate diagnosis and treatment of patients. There was also variation of reference interval values based on climate, gender, age, monthly income and geographical locations. Therefore, further study is required to establish reference intervals for Ethiopian population.	[Mekonnen, Zewdie; Amuamuta, Asmare; Mulu, Wondemagegn; Yimer, Mulat; Zenebe, Yohannes; Adem, Yesuf; Abera, Bayeh; Gebeyehu, Wondemu; Gebregziabher, Yakob] Bahir Dar Univ, Biotechnol Res Inst, Dept Biomed Res, Bahir Dar, Ethiopia; [Mekonnen, Zewdie; Amuamuta, Asmare] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Biochem, Bahir Dar, Ethiopia; [Mulu, Wondemagegn; Yimer, Mulat; Zenebe, Yohannes; Adem, Yesuf; Abera, Bayeh] Bahir Dar Univ, Coll Med & Hlth Sci, Dept Microbiol Parasitol & Immunol, Bahir Dar, Ethiopia; [Gebeyehu, Wondemu; Gebregziabher, Yakob] Amhara Natl Reg State Hlth Bearue, Amhara Natl Reg State Publ Hlth Inst, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University; Bahir Dar University	Mekonnen, Z (corresponding author), Bahir Dar Univ, Biotechnol Res Inst, Dept Biomed Res, Bahir Dar, Ethiopia.; Mekonnen, Z (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Dept Biochem, Bahir Dar, Ethiopia.	zewdmek2007@gmail.com	Abera, Bayeh/AAU-8754-2020; Mulu, Wondemagegn/X-3190-2019; /AAD-8608-2020; Limeneh, Asmare Amuamuta/AAB-5229-2021	/0000-0001-8016-6817; Limeneh, Asmare Amuamuta/0000-0002-9047-2962; Nigussie, Zewdie Mekonnen/0000-0002-0521-0213; chekol, yohannes zenebe/0000-0003-4522-4481	Biotechnology Research Institute of Bahir Dar University [2.1/9407/1.11.10]; Amhara National Regional health bureau	Biotechnology Research Institute of Bahir Dar University; Amhara National Regional health bureau	This project was financial supported by the Biotechnology Research Institute of Bahir Dar University with Grant number 2.1/9407/1.11.10. The URL of the institute is http://www.bdu.edu.et/ page/create-basic-pagebiotechnology-research institute. The role of the funding institute is close follow up of the research activity through monitoring and evaluation.; This research was financed by Biotechnology Research Institute of Bahir Dar University. We would like to acknowledge Debremarkos Referral Hospital for their permission to analyze the biochemical parameters in their settings. We also acknowledge Amhara National Regional health bureau for their permission and support to conduct the study in the zone of the region.	Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Ethiopian demography and health (internet source), 2008, AMH LANDF CLIM EC 20; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Karita E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004401; Katayev A, 2010, AM J CLIN PATHOL, V133, P180, DOI 10.1309/AJCPN5BMTSF1CDYP; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Koram K., 2007, GHANA MED J, V41; Kratz A, 2004, NEW ENGLAND J MED, V351; LESLIE WD, 1991, J NUCL MED, V32, P2306; Miri-Dashe T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093919; National Committee on Clinical Laboratory Standards (NCCLS), 2000, C28A2 NCCLS, V20; Odhiambo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123140; Quinto L, 2006, TROPICAL MED INTERNA, V11; Rustad P, 2004, SCAND J CLIN LAB INV, V64, P271, DOI 10.1080/00365510410006324; Saathoff E, 2008, TROPICAL MED INT HLT, V13; Segolodi TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093034; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	18	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184665	10.1371/journal.pone.0184665	http://dx.doi.org/10.1371/journal.pone.0184665			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886191	Green Submitted, gold, Green Published			2022-12-27	WOS:000410001100176
J	Miles, SR; Harik, JM; Hundt, NE; Mignogna, J; Pastorek, NJ; Thompson, KE; Freshour, JS; Yu, HJ; Cully, JA				Miles, Shannon R.; Harik, Juliette M.; Hundt, Natalie E.; Mignogna, Joseph; Pastorek, Nicholas J.; Thompson, Karin E.; Freshour, Jessica S.; Yu, Hong J.; Cully, Jeffrey A.			Delivery of mental health treatment to combat veterans with psychiatric diagnoses and TBI histories	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE PROCESSING THERAPY; POSTCONCUSSIVE SYMPTOMS; ENDURING FREEDOM; IRAQI FREEDOM; PTSD; AFGHANISTAN; ASSOCIATION; SOLDIERS	Traumatic brain injury (TBI) and mental health (MH) disorders are prevalent in combat veterans returning from Afghanistan and/or Iraq (hereafter referred to as returning veterans). Accurate estimates of service utilization for veterans with and without TBI exposure (referred to as TBI history) are imperative in order to provide high quality healthcare to returning veterans. We examined associations between TBI history and MH service utilization in a subsample of returning veterans who were newly diagnosed with posttraumatic stress disorder (PTSD), depression, and/or anxiety in the 2010 fiscal year (N = 55,458). Data were extracted from the Veterans Health Administration (VHA) National Patient Care Database. Veterans with MH diagnoses and TBI histories attended significantly more psychotherapy visits, (M = 8.32 visits, SD = 17.15) and were more likely to attend at least 8 psychotherapy visits, (15.7%) than veterans with MH diagnoses but no TBI history (M = 6.48 visits, SD = 12.12; 10.1% attended at least 8 sessions). PTSD and TBI history, but not depression or anxiety, were associated with a greater number of psychotherapy visits when controlling for demographic and clinical variables. PTSD, anxiety, depression, and TBI history were associated with number of psychotropic medication-management visits. TBI history was related to greater MH service utilization, independent of MH diagnoses. Future research should examine what MH services are being utilized and if these services are helping veterans recover from their disorders.	[Miles, Shannon R.] James A Haley Vet Hosp, Hlth Serv Res & Dev Ctr Innovat Disabil & Rehabil, Tampa, FL 33612 USA; [Miles, Shannon R.] Univ S Florida, Morsani Coll Med, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA; [Harik, Juliette M.] VA Med Ctr, Natl Ctr PTSD, Execut Div, 116D, White River Jct, VT USA; [Harik, Juliette M.] Geisel Sch Med Dartmouth, Hanover, NH USA; [Hundt, Natalie E.; Thompson, Karin E.; Freshour, Jessica S.; Yu, Hong J.; Cully, Jeffrey A.] Michael E DeBakey VA Med Ctr MEDVAMC 152, VA South Cent Mental Illness Res Educ & Clin Ctr, Houston, TX USA; [Hundt, Natalie E.; Thompson, Karin E.; Freshour, Jessica S.; Cully, Jeffrey A.] Baylor Coll Med, One Baylor Plaza, Houston, TX 77030 USA; [Hundt, Natalie E.; Cully, Jeffrey A.] MEDVAMC 152, VA HSR&D, Houston Ctr Innovat Qual Effectiveness & Safety, Houston, TX USA; [Mignogna, Joseph] Ctr Excellence Res Returning War Vet, Waco, TX USA; [Mignogna, Joseph] TX Texas A&M Hlth Sci Ctr, Cent Texas Vet Healthcare Syst, Temple, TX USA; [Mignogna, Joseph] Texas A&M Hlth Sci Ctr, Temple, TX USA; [Pastorek, Nicholas J.] MEDVAMC, Rehabil & Extended Care Line, Houston, TX USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; Dartmouth College; Baylor College of Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Miles, SR (corresponding author), James A Haley Vet Hosp, Hlth Serv Res & Dev Ctr Innovat Disabil & Rehabil, Tampa, FL 33612 USA.; Miles, SR (corresponding author), Univ S Florida, Morsani Coll Med, Dept Psychiat & Behav Neurosci, Tampa, FL 33620 USA.	shannon.miles@va.gov	Miles, Shannon/AAS-2173-2021	Miles, Shannon/0000-0001-8925-1321; Pastorek, Nicholas/0000-0002-9290-380X	Office of Academic Affiliations VA Advanced Fellowship Program in Mental Illness Research and Treatment; Department of Veterans Affairs South Central Mental Illness Research Education and Clinical Center (MIRECC); Houston VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety [CIN 13-413]	Office of Academic Affiliations VA Advanced Fellowship Program in Mental Illness Research and Treatment; Department of Veterans Affairs South Central Mental Illness Research Education and Clinical Center (MIRECC); Houston VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety	This research was supported by the Office of Academic Affiliations VA Advanced Fellowship Program in Mental Illness Research and Treatment, the Department of Veterans Affairs South Central Mental Illness Research Education and Clinical Center (MIRECC), and partly supported by resources and facilities of the Houston VA HSR&D Center for Innovations in Quality, Effectiveness, and Safety (CIN 13-413). The views expressed reflect those of the authors and not necessarily those of the Department of Veterans Affairs/Baylor College of Medicine.	Adler DA, 2011, PSYCHIAT SERV, V62, P39, DOI 10.1176/ps.62.1.pss6201_0039; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Bay E, 2009, CURR TREAT OPTION NE, V11, P377, DOI 10.1007/s11940-009-0042-4; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Brenner LA, 2009, REHABIL PSYCHOL, V54, P239, DOI 10.1037/a0016908; Brooks E, 2012, PSYCHIAT SERV, V63, P862, DOI 10.1176/appi.ps.201100444; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carroll LJ, 2004, J REHABIL MED, V36, P11, DOI 10.1080/16501960410023660; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Cooper DB, 2010, NEUROREHABILITATION, V26, P233, DOI 10.3233/NRE-2010-0559; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Deb S, 1999, AM J PSYCHIAT, V156, P374; Defense Medical Surveillance System, 2014, DOD NUMB TRAUM BRAIN; Department of Veterans' Affairs, 2016, NOT VET SERV MEMB EV; EPSTEIN RS, 1994, NEUROPSYCHIATRY TRAU, P3; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Galovski TE, 2012, J CONSULT CLIN PSYCH, V80, P968, DOI 10.1037/a0030600; Griffen J, 2014, HDB NEUROPSYCHOLOGY; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOWARD KI, 1986, AM PSYCHOL, V41, P159, DOI 10.1037/0003-066X.41.2.159; Hundt Natalie E, 2015, Psychol Trauma, V7, P539, DOI 10.1037/tra0000035; Kehle SM, 2011, J PSYCHIATR RES, V45, P126, DOI 10.1016/j.jpsychires.2010.05.013; Kelley AM, 2012, J PSYCHIATR RES, V46, P582, DOI 10.1016/j.jpsychires.2012.01.017; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Maguen S, 2013, J NEUROTRAUM, V30, P1123, DOI 10.1089/neu.2012.2744; McNally RJ, 2013, J ANXIETY DISORD, V27, P520, DOI 10.1016/j.janxdis.2013.07.002; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Olfson M, 2010, AM J PSYCHIAT, V167, P1456, DOI 10.1176/appi.ajp.2010.10040570; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rockefeller College, 2004, PAD 705 HANDOUT STAN; Rosenheck RA, 2007, HEALTH AFFAIR, V26, P1720, DOI 10.1377/hlthaff.26.6.1720; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Spoont MR, 2010, PSYCHIAT SERV, V61, P58, DOI 10.1176/appi.ps.61.1.58; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Veterans Affairs Information Resource Center (VIReC), 2012, DATA QUALITY; Veterans Affairs Information Resource Center (VIReC). VA Information Resource Center (VIReC), 2014, MED SAS DAT DOC; Veterans Health Administration, 2013, AN VA HLTH CAR UT OP; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Young JC, 2016, CLIN NEUROPSYCHOL, V30, P497, DOI 10.1080/13854046.2016.1159730	50	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184265	10.1371/journal.pone.0184265	http://dx.doi.org/10.1371/journal.pone.0184265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886114	Green Submitted, gold, Green Published			2022-12-27	WOS:000410001100089
J	Wang, XM; Wen, XY; Zhou, JJ; Qi, Y; Wu, RH; Wang, Y; Kui, YW; Hua, R; Jin, QL				Wang, Xiaomei; Wen, Xiaoyu; Zhou, Jingjing; Qi, Yue; Wu, Ruihong; Wang, Yao; Kui, Yiwen; Hua, Rui; Jin, Qinglong			MicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patients	PLOS ONE			English	Article							LIVER-INJURY; EXPRESSION; CIRRHOSIS; IDENTIFICATION; BIOMARKERS; BETA; RNAS	Recently, there is ample evidence suggesting the important role of microRNAs (miRNAs) in autoimmune diseases via modulating B cells function. Primary biliary cholangitis (PBC) is a progressive immune-mediated liver disease with unclear pathogenic mechanism. Whether the miRNA in peripheral B cells of PBC involve the mechanisms of pathology and progression is not known. The present study explores miRNA deregulation in peripheral B-cell of PBC from stage I to IV and healthy controls. Peripheral B cells were obtained from 72 PBC patients (stage I, n = 17; stage II, n = 23; stage III, n = 16; stage IV, n = 16) and 15 healthy controls. Initially, in a discovery study, miRNA array analysis was performed, subsequently, in a validation study, quantitative PCR was used to investigate miRNA expression profile in B cells of PBS patients compared to healthy controls. Based on bioinformatics analysis, we identified the potential biological processes and significant signaling pathways affected by these microRNAs, and generated the microRNA-gene network. The discovery study identified 558 miRNAs differentially expressed in B cells of PBC patients compared to controls. Interestingly, among all differentially expressed miRNAs, hsa-miR-223-3p and hsa-miR-215p were the only miRNAs that showed consistent and significant down-regulation from stage I to stage III of PBC. Bioinformatics showed that potential target genes of both miRNAs involved in migration, cell differentiation, apoptosis, and signal transduction pathways. In conclusion, our results suggest that the expression profiles of miRNA in peripheral B cells of PBC patients are closely associated with the disease progression, especially the downregulation of hsa-miR-223-3p and hsa-miR-21-5p. Taken together, our study offers novel perspectives on the role of miRNAs in PBC pathogenesis.	[Wang, Xiaomei; Wen, Xiaoyu; Zhou, Jingjing; Qi, Yue; Wu, Ruihong; Wang, Yao; Kui, Yiwen; Hua, Rui; Jin, Qinglong] Jilin Univ, Dept Hepatol, Hosp 1, Changchun, Jilin, Peoples R China; [Wang, Xiaomei] Minist Educ, Key Lab Zoonosis Res, Changchun, Jilin, Peoples R China	Jilin University	Jin, QL (corresponding author), Jilin Univ, Dept Hepatol, Hosp 1, Changchun, Jilin, Peoples R China.	qinglongjin01@163.com						Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fiorino S, 2016, WORLD J GASTROENTERO, V22, P3907, DOI 10.3748/wjg.v22.i15.3907; Floreani A, 2017, EUROPEAN J INTERNAL; Furer V, 2010, CLIN IMMUNOL, V136, P1, DOI 10.1016/j.clim.2010.02.005; Gulamhusein AF, 2015, SEMIN LIVER DIS, V35, P392, DOI 10.1055/s-0035-1567831; Gustafson D, 2016, BEST PRACT RES CL EN, V30, P563, DOI 10.1016/j.beem.2016.07.002; Kamel Refaat R, 2016, Open Access Maced J Med Sci, V4, P31, DOI 10.3889/oamjms.2016.038; Kar SP, 2013, GENES IMMUN, V14, P179, DOI 10.1038/gene.2013.1; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Lleo A, 2008, WORLD J GASTROENTERO, V14, P3328, DOI 10.3748/wjg.14.3328; Maes OC, 2008, MECH AGEING DEV, V129, P534, DOI 10.1016/j.mad.2008.05.004; Moritoki Y, 2011, CELL IMMUNOL, V268, P16, DOI 10.1016/j.cellimm.2011.01.005; Ninomiya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066086; Oertelt S, 2006, J IMMUNOL, V177, P1655, DOI 10.4049/jimmunol.177.3.1655; Park HK, 2016, J VET SCI, V17, P45, DOI 10.4142/jvs.2016.17.1.45; Park SK, 2016, J GASTROEN HEPATOL, V31, P1429, DOI 10.1111/jgh.13300; Qin BD, 2013, J GASTROEN HEPATOL, V28, P543, DOI 10.1111/jgh.12040; Qu B, 2015, INT J MOL SCI, V16, P9557, DOI 10.3390/ijms16059557; Raikhelson KL, 2014, TERAPEVT ARKH, V86, P44; Ray JL, 2017, TOXICOL SCI, V156, P428, DOI 10.1093/toxsci/kfw264; Salvoza NC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153497; Selmi C, 2004, GASTROENTEROLOGY, V127, P485, DOI 10.1053/j.gastro.2004.05.005; Silveira MG, 2010, HEPATOLOGY, V52, P349, DOI 10.1002/hep.23637; Smyk DS, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/610504; Takeuchi-Yorimoto A, 2016, TOXICOL LETT; Van Keuren-Jensen KR, 2016, LIVER INT, V36, P334, DOI 10.1111/liv.12919; Volinia S, 2010, BIOINFORMATICS, V26, P91, DOI 10.1093/bioinformatics/btp598; Wolenski FS, 2016, J APPL TOXICOL; Yokoyama T, 2006, LIVER INT, V26, P467, DOI 10.1111/j.1478-3231.2006.01254.x; Zekri ARN, 2016, TUMOR BIOL, V37, P12273, DOI 10.1007/s13277-016-5097-8; Zhou KS, 2012, LEUKEMIA LYMPHOMA, V53, P1155, DOI 10.3109/10428194.2011.642303	34	11	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184292	10.1371/journal.pone.0184292	http://dx.doi.org/10.1371/journal.pone.0184292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886078	Green Published, gold, Green Submitted			2022-12-27	WOS:000410001100092
J	Obilade, OA; Akanmu, AS; Pipkin, FB; Afolabi, BB				Obilade, Opeyemi Abayomi; Akanmu, Alani Suleimon; Pipkin, Fiona Broughton; Afolabi, Bosede Bukola			Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy	PLOS ONE			English	Article							PLASMA-VOLUME EXPANSION; HORMONAL CHANGES; HIGH-RISK; DISEASE; WOMEN; OUTCOMES	Background Pregnancy increases the risk of morbidity and mortality in sickle cell disease. We previously showed pregnant women with sickle cell disease to have a relatively low plasma renin concentration in late pregnancy, associated with a lack of the expected plasma volume expansion. We hypothesized this to be due to increased systemic vascular resistance through an imbalance between the vasodilator prostacyclin and vasoconstrictor thromboxane, associated with decreased glomerular filtration rate (GFR). Objective To compare estimated prostacyclin, thromboxane and GFR in non-pregnant and pregnant women with hemoglobin SS (HbSS) and AA (HbAA). Study design Four groups of 20 normotensive, nulliparous women were studied in Lagos, Nigeria: pregnant HbSS or HbAA women at 36-40 weeks gestation; non-pregnant HbSS and HbAA controls. We measured stable metabolites of prostacyclin and thromboxane A(2) by enzymelinked immunosorbent assay; GFR using the Cockcroft-Gault equation. Data analysis was by independent (Student's) t-test or Mann-Whitney U test for comparisons between any two groups of continuous variables, univariate ANOVA for multiple groups and Pearson's correlation coefficient for degree of association between variables. Results HbSS women had lower serum 6-keto-PGF1 alpha concentrations than HbAA, whether pregnant or non-pregnant (P<0.001; P<0.004 respectively). Conversely, pregnant HbSS women had higher serum TxB2 (P<0.001); non-pregnant HbSS women had non-significantly higher TxB2 concentrations. The 6-keto-PGF1a: TxB2 ratio was markedly increased (pro-vasodilatory) in HbAA pregnancy (P<0.001) but reduced in HbSS pregnancy (P = 0.037). GFRs (mL/min) were higher in non-pregnant HbSS than HbAA (P<0.008) but only marginally raised in HbSS women in late pregnancy (P = 0.019) while markedly raised in HbAA pregnancy (P<0.001). Conclusion The lower ratio of prostacyclin-thromboxane metabolites in HbSS pregnancy may indicate endothelial damage and an increased tendency to vasoconstriction and clotting. If confirmed by subsequent longitudinal studies, interventions to increase prostacyclin and reduce thromboxane, such as low dose aspirin, may be potentially useful in their management.	[Obilade, Opeyemi Abayomi; Afolabi, Bosede Bukola] Lagos Univ, Dept Obstet & Gynaecol, Teaching Hosp, Lagos, Nigeria; [Obilade, Opeyemi Abayomi] State House Med Ctr, Dept Obstet & Gynaecol, Asokoro, Abuja, Nigeria; [Akanmu, Alani Suleimon] Univ Lagos, Coll Med, Dept Haematol & Blood Transfus, Lagos, Nigeria; [Akanmu, Alani Suleimon] Lagos Univ, Dept Haematol & Blood Transfus, Teaching Hosp, Lagos, Nigeria; [Pipkin, Fiona Broughton] Univ Nottingham, Fac Med & Hlth Sci, Dept Obstet & Gynaecol, Nottingham, England; [Afolabi, Bosede Bukola] Univ Lagos, Coll Med, Dept Obstet & Gynaecol, Lagos, Nigeria	University of Lagos; University of Nottingham; University of Lagos	Afolabi, BB (corresponding author), Lagos Univ, Dept Obstet & Gynaecol, Teaching Hosp, Lagos, Nigeria.; Afolabi, BB (corresponding author), Univ Lagos, Coll Med, Dept Obstet & Gynaecol, Lagos, Nigeria.	bosedeafolabi2003@yahoo.com		Afolabi, Bosede/0000-0002-7511-7567; Akanmu, Alani Sulaimon/0000-0001-7424-6060	OAO as it formed part of the requirements towards the part II Fellowship exam of the Faculty of Obstetrics and Gynaecology of the National Postgraduate Medical College of Nigeria	OAO as it formed part of the requirements towards the part II Fellowship exam of the Faculty of Obstetrics and Gynaecology of the National Postgraduate Medical College of Nigeria	The study was internally funded by OAO as it formed part of the requirements towards the part II Fellowship exam of the Faculty of Obstetrics and Gynaecology of the National Postgraduate Medical College of Nigeria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUDU OO, 1988, J NATL MED ASSOC, V80, P906; Afolabi BB, 2016, J RENIN-ANGIO-ALDO S, V17, DOI 10.1177/1470320316670444; ALLON M, 1988, KIDNEY INT, V34, P500, DOI 10.1038/ki.1988.209; Alper AB, 2011, AM J PERINAT, V28, P425, DOI 10.1055/s-0030-1268712; Ataga KI, 2000, AM J HEMATOL, V63, P205, DOI 10.1002/(SICI)1096-8652(200004)63:4<205::AID-AJH8>3.3.CO;2-#; Boafor TK, 2016, BJOG-INT J OBSTET GY, V123, P691, DOI 10.1111/1471-0528.13786; BROWN MA, 1994, CLIN SCI, V86, P575, DOI 10.1042/cs0860575; Chakravorty S, 2015, ARCH DIS CHILD, V100, P48, DOI 10.1136/archdischild-2013-303773; Chavarria ME, 2003, AM J OBSTET GYNECOL, V188, P986, DOI 10.1067/mob.2003.203; Conrad KP, 2015, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 4TH EDITION, P335, DOI 10.1016/B978-0-12-407866-6.00016-X; De Franceschi L, 2011, SEMIN THROMB HEMOST, V37, P226, DOI 10.1055/s-0031-1273087; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Faupel-Badger JM, 2007, CANCER EPIDEM BIOMAR, V16, P1720, DOI 10.1158/1055-9965.EPI-07-0311; FITZGERALD DJ, 1987, CIRCULATION, V75, P956, DOI 10.1161/01.CIR.75.5.956; Fontana P, 2011, J THROMB HAEMOST, V9, P2109, DOI 10.1111/j.1538-7836.2011.04446.x; HYTTEN F, 1985, CLIN HAEMATOL, V14, P601; Koetje PMJL, 2011, REPROD SCI, V18, P456, DOI 10.1177/1933719110387831; Lafayette RA, 2011, CLIN NEPHROL, V75, P226, DOI 10.5414/CNP75226; Lewis DF, 2010, AM J REPROD IMMUNOL, V64, P376, DOI 10.1111/j.1600-0897.2010.00861.x; LEWIS PJ, 1980, BRIT MED J, V280, P1581, DOI 10.1136/bmj.280.6231.1581; Morken NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101897; Nielsen CB, 1997, BRIT J CLIN PHARMACO, V44, P471, DOI 10.1046/j.1365-2125.1997.t01-1-00608.x; Oteng-Ntim E, 2015, BLOOD, V125, P3316, DOI 10.1182/blood-2014-11-607317; Oteng-Ntim E, 2015, BRIT J HAEMATOL, V169, P129, DOI 10.1111/bjh.13270; Pipkin FB, 2012, DEWHURSTS TXB OBSTET, P5; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Salas SP, 2006, HYPERTENSION, V47, P203, DOI 10.1161/01.HYP.0000200042.64517.19; SALAS SP, 1993, OBSTET GYNECOL, V81, P1029; SCHIFF E, 1989, NEW ENGL J MED, V321, P351, DOI 10.1056/NEJM198908103210603; Serjeant GR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a011783; Tkachenko O, 2014, INT J ENDOCRINOL MET, V12, DOI 10.5812/ijem.14098; Vainio M, 2004, ACTA OBSTET GYN SCAN, V83, P1119, DOI 10.1111/j.0001-6349.2004.00396.x; Vainio M, 1999, ACTA OBSTET GYN SCAN, V78, P82, DOI 10.1034/j.1600-0412.1999.780202.x; von Tempelhoff GF, 2008, CLIN APPL THROMB-HEM, V14, P19, DOI 10.1177/1076029607304748; Walsh S., 2011, PROSTAGLANDINS PREGN, DOI DOI 10.3843/GLOWM.10315; Yawn BP, 2014, JAMA-J AM MED ASSOC, V312, P1033, DOI 10.1001/jama.2014.10517	36	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184345	10.1371/journal.pone.0184345	http://dx.doi.org/10.1371/journal.pone.0184345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880908	Green Published, gold, Green Accepted			2022-12-27	WOS:000409467200052
J	Zdravevski, E; Stojkoska, BR; Standl, M; Schulz, H				Zdravevski, Eftim; Stojkoska, Biljana Risteska; Standl, Marie; Schulz, Holger			Automatic machine-learning based identification of jogging periods from accelerometer measurements of adolescents under field conditions	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; PHYSICAL-ACTIVITY; ACTIVITY MONITORS; TIME; MORTALITY; EXERCISE; HEALTH; CLASSIFICATION; SMARTPHONE; PREVENTION	Background Assessment of health benefits associated with physical activity depend on the activity duration, intensity and frequency, therefore their correct identification is very valuable and important in epidemiological and clinical studies. The aims of this study are: to develop an algorithm for automatic identification of intended jogging periods; and to assess whether the identification performance is improved when using two accelerometers at the hip and ankle, compared to when using only one at either position. Methods The study used diarized jogging periods and the corresponding accelerometer data from thirty-nine, 15-year-old adolescents, collected under field conditions, as part of the GINIplus study. The data was obtained from two accelerometers placed at the hip and ankle. Automated feature engineering technique was performed to extract features from the raw accelerometer readings and to select a subset of the most significant features. Four machine learning algorithms were used for classification: Logistic regression, Support Vector Machines, Random Forest and Extremely Randomized Trees. Classification was performed using only data from the hip accelerometer, using only data from ankle accelerometer and using data from both accelerometers. Results The reported jogging periods were verified by visual inspection and used as golden standard. After the feature selection and tuning of the classification algorithms, all options provided a classification accuracy of at least 0.99, independent of the applied segmentation strategy with sliding windows of either 60s or 180s. The best matching ratio, i.e. the length of correctly identified jogging periods related to the total time including the missed ones, was up to 0.875. It could be additionally improved up to 0.967 by application of post-classification rules, which considered the duration of breaks and jogging periods. There was no obvious benefit of using two accelerometers, rather almost the same performance could be achieved from either accelerometer position. Conclusions Machine learning techniques can be used for automatic activity recognition, as they provide very accurate activity recognition, significantly more accurate than when keeping a diary. Identification of jogging periods in adolescents can be performed using only one accelerometer. Performance-wise there is no significant benefit from using accelerometers on both locations.	[Zdravevski, Eftim; Stojkoska, Biljana Risteska] St Cyril & Methodius Univ, Fac Comp Sci & Engn, Skopje, North Macedonia; [Standl, Marie; Schulz, Holger] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol 1, Neuherberg, Germany	Saints Cyril & Methodius University of Skopje; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Zdravevski, E (corresponding author), St Cyril & Methodius Univ, Fac Comp Sci & Engn, Skopje, North Macedonia.	eftim.zdravevski@finki.ukim.mk; marie.standl@helmholtz-muenchen.de	Zdravevski, Eftim/K-5276-2014	Zdravevski, Eftim/0000-0001-7664-0168; Standl, Marie/0000-0002-5345-2049	Faculty of Computer Science and Engineering at the Ss. Cyril and Methodius University in Skopje, Macedonia; European Commission, as part of ERAWEB - Erasmus Mundus Action 2 Partnerships	Faculty of Computer Science and Engineering at the Ss. Cyril and Methodius University in Skopje, Macedonia; European Commission, as part of ERAWEB - Erasmus Mundus Action 2 Partnerships(European CommissionEuropean Commission Joint Research Centre)	This study was part of the 15-year followup of the GINIplus cohort (German Infant Study on the influence of Nutrition Intervention PLUS environmental and genetic influences on allergy development). This study was partially financed by the Faculty of Computer Science and Engineering at the Ss. Cyril and Methodius University in Skopje, Macedonia. This study was partially supported from the European Commission, as part of ERAWEB project (ERASMUS-WESTERN BALKANS), financed by the Erasmus Mundus Action 2 Partnerships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhafiz AH, 2016, CLIN GERIATR MED, V31, P439; Alves AJ, 2016, WORLD J CARDIOL, V8, P575, DOI 10.4330/wjc.v8.i10.575; [Anonymous], 2010, GLOB REC PHYS ACT HL; Baek SS, 2016, J EXERC REHABIL, V12, P380, DOI 10.12965/jer.1632808.404; Banos O, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S2-S6; Banos O, 2014, SENSORS-BASEL, V14, P6474, DOI 10.3390/s140406474; Bastian T, 2015, J APPL PHYSIOL, V118, P716, DOI 10.1152/japplphysiol.01189.2013; Boulle M, 2015, ACSIS-ANN COMPUT SCI, V5, P389, DOI 10.15439/2015F423; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burley CV, 2016, EXP PHYSIOL, V101, P1178, DOI 10.1113/EP085672; Cooper C, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029736; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dai SF, 2015, J PHYS ACT HEALTH, V12, pS128, DOI 10.1123/jpah.2015-0038; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Ekelund U, 2012, JAMA-J AM MED ASSOC, V307, P704, DOI 10.1001/jama.2012.156; Fortune E, 2015, PHYSIOL MEAS, V36, P2519, DOI 10.1088/0967-3334/36/12/2519; Garcia-Aymerich J, 2006, THORAX, V61, P772, DOI 10.1136/thx.2006.060145; Garcia-Aymerich J, 2007, AM J RESP CRIT CARE, V175, P458, DOI 10.1164/rccm.200607-896OC; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Gremeaux V, 2012, MATURITAS, V73, P312, DOI 10.1016/j.maturitas.2012.09.012; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Helmerhorst HJF, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-103; Hespanhol LC, 2015, SPORTS MED, V45, P1455, DOI 10.1007/s40279-015-0359-y; Hosmer D.W., 2013, APPL LOGISTIC REGRES, V398; Hyndman RJ, 1996, AM STAT, V50, P361, DOI 10.2307/2684934; Janusz A, 2015, LECT NOTES ARTIF INT, V9437, P429, DOI 10.1007/978-3-319-25783-9_38; Japkowicz N., 2002, Intelligent Data Analysis, V6, P429; Jefferis BJ, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0338-1; Jones E, 2017, OPEN SOURCE SCI TOOL; Kahlmeier S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1412-3; Kokkinos P, 2008, ANGIOLOGY, V59, p26S, DOI 10.1177/0003319708318582; Lameski P, 2015, LECT NOTES ARTIF INT, V9437, P464, DOI 10.1007/978-3-319-25783-9_41; Lasek J, 2015, ACSIS-ANN COMPUT SCI, V5, P375, DOI 10.15439/2015F418; Lee D, 2017, I S BIOMED IMAGING, P15, DOI 10.1109/ISBI.2017.7950457; Leutheuser H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075196; Mannini A, 2013, MED SCI SPORT EXER, V45, P2193, DOI 10.1249/MSS.0b013e31829736d6; Martin H, 2013, PERS UBIQUIT COMPUT, V17, P675, DOI 10.1007/s00779-012-0515-4; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Meina M, 2015, ACSIS-ANN COMPUT SCI, V5, P367, DOI 10.15439/2015F426; Merghani A, 2016, TRENDS CARDIOVAS MED, V26, P232, DOI 10.1016/j.tcm.2015.06.005; Munoz-Organero M, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16091464; Oja P, 2015, BRIT J SPORT MED, V49, P434, DOI 10.1136/bjsports-2014-093885; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pfitzner R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065192; Preece SJ, 2009, IEEE T BIO-MED ENG, V56, P871, DOI 10.1109/TBME.2008.2006190; Reyes-Ortiz JL, 2016, NEUROCOMPUTING, V171, P754, DOI 10.1016/j.neucom.2015.07.085; Robusto KM, 2012, J SPORT SCI, V30, P1429, DOI 10.1080/02640414.2012.710761; Ruta D, 2014, ACSIS-ANN COMPUT SCI, V2, P375; Shiroma EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145950; Shoaib M, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16040426; Shoaib M, 2014, SENSORS-BASEL, V14, P10146, DOI 10.3390/s140610146; Siirtola P, 2012, INT J INTERACT MULTI, V1, P38, DOI 10.9781/ijimai.2012.155; Smith M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135630; Smith MP, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0152217; Straczkiewicz M, 2016, PHYSIOL MEAS, V37, P1757, DOI 10.1088/0967-3334/37/10/1757; Strath SJ, 2013, CIRCULATION; Sturges HA, 1926, J AM STAT ASSOC, V21, P65, DOI 10.1080/01621459.1926.10502161; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Zagorecki A, 2015, ACSIS-ANN COMPUT SCI, V5, P407, DOI 10.15439/2015F419; Zdravevski E, 2017, IEEE ACCESS, V5, P5262, DOI 10.1109/ACCESS.2017.2684913; Zdravevski E, 2015, ACSIS-ANN COMPUT SCI, V5, P381, DOI 10.15439/2015F420; Zdravevski E, 2015, ACSIS-ANN COMPUT SCI, V5, P169, DOI 10.15439/2015F90; Zwillinger D., 2000, CRC STANDARD PROBABI, DOI 10.1201/b16923	67	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184216	10.1371/journal.pone.0184216	http://dx.doi.org/10.1371/journal.pone.0184216			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880923	gold, Green Published, Green Submitted			2022-12-27	WOS:000409467200041
J	Kang, M; Lee, KH; Lee, HS; Jeong, CW; Ku, JH; Kim, HH; Kwak, C				Kang, Minyong; Lee, Kyoung-Hwa; Lee, Hye Sun; Jeong, Chang Wook; Ku, Ja Hyeon; Kim, Hyeon Hoe; Kwak, Cheol			Concurrent treatment with simvastatin and NF-kB inhibitor in human castration-resistant prostate cancer cells exerts synergistic anticancer effects via control of the NF-kB/LIN28/let-7 miRNA signaling pathway	PLOS ONE			English	Article							MEVALONATE PATHWAY; LIN28; APOPTOSIS; STATINS; ACTIVATION; PRODUCTS; GROWTH; TUMORS	We examined the anti-cancer effects and molecular mechanism of simvastatin in human castration-resistant prostate cancer (CRPC) cells, particularly focused on LIN28B and its target molecule, let-7 microRNA (miRNA) among the various target genes of NF-kB. A human CRPC cell line (PC3) was used in the current study. Gene expression patterns were evaluated using real time-PCR and western blot analysis. CCK-8 assay was used for assessing cell viability and proliferation, and a clonogenic assay was adopted to evaluate clonal proliferative capabilities. Induction of apoptotic cell death was analyzed via flow cytometry. Small interfering RNA (siRNA) and short-hairpin RNA (shRNA) were used for manipulating the expression of genes of interest. PC3 showed relatively higher expression levels of LIN28B and lower expression levels of let-7 miRNAs. Simvastatin treatment significantly inhibited cell viability and clonal proliferation in a dose-dependent manner. Importantly, the downregulated let-7 miRNA family was restored after simvastatin treatment. We further observed that human CRPC cells transfected with LIN28B-siRNA or shRNA also showed upregulated let-7 miRNAs. Finally, dual treatment with simvastatin and an NF-kB inhibitor (CAPE) synergistically induced apoptotic cell death, along with reduction of LIN28B expression, and restoration of let-7 miRNAs levels. Our data illustrate that simvastatin remarkably inhibits the growth of human CRPC cells by suppressing NF-kB and LIN28B and subsequently upregulating let-7 miRNAs. Moreover, concurrent treatment with simvastatin and an NF-kB inhibitor synergistically suppressed the growth of human CRPC cells, suggesting a novel therapeutic approach for human CRPC treatment.	[Kang, Minyong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul, South Korea; [Lee, Kyoung-Hwa; Lee, Hye Sun; Jeong, Chang Wook; Ku, Ja Hyeon; Kim, Hyeon Hoe; Kwak, Cheol] Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital	Kwak, C (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea.	mdrafael@snu.ac.kr	Song, Young Goo/AGV-5104-2022; Kang, Minyong/AAO-6484-2020	Song, Young Goo/0000-0002-0733-4156; 	Seoul National University Hospital [0320140010]; Astrazeneca Korea [0620132330]; National Research Foundation (NRF) of Korea - Ministry of Education [2016R1D1A1A02936950]	Seoul National University Hospital; Astrazeneca Korea(AstraZeneca); National Research Foundation (NRF) of Korea - Ministry of Education	This study was funded by a research grant from the Seoul National University Hospital Research Fund (No. 0320140010) and Astrazeneca Korea (No. 0620132330). This work was also supported by Basic Science Research Program through the National Research Foundation (NRF) of Korea funded by the Ministry of Education (No. 2016R1D1A1A02936950). The funders had no role in study design, experiments, data collection and analysis, preparation of the manuscript, or the decision to publish.	Bailey KM, 2012, ADV PHARMACOL, V65, P63, DOI 10.1016/B978-0-12-397927-8.00004-X; Clendening JW, 2012, ONCOGENE, V31, P4967, DOI 10.1038/onc.2012.6; Cornford P, 2016, EUROPEAN UROLOGY; Gopalan A, 2013, CANCER LETT, V329, P9, DOI 10.1016/j.canlet.2012.08.031; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ingersoll MA, 2016, CANCER LETT, V383, P94, DOI 10.1016/j.canlet.2016.09.008; Jiang P, 2014, BRIT J CANCER, V111, P1562, DOI 10.1038/bjc.2014.431; Kamel W, 2016, MOL CANC THERAPEUTIC; Kim JH, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-56; Manu KA, 2014, J MOL MED, V92, P267, DOI 10.1007/s00109-013-1095-0; Matusewicz L, 2015, TUMOR BIOL, V36, P4889, DOI 10.1007/s13277-015-3551-7; Nadiminty N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032832; Park YH, 2013, J UROLOGY, V189, P1547, DOI 10.1016/j.juro.2012.10.030; Popiolek M, 2013, EUR UROL, V63, P428, DOI 10.1016/j.eururo.2012.10.002; Spampanato C, 2012, INT J ONCOL, V40, P935, DOI 10.3892/ijo.2011.1273; Stancu C, 2001, J CELL MOL MED, V5, P378, DOI 10.1111/j.1582-4934.2001.tb00172.x; Suzman DL, 2014, THER ADV MED ONCOL, V6, P167, DOI 10.1177/1758834014529176; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsialikas J, 2015, DEVELOPMENT, V142, P2397, DOI 10.1242/dev.117580; Tummala R, 2016, PROSTATE, V76, P445, DOI 10.1002/pros.23134; Tummala R, 2013, AM J PATHOL, V183, P288, DOI 10.1016/j.ajpath.2013.03.011; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang H, 2016, TUMOR BIOL, V37, P2841, DOI 10.1007/s13277-015-4759-2; Wang TZ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0402-5; Wang TT, 2016, ONCOTARGET, V7, P2532, DOI 10.18632/oncotarget.6304; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006	26	24	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184644	10.1371/journal.pone.0184644	http://dx.doi.org/10.1371/journal.pone.0184644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910332	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200071
J	Lee, SR; Shim, S; Yu, T; Jeong, K; Chung, HW				Lee, Sa Ra; Shim, Sunah; Yu, Taeri; Jeong, Kyungah; Chung, Hye Won			Sources of pain in laparoendoscopic gynecological surgeons: An analysis of ergonomic factors and proposal of an aid to improve comfort	PLOS ONE			English	Article							MINIMALLY INVASIVE SURGERY; LAPAROSCOPIC SURGERY; GUIDELINES; HEIGHT	Minimally invasive surgery (MIS) offers cosmetic benefits to patients; however, surgeons often experience pain during MIS. We administered an ergonomic questionnaire to 176 Korean laparoscopic gynecological surgeons to determine potential sources of pain during surgery. Logistic regression analysis was used to identify factors that had a significant impact on gynecological surgeons' pain. Operating table height at the beginning of surgery and during the operation were significantly associated with neck and shoulder discomfort (P <0.001). The ability to control the operating table height was the single factor most significantly associated with neck (P <0.001) and shoulder discomfort (P <0.001). Discomfort of the hand/digits was significantly associated with the trocar site (P = 0.035). The type of electrocautery activation switch and foot pedal were significantly related to surgeons' foot and leg discomfort (P <0.001). In evaluating the co-occurrence of pain in 4 different sites (neck, shoulder, back, hand/digits), the neck and shoulder were determined to have the highest co-occurrence of pain (Spearman's. = 0.64, P <0.001). These results provide guidance for identifying ergonomic solutions to reduce gynecological laparoscopic surgeons' pain. Based on our results, we propose the use of an ergonomic surgical step stool to reduce physical pain related to performing laparoscopic operations.	[Lee, Sa Ra; Shim, Sunah; Yu, Taeri; Jeong, Kyungah; Chung, Hye Won] Ewha Womans Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea	Ewha Womans University	Lee, SR (corresponding author), Ewha Womans Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea.	sarahmd@ewha.ac.kr			National Research Foundation of Korea [NRF-2015R1C1A1A02038010]	National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by a research grant from the National Research Foundation of Korea (NRF-2015R1C1A1A02038010), www.nrf.re.kr/.	Berquer R, 2002, SURG ENDOSC, V16, P416, DOI 10.1007/s00464-001-8190-y; Franasiak J, 2012, GYNECOL ONCOL, V126, P437, DOI 10.1016/j.ygyno.2012.05.016; Lee Doo Haeng, 2015, Obstet Gynecol Sci, V58, P289, DOI 10.5468/ogs.2015.58.4.289; Matern U, 2005, SURG ENDOSC, V19, P436, DOI 10.1007/s00464-004-9030-7; Nguyen NT, 2001, AM J SURG, V182, P720, DOI 10.1016/S0002-9610(01)00801-7; Park A, 2010, J AM COLL SURGEONS, V210, P306, DOI 10.1016/j.jamcollsurg.2009.10.017; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramakrishnan VR, 2013, AM J RHINOL ALLERGY, V27, P245, DOI 10.2500/ajra.2013.27.3872; Sataa Sallami, 2012, Tunis Med, V90, P843; Soueid A, 2010, INT J SURG, V8, P118, DOI 10.1016/j.ijsu.2009.11.008; Szeto GPY, 2012, J SURG RES, V172, pE19, DOI 10.1016/j.jss.2011.08.004; Uhrich ML, 2002, SURG ENDOSC, V16, P635, DOI 10.1007/s00464-001-8151-5; van Det MJ, 2009, SURG ENDOSC, V23, P1279, DOI 10.1007/s00464-008-0148-x; van Veelen MA, 2003, SURG ENDOSC, V17, P1077, DOI 10.1007/s00464-002-9105-2; van Veelen MA, 2003, SURG ENDOSC, V17, P1086, DOI 10.1007/s00464-002-9185-z; van Veelen MA, 2002, SURG ENDOSC, V16, P674, DOI 10.1007/s00464-001-9116-4; van Veelen MA, 2002, J LAPAROENDOSC ADV A, V12, P47, DOI 10.1089/109264202753486920; Wauben LSGL, 2006, SURG ENDOSC, V20, P1268, DOI 10.1007/s00464-005-0647-y	18	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184400	10.1371/journal.pone.0184400	http://dx.doi.org/10.1371/journal.pone.0184400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910316	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200044
J	Rogan, A; McCarthy, K; McGregor, G; Hamborg, T; Evans, G; Hewins, S; Aldridge, N; Fletcher, S; Krishnan, N; Higgins, R; Zehnder, D; Ting, SM				Rogan, A.; McCarthy, K.; McGregor, G.; Hamborg, T.; Evans, G.; Hewins, S.; Aldridge, N.; Fletcher, S.; Krishnan, N.; Higgins, R.; Zehnder, D.; Ting, S. M.			Quality of life measures predict cardiovascular health and physical performance in chronic renal failure patients	PLOS ONE			English	Article							HEMODIALYSIS-PATIENTS; DIALYSIS PATIENTS; HYPERTENSIVE PATIENTS; ARTERIAL STIFFNESS; PRACTICE PATTERNS; CONTROLLED-TRIAL; HEART-FAILURE; MORTALITY; EXERCISE; DISEASE	Background Patients with advanced chronic kidney disease (CKD) experience complex functional and structural changes of the cardiopulmonary and musculoskeletal system. This results in reduced exercise tolerance, quality of life and ultimately premature death. We investigated the relationship between subjective measures of health related quality of life and objective, standardised functional measures for cardiovascular and pulmonary health. Methods Between April 2010 and January 2013, 143 CKD stage-5 or CKD5d patients (age 46.0 +/- 1.1y, 62.2% male), were recruited prospectively. A control group of 83 healthy individuals treated for essential hypertension (HTN; age 53.2 +/- 0.9y, 48.22% male) were recruited at random. All patients completed the SF-36 health survey questionnaire, echocardiography, vascular tonometry and cardiopulmonary exercise testing. Results Patients with CKD had significantly lower SF-36 scores than the HTN group; for physical component score (PCS; 45.0 vs 53.9, p<0.001) and mental component score (MCS; 46.9 vs. 54.9, p<0.001). CKD subjects had significantly poorer exercise tolerance and cardiorespiratory performance compared with HTN (maximal oxygen uptake; VO(2)peak 19.9 vs 25.0ml/kg/min, p<0.001). VO(2)peak was a significant independent predictor of PCS in both groups (CKD: b = 0.35, p = 0.02 vs HTN: b = 0.27, p = 0.001). No associations were noted between PCS scores and echocardiographic characteristics, vascular elasticity and cardiac biomarkers in either group. No associations were noted between MCS and any variable. The interaction effect of study group with VO(2)peak on PCS was not significant (Delta B = 0.08; 95% CI -0.28-0.45, p = 0.7). However, overall for a given VO(2)peak, the measured PCS was much lower for patients with CKD than for HTN cohort, a likely consequence of systemic uremia effects. Conclusion In CKD and HTN, objective physical performance has a significant effect on quality of life; particularly self-reported physical health and functioning. Therefore, these quality of life measures are indeed a good reflection of physical health correlating highly with objective physical performance measures.	[Rogan, A.] Wellington Hosp, Capital & Coast Dist Hlth Board, Dept Emergency Med, Wellington, New Zealand; [Rogan, A.; McCarthy, K.; McGregor, G.; Evans, G.; Hewins, S.; Aldridge, N.; Fletcher, S.; Krishnan, N.; Higgins, R.] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Renal Med & Transplantat, Coventry, W Midlands, England; [McGregor, G.] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Cardiac Rehabil & Cardiol, Coventry, W Midlands, England; [Hamborg, T.] Univ Warwick, Div Hlth Sci Stat & Epidemiol, Coventry, W Midlands, England; [Zehnder, D.] North Cumbria Univ Hosp NHS Trust, Dept Acute Med, Carlisle, England; [Zehnder, D.; Ting, S. M.] Univ Warwick, Div Translat Med, Coventry, W Midlands, England; [Ting, S. M.] Heart England NHS Fdn Trust, Dept Acute Med, Birmingham, W Midlands, England	University of Warwick; University of Warwick; University of Warwick; University of Warwick; Heart of England NHS Foundation Trust	Rogan, A (corresponding author), Wellington Hosp, Capital & Coast Dist Hlth Board, Dept Emergency Med, Wellington, New Zealand.; Rogan, A (corresponding author), Univ Hosp Coventry & Warwickshire NHS Trust, Dept Renal Med & Transplantat, Coventry, W Midlands, England.	alice.rogan@nhs.net	Higgins, Robert/AGZ-7064-2022; McGregor, Gordon/AAP-1917-2020	McGregor, Gordon/0000-0001-8963-9107; Rogan, Alice/0000-0003-1305-0325	British Heart Foundation (BHF) [PG/11/66/28982]; University Hospital Coventry and Warwickshire NHS Trust Charity	British Heart Foundation (BHF)(British Heart Foundation); University Hospital Coventry and Warwickshire NHS Trust Charity	This work was supported by the British Heart Foundation (BHF) Grant (PG/11/66/28982). BHF did not have any role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication.; We would like to thank the Reading family and University Hospital Coventry and Warwickshire NHS Trust Charity for funding the CPET machine used in this study. We thank the National Institute of Health Research (NIHR) for clinical staffing support providing assistance in the administrative work and data collection.	Avramovic M, 2012, ARTIF ORGANS, V36, P581, DOI 10.1111/j.1525-1594.2011.01429.x; Bayoumi Magda, 2013, Saudi J Kidney Dis Transpl, V24, P254; Beddhu S, 2009, CLIN J AM SOC NEPHRO, V4, P1901, DOI 10.2215/CJN.01970309; Beusterien KM, 1996, J AM SOC NEPHROL, V7, P763; Boman K, 2009, EUR J CARDIOV PREV R, V16, P242, DOI 10.1097/HJR.0b013e328329560e; Burton JO, 2009, CLIN J AM SOC NEPHRO, V4, P1925, DOI 10.2215/CJN.04470709; Cheema B, 2007, J AM SOC NEPHROL, V18, P1594, DOI 10.1681/ASN.2006121329; Cox S, 1997, HEART, V78, P182, DOI 10.1136/hrt.78.2.182; Erickson SR, 2001, J HUM HYPERTENS, V15, P539, DOI 10.1038/sj.jhh.1001236; Faria RD, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-184; FOLEY RN, 1995, J AM SOC NEPHROL, V5, P2024; Foley RN, 2009, CLIN J AM SOC NEPHRO, V4, P726, DOI 10.2215/CJN.04950908; Goldstein SL, 2006, PEDIATR NEPHROL, V21, P846, DOI 10.1007/s00467-006-0081-y; Hall YN, 2012, CLIN J AM SOC NEPHRO, V7, P782, DOI 10.2215/CJN.10601011; Heiwe S, 2014, AM J KIDNEY DIS, V64, P383, DOI 10.1053/j.ajkd.2014.03.020; Hu L, 2015, J AM SOC NEPHROL, V26, P626, DOI 10.1681/ASN.2014020144; Johansen KL, 2010, AM J KIDNEY DIS, V55, P535, DOI 10.1053/j.ajkd.2009.12.018; Juenger J, 2002, HEART, V87, P235, DOI 10.1136/heart.87.3.235; Kalantar-Zadeh K, 2001, J AM SOC NEPHROL, V12, P2797, DOI 10.1681/ASN.V12122797; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P489, DOI 10.1053/j.ajkd.2005.05.020; Kalantar-Zadeh K, 2003, KIDNEY INT, V63, P793, DOI 10.1046/j.1523-1755.2003.00803.x; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lim PO, 1996, ANN INTERN MED, V124, P41, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00008; Lopes AA, 2007, QUAL LIFE RES, V16, P545, DOI 10.1007/s11136-006-9143-7; Lowrie EG, 2003, AM J KIDNEY DIS, V41, P1286, DOI 10.1016/S0272-6386(03)00361-5; Macdonald JH, 2012, AM J KIDNEY DIS, V60, P930, DOI 10.1053/j.ajkd.2012.06.021; Majani G, 1999, EUR HEART J, V20, P1579, DOI 10.1053/euhj.1999.1712; Mapes DL, 2003, KIDNEY INT, V64, P339, DOI 10.1046/j.1523-1755.2003.00072.x; Pagels AA, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-71; Paudel K, 2015, NEPHROLOGY, V20, P1, DOI 10.1111/nep.12342; Raymond NT, 2007, NEPHROL DIAL TRANSPL, V22, P3214, DOI 10.1093/ndt/gfm396; Revuelta KL, 2004, NEPHROL DIAL TRANSPL, V19, P2347, DOI 10.1093/ndt/gfh392; Rosas SE, 2003, KIDNEY INT, V64, P232, DOI 10.1046/j.1523-1755.2003.00042.x; Rumsfeld JS, 1999, JAMA-J AM MED ASSOC, V281, P1298, DOI 10.1001/jama.281.14.1298; Segura-Orti E, 2010, SEMIN DIALYSIS, V23, P422, DOI 10.1111/j.1525-139X.2010.00766.x; Sietsema KE, 2004, KIDNEY INT, V65, P719, DOI 10.1111/j.1523-1755.2004.00411.x; Smart N, 2011, NEPHROLOGY, V16, P626, DOI 10.1111/j.1440-1797.2011.01471.x; Spiegel BMR, 2008, CLIN J AM SOC NEPHRO, V3, P1759, DOI 10.2215/CJN.00820208; Stenvinkel P, 2016, J AM SOC NEPHROL, V27, P1479, DOI 10.1681/ASN.2015030252; TIBBLIN G, 1993, J HYPERTENS, V11, pS81; Ting SMS, 2015, AM J KIDNEY DIS, V66, P274, DOI 10.1053/j.ajkd.2015.02.335; Ting SMS, 2014, J AM SOC NEPHROL, V25, P187, DOI 10.1681/ASN.2013040348; Ting SMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064335; Untas A, 2011, CLIN J AM SOC NEPHRO, V6, P142, DOI 10.2215/CJN.02340310; Van Craenenbroeck AH, 2015, AM J KIDNEY DIS, V66, P285, DOI 10.1053/j.ajkd.2015.03.015; Waren JE, 1994, MOS SF 36 PHYS MENTA; Wasserman K, 2005, PRINCIPLES EXERCISE; Wight JP, 1998, QUAL HEALTH CARE, V7, P209, DOI 10.1136/qshc.7.4.209; Wilkinson IB, 2002, AM J HYPERTENS, V15, P24, DOI 10.1016/S0895-7061(01)02252-X; Williams Christopher E, 2014, Can J Kidney Health Dis, V1, P16, DOI 10.1186/2054-3581-1-16	51	23	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0183926	10.1371/journal.pone.0183926	http://dx.doi.org/10.1371/journal.pone.0183926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910330	gold, Green Published, Green Submitted			2022-12-27	WOS:000410859200022
J	Vasek, J; Cepkova, PH; Viehmannova, I; Ocelak, M; Huansi, DC; Vejl, P				Vasek, Jakub; Cepkova, Petra Hlasna; Viehmannova, Iva; Ocelak, Martin; Cachique Huansi, Danter; Vejl, Pavel			Dealing with AFLP genotyping errors to reveal genetic structure in Plukenetia volubilis (Euphorbiaceae) in the Peruvian Amazon	PLOS ONE			English	Article							POPULATION-STRUCTURE; INFERENCE; HOMOPLASY; SOFTWARE; MARKERS; IMPACT; PARAMETERS; DIVERSITY; EVOLUTION; SELECTION	An analysis of the population structure and genetic diversity for any organism often depends on one or more molecular marker techniques. Nonetheless, these techniques are not absolutely reliable because of various sources of errors arising during the genotyping process. Thus, a complex analysis of genotyping error was carried out with the AFLP method in 169 samples of the oil seed plant Plukenetia volubilis L. from small isolated subpopulations in the Peruvian Amazon. Samples were collected in nine localities from the region of San Martin. Analysis was done in eight datasets with a genotyping error from 0 to 5%. Using eleven primer combinations, 102 to 275 markers were obtained according to the dataset. It was found that it is only possible to obtain the most reliable and robust results through a multiplelevel filtering process. Genotyping error and software set up influence both the estimation of population structure and genetic diversity, where in our case population number (K) varied between 2-9 depending on the dataset and statistical method used. Surprisingly, discrepancies in K number were caused more by statistical approaches than by genotyping errors themselves. However, for estimation of genetic diversity, the degree of genotyping error was critical because descriptive parameters (He, F-ST, PLP 5%) varied substantially (by at least 25%). Due to low gene flow, P. volubilis mostly consists of small isolated subpopulations (Phi(PT) = 0.252-0.323) with some degree of admixture given by socio-economic connectivity among the sites; a direct link between the genetic and geographic distances was not confirmed. The study illustrates the successful application of AFLP to infer genetic structure in non-model plants.	[Vasek, Jakub; Vejl, Pavel] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Genet & Breeding, Prague, Czech Republic; [Cepkova, Petra Hlasna] Crop Res Inst, Div Crop Genet & Breeding, Gene Bank, Prague, Czech Republic; [Viehmannova, Iva; Ocelak, Martin] Czech Univ Life Sci Prague, Fac Trop AgriSci, Dept Crop Sci & Agroforestry, Prague, Czech Republic; [Cachique Huansi, Danter] Peruvian Amazon Res Inst, Tarapoto, Peru	Czech University of Life Sciences Prague; Czech Crop Research Institute (CRI); Czech University of Life Sciences Prague	Cepkova, PH (corresponding author), Crop Res Inst, Div Crop Genet & Breeding, Gene Bank, Prague, Czech Republic.	hlasna@vurv.cz	Vasek, Jakub/ABA-2890-2021; Hlasna, Petra/GQP-8050-2022; Vejl, Pavel/ABA-2874-2021; Viehmannova, Iva/G-2633-2019	Viehmannova, Iva/0000-0002-2540-7443	Internal Grant Agency of the University of Life Science Prague CIGA Project [20144207]; Internal Grant Agency of Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague IGA Project [20165014]; Talent Foundation of Josef, Marie and Zdenka Hlavkovych; CULS Prague; UNU in Pucallpa; Ministry of Agriculture of the Czech Republic [R00415]	Internal Grant Agency of the University of Life Science Prague CIGA Project; Internal Grant Agency of Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague IGA Project; Talent Foundation of Josef, Marie and Zdenka Hlavkovych; CULS Prague; UNU in Pucallpa; Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This research was supported financially by an Internal Grant Agency of the University of Life Science Prague CIGA Project No. 20144207, by the Internal Grant Agency of Faculty of Tropical AgriSciences, Czech University of Life Sciences Prague IGA Project No. 20165014, by The Talent Foundation of Josef, Marie and Zdenka Hlavkovych and Scholarship ("Nadani Josefa, Marie a Zdenky Hlavkovych") provided on base of Bilateral Agreement between CULS Prague and UNU in Pucallpa and by the Ministry of Agriculture of the Czech Republic (no. R00415). We would like to thank Lucas Garcia Chujutalli for his cooperation in samples collection and Dr. Martina Melounova for help with scientific English terms and vocabulary.	Arrigo N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-33; Arthofer W, 2010, MOL ECOL RESOUR, V10, P385, DOI 10.1111/j.1755-0998.2009.02751.x; Bensch S, 2005, MOL ECOL, V14, P2899, DOI 10.1111/j.1365-294X.2005.02655.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Brack A., 1999, DICCIONARIO ENCICLO; Bussmann RW, 2013, ECON BOT, V67, P387, DOI 10.1007/s12231-013-9247-2; Caballero A, 2008, GENETICS, V179, P539, DOI 10.1534/genetics.107.083246; Caballero A, 2010, MOL BIOL EVOL, V27, P1139, DOI 10.1093/molbev/msq001; Chirinos R, 2013, FOOD CHEM, V141, P1732, DOI 10.1016/j.foodchem.2013.04.078; Chybicki IJ, 2011, HEREDITY, V107, P589, DOI 10.1038/hdy.2011.51; Coulon A, 2008, MOL ECOL, V17, P1685, DOI 10.1111/j.1365-294X.2008.03705.x; Crawford LA, 2012, MOL ECOL, V21, P5911, DOI 10.1111/mec.12069; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Duchesne P, 2002, MOL ECOL NOTES, V2, P380, DOI 10.1046/j.1471-8286.2002.00251.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fanali C, 2011, J AGR FOOD CHEM, V59, P13043, DOI 10.1021/jf203184y; GILLESPIE LJ, 1993, SYST BOT, V18, P575, DOI 10.2307/2419535; Greene SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105145; Guillen MD, 2003, J AM OIL CHEM SOC, V80, P755, DOI 10.1007/s11746-003-0768-z; Gupta S, 2013, MOL BIOTECHNOL, V53, P237, DOI 10.1007/s12033-012-9517-8; Gutierrez LF, 2011, GRASAS ACEITES, V62, P76, DOI 10.3989/gya044510; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; HAMAKER BR, 1992, CEREAL CHEM, V69, P461; Hasbun R, 2012, TREE GENET GENOMES, V8, P925, DOI 10.1007/s11295-011-0463-6; Herrmann D, 2010, GENOME, V53, P302, DOI [10.1139/G10-006, 10.1139/g10-006]; Herrmann M, 2013, MOL ECOL RESOUR, V13, P128, DOI 10.1111/1755-0998.12033; Holland BR, 2008, SYST BIOL, V57, P347, DOI 10.1080/10635150802044037; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, HEREDITY, V101, P92, DOI 10.1038/hdy.2008.34; Jombart T, 2009, HEREDITY, V102, P330, DOI 10.1038/hdy.2008.130; Keneni G, 2012, PLANT MOL BIOL REP, V30, P654, DOI 10.1007/s11105-011-0374-6; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lambert SM, 2013, MOL ECOL, V22, P3981, DOI 10.1111/mec.12292; Ley AC, 2013, MOL ECOL, V22, P1984, DOI 10.1111/mec.12214; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Maurer NE, 2012, FOOD CHEM, V134, P1173, DOI 10.1016/j.foodchem.2012.02.143; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Melito S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079043; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Osorio LRM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-77; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; Paris M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-287; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X., 2006, DARWIN SOFTWARE; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Porcher E, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0668-2; Price DL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-268; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2015, LANG ENV STAT COMP; Reisch C, 2014, PLANT ECOL, V215, P1493, DOI 10.1007/s11258-014-0409-9; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Stout AB, 1933, AGR EXPT STA B, V257; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Whitlock R, 2008, MOL ECOL RESOUR, V8, P725, DOI 10.1111/j.1755-0998.2007.02073.x; Zhang H, 2012, HEREDITY, V108, P616, DOI 10.1038/hdy.2011.132; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	65	12	13	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184259	10.1371/journal.pone.0184259	http://dx.doi.org/10.1371/journal.pone.0184259			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910307	Green Published, gold, Green Submitted			2022-12-27	WOS:000410859200035
J	Claassens, NJ; Siliakus, MF; Spaans, SK; Creutzburg, SCA; Nijsse, B; Schaap, PJ; Quax, TEF; van der Oost, J				Claassens, Nico J.; Siliakus, Melvin F.; Spaans, Sebastiaan K.; Creutzburg, Sjoerd C. A.; Nijsse, Bart; Schaap, Peter J.; Quax, Tessa E. F.; van der Oost, John			Improving heterologous membrane protein production in Escherichia coli by combining transcriptional tuning and codon usage algorithms	PLOS ONE			English	Article							GENE-EXPRESSION; GFP-FUSIONS; OVEREXPRESSION; OPTIMIZATION; GENOME; BIAS; SUBSTITUTIONS; PURIFICATION; TRANSLATION; LEMO21(DE3)	High-level, recombinant production of membrane-integrated proteins in Escherichia coli is extremely relevant for many purposes, but has also been proven challenging. Here we study a combination of transcriptional fine-tuning in E. coli LEMO21(DE3) with different codon usage algorithms for heterologous production of membrane proteins. The overexpression of 6 different membrane proteins is compared for the wild-type gene codon usage variant, a commercially codon-optimized variant, and a codon-harmonized variant. We show that transcriptional fine-tuning plays a major role in improving the production of all tested proteins. Moreover, different codon usage variants significantly improved production of some of the tested proteins. However, not a single algorithm performed consistently best for the membrane-integrated production of the 6 tested proteins. In conclusion, for improving heterologous membrane protein production in E. coli, the major effect is accomplished by transcriptional tuning. In addition, further improvements may be realized by attempting different codon usage variants, such as codon harmonized variants, which can now be easily generated through our online Codon Harmonizer tool.	[Claassens, Nico J.; Siliakus, Melvin F.; Spaans, Sebastiaan K.; Creutzburg, Sjoerd C. A.; van der Oost, John] Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands; [Nijsse, Bart; Schaap, Peter J.] Wageningen Univ & Res, Lab Syst & Synthet Biol, Wageningen, Netherlands; [Quax, Tessa E. F.] Albert Ludwigs Univ Freiburg, Inst Biol 2, Freiburg, Germany; [Siliakus, Melvin F.] NIOZ Royal Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, T Horntje Texel, Netherlands	Wageningen University & Research; Wageningen University & Research; University of Freiburg; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Claassens, NJ (corresponding author), Wageningen Univ & Res, Lab Microbiol, Wageningen, Netherlands.	nicoclaassens@gmail.com	van+der+Oost, John/Y-2548-2019; Quax, Tessa E.F./AAE-9830-2019	Quax, Tessa E.F./0000-0001-5516-5871; Schaap, Peter/0000-0002-4346-6084	SIAM Gravitation Grant [KW-17-003.02-024, 024.002.002]	SIAM Gravitation Grant	This work was supported by http://www.be-basic.orgi; www.wur.nl (KW-17-003.02-024) and SIAM Gravitation Grant (Netherlands Organization for Scientific Research) to Willem M. de Vos (Project reference: 024.002.002).	Angov E, 2011, METHODS MOL BIOL, V705, P1, DOI 10.1007/978-1-61737-967-3_1; Angov E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002189; Boel G, 2016, NATURE, V529, P358, DOI 10.1038/nature16509; Bratanov D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128390; Buhr F, 2016, MOL CELL, V61, P341, DOI 10.1016/j.molcel.2016.01.008; Caforio A, 2015, BIOCHEM J, V470, P343, DOI 10.1042/BJ20150626; Claassens NJ, 2013, TRENDS BIOTECHNOL, V31, P633, DOI 10.1016/j.tibtech.2013.08.006; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; dos Reis M, 2003, NUCLEIC ACIDS RES, V31, P6976, DOI 10.1093/nar/gkg897; Drew D, 2006, NAT METHODS, V3, P303, DOI 10.1038/nmeth0406-303; Drew DE, 2001, FEBS LETT, V507, P220, DOI 10.1016/S0014-5793(01)02980-5; Fath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017596; Fu HY, 2010, J BACTERIOL, V192, P5866, DOI 10.1128/JB.00642-10; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Gould Nathan, 2014, Front Bioeng Biotechnol, V2, P41, DOI 10.3389/fbioe.2014.00041; Gustafsson C, 2012, PROTEIN EXPRES PURIF, V83, P37, DOI 10.1016/j.pep.2012.02.013; Hjelm A, 2013, METHODS MOL BIOL, V1033, P381, DOI 10.1007/978-1-62703-487-6_24; Hsieh JM, 2010, PROTEIN SCI, V19, P868, DOI 10.1002/pro.365; Imasheva ES, 2009, BIOCHEMISTRY-US, V48, P10948, DOI 10.1021/bi901552x; Jain S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00641; Keniya MV, 2014, MOL PHARMACEUT, V11, P3452, DOI 10.1021/mp500230b; Lee KA, 2011, J NANOSCI NANOTECHNO, V11, P4261, DOI 10.1166/jnn.2011.3669; Lundstrom K, 2007, J CELL MOL MED, V11, P224, DOI 10.1111/j.1582-4934.2007.00028.x; Maertens B, 2010, PROTEIN SCI, V19, P1312, DOI 10.1002/pro.408; Marino J, 2015, J MOL BIOL, V427, P943, DOI 10.1016/j.jmb.2014.11.002; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mirzadeh K, 2015, ACS SYNTH BIOL, V4, P959, DOI 10.1021/acssynbio.5b00033; Norholm MHH, 2013, FEBS LETT, V587, P2352, DOI 10.1016/j.febslet.2013.05.063; Norholm MHH, 2012, BBA-BIOMEMBRANES, V1818, P1091, DOI 10.1016/j.bbamem.2011.08.018; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035; Raab David, 2010, Syst Synth Biol, V4, P215, DOI 10.1007/s11693-010-9062-3; Sarduy ES, 2012, PROTEIN EXPRES PURIF, V83, P59, DOI 10.1016/j.pep.2012.03.008; Saunders R, 2010, NUCLEIC ACIDS RES, V38, P6719, DOI 10.1093/nar/gkq495; Schlegel S, 2015, CELL REP, V10, P1758, DOI 10.1016/j.celrep.2015.02.029; Schlegel S, 2014, BBA-MOL CELL RES, V1843, P1739, DOI 10.1016/j.bbamcr.2013.10.023; Schlegel S, 2012, J MOL BIOL, V423, P648, DOI 10.1016/j.jmb.2012.07.019; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Spencer PS, 2012, J MOL BIOL, V422, P328, DOI 10.1016/j.jmb.2012.06.010; Van Zyl LJ, 2014, APPL MICROBIOL BIOT, V98, P1247, DOI 10.1007/s00253-013-5380-1; Vuoristo KS, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00849; Wagner S, 2008, P NATL ACAD SCI USA, V105, P14371, DOI 10.1073/pnas.0804090105; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Welch M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0520.focus; Zhang F, 2011, CELL, V147, P1446, DOI 10.1016/j.cell.2011.12.004; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	48	18	18	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184355	10.1371/journal.pone.0184355	http://dx.doi.org/10.1371/journal.pone.0184355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902855	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200032
J	Mercader, MA; He, DC; Sharma, AC; Marchitto, MC; Trachiotis, G; Bornzin, GA; Jonas, R; Moak, JP				Mercader, Marco A.; He, Dingchao; Sharma, Aditya C.; Marchitto, Mark C.; Trachiotis, Gregory; Bornzin, Gene A.; Jonas, Richard; Moak, Jeffrey P.			Selective autonomic stimulation of the AV node fat pad to control rapid post-operative atrial arrhythmias	PLOS ONE			English	Article							JUNCTIONAL ECTOPIC TACHYCARDIA; VENTRICULAR RATE CONTROL; VAGAL-STIMULATION; NERVE-STIMULATION; FIBRILLATION; HEART; MODEL; DOGS	Junctional ectopic tachycardia (JET) and atrial fibrillation (AF) occur in patients recovering from open-heart surgery (OHS). Pharmacologic treatment is used for the control of postoperative atrial arrhythmias (POAA), but is associated with side effects. There is a need for a reversible, modulated solution to rate control. We propose a non-pharmacologic technique that can modulate AV nodal conduction in a selective fashion. Ten mongrel dogs underwent OHS. Stimulation of the anterior right (AR) and inferior right (IR) fat pad (FP) was done using a 7-pole electrode. The IR was more effective in slowing the ventricular rate (VR) to AF (52 +/- 20 vs. 15 +/- 10%, p = 0.003) and JET (12 +/- 7 vs. 0 +/- 0%, p = 0.02). Selective site stimulation within a FP region could augment the effect of stimulation during AF (57 +/- 20% (maximum effect) vs. 0 +/- 0% (minimum effect), p<0.001). FP stimulation at increasing stimulation voltage (SV) demonstrated a voltage-dependent effect (8 +/- 14% (low V) vs. 63 +/- 17 (high V) %, p<0.001). In summary, AV node fat pad stimulation had a selective effect on the AV node by decreasing AV nodal conduction, with little effect on atrial activity.	[Mercader, Marco A.; Sharma, Aditya C.] George Washington Univ, Dept Med, Div Cardiol, Washington, DC 20052 USA; [He, Dingchao; Jonas, Richard] Childrens Natl Hlth Syst, Div Cardiac Surg, Dept Surg, Washington, DC USA; [Marchitto, Mark C.] George Washington Univ, Sch Med, Washington, DC USA; [Trachiotis, Gregory] George Washington Univ, Dept Surg, Div Cardiothorac Surg, Washington, DC USA; [Bornzin, Gene A.] St Jude Med, IESD, Sylmar, CA USA; [Moak, Jeffrey P.] Childrens Natl Hlth Syst, Div Cardiol, Dept Pediat, Washington, DC USA	George Washington University; Children's National Health System; George Washington University; George Washington University; Children's National Health System	Mercader, MA (corresponding author), George Washington Univ, Dept Med, Div Cardiol, Washington, DC 20052 USA.	mmercader@mfa.gwu.edu			Heart and Vascular Institute of The George Washington University; Children's Hospital Health System; St. Jude Medical	Heart and Vascular Institute of The George Washington University; Children's Hospital Health System; St. Jude Medical(St. Jude Medical)	Heart and Vascular Institute of The George Washington University provided us with a grant to pay for the cost of all ten experiments. Children's Hospital Health System also provided us with a grant to purchase equipment used in this experiments. St. Jude Medical (Gene Bornzin) provided us with the fat pad stimulation electrode prototype. St. Jude Medical did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials (fat pad stimulation electrode prototype).	Chinda K, 2016, HEART RHYTHM, V13, P771, DOI 10.1016/j.hrthm.2015.11.031; Dodge-Khatami A, 2002, EUR J CARDIO-THORAC, V21, P255, DOI 10.1016/S1010-7940(01)01089-2; FATKIN D, 1994, J AM COLL CARDIOL, V23, P307, DOI 10.1016/0735-1097(94)90412-X; Gillinov AM, 2016, NEW ENGL J MED, V374, P1911, DOI 10.1056/NEJMoa1602002; Grosse-Wortmann L, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-85; He DC, 2015, PEDIATR CARDIOL, V36, P1179, DOI 10.1007/s00246-015-1141-5; Lewis ME, 2001, J PHYSIOL-LONDON, V534, P547, DOI 10.1111/j.1469-7793.2001.00547.x; Mathew JP, 2004, JAMA-J AM MED ASSOC, V291, P1720, DOI 10.1001/jama.291.14.1720; Moak JP, 2013, PACE, V36, P1156, DOI 10.1111/pace.12163; Moak JP, 2013, CIRC-ARRHYTHMIA ELEC, V6, P641, DOI 10.1161/CIRCEP.113.000090; Moak JP, 2013, J THORAC CARDIOV SUR, V146, P212, DOI 10.1016/j.jtcvs.2012.08.068; Rossi P, 2009, J INTERV CARD ELECTR, V24, P37, DOI 10.1007/s10840-008-9286-2; Saul JP, 2005, CIRCULATION, V112, P3470, DOI 10.1161/CIRCULATIONAHA.105.534149; Schauerte P, 2000, J CARDIOVASC ELECTR, V11, P64, DOI 10.1111/j.1540-8167.2000.tb00738.x; Wallick DW, 2001, AM J PHYSIOL-HEART C, V281, pH1490, DOI 10.1152/ajpheart.2001.281.4.H1490; Zhang YH, 2005, CIRCULATION, V112, P2904, DOI 10.1161/CIRCULATIONAHA.105.568832; Zhang YH, 2004, HEART RHYTHM, V1, P469, DOI 10.1016/j.hrthm.2004.06.011; Zhuang SW, 2002, CIRCULATION, V106, P1853, DOI 10.1161/01.CIR.0000031802.58532.04	18	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0183804	10.1371/journal.pone.0183804	http://dx.doi.org/10.1371/journal.pone.0183804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902899	Green Published, gold, Green Submitted			2022-12-27	WOS:000410669200018
J	Steihaug, OM; Gjesdal, CG; Bogen, B; Kristoffersen, MH; Lien, G; Ranhoff, AH				Steihaug, Ole Martin; Gjesdal, Clara Gram; Bogen, Bard; Kristoffersen, Malfrid Holen; Lien, Gunhild; Ranhoff, Anette Hylen			Sarcopenia in patients with hip fracture: A multicenter cross-sectional study	PLOS ONE			English	Article							X-RAY ABSORPTIOMETRY; SKELETAL-MUSCLE MASS; BODY-COMPOSITION; ELDERLY-WOMEN; NUTRITIONAL SUPPLEMENTATION; SMOKING-CESSATION; CLINICAL-TRIALS; SERUM-ALBUMIN; OLDER PERSONS; RISK-FACTORS	Background Sarcopenia is prevalent in older persons and is a risk factor for falls, fractures, and mortality. The aim of this study was to determine a) the feasibility of determining sarcopenia in patients with acute hip fracture, b) the prevalence of sarcopenia and c) associations of sarcopenia with nutritional status and comorbidities. Methods A multicenter cross-sectional study on sarcopenia in male and female patients with acute hip fracture. Participants were previously ambulatory and living in the community. Sarcopenia was assessed postoperatively with muscle mass estimated by anthropometry using triceps skinfold, arm circumference, height, weight and sex. Grip strength was measured by Jamar dynamometer and pre-fracture mobility was by self-report using the New Mobility Score. Results Out of 282 patients, 202 were assessed for sarcopenia of whom 74 (37%) were diagnosed as sarcopenic. Sarcopenia was associated with age, odds ratio (OR) 1.4 per 5 years, 95% confidence interval (CI) [1.1, 1.8], ASA Physical Status Classification System score, OR 2.3 per point, 95% CI [1.3, 4.3] and number of medications at discharge, OR 1.2 per medication, 95% CI [1.0, 1.3] and inversely associated with BMI, OR 0.8, 95% CI [0.7, 0.9] and serum albumin, OR 0.9, 95% CI [0.8,1.0]. Conclusions Thirty-seven percent of assessed subjects were diagnosed with sarcopenia. Our data demonstrates that the prevalence of sarcopenia is associated with older age, malnutrition and comorbidities. Determining sarcopenia at the bedside was feasible in postoperative hip fracture patients by using grip strength, estimation of muscle mass by anthropometry and self-reported mobility.	[Steihaug, Ole Martin; Bogen, Bard; Ranhoff, Anette Hylen] Haraldsplass Deaconess Hosp, Kavli Res Ctr Geriatr & Dementia, Bergen, Norway; [Gjesdal, Clara Gram; Ranhoff, Anette Hylen] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Gjesdal, Clara Gram] Haukeland Hosp, Dept Rheumatol, Bergen, Norway; [Bogen, Bard] Bergen Univ Coll, Bergen, Norway; [Kristoffersen, Malfrid Holen] Haukeland Hosp, Dept Orthoped, Bergen, Norway; [Lien, Gunhild] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Western Norway University of Applied Sciences; University of Bergen; Haukeland University Hospital; Diakonhjemmet Hospital	Ranhoff, AH (corresponding author), Haraldsplass Deaconess Hosp, Kavli Res Ctr Geriatr & Dementia, Bergen, Norway.; Ranhoff, AH (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.	ahranhoff@yahoo.no	Steihaug, Ole Martin/N-4865-2016	Steihaug, Ole Martin/0000-0002-1849-3910; Kristoffersen, Malfrid/0000-0002-6680-3207	Western Regional Health authority, Stavanger, Norway [911829]	Western Regional Health authority, Stavanger, Norway	This research was funded by the Western Regional Health authority, Stavanger, Norway. https://helse-vest no/. Grant number 911829. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins JL, 2014, J AM GERIATR SOC, V62, P253, DOI 10.1111/jgs.12652; Baron JA, 2001, ARCH INTERN MED, V161, P983, DOI 10.1001/archinte.161.7.983; BASTOW MD, 1983, LANCET, V1, P143; Benichou O, 2016, CALCIFIED TISSUE INT, V98, P531, DOI 10.1007/s00223-016-0107-9; Bone J, 2016, MED SCI SPORTS EXERC; Bruyere O, 2016, EUR GERIATR MED, V7, P243, DOI 10.1016/j.eurger.2015.12.009; Cao L, 2016, J AM MED DIR ASSOC, V17, P675, DOI 10.1016/j.jamda.2016.06.001; Cauley JA, 2014, NAT REV ENDOCRINOL, V10, P338, DOI 10.1038/nrendo.2014.51; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Di Monaco M, 2015, EUROPEAN J PHYS REHA; Di Monaco M, 2015, AGING CLIN EXP RES, V27, P465, DOI 10.1007/s40520-014-0306-z; Di Monaco M, 2012, ARCH GERONTOL GERIAT, V55, pE48, DOI 10.1016/j.archger.2012.05.002; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; Fenstad A. M., 2015, NORWEGIAN ARTHROPLAS, P1893; Gonzalez-Montalvo JI, 2015, GERIATRICS GERONTOLO; Haleem S, 2008, INJURY, V39, P1157, DOI 10.1016/j.injury.2008.03.022; He H, 2016, OSTEOPOROSIS INT, V27, P473, DOI 10.1007/s00198-015-3241-8; HEYMSFIELD SB, 1982, AM J CLIN NUTR, V36, P680, DOI 10.1093/ajcn/36.4.680; Ho AWH, 2016, HONG KONG MED J, V22, P23, DOI 10.12809/hkmj154570; Hu FK, 2012, INJURY, V43, P676, DOI 10.1016/j.injury.2011.05.017; Hung WW, 2012, JAMA-J AM MED ASSOC, V307, P2185, DOI 10.1001/jama.2012.4842; Ispoglou T, 2016, EUR J CLIN NUTR, V70, P182, DOI 10.1038/ejcn.2015.91; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Jensen LD, 2014, INT J CLIN PHARM-NET, V36, P570, DOI 10.1007/s11096-014-9940-y; Kim J, 2002, AM J CLIN NUTR, V76, P378, DOI 10.1093/ajcn/76.2.378; Kondrup J, 2003, CLIN NUTR, V22, P321, DOI 10.1016/S0261-5614(02)00214-5; Koster A, 2011, J GERONTOL A-BIOL, V66, P888, DOI 10.1093/gerona/glr070; Kristensen Morten Tange, 2005, Ugeskr Laeger, V167, P3297; KRISTENSEN MT, 2012, DAN MED J, V59; Lai SW, 2010, MEDICINE, V89, P295, DOI 10.1097/MD.0b013e3181f15efc; Latham NK, 2008, ARCH PHYS MED REHAB, V89, P2146, DOI 10.1016/j.apmr.2008.04.016; Leahy S, 2013, BRIT J NUTR, V109, P678, DOI 10.1017/S0007114512001870; Lloyd BD, 2009, J GERONTOL A-BIOL, V64, P599, DOI 10.1093/gerona/glp003; MAHONEY F I, 1965, Md State Med J, V14, P61; Malafarina V, 2017, MATURITAS, V101, P42, DOI 10.1016/j.maturitas.2017.04.010; Malafarina V, 2013, J AM MED DIR ASSOC, V14, P10, DOI 10.1016/j.jamda.2012.08.001; Malmstrom TK, 2013, J AM MED DIR ASSOC, V14, P531, DOI 10.1016/j.jamda.2013.05.018; McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012; Michel JP, 2002, AGING CLIN EXP RES, V14, P389; Norton C, 2016, J NUTR, V146, P65, DOI 10.3945/jn.115.219022; O'Daly BJ, 2010, CLIN NUTR, V29, P89, DOI 10.1016/j.clnu.2009.07.007; Omsland TK, 2014, BONE, V63, P81, DOI 10.1016/j.bone.2014.02.016; Osnes EK, 2004, OSTEOPOROSIS INT, V15, P567, DOI 10.1007/s00198-003-1583-0; Oyen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092882; PARKER MJ, 1993, J BONE JOINT SURG BR, V75, P797, DOI 10.1302/0301-620X.75B5.8376443; Pompe E, 2017, EUR J RADIOL, V89, P177, DOI 10.1016/j.ejrad.2017.02.011; Prestmo A, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0218-1; Prestmo A, 2015, LANCET, V385, P1623, DOI 10.1016/S0140-6736(14)62409-0; Rom O, 2015, ADDICTION, V110, P326, DOI 10.1111/add.12761; Scott IA, 2015, JAMA INTERN MED, V175, P827, DOI 10.1001/jamainternmed.2015.0324; Singh NA, 2012, J AM MED DIR ASSOC, V13, P24, DOI 10.1016/j.jamda.2011.08.005; Song DS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163222; Steihaug OM, 2016, J NUTR HEALTH AGING, V20, P685, DOI 10.1007/s12603-016-0686-1; Steihaug OM, 2016, J NUTR HEALTH AGING, P1; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; Thiebaud D, 1997, OSTEOPOROSIS INT, V7, P457, DOI 10.1007/s001980050033; Thorin MH, 2016, OSTEOPOROSIS INT, V27, P249, DOI 10.1007/s00198-015-3290-z; Torbergsen AC, 2015, CLIN NUTR, V34, P101, DOI 10.1016/j.clnu.2014.01.016; Visser M, 2005, AM J CLIN NUTR, V82, P531; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wu LW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171707; Yoo JI, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0507-3	65	39	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184780	10.1371/journal.pone.0184780	http://dx.doi.org/10.1371/journal.pone.0184780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902873	Green Published, gold			2022-12-27	WOS:000410669200064
J	Kajiwara, T; Bollegala, D; Yoshida, Y; Kawarabayashi, K				Kajiwara, Tomoyuki; Bollegala, Danushka; Yoshida, Yuichi; Kawarabayashi, Ken-ichi			An iterative approach for the global estimation of sentence similarity	PLOS ONE			English	Article								Measuring the similarity between two sentences is often difficult due to their small lexical overlap. Instead of focusing on the sets of features in two given sentences between which we must measure similarity, we propose a sentence similarity method that considers two types of constraints that must be satisfied by all pairs of sentences in a given corpus. Namely, (a) if two sentences share many features in common, then it is likely that the remaining features in each sentence are also related, and (b) if two sentences contain many related features, then those two sentences are themselves similar. The two constraints are utilized in an iterative bootstrapping procedure that simultaneously updates both word and sentence similarity scores. Experimental results on SemEval 2015 Task 2 dataset show that the proposed iterative approach for measuring sentence semantic similarity is significantly better than the non-iterative counterparts.	[Kajiwara, Tomoyuki] Tokyo Metropolitan Univ, Tokyo, Japan; [Bollegala, Danushka] Univ Liverpool, Liverpool, Merseyside, England; [Yoshida, Yuichi; Kawarabayashi, Ken-ichi] Natl Inst Informat, Tokyo, Japan	Tokyo Metropolitan University; University of Liverpool; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan	Kajiwara, T (corresponding author), Tokyo Metropolitan Univ, Tokyo, Japan.	kajiwara-tomoyuki@ed.tmu.ac.jo						Agirre E., 2015, SEMEVAL NAACL HLT, P252, DOI 10.18653/v1/s15-2045; Agirre E., 2013, P C LEX COMP SEM, V1, P32; Chen K., 2013, ADV NEURAL INF PROCE, V26, P3111, DOI DOI 10.5555/2999792.2999959; Cheng Jianpeng, 2015, P 2015 C EMP METH NA, P1531, DOI DOI 10.18653/V1/D15-1177; Coster William, 2011, P 49 ANN M ASS COMP, P665; Dagan I, 2006, LECT NOTES ARTIF INT, V3944, P177; Ganitkevitch Juri, 2013, P NAACL HLT, P758; Guo W., 2012, LONG PAPERS, V1, P864; Han L., 2015, P 9 INT WORKSH SEM E, P172; Hanig C., 2015, SEMEVAL 2015, P264; Hill F., 2016, P 2016 C N AM ASS CO, P1367; Hu Baotian, 2014, P NIPS; Ji Y., 2013, EMNLP, P891; Kenter T., 2015, P 24 ACM INT C INFOR, P1411, DOI [10.1145/2806416.2806475, DOI 10.1145/2806416.2806475]; Kim Y., 2014, P 2014 C EMP METH NA, P1746; Kiros R., 2015, ADV NEURAL INFORM PR, P3294; Kusner  M.J., 2015, P ICML; Le Q., 2014, INT C MACH LEARN, P1188; Liu Y, 2015, 29 PAC AS C LANG INF, V1, P44; Mikolov T., 2013, P ICLR WORKSH 2013, DOI DOI 10.1162/153244303322533223; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Niwa Y., 1994, P 15 C COMP LING COL, P304; Ravichandran Deepak, 2005, P 43 ANN M ASS COMP, P622, DOI DOI 10.3115/1219840.1219917; Ross S., 2011, P 14 INT C ART INT S, P627; Salton G, 1983, INTRO MODERN INFORM; Socher Richard, 2011, P NIPS; Song Y., 2015, C N AM CHAPT ASS CO, P1275; Speer R, 2012, LREC 2012 - EIGHTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P3679; Sultan MA, 2015, SEMEVAL, P148; Tsatsaronis G, 2010, J ARTIF INTELL RES, V37, P1, DOI 10.1613/jair.2880; Turney PD, 2010, J ARTIF INTELL RES, V37, P141, DOI 10.1613/jair.2934; Vilarino D, 2012, P 6 INT WORKSH SEM E, P706; Yogatama Dani, 2014, P ACL; Yogatama Dani, 2014, P ICML; Yokote K., 2012, P 26 AAAI C ART INT, P1720; Zanzotto F. M., 2009, P C EMNLP SING, P91	37	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0180885	10.1371/journal.pone.0180885	http://dx.doi.org/10.1371/journal.pone.0180885			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898242	Green Submitted, Green Published, gold			2022-12-27	WOS:000410449500001
J	Holloway, IW; Traube, DE; Schrager, SM; Tan, D; Dunlap, S; Kipke, MD				Holloway, Ian W.; Traube, Dorian E.; Schrager, Sheree M.; Tan, Diane; Dunlap, Shannon; Kipke, Michele D.			Psychological distress, health protection, and sexual practices among young men who have sex with men: Using social action theory to guide HIV prevention efforts	PLOS ONE			English	Article							QUALITY-OF-LIFE; RISK BEHAVIOR; DRUG-USE; PRELIMINARY EFFICACY; SUBSTANCE-ABUSE; BISEXUAL MEN; MODEL; GAY; INTERVENTION; PEOPLE	The present study addresses gaps in the literature related to theory development for young men who have sex with men (YMSM) sexual practices through the application and modification of Social Action Theory. Data come from the Healthy Young Men study (N = 526), which longitudinally tracked a diverse cohort of YMSM ages 18-24 to characterize risk and protective factors associated with drug use and sexual practices. Structural equation modeling examined the applicability of, and any necessary modifications to a YMSM-focused version of Social Action Theory. The final model displayed excellent fit (CFI = 0.955, TLI = 0.947, RMSEA = 0.037) and suggested concordance between social support and personal capacity for sexual health promotion. For YMSM, practicing health promotion and avoiding practices that may put them at risk for HIV was associated with both social isolation and psychological distress (beta = -0.372, t = -4.601, p<0.001); psychological distress is an internalized response to environmental and cognitive factors and sexual practices are an externalized response. Results point to the utility of Social Action Theory as a useful model for understanding sexual practices among YMSM, the application of which shows health protective sexual practices are a function of sociocognitive factors that are influenced by environmental contexts. Social Action Theory can help prevention scientists better address the needs of this vulnerable population.	[Holloway, Ian W.; Dunlap, Shannon] Univ Calif Los Angeles, Dept Social Welf, Luskin Sch Publ Affairs, Los Angeles, CA USA; [Traube, Dorian E.] Univ Southern Calif, Suzanne Dworak Peck Sch Social Work, Los Angeles, CA USA; [Schrager, Sheree M.; Kipke, Michele D.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Tan, Diane] UCLA, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of California System; University of California Los Angeles	Holloway, IW (corresponding author), Univ Calif Los Angeles, Dept Social Welf, Luskin Sch Publ Affairs, Los Angeles, CA USA.	holloway@luskin.ucla.edu	Schrager, Sheree M./AAH-1302-2019	Schrager, Sheree M./0000-0001-6352-5056; Holloway, Courtney Jean/0000-0003-3661-1957	National Institute on Drug Abuse [R03DA024976-02, R01DA015638-05]; National Institute of Mental Health [P30MH058107]; California HIV/AIDS Research Program [RP15-LA-007]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD041022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH058107] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California HIV/AIDS Research Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute on Drug Abuse under Grants R03DA024976-02 and R01DA015638-05, the National Institute of Mental Health under Grant P30MH058107, and the California HIV/AIDS Research Program under Grant RP15-LA-007.	Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Bachanas PJ, 2002, J PEDIATR PSYCHOL, V27, P519, DOI 10.1093/jpepsy/27.6.519; Bandura A., 1977, SOCIAL LEARNING THEO; Bauermeister JA, 2015, AIDS BEHAV, V19, P1860, DOI 10.1007/s10461-015-1009-y; Beidas RS, 2012, AIDS PATIENT CARE ST, V26, P366, DOI 10.1089/apc.2011.0418; Bentler PM, 2007, PERS INDIV DIFFER, V42, P825, DOI 10.1016/j.paid.2006.09.024; Berger I, 2016, TRANSGENDER AND INTE; Bontempo DE, 2002, J ADOLESCENT HEALTH, V30, P364, DOI 10.1016/S1054-139X(01)00415-3; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; CATANIA JA, 1990, HEALTH EDUC QUART, V17, P53, DOI 10.1177/109019819001700107; CDC, 2014, HIV SURV REP; Centers for Disease Control, 2005, YOUTH RISK BEHAVIOR; Centers for Disease Control, 2009, YOUTH RISK BEHAVIOR; Centers for Disease Control, 2008, HIV SURVEILLANCE REP; Centers for Disease Control, 2016, HIV AMONG GAY AND BI; Chen E, 2002, HEALTH PSYCHOL, V21, P16, DOI 10.1037//0278-6133.21.1.16; Clark Leslie F, 2005, J Adolesc Health, V37, P337, DOI 10.1016/j.jadohealth.2004.09.024; Crepaz N, 2002, AIDS, V16, P135, DOI 10.1097/00002030-200201250-00002; DiClemente R. J., 2009, EMERGING THEORIES HL, P359; Donenberg GR, 2001, J AM ACAD CHILD PSY, V40, P642, DOI 10.1097/00004583-200106000-00008; Ellickson PL, 2003, AM J PUBLIC HEALTH, V93, P1830, DOI 10.2105/AJPH.93.11.1830; Emlet CA, 2013, GERONTOLOGIST, V53, P963, DOI 10.1093/geront/gns191; Ewart CK, 2004, HA CL HE PS, V3, P249; EWART CK, 1991, AM PSYCHOL, V46, P931, DOI 10.1037/0003-066X.46.9.931; FISHBEIN DH, 1994, ADDICT BEHAV, V19, P583, DOI 10.1016/0306-4603(94)90014-0; FISHER WA, 1995, HEALTH PSYCHOL, V14, P255, DOI 10.1037/0278-6133.14.3.255; Ford WL, 2009, J GAY LESBIAN SOC SE, V21, P357, DOI 10.1080/10538720802498280; Frew PM, 2010, PREV SCI, V11, P207, DOI 10.1007/s11121-009-0162-9; Gielen AC, 2001, SOC SCI MED, V52, P315, DOI 10.1016/S0277-9536(00)00135-0; Gore-Felton C, 2005, AIDS EDUC PREV, V17, P21, DOI 10.1521/aeap.17.2.21.58691; Guilamo-Ramos V, 2008, SOC WORK RES, V32, P29, DOI 10.1093/swr/32.1.29; Herek GM, 2007, J SOC ISSUES, V63, P905, DOI 10.1111/j.1540-4560.2007.00544.x; Hosek SG, 2013, JAIDS-J ACQ IMM DEF, V62, P447, DOI 10.1097/QAI.0b013e3182801081; Huebner DM, 2007, HEALTH PSYCHOL, V26, P627, DOI 10.1037/0278-6133.26.5.627; Janis I., 1982, HDB STRESS THEORETIC, P69; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Johnson MO, 2008, J CONSULT CLIN PSYCH, V76, P829, DOI 10.1037/0022-006X.76.5.829; Johnson MO, 2003, AIDS PATIENT CARE ST, V17, P645, DOI 10.1089/108729103771928708; Johnson WD, 2005, AIDS EDUC PREV, V17, P568, DOI 10.1521/aeap.2005.17.6.568; Joormann J, 2007, APPL PREV PSYCHOL, V12, P128, DOI 10.1016/j.appsy.2007.09.002; Kalichman SC, 1999, AIDS CARE, V11, P415, DOI 10.1080/09540129947794; Kalichman SC, 2014, EUR J PUBLIC HEALTH, V24, P833, DOI 10.1093/eurpub/ckt172; KIM N, 1997, THE JOURNAL OF ADOLE, V20, P204; Kipke MD, 2007, SUBST USE MISUSE, V42, P1723, DOI 10.1080/10826080701212261; Kline R. B., 2004, PRINCIPLES AND PRACT; Lacefield K, 2015, LGBT HEALTH, V2, P200, DOI 10.1089/lgbt.2014.0069; Laska MN, 2009, PREV SCI, V10, P376, DOI 10.1007/s11121-009-0140-2; Levin KD, 2002, PREVENTING SEXUALLY; Lightfoot M, 2005, BEHAV MODIF, V29, P227, DOI 10.1177/0145445504272599; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Lorimer K, 2013, AIDS CARE, V25, P133, DOI 10.1080/09540121.2012.699672; MacKellar D, 1996, PUBLIC HEALTH REP, V111, P138; MacKellar DA, 2005, JAIDS-J ACQ IMM DEF, V38, P603, DOI 10.1097/01.qai.0000141481.48348.7e; Maisto SA, 2009, J BEHAV MED, V32, P285, DOI 10.1007/s10865-009-9201-z; MARLATT GA, 1975, J ABNORM PSYCHOL, V84, P652, DOI 10.1037/0021-843X.84.6.652; Maulsby C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-625; McConnell EA, 2015, LGBT HEALTH, V2, P55, DOI 10.1089/lgbt.2014.0051; McKay MM, 2014, J CLIN CHILD ADOLESC, V43, P428, DOI 10.1080/15374416.2014.893519; MEYER IH, 1995, J HEALTH SOC BEHAV, V36, P38, DOI 10.2307/2137286; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Moore AR, 2007, SOC SCI MED, V64, P1057, DOI 10.1016/j.socscimed.2006.10.004; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Mustanski B, 2007, HEALTH PSYCHOL, V26, P618, DOI 10.1037/0278-6133.26.5.618; Mustanski B, 2015, J SEX RES, V52, P220, DOI 10.1080/00224499.2013.867924; Mustanski B, 2013, AIDS BEHAV, V17, P2999, DOI 10.1007/s10461-013-0507-z; Mustanski BS, 2011, J SEX RES, V48, P218, DOI 10.1080/00224499.2011.558645; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Needham BL, 2010, J YOUTH ADOLESCENCE, V39, P1189, DOI 10.1007/s10964-010-9533-6; Noar SM, 2005, HEALTH EDUC RES, V20, P275, DOI 10.1093/her/cyg113; NOTT KH, 1995, AIDS CARE, V7, P55, DOI 10.1080/09540129550126966; Patel Vikram, 2007, Lancet, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Petty R. E., 1986, COMMUN PERSUATION; Protogerou C, 2014, AIDS BEHAV, V18, P1847, DOI 10.1007/s10461-014-0807-y; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reynolds EK, 2010, PSYCHOL ADDICT BEHAV, V24, P311, DOI 10.1037/a0018929; Romer Daniel, 2003, Prev Sci, V4, P39, DOI 10.1023/A:1021734827116; Rosario M, 2006, AIDS EDUC PREV, V18, P444, DOI 10.1521/aeap.2006.18.5.444; Rosenblum A, 2009, SUBST USE MISUSE, V40, P581; Rotheram-Borus M J, 2000, Prev Sci, V1, P15, DOI 10.1023/A:1010071932238; Rounsaville BJ, 2001, CLIN PSYCHOL-SCI PR, V8, P133, DOI 10.1093/clipsy/8.2.133; Ryan C, 2010, J CHILD ADOL PS NURS, V23, P205, DOI 10.1111/j.1744-6171.2010.00246.x; Safren SA, 2010, JAIDS-J ACQ IMM DEF, V55, pS74, DOI 10.1097/QAI.0b013e3181fbc939; Safren SA, 2010, HEALTH PSYCHOL, V29, P215, DOI 10.1037/a0017859; Shepherd J, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14070; Sifakis F, 2010, AIDS BEHAV, V14, P904, DOI 10.1007/s10461-007-9317-5; Stall R., 2008, UNEQUAL OPPORTUNITY; Sullivan KM, 2017, J ADV NURS, V73, P162, DOI 10.1111/jan.13087; Traube DE, 2012, PSYCHOL ADDICT BEHAV, V26, P78, DOI 10.1037/a0024191; Traube DE, 2011, AIDS CARE, V23, P663, DOI 10.1080/09540121.2010.532532; Weintraub A, 2017, AIDS BEHAV, V21, P129, DOI 10.1007/s10461-016-1337-6; Wong CF, 2010, J ADOLESCENCE, V33, P463, DOI 10.1016/j.adolescence.2009.06.004	91	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184482	10.1371/journal.pone.0184482	http://dx.doi.org/10.1371/journal.pone.0184482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886128	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100135
J	Ranwez, V; Serra, A; Pot, D; Chantret, N				Ranwez, Vincent; Serra, Audrey; Pot, David; Chantret, Nathalie			Domestication reduces alternative splicing expression variations in sorghum	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; PURPLE ACID-PHOSPHATASES; MESSENGER-RNA DECAY; BICOLOR L. MOENCH; GENETIC DIVERSITY; REVEALS; PATTERNS; COMPLEX; EVENTS; WILD	Domestication is known to strongly reduce genomic diversity through population bottlenecks. The resulting loss of polymorphism has been thoroughly documented in numerous cultivated species. Here we investigate the impact of domestication on the diversity of alternative transcript expressions using RNAseq data obtained on cultivated and wild sorghum accessions (ten accessions for each pool). In that aim, we focus on genes expressing two isoforms in sorghum and estimate the ratio between expression levels of those isoforms in each accession. Noticeably, for a given gene, one isoform can either be overexpressed or underexpressed in some wild accessions, whereas in the cultivated accessions, the balance between the two isoforms of the same gene appears to be much more homogenous. Indeed, we observe in sorghum significantly more variation in isoform expression balance among wild accessions than among domesticated accessions. The possibility exists that the loss of nucleotide diversity due to domestication could affect regulatory elements, controlling transcription or degradation of these isoforms. Impact on the isoform expression balance is discussed. As far as we know, this is the first time that the impact of domestication on transcript isoform balance has been studied at the genomic scale. This could pave the way towards the identification of key domestication genes with finely tuned isoform expressions in domesticated accessions while being highly variable in their wild relatives.	[Ranwez, Vincent; Serra, Audrey] UMR AGAP, Montpellier SupAgro, Montpellier, France; [Pot, David] UMR AGAP, CIRAD, Montpellier, France; [Chantret, Nathalie] INRA, UMR AGAP, Montpellier, France	Institut Agro; Montpellier SupAgro; CIRAD; Universite de Montpellier; INRAE; Universite de Montpellier	Chantret, N (corresponding author), INRA, UMR AGAP, Montpellier, France.	nathalie.chantret@inra.fr	Pot, David/AAA-3983-2021; ranwez, vincent/I-5490-2017	ranwez, vincent/0000-0002-9308-7541; Chantret, Nathalie/0000-0002-2512-7644	Agropolis Fondation [ARCAD 0900-001]	Agropolis Fondation	This study was conducted in the framework of ARCAD (http://www.arcad-project.org), a project funded by Agropolis Fondation under the reference ID ARCAD 0900-001.	Bao Y, 2011, P NATL ACAD SCI USA, V108, P21152, DOI 10.1073/pnas.1115926109; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Barro-Kondombo C, 2010, THEOR APPL GENET, V120, P1511, DOI 10.1007/s00122-010-1272-2; Bellucci E, 2014, PLANT CELL, V26, P1901, DOI 10.1105/tpc.114.124040; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chuang TJ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0431-7; Cieply B, 2015, WIRES RNA, V6, P311, DOI 10.1002/wrna.1276; Clement Y, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006799; Dall'Osto L, 2015, BBA-BIOENERGETICS, V1847, P861, DOI 10.1016/j.bbabio.2015.02.009; Ding F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-431; Ezkurdia I, 2012, MOL BIOL EVOL, V29, P2265, DOI 10.1093/molbev/mss100; Feng JL, 2015, MOL PLANT, V8, P1038, DOI 10.1016/j.molp.2015.01.011; Filichkin S, 2015, CURR OPIN PLANT BIOL, V24, P125, DOI 10.1016/j.pbi.2015.02.008; Frere CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023041; Glemin S, 2009, NEW PHYTOL, V183, P273, DOI 10.1111/j.1469-8137.2009.02884.x; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Hamblin MT, 2006, GENETICS, V173, P953, DOI 10.1534/genetics.105.054312; Herritt M, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.08.0072; Huang J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1582-5; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Kane NC, 2007, GENETICS, V175, P1823, DOI 10.1534/genetics.106.067728; Kazan K, 2003, TRENDS PLANT SCI, V8, P468, DOI 10.1016/j.tplants.2003.09.001; Khan MA, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.04.0018; Koenig D, 2013, P NATL ACAD SCI USA, V110, pE2655, DOI 10.1073/pnas.1309606110; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lemmon ZH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004745; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li DP, 2002, J BIOL CHEM, V277, P27772, DOI 10.1074/jbc.M204183200; Lin ZW, 2012, NAT GENET, V44, P720, DOI 10.1038/ng.2281; Lopez-Diez R, 2013, GENOME BIOL EVOL, V5, P2420, DOI 10.1093/gbe/evt188; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Muraya MM, 2011, THEOR APPL GENET, V122, P1631, DOI 10.1007/s00122-011-1560-5; Mutegi E, 2012, CONSERV GENET, V13, P1059, DOI 10.1007/s10592-012-0353-y; Mutegi E, 2010, GENET RESOUR CROP EV, V57, P243, DOI 10.1007/s10722-009-9466-7; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Olsen KM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00290; Panahi B, 2015, FEBS LETT, V589, P3564, DOI 10.1016/j.febslet.2015.09.023; Panahi B, 2014, PHYSIOL MOL BIOL PLA, V20, P323, DOI 10.1007/s12298-014-0245-3; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Potenza E, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1922-5; Rapp RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-139; Sagnard F, 2011, THEOR APPL GENET, V123, P1231, DOI 10.1007/s00122-011-1662-0; Saidou AA, 2009, GENETICS, V182, P899, DOI 10.1534/genetics.109.102756; Sarah G, 2016, MOL ECOLOGY RESOURCE; Severing EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-154; Staiger D, 2013, PLANT CELL, V25, P3640, DOI 10.1105/tpc.113.113803; Sun Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2128-6; Swanson-Wagner R, 2012, P NATL ACAD SCI USA, V109, P11878, DOI 10.1073/pnas.1201961109; Thatcher SR, 2016, PLANT PHYSIOL, V170, P586, DOI 10.1104/pp.15.01267; Tommi K, 2013, FEBS LETT, V587, P1863, DOI 10.1016/j.febslet.2013.05.003; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Walters B, 2013, DNA RES, V20, P163, DOI 10.1093/dnares/dss041; Woods DP, 2014, GENETICS, V198, P397, DOI 10.1534/genetics.114.166785; Xia Yanshi, 2012, PLoS One, V7, pe37573, DOI 10.1371/journal.pone.0037573; Yang SM, 2014, INT J MOL SCI, V15, P10424, DOI 10.3390/ijms150610424; Zhang D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004061; Zhang Q, 2011, PLANT BIOLOGY, V13, P7, DOI 10.1111/j.1438-8677.2010.00346.x; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x; Zou HD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1996-0	71	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183454	10.1371/journal.pone.0183454	http://dx.doi.org/10.1371/journal.pone.0183454			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886042	Green Submitted, gold, Green Published			2022-12-27	WOS:000410001100023
J	Mauree, D; Coccolo, S; Kaempf, J; Scartezzini, JL				Mauree, Dasaraden; Coccolo, Silvia; Kaempf, Jerome; Scartezzini, Jean-Louis			Multi-scale modelling to evaluate building energy consumption at the neighbourhood scale	PLOS ONE			English	Article							CANOPY MODEL; URBAN; PARAMETERIZATION; PERFORMANCE; LAYER	A new methodology is proposed to couple a meteorological model with a building energy use model. The aim of such a coupling is to improve the boundary conditions of both models with no significant increase in computational time. In the present case, the Canopy Interface Model (CIM) is coupled with CitySim. CitySim provides the geometrical characteristics to CIM, which then calculates a high resolution profile of the meteorological variables. These are in turn used by CitySim to calculate the energy flows in an urban district. We have conducted a series of experiments on the EPFL campus in Lausanne, Switzerland, to show the effectiveness of the coupling strategy. First, measured data from the campus for the year 2015 are used to force CIM and to evaluate its aptitude to reproduce high resolution vertical profiles. Second, we compare the use of local climatic data and data from a meteorological station located outside the urban area, in an evaluation of energy use. In both experiments, we demonstrate the importance of using in building energy software, meteorological variables that account for the urban microclimate. Furthermore, we also show that some building and urban forms are more sensitive to the local environment.	[Mauree, Dasaraden; Coccolo, Silvia; Scartezzini, Jean-Louis] Ecole Polytech Fed Lausanne, Solar Energy & Bldg Phys Lab, CH-1015 Lausanne, Switzerland; [Kaempf, Jerome] HES SO Fribourg, Haute Ecole Ingn & Architecture, Bd Perolles 80, CH-1705 Fribourg, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Applied Sciences & Arts Western Switzerland	Mauree, D (corresponding author), Ecole Polytech Fed Lausanne, Solar Energy & Bldg Phys Lab, CH-1015 Lausanne, Switzerland.	dasaraden.mauree@gmail.com	Mauree, Dasaraden/C-2372-2011	Mauree, Dasaraden/0000-0001-8954-321X; Kampf, Jerome/0000-0002-4248-6788; Coccolo, Silvia/0000-0001-5881-4144	CTI [CTI.2014.0119]; EPFL Middle East; Swiss International School of Dubai; CCEM (IDEAS4cities project)	CTI; EPFL Middle East; Swiss International School of Dubai; CCEM (IDEAS4cities project)	The study was supported by a grant from the CTI for the funding of the SCCER Future Energy Efficient Buildings and Districts - FEEB&D (CTI.2014.0119), the EPFL Middle East and the Swiss International School of Dubai for supporting this research. The research presented in this paper has also been supported in part by funds from CCEM (IDEAS4cities project). The authors have no conflicts of interest to declare.; The authors would like to thank the CTI for the funding of the SCCER Future Energy Efficient Buildings and Districts-FEEB& D (CTI.2014.0119), the EPFL Middle East and the Swiss International School of Dubai for supporting this research. The research presented in this paper has also been supported in part by funds from CCEM (IDEAS4cities project). They also thank Sebastien Haussamann and Bernard Sperandio for the meteorological data from the EPFL Campus.	Ashie Y, 1999, J WIND ENG IND AEROD, V81, P237, DOI 10.1016/S0167-6105(99)00020-3; Bruse M, 1998, ENVIRON MODELL SOFTW, V13, P373, DOI 10.1016/S1364-8152(98)00042-5; Carneiro C., 2011, EXTRACTION URBAN ENV; Coccolo S., 2017, J ECOLE POLYTECHNIQU; Coccolo S, 2015, P 9 INT C URB CLIM J; Coccolo S, 2015, ENRGY PROCED, V78, P3174, DOI 10.1016/j.egypro.2015.11.776; Crawley DB, 2008, BUILD ENVIRON, V43, P661, DOI 10.1016/j.buildenv.2006.10.027; Kampf JH, 2007, ENERG BUILDINGS, V39, P445, DOI 10.1016/j.enbuild.2006.09.002; Kriesi R., 2015, COMMUNICATION; Krpo A, 2010, BOUND-LAY METEOROL, V136, P105, DOI 10.1007/s10546-010-9491-2; Kusaka H, 2001, BOUND-LAY METEOROL, V101, P329, DOI 10.1023/A:1019207923078; Martilli A, 2002, BOUND-LAY METEOROL, V104, P261, DOI 10.1023/A:1016099921195; Masson V, 2000, BOUND-LAY METEOROL, V94, P357, DOI 10.1023/A:1002463829265; Mauree D, 2015, 14TH INTERNATIONAL C; Mauree D., 2014, DEV MULTISCALE METER; Mauree D, 2017, FRONT EARTH SC-SWITZ, V4, DOI 10.3389/feart.2016.00109; Mirsadeghi M, 2013, APPL THERM ENG, V56, P134, DOI 10.1016/j.applthermaleng.2013.03.003; Ng E., 2010, J HONG KONG I PLANNE, V25, P26; NUNEZ M, 1977, J APPL METEOROL, V16, P11, DOI 10.1175/1520-0450(1977)016<0011:TEBOAU>2.0.CO;2; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; Ratti C, 2003, ENERG BUILDINGS, V35, P49, DOI 10.1016/S0378-7788(02)00079-8; Remund J., 2008, EUROPE, V6, P389; Robinson D, 2004, SOL ENERGY, V77, P295, DOI 10.1016/j.solener.2004.05.010; Robinson D., 2009, P 11 INT IBPSA C GLA, P1083, DOI [10.1017/S1368980016000446, DOI 10.1017/S1368980016000446]; Robinson D, 2012, COMPUTER MODELLING S; Salamanca F, 2010, THEOR APPL CLIMATOL, V99, P331, DOI [10.1007/s00704-009-0142-9, 10.1007/s00704-009-0143-8]; Salamanca F, 2011, J APPL METEOROL CLIM, V50, P1107, DOI 10.1175/2010JAMC2538.1; Santiago JL, 2010, BOUND-LAY METEOROL, V137, P417, DOI 10.1007/s10546-010-9538-4; Skamarock W C, 2008, DESCRIPTION ADV RES, P1, DOI [DOI 10.5065/D68S4MVH, 10.5065/D68S4MVH]; Upadhyay G., 2015, EVAPOTRANSPIRATION M; Vitasse Y, 2016, THEOR APPL CLIMATOL, P1; Walter E., 2015, P BS2015, P215	32	56	56	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0183437	10.1371/journal.pone.0183437	http://dx.doi.org/10.1371/journal.pone.0183437			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880883	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200018
J	Zou, S; Zhang, JP; Zhang, ZP				Zou, Shuai; Zhang, Jingpu; Zhang, Zuping			A novel approach for predicting microbe-disease associations by bi-random walk on the heterogeneous network	PLOS ONE			English	Article							OBESITY; ASTHMA; MIRNA; VALIDATION; GENES	Since the microbiome has a significant impact on human health and disease, microbe-disease associations can be utilized as a valuable resource for understanding disease pathogenesis and promoting disease diagnosis and prognosis. Accordingly, it is necessary for researchers to achieve a comprehensive and deep understanding of the associations between microbes and diseases. Nevertheless, to date, little work has been achieved in implementing novel human microbe-disease association prediction models. In this paper, we develop a novel computational model to predict potential microbe-disease associations by bi-random walk on the heterogeneous network (BiRWHMDA). The heterogeneous network was constructed by connecting the microbe similarity network and the disease similarity network via known microbe-disease associations. Microbe similarity and disease similarity were calculated by the Gaussian interaction profile kernel similarity measure; moreover, a logistic function was applied to regulate disease similarity. Additionally, leave-one-out cross validation and 5-fold cross validation were implemented to evaluate the predictive performance of our method; both cross validation methods performed well. The leave-one-out cross validation experiment results illustrate that our method outperforms other previously proposed methods. Furthermore, case studies on asthma and inflammatory bowel disease prove the favorable performance of our method. In conclusion, our method can be considered as an effective computational model for predicting novel microbe-disease associations.	[Zou, Shuai; Zhang, Jingpu; Zhang, Zuping] Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China	Central South University	Zhang, ZP (corresponding author), Cent S Univ, Sch Informat Sci & Engn, Changsha, Hunan, Peoples R China.	zpzhang@csu.edu.cn			National Natural Science Foundation of China [61379109, M1321007]; Science and Technology Plan of Hunan Province [2014GK2018, 2016JC2011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan of Hunan Province	This work was supported by the Nationa l Natural Science Foundation of China (61379109, M1321007) ( http://www. nsfc.gov.cn/ ) and Science and Technology Plan of Hunan Province (2014GK2 018, 2016JC 2011) ( http://ww w.hnst. gov.cn/ ). The funders had no role in study design, data collection This work was supported by the National Natural Science Foundation of China (61379109, M1321007) (http://www.nsfc.gov.cn/) and Science and Technology Plan of Hunan Province (2014GK2018, 2016JC2011) (http://www.hnst.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althani AA, 2016, J CELL PHYSIOL, V231, P1688, DOI 10.1002/jcp.25284; Azimirad M, 2012, PREVALENCE OF SUPERA; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Cao Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/167249; Chen X, 2017, MOL BIOSYST, V13, P1202, DOI 10.1039/c6mb00853d; Chen X, 2017, RNA BIOL, V14, P952, DOI 10.1080/15476286.2017.1312226; Chen X, 2017, BIOINFORMATICS, V33, P733, DOI 10.1093/bioinformatics/btw715; Chen X, 2016, ONCOTARGET, V7, P65257, DOI 10.18632/oncotarget.11251; Chen X, 2016, ONCOTARGET, V7, P57919, DOI 10.18632/oncotarget.11141; Chen X, 2016, SCI REP-UK, V6, DOI 10.1038/srep21106; Chen X, 2016, MOL BIOSYST, V12, P624, DOI 10.1039/c5mb00697j; Chen X, 2015, SCI REP-UK, V5, DOI 10.1038/srep16840; Chen X, 2013, BIOINFORMATICS, V29, P2617, DOI 10.1093/bioinformatics/btt426; Chen X, 2012, MOL BIOSYST, V8, P2792, DOI 10.1039/c2mb25180a; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; Ciaccio CE, 2014, J ALLERGY CLIN IMMUN, V133, pAB70, DOI 10.1016/j.jaci.2013.12.274; Dang Hien Thanh, 2013, Journal of Bacteriology and Virology, V43, P270, DOI 10.4167/jbv.2013.43.4.270; Edgar D C, 2015, J BIOINF COMPUT BIOL, V13; FEIN BERNARD T., 1955, ANN ALLERGY, V13, P639; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Holmes E, 2015, NAT REV GASTRO HEPAT, V12, P458, DOI 10.1038/nrgastro.2015.114; Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]; Hoppe B, 2011, NEPHROL DIAL TRANSPL, V26, P3609, DOI 10.1093/ndt/gfr107; Huang ZA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00233; Ju Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep33870; Jung JW, 2016, TUBERC RESPIR DIS, V79, P165, DOI 10.4046/trd.2016.79.3.165; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kojima A, 2014, ORAL DIS, V20, P359, DOI 10.1111/odi.12125; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li JQ, 2017, ONCOTARGET, V8, P21187, DOI 10.18632/oncotarget.15061; Luo HM, 2016, BIOINFORMATICS, V32, P2664, DOI 10.1093/bioinformatics/btw228; Luo JW, 2017, J BIOMED INFORM, V66, P194, DOI 10.1016/j.jbi.2017.01.008; Ma W, 2017, BRIEF BIOINFORM, V18, P85, DOI 10.1093/bib/bbw005; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MOORE WEC, 1995, APPL ENVIRON MICROB, V61, P3202, DOI 10.1128/AEM.61.9.3202-3207.1995; Nayfach S, 2015, BIOINFORMATICS, V31, P3368, DOI 10.1093/bioinformatics/btv382; Park HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109479; Preston JA, 2007, VACCINE, V25, P8154, DOI 10.1016/j.vaccine.2007.09.034; Qiu RH, 2016, CHEST, V149, p14A, DOI 10.1016/j.chest.2016.02.016; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Shen X, 2016, IEEE INT C BIOINF BI; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sonnenberg A, 2012, ALIMENT PHARM THER, V35, P469, DOI 10.1111/j.1365-2036.2011.04969.x; Sun DD, 2016, MOL BIOSYST, V12, P2224, DOI 10.1039/c6mb00049e; Szafranski SP, 2015, APPL ENVIRON MICROB, V81, P1047, DOI 10.1128/AEM.03534-14; Thomas M, 2015, M S-MED SCI, V31, P715, DOI 10.1051/medsci/20153108004; Vael C, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-68; Vael Carl, 2008, BMC Pulm Med, V8, P19, DOI 10.1186/1471-2466-8-19; van Laarhoven T, 2011, BIOINFORMATICS, V27, P3036, DOI 10.1093/bioinformatics/btr500; van Nimwegen FA, 2011, J ALLERGY CLIN IMMUN, V128, P948, DOI 10.1016/j.jaci.2011.07.027; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039; Wang W, 2014, J CLIN MICROBIOL, V52, P398, DOI 10.1128/JCM.01500-13; Xie M, 2012, PAC AS C ADV KNOWL D; Xie MQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125138; You ZH, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005455; Yu J, 2010, ALLERGY ASTHMA IMMUN, V2, P199, DOI 10.4168/aair.2010.2.3.199; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zeng XX, 2016, BBA-GEN SUBJECTS, V1860, P2735, DOI 10.1016/j.bbagen.2016.03.016; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106; Zou Q, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0353-5; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024; Zou Q, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/416323	66	32	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184394	10.1371/journal.pone.0184394	http://dx.doi.org/10.1371/journal.pone.0184394			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880967	gold, Green Published, Green Submitted			2022-12-27	WOS:000409467200064
J	Bartels, DJP; van Laarhoven, AIM; Stroo, M; Hijne, K; Peerdeman, KJ; Donders, ART; van de Kerkhof, PCM; Evers, AWM				Bartels, Danielle J. P.; van Laarhoven, Antoinette I. M.; Stroo, Michiel; Hijne, Kim; Peerdeman, Kaya J.; Donders, A. Rogier T.; van de Kerkhof, Peter C. M.; Evers, Andrea W. M.			Minimizing nocebo effects by conditioning with verbal suggestion: A randomized clinical trial in healthy humans	PLOS ONE			English	Article							HISTAMINE-INDUCED ITCH; ATOPIC-DERMATITIS; TRAIT ANXIETY; PLACEBO; MECHANISMS; EXPECTATIONS; RESPONSES; SCALE; PAIN; EXTINCTION	Nocebo effects, i.e., adverse treatment effects which are induced by patients' expectations, are known to contribute to the experience of physical symptoms such as pain and itch. A better understanding of how to minimize nocebo responses might eventually contribute to enhanced treatment effects. However, little is known about how to reduce nocebo effects. In the current randomized controlled study, we tested whether nocebo effects can be minimized by positive expectation induction with respect to electrical and histaminic itch stimuli. First, negative expectations about electrical itch stimuli were induced by verbal suggestion and conditioning (part 1: induction of nocebo effect). Second, participants were randomized to either the experimental group or one of the control groups (part 2: reversing nocebo effect). In the experimental group, positive expectations were induced by conditioning with verbal suggestion. In the control groups either the negative expectation induction was continued or an extinction procedure was applied. Afterwards, a histamine application test was conducted. Positive expectation induction resulted in a significantly smaller nocebo effect in comparison with both control groups. Mean change itch NRS scores showed that the nocebo effect was even reversed, indicating a placebo effect. Comparable effects were also found for histamine application. This study is the first to demonstrate that nocebo effects can be minimized and even reversed by conditioning with verbal suggestion. The results of the current study indicate that learning via counterconditioning and verbal suggestion represents a promising strategy for diminishing nocebo responses.	[Bartels, Danielle J. P.; van Laarhoven, Antoinette I. M.; Stroo, Michiel; Hijne, Kim; Peerdeman, Kaya J.; Evers, Andrea W. M.] Leiden Univ, Inst Psychol, Unit Hlth Med & Neuropsychol, Leiden, Netherlands; [Bartels, Danielle J. P.; van Laarhoven, Antoinette I. M.; Peerdeman, Kaya J.; Evers, Andrea W. M.] Leiden Univ, LIBC, Leiden, Netherlands; [Donders, A. Rogier T.] Radboud Univ Nijmegen, Dept Hlth Evidence, Med Ctr, Nijmegen, Netherlands; [van de Kerkhof, Peter C. M.] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, Nijmegen, Netherlands; [Evers, Andrea W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Med Psychol, Nijmegen, Netherlands; [Evers, Andrea W. M.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bartels, DJP (corresponding author), Leiden Univ, Inst Psychol, Unit Hlth Med & Neuropsychol, Leiden, Netherlands.; Bartels, DJP (corresponding author), Leiden Univ, LIBC, Leiden, Netherlands.	d.bartels@fsw.leidenuniv.nl	Donders, A.R.T./L-4277-2015; Evers, Andrea/GWV-9705-2022; Evers, A.W.M./L-4299-2015; Evers, Andrea/U-8983-2019; van de Kerkhof, P.C.M./H-8059-2014; Peerdeman, Kaya/AAF-9060-2020	Donders, A.R.T./0000-0002-0484-1419; Evers, Andrea/0000-0002-0090-5091; Peerdeman, Kaya/0000-0001-7622-1166; van Laarhoven, Antoinette/0000-0001-6932-9283	Netherlands Organization for Scientific Research [452-09-015]; ERC from European Research Council [617700]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); ERC from European Research Council	This research was supported by an Innovation Scheme (Vidi) Grant of the Netherlands Organization for Scientific Research (granted to AE, grant number 452-09-015) (http://www.nwo.ni/) and by an ERC Consolidator Grant from the European Research Council (granted to AE, grant number 617700) (https.//erc.europa.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen HH, 2015, ACTA DERM-VENEREOL, V95, P771, DOI 10.2340/00015555-2146; BAEYENS F, 1989, BEHAV RES THER, V27, P279, DOI 10.1016/0005-7967(89)90047-8; Bandura A, 1969, PRINCIPLES BEHAV MOD, VIX; Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622; Bartels DJP, 2017, CLIN THER, V39, P502, DOI [10.1010/j.clinthera.2017.02.004, 10.1016/j.clinthera.2017.02.004]; Bartels DJP, 2016, EUR J PAIN, V20, P8, DOI 10.1002/ejp.750; Bartels DJP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091727; Benedetti F., 2014, PLACEBO EFFECTS, V2nd; Benedetti F, 2008, ANNU REV PHARMACOL, V48, P33, DOI 10.1146/annurev.pharmtox.48.113006.094711; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Carlino E, 2015, EUR J PAIN, V19, P546, DOI 10.1002/ejp.579; Colagiuri B, 2015, J PAIN; Colloca L, 2008, PAIN, V136, P211, DOI 10.1016/j.pain.2008.02.006; Colloca L, 2011, PSYCHOSOM MED, V73, P598, DOI 10.1097/PSY.0b013e3182294a50; Colloca L, 2011, PHILOS T R SOC B, V366, P1922, DOI 10.1098/rstb.2010.0399; Colloca L, 2010, PAIN, V151, P430, DOI 10.1016/j.pain.2010.08.007; Crichton F, 2015, J PSYCHOSOM RES, V79, P185, DOI 10.1016/j.jpsychores.2015.04.014; Darragh M, 2015, J PSYCHOSOM RES, V78, P489, DOI 10.1016/j.jpsychores.2015.01.011; De Houwer J, 2007, SPAN J PSYCHOL, V10, P230, DOI 10.1017/S1138741600006491; Evers AWM, 2008, BRIT J DERMATOL, V158, P101, DOI 10.1111/j.1365-2133.2007.08296.x; Evers AWM, 2017, EXP DERMATOL, V26, P18, DOI 10.1111/exd.13158; Evers AWM, 2014, PSYCHOTHER PSYCHOSOM, V83, P148, DOI 10.1159/000358309; Eysenck HJ, 1975, EPQ EYSENCK PERSONAL; Faasse K, 2013, POSTGRAD MED J, V89, P540, DOI 10.1136/postgradmedj-2012-131730; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gast A, 2013, LEARN MOTIV, V44, P312, DOI 10.1016/j.lmot.2013.03.003; Goebel MU, 2008, PSYCHOTHER PSYCHOSOM, V77, P227, DOI 10.1159/000126074; Hanssen MM, 2013, PAIN, V154, P53, DOI 10.1016/j.pain.2012.08.006; Hartrick Craig T, 2003, Pain Pract, V3, P310; Hofmann M, 2014, Z PSYCHOL, V222, P171, DOI 10.1027/2151-2604/a000180; Holle H, 2012, P NATL ACAD SCI USA, V109, P19816, DOI 10.1073/pnas.1216160109; Ishiuji Y, 2009, BRIT J DERMATOL, V161, P1072, DOI 10.1111/j.1365-2133.2009.09308.x; Kanfer FH, 1970, LEARNING FDN BEHAV T, Vxi; KERCHER K, 1992, RES AGING, V14, P131, DOI 10.1177/0164027592142001; Kerkhof I, 2015, COUNTERCONDITIONING; Kerkhof I, 2011, EXP PSYCHOL, V58, P31, DOI 10.1027/1618-3169/a000063; Kessner S, 2013, JAMA INTERN MED, V173, P1468, DOI 10.1001/jamainternmed.2013.6705; Leganger A, 2000, PSYCHOL HEALTH, V15, P51, DOI 10.1080/08870440008400288; Ley HL, 2013, CLIN DERMATOL, V31, P31, DOI 10.1016/j.clindermatol.2011.11.004; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Meulders A, 2015, J PAIN, V16, P1353, DOI 10.1016/j.jpain.2015.09.007; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Misery L, 2017, EXP DERMATOL, V26, P24, DOI 10.1111/exd.13232; Napadow V, 2015, ALLERGY, V70, P1485, DOI 10.1111/all.12727; Papoiu A D P, 2011, Br J Dermatol, V164, P1299, DOI 10.1111/j.1365-2133.2011.10318.x; Papoiu ADP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017786; Quinn VF, 2016, PSYCHOSOM MED, V78, P365, DOI 10.1097/PSY.0000000000000265; Raes AK, 2012, BEHAV THER, V43, P757, DOI 10.1016/j.beth.2012.03.012; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schneider G, 2008, EUR J PAIN, V12, P834, DOI 10.1016/j.ejpain.2007.12.003; Scholz O, 1994, Z KLIN PSYCHOL-FORSC, V23, P127; Schut C, 2014, ACTA DERM-VENEREOL, V94, P20, DOI 10.2340/00015555-1634; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Tekampe J., PSYCHOTHER IN PRESS; Van Gucht D, 2010, EMOTION, V10, P688, DOI 10.1037/a0019463; van Laarhoven AIM, 2015, J INVEST DERMATOL, V135, P1234, DOI 10.1038/jid.2014.522; van Laarhoven AIM, 2011, PAIN, V152, P1486, DOI 10.1016/j.pain.2011.01.043; Verhoeven EWM, 2008, ACTA DERM-VENEREOL, V88, P211, DOI 10.2340/00015555-0452; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	35	35	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0182959	10.1371/journal.pone.0182959	http://dx.doi.org/10.1371/journal.pone.0182959			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FH0VR	28910291	Green Published, gold			2022-12-27	WOS:000410859200005
J	Horsch, S; Kopczynski, D; Kuthe, E; Baumbach, JI; Rahmann, S; Rahnenfuhrer, J				Horsch, Salome; Kopczynski, Dominik; Kuthe, Elias; Baumbach, Joerg Ingo; Rahmann, Sven; Rahnenfuehrer, Joerg			A detailed comparison of analysis processes for MCC-IMS data in disease classification-Automated methods can replace manual peak annotations	PLOS ONE			English	Article							ION MOBILITY SPECTROMETRY; ALGORITHM	Motivation: Disease classification from molecular measurements typically requires an analysis pipeline from raw noisy measurements to final classification results. Multi capillary column-ion mobility spectrometry (MCC-IMS) is a promising technology for the detection of volatile organic compounds in the air of exhaled breath. From raw measurements, the peak regions representing the compounds have to be identified, quantified, and clustered across different experiments. Currently, several steps of this analysis process require manual intervention of human experts. Our goal is to identify a fully automatic pipeline that yields competitive disease classification results compared to an established but subjective and tedious semi-manual process. Method: We combine a large number of modern methods for peak detection, peak clustering, and multivariate classification into analysis pipelines for raw MCC-IMS data. We evaluate all combinations on three different real datasets in an unbiased cross-validation setting. We determine which specific algorithmic combinations lead to high AUC values in disease classifications across the different medical application scenarios. Results: The best fully automated analysis process achieves even better classification results than the established manual process. The best algorithms for the three analysis steps are (i) SGLTR (Savitzky-Golay Laplace-operator filter thresholding regions) and LM (Local Maxima) for automated peak identification, (ii) EM clustering (Expectation Maximization) and DBSCAN (Density-Based Spatial Clustering of Applications with Noise) for the clustering step and (iii) RF (Random Forest) for multivariate classification. Thus, automated methods can replace the manual steps in the analysis process to enable an unbiased high throughput use of the technology.	[Horsch, Salome; Rahnenfuehrer, Joerg] TU Dortmund Univ, Dept Stat, Dortmund, Germany; [Kopczynski, Dominik; Rahmann, Sven] TU Dortmund Univ, Bioinformat, Comp Sci 11, Dortmund, Germany; [Kuthe, Elias; Rahmann, Sven] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Genome Informat, Essen, Germany; [Baumbach, Joerg Ingo] Reutlingen Univ, Fac Appl Chem, Reutlingen, Germany; [Kopczynski, Dominik] Leibniz Inst Analyt Wissensch ISAS eV, Dortmund, Germany	Dortmund University of Technology; Dortmund University of Technology; University of Duisburg Essen; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS)	Rahnenfuhrer, J (corresponding author), TU Dortmund Univ, Dept Stat, Dortmund, Germany.	rahnenfuehrer@statistik.tu-dortmund.de		Kopczynski, Dominik/0000-0001-5885-4568; Rahnenfuhrer, Jorg/0000-0002-8947-440X	Deutsche Forschungsgemeinschaft (DFG, Germany) within the Collaborative Research Center (Sonderforschungsbereich) [SFB 876]; Mercator Research Center Ruhr, project MERCUR [Pe-2013-0012]	Deutsche Forschungsgemeinschaft (DFG, Germany) within the Collaborative Research Center (Sonderforschungsbereich)(German Research Foundation (DFG)); Mercator Research Center Ruhr, project MERCUR	This study was supported by Deutsche Forschungsgemeinschaft (DFG, Germany) within the Collaborative Research Center (Sonderforschungsbereich) SFB 876 "Providing Information by Resource-Constrained Analysis", projects TB1 and C1. Sven Rahmann acknowledges support from Mercator Research Center Ruhr, project MERCUR Pe-2013-0012 (UA Ruhr Professorship "Computational Biology"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader S, 2005, INT J ION MOBIL SPEC, V8, P1; Bader S, 2008, INT J ION MOBIL SPEC, V11, P43, DOI 10.1007/s12127-008-0005-6; Bocker S, 2011, ALGORITHMICA, V60, P316, DOI 10.1007/s00453-009-9339-7; Bodeker B, 2008, INT J ION MOBIL SPEC, V11, P83, DOI 10.1007/s12127-008-0012-7; Bodeker B, 2008, INT J ION MOBIL SPEC, V11, P77, DOI 10.1007/s12127-008-0011-8; Cao WQ, 2006, CLIN CHEM, V52, P800, DOI 10.1373/clinchem.2005.063545; D'Addario M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-25; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Egorov A, 2014, RESSOURCENBESCHRANKR; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fink T, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/2/027104; Hastie T., 2009, UNSUPERVISED LEARNIN; Hauschild AC, 2013, METABOLITES, V3, P277, DOI 10.3390/metabo3020277; Horsch S, 2015, PEERJ PREPRINTS, V3, pe1591; Kopczynski D, 2015, ALGORITHM MOL BIOL, V10, DOI 10.1186/s13015-015-0045-5; Kopczynski D, 2012, EUR SIGNAL PR CONF, P1801; Rabis T, 2011, INT J ION MOBIL SPEC, V14, P187, DOI 10.1007/s12127-011-0077-6; Rahmann Sven, 2007, Comput Syst Bioinformatics Conf, V6, P391, DOI 10.1142/9781860948732_0040; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Westhoff M, 2010, INT J ION MOBIL SPEC, V13, P131, DOI 10.1007/s12127-010-0049-2	20	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184321	10.1371/journal.pone.0184321	http://dx.doi.org/10.1371/journal.pone.0184321			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910313	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200040
J	Liu, D; Lyu, J; Zhao, HY; An, YZ				Liu, Dan; Lyu, Jie; Zhao, Huiying; An, Youzhong			The influence of analgesic-based sedation protocols on delirium and outcomes in critically ill patients: A randomized controlled trial	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; MECHANICAL VENTILATION; RISK-FACTORS; POSTOPERATIVE DELIRIUM; REMIFENTANIL; DURATION; PREVALENCE	Objective To investigate the influence of analgesic-based midazolam sedation on delirium and outcomes in critically ill patients and to analyze the risk factors of delirium. Design Single center, prospective randomized controlled trial. Setting A surgical intensive care unit (ICU) in a tertiary care hospital in China. Patients Mechanically ventilated patients requiring sedation. Measurements and main results Patients admitted to the surgical intensive care unit who required sedation and were undergoing mechanical ventilation for longer than 24 hours were randomly divided into three groups: 1) the remifentanil group received remifentanil and midazolam, 2) the fentanyl group received fentanyl and midazolam, and 3) the control group received only midazolam. The analgesic effect, sedation depth, and presence of delirium were evaluated. To compare the effect of different therapies on the occurrence of delirium, days of mechanical ventilation, length of the ICU stay, and 28-day mortality were measured along with the risk factors for delirium. A total of 105 patients were enrolled, and 35 patients were included in each group. Compared to the control group, patients who received remifentanil and fentanyl required less midazolam each day (P = 0.038 and <0.001, respectively). Remifentanil has a significant effect on reducing the occurrence of delirium (P = 0.007). The logistic regression analysis of delirium demonstrated that remifentanil (OR 0.230, 95%Cl 0.0740.711, P = 0.011) is independent protective factors for delirium, and high APACHE II score (OR 1.103, 95%Cl 1.0071.208, P = 0.036) is the independent risk factor for delirium. Conclusion Remifentanil and fentanyl can reduce the amount of midazolam required, and remifentanil could further reduce the occurrence of delirium.	[Liu, Dan; Lyu, Jie; Zhao, Huiying; An, Youzhong] Peking Univ, Peoples Hosp, Dept Crit Care, Beijing, Peoples R China	Peking University	An, YZ (corresponding author), Peking Univ, Peoples Hosp, Dept Crit Care, Beijing, Peoples R China.	bjicu@163.com			Chinese Medical Association of Clinical Medicine Research Fund [2014-Z-15]	Chinese Medical Association of Clinical Medicine Research Fund	This study was supported by a grant from the Chinese Medical Association of Clinical Medicine Research Fund (No.2014-Z-15).	Agarwal V, 2010, J BURN CARE RES, V31, P706, DOI 10.1097/BCR.0b013e3181eebee9; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Breen D, 2005, CRIT CARE, V9, pR200, DOI 10.1186/cc3495; Dahaba AA, 2004, ANESTHESIOLOGY, V101, P640, DOI 10.1097/00000542-200409000-00012; Flaherty JH, 2007, J AM MED DIR ASSOC, V8, P273, DOI 10.1016/j.jamda.2007.03.006; Kapfhammer HP, 2004, AM J PSYCHIAT, V161, P45, DOI 10.1176/appi.ajp.161.1.45; Karabinis A, 2004, CRIT CARE, V8, pR268, DOI 10.1186/cc2896; Kollef MH, 1998, CHEST, V114, P541, DOI 10.1378/chest.114.2.541; Morandi A, 2011, NEUROL CLIN, V29, P749, DOI 10.1016/j.ncl.2011.08.004; Morrison RS, 2003, J GERONTOL A-BIOL, V58, P76; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Pandharipande PP, 2010, CRIT CARE, V14, DOI 10.1186/cc8916; Pisani MA, 2009, AM J RESP CRIT CARE, V180, P1092, DOI 10.1164/rccm.200904-0537OC; Radtke FM, 2010, J INT MED RES, V38, P1225, DOI 10.1177/147323001003800403; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rotondi AJ, 2002, CRIT CARE MED, V30, P746, DOI 10.1097/00003246-200204000-00004; Rozendaal F, 2009, INTENS CARE MED, V35, P291, DOI 10.1007/s00134-008-1328-9; Serafim RB, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-51; Shehabi Y, 2010, CRIT CARE MED, V38, P2311, DOI 10.1097/CCM.0b013e3181f85759; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; Veiga D, 2012, REV BRAS ANESTESIOL, V62, P469, DOI 10.1016/S0034-7094(12)70146-0; Wu Jie, 2013, J MED THEOR PRAC, V26, P2948	23	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2017	12	9							e0184310	10.1371/journal.pone.0184310	http://dx.doi.org/10.1371/journal.pone.0184310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FH0VR	28910303	Green Published, Green Submitted, gold			2022-12-27	WOS:000410859200039
J	Chen, JF; Li, RH; Xia, YS; Bai, GH; Guo, PG; Wang, ZL; Zhang, H; Siddique, KHM				Chen, Jingfang; Li, Ronghua; Xia, Yanshi; Bai, Guihua; Guo, Peiguo; Wang, Zhiliang; Zhang, Hua; Siddique, Kadambot H. M.			Development of EST-SSR markers in flowering Chinese cabbage (Brassica campestris L. ssp chinensis var. utilis Tsen et Lee) based on de novo transcriptomic assemblies	PLOS ONE			English	Article							MICROSATELLITES; GENES; TOOL	Flowering Chinese cabbage is one of the most important vegetable crops in southern China. Genetic improvement of various agronomic traits in this crop is underway to meet high market demand in the region, but the progress is hampered by limited number of molecular markers available in this crop. This study aimed to develop EST-SSR markers from transcriptome sequences generated by next-generation sequencing. RNA-seq of eight cabbage samples identified 48,975 unigenes. Of these unigenes, 23,267 were annotated in 56 gene ontology ( GO) categories, 6,033 were mapped to 131 KEGG pathways, and 7,825 were assigned to clusters of orthologous groups (COGs). From the unigenes, 8,165 EST-SSR loci were identified and 98.57% of them were 1-3 nucleotide repeats with 14.32%, 41.08% and 43.17% of mono-, di- and tri-nucleotide repeats, respectively. Fifty-eight types of motifs were identified with A/T, AG/CT, AT/AT, AC/GT, AAG/CTT and AGG/CCT the most abundant. The lengths of repeated nucleotide sequences in all SSR loci ranged from 12 to 60 bp, with most (88.51%) under 20 bp. Among 170 primer pairs were randomly selected from a total of 4,912 SSR primers we designed, 48 yielded unambiguously polymorphic bands with high reproducibility. Cluster analysis using 48 SSRs classified 34 flowering Chinese cabbage cultivars into three groups. A large number of EST-SSR markers identified in this study will facilitate marker-assisted selection in the breeding programs of flowering Chinese cabbage.	[Chen, Jingfang; Li, Ronghua; Xia, Yanshi; Guo, Peiguo; Wang, Zhiliang] Guangzhou Univ, Coll Life Sci, Int Crop Res Ctr Stress Resistance, Guangzhou, Guangdong, Peoples R China; [Bai, Guihua] USDA ARS, Hard Winter Wheat Genet Res Unit, Manhattan, KS USA; [Zhang, Hua] Guangzhou Acad Agr Sci, Guangzhou, Guangdong, Peoples R China; [Siddique, Kadambot H. M.] Univ Western Australia, UWA Inst Agr, Perth, WA, Australia; [Siddique, Kadambot H. M.] Univ Western Australia, Sch Agr & Environm, Perth, WA, Australia	Guangzhou University; United States Department of Agriculture (USDA); University of Western Australia; University of Western Australia	Guo, PG (corresponding author), Guangzhou Univ, Coll Life Sci, Int Crop Res Ctr Stress Resistance, Guangzhou, Guangdong, Peoples R China.	guopg@gzhu.edu.cn	bai, guihua/L-6374-2019; Siddique, Kadambot H.M./B-3462-2011; Li, Ronghua/AAP-8236-2021	bai, guihua/0000-0002-1194-319X; Siddique, Kadambot H.M./0000-0001-6097-4235; 	Guangdong Natural Science Foundation of China [2015A030313500]; Provincial Key International Cooperative Research Platform of Guangdong Higher Education [2015KGJHZ015]; Major Scientific Research Project of Guangdong Higher Education [2015KGJHZ015]; Science and Technology Plan of Guangdong of China [2016B020201001]	Guangdong Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province); Provincial Key International Cooperative Research Platform of Guangdong Higher Education; Major Scientific Research Project of Guangdong Higher Education; Science and Technology Plan of Guangdong of China	This work was supported by the Guangdong Natural Science Foundation of China (http://www.gdstc.gov.cn) through grant 2015A030313500 to PG, by the Provincial Key International Cooperative Research Platform and the Major Scientific Research Project of Guangdong Higher Education (http://www.gdhed.edu.cn) through grant 2015KGJHZ015 to PG, and by the Science and Technology Plan of Guangdong of China (http://www.gdstc.gov.cn) through grant 2016B020201001 to RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas MK, 2012, MOL BIOL REP, V39, P5373, DOI 10.1007/s11033-011-1338-5; Blavet N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-376; Chen HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151040; Chen HK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132519; Chen J, 2016, NO HORTICULTURE, V15, P86; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Ding Q, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/473028; Du F, 2015, PLANT MOL BIOL REP, V33, P281, DOI 10.1007/s11105-014-0746-9; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Galvao KSC, 2015, GENET MOL RES, V14, P7344, DOI 10.4238/2015.July.3.10; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; [郭培国 Guo Peiguo], 2015, [园艺学报, Acta Horticulturae Sinica], V42, P350; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Huang X, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00496; Krawczak M, 2006, COMMUNITY GENETICS, V9; Li HE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111054; Li Rui, 2009, ELECT APPL METALLURG, V28, P16; Liu WJ, 2017, ELECTROPHORESIS, V38, P1175, DOI 10.1002/elps.201700009; Liu Z, 2013, PLOS ONE, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0083549; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; MORGANTE M, 1993, PLANT J, V3, P175, DOI 10.1111/j.1365-313X.1993.tb00020.x; Nagy S, 2012, BIOCHEM GENET, V50, P670, DOI 10.1007/s10528-012-9509-1; Pejic I, 1998, THEOR APPL GENET, V97, P1248, DOI 10.1007/s001220051017; Qiao Y, 2012, MOL PLANT BREEDING, V10, P1369; Rohlf F, 2000, MULTIVARIATE ANAL SY; Russell J, 2014, MOL BREEDING, V33, P835, DOI 10.1007/s11032-013-9996-8; Singh H, 2010, MOL BREEDING, V25, P359, DOI 10.1007/s11032-009-9328-1; Song XM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1534-0; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Tsai CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141761; Tuler AC, 2015, MOL BIOL REP, V42, P1501, DOI 10.1007/s11033-015-3927-1; Varshney RK, 2006, THEOR APPL GENET, V113, P239, DOI 10.1007/s00122-006-0289-z; Wang SF, 2012, PLANT CELL REP, V31, P1437, DOI 10.1007/s00299-012-1259-3; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084105; Wei WL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-451; Yagi M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-734; Yates SA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-453; Zhai LL, 2014, MOL BREEDING, V33, P611, DOI 10.1007/s11032-013-9978-x; Zhang HY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-316; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhang XW, 2014, GENE, V551, P206, DOI 10.1016/j.gene.2014.08.058	45	20	28	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0184736	10.1371/journal.pone.0184736	http://dx.doi.org/10.1371/journal.pone.0184736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG8GZ	28902884	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200057
J	Coertjens, L; Donche, V; De Maeyer, S; Vanthournout, G; Van Petegem, P				Coertjens, Liesje; Donche, Vincent; De Maeyer, Sven; Vanthournout, Gert; Van Petegem, Peter			To what degree does the missing-data technique influence the estimated growth in learning strategies over time? A tutorial example of sensitivity analysis for longitudinal data	PLOS ONE			English	Article							PATTERN-MIXTURE MODELS; ATTRITION; IMPUTATION; TRAJECTORIES; PERFORMANCE; PSYCHOLOGY; VARIABLES; BIAS	Longitudinal data is almost always burdened with missing data. However, in educational and psychological research, there is a large discrepancy between methodological suggestions and research practice. The former suggests applying sensitivity analysis in order to the robustness of the results in terms of varying assumptions regarding the mechanism generating the missing data. However, in research practice, participants with missing data are usually discarded by relying on listwise deletion. To help bridge the gap between methodological recommendations and applied research in the educational and psychological domain, this study provides a tutorial example of sensitivity analysis for latent growth analysis. The example data concern students' changes in learning strategies during higher education. One cohort of students in a Belgian university college was asked to complete the Inventory of Learning Styles-Short Version, in three measurement waves. A substantial number of students did not participate on each occasion. Change over time in student learning strategies was assessed using eight missing data techniques, which assume different mechanisms for missingness. The results indicated that, for some learning strategy sub-scales, growth estimates differed between the models. Guidelines in terms of reporting the results from sensitivity analysis are synthesised and applied to the results from the tutorial example.	[Coertjens, Liesje] Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium; [Coertjens, Liesje; Donche, Vincent; De Maeyer, Sven; Van Petegem, Peter] Univ Antwerp, Fac Social Sci, Dept Educ Sci, Antwerp, Belgium; [Vanthournout, Gert] Artesis Plantin Univ Coll, Antwerp, Belgium	Universite Catholique Louvain; University of Antwerp	Coertjens, L (corresponding author), Catholic Univ Louvain, Psychol Sci Res Inst, Louvain La Neuve, Belgium.; Coertjens, L (corresponding author), Univ Antwerp, Fac Social Sci, Dept Educ Sci, Antwerp, Belgium.	Liesje.coertjens@uclouvain.be	De Maeyer, Sven/K-7446-2015; Van Petegem, Peter/R-5494-2016; Donche, Vincent/R-5757-2016	De Maeyer, Sven/0000-0003-2888-1631; Van Petegem, Peter/0000-0002-4078-7800; Donche, Vincent/0000-0002-9405-3896; Coertjens, Liesje/0000-0003-1209-5089	University of Antwerp	University of Antwerp	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The research reported in this article was supported by a grant from the "Special Research Fund: New Research Initiatives" from the Research Board of the University of Antwerp (www.uantwerp.be) offered to PVP and VD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P.D, 2009, SAGE HDB QUANTITATIV, P72, DOI DOI 10.4135/9780857020994.N4; Busato VV, 1998, BRIT J EDUC PSYCHOL, V68, P427, DOI 10.1111/j.2044-8279.1998.tb01302.x; Cheema J. R., 2014, REV ED RES; Coertjens L, 2017, HIGH EDUC, V73, P499, DOI 10.1007/s10734-016-0093-x; Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; Crameri A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01042; Dantan E, 2008, INT J BIOSTATISTICS; Demirtas H, 2003, STAT MED, V22, P2553, DOI 10.1002/sim.1475; Donche V., 2008, STYLE CULTURAL DIFFE, P49; Duncan T, 2006, INTRO LATENT VARIABL; Enders C. K., 2010, APPL MISSING DATA AN; Enders CK, 2001, STRUCT EQU MODELING, V8, P128, DOI 10.1207/S15328007SEM0801_7; Enders CK, 2011, PSYCHOL METHODS, V16, P1, DOI 10.1037/a0022640; Feldman BJ, 2012, J EDUC BEHAV STAT, V37, P703, DOI 10.3102/1076998612458701; Fitzmaurice G, 2009, CH CRC HANDB MOD STA, P1; Foster EM, 2004, EVALUATION REV, V28, P434, DOI 10.1177/0193841X04264662; Germeijs V, 2007, J VOCAT BEHAV, V70, P223, DOI 10.1016/j.jvb.2006.10.004; GLYNN R. J., 1986, DRAWING INFERENCES S, P115, DOI DOI 10.1007/978-1-4612-4976-4_10; Graham J. W., 1999, STAT STRATEGIES SMAL, V50, P1, DOI DOI 10.1177/0013164496056006006; Graham JM, 2003, STRUCT EQU MODELING, V10, P142, DOI 10.1207/S15328007SEM1001_7; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; GRAHAM JW, 1993, J APPL PSYCHOL, V78, P119, DOI 10.1037/0021-9010.78.1.119; Grittner U, 2011, INT J METH PSYCH RES, V20, P50, DOI 10.1002/mpr.330; Hardt J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-184; Hawkinson LE, 2013, EARLY CHILD RES Q, V28, P388, DOI 10.1016/j.ecresq.2012.10.002; Heckman JJ, 1976, ANN ECON SOC MEAS, P4; Hedeker D, 1997, PSYCHOL METHODS, V2, P64, DOI 10.1037/1082-989X.2.1.64; Hox JJ, 2000, MODELING LONGITUDINAL AND MULTILEVEL DATA, P15; Jackling B., 2005, ACCOUNT FINANC, V45, P597, DOI DOI 10.1111/J.1467-629X.2005.00142.X; Jelicic H, 2010, J YOUTH ADOLESCENCE, V39, P816, DOI 10.1007/s10964-010-9542-5; Jelicic H, 2009, DEV PSYCHOL, V45, P1195, DOI 10.1037/a0015665; Johnson DR, 2011, J MARRIAGE FAM, V73, P926, DOI 10.1111/j.1741-3737.2011.00861.x; Little R.J.A., 2002, STAT ANAL MISSING DA; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; LITTLE RJA, 1993, J AM STAT ASSOC, V88, P125, DOI 10.1080/01621459.1993.10594302; LITTLE RJA, 1995, J AM STAT ASSOC, V90, P1112, DOI 10.2307/2291350; Little R, 2009, CH CRC HANDB MOD STA, P409; Mazumdar S, 2007, J PSYCHIATR RES, V41, P1032, DOI 10.1016/j.jpsychires.2006.09.007; Molenberghs G, 2009, CH CRC HANDB MOD STA, P395; Molenberghs G, 2009, CH CRC HANDB MOD STA, P501; Moreno-Betancur M, 2013, STAT METHODS MED RES, P1; Muthen B, 2011, PSYCHOL METHODS, V16, P17, DOI 10.1037/a0022634; Muthen LK, 2010, MPLUS SHORT COURSES2; Nicholson JS, 2017, INT J BEHAV DEV, V41, P143, DOI 10.1177/0165025415618275; Peeters M, 2015, EUR J DEV PSYCHOL, V12, P377, DOI 10.1080/17405629.2015.1049526; Peugh JL, 2004, REV EDUC RES, V74, P525, DOI 10.3102/00346543074004525; Raudenbush SW, 2001, ANNU REV PSYCHOL, V52, P501, DOI 10.1146/annurev.psych.52.1.501; Richardson M, 2012, PSYCHOL BULL, V138, P353, DOI 10.1037/a0026838; Rombach I, 2016, QUAL LIFE RES, V25, P1613, DOI 10.1007/s11136-015-1206-1; Roy J, 2003, BIOMETRICS, V59, P829, DOI 10.1111/j.0006-341X.2003.00097.x; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Rubin R., 1987, MULTIPLE IMPUTATION; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Thijs H, 2002, BIOSTATISTICS, V3, P245, DOI 10.1093/biostatistics/3.2.245; Thoemmes F, 2014, MULTIVAR BEHAV RES, V49, P443, DOI 10.1080/00273171.2014.931799; Vanthournout G, 2012, EDUC RES INT, V2012, DOI 10.1155/2012/152747; Vermunt JD, 2005, HIGH EDUC, V49, P205, DOI 10.1007/s10734-004-6664-2; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Wothke W, 2000, MODELING LONGITUDINAL AND MULTILEVEL DATA, P219; Wu M.L, 2010, STRUCTURAL EQUATION; Xu S, 2011, J EDUC BEHAV STAT, V36, P237, DOI 10.3102/1076998610375836; Yang MS, 2015, BRIT J MATH STAT PSY, V68, P246, DOI 10.1111/bmsp.12043; Yang MS, 2014, PSYCHOL METHODS, V19, P188, DOI 10.1037/a0033804; Yang XW, 2008, STAT MED, V27, P2826, DOI 10.1002/sim.3111; Zeegers P, 2001, BRIT J EDUC PSYCHOL, V71, P115, DOI 10.1348/000709901158424	67	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2017	12	9							e0182615	10.1371/journal.pone.0182615	http://dx.doi.org/10.1371/journal.pone.0182615			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG8GZ	28902849	Green Published, Green Submitted, gold			2022-12-27	WOS:000410669200004
J	Chen, YK; Zhi, JK; Zhang, H; Li, J; Zhao, QH; Xu, JC				Chen, Yongkun; Zhi, Junkai; Zhang, Hao; Li, Jian; Zhao, Qihong; Xu, Jichen			Transcriptome analysis of Phytolacca americana L. in response to cadmium stress	PLOS ONE			English	Article							ARABIDOPSIS-HALLERI; HYPERACCUMULATING PLANTS; SALT STRESS; METAL; GENE; ROOT; CD; PHYTOREMEDIATION; ACCUMULATION; METALLOTHIONEINS	Phytolacca americana L. (pokeweed) has metal phytoremediation potential, but little is known about its metal accumulation-related genes. In this study, the de novo sequencing of total RNA produced 53.15 million reads covering 10.63 gigabases of transcriptome raw data in cadmium (Cd)-treated and untreated pokeweed. Of the 97,502 assembled unigenes, 42,197 had significant matches in a public database and were annotated accordingly. An expression level comparison between the samples revealed 1515 differentially expressed genes (DEGs), 923 down-and 592 up-regulated under Cd treatment. A KEGG pathway enrichment analysis of DEGs revealed that they were involved in 72 metabolism pathways, with photosynthesis, phenylalanine metabolism, ribosome, phenylpropanoid biosynthesis, flavonoid biosynthesis and carbon fixation in photosynthetic organisms containing 24, 18, 72, 14, 7 and 15 genes, respectively. Genes related to heavy metal tolerance, absorption, transport and accumulation were also identified, including 11 expansins, 8 nicotianamine synthases, 6 aquaporins, 4 ZRT/IRT-like proteins, 3 ABC transporters and 3 metallothioneins. The gene expression results of 12 randomly selected DEGs were validated using quantitative real-time PCR, and showed different response patterns to Cd in their roots, stems and leaves. These results may be helpful in increasing our understanding of heavy metal hyperaccumulators and in future phytoremediation applications.	[Chen, Yongkun; Zhi, Junkai; Zhang, Hao; Li, Jian; Zhao, Qihong; Xu, Jichen] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China	Beijing Forestry University	Xu, JC (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	jcxu282@sina.com			Fundamental Research Funds for the Central Universities grants [2015ZCQ-SW-01]; Beijing Natural Science Foundation [5122019]	Fundamental Research Funds for the Central Universities grants; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the Fundamental Research Funds for the Central Universities grants (2015ZCQ-SW-01) and Beijing Natural Science Foundation (5122019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon R, 2003, PLANT CELL, V15, P439, DOI 10.1105/tpc.009225; Ali H, 2013, CHEMOSPHERE, V91, P869, DOI 10.1016/j.chemosphere.2013.01.075; Alvarez S, 2009, PROTEOMICS, V9, P3220, DOI [10.1002/pmic.200800478, 10.1002/pmic.200990042]; Callahan DL, 2006, J BIOL INORG CHEM, V11, P2, DOI 10.1007/s00775-005-0056-7; Chaturvedi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111379; Chen YK, 2015, PLANT CELL TISS ORG, V121, P389, DOI 10.1007/s11240-015-0710-x; Colangelo EP, 2006, CURR OPIN PLANT BIOL, V9, P322, DOI 10.1016/j.pbi.2006.03.015; Delalande O, 2010, FEBS J, V277, P5086, DOI 10.1111/j.1742-4658.2010.07913.x; Eapen S, 2005, BIOTECHNOL ADV, V23, P97, DOI 10.1016/j.biotechadv.2004.10.001; Fu XP, 2011, J HAZARD MATER, V186, P103, DOI 10.1016/j.jhazmat.2010.10.122; Gao J, 2015, BIOCHEM BIOPH RES CO, V459, P60, DOI 10.1016/j.bbrc.2015.02.066; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064643; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; He JL, 2013, PLANT PHYSIOL, V162, P424, DOI 10.1104/pp.113.215681; Kelly G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087888; Kramer U, 2005, CURR OPIN BIOTECH, V16, P133, DOI 10.1016/j.copbio.2005.02.006; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee J, 2004, PLANT MOL BIOL, V54, P805, DOI 10.1007/s11103-004-0190-6; Lin YF, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00261; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; Liu J, 2015, J HAZARD MATER, V294, P99, DOI 10.1016/j.jhazmat.2015.03.060; Liu XQ, 2010, CHEMOSPHERE, V78, P1136, DOI 10.1016/j.chemosphere.2009.12.030; Lochlainn SO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017814; Maurel C, 1997, ANNU REV PLANT PHYS, V48, P399, DOI 10.1146/annurev.arplant.48.1.399; McGrath SP, 2006, ENVIRON POLLUT, V141, P115, DOI 10.1016/j.envpol.2005.08.022; Milner MJ, 2014, PLANT J, V78, P398, DOI 10.1111/tpj.12480; Peng KJ, 2008, J HAZARD MATER, V154, P674, DOI 10.1016/j.jhazmat.2007.10.080; Rascio N, 2011, PLANT SCI, V180, P169, DOI 10.1016/j.plantsci.2010.08.016; Sade N, 2010, PLANT PHYSIOL, V152, P245, DOI 10.1104/pp.109.145854; SALT DE, 1995, PLANT PHYSIOL, V109, P1427, DOI 10.1104/pp.109.4.1427; Talke IN, 2006, PLANT PHYSIOL, V142, P148, DOI 10.1104/pp.105.076232; Venkatachalam P, 2009, ENVIRON SCI TECHNOL, V43, P843, DOI 10.1021/es801304n; Weber M, 2006, PLANT CELL ENVIRON, V29, P950, DOI 10.1111/j.1365-3040.2005.01479.x; Xie Y, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.7015.00202, 10.3389/fpls.2015.00202]; Xu J, 2012, NEW PHYTOL, V196, P110, DOI 10.1111/j.1469-8137.2012.04235.x; Xu L, 2015, PLANT SCI, V236, P313, DOI 10.1016/j.plantsci.2015.04.015; Xu X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093275; [严海燕 Yan Haiyan], 2011, [华北农学报, Acta Agriculturae Boreali-Sinica], V26, P16; Zhao L, 2011, CHEMOSPHERE, V85, P56, DOI 10.1016/j.chemosphere.2011.06.029; Zhou ZS, 2013, J HAZARD MATER, V252, P123, DOI 10.1016/j.jhazmat.2013.02.011; Zimeri AM, 2005, PLANT MOL BIOL, V58, P839, DOI 10.1007/s11103-005-8268-3	42	24	25	9	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184681	10.1371/journal.pone.0184681	http://dx.doi.org/10.1371/journal.pone.0184681			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898278	Green Published, Green Submitted, gold			2022-12-27	WOS:000410449500043
J	Chen, YY; Sheu, SJ; Hu, HY; Chu, DC; Chou, P				Chen, Yu-Yen; Sheu, Shwu-Jiuan; Hu, Hsiao-Yun; Chu, Dachen; Chou, Pesus			Association between retinal vein occlusion and an increased risk of acute myocardial infarction: A nationwide population-based follow-up study	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; MORTALITY; HOMOCYSTEINE; PREVALENCE; BRANCH; VALIDATION; MORBIDITY; STROKE	Objective To investigate a possible association between retinal vein occlusion (RVO) and an increased risk of developing acute myocardial infarction (AMI). Design A population-based retrospective cohort study using the entire population of the Taiwan National Health Insurance Research Database (NHIRD) from 1 st January, 2001 to 31 st December, 2013. Methods A total of 37921 subjects with RVO were enrolled in the RVO group, and 113763 subjects without RVO were enrolled in the comparison group. The comparison group consisted of randomly selected individuals who were propensity score (PS)-matched with the RVO group at a ratio of 1: 3, based on age, gender, obesity, stroke, hyperviscosity syndrome, glaucoma, and the use of antithrombotic drugs. A log-rank test was used to compare the cumulative hazard of AMI between the two groups. A multivariate Cox regression analysis was used to estimate the adjusted hazard ratios (HRs) of AMI, adjusted for PS, diabetes, hypertension, hyperlipidemia, congestive heart failure, and chronic renal failure. Results The mean age of the cohort was 62.4 +/- 13.2 years. RVO patients had significantly higher proportions of diabetes, hypertension, hyperlipidemia, congestive heart failure, and chronic renal failure than the comparisons. The mean follow-up period was 5.52 years in the RVO group and 5.55 years in the comparison group (p = 0.16). A log-rank test comparing the cumulative hazard curves of AMI for the two groups revealed a significant difference (p< 0.0001). In the multivariate Cox regression after adjustment for PS and confounders, the RVO group had a significantly higher risk of AMI (adjusted HR = 1.21; 95% CI: 1.13 to 1.30). When the RVO group was divided into central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO) and analyzed separately, both groups had significantly higher adjusted HRs for developing AMI than the comparison group. Moreover, the CRVO group had a significantly higher risk of AMI than the BRVO group. Conclusions People with RVO are at significantly greater risk of developing AMI than individuals without RVO.	[Chen, Yu-Yen; Sheu, Shwu-Jiuan] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Yu-Yen] Natl Yang Ming Univ Hosp, Dept Ophthalmol, Yilan, Yilan County, Taiwan; [Chen, Yu-Yen; Hu, Hsiao-Yun; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan; [Chen, Yu-Yen; Hu, Hsiao-Yun; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Sheu, Shwu-Jiuan; Chu, Dachen] Kaohsiung Vet Gen Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Hu, Hsiao-Yun; Chu, Dachen] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Chu, Dachen] Taipei City Hosp, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; Taipei City Hospital; Taipei City Hospital	Chou, P (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan.; Chou, P (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.	pschou@ym-edu.tw						APPIAH AP, 1989, ANN OPHTHALMOL, V21, P153; Bertelsen M, 2014, OPHTHALMOLOGY, V121, P637, DOI 10.1016/j.ophtha.2013.07.025; Bertelsen M, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7885; Bonow R., 2012, BRAUNWALDS HEART DIS, DOI DOI 10.1093/eurheartj/ehw249; Cheng CL, 2015, INT J CARDIOL, V201, P96, DOI 10.1016/j.ijcard.2015.07.075; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheung N, 2008, INVEST OPHTH VIS SCI, V49, P4297, DOI 10.1167/iovs.08-1826; Di Capua M, 2012, NUTR METAB CARDIOVAS, V22, P23, DOI 10.1016/j.numecd.2010.03.008; Di Capua M, 2010, J THROMB THROMBOLYS, V30, P16, DOI 10.1007/s11239-009-0388-1; Hu CC, 2009, BRIT J OPHTHALMOL, V93, P717, DOI 10.1136/bjo.2008.151605; Jones M, 2016, J CRIT CARE, V36, P195, DOI 10.1016/j.jcrc.2016.07.017; Kesler A, 2008, BLOOD COAGUL FIBRIN, V19, P259, DOI 10.1097/MBC.0b013e3282f2b60e; Klein R, 2000, Trans Am Ophthalmol Soc, V98, P133; Kolar P, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/724780; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Lim LL, 2008, BRIT J OPHTHALMOL, V92, P1316, DOI 10.1136/bjo.2008.140640; MANSOUR AM, 1992, OPHTHALMOLOGICA, V204, P199, DOI 10.1159/000310294; McGimpsey SJ, 2009, OPHTHALMOLOGY, V116, P1778, DOI 10.1016/j.ophtha.2009.02.033; Newman-Casey PA, 2014, OPHTHALMOLOGY, V121, P1939, DOI 10.1016/j.ophtha.2014.04.045; Parsons LS, PERFROMING 1 N CASE; Ponto KA, 2015, J THROMB HAEMOST, V13, P1254, DOI 10.1111/jth.12982; Rim TH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22351; Shih CH, 2015, INT J CARDIOL, V178, P256, DOI 10.1016/j.ijcard.2014.10.110; Sodi A, 2011, RETINA-J RET VIT DIS, V31, P724, DOI 10.1097/IAE.0b013e3181eef419; Sofi F, 2008, ATHEROSCLEROSIS, V198, P223, DOI 10.1016/j.atherosclerosis.2007.09.009; The Taiwan National Health Research Institutes, NAT HLTH INS RES DAT; Tsaloumas MD, 2000, EYE, V14, P821, DOI 10.1038/eye.2000.230; Werther W, 2011, ARCH OPHTHALMOL-CHIC, V129, P326, DOI 10.1001/archophthalmol.2011.2; Yasuda M, 2010, INVEST OPHTH VIS SCI, V51, P3205, DOI 10.1167/iovs.09-4453; Zhou JQ, 2013, OPHTHALMOLOGY, V120, P803, DOI 10.1016/j.ophtha.2012.09.033	31	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184016	10.1371/journal.pone.0184016	http://dx.doi.org/10.1371/journal.pone.0184016			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898259	Green Published, gold, Green Submitted			2022-12-27	WOS:000410449500011
J	Kumar, B; Miller, K; Charon, NW; Legleiter, J				Kumar, Bharath; Miller, Kelly; Charon, Nyles W.; Legleiter, Justin			Periplasmic flagella in Borrelia burgdoferi function to maintain cellular integrity upon external stress	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; BURGDORFERI; MOTILITY; PROTEIN; CHEMOTAXIS; DYNAMICS; SHAPE; COMPLEMENTATION; INACTIVATION; CYTOSKELETON	Tapping mode atomic force microscopy (AFM) in solution was used to analyze the role of the internally located periplasmic flagella (PFs) of the Lyme disease spirochete Borrelia burgdorferi in withstanding externally applied cellular stresses. By systematically imaging immobilized spirochetes with increasing tapping forces, we found that mutants that lack PFs are more readily compressed and damaged by the imaging process compared to wild-type cells. This finding suggest that the PFs, aside from being essential for motility and involved in cell shape, play a cytoskeletal role in dissipating energy and maintaining cellular integrity in the presence of external stress.	[Kumar, Bharath; Legleiter, Justin] West Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA; [Miller, Kelly; Charon, Nyles W.] West Virginia Univ, Robert C Byrd Hlth Sci Ctr, Dept Microbiol Immunol & Cell Biol, Morgantown, WV USA; [Charon, Nyles W.; Legleiter, Justin] West Virginia Univ, WVU nanoSAFE, Morgantown, WV 26506 USA; [Legleiter, Justin] West Virginia Univ, Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26506 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University	Legleiter, J (corresponding author), West Virginia Univ, C Eugene Bennett Dept Chem, Morgantown, WV 26506 USA.; Legleiter, J (corresponding author), West Virginia Univ, WVU nanoSAFE, Morgantown, WV 26506 USA.; Legleiter, J (corresponding author), West Virginia Univ, Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26506 USA.	justin.legleiter@mail.wvu.edu		Legleiter, Justin/0000-0002-5262-1867	National Institutes of Health [R01-DE023431, R01-A10297]; WV Higher Education Policy Commission/Division of Science and Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023431] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WV Higher Education Policy Commission/Division of Science and Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by ther National Institutes of Health, Grant # R01-DE023431 and Grant # R01-A10297, (https://www.nih.gov/) and the WV Higher Education Policy Commission/Division of Science and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker RG, 2007, APPL ENVIRON MICROB, V73, P1180, DOI 10.1128/AEM.01913-06; Burke KA, 2013, BIOCHEMISTRY-US, V52, P808, DOI 10.1021/bi301070v; Caro-Quintero A, 2012, MBIO, V3, DOI 10.1128/mBio.00025-12; Chaibva M, 2015, SURFACE SCI TOOLS NA, P69; CHARON NW, 1992, J BACTERIOL, V174, P832, DOI 10.1128/jb.174.3.832-840.1992; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Charon NW, 2012, ANNU REV MICROBIOL, V66, P349, DOI 10.1146/annurev-micro-092611-150145; Charon NW, 2009, J BACTERIOL, V191, P600, DOI 10.1128/JB.01288-08; Collinsworth AM, 2002, AM J PHYSIOL-CELL PH, V283, pC1219, DOI 10.1152/ajpcell.00502.2001; Dombrowski C, 2009, BIOPHYS J, V96, P4409, DOI 10.1016/j.bpj.2009.02.066; Ebady R, 2016, CELL REP, V16, P2593, DOI 10.1016/j.celrep.2016.08.013; Gode-Potratz CJ, 2011, MOL MICROBIOL, V79, P240, DOI 10.1111/j.1365-2958.2010.07445.x; Goldstein SF, 1996, J BACTERIOL, V178, P6539, DOI 10.1128/jb.178.22.6539-6545.1996; GOLDSTEIN SF, 1994, P NATL ACAD SCI USA, V91, P3433, DOI 10.1073/pnas.91.8.3433; Guzman HV, 2013, ACS NANO, V7, P3198, DOI 10.1021/nn4012835; Harman M, 2013, BIOPHYS J, V105, P2273, DOI 10.1016/j.bpj.2013.10.004; Kan WX, 2007, BIOPHYS J, V93, P54, DOI 10.1529/biophysj.106.103143; Kumar B, 2010, J APPL PHYS, V107, DOI 10.1063/1.3309330; Legleiter J, 2006, P NATL ACAD SCI USA, V103, P4813, DOI 10.1073/pnas.0505628103; Li CH, 2000, J MOL MICROB BIOTECH, V2, P345; Li CH, 2010, MOL MICROBIOL, V75, P1563, DOI 10.1111/j.1365-2958.2010.07078.x; Limberger RJ, 2004, J MOL MICROB BIOTECH, V7, P30, DOI 10.1159/000077867; Lin T, 2015, MBIO, V6, DOI 10.1128/mBio.00579-15; Marx KA, 2007, ANAL BIOCHEM, V361, P77, DOI 10.1016/j.ab.2006.09.023; Miller KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098338; Miller MR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.134, 10.1038/nmicrobiol.2016.134]; Moon KH, 2016, MOL MICROBIOL, V102, P336, DOI 10.1111/mmi.13463; Motaleb MA, 2000, P NATL ACAD SCI USA, V97, P10899, DOI 10.1073/pnas.200221797; Motaleb MA, 2015, CURR OPIN MICROBIOL, V28, P106, DOI 10.1016/j.mib.2015.09.006; Paster BJ, 2011, BERGEYS MANUAL SYSTE, V3, P471; Picardeau M, 2001, MOL MICROBIOL, V40, P189, DOI 10.1046/j.1365-2958.2001.02374.x; Sal MS, 2008, J BACTERIOL, V190, P1912, DOI 10.1128/JB.01421-07; Sartakova ML, 2001, J BACTERIOL, V183, P6558, DOI 10.1128/JB.183.22.6558-6564.2001; Shaik NH, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4866664; Shamitko-Klingensmith N, 2015, SCANNING, V37, P23, DOI 10.1002/sca.21175; Shamitko-Klingensmith N, 2012, LANGMUIR, V28, P13411, DOI 10.1021/la302705f; Sultan SZ, 2015, INFECT IMMUN, V83, P1765, DOI 10.1128/IAI.03097-14; Sultan SZ, 2013, INFECT IMMUN, V81, P2012, DOI 10.1128/IAI.01228-12; Sze CW, 2012, INFECT IMMUN, V80, P2485, DOI 10.1128/IAI.00145-12; Sze CW, 2011, MOL MICROBIOL, V82, P851, DOI 10.1111/j.1365-2958.2011.07853.x; Vig DK, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.218104; Wolgemuth CW, 2006, J MOL MICROB BIOTECH, V11, P221, DOI 10.1159/000094056; Wolgemuth CW, 2015, SEMIN CELL DEV BIOL, V46, P104, DOI 10.1016/j.semcdb.2015.10.015; Wunder EA, 2016, MOL MICROBIOL, V101, P457, DOI 10.1111/mmi.13403; Xue RD, 2015, ADV SCI, V2, DOI 10.1002/advs.201500129; Yang J, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.268101; Zhang K, 2012, MOL MICROBIOL, V85, P782, DOI 10.1111/j.1365-2958.2012.08139.x; Zhao XW, 2013, P NATL ACAD SCI USA, V110, P14390, DOI 10.1073/pnas.1308306110	49	0	0	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184648	10.1371/journal.pone.0184648	http://dx.doi.org/10.1371/journal.pone.0184648			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898274	Green Published, gold, Green Submitted			2022-12-27	WOS:000410449500039
J	Leijs, MM; Koppe, JG; Vulsma, T; Olie, K; van Aalderen, WMC; de Voogt, P; Legler, J; ten Tusscher, GW				Leijs, Marike M.; Koppe, Janna G.; Vulsma, Thomas; Olie, Kees; van Aalderen, Wim M. C.; de Voogt, Pim; Legler, Juliette; ten Tusscher, Gavin W.			Alterations in the programming of energy metabolism in adolescents with background exposure to dioxins, dl-PCBs and PBDEs	PLOS ONE			English	Article							POLYBROMINATED DIPHENYL ETHERS; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; POLYCHLORINATED-BIPHENYLS; INSULIN-SECRETION; DIABETES-MELLITUS; AH RECEPTOR; HEALTH; ASSOCIATIONS; VETERANS; PATHWAY	Objectives Dioxins and PCBs are highly toxic and persistent environmental pollutants that are measurable in humans worldwide. These persistent organic pollutants are associated with a higher incidence of diabetes mellitus. We hypothesise that perinatal (background) exposure to industrial pollutants like dioxins also influences body mass development and energy metabolism in later life. Study design In The Netherlands, the perinatal exposure (prenatal exposure and postnatal lactational intake) to dioxins has been studied prospectively since 1987. Fasting glucose, insulin, HbA1c and leptin were analysed in 33 children of the original cohort of 60. BMI, glucose: insulin and BMI: leptin ratios were calculated. Prenatal exposure, lactational intake and current serum levels of dioxins (PCDD/F), dl-PCBs and PBDE concentrations were determined using (HR)GC-MS. Results Prenatal dioxin (PCDD/F) exposure was positively correlated to the glucose: insulin ratio (p = 0.024) and negatively correlated to the fasting insulin concentration (p = 0.017) in adolescence. Postnatal lactational PCDD/F intake was also negatively correlated to fasting insulin concentration (p = 0.028). Current serum levels of PCDD/Fs and total TEQ (dl-PCBs +PCDD/Fs) were positively correlated to the fasting serum glucose concentration (p = 0.015 and p = 0.037, respectively). No metabolic effects were seen in association with current serum levels of PBDEs. A positive correlation between the insulin and leptin concentrations (p = 0.034) was observed. No effects were found on leptin levels, BMI: leptin ratio, HbA1c levels or BMI. Discussion/Conclusion This study indicates that prenatal and lactational exposure influences glucose metabolism in adolescents, presumably through a negative effect on insulin secretion by pancreatic beta cells. Additionally, the very low recent background exposure to dioxins in puberty possibly has an effect on the glucose level.	[Leijs, Marike M.; Koppe, Janna G.; Vulsma, Thomas; van Aalderen, Wim M. C.] Acad Med Ctr, Emma Childrens Hosp, Dept Paediat & Neonatol, Amsterdam, Netherlands; [Leijs, Marike M.; Olie, Kees; de Voogt, Pim] Univ Amsterdam, IBED AEE, Amsterdam, Netherlands; [Koppe, Janna G.] Ecobaby Fdn, Loenersloot, Netherlands; [de Voogt, Pim] KWR Watercycle Res Inst, Nieuwegein, Netherlands; [Legler, Juliette] Vrije Univ Amsterdam, Inst Environm Studies IVM, Amsterdam, Netherlands; [ten Tusscher, Gavin W.] Westfriesgasthuis, Dept Paediat & Neonatol, Hoorn, Netherlands; [Leijs, Marike M.] RTWH Univ Aachen, Dept Dermatol & Allergol, Aachen, Germany; [Legler, Juliette] Brunel Univ, Coll Hlth & Life Sci, London, England	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; KWR Watercycle Research Institute; Vrije Universiteit Amsterdam; Brunel University	Leijs, MM (corresponding author), Acad Med Ctr, Emma Childrens Hosp, Dept Paediat & Neonatol, Amsterdam, Netherlands.; Leijs, MM (corresponding author), Univ Amsterdam, IBED AEE, Amsterdam, Netherlands.; ten Tusscher, GW (corresponding author), Westfriesgasthuis, Dept Paediat & Neonatol, Hoorn, Netherlands.; Leijs, MM (corresponding author), RTWH Univ Aachen, Dept Dermatol & Allergol, Aachen, Germany.	mleijs@ukaachen.de; g.tentusscher@westfriesgasthuis.nl	de Voogt, Pim/C-5683-2017; ten Tusscher, Gavin/ABG-5282-2021	de Voogt, Pim/0000-0001-9065-9797; ten Tusscher, Gavin/0000-0001-6448-5631; Leijs, Marike/0000-0002-2911-1025	Netherlands Ministry of Housing, Spatial Planning and the Environment; E.C. grant [227391]	Netherlands Ministry of Housing, Spatial Planning and the Environment; E.C. grant	The study was financially supported by the Netherlands Ministry of Housing, Spatial Planning and the Environment. The paper was supported by E.C. grant: OBELIX nr: 227391.	Bertazzi PA, 2001, AM J EPIDEMIOL, V153, P1031, DOI 10.1093/aje/153.11.1031; Bouret SG, 2004, ENDOCRINOLOGY, V145, P2621, DOI 10.1210/en.2004-0231; Darnerud PO, 2001, ENVIRON HEALTH PERSP, V109, P49, DOI 10.2307/3434846; de Voogt P., 1989, HALOGENATED BIPHENYL, V3 -45; Esser A, 2016, INT J HYG ENVIR HEAL, V219, P557, DOI 10.1016/j.ijheh.2016.06.001; Fierens S, 2003, BIOMARKERS, V8, P529, DOI 10.1080/1354750032000158420; Godfrey KM, 2011, DIABETES, V60, P1528, DOI 10.2337/db10-0979; Grandjean P, 2011, EPIDEMIOLOGY, V22, P410, DOI 10.1097/EDE.0b013e318212fab9; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Ilsen A, 1996, CHEMOSPHERE, V33, P1317, DOI 10.1016/0045-6535(96)00269-X; Jensen TK, 2014, J CLIN ENDOCR METAB, V99, pE2643, DOI 10.1210/jc.2014-1683; Jones OAH, 2008, LANCET, V371, P287, DOI 10.1016/S0140-6736(08)60147-6; Kim YH, 2009, INT J TOXICOL, V28, P151, DOI 10.1177/1091581809336885; Koizumi A, 2005, ENVIRON RES, V99, P31, DOI 10.1016/j.envres.2004.12.002; Kurita H, 2009, J APPL TOXICOL, V29, P689, DOI 10.1002/jat.1459; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lee YH, 2003, INT J DEV BIOL, V47, P459; Leijs M., 2014, BIOMONITORING, V1, P1; Leijs MM, 2008, CHEMOSPHERE, V73, P176, DOI 10.1016/j.chemosphere.2008.05.056; Leijs MM, 2008, CHEMOSPHERE, V73, P999, DOI 10.1016/j.chemosphere.2008.05.053; Liem AKD, 2000, FOOD ADDIT CONTAM, V17, P241, DOI 10.1080/026520300283324; Linden J, 2005, J BIOCHEM MOL TOXIC, V19, P139, DOI 10.1002/jbt.20065; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Matsumura F, 2009, BIOCHEM PHARMACOL, V77, P608, DOI 10.1016/j.bcp.2008.10.013; McDonald E, 2012, INT J BIOCHEM CELL B, V44, P72, DOI 10.1016/j.biocel.2011.09.008; Michalek J, 2000, VETERANS AGENT ORANG; Michalek JE, 2003, J TOXICOL ENV HEAL A, V66, P211, DOI 10.1080/15287390306373; Michalek JE, 2008, J OCCUP ENVIRON MED, V50, P330, DOI 10.1097/JOM.0b013e31815f889b; Mimura J, 1997, GENES CELLS, V2, P645, DOI 10.1046/j.1365-2443.1997.1490345.x; Nash JT, 2013, J TOXICOL ENV HEAL A, V76, P142, DOI 10.1080/15287394.2012.738457; Novelli M, 2005, TOXICOL LETT, V156, P307, DOI 10.1016/j.toxlet.2004.12.004; OLIE K, 1977, Chemosphere, V6, P455, DOI 10.1016/0045-6535(77)90035-2; Pilsner JR, 2017, REPROD TOXICOL, V69, P221, DOI 10.1016/j.reprotox.2017.03.002; PLUIM HJ, 1994, ACTA PAEDIATR, V83, P583; PLUIM HJ, 1994, ENVIRON HEALTH PERSP, V102, P968, DOI 10.2307/3431920; Pluim HJ, 2003, PRE POSTNATAL EXPOSU; Ravelli A. C. J., 1998, International Journal of Obesity, V22, pS18; Remillard RBJ, 2002, ENVIRON HEALTH PERSP, V110, P853, DOI 10.1289/ehp.02110853; Sales LB, 2013, TOXICOL IN VITRO, V27, P1634, DOI 10.1016/j.tiv.2013.04.005; Schmidt JV, 1996, ANNU REV CELL DEV BI, V12, P55, DOI 10.1146/annurev.cellbio.12.1.55; Schoeters G, 2008, BASIC CLIN PHARMACOL, V102, P168, DOI 10.1111/j.1742-7843.2007.00180.x; Stapleton HM, 2012, ENVIRON HEALTH PERSP, V120, P1049, DOI 10.1289/ehp.1104802; ten Tusscher GW, 2004, CHEMOSPHERE, V54, P1329, DOI 10.1016/S0045-6535(03)00254-6; ten Tusscher GW, 1999, ORGANOHALOGEN COMPOU, V42, P213; ten Tusscher GW, 2002, THESIS; Uchi Hiroshi, 2013, Fukuoka Acta Medica, V104, P85; Uemura H, 2008, ENVIRON RES, V108, P63, DOI 10.1016/j.envres.2008.06.002; Van den Berg M, 2006, TOXICOL SCI, V93, P223, DOI 10.1093/toxsci/kfl055; Villano CM, 2006, TOXICOL SCI, V92, P1, DOI 10.1093/toxsci/kfj215; Wang SL, 2008, DIABETES CARE, V31, P1574, DOI 10.2337/dc07-2449; Yoshioka W, 2011, TOXICOL SCI, V122, P457, DOI 10.1093/toxsci/kfr130; Zhang SQ, 2015, ENVIRON SCI TECHNOL, V49, P10084, DOI 10.1021/acs.est.5b01597	52	16	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184006	10.1371/journal.pone.0184006	http://dx.doi.org/10.1371/journal.pone.0184006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898241	Green Published, Green Submitted, gold			2022-12-27	WOS:000410449500010
J	Lopez-Diez, E; Perez, S; Carballo, M; Inarrea, A; de la Orden, A; Castro, M; Rodriguez, M; Almuster, S; Montero, R; Perez, M; Sanchez, J; Ojea, A				Lopez-Diez, Elena; Perez, Sonia; Carballo, Manuel; Inarrea, Amparo; de la Orden, Angel; Castro, Maximo; Rodriguez, Moises; Almuster, Sheila; Montero, Ruben; Perez, Miguel; Sanchez, Jorge; Ojea, Antonio			Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population	PLOS ONE			English	Article							MALE SEXUAL PARTNERS; GENITAL HUMAN-PAPILLOMAVIRUS; FEMALE PARTNERS; HPV INFECTION; MALE CIRCUMCISION; CERVICAL-CANCER; PENILE CANCER; CONDOM USE; MEN; WOMEN	Background High risk human papillomavirus (HR-HPV) infection in males is a health issue with implications for HPV-related lesions in their partners. The identification of risk factors for male infection may improve our understanding of HR-HPV transmission and prevention. The aim of this study was to evaluate the relationships between lifestyle, genital warts and HR-HPV infection. The study was focused on men with an increased risk of HR-HPV infection: male sexual partners of women diagnosed with high-grade squamous intraepithelial cervical lesions. Methods Men were enrolled and prospectively recruited within the first six months after diagnosis of cervical lesions in their female partners (n = 175, 2013-2016). Epidemiological and sexual behaviour data were obtained. The presence of genital warts was established by visual inspection. Detection and genotyping of HR-HPV infection in genital samples were performed with a Linear Array HPV Genotyping Test. All HR-HPV positive men were offered a follow-up exam at 12 months. SPSS version 19 was used for statistical analysis. Results and discussion The prevalence of HR-HPV infection in men was 45.1% (79/175). Genital warts were observed in 10.3% (18/175) of the subjects. Detection of genital warts (OR 3.5, p = 0.015), smoking habits (OR 2.3, p = 0.006) and sexual debut before 16 years old (OR 2, p = 0.035) were associated with an increased risk for HR-HPV infection (univariate analysis). This association was also observed for genital warts and smoking status in a multivariate analysis. The same genotype was found after one year in 71.4% (20/28) of subjects. Conclusions The presence of genital warts and smoking habits seem to be associated with a higher risk of HR-HPV infection in males. Earlier sexual debut may increase this risk. Extensive knowledge of the natural history of HR-HPV infection in males is an absolute requirement for the design and implementation of prevention strategies for the general population as well as for specific populations such as couples after treatment for high-grade cervical lesions.	[Lopez-Diez, Elena; Carballo, Manuel; Castro, Maximo; Rodriguez, Moises; Almuster, Sheila; Montero, Ruben; Perez, Miguel; Sanchez, Jorge; Ojea, Antonio] Univ Hosp Vigo, Dept Urol, Vigo, Spain; [Perez, Sonia] Univ Hosp Vigo, Dept Microbiol, Vigo, Spain; [Inarrea, Amparo; de la Orden, Angel] Univ Hosp Vigo, Dept Obstet & Gynecol, Vigo, Spain	Complexo Hospitalario Universitario de Vigo; Complexo Hospitalario Universitario de Vigo; Complexo Hospitalario Universitario de Vigo	Lopez-Diez, E (corresponding author), Univ Hosp Vigo, Dept Urol, Vigo, Spain.	elena.lopez.diez@sergas.es	Almuster, Sheila/AFV-2386-2022; Carballo Quinta, Manuel/ABF-5188-2021	Lopez Diez, Elena/0000-0002-8411-6945; PEREZ CASTRO, SONIA/0000-0003-1734-1904				Afonso LA, 2013, BRAZ J MED BIOL RES, V46, P533, DOI 10.1590/1414-431X20132519; Albero G, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-18; Alemany L, 2016, EUR UROL, V69, P953, DOI 10.1016/j.eururo.2015.12.007; Andrews JC, 2016, J LOW GENIT TRACT DI, V20, P195, DOI 10.1097/LGT.0000000000000226; [Anonymous], 2003, J NATL CANC I MONOGR, P20; Arbyn M, 2014, J PATHOL; Baldwin SB, 2003, J INFECT DIS, V187, P1064, DOI 10.1086/368220; Bar-Am A, 2007, EUR J GYNAECOL ONCOL, V28, P207; Bleeker MCG, 2003, INT J CANCER, V107, P804, DOI 10.1002/ijc.11473; Blomberg M, 2012, J INFECT DIS, V205, P1544, DOI 10.1093/infdis/jis228; Bosch FX, 1996, JNCI-J NATL CANCER I, V88, P1060, DOI 10.1093/jnci/88.15.1060; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Burchell AN, 2014, J INFECT DIS, V210, P846, DOI 10.1093/infdis/jiu200; Castellsague X, 2002, NEW ENGL J MED, V346, P1105, DOI 10.1056/NEJMoa011688; Daling JR, 2005, INT J CANCER, V116, P606, DOI 10.1002/ijc.21009; de Bruijn RE, 2013, BJU INT, V112, P905, DOI 10.1111/bju.12237; de Irala J, 2011, ARCH SEX BEHAV, V40, P853, DOI 10.1007/s10508-011-9779-4; Dunne EF, 2013, INFECT DIS CLIN N AM, V27, P765, DOI 10.1016/j.idc.2013.09.001; Franceschi S, 2002, BRIT J CANCER, V86, P705, DOI 10.1038/sj.bjc.6600194; Giraldo PC, 2008, EUR J OBSTET GYN R B, V137, P88, DOI 10.1016/j.ejogrb.2006.12.026; Gray RH, 2010, J INFECT DIS, V201, P1455, DOI 10.1086/652184; Hebnes JB, 2014, J SEX MED, V11, P2630, DOI 10.1111/jsm.12652; Kalra R, 2000, J PHARMACOL EXP THER, V293, P166; Lopez Diez E, 2016, ENFERM INFEC MICR CL; Lopez-Diez E, 2016, INTECH; Lopez-Romero R, 2013, INT J CLIN EXP PATHO, V6, P1409; Lu BB, 2012, CANCER EPIDEM BIOMAR, V21, P1542, DOI 10.1158/1055-9965.EPI-12-0483; Lu BB, 2009, J INFECT DIS, V199, P362, DOI 10.1086/596050; Martin-Ezquerra G, 2012, EUR J DERMATOL, V22, P200, DOI 10.1684/ejd.2011.1622; McGinley KF, 2011, J AM OSTEOPATH ASSOC, V111, pS26; Morales R, 2012, CANCER EPIDEM BIOMAR, V21, P1956, DOI 10.1158/1055-9965.EPI-12-0470; Munk AC, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-30; Munk AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045114; Nicolau SM, 2005, UROLOGY, V65, P251, DOI 10.1016/j.urology.2004.09.031; Nielson CM, 2007, J INFECT DIS, V196, P1137, DOI 10.1086/521632; Nyitray AG, 2014, CURR PROBL DERMATOL, V45, P75, DOI 10.1159/000358370; Parada R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-223; Park Ina U, 2010, Curr Infect Dis Rep, V12, P126, DOI 10.1007/s11908-010-0090-7; Perez-Castro S, 2013, ENFERM INFEC MICR CL; Reiter PL, 2010, CANCER EPIDEM BIOMAR, V19, P2916, DOI 10.1158/1055-9965.EPI-10-0576; Repp KK, 2012, J INFECT DIS, V205, P1287, DOI 10.1093/infdis/jis181; Arroyo LS, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2713-x; Schabath MB, 2012, CANCER EPIDEM BIOMAR, V21, P102, DOI 10.1158/1055-9965.EPI-11-0591; Schillaci R, 2013, FERTIL STERIL, V100, P1236, DOI 10.1016/j.fertnstert.2013.06.042; Smith MA, 2015, J INFECT DIS, V211, P91, DOI 10.1093/infdis/jiu370; Tornu Bladu A., 2012, PROG OBSTET GINECOL, V55, P10, DOI DOI 10.1016/S0304-5013(12)73065-0; Vandepapeliere P, 2005, J INFECT DIS, V192, P2099, DOI 10.1086/498164; Zhu YP, 2017, ASIAN J ANDROL, V19, P125, DOI 10.4103/1008-682X.175092	48	7	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2017	12	9							e0184492	10.1371/journal.pone.0184492	http://dx.doi.org/10.1371/journal.pone.0184492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG6AR	28898279	gold, Green Submitted, Green Published			2022-12-27	WOS:000410449500030
J	Blagodatskikh, KA; Kramarov, VM; Barsova, EV; Garkovenko, AV; Shcherbo, DS; Shelenkov, AA; Ustinova, VV; Tokarenko, MR; Baker, SC; Kramarova, TV; Ignatov, KB				Blagodatskikh, Konstantin A.; Kramarov, Vladimir M.; Barsova, Ekaterina V.; Garkovenko, Alexey V.; Shcherbo, Dmitriy S.; Shelenkov, Andrew A.; Ustinova, Vera V.; Tokarenko, Maria R.; Baker, Simon C.; Kramarova, Tatiana V.; Ignatov, Konstantin B.			Improved DOP-PCR (iDOP-PCR): A robust and simple WGA method for efficient amplification of low copy number genomic DNA	PLOS ONE			English	Article							CELL	Whole-genome amplification (WGA) techniques are used for non-specific amplification of low-copy number DNA, and especially for single-cell genome and transcriptome amplification. There are a number of WGA methods that have been developed over the years. One example is degenerate oligonucleotide-primed PCR (DOP-PCR), which is a very simple, fast and inexpensive WGA technique. Although DOP-PCR has been regarded as one of the pioneering methods for WGA, it only provides low genome coverage and a high allele dropout rate when compared to more modern techniques. Here we describe an improved DOP-PCR (iDOP-PCR). We have modified the classic DOP-PCR by using a new thermostable DNA polymerase (SD polymerase) with a strong strand-displacement activity and by adjustments in primers design. We compared iDOP-PCR, classic DOP-PCR and the well-established PicoPlex technique for whole genome amplification of both high-and low-copy number human genomic DNA. The amplified DNA libraries were evaluated by analysis of short tandem repeat genotypes and NGS data. In summary, iDOP-PCR provided a better quality of the amplified DNA libraries compared to the other WGA methods tested, especially when low amounts of genomic DNA were used as an input material.	[Blagodatskikh, Konstantin A.; Kramarov, Vladimir M.; Ignatov, Konstantin B.] Russian Acad Sci, All Russia Inst Agr Biotechnol, Moscow, Russia; [Kramarov, Vladimir M.; Shelenkov, Andrew A.; Ignatov, Konstantin B.] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Barsova, Ekaterina V.; Garkovenko, Alexey V.; Shcherbo, Dmitriy S.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Garkovenko, Alexey V.] Genet Expertise LLC, Moscow, Russia; [Shcherbo, Dmitriy S.; Shelenkov, Andrew A.; Tokarenko, Maria R.] Evrogen JSC, Moscow, Russia; [Shcherbo, Dmitriy S.] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Ustinova, Vera V.] Syntol JSC, Moscow, Russia; [Baker, Simon C.] Bioline Ltd, London, England; [Baker, Simon C.] Birkbeck Univ London, London, England; [Kramarova, Tatiana V.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden	All-Russia Research Institute of Agricultural Biotechnology; Russian Academy of Sciences; Russian Academy of Sciences; Vavilov Institute of General Genetics; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Pirogov Russian National Research Medical University; University of London; Birkbeck University London; Stockholm University	Ignatov, KB (corresponding author), Russian Acad Sci, All Russia Inst Agr Biotechnol, Moscow, Russia.; Ignatov, KB (corresponding author), Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia.	ignatovkb@bk.ru	Shelenkov, Andrey/G-2916-2011; Ignatov, Konstantin/D-9593-2018; Tokarenko, Maria/AAB-6537-2020; Ustinova, Vera V/I-9476-2014; Blagodatskikh, Konstantin A/A-4521-2011	Shelenkov, Andrey/0000-0002-7409-077X; Ignatov, Konstantin/0000-0001-8900-5278; Garkovenko, Alexey/0000-0001-6809-5999; Blagodatskikh, Konstantin/0000-0002-8732-0300	Ministry of Education and Science of Russian Federation [14.579.21.0012, RFMEFI57914X0012]; Russian State Budget [0112-2016-0006]	Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Russian State Budget	The work was supported by the Ministry of Education and Science of Russian Federation, grant 14.579.21.0012 (ID # RFMEFI57914X0012) and by the grant 0112-2016-0006 from the Russian State Budget. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genetic Expertise LLC provided support in the form of salaries for A.V.G. and provided equipment for STR-analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Syntol JSC provided support in the form of salaries for V.V.U. and reagents for NGS-analysis, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bioline Ltd provided support in the form of salaries for S.C.B., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.Evrogen JSC provided equipment for NGS-analysis and provided support in the form of salaries for authors E.V.B., D.S.S., A.A.S. and M.R.T., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Bergen AW, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-24; de Bourcy CFA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105585; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Deleye L, 2015, FERTIL STERIL, V104, P1276, DOI 10.1016/j.fertnstert.2015.07.1144; Deleye L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11711; Dodt Matthias, 2012, Biology (Basel), V1, P895, DOI 10.3390/biology1030895; Garvin T, 2015, NAT METHODS, V12, P1058, DOI [10.1038/NMETH.3578, 10.1038/nmeth.3578]; Gawad C, 2016, NAT REV GENET, V17, P175, DOI 10.1038/nrg.2015.16; Huang L, 2015, ANNU REV GENOM HUM G, V16, P79, DOI 10.1146/annurev-genom-090413-025352; Ignatov KB, 2014, BIOTECHNIQUES, V57, P81, DOI 10.2144/000114198; Kamberov E, 2012, US Patent, Patent No. [8,206,913, 8]; Korfhage Christian, 2013, Curr Protoc Mol Biol, V104, DOI 10.1002/0471142727.mb0714s104; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Macaulay IC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004126; Shojaei S. H., 2014, BMC GENOMICS, V15, P1; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Van der Aa N, 2013, GENOME MED, V5, DOI 10.1186/gm475; Zheng YM, 2011, J ZHEJIANG UNIV-SC B, V12, P1, DOI 10.1631/jzus.B1000196; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	19	19	22	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2017	12	9							e0184507	10.1371/journal.pone.0184507	http://dx.doi.org/10.1371/journal.pone.0184507			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG4OS	28892497	Green Published, Green Submitted, gold			2022-12-27	WOS:000410243200015
J	Fernandez-Perez, J; Nanton, A; Ruiz-Ruano, FJ; Camacho, JPM; Mendez, J				Fernandez-Perez, Jenyfer; Nanton, Ana; Ruiz-Ruano, Francisco J.; Camacho, Juan Pedro M.; Mendez, Josefina			First complete female mitochondrial genome in four bivalve species genus Donax and their phylogenetic relationships within the Veneroida order	PLOS ONE			English	Article							DOUBLY UNIPARENTAL INHERITANCE; TRANSFER-RNA GENES; DNA CONTROL REGION; MOLLUSCA-BIVALVIA; COELOMACTRA-ANTIQUATA; TANDEM REPEATS; MYTILUS-EDULIS; SOUTHERN PORTUGAL; COMPLETE MTDNA; TRUNCULUS L.	Background Four species of the genus Donax (D. semistriatus, D. trunculus, D. variegatus and D. vittatus) are common on Iberian Peninsula coasts. Nevertheless, despite their economic importance and overexploitation, scarce genetic resources are available. In this work, we newly determined the complete mitochondrial genomes of these four representatives of the family Donacidae, with the aim of contributing to unveil phylogenetic relationships within the Veneroida order, and of developing genetic markers being useful in wedge clam identification and authentication, and aquaculture stock management. Principal findings The complete female mitochondrial genomes of the four species vary in size from 17,044 to 17,365 bp, and encode 13 protein-coding genes ( including the atp8 gene), 2 rRNAs and 22 tRNAs, all located on the same strand. A long non-coding region was identified in each of the four Donax species between cob and cox2 genes, presumably corresponding to the Control Region. The Bayesian and Maximum Likelihood phylogenetic analysis of the Veneroida order indicate that all four species of Donax form a single clade as a sister group of other bivalves within the Tellinoidea superfamily. However, although Tellinoidea is actually monophyletic, none of its families are monophyletic. Conclusions Sequencing of complete mitochondrial genomes provides highly valuable information to establish the phylogenetic relationships within the Veneroida order. Furthermore, we provide here significant genetic resources for further research and conservation of this commercially important fishing resource.	[Fernandez-Perez, Jenyfer; Nanton, Ana; Mendez, Josefina] Univ A Coruna, Grp Xenomar, Dept Biol, Fac Ciencias, Campus A Zapateira, La Coruna, Spain; [Fernandez-Perez, Jenyfer; Nanton, Ana; Mendez, Josefina] Univ A Coruna, CICA, Campus A Zapateira, La Coruna, Spain; [Ruiz-Ruano, Francisco J.; Camacho, Juan Pedro M.] Univ Granada, Fac Ciencias, Dept Genet, Granada, Spain	Universidade da Coruna; Universidade da Coruna; University of Granada	Fernandez-Perez, J (corresponding author), Univ A Coruna, Grp Xenomar, Dept Biol, Fac Ciencias, Campus A Zapateira, La Coruna, Spain.; Fernandez-Perez, J (corresponding author), Univ A Coruna, CICA, Campus A Zapateira, La Coruna, Spain.	jenyfer.fernandez.perez@udc.es	Méndez, Josefina/H-7318-2016; Camacho, Juan Pedro M/L-6869-2014; Ruiz-Ruano, Francisco J./D-8254-2014; Fernandez-Perez, Jenyfer/H-3985-2016	Méndez, Josefina/0000-0002-7567-980X; Camacho, Juan Pedro M/0000-0002-2507-9814; Ruiz-Ruano, Francisco J./0000-0002-5391-301X; Fernandez-Perez, Jenyfer/0000-0001-8417-1541	Ministerio de Economia y Competitividad (Spain) [AGL2016-75288-R AEI/FEDER]	Ministerio de Economia y Competitividad (Spain)	This work was supported by the Ministerio de Economia y Competitividad (Spain) through project AGL2016-75288-R AEI/FEDER, UE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dra D. Martinez Patino and S. Novoa from Centro de Cultivos Marinos de Ribadeo-CIMA (Xunta de Galicia) and Dr. M.B. Gaspar from Instituto Portugues do Mar e da Atmosfera-IPMA (Portugal) for providing specimens. The authors wish to thank the three anonymous reviewers for helpful remarks and suggestions that improved the quality of the manuscript. We also thank Dr. D. Huchon for useful comments during manuscript review. This work was supported by the Ministerio de Economia y Competitividad (Spain) through project AGL2016-75288-R AEI/FEDER, UE.	Ansell A.D., 1983, Developments in Hydrobiology, V19, P607; ANSELL AD, 1980, MAR BIOL, V57, P287, DOI 10.1007/BF00387572; Bao XB, 2016, MITOCHONDRIAL DNA A, V27, P3648, DOI 10.3109/19401736.2015.1079838; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Bettinazzi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153631; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; BOORE JL, 1994, GENETICS, V138, P423; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Breton S, 2010, MAR GENOM, V3, P11, DOI 10.1016/j.margen.2010.01.001; Breton S, 2009, GENETICS, V183, P1575, DOI 10.1534/genetics.109.110700; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chicharo L, 2002, J MAR BIOL ASSOC UK, V82, P41, DOI 10.1017/S0025315402005167; Combosch DJ, 2017, MOL PHYLOGENET EVOL, V107, P191, DOI 10.1016/j.ympev.2016.11.003; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dong PZ, 2016, MITOCHONDRIAL DNA B, V1, P173, DOI 10.1080/23802359.2016.1149786; Dreyer Hermann, 2006, Front Zool, V3, P13, DOI 10.1186/1742-9994-3-13; Drummond AJ., 2009, GENEIOUS V4 8 5; Faber JE, 1998, MOL PHYLOGENET EVOL, V10, P310, DOI 10.1006/mpev.1998.0530; Fernandez A., 2008, REV GAL REC MAR, V2, P1; Fernandez-Perez J, 2017, EST COAST S IN PRESS; Gan HM, 2016, MITOCHONDRIAL DNA A, V27, P3220, DOI 10.3109/19401736.2015.1007355; Gan HM, 2016, MITOCHONDRIAL DNA A, V27, P335, DOI 10.3109/19401736.2014.892104; Gaspar MB, 1999, FISH RES, V41, P309, DOI 10.1016/S0165-7836(99)00017-X; Gaspar MB, 2002, HYDROBIOLOGIA, V477, P73, DOI 10.1023/A:1021009031717; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Glockner G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082857; Gusman A, 2016, PEERJ, V4, DOI 10.7717/peerj.2760; Hahn C, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt371; He CB, 2011, MOL BIOL REP, V38, P3401, DOI 10.1007/s11033-010-0449-8; HOFFMANN RJ, 1992, GENETICS, V131, P397; Hwang JY, 2016, MITOCHONDRIAL DNA A, V27, P3462, DOI 10.3109/19401736.2015.1066348; Imanishi Y, 2013, FISHERIES SCI, V79, P949, DOI 10.1007/s12562-013-0662-1; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Liu HL, 2016, MITOCHONDRIAL DNA A, V27, P4333, DOI 10.3109/19401736.2015.1089488; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Marie AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep39152; Meng XP, 2012, COMP BIOCHEM PHYS D, V7, P175, DOI 10.1016/j.cbd.2012.02.001; Mundy NI, 1996, J HERED, V87, P21, DOI 10.1093/oxfordjournals.jhered.a022948; Nanton A, 2015, EUR FOOD RES TECHNOL, V240, P1129, DOI 10.1007/s00217-015-2416-z; Nanton A, 2014, MOL BIOL REP, V41, P5351, DOI 10.1007/s11033-014-3406-0; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Ozawa G, 2017, MAR GENOM, V31, P43, DOI 10.1016/j.margen.2016.09.003; Passamonti M, 2009, DNA CELL BIOL, V28, P79, DOI 10.1089/dna.2008.0807; Pereira AM, 2012, FOOD CONTROL, V23, P268, DOI 10.1016/j.foodcont.2011.05.020; Pereira SL, 2000, GENET MOL BIOL, V23, P745, DOI 10.1590/S1415-47572000000400008; Plazzi F, 2016, GENOME BIOL EVOL, V8, P2544, DOI 10.1093/gbe/evw187; Plazzi F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-409; Ramon M., 2005, Boletin Instituto Espanol de Oceanografia, V21, P361; Ren JF, 2010, J MOL EVOL, V70, P57, DOI 10.1007/s00239-009-9308-4; Ren JF, 2009, MITOCHONDR DNA, V20, P78, DOI 10.1080/19401730902964425; Rokas A, 2000, TRENDS ECOL EVOL, V15, P454, DOI 10.1016/S0169-5347(00)01967-4; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rufino MM, 2010, SCI MAR, V74, P163, DOI 10.3989/scimar.2010.74n1163; Saito S, 2005, GENETICS, V171, P1695, DOI 10.1534/genetics.105.046243; Salas C, 2001, J SEA RES, V46, P43, DOI 10.1016/S1385-1101(01)00064-8; Salas-Casanova C., 1990, P213; Salas-Casanova C., 1987, DONACIDAE BAY MALAGA, V51, P33; Saunier A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0259-z; Shen X, 2016, MITOCHONDRIAL DNA B, V1, P525, DOI 10.1080/23802359.2016.1197064; Shen X, 2014, COMP BIOCHEM PHYS D, V12, P1, DOI 10.1016/j.cbd.2014.08.002; Shen X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-136; Smietanka B, 2010, J MOL EVOL, V71, P385, DOI 10.1007/s00239-010-9393-4; Smith DR, 2007, J MOL EVOL, V65, P380, DOI 10.1007/s00239-007-9016-x; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; STEWART DT, 1995, MOL BIOL EVOL, V12, P735; Sutherland B, 1998, GENETICS, V148, P341; Taylor JD, 2007, ZOOL SCR, V36, P587, DOI 10.1111/j.1463-6409.2007.00299.x; Thebaud O, 2005, INCIDENCES PISODES E, P88; Theologidis I, 2008, EVOLUTION, V62, P959, DOI 10.1111/j.1558-5646.2008.00329.x; Wang HX, 2011, MAR GENOM, V4, P263, DOI 10.1016/j.margen.2011.06.006; Wang HX, 2010, COMP BIOCHEM PHYS D, V5, P256, DOI 10.1016/j.cbd.2010.07.003; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu XY, 2014, GENE, V533, P439, DOI 10.1016/j.gene.2013.09.077; Wu XY, 2012, GENE, V507, P112, DOI 10.1016/j.gene.2012.07.032; Xu XD, 2012, GENE, V494, P17, DOI 10.1016/j.gene.2011.12.002; Xu XD, 2010, GENOME, V53, P1041, DOI 10.1139/G10-096; Yuan Y, 2013, GENES GENOM, V35, P693, DOI 10.1007/s13258-013-0120-6; Yuan Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032353; Yuan Y, 2012, MITOCHONDR DNA, V23, P112, DOI 10.3109/19401736.2011.653802; Yuan Y, 2012, MOL BIOL REP, V39, P1287, DOI 10.1007/s11033-011-0861-8; Zeichen MM, 2002, ESTUAR COAST SHELF S, V54, P971, DOI 10.1006/ecss.2001.0868; Zhou Y, 2009, GENE, V447, P86, DOI 10.1016/j.gene.2009.07.009; Zouros E, 2013, EVOL BIOL, V40, P1, DOI 10.1007/s11692-012-9195-2	87	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184464	10.1371/journal.pone.0184464	http://dx.doi.org/10.1371/journal.pone.0184464			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886105	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100128
J	Guo, HN; Zhao, Y; Niu, T; Tsui, KL				Guo, Hainan; Zhao, Yang; Niu, Tie; Tsui, Kwok-Leung			Hong Kong Hospital Authority resource efficiency evaluation: Via a novel DEA-Malmquist model and Tobit regression model	PLOS ONE			English	Article								The Hospital Authority (HA) is a statutory body managing all the public hospitals and institutes in Hong Kong (HK). In recent decades, Hong Kong Hospital Authority (HKHA) has been making efforts to improve the healthcare services, but there still exist some problems like unfair resource allocation and poor management, as reported by the Hong Kong medical legislative committee. One critical consequence of these problems is low healthcare efficiency of hospitals, leading to low satisfaction among patients. Moreover, HKHA also suffers from the conflict between limited resource and growing demand. An effective evaluation of HA is important for resource planning and healthcare decision making. In this paper, we propose a two-phase method to evaluate HA efficiency for reducing healthcare expenditure and improving healthcare service. Specifically, in Phase I, we measure the HKHA efficiency changes from 2000 to 2013 by applying a novel DEA-Malmquist index with undesirable factors. In Phase II, we further explore the impact of some exogenous factors (e.g., population density) on HKHA efficiency by Tobit regression model. Empirical results show that there are significant differences between the efficiencies of different hospitals and clusters. In particular, it is found that the public hospital serving in a richer district has a relatively lower efficiency. To a certain extent, this reflects the socioeconomic reality in HK that people with better economic condition prefers receiving higher quality service from the private hospitals.	[Guo, Hainan] Shenzhen Univ, Res Inst Business Analyt & Supply Chain Managemen, Coll Management, Shenzhen, Peoples R China; [Zhao, Yang; Tsui, Kwok-Leung] City Univ Hong Kong, Dept Syst Engn & Engn Management, Kowloon, Hong Kong, Peoples R China; [Zhao, Yang; Tsui, Kwok-Leung] City Univ Hong Kong, Ctr Syst Informat Engn, Kowloon, Hong Kong, Peoples R China; [Niu, Tie] Hosp Affiliated Dalian Med Univ, Informat Ctr, Dalian, Liaoning, Peoples R China	Shenzhen University; City University of Hong Kong; City University of Hong Kong	Zhao, Y (corresponding author), City Univ Hong Kong, Dept Syst Engn & Engn Management, Kowloon, Hong Kong, Peoples R China.; Zhao, Y (corresponding author), City Univ Hong Kong, Ctr Syst Informat Engn, Kowloon, Hong Kong, Peoples R China.	yangzhao9@cityu.edu.hk			National Natural Science Foundation of China (NSFC) [71701132, 71420107023]; Research Grants Council (RGC) Theme-Based Research Scheme [T32-102/14-N]; Social Science Foundation of Guangdong [2016WZDXM005]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research Grants Council (RGC) Theme-Based Research Scheme; Social Science Foundation of Guangdong	This work was supported in part by the National Natural Science Foundation of China (NSFC) under Grant 71701132 and Grant 71420107023, in part by Research Grants Council (RGC) Theme-Based Research Scheme under Grant T32-102/14-N, and in part by Major Program of Social Science Foundation of Guangdong under Grant 2016WZDXM005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoe Hoff, 2007, EUR J OPER RES, V1, P425; Chang SJ, 2011, OMEGA-INT J MANAGE S, V39, P14, DOI 10.1016/j.omega.2010.01.006; Chien-Ming Chen, 2012, DECIS SUPPORT SYST, V1, P1330; Chilingerian J., 2011, INT SER OPER RES MAN, V164, DOI [10.1007/978-1-4419-6151-8_16, DOI 10.1007/978-1-4419-6151-8_16]; Cia CIA, 2013, WORLD FACTBOOK; Cook WD, 2009, EUR J OPER RES, V192, P1, DOI 10.1016/j.ejor.2008.01.032; Cristina Gramani Maria, 2014, PLOS ONE, V1; Dimas G, 2012, OPER RES-GER, V12, P15, DOI 10.1007/s12351-010-0082-2; Du J, 2014, ANN OPER RES, V221, P161, DOI 10.1007/s10479-011-0838-y; Dutta A, 2014, J ASIAN PUBLIC POLIC, V7, P231, DOI 10.1080/17516234.2013.873340; Fare R, 2004, EUR J OPER RES, V157, P242, DOI 10.1016/S0377-2217(03)00191-7; GOLANY B, 1989, OMEGA-INT J MANAGE S, V17, P237, DOI 10.1016/0305-0483(89)90029-7; Guo Hainan, 2016, COMPUTERS IND UNPUB; Hollingsworth B, 2008, HEALTH ECON, V17, P1107, DOI 10.1002/hec.1391; Hu HH, 2012, J OPER RES SOC, V63, P715, DOI 10.1057/jors.2011.77; Jeanne Luh, 2016, PLOS ONE, V1; Kawaguchi H, 2014, HEALTH CARE MANAG SC, V17, P101, DOI 10.1007/s10729-013-9248-9; Koopmans T.C., 1951, ACTIVITY ANAL PRODUC, P33; Li H, 2013, MATH COMPUT MODEL, V58, P1018, DOI 10.1016/j.mcm.2012.09.007; Liu JS, 2013, OMEGA-INT J MANAGE S, V41, P893, DOI 10.1016/j.omega.2012.11.004; Liu JS, 2013, OMEGA-INT J MANAGE S, V41, P3, DOI 10.1016/j.omega.2010.12.006; Liu John S, 2016, OMEGA, V58, P33; Liu W., 1999, DATA ENVELOPMENT ANA, P79; Liu WB, 2010, ANN OPER RES, V173, P177, DOI 10.1007/s10479-009-0587-3; Lovell CAK, 1995, EUR J OPER RES, V87, P507, DOI 10.1016/0377-2217(95)00226-X; Lozano S, 2015, COMPUT IND ENG, V82, P33, DOI 10.1016/j.cie.2015.01.008; Malmquist S, 1953, TRABAJOS ESTATISTICA, V4, P1209, DOI [DOI 10.1007/BF03006863, 10.1007/BF03006863]; Man Chi Yin, 2003, Emerg Med (Fremantle), V15, P418; McDonald J, 2009, EUR J OPER RES, V197, P792, DOI 10.1016/j.ejor.2008.07.039; Nataraja NR, 2011, EUR J OPER RES, V215, P662, DOI 10.1016/j.ejor.2011.06.045; O'Neill L., 2008, SOCIO-ECON PLAN SCI, V42, P158, DOI [DOI 10.1016/J.SEPS.2007.03.001, 10.1016/j.seps.2007.03.001]; Ouellette P, 2004, EUR J OPER RES, V154, P755, DOI 10.1016/S0377-2217(02)00712-9; Pastor J. T., 2015, DATA ENVELOPMENT ANA, P245; Pestana Barros Carlos, 2008, HLTH CARE MANAGEMENT, V4, P373; R Core Team, 2018, R LANG ENV STAT COMP; Ruggiero J, 1998, EUR J OPER RES, V111, P461, DOI 10.1016/S0377-2217(97)00306-8; Seiford LM, 2005, EUR J OPER RES, V161, P579, DOI 10.1016/j.ejor.2003.09.018; Seiford LM, 2002, EUR J OPER RES, V142, P16, DOI 10.1016/S0377-2217(01)00293-4; Sharp John A, 2007, J OPERATIONAL RES SO, V12, P1672; Shimshak DG, 2009, OMEGA-INT J MANAGE S, V37, P672, DOI 10.1016/j.omega.2008.05.004; Syam SS, 2010, OMEGA-INT J MANAGE S, V38, P157, DOI 10.1016/j.omega.2009.08.001; Tone K, 2001, EUR J OPER RES, V130, P498, DOI 10.1016/S0377-2217(99)00407-5	42	20	20	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184211	10.1371/journal.pone.0184211	http://dx.doi.org/10.1371/journal.pone.0184211			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886087	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100082
J	Iordens, GIT; Den Hartog, D; Tuinebreijer, WE; Eygendaal, D; Schep, NWL; Verhofstad, MHJ; Van Lieshout, EMM				Iordens, Gijs I. T.; Den Hartog, Dennis; Tuinebreijer, Wim E.; Eygendaal, Denise; Schep, Niels W. L.; Verhofstad, Michael H. J.; Van Lieshout, Esther M. M.		FuncSIE Trial Investigators	Minimal important change and other measurement properties of the Oxford Elbow Score and the Quick Disabilities of the Arm, Shoulder, and Hand in patients with a simple elbow dislocation; validation study alongside the multicenter FuncSiE trial	PLOS ONE			English	Article							DASH OUTCOME QUESTIONNAIRE; CROSS-CULTURAL ADAPTATION; HEALTH-STATUS; CONSTRUCT-VALIDITY; CLINICAL-PRACTICE; GERMAN VERSION; RELIABILITY; RESPONSIVENESS; SURGERY; SF-36	Study design Validation study using data from a multicenter, randomized, clinical trial (RCT). Objectives To evaluate the reliability, validity, responsiveness, and minimal important change (MIC) of the Dutch version of the Oxford Elbow Score (OES) and the Quick Disabilities of the Arm, Shoulder, and Hand (Quick-DASH) in patients with a simple elbow dislocation. Background Patient-reported outcome measures are increasingly important for assessing outcome following elbow injuries, both in daily practice and in clinical research. However measurement properties of the OES and Quick-DASH in these patients are not fully known. Methods OES and Quick-DASH were completed four times until one year after trauma. Mayo Elbow Performance Index, pain (VAS), Short Form-36, and EuroQol-5D were completed for comparison. Data of a multicenter RCT (n = 100) were used. Internal consistency was determined using Cronbach's alpha. Construct and longitudinal validity were assessed by determining hypothesized strength of correlation between scores or changes in scores, respectively, of (sub) scales. Finally, floor and ceiling effects, MIC, and smallest detectable change (SDC) were determined. Results OES and Quick-DASH demonstrated adequate internal consistency (Cronbach a, 0.882 and 0.886, respectively). Construct validity and longitudinal validity of both scales were supported by >75% correctly hypothesized correlations. MIC and SDC were 8.2 and 12.0 point for OES, respectively. For Quick-DASH, these values were 11.7 and 25.0, respectively. Conclusions OES and Quick-DASH are reliable, valid, and responsive instruments for evaluating elbow-related quality of life. The anchor-based MIC was 8.2 points for OES and 11.7 for Quick-DASH.	[Iordens, Gijs I. T.; Den Hartog, Dennis; Tuinebreijer, Wim E.; Verhofstad, Michael H. J.; Van Lieshout, Esther M. M.] Erasmus MC, Univ Med Ctr Rotterdam, Dept Surg, Trauma Res Unit, Rotterdam, Netherlands; [Eygendaal, Denise] Amphia Hosp, Dept Orthopaed Surg, Upper Limb Unit, Breda, Netherlands; [Schep, Niels W. L.] Acad Med Ctr, Dept Surg, Trauma Unit, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Amphia Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Van Lieshout, EMM (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Dept Surg, Trauma Res Unit, Rotterdam, Netherlands.	e.vanlieshout@erasmusmc.nl			European Society for Surgery of the Shoulder; Elbow	European Society for Surgery of the Shoulder; Elbow	This project was supported by a grant from the European Society for Surgery of the Shoulder and the Elbow (www.secec.org; (SECEC/ESSSE grant 2010) to DE. This organization was not involved in the trial design, patient recruitment, data collection, data analysis, data interpretation, publication decisions, or in any aspect pertinent to this study.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Angst F, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-26; Atroshi I, 2000, ACTA ORTHOP SCAND, V71, P613, DOI 10.1080/000164700317362262; Beaton D E, 2001, J Hand Ther, V14, P128; Beaton DE, 2005, J BONE JOINT SURG AM, V87A, P1038, DOI 10.2106/JBJS.D.02060; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Cohen J., 1997, STAT POWER ANAL BEHA, P474; Davidson M, 2014, BRIT J SPORT MED, V48, P792, DOI 10.1136/bjsports-2012-091704; Dawson J, 2008, J BONE JOINT SURG BR, V90B, P466, DOI 10.1302/0301-620X.90B4.20290; Dawson J, 2012, ORTHOP TRAUMATOL-SUR, V98, P652, DOI 10.1016/j.otsr.2012.05.011; Dawson J, 2008, QUAL LIFE RES, V17, P1257, DOI 10.1007/s11136-008-9409-3; de Boer YA, 1999, J RHEUMATOL, V26, P1909; de Haan J, 2011, PATIENT-RELAT OUTCOM, V2, P145, DOI 10.2147/PROM.S22257; de Haan J, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-39; de Haan J, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-263; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; de Vet HW, 2011, MEASUREMENT MED PRAC; Fayad F, 2009, MANUAL THER, V14, P206, DOI 10.1016/j.math.2008.01.013; Forget NJ, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-361; Franchignoni F, 2014, J ORTHOP SPORT PHYS, V44, P30, DOI 10.2519/jospt.2014.4893; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Gummesson C, 2003, BMC MUSCULOSKELET DI, V4, DOI 10.1186/1471-2474-4-11; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Iordens GIT, 2016, BR J SPORTS MED; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; Lamers LM, 2005, NED TIJDSCHR GENEES, V149, P1574; Lindenhovius ALC, 2008, J BONE JOINT SURG AM, V90A, P2090, DOI 10.2106/JBJS.G.00793; Lovgren Anneli, 2012, Physiotherapy Theory and Practice, V28, P188, DOI 10.3109/09593985.2011.583174; Macdermid JC, 2015, J ORTHOP SPORT PHYS, V45, P25, DOI 10.2519/jospt.2015.5033; Mahabier KC, 2016, J SHOULDER IN PRESS; Marquardt J, 2016, ORTHOPADE, V45, P695, DOI 10.1007/s00132-016-3292-3; MCHORNEY CA, 1995, QUAL LIFE RES, V4, P293, DOI 10.1007/BF01593882; Middel Berrie, 2002, Int J Integr Care, V2, pe15; Mintken PE, 2009, J SHOULDER ELB SURG, V18, P920, DOI 10.1016/j.jse.2008.12.015; Morrey BF, 1993, ELBOW ITS DISORDERS, V2nd, P86; Offenbaecher M, 2002, J RHEUMATOL, V29, P401; Padua R, 2003, J HAND SURG-BRIT EUR, V28B, P179, DOI 10.1016/S0266-7681(02)00303-0/jhsb.2001.0876; Plaschke HC, 2013, DAN MED J, V60; Polinder S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-531; Polson K, 2010, MANUAL THER, V15, P404, DOI 10.1016/j.math.2010.03.008; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Slobogean GP, 2010, J SHOULDER ELB SURG, V19, P342, DOI 10.1016/j.jse.2009.10.021; SooHoo NF, 2002, J HAND SURG-AM, V27A, P537, DOI 10.1053/jhsu.2002.32964; Sorensen AA, 2013, J HAND SURG-AM, V38A, P641, DOI 10.1016/j.jhsa.2012.12.032; Stepan Jeffrey G, 2013, J Bone Joint Surg Am, V95, pe176, DOI 10.2106/JBJS.L.01485; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; The B, 2013, J SHOULDER ELB SURG, V22, P1380, DOI 10.1016/j.jse.2013.04.013; Valderas JM, 2008, QUAL LIFE RES, V17, P179, DOI 10.1007/s11136-007-9295-0; vanBeeck EF, 1997, J TRAUMA, V42, P1116, DOI 10.1097/00005373-199706000-00023; Veehof Martine M, 2002, J Hand Ther, V15, P347; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405; Wylie JD, 2014, WORLD J ORTHOP, V5, P623, DOI 10.5312/wjo.v5.i5.623	54	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0182557	10.1371/journal.pone.0182557	http://dx.doi.org/10.1371/journal.pone.0182557			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FG2YO	28886018	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100008
J	Nguyen, KA; Peer, N; de Villiers, A; Mukasa, B; Matsha, TE; Mills, EJ; Kengne, AP				Nguyen, Kim A.; Peer, Nasheeta; de Villiers, Anniza; Mukasa, Barbara; Matsha, Tandi E.; Mills, Edward J.; Kengne, Andre P.			Optimal waist circumference threshold for diagnosing metabolic syndrome in African people living with HIV infection	PLOS ONE			English	Article							CARDIOMETABOLIC RISK; MANAGEMENT; CUTOFF; MEN	Background The applicability of the internationally advocated cut-off points of waist circumference (WC) derived from Caucasians to diagnose metabolic syndrome (MS) in HIV-infected Africans is unknown. This study aimed to determine the optimal WC cutoffs for MS diagnosis in HIV-infected people receiving care at public healthcare facilities in the Western Cape Province in South Africa. Methods Data from 748 randomly selected participants (591 women), with a median age of 38 years, were analysed. The Youden's index and the top-left-point approaches were used to determine the optimal cutoffs of WC for predicting >= 2 non-adipose MS components. Results The two approaches generated the same WC cut-off point in women, 92 cm (sensitivity 64%, specificity 64%) but different cut-off points in men: 87 cm (sensitivity 48%, specificity 85%) based on the Younden's index and 83 cm (sensitivity 59%, specificity 74%) by the top-left- point method. The advocated thresholds of 94 cm in men had low sensitivity (30%) but high specificity (92%) whereas 80 cm in women showed low specificity (32%) but high sensitivity (85%) for diagnosing MS in this sample. Most African-specific cut-off points performed well, with 90 cm providing acceptable performance in both men (sensitivity 43%, specificity 88%) and women (sensitivity 66%, specificity 59%). Conclusions This study underlines the sub-optimal performance of internationally recommended WC thresholds for MS diagnosis in HIV-infected Africans, and supports the need to revisit the guidelines on WC criterion in African population across the board. A single threshold of 90 cm for both genders would be a practical suggestion.	[Nguyen, Kim A.; Peer, Nasheeta; de Villiers, Anniza; Kengne, Andre P.] South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa; [Nguyen, Kim A.; Peer, Nasheeta; Kengne, Andre P.] Univ Cape Town, Dept Med, Cape Town, South Africa; [Mukasa, Barbara] United Nations Populat Fund UNFPA, Mildmay, Uganda; [Matsha, Tandi E.] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Dept Biomed Sci, Cape Town, South Africa; [Mills, Edward J.] Global Evaluat Sci, Vancouver, BC, Canada	South African Medical Research Council; University of Cape Town; United Nations Population Fund; Cape Peninsula University of Technology	Nguyen, KA (corresponding author), South African Med Res Council, Noncommunicable Dis Res Unit, Cape Town, South Africa.; Nguyen, KA (corresponding author), Univ Cape Town, Dept Med, Cape Town, South Africa.	kim.nguyen@mrc.ac.za	Kengne, Andre Pascal/ABB-3696-2020; De Villiers, Anniza/GQB-3288-2022	Matsha, Tandi/0000-0001-5251-030X; Peer, Nasheeta/0000-0003-2131-8344; Kengne, Andre Pascal/0000-0002-5183-131X	Grand Challenge Canada, through the Global Alliance on Chronic Diseases initiative; NRF Innovation Doctoral Research Scholarship; Doctoral Scholarship and Yeoman Bequest Bursary through the University of Cape Town	Grand Challenge Canada, through the Global Alliance on Chronic Diseases initiative; NRF Innovation Doctoral Research Scholarship; Doctoral Scholarship and Yeoman Bequest Bursary through the University of Cape Town	The study was funded by Grand Challenge Canada, through the Global Alliance on Chronic Diseases initiative. KAN is supported by the NRF Innovation Doctoral Research Scholarship, Doctoral Scholarship and Yeoman Bequest Bursary through the University of Cape Town. The founding sponsors had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, and in the decision to publish the results.; The study was funded by Grand Challenge Canada, through the Global Alliance on Chronic Diseases initiative. KAN is supported by the NRF Innovation Doctoral Research Scholarship, Doctoral Scholarship and Yeoman Bequest Bursary through the University of Cape Town.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Beraldo RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149905; Bewick V, 2004, CRIT CARE, V8, P508, DOI 10.1186/cc3000; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; EL Mabchour A, 2015, DIABET METAB SYND OB, V8, P513, DOI 10.2147/DMSO.S88893; Kalk WJ, 2011, METAB SYNDR RELAT D, V9, P491, DOI 10.1089/met.2011.0063; Nguyen KA, 2015, AIDS REV, V17, P83; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Matsha TE, 2013, INT J CARDIOL, V168, P2954, DOI 10.1016/j.ijcard.2013.03.150; Matsha TE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071133; Motala AA, 2011, DIABETES CARE, V34, P1032, DOI 10.2337/dc10-1921; Nguyen KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150970; Nguyen KA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060299; Peer N, 2016, J PUBLIC HEALTH-UK, V38, P175, DOI 10.1093/pubmed/fdu115; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Prinsloo J, 2011, EXP CLIN ENDOCR DIAB, V119, P599, DOI 10.1055/s-0031-1280801; Soreide K, 2009, J CLIN PATHOL, V62, P1, DOI 10.1136/jcp.2008.061010	19	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0183029	10.1371/journal.pone.0183029	http://dx.doi.org/10.1371/journal.pone.0183029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886047	gold, Green Submitted, Green Published			2022-12-27	WOS:000410001100015
J	Tian, L; Chen, JQ; Zhang, YJ				Tian, Li; Chen, Jiquan; Zhang, Yangjian			Growing season carries stronger contributions to albedo dynamics on the Tibetan plateau	PLOS ONE			English	Article							LAND-SURFACE ALBEDO; QINGHAI-XIZANG PLATEAU; CLIMATE-CHANGE; VEGETATION; SNOW; MODIS; FEEDBACK; IMPACTS; MODELS; CARBON	The Tibetan Plateau has experienced higher-than-global-average climate warming in recent decades, resulting in many significant changes in ecosystem structure and function. Among them is albedo, which bridges the causes and consequences of land surface processes and climate. The plateau is covered by snow/ice and vegetation in the non-growing season (nGS) and growing season (GS), respectively. Based on the MODIS products, we investigated snow/ice cover and vegetation greenness in relation to the spatiotemporal changes of albedo on the Tibetan Plateau from 2000 through 2013. A synchronous relationship was found between the change in GSNDVI and GSalbedo over time and across the Tibetan landscapes. We found that the annual average albedo had a decreasing trend, but that the albedo had slightly increased during the nGS and decreased during the GS. Across the landscapes, the nGSalbedo fluctuated in a synchronous pattern with snow/ice cover. Temporally, monthly snow/ice coverage also had a high correspondence with albedo, except in April and October. We detected clear dependencies of albedo on elevation. With the rise in altitude, the nGSalbedo decreased below 4000 m, but increased for elevations of 4500 - 5500 m. Above 5500 m, the nGSalbedo decreased, which was in accordance with the decreased amount of snow/ice coverage and the increased soil moisture on the plateau. More importantly, the decreasing albedo in the most recent decade appeared to be caused primarily by lowered growing season albedo.	[Tian, Li] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Qianyanzhou Ecol Res Stn, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Tian, Li; Zhang, Yangjian] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modelling, Lhasa Stn, Beijing, Peoples R China; [Chen, Jiquan] Michigan State Univ, CGCEO, E Lansing, MI 48824 USA; [Chen, Jiquan] Michigan State Univ, Dept Geog Environm & Spatial Sci, E Lansing, MI 48824 USA	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Michigan State University; Michigan State University	Tian, L (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Qianyanzhou Ecol Res Stn, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.; Tian, L (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modelling, Lhasa Stn, Beijing, Peoples R China.	tianli@igsnrr.ac.cn	Chen, Jiquan/D-1955-2009	Chen, Jiquan/0000-0003-0761-9458	National Natural Science Foundation of China [41601100]; Project of Science and Technology plan of Institute of Geographic Sciences [Y5V5001JYE]; Project of Natural Resource Research, Chinese Academy of Sciences [Y5V5001JYE]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Science and Technology plan of Institute of Geographic Sciences; Project of Natural Resource Research, Chinese Academy of Sciences	This research was partially supported by 41601100, www.nsfc.gov.cn, National Natural Science Foundation of China, LT; Y5V5001JYE, the Projects of Science and Technology plan of Institute of Geographic Sciences and Natural Resource Research, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033567; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; Blok D, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/035502; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Brovkin V, 2013, J ADV MODEL EARTH SY, V5, P48, DOI 10.1029/2012MS000169; Chapin FS, 2000, J CLIMATE, V13, P2002, DOI 10.1175/1520-0442(2000)013<2002:SDAAEI>2.0.CO;2; Cierniewski J, 2015, IEEE J-STARS, V8, P493, DOI 10.1109/JSTARS.2014.2330691; Dessler AE, 2013, J CLIMATE, V26, P333, DOI 10.1175/JCLI-D-11-00640.1; Diaz HF, 1997, CLIMATIC CHANGE, V36, P253, DOI 10.1023/A:1005335731187; Elmendorf SC, 2012, NAT CLIM CHANGE, V2, P453, DOI 10.1038/NCLIMATE1465; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Ghatak D, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/114008; He T, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2014JD021667; He T, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/044043; Juszak I, 2014, REMOTE SENS ENVIRON, V153, P79, DOI 10.1016/j.rse.2014.07.021; Lee JY, 2014, J CLIMATE, V27, P3643, DOI 10.1175/JCLI-D-13-00261.1; Liu JY, 2003, SCI CHINA SER D, V46, P373; Liu NF, 2013, HYDROL EARTH SYST SC, V17, P2121, DOI 10.5194/hess-17-2121-2013; Liu XD, 2009, GLOBAL PLANET CHANGE, V68, P164, DOI 10.1016/j.gloplacha.2009.03.017; Liu YY, 2012, REMOTE SENS ENVIRON, V123, P280, DOI 10.1016/j.rse.2012.03.014; Loarie SR, 2011, NAT CLIM CHANGE, V1, P105, DOI [10.1038/nclimate1067, 10.1038/NCLIMATE1067]; Loranty MM, 2014, GLOBAL CHANGE BIOL, V20, P594, DOI 10.1111/gcb.12391; MacDonald GM, 2008, PHILOS T R SOC B, V363, P2285, DOI 10.1098/rstb.2007.2200; Moore GWK, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021046; Myers-Smith IH, 2015, NAT CLIM CHANGE, V5, P887, DOI [10.1038/nclimate2697, 10.1038/NCLIMATE2697]; Nicholas CS, 2001, J CLIMATE, V14, P1360; Oleson KW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016749; Pederson GT, 2010, CLIMATIC CHANGE, V98, P133, DOI 10.1007/s10584-009-9642-y; Piao SL, 2006, CLIMATIC CHANGE, V74, P253, DOI 10.1007/s10584-005-6339-8; Pistone K, 2014, P NATL ACAD SCI USA, V111, P3322, DOI 10.1073/pnas.1318201111; Pu ZX, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029262; Qin J, 2009, CLIMATIC CHANGE, V97, P321, DOI 10.1007/s10584-009-9733-9; Rangwala I, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024040; Rangwala I, 2012, CLIMATIC CHANGE, V114, P527, DOI 10.1007/s10584-012-0419-3; Rangwala I, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037245; Refslund J, 2013, IAHS-AISH P, V359, P233; Riihela A, 2013, NAT CLIM CHANGE, V3, P895, DOI [10.1038/NCLIMATE1963, 10.1038/nclimate1963]; Schaaf CB, 2002, REMOTE SENS ENVIRON, V83, P135, DOI 10.1016/S0034-4257(02)00091-3; Schaphoff S, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014026; Scherrer SC, 2012, THEOR APPL CLIMATOL, V110, P509, DOI 10.1007/s00704-012-0712-0; Seidel DJ, 2014, NAT CLIM CHANGE, V4, P93, DOI 10.1038/NCLIMATE2076; SELLERS PJ, 1995, REMOTE SENS ENVIRON, V51, P3, DOI 10.1016/0034-4257(94)00061-Q; Song CQ, 2013, REMOTE SENS ENVIRON, V135, P25, DOI 10.1016/j.rse.2013.03.013; Sturm M, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000013; Tao J, 2014, THEOR APPL CLIMATOL, V117, P61, DOI 10.1007/s00704-013-0976-z; Tian L, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/10/104001; Wang KC, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD004229; Warren SG, 2013, J GEOPHYS RES-ATMOS, V118, P779, DOI 10.1029/2012JD018476; Xu W, 2016, J CLIMATE; Yang JT, 2013, INT GEOSCI REMOTE SE, P1182, DOI 10.1109/IGARSS.2013.6721377; Yang K, 2014, GLOBAL PLANET CHANGE, V112, P79, DOI 10.1016/j.gloplacha.2013.12.001; Yang Q.-Y., 1982, PHYS GEOGRAPHY XIZAN; Yang XG, 2011, AGR SCI CHINA, V10, P585, DOI 10.1016/S1671-2927(11)60040-0; Zhang GL, 2013, P NATL ACAD SCI USA, V110, P4309, DOI 10.1073/pnas.1210423110; Zhang WJ, 2015, REMOTE SENS-BASEL, V7, P16607, DOI 10.3390/rs71215847	56	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0180559	10.1371/journal.pone.0180559	http://dx.doi.org/10.1371/journal.pone.0180559			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886037	gold, Green Published, Green Submitted			2022-12-27	WOS:000410001100001
J	Wen, YH; Chen, Z; Lu, JF; Ables, E; Scemama, JL; Yang, LV; Lu, JQ; Hu, XH				Wen, Yuhua; Chen, Zhan; Lu, Jianfen; Ables, Elizabeth; Scemama, Jean-Luc; Yang, Li V.; Lu, Jun Q.; Hu, Xin-Hua			Quantitative analysis and comparison of 3D morphology between viable and apoptotic MCF-7 breast cancer cells and characterization of nuclear fragmentation	PLOS ONE			English	Article							MELANOMA-CELLS; FLOW CYTOMETER; DOXORUBICIN; CLASSIFICATION; MICROSCOPE	Morphological changes in apoptotic cells provide essential markers for defining and detection of apoptosis as a fundamental mechanism of cell death. Among these changes, the nuclear fragmentation and condensation have been regarded as the important markers but quantitative characterization of these changes is yet to be achieved. We have acquired confocal image stacks of 206 viable and apoptotic MCF-7 cells stained by three fluorescent dyes. Three-dimensional (3D) parameters were extracted to quantify and compare their differences in morphology. To analyze nuclear fragmentation, a new method has been developed to determine clustering of nuclear voxels in the reconstructed cells due to fluorescence intensity changes in nuclei of apoptotic cells. The results of these studies reveal that the 3D morphological changes in cytoplasm and nuclear membranes in apoptotic cells provide sensitive targets for label-free detection and staging of apoptosis. Furthermore, the clustering analysis and morphological data on nuclear fragmentation are highly useful for derivation of optical cell models and simulation of diffraction images to investigate light scattering by early apoptotic cells, which can lead to future development of label-free and rapid methods of apoptosis assay based on cell morphology.	[Wen, Yuhua; Hu, Xin-Hua] Hunan Inst Sci & Technol, Inst Adv Opt, Yueyang, Hunan, Peoples R China; [Wen, Yuhua] Hunan Inst Sci & Technol, Sch Phys, Yueyang, Hunan, Peoples R China; [Chen, Zhan; Lu, Jun Q.; Hu, Xin-Hua] East Carolina Univ, Dept Phys, Greenville, NC 27858 USA; [Lu, Jianfen; Ables, Elizabeth; Scemama, Jean-Luc] East Carolina Univ, Dept Biol, Greenville, NC USA; [Yang, Li V.] East Carolina Univ, Dept Internal Med, Brody Sch Med, Greenville, NC USA	Hunan Institute of Science & Technology; Hunan Institute of Science & Technology; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	Hu, XH (corresponding author), Hunan Inst Sci & Technol, Inst Adv Opt, Yueyang, Hunan, Peoples R China.; Hu, XH (corresponding author), East Carolina Univ, Dept Phys, Greenville, NC 27858 USA.	hux@ecu.edu	wen, yu/AAJ-7482-2021	Yang, Li/0000-0002-8654-4927; Ables, Elizabeth/0000-0002-6934-9302; Hu, Xin/0000-0002-4353-9028	National Natural Science Foundation of China [51407066]; Natural Science Foundation of Hunan Province of China [13JJ6066]; China Scholarship Council [201508430226]; XHH; JLS; East Carolina University [IRA-2016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province of China(Natural Science Foundation of Hunan Province); China Scholarship Council(China Scholarship Council); XHH; JLS; East Carolina University	YW acknowledges grant support from National Natural Science Foundation of China (#51407066), Natural Science Foundation of Hunan Province of China (#13JJ6066) and China Scholarship Council (#201508430226); XHH, JLS and JQL acknowledge an internal research grant support from East Carolina University (IRA-2016).; Financial Disclosure: YW acknowledges grant support from National Natural Science Foundation of China (#51407066), Natural Science Foundation of Hunan Province of China (#13JJ6066) and China Scholarship Council (#201508430226); XHH, JLS and JQL acknowledge an internal research grant support from East Carolina University (IRA-2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brock RS, 2006, J QUANT SPECTROSC RA, V102, P25, DOI 10.1016/j.jqsrt.2006.02.075; Chorna I, 2004, EXP ONCOL, V26, P111; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Czeczuga-Semeniuk E, 2004, FOLIA HISTOCHEM CYTO, V42, P221; Darzynkiewicz Z, METHODS CELL BIOL, P527; Dong K, 2011, BIOMED OPT EXPRESS, V2, P1717, DOI 10.1364/BOE.2.001717; Fauver M, 2005, OPT EXPRESS, V13, P4210, DOI 10.1364/OPEX.13.004210; Feng YM, 2014, CYTOM PART A, V85A, P817, DOI 10.1002/cyto.a.22504; Hamerly G, 2003, NIPS; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Isikman SO, 2011, P NATL ACAD SCI USA, V108, P7296, DOI 10.1073/pnas.1015638108; Jacobs KM, 2009, J BIOPHOTONICS, V2, P521, DOI 10.1002/jbio.200910044; Jacobs KM, 2009, OPT LETT, V34, P2985, DOI 10.1364/OL.34.002985; Jiang WH, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.7.071102; Kosar PA, 2016, J MEMBRANE BIOL, V249, P129, DOI 10.1007/s00232-015-9855-0; Lee ES, 2005, J CONTROL RELEASE, V103, P405, DOI 10.1016/j.jconrel.2004.12.018; Mangan AP, 1999, IEEE T VIS COMPUT GR, V5, P308, DOI 10.1109/2945.817348; Rastegar Hussein, 2013, Acta Med Iran, V51, P591; Shi HB, 2012, J AM CHEM SOC, V134, P17972, DOI 10.1021/ja3064588; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wang H, 2016, PATTERN REC IN PRESS, V61, P234; Wlodkowic D, 2007, CYTOM PART A, V71A, P61, DOI 10.1002/cyto.a.20366; Yang X, 2014, BIOMED OPT EXPRESS, V5, P2172, DOI 10.1364/BOE.5.002172; Yoon J, 2015, BIOMED OPT EXPRESS, V6, P3865, DOI 10.1364/BOE.6.003865; Zhang J, 2016, OPT EXPRESS, V24, P366, DOI 10.1364/OE.24.000366; Zhang Y, 2012, INTEGR BIOL-UK, V4, P1428, DOI 10.1039/c2ib20153d	27	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2017	12	9							e0184726	10.1371/journal.pone.0184726	http://dx.doi.org/10.1371/journal.pone.0184726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG2YO	28886199	Green Submitted, Green Published, gold			2022-12-27	WOS:000410001100181
J	Chen, LL; Zhu, J; Schumacher, J; Wei, CJ; Ramdas, L; Prieto, VG; Jimenez, A; Velasco, MA; Tripp, SR; Andtbacka, RHI; Gouw, L; Rodgers, GM; Zhang, LS; Chan, BK; Cassidy, PB; Benjamin, RS; Leachman, SA; Frazier, ML				Chen, Lei L.; Zhu, Jing; Schumacher, Jonathan; Wei, Chongjuan; Ramdas, Latha; Prieto, Victor G.; Jimenez, Arnie; Velasco, Marco A.; Tripp, Sheryl R.; Andtbacka, Robert H. I.; Gouw, Launce; Rodgers, George M.; Zhang, Liansheng; Chan, Benjamin K.; Cassidy, Pamela B.; Benjamin, Robert S.; Leachman, Sancy A.; Frazier, Marsha L.			SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally-and spatially-precise nitric oxide to modulate SCF-and or KIT-expressing cell functions	PLOS ONE			English	Article							GASTROINTESTINAL STROMAL TUMORS; CHRONIC MYELOID-LEUKEMIA; TYROSINE-HYDROXYLASE ACTIVITY; RAT ANTERIOR HYPOTHALAMUS; CHRONIC MYELOGENOUS LEUKEMIA; ARTERIAL OCCLUSIVE DISEASE; MIGRATING MOTOR COMPLEX; ENTERIC NERVOUS-SYSTEM; SMOOTH-MUSCLE-CELLS; C-KIT	We demonstrate that SCF-KIT signaling induces synthesis and secretion of endothelin-3 (ET3) in human umbilical vein endothelial cells and melanoma cells in vitro, gastrointestinal stromal tumors, human sun-exposed skin, and myenteric plexus of human colon post-fasting in vivo. This is the first report of a physiological mechanism of ET3 induction. Integrating our finding with supporting data from literature leads us to discover a previously unreported pathway of nitric oxide (NO) generation derived from physiological endothelial NO synthase (eNOS) or neuronal NOS (nNOS) activation (referred to as the KIT-ET3-NO pathway). It involves: (1) SCF-expressing cells communicate with neighboring KIT-expressing cells directly or indirectly (cleaved soluble SCF). (2) SCF-KIT signaling induces timely local ET3 synthesis and secretion. (3) ET3 binds to ETBR on both sides of intercellular space. (4) ET3-binding-initiated-ETBR activation increases cytosolic Ca2+, activates cell-specific eNOS or nNOS. (5) Temporally-and spatially-precise NO generation. NO diffuses into neighboring cells, thus acts in both SCF-and KIT-expressing cells. (6) NO modulates diverse cell-specific functions by NO/cGMP pathway, controlling transcriptional factors, or other mechanisms. We demonstrate the critical physiological role of the KIT-ET3-NO pathway in fulfilling high demand (exceeding basal level) of endothelium-dependent NO generation for coping with atherosclerosis, pregnancy, and aging. The KIT-ET3-NO pathway most likely also play critical roles in other cell functions that involve dual requirement of SCF-KIT signaling and NO. New strategies (e.g. enhancing the KIT-ET3-NO pathway) to harness the benefit of endogenous eNOS and nNOS activation and precise NO generation for correcting pathophysiology and restoring functions warrant investigation.	[Chen, Lei L.; Benjamin, Robert S.] Univ Texas MD Anderson Canc Ctr, Dept Sarcoma, Houston, TX 77030 USA; [Zhu, Jing; Wei, Chongjuan; Frazier, Marsha L.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Schumacher, Jonathan; Tripp, Sheryl R.; Rodgers, George M.] ARUP Labs, Salt Lake City, UT USA; [Ramdas, Latha] Univ Texas MD Anderson Canc Ctr, Res Informat Serv & Technol, Houston, TX 77030 USA; [Prieto, Victor G.] Univ Texas MD Anderson Canc Ctr, Pathol, Houston, TX 77030 USA; [Jimenez, Arnie; Velasco, Marco A.] Vel Lab Res, Missouri City, TX USA; [Andtbacka, Robert H. I.] Univ Utah, Dept Surg, Salt Lake City, UT USA; [Gouw, Launce; Rodgers, George M.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Zhang, Liansheng] Lanzhou Univ, Dept Hematol & Oncol, Hosp 2, Lanzhou, Gansu, Peoples R China; [Chan, Benjamin K.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Cassidy, Pamela B.; Leachman, Sancy A.] Univ Utah, Dept Dermatol, Salt Lake City, UT USA; [Frazier, Marsha L.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Cassidy, Pamela B.; Leachman, Sancy A.] Oregon Hlth & Sci Univ, Dept Dermatol, Portland, OR 97201 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Utah System of Higher Education; University of Utah; ARUP Laboratories; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Lanzhou University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Texas System; UTMD Anderson Cancer Center; Oregon Health & Science University	Chen, LL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Sarcoma, Houston, TX 77030 USA.	leileichen7@gmail.com	De Velasco, Marco/R-1022-2019; Stefanadis, Christodoulos/ABH-2232-2020	De Velasco, Marco/0000-0002-4011-6572; Stefanadis, Christodoulos/0000-0001-5974-6454				Agaram NP, 2008, CLIN CANCER RES, V14, P3204, DOI 10.1158/1078-0432.CCR-07-1984; Aichberger KJ, 2011, AM J HEMATOL, V86, P533, DOI 10.1002/ajh.22037; Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; Al-Shboul OA, 2013, SAUDI J GASTROENTERO, V19, P3, DOI 10.4103/1319-3767.105909; Amyere M, 2011, J INVEST DERMATOL, V131, P1234, DOI 10.1038/jid.2011.29; Anita I, 2006, CELL MOL NEUROBIOL, V26, P703, DOI 10.1007/s10571-006-9111-3; Anversa P, 2013, J CLIN INVEST, V123, P62, DOI 10.1172/JCI63068; Ari G, 1996, EUR J PHARMACOL, V307, P69, DOI 10.1016/0014-2999(96)00172-0; AYE MT, 1992, EXP HEMATOL, V20, P523; Bacon CR, 1996, BRIT J PHARMACOL, V117, P986, DOI 10.1111/j.1476-5381.1996.tb15292.x; Bagnall AJ, 2006, HYPERTENSION, V48, P286, DOI 10.1161/01.HYP.0000229907.58470.4c; Balez R, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3806157; Bantubungi K, 2008, MOL CELL NEUROSCI, V37, P454, DOI 10.1016/j.mcn.2007.11.001; Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Bayguinov PO, 2010, J PHYSIOL-LONDON, V588, P399, DOI 10.1113/jphysiol.2009.181172; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; BLUMEJENSEN P, 1991, EMBO J, V10, P4121, DOI 10.1002/j.1460-2075.1991.tb04989.x; Bouallegue A, 2007, AM J PHYSIOL-HEART C, V293, pH2072, DOI 10.1152/ajpheart.01097.2006; BOULANGER C, 1990, J CLIN INVEST, V85, P587, DOI 10.1172/JCI114477; Brand M, 1998, J CLIN INVEST, V101, P549, DOI 10.1172/JCI524; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; BROUDY VC, 1994, BLOOD, V83, P2145; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Casey DP, 2011, J PHYSIOL-LONDON, V589, P1477, DOI 10.1113/jphysiol.2010.203539; Chang HR, 2003, ARCH DERMATOL RES, V295, P293, DOI 10.1007/s00403-003-0433-4; Chen LL, 2008, MODERN PATHOL, V21, P826, DOI 10.1038/modpathol.2008.46; Chen LL, 2004, CANCER RES, V64, P5913, DOI 10.1158/0008-5472.CAN-04-0085; Choi W, 2010, J CELL SCI, V123, P3102, DOI 10.1242/jcs.064774; Contestabile A, 2004, NEUROCHEM INT, V45, P903, DOI 10.1016/j.neuint.2004.03.021; Coon EA, 2013, AM J HEMATOL, V88, P534, DOI 10.1002/ajh.23442; Davenport AP, 2016, PHARMACOL REV, V68, P357, DOI 10.1124/pr.115.011833; Deliu E, 2012, J BIOL CHEM, V287, P41023, DOI 10.1074/jbc.M112.418533; Dentelli P, 2007, BLOOD, V109, P4264, DOI 10.1182/blood-2006-06-029603; Desjardins F, 2006, ACTA CLIN BELG, V61, P326, DOI 10.1179/acb.2006.052; Di Nunzio AS, 2002, AM J PHYSIOL-REG I, V283, pR615, DOI 10.1152/ajpregu.00026.2002; Dickson EJ, 2010, AM J PHYSIOL-GASTR L, V298, pG222, DOI 10.1152/ajpgi.00399.2009; Herrera MD, 2010, AGEING RES REV, V9, P142, DOI 10.1016/j.arr.2009.07.002; Ellison GM, 2013, CELL, V154, P827, DOI 10.1016/j.cell.2013.07.039; Emole J, 2016, BIOL-TARGETS THER, V10, P23, DOI 10.2147/BTT.S67844; EMORI T, 1991, BIOCHEM BIOPH RES CO, V174, P228, DOI 10.1016/0006-291X(91)90510-E; Feng ZC, 2012, DIABETOLOGIA, V55, P2214, DOI 10.1007/s00125-012-2566-5; FUKUDA N, 1990, BIOCHEM BIOPH RES CO, V167, P739, DOI 10.1016/0006-291X(90)92087-G; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Garcia RJ, 2008, J INVEST DERMATOL, V128, P131, DOI 10.1038/sj.jid.5700948; Gil V, 2010, AM J PHYSIOL-GASTR L, V299, pG158, DOI 10.1152/ajpgi.00448.2009; Giri U, 2006, INT J RADIAT ONCOL, V64, P670, DOI 10.1016/j.ijrobp.2005.08.032; Grichnik JM, 1996, J INVEST DERMATOL, V106, P967, DOI 10.1111/1523-1747.ep12338471; Gugliotta G, 2015, HAEMATOLOGICA, V100, P1146, DOI 10.3324/haematol.2015.129221; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hasegawa J, 2008, PIGM CELL MELANOMA R, V21, P687, DOI 10.1111/j.1755-148X.2008.00492.x; Hebeiss K, 1998, NEUROSCIENCE, V82, P623; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Herrmann J, 2016, CIRCULATION, V133, P1272, DOI 10.1161/CIRCULATIONAHA.115.018347; Herrmann J, 2014, TRENDS CARDIOVAS MED, V24, P285, DOI 10.1016/j.tcm.2014.07.003; HIRATA Y, 1993, J CLIN INVEST, V91, P1367, DOI 10.1172/JCI116338; Holden JA, 2007, AM J CLIN PATHOL, V128, P230, DOI 10.1309/7TEH56K6WWXENNQY; HORI S, 1992, ENDOCRINOLOGY, V130, P1885, DOI 10.1210/en.130.4.1885; Hu CH, 2010, CLIN EXP PHARMACOL P, V37, P551, DOI 10.1111/j.1440-1681.2010.05347.x; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Ii M, 2005, CIRCULATION, V111, P1114, DOI 10.1161/01.CIR.0000157144.24888.7E; Iino S, 2008, NEUROSCIENCE, V152, P437, DOI 10.1016/j.neuroscience.2007.12.044; Ikuta T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144561; INOUE A, 1989, P NATL ACAD SCI USA, V86, P2863, DOI 10.1073/pnas.86.8.2863; Ishii S, 2009, J GASTROENTEROL, V44, P834, DOI 10.1007/s00535-009-0077-z; Ito M, 1999, J INVEST DERMATOL, V112, P796, DOI 10.1046/j.1523-1747.1999.00552.x; Jaureguiberry MS, 2004, PEPTIDES, V25, P1133, DOI 10.1016/j.peptides.2004.04.005; Jezierski A, 2012, J NEUROSCI RES, V90, P2362, DOI 10.1002/jnr.23118; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kapakos G, 2010, CURR CARDIOL REV, V6, P247, DOI 10.2174/157340310793566055; Kawaguchi Y, 2001, J INVEST DERMATOL, V116, P920, DOI 10.1046/j.0022-202x.2001.01370.x; Kim BJ, 2012, CELL PHYSIOL BIOCHEM, V30, P359, DOI 10.1159/000339070; Kim TD, 2013, LEUKEMIA, V27, P1316, DOI 10.1038/leu.2013.70; Kohgami S, 2010, NEUROL RES, V32, P938, DOI 10.1179/016164110X12681290831243; Krishnamurthy M, 2007, ENDOCRINOLOGY, V148, P5520, DOI 10.1210/en.2007-0387; Kristensen Tilde, 2012, Leuk Res Rep, V1, P1, DOI 10.1016/j.lrr.2012.09.002; Kuhlencordt PJ, 2001, CIRCULATION, V104, P448, DOI 10.1161/hc2901.091399; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Kurohane K.Y., 2013, J PHARM SCI, V123, P295; Lameu C, 2012, J BIOL CHEM, V287, P29690, DOI 10.1074/jbc.M111.338095; Larson RA, 2012, LEUKEMIA, V26, P2197, DOI 10.1038/leu.2012.134; Lattmann T, 2005, BIOCHEM BIOPH RES CO, V327, P234, DOI 10.1016/j.bbrc.2004.11.160; Le Coutre P, 2011, J NATL CANCER I, V103, P1347, DOI 10.1093/jnci/djr292; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Lees-Green R, 2014, AM J PHYSIOL-GASTR L, V306, pG711, DOI 10.1152/ajpgi.00449.2013; Levato L, 2013, EUR J HAEMATOL, V90, P531, DOI 10.1111/ejh.12096; Li JM, 2006, INT J BIOCHEM CELL B, V38, P961, DOI 10.1016/j.biocel.2005.08.014; Liang J, 2013, INT J BIOL SCI, V9, P435, DOI 10.7150/ijbs.6087; LIN HY, 1991, P NATL ACAD SCI USA, V88, P3185, DOI 10.1073/pnas.88.8.3185; Contreras DL, 2006, PHARMACOL THERAPEUT, V112, P553, DOI 10.1016/j.pharmthera.2006.05.003; MAEDA H, 1992, DEVELOPMENT, V116, P369; Magness RR, 2001, AM J PHYSIOL-HEART C, V280, pH1692, DOI 10.1152/ajpheart.2001.280.4.H1692; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Manley PW, 2002, EUR J CANCER, V38, pS19, DOI 10.1016/S0959-8049(02)80599-8; Mathison Y, 1998, BRAIN RES BULL, V45, P15, DOI 10.1016/S0361-9230(97)00274-8; Mathison Y, 2002, CELL MOL NEUROBIOL, V22, P783, DOI 10.1023/A:1021817326632; Mazzuca MQ, 2014, HYPERTENSION, V64, P632, DOI 10.1161/HYPERTENSIONAHA.114.03315; Mazzuca MQ, 2013, BRIT J PHARMACOL, V169, P1335, DOI 10.1111/bph.12225; Mazzuca MQ, 2012, BIOCHEM PHARMACOL, V84, P147, DOI 10.1016/j.bcp.2012.03.020; McIlhenny S, 2015, J TISSUE ENG REGEN M, V9, P1277, DOI 10.1002/term.1645; McLean SR, 2005, MOL CANCER THER, V4, P2008, DOI 10.1158/1535-7163.MCT-05-0070; Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466; Mirault T, 2015, EUR J HAEMATOL, V94, P363, DOI 10.1111/ejh.12367; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Moncada S, 2006, BRIT J PHARMACOL, V147, pS193, DOI 10.1038/sj.bjp.0706458; Morgazo C, 2005, BIOCHEM BIOPH RES CO, V334, P796, DOI 10.1016/j.bbrc.2005.06.168; Mori F, 2000, INVEST OPHTH VIS SCI, V41, P3955; Mujoo K, 2008, P NATL ACAD SCI USA, V105, P18924, DOI 10.1073/pnas.0810230105; Munugalavadla V, 2005, CRIT REV ONCOL HEMAT, V54, P63, DOI 10.1016/j.critrevonc.2004.11.005; NAMIKI A, 1992, LIFE SCI, V50, P677, DOI 10.1016/0024-3205(92)90470-A; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; OGAWA Y, 1991, BIOCHEM BIOPH RES CO, V178, P248, DOI 10.1016/0006-291X(91)91806-N; OKURA M, 1995, J INVEST DERMATOL, V105, P322, DOI 10.1111/1523-1747.ep12319939; OWADA A, 1994, J CLIN INVEST, V93, P556, DOI 10.1172/JCI117007; Perfume G, 2008, AM J PHYSIOL-REG I, V294, pR905, DOI 10.1152/ajpregu.00555.2007; Perfume G, 2007, REGUL PEPTIDES, V142, P69, DOI 10.1016/j.regpep.2007.01.011; Picardo M, 2011, J INVEST DERMATOL, V131, P1182, DOI 10.1038/jid.2011.67; Quaschning T, 2005, J HYPERTENS, V23, P979, DOI 10.1097/01.hjh.0000166838.55688.7e; Quintas-Cardama A, 2012, CL LYMPH MYELOM LEUK, V12, P337, DOI 10.1016/j.clml.2012.04.005; Rajendran P, 2013, INT J BIOL SCI, V9, P1057, DOI 10.7150/ijbs.7502; Ro S, 2006, AM J PHYSIOL-GASTR L, V290, pG710, DOI 10.1152/ajpgi.00420.2005; RomeroGraillet C, 1997, J CLIN INVEST, V99, P635, DOI 10.1172/JCI119206; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Schuh A, 2008, BASIC RES CARDIOL, V103, P69, DOI 10.1007/s00395-007-0685-9; Seals DR, 2011, CLIN SCI, V120, P357, DOI 10.1042/CS20100476; Sobrevia L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/9782346; Sommer G, 2003, P NATL ACAD SCI USA, V100, P6706, DOI 10.1073/pnas.1037763100; Tasigna [Nilotinib] highlights of prescribing information initial US approval: 2007, 2015, TASIGNA NILOTINIB HI; Tefferi A, 2013, LEUKEMIA, V27, P1939, DOI 10.1038/leu.2013.112; Tefferi A, 2011, AM J HEMATOL, V86, P610, DOI 10.1002/ajh.22051; Tirapelli CR, 2005, BRIT J PHARMACOL, V146, P903, DOI 10.1038/sj.bjp.0706388; Tong WD, 2010, SCAND J GASTROENTERO, V45, P844, DOI 10.3109/00365521003782371; Torihashi S, 1996, BRAIN RES, V738, P323, DOI 10.1016/S0006-8993(96)00935-3; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Valent P, 2015, BLOOD, V125, P901, DOI 10.1182/blood-2014-09-594432; Verma S, 2003, CIRCULATION, V108, P2054, DOI 10.1161/01.CIR.0000089191.72957.ED; Walsh T, 2009, J AM GERIATR SOC, V57, P140, DOI 10.1111/j.1532-5415.2008.02051.x; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; Weller R, 2003, CLIN EXP DERMATOL, V28, P511, DOI 10.1046/j.1365-2230.2003.01365.x; Weller R, 2003, AM J PHYSIOL-CELL PH, V284, pC1140, DOI 10.1152/ajpcell.00462.2002; WILLIAMS DE, 1992, DEV BIOL, V151, P368, DOI 10.1016/0012-1606(92)90176-H; WOOD JD, 1973, AM J DIG DIS, V18, P477, DOI 10.1007/BF01076598; Yamada K, 1999, J PHARMACOL EXP THER, V290, P1175; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yetik-Anacak G, 2006, VASC PHARMACOL, V45, P268, DOI 10.1016/j.vph.2006.08.002; YOHN JJ, 1994, BBA-MOL CELL RES, V1224, P454, DOI 10.1016/0167-4889(94)90282-8; Yoshida H, 1996, DEV DYNAM, V207, P222; Zhong WM, 2008, DEV CELL, V15, P635, DOI 10.1016/j.devcel.2008.10.012	149	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2017	12	9							e0184154	10.1371/journal.pone.0184154	http://dx.doi.org/10.1371/journal.pone.0184154			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG0PY	28880927	Green Published, Green Submitted, gold			2022-12-27	WOS:000409467200037
